,CUI1,CUI2
0,Carcinomatous Component Present,ENSAT Stage II Adrenal Cortex Carcinoma
1,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,"Leukemia, Myeloid, Chronic-Phase"
2,Metaplasia,Urethral Nephrogenic Adenoma
3,Epithelial Component Present,Invasive Apocrine Breast Carcinoma
4,Diffuse Pattern,Childhood Diffuse Astrocytoma
5,Blasts of Mixed Phenotype Present,Acute biphenotypic leukemia
6,Infiltrative Growth Pattern,Childhood Gliosarcoma
7,Burn injury,Old Burn Scar-Related Skin Squamous Cell Carcinoma
8,Myxoid Stroma Formation,Follicular Myxoma
9,Diffuse Pattern,T-cell/histiocyte rich large B-cell lymphoma
10,Hypertensive disease,Hypertensive crisis
11,Well-Circumscribed Lesion,Papillary mucinous cystadenoma
12,Cystic Change,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia
13,Melanin Pigment Present,Pigmented Basal Cell Carcinoma
14,Secondary Lesion,Secondary malignant neoplasm of lymph node
15,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Juvenile Myelomonocytic Leukemia
16,Cutaneous Involvement,"Keratoderma, Palmoplantar, Epidermolytic"
17,Severe dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7
18,Papillary Pattern,Lung Glandular Papilloma
19,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Tumor G1
20,Carcinomatous Component Present,Ampulla of Vater Neuroendocrine Carcinoma
21,Carcinomatous Component Present,Stage IVA Oropharyngeal Carcinoma AJCC v7
22,Epithelial Component Present,Stage IVA Oropharyngeal Carcinoma AJCC v7
23,Well-Circumscribed Lesion,Large Bowel Juvenile Polyp
24,Hereditary Lesion,Hereditary pyropoikilocytosis
25,Carcinomatous Component Present,"Carcinoma, Endometrioid"
26,Carcinomatous Component Present,adenosquamous carcinoma of pancreas
27,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Teratoma
28,Villous Pattern,Cervical Villoglandular Adenocarcinoma
29,Carcinomatous Component Present,large cell carcinoma of salivary gland
30,Cystic Change,Brenner Tumor
31,Squamous Metaplasia of Malignant Cells Present,Ductal Breast Carcinoma with Squamous Metaplasia
32,Papillary Pattern,Ureter Urothelial Papilloma
33,Epithelial Component Present,Bladder Urachal Squamous Cell Carcinoma
34,Carcinomatous Component Present,Stage III Esophageal Cancer AJCC v7
35,Ineffective hematopoiesis,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
36,Epithelial Component Present,Gastric Neuroendocrine Neoplasm
37,Cutaneous Involvement,"lymphomatoid papulosis, type C"
38,Papillary Pattern,Schneiderian papilloma
39,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Childhood Acute Myelomonocytic Leukemia
40,Fascicular Pattern,Adult Clear Cell Sarcoma of Soft Parts
41,Ineffective hematopoiesis,"Myelodysplastic syndrome, no ICD-O subtype"
42,Benign Cellular Infiltrate,Benign neoplasm of small intestine
43,Vascular Channel Formation,Adult Angiosarcoma
44,Systemic disease,Aggressive Systemic Mastocytosis
45,Epithelial Component Present,Respiratory papilloma
46,Carcinomatous Component Present,"Carcinoma, Neuroendocrine"
47,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with Minimal Differentiation
48,Carcinomatous Component Present,Colon Micropapillary Adenocarcinoma
49,Epithelial Component Present,Intestinal Neuroendocrine Tumor
50,Thick-Walled Vessels Present,Childhood Kidney Angiomyolipoma
51,Indolent Clinical Course,Benign neoplasm of spleen
52,Nuclear Atypia,Adult Gliosarcoma
53,Rapidly Enlarging Mass,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
54,Metastatic Lesion,Secondary malignant neoplasm of hypopharynx
55,Carcinomatous Component Present,Disseminated carcinoma
56,Local disease,Lipoma of spermatic cord
57,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic
58,Epithelial Component Present,Stage IIIA Lung Small Cell Carcinoma AJCC v7
59,Benign Cellular Infiltrate,Colon Ganglioneuroma
60,Carcinomatous Component Present,Esophageal carcinoma recurrent
61,Cutaneous Involvement,Adenoid cystic eccrine carcinoma
62,Carcinomatous Component Present,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
63,Nuclear Grooves,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
64,Epithelial Component Present,Orbit Paraganglioma
65,Solitary Skin Tumor,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology"
66,Neuroendocrine Differentiation,Jejunal Somatostatin-Producing Neuroendocrine Tumor
67,Carcinomatous Component Present,Recurrent Skin Carcinoma
68,Adulthood Lesion,Adult Immunoblastic Lymphoma
69,Epithelial Component Present,Laryngeal Paraganglioma
70,Carcinomatous Component Present,Parotid Gland Carcinosarcoma
71,Adulthood Lesion,Adult Pleomorphic Rhabdomyosarcoma
72,Localized Lesion,Solitary Osteochondroma
73,Epithelial Component Present,Thyroid stimulating hormone-producing pituitary tumor
74,Epithelial Component Present,Skin Signet Ring Cell Basal Cell Carcinoma
75,Inflammation,Inflammatory Hepatocellular Adenoma
76,Benign Cellular Infiltrate,Colorectal Leiomyoma
77,Follicular Cell Differentiation,Nonencapsulated sclerosing tumor
78,Borderline Lesion,Glomus Tumor of Uncertain Malignant Potential
79,Chromogranin A Positive Neoplastic Cells Present,Hindgut Carcinoid Tumor
80,Acanthosis,Vulvar Warty Carcinoma
81,Multinodular Lesion,Uterine Corpus Dissecting Leiomyoma
82,Vascular Channel Formation,Colon Kaposi Sarcoma
83,Rapidly Enlarging Mass,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type"
84,Invasive Lesion,Breast Carcinoma with Osseous Metaplasia
85,Angiocentric Pattern,Recurrent Grade I Lymphomatoid Granulomatosis
86,Epithelial Component Present,Carcinoid tumor of the duodenum
87,Carcinomatous Component Present,Early Hepatocellular Carcinoma
88,Adnexal Differentiation,Basal cell carcinoma - follicular
89,Cutaneous Involvement,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
90,Local disease,Localized Gallbladder Carcinoma
91,Infiltrative Growth Pattern,Infiltrating basal cell carcinoma
92,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
93,Dysplasia,Esophageal High Grade Intraepithelial Neoplasia
94,Severe dysplasia,Gastrointestinal carcinoma in situ
95,Recurrent disease,Recurrent Pancreatic Neuroendocrine Carcinoma
96,Diffuse Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
97,Macrocystic Change,"Lymphangioma, Cystic"
98,Epithelial Component Present,Stage IIA Prostate Cancer AJCC v7
99,Carcinomatous Component Present,neuroendocrine carcinoma of anal canal
100,Severe cytologic atypia,neuroendocrine carcinoma of anal canal
101,Hemorrhagic,Post-Radiotherapy Breast Angiosarcoma
102,Biphasic Pattern,Adenomyoma
103,Epithelial Component Present,Densely Granulated Lactotroph Adenoma
104,Osteoid formation,Extraskeletal osteosarcoma non-metastatic
105,Well Differentiated Hyaline Cartilage Present,Mesenchymal Chondrosarcoma
106,Mucoid Stroma Formation,Mucinous cystadenocarcinoma appendix
107,Intraluminal Tumor Growth,Intimal sarcoma
108,Hereditary Lesion,Hereditary Kidney Oncocytoma
109,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage II
110,High Grade Lesion,Alveolar soft part sarcoma non-metastatic
111,Tissue Differentiation Uncertain,"Synovial sarcoma, spindle cell"
112,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Lepidic Predominant Adenocarcinoma
113,Syncytial Pattern,Lung Lymphoepithelioma-Like Carcinoma
114,Macrofollicular Structures Present,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor
115,Extraosseous Lesion,Extra-osseous Ewing's sarcoma non-metastatic
116,Epithelial Component Present,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
117,Angiodestructive Pattern,Adult Grade III Lymphomatoid Granulomatosis
118,Carcinomatous Component Present,Ovarian Cancer by FIGO Stage
119,Indolent Clinical Course,Senile hemangioma of lip
120,Epithelial Component Present,FIGO Stage IC2 Ovarian Cancer
121,Neuroendocrine Differentiation,Thyroid Gland Paraganglioma
122,Hyperplastic Tissue Present,"Reticuloendotheliosis, X-linked"
123,Indolent Clinical Course,"Hemangioma, Cavernous"
124,Glial Differentiation,Desmoplastic infantile astrocytoma
125,Childhood Lesion,Childhood B Acute Lymphoblastic Leukemia
126,atypia morphology,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
127,Recurrent disease,Recurrent Oral Cavity Carcinoma
128,Childhood Lesion,"Childhood Ganglioneuroblastoma, Nodular"
129,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Lung
130,Myxoid Stroma Formation,Myxoma
131,Epithelial Component Present,Pleomorphic carcinoma
132,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Indolent multiple myeloma
133,Adulthood Lesion,Adult Extraskeletal Myxoid Chondrosarcoma
134,Childhood Lesion,Childhood Brain Stem Mixed Glioma
135,Papillary Pattern,Intraductal papillary breast neoplasm
136,Epithelial Component Present,Papillary squamous cell carcinoma
137,Anaplasia,Anaplastic Brain Stem Astrocytoma
138,Cutaneous Involvement,Melanocytic tumor of skin
139,Cystic Change,Testicular Dermoid Cyst
140,Neutrophilia (finding),"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
141,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v6 and v7
142,Poorly Differentiated Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
143,Carcinomatous Component Present,Stage III Fallopian Tube Cancer AJCC v7
144,Anaplasia,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
145,Slow Growing Mass,Childhood Pilocytic Astrocytoma
146,Hemorrhagic,Prostate Angiosarcoma
147,Papillary Pattern,Vaginal Papillary Carcinoma
148,Epithelial Component Present,large cell neuroendocrine carcinoma of anal canal
149,Mixed Cellular Population,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
150,Carcinomatous Component Present,Childhood Esophageal Carcinoma
151,Indolent Clinical Course,Venous Angioleiomyoma
152,Cutaneous Involvement,Cutaneous Fibrous Histiocytoma
153,Diffuse Cellular Infiltrate,Sporadic Diffuse Gastric Adenocarcinoma
154,Metastatic Lesion,Secondary malignant neoplasm of parathyroid gland
155,Carcinomatous Component Present,Stage IVA Cervical Cancer AJCC v6 and v7
156,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuroma of skin
157,Indolent Clinical Course,Degeneration of uterine fibroid
158,Recurrent disease,Recurrent Childhood Hepatocellular Carcinoma
159,Metastatic/Recurrent Disease,Clear Cell Sarcoma of Soft Tissue
160,Fascicular Pattern,Clear Cell Sarcoma of Soft Tissue
161,Large Spaces Filled with Blood Present,Telangiectatic osteosarcoma
162,Pseudopapillary Pattern,Papillary Meningioma
163,Carcinomatous Component Present,Stage I Merkel Cell Carcinoma AJCC v7
164,Dysplasia,Vaginal intraepithelial neoplasia
165,Favorable Clinical Outcome,Colorectal Ganglioneuroma
166,High Grade Non Cartilaginous Sarcomatous Stroma Present,Dedifferentiated chondrosarcoma
167,Eosinophilic inflammation,Breast Inflammatory Myofibroblastic Tumor
168,Plasma cell inflammation,Breast Inflammatory Myofibroblastic Tumor
169,Epithelial Component Present,"Adenoma, Monomorphic"
170,Epithelial Component Present,Malignant tumor of choroid plexus
171,Pregnancy Complications,Stage IVB Gestational Trophoblastic Tumor AJCC v7
172,Non-Invasive Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential
173,Epithelial Component Present,Stage IIIA Vulvar Cancer AJCC v7
174,Monomorphic Cellular Infiltrate,Childhood Oligodendroglioma
175,Favorable Clinical Outcome,Ganglioneuroma
176,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
177,Diffuse Pattern,Adult Anaplastic Oligodendroglioma
178,Carcinomatous Component Present,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
179,Melanin Pigment Present,GIANT PIGMENTED HAIRY NEVUS
180,Slow Growing Mass,Adult Subependymal Giant Cell Astrocytoma
181,Firm mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
182,Epithelial Component Present,Stage IIB Cervical Cancer AJCC v6 and v7
183,Anaplasia,Secondary Supratentorial Anaplastic Astrocytoma
184,Well-Circumscribed Lesion,Hereditary Kidney Wilms Tumor
185,Invasive Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
186,Cutaneous Involvement,Malignant neoplasm of sweat gland
187,Epithelial Component Present,Serous Tubal Intraepithelial Carcinoma
188,Epithelial Component Present,Cervical Cancer by AJCC v7 Stage
189,Radiation Sickness,Radiation-induced myelopathy
190,Epithelial Component Present,Small intestine carcinoma stage I
191,Cutaneous Involvement,Hereditary Melanoma
192,Low Mitotic Activity,Low Grade Ovarian Serous Adenocarcinoma
193,Carcinomatous Component Present,Stage IVA Lip Cancer AJCC v6 and v7
194,Carcinomatous Component Present,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
195,Epithelial Component Present,Stage IIC Fallopian Tube Cancer AJCC v6 and v7
196,Infiltrative Growth Pattern,Fibrillary Astrocytoma
197,Indolent Clinical Course,Fallopian tube leiomyoma
198,Childhood Lesion,Recurrent Childhood Hodgkin Lymphoma
199,Acanthosis,Seborrheic keratosis
200,Cutaneous Involvement,Pilomatrix carcinoma of skin
201,Anaplasia,"Glioblastoma, IDH-Mutant"
202,Diffuse Pattern,Cerebral Glioblastoma
203,Adulthood Lesion,Refractory Adult Spinal Cord Neoplasm
204,Diffuse Pattern,Anaplastic Oligodendroglioma
205,High Grade Lesion,Brain Glioblastoma
206,Epithelial Component Present,Stage IV Renal Cell Cancer
207,Carcinomatous Component Present,Non-small cell lung cancer stage II
208,Fibrotic Stroma Formation,Peripheral Intrahepatic Cholangiocarcinoma
209,Carcinomatous Component Present,Stage III Pancreatic Cancer AJCC v6 and v7
210,Hyperkeratosis,Plantar Verrucous Skin Carcinoma
211,Carcinomatous Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
212,Metastatic Lesion,CNS metastases
213,Invasive Lesion,Mucoepidermoid Breast Carcinoma
214,Tissue Differentiation Uncertain,Malignant Uterine Corpus PEComa
215,Carcinomatous Component Present,Carcinomatosis
216,Invasive Lesion,Breast Carcinoma with Choriocarcinomatous Features
217,Infiltrative Growth Pattern,Adult Infiltrating Astrocytoma
218,Epithelial Component Present,Well Differentiated Pancreatic Endocrine Tumor
219,Stromal Invasion,FIGO Stage III Ovarian Cancer
220,Cutaneous Involvement,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
221,Collagenous Stroma Formation,Extra-abdominal fibromatosis
222,Borderline Lesion,Peritoneal cystic mesothelioma
223,Carcinomatous Component Present,Squamous cell carcinoma of nasopharynx
224,Indolent Clinical Course,Cavernous hemangioma of retina
225,Vascular Channel Formation,Cavernous hemangioma of retina
226,Cutaneous Involvement,Anal Papillary Hidradenoma
227,Solid Growth Pattern,Breast Columnar Cell Mucinous Carcinoma
228,Childhood Lesion,Recurrent Childhood Anaplastic Astrocytoma
229,Locally Aggressive Lesion,"Phosphaturic mesenchymal tumor, benign"
230,Fibrotic Stroma Formation,Ovarian Microcystic Stromal Tumor
231,Epithelial Component Present,Primary solid type intraosseous squamous cell carcinoma
232,Melanin Pigment Present,"Nevus, Blue"
233,Metastatic Lesion,Malignant fibrous histiocytoma metastatic
234,Dilated Thin-Walled Vascular Space Formation,Vaginal Angiomyofibroblastoma
235,Low Mitotic Activity,Carcinoid tumor of ileum
236,Carcinomatous Component Present,Ethmoid Sinus Adenoid Cystic Carcinoma
237,Indolent Clinical Course,Lymphangioma of skin
238,Carcinomatous Component Present,Stage IVA Vulvar Cancer AJCC v6
239,Nodular Pattern,Adult Nodular Sclerosis Classical Hodgkin Lymphoma
240,Cutaneous Involvement,Multifocal superficial basal cell carcinoma
241,Thyroglobulin Positive Neoplastic Cells Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
242,Epithelial Component Present,Childhood Thyroid Gland Medullary Carcinoma
243,Hypercellular bone marrow,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable"
244,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Neuroendocrine Tumor G1
245,Epithelial Component Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
246,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Adenofibroma
247,Epithelial Component Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
248,atypia morphology,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)
249,Epithelial Component Present,Stage II Colorectal Cancer
250,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
251,Childhood Lesion,Childhood Lung Non-Small Cell Carcinoma
252,Epithelial Component Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst
253,Nuclear Atypia,Anaplastic Hemispheric Astrocytoma
254,Adulthood Lesion,Benign Adult Brain Neoplasm
255,Tumor Vascular Invasion,Malignant Testicular Sex Cord-Stromal Tumor
256,Diffuse Pattern,Desmoplastic mesothelioma
257,Splenomegaly,Blast Phase
258,Well-Circumscribed Lesion,Vulvar Nodular Hidradenoma
259,Cutaneous Involvement,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
260,Carcinomatous Component Present,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
261,Tubular Structures Present,Benign mixed epithelial and stromal tumor of kidney
262,Epithelial Component Present,Prostate carcinoma
263,Nerve palsy,Facial Nerve Palsy Related to Birth
264,Carcinomatous Component Present,Nasal cavity carcinoma
265,Epithelial Component Present,Unresectable Extrahepatic Bile Duct Carcinoma
266,No Evidence of Metastatic Disease,Benign pheochromocytoma of adrenal gland
267,Macrofollicular Structures Present,Juvenile type ovarian granulosa cell tumor
268,Epithelial Component Present,Carcinoma of hard palate
269,Neuroendocrine Differentiation,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
270,Carcinomatous Component Present,Papillary Renal Cell Carcinoma
271,Lepidic Growth Pattern,Bronchioloalveolar Adenocarcinoma
272,Carcinomatous Component Present,Gastroesophageal Junction Neuroendocrine Carcinoma
273,Epithelial Component Present,Vaginal Cancer by AJCC v6 Stage
274,Epithelial Component Present,Laryngeal verrucous carcinoma recurrent
275,Locally Aggressive Lesion,"Fibromatosis, Plantar"
276,Epithelial Component Present,Superficial Epithelioma with Sebaceous Differentiation
277,More than 10 Mitoses per 10HPF,Stage IA Lung Small Cell Carcinoma AJCC v7
278,Carcinomatous Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7
279,Exophytic Polypoid Lesion,Hamartomatous polyposis
280,Disease regression,Regressing Non-Cutaneous Melanoma
281,Intestinal metaplasia of gastric mucosa,villous adenoma of stomach
282,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Squamous Metaplasia
283,Mixture of Embryonal and Alveolar Features Present,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
284,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
285,Carcinomatous Component Present,Carcinoma in situ in a polyp
286,Favorable Clinical Outcome,Maturing Ganglioneuroma
287,Cutaneous Involvement,Tinea Favosa
288,Schwannian Stroma Predominant Component of the Tumor Volume,Mature Ganglioneuroma
289,Cutaneous Involvement,Deep seated dermatophytosis
290,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
291,Multifocal Lesion,Multifocal breast carcinoma
292,Primary Lesion,Diffuse Intrinsic Pontine Glioma
293,Polymorphic Cellular Infiltrate,Cutaneous Angioimmunoblastic T-Cell Lymphoma
294,Mesenchymal Metaplasia,Adenocarcinoma with cartilaginous metaplasia
295,Epithelial Component Present,Papillary transitional cell carcinoma
296,Nuclear Clearing,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
297,Multifocal Unisystem Disease,"Histiocytosis, Langerhans-Cell"
298,Nested Pattern,Paraganglioma-Like Dermal Melanocytic Tumor
299,Adulthood Lesion,Stage I Indolent Adult Non-Hodgkin Lymphoma
300,Keratin pearl formation,"Lung Squamous Cell Carcinoma, Small Cell Variant"
301,Epithelial Component Present,Mixed Squamous Cell Carcinoma of the Penis
302,Papillary Pattern,Inverting papilloma of the paranasal sinus
303,Epithelial Component Present,Vaginal Adenoid Basal Carcinoma
304,Epithelial Component Present,"Adenocarcinoma, intestinal type"
305,Rarely Metastasizing Lesion,Retiform hemangioendothelioma
306,Diffuse Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
307,In Situ Lesion,Intraductal Cribriform Breast Adenocarcinoma
308,Epithelial Component Present,Adrenal Cortex Carcinoma by ENSAT Stage
309,Edematous Stroma Formation,Vulvar Superficial Angiomyxoma
310,Epithelial Component Present,AIDS-Related Carcinoma
311,Cutaneous Involvement,Benign melanocytic nevus
312,Carcinomatous Component Present,Stage III Lip Basal Cell Carcinoma
313,Tubular Pattern,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
314,Perineural spread,adenoid cystic carcinoma of lung
315,Desmoplastic Stroma Formation,Desmoplastic trichoepithelioma
316,Indolent Clinical Course,Vulvar Cellular Angiofibroma
317,Well-Circumscribed Lesion,Gallbladder Hyperplastic Polyp
318,Dysplasia,Gallbladder Papillary Biliary Intraepithelial Neoplasia
319,Nuclear Atypia,Childhood Gliosarcoma
320,Childhood Lesion,Childhood Gliosarcoma
321,Neuroendocrine Differentiation,Malignant Intrathoracic Paravertebral Paraganglioma
322,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Cellular Leiomyoma
323,Carcinomatous Component Present,Alcohol-Related Esophageal Squamous Cell Carcinoma
324,Cartilaginous Differentiation,Adult Mesenchymal Chondrosarcoma
325,atypia morphology,"Serous cystadenoma, borderline malignancy"
326,Epithelial Component Present,Lung Mixed Squamous Cell and Glandular Papilloma
327,Osteoid formation,Childhood Extraskeletal Osteosarcoma
328,Intestinal metaplasia,Ampulla of Vater Intestinal-Type Adenocarcinoma
329,Trabecular Pattern,Somatostatinoma
330,Malignant Germinomatous Cellular Infiltrate,Dysgerminoma of ovary
331,Comedo Necrosis,Comedocarcinoma
332,Cystic Change,Cystic Oncocytic Neoplasm
333,Metastatic Lesion,Adenocarcinoma of the prostate metastatic
334,Indolent Clinical Course,Chronic Lymphoproliferative Disorder of NK-Cells
335,Epithelial Component Present,Nasopharyngeal carcinoma
336,Epithelial Component Present,Recurrent Rectal Cancer
337,Metaplasia of Malignant Cells Present,Ductal Breast Carcinoma with Squamous Metaplasia
338,Carcinomatous Component Present,Stage IVC Lip Cancer AJCC v6 and v7
339,Exophytic Polypoid Lesion,Adenoma of rectum
340,Organoid Pattern,Vulvar Alveolar Soft Part Sarcoma
341,Single Type of Tissue Derived from One Embryonic Layer Present,Struma Ovarii
342,Solar Radiation Toxicity,Solar Radiation-Related Cutaneous Melanoma
343,Carcinomatous Component Present,Gastric Large Cell Neuroendocrine Carcinoma
344,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Collapsing Variant
345,Diffuse Pattern,Childhood Anaplastic Oligoastrocytoma
346,Thick-Walled Hyalinized Vessels Present,Ureter Schwannoma
347,In Situ Lesion,"Glandular intraepithelial neoplasia, grade III"
348,Carcinomatous Component Present,Breast Carcinoma by Gene Expression Profile
349,Hereditary Lesion,Cutaneous Malignant Melanoma 2
350,Epithelial Component Present,Luminal A Breast Carcinoma
351,Preserved Nuclear Polarity,Inverted papilloma of urinary bladder
352,Benign Cellular Infiltrate,Gastric Lipoma
353,Well-Circumscribed Lesion,Breast Apocrine Adenoma
354,Benign Cellular Infiltrate,Benign neoplasm of anus
355,Diarrhea,Pancreatic Vipoma
356,Mitotic Activity,Adult Gliosarcoma
357,Locally Aggressive Lesion,Giant Cell Tumor of Bone
358,Well-Circumscribed Lesion,Ampulla of Vater Tubulovillous Adenoma
359,Epithelial Component Present,Digestive System Neuroendocrine Carcinoma
360,Childhood Lesion,Childhood Renal Cell Carcinoma
361,Epithelial Component Present,Stage IV Bladder Cancer AJCC v6
362,Osteoid formation,Osteoma
363,Cystic Change,"Cystadenocarcinoma, Serous"
364,Epithelial Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
365,Cutaneous Involvement,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology"
366,Neuroendocrine Differentiation,Stage IV Lung Small Cell Carcinoma AJCC v7
367,Epithelial Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7
368,Pseudorosette Formation,Duodenal Gastrin-Producing Neuroendocrine Tumor
369,Cysts Containing Proteinaceous Fluid Present,Serous cystadenoma of ovary
370,Neuroendocrine Differentiation,Occult Lung Small Cell Carcinoma
371,Epidermal Involvement,Classical Poroma
372,Low Mitotic Activity,Small Intestinal Carcinoid Tumor
373,Capillary Sized Vascular Channel Formation,Retinal hemangioblastoma
374,Cystic Change,cystadenoma of salivary gland
375,Anaplasia,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
376,Indolent Clinical Course,Capillary hemangioma of eyelid
377,Dedifferentiated Malignant Infiltrate,Endometrial Dedifferentiated Carcinoma
378,Carcinomatous Component Present,Bladder squamous cell carcinoma stage III
379,Mucoid Stroma Formation,Adult Myxopapillary Ependymoma
380,High Grade Lesion,Dedifferentiated chordoma
381,Primary Lesion,Stage III Osteosarcoma AJCC v7
382,Papillary Pattern,Vulvar Warty Carcinoma
383,Mammary Gland Type Features Present,Vulvar Adenocarcinoma of Mammary Gland Type
384,Carcinomatous Component Present,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
385,Epithelial Component Present,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm
386,Cutaneous Involvement,Cystic basal cell carcinoma
387,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
388,Alternative Fascicle (Bundle) Pattern,Benign Metastasizing Leiomyoma of the Uterine Corpus
389,Recurrent disease,Recurrent Grade I Lymphomatoid Granulomatosis
390,Hereditary Lesion,Hereditary Renal Cell Carcinoma
391,Recurrent disease,Cervix carcinoma recurrent
392,Carcinomatous Component Present,Intraductal carcinoma and lobular carcinoma in situ
393,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Melanoma
394,Exophytic Polypoid Lesion,Colorectal Peutz-Jeghers Polyp
395,Refractory Disease,Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma
396,Epithelial Component Present,Frontal Sinus Schneiderian Papilloma
397,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
398,Extraosseous Lesion,Extraosseous/Peripheral Ameloblastoma
399,Epithelial Component Present,Non-small cell carcinoma
400,Tubular Pattern,Tubular adenoma of colon
401,Biphasic Pattern,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm
402,atypia morphology,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral"
403,Infiltrative Growth Pattern,Adult Anaplastic Astrocytoma
404,Anaplasia,Adult Anaplastic Astrocytoma
405,Diffuse Pattern,Thyroid Immunoblastic Lymphoma
406,Absence of Stromal Invasion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
407,Nodular Pattern,Ann Arbor Stage II Grade 3 Follicular Lymphoma
408,Dysplasia,High Grade Esophageal Glandular Intraepithelial Neoplasia
409,Cutaneous Involvement,Follicular mycosis fungoides
410,Cutaneous Involvement,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E"
411,Delicate Vascular Network Formation,Grade 1 Clear Cell Renal Cell Carcinoma
412,Osseous Differentiation,Central Nervous System Extraskeletal Osteosarcoma
413,Mild dysplasia,Low Grade Penile Intraepithelial Neoplasia
414,Dysplasia,Carcinoma in situ of vagina
415,Skin Ulcer,Nodulo-ulcerative basal cell carcinoma
416,Solid Growth Pattern,Solid Lung Adenocarcinoma
417,Carcinomatous Component Present,Differentiated Thyroid Gland Carcinoma
418,Preserved Nuclear Polarity,Urethral Inverted Papilloma
419,Diffuse Pattern,Childhood Malignant Peripheral Nerve Sheath Tumor
420,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Teratoma
421,Mixed Cellular Population,serous adenocarcinofibroma of ovary
422,Blastemal Pattern,Blastema Predominant Kidney Wilms Tumor
423,Carcinomatous Component Present,Noninfiltrating intraductal papillary adenocarcinoma
424,Epithelial Component Present,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
425,Cystic Change,Intracystic papillary adenoma
426,Epithelial Component Present,Small cell carcinoma of ovary
427,Dysplasia,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
428,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
429,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
430,Microvascular Proliferation,Recurrent Childhood Pilocytic Astrocytoma
431,Low Cellularity Present,Recurrent Childhood Pilocytic Astrocytoma
432,Tissue of Mullerian Origin Present,Vaginal Carcinosarcoma
433,Well-Circumscribed Lesion,Ovarian Wilms Tumor
434,Mixed Cellular Population,Ovarian Wilms Tumor
435,Absence of Invasion,Carcinoma in situ of cecum
436,Organoid Pattern,Cervical Alveolar Soft Part Sarcoma
437,Epithelial Component Present,Stage 0 Vaginal Cancer AJCC v7
438,Moderate dysplasia,Grade II Glandular Intraepithelial Neoplasia
439,Neuroectodermal Differentiation,Familial Neuroblastoma
440,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
441,Cystic Lesion,Desmoplastic infantile astrocytoma
442,Metastatic Lesion,Lung Carcinoma Metastatic in the Bone
443,CD30-Positive Neoplastic Cells Present,"Anaplastic large cell lymphoma, ALK negative"
444,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Carcinoma
445,High Grade Lesion,Anaplastic astrocytoma
446,Secondary Lesion,Prostate Carcinoma Metastatic in the Bone
447,Carcinomatous Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma
448,Carcinomatous Component Present,Bladder Cancer by AJCC v6 Stage
449,Indolent Clinical Course,Endometrial stromal nodule
450,Secondary Lesion,Prostate Carcinoma Metastatic in the Lung
451,Indolent Clinical Course,Myxoma
452,Epithelial Component Present,Stage III Cervical Cancer AJCC v6 and v7
453,Mild cytologic atypia,Low Grade Endometrial Stromal Sarcoma
454,Papillary Pattern,serous surface papillary carcinoma of ovary
455,Swelling,Bizarre parosteal osteochondromatous proliferation
456,Epithelial Component Present,Scirrhous carcinoma of breast
457,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Aleukemic Monocytic Leukemia Cutis
458,Recurrent disease,Recurrent Salivary Gland Cancer
459,Indolent Clinical Course,Tufted angioma of skin
460,Myxoid Stroma Formation,Juxta-Articular Myxoma
461,Neuroendocrine Differentiation,"Carcinoid, Goblet Cell"
462,Carcinomatous Component Present,Verrucous carcinoma
463,Epithelial Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
464,Pseudoencapsulated Mass,Adult Malignant Peripheral Nerve Sheath Tumor
465,Epithelial Component Present,Encapsulated Thymoma
466,Glomeruloid Vessels Present,Childhood Pilocytic Astrocytoma
467,Apocrine metaplasia,Adenocarcinoma with apocrine metaplasia
468,Epithelial Component Present,Childhood Laryngeal Carcinoma
469,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Angiosarcoma
470,Recurrent disease,Recurrent Childhood Oligodendroglioma
471,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Liver
472,Fibrotic Stroma Formation,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
473,Carcinomatous Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
474,Chronic lymphocytic inflammation,Lymphoepithelioma-Like Hepatocellular Carcinoma
475,Carcinomatous Component Present,Stage IIIA Cervical Carcinoma
476,Epithelial Component Present,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
477,Carcinomatous Component Present,Squamous Cell Carcinoma of Unknown Primary
478,Adnexal Differentiation,Sweat Gland Tubular Carcinoma
479,Carcinomatous Component Present,Recurrent Childhood Hepatocellular Carcinoma
480,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma
481,Epithelial Component Present,Cervical Squamous Intraepithelial Neoplasia 1
482,High Mitotic Activity,Stage I Merkel Cell Carcinoma AJCC v7
483,Mild cytologic atypia,verrucous carcinoma of vagina
484,Metaplasia,Barrett Esophagus
485,Indolent Clinical Course,Gastric Hemangioma
486,Cutaneous Involvement,Glomus tumor of skin
487,atypia morphology,Vulvar Dysplastic Melanocytic Nevus
488,Epithelial Component Present,papillary carcinoma of renal pelvis
489,Blasts Expressing CD56 and Immature T-Cell Markers Present,NK-lymphoblastic leukemia/lymphoma
490,Smooth Muscle Component Present,Angiomyolipoma of kidney
491,Adnexal Differentiation,Benign Breast Eccrine Spiradenoma
492,Mixed Cellular Population,Ovarian Endometrioid Cystadenofibroma
493,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v6 Stage
494,Single Malignant Cells Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant"
495,Dysplasia,Vulval intraepithelial neoplasia
496,Hyperkeratosis,Cervical Warty Carcinoma
497,Papillary Pattern,Cervical Papillary Squamous Cell Carcinoma
498,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
499,Anaplasia,Classical Glioblastoma
500,Carcinomatous Component Present,Recurrent Hepatocellular Carcinoma
501,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Secondary Myelodysplastic Syndrome
502,Splenomegaly,Splenic marginal zone lymphoma recurrent
503,Mixed Cellular Population,Hereditary Kidney Wilms Tumor
504,Local disease,lipoma of mediastinum
505,Multinodular Mass,Colorectal Angiosarcoma
506,Recurrent disease,Malignant neoplasm of bladder recurrent
507,Carcinomatous Component Present,Stage IV Gallbladder Cancer AJCC v7
508,Low Mitotic Activity,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
509,Immunologic Deficiency Syndromes,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
510,Immunologic Deficiency Syndromes,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
511,Well-Circumscribed Lesion,Giant Cell Tumor of Soft Tissue
512,Microvascular Proliferation,Giant Cell Glioblastoma
513,Epithelial Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
514,Anastomosing Strands of Tumor Cells Present,Plexiform ameloblastoma
515,Focal dysplasia,Colorectal Sessile Serrated Adenoma/Polyp
516,Anaplasia,"Seminoma, anaplastic"
517,Carcinomatous Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
518,Indolent Clinical Course,Pyogenic granuloma
519,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
520,Carcinomatous Component Present,Stage II Fallopian Tube Cancer
521,Epithelial Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
522,Endophytic Tumor Growth,Subglottic Verrucous Carcinoma
523,Childhood Lesion,Childhood Diffuse Large B-Cell Lymphoma
524,Extraosseous Lesion,Extra-osseous Ewing's sarcoma
525,Carcinomatous Component Present,Stage 0 Gastric Cancer AJCC v6 and v7
526,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
527,Fibrotic Stroma Formation,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
528,HMB-45-Positive Neoplastic Cells Present,Benign Uterine Corpus PEComa
529,Epithelial Component Present,small cell carcinoma of gallbladder
530,Diffuse Pattern,Adult Brain Stem Mixed Glioma
531,Recurrent disease,Recurrent Childhood Malignant Germ Cell Tumor
532,Epithelial Component Present,Vulvar Papillary Hidradenoma
533,Carcinomatous Component Present,Pleomorphic Hepatocellular Carcinoma
534,Solar Radiation Toxicity,Solar Radiation-Related Malignant Neoplasm
535,Confluent Sheets of Anaplastic T-Lymphocytes Present,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
536,High Mitotic Activity,Endometrial Small Cell Carcinoma
537,Vascular Channel Formation,Congenital hemangioma
538,Benign Cellular Infiltrate,Benign neoplasm of peritoneum
539,Necrotic changes (finding),Vulvar Small Cell Carcinoma
540,Carcinomatous Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
541,Epithelial Component Present,Metastatic Kidney Carcinoma
542,Congenital Lesion,Congenital spondylolysis
543,Epithelial Component Present,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
544,Epithelial Component Present,Borderline cystadenoma
545,Metaplasia,Metaplastic carcinoma
546,Metastatic Lesion,"Squamous cell carcinoma, metastatic"
547,Epithelial Component Present,Infiltrating duct and lobular carcinoma
548,Carcinomatous Component Present,Primary solid type intraosseous squamous cell carcinoma
549,Epithelial Component Present,apocrine adenocarcinoma of vulva
550,Cystic Change,Erosive Adenomatosis of the Nipple
551,Encapsulated Mass,Clear cell papillary renal cell carcinoma
552,atypia morphology,Prostatic Atypical Adenomatous Hyperplasia
553,Cutaneous Involvement,"Nevus, Intradermal"
554,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v7
555,Anaplasia,Stage II Anaplastic Large Cell Lymphoma
556,Epithelial Component Present,Prostate Acinar Adenocarcinoma
557,Well-Circumscribed Lesion,Vulvar Angiomyofibroblastoma
558,Epithelial Component Present,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
559,Multinodular Mass,Angiosarcoma recurrent
560,Multinodular Mass,Aortic Angiosarcoma
561,Refractory Disease,Peripheral T-cell lymphoma unspecified refractory
562,Dysplasia,High-Grade Prostatic Intraepithelial Neoplasia
563,Blasts Under 20 Percent of Peripheral Blood White Cells,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable"
564,Biphasic Pattern,mesenchymal chondrosarcoma of bone
565,Carcinomatous Component Present,carcinoma ex pleomorphic adenoma of salivary gland
566,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I
567,Metastatic Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
568,Borderline Lesion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
569,Adulthood Lesion,Metastatic Malignant Neoplasm in the Adult Brain
570,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma In Situ
571,Low Grade Lesion,Juvenile Pilocytic Astrocytoma
572,Well-Circumscribed Lesion,Adult Type Testicular Granulosa Cell Tumor
573,Immunologic Deficiency Syndromes,Monomorphic Post-Transplant Lymphoproliferative Disorder
574,Carcinomatous Component Present,Throat cancer
575,Well-Circumscribed Lesion,Ovarian Cystadenoma
576,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
577,Intracanalicular Growth Pattern,Phyllodes Tumor
578,Therapy-Related Toxicity,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
579,Epithelial Component Present,Small Intestinal Low Grade Intraepithelial Neoplasia
580,Fibrotic Stroma Formation,Low Grade Salivary Gland Mucoepidermoid Carcinoma
581,Carcinomatous Component Present,Pancreatic Ductal Adenocarcinoma
582,Low Grade Lesion,Epithelioid hemangioendothelioma
583,Invasive Lesion,Submucosal Invasive Colon Adenocarcinoma
584,Epithelial Component Present,Grade 1 Endometrial Mucinous Adenocarcinoma
585,Epithelial Component Present,Thymic Squamous Cell Carcinoma
586,Local disease,Lipoma of pleura
587,Perivascular Arrangement of Tumor Cells,Hemangiopericytoma of meninges
588,Indolent Clinical Course,Benign lipomatous tumor
589,Mild cytologic atypia,Glottis Verrucous Carcinoma
590,Anaplasia,Stage III Childhood Anaplastic Large Cell Lymphoma
591,Epithelial Component Present,Recurrent Vulvar Carcinoma
592,Childhood Lesion,Childhood Cerebellar Neoplasm
593,Epithelial Component Present,Rectosigmoid Mucinous Adenocarcinoma
594,Chronic Inflammatory Infiltrate,Grade I Lymphomatoid Granulomatosis
595,Mixed Cellular Population,Borderline Ovarian Mucinous Adenofibroma
596,atypia morphology,Malignant Testicular Leydig Cell Tumor
597,Unifocal Disease at Presentation,Mast-Cell Sarcoma
598,Epithelial Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v7
599,Carcinomatous Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v7
600,High Grade Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
601,Local disease,Colon Lipoma
602,Lymphoplasmacytic Infiltrate,Angiolymphoid hyperplasia
603,Hypercellular bone marrow,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
604,Cutaneous Involvement,"Carcinoma, Basal Cell"
605,Nuclear Molding,large cell neuroendocrine carcinoma of lung
606,Epithelial Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
607,Primary Lesion,Stage IV Osteosarcoma AJCC v7
608,Diffuse Pattern,Centroblastic lymphoma recurrent
609,Invasive Lesion,Infiltrating duct and lobular carcinoma
610,Epithelial Component Present,Infiltrating duct and lobular carcinoma
611,Benign Cellular Infiltrate,Gastric Schwannoma
612,High Mitotic Activity,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
613,Epithelial Component Present,Squamous cell carcinoma of prostate
614,S-100-Positive Neoplastic Cells Present,Letterer-Siwe Disease
615,Carcinomatous Component Present,Bladder Enteric Type Adenocarcinoma
616,Neuroendocrine Differentiation,Stage I Digestive System Neuroendocrine Tumor AJCC v7
617,Epithelial Component Present,Laryngeal Lymphoepithelial Carcinoma
618,Carcinomatous Component Present,Pyriform Fossa Squamous Cell Carcinoma
619,'Starry-sky' pattern,Classical Burkitt Lymphoma
620,High Grade Lesion,Alveolar Soft Part Sarcoma
621,Neuroendocrine Differentiation,Stage IIA Lung Small Cell Carcinoma AJCC v7
622,bone marrow fibrosis,Post polycythaemia vera myelofibrosis
623,Carcinomatous Component Present,Stage IVA Laryngeal Cancer AJCC v7
624,Osseous Differentiation,Chondroblastic osteosarcoma
625,Secondary Lesion,Adenocarcinoma of the prostate stage IV
626,Carcinomatous Component Present,Adenocarcinoma of the prostate stage IV
627,Granulocytes Increased in Bone Marrow,Overt Primary Myelofibrosis
628,Cutaneous Involvement,Type A Tylosis
629,Bone Marrow Eosinophilia,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
630,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
631,Childhood Lesion,Diffuse Intrinsic Pontine Glioma
632,Spindle Cell Osteo-Fibrous Component Present,Tibial adamantinoma
633,Carcinomatous Component Present,Stage IV Hepatocellular Carcinoma AJCC v6
634,Cutaneous Involvement,Transplant-Related Skin Squamous Cell Carcinoma
635,Chromogranin A Positive Neoplastic Cells Present,Strumal carcinoid
636,Monomorphic Cellular Infiltrate,Basaloid carcinoma
637,Exophytic Polypoid Lesion,Esophageal Spindle Cell Carcinoma
638,Villous Pattern,Small Intestinal Villous Adenoma
639,Carcinomatous Component Present,Papillary serous cystadenocarcinoma
640,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
641,Dysplasia,Small Intestinal Tubular Adenoma
642,Epithelial Component Present,Pyriform Fossa Carcinoma
643,Carcinomatous Component Present,Esophageal Basaloid Carcinoma
644,Nodular lesions,Nodular amyloidosis
645,Carcinomatous Component Present,Advanced Adult Hepatocellular Carcinoma
646,Peripheral Nuclear Palisading,Small cell lung cancer limited stage
647,Neuroendocrine Differentiation,Small cell lung cancer limited stage
648,Carcinomatous Component Present,Extraocular Cutaneous Sebaceous Carcinoma
649,Vascular Channel Formation,Radiation-Related Angiosarcoma
650,Nuclear Pseudoinclusion,Papillary Thyroid Microcarcinoma
651,Pseudoencapsulated Mass,Esophageal Malignant Peripheral Nerve Sheath Tumor
652,Non-Hereditary Lesion,Sporadic Burkitt's lymphoma
653,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Adult Pure Erythroid Leukemia
654,Epithelial Component Present,Nipple Carcinoma
655,Bone marrow reticulin fibrosis,Progressive Hairy Cell Leukemia Initial Treatment
656,Epithelial Component Present,Adenoma of ampulla of Vater
657,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma
658,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage III
659,Anaplasia,Childhood Gliosarcoma
660,Epithelial Component Present,Stage IIC Colon Cancer AJCC v7
661,Lymphoplasmacytic Infiltrate,"Castleman Disease, Hyaline-Vascular Type"
662,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Tumor G1
663,Cicatrix,Old Burn Scar-Related Skin Squamous Cell Carcinoma
664,Stromal Invasion,Carcinosarcoma of ovary
665,Tissue Differentiation Uncertain,Adult Alveolar Soft Part Sarcoma
666,Well-Circumscribed Lesion,Conventional Cardiac Rhabdomyoma
667,Extraosseous Lesion,Childhood Extraskeletal Osteosarcoma
668,Hereditary Lesion,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations
669,Cystic Change,"Papillary mucinous cystadenoma, borderline malignancy"
670,Indolent Clinical Course,Uterine Corpus Myxoid Leiomyoma
671,Papillary Pattern,"Papillary cystadenoma, borderline malignancy"
672,Osseous Component Present,Hamartoma of lung
673,Congenital Lesion,Congenital aphakia
674,Recurrent disease,recurrent gastric cancer
675,Carcinomatous Component Present,Nasopharyngeal carcinoma
676,Epithelial Component Present,Proliferating Brenner Tumor
677,Epithelial Component Present,Occult Lung Large Cell Carcinoma
678,Monoclonal Gammapathies,Waldenstrom Macroglobulinemia
679,Necrotic changes (finding),Large cell neuroendocrine carcinoma
680,Metastatic Lesion,Metastatic Malignant Neoplasm to the Thyroid
681,Localized Lesion,Plasmacytoma anaplastic
682,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Acute promyelocytic leukemia - hypogranular variant
683,Alternative Fascicle (Bundle) Pattern,Bizarre leiomyoma
684,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage
685,Carcinomatous Component Present,small cell carcinoma of larynx
686,Malignant Component Present,Ovarian Dermoid Cyst with Leiomyosarcoma
687,Epithelial Component Present,undifferentiated carcinoma of appendix
688,Micropapillary Pattern,Invasive micropapillary carcinoma of breast
689,Diffuse Pattern,Childhood Cerebellar Anaplastic Astrocytoma
690,High Mitotic Activity,Childhood Anaplastic Oligodendroglioma
691,Necrotic changes (finding),Adult Gliosarcoma
692,Epithelial Component Present,Basal-Like Breast Carcinoma
693,High Mitotic Activity,Digestive System Neuroendocrine Carcinoma
694,Carcinomatous Component Present,Parietal cell carcinoma
695,Well-Circumscribed Lesion,Polyp of ethmoidal sinus
696,Secondary Lesion,Secondary malignant neoplasm of peritoneum
697,Childhood Lesion,Recurrent Childhood Giant Cell Glioblastoma
698,Necrotic changes (finding),Childhood Brain Stem Gliosarcoma
699,Enterochromaffin-Like Type Granules Present,Gastric Carcinoid Tumor
700,Mild cytologic atypia,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
701,Borderline Lesion,Moderate pancreatic duct dysplasia
702,Exophytic Papillary Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
703,Carcinomatous Component Present,Prostate Cancer by AJCC v6 Stage
704,Well-Circumscribed Lesion,Skin tag
705,Cutaneous Involvement,Ancell-Spiegler cylindromas
706,Neuroendocrine Differentiation,Laryngeal Paraganglioma
707,Cutaneous Involvement,Primary cutaneous CD30+ T-cell lymphoproliferative disorder
708,Invasive Lesion,Thymoma malignant invasive
709,Mixed Cellular Population,Parotid Gland Carcinosarcoma
710,Recurrent disease,Recurrent Brain Neoplasm
711,Epithelial Component Present,adenosquamous carcinoma of ovary
712,Diffuse Pattern,AIDS-Related Diffuse Large B-cell Lymphoma
713,Cystic Change,sialadenoma papilliferum of salivary gland
714,Microvascular Proliferation,Small cell glioblastoma
715,Well-Circumscribed Lesion,Colon Traditional Serrated Adenoma
716,Tubular Pattern,Collecting Duct Carcinoma of the Kidney
717,Epithelial Component Present,Tubulovillous adenoma of rectum
718,Carcinomatous Component Present,Minor Salivary Gland Carcinoma
719,Carcinomatous Component Present,Keratinizing Paranasal Sinus Squamous Cell Carcinoma
720,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Dissecting Leiomyoma
721,Cysts Containing Proteinaceous Fluid Present,Papillary serous cystadenocarcinoma
722,Slow Growing Mass,Recurrent Childhood Ependymoma
723,Carcinomatous Component Present,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type"
724,Chronic Inflammatory Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis
725,Exophytic Polypoid Lesion,Pseudopolyposis of colon
726,Pseudoencapsulated Mass,High Grade Malignant Peripheral Nerve Sheath Tumor
727,Carcinomatous Component Present,Schneiderian carcinoma
728,Exophytic Polypoid Lesion,Gastric Hamartoma
729,Myxoid Stroma Formation,Botryoid-Type Embryonal Rhabdomyosarcoma
730,Numerous Stromal Mast Cells Present,Mammary-Type Myofibroblastoma
731,Peripheral Nuclear Palisading,basaloid carcinoma of anus
732,Epithelial Component Present,basaloid carcinoma of anus
733,Fibrosis,"Hepatocellular carcinoma, scirrhous"
734,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Megakaryoblastic Leukemia
735,Carcinomatous Component Present,Large cell lung cancer stage III
736,Mild cytologic atypia,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
737,High Grade Lesion,Kaposi Sarcoma NCI Grade 3
738,Epithelial Component Present,"Papillary squamous cell carcinoma, non-invasive"
739,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma
740,Vascular Channel Formation,Kaposi's sarcoma of cornea
741,Hereditary Lesion,Werner Syndrome
742,Tissue Differentiation Uncertain,Alveolar soft part sarcoma non-metastatic
743,Papillary Pattern,Ureter Inverted Papilloma
744,Tissue Differentiation Uncertain,Childhood Epithelioid Sarcoma
745,Contiguous Disease,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma
746,Thick-Walled Hyalinized Vessels Present,Mediastinal Schwannoma
747,Capillary Sized Vascular Channel Formation,Breast Epithelioid Hemangioma
748,Lepidic Growth Pattern,Lepidic Predominant Adenocarcinoma
749,Perivascular Arrangement of Tumor Cells,Uterine Corpus PEComa
750,Carcinomatous Component Present,Biliary Intraepithelial Neoplasia-3
751,Epithelial Component Present,adenosquamous carcinoma of esophagus
752,Spindle Cell Component Present,"Synovial sarcoma, biphasic"
753,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
754,High Mitotic Activity,Blastoid Variant Mantle Cell Lymphoma
755,Encapsulated Mass,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
756,Nodular lesions,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
757,Infantile Lesion,Fibrous Hamartoma of Infancy
758,Childhood Lesion,Childhood Spindle Cell Rhabdomyosarcoma
759,Epithelial Component Present,Intramucosal Adenocarcinoma
760,High Mitotic Activity,Undifferentiated Endocervical Sarcoma
761,Non-Hereditary Lesion,Gastric Mixed Adenocarcinoma
762,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
763,Well-Circumscribed Lesion,Polyp of vocal cord
764,Hyperplastic Tissue Present,Intraepithelial Melanocytic Hyperplasia
765,High Grade Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans
766,Hypertensive disease,Hypertensive episode
767,Epithelial Component Present,Cystadenofibroma of fallopian tube
768,Epithelial Component Present,Non-Functioning Pituitary Gland Microadenoma
769,Carcinomatous Component Present,Vulvar Cancer by AJCC v6 Stage
770,Low Grade Lesion,Pilocytic astrocytoma of cerebellum
771,Epithelial Component Present,Ghost Cell Odontogenic Carcinoma
772,Radiation Sickness,Radiation-Induced Vascular Disease
773,Papillary Pattern,Papillary squamous cell carcinoma
774,Carcinomatous Component Present,Scirrhous carcinoma of breast
775,Recurrent disease,Recurrent Gestational Trophoblastic Tumor
776,Intracanalicular Growth Pattern,"Phyllodes tumor, benign"
777,Epithelial Component Present,Intraductal papillomatosis
778,Resectable Mass,Cholangiocarcinoma resectable
779,Slow Growing Mass,Chondroid chordoma
780,Pregnancy Complications,Stage III Gestational Trophoblastic Tumor AJCC v7
781,Epithelial Component Present,Apocrine breast carcinoma
782,Multilayered Rosette Formation,Ependymoblastoma
783,Epithelial Component Present,Small cell carcinoma of lung
784,Epithelial Component Present,Stage III Colon Cancer
785,Chronic lymphocytic inflammation,Testicular Typical Seminoma
786,Vascular Channel Formation,Kaposi's sarcoma of esophagus
787,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
788,Indolent Clinical Course,Solid Angioleiomyoma
789,Metastatic Lesion,Breast Carcinoma Metastatic in the Lung
790,Low Grade Lesion,Recurrent Childhood Subependymal Giant Cell Astrocytoma
791,Venous Type Vascular Channel Formation,Venous Angioleiomyoma
792,Dysplasia,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia
793,Chronic lymphocytic inflammation,Inflammatory pseudotumor of liver
794,Childhood Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
795,In Situ Lesion,Stage 0 Rectal Cancer AJCC v6 and v7
796,Unresectable Mass,Unresectable Esophageal Carcinoma
797,Adnexal Differentiation,Benign Apocrine Neoplasm
798,Epithelial Component Present,Well Differentiated Hepatocellular Carcinoma
799,Fibrosis,Breast Sclerosing Adenosis
800,Carcinomatous Component Present,Stage II Pharynx Carcinoma
801,Neuroectodermal Differentiation,Childhood Central Nervous System Ganglioneuroblastoma
802,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
803,Intraosseous Lesion,Intraosseous well differentiated osteosarcoma
804,Well-Circumscribed Lesion,Colorectal Perineurioma
805,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Childhood Ganglioneuroblastoma, Intermixed"
806,Endophytic Tumor Growth,verrucous carcinoma of vagina
807,Epithelial Component Present,Stage IIIC Esophageal Cancer AJCC v7
808,Alternative Fascicle (Bundle) Pattern,Breast Leiomyoma
809,Anaplasia,Anaplastic large cell lymphoma T- and null-cell types refractory
810,Mesenchymal Component Present,Salivary Gland Pleomorphic Adenoma
811,Benign Cellular Infiltrate,lipoma of esophagus
812,Absence of Stromal Invasion,"Endometrioid adenoma, borderline malignancy"
813,Melanosomes Present,Melanotic malignant nerve sheath tumor
814,Carcinomatous Component Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
815,Severe dysplasia,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
816,Local disease,Locally Recurrent Malignant Neoplasm
817,Stromal Invasion,FIGO Stage IIIC Ovarian Cancer
818,Myomatous Stroma Formation,"Cervical Adenomyoma, Endometrial Type"
819,Pregnancy Complications,Gestational choriocarcinoma
820,Mixed Cellular Population,Cervical Wilms Tumor
821,Multifocal Lesion,Myofibromatosis
822,Carcinomatous Component Present,Sporadic Thyroid Gland Medullary Carcinoma
823,Carcinomatous Component Present,Stage IIA Esophageal Adenocarcinoma AJCC v7
824,Cutaneous Involvement,Juvenile Xanthogranuloma
825,Cutaneous Involvement,"Xeroderma pigmentosum, group A"
826,High Mitotic Activity,High Grade Ovarian Serous Adenocarcinoma
827,Refractory Disease,Primary mediastinal large B-cell lymphoma refractory
828,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage II
829,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage III
830,Epithelial Component Present,Gallbladder Carcinoma
831,Epithelial Component Present,Secretory adenoma of pituitary
832,Lobulated Growth Pattern,Ventricular myxoma
833,Hyperkeratosis,inverted follicular keratosis
834,Epithelial Component Present,Malignant Thymoma
835,Diffuse Pattern,Brain Glioblastoma
836,Exophytic Polypoid Lesion,Colorectal Sessile Serrated Adenoma/Polyp
837,Carcinomatous Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7
838,Childhood Lesion,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7
839,Carcinomatous Component Present,Squamous cell carcinoma of scrotum
840,Carcinomatous Component Present,Carcinosarcoma
841,Immunologic Deficiency Syndromes,Chronic rejection of renal transplant
842,Carcinomatous Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
843,Thrombocytosis,"Thrombocythemia, Essential"
844,Keratin pearl formation,External Ear Squamous Cell Carcinoma
845,Carcinomatous Component Present,Recurrent Carcinoma of Unknown Primary
846,Epithelial Component Present,Stage IV Lip Cancer AJCC v6 and v7
847,Carcinomatous Component Present,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
848,Invasive Lesion,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation
849,Cystic Change,High Grade Mucoepidermoid Breast Carcinoma
850,Carcinomatous Component Present,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
851,Well-Circumscribed Lesion,Ovarian Papillary Cystadenoma
852,Mitotic Activity,Liver Yolk Sac Tumor
853,Mixed Cellular Population,Uterine Corpus Adenofibroma
854,Geographic Necrosis,Childhood Embryonal Carcinoma
855,Carcinomatous Component Present,Adenocarcinoma of appendix
856,Epithelial Component Present,Squamous cell carcinoma of nasopharynx
857,'Starry-sky' pattern,Burkitt's lymphoma of small intestine
858,Mitotic Activity,Recurrent Childhood Anaplastic Astrocytoma
859,Osteoid formation,Childhood Conventional Osteosarcoma
860,Sinusoidal Infiltration,Hepatosplenic T-cell lymphoma
861,Epithelial Component Present,Breast Cancer by AJCC v7 Stage
862,Vascular Channel Formation,Kaposi Sarcoma Related to Immunosuppressive Treatment
863,Exophytic Polypoid Lesion,Duodenal Adenoma
864,Carcinomatous Component Present,Stage I Lung Cancer AJCC v6
865,Metastatic/Recurrent Disease,"Phosphaturic mesenchymal tumor, malignant"
866,Chronic lymphocytic inflammation,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
867,Fibrotic Stroma Formation,High Grade Salivary Gland Mucoepidermoid Carcinoma
868,Childhood Lesion,Childhood Lymphoblastic Lymphoma
869,Epithelial Component Present,Ameloblastic Carcinoma
870,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7
871,Epithelial Component Present,Prostate cancer stage A
872,Childhood Lesion,Childhood Thyroid Gland Follicular Carcinoma
873,Single Cell Necrosis,Stage II Merkel Cell Carcinoma AJCC v7
874,Childhood Lesion,Childhood Testicular Germ Cell Tumor
875,Vascular Channel Formation,Uterine Angiosarcoma
876,Myxoid Stroma Formation,Odontogenic myxoma
877,Secondary Lesion,carcinoma ex pleomorphic adenoma of salivary gland
878,Pregnancy Complications,Placenta Increta
879,Carcinomatous Component Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
880,Cutaneous Involvement,Eccrine acrospiroma
881,Epithelial Component Present,Cervical Squamous Cell Carcinoma In Situ
882,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
883,Desmoplastic Stroma Formation,Testicular Sclerosing Sertoli Cell Tumor
884,Slow Growing Mass,Plexiform fibrohistiocytic tumor
885,Carcinomatous Component Present,Stage I Carcinoma of Bladder
886,Vascular Channel Formation,Recurrent Kaposi Sarcoma
887,Thick-Walled Hyalinized Vessels Present,Degenerated Schwannoma
888,Multinodular Mass,Thyroid Angiosarcoma
889,Well-Circumscribed Lesion,Cavernous Angioleiomyoma
890,Childhood Lesion,Childhood Acute Myeloid Leukemia Not Otherwise Specified
891,Carcinomatous Component Present,Childhood Nasal Cavity Carcinoma
892,Childhood Lesion,Childhood Nasal Cavity Carcinoma
893,Mitotic Activity,yolk sac tumor of mediastinum
894,Carcinomatous Component Present,Malignant eccrine spiradenoma
895,High Grade Lesion,Gallbladder Rhabdomyosarcoma
896,Cystic Change,Mucoepidermoid carcinoma of the oral cavity
897,Neuroectodermal Differentiation,Childhood Central Nervous System Neuroblastoma
898,Immunosuppression-Related Post-Transplant Toxicity,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
899,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage III
900,Monoclonal Cellular Population Present,Malignant mastocytosis
901,Immunosuppression-Related Post-Transplant Toxicity,Renal transplant rejection
902,Carcinomatous Component Present,Low Grade Salivary Gland Mucoepidermoid Carcinoma
903,Neuroectodermal Differentiation,Ewings sarcoma-primitive neuroectodermal tumor (PNET)
904,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage IV
905,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage I
906,Low Mitotic Activity,Appendix Neuroendocrine Tumor
907,Cutaneous Involvement,T-Cell Proliferation of Uncertain Malignant Potential
908,Dilated Thin-Walled Vascular Space Formation,Angiomyofibroblastoma
909,Pseudopapillary Pattern,Extragonadal primary embryonal carcinoma
910,Cystic Lesion,Papillary craniopharyngioma
911,Secondary Lesion,Secondary malignant neoplasm of pericardium
912,Angiocentric Pattern,Lymphomatoid Granulomatosis
913,Immunosuppression-Related Post-Transplant Toxicity,Post-transplant lymphoproliferative disorder
914,Epithelial Component Present,Carcinoid tumor of the liver
915,Favorable Clinical Outcome,"Mastocytosis, Diffuse Cutaneous"
916,Vascular Channel Formation,Congenital Cystic Hygroma
917,Rapidly Enlarging Mass,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
918,Neuroendocrine Differentiation,Benign pheochromocytoma of adrenal gland
919,Metastatic Lesion,Breast Carcinoma Metastatic in the Skin
920,Secondary Lesion,Metastatic Malignant Neoplasm in the Soft Tissues
921,Immature Myeloid Cells Increased in Bone Marrow,Secondary Acute Myeloid Leukemia
922,Mesenchymal Component Present,Malignant Phyllodes Tumor of Prostate
923,Carcinomatous Component Present,Low Grade Adenosquamous Breast Carcinoma
924,Splenomegaly,Splenic Manifestation of B-Cell Prolymphocytic Leukemia
925,Carcinomatous Component Present,Seminal Vesicle Adenocarcinoma
926,Cutaneous Involvement,Superficial Epithelioma with Sebaceous Differentiation
927,Thin-Walled Branching Vascular Pattern,Solitary fibrous tumor
928,Follicular Structures Present,Thyroid Gland Lipoadenoma
929,Epithelial Component Present,Seminal Vesicle Cystadenoma
930,Necrotic changes (finding),Stage IA Lung Small Cell Carcinoma AJCC v7
931,Secondary Lesion,Metastatic signet ring cell carcinoma
932,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
933,Monocytosis,Chronic Myelomonocytic Leukemia-1
934,Recurrent disease,Anal cancer recurrent
935,Epithelial Component Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
936,Carcinomatous Component Present,Stage IVB Laryngeal Cancer AJCC v7
937,Peripheral Nuclear Palisading,Stage IIA Lung Small Cell Carcinoma AJCC v7
938,Peripheral Nuclear Palisading,Laryngeal Basaloid Carcinoma
939,Secondary Lesion,Metastatic Malignant Neoplasm to the Leptomeninges
940,"Undifferentiated ""Fetal-Type"" Tissues Present",Malignant Ovarian Teratoma
941,Epithelial Component Present,Recurrent respiratory papillomatosis
942,Local disease,Benign neoplasm of mesothelial tissue of peritoneum
943,Severe cytologic atypia,Rectal Small Cell Neuroendocrine Carcinoma
944,Epithelial Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v7
945,Epithelial Component Present,Actinic keratosis
946,Epithelial Component Present,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia
947,Carcinomatous Component Present,Basaloid carcinoma
948,Well-Circumscribed Lesion,HNF1alpha-Inactivated Hepatocellular Adenoma
949,Carcinomatous Component Present,Adenocarcinoma in Situ
950,Epithelial Component Present,Bile duct clear cell adenocarcinoma
951,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant"
952,Hereditary Lesion,WAGR Syndrome
953,Osseous Differentiation,Stage II Osteosarcoma AJCC v7
954,Neuroendocrine Differentiation,Ampulla of Vater Gangliocytic Paraganglioma
955,Cutaneous Involvement,Stage II Lip Basal Cell Carcinoma
956,Mixed Cellular Population,Adult Kidney Wilms Tumor
957,Carcinomatous Component Present,Appendix Mixed Adenoneuroendocrine Carcinoma
958,Severe cytologic atypia,Childhood Pleomorphic Rhabdomyosarcoma
959,Dysplasia,Carcinoma in situ of prostate
960,Parakeratosis,Desmoplastic trichilemmoma
961,Severe dysplasia,Stage 0 Pharynx Carcinoma
962,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells
963,Prominent Intraductal Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
964,Epithelial Component Present,Gallbladder Flat Biliary Intraepithelial Neoplasia
965,Well-Circumscribed Lesion,Cystic Partially Differentiated Nephroblastoma
966,Microvascular Proliferation,Childhood Giant Cell Glioblastoma
967,Cutaneous Involvement,Desmoplastic trichoepithelioma
968,Epithelial Component Present,Medullary carcinoma of thyroid
969,Calcitonin serum level increased,Medullary carcinoma of thyroid
970,Carcinomatous Component Present,"Pancreatic carcinoma, familial"
971,Mild dysplasia,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia
972,Lobular Pattern,Sebaceous adenoma
973,Nuclear Grooves,Follicular Variant Thyroid Gland Papillary Carcinoma
974,Indolent Clinical Course,Uterine Corpus Cellular Leiomyoma
975,Carcinomatous Component Present,undifferentiated carcinoma of cervix
976,Carcinomatous Component Present,Hepatoma resectable
977,Stromal Invasion,Ovarian Cystadenocarcinoma
978,Hyaline Cartilage Differentiation,Adult Mesenchymal Chondrosarcoma
979,Epithelial Component Present,Urethral Condyloma Acuminatum
980,Nodular Pattern,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma
981,Epithelial Component Present,"Carcinoma, Ovarian Epithelial"
982,Recurrent disease,Intrahepatic cholangiocarcinoma recurrent
983,Carcinomatous Component Present,lymphoepithelial squamous cell carcinoma of salivary gland
984,Mesenchymal Component Present,"Phyllodes tumor, borderline"
985,Epithelial Component Present,Adenocarcinoma of the prostate metastatic
986,Melanin-Forming Neuroepithelial Cells Present,"Neuroectodermal Tumor, Melanotic"
987,Monomorphic Cellular Infiltrate,sebaceous adenoma of salivary gland
988,Carcinomatous Component Present,Bladder Urachal Adenocarcinoma
989,Epithelial Component Present,Urothelial Neoplasm
990,Epithelial Component Present,cloacogenic carcinoma of rectum
991,Thick-Walled Hyalinized Vessels Present,Neurilemmoma
992,Recurrent disease,Duodenal carcinoma recurrent
993,Apocrine Differentiation,Ceruminous Neoplasm
994,Epithelial Component Present,Breast Carcinoma
995,Neuroendocrine Differentiation,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma
996,Pseudopapillary Pattern,Testicular embryonal carcinoma
997,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic syndrome, no ICD-O subtype"
998,Carcinomatous Component Present,Grade 2 Rectal Adenocarcinoma
999,Fibrovascular Septa Present,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
1000,Epithelial Component Present,"Thymoma, type B2, malignant"
1001,Metastatic Lesion,Secondary malignant neoplasm of anus
1002,Secondary Lesion,Secondary malignant neoplasm of anus
1003,Epithelial Component Present,"Adenocarcinoma, Clear Cell"
1004,Adulthood Lesion,Adult Giant Cell Glioblastoma
1005,Nuclear Atypia,Adult Giant Cell Glioblastoma
1006,Rapidly Enlarging Mass,Spindle Cell/Sclerosing Rhabdomyosarcoma
1007,Diffuse Pattern,Well Differentiated Oligodendroglioma
1008,Necrotic changes (finding),Recurrent Childhood Gliosarcoma
1009,Carcinomatous Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
1010,Carcinomatous Component Present,Ovarian Transitional Cell Carcinoma
1011,Unresectable Mass,Hepatoblastoma non-resectable
1012,Epithelial Component Present,Carcinoma of the Floor of the Mouth
1013,Epithelial Component Present,Mucoepidermoid carcinoma of skin
1014,Adnexal Differentiation,Classical Poroma
1015,Epithelial Component Present,Chromophobe Renal Cell Carcinoma
1016,Epithelial Component Present,Vulvar Squamous Neoplasm
1017,Carcinomatous Component Present,Squamous cell carcinoma of pharynx
1018,Carcinomatous Component Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12)
1019,Low Mitotic Activity,Functioning Pancreatic Neuroendocrine Tumor
1020,Childhood Lesion,Childhood Ependymal Tumor
1021,Cutaneous Involvement,Stage II Cutaneous Melanoma AJCC v6 and v7
1022,Indolent Clinical Course,Myxoid leiomyoma
1023,Multinodular Mass,Mediastinal Angiosarcoma
1024,Firm mass,High Grade Malignant Peripheral Nerve Sheath Tumor
1025,Firm mass,Cervical Malignant Peripheral Nerve Sheath Tumor
1026,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Hyalinizing Trabecular Adenoma
1027,Carcinomatous Component Present,Recurrent Pancreatic Neuroendocrine Carcinoma
1028,Cystic Change,Cystadenoma of pancreas
1029,Hyperplastic Tissue Present,Urothelial Hyperplasia
1030,Pregnancy Complications,Ectopic Pregnancy
1031,Osseous Differentiation,Intermediate Osteogenic Neoplasm
1032,Vascular Channel Formation,Angiosarcoma NCI Grade 3
1033,Epithelial Component Present,Epithelial-myoepithelial carcinoma
1034,Fibrotic Stroma Formation,Granular cell ameloblastoma
1035,Cribriform Pattern,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
1036,Non-Invasive Lesion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
1037,Neuroendocrine Differentiation,Mediastinal Paraganglioma
1038,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
1039,Carcinomatous Component Present,Head and Neck Carcinoma
1040,Neuroendocrine Differentiation,Carcinoid tumor of the cecum
1041,Comedo Necrosis,Colon Cribriform Comedo-Type Adenocarcinoma
1042,Carcinomatous Component Present,Stage IV Major Salivary Gland Carcinoma without Metastasis
1043,Epithelial Component Present,Inverted Squamous Cell Papilloma
1044,Well-Circumscribed Lesion,Fundic gland polyp
1045,Epithelial Component Present,Stage IIA2 Cervical Cancer AJCC v7
1046,Mucoid Stroma Formation,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
1047,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
1048,Mild cytologic atypia,verrucous carcinoma of esophagus
1049,Neuroendocrine Differentiation,Gastrointestinal Carcinoid Tumor
1050,Carcinomatous Component Present,Upper Gingival Verrucous Carcinoma
1051,Cutaneous Involvement,Benign Dermal Neoplasm
1052,Invasive Lesion,malignant myoepithelioma of breast
1053,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I
1054,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
1055,Skin nodule,Skin Nodular Basal Cell Carcinoma
1056,Epithelial Component Present,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7
1057,Primary Lesion,Childhood Brain Anaplastic Astrocytoma
1058,Intestinal metaplasia,Gastric Mixed Adenocarcinoma
1059,Carcinomatous Component Present,Colon Medullary Carcinoma
1060,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Fallopian Tube Endometrioid Tumor
1061,Epithelial Component Present,Gastric dysplasia
1062,Intraductal Lesion,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
1063,Carcinomatous Component Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
1064,Carcinomatous Component Present,Neck Carcinoma
1065,Anaplasia,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative"
1066,Exophytic Polypoid Lesion,Fallopian Tube Endometrioid Polyp
1067,Benign Cellular Infiltrate,Leiomyomatosis peritonealis disseminata
1068,Indolent Clinical Course,Leiomyomatosis peritonealis disseminata
1069,Painless Mass,Central Nervous System Chondroma
1070,Recurrent disease,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
1071,Papillary Pattern,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
1072,Multilocular Lesion,"Bone Cysts, Aneurysmal"
1073,Recurrent disease,Cholangiocarcinoma recurrent
1074,Hyperplastic Tissue Present,Basal cell hyperplasia
1075,Recurrent disease,Recurrent Extragonadal Seminoma
1076,Carcinomatous Component Present,Recurrent Fallopian Tube Carcinoma
1077,Dermal Involvement,Cervical Blue Nevus
1078,Plasma cell inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor
1079,Diffuse Pattern,ALK positive large B-cell lymphoma
1080,Carcinomatous Component Present,Gastric Cancer by AJCC v7 Stage
1081,Indolent Clinical Course,Lipomatosis of Nerve
1082,Perineural spread,Lipomatosis of Nerve
1083,Immunologic Deficiency Syndromes,AIDS-Related Malignant Neoplasm
1084,Epithelial Component Present,Bowenoid papulosis of penis
1085,Absence of Invasion,Stage 0 Oropharyngeal Carcinoma
1086,Metastatic Lesion,Secondary Central Nervous System Lymphoma
1087,High Grade Lesion,Recurrent Childhood Rhabdomyosarcoma
1088,Exophytic Polypoid Lesion,adenoma of extrahepatic bile duct
1089,Dysplasia,Villous adenoma of rectum
1090,Eosinophilic inflammation,Inflammatory pseudotumor of liver
1091,Apocrine Differentiation,Benign Apocrine Neoplasm
1092,Epithelial Component Present,papillomatosis of extrahepatic bile duct
1093,Carcinomatous Component Present,Rectal Cancer by AJCC v6 Stage
1094,Cavernous Vascular Space Formation,Cardiac Cavernous Hemangioma
1095,Carcinomatous Component Present,Colorectal Sarcomatoid Carcinoma
1096,Pregnancy Complications,"Pregnancy, Abdominal"
1097,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
1098,Chronic Inflammatory Infiltrate,Pyothorax-Associated Lymphoma
1099,Vascular Channel Formation,Gastric Hemangioma
1100,Indolent Clinical Course,Breast Leiomyoma
1101,Benign Cellular Infiltrate,Colorectal Benign Granular Cell Tumor
1102,Carcinomatous Component Present,Occult Lung Adenocarcinoma
1103,Carcinomatous Component Present,Hard Palate Adenoid Cystic Carcinoma
1104,Smooth Muscle Component Present,Endobronchial Hamartoma
1105,Carcinomatous Component Present,Childhood Breast Carcinoma
1106,Epithelial Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma
1107,Indolent Clinical Course,Cardiac rhabdomyoma
1108,Epithelial Component Present,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8"
1109,Indolent Clinical Course,Vaginal Myofibroblastoma
1110,Carcinomatous Component Present,Stage IIIA Vulvar Cancer AJCC v7
1111,Tissue of Mullerian Origin Present,Borderline Ovarian Endometrioid Cystadenofibroma
1112,Mitotic Activity,Grade III Childhood Astrocytoma
1113,Mitotic Activity,Glioblastoma by Gene Expression Profile
1114,Dysplasia,Transitional Cell Intraepithelial Neoplasia
1115,Angiodestructive Pattern,Cutaneous Lymphomatoid Granulomatosis
1116,Diffuse Pattern,Melanotic malignant nerve sheath tumor
1117,Epithelial Component Present,Diffuse Gastric Adenocarcinoma
1118,Absence of Invasion,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
1119,Recurrent disease,Recurrent Uterine Corpus Sarcoma
1120,Lymphadenopathy,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
1121,Recurrent disease,Recurrent Childhood Brain Stem Astrocytoma
1122,Cutaneous Involvement,Verruciform xanthoma of skin
1123,Epithelial Component Present,Stage IV Rectal Cancer AJCC v7
1124,Epithelial Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
1125,Mitotic Activity,Classical Glioblastoma
1126,Lymphoplasmacytic Infiltrate,Cervical Lymphoepithelioma-Like Carcinoma
1127,Childhood Lesion,Benign Childhood Cerebral Neoplasm
1128,Oligodendroglial Component Present,Mixed Astrocytoma-Ependymoma-Oligodendroglioma
1129,Adulthood Lesion,Adult Acute Myeloid Leukemia without Maturation
1130,Childhood Lesion,Childhood Testicular Mixed Germ Cell Tumor
1131,Recurrent disease,Splenic marginal zone lymphoma recurrent
1132,Malignant Cellular Infiltrate,Adult Anaplastic (Malignant) Meningioma
1133,Mitotic Activity,Vaginal Yolk Sac Tumor
1134,Hyalinized Stroma Formation,Pericardial Solitary Fibrous Tumor
1135,Primary Lesion,Epithelioid glioblastoma
1136,Adulthood Lesion,Recurrent Adult Immunoblastic Lymphoma
1137,Biphasic Pattern,"Mesothelioma, biphasic, malignant"
1138,Epithelial Component Present,Accessory Urethral Gland Carcinoma
1139,Epithelial Component Present,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
1140,Thick-Walled Vessels Present,Endometrial Polyp
1141,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Adult Acute Monoblastic Leukemia
1142,Neuroendocrine Differentiation,Stage IV Appendix Neuroendocrine Tumor AJCC v7
1143,Epithelial Component Present,Gastrointestinal tract adenoma
1144,Epithelial Component Present,Malignant myoepithelioma
1145,Hyperkeratosis,Melanoacanthoma
1146,Ineffective hematopoiesis,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
1147,Dome-Shaped Lesion,keratoacanthoma
1148,Well-Circumscribed Lesion,Polyp of gallbladder
1149,Tissue of Mullerian Origin Present,Broad Ligament Serous Adenofibroma
1150,Epithelial Component Present,Squamous cell carcinoma of oropharynx
1151,Carcinomatous Component Present,Ear carcinoma
1152,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
1153,Epithelial Component Present,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
1154,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change
1155,Mesenchymal Differentiation,Adult Brain Stem Gliosarcoma
1156,Multinodular Mass,Angiosarcoma of liver
1157,Carcinomatous Component Present,Serous cystadenocarcinoma ovary
1158,Carcinomatous Component Present,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
1159,Fibrous Septa Present,Stage II Ovarian Dysgerminoma AJCC v6 and v7
1160,Low Grade Lesion,Parosteal Osteosarcoma
1161,Carcinomatous Component Present,Stage 0 Gallbladder Cancer AJCC v6 and v7
1162,Thyroglobulin Positive Neoplastic Cells Present,Follicular thyroid carcinoma
1163,Carcinomatous Component Present,Skin Pseudovascular Squamous Cell Carcinoma
1164,High Mitotic Activity,Childhood Anaplastic Ependymoma
1165,Deep Lesion,Perineural Hemangioma
1166,Nuclear Grooves,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
1167,Epithelial Component Present,Stage III Ampulla of Vater Cancer AJCC v7
1168,Vascular Channel Formation,Capillary hemangioma of retina
1169,Epithelial Component Present,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified"
1170,Carcinomatous Component Present,Grade 3 Rectal Adenocarcinoma
1171,Carcinomatous Component Present,BCLC Stage B Hepatocellular Carcinoma
1172,Epithelial Component Present,mucinous adenocarcinofibroma of ovary
1173,Epithelial Component Present,Fallopian Tube Serous Adenocarcinoma
1174,Carcinomatous Component Present,"Squamous cell carcinoma, metastatic"
1175,High Mitotic Activity,Recurrent Childhood Anaplastic Oligodendroglioma
1176,Recurrent Genetic Abnormalities Present,Hypodiploid B Acute Lymphoblastic Leukemia
1177,'Starry-sky' pattern,Stage II Adult Burkitt Lymphoma
1178,Adnexal Differentiation,Vulvar Sebaceous Carcinoma
1179,Anaplasia,Stage III Anaplastic Large Cell Lymphoma
1180,Low Grade Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
1181,Epithelial Component Present,Carcinoma in situ of ampulla of Vater
1182,Single Cell Necrosis,Stage IIA Merkel Cell Carcinoma AJCC v7
1183,Epithelial Component Present,Fibroepithelioma of Pinkus
1184,Fibrovascular Stroma Formation,Fibroepithelioma of Pinkus
1185,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma
1186,Low Mitotic Activity,Carcinoid tumor of pancreas
1187,Splenomegaly,Philadelphia chromosome negative chronic myelogenous leukemia
1188,Small Lesion,Small Congenital Melanocytic Nevus
1189,Pregnancy Complications,Placenta Percreta
1190,Carcinomatous Component Present,epithelial-myoepithelial carcinoma of lung
1191,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Pericardial Teratoma
1192,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
1193,Epithelial Component Present,Clear Cell Hepatocellular Carcinoma
1194,Carcinomatous Component Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma
1195,Biphasic Pattern,Borderline Ovarian Clear Cell Cystadenofibroma
1196,Cutaneous Involvement,Apocrine adenoma
1197,Skin nodule,Proliferative dermal lesion in congenital nevus
1198,Epithelial Component Present,Squamous cell carcinoma of trachea
1199,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Ganglioneuroblastoma, Nodular"
1200,Epithelial Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma
1201,Epithelial Component Present,Stage II Bladder Cancer AJCC v6 and v7
1202,Antoni A Pattern,Schwannomatosis
1203,Epithelial Component Present,Spindle Cell Oncocytoma of the Adenohypophysis
1204,Biphasic Pattern,Phyllodes Tumor
1205,Epithelial Component Present,Childhood Paranasal Sinus Carcinoma
1206,Papillary Pattern,Inverted Papilloma
1207,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage IV
1208,Invasive Lesion,Infiltrating Intramuscular Lipoma
1209,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
1210,Diffuse Lesion,Angiomatosis
1211,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor G2
1212,Neuroectodermal Differentiation,Localized Askin Tumor
1213,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Basophilic Leukemia
1214,Koilocytotic atypia,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
1215,Childhood Lesion,Recurrent Childhood Astrocytic Tumor
1216,Macrofollicular Structures Present,Macrofollicular adenoma
1217,Single Cell Necrosis,Stage IA Merkel Cell Carcinoma AJCC v7
1218,Epithelial Component Present,Moderately Differentiated Prostate Adenocarcinoma
1219,Local disease,Localized Extrahepatic Bile Duct Carcinoma
1220,Epithelial Component Present,Eccrine hidrocystoma
1221,Epithelial Component Present,Carcinoma of subglottis
1222,Recurrent disease,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
1223,Indolent Clinical Course,Intramuscular lipoma
1224,Epithelial Component Present,adenoid cystic carcinoma of accessory sinus
1225,Carcinomatous Component Present,Carcinoma of supraglottis
1226,Bone marrow reticulin fibrosis,Splenic Manifestation of Hairy Cell Leukemia
1227,Secondary Lesion,Secondary Acute Myeloid Leukemia
1228,Neuroendocrine Differentiation,Colorectal Large Cell Neuroendocrine Carcinoma
1229,Splenomegaly,Splenic Manifestation of Prolymphocytic Leukemia
1230,Carcinomatous Component Present,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
1231,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of lung
1232,Severe dysplasia,Stage 0 Esophageal Cancer AJCC v7
1233,Mild cytologic atypia,Laryngeal verrucous carcinoma stage IV
1234,Epithelial Component Present,Low Grade Broad Ligament Serous Adenocarcinoma
1235,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Splenic Manifestation of B-Cell Prolymphocytic Leukemia
1236,Epithelial Component Present,Serous cystadenoma of pancreas
1237,Epithelial Component Present,High Grade Broad Ligament Serous Adenocarcinoma
1238,Perineural spread,Adenoid cystic carcinoma of submandibular gland
1239,Carcinomatous Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma
1240,Poorly Differentiated Lesion,Poorly Differentiated Fibrosarcoma
1241,Epithelial Component Present,Mucoepidermoid carcinoma of submandibular gland
1242,Necrotic changes (finding),Choroid Necrotic Melanoma
1243,Villous Pattern,villous adenoma of stomach
1244,Exophytic Polypoid Lesion,villous adenoma of stomach
1245,Vascular Channel Formation,Fibroblastic osteosarcoma
1246,Tissues Derived from Two or Three Embryonic Layers Present,Grade 1 Ovarian Teratoma
1247,Epithelial Component Present,Malignant neoplasm of carotid body
1248,Hyperkeratosis,Bowen's Disease
1249,Epithelial Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
1250,Exophytic Polypoid Lesion,Colorectal Tubular Adenoma
1251,Mesenchymal Metaplasia,Adenocarcinoma with cartilaginous and osseous metaplasia
1252,Seizures,Dysembryoplastic neuroepithelial tumor
1253,Bone Marrow Eosinophilia,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
1254,Epithelial Component Present,Biliary papillomatosis
1255,Well-Circumscribed Lesion,Small Intestinal Villous Adenoma
1256,Epithelial Component Present,Endometrial adenocarcinoma
1257,Therapy-Related Toxicity,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
1258,Immunosuppression-Related Post-Transplant Toxicity,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
1259,Epithelial Component Present,Disseminated squamous cell carcinoma
1260,Local disease,Tonsillar Lipoma
1261,Neoplastic Plasma Cells Present in Bone Marrow,Plasma cell myeloma recurrent
1262,Epithelial Component Present,High Grade Lung Neuroendocrine Neoplasm
1263,Neuroendocrine Differentiation,small cell carcinoma of appendix
1264,Intestinal metaplasia,intestinal type adenocarcinoma of gallbladder
1265,Thin-Walled Branching Vascular Pattern,Malignant Solitary Fibrous Tumor
1266,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, t(16;16)(p13;q22)"
1267,Splenomegaly,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta
1268,Cutaneous Involvement,Stage I Lip Basal Cell Carcinoma
1269,Vascular Channel Formation,Verrucous keratotic hemangioma
1270,Myxoid Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma"
1271,Cutaneous Involvement,Lymphomatoid Papulosis
1272,Diffuse Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma
1273,Oligodendroglial Component Present,Childhood Oligoastrocytoma
1274,Carcinomatous Component Present,Adenosquamous cell lung cancer
1275,Hypercellular bone marrow,"Leukemia, Myeloid, Chronic-Phase"
1276,Indolent Clinical Course,Aggressive angiomyxoma
1277,Adnexal Differentiation,Invasive Apocrine Breast Carcinoma
1278,Progressive Clinical Course,Progressive Hairy Cell Leukemia Initial Treatment
1279,Non-Invasive Lesion,Adenoma of ampulla of Vater
1280,Deep Lesion,Sclerosing liposarcoma
1281,Well-Circumscribed Lesion,Pericardial Adenomatoid Tumor
1282,Bone Marrow Dysplasia Present,"Leukemia, Myelomonocytic, Chronic"
1283,Carcinomatous Component Present,Follicular Variant Thyroid Gland Papillary Carcinoma
1284,Thyroglobulin Positive Neoplastic Cells Present,Follicular Variant Thyroid Gland Papillary Carcinoma
1285,Epithelial Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7
1286,Carcinomatous Component Present,Posterior Tongue Adenoid Cystic Carcinoma
1287,Wedge-Shaped Growth Pattern,Deep Penetrating Nevus
1288,Adnexal Differentiation,Ceruminous adenocarcinoma
1289,Acanthosis,Urethral Condyloma Acuminatum
1290,Benign Cellular Infiltrate,Liver Cavernous Hemangioma
1291,Epithelial Component Present,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
1292,Well Differentiated Lesion,papillary carcinoma of penis
1293,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
1294,Primary Lesion,Lymphoma of retina
1295,Tubular Pattern,tubular adenoma of gallbladder
1296,Carcinomatous Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v7
1297,Carcinomatous Component Present,Mucin-producing adenocarcinoma
1298,Secondary Lesion,Distantly Metastatic Malignant Neoplasm
1299,Diffuse Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS"
1300,Childhood Lesion,Childhood Embryonal Rhabdomyosarcoma
1301,Epithelial Component Present,Bladder Urachal Urothelial Carcinoma
1302,Tissue Differentiation Uncertain,Lung Clear Cell Tumor
1303,Cutaneous Involvement,Hidroacanthoma simplex
1304,Carcinomatous Component Present,Bladder Urachal Squamous Cell Carcinoma
1305,Epithelial Component Present,Intestinal Neuroendocrine Neoplasm
1306,Mitotic Activity,Chondroblastoma
1307,Tricholemmal Differentiation,Classic Type Trichilemmoma
1308,Mild cytologic atypia,Ovarian Low Grade Endometrioid Stromal Sarcoma
1309,Papillary Pattern,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
1310,Multifocal Lesion,Diffuse Lipomatosis
1311,Cutaneous Involvement,Asian desert cutaneous leishmaniasis
1312,Cutaneous Involvement,Eccrine spiradenoma
1313,Monomorphic Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma
1314,Nodular Pattern,Recurrent Grade 1 Follicular Lymphoma
1315,Carcinomatous Component Present,Mucinous adenocarcinoma gastric
1316,Intestinal metaplasia,Vaginal Tubulovillous Adenoma
1317,Epithelial Component Present,Transitional cell carcinoma urethra
1318,Epithelial Component Present,Breast Apocrine Adenoma
1319,Tissue Differentiation Uncertain,Childhood Kidney Angiomyolipoma
1320,High Grade Lesion,Childhood Cerebral Anaplastic Astrocytoma
1321,Childhood Lesion,Recurrent Childhood Fibrillary Astrocytoma
1322,Generalized illness,Disseminated carcinoma
1323,Rapidly Enlarging Mass,Rectal Rhabdomyosarcoma
1324,Carcinomatous Component Present,Submandibular Gland Adenocarcinoma
1325,Fibrotic Stroma Formation,Nasopharyngeal Angiofibroma
1326,Pain,Osteoid osteoma
1327,Epithelial Component Present,Penile Cancer by AJCC v6 Stage
1328,Adnexal Differentiation,Mucoepidermoid carcinoma of skin
1329,Diffuse Pattern,Glandular malignant peripheral nerve sheath tumor
1330,Inflammatory infiltrate,Inflammatory Leiomyosarcoma
1331,Malignant Cellular Infiltrate,Stage III Ovarian Polyembryoma AJCC v6 and v7
1332,Carcinomatous Component Present,Collecting Duct Carcinoma of the Kidney
1333,Epithelial Component Present,Stage IB Breast Cancer AJCC v7
1334,Necrotic changes (finding),Epithelioid Malignant Peripheral Nerve Sheath Tumor
1335,Epithelial Component Present,Skin Sarcomatoid Basal Cell Carcinoma
1336,Carcinomatous Component Present,Basal cell carcinoma - adenoid
1337,Epithelial Component Present,Esophageal Mixed Adenoneuroendocrine Carcinoma
1338,Carcinomatous Component Present,"Carcinoma, Lobular"
1339,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts
1340,Carcinomatous Component Present,Mucoepidermoid carcinoma of salivary gland
1341,Primary Lesion,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
1342,Recurrent disease,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter
1343,Multinodular Mass,Cutaneous Radiation-Related Angiosarcoma
1344,Carcinomatous Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
1345,Acinar Cell Differentiation,Acinar cell adenoma
1346,Schwannian Stroma More than 50 Percent of the Tumor Volume,Central Nervous System Ganglioneuroblastoma
1347,Epithelial Component Present,"Hepatocellular carcinoma, scirrhous"
1348,Multinodular Mass,Angiosarcoma of spleen
1349,Islands of Odontogenic Epithelium Present,Follicular ameloblastoma
1350,Hyperplastic Tissue Present,Esophageal Basal Cell Hyperplasia
1351,Islands of Odontogenic Epithelium Present,Granular cell ameloblastoma
1352,Epithelial Component Present,Signet-ring cell adenocarcinoma of colon
1353,Childhood Lesion,Childhood Alveolar Soft Part Sarcoma
1354,Epithelial Component Present,Combined Lung Large Cell Neuroendocrine Carcinoma
1355,Nuclear Molding,Combined Lung Large Cell Neuroendocrine Carcinoma
1356,Carcinomatous Component Present,Mucinous cystadenocarcinoma appendix
1357,Carcinomatous Component Present,Carcinoma of Littre Glands
1358,Epithelial Component Present,Gastric Tubular Adenocarcinoma
1359,Carcinomatous Component Present,Nodulo-ulcerative basal cell carcinoma
1360,Carcinomatous Component Present,Carcinoma of anal canal
1361,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Seminoma
1362,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic Lymphadenopathy
1363,Hemorrhagic,Angiosarcoma of the breast
1364,Well-Circumscribed Lesion,Myofibroblastoma
1365,Collagenous Stroma Formation,Myofibroblastoma
1366,Indolent Clinical Course,Appendix Leiomyoma
1367,Oligodendroglial Component Present,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
1368,Breast Microcalcification,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
1369,Intraductal Lesion,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
1370,Epithelial Component Present,Adenocarcinoid tumor
1371,Refractory Disease,Refractory Follicular Lymphoma
1372,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of cervix uteri
1373,Well-Circumscribed Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma
1374,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts II
1375,Pregnancy Complications,Leuteoma of Pregnancy
1376,Stromal Invasion,FIGO Stage IC2 Ovarian Cancer
1377,Metastatic Lesion,Breast Carcinoma Metastatic in the Bone
1378,Carcinomatous Component Present,Early gastric cancer
1379,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214
1380,Nuclear Atypia,Infratentorial Glioblastoma
1381,Severe dysplasia,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia
1382,CD30-Positive Neoplastic Cells Present,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative"
1383,Cartilaginous Component Present,Subungual exostoses
1384,Large Spaces Filled with Blood Present,"Bone Cysts, Aneurysmal"
1385,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage II
1386,Epithelial Component Present,Stage IVB Colon Cancer AJCC v7
1387,Carcinomatous Component Present,Liver and Intrahepatic Biliary Tract Carcinoma
1388,Refractory Disease,Refractory Spinal Cord Neoplasm
1389,Locally Aggressive Lesion,Retroperitoneal Inflammatory Myofibroblastic Tumor
1390,Cutaneous Involvement,Desmoplastic Nevus
1391,Epithelial Component Present,Testicular Carcinoid Tumor
1392,Cutaneous Involvement,Apocrine Breast Carcinoma In Situ
1393,atypia morphology,Bowenoid papulosis of penis
1394,Benign Cellular Infiltrate,lipoma of extrahepatic bile duct
1395,Indolent Clinical Course,Infiltrating angiolipoma
1396,Anaplasia,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
1397,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma
1398,Epithelial Component Present,Stage IIB Lung Cancer AJCC v7
1399,Carcinomatous Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
1400,Calcitonin serum level increased,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
1401,Carcinomatous Component Present,Stage IIA Ampulla of Vater Cancer AJCC v7
1402,Hyperplastic Epithelial Tissue Present,Atypical Breast Myoepitheliosis
1403,Moderate dysplasia,Cervical intraepithelial neoplasia grade 2
1404,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma
1405,Carcinomatous Component Present,papillary carcinoma of renal pelvis
1406,Absence of Invasion,Stage 0 Vulvar Carcinoma
1407,No Identifiable Line of Differentiation,Cardiac Malignant Fibrous Histiocytoma
1408,Fibrotic Stroma Formation,Ovarian Seromucinous Adenofibroma
1409,Carcinomatous Component Present,Ovarian Clear Cell Cystadenocarcinoma
1410,Epithelial Component Present,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
1411,Recurrent disease,Recurrent Male Reproductive System Carcinoma
1412,High Grade Lesion,Grade III Childhood Astrocytoma
1413,Carcinomatous Component Present,Stage IIIB Vulvar Cancer AJCC v7
1414,Infiltrative Growth Pattern,Proneural Glioblastoma
1415,Pseudoencapsulated Mass,"Perineurioma, malignant"
1416,Fibrotic Stroma Formation,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
1417,Carcinomatous Component Present,Stage III Skin Cancer
1418,Adulthood Lesion,Adult Anaplastic Oligodendroglioma
1419,Stromal Invasion,Stage IIB Ovarian Cancer AJCC v6 and v7
1420,Recurrent disease,Locally Recurrent Malignant Neoplasm
1421,Epithelial Component Present,Stage IIB Lung Squamous Cell Carcinoma AJCC v7
1422,Myxoid Stroma Formation,Cellular Myxoma
1423,Childhood Lesion,Malignant Childhood Germ Cell Tumor
1424,Epithelial Component Present,Colon Cancer by AJCC v6 Stage
1425,Exophytic Polypoid Lesion,Vulvar Fibroepithelial Stromal Polyp
1426,Ineffective hematopoiesis,Secondary Myelodysplastic Syndrome
1427,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome NOS
1428,Cutaneous Involvement,Xeroderma Pigmentosum
1429,Carcinomatous Component Present,Small intestine carcinoma stage II
1430,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v7
1431,Epithelial Component Present,Bartholin Gland Adenoid Cystic Carcinoma
1432,Mesenchymal Component Present,Soft Palate Pleomorphic Adenoma
1433,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monocytic Leukemia
1434,Nuclear Atypia,Fibrillary Astrocytoma
1435,Well-Circumscribed Lesion,Polyp of small intestine
1436,Epithelial Component Present,Bartholin Gland Small Cell Carcinoma
1437,Necrotic changes (finding),"Glioblastoma, IDH-Mutant"
1438,Neuroendocrine Differentiation,Vulvar Merkel Cell Carcinoma
1439,Diffuse Pattern,Diffuse Astrocytoma
1440,Epithelial Component Present,Melanoacanthoma
1441,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
1442,Epithelial Component Present,Gonadotroph adenoma
1443,Carcinomatous Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
1444,Epithelial Component Present,Posterior Pharyngeal Wall Carcinoma
1445,Epithelial Component Present,Choroid Plexus Carcinoma
1446,Carcinomatous Component Present,adenocarcinoma of breast with squamous metaplasia
1447,Diffuse Pattern,Adult Diffuse Large B-Cell Lymphoma
1448,Lymphoplasmacytic Infiltrate,Pineal germinoma
1449,Neuroendocrine Differentiation,Small cell carcinoma of esophagus
1450,Invasive Lesion,Medullary carcinoma of breast
1451,Mitotic Activity,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
1452,Neuropil Present,Poorly Differentiated Neuroblastoma
1453,Vascular Channel Formation,Superior Vena Cava Angiosarcoma
1454,Epithelial Component Present,Middle Ear Paraganglioma
1455,HMB-45-Positive Neoplastic Cells Present,Malignant Uterine Corpus PEComa
1456,Neuronal Differentiation,Adult Ganglioglioma
1457,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage I
1458,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical"
1459,Adulthood Lesion,Hodgkin Lymphoma During Pregnancy
1460,Epithelial Component Present,Endometrial Transitional Cell Carcinoma
1461,Cystic Change,Mucinous cystadenofibroma
1462,Peripheral Nuclear Palisading,Skin Basaloid Carcinoma
1463,Non-Hereditary Lesion,Gastric Carcinoma with Lymphoid Stroma
1464,Stromal Invasion,Stage IIIA Ovarian Carcinoma
1465,Cutaneous Involvement,Pigmented hairy epidermal nevus
1466,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma refractory
1467,Cutaneous Involvement,Radiation-Recall Dermatitis
1468,Monomorphic Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified"
1469,Chondromyxoid Stroma Formation,Ectomesenchymal Chondromyxoid Tumor
1470,Invasive Lesion,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma
1471,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant"
1472,Somatostatin Positive Neoplastic Cells Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor
1473,Epithelial Component Present,Colorectal Neuroendocrine Tumor G1
1474,Epithelial Component Present,Colon Sessile Serrated Adenoma/Polyp
1475,Poorly Differentiated Lesion,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
1476,Invasive Lesion,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
1477,Cutaneous Involvement,Cellular Blue Nevus
1478,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Tubular Variant"
1479,Mixed Cellular Population,mucinous adenocarcinofibroma of ovary
1480,High Grade Lesion,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
1481,Moderately Differentiated Lesion,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
1482,Necrotic changes (finding),pleomorphic carcinoma of breast
1483,Carcinomatous Component Present,Childhood Thyroid Gland Papillary Carcinoma
1484,Nuclear Grooves,Childhood Thyroid Gland Papillary Carcinoma
1485,Papillary Pattern,Warty Carcinoma of the Penis
1486,Perivascular Arrangement of Tumor Cells,Bone Glomus Tumor
1487,Tissue Differentiation Uncertain,Atypical fibroxanthoma of skin
1488,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7
1489,Synchronous Lesion,Synchronous Bilateral Breast Carcinoma
1490,Epithelial Component Present,High-Grade Prostatic Intraepithelial Neoplasia
1491,Carcinomatous Component Present,Stage II Lip Cancer AJCC v6 and v7
1492,Carcinomatous Component Present,Adenocarcinoma with neuroendocrine differentiation
1493,Increased Cellularity Present,Kadish Stage C Olfactory Neuroblastoma
1494,Epithelial Component Present,Adenomatous polyp of rectum
1495,Epithelial Component Present,Cervical Squamous Intraepithelial Neoplasia
1496,Carcinomatous Component Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
1497,Cutaneous Involvement,Epithelioid cell nevus
1498,Nuclear pleomorphism,Degenerated Schwannoma
1499,S-100-Positive Neoplastic Cells Present,Sclerosing PEComa
1500,Calcitonin serum level increased,Sporadic Thyroid Gland Micromedullary Carcinoma
1501,Epithelial Component Present,Carcinoma of apocrine gland
1502,Generalized illness,Schwannomatosis
1503,Epithelial Component Present,benign myoepithelioma of salivary gland
1504,Well-Circumscribed Lesion,Rectal Juvenile Polyp
1505,Dysplasia,Small Intestinal Intraepithelial Neoplasia
1506,Carcinomatous Component Present,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7
1507,Epithelial Component Present,Widely Invasive Thymoma
1508,Hereditary Lesion,Multiple self-healing epithelioma of Ferguson-Smith
1509,Mixed Cellular Population,Pleomorphic adenoma of parotid gland
1510,Solitary mass,Epithelioid hemangioendothelioma
1511,Endophytic Tumor Growth,Laryngeal verrucous carcinoma
1512,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
1513,Neuroendocrine Differentiation,Neuroendocrine carcinoma of appendix
1514,Epithelial Component Present,Colorectal Medullary Carcinoma
1515,Adnexal Differentiation,"Adenoma, Sweat Gland"
1516,Stromal Invasion,Malignant Ovarian Serous Tumor
1517,Nodules of Compact Keratin Present,Adamantinous Craniopharyngioma
1518,Epithelial Component Present,Preinvasive Neoplasm of the Ampullary Region
1519,Fibrotic Stroma Formation,Biliary Adenofibroma
1520,Pancreatobiliary-Type Malignant Cells Present,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
1521,Angiocentric Pattern,Grade I Lymphomatoid Granulomatosis
1522,Carcinomatous Component Present,Lung Pleomorphic Carcinoma
1523,Chronic Inflammatory Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma
1524,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
1525,Mixed Cellular Population,carcinosarcoma of lung
1526,Epithelial Component Present,Benign pheochromocytoma of adrenal gland
1527,Carcinomatous Component Present,Transitional cell cancer of renal pelvis and ureter metastatic
1528,Myxoid Stroma Formation,Odontogenic myxofibroma
1529,Trabecular Pattern,Tall Cell Variant Thyroid Gland Papillary Carcinoma
1530,High Grade Lesion,large cell neuroendocrine carcinoma of lung
1531,Cutaneous Involvement,Invasive Cutaneous Melanoma
1532,Indolent Clinical Course,Trichodiscoma
1533,Epithelial Component Present,Ovarian Mucinous Cystadenofibroma
1534,Necrotic changes (finding),Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
1535,More than 10 Mitoses per 10HPF,Stage I Lung Small Cell Carcinoma AJCC v7
1536,Cutaneous Involvement,Stage IIB Cutaneous Melanoma AJCC v6 and v7
1537,Carcinomatous Component Present,Acinar Prostate Mucinous Adenocarcinoma
1538,Well-Circumscribed Lesion,Sebaceoma
1539,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
1540,Nodular Pattern,Ann Arbor Stage IV Grade 2 Follicular Lymphoma
1541,Severe dysplasia,Stage 0 Anal Canal Cancer AJCC v6 and v7
1542,Parakeratosis,Bowen's Disease
1543,Epithelial Component Present,Vaginal Non-Keratinizing Squamous Cell Carcinoma
1544,Carcinomatous Component Present,Stage III Lung Small Cell Carcinoma AJCC v7
1545,Increased megakaryocytes (bone marrow),Prefibrotic/Early Primary Myelofibrosis
1546,Prominent In Situ Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
1547,Juvenile Lesion,Juvenile papillomatosis of breast
1548,Nodular Pattern,Dysembryoplastic neuroepithelial tumor
1549,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
1550,Recurrent disease,Recurrent Malignant Solid Neoplasm
1551,Epithelial Component Present,Basaloid carcinoma
1552,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
1553,Carcinomatous Component Present,Tongue Carcinoma
1554,Nuclear Grooves,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
1555,Epithelial Component Present,Stage I Adult Liver Cancer AJCC v7
1556,Diffuse Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma
1557,Neuroendocrine Differentiation,Small cell carcinoma of prostate
1558,Infiltrative Growth Pattern,Childhood Glioblastoma
1559,Recurrent disease,Recurrent Malignant Neoplasm of Salivary Gland
1560,Carcinomatous Component Present,Basal cell carcinoma of vulva
1561,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Vagina
1562,Koilocytotic atypia,Human Papillomavirus-Related Squamous Cell Carcinoma
1563,Diffuse Pattern,Stage I Diffuse Large B-Cell Lymphoma
1564,Pseudoglandular Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
1565,Slow Growing Painless Mass,Lipoblastoma
1566,Indolent Clinical Course,Paratesticular Lipoma
1567,Neuroendocrine Differentiation,Familial Paraganglioma
1568,Immunologic Deficiency Syndromes,AIDS-Related Carcinoma
1569,Necrotic changes (finding),Childhood Giant Cell Glioblastoma
1570,Infiltrative Growth Pattern,Childhood Giant Cell Glioblastoma
1571,Indolent Clinical Course,Vulvar Leiomyoma
1572,Adnexal Differentiation,Hidradenoma Papilliferum
1573,Smooth Muscle Component Present,Hepatic Angiomyolipoma
1574,Absence of Invasion,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
1575,Mixed Cellular Population,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm
1576,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
1577,Epithelial Component Present,Adenocarcinoma of prostate
1578,Primary Lesion,Adult Primary Melanocytic Lesion of Meninges
1579,Tissue of Mullerian Origin Present,Adenocarcinofibroma
1580,Well-Circumscribed Lesion,Metachronous Wilms Tumor
1581,Carcinomatous Component Present,Stage IIC Colon Cancer AJCC v7
1582,Mesenchymal Component Present,Prostate Phyllodes Tumor
1583,Epithelial Component Present,Borderline Ovarian Mucinous Tumor
1584,Hyperplastic Tissue Present,Sebaceous hyperplasia
1585,Basal Cells with Pale Cytoplasm Present,"Acanthoma, Clear Cell"
1586,Mixture of Germ Cell Neoplastic Components Present,Mixed Germ Cell Tumor
1587,Indolent Clinical Course,Hemangioma of skin
1588,Hypercellular bone marrow,Juvenile Myelomonocytic Leukemia
1589,Childhood Lesion,Childhood Brain Germ Cell Tumor
1590,Pseudorosette Formation,Pancreatic Gastrin-Producing Neuroendocrine Tumor
1591,Vascular Channel Formation,Vascular neoplasm of skin
1592,Secondary Lesion,Vaginal adenocarcinoma metastatic
1593,Adulthood Lesion,BCLC Stage D Adult Hepatocellular Carcinoma
1594,Severe dysplasia,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
1595,Carcinomatous Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
1596,Mitotic Activity,Glioblastoma
1597,Epithelial Component Present,Gastric Neuroendocrine Tumor
1598,Neuroendocrine Differentiation,Gastric Neuroendocrine Tumor
1599,Indolent Clinical Course,Lipoma of external auditory meatus
1600,Borderline Lesion,Proliferating Brenner Tumor
1601,Carcinomatous Component Present,Recurrent Rectal Cancer
1602,Non-Malignant Cellular Infiltrate,Cervical lymphadenitis
1603,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anaemia with excess blasts
1604,Epithelial Component Present,Intracystic Papillary Breast Carcinoma
1605,Carcinomatous Component Present,Submandibular Gland Undifferentiated Carcinoma
1606,Well-Circumscribed Lesion,Appendix Tubular Adenoma
1607,Dysplasia,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
1608,Severe cytologic atypia,Gastric Large Cell Neuroendocrine Carcinoma
1609,Epithelial Component Present,Syringofibroadenoma
1610,Nuclear Atypia,Adult Glioblastoma
1611,Undifferentiated Lesion,Undifferentiated Stromal Sarcoma
1612,Childhood Lesion,Childhood Burkitt Lymphoma
1613,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v7
1614,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,"Myelodysplastic syndrome, no ICD-O subtype"
1615,Epithelial Component Present,Invasive micropapillary carcinoma of breast
1616,Local disease,Localized Castleman Disease
1617,Childhood Lesion,Childhood Clear Cell Sarcoma of Soft Parts
1618,Nodular Pattern,Hodgkin's disease nodular sclerosis refractory
1619,Carcinomatous Component Present,Colorectal Micropapillary Adenocarcinoma
1620,Intraductal Lesion,Intraductal Hyperplasia
1621,Villous Pattern,Vaginal Villous Adenoma
1622,Exophytic Polypoid Lesion,Vaginal Villous Adenoma
1623,Epithelial Component Present,Benign neoplasm of sebaceous gland
1624,Myxoid Stroma Formation,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
1625,Carcinomatous Component Present,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma
1626,Cutaneous Involvement,Epidermolysis Bullosa Simplex
1627,Epithelial Component Present,Stage IIIC Adult Liver Cancer AJCC v7
1628,Increased Cellularity Present,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
1629,Endophytic Tumor Growth,Anal Verrucous Carcinoma
1630,Cystic Change,"Cystadenocarcinoma, Mucinous"
1631,Acinar Cell Differentiation,Acinar Cell Carcinoma
1632,Epithelial Component Present,Atypical Breast Papilloma
1633,Well-Circumscribed Lesion,Nasopharyngeal Angiofibroma
1634,Tissue Differentiation Uncertain,Mediastinal Synovial Sarcoma
1635,Benign Cellular Infiltrate,Benign neoplasm of appendix
1636,High Mitotic Activity,Stage IIIA Lung Small Cell Carcinoma AJCC v7
1637,Cutaneous Involvement,Corn of toe
1638,Epithelial Component Present,Stage IIA Esophagus Carcinoma
1639,Nerve palsy,Cranial nerve palsies
1640,Recurrent disease,Recurrent Digestive System Neuroendocrine Tumor G1
1641,Lymphadenopathy,Monocytoid B-cell lymphoma
1642,Epithelial Component Present,Pituitary Adenoma
1643,Epithelial Component Present,Signet-ring cell adenocarcinoma gastric
1644,Epithelial Component Present,Carcinoid tumor of appendix
1645,Low Mitotic Activity,Carcinoid tumor of appendix
1646,Papillary Pattern,inverted ductal papilloma of salivary gland
1647,Carcinomatous Component Present,Bladder squamous cell carcinoma stage I
1648,Dysplasia,Cervical Intraepithelial Neoplasia Grade 2/3
1649,Indolent Clinical Course,Chondromyxoid fibroma
1650,Nuclear Atypia,Small cell glioblastoma
1651,Cutaneous Involvement,Bowenoid papulosis
1652,Metaplasia,Squamous Lung Dysplasia
1653,Adulthood Lesion,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
1654,Low Mitotic Activity,Meckel Diverticulum Neuroendocrine Tumor G1
1655,Papillary Pattern,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm
1656,Carcinomatous Component Present,Mucoepidermoid Carcinoma
1657,Cutaneous Involvement,Herpes zoster dermatitis
1658,Carcinomatous Component Present,Intraductal papillary adenocarcinoma with invasion
1659,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation
1660,Poorly Differentiated Lesion,Poorly Differentiated Angiosarcoma
1661,Local disease,Localized Ewing Sarcoma
1662,Carcinomatous Component Present,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7
1663,Cutaneous Involvement,Tinea Versicolor
1664,Lymphoplasmacytic Infiltrate,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
1665,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic eosinophilic leukemia
1666,Intraosseous Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous"
1667,Nodular Pattern,Ann Arbor Stage II Grade 2 Follicular Lymphoma
1668,Smooth Muscle Component Present,Mixed Endometrial Stromal and Smooth Muscle Neoplasm
1669,Carcinomatous Component Present,Stage IIIA Gastric Carcinoma
1670,Mixed Cellular Population,Combined Lung Large Cell Neuroendocrine Carcinoma
1671,Necrotic changes (finding),Combined Lung Large Cell Neuroendocrine Carcinoma
1672,Epithelial Component Present,Multiple Endocrine Neoplasia Type 1
1673,Mesenchymal Component Present,Mixed Salivary Gland Tumor
1674,Well Differentiated Lesion,verrucous carcinoma of esophagus
1675,Carcinomatous Component Present,Lepidic Predominant Adenocarcinoma
1676,Epithelial Component Present,Carcinomatosis of peritoneal cavity
1677,Epithelial Component Present,Invasive Ductal Breast Carcinoma
1678,Embryoid Bodies Present,Gonadal Polyembryoma
1679,Perineural spread,Desmoplastic Neurotropic Melanoma
1680,atypia morphology,Borderline epithelial tumor of ovary
1681,Epithelial Component Present,Anal Canal Mixed Adenoneuroendocrine Carcinoma
1682,Secondary Lesion,Metastatic Neoplasm to the Gallbladder
1683,Locally Aggressive Lesion,"Dermatofibrosarcoma Protuberans, Myxoid"
1684,Exophytic Polypoid Lesion,Foveolar-Type Adenoma
1685,Well-Circumscribed Lesion,Fetal rhabdomyoma
1686,Epithelial Component Present,Borderline Fallopian Tube Endometrioid Tumor
1687,In Situ Lesion,Stage 0is Renal Pelvis Cancer AJCC v7
1688,Adulthood Lesion,Recurrent Adult Acute Lymphoblastic Leukemia
1689,Indolent Clinical Course,Ovarian Fibromata
1690,Metastatic Lesion,Prostate Carcinoma Metastatic in the Lung
1691,Epithelial Component Present,Prostate Carcinoma Metastatic in the Lung
1692,Epithelial Component Present,Vaginal high grade squamous intraepithelial lesion
1693,Indolent Clinical Course,Atrial myxoma
1694,Epithelial Component Present,malignant gastrinoma of pancreas
1695,Anaplasia,Anaplastic Oligodendroglioma
1696,Slow Growing Mass,Pilocytic astrocytoma of cerebellum
1697,Cutaneous Involvement,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7
1698,Epithelial Component Present,Stage IIIA Ovarian Cancer AJCC v6 and v7
1699,Chronic Inflammatory Infiltrate,Mixed Cellularity Hodgkin Lymphoma
1700,Epithelial Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v7
1701,Whorling Growth Pattern,Classical Low Grade Fibromyxoid Sarcoma
1702,Diffuse Pattern,Oligodendroglioma of spinal cord
1703,Carcinomatous Component Present,Stage IIIB Small Intestinal Cancer AJCC v7
1704,Carcinomatous Component Present,Pituitary carcinoma
1705,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v6
1706,High Grade Lesion,High Grade Fallopian Tube Serous Adenocarcinoma
1707,Severe dysplasia,Stage 0 Oropharyngeal Carcinoma
1708,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
1709,Severe cytologic atypia,Primary hepatic neuroendocrine carcinoma
1710,Microinvasive tumor,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension
1711,Edematous Stroma Formation,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor
1712,Fibrotic Stroma Formation,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
1713,Epithelial Component Present,Carcinoma of larynx
1714,Epithelial Component Present,Stage IA2 Cervical Cancer
1715,Favorable Clinical Outcome,Ganglioneuroma of skin
1716,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type"
1717,Epithelial Component Present,Helicobacter Pylori-Related Carcinoma
1718,Cervical Glandular Dysplasia,Cervical Adenocarcinoma In Situ
1719,Recurrent disease,Malignant neoplasm of nasopharynx recurrent
1720,Carcinomatous Component Present,Helicobacter Pylori-Related Gastric Adenocarcinoma
1721,Lesion with Diameter of 4mm or More,Vulvar Dysplastic Melanocytic Nevus
1722,Acquired Lesion,Acquired postural kyphosis
1723,Epithelial Component Present,Stage 0 Vulvar Carcinoma
1724,Absence of Invasion,Stage 0 Oral Cavity Cancer AJCC v6 and v7
1725,Well-Circumscribed Lesion,Breast Pleomorphic Adenoma
1726,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Conventional Leiomyosarcoma
1727,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7
1728,Well-Circumscribed Lesion,Vaginal Myofibroblastoma
1729,Rapidly Enlarging Mass,rhabdomyosarcoma of extrahepatic bile duct
1730,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
1731,Cutaneous Involvement,Cutaneous Lymphomatoid Granulomatosis
1732,Vascular Channel Formation with Muscular Walls,Glomangiomyoma
1733,Epithelial Component Present,Stage IC Ovarian Cancer AJCC v6 and v7
1734,Cutaneous Involvement,Benign Cutaneous Vascular Neoplasm
1735,Indolent Clinical Course,Vaginal Leiomyoma
1736,Carcinomatous Component Present,Adrenocortical carcinoma
1737,Epithelial Component Present,Cervical Lymphoepithelioma-Like Carcinoma
1738,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monocytic Leukemia
1739,Perineural spread,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
1740,Inflammatory infiltrate,Nodular tenosynovitis
1741,Carcinomatous Component Present,Stage IIB Lung Squamous Cell Carcinoma AJCC v7
1742,Local disease,Epidural Spinal Canal Angiolipoma
1743,Primary Lesion,Benign Adult Brain Stem Neoplasm
1744,Mitotic Activity,Childhood Testicular Yolk Sac Tumor
1745,Hemorrhagic,Colorectal Angiosarcoma
1746,Neuroendocrine Differentiation,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
1747,Myxoid Stroma Formation,Clivus Chondroid Chordoma
1748,Epithelial Component Present,carcinoma of middle ear
1749,Carcinomatous Component Present,Invasive Mixed Breast Carcinoma
1750,Epithelial Component Present,Bladder papilloma
1751,Nuclear Atypia,"Glioblastoma, IDH-Wildtype"
1752,High Mitotic Activity,Anaplastic Oligoastrocytoma
1753,Epidermotropic Lymphocytic Infiltrate,Pagetoid reticulosis
1754,Microvascular Proliferation,"Glioblastoma, IDH-Mutant"
1755,Non-Hereditary Lesion,Gastric Intestinal-Type Adenocarcinoma
1756,Cystic Change,inverted follicular keratosis
1757,Epithelial Component Present,Colorectal Filiform Serrated Adenoma
1758,Fibrotic Stroma Formation,Vaginal Rhabdomyoma
1759,Carcinomatous Component Present,Papillary adenocarcinoma
1760,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
1761,Mitotic Activity,Brain Glioblastoma
1762,Neuroectodermal Differentiation,Askin's tumor
1763,Fibrotic Stroma Formation,Perihilar Intrahepatic Cholangiocarcinoma
1764,Exophytic Polypoid Lesion,Gallbladder adenoma
1765,New bone formation (morphologic abnormality),Osteoblastic Osteosarcoma
1766,Dysplasia,Carcinoma in situ of penis
1767,Epithelial Component Present,Broad Ligament Serous Cystadenofibroma
1768,Mitotic Activity,Recurrent Glioblastoma
1769,Hyalinized Vessels Present,Adult Pilocytic Astrocytoma
1770,Necrotic changes (finding),Colon Small Cell Neuroendocrine Carcinoma
1771,Cutaneous Involvement,Meyerson Nevus
1772,Nodular Pattern,Ann Arbor Stage III Grade 1 Follicular Lymphoma
1773,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
1774,Neuroendocrine Differentiation,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
1775,Epithelial Component Present,Posterior Tongue Squamous Cell Carcinoma
1776,Mitotic Activity,Childhood Central Nervous System Yolk Sac Tumor
1777,High Mitotic Activity,small cell carcinoma of salivary gland
1778,Metastatic Lesion,Meningeal Leukemia
1779,Neuroendocrine Differentiation,small cell carcinoma of gallbladder
1780,Adulthood Lesion,Adult B Lymphoblastic Lymphoma
1781,Absence of Stromal Invasion,Serous Endometrial Intraepithelial Carcinoma
1782,Epithelial Component Present,Gastric Small Cell Carcinoma
1783,Epithelial Component Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation
1784,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage I
1785,Adulthood Lesion,Adult Central Nervous System Mixed Germ Cell Tumor
1786,Biphasic Pattern,Mucinous cystadenofibroma
1787,Childhood Lesion,PRETEXT Stage 1 Hepatoblastoma
1788,Epithelial Component Present,Breast Neuroendocrine Neoplasm
1789,Adulthood Lesion,Adult Brain Meningioma
1790,Epithelial Component Present,Stage IIIA Ovarian Carcinoma
1791,Cribriform Pattern,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
1792,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Therapy-related myelodysplastic syndrome
1793,Thyroglobulin Positive Neoplastic Cells Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
1794,Cellular Pleomorphism,Inflammatory malignant fibrous histiocytoma
1795,Epithelial Component Present,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1796,Carcinomatous Component Present,Breast Mucinous Cystadenocarcinoma
1797,Generalized Dysplasia,Rectal Traditional Serrated Adenoma
1798,Epithelial Component Present,undifferentiated carcinoma of anal canal
1799,Anaplasia,Recurrent Childhood Anaplastic Oligodendroglioma
1800,Skin Erosion,Erosive Adenomatosis of the Nipple
1801,Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia recurrent
1802,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma metastatic
1803,Neuroendocrine Differentiation,Transverse Colon Neuroendocrine Tumor G1
1804,Well-Circumscribed Lesion,Metaplastic thymoma
1805,Nodular Pattern,Ann Arbor Stage I Grade 3 Follicular Lymphoma
1806,Childhood Lesion,Childhood Thyroid Gland Papillary Carcinoma
1807,Bilateral Disease,Synchronous Bilateral Breast Carcinoma
1808,Progressive Clinical Course,mu-Chain Disease
1809,Carcinomatous Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
1810,Splenomegaly,Philadelphia chromosome positive chronic myelogenous leukemia
1811,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage I
1812,Immunologic Deficiency Syndromes,AIDS-Related Non-Hodgkin Lymphoma
1813,High Grade Lesion,Anaplastic Hemispheric Astrocytoma
1814,Neuroendocrine Differentiation,Childhood Lung Small Cell Carcinoma
1815,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
1816,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Yolk Sac Tumor and Teratoma
1817,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma recurrent
1818,Carcinomatous Component Present,Tonsillar Undifferentiated Carcinoma
1819,Epithelial Component Present,Prostate Cancer by Whitmore-Jewett Stage
1820,Neuroendocrine Differentiation,Gallbladder Neuroendocrine Tumor G2
1821,Severe dysplasia,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7
1822,Carcinomatous Component Present,Maxillary Sinus Carcinoma
1823,Tissue Differentiation Uncertain,Extraskeletal Myxoid Chondrosarcoma
1824,Well-Circumscribed Lesion,Hemangioblastoma
1825,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant"
1826,Carcinomatous Component Present,Oropharyngeal lymphoepithelioma stage III
1827,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Mixed Somatotroph and Lactotroph Adenoma
1828,Pseudopapillary Pattern,Papillary craniopharyngioma
1829,Anaplasia,Stage IV Childhood Anaplastic Large Cell Lymphoma
1830,Malignant Cellular Infiltrate,Childhood Ovarian Dysgerminoma
1831,Collagenous Stroma Formation,Gardner Fibroma
1832,Carcinomatous Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7
1833,Papillary Pattern,Borderline Ovarian Serous Adenofibroma
1834,Abundant Intracytoplasmic Lipofuscin Present,Heavily Pigmented Adrenal Cortical Adenoma
1835,Cellular Pleomorphism,Intracortical osteosarcoma
1836,Lymphoplasmacytic Infiltrate,Angiocentric immunoproliferative lesion grade 2
1837,Pregnancy Complications,"Trophoblastic Tumor, Placental Site"
1838,Carcinomatous Component Present,Carcinoma ex pleomorphic adenoma of parotid gland
1839,Recurrent Genetic Abnormalities Present,Core binding factor acute myeloid leukemia
1840,Mitotic Activity,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7
1841,Carcinomatous Component Present,Bladder adenocarcinoma stage I
1842,Dysplasia,Adenoma of large intestine
1843,Cutaneous Involvement,Non-Neoplastic Skin Disorder
1844,Papillary Pattern,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
1845,Carcinomatous Component Present,Squamous cell carcinoma of penis
1846,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Immature Teratoma
1847,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage I
1848,Epithelial Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7
1849,Anaplasia,Sarcomatoid Renal Cell Carcinoma
1850,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
1851,Epithelial Component Present,Stage IIA Small Intestinal Cancer AJCC v7
1852,Encapsulated Mass,Thyroid Gland Clear Cell Follicular Adenoma
1853,Necrotic changes (finding),Stage IB Lung Small Cell Carcinoma AJCC v7
1854,Necrotic changes (finding),Stage IIB Lung Small Cell Carcinoma AJCC v7
1855,Moderate dysplasia,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
1856,Eccrine Differentiation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
1857,Intraluminal Tumor Growth,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia
1858,Necrotic changes (finding),Stage II Lung Small Cell Carcinoma AJCC v7
1859,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Isolated del(5q)
1860,Alternative Fascicle (Bundle) Pattern,Leiomyoma of ciliary body
1861,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Carcinoma
1862,Absence of a Hormonal Syndrome,Non-Functioning Endocrine Neoplasm
1863,Benign Cellular Infiltrate,Rectal Lipoma
1864,Carcinomatous Component Present,Metastatic Carcinoma in the Adrenal Medulla
1865,Carcinomatous Component Present,Carcinoma in situ of trachea
1866,Marked Bone Marrow Fibrosis,Overt Primary Myelofibrosis
1867,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Gene Mutation
1868,Immunoglobulin Deposition,Primary amyloidosis
1869,Cutaneous Involvement,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype"
1870,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1
1871,Carcinomatous Component Present,Adenocarcinoma with cartilaginous metaplasia
1872,Epithelial Component Present,Papillary cystic tumor
1873,Indolent Clinical Course,Endobronchial lipoma
1874,In Situ Lesion,Adenocarcinoma in Situ
1875,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
1876,Papillary Pattern,"Lung Squamous Cell Carcinoma, Papillary Variant"
1877,'Starry-sky' pattern,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
1878,Adnexal Differentiation,Ocular Sebaceous Carcinoma
1879,Carcinomatous Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant"
1880,Monomorphic Cellular Infiltrate,Benign oncocytoma of salivary gland
1881,Well-Circumscribed Lesion,Gallbladder Papillary Adenoma
1882,More than 10 Mitoses per 10HPF,Small cell carcinoma of prostate
1883,Exophytic Polypoid Lesion,Gastric hyperplastic polyp
1884,Nuclear Atypia,Childhood Glioblastoma
1885,Vascular Channel Formation,Kaposiform Hemangioendothelioma
1886,atypia morphology,Recurrent Grade III Lymphomatoid Granulomatosis
1887,Carcinomatous Component Present,Sphenoid Sinus Squamous Cell Carcinoma
1888,Cutaneous Involvement,Verrucous keratotic hemangioma
1889,Epithelioid Differentiation,Pleural Epithelioid Mesothelioma
1890,Diffuse Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
1891,Carcinomatous Component Present,Carcinoma in situ of prostate
1892,Carcinomatous Component Present,Frontal Sinus Squamous Cell Carcinoma
1893,Complete Spontaneous Regression,Lymphomatoid Papulosis
1894,Dysplasia,tubulovillous adenoma of stomach
1895,Invasive Lesion,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
1896,Mixed Cellular Population,Childhood Oligoastrocytoma
1897,Firm mass,Esophageal Malignant Peripheral Nerve Sheath Tumor
1898,Therapy-Related Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
1899,Lesion with Diameter of 5cm or Less,"Gastrointestinal stromal tumor, benign"
1900,Collagenous Stroma Formation,Sclerosing Epithelioid Fibrosarcoma
1901,High Grade Lesion,Uterine Corpus Rhabdomyosarcoma
1902,Lymphoplasmacytic Infiltrate,Adult Central Nervous System Germinoma
1903,Epithelial Component Present,Breast Solid Neuroendocrine Carcinoma
1904,Adnexal Differentiation,Follicular Myxoma
1905,Follicular Cell Differentiation,Follicular Variant Thyroid Gland Papillary Carcinoma
1906,Cystic Change,Serous papillary cystic tumor of borderline malignancy
1907,Well-Circumscribed Lesion,Serous papillary cystic tumor of borderline malignancy
1908,Neuroendocrine Differentiation,Endometrial Large Cell Neuroendocrine Carcinoma
1909,Nodular lesions,Bronchial adenoma
1910,Swelling,Childhood Mesenchymal Chondrosarcoma
1911,Malignant Component Present,"Struma ovarii, malignant"
1912,Hyperkeratosis,papillary carcinoma of penis
1913,Immunologic Deficiency Syndromes,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
1914,Infantile Lesion,Infant Acute Biphenotypic Leukemia
1915,Papillary Pattern,Papillomatosis
1916,Ineffective hematopoiesis,Epipodophyllotoxin-Related Myelodysplastic Syndrome
1917,Indolent Clinical Course,Lipoma of spinal cord
1918,Epithelial Component Present,undifferentiated carcinoma of pancreas
1919,Epithelial Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
1920,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Secretory breast carcinoma
1921,Tissue Differentiation Uncertain,Epithelioid Type Angiomyolipoma
1922,Carcinomatous Component Present,Stage IIIB Eyelid Carcinoma AJCC v7
1923,Epithelial Component Present,Hypopharyngeal Carcinoma by AJCC v6 Stage
1924,Cutaneous Involvement,Classic Type Trichilemmoma
1925,Epithelial Component Present,Stage IA Lung Squamous Cell Carcinoma AJCC v7
1926,Dysplasia,"Glandular intraepithelial neoplasia, grade III"
1927,Carcinomatous Component Present,Stage IVB Oral Cavity Cancer AJCC v6 and v7
1928,Well-Circumscribed Lesion,Cervical Fibroepithelial Polyp
1929,Micropapillary Pattern,Colon Micropapillary Adenocarcinoma
1930,Neuroendocrine Differentiation,Merkel cell carcinoma
1931,Secondary Lesion,Secondary malignant neoplasm of large intestine
1932,Sebaceous Differentiation,Benign neoplasm of sebaceous gland
1933,Thyroglobulin Positive Neoplastic Cells Present,minimally invasive follicular carcinoma of the thyroid gland
1934,Childhood Lesion,Childhood Malignant Small Intestinal Neoplasm
1935,Epithelial Component Present,Grade 3 Colon Adenocarcinoma
1936,Mitotic Activity,Childhood Brain Stem Gliosarcoma
1937,Well-Circumscribed Lesion,Polyp of sphenoidal sinus
1938,Epithelial Component Present,Tubular adenoma
1939,Osseous Differentiation,Osteoma
1940,In Situ Lesion,Low Grade Ductal Breast Carcinoma In Situ
1941,Low Mitotic Activity,Small Intestinal Neuroendocrine Tumor G2
1942,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma AJCC v7
1943,Refractory Disease,Mantle cell lymphoma refractory
1944,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of skin
1945,Cutaneous Involvement,Pseudoporphyria
1946,Low Mitotic Activity,Gastric Neuroendocrine Tumor G2
1947,Carcinomatous Component Present,Minor Salivary Gland Mucoepidermoid Carcinoma
1948,Dermal Involvement,Vaginal Blue Nevus
1949,Melanin Pigment Present,Vaginal Blue Nevus
1950,Precise Histogenesis Unknown,Retinal hemangioblastoma
1951,Cutaneous Involvement,"lymphomatoid papulosis, type A"
1952,Epithelial Component Present,keratinizing squamous cell carcinoma of vulva
1953,Glandular Pattern,Glandular malignant peripheral nerve sheath tumor
1954,Drug toxicity,Transplant-Related Kaposi Sarcoma
1955,Primary Lesion,Stage IIA Osteosarcoma AJCC v7
1956,Favorable Clinical Outcome,Inflammatory Hepatocellular Adenoma
1957,Adulthood Lesion,Adult Astrocytic Tumor
1958,Embryoid Bodies Present,Stage IV Ovarian Polyembryoma AJCC v6 and v7
1959,Cutaneous Involvement,Skin Sarcomatoid Basal Cell Carcinoma
1960,Epithelial Component Present,Hindgut Carcinoid Tumor
1961,Fibrotic Stroma Formation,Mucoepidermoid Carcinoma
1962,Epithelial Component Present,Infiltrating papillary adenocarcinoma
1963,Carcinomatous Component Present,Distal Urethral Carcinoma
1964,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,de novo Myelodysplastic Syndrome
1965,Diffuse Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor
1966,Hyaline Cartilage Differentiation,Secondary Peripheral Chondrosarcoma
1967,High Grade Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma
1968,Ganglion Cell-Like Elements Present,Small Intestinal Gangliocytic Paraganglioma
1969,Epithelial Component Present,Inflammatory carcinoma of breast stage III
1970,Epithelial Component Present,Bladder squamous cell carcinoma stage II
1971,Carcinomatous Component Present,Bladder squamous cell carcinoma stage II
1972,Mild cytologic atypia,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
1973,Recurrent disease,Recurrent Oropharyngeal Undifferentiated Carcinoma
1974,Adulthood Lesion,Stage IIA Adult Soft Tissue Sarcoma AJCC v7
1975,Immunologic Deficiency Syndromes,AIDS-related anal cancer recurrent
1976,In Situ Lesion,Papillary carcinoma in situ
1977,Acinar Cell Differentiation,Major Salivary Gland Acinic Cell Carcinoma
1978,Indolent Clinical Course,"Chondromatosis, Synovial"
1979,Neuroendocrine Differentiation,Gallbladder Goblet Cell Carcinoid
1980,Dysplasia,Low Grade Penile Intraepithelial Neoplasia
1981,Cutaneous Involvement,Malignant Hair Follicle Neoplasm
1982,Childhood Lesion,Childhood Pineoblastoma
1983,Monomorphic Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma
1984,Chronic lymphocytic inflammation,Abdominal Inflammatory Myofibroblastic Tumor
1985,Fibrotic Stroma Formation,serous adenocarcinofibroma of ovary
1986,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
1987,Carcinomatous Component Present,Stage IV Major Salivary Gland Cancer AJCC v7
1988,Diffuse Lesion,Carcinomatosis of peritoneal cavity
1989,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma
1990,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma
1991,Monoclonal Cellular Population Present,Thyroid Gland Hyperfunctioning Adenoma
1992,Dysplasia,Squamous intraepithelial lesion
1993,Rapidly Enlarging Mass,Childhood Spindle Cell Rhabdomyosarcoma
1994,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor G2
1995,Recurrent disease,Recurrent Childhood Pineoblastoma
1996,atypia morphology,Columnar Cell Hyperplasia of the Breast with Atypia
1997,Nuclear Atypia,Anaplastic astrocytoma
1998,Cutaneous Involvement,Stage II Superficial Spreading Melanoma AJCC v6 and v7
1999,Tubular Pattern,Cholangiolocellular Carcinoma
2000,Multinodular Mass,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
2001,Epithelial Component Present,Combined Thymic Epithelial Neoplasm
2002,Epithelial Component Present,Bladder Cancer by AJCC v6 Stage
2003,Metastatic Lesion,Colon Carcinoma Metastatic in the Liver
2004,Carcinomatous Component Present,serous surface papillary carcinoma of ovary
2005,Epithelial Component Present,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma
2006,Primary Lesion,Primary malignant neoplasm of brain
2007,Blasts Under 20 Percent of Peripheral Blood White Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
2008,Fibrotic Stroma Formation,Classical Low Grade Fibromyxoid Sarcoma
2009,Carcinomatous Component Present,"Carcinoid, Goblet Cell"
2010,Carcinomatous Component Present,Early Invasive Cervical Squamous Cell Carcinoma
2011,Absence of Invasion,Bowenoid papulosis of penis
2012,Carcinomatous Component Present,Adenocarcinoma with squamous metaplasia
2013,Invasive Lesion,Minimally Invasive Thymoma
2014,Neuroendocrine Differentiation,"Ovarian Small Cell Carcinoma, Pulmonary Type"
2015,Recurrent disease,Recurrent Primary Peritoneal Carcinoma
2016,Nodular Pattern,"Lymphoma, Large-Cell, Follicular"
2017,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
2018,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
2019,Epithelial Component Present,Anterior Tongue Mucoepidermoid Carcinoma
2020,Secondary Lesion,Metastatic Neoplasm to the Placenta
2021,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
2022,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
2023,Well-Circumscribed Lesion,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
2024,Poorly Differentiated Lesion,Colorectal Sarcomatoid Carcinoma
2025,Carcinomatous Component Present,"Carcinoma, Granular Cell"
2026,Cutaneous Involvement,Cutaneous Melanoma
2027,Carcinomatous Component Present,Oropharyngeal Poorly Differentiated Carcinoma
2028,Lobulated Growth Pattern,Breast Sclerosing Adenosis
2029,Metastatic Lesion,Squamous Cell Carcinoma of Unknown Primary
2030,Acanthosis,verrucous carcinoma of vagina
2031,Biphasic Pattern,Breast Fibroepithelial Neoplasm
2032,Mixed Cellular Population,mixed gliomas
2033,Indolent Clinical Course,Gastric Lymphangioma
2034,Tissue Differentiation Uncertain,Cardiac Biphasic Synovial Sarcoma
2035,Epithelial Component Present,Microcystic adnexal carcinoma
2036,Indolent Clinical Course,Hemangioma of bone
2037,Mesenchymal Component Present,Hard Palate Pleomorphic Adenoma
2038,Monomorphic Cellular Infiltrate,"Adenoma, Monomorphic"
2039,Epithelial Component Present,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8"
2040,Tissue Differentiation Uncertain,Lung Synovial Sarcoma
2041,Carcinomatous Component Present,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8"
2042,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Cystadenofibroma
2043,Carcinomatous Component Present,Non-small cell lung cancer stage IIIA
2044,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,MYELODYSPLASTIC SYNDROME
2045,Diffuse Pattern,Proneural Glioblastoma
2046,Radiation Sickness,Radiation-induced fibrous mediastinitis
2047,Myxoid Stroma Formation,Cardiac Epithelioid Hemangioendothelioma
2048,Nuclear Atypia,Neural Glioblastoma
2049,Lobulated Growth Pattern,Chordoma of clivus
2050,Intraosseous Lesion,Solid/Multicystic Ameloblastoma
2051,Epithelial Component Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
2052,Tissue of Mullerian Origin Present,Mucinous adenofibroma
2053,Adulthood Lesion,Chronic Adult T-Cell Leukemia/Lymphoma
2054,Adulthood Lesion,Adult Pineal Parenchymal Cell Neoplasm
2055,Carcinomatous Component Present,"Uterine Carcinosarcoma, Homologous Type"
2056,Stromal Invasion,FIGO Stage IVA Ovarian Cancer
2057,Epithelial Component Present,FIGO Stage IVB Ovarian Cancer
2058,S-100-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis
2059,Indolent Clinical Course,Juvenile Xanthogranuloma
2060,Epithelial Component Present,Fibroadenoma of breast
2061,Carcinomatous Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
2062,Carcinomatous Component Present,Thyroid carcinoma
2063,Well-Circumscribed Lesion,Endometrial Polyp
2064,Hyperkeratosis,Seborrheic keratosis
2065,Acquired Lesion,"Nose Deformities, Acquired"
2066,Severe dysplasia,Stage 0 Cervical Cancer AJCC v6
2067,Well-Circumscribed Lesion,Filiform Serrated Adenoma
2068,Generalized Dysplasia,Colorectal Filiform Serrated Adenoma
2069,Epithelial Component Present,Stage I Nasopharyngeal Carcinoma
2070,Anaplasia,Cerebral Glioblastoma
2071,Lymphatic Spread,Inflammatory Breast Carcinoma
2072,Epithelial Component Present,Stage IA Lung Non-Small Cell Carcinoma AJCC v7
2073,Tartrate Resistant Acid Phosphatase Positive Cells Present,Hairy Cell Leukemia
2074,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
2075,Hereditary Lesion,Hereditary spherocytosis
2076,Carcinomatous Component Present,Non-small cell lung cancer stage III
2077,Hyperkeratosis,Subglottic Verrucous Carcinoma
2078,Pseudopapillary Pattern,Childhood Central Nervous System Embryonal Carcinoma
2079,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v7
2080,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage II Plasma Cell Myeloma
2081,Epithelial Component Present,Stage IVB Major Salivary Gland Cancer AJCC v7
2082,Epithelial Component Present,Serous cystadenocarcinoma ovary
2083,Epithelial Component Present,Nasopharyngeal lymphoepithelioma recurrent
2084,Slow Growing Mass,Adult Brain Ependymoma
2085,Finding related to pregnancy,Hodgkin Lymphoma During Pregnancy
2086,Epithelial Component Present,Adenocarcinoma in adenomatous polyp
2087,Papillary Pattern,Ovarian Papillary Cystadenoma
2088,Mixed Cellular Population,Vulvar Ectopic Fibroadenoma
2089,Neuroendocrine Differentiation,Well Differentiated Pancreatic Endocrine Tumor
2090,Carcinomatous Component Present,Vulvar Neuroendocrine Carcinoma
2091,Myxoid Stroma Formation,Fibromyxosarcoma
2092,Epithelial Component Present,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
2093,Nuclear Grooves,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
2094,Epithelial Component Present,Adenocarcinoma in situ in tubular adenoma
2095,Epithelial Component Present,Penis carcinoma
2096,Recurrent disease,Breast cancer recurrent
2097,Epithelial Component Present,FIGO Stage IIIA1(i) Ovarian Cancer
2098,Carcinomatous Component Present,FIGO Stage IIIA1(i) Ovarian Cancer
2099,Epithelial Component Present,BCLC Stage A Hepatocellular Carcinoma
2100,Epithelial Component Present,Stage I Gastric Carcinoma
2101,Cellular Pleomorphism,Childhood Conventional Osteosarcoma
2102,Carcinomatous Component Present,mucinous adenocarcinoma of salivary gland
2103,Well-Circumscribed Lesion,Borderline cystadenoma
2104,Epithelial Component Present,Endocervical polyp
2105,Carcinomatous Component Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
2106,Epithelial Component Present,Stage IB Merkel Cell Carcinoma AJCC v7
2107,Neuroendocrine Differentiation,Pancreatic Small Cell Neuroendocrine Carcinoma
2108,High Mitotic Activity,Pancreatic Small Cell Neuroendocrine Carcinoma
2109,Carcinomatous Component Present,Prostate cancer stage A
2110,Recurrent disease,Recurrent Hodgkin Lymphoma
2111,Carcinomatous Component Present,Endometrial adenocarcinoma metastatic
2112,Epithelial Component Present,Jejunal Neuroendocrine Tumor G1
2113,Neuroendocrine Differentiation,Neuroendocrine Tumors
2114,Villous Pattern,Urethral Villous Adenoma
2115,Hypercellular bone marrow,Philadelphia chromosome positive chronic myelogenous leukemia
2116,Slow Growing Mass,Craniopharyngioma
2117,Glandular metaplasia,Urethral Glandular Metaplasia
2118,Secondary Lesion,Ameloblastic Carcinoma Derived From Odontogenic Cyst
2119,Epithelial Component Present,large cell neuroendocrine carcinoma of gallbladder
2120,Neuroectodermal Differentiation,"Ganglioneuroblastoma, Intermixed"
2121,Secondary Lesion,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
2122,Multinodular Pattern,Plexiform fibrohistiocytic tumor
2123,Nuclear Molding,Childhood Lung Small Cell Carcinoma
2124,Pseudo-'onion bulb' formation,Intraneural perineurioma
2125,Cytopenia,Refractory Cytopenia of Childhood
2126,Well Differentiated Lesion,Buccal Mucosa Verrucous Carcinoma
2127,Pushing Tumor Margin,Buccal Mucosa Verrucous Carcinoma
2128,Primary Lesion,Hodgkin's lymphoma of CNS
2129,Ineffective hematopoiesis,Myelodysplastic Syndrome with Excess Blasts and Fibrosis
2130,Adnexal Differentiation,Vulvar Neoplasm of Skin Appendage Origin
2131,In Situ Lesion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7
2132,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage III
2133,Cystic Change,mucoepidermoid carcinoma of floor of mouth
2134,Epidermal Involvement,Vulvar Eccrine Porocarcinoma
2135,Hereditary Lesion,"Breast Cancer, Familial"
2136,Carcinomatous Component Present,Primary Peritoneal Serous Adenocarcinoma
2137,Severe cytologic atypia,large cell neuroendocrine carcinoma of appendix
2138,Mixed Cellular Population,Malignant Kidney Mixed Epithelial and Stromal Tumor
2139,Epithelial Component Present,Thymic Adenocarcinoma
2140,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma
2141,Poorly Differentiated Lesion,Lung Pleomorphic Carcinoma
2142,Epithelial Component Present,Lung Pleomorphic Carcinoma
2143,Absence of Stromal Invasion,Borderline Ovarian Serous Cystadenofibroma
2144,Refractory Disease,Refractory Childhood Hodgkin Lymphoma
2145,Sarcomatous Component Present,Malignant Phyllodes Tumor of Prostate
2146,Carcinomatous Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7
2147,Benign Cellular Infiltrate,benign lipoma of gallbladder
2148,Childhood Lesion,Stage IV Childhood Lymphoblastic Lymphoma
2149,Metastatic Lesion,Pancreatic adenocarcinoma metastatic
2150,Epithelial Component Present,Pancreatic adenocarcinoma metastatic
2151,Epithelial Component Present,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
2152,High Mitotic Activity,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
2153,Mild cytologic atypia,verrucous carcinoma of bladder
2154,Apocrine Differentiation,Apocrine cystadenoma
2155,Trabecular Pattern,Moderately Differentiated Hepatocellular Carcinoma
2156,Neuroendocrine Differentiation,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
2157,Epithelial Component Present,"Carcinoma, Papillary"
2158,Invasive Lesion,Oncocytic Breast Carcinoma
2159,Childhood Lesion,Childhood Ovarian Choriocarcinoma
2160,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm
2161,Hyalinized Stroma Formation,Thymus Solitary Fibrous Tumor
2162,Absence of Invasion,Stage 0 Anal Canal Cancer AJCC v6 and v7
2163,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IIIA
2164,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
2165,Epithelial Component Present,Fallopian Tube Mucinous Neoplasm
2166,Cafe-au-Lait Spots,Neurofibromatosis 1
2167,Intramucosal Lesion,Gastric Intramucosal Adenocarcinoma
2168,Thin Bands of Collagen Present,Pleural Solitary Fibrous Tumor
2169,Thin-Walled Branching Vascular Pattern,Pleural Solitary Fibrous Tumor
2170,Epithelial Component Present,Stage II Rectal Cancer AJCC v7
2171,Carcinomatous Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7
2172,Neuroectodermal Differentiation,Neuroblastoma of brain
2173,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa
2174,Borderline Lesion,cystic mucinous tumor of pancreas with moderate dysplasia
2175,More than 10 Mitoses per 10HPF,Small cell lung cancer limited stage
2176,Carcinomatous Component Present,Adenoid cystic carcinoma of oropharynx
2177,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Clear Cell Variant"
2178,Adnexal Differentiation,Extraocular Cutaneous Sebaceous Carcinoma
2179,Tissue Differentiation Uncertain,Proximal-Type Epithelioid Sarcoma
2180,Carcinomatous Component Present,Parotid Gland Acinic Cell Carcinoma
2181,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, inv(16)(p13q22)"
2182,Absence of Invasion,Intraductal Non-Comedo Breast Adenocarcinoma
2183,Capillary Sized Vascular Channel Formation,Histiocytoid hemangioma
2184,High Grade Lesion,Childhood Pleomorphic Rhabdomyosarcoma
2185,Childhood Lesion,Childhood Pleomorphic Rhabdomyosarcoma
2186,Intramucosal Lesion,"Carcinoma of urinary bladder, superficial"
2187,Carcinomatous Component Present,Adenoid cystic carcinoma of salivary gland
2188,Thick-Walled Hyalinized Vessels Present,Benign Bone Schwannoma
2189,Epithelial Component Present,Glomus vagale tumor
2190,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
2191,Metastatic Lesion,Secondary malignant neoplasm of urethra
2192,Epithelial Component Present,Gallbladder Papillary Biliary Intraepithelial Neoplasia
2193,Glial Differentiation,Childhood Gliosarcoma
2194,Papillary Pattern,Papillary Epithelial Neoplasm
2195,Osseous Differentiation,Benign Osteogenic Neoplasm
2196,Absence of Stromal Invasion,Borderline Ovarian Mucinous Tumor
2197,Nuclear Clearing,Follicular Variant Thyroid Gland Papillary Carcinoma
2198,Epithelial Component Present,Serous papillary cystic tumor of borderline malignancy
2199,Epithelial Component Present,Multiple endocrine neoplasia Type 2
2200,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor G2
2201,Metastatic/Recurrent Disease,Adult Alveolar Soft Part Sarcoma
2202,Exophytic Polypoid Lesion,Colorectal Inflammatory Polyp
2203,Indolent Clinical Course,Liver Cavernous Hemangioma
2204,Epithelial Component Present,Squamous cell carcinoma of the oral cavity recurrent
2205,Neuroendocrine Differentiation,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
2206,Slow Growing Mass,Benign Intracranial Meningioma
2207,Carcinomatous Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v7
2208,Hyperkeratosis,Seborrheic keratosis of eyelid
2209,Metastatic Lesion,Vaginal adenocarcinoma metastatic
2210,Epithelial Component Present,Cervical Villoglandular Adenocarcinoma
2211,Carcinomatous Component Present,Stage IVC Nasopharyngeal Carcinoma AJCC v7
2212,Epithelial Component Present,adenosquamous carcinoma of salivary gland
2213,Carcinomatous Component Present,recurrent gastric cancer
2214,Necrotic changes (finding),large cell neuroendocrine carcinoma of thymus
2215,Cutaneous Involvement,regressing melanoma of skin
2216,Carcinomatous Component Present,Ampulla of Vater Undifferentiated Carcinoma
2217,Anaplasia,Rectal Sarcomatoid Carcinoma
2218,Local disease,Spindle cell lipoma
2219,Carcinomatous Component Present,Stage IIIC Eyelid Carcinoma AJCC v7
2220,Severe cytologic atypia,Gastric Neuroendocrine Carcinoma
2221,Necrotic changes (finding),small cell carcinoma of kidney
2222,Epithelial Component Present,ACTH-producing pituitary tumor
2223,Epithelial Component Present,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma
2224,Ineffective hematopoiesis,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
2225,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,"Myelodysplastic syndrome, no ICD-O subtype"
2226,Epithelial Component Present,Rectal Cribriform Comedo-Type Adenocarcinoma
2227,Aggressive Clinical Course,Aggressive Systemic Mastocytosis
2228,Neuroendocrine Differentiation,Pancreatic Somatostatinoma
2229,Rapidly Enlarging Mass,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
2230,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myeloid leukemia with abnormal marrow eosinophils
2231,Carcinomatous Component Present,Clear cell odontogenic carcinoma
2232,Mucoid Stroma Formation,mucinous adenocarcinoma of rectum
2233,VIP Positive Neoplastic Cells Present,Pancreatic Vipoma
2234,Adnexal Differentiation,Benign neoplasm of sebaceous gland
2235,Dysplasia,Flat adenoma
2236,Cellular Pleomorphism,Childhood Undifferentiated Pleomorphic Sarcoma
2237,Recurrent disease,Recurrent Childhood Optic Nerve Astrocytoma
2238,Epithelial Component Present,minimally invasive follicular carcinoma of the thyroid gland
2239,Carcinomatous Component Present,Anal Verrucous Carcinoma
2240,Chronic Inflammatory Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis
2241,Necrotic changes (finding),Recurrent Childhood Giant Cell Glioblastoma
2242,Childhood Lesion,Childhood Grade II Meningioma
2243,Microvascular Proliferation,Recurrent Childhood Gliosarcoma
2244,Recurrent disease,Recurrent Childhood Gliomatosis Cerebri
2245,Epithelial Component Present,Submandibular Gland Squamous Cell Carcinoma
2246,Chromogranin A Positive Neoplastic Cells Present,Recurrent Digestive System Neuroendocrine Tumor G1
2247,Indolent Clinical Course,Fibromyxolipoma
2248,Sarcomatous Component Present,Ovarian Dermoid Cyst with Secondary Sarcoma
2249,Angiodestructive Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
2250,Recurrent disease,Recurrent Anterior Pituitary Gland Neoplasm
2251,Hereditary Lesion,Sturge-Weber Syndrome
2252,Epithelial Component Present,Oropharyngeal Carcinoma by AJCC v6 Stage
2253,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,adenosquamous carcinoma of ovary
2254,Myxoid Stroma Formation,Myxoma of the Endocardium
2255,Dysplasia,Bladder squamous cell carcinoma stage 0
2256,Acute inflammation,"lymphomatoid papulosis, type A"
2257,High Grade Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
2258,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage III
2259,Carcinomatous Component Present,keratinizing squamous cell carcinoma of vulva
2260,Epithelial Component Present,Minor Salivary Gland Small Cell Carcinoma
2261,Slow Growing Mass,Adult Myxopapillary Ependymoma
2262,Hyperplastic Tissue Present,Cervical Mesonephric Remnants and Hyperplasia
2263,Childhood Lesion,Childhood Ependymoma
2264,Recurrent disease,Recurrent Childhood Ependymoma
2265,Adulthood Lesion,Adult Intracranial Neoplasm
2266,Recurrent Genetic Abnormalities Present,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
2267,Epithelial Component Present,Stage IIB Pancreatic Cancer AJCC v6 and v7
2268,Indolent Clinical Course,Fibrolipoma
2269,Well-Circumscribed Lesion,Gastric Hamartoma
2270,Neuroendocrine Differentiation,Recurrent Pancreatic Neuroendocrine Carcinoma
2271,Cartilaginous Differentiation,Cartilaginous exostosis
2272,Indolent Clinical Course,Cartilaginous exostosis
2273,Secondary Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous"
2274,Well Differentiated Lesion,Well Differentiated Fibrosarcoma
2275,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage II
2276,"Fully Differentiated ""Adult-Type"" Tissues Present",benign mature teratoma of pancreas
2277,Childhood Lesion,Hepatoblastoma
2278,No Evidence of Hormonal Immunoreactivity Present,Pituitary Gland Oncocytic Adenoma
2279,Thin Bands of Collagen Present,Peritoneal Solitary Fibrous Tumor
2280,Bone Marrow Dysplasia Present,Refractory cytopenia with multilineage dysplasia
2281,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia
2282,Carcinomatous Component Present,Gastric Tubular Adenocarcinoma
2283,Locally Aggressive Lesion,Abdominal Inflammatory Myofibroblastic Tumor
2284,Indolent Clinical Course,Myofibroblastoma
2285,Recurrent disease,Alveolar soft part sarcoma recurrent
2286,Well-Circumscribed Lesion,Rectal polyp
2287,Immunologic Deficiency Syndromes,AIDS-Related Malignant Anal Neoplasm
2288,Myxoid Stroma Formation,Bone Epithelioid Hemangioendothelioma
2289,Carcinomatous Component Present,Nipple Duct Carcinoma
2290,Myofibroblastic Differentiation,Dermatofibrosarcoma protuberans with myoid differentiation
2291,Rapidly Enlarging Mass,Vulvar Alveolar Rhabdomyosarcoma
2292,Nuclear Atypia,Childhood Brain Anaplastic Astrocytoma
2293,Childhood Lesion,Childhood Brain Meningioma
2294,Carcinomatous Component Present,Lung Acinar Adenocarcinoma
2295,Mallory Bodies,"Hepatitis, Alcoholic"
2296,Hyperplastic Epithelial Tissue Present,Columnar Cell Hyperplasia of the Breast with Atypia
2297,Carcinomatous Component Present,Stage IIIC Breast Cancer AJCC v6
2298,High Grade Lesion,Supratentorial Glioblastoma
2299,Epithelial Component Present,High Grade Glandular Intraepithelial Neoplasia
2300,Well Differentiated Lesion,Conventional Schwannoma
2301,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor G2
2302,Diffuse Pattern,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
2303,Childhood Lesion,Childhood Astrocytoma
2304,Moderate dysplasia,Grade II Prostatic Intraepithelial Neoplasia
2305,Unresectable Mass,Cholangiocarcinoma non-resectable
2306,Vascular Channel Formation,vascular neoplasm of bone
2307,Nuclear Pseudoinclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
2308,Diffuse Pattern,Anaplastic Brain Stem Astrocytoma
2309,Adulthood Lesion,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma
2310,Carcinomatous Component Present,Cholangiocarcinoma recurrent
2311,Carcinomatous Component Present,Stage IVA Colon Cancer AJCC v7
2312,Epithelial Component Present,Papilloma of nasal vestibule
2313,Epithelial Component Present,Recurrent Fallopian Tube Carcinoma
2314,Vascular Channel Formation,Hemangioma of spleen
2315,Myxoid Stroma Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
2316,Carcinomatous Component Present,Stage IIIC Breast Cancer AJCC v7
2317,Epithelial Component Present,Stage IIIC Appendix Carcinoma AJCC v7
2318,Cutaneous Involvement,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other"
2319,Cribriform Pattern,Invasive Cribriform Breast Carcinoma
2320,Microvascular Proliferation,Glioblastoma multiforme of spinal cord
2321,High Grade Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells
2322,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
2323,Tall Papillae Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
2324,Hemosiderin pigmentation,Giant Cell Lesion of Small Bones
2325,Cutaneous Involvement,Alopecia
2326,Carcinomatous Component Present,Stage 0 Rectal Cancer AJCC v6 and v7
2327,Carcinomatous Component Present,Unresectable Esophageal Carcinoma
2328,Dysplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia
2329,Epithelial Component Present,Low Grade Cervical Squamous Intraepithelial Neoplasia
2330,atypia morphology,Malignant Granulosa Cell Tumor
2331,Epithelial Component Present,Grade 3 Invasive Breast Carcinoma
2332,Papillary Pattern,Intrahepatic Bile Duct Papillary Neoplasm
2333,Carcinomatous Component Present,Stage IIIB Lung Cancer AJCC v7
2334,Carcinomatous Component Present,Lipid-rich carcinoma
2335,Mucoid Stroma Formation,Pseudomyxoma Peritonei
2336,Increased Cellularity Present,Stage 1 Neuroblastoma
2337,Carcinomatous Component Present,Sweat Gland Tubular Carcinoma
2338,Acquired Lesion,Acquired kyphosis
2339,Cutaneous Involvement,Vulvar Dysplastic Melanocytic Nevus
2340,Hyperplastic Tissue Present,Atypical Ductal Breast Hyperplasia
2341,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Mutant"
2342,Carcinomatous Component Present,Parasite-Related Carcinoma
2343,Vascular Channel Formation,Hemangioma of bone
2344,Biphasic Pattern,Breast Complex Fibroadenoma
2345,Fibrotic Stroma Formation,Ovarian Endometrioid Cystadenofibroma
2346,Mitotic Activity,Prostate Stromal Sarcoma
2347,Mild cytologic atypia,Cervical Verrucous Carcinoma
2348,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v7
2349,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,"Amyloidosis, Familial"
2350,Primary Site Unspecified,Primary Carcinoma Unspecified Site
2351,Tissue of Mullerian Origin Present,Female Reproductive System Adenofibroma
2352,Infiltrative Growth Pattern,Classical Glioblastoma
2353,Mixed Cellular Population,Mixed astrocytoma-ependymoma
2354,Ground Glass Nuclear Inclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
2355,Carcinomatous Component Present,Colorectal Cancer by AJCC v6 Stage
2356,Pseudoencapsulated Mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
2357,Tissue of Mullerian Origin Present,"Uterine Carcinosarcoma, Homologous Type"
2358,Invasive Lesion,adenocarcinoma of breast with spindle cell metaplasia
2359,Local disease,Kidney Lipoma
2360,Carcinomatous Component Present,adenosquamous carcinoma of breast
2361,Juvenile Lesion,Juvenile Xanthogranuloma
2362,Epithelial Component Present,Small intestine carcinoma stage II
2363,Cutaneous Involvement,External Auditory Canal Ceruminous Adenoma
2364,Mitotic Activity,"Testicular Yolk Sac Tumor, Myxomatous Pattern"
2365,Diffuse Pattern,Recurrent Adult Immunoblastic Lymphoma
2366,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage III
2367,Infiltrative Growth Pattern,Infantile digital fibromatosis
2368,Aggressive Clinical Course,Burkitt Leukemia
2369,Carcinomatous Component Present,Salivary Gland Oncocytic Carcinoma
2370,Mesenchymal Component Present,Cellular Pleomorphic Adenoma
2371,Primary Lesion,Giant Cell Glioblastoma
2372,Myxoid Stroma Formation,Ameloblastic fibrodentinoma
2373,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
2374,Epithelial Component Present,Penile Cancer by AJCC v7 Stage
2375,Perivascular Arrangement of Tumor Cells,Glomangioma of skin
2376,Neuroectodermal Differentiation,Stage 2B Neuroblastoma
2377,High Mitotic Activity,Anaplastic Astroblastoma
2378,Low Mitotic Activity,Esophageal Neuroendocrine Tumor G1
2379,Biphasic Pattern,Broad Ligament Serous Adenofibroma
2380,Malignant Germinomatous Cellular Infiltrate,Childhood Seminoma
2381,Epithelial Component Present,Stage II Laryngeal Cancer AJCC v6 and v7
2382,Lobulated Growth Pattern,Salivary Gland Myoepithelial Carcinoma
2383,Biphasic Pattern,Uterine Corpus Carcinosarcoma
2384,Carcinomatous Component Present,Stage IVA Major Salivary Gland Cancer AJCC v7
2385,Carcinomatous Component Present,Childhood Salivary Gland Carcinoma
2386,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Mucinous adenocarcinoma, endocervical type"
2387,Chronic Inflammatory Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7
2388,High Mitotic Activity,Malignant Uterine Corpus PEComa
2389,Syncytial Pattern,Nasopharyngeal lymphoepithelioma recurrent
2390,Severe dysplasia,Squamous Cell Carcinoma In Situ of the Nipple
2391,Local disease,Lipoma
2392,Hyperplastic Tissue Present,Nodular Bartholin Gland Hyperplasia
2393,Pseudoangiomatoid Space Formation,"Histiocytoma, Angiomatoid Fibrous"
2394,Indolent Clinical Course,Synovial Hemangioma
2395,Congenital Lesion,Congenital hemangioma
2396,Thyroglobulin Positive Neoplastic Cells Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
2397,Epithelial Component Present,Stage IIIA Breast Carcinoma
2398,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
2399,Deep Lesion,Extra-abdominal fibromatosis
2400,Intraductal Lesion,Sclerosing Breast Papilloma
2401,Diffuse Lesion,Pigmented villonodular synovitis
2402,Perivascular Arrangement of Tumor Cells,Benign Pericytic Neoplasm
2403,Increased Cellularity Present,Cellular Blue Nevus
2404,Mixed Cellular Population,Recurrent Childhood Anaplastic Oligoastrocytoma
2405,Calcinosis,Dentinogenic Ghost Cell Tumor
2406,Carcinomatous Component Present,Nasopharyngeal Differentiated Carcinoma
2407,Lymphoplasmacytic Infiltrate,Lymphoepithelial carcinoma
2408,Malignant Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor
2409,Locally Aggressive Lesion,Atypical fibroxanthoma of skin
2410,Adulthood Lesion,Adult Nodular Sclerosis Classical Hodgkin Lymphoma
2411,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
2412,Refractory Disease,Refractory Carcinoma
2413,Exophytic Papillary Lesion,Verrucous carcinoma of penis
2414,Secondary Lesion,Malignant Neoplasm with Regional Lymph Node Involvement
2415,Epithelial Component Present,Low Grade Prostatic Intraepithelial Neoplasia
2416,Single Cell Necrosis,Stage IIB Merkel Cell Carcinoma AJCC v7
2417,Epithelial Component Present,Adrenal Gland Composite Pheochromocytoma
2418,Carcinomatous Component Present,Stage II Colorectal Cancer
2419,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
2420,Epithelial Component Present,HPV positive oropharyngeal squamous cell carcinoma
2421,Deep Lesion,Deep Hemangioma
2422,Carcinomatous Component Present,Stage III Colorectal Cancer
2423,Childhood Lesion,Childhood Soft Tissue Sarcoma
2424,Nuclear Atypia,Pineal parenchymal tumor of intermediate differentiation
2425,Recurrent disease,Bladder cancer recurrent
2426,Epithelial Component Present,Carcinoma of sublingual gland
2427,Carcinomatous Component Present,Grade 1 Endometrial Mucinous Adenocarcinoma
2428,Microvascular Proliferation,Diencephalic Glioblastoma
2429,Carcinomatous Component Present,Lung squamous cell carcinoma recurrent
2430,Cutaneous Involvement,Neoplasm of skin with adnexal differentiation
2431,Infiltrative Growth Pattern,gliosarcoma
2432,Epithelial Component Present,Fallopian Tube Carcinoma
2433,Hyperplastic Tissue Present,Atypical Endometrial Hyperplasia
2434,Chronic lymphocytic inflammation,Micronodular thymoma with lymphoid stroma
2435,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of appendix
2436,Absence of Stromal Invasion,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor
2437,Endophytic Tumor Growth,Human Papillomavirus-Related Verrucous Carcinoma
2438,Metastatic/Recurrent Disease,Epithelioid Sarcoma NCI Grade 2
2439,Epithelial Component Present,Lung Spindle Cell Carcinoma
2440,Epithelial Component Present,signet ring cell carcinoma of breast
2441,Systemic disease,"Leukemia, Mast-Cell"
2442,Indolent Clinical Course,Rhabdomyoma
2443,Geographic Necrosis,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
2444,Hypercellular bone marrow,Acute panmyelosis with myelofibrosis
2445,Collagenous Stroma Formation,Odontogenic myxofibroma
2446,Biphasic Pattern,Benign Prostate Phyllodes Tumor
2447,Pushing Tumor Margin,Benign Prostate Phyllodes Tumor
2448,Carcinomatous Component Present,Stage IA Lung Large Cell Carcinoma AJCC v7
2449,Adnexal Differentiation,Fibrofolliculoma
2450,Carcinomatous Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
2451,Epithelial Component Present,Ovarian Mucinous Adenofibroma
2452,Epithelial Component Present,Bronchioloalveolar Adenocarcinoma
2453,Thick-Walled Hyalinized Vessels Present,Gastric Schwannoma
2454,Epithelial Component Present,Apocrine cystadenoma
2455,Hyperkeratosis,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
2456,High Mitotic Activity,Stage I Lung Small Cell Carcinoma AJCC v7
2457,Carcinomatous Component Present,Rectosigmoid cancer recurrent
2458,Epithelial Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma
2459,Epithelial Component Present,Papillary Eccrine Carcinoma
2460,Invasive Lesion,Prostate Adenosquamous Carcinoma
2461,Hemosiderin pigmentation,Hemosiderotic Fibrolipomatous Tumor
2462,Refractory Disease,Refractory Malignant Germ Cell Tumor
2463,High Grade Lesion,Chondroblastic osteosarcoma
2464,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v6
2465,Epithelial Component Present,large cell neuroendocrine carcinoma of ovary
2466,Papillary Pattern,Recurrent respiratory papillomatosis
2467,Carcinomatous Component Present,Lung Micropapillary Adenocarcinoma
2468,Micropapillary Pattern,Lung Micropapillary Adenocarcinoma
2469,Epithelial Component Present,Colorectal Adenoma with Moderate Dysplasia
2470,Indolent Clinical Course,Hemangioma of choroid
2471,Vascular Channel Formation,Hemangioma of choroid
2472,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
2473,Epithelial Component Present,Hereditary Male Breast Carcinoma
2474,Mild dysplasia,Colorectal Adenoma with Mild Dysplasia
2475,Epithelial Component Present,Tibial adamantinoma
2476,Epithelial Component Present,Early-Stage Breast Carcinoma
2477,Cutaneous Involvement,Cutaneous Adult T-Cell Leukemia/Lymphoma
2478,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
2479,Primary Lesion,Primary serous papillary carcinoma of peritoneum
2480,Secondary Lesion,Secondary malignant neoplasm of small intestine
2481,Exophytic Polypoid Lesion,Gastrointestinal polyps
2482,Epithelial Component Present,Stage II Adult Liver Cancer AJCC v7
2483,Carcinomatous Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
2484,Poorly Differentiated Lesion,"Lung Squamous Cell Carcinoma, Small Cell Variant"
2485,Epithelial Component Present,Vulvar adenocarcinoma
2486,Carcinomatous Component Present,Small cell lung cancer limited stage
2487,Carcinomatous Component Present,Paget's disease and intraductal carcinoma of breast
2488,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1B
2489,Childhood Lesion,Childhood Subependymal Giant Cell Astrocytoma
2490,Neuroendocrine Differentiation,Intra-Abdominal Paraganglioma
2491,Indolent Clinical Course,Adenomatoid tumor of epididymis
2492,Necrotic changes (finding),Vaginal Small Cell Carcinoma
2493,High Grade Lesion,Adult Rhabdomyosarcoma
2494,Exophytic Polypoid Lesion,tubulovillous adenoma of stomach
2495,Papillary Pattern,Bladder Papillary Clear Cell Adenocarcinoma
2496,Metastatic Lesion,Carcinoma of unknown primary
2497,Cystic Change,Hidradenoma Papilliferum
2498,Myxoid Stroma Formation,Aggressive angiomyxoma
2499,Tissue Differentiation Uncertain,Aggressive angiomyxoma
2500,Well-Circumscribed Lesion,Myopericytoma
2501,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma
2502,Indolent Clinical Course,Benign Osteogenic Neoplasm
2503,Adnexal Differentiation,Apocrine adenoma
2504,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Epithelioid Leiomyoma
2505,Epithelial Component Present,Cervical Adenoid Cystic Carcinoma
2506,Aberrant Thyroid Tissue Present,"Struma ovarii, malignant"
2507,Epithelial Component Present,ACTH-Secreting Pituitary Adenoma
2508,Indolent Clinical Course,Conventional Cardiac Rhabdomyoma
2509,Carcinomatous Component Present,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations
2510,Cystic Change,Seborrheic keratosis of eyelid
2511,Epithelial Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7
2512,Epithelial Component Present,"Phyllodes tumor, borderline"
2513,Cutaneous Involvement,Lipoma of skin
2514,Well-Circumscribed Lesion,tubular adenoma of gallbladder
2515,Neuroendocrine Differentiation,Prostate Neuroendocrine Neoplasm
2516,Angiodestructive Pattern,Pulmonary Lymphomatoid Granulomatosis
2517,Invasive Lesion,Ductal Breast Carcinoma with Squamous Metaplasia
2518,Epithelial Component Present,Thymic Clear Cell Carcinoma
2519,Pregnancy Complications,Placental Malformation
2520,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Acute monocytic/monoblastic leukemia
2521,Indolent Clinical Course,Chondroid lipoma
2522,Epithelial Component Present,Carcinoid tumor of the prostate
2523,Infiltrative Growth Pattern,Adult Glioblastoma
2524,Necrotic changes (finding),Adult Glioblastoma
2525,Diffuse Pattern,Adult Glioblastoma
2526,Carcinomatous Component Present,Stage IA Lung Squamous Cell Carcinoma AJCC v7
2527,Epithelial Component Present,Solar Radiation-Related Skin Squamous Cell Carcinoma
2528,Adnexal Differentiation,Eccrine spiradenoma
2529,Chemotherapeutic Agent Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
2530,Systemic disease,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease"
2531,Chromogranin A Positive Neoplastic Cells Present,Thymic Atypical Carcinoid Tumor
2532,Nodular Pattern,Hodgkin's disease nodular sclerosis recurrent
2533,Glandular Pattern,"Somatostatinoma, malignant"
2534,Extraocular Dissemination of Disease,Extraocular retinoblastoma
2535,Carcinomatous Component Present,Klatskin Tumor
2536,Childhood Lesion,Recurrent Childhood Diffuse Astrocytoma
2537,Indolent Clinical Course,Cervical Rhabdomyoma
2538,Sarcomatous Component Present,Malignant Vulvar Phyllodes Tumor
2539,Fibrotic Stroma Formation,Breast Ductal Adenoma
2540,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma
2541,Carcinomatous Component Present,Basal-Like Breast Carcinoma
2542,Metastatic Lesion,Secondary malignant neoplasm of bone marrow
2543,Carcinomatous Component Present,minimally invasive follicular carcinoma of the thyroid gland
2544,Carcinomatous Component Present,Stage IV Adult Liver Cancer AJCC v7
2545,"Amorphus, Eosinophilic, and Acellular Deposit",Primary Systemic Amyloidosis
2546,atypia morphology,Atypical Breast Papilloma
2547,Well Differentiated Lesion,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
2548,Childhood Lesion,Childhood Grade III Meningioma
2549,Vascular Channel Formation,Parotid Gland Kaposi Sarcoma
2550,Cutaneous Involvement,Dermal Duct Tumor
2551,Chromogranin A Positive Neoplastic Cells Present,Small Intestinal Carcinoid Tumor
2552,Primary Lesion,Adult Brain Stem Glioma
2553,Recurrent disease,Thymoma malignant recurrent
2554,Rapidly Enlarging Mass,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
2555,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Cellular Variant
2556,Necrotic changes (finding),Small cell glioblastoma
2557,Anaplasia,Small cell glioblastoma
2558,Severe cytologic atypia,Esophageal Large Cell Neuroendocrine Carcinoma
2559,Intraductal Lesion,Intraductal breast neoplasm
2560,Local disease,lipoma of large intestine
2561,Erythroid hyperplasia,Refractory anemia with ringed sideroblasts
2562,Hyaline Cartilage Differentiation,Grade III Chondrosarcoma
2563,Epithelial Component Present,Cervical Large Cell Neuroendocrine Carcinoma
2564,Neuroendocrine Differentiation,Carcinoid tumor of lung
2565,Nested Pattern,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
2566,Metastatic Lesion,Malignant Ameloblastoma
2567,Endophytic Tumor Growth,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
2568,Necrotic changes (finding),malignant peripheral nerve sheath tumor (MPNST) of mediastinum
2569,Firm mass,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
2570,Carcinomatous Component Present,Adenocarcinoma in villous adenoma
2571,Intraosseous Lesion,Granular cell ameloblastoma
2572,Epithelial Component Present,Large cell lung cancer stage III
2573,Vascular Channel Formation,Colon Lymphangioma
2574,Monomorphic Cellular Infiltrate,Adult Spinal Cord Ependymoma
2575,Low Mitotic Activity,Carcinoid tumor of the cecum
2576,Cutaneous Involvement,"Connective tissue nevus, NOS"
2577,Storiform Growth Pattern,Malignant fibrous histiocytoma recurrent
2578,Cutaneous Involvement,Ocular Cicatricial Pemphigoid
2579,Endophytic Tumor Growth,Urethral Inverted Papilloma
2580,Epithelial Component Present,Stage IA Breast Cancer AJCC v7
2581,Intraductal Lesion,Intraductal Breast Papillomatosis
2582,Epithelial Component Present,Stage IV Major Salivary Gland Cancer AJCC v7
2583,Carcinomatous Component Present,Lung Lymphoepithelioma-Like Carcinoma
2584,Carcinomatous Component Present,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
2585,Angiocentric Pattern,Adult Grade III Lymphomatoid Granulomatosis
2586,CD30-Positive Neoplastic Cells Present,Childhood Anaplastic Large Cell Lymphoma
2587,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v7
2588,Tissue of Mullerian Origin Present,"Mixed Tumor, Mullerian"
2589,Epithelial Component Present,Breast Carcinoma Metastatic in the Bone
2590,Anaplasia,alk-positive anaplastic large cell lymphoma
2591,Dense Intercellular Reticulin Network Present,Recurrent Childhood Pleomorphic Xanthoastrocytoma
2592,Epithelial Component Present,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
2593,Carcinomatous Component Present,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7
2594,Slit-Like Stromal Retraction Present,Superficial basal cell carcinoma
2595,Adulthood Lesion,Adult Extracardiac Rhabdomyoma
2596,Well Differentiated Lesion,Verrucous carcinoma of the oral cavity recurrent
2597,Cutaneous Involvement,Stage IA Cutaneous Melanoma AJCC v7
2598,Hypercellular bone marrow,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
2599,Diffuse Pattern,Anaplastic Oligodendroglioma
2600,Extraosseous Lesion,Adult Extraskeletal Myxoid Chondrosarcoma
2601,atypia morphology,Fallopian Tube Metaplastic Papillary Tumor
2602,Myxoid Stroma Formation,Pleural Epithelioid Hemangioendothelioma
2603,Epithelial Component Present,Recurrent Salivary Gland Cancer
2604,Epithelial Component Present,basal cell carcinoma of penis
2605,Childhood Lesion,Extrarenal Rhabdoid Tumor of the Liver
2606,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v6
2607,Carcinomatous Component Present,Colorectal Cancer by AJCC v7 Stage
2608,Carcinomatous Component Present,Gastric Pylorus Carcinoma
2609,Biphasic Pattern,Pilocytic Astrocytoma
2610,Carcinomatous Component Present,Stage 0is Ureter Cancer AJCC v7
2611,Cutaneous Involvement,Halo nevus
2612,Epithelial Component Present,Childhood Carcinoid Tumor
2613,Numerous Stromal Mast Cells Present,Palisaded Lymph Node Myofibroblastoma
2614,Anaplasia,Mesenchymal Glioblastoma
2615,Epithelial Component Present,Stage III Oropharyngeal Carcinoma AJCC v7
2616,Epithelial Component Present,Breast Carcinoma Metastatic in the Lung
2617,Invasive Lesion,Grade 1 Invasive Breast Carcinoma
2618,Epithelial Component Present,Stage IVC Paranasal Sinus Cancer AJCC v7
2619,Extensive Secretory Changes Present,Lactating adenoma
2620,Indolent Clinical Course,Central Nervous System Hibernoma
2621,Vascular Channel Formation,Cardiac Capillary Hemangioma
2622,Tubular Structures Present,Sweat Gland Tubular Carcinoma
2623,Hyperplastic Tissue Present,Intraductal Breast Myoepitheliosis
2624,Severe dysplasia,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
2625,Dysplasia,Cervical Squamous Intraepithelial Neoplasia 1
2626,Perivascular Arrangement of Tumor Cells,Glomus tumor of skin
2627,Cystic Change,Cystic tumor of atrio-ventricular node
2628,Recurrent disease,Peripheral neuroepithelioma of bone recurrent
2629,In Situ Lesion,Stage 0is Urethral Cancer AJCC v7
2630,Severe dysplasia,Stage 0 Lip Carcinoma
2631,CD30-Positive Neoplastic Cells Present,Anaplastic large cell lymphoma T- and null-cell types refractory
2632,Diffuse Lesion,Diffuse Pulmonary Lymphangiomatosis
2633,Diffuse Pattern,"Gemistocytic Astrocytoma, IDH-Mutant"
2634,Metastatic/Recurrent Disease,Lung Synovial Sarcoma
2635,CD30-Positive Neoplastic Cells Present,Stage I Anaplastic Large Cell Lymphoma
2636,Undifferentiated Lesion,"Endometrial stromal sarcoma, high grade"
2637,Epithelial Component Present,Adenosquamous cell lung cancer stage III
2638,Local disease,lipoma of esophagus
2639,Epithelial Component Present,Stage IB Ovarian Cancer AJCC v6 and v7
2640,Single Malignant Cells Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
2641,Epithelial Component Present,Benign phyllodes neoplasm of breast
2642,Carcinomatous Component Present,Anterior Tongue Squamous Cell Carcinoma
2643,Biphasic Pattern,Malignant Mixed Mesodermal (Mullerian) Tumor
2644,Nuclear Atypia,Classical Glioblastoma
2645,Glomerular Hypertrophy,Primary Focal Segmental Glomerulosclerosis
2646,Myomatous Stroma Formation,"Cervical Adenomyoma, Endocervical Type"
2647,Papillary Pattern,Cervical Squamotransitional Carcinoma
2648,Epithelial Component Present,Borderline serous tumor of ovary
2649,Mesenchymal Differentiation,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
2650,Carcinomatous Component Present,adenocarcinoma of breast with spindle cell metaplasia
2651,Childhood Lesion,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma
2652,High Grade Lesion,"Anaplastic Astrocytoma, IDH-Mutant"
2653,Radiation Sickness,"Leukemia, Radiation-Induced"
2654,Neuroendocrine Differentiation,Malignant Paraganglionic Neoplasm
2655,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
2656,Non-Invasive Lesion,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
2657,Carcinomatous Component Present,Fallopian Tube Adenocarcinoma
2658,Carcinomatous Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma
2659,Slow Growing Mass,Ependymoma of brain stem
2660,Recurrent disease,Recurrent Adult Immunoblastic Lymphoma
2661,Resectable Mass,Pancreatic carcinoma resectable
2662,Oligodendroglial Component Present,Anaplastic Oligoastrocytoma
2663,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage IV
2664,Presence of a Hormonal Syndrome,Secretory adenoma of pituitary
2665,Papillary Pattern,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
2666,Myxoid Stroma Formation,Ventricular myxoma
2667,Melanin Pigment Present,Melanoacanthoma
2668,High Mitotic Activity,Anaplastic Oligodendroglioma
2669,Carcinomatous Component Present,Invasive Carcinoma
2670,Adulthood Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma
2671,Necrotic changes (finding),"Leydig cell tumor, malignant"
2672,Neuroendocrine Differentiation,Malignant Pancreatic Vipoma
2673,Epithelial Component Present,Stage I Laryngeal Cancer AJCC v6 and v7
2674,Carcinomatous Component Present,Colon Intramucosal Adenocarcinoma
2675,Vascular Channel Formation,Peripheral Intraneural Angiosarcoma
2676,Epithelial Component Present,Urothelial carcinoma bladder recurrent
2677,Epithelial Component Present,External Ear Squamous Cell Carcinoma
2678,Mixed Cellular Population,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
2679,Perivascular Arrangement of Tumor Cells,Benign Uterine Corpus PEComa
2680,Adulthood Lesion,Recurrent Adult Hodgkin Lymphoma
2681,Epithelial Component Present,Mucoepidermoid Breast Carcinoma
2682,Cutaneous Involvement,Balloon cell nevus
2683,Epithelial Component Present,"Extra-adrenal paraganglioma, malignant"
2684,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myeloid Leukemia with Maturation
2685,Epithelial Component Present,Vulvar Ectopic Fibroadenoma
2686,Adulthood Lesion,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
2687,Epithelial Component Present,Clear Cell Intrahepatic Cholangiocarcinoma
2688,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage III
2689,Deep Lesion,Leiomyosarcoma of Deep Soft Tissue
2690,Collagenous Stroma Formation,Calcifying Fibrous Pseudotumor
2691,Carcinomatous Component Present,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
2692,Biphasic Pattern,Uterine Corpus Adenomyoma
2693,Bone Marrow Dysplasia Present,Therapy-related myelodysplastic syndrome
2694,High Grade Lesion,Rhabdomyosarcoma of the orbit
2695,Stromal Invasion,FIGO Stage IIIA1(i) Ovarian Cancer
2696,Necrotic changes (finding),Ampulla of Vater Small Cell Neuroendocrine Carcinoma
2697,Histiocytosis haematophagic,Hemophagocytic Syndrome
2698,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Carcinosarcoma
2699,Biphasic Pattern,Uterine Carcinosarcoma
2700,Epithelial Component Present,Stage III Lung Cancer AJCC v6
2701,Adnexal Differentiation,apocrine adenocarcinoma of vulva
2702,Epithelial Component Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
2703,Epithelial Component Present,Erosive Adenomatosis of the Nipple
2704,Perivascular Lymphocytic Infiltrate,Cutaneous pseudolymphoma
2705,Recurrent disease,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
2706,Primary Site Unknown,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
2707,Carcinomatous Component Present,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
2708,Acanthosis,Verrucous carcinoma of penis
2709,Follicular Cell Differentiation,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
2710,Cytoplasmic Membrane-Bound Granules Present,Stage III Merkel Cell Carcinoma AJCC v7
2711,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage I
2712,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
2713,Epithelial Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7
2714,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage II
2715,Hyalinized Vessels Present,Juvenile Pilocytic Astrocytoma
2716,Carcinomatous Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma
2717,Nuclear Pseudoinclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
2718,Epithelial Component Present,Benign Ovarian Clear Cell Tumor
2719,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
2720,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
2721,Locally Aggressive Lesion,Lipofibromatosis
2722,Carcinomatous Component Present,Bladder adenocarcinoma stage IV
2723,Hypercellular bone marrow,Blast Phase
2724,Nodular Pattern,Vulvar Nodular Hidradenoma
2725,Cutaneous Involvement,Primary cutaneous diffuse large cell B-cell lymphoma
2726,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v7
2727,Mucoid Stroma Formation,High Grade Appendix Mucinous Adenocarcinoma
2728,Microcystic Change,Subependymal Glioma
2729,Well Differentiated Lesion,Glottis Verrucous Carcinoma
2730,Epithelial Component Present,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
2731,Hyperplastic Tissue Present,Prostatic Cribriform Hyperplasia
2732,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage I
2733,Absence of Stromal Invasion,Borderline Ovarian Serous Adenofibroma
2734,Nodular Pattern,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma
2735,Epithelial Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v7
2736,Increased Cellularity Present,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
2737,Childhood Lesion,Stage II Childhood Lymphoblastic Lymphoma
2738,Angiocentric Pattern,Angiocentric immunoproliferative lesion grade 2
2739,Epithelial Component Present,carcinosarcoma of lung
2740,Carcinomatous Component Present,Stage IIIC Gastric Cancer AJCC v7
2741,Vascular Channel Formation,Chorioangioma
2742,Metastatic Lesion,Transitional cell cancer of renal pelvis and ureter metastatic
2743,Infiltrating Tumor Margins Present,Malignant Phyllodes Tumor of Prostate
2744,Follicular Cell Differentiation,Tall Cell Variant Thyroid Gland Papillary Carcinoma
2745,Nuclear Grooves,Tall Cell Variant Thyroid Gland Papillary Carcinoma
2746,Mixed Cellular Population,Benign Prostate Phyllodes Tumor
2747,Splenomegaly,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
2748,Epithelial Component Present,"Glucagonoma, malignant"
2749,Dilated Vascular Space Formation,Telangiectatic Glomangioma
2750,Mucoid Stroma Formation,Thyroid Gland Mucinous Follicular Adenoma
2751,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
2752,Carcinomatous Component Present,Vaginal Cancer by AJCC v6 Stage
2753,Rapidly Enlarging Mass,Fusion-Negative Alveolar Rhabdomyosarcoma
2754,Epithelial Component Present,Malignant Vipoma
2755,Sebaceous Differentiation,Superficial Epithelioma with Sebaceous Differentiation
2756,Birbeck Granules Present,Letterer-Siwe Disease
2757,CD1a-Positive Neoplastic Cells Present,Letterer-Siwe Disease
2758,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Hodgkin Lymphoma
2759,Carcinomatous Component Present,Stage IIIA Lung Large Cell Carcinoma AJCC v7
2760,Diffuse Pattern,Metastatic Malignant Peripheral Nerve Sheath Tumor
2761,Adnexal Differentiation,Sebaceoma
2762,Perineural spread,Minor Salivary Gland Adenoid Cystic Carcinoma
2763,Hyperplastic Tissue Present,Inflammatory fibrous hyperplasia of mouth
2764,Loss of INI 1 Protein Expression,Cribriform Neuroepithelial Tumor
2765,Malignant Cellular Infiltrate,Childhood Ovarian Choriocarcinoma
2766,Myxoid Stroma Formation,Sternal Chondromyxoid Fibroma
2767,Epithelial Component Present,Intracystic papillary neoplasm with low grade intraepithelial neoplasia
2768,Neuroendocrine Differentiation,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7
2769,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic
2770,Severe dysplasia,Adenocarcinoma in situ in a polyp
2771,Neuroendocrine Differentiation,Gastrinoma
2772,Carcinomatous Component Present,Stage IV Laryngeal Cancer AJCC v6
2773,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Overt Primary Myelofibrosis
2774,Nested Pattern,Gonadoblastoma
2775,Increased Cellularity Present,Stage 4S neuroblastoma
2776,Epithelial Component Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
2777,Papillary Pattern,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
2778,Immunologic Deficiency Syndromes,Transplant-Related Skin Squamous Cell Carcinoma
2779,Papillary Pattern,Pancreatic Intraductal Papillary-Mucinous Adenoma
2780,Hyalinized Stroma Formation,Pleural Solitary Fibrous Tumor
2781,Papillary Pattern,Papillary cystic tumor
2782,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
2783,Compartmentalized Pattern,Senile Sebaceous Hyperplasia
2784,Encapsulated Mass,Thyroid Gland Signet Ring Cell Follicular Adenoma
2785,Dysplasia,High Grade Ductal Breast Carcinoma In Situ
2786,Cellular Pleomorphism,Adult Undifferentiated Pleomorphic Sarcoma
2787,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity stage II
2788,Absence of Muscle Invasion,"Carcinoma of urinary bladder, superficial"
2789,Endophytic Tumor Growth,verrucous carcinoma of vulva
2790,Exophytic Papillary Lesion,verrucous carcinoma of vulva
2791,Contiguous Disease,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma
2792,Carcinomatous Component Present,Liver Adenosquamous Carcinoma
2793,Absence of Invasion,Stage 0 Pharynx Carcinoma
2794,Epithelial Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
2795,Carcinomatous Component Present,Bladder Papillary Clear Cell Adenocarcinoma
2796,Carcinomatous Component Present,Hepatitis Virus-Related Hepatocellular Carcinoma
2797,Epithelial Component Present,Endometrial Clear Cell Adenocarcinoma
2798,Tubular Structures Present,Sertoli cell tumor of testis
2799,Trichoblastic Differentiation,Desmoplastic trichoepithelioma
2800,Epithelial Component Present,Pancreatic carcinoma recurrent
2801,Epithelial Component Present,Papillary carcinoma of the breast
2802,Adulthood Lesion,Adult Choroid Plexus Neoplasm
2803,Blasts Under 20 Percent of Peripheral Blood White Cells,"Leukemia, Myelomonocytic, Chronic"
2804,Epithelial Component Present,Squamous cell carcinoma of lung
2805,Ground Glass Nuclear Inclusion,Follicular Variant Thyroid Gland Papillary Carcinoma
2806,Epithelial Component Present,Paget Disease of the Breast with Invasive Ductal Carcinoma
2807,Biphasic Pattern,Adult Mesenchymal Chondrosarcoma
2808,Well-Circumscribed Lesion,Peutz-Jeghers polyps of small bowel
2809,Epithelial Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
2810,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia
2811,Adulthood Lesion,Adult Burkitt Leukemia
2812,Pregnancy Complications,Chorioamnionitis
2813,Well-Circumscribed Lesion,Polyp of external auditory meatus
2814,Mitotic Activity,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
2815,Macule,Stage I Acral Lentiginous Melanoma AJCC v7
2816,Epithelial Component Present,Metastatic Prostate Carcinoma
2817,Adulthood Lesion,Adult Grade III Meningioma
2818,Hereditary Lesion,Bannayan-Riley-Ruvalcaba Syndrome
2819,Well-Circumscribed Lesion,Colorectal Adenoma with Severe Dysplasia
2820,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of rectum
2821,Secondary Lesion,Alkylating Agent-Related Acute Myeloid Leukemia
2822,Epithelial Component Present,Recurrent Thyroid Carcinoma
2823,Epithelial Component Present,Appendix Tubular Adenoma
2824,Carcinomatous Component Present,Transitional cell carcinoma in situ
2825,Anaplasia,Plasmacytoma anaplastic
2826,Adulthood Lesion,Adult Papillary Meningioma
2827,Epithelial Component Present,Large cell carcinoma with rhabdoid phenotype
2828,Epithelial Component Present,Bladder Signet Ring Cell Adenocarcinoma
2829,Severe dysplasia,"Glandular intraepithelial neoplasia, grade III"
2830,Exophytic Polypoid Lesion,polyps
2831,Perivascular Arrangement of Tumor Cells,Glomus Tumor
2832,Exophytic Polypoid Lesion,Vaginal Tubular Adenoma
2833,Rapidly Enlarging Mass,Pleomorphic Rhabdomyosarcoma
2834,Cutaneous Involvement,Stage III Lentigo Maligna Melanoma AJCC v7
2835,Epithelial Component Present,Stage 0a Ureter Cancer AJCC v7
2836,Epithelial Component Present,Metastatic urothelial carcinoma
2837,Epithelial Component Present,Pancreatic ACTH-Producing Neuroendocrine Tumor
2838,CD30-Positive Neoplastic Cells Present,Anaplastic small cell lymphoma
2839,Nuclear pleomorphism,Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma
2840,Epithelial Component Present,Stage III Vulvar Cancer AJCC v7
2841,Nuclear Atypia,Childhood Cerebellar Anaplastic Astrocytoma
2842,Carcinomatous Component Present,Mammary Analog Secretory Carcinoma of Salivary Gland
2843,Cutaneous Involvement,Preauricular skin tag
2844,Glial Differentiation,Adult Gliosarcoma
2845,Cambium Layer,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
2846,Glandular Pattern,Breast Ductal Adenoma
2847,Immunologic Deficiency Syndromes,AIDS-Related Lymphoblastic Lymphoma
2848,Diffuse Pattern,Recurrent Childhood Fibrillary Astrocytoma
2849,Carcinomatous Component Present,"Adenocarcinoma, Clear Cell"
2850,Swelling,Benign Osteoclastic Giant Cell-Rich Tumor of Bone
2851,Carcinomatous Component Present,Intestinal Neuroendocrine Carcinoma
2852,Epithelial Component Present,Parietal cell carcinoma
2853,Mitotic Activity,Recurrent Childhood Giant Cell Glioblastoma
2854,Epithelial Component Present,Gastric Carcinoid Tumor
2855,Endophytic Tumor Growth,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
2856,Absence of Invasion,Low Grade Ductal Breast Carcinoma In Situ
2857,Epithelial Component Present,Adenoid cystic eccrine carcinoma
2858,Myxoid Stroma Formation,Intracranial Extraskeletal Myxoid Chondrosarcoma
2859,Epithelial Component Present,Occult Lung Small Cell Carcinoma
2860,Monomorphic Cellular Infiltrate,Adult Ependymoma
2861,Lepidic Growth Pattern,"Bronchiolo-alveolar carcinoma, non-mucinous"
2862,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v6
2863,Epithelial Component Present,Bladder Cancer by AJCC v7 Stage
2864,Hemorrhagic,Small Intestinal Angiosarcoma
2865,Ineffective hematopoiesis,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
2866,Epithelial Component Present,Paranasal Sinus Schneiderian Papilloma
2867,Metastatic Lesion,Pleural Carcinomatosis
2868,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation
2869,Tissue Differentiation Uncertain,Esophageal Synovial Sarcoma
2870,Immunologic Deficiency Syndromes,AIDS related complication
2871,Recurrent disease,Recurrent Inverted Schneiderian Papilloma
2872,Dysplasia,Biliary Intraepithelial Neoplasia
2873,Pregnancy Complications,Malignant Placental Neoplasm
2874,Local disease,Angiolipoma
2875,Mild dysplasia,Low Grade Esophageal Squamous Intraepithelial Neoplasia
2876,Secondary Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral"
2877,Epithelial Component Present,Colon Serrated Adenocarcinoma
2878,Slow Growing Mass,Adult Spinal Cord Ependymoma
2879,Epithelial Component Present,Lung Basaloid Squamous Cell Carcinoma
2880,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Teratoma
2881,High Mitotic Activity,Salivary duct carcinoma
2882,More than 10 Mitoses per 10HPF,Small cell lung cancer recurrent
2883,Intracellular Accumulation of Lipids,Anaplastic Pleomorphic Xanthoastrocytoma
2884,Indolent Clinical Course,Cementoma
2885,Secondary Lesion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
2886,Epithelial Component Present,Undifferentiated carcinoma of esophagus
2887,Carcinomatous Component Present,Sinonasal undifferentiated carcinoma
2888,Exophytic Polypoid Lesion,adenomatous polyp of stomach
2889,Glomeruloid Vessels Present,Recurrent Childhood Pilocytic Astrocytoma
2890,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Carcinosarcoma
2891,Mixture of Germ Cell Neoplastic Components Present,Choriocarcinoma combined with other germ cell elements
2892,Mixed Cellular Population,"Mixed Tumor, Mullerian"
2893,Carcinomatous Component Present,Hypopharyngeal Carcinoma
2894,Eosinophil count raised (finding),Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA
2895,Benign Cellular Infiltrate,Anal Canal Squamous Papilloma
2896,Primary Lesion,Brain Stem Hemangioblastoma
2897,Primary Lesion,Childhood Parosteal Osteosarcoma
2898,Indolent Clinical Course,Dartoic myoma
2899,Cutaneous Involvement,Pilar tumor
2900,Indolent Clinical Course,Central Nervous System Rhabdomyoma
2901,Mesenchymal Component Present,Pericanalicular fibroadenoma
2902,Mucoid Stroma Formation,mucinous adenocarcinoma of gallbladder
2903,Exophytic Papillary Lesion,Papillary squamous cell carcinoma
2904,Epithelial Component Present,Non-Functioning Adrenal Cortex Adenoma
2905,Sarcomatous Component Present,Malignant Cystosarcoma Phyllodes
2906,Carcinomatous Component Present,malignant neoplasm of breast stage I
2907,Carcinomatous Component Present,Stage III Breast Cancer AJCC v7
2908,Biphasic Pattern,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
2909,Childhood Lesion,Macrotrabecular Hepatoblastoma
2910,Neuroendocrine Differentiation,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7
2911,Primary Lesion,Recurrent Primary Peritoneal Carcinoma
2912,Thin-Walled Branching Vascular Pattern,Infiltrating angiolipoma
2913,Glomerular Hypertrophy,Secondary Focal Segmental Glomerulosclerosis
2914,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Lung
2915,Epithelial Component Present,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia
2916,Childhood Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
2917,Capillary Sized Vascular Channel Formation,Pyogenic granuloma of oral mucosa
2918,Tubular Pattern,Lactating adenoma
2919,Argentaffin Positive Neoplastic Cells Present,Ovarian Insular Carcinoid Tumor
2920,Epithelial Component Present,Stage IV Lung Squamous Cell Carcinoma AJCC v7
2921,Carcinomatous Component Present,Stage IV Lung Squamous Cell Carcinoma AJCC v7
2922,Mild dysplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia
2923,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
2924,Mixed Cellular Population,Combined Lung Small Cell and Squamous Cell Carcinoma
2925,Multifocal Lesion,Intraductal Breast Myoepitheliosis
2926,Psammoma Body Formation,Psammomatous Meningioma
2927,Epithelial Component Present,Papillary Breast Neoplasm
2928,Epithelial Component Present,Stage IV Renal Pelvis Cancer AJCC v7
2929,Papillary Pattern,papillary carcinoma of renal pelvis
2930,Encapsulated Mass,Tumor contained within organ capsule
2931,Carcinomatous Component Present,Small Intestinal Small Cell Neuroendocrine Carcinoma
2932,Well-Circumscribed Lesion,Ureteric polyp
2933,Low Grade Cartilaginous Component Present,Dedifferentiated chondrosarcoma
2934,Epithelial Component Present,Benign Basal Cell Neoplasm
2935,Vascular Channel Formation,Angiomyoma
2936,High Mitotic Activity,"Carcinoma, Small Cell"
2937,Vascular Channel Formation,Prostate Kaposi Sarcoma
2938,Carcinomatous Component Present,Squamous cell carcinoma of vulva
2939,Systemic disease,Primary Systemic Mastocytosis
2940,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Wildtype"
2941,Regional Disease,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter
2942,Neuroendocrine Differentiation,Extra-Adrenal Paraganglioma
2943,Low Mitotic Activity,Extrahepatic Bile Duct Carcinoid Tumor
2944,Acanthosis,Cervical Verrucous Carcinoma
2945,Carcinomatous Component Present,Skin carcinoma
2946,Papillary Pattern,Papillary Urothelial Neoplasm
2947,Hyalinized Stroma Formation,Cardiac Epithelioid Hemangioendothelioma
2948,Diffuse Pattern,Mixed astrocytoma-ependymoma
2949,Papillary Pattern,Vaginal Squamous Papilloma
2950,Metastatic Lesion,Secondary malignant neoplasm of ureter
2951,Cystic Change,Vulvar Seborrheic Keratosis
2952,Low Grade Lesion,Adult Subependymal Giant Cell Astrocytoma
2953,Cutaneous Involvement,Chronic Adult T-Cell Leukemia/Lymphoma
2954,Metastatic/Recurrent Disease,Monophasic Synovial Sarcoma
2955,Carcinomatous Component Present,Squamous cell carcinoma of palate
2956,Carcinomatous Component Present,"Squamous cell carcinoma, large cell, nonkeratinizing"
2957,Mixed Cellular Population,Fallopian Tube Adenosarcoma
2958,Exophytic Polypoid Lesion,Polyp of vagina
2959,Epithelial Component Present,Stage II Oropharyngeal Carcinoma
2960,Adulthood Lesion,Recurrent Adult Lymphoblastic Lymphoma
2961,Hereditary Lesion,"Neoplastic Syndromes, Hereditary"
2962,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage IV
2963,Cutaneous Involvement,Trichilemmoma
2964,Lymphoplasmacytic Infiltrate,Nasopharyngeal Nonkeratinizing Carcinoma
2965,Diffuse Pattern,Childhood Cerebral Diffuse Astrocytoma
2966,Cutaneous Involvement,Psoriasiform eczema
2967,Carcinomatous Component Present,Large cell carcinoma of lung
2968,Exophytic Papillary Lesion,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
2969,Epithelial Component Present,Bartholin Gland Adenoma
2970,Carcinomatous Component Present,Fallopian Tube Endometrioid Adenocarcinoma
2971,Carcinomatous Component Present,Low grade appendiceal mucinous neoplasm
2972,Dilated Cystic Spaces Present,Tubulocystic renal cell carcinoma
2973,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
2974,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Childhood Myelodysplastic Syndrome
2975,Encapsulated Mass,Atypical follicular adenoma
2976,atypia morphology,"Leydig cell tumor, malignant"
2977,Slow Growing Mass,Pituitary Gland Gangliocytoma
2978,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
2979,Carcinomatous Component Present,mucoepidermoid carcinoma of lacrimal gland
2980,Pleural effusion disorder,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
2981,Well-Circumscribed Lesion,Pulmonary Sclerosing Hemangioma
2982,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
2983,Local disease,Lung Myolipoma
2984,Metastatic Lesion,Secondary malignant neoplasm of parathyroid gland
2985,Carcinomatous Component Present,Stage IB Fallopian Tube Cancer AJCC v6 and v7
2986,Carcinomatous Component Present,"Basal cell carcinoma, infundibulocystic"
2987,Epithelial Component Present,"Basal cell carcinoma, infundibulocystic"
2988,Epithelial Component Present,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
2989,Carcinomatous Component Present,Stage 0 Vulvar Cancer
2990,Thyroglobulin Positive Neoplastic Cells Present,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
2991,Adnexal Differentiation,Benign Pilar-Associated Mesenchyme Neoplasm
2992,Well-Circumscribed Lesion,Peutz-Jeghers Polyp of the Stomach
2993,Indolent Clinical Course,Benign Pericytic Neoplasm
2994,Indolent Clinical Course,Tendon Sheath Lipoma
2995,Neuroendocrine Differentiation,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
2996,Secondary Lesion,Metastases to abdominal cavity
2997,Mixed Cellular Population,Parathyroid mixed cell type adenoma
2998,CD8-Positive Neoplastic Cells Present,Subcutaneous panniculitis-like T-cell lymphoma
2999,Nuclear Atypia,Recurrent Childhood Anaplastic Oligoastrocytoma
3000,Fibrotic Stroma Formation,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
3001,Epithelial Component Present,Ethmoid Sinus Adenocarcinoma
3002,Nodular Pattern,Ann Arbor Stage I Grade 2 Follicular Lymphoma
3003,Koilocytotic atypia,basaloid carcinoma of penis
3004,High Mitotic Activity,Stage IB Merkel Cell Carcinoma AJCC v7
3005,Indolent Clinical Course,Vulvar Angiomyofibroblastoma
3006,Storiform Growth Pattern,Malignant Fibrous Histiocytoma
3007,Cicatrix,Old Burn Scar-Related Neoplasm
3008,Low Mitotic Activity,Pancreatic Neuroendocrine Tumor G1
3009,Osseous Differentiation,Bone Surface (Peripheral) Osteosarcoma
3010,Carcinomatous Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
3011,Stromal Invasion,Undifferentiated carcinoma of ovary
3012,Epithelial Component Present,intraepithelial glandular neoplasia of cervix
3013,Carcinomatous Component Present,Stage III Breast Cancer AJCC v6
3014,Epithelial Component Present,Solid Papillary Breast Carcinoma
3015,Carcinomatous Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
3016,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Central Nervous System Choriocarcinoma
3017,Epithelial Component Present,Thyrotroph adenoma
3018,Epithelial Component Present,Endometrial Mucinous Adenocarcinoma
3019,Well-Circumscribed Lesion,Rectal hyperplastic polyp
3020,Childhood Lesion,Childhood Parathyroid Gland Carcinoma
3021,Carcinomatous Component Present,Metastatic Lobular Breast Carcinoma
3022,Cutaneous Involvement,Lip basal cell carcinoma
3023,Dysplasia,tubulopapillary adenoma of extrahepatic bile duct
3024,Tissues Derived from Two or Three Embryonic Layers Present,Dermoid cyst of ovary
3025,Therapy-Related Toxicity,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder
3026,Cutaneous Involvement,Squamous cell papilloma of skin
3027,Severe dysplasia,Skin Squamous Cell Carcinoma In Situ
3028,Well Developed Rough Endoplasmic Reticulum Present,Densely Granulated Somatotroph Adenoma
3029,Slow Growing Mass,Hemangioblastoma
3030,Mixture of Morphologic Patterns,Bladder Mixed Adenocarcinoma
3031,High Mitotic Activity,Stage IA Merkel Cell Carcinoma AJCC v7
3032,Collagenous Stroma Formation,Angiomyofibroblastoma
3033,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Somatotroph/Lactotroph Adenoma
3034,Well-Circumscribed Lesion,"Adenoma, Sweat Gland"
3035,Well Differentiated Lesion,Human Papillomavirus-Related Verrucous Carcinoma
3036,Carcinomatous Component Present,Stage III Paranasal Sinus Cancer AJCC v6 and v7
3037,Multilayered Rosette Formation,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
3038,Carcinomatous Component Present,Adenoid Cystic Carcinoma
3039,Fibrotic Stroma Formation,Odontoameloblastoma
3040,Congenital Lesion,Congenital ptosis
3041,Childhood Lesion,Stage I Childhood Anaplastic Large Cell Lymphoma
3042,Carcinomatous Component Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
3043,Absence of Invasion,Stage 0 Colorectal Cancer AJCC v6 and v7
3044,Secondary Lesion,Secondary malignant neoplasm of heart
3045,Malignant Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7
3046,In Situ Lesion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
3047,Epithelial Component Present,Lung Hilum Carcinoma
3048,Immunologic Deficiency Syndromes,Allograft Thrombosis
3049,Cutaneous Involvement,"Carcinoma, Basosquamous"
3050,Benign Cellular Infiltrate,Pancreatic Acinar Cell Cystadenoma
3051,Carcinomatous Component Present,verrucous carcinoma of bladder
3052,Tissue of Mullerian Origin Present,Ovarian Mucinous Cystadenofibroma
3053,Well-Circumscribed Lesion,Colorectal Traditional Serrated Adenoma
3054,Carcinomatous Component Present,Moderately Differentiated Hepatocellular Carcinoma
3055,Metastatic Lesion,Secondary malignant neoplasm of colon
3056,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma
3057,Recurrent disease,Recurrent Uterine Corpus Carcinoma
3058,Firm mass,Metastatic Malignant Peripheral Nerve Sheath Tumor
3059,Below the Diaphragm Disease,Hodgkin's disease mixed cellularity stage II subdiaphragmatic
3060,Carcinomatous Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7
3061,Carcinomatous Component Present,Anal cancer recurrent
3062,Myxoid Stroma Formation,Ovarian Myxoid Liposarcoma
3063,Diffuse Pattern,Gliomatosis Cerebri Type I
3064,Nerve palsy,Abducens Nerve Palsy
3065,Epithelial Component Present,Stage 0 Anal Canal Cancer AJCC v6 and v7
3066,Refractory Disease,Refractory Childhood Malignant Germ Cell Tumor
3067,Anaplasia,Chondroblastic osteosarcoma
3068,Cartilaginous Differentiation,Chondroblastic osteosarcoma
3069,Fetal -Epithelial Differentiation,Hepatoblastoma with Pure Fetal Epithelial Differentiation
3070,Recurrent disease,Synovial sarcoma recurrent
3071,In Situ Lesion,Stage 0 Colon Cancer AJCC v6 and v7
3072,In Situ Lesion,Carcinoma in situ in a polyp
3073,Schwannian Stroma Predominant Component of the Tumor Volume,Maturing Ganglioneuroma
3074,Secondary Lesion,Metastatic Carcinoma in the Adrenal Medulla
3075,Increased megakaryocytes (bone marrow),Overt Primary Myelofibrosis
3076,Carcinomatous Component Present,Rectal Small Cell Neuroendocrine Carcinoma
3077,Carcinomatous Component Present,Bladder transitional cell carcinoma stage 0
3078,Micropapillary Pattern,"Transitional cell carcinoma, micropapillary"
3079,Metaplasia of Malignant Cells Present,Adenocarcinoma with cartilaginous and osseous metaplasia
3080,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
3081,Well-Circumscribed Lesion,Colorectal Adenoma with Mild Dysplasia
3082,Mesenchymal Differentiation,"Transitional cell carcinoma, spindle cell"
3083,Epithelial Component Present,Benign tumor of endocrine gland
3084,Zonal Pattern,Tibial adamantinoma
3085,Carcinomatous Component Present,Esophageal Spindle Cell Carcinoma
3086,Epithelial Component Present,Small intestine carcinoma
3087,Well-Circumscribed Lesion,Beta-Catenin-Activated Hepatocellular Adenoma
3088,Below the Diaphragm Disease,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
3089,Locally Aggressive Lesion,Gastric Inflammatory Myofibroblastic Tumor
3090,Epithelial Component Present,Stage IIIC Colon Cancer AJCC v7
3091,Cutaneous Involvement,Lentigo
3092,CD1a-Positive Neoplastic Cells Present,Langerhans Cell Sarcoma
3093,Non-Invasive Lesion,cystic mucinous tumor of pancreas with moderate dysplasia
3094,Immunologic Deficiency Syndromes,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
3095,Epithelial Component Present,Lobular carcinoma in situ of breast
3096,Splenomegaly,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant"
3097,Therapy-Related Toxicity,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
3098,Diffuse Pattern,Diffuse large B-cell lymphoma refractory
3099,Vascular Channel Formation,Angiosarcoma Associated with Lymphedema
3100,Vascular Channel Formation,Hemangioma of intracranial structure
3101,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage IV
3102,Indolent Clinical Course,lipoma of bone
3103,Intraductal Lesion,Ductal Breast Hyperplasia
3104,Epithelial Component Present,Stage III Lip Basal Cell Carcinoma
3105,Carcinomatous Component Present,Renal medullary carcinoma
3106,Fenestrated Pattern,Desmoplastic trichoepithelioma
3107,Cystic Change,cystadenocarcinoma of salivary gland
3108,Carcinomatous Component Present,cystadenocarcinoma of salivary gland
3109,Epithelial Component Present,Prostate Phyllodes Tumor
3110,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myelomonocytic, Chronic"
3111,Carcinomatous Component Present,Adenoma of the Colon with Intramucosal Adenocarcinoma
3112,Invasive Lesion,Paget Disease of the Breast with Invasive Ductal Carcinoma
3113,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type"
3114,Stable Disease,Smoldering myeloma
3115,Carcinomatous Component Present,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
3116,Mixed Cellular Population,Lung Pleomorphic Adenoma
3117,Cutaneous Involvement,Seborrheic dermatitis
3118,Metaplasia,Ampulla of Vater Intestinal-Type Adenocarcinoma
3119,Recurrent disease,Squamous cell carcinoma of the oral cavity recurrent
3120,Childhood Lesion,Childhood Myxoid Chondrosarcoma
3121,Syncytial Pattern,lymphoepithelial squamous cell carcinoma of salivary gland
3122,Angiocentric Pattern,Lymphomatoid Granulomatosis
3123,Invasive Lesion,Adenocarcinoma of the prostate metastatic
3124,Tissue of Mullerian Origin Present,Ovarian Adenosarcoma
3125,Therapy-Related Toxicity,Methotrexate-Associated Burkitt Lymphoma
3126,Metaplasia,Bladder Urachal Squamous Cell Carcinoma
3127,Neuroendocrine Differentiation,Gastric Neuroendocrine Neoplasm
3128,Hyperplastic Tissue Present,Utricle-Associated Mucosal Gland Hyperplasia
3129,Hypercellular bone marrow,"Leukemia, Myeloid, Accelerated Phase"
3130,Adnexal Differentiation,Ceruminous Neoplasm
3131,Epithelial Component Present,Gastric Mixed Adenoneuroendocrine Carcinoma
3132,Carcinomatous Component Present,Gastric Mixed Adenoneuroendocrine Carcinoma
3133,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
3134,Carcinomatous Component Present,Carcinoma in situ of small intestine
3135,CD56-Positive Neoplastic Cells Present,Aggressive natural killer-cell leukemia
3136,Intestinal metaplasia,Vaginal Tubular Adenoma
3137,Somatostatin Positive Neoplastic Cells Present,"Somatostatinoma, malignant"
3138,Epithelial Component Present,Mixed Ductal-Endocrine Carcinoma
3139,Invasive Lesion,Invasive papillary breast carcinoma
3140,Exposure to asbestos,Asbestos-Related Malignant Mesothelioma
3141,Hypoglycemia,insulinoma
3142,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myeloid leukemia with abnormal marrow eosinophils
3143,Carcinomatous Component Present,Asbestos-Related Lung Carcinoma
3144,Secondary Lesion,Metastatic Carcinoma in the Liver
3145,Epithelial Component Present,Gastro-enteropancreatic neuroendocrine tumor
3146,Epithelial Component Present,Rectal Micropapillary Adenocarcinoma
3147,Pain,Benign Osteoclastic Giant Cell-Rich Tumor of Bone
3148,Rapidly Enlarging Mass,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
3149,No Identifiable Line of Differentiation,Childhood Undifferentiated Pleomorphic Sarcoma
3150,Mitotic Activity,Recurrent Childhood Glioblastoma
3151,Cutaneous Involvement,Perifollicular fibroma
3152,Thyroglobulin Positive Neoplastic Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
3153,Cutaneous Involvement,Sporadic Cylindroma
3154,Adnexal Differentiation,Sporadic Cylindroma
3155,Carcinomatous Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7
3156,Carcinomatous Component Present,Skin Basal Cell Carcinoma with Sebaceous Differentiation
3157,Well-Circumscribed Lesion,Adenomatous Polyposis Coli
3158,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v7
3159,High Mitotic Activity,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
3160,Epithelial Component Present,Collecting Duct Carcinoma of the Kidney
3161,Epithelial Component Present,Esophageal Large Cell Neuroendocrine Carcinoma
3162,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma recurrent
3163,Indolent Clinical Course,Intravenous leiomyomatosis
3164,Regional Disease,Urethral cancer regional
3165,Lesion with Diameter Greater than 10mm,Non-Functioning Pituitary Gland Macroadenoma
3166,Epithelial Component Present,Alveolar adenoma
3167,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II
3168,Cutaneous Involvement,Sweat gland adenocarcinoma
3169,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphepithelioma
3170,Mediastinal mass,Mediastinal T Lymphoblastic Lymphoma
3171,Carcinomatous Component Present,Non-small cell carcinoma
3172,Non-Contiguous Disease,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma
3173,Extraosseous Lesion,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral"
3174,Hemorrhagic,Angiosarcoma NCI Grade 3
3175,Epithelial Component Present,neuroendocrine carcinoma of anal canal
3176,Vascular Channel Formation,Kaposi Sarcoma NCI Grade 2
3177,atypia morphology,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
3178,Childhood Lesion,Childhood Acute Promyelocytic Leukemia with PML-RARA
3179,Thin Bands of Collagen Present,Mediastinal Solitary Fibrous Tumor
3180,Well-Circumscribed Lesion,Clear cell sarcoma of kidney
3181,Rapidly Enlarging Mass,Conventional Alveolar Rhabdomyosarcoma
3182,Papillary Pattern,"Papillary squamous cell carcinoma, non-invasive"
3183,Epithelial Component Present,Appendix Villous Adenoma
3184,Epithelial Component Present,Stage II Major Salivary Gland Cancer AJCC v7
3185,Carcinomatous Component Present,Lung Basaloid Squamous Cell Carcinoma
3186,Peripheral Nuclear Palisading,Lung Basaloid Squamous Cell Carcinoma
3187,Infantile Lesion,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement
3188,Childhood Lesion,Childhood Non-Hodgkin Lymphoma
3189,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Teratoma
3190,Recurrent disease,Recurrent Childhood Visual Pathway Glioma
3191,Tubal Diverticulosis,Salpingitis isthmica nodosa
3192,Well-Circumscribed Lesion,Fibrous polyp
3193,Crystal deposition,Alveolar soft part sarcoma recurrent
3194,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Fetal Lung Adenocarcinoma
3195,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
3196,Absence of Invasion,Biliary Intraepithelial Neoplasia-3
3197,Epithelial Component Present,Stage IVA Vaginal Cancer AJCC v6 and v7
3198,Endophytic Tumor Growth,Ethmoid Sinus Inverted Papilloma
3199,Epithelial Component Present,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
3200,Carcinomatous Component Present,Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
3201,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts I
3202,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Carcinosarcoma
3203,Epithelial Component Present,Acanthoma
3204,Cambium Layer,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
3205,Well-Circumscribed Lesion,Vulvar Superficial Myofibroblastoma
3206,Hereditary Lesion,Hereditary Leiomyomatosis and Renal Cell Cancer
3207,Cutaneous Involvement,"Dermatofibrosarcoma Protuberans, Myxoid"
3208,Hyperplastic Epithelial Tissue Present,Columnar Cell Hyperplasia of the Breast
3209,Severe cytologic atypia,Extrahepatic Bile Duct Neuroendocrine Carcinoma
3210,Cutaneous Involvement,Cutaneous leiomyoma
3211,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Childhood Ganglioneuroblastoma, Nodular"
3212,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma
3213,Lobular Pattern,Pilar tumor
3214,Slow Growing Mass,Pilar tumor
3215,Invasive Lesion,Scirrhous carcinoma of breast
3216,Intraductal Lesion,Intraductal papillomatosis
3217,Adulthood Lesion,Adult Brain Stem Neoplasm
3218,Hypercellular bone marrow,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
3219,Lobulated Growth Pattern,Juxta-Articular Myxoma
3220,Melanin Pigment Present,Cervical Blue Nevus
3221,Solitary mass,Chondroid chordoma
3222,Chromogranin A Positive Neoplastic Cells Present,Testicular Carcinoid Tumor
3223,Osseous Differentiation,Aggressive osteoblastoma
3224,Epithelial Component Present,Early Invasive Cervical Squamous Cell Carcinoma
3225,Cutaneous Involvement,Bowenoid papulosis of penis
3226,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v7
3227,Epithelial Component Present,Stage IB Lung Cancer AJCC v7
3228,Epithelial Component Present,Stage III Childhood Hepatocellular Carcinoma AJCC v7
3229,Myxoid Stroma Formation,Metastasizing Chondroblastoma
3230,Epithelial Component Present,Basophilic Adenocarcinoma
3231,Epithelial Component Present,Stage IB Ampulla of Vater Cancer AJCC v7
3232,Glandular Pattern,Ovarian Mucinous Carcinoid Tumor
3233,Epithelial Component Present,Stage IIIA Lung Cancer AJCC v7
3234,Pain,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone
3235,Swelling,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone
3236,Childhood Lesion,Recurrent Childhood Kidney Neoplasm
3237,Recurrent disease,Recurrent Childhood Central Nervous System Neoplasm
3238,Adulthood Lesion,Adult Lymphoblastic Lymphoma
3239,Osseous Differentiation,Telangiectatic osteosarcoma
3240,Cutaneous Involvement,Stage I Merkel Cell Carcinoma AJCC v7
3241,Carcinomatous Component Present,Clitoral Carcinoma
3242,Hyperplastic Tissue Present,Mesothelial hyperplasia
3243,Exophytic Polypoid Lesion,Ureteric polyp
3244,Storiform Growth Pattern,Cardiac Malignant Fibrous Histiocytoma
3245,Epithelial Component Present,Squamous cell carcinoma of floor of mouth
3246,Mixed Cellular Population,Nephroblastoma
3247,Benign Cellular Infiltrate,Benign Gastric Granular Cell Tumor
3248,Epithelial Component Present,clear cell neoplasm of ovary
3249,Epithelial Component Present,Stage IA Vulvar Carcinoma AJCC v6
3250,Epithelial Component Present,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8"
3251,Anaplasia,Stage I Anaplastic Large Cell Lymphoma
3252,Tissue Differentiation Uncertain,Lung Biphasic Synovial Sarcoma
3253,Extracutaneous Dissemination of Disease,Disseminated Juvenile Xanthogranuloma
3254,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant"
3255,Localized Lesion,Solitary Osseous Plasmacytoma
3256,Benign Cellular Infiltrate,Benign Esophageal Schwannoma
3257,Recurrent disease,Recurrent Adult Soft Tissue Sarcoma
3258,Epithelial Component Present,Stage III Skin Cancer
3259,Necrotic changes (finding),Classical Glioblastoma
3260,Biphasic Pattern,"Cervical Adenomyoma, Endocervical Type"
3261,Carcinomatous Component Present,Stage IIC Ovarian Carcinoma
3262,Pregnancy Complications,Acute Placental Infarction
3263,Tissue Differentiation Uncertain,Cellular Myxoma
3264,Epithelial Component Present,Stage I Gallbladder Cancer AJCC v7
3265,Glucagon-Like Peptide Positive Neoplastic Cells Present,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
3266,Infiltrative Growth Pattern,"Anaplastic Astrocytoma, IDH-Mutant"
3267,Keratin pearl formation,squamous cell carcinoma of middle ear
3268,Secondary Lesion,Secondary Neoplasm
3269,Carcinomatous Component Present,Sarcomatoid Hepatocellular Carcinoma
3270,Cutaneous Involvement,"Dermatitis, Phototoxic"
3271,Infiltrative Growth Pattern,Childhood Cerebral Diffuse Astrocytoma
3272,High Grade Lesion,"Liposarcoma, Pleomorphic"
3273,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Fallopian Tube Gestational Choriocarcinoma
3274,Childhood Lesion,Childhood Acute Myeloid Leukemia without Maturation
3275,Carcinomatous Component Present,Inflammatory Breast Carcinoma
3276,Carcinomatous Component Present,Stage I Pancreatic Cancer AJCC v6 and v7
3277,Secondary Lesion,Secondary malignant neoplasm of retina
3278,Invasive Lesion,adenocarcinoma of breast with squamous metaplasia
3279,Carcinomatous Component Present,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
3280,Endophytic Tumor Growth,Plantar Verrucous Skin Carcinoma
3281,Adulthood Lesion,Adult Oligodendroglioma
3282,Carcinomatous Component Present,small cell carcinoma of salivary gland
3283,Carcinomatous Component Present,Grade 3 Endometrial Mucinous Adenocarcinoma
3284,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change
3285,Secondary Lesion,Chondrosarcoma metastatic
3286,Neuroendocrine Differentiation,Parasympathetic paraganglioma
3287,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma stage I
3288,atypia morphology,Malignant Ovarian Luteinized Thecoma
3289,Indolent Clinical Course,Dermal Fibroma
3290,Carcinomatous Component Present,Metastatic Carcinoma to the Uterine Cervix
3291,Nuclear Pseudoinclusion,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
3292,Mesenchymal Component Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
3293,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gastric Choriocarcinoma
3294,Chromogranin A Positive Neoplastic Cells Present,Carcinoid Tumor
3295,Carcinomatous Component Present,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
3296,High Grade Lesion,synovial sarcoma
3297,Neuroendocrine Differentiation,Stage III Appendix Neuroendocrine Tumor AJCC v7
3298,Fibrotic Stroma Formation,Pigmented villonodular synovitis
3299,Epithelial Component Present,Gallbladder Cancer by AJCC v6 Stage
3300,Childhood Lesion,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
3301,Carcinomatous Component Present,Stage IVB Basal Cell Lip Carcinoma
3302,Epithelial Component Present,Gallbladder Papillomatosis
3303,Epithelial Component Present,Childhood Thyroid Gland Papillary Carcinoma
3304,Local disease,Localized Resectable Neuroblastoma
3305,Indolent Clinical Course,Benign fibrohistiocytic neoplasm of skin
3306,Adulthood Lesion,Adult Liver Carcinoma
3307,Carcinomatous Component Present,Cigarette Smoking-Related Carcinoma
3308,Carcinomatous Component Present,Lung Cancer by AJCC v6 Stage
3309,Adnexal Differentiation,Clear cell hidradenoma
3310,Carcinomatous Component Present,adenoid cystic carcinoma of pharynx
3311,Pushing Tumor Margin,Urethral Verrucous Carcinoma
3312,Epithelial Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma
3313,Epithelial Component Present,Thymic Carcinoma
3314,Childhood Lesion,Juvenile Pilocytic Astrocytoma
3315,Therapy-Related Toxicity,Monomorphic Post-Transplant Lymphoproliferative Disorder
3316,Childhood Lesion,Childhood Bladder Carcinoma
3317,Primary Lesion,Anaplastic Diencephalic Astrocytoma
3318,Epithelial Component Present,Renal Pelvis and Ureter Urothelial Carcinoma
3319,Bone Marrow Dysplasia Present,Refractory Thrombocytopenia
3320,Carcinomatous Component Present,Metastatic Ductal Breast Carcinoma
3321,Epithelial Component Present,Stage IIA Cervical Cancer AJCC v7
3322,Monomorphic Cellular Infiltrate,Childhood Brain Oligodendroglioma
3323,Epithelial Component Present,Small Intestinal Signet Ring Cell Carcinoma
3324,Carcinomatous Component Present,Vaginal Endometrioid Adenocarcinoma
3325,Epithelial Component Present,Gallbladder Neuroendocrine Tumor G2
3326,Carcinomatous Component Present,Gastric Fundus Carcinoma
3327,Mild dysplasia,Small Intestinal Low Grade Intraepithelial Neoplasia
3328,Indolent Clinical Course,Infiltrating Intramuscular Lipoma
3329,Fenestrated Pattern,Vulvar Trichoepithelioma
3330,Mucoid Stroma Formation,Chordoid Glioma of the Third Ventricle
3331,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma
3332,Mixed Cellular Population,Benign mixed epithelial and stromal tumor of kidney
3333,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intraspinal Meningioma
3334,Carcinomatous Component Present,Stage IA Merkel Cell Carcinoma AJCC v7
3335,Micronodular Pattern,Micronodular thymoma with lymphoid stroma
3336,Neuroendocrine Differentiation,Pancreatic Large Cell Neuroendocrine Carcinoma
3337,Cutaneous Involvement,Benign Germinative Follicular Epithelium Neoplasm
3338,Epithelial Component Present,Localized Extrahepatic Bile Duct Carcinoma
3339,Deep Lesion,Intramuscular lipoma
3340,Splenomegaly,Splenic Manifestation of Hairy Cell Leukemia
3341,Diffuse Pattern,Grade III Lymphomatoid Granulomatosis
3342,Secondary Lesion,Metastatic Squamous Cell Breast Carcinoma
3343,Well-Circumscribed Lesion,Hepatocellular Adenoma
3344,Fibrotic Stroma Formation,mucoepidermoid carcinoma of esophagus
3345,Bilateral Disease,Contralateral Breast Carcinoma
3346,Hypoglycemia,Malignant Pancreatic Insulinoma
3347,Epithelial Component Present,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
3348,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype"
3349,Osseous Differentiation,Stage IV Osteosarcoma AJCC v7
3350,Anaplasia,Glioblastoma
3351,Epithelial Component Present,Bladder adenocarcinoma stage II
3352,Splenomegaly,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
3353,Epithelial Component Present,Gastroesophageal Junction Neuroendocrine Carcinoma
3354,Epithelial Component Present,Non-Small Cell Lung Carcinoma
3355,Epithelial Component Present,Colon Neuroendocrine Tumor G1
3356,Carcinomatous Component Present,Squamous cell carcinoma of prostate
3357,Adnexal Differentiation,Sebaceous Breast Carcinoma
3358,Ineffective hematopoiesis,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm
3359,Monocytosis,Chronic Myelomonocytic Leukemia-2
3360,Cutaneous Involvement,Eccrine carcinoma of skin
3361,More than 10 Mitoses per 10HPF,Stage IIA Lung Small Cell Carcinoma AJCC v7
3362,Epithelial Component Present,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor
3363,Well-Circumscribed Lesion,Cellular angiofibroma
3364,Epithelial Component Present,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia
3365,Carcinomatous Component Present,Vaginal Non-Keratinizing Squamous Cell Carcinoma
3366,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Isolated del(5q)
3367,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage III
3368,Immunologic Deficiency Syndromes,Transplant-Related Carcinoma
3369,Local disease,Rectal Lipoma
3370,Adulthood Lesion,Stage III Adult Lymphoblastic Lymphoma
3371,Poikilocytosis,Overt Primary Myelofibrosis
3372,Epithelial Component Present,Adenosquamous cell lung cancer stage IIIB
3373,Cutaneous Involvement,Ichthyosis linearis circumflexa
3374,Carcinomatous Component Present,Adenocarcinoma of Accessory Sinus
3375,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
3376,Epithelial Component Present,Prostatic Urethra Urothelial Carcinoma
3377,Local disease,Endobronchial lipoma
3378,Carcinomatous Component Present,Endometrial adenocarcinoma
3379,Severe dysplasia,solid type ductal carcinoma in situ of breast
3380,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
3381,Epithelial Component Present,Mesonephric tumor
3382,Epithelial Component Present,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma
3383,Indolent Clinical Course,Cellular fibroma
3384,Local disease,Uterine Corpus Adenomatoid Tumor
3385,Lymphoplasmacytic Infiltrate,Undifferentiated carcinoma of nasopharynx
3386,Below the Diaphragm Disease,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
3387,Epithelial Component Present,Vaginal Adenoid Cystic Carcinoma
3388,Multinodular Pattern,Eccrine dermal cylindroma
3389,Pseudoencapsulated Mass,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
3390,Locally Aggressive Lesion,Endovascular papillary angioendothelioma
3391,Epithelial Component Present,Inverting papilloma of the paranasal sinus
3392,Epithelial Component Present,Squamous Cell Bile Duct Carcinoma
3393,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
3394,Therapy-Related Toxicity,Methotrexate-Associated Hodgkin Lymphoma
3395,Infiltrative Growth Pattern,Childhood Fibrillary Astrocytoma
3396,Perivascular Arrangement of Tumor Cells,Pulmonary lymphangioleiomyomatosis
3397,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
3398,Epithelial Component Present,tubular adenoma of stomach
3399,Vascular Channel Formation,Hemangioma of orbit
3400,Carcinomatous Component Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
3401,Papillary Pattern,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
3402,'Starry-sky' pattern,Immunodeficiency-associated Burkitt's lymphoma
3403,Hereditary Lesion,Turcot Syndrome Type 1
3404,Diffuse Pattern,Childhood Giant Cell Glioblastoma
3405,Local disease,Lipoma of small intestine
3406,Cystic Change,Syringocystadenoma Papilliferum
3407,Dysplasia,Adenoma of ampulla of Vater
3408,Biphasic Pattern,Childhood Gliosarcoma
3409,Epithelial Component Present,Ampulla of Vater Villous Adenoma
3410,Low Mitotic Activity,Metastatic Digestive System Neuroendocrine Tumor G1
3411,Lymphadenopathy,Sezary Syndrome
3412,Rapidly Enlarging Mass,Uterine Corpus Rhabdomyosarcoma
3413,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of ovary
3414,Indolent Clinical Course,Benign Fibroblastic Neoplasm
3415,Carcinomatous Component Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7
3416,Fever,Multi-centric Castleman's Disease
3417,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP D2"
3418,Carcinomatous Component Present,Stage 0 Esophageal Adenocarcinoma AJCC v7
3419,Epithelial Component Present,"Carcinoma, Spindle-Cell"
3420,Chromogranin A Positive Neoplastic Cells Present,Ovarian Carcinoid Tumor
3421,Epithelial Component Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25)
3422,Necrotic changes (finding),Ampulla of Vater Large Cell Neuroendocrine Carcinoma
3423,Blasts of Mixed Phenotype Present,Infant Acute Biphenotypic Leukemia
3424,Epithelial Component Present,"Carcinoma, Endometrioid"
3425,Tubular Pattern,Somatostatinoma
3426,Epithelial Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v7
3427,Carcinomatous Component Present,Vaginal adenocarcinoma metastatic
3428,Therapy-Related Toxicity,Epipodophyllotoxin-Related Myelodysplastic Syndrome
3429,Metastatic Lesion,Metastatic Prostate Carcinoma
3430,Fibrotic Stroma Formation,carcinoma of pancreas with osteoclast-like giant cells
3431,Well-Circumscribed Lesion,Classic Rhabdomyoma
3432,Cystic Change,Serous cystadenocarcinoma of pancreas
3433,Carcinomatous Component Present,Adenocarcinoma of the prostate stage II
3434,Epithelial Component Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
3435,Carcinomatous Component Present,Intestinal-Type Sinonasal Adenocarcinoma
3436,Hydropic Villous Change,Complete hydatidiform mole
3437,Epithelial Component Present,Occult Lung Squamous Cell Carcinoma
3438,Perivascular Arrangement of Tumor Cells,Adult Papillary Meningioma
3439,Bone Marrow and Blood Involvement,Splenic diffuse red pulp small B-cell lymphoma
3440,Carcinomatous Component Present,Hereditary Diffuse Gastric Adenocarcinoma
3441,Non-Invasive Lesion,Stage 0a Renal Pelvis Cancer AJCC v7
3442,Cutaneous Involvement,Stage IV Cutaneous Melanoma AJCC v6 and v7
3443,Insular Pattern,"Somatostatinoma, malignant"
3444,Presence of a Hormonal Syndrome,Pancreatic Somatostatinoma
3445,Preserved Nuclear Polarity,Bladder Urothelial Papilloma
3446,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Cervical Endometrioid Adenocarcinoma
3447,Diffuse Pattern,Recurrent Childhood Diffuse Astrocytoma
3448,Neuroendocrine Differentiation,Intestinal Neuroendocrine Tumor
3449,Cutaneous Involvement,Malignant tumor of epidermal appendage
3450,Diffuse Pattern,Adult Giant Cell Glioblastoma
3451,Benign Cellular Infiltrate,Benign tumor of exocrine pancreas
3452,Rapidly Enlarging Mass,rhabdomyosarcoma of mediastinum
3453,Severe cytologic atypia,Small Intestinal Large Cell Neuroendocrine Carcinoma
3454,Metastatic Lesion,Secondary malignant neoplasm of testis
3455,Oligodendroglial Component Present,Well Differentiated Oligodendroglioma
3456,Carcinomatous Component Present,"Cystadenocarcinoma, Serous"
3457,Low Grade Lesion,Grade I Chondrosarcoma
3458,Epithelial Component Present,Prostate cancer recurrent
3459,Carcinomatous Component Present,Solid carcinoma
3460,Carcinomatous Component Present,Stage I Esophageal Cancer AJCC v7
3461,Carcinomatous Component Present,Adenocarcinoma of colon
3462,Non-Invasive Lesion,Stage 0 Renal Pelvis Cancer AJCC v7
3463,Dysplasia,Colon Traditional Serrated Adenoma
3464,Carcinomatous Component Present,Infiltrating Cervical Carcinoma
3465,Epithelial Component Present,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
3466,Vascular Channel Formation,Hemangioma of gingiva
3467,Necrotic changes (finding),small cell carcinoma of extrahepatic bile duct
3468,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation
3469,Epithelial Component Present,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter
3470,Epithelial Component Present,Adenosquamous cell lung cancer recurrent
3471,Epithelial Component Present,Esophageal High Grade Intraepithelial Neoplasia
3472,Lesion with Diameter Greater than 2cm,Osteoblastoma
3473,Epithelial Component Present,Stage IIIa Penile Cancer AJCC v7
3474,Eosinophil count raised (finding),Adult Acute Eosinophilic Leukemia
3475,Epithelial Component Present,Invasive carcinoma of breast
3476,Indolent Clinical Course,"Lymphangioma, Cystic"
3477,Carcinomatous Component Present,Stage IV Prostate Cancer AJCC v7
3478,Pushing Tumor Margin,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
3479,Thin-Walled Branching Vascular Pattern,Angiolipoma
3480,Dysplasia,Low Grade Esophageal Squamous Intraepithelial Neoplasia
3481,Epithelial Component Present,Carcinoma Arising in Nasal Papillomatosis
3482,Biphasic Pattern,Adenosarcoma of cervix uteri
3483,Well-Circumscribed Lesion,Benign Vaginal Mixed Tumor
3484,Severe dysplasia,Papillary carcinoma in situ
3485,Epithelial Component Present,Warty dyskeratoma
3486,Cystic Change,Mucinous cystadenocarcinoma appendix
3487,Epithelial Component Present,signet ring cell carcinoma of gallbladder
3488,Increased Cellularity Present,Childhood Pineoblastoma
3489,Immature Myeloid Cells Increased in Bone Marrow,Benzene-Related Acute Myeloid Leukemia
3490,Radiation Sickness,Radiation Pneumonitis
3491,Crystal deposition,Alveolar soft part sarcoma non-metastatic
3492,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
3493,Perineural spread,Major Salivary Gland Adenoid Cystic Carcinoma
3494,Epithelial Component Present,Major Salivary Gland Adenoid Cystic Carcinoma
3495,Metastatic Lesion,Carcinomatosis of peritoneal cavity
3496,Epithelial Component Present,Lung Lymphoepithelioma-Like Carcinoma
3497,Recurrent disease,Recurrent Childhood Pilocytic Astrocytoma
3498,Adnexal Differentiation,Tumor of follicular infundibulum
3499,Cutaneous Involvement,Skin Nodular Basal Cell Carcinoma
3500,Absence of Invasion of the Muscularis Externa,Early gastric cancer
3501,Infantile Lesion,Desmoplastic infantile astrocytoma
3502,Low Cellularity Present,Recurrent Childhood Protoplasmic Astrocytoma
3503,Epithelial Component Present,Recurrent Lip Basal Cell Carcinoma
3504,Hemorrhagic,Hemangiosarcoma
3505,Adulthood Lesion,Recurrent Adult Brain Neoplasm
3506,Necrotic changes (finding),large cell neuroendocrine carcinoma of extrahepatic bile duct
3507,Hyperplastic Tissue Present,Adrenocortical hyperplasia
3508,Childhood Lesion,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood
3509,Carcinomatous Component Present,Stage IVB Colon Cancer AJCC v7
3510,Fibrosis,Lipomatosis of Nerve
3511,Favorable Clinical Outcome,Ganglioneuroma of mediastinum
3512,Tissue Differentiation Uncertain,Nonossifying Fibromyxoid Tumor
3513,Vascular Channel Formation,Prostate Angiosarcoma
3514,Cutaneous Involvement,Type B Tylosis
3515,Slit-Like Vascular Channel Formation,Solid Angioleiomyoma
3516,Bone marrow reticulin fibrosis,Refractory Hairy Cell Leukemia
3517,Slow Growing Mass,Recurrent Childhood Subependymal Giant Cell Astrocytoma
3518,Papillary Pattern,Ovarian Papillary Tumor
3519,Epithelial Component Present,Localized Parathyroid Gland Carcinoma
3520,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
3521,Epithelial Component Present,Recurrent Combined Thymic Epithelial Neoplasm
3522,Psammoma Body Formation,Benign Mediastinal Psammomatous Schwannoma
3523,Cutaneous Involvement,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma
3524,Adulthood Lesion,Stage II Adult Soft Tissue Sarcoma AJCC v7
3525,Nodular Pattern,Recurrent Follicular Lymphoma
3526,'Starry-sky' pattern,Recurrent Burkitt Lymphoma
3527,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
3528,Neuroectodermal Differentiation,Localized Unresectable Neuroblastoma
3529,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type"
3530,Adulthood Lesion,Adult Anaplastic Ependymoma
3531,Cutaneous Involvement,Skin Lymphangiosarcoma
3532,Plasma cell inflammation,Cardiac Inflammatory Myofibroblastic Tumor
3533,Carcinomatous Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland
3534,Carcinomatous Component Present,Stage IIIB Esophageal Cancer AJCC v7
3535,Benign Cellular Infiltrate,Colorectal Ganglioneuroma
3536,Schwannian Stroma Predominant Component of the Tumor Volume,Colorectal Ganglioneuroma
3537,Epithelial Component Present,Stage 0 Ureter Cancer AJCC v7
3538,Absence of Invasion,Stage 0is Urethral Cancer AJCC v7
3539,Severe dysplasia,Stage 0is Urethral Cancer AJCC v7
3540,More than 10 Mitoses per 10HPF,Small cell lung cancer extensive stage
3541,Carcinomatous Component Present,"Carcinoma, Small Cell"
3542,Carcinomatous Component Present,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
3543,High Mitotic Activity,Small cell carcinoma of the cervix
3544,Carcinomatous Component Present,Laryngeal Squamous Cell Carcinoma
3545,Epithelial Component Present,Fallopian Tube Cancer by AJCC v6 Stage
3546,Benign Cellular Infiltrate,Extrahepatic Bile Duct Benign Granular Cell Tumor
3547,Cutaneous Involvement,Benign neoplasm of skin
3548,Nuclear Atypia,Glioblastoma by Gene Expression Profile
3549,Cutaneous Involvement,Junctional nevus
3550,Stromal Invasion,Stage IC Ovarian Cancer AJCC v6 and v7
3551,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Mixed Mesodermal (Mullerian) Tumor
3552,Neuronal Differentiation,Neural Glioblastoma
3553,Epithelial Component Present,Primary Carcinoma Unspecified Site
3554,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma
3555,Vascular Channel Formation,Adult Epithelioid Hemangioendothelioma
3556,Hyperkeratosis,Vulvar Seborrheic Keratosis
3557,Mixed Cellular Population,"Cervical Adenomyoma, Endocervical Type"
3558,Fibrotic Stroma Formation,Basal Cell Ameloblastoma
3559,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Gastric Type"
3560,Biphasic Pattern,"Uterine Carcinosarcoma, Heterologous Type"
3561,Neuroendocrine Differentiation,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
3562,Microvascular Proliferation,Brain Stem Glioblastoma
3563,Epithelial Component Present,High Grade Ovarian Serous Adenocarcinoma
3564,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v7
3565,Intermediate Grade Lesion,Periosteal Osteosarcoma
3566,Necrotic changes (finding),"Glioblastoma, IDH-Wildtype"
3567,Cutaneous Involvement,Melanoacanthoma
3568,Neuroendocrine Differentiation,Paraganglioma
3569,Infiltrative Growth Pattern,Giant Cell Glioblastoma
3570,High Grade Lesion,Giant Cell Glioblastoma
3571,Well-Circumscribed Lesion,Colorectal Filiform Serrated Adenoma
3572,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma
3573,Dilated Vascular Space Formation,Glomangioma of skin
3574,Splenomegaly,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant"
3575,Smooth Muscle Component Present,Lymphangiomyoma
3576,Squamous Metaplasia of Malignant Cells Present,adenocarcinoma of gallbladder with squamous metaplasia
3577,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid tumor
3578,Childhood Lesion,Childhood Adrenal Gland Pheochromocytoma
3579,Microvascular Proliferation,Recurrent Glioblastoma
3580,Low Grade Lesion,Adult Pilocytic Astrocytoma
3581,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
3582,Epithelial Component Present,Uterine Corpus Carcinosarcoma
3583,Carcinomatous Component Present,Stage I Liver Carcinoma
3584,Papillary Pattern,Supraglottic Verrucous Carcinoma
3585,Childhood Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
3586,Cellular Pleomorphism,Giant Cell Fibrous Histiocytoma
3587,Hyaline Cartilage Differentiation,chondroma of lung
3588,Adulthood Lesion,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
3589,Secondary Lesion,Carcinomatosis
3590,Carcinomatous Component Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
3591,Adulthood Lesion,Adult Brain Ependymoma
3592,Adulthood Lesion,Adult Pleomorphic Hepatocellular Carcinoma
3593,Neuroendocrine Differentiation,Combined Lung Carcinoma
3594,Necrotic changes (finding),Endometrial Small Cell Carcinoma
3595,Epithelial Component Present,Renal carcinoma
3596,Insular Pattern,Duodenal Somatostatin-Producing Neuroendocrine Tumor
3597,Myxoid Stroma Formation,Myxoinflammatory fibroblastic sarcoma
3598,Heterologous Elements Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
3599,Hyperkeratosis,Common wart
3600,Carcinomatous Component Present,Ovarian cancer stage III
3601,High Mitotic Activity,Recurrent Childhood Anaplastic Oligoastrocytoma
3602,Severe dysplasia,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
3603,Adulthood Lesion,Stage II Adult Lymphoblastic Lymphoma
3604,Plasma cell inflammation,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
3605,Carcinomatous Component Present,High Grade Salivary Gland Mucoepidermoid Carcinoma
3606,Invasive Lesion,Prostate Acinar Adenocarcinoma
3607,Acinar Cell Differentiation,Prostate Acinar Adenocarcinoma
3608,Koilocytotic atypia,Warty Carcinoma of the Penis
3609,Carcinomatous Component Present,Stage I Lip Carcinoma
3610,Invasive Lesion,Bladder transitional cell carcinoma stage IV
3611,Chromogranin A Positive Neoplastic Cells Present,Descending Colon Neuroendocrine Tumor G1
3612,Hyperkeratosis,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
3613,Locally Aggressive Lesion,Inflammatory Myofibroblastic Tumor
3614,Borderline Lesion,Borderline Ovarian Clear Cell Tumor
3615,Cutaneous Involvement,Pruritus
3616,Carcinomatous Component Present,Stage IIC Merkel Cell Carcinoma AJCC v7
3617,Cytoplasmic Membrane-Bound Granules Present,Stage IIB Merkel Cell Carcinoma AJCC v7
3618,Cystic Change,Cystadenoma
3619,Fibrotic Stroma Formation,mucoepidermoid carcinoma of lung
3620,Adulthood Lesion,Acute Adult T-Cell Leukemia/Lymphoma
3621,Hereditary Lesion,"Optic Atrophy, Hereditary, Leber"
3622,Metastatic Lesion,Metastatic Meningioma
3623,Seminomatous Component Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma
3624,HMB-45-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, malignant"
3625,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Cytopenia of Childhood
3626,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood
3627,Papillary Pattern,Buccal Mucosa Verrucous Carcinoma
3628,Well-Circumscribed Lesion,Soft tissue perineurioma
3629,Pushing Tumor Margin,Lower Gingival Verrucous Carcinoma
3630,Deep Lesion,Infiltrating Intramuscular Lipoma
3631,Epithelial Component Present,Benign Outer Hair Sheath and Infundibulum Neoplasm
3632,Recurrent disease,Lung squamous cell carcinoma recurrent
3633,Epithelial Component Present,Thymic Basaloid Carcinoma
3634,Diffuse Pattern,gliosarcoma
3635,Carcinomatous Component Present,Stage IC Eyelid Carcinoma AJCC v7
3636,Severe dysplasia,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
3637,Ground Glass Nuclear Inclusion,Multicentric Thyroid Gland Papillary Carcinoma
3638,Papillary Pattern,Multicentric Thyroid Gland Papillary Carcinoma
3639,Undifferentiated Lesion,"Retinoblastoma, undifferentiated"
3640,Carcinomatous Component Present,signet ring cell carcinoma of breast
3641,Angiodestructive Pattern,Angiocentric immunoproliferative lesion grade 2
3642,Epithelial Component Present,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
3643,Non-Malignant Cellular Infiltrate,Pulmonary nodular lymphoid hyperplasia
3644,Endophytic Tumor Growth,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
3645,Malignant Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7
3646,Childhood Lesion,Childhood Kidney Wilms Tumor
3647,Lymphoplasmacytic Infiltrate,germinoma of brain
3648,Exophytic Polypoid Lesion,Esophageal squamous papilloma
3649,Multilocular Lesion,Juvenile type ovarian granulosa cell tumor
3650,Aggravated Disease,Neoplasm malignant aggravated
3651,Necrotic changes (finding),Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
3652,Rapidly Enlarging Mass,Fusion-Positive Alveolar Rhabdomyosarcoma
3653,Carcinomatous Component Present,Laryngeal verrucous carcinoma recurrent
3654,Epithelial Component Present,Breast Papillomatosis
3655,Cystic Change,Seminal Vesicle Cystadenoma
3656,Carcinomatous Component Present,Adenoid cystic carcinoma of submandibular gland
3657,Peripheral Nuclear Palisading,Stage IA Lung Small Cell Carcinoma AJCC v7
3658,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Glycogen-Rich, Clear Cell Breast Carcinoma"
3659,Epithelial Component Present,Stage III Rectal Cancer AJCC v6
3660,Peripheral Nuclear Palisading,Stage IB Lung Small Cell Carcinoma AJCC v7
3661,Carcinomatous Component Present,Stage IV Prostate Carcinoma
3662,Tissue Differentiation Uncertain,Synovial sarcoma metastatic
3663,Cutaneous Involvement,Erythema Multiforme Major
3664,Childhood Lesion,Refractory Childhood Malignant Germ Cell Tumor
3665,Epithelial Component Present,Laryngeal Acantholytic Squamous Cell Carcinoma
3666,Diffuse Pattern,Stage III Adult Immunoblastic Lymphoma
3667,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
3668,Peripheral Nuclear Palisading,Vaginal Basaloid Carcinoma
3669,Multinodular Mass,Angiosarcoma non-metastatic
3670,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma
3671,Primary Lesion,Primary central nervous system lymphoma
3672,Metastatic Lesion,Metastatic Carcinoma in the Adrenal Medulla
3673,Epithelial Component Present,Carcinoma in situ of trachea
3674,Carcinomatous Component Present,Stage IIB Rectal Cancer AJCC v7
3675,Vascular Channel Formation,Colon Cavernous Hemangioma
3676,Moderate dysplasia,Colorectal Adenoma with Moderate Dysplasia
3677,Epithelial Component Present,"Transitional cell carcinoma, spindle cell"
3678,Epithelial Component Present,Gastric Intramucosal Adenocarcinoma
3679,Cutaneous Involvement,Infestation by Phthirus pubis
3680,Epithelial Component Present,Colorectal Intraepithelial Neoplasia
3681,Lobulated Growth Pattern,Juxtacortical chondrosarcoma
3682,Epithelial Component Present,HNF1alpha-Inactivated Hepatocellular Adenoma
3683,Local disease,Spindle Cell/Pleomorphic Lipoma
3684,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
3685,Therapy-Related Toxicity,Transplant-Related Renal Cell Carcinoma
3686,Childhood Lesion,Childhood Classic Hodgkin Lymphoma
3687,Systemic disease,Langerhans Cell Sarcoma
3688,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
3689,Carcinomatous Component Present,Bile duct clear cell adenocarcinoma
3690,Epithelial Component Present,Maxillary Sinus Adenocarcinoma
3691,Epithelial Component Present,Advanced Adult Hepatocellular Carcinoma
3692,Geographic Necrosis,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
3693,Dysplasia,Small Intestinal Tubulovillous Adenoma
3694,Immunosuppression-Related Post-Transplant Toxicity,"Post-transplant lymphoproliferative disorder, polymorphic"
3695,Epithelial Component Present,Small cell lung cancer limited stage
3696,High Grade Lesion,Childhood Glioblastoma
3697,Recurrent disease,Recurrent Grade III Lymphomatoid Granulomatosis
3698,Carcinomatous Component Present,signet ring cell carcinoma of appendix
3699,Carcinomatous Component Present,Stage III Colorectal Cancer AJCC v7
3700,Well-Circumscribed Lesion,Gastric Juvenile Polyp
3701,Absence of Invasion,Carcinoma in situ of skin
3702,Carcinomatous Component Present,Carcinoma in situ of skin
3703,Local disease,Malignant neoplasm of gallbladder localized
3704,Abnormal Eosinophilic Granules Present,"Acute myeloid leukemia, t(16;16)(p13;q22)"
3705,Epithelial Component Present,Primary Prostate Urothelial Carcinoma
3706,Mixed Cellular Population,Malignant mixed salivary gland tumor
3707,Cytoplasmic Eosinophilic Globules Present,Undifferentiated (Embryonal) Sarcoma
3708,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-3
3709,Tissue of Mullerian Origin Present,Atypical polypoid adenomyoma
3710,Epithelial Component Present,Thymic Undifferentiated Carcinoma
3711,Epithelial Component Present,Bladder Villous Adenoma
3712,Epithelial Component Present,Liver Adenosquamous Carcinoma
3713,Gastric dysplasia,tubulovillous adenoma of stomach
3714,Epithelial Component Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
3715,Dysplasia,Gallbladder Flat Biliary Intraepithelial Neoplasia
3716,Carcinomatous Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
3717,Stromal Invasion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
3718,Splenomegaly,"Leukemia, Myeloid, Chronic-Phase"
3719,Cutaneous Involvement,Hidradenoma Papilliferum
3720,Carcinomatous Component Present,Lip Carcinoma
3721,Perivascular Arrangement of Tumor Cells,Hepatic Angiomyolipoma
3722,Immunologic Deficiency Syndromes,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
3723,Apocrine Differentiation,Invasive Apocrine Breast Carcinoma
3724,Fibrosis,Radial scar
3725,Multifocal Lesion,Steroid Lipomatosis
3726,Childhood Lesion,Childhood Desmoplastic Small Round Cell Tumor
3727,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP C"
3728,Invasive Lesion,Adenoid cystic breast carcinoma
3729,Non-Contiguous Disease,Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma
3730,High Mitotic Activity,Ampulla of Vater Neuroendocrine Carcinoma
3731,Neuroendocrine Differentiation,Superior and Inferior Paraaortic Paraganglioma
3732,Carcinomatous Component Present,Stage IVB Oropharyngeal Carcinoma AJCC v7
3733,Secondary Lesion,Lymphangitis carcinomatosa
3734,Mitotic Activity,Endodermal sinus tumor of ovary
3735,Pseudoglandular Pattern,Ovarian Embryonal Carcinoma
3736,HMB-45-Positive Neoplastic Cells Present,Perivascular Epithelioid Cell Neoplasms
3737,Epithelial Component Present,Adenoma of rectum
3738,Ineffective hematopoiesis,Refractory anaemia with excess blasts
3739,Epithelial Component Present,Benign Adrenal Gland Composite Pheochromocytoma
3740,Carcinomatous Component Present,Hypopharyngeal Carcinoma by AJCC v6 Stage
3741,Epithelial Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas
3742,Epithelial Component Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
3743,Papillary Pattern,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
3744,Carcinomatous Component Present,Stage IV Urethral Cancer AJCC v7
3745,Antoni A Pattern,Ureter Schwannoma
3746,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Perihilar Variant
3747,Anaplasia,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma
3748,Exophytic Polypoid Lesion,Giant Fibrovascular Esophageal Polyp
3749,Local disease,Gastric Lipoma
3750,Absence of Invasion,Stage 0 Lung Cancer AJCC v6 and v7
3751,Increased Cellularity Present,Childhood Anaplastic Oligodendroglioma
3752,Exposure to asbestos,Asbestos-Related Lung Carcinoma
3753,atypia morphology,Borderline Ovarian Endometrioid Adenofibroma
3754,Epithelial Component Present,Stage IV Colorectal Cancer AJCC v7
3755,Diffuse Pattern,Childhood Cerebral Anaplastic Astrocytoma
3756,Papillary Pattern,Papillary adenoma
3757,Recurrent disease,Recurrent Adult Burkitt Lymphoma
3758,Congenital Lesion,Congenital hamartoma
3759,Epithelial Component Present,Anaplastic Carcinoma of the Rectum
3760,Benign Cellular Infiltrate,Benign tumor of pancreas
3761,Indolent Clinical Course,Gingival Angiofibroma
3762,Cutaneous Involvement,Vulvar Keratoacanthoma
3763,Neuroendocrine Differentiation,Small Intestinal Large Cell Neuroendocrine Carcinoma
3764,Indolent Clinical Course,Osteoid osteoma
3765,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic
3766,Exophytic Polypoid Lesion,Multiple adenomatous polyps
3767,Epithelial Component Present,Growth Hormone-Producing Pituitary Gland Neoplasm
3768,Carcinomatous Component Present,Transitional cell carcinoma of bladder
3769,Epithelial Component Present,Carcinoid tumor of intestine
3770,Carcinomatous Component Present,Parotid Gland Undifferentiated Carcinoma
3771,Cystic Change,Polycystic liver disease
3772,Exophytic Papillary Lesion,sialadenoma papilliferum of salivary gland
3773,Epithelial Component Present,"Bronchiolo-alveolar carcinoma, non-mucinous"
3774,Serrated Glandular Architecture,Colon Traditional Serrated Adenoma
3775,Immunologic Deficiency Syndromes,Transplant-Related Kaposi Sarcoma
3776,Necrotic changes (finding),Esophageal Poorly Differentiated Squamous Cell Carcinoma
3777,'Starry-sky' pattern,Burkitt's tumor of spleen
3778,Carcinomatous Component Present,Pancreatic Endocrine Carcinoma
3779,Papillary Pattern,Nonencapsulated sclerosing tumor
3780,Epithelial Component Present,Vulvar Cancer by AJCC v7 Stage
3781,Lobulated Growth Pattern,Left atrial myxoma
3782,Carcinomatous Component Present,Transitional cell carcinoma of ureter
3783,Epithelial Component Present,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7
3784,Adulthood Lesion,Stage IIIB Adult Liver Cancer AJCC v7
3785,Secondary Lesion,Metastatic Ewing's Sarcoma
3786,Well-Circumscribed Lesion,Mammary-Type Myofibroblastoma
3787,Carcinomatous Component Present,Inflammatory carcinoma of breast stage III
3788,Vascular Channel Formation,Angiosarcoma of spleen
3789,Epithelial Component Present,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
3790,Carcinomatous Component Present,Stage IIA Prostate Cancer AJCC v7
3791,Adulthood Lesion,Adult Anaplastic Astrocytoma
3792,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
3793,Exanthema,Rothmund-Thomson syndrome
3794,Syncytial Pattern,Recurrent Oropharyngeal Undifferentiated Carcinoma
3795,Carcinomatous Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma
3796,Primary Lesion,Central Nervous System T-Cell Non-Hodgkin Lymphoma
3797,Absence of Stromal Invasion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
3798,Epithelial Component Present,Mediastinal Paraganglioma
3799,Mixed Cellular Population,Malignant Mixed Tumor
3800,Epithelial Component Present,Carcinoid tumor of the cecum
3801,Carcinomatous Component Present,Bladder squamous cell carcinoma recurrent
3802,Organoid Pattern,Childhood Alveolar Soft Part Sarcoma
3803,Immunologic Deficiency Syndromes,AIDS-Related Cervical Carcinoma
3804,Neoplastic Plasma Cells Present in Bone Marrow,Non-Secretory Plasma Cell Myeloma
3805,Cutaneous Involvement,Nodulo-ulcerative basal cell carcinoma
3806,Cystic Change,Fundic gland polyp
3807,Vascular Channel Formation,Angiosarcoma of the breast
3808,Metastatic/Recurrent Disease,Childhood Epithelioid Sarcoma
3809,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma metastatic
3810,Epithelial Component Present,Frontal Sinus Inverted Papilloma
3811,Smooth Muscle Component Present,Lymphangioleiomyomatosis of skin
3812,High Mitotic Activity,Anaplastic Medulloblastoma
3813,Nuclear pleomorphism,Anaplastic Medulloblastoma
3814,Cystic Change,Laryngeal Mucoepidermoid Carcinoma
3815,Epithelial Component Present,"Acanthoma, Pilar Sheath"
3816,Epithelial Component Present,"Papilloma, Intraductal"
3817,Necrotic changes (finding),Anal Canal Small Cell Neuroendocrine Carcinoma
3818,Tissue Differentiation Uncertain,Myxoma
3819,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Acute Myeloid Leukemia (AML-M2)
3820,Locally Aggressive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation
3821,Well-Circumscribed Lesion,Brain Stem Hemangioblastoma
3822,Capillary Sized Vascular Channel Formation,Brain Stem Hemangioblastoma
3823,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile astrocytoma
3824,Necrotic changes (finding),Infratentorial Glioblastoma
3825,Storiform Growth Pattern,Dedifferentiated Dermatofibrosarcoma Protuberans
3826,Cutaneous Involvement,Trichoepithelioma
3827,Recurrent disease,Recurrent Lip Basal Cell Carcinoma
3828,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
3829,Cutaneous Involvement,Grade 1 Cutaneous Follicular Lymphoma
3830,Primary Lesion,"Brain Tumor, Primary"
3831,Lobulated Growth Pattern,Atrial myxoma
3832,Radiation Sickness,Radiation-Induced Dermatitis
3833,Tissue Differentiation Uncertain,Phosphaturic Mesenchymal Tumor
3834,Epithelial Component Present,Stage I Hypopharyngeal Carcinoma AJCC v6
3835,Epithelial Component Present,Fallopian Tube Endometrioid Polyp
3836,Cutaneous Involvement,Nevus of Ota
3837,Childhood Lesion,Systemic EBV positive T-cell lymphoproliferative disease of childhood
3838,Stromal Invasion,Stage IIIA Ovarian Cancer AJCC v6 and v7
3839,Nodular Pattern,"Trophoblastic tumor, epithelioid"
3840,Pain,Malignant Giant Cell Tumor of Bone
3841,Metastatic Lesion,Secondary malignant neoplasm of chest wall
3842,Carcinomatous Component Present,Esophageal Cancer by AJCC v7 Stage
3843,Locally Aggressive Lesion,Aggressive osteoblastoma
3844,Osteoid formation,Aggressive osteoblastoma
3845,Epithelial Component Present,Stage III Breast Cancer AJCC v7
3846,Lobulated Growth Pattern,Focal nodular hyperplasia of liver
3847,Non-Invasive Lesion,Stage 0is Ureter Cancer AJCC v7
3848,Biphasic Pattern,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
3849,Oligodendroglial Component Present,Recurrent Childhood Oligoastrocytoma
3850,Carcinomatous Component Present,Vaginal Papillary Carcinoma
3851,Vascular Channel Formation,Soft Tissue Angiosarcoma
3852,Epithelial Component Present,adenoma of extrahepatic bile duct
3853,Exophytic Polypoid Lesion,Villous adenoma of rectum
3854,Papillary Pattern,Type 1 Papillary Renal Cell Carcinoma
3855,Vascular Channel Formation,Pyogenic granuloma of oral mucosa
3856,Aberrant Thyroid Tissue Present,Benign Struma Ovarii
3857,Secondary Lesion,Breast Carcinoma Metastatic in the Brain
3858,Pseudoglandular Pattern,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
3859,Carcinomatous Component Present,Stage IIIB Cervical Cancer AJCC v6 and v7
3860,Epithelial Component Present,Prostate cancer stage D
3861,Carcinomatous Component Present,Metastatic Parathyroid Gland Carcinoma
3862,Slow Growing Mass,Cerebellar hemangioblastoma
3863,Immunologic Deficiency Syndromes,"Lymphoma, AIDS-Related"
3864,Epithelial Component Present,Pseudomyxoma Peritonei
3865,Carcinomatous Component Present,Stage III Renal Pelvis Cancer AJCC v7
3866,Thick-Walled Hyalinized Vessels Present,Pleural Schwannoma
3867,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Seminoma
3868,Severe cytologic atypia,Small Intestinal Small Cell Neuroendocrine Carcinoma
3869,Vascular Channel Formation,Infantile hemangioma of liver
3870,Carcinomatous Component Present,Stage I Adrenal Cortex Carcinoma AJCC v7
3871,Stromal Invasion,Ovarian Clear Cell Cystadenocarcinoma
3872,Alternative Fascicle (Bundle) Pattern,Endobronchial Leiomyoma
3873,Epithelial Component Present,Well Differentiated Adrenal Cortex Carcinoma
3874,Collagenous Stroma Formation,Vaginal Myofibroblastoma
3875,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
3876,Carcinomatous Component Present,Recurrent Urinary System Carcinoma
3877,Rapidly Enlarging Mass,embryonal rhabdomyosarcoma of prostate
3878,Epithelial Component Present,Oropharyngeal squamous papilloma
3879,Adulthood Lesion,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified"
3880,Epithelial Component Present,Gastric Cancer by AJCC v6 Stage
3881,Immunologic Deficiency Syndromes,AIDS-Associated Nephropathy
3882,Cutaneous Involvement,Stage IV Skin Cancer
3883,Mixed Cellular Population,Papillary adenofibroma
3884,Epithelial Component Present,hepatoid adenocarcinoma of gallbladder
3885,Dermal Involvement,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder
3886,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Gastric Type"
3887,atypia morphology,Borderline serous tumor of ovary
3888,Eosinophil count raised (finding),"Leukemia, Eosinophilic, Acute"
3889,Carcinomatous Component Present,Stage II Gallbladder Cancer AJCC v7
3890,Metastatic Lesion,Metastatic Neoplasm
3891,Adnexal Differentiation,Malignant neoplasm of sweat gland
3892,Recurrent disease,Primary mediastinal large B-cell lymphoma recurrent
3893,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v7
3894,Splenomegaly,Splenic marginal zone lymphoma refractory
3895,Epithelial Component Present,Anal Canal Neuroendocrine Neoplasm
3896,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
3897,Diffuse Pattern,Brain Stem Glioblastoma
3898,Carcinomatous Component Present,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
3899,Epithelial Component Present,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
3900,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant"
3901,Adulthood Lesion,Adult Acute Myeloblastic Leukemia
3902,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Childhood Acute Monocytic Leukemia
3903,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage IV
3904,Epithelial Component Present,Uterine Ligament Adenocarcinoma
3905,Adulthood Lesion,Adult Pineocytoma
3906,Peripheral Nuclear Palisading,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
3907,Infiltrative Growth Pattern,Cerebral Glioblastoma
3908,Diffuse Pattern,Adult Diffuse Astrocytoma
3909,Bone marrow reticulin fibrosis,Hairy Cell Leukemia
3910,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v6
3911,Carcinomatous Component Present,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
3912,In Situ Lesion,Carcinoma in situ of penis
3913,Neuroectodermal Differentiation,neuroblastoma of spinal cord
3914,Immunosuppression-Related Post-Transplant Toxicity,Chronic Allograft Arteriopathy
3915,Epithelial Component Present,mucoepidermoid carcinoma of lacrimal gland
3916,Epithelial Component Present,Salivary Gland Myoepithelial Carcinoma
3917,Neuroendocrine Differentiation,Sympathetic paraganglioma
3918,High Mitotic Activity,small cell carcinoma of gallbladder
3919,Cutaneous Involvement,Vulvar Inverted Follicular Keratosis
3920,Acanthosis,Vulvar Inverted Follicular Keratosis
3921,Deep Lesion,"Fibromatosis, Aggressive"
3922,Superficial Lesion,Superficial fibromatosis
3923,Vertical Growth Phase,Balloon cell malignant melanoma
3924,Exophytic Polypoid Lesion,Uterine Polyp
3925,Neuroendocrine Differentiation,"Extra-adrenal paraganglioma, malignant"
3926,Epithelial Component Present,Vulvar Neuroendocrine Carcinoma
3927,Hyperplastic Tissue Present,Tubal Hyperplasia
3928,Childhood Lesion,Childhood Central Nervous System Immature Teratoma
3929,Epithelial Component Present,Stage I Vulvar Cancer
3930,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Therapy-related myelodysplastic syndrome
3931,Mucoid Stroma Formation,Myxopapillary ependymoma
3932,Perivascular fibrosis,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion"
3933,Cutaneous Involvement,Outer Hair Sheath and Infundibulum Neoplasm
3934,Epithelial Component Present,Stage III Pharynx Carcinoma
3935,Adnexal Differentiation,Sebaceous Gland Neoplasms
3936,Inclusion-Like Nucleoli,Myxoinflammatory fibroblastic sarcoma
3937,Epithelial Component Present,Metastatic Carcinoma in the Lung
3938,Carcinomatous Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
3939,Exophytic Papillary Lesion,Condyloma acuminata of vulva
3940,Indolent Clinical Course,Hobnail Hemangioma
3941,Epithelial Component Present,Transverse Colon Neuroendocrine Tumor G1
3942,Perineural spread,Ethmoid Sinus Adenoid Cystic Carcinoma
3943,Carcinomatous Component Present,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
3944,Carcinomatous Component Present,Refractory Carcinoma
3945,Local disease,Cardiac Lipoma
3946,Arborising Network of Cords of Basaloid Cells Present,Fibroepithelioma of Pinkus
3947,Recurrent disease,Small intestine carcinoma recurrent
3948,Well-Circumscribed Lesion,Mixed Cell Adrenal Cortical Adenoma
3949,Tubular Structures Present,Testicular Sclerosing Sertoli Cell Tumor
3950,Non-Malignant Cellular Infiltrate,Chronic lymphadenitis
3951,Microcystic Change,Juvenile Pilocytic Astrocytoma
3952,Non-Hereditary Lesion,Sporadic Thyroid Gland Micromedullary Carcinoma
3953,Carcinomatous Component Present,Childhood Bladder Carcinoma
3954,Cutaneous Involvement,Granular cell tumor of skin
3955,Epithelial Component Present,Pituitary Gland Macroadenoma
3956,Epithelial Component Present,Low Grade Salivary Gland Carcinoma
3957,Metastatic Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma
3958,Carcinomatous Component Present,Buccal Mucosa Verrucous Carcinoma
3959,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
3960,Benign Cellular Infiltrate,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma
3961,Carcinomatous Component Present,Type I Endometrial Adenocarcinoma
3962,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity
3963,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage III
3964,Hyperplastic Tissue Present,Bone marrow hyperplasia
3965,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v7
3966,Myxoid Stroma Formation,Epithelioid hemangioendothelioma
3967,Favorable Clinical Outcome,Good Prognosis Metastatic Gestational Trophoblastic Tumor
3968,Carcinomatous Component Present,Subglottic Squamous Cell Carcinoma
3969,Trichoblastic Differentiation,Vulvar Trichoepithelioma
3970,Adnexal Differentiation,Vulvar Trichoepithelioma
3971,Cutaneous Involvement,Skin Squamous Cell Carcinoma In Situ
3972,Epithelial Component Present,Oropharyngeal lymphoepithelioma stage I
3973,Carcinomatous Component Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma
3974,High Grade Lesion,Rhabdomyosarcoma of cervix uteri
3975,Carcinomatous Component Present,Neuroendocrine carcinoma of appendix
3976,Hemorrhagic,Cervical Angiosarcoma
3977,Nerve palsy,Acquired Facial Nerve Palsy
3978,Poorly Differentiated Lesion,Sarcomatoid carcinoma of the lung
3979,Adnexal Differentiation,Benign Germinative Follicular Epithelium Neoplasm
3980,Epithelial Component Present,Human Papillomavirus-Related Verrucous Carcinoma
3981,Epithelial Component Present,Intrapulmonary thymoma
3982,Carcinomatous Component Present,Tracheal Carcinoma
3983,Epithelial Component Present,Adenoid Cystic Carcinoma
3984,Tumor Vascular Invasion,Malignant Testicular Leydig Cell Tumor
3985,Polymorphic Cellular Infiltrate,Angiocentric immunoproliferative lesion grade 2
3986,Carcinomatous Component Present,Carcinoma of upper gum
3987,Childhood Lesion,Pediatric nodal marginal zone lymphoma
3988,Epithelial Component Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
3989,Papillary Pattern,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
3990,Metastatic Lesion,Metastatic Squamous Cell Breast Carcinoma
3991,Calcinosis,Calcifying Odontogenic Cyst
3992,Well-Circumscribed Lesion,Benign Prostate Phyllodes Tumor
3993,Immunologic Deficiency Syndromes,Acute humoral allograft nephropathy
3994,Epithelial Component Present,large cell neuroendocrine carcinoma of lung
3995,Hyperkeratosis,Laryngeal verrucous carcinoma stage IV
3996,Epithelial Component Present,Bladder Non-Invasive Papillary Urothelial Neoplasm
3997,Secondary Lesion,Radiation-Related Osteosarcoma
3998,Anaplasia,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype"
3999,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
4000,Mild cytologic atypia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
4001,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma
4002,Epithelial Component Present,Stage II Rectal Cancer
4003,Cystic Change,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei
4004,Metastatic Lesion,Secondary malignant neoplasm of stomach
4005,Epithelial Component Present,Metastatic signet ring cell carcinoma
4006,Neuroendocrine Differentiation,Colorectal Neuroendocrine Neoplasm
4007,Epithelial Component Present,Bladder Enteric Type Adenocarcinoma
4008,Carcinomatous Component Present,Stage IVC Laryngeal Cancer AJCC v7
4009,Mild dysplasia,Intracystic papillary neoplasm with low grade intraepithelial neoplasia
4010,No Evidence of Hormonal Immunoreactivity Present,Null Cell Pituitary Gland Adenoma
4011,Blasts Under 20 Percent of Peripheral Blood White Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm
4012,In Situ Lesion,Carcinoma in situ of fallopian tube
4013,Carcinomatous Component Present,Stage 0 Anal Canal Cancer AJCC v6 and v7
4014,atypia morphology,Borderline Fallopian Tube Neoplasm
4015,Indolent Clinical Course,Cellular angiofibroma
4016,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q)
4017,Carcinomatous Component Present,"Squamous cell carcinoma, clear cell type"
4018,Carcinomatous Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
4019,Neuroectodermal Differentiation,Olfactory Neuroblastoma
4020,Severe dysplasia,Carcinoma in situ of trachea
4021,Epithelial Component Present,combined small cell carcinoma of lung
4022,Well-Circumscribed Lesion,Colorectal Adenoma with Moderate Dysplasia
4023,Well-Circumscribed Lesion,Vaginal Fibroepithelial Polyp
4024,Epithelial Component Present,Exophytic Schneiderian Papilloma
4025,Fibrotic Stroma Formation,Pancreatic Foamy Gland Adenocarcinoma
4026,Dysplasia,Appendix adenoma
4027,Dysplasia,Small Intestinal Villous Adenoma
4028,Papillary Pattern,Intraductal papillary neoplasm with high grade intraepithelial neoplasia
4029,Intraductal Lesion,Intraductal papillary neoplasm with high grade intraepithelial neoplasia
4030,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
4031,Nodular lesions,Thyroid Gland Signet Ring Cell Follicular Adenoma
4032,Immunologic Deficiency Syndromes,AIDS-Related Primary Effusion Lymphoma
4033,Sebaceous Differentiation,Extraocular Cutaneous Sebaceous Carcinoma
4034,Carcinomatous Component Present,Paget Disease of the Scrotum
4035,Epithelial Component Present,"Thymoma, type AB"
4036,Acinar Cell Differentiation,Submandibular Gland Acinic Cell Carcinoma
4037,Indolent Clinical Course,Verrucous keratotic hemangioma
4038,Epithelial Component Present,Vaginal Undifferentiated Carcinoma
4039,atypia morphology,Atypical adenomatous hyperplasia
4040,Severe dysplasia,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
4041,Epithelial Component Present,Stage IIB Colon Cancer AJCC v7
4042,Well-Circumscribed Lesion,Extracardiac Rhabdomyoma
4043,Epithelial Component Present,Adult Choroid Plexus Neoplasm
4044,Indolent Clinical Course,mediastinal lipomatosis
4045,Recurrent disease,Intestinal T-cell lymphoma recurrent
4046,Granulocytes Increased in Bone Marrow,Chronic Neutrophilic Leukemia
4047,Epithelial Component Present,Hepatoma resectable
4048,Absence of Invasion,Stage 0 Esophageal Adenocarcinoma AJCC v7
4049,Immunosuppression-Related Post-Transplant Toxicity,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
4050,Mixed Cellular Population,Lung Mixed Squamous Cell and Glandular Papilloma
4051,Tissue Differentiation Uncertain,Adult Epithelioid Sarcoma
4052,Childhood Lesion,Childhood T Acute Lymphoblastic Leukemia
4053,Carcinomatous Component Present,BCLC Stage D Adult Hepatocellular Carcinoma
4054,Necrotic changes (finding),Thymic Small Cell Carcinoma
4055,Cartilaginous Differentiation,Adult Myxoid Chondrosarcoma
4056,CD1a-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
4057,Immunologic Deficiency Syndromes,Delayed Graft Function
4058,Carcinomatous Component Present,Adenocarcinoma of the prostate metastatic
4059,Epithelial Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v7
4060,Nuclear pleomorphism,Large Cell Dysplasia
4061,Papillary Pattern,Condyloma acuminata of cervix
4062,High Grade Lesion,Vulvar Alveolar Soft Part Sarcoma
4063,Myxoid Stroma Formation,Chondroblastoma
4064,Papillary Pattern,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
4065,Epithelial Component Present,Stage III Oral Cavity Cancer AJCC v6 and v7
4066,Epithelial Component Present,Syringoma
4067,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1
4068,Primary Lesion,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease"
4069,Non-Hereditary Lesion,Gastric Cardia Adenocarcinoma
4070,Epithelial Component Present,Vaginal Tubular Adenoma
4071,Neuroendocrine Differentiation,"Somatostatinoma, malignant"
4072,Carcinomatous Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
4073,Hereditary Lesion,"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)"
4074,Cutaneous Involvement,Epidermolysis Bullosa Dystrophica
4075,S-100-Positive Neoplastic Cells Present,Childhood Kidney Angiomyolipoma
4076,Epithelial Component Present,Normal Breast-Like Subtype of Breast Carcinoma
4077,Well-Circumscribed Lesion,Polyp of maxillary sinus
4078,Epithelial Component Present,Central Breast Papilloma
4079,Glandular Pattern,"Vulvar Adenocarcinoma, Intestinal-Type"
4080,Carcinomatous Component Present,"Vulvar Adenocarcinoma, Intestinal-Type"
4081,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute myeloid leukemia with multilineage dysplasia
4082,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Primary Systemic Amyloidosis
4083,Hyperkeratosis,Anal Verrucous Carcinoma
4084,Well Differentiated Lesion,Vulvar Keratoacanthoma
4085,High Grade Lesion,Recurrent Childhood Giant Cell Glioblastoma
4086,Epithelial Component Present,Skin Papilloma
4087,Microvascular Proliferation,Childhood Brain Stem Gliosarcoma
4088,Tubular Pattern,Tubular adenoma
4089,Hyperplastic Tissue Present,Hyperplasia
4090,Nodular Pattern,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic
4091,Nested Pattern,Testicular gonadoblastoma
4092,Pseudoencapsulated Mass,Low Grade Malignant Peripheral Nerve Sheath Tumor
4093,High Grade Lesion,CIC-DUX Sarcoma
4094,Moderate cytologic atypia,Moderate pancreatic duct dysplasia
4095,Dysplasia,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7
4096,Epithelial Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7
4097,Adnexal Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation
4098,Well-Circumscribed Lesion,Serous cystadenoma of ovary
4099,Nuclear pleomorphism,Adult Pleomorphic Rhabdomyosarcoma
4100,Carcinomatous Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma
4101,Epithelial Component Present,Stage IV Primary Peritoneal Cancer AJCC v7
4102,Carcinomatous Component Present,Stage 0 Renal Pelvis Cancer AJCC v7
4103,Absence of Invasion,Bowenoid papulosis
4104,Diffuse Pattern,Activated B-cell type diffuse large B-cell lymphoma
4105,Micropapillary Pattern,Digital papillary eccrine carcinoma of skin
4106,Epithelial Component Present,Midgut Carcinoid Tumor
4107,Neuroendocrine Differentiation,Midgut Carcinoid Tumor
4108,Carcinomatous Component Present,basaloid squamous cell carcinoma of vulva
4109,High Mitotic Activity,Testicular embryonal carcinoma stage II
4110,Follicular Cell Differentiation,Papillary thyroid carcinoma
4111,Keratin pearl formation,keratinizing squamous cell carcinoma of nasal cavity
4112,Metastatic Lesion,Benign Metastasizing Leiomyoma of the Uterine Corpus
4113,Epithelial Component Present,Cervix carcinoma recurrent
4114,Immature Myeloid Cells Increased in Bone Marrow,Treatment related acute myeloid leukaemia
4115,Epithelial Component Present,Carcinoid tumor of lung
4116,Cutaneous Involvement,Acquired ichthyosis
4117,Endobronchial Lesion,Lung Squamous Cell Papilloma
4118,Poorly Differentiated Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
4119,Lymphoplasmacytic Infiltrate,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
4120,Epithelial Component Present,Tubular adenoma of colon
4121,Carcinomatous Component Present,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
4122,Epithelial Component Present,Basal cell carcinoma - keratotic
4123,Mass of body structure,Mediastinal Myeloid Sarcoma
4124,High Mitotic Activity,neuroendocrine carcinoma of anal canal
4125,Secondary Lesion,Extraskeletal osteosarcoma metastatic
4126,Low Cellularity Present,Protoplasmic astrocytoma
4127,Carcinomatous Component Present,AIDS-related anal cancer recurrent
4128,Serrated Glandular Architecture,Rectal Serrated Adenocarcinoma
4129,Thin-Walled Branching Vascular Pattern,Mediastinal Solitary Fibrous Tumor
4130,Hyalinized Stroma Formation,Dedifferentiated Solitary Fibrous Tumor
4131,Well-Circumscribed Lesion,Peutz Jehgers polyp
4132,Nodular Pattern,Nodulo-ulcerative basal cell carcinoma
4133,Epithelial Component Present,Conventional (Clear Cell) Renal Cell Carcinoma
4134,Rarely Metastasizing Lesion,Polymorphus Hemangioendothelioma
4135,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Diffuse Leiomyomatosis
4136,Carcinomatous Component Present,Fetal Lung Adenocarcinoma
4137,Epithelial Component Present,Biliary Intraepithelial Neoplasia-2
4138,Epithelial Component Present,Major Salivary Gland Carcinoma
4139,Epithelial Component Present,small cell carcinoma of ureter
4140,Nodular Pattern,Grade I Nodular Sclerosis Hodgkin's Lymphoma
4141,Carcinomatous Component Present,Stage III Vulvar Cancer AJCC v6
4142,Juvenile Lesion,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor
4143,Precise Histogenesis Unknown,Central Nervous System Hemangioblastoma
4144,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
4145,Epithelial Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
4146,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Testicular Teratoma
4147,Epithelial Component Present,Nipple Duct Carcinoma
4148,Lobulated Growth Pattern,Myxoma
4149,Undifferentiated Lesion,Undifferentiated Endocervical Sarcoma
4150,Carcinomatous Component Present,Stage IV Oropharyngeal Carcinoma AJCC v7
4151,Epithelial Component Present,Rectal Medullary Carcinoma
4152,Carcinomatous Component Present,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7
4153,High Grade Lesion,Childhood Brain Anaplastic Astrocytoma
4154,Dysplasia,Foveolar-Type Adenoma
4155,Desmoplastic Stroma Formation,Desmoplastic infantile astrocytoma
4156,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v7
4157,Dilated Terminal Duct Lobular Units Present,Columnar Cell Hyperplasia of the Breast with Atypia
4158,Cutaneous Involvement,Monilethrix
4159,Composite Lesion,"Childhood Ganglioneuroblastoma, Nodular"
4160,Thick-Walled Hyalinized Vessels Present,Conventional Schwannoma
4161,Tissue Differentiation Uncertain,Adult Extraskeletal Myxoid Chondrosarcoma
4162,Refractory Disease,Chronic lymphocytic leukemia refractory
4163,Fibrous Septa Present,"Bone Cysts, Aneurysmal"
4164,Diffuse Lesion,Intraductal papillomatosis
4165,Nodular Pattern,Nodular Sclerosis Classical Hodgkin Lymphoma
4166,Vascular Channel Formation,Skin Angiosarcoma
4167,Metaplasia of Malignant Cells Present,Adenocarcinoma with squamous metaplasia
4168,Increased Cellularity Present,Ependymoblastoma
4169,Low Grade Lesion,Childhood Pilocytic Astrocytoma
4170,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
4171,Vascular Channel Formation,Solid Angioleiomyoma
4172,Nuclear Atypia,Mesenchymal Glioblastoma
4173,Increased Cellularity Present,Anaplastic Ependymoma
4174,Childhood Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7
4175,Cutaneous Involvement,adenosquamous carcinoma of skin
4176,Epithelial Component Present,Childhood Esophageal Carcinoma
4177,Epithelial Component Present,Benign Breast Adenomyoepithelioma
4178,Well-Circumscribed Lesion,Sclerosing Polycystic Adenosis
4179,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm
4180,Infiltrative Growth Pattern,Fibromatosis
4181,Intraductal Lesion,Intraductal Breast Myoepitheliosis
4182,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
4183,Epithelial Component Present,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
4184,Well-Circumscribed Lesion,Cecum Villous Adenoma
4185,In Situ Lesion,Stage 0 Vulvar Carcinoma
4186,Carcinomatous Component Present,Stage IV Esophagus Carcinoma
4187,Biphasic Pattern,Cardiac Biphasic Synovial Sarcoma
4188,Well-Circumscribed Lesion,Ovarian Endometrioid Cystadenoma
4189,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma
4190,Epithelial Component Present,Stage 0 Lip Carcinoma
4191,Absence of Invasion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
4192,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Endometrioid Cystadenofibroma
4193,Cystic Change,Ovarian Endometrioid Cystadenofibroma
4194,Fibrotic Stroma Formation,Hard Palate Mucoepidermoid Carcinoma
4195,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Cystadenofibroma
4196,Epithelial Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
4197,Nuclear Clearing,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
4198,Diffuse Cellular Infiltrate,Diffuse Gastric Adenocarcinoma
4199,Epithelial Component Present,Low-grade intraurothelial neoplasia
4200,Mitotic Activity,Neural Glioblastoma
4201,Neuroectodermal Differentiation,Kadish Stage A Olfactory Neuroblastoma
4202,IDH Gene Family Mutation Status Unknown,Diffuse Astrocytoma
4203,Fibrosis,Breast Apocrine Adenosis
4204,Epithelial Component Present,Vaginal intraepithelial neoplasia grade 2
4205,Low Mitotic Activity,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
4206,Well Differentiated Lesion,Cervical Squamotransitional Carcinoma
4207,Recurrent disease,Leiomyosarcoma recurrent
4208,In Situ Lesion,Serous Tubal Intraepithelial Carcinoma
4209,Severe dysplasia,Serous Tubal Intraepithelial Carcinoma
4210,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma stage II
4211,Schwannian Stroma Predominant Component of the Tumor Volume,Retroperitoneal Ganglioneuroma
4212,Cutaneous Involvement,"Xeroderma pigmentosum, group B"
4213,Well-Circumscribed Lesion,Polyp of vagina
4214,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma stage III
4215,Malignant Cellular Infiltrate,Childhood Ovarian Mixed Germ Cell Tumor
4216,Low Mitotic Activity,insulinoma
4217,Fibrosis,Primary mediastinal large B-cell lymphoma stage IV
4218,Dense Intercellular Reticulin Network Present,Pleomorphic Xanthoastrocytoma
4219,Well-Circumscribed Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
4220,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
4221,Pushing Tumor Margin,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
4222,Cutaneous Involvement,Crusted scabies
4223,Epithelial Component Present,Stage II Skin Cancer
4224,Carcinomatous Component Present,Primary Carcinoma
4225,Indolent Clinical Course,Periosteal fibroma
4226,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v6
4227,Indolent Clinical Course,Intracranial lipoma
4228,Cutaneous Involvement,Lymphoproliferative Disorder of the Skin
4229,Mixed Cellular Population,Ovarian gonadoblastoma
4230,Carcinomatous Component Present,Stage III Oropharyngeal Carcinoma AJCC v6
4231,Neuroendocrine Differentiation,Colon Small Cell Neuroendocrine Carcinoma
4232,Cutaneous Involvement,Furunculosis
4233,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma
4234,Exophytic Papillary Lesion,Subglottic Verrucous Carcinoma
4235,Pseudopapillary Pattern,Testicular embryonal carcinoma stage III
4236,Microvascular Proliferation,Acinar cell carcinoma of pancreas
4237,Anaplasia,anaplastic large cell lymphoma of central nervous system
4238,Carcinomatous Component Present,Endometrioid carcinoma of prostate
4239,Fibrosis,Fibrosclerosis of breast
4240,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Immature Teratoma
4241,Cystic Change,Serous cystadenocarcinoma ovary
4242,Adulthood Lesion,Adult Brain Stem Mixed Glioma
4243,Mitotic Activity,"Ovarian Yolk Sac Tumor, Hepatoid Pattern"
4244,Carcinomatous Component Present,Endometrioid carcinoma ovary
4245,Cutaneous plaque,"Basal cell carcinoma, micronodular"
4246,Monomorphic Cellular Infiltrate,Adult Brain Ependymoma
4247,Childhood Lesion,Childhood Anaplastic Ependymoma
4248,CD30-Positive Neoplastic Cells Present,Adult Systemic Anaplastic Large Cell Lymphoma
4249,Epithelial Component Present,Adenocarcinoma of rectum
4250,Carcinomatous Component Present,Stage I Hepatocellular Carcinoma AJCC v6 and v7
4251,Anaplasia,Adult Anaplastic Large Cell Lymphoma
4252,Low Mitotic Activity,Stage II Appendix Neuroendocrine Tumor AJCC v7
4253,Neuroendocrine Differentiation,Vulvar Large Cell Neuroendocrine Carcinoma
4254,Neuroendocrine Differentiation,Duodenal Somatostatin-Producing Neuroendocrine Tumor
4255,Increased Cellularity Present,Recurrent Childhood Anaplastic Astrocytoma
4256,Anaplasia,Childhood Conventional Osteosarcoma
4257,Indolent Clinical Course,Capillary hemangioma of orbit
4258,Carcinomatous Component Present,Recurrent ovarian cancer
4259,Recurrent disease,Waldenstrom's macroglobulinemia recurrent
4260,Cellular Pleomorphism,Malignant fibrous histiocytoma metastatic
4261,Childhood Lesion,Recurrent Childhood Brain Neoplasm
4262,Cutaneous Involvement,Stage IIA Cutaneous Melanoma AJCC v6 and v7
4263,Epithelial Component Present,Gingival Spindle Cell Carcinoma
4264,Epithelial Component Present,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
4265,Cutaneous Involvement,Cutaneous pseudolymphoma
4266,Epithelial Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
4267,Multifocal Lesion,Multifocal superficial basal cell carcinoma
4268,Burn injury,Old Burn Scar-Related Neoplasm
4269,Epithelial Component Present,Sclerosing thymoma
4270,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Tumor G1
4271,Cartilaginous Differentiation,mesenchymal chondrosarcoma of bone
4272,Defective Mu Heavy Chain Present,mu-Chain Disease
4273,Cutaneous Involvement,Stage III Merkel Cell Carcinoma AJCC v7
4274,Carcinomatous Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7
4275,Exposure to asbestos,Asbestos-Related Malignant Neoplasm
4276,Severe cytologic atypia,large cell neuroendocrine carcinoma of gallbladder
4277,Exophytic Papillary Lesion,Urethral Verrucous Carcinoma
4278,Immunologic Deficiency Syndromes,Neoplastic Post-Transplant Lymphoproliferative Disorder
4279,Immunosuppression-Related Post-Transplant Toxicity,Neoplastic Post-Transplant Lymphoproliferative Disorder
4280,Cutaneous Involvement,Cutaneous Liposarcoma
4281,Apocrine Differentiation,Apocrine adenoma
4282,Nodular lesions,Thyroid Gland Oncocytic Adenoma
4283,Carcinomatous Component Present,Carcinoma of apocrine gland
4284,Immunosuppression-Related Post-Transplant Toxicity,Non-Destructive Post-Transplant Lymphoproliferative Disorder
4285,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Thrombocytopenia
4286,Recurrent disease,Angioimmunoblastic T-cell lymphoma recurrent
4287,Diffuse Pattern,Centroblastic lymphoma stage I
4288,Paucicellular Stroma Present,canalicular adenoma of salivary gland
4289,Indolent Clinical Course,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm"
4290,Metastatic Lesion,Metastatic angiosarcoma
4291,Extraosseous Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma
4292,Hereditary Lesion,Li-Fraumeni Syndrome
4293,Epithelial Component Present,Low Grade Salivary Gland Mucoepidermoid Carcinoma
4294,Carcinomatous Component Present,Gallbladder Mixed Adenoneuroendocrine Carcinoma
4295,Epithelial Component Present,Gastric Body Carcinoma
4296,Perineural spread,Prostate Adenoid Cystic Carcinoma
4297,Carcinomatous Component Present,Thymic Basaloid Carcinoma
4298,Nuclear Atypia,gliosarcoma
4299,Primary Lesion,Primary Peritoneal Serous Adenocarcinoma
4300,Numerous Stromal Mast Cells Present,Angiomyofibroblastoma
4301,atypia morphology,Atypical Endometrial Hyperplasia
4302,Carcinomatous Component Present,Stage III Lung Cancer AJCC v7
4303,Anaplasia,Sarcomatoid carcinoma of the lung
4304,Epithelial Component Present,Stage IV Lung Cancer AJCC v7
4305,Invasive Lesion,signet ring cell carcinoma of breast
4306,Carcinomatous Component Present,Triple-Negative Breast Carcinoma
4307,Rapidly Enlarging Mass,rhabdomyosarcoma of liver
4308,Carcinomatous Component Present,Colorectal Mixed Adenoneuroendocrine Carcinoma
4309,Epithelial Component Present,Exocervical Carcinoma
4310,Childhood Lesion,Metastatic Childhood Soft Tissue Sarcoma
4311,Epithelial Component Present,Stage 0 Esophageal Cancer AJCC v7
4312,Well Differentiated Lesion,Laryngeal verrucous carcinoma stage IV
4313,Epithelial Component Present,Pancreatic Acinar Cell Cystadenoma
4314,Cutaneous Involvement,Trichodiscoma
4315,Epithelial Component Present,Stage IIIA Adult Liver Cancer AJCC v7
4316,Adnexal Differentiation,Superficial Epithelioma with Sebaceous Differentiation
4317,Monoclonal Langerhans Cells Present,Letterer-Siwe Disease
4318,Vascular Channel Formation,Strawberry nevus of skin
4319,Firm mass,Recurrent Malignant Peripheral Nerve Sheath Tumor
4320,Sebaceous Differentiation,Sebaceoma
4321,Carcinomatous Component Present,Stage IB Eyelid Carcinoma AJCC v7
4322,atypia morphology,Malignant Ovarian Thecoma
4323,Well-Circumscribed Lesion,Ovarian Myxoid Liposarcoma
4324,Epithelial Component Present,"Pheochromocytoma, Extra-Adrenal"
4325,Neuroendocrine Differentiation,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
4326,Fibromyxoid Stroma Formation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
4327,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
4328,Invasive Lesion,Tubular breast carcinoma
4329,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
4330,Epithelial Component Present,Stage III Lung Small Cell Carcinoma AJCC v7
4331,Epithelial Component Present,Thyroid Hurthle Cell Carcinoma
4332,Fetiform Mass,Ovarian Fetiform Teratoma
4333,Increased Cellularity Present,Olfactory Neuroblastoma
4334,Carcinomatous Component Present,Vaginal Warty Carcinoma
4335,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Bladder Urothelial Carcinoma
4336,Mixed Cellular Population,Adenocarcinoma with cartilaginous and osseous metaplasia
4337,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
4338,Cutaneous Involvement,Stage IIIA Cutaneous Melanoma AJCC v7
4339,Epithelial Component Present,Stage IVB Hepatocellular Carcinoma AJCC v7
4340,Epithelial Component Present,Small Intestinal Villous Adenoma
4341,Primary Lesion,Stage IB Osteosarcoma AJCC v7
4342,In Situ Lesion,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
4343,Fibrous Septa Present,Stage III Ovarian Dysgerminoma AJCC v6 and v7
4344,Endophytic Tumor Growth,Inverting papilloma of the paranasal sinus
4345,Granulocytes Increased in Bone Marrow,Primary Myelofibrosis
4346,Neuroendocrine Differentiation,Vaginal Small Cell Carcinoma
4347,Severe cytologic atypia,Pancreatic Intraepithelial Neoplasia-3
4348,Epithelial Component Present,Stage I Lip Basal Cell Carcinoma
4349,Carcinomatous Component Present,Fallopian Tube Mucinous Adenocarcinoma
4350,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma
4351,Desmoplastic Stroma Formation,Desmoplastic trichilemmoma
4352,Collagenous Stroma Formation,Desmoplastic fibroblastoma
4353,Carcinomatous Component Present,ENSAT Stage III Adrenal Cortex Carcinoma
4354,Secondary Lesion,Metastatic malignant neoplasm to brain
4355,Cutaneous Involvement,Pustulosis of Palms and Soles
4356,Carcinomatous Component Present,Cecum Carcinoma
4357,Exophytic Polypoid Lesion,Adenoma of ampulla of Vater
4358,Epithelial Component Present,Stage IA Esophageal Adenocarcinoma AJCC v7
4359,Epithelial Component Present,Retroperitoneal Carcinoma
4360,Biphasic Pattern,Carcinosarcoma of ovary
4361,Tissue Differentiation Uncertain,Follicular Myxoma
4362,Well-Circumscribed Lesion,Ampulla of Vater Tubular Adenoma
4363,Epithelial Component Present,Alcohol-Related Carcinoma
4364,Adulthood Lesion,Adult Desmoplastic Small Round Cell Tumor
4365,Mucoid Stroma Formation,Childhood Myxopapillary Ependymoma
4366,'Starry-sky' pattern,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma
4367,Epithelial Component Present,Alcohol-Related Esophageal Squamous Cell Carcinoma
4368,Indolent Clinical Course,Cranial Nodular Fasciitis
4369,Cutaneous Involvement,Pigmented Basal Cell Carcinoma
4370,Epithelial Component Present,Stage 0 Esophageal Adenocarcinoma AJCC v7
4371,Exophytic Papillary Lesion,papillary carcinoma of penis
4372,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Solid Variant"
4373,Exophytic Polypoid Lesion,Large Bowel Juvenile Polyp
4374,Myxoid Stroma Formation,Childhood Myxoid Chondrosarcoma
4375,Exophytic Polypoid Lesion,Colorectal hyperplastic polyp
4376,Pregnancy Complications,"Hydatidiform Mole, Invasive"
4377,Vascular Channel Formation,Intravascular Angioleiomyoma
4378,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma
4379,Alternative Fascicle (Bundle) Pattern,Intravenous leiomyomatosis
4380,Ineffective hematopoiesis,Alkylating Agent-Related Myelodysplastic Syndrome
4381,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia
4382,Mixed Cellular Population,Stage III Kidney Wilms Tumor
4383,Anaplasia,Thymic Sarcomatoid Carcinoma
4384,Childhood Lesion,Recurrent Childhood Non-Hodgkin Lymphoma
4385,Macule,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7
4386,Cystic Change,Invasive intraductal papillary-mucinous carcinoma of pancreas
4387,Chemotherapeutic Agent Toxicity,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
4388,Necrotic changes (finding),Gastric Large Cell Neuroendocrine Carcinoma
4389,Carcinomatous Component Present,Cervical Mesonephric Adenocarcinoma
4390,Monoclonal Cellular Population Present,Aggressive Systemic Mastocytosis
4391,Tubular Pattern,Vaginal Tubular Adenoma
4392,Childhood Lesion,Postsurgical Stage I Hepatoblastoma
4393,Chronic lymphocytic inflammation,"Thymoma, type B2"
4394,Infiltrative Growth Pattern,Recurrent Childhood Diffuse Astrocytoma
4395,Recurrent disease,Recurrent Grade 3 Follicular Lymphoma
4396,Childhood Lesion,Childhood Central Nervous System Germ Cell Tumor
4397,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Soft Tissue Amyloid Neoplasm
4398,Secondary Lesion,Secondary malignant neoplasm of hypopharynx
4399,Microcystic Change,Recurrent Childhood Fibrillary Astrocytoma
4400,Carcinomatous Component Present,Adult Salivary Gland Carcinoma
4401,Childhood Lesion,Childhood Undifferentiated Pleomorphic Sarcoma
4402,Epithelial Component Present,BCLC Stage B Adult Hepatocellular Carcinoma
4403,Severe cytologic atypia,Small Intestinal Neuroendocrine Carcinoma
4404,Metastatic Lesion,Secondary malignant neoplasm of peritoneum
4405,Cutaneous Involvement,Lentigo simplex
4406,Carcinomatous Component Present,Bile duct adenocarcinoma
4407,Indolent Clinical Course,Benign neoplasm of body of uterus
4408,Low Mitotic Activity,Regional Digestive System Neuroendocrine Tumor G1
4409,Carcinomatous Component Present,Bladder adenocarcinoma recurrent
4410,Epithelial Component Present,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
4411,Pseudostratified Columnar Tumor Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
4412,Exophytic Polypoid Lesion,Bile duct adenoma
4413,Trabecular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor
4414,Poorly Cohesive Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric
4415,Solid Growth Pattern,Solid carcinoma
4416,Adnexal Differentiation,Dermal Duct Tumor
4417,Well Differentiated Lesion,Minimally Invasive Mucinous Lung Adenocarcinoma
4418,Indolent Clinical Course,Appendix Lipoma
4419,Papillary Pattern,Endolymphatic sac tumor
4420,Immunologic Deficiency Syndromes,AIDS-Related Cryptococcosis
4421,Immunologic Deficiency Syndromes,AIDS-Related Non-Hodgkin Lymphoma of the Cervix
4422,Embryoid Bodies Present,Stage III Ovarian Polyembryoma AJCC v6 and v7
4423,Invasive Lesion,Infiltrating Cervical Carcinoma
4424,Thyroglobulin Positive Neoplastic Cells Present,Nonencapsulated sclerosing tumor
4425,Carcinomatous Component Present,Skin Clear Cell Basal Cell Carcinoma
4426,Indolent Clinical Course,Uterine Corpus Dissecting Leiomyoma
4427,Cystic Change,Mucoepidermoid carcinoma of salivary gland
4428,Tissue Differentiation Uncertain,Right atrial myxoma
4429,Hereditary Lesion,TUBEROUS SCLEROSIS 1 (disorder)
4430,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation
4431,High Mitotic Activity,Recurrent Pancreatic Neuroendocrine Carcinoma
4432,Epithelial Component Present,Stage III Prostate Cancer AJCC v7
4433,Multinodular Mass,Angiosarcoma NCI Grade 3
4434,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
4435,Osseous Differentiation,Extraskeletal osteosarcoma non-metastatic
4436,Ineffective hematopoiesis,Refractory anemias
4437,Carcinomatous Component Present,Adenosquamous carcinoma
4438,Local disease,Conventional Lipoma
4439,Carcinomatous Component Present,Colorectal Cribriform Comedo-Type Adenocarcinoma
4440,Lytic lesion,Osteoclastic Giant Cell-Rich Tumor of Bone
4441,Primary Lesion,Primary cerebral lymphoma
4442,Carcinomatous Component Present,Major Salivary Gland Mucoepidermoid Carcinoma
4443,Pseudoalveolar Pattern,Alveolar soft part sarcoma recurrent
4444,Well-Circumscribed Lesion,Stromal Predominant Kidney Wilms Tumor
4445,Epithelial Component Present,Oral Cavity Adenoma
4446,Epithelial Component Present,Papillary tumor of renal pelvis
4447,Angiodestructive Pattern,Recurrent Childhood Lymphomatoid Granulomatosis
4448,Recurrent disease,Nasopharyngeal cancer recurrent
4449,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage IV
4450,Well-Circumscribed Lesion,Mixed Cell Type Kidney Wilms Tumor
4451,Neuroendocrine Differentiation,small cell carcinoma of ureter
4452,Low Mitotic Activity,Gastrointestinal Carcinoid Tumor
4453,Humoral hypercalcemia of malignancy (disorder),"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
4454,Bilateral Mass,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor
4455,Capillary Sized Vascular Channel Formation,Central Nervous System Hemangioblastoma
4456,Red Papular Lesion,Senile hemangioma of lip
4457,Metastatic/Recurrent Disease,Cervical Alveolar Soft Part Sarcoma
4458,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma
4459,Hereditary Lesion,Familial Neuroblastoma
4460,Carcinomatous Component Present,Recurrent Ureter Carcinoma
4461,Nuclear Atypia,Supratentorial Glioblastoma
4462,Systemic disease,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive"
4463,Non-Malignant Cellular Infiltrate,Infectious Mononucleosis
4464,Fibrotic Stroma Formation,Mucin-Producing Intrahepatic Cholangiocarcinoma
4465,Gyriform Trabecular Pattern,malignant gastrinoma of pancreas
4466,Tumor Droplets Present,Adenoameloblastoma
4467,High Mitotic Activity,Anaplastic Oligodendroglioma
4468,IDH Gene Family Mutation Status Unknown,Anaplastic Oligodendroglioma
4469,Epithelial Component Present,Stage IV Cervical Cancer AJCC v6 and v7
4470,Papillary Pattern,Fallopian Tube Metaplastic Papillary Tumor
4471,Indolent Clinical Course,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor
4472,Cutaneous Involvement,"Pemphigoid, Benign Mucous Membrane"
4473,White blood cell count increased (lab result),"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
4474,Cutaneous Involvement,basal cell carcinoma of penis
4475,Eosinophilic inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor
4476,Pain,Aggressive osteoblastoma
4477,Childhood Lesion,Childhood Brain Stem Neoplasm
4478,Carcinomatous Component Present,Stage 0 Oropharyngeal Carcinoma
4479,Poorly Differentiated Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
4480,Childhood Lesion,Recurrent Childhood Rhabdomyosarcoma
4481,Carcinomatous Component Present,Morpheic basal cell carcinoma
4482,Intravascular Fibrin Thrombus Formation,Infiltrating angiolipoma
4483,Carcinomatous Component Present,Adenocarcinoma with apocrine metaplasia
4484,Mitotic Activity,Mesenchymal Glioblastoma
4485,Epithelial Component Present,Stage IIA Lung Cancer AJCC v7
4486,Carcinomatous Component Present,Lung adenocarcinoma recurrent
4487,Epithelial Component Present,Breast Carcinoma Metastatic in the Brain
4488,Lytic lesion,Giant Cell Lesion of Small Bones
4489,Epithelial Component Present,adenocarcinoma of renal pelvis
4490,Diffuse Pattern,Immunoblastic Large-Cell Lymphoma
4491,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v7
4492,Secondary Lesion,Secondary malignant neoplasm of extrahepatic bile ducts
4493,Cutaneous Involvement,Rosacea
4494,Epithelial Component Present,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor
4495,Epithelial Component Present,Papilloma
4496,High Mitotic Activity,Small Intestinal Small Cell Neuroendocrine Carcinoma
4497,Benign Cellular Infiltrate,Anal Leiomyoma
4498,Epithelial Component Present,Recurrent Urinary System Carcinoma
4499,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v7
4500,Benign Cellular Infiltrate,Extrahepatic Bile Duct Fibroma
4501,Nuclear Atypia,Proneural Glioblastoma
4502,Biphasic Pattern,Cervical Adenofibroma
4503,Carcinomatous Component Present,Primary Carcinoma Unspecified Site
4504,Well Differentiated Lesion,Cervical Papillary Squamous Cell Carcinoma
4505,Increased Cellularity Present,Papillary transitional cell neoplasm of low malignant potential
4506,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,"Acute Myeloid Leukemia, M1"
4507,Epithelial Component Present,Stage I Renal Cell Carcinoma
4508,Congenital Lesion,GIANT PIGMENTED HAIRY NEVUS
4509,Adulthood Lesion,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma
4510,Antoni A Pattern,Cerebellopontine Angle Schwannoma
4511,Endocervical Type Epithelium Present,"Cervical Adenomyoma, Endocervical Type"
4512,Papillary Pattern,Papillary adenofibroma
4513,Adulthood Lesion,Stage IV Indolent Adult Non-Hodgkin Lymphoma
4514,Immunologic Deficiency Syndromes,Ann Arbor Stage I AIDS-Related Lymphoma
4515,Myxoid Stroma Formation,Childhood Epithelioid Hemangioendothelioma
4516,Rapidly Enlarging Mass,rhabdomyosarcoma of testis
4517,Polymorphic Cellular Infiltrate,Adult Langerhans Cell Histiocytosis
4518,Birbeck Granules Present,Adult Langerhans Cell Histiocytosis
4519,Carcinomatous Component Present,Squamous cell carcinoma of tongue
4520,Pregnancy Complications,Necrotizing Funisitis
4521,Epithelial Component Present,Stage IA Lung Adenocarcinoma AJCC v7
4522,Infiltrative Growth Pattern,Brain Stem Glioblastoma
4523,Carcinomatous Component Present,Stage II Carcinoma of Penis
4524,Secondary Lesion,Secondary malignant neoplasm of kidney
4525,Non-Malignant Cellular Infiltrate,Postauricular lymphadenitis
4526,Pseudoglandular Pattern,Childhood Testicular Embryonal Carcinoma
4527,Carcinomatous Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
4528,Fibrosis,Primary mediastinal large B-cell lymphoma stage II
4529,Tissue of Mullerian Origin Present,carcinosarcoma of fallopian tube
4530,Mixed Cellular Population,Invasive Mixed Breast Carcinoma
4531,Epithelial Component Present,Pancreatic Hepatoid Adenocarcinoma
4532,Calcitonin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
4533,Cystic Change,Seborrheic keratosis
4534,Childhood Lesion,Neonatal leukemia
4535,Neonatal Lesion,Neonatal leukemia
4536,Dysplasia,Stage 0 Cervical Cancer AJCC v6
4537,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Childhood Acute Myeloid Leukemia without Maturation
4538,Aggravated Disease,Neurofibromatosis aggravated
4539,BRAF V600E Mutation Present,Hairy Cell Leukemia
4540,Pseudostratified Neuroepithelial Tumor Cells Present,Medulloepithelioma
4541,Carcinomatous Component Present,Rectal Signet Ring Cell Adenocarcinoma
4542,Epithelial Component Present,Squamous cell carcinoma of conjunctiva
4543,Vascular Channel Formation,Mediastinal Lymphangioma
4544,Cellular Pleomorphism,"Seminoma, anaplastic"
4545,Cystic Change,Broad Ligament Serous Cystadenofibroma
4546,Carcinomatous Component Present,Posterior Pharyngeal Wall Carcinoma
4547,Infiltrative Growth Pattern,Recurrent Glioblastoma
4548,Indolent Clinical Course,Solitary Myofibromatosis
4549,Neuroendocrine Differentiation,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
4550,Pushing Tumor Margin,Plantar Verrucous Skin Carcinoma
4551,Epithelial Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
4552,Epithelial Component Present,Stage IVA Major Salivary Gland Cancer AJCC v7
4553,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v6 and v7
4554,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
4555,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
4556,Carcinomatous Component Present,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
4557,Secondary Lesion,Meningeal Leukemia
4558,Childhood Lesion,Childhood Ganglioglioma
4559,Necrotic changes (finding),Malignant Uterine Corpus PEComa
4560,Poorly Differentiated Lesion,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
4561,Malignant Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7
4562,Metastatic Lesion,Carcinomatosis
4563,Recurrent disease,Recurrent Carcinoma
4564,Indolent Clinical Course,Fibroma of tendon sheath
4565,Hemosiderin pigmentation,"Histiocytoma, Angiomatoid Fibrous"
4566,Junctional Proliferation,Dysplastic Nevus
4567,Epithelial Component Present,Atypical choroid plexus papilloma
4568,Indolent Clinical Course,Nuchal-type fibroma
4569,Disease regression,"Malignant melanoma, regressing"
4570,Carcinomatous Component Present,Stage II Ampulla of Vater Cancer AJCC v7
4571,Carcinomatous Component Present,Hepatocellular Carcinoma by BCLC Stage
4572,Squamoid Differentiation,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
4573,Nuclear Clearing,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
4574,Papillary Pattern,Myxopapillary ependymoma
4575,Carcinomatous Component Present,large cell neuroendocrine carcinoma of breast
4576,Adnexal Differentiation,Outer Hair Sheath and Infundibulum Neoplasm
4577,Carcinomatous Component Present,undifferentiated carcinoma of anal canal
4578,Epithelial Component Present,Stage IV Pharynx Carcinoma
4579,Storiform Growth Pattern,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
4580,Carcinomatous Component Present,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
4581,Indolent Clinical Course,Cavernous hemangioma of orbit
4582,Absence of Stromal Invasion,Borderline cystadenoma
4583,Biphasic Pattern,mucinous adenocarcinofibroma of ovary
4584,High Mitotic Activity,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
4585,Epithelial Component Present,Condyloma acuminata of vulva
4586,Diffuse Pattern,Stage II Adult Immunoblastic Lymphoma
4587,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligodendroglioma
4588,Collagen Bundles Formation,Lymphangioendothelioma
4589,Indolent Clinical Course,Intra-Abdominal Lymphangioma
4590,Epithelial Component Present,Malignant Pancreatic Somatostatinoma
4591,Tubular Pattern,Malignant Pancreatic Somatostatinoma
4592,Epithelial Component Present,High Grade Cervical Intraepithelial Neoplasia
4593,Carcinomatous Component Present,Lymphoepithelial malignant thymoma
4594,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Microscopic Thymoma
4595,Adulthood Lesion,Adult Mixed Cellularity Classical Hodgkin Lymphoma
4596,Childhood Lesion,Childhood Thyroid Gland Medullary Carcinoma
4597,Pain,mesenchymal chondrosarcoma of bone
4598,Cutaneous Involvement,Nevoid Melanoma
4599,Mitotic Activity,Testicular yolk sac tumor
4600,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
4601,Mitotic Activity,Central Nervous System Yolk Sac Tumor
4602,Mixed Cellular Population,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma
4603,Epithelial Component Present,Thyroid Gland Oncocytic Adenoma
4604,High Grade Lesion,Childhood Lung Small Cell Carcinoma
4605,Antoni A Pattern,Degenerated Schwannoma
4606,Chronic Inflammatory Infiltrate,Chronic lymphadenitis
4607,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage III
4608,Nuclear Atypia,Anaplastic Diencephalic Astrocytoma
4609,Hereditary Lesion,Schwannomatosis
4610,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Mature Teratoma
4611,Mild dysplasia,Colorectal Low Grade Intraepithelial Neoplasia
4612,Biphasic Pattern,Ovarian Clear Cell Adenofibroma
4613,Papillary Pattern,Lower Gingival Verrucous Carcinoma
4614,Chromogranin A Positive Neoplastic Cells Present,Cervical Atypical Carcinoid Tumor
4615,Neuroendocrine Differentiation,Cervical Atypical Carcinoid Tumor
4616,Cutaneous Involvement,Vulvar Nodular Hidradenoma
4617,Villous Pattern,tubulopapillary adenoma of extrahepatic bile duct
4618,Cutaneous Involvement,Malignant Vulvar Sweat Gland Neoplasm
4619,Carcinomatous Component Present,Krukenberg Tumor
4620,Well-Circumscribed Lesion,Sessile Serrated Adenoma/Polyp
4621,Carcinomatous Component Present,Thymic Squamous Cell Carcinoma
4622,Epithelial Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
4623,Mitotic Activity,Pilomyxoid astrocytoma
4624,Epithelial Component Present,Sarcomatoid Intrahepatic Cholangiocarcinoma
4625,Carcinomatous Component Present,Thymic Mucoepidermoid Carcinoma
4626,Indolent Clinical Course,benign fibrous histiocytoma of bone
4627,Epithelial Component Present,Stage II Hilar Cholangiocarcinoma AJCC v7
4628,Primary Lesion,Non-Hodgkin's lymphoma of central nervous system
4629,Tubular Structures Present,Malignant Kidney Mixed Epithelial and Stromal Tumor
4630,Carcinomatous Component Present,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
4631,Epithelial Component Present,Inflammatory carcinoma of breast recurrent
4632,Multifocal Lesion,Multicentric Thyroid Gland Papillary Carcinoma
4633,Congenital Lesion,Congenital anomaly of eyelid
4634,Childhood Lesion,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
4635,Carcinomatous Component Present,mucoepidermoid carcinoma of accessory sinus
4636,Osseous Differentiation,Liver Extraskeletal Osteosarcoma
4637,Cambium Layer,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
4638,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
4639,Cysts Containing Proteinaceous Fluid Present,Pancreatic Macrocystic Serous Cystadenoma
4640,High Mitotic Activity,embryonal carcinoma of mediastinum
4641,Squamous Differentiation,"Carcinoma, Basosquamous"
4642,Radiation Sickness,Radiation-Related Osteosarcoma
4643,Pushing Tumor Margin,verrucous carcinoma of bladder
4644,Borderline Lesion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
4645,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
4646,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
4647,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma recurrent
4648,Well-Circumscribed Lesion,Apocrine cystadenoma
4649,Bone Marrow Dysplasia Present,Chronic Myelomonocytic Leukemia with Eosinophilia
4650,Increased Cellularity Present,Metanephric adenoma
4651,Neuroendocrine Differentiation,Stage IA Lung Small Cell Carcinoma AJCC v7
4652,Well Differentiated Lesion,Well-differentiated papillary mesothelioma
4653,Cutaneous Involvement,Breast Nevus
4654,Carcinomatous Component Present,undifferentiated carcinoma of liver
4655,Adnexal Differentiation,Eccrine ductal carcinoma
4656,Multinodular Mass,Dermatofibrosarcoma Protuberans
4657,Hyperplastic Tissue Present,Diffuse hyperplasia
4658,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
4659,Indolent Clinical Course,Scrotal Hemangioma
4660,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Malignant Neoplasm
4661,Epithelial Component Present,Small intestine carcinoma resectable
4662,Cystic Change,Ovarian Cystic Teratoma
4663,High Mitotic Activity,combined small cell carcinoma of lung
4664,Indolent Clinical Course,Nodular fasciitis
4665,Bile Pigment Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
4666,Biphasic Pattern,"Transitional cell carcinoma, spindle cell"
4667,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
4668,Papillary Pattern,Papillary transitional cell carcinoma
4669,Primary Lesion,Stage IA Osteosarcoma AJCC v7
4670,Carcinomatous Component Present,Stage II Adult Liver Cancer AJCC v7
4671,Carcinomatous Component Present,Human Papillomavirus-Related Adenosquamous Carcinoma
4672,Osseous Differentiation,Stage IB Osteosarcoma AJCC v7
4673,Well Differentiated Lesion,"Lung Squamous Cell Carcinoma, Papillary Variant"
4674,"Amorphus, Eosinophilic, and Acellular Deposit",Nodular amyloidosis
4675,Secondary Lesion,Disseminated squamous cell carcinoma
4676,Primary Lesion,Stage II Osteosarcoma AJCC v7
4677,Epithelial Component Present,Paget's disease and intraductal carcinoma of breast
4678,Lobulated Growth Pattern,Skull Base Chordoma
4679,Rapidly Enlarging Mass,Adult Rhabdomyosarcoma
4680,Epithelial Component Present,Stage II Lung Cancer AJCC v7
4681,High Grade Lesion,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
4682,Diffuse Pattern,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
4683,Extraosseous Lesion,Kidney Extraskeletal Osteosarcoma
4684,Well-Circumscribed Lesion,Traditional Serrated Adenoma
4685,Immunologic Deficiency Syndromes,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
4686,Exophytic Polypoid Lesion,Renal Pelvis Fibroepithelial Polyp
4687,High Mitotic Activity,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
4688,Adulthood Lesion,Adult Oligodendroglial Tumor
4689,Neuroendocrine Differentiation,Atrial Paraganglioma
4690,Nuclear Grooves,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
4691,Nodular lesions,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
4692,Secondary Lesion,Carcinoma of unknown primary
4693,Well-Circumscribed Lesion,Villous adenoma of duodenum
4694,Indolent Clinical Course,Desmoplastic fibroblastoma
4695,Hyperplastic Tissue Present,Atypical adenomatous hyperplasia
4696,Splenomegaly,Progressive Hairy Cell Leukemia Initial Treatment
4697,Epithelial Component Present,Epidermolytic acanthoma
4698,Necrotic changes (finding),Childhood Gliosarcoma
4699,Epithelial Component Present,Intraepithelial Neoplasia
4700,Epithelial Component Present,Old Burn Scar-Related Skin Squamous Cell Carcinoma
4701,Local disease,Lipoma of axilla
4702,Burn injury,Old Burn Scar-Related Cutaneous Melanoma
4703,Necrotic changes (finding),Endometrial Large Cell Neuroendocrine Carcinoma
4704,Carcinomatous Component Present,Paget Disease of the Breast with Invasive Ductal Carcinoma
4705,Childhood Lesion,Childhood Central Nervous System Neoplasm
4706,Radiation Sickness,Radiation-Induced Intracranial Meningioma
4707,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity recurrent
4708,Severe cytologic atypia,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
4709,Secondary Lesion,Epipodophyllotoxin-Related Myelodysplastic Syndrome
4710,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome
4711,Secondary Lesion,Locally Metastatic Malignant Neoplasm
4712,Epithelial Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7
4713,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Alkylating Agent-Related Myelodysplastic Syndrome
4714,Hyperplastic Tissue Present,Endometrial Hyperplasia
4715,Absence of Stromal Invasion,Proliferating Brenner Tumor
4716,Nodular Pattern,Methotrexate-Associated Follicular Lymphoma
4717,Lipomatous Component Present,Epithelioid Type Angiomyolipoma
4718,Epithelial Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7
4719,Cartilaginous Differentiation,Chondrosarcoma
4720,Non-Invasive Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
4721,Dysplasia,Appendix Tubulovillous Adenoma
4722,Carcinomatous Component Present,Breast Carcinoma
4723,Infantile Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6
4724,Epithelial Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7
4725,Epithelial Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
4726,High Mitotic Activity,small cell carcinoma of larynx
4727,Acinar Cell Differentiation,mixed acinar-endocrine carcinoma of pancreas
4728,Epithelial Component Present,Breast adenoma
4729,Myxoid Stroma Formation,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
4730,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v6 and v7
4731,Low Mitotic Activity,Esophageal Neuroendocrine Tumor
4732,Perivascular Arrangement of Tumor Cells,Childhood Kidney Angiomyolipoma
4733,Metastatic Lesion,Secondary malignant neoplasm of sternum
4734,Infiltrative Growth Pattern,Recurrent Childhood Giant Cell Glioblastoma
4735,Carcinomatous Component Present,Acinar Cell Carcinoma
4736,Nodular Pattern,Grade 3a Follicular Lymphoma
4737,Epithelial Component Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
4738,Mild cytologic atypia,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
4739,Epithelial Component Present,Transitional cell carcinoma of bladder
4740,Multifocal Lesion,Ancell-Spiegler cylindromas
4741,Epithelial Component Present,carcinoma of lacrimal gland
4742,Epithelial Component Present,Serous cystadenoma of ovary
4743,High Grade Lesion,Central Nervous System Rhabdomyosarcoma
4744,Severe cytologic atypia,Adult Pleomorphic Rhabdomyosarcoma
4745,Epithelial Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v7
4746,Primary Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v7
4747,Primary Lesion,Gastric Diffuse Large B-Cell Lymphoma
4748,Carcinomatous Component Present,Esophageal Moderately Differentiated Squamous Cell Carcinoma
4749,Cystic Change,Hidrocystoma
4750,Chromogranin A Positive Neoplastic Cells Present,Foregut Carcinoid Tumor
4751,Well-Circumscribed Lesion,Colorectal Villous Adenoma
4752,Neuroendocrine Differentiation,Pancreatic Endocrine Carcinoma
4753,Carcinomatous Component Present,Stage IIA Pancreatic Cancer AJCC v6 and v7
4754,Cartilaginous Differentiation,Secondary Central Chondrosarcoma
4755,Carcinomatous Component Present,Bile duct mucinous adenocarcinoma
4756,Squamous Differentiation,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation
4757,Osteoid formation,Ivory Exostosis
4758,Epithelial Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous"
4759,Epithelial Component Present,Stage IV Prostate Cancer AJCC v7
4760,Alopecia,Rothmund-Thomson syndrome
4761,Infiltrative Growth Pattern,Protoplasmic astrocytoma
4762,Primary Lesion,Stage III Primary Peritoneal Cancer AJCC v7
4763,Epithelial Component Present,Papillary carcinoma in situ
4764,Sarcomatous Component Present,carcinosarcoma of gallbladder
4765,High Grade Lesion,Childhood Alveolar Soft Part Sarcoma
4766,Carcinomatous Component Present,AIDS-Related Cervical Carcinoma
4767,Tubular Structures Present,Ovarian Sertoli Cell Tumor with Lipid Storage
4768,Biphasic Pattern,Juvenile fibroadenoma of breast
4769,Mesenchymal Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
4770,Carcinomatous Component Present,Small cell lung cancer recurrent
4771,Neuroendocrine Differentiation,Small cell lung cancer recurrent
4772,Multifocal Lesion,Multiple Endocrine Neoplasia Type 2b
4773,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Cortex
4774,Exophytic Papillary Lesion,verrucous carcinoma of esophagus
4775,Hyperplastic Tissue Present,Verumontanum Mucosal Gland Hyperplasia
4776,Vascular Channel Formation,Bone Epithelioid Hemangioendothelioma
4777,Epithelial Component Present,Stage III Vulvar Cancer AJCC v6
4778,Cutaneous Involvement,Kaposi's sarcoma of skin
4779,Epithelioid Component Present,"Synovial sarcoma, biphasic"
4780,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
4781,Anaplasia,Childhood Anaplastic Large Cell Lymphoma
4782,Monomorphic Cellular Infiltrate,Hard Palate Monomorphic Adenoma
4783,Myxoid Stroma Formation,Fibrous Hamartoma of Infancy
4784,Dysplasia,Low Grade Squamous Intraepithelial Neoplasia
4785,Epithelial Component Present,Pancreatic Neuroendocrine Microadenoma
4786,Multinodular Pattern,Metastatic Extraskeletal Myxoid Chondrosarcoma
4787,Vertical Growth Phase,Desmoplastic Neurotropic Melanoma
4788,Adulthood Lesion,Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma
4789,Monomorphic Cellular Infiltrate,Basaloid squamous cell carcinoma
4790,Malignant Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7
4791,Low Grade Lesion,Childhood Parosteal Osteosarcoma
4792,Trichoblastic Differentiation,Trichoepithelioma
4793,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Lipoleiomyoma
4794,Carcinomatous Component Present,Recurrent Lip and Oral Cavity Carcinoma
4795,Epithelial Component Present,Colon Carcinoma Metastatic in the Liver
4796,Papillary Pattern,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
4797,Monoclonal Paraproteinemia,Indolent multiple myeloma
4798,Epithelial Component Present,Grade II Prostatic Intraepithelial Neoplasia
4799,Plexiform Vasculature Present,Low Grade Endometrial Stromal Sarcoma
4800,Epithelial Component Present,Gallbladder papillary adenocarcinoma
4801,Cutaneous Involvement,Primary Cutaneous Hodgkin Lymphoma
4802,Carcinomatous Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma
4803,Confluent Sheets of Anaplastic T-Lymphocytes Present,Primary Cutaneous Anaplastic Large Cell Lymphoma
4804,Alternative Fascicle (Bundle) Pattern,Leiomyomatosis peritonealis disseminata
4805,Epithelial Component Present,Intraductal papillary breast neoplasm
4806,Perivascular Arrangement of Tumor Cells,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
4807,Vascular Channel Formation,hemangioendothelial sarcoma of bone
4808,Biphasic Pattern,"Phyllodes tumor, benign"
4809,Lymphoplasmacytic Infiltrate,Intracranial Germinoma
4810,Glandular Differentiation,"Carcinoid, Goblet Cell"
4811,Fibrotic Stroma Formation,Central odontogenic fibroma
4812,Epithelial Component Present,Verrucous carcinoma
4813,Hyperkeratosis,Verrucous carcinoma
4814,Multifocal Lesion,Lipomatosis of Nerve
4815,Cutaneous Involvement,Nevus spilus
4816,Epithelial Component Present,Stage 0 Oropharyngeal Carcinoma
4817,Carcinomatous Component Present,Hereditary clear cell renal cell carcinoma
4818,Non-Hereditary Lesion,Non-Hereditary Clear Cell Renal Cell Carcinoma
4819,Perivascular Pseudorosette Formation,Anaplastic Ependymoma
4820,Exophytic Papillary Lesion,Vaginal Papillary Carcinoma
4821,Carcinomatous Component Present,Papillary renal cell carcinoma type 2
4822,atypia morphology,Borderline Uterine Ligament Neoplasm
4823,Capillary Sized Vascular Channel Formation,Cardiac Capillary Hemangioma
4824,Carcinomatous Component Present,Recurrent Parathyroid Gland Carcinoma
4825,Necrotic changes (finding),Combined Lung Small Cell and Squamous Cell Carcinoma
4826,Cutaneous Involvement,Skin appendage adenoma
4827,Indolent Clinical Course,Leiomyomatosis
4828,Mixed Cellular Population,Hard Palate Pleomorphic Adenoma
4829,Perivascular Arrangement of Tumor Cells,Angiomyolipoma of kidney
4830,Rapidly Enlarging Mass,Alveolar rhabdomyosarcoma
4831,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
4832,Cartilaginous Component Present,Endobronchial Hamartoma
4833,Epithelial Component Present,Ovarian Endometrioid Cystadenofibroma
4834,Carcinomatous Component Present,Recurrent Digestive System Carcinoma
4835,Biphasic Pattern,Borderline Ovarian Endometrioid Cystadenofibroma
4836,Metastatic Lesion,Fibrosarcoma metastatic
4837,Epithelial Component Present,Recurrent Merkel Cell Carcinoma
4838,Childhood Lesion,Stage III Childhood Non-Hodgkin Lymphoma
4839,Epithelial Component Present,ductal papilloma of salivary gland
4840,Epithelial Component Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma
4841,Osseous Differentiation,Duodenal Extraskeletal Osteosarcoma
4842,Carcinomatous Component Present,Renal cell carcinoma recurrent
4843,Cutaneous Involvement,Nevus of eyelid
4844,Well-Circumscribed Lesion,Sporadic Thyroid Gland Medullary Carcinoma
4845,Storiform Growth Pattern,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
4846,Recurrent disease,Recurrent Indolent Adult Non-Hodgkin Lymphoma
4847,Serotonin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
4848,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v7
4849,Nuclear Atypia,Anaplastic astrocytoma
4850,Epithelial Component Present,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
4851,Thin Bands of Collagen Present,Pericardial Solitary Fibrous Tumor
4852,Epithelial Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
4853,Chromogranin A Positive Neoplastic Cells Present,Metastatic carcinoid tumor
4854,Papillary Pattern,Fallopian Tube Papillary Adenocarcinoma
4855,Immunologic Deficiency Syndromes,Intestinal Graft Versus Host Disease
4856,Cutaneous Involvement,"Xeroderma pigmentosum, group G"
4857,Adulthood Lesion,Adult Acute Promyelocytic Leukemia with PML-RARA
4858,Microcystic Change,Lymphangioma circumscriptum
4859,Carcinomatous Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
4860,Secondary Lesion,"Glioblastoma, IDH-Mutant"
4861,Cutaneous Involvement,Vulvar Merkel Cell Carcinoma
4862,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
4863,Carcinomatous Component Present,Uterine Ligament Endometrioid Adenocarcinoma
4864,Exophytic Polypoid Lesion,Colorectal Filiform Serrated Adenoma
4865,Papillary Pattern,Buschke-Lowenstein Tumor
4866,Carcinomatous Component Present,Adenocarcinoma
4867,Necrotic changes (finding),Cerebral Glioblastoma
4868,Refractory Disease,Refractory Adult Spinal Cord Neoplasm
4869,Epithelial Component Present,Uterine Ligament Clear Cell Adenocarcinoma
4870,Carcinomatous Component Present,Stage II Skin Cancer
4871,Cutaneous Involvement,Keloid
4872,Carcinomatous Component Present,Carcinoma of ampulla of Vater
4873,VIP Positive Neoplastic Cells Present,Malignant Pancreatic Vipoma
4874,Absence of Invasion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
4875,Cutaneous Involvement,Plantar Verrucous Skin Carcinoma
4876,Carcinomatous Component Present,Plantar Verrucous Skin Carcinoma
4877,Tissue of Mullerian Origin Present,Uterine Corpus Carcinosarcoma
4878,Solid Growth Pattern,Pleuropulmonary blastoma type III
4879,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II
4880,Epithelial Component Present,Corneal intraepithelial neoplasia
4881,Infiltrative Growth Pattern,Adult Brain Stem Gliosarcoma
4882,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma recurrent
4883,Neuroectodermal Differentiation,Differentiating Neuroblastoma
4884,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid carcinoma ovary
4885,Epithelial Component Present,Pleomorphic Hepatocellular Carcinoma
4886,Carcinomatous Component Present,Childhood Choroid Plexus Carcinoma
4887,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage I
4888,Tissue Differentiation Uncertain,"Histiocytoma, Angiomatoid Fibrous"
4889,Epithelial Component Present,Adenoid cystic carcinoma of lacrimal gland
4890,Epithelial Component Present,FIGO Stage III Ovarian Cancer
4891,Epithelial Component Present,Ovarian Surface Papilloma
4892,Carcinomatous Component Present,Adenocarcinoma in situ in adenomatous polyp
4893,Nuclear pleomorphism,Fibromyxosarcoma
4894,Adulthood Lesion,Adult Yolk Sac Tumor
4895,Diffuse Pattern,Thyroid Diffuse Large B-Cell Lymphoma
4896,Tissue Differentiation Uncertain,synovial sarcoma
4897,Epithelial Component Present,Rectal Traditional Serrated Adenoma
4898,Carcinomatous Component Present,Penis carcinoma
4899,Wide Vessel-Like Spaces Formation,Giant Cell Fibroblastoma
4900,Epithelial Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
4901,Severe cytologic atypia,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
4902,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Pseudoglandular Variant"
4903,Epithelial Component Present,Malignant Ovarian Transitional Cell Tumor
4904,Drug toxicity,Kaposi Sarcoma Related to Immunosuppressive Treatment
4905,Tissue Differentiation Uncertain,"Phosphaturic mesenchymal tumor, benign"
4906,Epithelial Component Present,Stage IVB Colorectal Cancer AJCC v7
4907,Adulthood Lesion,Stage II Adult Immunoblastic Lymphoma
4908,Recurrent disease,Recurrent ovarian cancer
4909,Necrotic changes (finding),Pancreatic Small Cell Neuroendocrine Carcinoma
4910,Koilocytotic atypia,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
4911,Low Mitotic Activity,Descending Colon Neuroendocrine Tumor G1
4912,Epithelial Component Present,Cholangiocarcinoma
4913,Carcinomatous Component Present,Liver carcinoma
4914,Well-Circumscribed Lesion,Cystadenoma
4915,Indolent Clinical Course,Hemangioma acquired
4916,Secondary Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
4917,Epithelial Component Present,Urethral Verrucous Carcinoma
4918,Epithelial Component Present,Borderline Ovarian Clear Cell Cystadenofibroma
4919,Cutaneous Involvement,Stage IIIB Merkel Cell Carcinoma AJCC v7
4920,Invasive Lesion,Ampulla of Vater Invasive Papillary Adenocarcinoma
4921,Composite Lesion,"Ganglioneuroblastoma, Nodular"
4922,Well-Circumscribed Lesion,Anal Inflammatory Cloacogenic Polyp
4923,Lesion Less than 10mm in Diameter,Sporadic Thyroid Gland Micromedullary Carcinoma
4924,Vascular Channel Formation,Thyroid Angiosarcoma
4925,Cold Nodule,Thyroid Angiosarcoma
4926,Multilocular Lesion,Juvenile Type Testicular Granulosa Cell Tumor
4927,Epithelial Component Present,Acinic cell carcinoma of salivary gland
4928,Well Differentiated Lesion,Lower Gingival Verrucous Carcinoma
4929,Carcinomatous Component Present,"Squamous Cell Carcinoma of the Penis, Usual Type"
4930,Cystic Change,Low Grade Salivary Gland Mucoepidermoid Carcinoma
4931,Childhood Lesion,Benign Childhood Central Nervous System Neoplasm
4932,Carcinomatous Component Present,Bladder transitional cell carcinoma stage II
4933,Epithelial Component Present,Submucosal Invasive Colon Adenocarcinoma
4934,Adnexal Differentiation,Benign Outer Hair Sheath and Infundibulum Neoplasm
4935,Indolent Clinical Course,Angiomatosis
4936,Epithelial Component Present,Thyroid Gland Mucoepidermoid Carcinoma
4937,Cutaneous Involvement,Stage IA Merkel Cell Carcinoma AJCC v7
4938,Mitotic Activity,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
4939,Multinodular Mass,Cervical Angiosarcoma
4940,Lymphoplasmacytic Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
4941,Peau d'orange surface of breast,Inflammatory carcinoma of breast recurrent
4942,Epithelial Component Present,Squamous cell carcinoma of esophagus
4943,Hyperkeratosis,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
4944,Childhood Lesion,Recurrent Childhood Medulloblastoma
4945,atypia morphology,Grade III Lymphomatoid Granulomatosis
4946,Osteoid formation,Secondary osteosarcoma
4947,Secondary Lesion,Metastatic Childhood Soft Tissue Sarcoma
4948,Secondary Lesion,Metastatic melanoma
4949,Well-Circumscribed Lesion,Colorectal Microvesicular Hyperplastic Polyp
4950,Hemorrhagic,Ovarian Angiosarcoma
4951,Carcinomatous Component Present,Stage 0 Eyelid Carcinoma AJCC v7
4952,Epithelial Component Present,Colorectal Tubulovillous Adenoma
4953,Carcinomatous Component Present,Oncocytic Breast Carcinoma
4954,Nuclear Molding,Stage IA Lung Small Cell Carcinoma AJCC v7
4955,Carcinomatous Component Present,Stage IIA Small Intestinal Cancer AJCC v7
4956,Cartilaginous Differentiation,Sternal Chondromyxoid Fibroma
4957,Recurrent disease,Recurrent Rhabdomyosarcoma
4958,Carcinomatous Component Present,Laryngeal Giant Cell Carcinoma
4959,Vascular Channel Formation,Chondroblastic osteosarcoma
4960,Severe dysplasia,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia
4961,Peripheral Nuclear Palisading,Stage II Lung Small Cell Carcinoma AJCC v7
4962,Myxoid Stroma Formation,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
4963,Cutaneous Involvement,"Dermatitis, Occupational"
4964,Lymphoplasmacytic Infiltrate,Germinoma
4965,Epithelial Component Present,Carcinoma in a polyp
4966,Epithelial Component Present,Transplant-Related Hepatocellular Carcinoma
4967,Exophytic Polypoid Lesion,Adenoma of small intestine
4968,Carcinomatous Component Present,"Transitional cell carcinoma, spindle cell"
4969,Ground Glass Nuclear Inclusion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
4970,Carcinomatous Component Present,Tonsillar Carcinoma
4971,Carcinomatous Component Present,adenocarcinoma of epididymis
4972,Carcinomatous Component Present,Ocular Sebaceous Carcinoma
4973,Carcinomatous Component Present,Stage I Esophageal Adenocarcinoma AJCC v7
4974,Papillary Pattern,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
4975,Carcinomatous Component Present,"Lung Squamous Cell Carcinoma, Clear Cell Variant"
4976,Epithelial Component Present,Stage II Lip Basal Cell Carcinoma
4977,Carcinomatous Component Present,Intraductal Non-Comedo Breast Adenocarcinoma
4978,Carcinomatous Component Present,Intraductal Cribriform Breast Adenocarcinoma
4979,Carcinomatous Component Present,Primary Prostate Urothelial Carcinoma
4980,Carcinomatous Component Present,Minor Salivary Gland Acinic Cell Carcinoma
4981,Carcinomatous Component Present,Adrenal Cortex Carcinoma by ENSAT Stage
4982,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
4983,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
4984,Pushing Tumor Margin,verrucous carcinoma of vulva
4985,Tissue Differentiation Uncertain,Clear-Cell Myomelanocytic Tumors
4986,Superficial Lesion,Vulvar Superficial Angiomyxoma
4987,Epithelial Component Present,Stage 0 Pharynx Carcinoma
4988,Tubular Pattern,tubulovillous adenoma of stomach
4989,Epithelial Component Present,Carcinoma in Situ
4990,atypia morphology,Atypical hyperplasia
4991,Metaplasia,Urinary Bladder Nephrogenic Adenoma
4992,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma
4993,Diffuse Pattern,Plasmablastic Lymphoma of Mucosa Site
4994,Epithelial Component Present,"Acanthoma, Clear Cell"
4995,Monoclonal Paraproteinemia,Smoldering myeloma
4996,Epithelial Component Present,Laryngeal Adenosquamous Carcinoma
4997,Tissue Differentiation Uncertain,"Sarcoma, Epithelioid"
4998,Cutaneous Involvement,Junctional Epidermolysis Bullosa
4999,Carcinomatous Component Present,Ovarian Cancer by AJCC v6 and v7 Stage
5000,High Mitotic Activity,Ovarian Embryonal Carcinoma
5001,Anaplasia,Glioblastoma with Primitive Neuronal Component
5002,Recurrent Malignant Neoplasm,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5003,Cutaneous Involvement,Benign Hair Follicle Neoplasm
5004,Well-Circumscribed Lesion,Stage IV Kidney Wilms Tumor
5005,No Evidence of Metastatic Disease,Chondroblastoma
5006,Epithelial Component Present,Classic Type Trichilemmoma
5007,Dysplasia,Appendix Tubular Adenoma
5008,Cutaneous Involvement,Stage I Lentigo Maligna Melanoma AJCC v7
5009,Absence of Invasion,Carcinoma in situ of small intestine
5010,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1
5011,Epithelial Component Present,Laryngeal Carcinoid Tumor
5012,Recurrent Genetic Abnormalities Present,Acute promyelocytic leukemia - hypogranular variant
5013,Epithelial Component Present,Thymic Atypical Carcinoid Tumor
5014,Vascular Channel Formation,Breast Angiomatosis
5015,Recurrent disease,Recurrent Childhood Brain Stem Glioma
5016,Papillary Pattern,Cervical Squamous Papilloma
5017,Rapidly Enlarging Mass,Anaplastic Embryonal Rhabdomyosarcoma
5018,Nuclear pleomorphism,Anaplastic Embryonal Rhabdomyosarcoma
5019,Tissue Differentiation Uncertain,Childhood Clear Cell Sarcoma of Soft Parts
5020,Villous Pattern,Vaginal Tubulovillous Adenoma
5021,Endophytic Tumor Growth,Inverted papilloma of urinary bladder
5022,Infiltrative Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma
5023,Infiltrative Growth Pattern,Adult Giant Cell Glioblastoma
5024,Pushing Tumor Margin,Anal Verrucous Carcinoma
5025,Secondary Lesion,Secondary malignant neoplasm of sternum
5026,Cystic Change,"Cystadenocarcinoma, Papillary"
5027,Epithelial Component Present,signet ring cell carcinoma of pancreas
5028,Papillary Pattern,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
5029,Well Differentiated Lesion,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
5030,Tissue Differentiation Uncertain,Intracranial Extraskeletal Myxoid Chondrosarcoma
5031,Cutaneous Involvement,Recurrent Skin Carcinoma
5032,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Sarcoma
5033,Primary Lesion,Primary cutaneous CD30+ T-cell lymphoproliferative disorder
5034,Hereditary Lesion,Hereditary Prostate Carcinoma
5035,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage I
5036,Cutaneous Involvement,Vaginal Blue Nevus
5037,Rarely Metastasizing Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma
5038,Lepidic Growth Pattern,Minimally Invasive Mucinous Lung Adenocarcinoma
5039,Indolent Clinical Course,Osteochondromatosis
5040,Cutaneous Involvement,Tumor of dermis
5041,Cartilaginous Differentiation,Chondromyxoid fibroma
5042,Necrotic changes (finding),Glandular malignant peripheral nerve sheath tumor
5043,Tubular Pattern,Tubulovillous adenoma of rectum
5044,Multifocal Lesion,Glomangiomatosis
5045,Epithelial Component Present,Rectal Adenoma with Severe Dysplasia
5046,Slow Growing Mass,Dedifferentiated chordoma
5047,Glial Differentiation,Desmoplastic infantile ganglioglioma
5048,Vascular proliferation,Uterine Corpus Dissecting Leiomyoma
5049,Meckel Diverticulum,Meckel Diverticulum Neuroendocrine Tumor G1
5050,Multinodular Mass,Small Intestinal Angiosarcoma
5051,Epithelial Component Present,Adenoma of middle ear
5052,Severe dysplasia,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
5053,Metaplasia of Malignant Cells Present,Breast Carcinoma with Osseous Metaplasia
5054,Epithelial Component Present,Early Hepatocellular Carcinoma
5055,Increased Cellularity Present,Cellular Congenital Mesoblastic Nephroma
5056,Dysplasia,Mild esophageal dysplasia
5057,Mixed Cellular Population,Intraductal carcinoma and lobular carcinoma in situ
5058,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage II
5059,Carcinomatous Component Present,Adenosquamous cell lung cancer recurrent
5060,Syncytial Pattern,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
5061,Cold Nodule,Thyroid Hyalinizing Trabecular Adenoma
5062,Exophytic Polypoid Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma
5063,Carcinomatous Component Present,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
5064,Epithelial Component Present,papillary adenoma of extrahepatic bile duct
5065,Sarcomatous or Carcinomatous Component Present,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy
5066,Prominent Keratin Formation,Basal cell carcinoma - keratotic
5067,Smooth Muscle Component Present,Lymphangioleiomyomatosis
5068,Aggressive Clinical Course,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
5069,Alternative Fascicle (Bundle) Pattern,Urethral Leiomyoma
5070,Carcinomatous Component Present,"Papillary squamous cell carcinoma, non-invasive"
5071,Diffuse Pattern,Mixed Oligodendroglioma-Astrocytoma
5072,Epithelial Component Present,Papillary mucinous cystadenocarcinoma
5073,Collagenous Stroma Formation,Pelvic Fibromatosis
5074,Angiodestructive Pattern,Childhood Lymphomatoid Granulomatosis
5075,Hereditary Lesion,Wiskott-Aldrich Syndrome
5076,Epithelial Component Present,Maxillary Sinus Inverted Papilloma
5077,Carcinomatous Component Present,Keratinizing Head and Neck Squamous Cell Carcinoma
5078,Monophasic Pattern,"Synovial sarcoma, spindle cell"
5079,Epithelial Component Present,adenocarcinoma of oral cavity
5080,Epithelial Component Present,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
5081,Carcinomatous Component Present,Laryngeal Adenoid Cystic Carcinoma
5082,Metastatic Lesion,Meningeal Carcinomatosis
5083,Epithelial Component Present,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
5084,Plasma cell inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor
5085,Mesenchymal Differentiation,Metaplastic meningioma
5086,atypia morphology,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
5087,Mitotic Activity,Recurrent Childhood Pilomyxoid Astrocytoma
5088,Plexiform Vasculature Present,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
5089,Glandular Pattern,Gastric Mixed Adenocarcinoma
5090,Absence of a Hormonal Syndrome,Non functioning pancreatic endocrine tumor
5091,Increased Cellularity Present,Recurrent Olfactory Neuroblastoma
5092,Dysplasia,"Glandular intraepithelial neoplasia, low grade"
5093,Borderline Lesion,Borderline Fallopian Tube Endometrioid Tumor
5094,High Grade Lesion,Primary Peritoneal High Grade Serous Adenocarcinoma
5095,Pagetoid Proliferation,Stage II Superficial Spreading Melanoma AJCC v6 and v7
5096,Radial Growth Phase,Stage II Superficial Spreading Melanoma AJCC v6 and v7
5097,Dysplasia,Gastric dysplasia
5098,Epithelial Component Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
5099,Acanthosis,Verrucous carcinoma of the oral cavity recurrent
5100,Adulthood Lesion,Adult Hodgkin Lymphoma
5101,Severe cytologic atypia,large cell neuroendocrine carcinoma of extrahepatic bile duct
5102,Papillary Pattern,Gallbladder papillary adenocarcinoma
5103,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant"
5104,Well-Circumscribed Lesion,Central Nervous System Chondroma
5105,Follicular Cell Differentiation,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
5106,Well-Circumscribed Lesion,estrogen-producing adrenal cortical adenoma
5107,Local disease,Oral Cavity Lipoma
5108,Swelling,Malignant Giant Cell Tumor of Bone
5109,Nodular Pattern,Follicular T-cell lymphoma
5110,Birbeck Granules Present,Eosinophilic Granuloma
5111,Dysplasia,Colon Adenoma with Severe Dysplasia
5112,Indolent Clinical Course,Pleomorphic hyalinizing angiectatic tumor of soft tissue
5113,Cutaneous Involvement,Stage III Cutaneous Melanoma AJCC v7
5114,Carcinomatous Component Present,Adenocarcinoma of duodenum
5115,Cutaneous Involvement,Lichen Planus
5116,Fibrotic Stroma Formation,Peripheral Odontogenic Fibroma
5117,Carcinomatous Component Present,Occult Lung Carcinoma
5118,Systemic disease,Systemic Anaplastic Large Cell Lymphoma
5119,Epithelial Component Present,Stage IV Distal Bile Duct Cancer AJCC v7
5120,Immunologic Deficiency Syndromes,Engraftment syndrome
5121,Aggressive Clinical Course,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM"
5122,Cutaneous Involvement,Unna-Thost Syndrome
5123,Carcinomatous Component Present,Adult Cholangiocarcinoma
5124,"Amorphus, Eosinophilic, and Acellular Deposit",Calcifying Epithelial Odontogenic Tumor
5125,Metastatic Lesion,Disseminated adenocarcinoma
5126,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Mixed phenotype acute leukemia B/myeloid
5127,Carcinomatous Component Present,Anterior Tongue Adenoid Cystic Carcinoma
5128,Invasive Lesion,Grade 3 Invasive Breast Carcinoma
5129,Carcinomatous Component Present,Grade 3 Invasive Breast Carcinoma
5130,Epithelial Component Present,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
5131,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Mixed phenotype acute leukemia T/myeloid
5132,Epithelial Component Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
5133,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Vulvar Dysplastic Melanocytic Nevus
5134,Carcinomatous Component Present,Stage III Esophageal Cancer
5135,Childhood Lesion,Childhood Atypical Teratoid/Rhabdoid Tumor
5136,Rapidly Enlarging Mass,Embryonal Rhabdomyosarcoma
5137,Papillary Pattern,Renal papillary adenoma
5138,Carcinomatous Component Present,Stage IA Distal Bile Duct Cancer AJCC v7
5139,Absence of Stromal Invasion,Benign Brenner Tumor
5140,Well-Circumscribed Lesion,Benign Brenner Tumor
5141,Tissue Differentiation Uncertain,Liver Synovial Sarcoma
5142,Epithelial Component Present,Squamous cell carcinoma of skin
5143,Carcinomatous Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
5144,Stromal Invasion,Stage IA Ovarian Cancer
5145,Recurrent disease,Recurrent Urinary System Carcinoma
5146,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v7
5147,Pushing Tumor Margin,Benign phyllodes neoplasm of breast
5148,Childhood Lesion,Childhood Brain Stem Astrocytoma
5149,In Situ Lesion,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
5150,Myomatous Stroma Formation,Cervical Adenomyoma
5151,Epithelial Component Present,Stage IIB Ovarian Cancer AJCC v6 and v7
5152,Carcinomatous Component Present,Hepatic cancer stage IVA
5153,Islands of Odontogenic Epithelium Present,Basal Cell Ameloblastoma
5154,Endometrial Type Glands and Stroma Present,"Cervical Adenomyoma, Endometrial Type"
5155,Fibrotic Stroma Formation,Cystadenofibroma
5156,Pseudorosette Formation,Gastric Gastrin-Producing Neuroendocrine Tumor
5157,Complex Glandular Pattern,Cervical Atypical Polypoid Adenomyoma
5158,Myomatous Stroma Formation,Cervical Atypical Polypoid Adenomyoma
5159,Pregnancy Complications,Remote Placental Infarction
5160,Mitotic Activity,"Anaplastic Astrocytoma, IDH-Mutant"
5161,Primary Lesion,Liposarcoma non-metastatic
5162,Mitotic Activity,Anaplastic astrocytoma
5163,Epithelial Component Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
5164,Biphasic Pattern,Fallopian Tube Adenosarcoma
5165,Radiation Sickness,"Neoplasms, Radiation-Induced"
5166,Epithelial Component Present,Breast Carcinoma with Osteoclastic Giant Cells
5167,Carcinomatous Component Present,Stage II Anal Canal Cancer AJCC v6 and v7
5168,Epithelial Component Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified"
5169,Exophytic Papillary Lesion,keratoacanthoma
5170,Carcinomatous Component Present,Stage IV Renal Cell Cancer
5171,Sarcomatous Component Present,Carcinosarcoma
5172,Carcinomatous Component Present,Colon Small Cell Neuroendocrine Carcinoma
5173,Epithelial Component Present,Stage 0 Gastric Cancer AJCC v6 and v7
5174,Epithelial Component Present,Recurrent Carcinoma of Unknown Primary
5175,Carcinomatous Component Present,Supraglottic Verrucous Carcinoma
5176,Neuropil Present,Differentiating Neuroblastoma
5177,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
5178,Carcinomatous Component Present,Polymorphous low grade adenocarcinoma of salivary gland
5179,Carcinomatous Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8"
5180,Epithelial Component Present,Stage I Hypopharyngeal Carcinoma AJCC v7
5181,In Situ Lesion,Stage 0 Vulvar Cancer
5182,Carcinomatous Component Present,FIGO Stage III Ovarian Cancer
5183,Indolent Clinical Course,Perineural Hemangioma
5184,Carcinomatous Component Present,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
5185,Pseudopapillary Pattern,Childhood Embryonal Carcinoma
5186,Nuclear Atypia,Adult Brain Glioblastoma
5187,Epithelial Component Present,squamous cell carcinoma of salivary gland
5188,Refractory Disease,Angiocentric lymphoma refractory
5189,No Evidence of Metastatic Disease,Non-Metastatic Childhood Soft Tissue Sarcoma
5190,Epithelial Component Present,Trichilemmocarcinoma
5191,Trabecular Pattern,Duodenal Somatostatin-Producing Neuroendocrine Tumor
5192,Epithelial Component Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor
5193,Anaplasia,Cerebellar Glioblastoma
5194,Nuclear Atypia,Cerebellar Glioblastoma
5195,Tissue of Mullerian Origin Present,mucinous adenocarcinofibroma of ovary
5196,Epithelial Component Present,Vulvar Clear Cell Hidradenocarcinoma
5197,Well-Circumscribed Lesion,Vaginal Angiomyofibroblastoma
5198,Carcinomatous Component Present,Acantholytic squamous cell carcinoma
5199,Epithelial Component Present,Epithelial neoplasm of skin
5200,Syncytial Pattern,Lymphoepithelial malignant thymoma
5201,Thick-Walled Hyalinized Vessels Present,Schwannoma of the Twelfth Cranial Nerve
5202,Cellular Pleomorphism,Malignant Fibrous Histiocytoma
5203,Carcinomatous Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
5204,Epithelial Component Present,Urethral Villous Adenoma
5205,Carcinomatous Component Present,Childhood Gastric Carcinoma
5206,High Mitotic Activity,Stage IIIA Merkel Cell Carcinoma AJCC v7
5207,Indolent Clinical Course,Deep Hemangioma
5208,Carcinomatous Component Present,Squamous cell carcinoma of trachea
5209,Epithelial Component Present,Metastatic Penile Cancer
5210,Hemorrhagic,Pulmonary Artery Angiosarcoma
5211,Marked Nuclear Atypia Present,"Perivascular epithelioid tumor, malignant"
5212,Cutaneous Involvement,Malignant eccrine spiradenoma
5213,Epithelial Component Present,Grade 2 Endometrial Endometrioid Adenocarcinoma
5214,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v6 Stage
5215,Carcinomatous Component Present,Skin Squamous Cell Carcinoma In Situ
5216,Vascular Channel Formation,Cervical Angiosarcoma
5217,Invasive Lesion,Inflammatory carcinoma of breast recurrent
5218,Metastatic Lesion,Secondary malignant neoplasm of pericardium
5219,atypia morphology,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor
5220,Cutaneous Involvement,Parapsoriasis en Plaques
5221,Metastatic Lesion,Secondary malignant neoplasm of trachea
5222,Neuroectodermal Differentiation,Neuroblastic tumors
5223,Mitotic Activity,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7
5224,Favorable Clinical Outcome,Hepatocellular Adenoma
5225,Chronic Inflammatory Infiltrate,Recurrent Lymphomatoid Granulomatosis
5226,Angiodestructive Pattern,Recurrent Lymphomatoid Granulomatosis
5227,Bilateral Mass,Contralateral Breast Carcinoma
5228,Metastatic Lesion,Metastatic Childhood Soft Tissue Sarcoma
5229,Epithelial Component Present,Cervical Adenocarcinoma
5230,Nuclear pleomorphism,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
5231,Absence of Invasion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
5232,Neuroendocrine Differentiation,Cervical Neuroendocrine Neoplasm
5233,Severe cytologic atypia,Gastroesophageal Junction Neuroendocrine Carcinoma
5234,Mixed Cellular Population,Infiltrating duct and lobular carcinoma
5235,Encapsulated Mass,Thyroid Gland Mucinous Follicular Adenoma
5236,Metastatic Lesion,Secondary malignant neoplasm of ovary
5237,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma
5238,Necrotic changes (finding),Metastatic Malignant Peripheral Nerve Sheath Tumor
5239,Invasive Lesion,"Glycogen-Rich, Clear Cell Breast Carcinoma"
5240,Epithelial Component Present,Thymoma malignant invasive
5241,Secondary Lesion,Secondary malignant neoplasm of stomach
5242,Exophytic Polypoid Lesion,Skin tag
5243,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
5244,Exophytic Polypoid Lesion,Colon adenoma
5245,Epithelial Component Present,villous adenoma of stomach
5246,Absence of Invasion,Carcinoma in situ of fallopian tube
5247,Epithelial Component Present,atypical medullary carcinoma of breast
5248,Carcinomatous Component Present,basal cell carcinoma of scrotum
5249,Nodular lesions,Thyroid Nodule
5250,Hereditary Lesion,Hereditary Ovarian Carcinoma
5251,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
5252,High Mitotic Activity,Stage II Lung Small Cell Carcinoma AJCC v7
5253,Dysplasia,Stage 0 Esophageal Cancer AJCC v6
5254,Peripheral Nuclear Palisading,Stage III Lung Small Cell Carcinoma AJCC v7
5255,Severe cytologic atypia,Gallbladder Neuroendocrine Carcinoma
5256,Carcinomatous Component Present,Stage IIIA Hepatocellular Carcinoma AJCC v7
5257,Epithelial Component Present,Rectal Small Cell Neuroendocrine Carcinoma
5258,Epithelial Component Present,Adenoma of small intestine
5259,Intraductal Lesion,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia
5260,Peripheral Nuclear Palisading,Basaloid carcinoma
5261,Epithelial Component Present,Intraductal papillary neoplasm with high grade intraepithelial neoplasia
5262,Intraductal Lesion,solid type ductal carcinoma in situ of breast
5263,Carcinomatous Component Present,"Adenocarcinoma, metastatic"
5264,Childhood Lesion,Childhood Glioblastoma
5265,Intravascular papillary endothelial hyperplasia,Endovascular papillary angioendothelioma
5266,Mitotic Activity,High Grade Ductal Breast Carcinoma In Situ
5267,Epithelial Component Present,Paget Disease of the Scrotum
5268,Absence of Invasion,Intraductal Cribriform Breast Adenocarcinoma
5269,High Mitotic Activity,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
5270,Osteoid formation,Kidney Extraskeletal Osteosarcoma
5271,Epithelial Component Present,Squamous Cell Carcinoma of Anal Margin
5272,Carcinomatous Component Present,verrucous carcinoma of vulva
5273,Epithelial Component Present,"Cystadenocarcinoma, Serous"
5274,Diffuse Pattern,Stage II Diffuse Large B-Cell Lymphoma
5275,Therapy-Related Toxicity,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
5276,Epithelial Component Present,Recurrent Head and Neck Carcinoma
5277,Vascular Channel Formation,Hemangioma of retina
5278,Indolent Clinical Course,Hemangioma of orbit
5279,Epithelial Component Present,Hidradenoma Papilliferum
5280,Epithelial Component Present,Bladder Diffuse Clear Cell Adenocarcinoma
5281,Diffuse Pattern,Bladder Diffuse Clear Cell Adenocarcinoma
5282,Invasive Lesion,Invasive Apocrine Breast Carcinoma
5283,Hereditary Lesion,X-linked agammaglobulinemia
5284,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Adult Erythroleukemia
5285,High Grade Lesion,Osteosarcoma Arising in Paget Disease of Bone
5286,Germinal Centers with Prominent Hyalinized Vessels Present,"Castleman Disease, Hyaline-Vascular Type"
5287,Cellular Stratification,Borderline Ovarian Mucinous Tumor
5288,Borderline Lesion,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
5289,Biphasic Pattern,Breast Phyllodes Tumor
5290,Epithelial Component Present,Breast Phyllodes Tumor
5291,Papillary Pattern,Serous papillary cystic tumor of borderline malignancy
5292,Epithelial Component Present,Infiltrating duct and lobular carcinoma
5293,Cutaneous Involvement,Hemangioma of skin
5294,In Situ Lesion,Stage 0 Esophageal Adenocarcinoma AJCC v7
5295,Metastatic Lesion,Endometrioid adenocarcinoma metastatic
5296,Glandular Pattern,Somatostatinoma
5297,Chronic Inflammatory Infiltrate,Lymphomatoid Granulomatosis
5298,Acanthosis,Condyloma acuminata of cervix
5299,High Grade Lesion,Childhood Embryonal Rhabdomyosarcoma
5300,Varicosity,Phlebitis
5301,Childhood Lesion,Childhood Protoplasmic Astrocytoma
5302,atypia morphology,Liver Dysplastic Nodule
5303,Anaplasia,Adult Glioblastoma
5304,Epithelial Component Present,Neuroendocrine neoplasm of larynx
5305,Epithelial Component Present,Schneiderian papilloma
5306,Neuroendocrine Differentiation,Atypical carcinoid tumor
5307,Cutaneous Involvement,Malignant Eccrine Neoplasm
5308,Neuroendocrine Differentiation,Laryngeal Carcinoid Tumor
5309,Epithelial Component Present,"Glandular intraepithelial neoplasia, grade III"
5310,Polyclonal hypergammaglobulinemia,Sinus histiocytosis
5311,Hemorrhagic,Adult Angiosarcoma
5312,Severe cytologic atypia,Pleomorphic Rhabdomyosarcoma
5313,Epithelial Component Present,Inverted papilloma of urinary bladder
5314,Carcinomatous Component Present,HER2-positive carcinoma of breast
5315,Neuroendocrine Differentiation,"Carcinoma, Neuroendocrine"
5316,Childhood Lesion,Childhood Cerebellar Anaplastic Astrocytoma
5317,Carcinomatous Component Present,Cervical Clear Cell Adenocarcinoma
5318,Lipomatous Component Present,Childhood Kidney Angiomyolipoma
5319,Adulthood Lesion,Adult Gliosarcoma
5320,Anaplasia,Adult Gliosarcoma
5321,Adulthood Lesion,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified"
5322,Well-Circumscribed Lesion,Breast Ductal Adenoma
5323,Absence of Invasion,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8"
5324,Epithelial Component Present,Metastatic Jugulotympanic Paraganglioma
5325,Systemic disease,Primary Systemic Amyloidosis
5326,Carcinomatous Component Present,BCLC Stage B Adult Hepatocellular Carcinoma
5327,Papillary Pattern,Peripheral Breast Papilloma
5328,Anaplasia,Recurrent Childhood Giant Cell Glioblastoma
5329,Epithelial Component Present,Adenocarcinoma of anal canal
5330,Infiltrative Growth Pattern,Recurrent Childhood Glioblastoma
5331,Monomorphic Cellular Infiltrate,Well Differentiated Oligodendroglioma
5332,Epithelial Component Present,Adenocarcinoma in adenomatous polyposis coli
5333,Epithelial Component Present,Squamous cell carcinoma of the parotid gland
5334,Epithelial Component Present,Ovarian Transitional Cell Carcinoma
5335,Adnexal Differentiation,Ancell-Spiegler cylindromas
5336,Epithelial Component Present,Occult Lung Non-Small Cell Carcinoma
5337,Mesenchymal Component Present,Eccrine mixed tumor of skin
5338,Exophytic Polypoid Lesion,Colorectal Villous Adenoma
5339,Anaplasia,Skin Sarcomatoid Basal Cell Carcinoma
5340,Chronic lymphocytic inflammation,Nonencapsulated sclerosing tumor
5341,Ground Glass Nuclear Inclusion,Papillary thyroid carcinoma
5342,Epithelial Component Present,Squamous Lung Dysplasia
5343,Hyaline Cartilage Differentiation,Enchondroma
5344,Metastatic Lesion,Metastatic Bone Ewing Sarcoma
5345,High Mitotic Activity,Cervical Large Cell Neuroendocrine Carcinoma
5346,Childhood Lesion,Cellular Congenital Mesoblastic Nephroma
5347,Carcinomatous Component Present,Basal cell carcinoma - follicular
5348,Childhood Lesion,Recurrent Childhood Visual Pathway Astrocytoma
5349,Papillary Pattern,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
5350,Carcinomatous Component Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
5351,Carcinomatous Component Present,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
5352,Dysplasia,papillary adenoma of extrahepatic bile duct
5353,Carcinomatous Component Present,adenocarcinoma of middle ear
5354,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma
5355,Mitotic Activity,Cervical Yolk Sac Tumor
5356,Carcinomatous Component Present,Stage IIIB Gastric Carcinoma
5357,Epithelial Component Present,Pre-Malignant Skin Epithelial Lesion
5358,Infantile Lesion,Infant Acute Lymphoblastic Leukemia
5359,Radiation Sickness,Ionizing Radiation-Related Malignant Neoplasm
5360,Ionizing Radiation Toxicity,Ionizing Radiation-Related Malignant Neoplasm
5361,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia
5362,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis
5363,Extracutaneous Dissemination of Disease,Mycosis fungoides stage III
5364,Plasma cell inflammation,Abdominal Inflammatory Myofibroblastic Tumor
5365,Epithelial Component Present,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
5366,High Grade Lesion,Small cell lung cancer recurrent
5367,Mesenchymal Differentiation,Stromal Predominant Kidney Wilms Tumor
5368,Lytic lesion,Osteolytic Neoplasm
5369,Metastatic Lesion,Stage IV Major Salivary Gland Carcinoma with Metastasis
5370,Childhood Lesion,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
5371,Neuroendocrine Differentiation,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
5372,Epithelial Component Present,Laryngeal Mucoepidermoid Carcinoma
5373,Defective Heavy Chain Present,Heavy Chain Disease
5374,Epithelial Component Present,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant"
5375,Extraosseous Lesion,Extra-osseous Ewing's sarcoma recurrent
5376,Epithelial Component Present,Hard Palate Monomorphic Adenoma
5377,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor G1
5378,Infiltrating Tumor Margins Present,Low Grade Endometrioid Stromal Sarcoma of the Cervix
5379,Epithelial Component Present,Pulmonary Blastoma
5380,Epithelial Component Present,"Ovarian Small Cell Carcinoma, Hypercalcemic Type"
5381,Carcinomatous Component Present,Recurrent Oral Cavity Carcinoma
5382,Anaplasia,Supratentorial Glioblastoma
5383,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Liver
5384,Fibrotic Stroma Formation,Cholangiolocellular Carcinoma
5385,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia
5386,Cutaneous Involvement,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
5387,Epithelial Component Present,Carcinoma duodenum resectable
5388,Adulthood Lesion,Adult B Acute Lymphoblastic Leukemia
5389,Pericanalicular Growth Pattern,Pericanalicular fibroadenoma
5390,Thyroglobulin Positive Neoplastic Cells Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
5391,Hyperkeratosis,Papillary squamous cell carcinoma
5392,Nuclear Atypia,Anaplastic Brain Stem Astrocytoma
5393,Multinodular Mass,hemangioendothelial sarcoma of bone
5394,Thick-Walled Hyalinized Vessels Present,Sympathetic Schwannoma
5395,Gastrin Positive Neoplastic Cells Present,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
5396,Carcinomatous Component Present,Stage IA Esophageal Cancer AJCC v7
5397,Mild cytologic atypia,Verrucous carcinoma
5398,Recurrent disease,Aggressive osteoblastoma
5399,Epithelial Component Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
5400,Mesenchymal Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
5401,High Mitotic Activity,Small cell carcinoma of lung
5402,Epithelial Component Present,Invasive Cribriform Breast Carcinoma
5403,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of anal canal
5404,Well-Circumscribed Lesion,Villous adenoma of rectum
5405,Mesenchymal Differentiation,Mixed epithelial-mesenchymal hepatoblastoma
5406,Mesenchymal Differentiation,Mixed Hepatoblastoma with Teratoid Features
5407,Diffuse Pattern,large B-cell diffuse lymphoma of accessory sinus
5408,Carcinomatous Component Present,Stage I Renal Pelvis Cancer AJCC v7
5409,Primary Lesion,Asynchronous Multifocal Osteosarcoma
5410,Well Differentiated Lesion,Well Differentiated Hepatocellular Carcinoma
5411,Indolent Clinical Course,Central Nervous System Leiomyoma
5412,Proliferation of Small Ducts Present,adenoma of intrahepatic bile duct
5413,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Tumor
5414,Papillary Pattern,Papillary Breast Neoplasm
5415,Dysplasia,Intrahepatic Bile Duct Microcystic Adenoma
5416,Seminomatous Component Present,Testicular Mixed Choriocarcinoma and Seminoma
5417,Mixed Cellular Population,Breast Fibroepithelial Neoplasm
5418,Cellular Pleomorphism,Cardiac Malignant Fibrous Histiocytoma
5419,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Endometrioid Cystadenoma
5420,Carcinomatous Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing"
5421,Carcinomatous Component Present,Stage IA Vulvar Carcinoma AJCC v6
5422,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
5423,Epithelial Component Present,Small cell carcinoma of the cervix
5424,Local disease,Fallopian Tube Adenomatoid Tumor
5425,Fibrotic Stroma Formation,Borderline Ovarian Endometrioid Cystadenofibroma
5426,Stromal Invasion,clear cell adenocarcinofibroma of ovary
5427,Epithelial Component Present,Cervical Verrucous Carcinoma
5428,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged
5429,Carcinomatous Component Present,"Adenocarcinoma of lung, stage IV"
5430,Carcinomatous Component Present,Localized Non-Resectable Adult Liver Carcinoma
5431,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Mixed Mesodermal (Mullerian) Tumor
5432,Congenital Lesion,Coloboma of eyelid
5433,Mixed Cellular Population,Cervical Adenomyoma
5434,Carcinomatous Component Present,FIGO Stage IIIB Ovarian Cancer
5435,Carcinomatous Component Present,Cervical Squamotransitional Carcinoma
5436,Epithelial Component Present,FIGO Stage IIIC Ovarian Cancer
5437,Deep Lesion,"Fibromatosis, Abdominal"
5438,Tissue of Mullerian Origin Present,Cystadenofibroma
5439,Metastatic Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
5440,Epithelial Component Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
5441,Epithelial Component Present,Nasopharyngeal Basaloid Squamous Cell Carcinoma
5442,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage I
5443,Fibrosis,Primary mediastinal large B-cell lymphoma stage I
5444,Mitotic Activity,Vulvar Yolk Sac Tumor
5445,Carcinomatous Component Present,carcinoma of middle ear
5446,Cutaneous Involvement,"Xeroderma pigmentosum, group F"
5447,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage IV
5448,Tricholemmal Differentiation,Trichilemmoma
5449,Honeycomb Pattern,Brain Oligodendroglioma
5450,Eosinophil count raised (finding),Childhood Acute Eosinophilic Leukemia
5451,Diffuse Pattern,Multifocal Glioblastomas
5452,Infiltrative Growth Pattern,"Glioblastoma, IDH-Mutant"
5453,Carcinomatous Component Present,Stage IIA Colorectal Cancer AJCC v7
5454,Epithelial Component Present,Fallopian Tube Endometrioid Adenocarcinoma
5455,Epithelial Component Present,Paraganglioma
5456,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma
5457,Dysplasia,Colorectal Filiform Serrated Adenoma
5458,Epithelial Component Present,Prostate Cancer by AJCC v7 Stage
5459,Invasive Lesion,Inflammatory Breast Carcinoma
5460,Cutaneous Involvement,Stage II Skin Cancer
5461,Microvascular Proliferation,Brain Glioblastoma
5462,Cutaneous Involvement,Glomangioma of skin
5463,Epithelial Component Present,Secondary carcinoma
5464,Epithelial Component Present,keratoacanthoma
5465,Exophytic Polypoid Lesion,Polyp of gallbladder
5466,Squamous Metaplasia of Malignant Cells Present,adenocarcinoma of breast with squamous metaplasia
5467,Hereditary Lesion,Neurocutaneous Syndromes
5468,Carcinomatous Component Present,Distal 1/3 of the Common Bile Duct Adenocarcinoma
5469,Absence of Invasion,Stage 0 Gastric Cancer AJCC v6 and v7
5470,Well Differentiated Lesion,Supraglottic Verrucous Carcinoma
5471,Multinodular Mass,Superior Vena Cava Angiosarcoma
5472,Invasive Lesion,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation
5473,Cellular Pleomorphism,Malignant Uterine Corpus PEComa
5474,Locally Aggressive Lesion,"Fibromatosis, Aggressive"
5475,Cryptitis,Chronic Active Colitis
5476,Cystic Change,Vulvar Papillary Hidradenoma
5477,Antoni A Pattern,Jugular Foramen Schwannoma
5478,Epithelial Component Present,Endometrioid carcinoma ovary
5479,Well-Circumscribed Lesion,Uterine Polyp
5480,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyp
5481,Epithelial Component Present,Skin Basaloid Carcinoma
5482,Childhood Lesion,Childhood Central Nervous System Mature Teratoma
5483,Epithelial Component Present,Anaplastic adrenocortical carcinoma
5484,Epithelial Component Present,Digestive System Neuroendocrine Neoplasm
5485,Serrated Glandular Architecture,Rectal Traditional Serrated Adenoma
5486,Carcinomatous Component Present,Stage III Pharynx Carcinoma
5487,Chronic Inflammatory Infiltrate,Myxoinflammatory fibroblastic sarcoma
5488,Carcinomatous Component Present,Metastatic Carcinoma in the Lung
5489,Absence of Invasion,Gastric Body Carcinoma In Situ AJCC v6 and v7
5490,Childhood Lesion,Recurrent Childhood Anaplastic Large Cell Lymphoma
5491,Indolent Clinical Course,Benign neoplasm of soft tissue
5492,Indolent Clinical Course,leiomyoma of trachea
5493,Metastatic/Recurrent Disease,Epithelioid sarcoma recurrent
5494,Hyperplastic Tissue Present,Prostatic Atypical Adenomatous Hyperplasia
5495,Exophytic Papillary Lesion,Condylomata Acuminata
5496,Fibrotic Stroma Formation,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
5497,Ground Glass Nuclear Inclusion,Childhood Thyroid Gland Papillary Carcinoma
5498,Eosinophil count raised (finding),B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH
5499,Neuroectodermal Differentiation,Localized Resectable Neuroblastoma
5500,Local disease,Liver Lipoma
5501,Neuroectodermal Differentiation,Undifferentiated Neuroblastoma
5502,Cystic Change,Cystadenocarcinoma
5503,"Fully Differentiated ""Adult-Type"" Tissues Present",Adult Central Nervous System Mature Teratoma
5504,Dysplasia,Cervical Squamous Intraepithelial Neoplasia
5505,Carcinomatous Component Present,HPV positive oropharyngeal squamous cell carcinoma
5506,Secondary Lesion,Metastatic Malignant Neoplasm in the Adult Brain
5507,Papillary Pattern,Ampulla of Vater Invasive Papillary Adenocarcinoma
5508,Carcinomatous Component Present,Childhood Lung Small Cell Carcinoma
5509,Follicular Cell Differentiation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
5510,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Neutropenia
5511,Fibrotic Stroma Formation,Ovarian Clear Cell Adenofibroma
5512,Unilineage Dysplasia Present,Refractory Thrombocytopenia
5513,Biphasic Pattern,Ovarian Clear Cell Cystadenofibroma
5514,Bone marrow reticulin fibrosis,Myelodysplastic Syndrome with Excess Blasts and Fibrosis
5515,Epithelial Component Present,Bladder adenocarcinoma stage IV
5516,Epithelial Component Present,Metastatic Lobular Breast Carcinoma
5517,Metastatic Lesion,Krukenberg Tumor
5518,Tubular Pattern,Vulvar Syringoma
5519,Epithelial Component Present,Lung squamous cell carcinoma recurrent
5520,Cutaneous Involvement,Vulvar Eccrine Porocarcinoma
5521,Hyperplastic Tissue Present,Focal Epithelial Hyperplasia
5522,Fibrotic Stroma Formation,Thymic Mucoepidermoid Carcinoma
5523,Epithelial Component Present,Stage II Prostate Carcinoma
5524,Thyroglobulin Positive Neoplastic Cells Present,Macrofollicular adenoma
5525,Severe cytologic atypia,Neuroendocrine carcinoma of appendix
5526,Carcinomatous Component Present,Small intestine carcinoma stage IV
5527,Epithelial Component Present,Oropharyngeal lymphoepithelioma stage III
5528,Epithelial Component Present,Thymic Adenosquamous Carcinoma
5529,Epithelial Component Present,Malignant phyllodes tumor of breast
5530,Carcinomatous Component Present,Unresectable Gallbladder Carcinoma
5531,Epithelial Component Present,Unresectable Gallbladder Carcinoma
5532,Carcinomatous Component Present,Multicentric Thyroid Gland Papillary Carcinoma
5533,Carcinomatous Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma
5534,Carcinomatous Component Present,Squamous cell carcinoma of colon
5535,Cystic Change,Eccrine hidrocystoma
5536,Eccrine Differentiation,Eccrine hidrocystoma
5537,Neuroendocrine Differentiation,Carcinoid tumor of the liver
5538,Low Mitotic Activity,Carcinoid tumor of the liver
5539,Solid Growth Pattern,Ovarian Solid Teratoma
5540,bone marrow fibrosis,"Leukemia, Mast-Cell"
5541,Carcinomatous Component Present,Paget Disease
5542,Tartrate Resistant Acid Phosphatase Positive Cells Present,Splenic Manifestation of Hairy Cell Leukemia
5543,High Mitotic Activity,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
5544,Lymphadenopathy,Pediatric nodal marginal zone lymphoma
5545,Heterologous Elements Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
5546,Epithelial Component Present,Low Grade Adenosquamous Breast Carcinoma
5547,Epithelial Component Present,Thyroid Gland Mucinous Follicular Adenoma
5548,Cystic Change,Ovarian Mucinous Cystadenofibroma
5549,Epithelial Component Present,Noninfiltrating Intraductal Carcinoma
5550,Epithelial Component Present,Stage IVB Pharyngeal Carcinoma
5551,Epithelial Component Present,Colorectal cancer recurrent
5552,Epithelial Component Present,Sarcomatoid Renal Cell Carcinoma
5553,Absence of Invasion or Limited Invasion Present,Well-differentiated papillary mesothelioma
5554,Carcinomatous Component Present,Stage IA Eyelid Carcinoma AJCC v7
5555,Cutaneous Involvement,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
5556,Skin Papule,Sebaceoma
5557,Epithelial Component Present,Colon adenoma
5558,Follicular Cell Differentiation,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
5559,Lymphoplasmacytic Infiltrate,Malignant lymphoma - lymphoplasmacytic
5560,Carcinomatous Component Present,Eccrine carcinoma of skin
5561,Diffuse Pattern,Gliomatosis Cerebri Type II
5562,Carcinomatous Component Present,Stage II Renal Cell Cancer AJCC v7
5563,Epithelial Differentiation,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
5564,More than 10 Mitoses per 10HPF,Stage III Lung Small Cell Carcinoma AJCC v7
5565,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v6
5566,Carcinomatous Component Present,Small intestine carcinoma resectable
5567,Papillary Pattern,Juvenile papillomatosis of breast
5568,Well-Circumscribed Lesion,Colorectal Tubular Adenoma
5569,Eccrine Differentiation,Eccrine porocarcinoma
5570,Indolent Clinical Course,Rectal Leiomyoma
5571,Carcinomatous Component Present,carcinoma of gingiva
5572,Adulthood Lesion,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
5573,Epithelial Component Present,Multifocal breast carcinoma
5574,Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
5575,Monomorphic Cellular Infiltrate,Oropharyngeal Basaloid Carcinoma
5576,Syncytial Pattern,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
5577,Epithelial Component Present,solid type ductal carcinoma in situ of breast
5578,Lobulated Growth Pattern,Transitional Meningioma
5579,Secondary Lesion,"Adenocarcinoma, metastatic"
5580,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
5581,Carcinomatous Component Present,Vaginal clear cell adenocarcinoma
5582,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage I
5583,Well-Circumscribed Lesion,Small Intestinal Tubulovillous Adenoma
5584,Venous Type Vascular Channel Formation,Venous hemangioma
5585,Epithelial Component Present,Intestinal Gangliocytic Paraganglioma
5586,Absence of Invasion,High Grade Ductal Breast Carcinoma In Situ
5587,Nuclear pleomorphism,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
5588,Epithelial Component Present,Soft Palate Squamous Cell Carcinoma
5589,Indolent Clinical Course,"Vulvar Deep ""Aggressive"" Angiomyxoma"
5590,Epidermotropic Lymphocytic Infiltrate,Mycosis Fungoides
5591,Hyperplastic Epithelial Tissue Present,Ductal Breast Hyperplasia
5592,Nuclear Pseudoinclusion,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
5593,Papillary Pattern,Hidradenoma Papilliferum
5594,High Mitotic Activity,Adult Central Nervous System Embryonal Carcinoma
5595,Moderate dysplasia,Squamous intraepithelial neoplasia grade 2
5596,Epithelial Component Present,Poorly Differentiated Prostate Adenocarcinoma
5597,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
5598,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP B"
5599,Borderline Lesion,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
5600,Well-Circumscribed Lesion,Apocrine adenoma
5601,Cicatrix,Old Burn Scar-Related Cutaneous Melanoma
5602,Epithelial Component Present,Posterior Tongue Adenoid Cystic Carcinoma
5603,Cartilaginous Differentiation,Childhood Mesenchymal Chondrosarcoma
5604,Carcinomatous Component Present,Carcinoma of lung
5605,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Tumor
5606,Adulthood Lesion,Adult Alveolar Soft Part Sarcoma
5607,Microcystic Change,Adult Subependymoma
5608,Carcinomatous Component Present,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
5609,Epithelial Component Present,papillary carcinoma of penis
5610,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25)
5611,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myelomonocytic leukemia
5612,Mucoid Stroma Formation,Colloid Carcinoma of the Pancreas
5613,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell"
5614,Carcinomatous Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7
5615,Carcinomatous Component Present,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
5616,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anaemia with excess blasts
5617,Childhood Lesion,PRETEXT Stage 3 Hepatoblastoma
5618,Mucinous degeneration,Childhood Protoplasmic Astrocytoma
5619,Neuroendocrine Differentiation,Gastric Large Cell Neuroendocrine Carcinoma
5620,Well-Circumscribed Lesion,polyps
5621,Glandular Pattern,Pancreatic Somatostatinoma
5622,Papillary Pattern,Invasive micropapillary carcinoma of breast
5623,Primary Lesion,Indolent Systemic Mastocytosis
5624,Epithelial Component Present,Stage III Rectosigmoid Cancer AJCC v7
5625,Cutaneous Involvement,"Lichen Planus, Oral"
5626,Metastatic Lesion,Locally Advanced Malignant Neoplasm
5627,Abnormal Eosinophilic Granules Present,Acute myeloid leukemia with abnormal marrow eosinophils
5628,Cutaneous Involvement,Merkel cell carcinoma
5629,Diffuse Pattern,Adult Gliosarcoma
5630,Epithelial Component Present,Adenocarcinoma of the gastroesophageal junction
5631,Epithelial Component Present,"Carcinoma, Signet Ring Cell"
5632,Carcinomatous Component Present,Stage IIIC Adult Liver Cancer AJCC v7
5633,Cutaneous Involvement,"Carcinoma, Skin Appendage"
5634,Carcinomatous Component Present,"Carcinoma, Skin Appendage"
5635,Primary Lesion,Primary Bone Osteosarcoma
5636,Recurrent disease,Penis carcinoma recurrent
5637,Necrotic changes (finding),Stage IIIA Lung Small Cell Carcinoma AJCC v7
5638,Well-Circumscribed Lesion,Multiple adenomatous polyps
5639,Well Differentiated Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
5640,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v6 Stage
5641,Chronic Inflammatory Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
5642,Childhood Lesion,Childhood T Lymphoblastic Lymphoma
5643,Metaplasia,Bladder squamous cell carcinoma stage 0
5644,Dysplasia,Adenomatous Polyposis Coli
5645,Adnexal Differentiation,Eccrine mixed tumor of skin
5646,Slow Growing Mass,Adult Ependymoma
5647,Favorable Clinical Outcome,"lymphomatoid papulosis, type A"
5648,Carcinomatous Component Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
5649,Carcinomatous Component Present,Minor Salivary Gland Small Cell Carcinoma
5650,Alternative Fascicle (Bundle) Pattern,Colorectal Leiomyoma
5651,Vascular Channel Formation,Esophageal hemangioma
5652,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts
5653,Cystic Change,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm
5654,Invasive Lesion,Infiltrating papillary adenocarcinoma
5655,Recurrent disease,Recurrent Grade II Lymphomatoid Granulomatosis
5656,Hemorrhagic,Poorly Differentiated Angiosarcoma
5657,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Sebaceous Adenoma
5658,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous"
5659,Vascular Channel Formation,Angiosarcoma NCI Grade 2
5660,Acanthosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
5661,Carcinomatous Component Present,Epithelial-myoepithelial carcinoma
5662,Epithelial Component Present,Skin Basal Cell Carcinoma with Adnexal Differentiation
5663,Epithelial Component Present,carcinosarcoma of gallbladder
5664,Swelling,Mesenchymal Chondrosarcoma
5665,Lesion with Diameter of 5cm or Less,Benign Gastric Gastrointestinal Stromal Tumor
5666,Epithelial Component Present,clear cell adenocarcinoma of urethra
5667,Carcinomatous Component Present,Papillary mucinous cystadenocarcinoma
5668,Benign Cellular Infiltrate,Fundic gland polyp
5669,Cutaneous Involvement,Non-Neoplastic Hair Disorder
5670,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v6 and v7
5671,Epithelial Component Present,Intracystic papillary adenoma
5672,Recurrent disease,Recurrent Childhood Lymphomatoid Granulomatosis
5673,Ependymal Differentiation,Papillary tumor of the pineal region
5674,Papillary Pattern,Papillary tumor of the pineal region
5675,Lipomatous Differentiation,Cerebellar Liponeurocytoma
5676,Borderline Lesion,Minimal Deviation Melanoma
5677,Metastatic/Recurrent Disease,"Synovial sarcoma, biphasic"
5678,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
5679,Mixed Cellular Population,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma
5680,Epithelial Component Present,malignant myoepithelioma of breast
5681,Low Grade Lesion,Recurrent Childhood Pilocytic Astrocytoma
5682,Slow Growing Mass,Papillary ependymoma
5683,Indolent Clinical Course,Benign neoplasm of blood vessel
5684,High Grade Lesion,Childhood Spindle Cell Rhabdomyosarcoma
5685,Dysplasia,Esophageal Glandular Intraepithelial Neoplasia
5686,Lobulated Growth Pattern,Cutaneous myxoma
5687,Deep Lesion,Spindle cell liposarcoma
5688,Nuclear pleomorphism,Pleomorphic Variant Mantle Cell Lymphoma
5689,Mixed Cellular Population,Adenosarcoma
5690,Secondary Lesion,Lung Carcinoma Metastatic in the Brain
5691,Radial Growth Phase,Stage I Superficial Spreading Melanoma AJCC v7
5692,Epithelial Component Present,Superficial basal cell carcinoma
5693,Mitotic Activity,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7
5694,Carcinomatous Component Present,Extrahepatic Bile Duct Neuroendocrine Carcinoma
5695,Epithelial Component Present,Verrucous carcinoma of the oral cavity recurrent
5696,Epithelial Component Present,Distal Bile Duct Carcinoma
5697,Alternative Fascicle (Bundle) Pattern,Dartoic myoma
5698,Benign Cellular Infiltrate,Benign digestive system neoplasms
5699,Carcinomatous Component Present,Colon Carcinoma Metastatic in the Liver
5700,Mixed Cellular Population,Cystadenofibroma of fallopian tube
5701,High Mitotic Activity,large cell neuroendocrine carcinoma of extrahepatic bile duct
5702,Glomeruloid Vessels Present,Pilocytic astrocytoma of cerebellum
5703,Anaplasia,Primary Cutaneous Anaplastic Large Cell Lymphoma
5704,Absence of Stromal Invasion,Fallopian Tube Metaplastic Papillary Tumor
5705,Epithelial Component Present,Stage IIIB Ovarian Cancer AJCC v6 and v7
5706,Epithelial Component Present,"Carcinoma, Large Cell"
5707,Carcinomatous Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v7
5708,Tissue Differentiation Uncertain,Juxta-Articular Myxoma
5709,Dilated Thin-Walled Vascular Space Formation,Pleomorphic hyalinizing angiectatic tumor of soft tissue
5710,High Grade Lesion,Spindle cell rhabdomyosarcoma
5711,Adulthood Lesion,Adult Cerebellar Neoplasm
5712,Well-Circumscribed Lesion,Ectopic hamartomatous thymoma
5713,Epineurial Invasion,Lipomatosis of Nerve
5714,Extraosseous Lesion,Peripheral Odontogenic Fibroma
5715,Adulthood Lesion,Adult T Lymphoblastic Lymphoma
5716,High Grade Lesion,Pleural Biphasic Synovial Sarcoma
5717,Adnexal Differentiation,Apocrine breast carcinoma
5718,Epithelial Component Present,Minimally Invasive Thymoma
5719,Epithelial Component Present,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7
5720,Recurrent Genetic Abnormalities Present,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM"
5721,Childhood Lesion,Childhood Laryngeal Carcinoma
5722,Lytic lesion,Metastasizing Chondroblastoma
5723,Recurrent disease,Metastasizing Chondroblastoma
5724,Childhood Lesion,Childhood Craniopharyngioma
5725,Calcitonin Positive Neoplastic Cells Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
5726,Childhood Lesion,Childhood Esophageal Carcinoma
5727,Cystic Change,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
5728,Carcinomatous Component Present,Stage IB Ampulla of Vater Cancer AJCC v7
5729,Fibrotic Stroma Formation,Anterior Tongue Mucoepidermoid Carcinoma
5730,Storiform Growth Pattern,Cutaneous Fibrous Histiocytoma
5731,Increased Cellularity Present,Childhood Neuroblastoma
5732,Secondary Lesion,Pseudomyxoma Peritonei
5733,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v6
5734,Thick-Walled Hyalinized Vessels Present,Colorectal Schwannoma
5735,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type"
5736,Carcinomatous Component Present,Stage II Esophageal Cancer
5737,Increased Cellularity Present,Adult Anaplastic Ependymoma
5738,Childhood Lesion,"Childhood Ganglioneuroblastoma, Intermixed"
5739,Benign Cellular Infiltrate,Gastric Hemangioma
5740,Epithelial Component Present,Breast Fibroepithelial Neoplasm
5741,Diffuse Pattern,mixed gliomas
5742,Epithelial Component Present,Cecum Villous Adenoma
5743,Multinodular Mass,Conventional Angiosarcoma
5744,Anaplasia,Malignant Meningioma
5745,Epithelial Component Present,Stage II Adrenal Cortex Carcinoma AJCC v7
5746,Mesenchymal Component Present,Breast Pleomorphic Adenoma
5747,Carcinomatous Component Present,"Adenocarcinoma of lung, stage II"
5748,Extraosseous Lesion,Extraskeletal Osteosarcoma
5749,Nuclear Atypia,Grade III Childhood Astrocytoma
5750,Oligodendroglial Component Present,Childhood Oligodendroglioma
5751,Angiocentric Pattern,Cutaneous Lymphomatoid Granulomatosis
5752,Carcinomatous Component Present,Stage IIB Distal Bile Duct Cancer AJCC v7
5753,Cutaneous Involvement,Malignant neoplasm of scrotum
5754,Tissue of Mullerian Origin Present,Cervical Adenofibroma
5755,Cytoplasmic Membrane-Bound Granules Present,Recurrent Merkel Cell Carcinoma
5756,Diffuse Pattern,Classical Glioblastoma
5757,Microvascular Proliferation,Classical Glioblastoma
5758,Tissue of Mullerian Origin Present,Cervical Adenomyoma
5759,Epithelial Component Present,Bilateral Carcinoma
5760,Increased Cellularity Present,Cellular Myxoma
5761,Epithelial Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7
5762,Necrotic changes (finding),Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
5763,Cribriform Pattern,Gallbladder Cribriform Carcinoma
5764,Epithelial Component Present,Stage IIA Esophageal Adenocarcinoma AJCC v7
5765,Primary Lesion,Splenic marginal zone lymphoma recurrent
5766,Monoclonal Langerhans Cells Present,Adult Langerhans Cell Histiocytosis
5767,Collagenous Stroma Formation,Fibromatosis colli
5768,High Grade Lesion,Anaplastic astrocytoma
5769,Above the Diaphragm Disease,Hodgkin's disease mixed cellularity stage II supradiaphragmatic
5770,Carcinomatous Component Present,Colorectal Signet Ring Cell Carcinoma
5771,Epithelial Component Present,Bartholin Gland Adenosquamous Carcinoma
5772,Benign Cellular Infiltrate,Benign Anal Granular Cell Tumor
5773,Splenomegaly,T-Cell Prolymphocytic Leukemia
5774,Diffuse Pattern,"Glioblastoma, IDH-Wildtype"
5775,Epithelial Component Present,Stage IA Fallopian Tube Cancer AJCC v6 and v7
5776,Nuclear Atypia,Anaplastic Oligoastrocytoma
5777,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
5778,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
5779,Well Differentiated Lesion,Well Differentiated Leiomyosarcoma
5780,High Mitotic Activity,Medulloepithelioma
5781,Well-Circumscribed Lesion,Colorectal Sessile Serrated Adenoma/Polyp
5782,atypia morphology,External Ear Actinic Keratosis
5783,Squamous metaplasia,Adenolymphoma
5784,Slow Growing Mass,Cellular Ependymoma
5785,Childhood Lesion,Childhood Choroid Plexus Papilloma
5786,Metastatic Lesion,Secondary malignant neoplasm of retina
5787,Multinodular Mass,Peripheral Intraneural Angiosarcoma
5788,Carcinomatous Component Present,Metaplastic carcinoma of breast
5789,Borderline Lesion,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
5790,Pushing Tumor Margin,Supraglottic Verrucous Carcinoma
5791,Adulthood Lesion,Adult Brain Stem Gliosarcoma
5792,No Identifiable Line of Differentiation,Giant Cell Fibrous Histiocytoma
5793,CD30-Positive Neoplastic Cells Present,anaplastic large cell lymphoma of central nervous system
5794,S-100-Positive Neoplastic Cells Present,Indeterminate dendritic cell tumor
5795,Neuronal Differentiation,Childhood Ganglioglioma
5796,Epithelial Component Present,Parasympathetic paraganglioma
5797,Childhood Lesion,Childhood Testicular Immature Teratoma
5798,Carcinomatous Component Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation
5799,In Situ Lesion,Stage 0 Gallbladder Cancer AJCC v6 and v7
5800,Koilocytotic atypia,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
5801,Epithelial Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
5802,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma
5803,Carcinomatous Component Present,Stage IIIB Fallopian Tube Cancer AJCC v7
5804,Fibrotic Stroma Formation,Clear Cell Intrahepatic Cholangiocarcinoma
5805,Carcinomatous Component Present,Clear Cell Intrahepatic Cholangiocarcinoma
5806,Absence of Invasion,Adenocarcinoma in situ in adenomatous polyp
5807,Nuclear Pseudoinclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
5808,Papillary Pattern,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
5809,Epithelial Component Present,Breast Mucinous Cystadenocarcinoma
5810,Osseous Differentiation,Osteosarcoma localised
5811,Local disease,Osteosarcoma localised
5812,Epithelial Component Present,Ovarian serous cystadenofibroma
5813,Metastatic Lesion,Metastatic osteosarcoma
5814,Low Mitotic Activity,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
5815,Cavernous Vascular Space Formation,Cavernous hemangioma of orbit
5816,Dysplasia,Duodenal Adenoma
5817,Tissue of Mullerian Origin Present,Uterine Carcinosarcoma
5818,Dysplasia,Anal Canal Squamous Intraepithelial Neoplasia
5819,Nuclear pleomorphism,Burkitt-like lymphoma
5820,Carcinomatous Component Present,Stage II Nasopharyngeal Carcinoma AJCC v7
5821,Carcinomatous Component Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
5822,Epithelial Component Present,"Squamous cell carcinoma, keratinizing"
5823,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
5824,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v6
5825,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma AJCC v7
5826,No Identifiable Line of Differentiation,Undifferentiated round cell sarcoma
5827,Firm mass,Malignant Peripheral Nerve Sheath Tumor
5828,Epithelial Component Present,Carcinoid tumor of ileum
5829,Numerous Stromal Mast Cells Present,Vulvar Angiomyofibroblastoma
5830,Well-Circumscribed Lesion,Anal skin tag
5831,High Mitotic Activity,Stage II Merkel Cell Carcinoma AJCC v7
5832,Slow Growing Mass,Kadish Stage C Olfactory Neuroblastoma
5833,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Adenofibroma
5834,Tobacco Toxicity,Tobacco Chewing-Related Carcinoma
5835,Papillary Pattern,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
5836,Follicular Cell Differentiation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
5837,Infiltrative Growth Pattern,Anaplastic Hemispheric Astrocytoma
5838,Epithelial Component Present,High Grade Intraepithelial Neoplasia
5839,Immunosuppression-Related Post-Transplant Toxicity,Monomorphic Post-Transplant Lymphoproliferative Disorder
5840,Carcinomatous Component Present,Stage II Bladder Cancer AJCC v6 and v7
5841,Unilineage Dysplasia Present,Refractory Neutropenia
5842,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent
5843,Epithelial Component Present,Recurrent Cancer of Gallbladder
5844,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage II
5845,Epithelial Component Present,Malignant neoplasm of stomach stage II
5846,Beaded Anastomosing Cords Present,canalicular adenoma of salivary gland
5847,Carcinomatous Component Present,Vaginal Mucinous Adenocarcinoma
5848,Immunosuppression-Related Post-Transplant Toxicity,Acute cellular allograft nephropathy
5849,Epithelial Component Present,Ovarian Serous Adenocarcinoma
5850,Stromal Invasion,Ovarian Serous Adenocarcinoma
5851,Adnexal Differentiation,Vulvar Syringoma
5852,Cutaneous Involvement,Vulvar Syringoma
5853,Immunosuppression-Related Post-Transplant Toxicity,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder
5854,Epithelial Component Present,"Adenocarcinoma, Oxyphilic"
5855,Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
5856,Epithelial Component Present,Vulvar Trichoepithelioma
5857,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
5858,Adnexal Differentiation,"Adenoma, Sweat Gland"
5859,Enterochromaffin Type Granules Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
5860,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant"
5861,Recurrent disease,Recurrent Childhood Astrocytic Tumor
5862,Epithelial Component Present,Primary Peritoneal Serous Adenocarcinoma
5863,Macule,Acral Lentiginous Malignant Melanoma
5864,Cystic Change,Benign mixed epithelial and stromal tumor of kidney
5865,Carcinomatous Component Present,Pancreatic carcinoma non-resectable
5866,Mucoid Stroma Formation,Rectosigmoid Mucinous Adenocarcinoma
5867,Carcinomatous Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v7
5868,Recurrent disease,Recurrent Extrahepatic Bile Duct Carcinoma
5869,Carcinomatous Component Present,Mucinous cystadenocarcinoma of ovary
5870,Recurrent disease,Recurrent Childhood Medulloblastoma
5871,Deep Lesion,Intramuscular lipoma
5872,CD30-Positive Neoplastic Cells Present,Stage I Childhood Anaplastic Large Cell Lymphoma
5873,Capillary Sized Vascular Channel Formation,Multiple Lobular Capillary Hemangiomas
5874,Epithelial Component Present,Stage IA Lung Large Cell Carcinoma AJCC v7
5875,Retiform Structures Comprise 90% or More of the Tumor,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
5876,Epithelial Component Present,Stage IB Lung Large Cell Carcinoma AJCC v7
5877,Presence of a Hormonal Syndrome,"Glucagonoma, malignant"
5878,Indolent Clinical Course,Piloleiomyoma
5879,Well Differentiated Lesion,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
5880,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,lipid-rich carcinoma of breast
5881,Epithelial Component Present,Stage IIIA Lung Large Cell Carcinoma AJCC v7
5882,Nodular lesions,Thyroid Gland Clear Cell Follicular Adenoma
5883,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1
5884,Epithelial Component Present,Pyriform Fossa Squamous Cell Carcinoma
5885,High Grade Lesion,Fusion-Negative Rhabdomyosarcoma
5886,Neuroendocrine Differentiation,"Pheochromocytoma, Extra-Adrenal"
5887,Necrotic changes (finding),Stage IIA Lung Small Cell Carcinoma AJCC v7
5888,Exophytic Polypoid Lesion,Cervix adenomatous polyp
5889,Metastatic Lesion,Metastatic Malignant Neoplasm to the Leptomeninges
5890,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
5891,Antoni A Pattern,Sternal Intraosseous Schwannoma
5892,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
5893,Carcinomatous Component Present,Gastric Intramucosal Adenocarcinoma
5894,'Starry-sky' pattern,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation
5895,Epithelial Component Present,Urethral Urothelial Papilloma
5896,Papillary Pattern,Urethral Urothelial Papilloma
5897,Cutaneous Involvement,Apocrine Sweat Gland Hamartoma
5898,Epithelial Component Present,Palate carcinoma
5899,Lymphoplasmacytic Infiltrate,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
5900,Chronic lymphocytic inflammation,Gastric Inflammatory Myofibroblastic Tumor
5901,In Situ Lesion,solid type ductal carcinoma in situ of breast
5902,'Starry-sky' pattern,Stage III Burkitt Lymphoma
5903,Birbeck Granules Present,Langerhans Cell Sarcoma
5904,Juvenile Lesion,Juvenile Chronic Polyarthritis
5905,Nuclear Atypia,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation
5906,Finding related to pregnancy,Non-Hodgkin Lymphoma During Pregnancy
5907,Rarely Metastasizing Lesion,Endovascular papillary angioendothelioma
5908,Carcinomatous Component Present,Vaginal Adenoid Basal Carcinoma
5909,Carcinomatous Component Present,Ethmoid Sinus Squamous Cell Carcinoma
5910,Eosinophilic inflammation,Histiocytoid hemangioma
5911,Mixed Cellular Population,Mixed Congenital Mesoblastic Nephroma
5912,Exophytic Polypoid Lesion,Gastric adenoma
5913,Cartilaginous Differentiation,Secondary Chondrosarcoma
5914,Epithelial Component Present,Paraganglioma of head and neck
5915,Localized Lesion,Peritoneal Well Differentiated Papillary Mesothelioma
5916,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
5917,Carcinomatous Component Present,ENSAT Stage I Adrenal Cortex Carcinoma
5918,Carcinomatous Component Present,Stage IIA Breast Carcinoma
5919,Diffuse Pattern,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma
5920,Epithelial Component Present,Carcinoma
5921,Nodular Pattern,Ann Arbor Stage IV Grade 1 Follicular Lymphoma
5922,Indolent Clinical Course,Benign Bone Schwannoma
5923,Cystic Change,Cystic Partially Differentiated Nephroblastoma
5924,Indolent Clinical Course,Hemangioma of intra-abdominal structure
5925,Biphasic Pattern,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm
5926,Perivascular Arrangement of Tumor Cells,Myopericytoma
5927,Epithelial Component Present,"Adenocarcinoma, Scirrhous"
5928,Cystic Change,cystadenoma of intrahepatic bile duct
5929,Mesenchymal Differentiation,Childhood Gliosarcoma
5930,Vascular proliferation,"Castleman Disease, Hyaline-Vascular Type"
5931,Epithelial Component Present,Mild epithelial dysplasia
5932,Dysplasia,Ampulla of Vater Tubular Adenoma
5933,Splenomegaly,Chronic Neutrophilic Leukemia
5934,Alcohol Toxicity,Alcohol-Related Esophageal Squamous Cell Carcinoma
5935,Hyaline Cartilage Differentiation,Childhood Mesenchymal Chondrosarcoma
5936,Cystic Change,Ovarian Cystadenocarcinoma
5937,Adulthood Lesion,Adult cystic teratoma
5938,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
5939,Exophytic Polypoid Lesion,Peutz-Jeghers polyps of small bowel
5940,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(5;17)(q35;q21)
5941,Chromogranin A Positive Neoplastic Cells Present,Thymic Typical Carcinoid Tumor
5942,High Mitotic Activity,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
5943,Juvenile Lesion,Large Bowel Juvenile Polyp
5944,Epithelial Component Present,Somatostatinoma
5945,Epithelial Component Present,Thymic Small Cell Carcinoma
5946,Epithelial Component Present,Childhood Hepatocellular Carcinoma
5947,Bone Marrow Dysplasia Present,Alkylating Agent-Related Myelodysplastic Syndrome
5948,Mitotic Activity,Childhood Pilomyxoid Astrocytoma
5949,Epithelial Component Present,Anal margin Paget's disease
5950,Low Mitotic Activity,Carcinoid tumor of rectum
5951,Epithelial Component Present,Infiltrating Urothelial Carcinoma
5952,Epithelial Component Present,Anal canal squamous cell carcinoma
5953,Carcinomatous Component Present,Anal canal squamous cell carcinoma
5954,Adulthood Lesion,Adult Acute Monoblastic and Monocytic Leukemia
5955,Neuroendocrine Differentiation,Large cell neuroendocrine carcinoma
5956,Epithelial Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
5957,Epithelial Component Present,Stage IV Urethral Cancer AJCC v7
5958,Tubular Pattern,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma
5959,Villous Pattern,Appendix Tubulovillous Adenoma
5960,Carcinomatous Component Present,Vaginal Mesonephric Adenocarcinoma
5961,Childhood Lesion,Childhood Acute Myelomonocytic Leukemia
5962,Childhood Lesion,Postsurgical Stage III Hepatoblastoma
5963,Recurrent disease,Hodgkin's disease nodular sclerosis recurrent
5964,Epithelial Component Present,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7
5965,Carcinomatous Component Present,Minor Salivary Gland Squamous Cell Carcinoma
5966,Epithelial Component Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor
5967,Well-Circumscribed Lesion,Adenomatous Polyps
5968,Exophytic Polypoid Lesion,Preauricular skin tag
5969,Exophytic Polypoid Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
5970,Micropapillary Pattern,Rectal Micropapillary Adenocarcinoma
5971,Necrotic changes (finding),Adult Giant Cell Glioblastoma
5972,Carcinomatous Component Present,Lip and Oral Cavity Carcinoma
5973,Epithelial Component Present,Esophageal Neuroendocrine Carcinoma
5974,Microvascular Proliferation,Recurrent Childhood Giant Cell Glioblastoma
5975,High Grade Lesion,Mediastinal Synovial Sarcoma
5976,Carcinomatous Component Present,Carcinoma Metastatic to the Skin
5977,In Situ Lesion,Intermediate Grade Ductal Breast Carcinoma In Situ
5978,Varicosity,Coronary Venous Dissection
5979,Epithelial Component Present,Bile duct cancer resectable
5980,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma AJCC v7
5981,Childhood Lesion,Recurrent Childhood Gliomatosis Cerebri
5982,Low Mitotic Activity,Jejunal Somatostatin-Producing Neuroendocrine Tumor
5983,Nuclear Molding,Occult Lung Small Cell Carcinoma
5984,Extraocular Dissemination of Disease,Ocular Melanoma with Extraocular Extension
5985,Slow Growing Mass,Retinal hemangioblastoma
5986,Well-Circumscribed Lesion,cystadenoma of salivary gland
5987,Primary Lesion,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
5988,Delicate Vascular Network Formation,Grade 3 Clear Cell Renal Cell Carcinoma
5989,Well Differentiated Lesion,Esophageal Well Differentiated Squamous Cell Carcinoma
5990,Villous Pattern,Colorectal Villous Adenoma
5991,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Kaposi Sarcoma
5992,Epithelial Component Present,Localized Resectable Adult Liver Carcinoma
5993,Eccrine Differentiation,Digital papillary eccrine carcinoma of skin
5994,Well-Circumscribed Lesion,Inflammatory Hepatocellular Adenoma
5995,Epithelial Component Present,Inflammatory Hepatocellular Adenoma
5996,Well-Circumscribed Lesion,Rectal Adenoma with Severe Dysplasia
5997,Epithelial Component Present,Pancreatic Endocrine Carcinoma
5998,Hydropic degeneration,Uterine Corpus Dissecting Leiomyoma
5999,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia with abnormal eosinophils
6000,Epithelial Component Present,Non-Functioning Pituitary Gland Macroadenoma
6001,Carcinomatous Component Present,Infiltrating papillary adenocarcinoma
6002,Carcinomatous Component Present,Localized Gallbladder Carcinoma
6003,Carcinomatous Component Present,Infiltrating basal cell carcinoma
6004,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
6005,Hereditary Lesion,Peutz-Jeghers Syndrome
6006,Adulthood Lesion,Stage II Adult Hodgkin Lymphoma
6007,Hemorrhagic,Angiosarcoma NCI Grade 2
6008,Hyperplastic Tissue Present,Flat Urothelial Hyperplasia
6009,Papillary Pattern,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
6010,Nodular Pattern,Ann Arbor Stage II Follicular Lymphoma
6011,Schwannian Stroma More than 50 Percent of the Tumor Volume,ganglioneuroblastoma of mediastinum
6012,Duct-Like Structures Present,Epithelial-myoepithelial carcinoma
6013,Lipomatous Component Present,Angiomyolipoma
6014,Histiocytosis haematophagic,Secondary haemophagocytic lymphohistiocytosis
6015,Epithelial Component Present,Gastric carcinoma stage IV
6016,Hyaline Cartilage Differentiation,Mesenchymal Chondrosarcoma
6017,Indolent Clinical Course,Urethral Leiomyoma
6018,Fibrotic Stroma Formation,Serous adenofibroma
6019,Pain,Osteoclastic Giant Cell-Rich Tumor of Bone
6020,Epithelial Component Present,Low Grade Penile Intraepithelial Neoplasia
6021,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma
6022,Hereditary Lesion,Hereditary Multiple Exostoses
6023,Carcinomatous Component Present,Conventional (Clear Cell) Renal Cell Carcinoma
6024,Mixed Cellular Population,Blastema Predominant Kidney Wilms Tumor
6025,Papillary Pattern,Noninfiltrating intraductal papillary adenocarcinoma
6026,Low Grade Lesion,Bone Epithelioid Hemangioendothelioma
6027,Cutaneous Involvement,Melanoma in Congenital Melanocytic Nevus
6028,Fibrotic Stroma Formation,Vulvar Fibrolipoma
6029,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile"
6030,Carcinomatous Component Present,Mucin-producing adenocarcinoma
6031,Gastric-Type Epithelial Differentiation,Foveolar-Type Adenoma
6032,Childhood Lesion,Childhood Parosteal Osteosarcoma
6033,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage IV
6034,Adulthood Lesion,recurrent adult acute myeloid leukemia
6035,Hypertensive disease,Hypertensive Encephalopathy
6036,Absence of Stromal Invasion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
6037,Epithelial Component Present,Trichoepithelioma
6038,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia
6039,Cutaneous Involvement,Ingestion dermatitis due to food
6040,Indolent Clinical Course,Cutaneous leiomyoma
6041,Urine phosphorous concentration above normal,Oncogenic osteomalacia
6042,Carcinomatous Component Present,Mucin-Producing Intrahepatic Cholangiocarcinoma
6043,Rosette-Like Configurations Present,Adenoameloblastoma
6044,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant"
6045,Multinodular Pattern,Adult Extraskeletal Myxoid Chondrosarcoma
6046,Locally Aggressive Lesion,Intermediate Chondrogenic Neoplasm
6047,Primary Lesion,Anaplastic Brain Stem Astrocytoma
6048,Low Grade Lesion,Pleural Epithelioid Hemangioendothelioma
6049,Melanin Pigment Present,Common blue nevus of skin
6050,Carcinomatous Component Present,Basal cell carcinoma - adamantinoid
6051,Tissue Differentiation Uncertain,Pleural Monophasic Synovial Sarcoma
6052,Multinodular Mass,Skin Angiosarcoma
6053,Carcinomatous Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type"
6054,Epithelial Component Present,Morpheic basal cell carcinoma
6055,Epithelial Component Present,Stage IVA Paranasal Sinus Cancer AJCC v7
6056,Recurrent Genetic Abnormalities Present,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM"
6057,Cutaneous Involvement,Poikiloderma
6058,Childhood Lesion,Childhood Solid Neoplasm
6059,Carcinomatous Component Present,Stage IIB Lung Cancer AJCC v7
6060,Pseudolobular Pattern,Ovarian Sclerosing Stromal Tumor
6061,Collagenous Stroma Formation,Sclerosing Polycystic Adenosis
6062,Adulthood Lesion,Stage I Adult Soft Tissue Sarcoma AJCC v7
6063,Thick-Walled Hyalinized Vessels Present,Benign Mediastinal Psammomatous Schwannoma
6064,Antoni A Pattern,Benign Mediastinal Psammomatous Schwannoma
6065,Epithelial Component Present,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
6066,Exophytic Polypoid Lesion,Intrahepatic Bile Duct Microcystic Adenoma
6067,Carcinomatous Component Present,Adenocarcinoma of lung (disorder)
6068,Melanin Pigment Present,Vulvar Blue Nevus
6069,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage IV
6070,Mixed Cellular Population,Mixed Oligodendroglioma-Astrocytoma
6071,Fibromyxoid Stroma Formation,"Ossifying fibromyxoid tumor, malignant"
6072,Epithelial Component Present,Childhood Breast Carcinoma
6073,Fibrotic Stroma Formation,Benign Brenner Tumor
6074,Carcinomatous Component Present,Transitional cell cancer of the renal pelvis and ureter localized
6075,Indolent Clinical Course,Fallopian Tube Adenomatoid Tumor
6076,Childhood Lesion,Grade III Childhood Astrocytoma
6077,Mitotic Activity,Proneural Glioblastoma
6078,High Grade Lesion,Proneural Glioblastoma
6079,Nuclear Atypia,"Perineurioma, malignant"
6080,Anaplasia,Neural Glioblastoma
6081,Mixed Cellular Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified"
6082,Diffuse Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis
6083,Carcinomatous Component Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
6084,Nuclear Pseudoinclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
6085,Dysplasia,Pyloric Gland Adenoma
6086,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Adult Acute Myeloid Leukemia without Maturation
6087,Thyroglobulin Positive Neoplastic Cells Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma
6088,Dysplasia,Vaginal intraepithelial neoplasia grade 2
6089,Epithelial Component Present,Sporadic Gastric Adenocarcinoma
6090,Lymphadenopathy,Chronic Adult T-Cell Leukemia/Lymphoma
6091,Gyriform Trabecular Pattern,Gastric Gastrin-Producing Neuroendocrine Tumor
6092,High Grade Lesion,Leiomyosarcoma NCI Grade 3
6093,Vascular Channel Formation,Childhood Epithelioid Hemangioendothelioma
6094,Increased Cellularity Present,"Anaplastic Astrocytoma, IDH-Wildtype"
6095,Carcinomatous Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
6096,Primary Lesion,Brain Stem Glioblastoma
6097,Carcinomatous Component Present,Bartholin Gland Squamous Cell Carcinoma
6098,Epithelial Component Present,Thymic Carcinoid Tumor
6099,Epithelial Component Present,Fallopian Tube Cancer by AJCC v7 Stage
6100,High Mitotic Activity,Childhood Ovarian Embryonal Carcinoma
6101,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage III
6102,Epithelial Component Present,Stage IVA Lip Cancer AJCC v6 and v7
6103,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,carcinosarcoma of fallopian tube
6104,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage III Plasma Cell Myeloma
6105,Carcinomatous Component Present,Colorectal Adenosquamous Carcinoma
6106,Well-Circumscribed Lesion,Nephroblastoma
6107,Epithelial Component Present,Bartholin Gland Transitional Cell Carcinoma
6108,Primary Lesion,"Brain Stem Neoplasms, Primary"
6109,Cutaneous Involvement,Pagetoid reticulosis
6110,Carcinomatous Component Present,Stage IB1 Cervical Cancer
6111,Intestinal metaplasia,Gastric Intestinal-Type Adenocarcinoma
6112,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma
6113,Epithelial Component Present,"Paget's Disease, Mammary"
6114,Dysplasia,Filiform Serrated Adenoma
6115,Carcinomatous Component Present,Stage IB2 Cervical Cancer
6116,Poorly Differentiated Lesion,Giant cell carcinoma of lung
6117,Epithelial Component Present,Inflammatory Breast Carcinoma
6118,Nuclear Pseudoinclusion,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
6119,Adulthood Lesion,Recurrent Aggressive Adult Non-Hodgkin Lymphoma
6120,Pregnancy Complications,Gestational Trophoblastic Neoplasms
6121,Locally Aggressive Lesion,Intermediate Soft Tissue Tumor of Uncertain Differentiation
6122,Indolent Clinical Course,Mediastinal Chondroma
6123,High Mitotic Activity,Colon Small Cell Neuroendocrine Carcinoma
6124,Localized Lesion,Solitary Myofibromatosis
6125,Mixed Cellular Population,Uterine Corpus Carcinosarcoma
6126,High Mitotic Activity,Testicular embryonal carcinoma stage III
6127,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma
6128,Carcinomatous Component Present,Posterior Tongue Squamous Cell Carcinoma
6129,Indolent Clinical Course,Lung Myolipoma
6130,Low Grade Lesion,Extracutaneous Mastocytoma
6131,Cartilaginous Differentiation,chondroma of lung
6132,Stromal Invasion,Serous cystadenocarcinoma ovary
6133,Pregnancy Complications,Placental polyp
6134,Epithelial Component Present,Regional Adrenal Gland Pheochromocytoma
6135,Monoclonal Cellular Population Present,Cutaneous Mastocytosis
6136,Composite Lesion,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
6137,Ganglioneuroblastoma Component Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
6138,Carcinomatous Component Present,Gastric Carcinoma with Lymphoid Stroma
6139,Lobulated Growth Pattern,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
6140,Floret-Like Pattern,Pleomorphic Lipoma
6141,Desmoplastic Stroma Formation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
6142,Biphasic Pattern,Ovarian Serous Adenofibroma
6143,Carcinomatous Component Present,Stage IA Vulvar Cancer AJCC v7
6144,Cavernous Vascular Space Formation,Cavernous hemangioma of retina
6145,Trabecular Pattern,Pancreatic Somatostatinoma
6146,Mixed Cellular Population,"Mixed Tumor, Not Otherwise Specified"
6147,Epithelial Component Present,Stage IV Esophageal Cancer AJCC v7
6148,Tubular Pattern,Duodenal Somatostatin-Producing Neuroendocrine Tumor
6149,Well-Circumscribed Lesion,Colon Sessile Serrated Adenoma/Polyp
6150,Severe dysplasia,Gastric Body Carcinoma In Situ AJCC v6 and v7
6151,Dysplasia,Rectal Sessile Serrated Adenoma/Polyp
6152,Epithelial Component Present,Common wart
6153,Serrated Glandular Architecture,Appendix Sessile Serrated Adenoma/Polyp
6154,Cutaneous Involvement,Subcutaneous panniculitis-like T-cell lymphoma
6155,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
6156,Argentaffin Positive Neoplastic Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
6157,Epithelial Component Present,High Grade Salivary Gland Mucoepidermoid Carcinoma
6158,Non-Malignant Cellular Infiltrate,Cutaneous pseudolymphoma
6159,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1A
6160,Indolent Clinical Course,Liver Lipoma
6161,Metastatic Lesion,Malignant Neoplasm with Regional Lymph Node Involvement
6162,Chronic Inflammatory Infiltrate,Histiocytoma
6163,Cutaneous Involvement,Stage IIB Merkel Cell Carcinoma AJCC v7
6164,Cervical Glandular Dysplasia,Low grade cervical glandular intraepithelial neoplasia
6165,Metastatic Lesion,Metastatic Benign Neoplasm
6166,Epithelial Component Present,Eccrine acrospiroma
6167,Neuroectodermal Differentiation,Extracranial Neuroblastoma
6168,Epithelial Component Present,"Cystadenoma, Papillary"
6169,Increased Cellularity Present,Anaplastic Hemispheric Astrocytoma
6170,Endophytic Tumor Growth,"Schneiderian papilloma, inverted"
6171,Intraductal Lesion,Usual ductal hyperplasia of breast
6172,Mild cytologic atypia,Verrucous carcinoma of oral cavity
6173,Childhood Lesion,Childhood Intracranial Neoplasm
6174,Metastatic/Recurrent Disease,"Perivascular epithelioid tumor, malignant"
6175,Dysplasia,Colorectal High Grade Intraepithelial Neoplasia
6176,Carcinomatous Component Present,Grade 2 Endometrial Endometrioid Adenocarcinoma
6177,Papillary Pattern,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
6178,Absence of Malignant Features,Benign tumor of choroid plexus
6179,Metastatic Lesion,Good Prognosis Metastatic Gestational Trophoblastic Tumor
6180,Multiple Tumor Masses,Multiple Skull Base Meningiomas
6181,Cutaneous Involvement,Benign Outer Hair Sheath and Infundibulum Neoplasm
6182,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Pineal Region Choriocarcinoma
6183,Immunosuppression-Related Post-Transplant Toxicity,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
6184,Well-Circumscribed Lesion,"Adenoma, Sweat Gland"
6185,Benign Cellular Infiltrate,Leiomyoma of esophagus
6186,Carcinomatous Component Present,Prostate carcinoma
6187,Epithelial Component Present,Glottis Verrucous Carcinoma
6188,Monoclonal Cellular Population Present,Macrofollicular adenoma
6189,Indolent Clinical Course,Bone Leiomyoma
6190,Misplaced Exocytosis Present,Mammosomatotroph Adenoma
6191,High Mitotic Activity,Pancreatic Large Cell Neuroendocrine Carcinoma
6192,Papillary Pattern,Human Papillomavirus-Related Verrucous Carcinoma
6193,Cholesterolosis,Adamantinous Craniopharyngioma
6194,Epithelial Component Present,Borderline Ovarian Serous Tumor with Microinvasion
6195,Microinvasive tumor,Borderline Ovarian Serous Tumor with Microinvasion
6196,Carcinomatous Component Present,Fallopian Tube Clear Cell Adenocarcinoma
6197,Angiodestructive Pattern,Grade I Lymphomatoid Granulomatosis
6198,Single Type of Tissue Derived from One Embryonic Layer Present,Monodermal teratoma
6199,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Skin
6200,Carcinomatous Component Present,adenoid cystic carcinoma of esophagus
6201,Cutaneous Involvement,Malignant neoplasm of skin
6202,Locally Aggressive Lesion,Intermediate Lipomatous Neoplasm
6203,Carcinomatous Component Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma
6204,Epithelial Component Present,Benign Prostate Phyllodes Tumor
6205,Indolent Clinical Course,Fibrofolliculoma
6206,Distortion of the Hair Follicle,Fibrofolliculoma
6207,Absence of Invasion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
6208,Non-Invasive Lesion,Bladder Non-Invasive Papillary Urothelial Neoplasm
6209,Epithelial Component Present,Carcinoma of extrahepatic bile duct
6210,Fibrotic Stroma Formation,Ovarian Mucinous Adenofibroma
6211,Epithelial Component Present,Laryngeal squamous cell carcinoma recurrent
6212,Adnexal Differentiation,Apocrine cystadenoma
6213,Epithelial Component Present,Moderately Differentiated Hepatocellular Carcinoma
6214,Osseous Differentiation,Stage IVB Osteosarcoma AJCC v7
6215,Contiguous Disease,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
6216,Papillary Pattern,"Carcinoma, Papillary"
6217,Epithelial Component Present,Intraductal papilloma of breast
6218,Locally Aggressive Lesion,Chest Wall Fibromatosis
6219,Epithelial Component Present,Thyroid Gland Clear Cell Follicular Adenoma
6220,Well-Circumscribed Lesion,Colorectal Adenomatous Polyp
6221,Indolent Clinical Course,Benign bone neoplasm
6222,Epithelial Component Present,Eccrine ductal carcinoma
6223,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical"
6224,Osseous Differentiation,Stage I Osteosarcoma AJCC v7
6225,Indolent Clinical Course,benign neoplasm of lymph nodes
6226,Cutaneous Involvement,Ductal Eccrine Carcinoma with Squamous Metaplasia
6227,Metastatic Lesion,Metastatic Non-Cutaneous Melanoma
6228,Dysplasia,Anogenital papillomaviral intraepithelial neoplasia
6229,Papillary Pattern,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia
6230,Epithelial Component Present,"Squamous cell carcinoma, clear cell type"
6231,Capillary Sized Vascular Channel Formation,Bone Epithelioid Hemangioma
6232,Immunologic Deficiency Syndromes,Transplant-Related Hepatocellular Carcinoma
6233,Cutaneous Involvement,Subcutaneous Nodular Fasciitis
6234,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
6235,Well-Circumscribed Lesion,Polyp of vulva
6236,Epithelial Component Present,"Carcinoma, Transitional Cell"
6237,Epithelial Component Present,Vaginal Adenosquamous Carcinoma
6238,Epithelial Component Present,Ocular Sebaceous Carcinoma
6239,Increased Cellularity Present,Cellular fibroma
6240,Local disease,Inner Ear Lipoma
6241,Epithelial Component Present,High Grade Ductal Breast Carcinoma In Situ
6242,Exophytic Polypoid Lesion,Gastric Juvenile Polyp
6243,Vascular Channel Formation,Retiform hemangioendothelioma
6244,atypia morphology,Atypical Adenomatous Lung Hyperplasia
6245,Neuroectodermal Differentiation,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
6246,Carcinomatous Component Present,Stage IIA Colon Cancer AJCC v7
6247,Recurrent disease,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma
6248,Well-Circumscribed Lesion,Desmoplastic fibroblastoma
6249,White blood cell count increased (lab result),"Leukemia, Myeloid, Chronic-Phase"
6250,Edematous Stroma Formation,Aggressive angiomyxoma
6251,Invasive Lesion,Poorly Differentiated Prostate Adenocarcinoma
6252,Indolent Clinical Course,Lipoma of small intestine
6253,Fried-Egg Appearance of the Bone Marrow,Progressive Hairy Cell Leukemia Initial Treatment
6254,Indolent Clinical Course,Pelvic lipomatosis
6255,Secondary Lesion,Secondary malignant neoplasm of urethra
6256,Desmoplastic Stroma Formation,Childhood Desmoplastic Small Round Cell Tumor
6257,Neuroendocrine Differentiation,Uterine Corpus Neuroendocrine Neoplasm
6258,Exophytic Polypoid Lesion,Ampulla of Vater Tubular Adenoma
6259,Childhood Lesion,Childhood Myxopapillary Ependymoma
6260,Lymphadenopathy,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
6261,Cutaneous Involvement,Deep Penetrating Nevus
6262,Epithelial Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7
6263,Single Type of Tissue Derived from One Embryonic Layer Present,"Struma ovarii, malignant"
6264,Cutaneous Involvement,Malignant vascular tumor of skin
6265,Indolent Clinical Course,Uterine Corpus Apoplectic Leiomyoma
6266,Epithelial Component Present,"Serous cystadenoma, borderline malignancy"
6267,Immunosuppression-Related Post-Transplant Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
6268,Epithelial Component Present,Squamous cell papilloma of eyelid
6269,Hereditary Lesion,Hyperparathyroidism-Jaw Tumor Syndrome
6270,Epithelial Component Present,Papillomatosis
6271,Infantile Lesion,Infant T Acute Lymphoblastic Leukemia
6272,Therapy-Related Toxicity,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
6273,Hydropic Villous Change,"Hydatidiform Mole, Invasive"
6274,Immunologic Deficiency Syndromes,AIDS-Related Anal Non-Hodgkin Lymphoma
6275,Papillary Pattern,"Papillomatosis, glandular"
6276,Encapsulated Mass,Benign cystic nephroma
6277,Perivascular Arrangement of Tumor Cells,Perivascular Epithelioid Cell Neoplasms
6278,Angiocentric Pattern,Pulmonary Lymphomatoid Granulomatosis
6279,Cutaneous Involvement,Stage I Acral Lentiginous Melanoma AJCC v7
6280,Local disease,Lumbosacral Lipoma
6281,Low Grade Lesion,Low Grade Lung Neuroendocrine Neoplasm
6282,S-100-Positive Neoplastic Cells Present,Epithelioid Type Angiomyolipoma
6283,Cutaneous Involvement,Stage III Acral Lentiginous Melanoma AJCC v7
6284,Invasive Lesion,Adenocarcinoma of the prostate stage II
6285,Cutaneous Involvement,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7
6286,Parakeratosis,Classic Type Trichilemmoma
6287,Plexiform Vasculature Present,Ovarian Low Grade Endometrioid Stromal Sarcoma
6288,Melanosomes Present,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
6289,High Mitotic Activity,Childhood Anaplastic Oligoastrocytoma
6290,Indolent Clinical Course,Gastric Leiomyoma
6291,Adulthood Lesion,Adult Mixed Glioma
6292,Locally Aggressive Lesion,Atypical Lipoma
6293,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
6294,Epithelial Component Present,Adenocarcinoma of pancreas
6295,Nuclear pleomorphism,Bizarre leiomyoma
6296,Carcinomatous Component Present,Stage IVA Oral Cavity Cancer AJCC v6 and v7
6297,Exophytic Polypoid Lesion,Gardner Syndrome
6298,Carcinomatous Component Present,Stage III Rectal Cancer AJCC v7
6299,Adulthood Lesion,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
6300,Anaplasia,Childhood Cerebellar Anaplastic Astrocytoma
6301,Lytic lesion,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone
6302,Low Mitotic Activity,Glucagonoma
6303,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v7
6304,Well-Circumscribed Lesion,Preauricular skin tag
6305,Cutaneous Involvement,Cutaneous Follicular Lymphoma
6306,Swelling,Giant Cell Tumor of Bone
6307,Indolent Clinical Course,Benign Osteoclastic Giant Cell-Rich Tumor of Bone
6308,Epithelial Component Present,Fibrolamellar Hepatocellular Carcinoma
6309,Childhood Lesion,Recurrent Childhood Optic Nerve Astrocytoma
6310,Ineffective hematopoiesis,Acute myeloid leukemia with multilineage dysplasia
6311,Papillary Pattern,Anal Verrucous Carcinoma
6312,Low Grade Lesion,Congenital Mesoblastic Nephroma
6313,Mitotic Activity,Recurrent Childhood Gliosarcoma
6314,Dysplasia,Low Grade Ductal Breast Carcinoma In Situ
6315,Secondary Lesion,Metastatic Neoplasm to the Bladder
6316,Diffuse Pattern,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified"
6317,Epithelial Component Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
6318,Nuclear Pseudoinclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
6319,Extraosseous Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma
6320,Fibromyxoid Stroma Formation,Fibromyxolipoma
6321,Biphasic Pattern,carcinosarcoma of extrahepatic bile duct
6322,CD30-Positive Neoplastic Cells Present,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder
6323,Epithelial Component Present,Minor Salivary Gland Undifferentiated Carcinoma
6324,Cutaneous Involvement,Cutaneous Fibrohistiocytic Neoplasm
6325,Cutaneous Involvement,Eccrine Poroma
6326,atypia morphology,Bowenoid papulosis
6327,Local disease,Localized Malignant Neoplasm
6328,Aggressive Clinical Course,Digital papillary eccrine carcinoma of skin
6329,Epithelial Component Present,Stage IA Gastric Carcinoma
6330,Hereditary Lesion,Beckwith-Wiedemann Syndrome
6331,Osseous Differentiation,Stage III Osteosarcoma AJCC v7
6332,Secondary Lesion,Metastatic Bone Ewing Sarcoma
6333,Childhood Lesion,Classic Congenital Mesoblastic Nephroma
6334,Childhood Lesion,Childhood Gastrointestinal Stromal Tumor
6335,Secondary Lesion,Adenocarcinoma of Unknown Primary
6336,Therapy-Related Toxicity,Cutaneous Radiation-Related Angiosarcoma
6337,Hemorrhagic,Cutaneous Radiation-Related Angiosarcoma
6338,Non-Invasive Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
6339,Mitotic Activity,Adult Anaplastic Astrocytoma
6340,Carcinomatous Component Present,Gastric carcinoma stage IV
6341,Borderline Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
6342,Carcinomatous Component Present,Papillary Lung Adenocarcinoma
6343,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma
6344,Multinodular Mass,Angiosarcoma of the breast
6345,Organoid Pattern,Alveolar soft part sarcoma recurrent
6346,High Mitotic Activity,Anaplastic Pleomorphic Xanthoastrocytoma
6347,Cutaneous Involvement,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7
6348,Carcinomatous Component Present,Stage II Vulva Cancer AJCC v6
6349,Epithelial Component Present,Stage II Vulva Cancer AJCC v6
6350,Osseous Differentiation,Cementoma
6351,Recurrent disease,Adult T-cell lymphoma/leukemia recurrent
6352,Calcitonin serum level increased,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
6353,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
6354,Epithelial Component Present,Ethmoid Sinus Inverted Papilloma
6355,Carcinomatous Component Present,Laryngeal Mucoepidermoid Carcinoma
6356,Cystic Change,Pilomatrixoma
6357,Indolent Clinical Course,Bladder Leiomyoma
6358,Lymphoplasmacytic Infiltrate,gamma-Chain Disease
6359,Severe dysplasia,Stage 0 Appendix Carcinoma AJCC v7
6360,Myxoid Stroma Formation,Cutaneous myxoma
6361,Increased Cellularity Present,Childhood Brain Anaplastic Astrocytoma
6362,Carcinomatous Component Present,Gastric Mixed Adenocarcinoma
6363,CD30-Positive Neoplastic Cells Present,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive"
6364,Mesenchymal Component Present,Intracanalicular fibroadenoma
6365,Non-Malignant Cellular Infiltrate,Suppurative lymphadenopathy
6366,Carcinomatous Component Present,Cholangiocarcinoma non-resectable
6367,Locally Aggressive Lesion,Lung Inflammatory Myofibroblastic Tumor
6368,Gyriform Trabecular Pattern,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
6369,Epithelial Differentiation,Epithelial Predominant Kidney Wilms Tumor
6370,Epithelial Component Present,"Carcinoid, Goblet Cell"
6371,Carcinomatous Component Present,Gastric Cardia Carcinoma
6372,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v7
6373,Microcystic Change,Pilocytic Astrocytoma
6374,Epithelial Component Present,"Cystadenoma, Serous"
6375,Cartilaginous Differentiation,Metastasizing Chondroblastoma
6376,Hyperkeratosis,Vaginal Papillary Carcinoma
6377,Carcinomatous Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
6378,Epithelial Component Present,Rectosigmoid Cancer by AJCC v7 Stage
6379,Slow Growing Mass,olfactory neuroblastoma of nasal cavity
6380,High Mitotic Activity,Primary hepatic neuroendocrine carcinoma
6381,Chromogranin A Positive Neoplastic Cells Present,Ovarian Mucinous Carcinoid Tumor
6382,Neuroendocrine Differentiation,Ovarian Trabecular Carcinoid Tumor
6383,Perineural spread,Anterior Tongue Adenoid Cystic Carcinoma
6384,Epithelial Component Present,Stage IIB Ampulla of Vater Cancer AJCC v7
6385,Nodular Pattern,Grade 3 Cutaneous Follicular Lymphoma
6386,Epithelial Component Present,Adenoma of rete ovarii
6387,In Situ Lesion,Cervical Adenocarcinoma In Situ
6388,Cavernous Lymphatic Space Formation,Cavernous lymphangioma
6389,Collagenous Stroma Formation,Gliofibroma
6390,Cartilaginous Differentiation,"Chondrosarcoma, Clear Cell"
6391,Well-Circumscribed Lesion,Rete Ovarii Cystadenoma
6392,Epithelial Component Present,Vaginal Large Cell Neuroendocrine Carcinoma
6393,Alternative Fascicle (Bundle) Pattern,Leiomyoma of lung
6394,Carcinomatous Component Present,Stage 0 Lip Carcinoma
6395,Metastatic/Recurrent Disease,Cardiac Synovial Sarcoma
6396,Pregnancy Complications,Stage IVA Gestational Trophoblastic Tumor AJCC v7
6397,Severe dysplasia,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8"
6398,Fibrotic Stroma Formation,endometrioid adenofibroma of ovary
6399,atypia morphology,"Endometrioid adenoma, borderline malignancy"
6400,Osteoid formation,Extraskeletal Osteosarcoma
6401,Biphasic Pattern,clear cell adenocarcinofibroma of ovary
6402,Myxoid Stroma Formation,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
6403,Papillary Pattern,Cervical Verrucous Carcinoma
6404,Hyperkeratosis,Cervical Verrucous Carcinoma
6405,Keratin Horn Pearls Formation,Squamous cell carcinoma with horn formation
6406,Recurrent disease,Extraskeletal osteosarcoma recurrent
6407,Carcinomatous Component Present,Stage IV Skin Cancer
6408,Epithelial Component Present,Oropharyngeal Carcinoma
6409,Carcinomatous Component Present,Lung squamous cell carcinoma stage I
6410,Syncytial Pattern,Cervical Lymphoepithelioma-Like Carcinoma
6411,Exophytic Polypoid Lesion,Polyp of esophagus
6412,Locally Aggressive Lesion,Desmoplastic fibroma
6413,Carcinomatous Component Present,Adenocarcinoma of anus
6414,Slow Growing Painless Mass,Nodular tenosynovitis
6415,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gestational choriocarcinoma
6416,Mixed Cellular Population,"Uterine Carcinosarcoma, Homologous Type"
6417,Carcinomatous Component Present,FIGO Stage IVB Ovarian Cancer
6418,Cafe-au-Lait Spots,McCune-Albright Syndrome
6419,Epithelial Component Present,Malignant Paraganglionic Neoplasm
6420,Mixed Cellular Population,Fibroadenoma of breast
6421,Hyperplastic Tissue Present,Bronchial Epithelial Hyperplasia
6422,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Mature Teratoma
6423,Epithelial Component Present,Childhood Choroid Plexus Neoplasm
6424,Vascular Channel Formation,Skin Cavernous Hemangioma
6425,Severe cytologic atypia,Colorectal Small Cell Neuroendocrine Carcinoma
6426,Cystic Change,Malignant ovarian cyst
6427,Carcinomatous Component Present,Stage IIB Fallopian Tube Cancer AJCC v6 and v7
6428,Epithelial Component Present,Pilomatrix carcinoma of skin
6429,Cutaneous Involvement,Metastatic Dermatofibrosarcoma Protuberans
6430,Neuroendocrine Differentiation,Bartholin Gland Small Cell Carcinoma
6431,Carcinomatous Component Present,Uterine Ligament Adenocarcinoma
6432,Nuclear Atypia,"Glioblastoma, IDH-Mutant"
6433,Indolent Clinical Course,Ventricular myxoma
6434,Cutaneous Involvement,inverted follicular keratosis
6435,Epithelial Component Present,inverted follicular keratosis
6436,Infiltrative Growth Pattern,Diffuse Astrocytoma
6437,Carcinomatous Component Present,Gallbladder adenocarcinoma
6438,Diffuse Pattern,Giant Cell Glioblastoma
6439,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Childhood Myelodysplastic Syndrome
6440,Tissue Differentiation Uncertain,Myxofibroma
6441,Epithelial Component Present,Rectal Signet Ring Cell Adenocarcinoma
6442,Childhood Lesion,Childhood Malignant Ovarian Germ Cell Tumor
6443,Locally Aggressive Lesion,Dupuytren Contracture
6444,Adulthood Lesion,Indolent Adult Non-Hodgkin Lymphoma
6445,Vater-Pacini Corpuscles-Like Structures Present,Pacinian tumor
6446,Epithelial Component Present,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor
6447,Hyaline Cartilage Differentiation,Mediastinal Chondroma
6448,Epithelial Component Present,Broad Ligament Serous Adenofibroma
6449,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v7
6450,Hereditary Lesion,Hereditary Fallopian Tube Carcinoma
6451,Childhood Lesion,Malignant Childhood Neoplasm
6452,Epithelial Differentiation,Secretory meningioma
6453,Epithelial Component Present,Oropharyngeal cancer recurrent
6454,Well-Circumscribed Lesion,Medullary carcinoma of breast
6455,S-100-Positive Neoplastic Cells Present,Benign Uterine Corpus PEComa
6456,Well-Circumscribed Lesion,Anaplastic Kidney Wilms Tumor
6457,"Undifferentiated ""Fetal-Type"" Tissues Present",Adult Central Nervous System Immature Teratoma
6458,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
6459,Cutaneous Involvement,Keratosis pilaris
6460,Carcinomatous Component Present,Stage III Liver Cancer
6461,Epithelial Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7
6462,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7
6463,Carcinomatous Component Present,Endometrial Small Cell Carcinoma
6464,Epithelial Component Present,Low Grade Conjunctival Intraepithelial Neoplasia
6465,Epithelial Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7
6466,Calcitonin Positive Neoplastic Cells Present,Familial medullary thyroid carcinoma
6467,Follicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
6468,Malignant Germinomatous Cellular Infiltrate,Childhood Central Nervous System Germinoma
6469,Epithelial Component Present,Adenocarcinoma of appendix
6470,Epithelial Component Present,Stage IV Ampulla of Vater Cancer AJCC v7
6471,Carcinomatous Component Present,Breast cancer recurrent
6472,Epithelial Component Present,Stage III Appendix Neuroendocrine Tumor AJCC v7
6473,Multifocal Lesion,Chondromatosis
6474,Cystic Change,Trichoadenoma
6475,Well-Circumscribed Lesion,Endocervical polyp
6476,Pregnancy Complications,Uterine Corpus Choriocarcinoma
6477,Epithelial Component Present,Stage III Nasopharyngeal Carcinoma AJCC v7
6478,Recurrent disease,Recurrent Childhood Acute Lymphoblastic Leukemia
6479,Collagenous Stroma Formation,Vaginal Angiomyofibroblastoma
6480,Pseudoglandular Pattern,Acantholytic squamous cell carcinoma
6481,Epithelial Component Present,Ethmoid Sinus Adenoid Cystic Carcinoma
6482,Papillary Pattern,Childhood Thyroid Gland Papillary Carcinoma
6483,Immunologic Deficiency Syndromes,Immunodeficiency-Related Malignant Neoplasm
6484,Epithelial Component Present,Appendix Low Grade Intraepithelial Neoplasia
6485,Hereditary Lesion,Dominant hereditary optic atrophy
6486,Multinodular Pattern,Vulvar Proximal-Type Epithelioid Sarcoma
6487,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
6488,Papillary Pattern,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
6489,Slit-Like Stromal Retraction Present,Multifocal superficial basal cell carcinoma
6490,Follicular Cell Differentiation,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
6491,Epithelial Component Present,Adenocarcinoma with neuroendocrine differentiation
6492,Calcitonin Positive Neoplastic Cells Present,Childhood Thyroid Gland Medullary Carcinoma
6493,Exophytic Polypoid Lesion,Urethral Villous Adenoma
6494,Acquired Lesion,Hemangioma acquired
6495,Cutaneous Involvement,Malignant Cutaneous Granular Cell Tumor
6496,Severe dysplasia,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
6497,Cytoplasmic Membrane-Bound Granules Present,Stage IIIA Merkel Cell Carcinoma AJCC v7
6498,Cutaneous Involvement,Signet Ring Melanoma
6499,Nuclear Pseudoinclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
6500,Anaplasia,Anaplastic Hemispheric Astrocytoma
6501,Mitotic Activity,Anaplastic Diencephalic Astrocytoma
6502,Hyperplastic Epithelial Tissue Present,Usual ductal hyperplasia of breast
6503,Epithelial Component Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
6504,Carcinomatous Component Present,Low Grade Salivary Gland Carcinoma
6505,Cystic Change,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
6506,Well-Circumscribed Lesion,Colon Hyperplastic Polyp
6507,Epithelial Component Present,Appendix High Grade Intraepithelial Neoplasia
6508,Eccrine Differentiation,eccrine adenocarcinoma of vulva
6509,Carcinomatous Component Present,Stage IV Hepatocellular Carcinoma AJCC v7
6510,Thin-Walled Branching Vascular Pattern,Hemangiopericytoma of meninges
6511,Epithelial Component Present,Stage I Paranasal Sinus Cancer
6512,High Mitotic Activity,Extragonadal primary embryonal carcinoma
6513,Sarcomatous Component Present,Malignant phyllodes tumor of breast
6514,Primary Lesion,Small cell osteosarcoma
6515,Oligodendroglial Component Present,Oligodendroglial Neoplasm
6516,Slow Growing Mass,Adamantinous Craniopharyngioma
6517,Epithelial Component Present,Squamous Papilloma of the Larynx
6518,Epithelial Component Present,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
6519,Carcinomatous Component Present,Undifferentiated Fallopian Tube Carcinoma
6520,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage IV
6521,Local disease,Intramuscular lipoma
6522,Diffuse Pattern,Centroblastic lymphoma stage IV
6523,Childhood Lesion,Primary Childhood Soft Tissue Sarcoma
6524,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma
6525,Epithelial Component Present,Esophageal squamous papilloma
6526,Epithelial Component Present,"Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8"
6527,Nuclear Atypia,Glioblastoma
6528,Carcinomatous Component Present,Bladder adenocarcinoma stage II
6529,Papillary Pattern,verrucous carcinoma of bladder
6530,Epithelial Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
6531,Dysplasia,Colorectal Traditional Serrated Adenoma
6532,Moderately Differentiated Lesion,Moderately Differentiated Hepatocellular Carcinoma
6533,Endophytic Tumor Growth,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
6534,Epithelial Component Present,Unclassified Renal Cell Carcinoma
6535,Mucoid Stroma Formation,Acinar Prostate Mucinous Adenocarcinoma
6536,Syncytial Pattern,Laryngeal Lymphoepithelial Carcinoma
6537,Cellular Changes Resembling Foveolar Epithelium Cells,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
6538,Tissue Differentiation Uncertain,Hemosiderotic Fibrolipomatous Tumor
6539,Epithelial Component Present,Small Intestinal Medullary Carcinoma
6540,Tubular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
6541,Epithelial Component Present,Stage II Lung Small Cell Carcinoma AJCC v7
6542,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q)
6543,Cutaneous Involvement,Acrokeratosis Verruciformis of Hopf
6544,Carcinomatous Component Present,Thyroid Hurthle Cell Carcinoma
6545,Indolent Clinical Course,Solitary Adult Fibroma
6546,Carcinomatous Component Present,Transplant-Related Carcinoma
6547,Indolent Clinical Course,Rectal Lipoma
6548,Epithelial Component Present,Stage IIB Rectal Cancer AJCC v7
6549,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myelomonocytic Leukemia
6550,Rapidly Enlarging Mass,Nodular fasciitis
6551,Cutaneous Involvement,Scabies <infestation>
6552,Carcinomatous Component Present,Hereditary Male Breast Carcinoma
6553,Well-Circumscribed Lesion,Adenoma of small intestine
6554,Childhood Lesion,Dysembryoplastic neuroepithelial tumor
6555,Cutaneous Involvement,Skin Pigmentation Disorder
6556,Lymphadenopathy,Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma
6557,Therapy-Related Toxicity,Transplant-Related Lung Carcinoma
6558,Alternative Fascicle (Bundle) Pattern,Leiomyoma of small intestine
6559,Local disease,Adrenal Cortex Adenomatoid Tumor
6560,Keratin pearl formation,"Lung Squamous Cell Carcinoma, Papillary Variant"
6561,Cutaneous Involvement,Ocular Sebaceous Carcinoma
6562,Locally Aggressive Lesion,Kaposiform Hemangioendothelioma
6563,Immunologic Deficiency Syndromes,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
6564,Multinodular Pattern,Proximal-Type Epithelioid Sarcoma
6565,Dysplasia,tubulopapillary adenoma of gallbladder
6566,Carcinomatous Component Present,undifferentiated carcinoma of salivary gland
6567,Epithelial Component Present,Gastric adenoma
6568,Epithelial Component Present,verrucous carcinoma of vulva
6569,Tissue Differentiation Uncertain,"Vulvar Deep ""Aggressive"" Angiomyxoma"
6570,Epithelial Component Present,ENSAT Stage I Adrenal Cortex Carcinoma
6571,Vascular Channel Formation,Vulvar Superficial Angiomyxoma
6572,Local disease,lipoma of bone
6573,Carcinomatous Component Present,Fallopian Tube Transitional Cell Carcinoma
6574,CD56-Positive Neoplastic Cells Present,childhood nasal type extranodal NK/T-cell lymphoma
6575,Metastatic Lesion,Metastatic malignant neoplasm to brain
6576,Rapidly Enlarging Mass,Anaplastic thyroid carcinoma
6577,Carcinomatous Component Present,Oropharyngeal Carcinoma by AJCC v7 Stage
6578,Cutaneous Involvement,Epidermolytic acanthoma
6579,Neuroendocrine Differentiation,Glomus Tympanicum Tumor
6580,Well-Circumscribed Lesion,Medullary carcinoma of thyroid
6581,Well-Circumscribed Lesion,Precancerous Polyp
6582,Dysplasia,Intraepithelial Neoplasia
6583,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Tumor G1
6584,Metastatic/Recurrent Disease,Childhood Desmoplastic Small Round Cell Tumor
6585,Epithelial Component Present,Stage IIA Rectal Cancer AJCC v7
6586,atypia morphology,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
6587,Epithelial Component Present,Ampulla of Vater Tubular Adenoma
6588,Metastatic/Recurrent Disease,Adult Desmoplastic Small Round Cell Tumor
6589,Perineural spread,Adenoid cystic breast carcinoma
6590,Dentin formation,"Fibro-odontoma, Ameloblastic"
6591,Epithelial Component Present,Stage IB Lung Adenosquamous Carcinoma AJCC v7
6592,Recurrent disease,recurrent childhood acute myeloid leukemia
6593,Fibrotic Stroma Formation,Brenner Tumor
6594,Cutaneous Involvement,Benign neoplasm of sweat gland
6595,Cartilaginous Component Present,Hamartoma of lung
6596,Invasive Lesion,Adenocarcinoma of the prostate stage I
6597,Intraductal Lesion,Intracystic Papillary Breast Carcinoma
6598,Pseudoalveolar Pattern,Vulvar Alveolar Soft Part Sarcoma
6599,Systemic disease,Smoldering Systemic Mastocytosis
6600,Epithelial Component Present,Rectal Sarcomatoid Carcinoma
6601,Cartilaginous Differentiation,Chondroblastoma
6602,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Alkylating Agent-Related Acute Myeloid Leukemia
6603,Bone Marrow Involvement,Waldenstrom Macroglobulinemia
6604,Adulthood Lesion,Adult Pineoblastoma
6605,Dysplasia,Transitional cell carcinoma in situ
6606,Adnexal Differentiation,Syringoma
6607,Severe dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
6608,Epithelial Component Present,Atypical carcinoid tumor
6609,Carcinomatous Component Present,Gastric Cardia Adenocarcinoma
6610,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myelomonocytic Leukemia
6611,Nested Pattern,Adult Clear Cell Sarcoma of Soft Parts
6612,Nodular Pattern,Recurrent Grade 2 Follicular Lymphoma
6613,Epithelial Component Present,Bladder Urothelial Papilloma
6614,Metastatic Lesion,Undifferentiated Carcinoma of Unknown Primary
6615,Secondary Lesion,Metastatic urothelial carcinoma
6616,Papillary Pattern,Serous surface papilloma
6617,Epithelial Component Present,Serous surface papilloma
6618,Pseudorosette Formation,Pancreatic Gastrin-Producing Neuroendocrine Tumor
6619,Carcinomatous Component Present,Luminal B Breast Carcinoma
6620,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Flat Ductal Epithelial Atypia of the Breast
6621,Microfollicular Structures Present,Ovarian gynandroblastoma
6622,Epithelial Component Present,Grade 2 Colon Adenocarcinoma
6623,Childhood Lesion,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
6624,Osseous Differentiation,Primary Bone Osteosarcoma
6625,Non-Hereditary Lesion,Parietal cell carcinoma
6626,Well-Circumscribed Lesion,Gingival Angiofibroma
6627,Hereditary Lesion,Hereditary corneal dystrophy
6628,Severe cytologic atypia,Esophageal Neuroendocrine Carcinoma
6629,Epithelial Component Present,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor
6630,Pseudopapillary Pattern,Solid pseudopapillary tumor of the pancreas
6631,High Grade Lesion,Sclerosing rhabdomyosarcoma
6632,Diffuse Pattern,Recurrent Childhood Glioblastoma
6633,Papillary Pattern,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
6634,Glial Differentiation,Recurrent Childhood Gliosarcoma
6635,Follicular Cell Differentiation,Familial Nonmedullary Thyroid Gland Carcinoma
6636,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma AJCC v7
6637,Epithelial Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
6638,Tubular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor
6639,Resectable Mass,Hepatoblastoma resectable
6640,High Grade Lesion,Occult Lung Small Cell Carcinoma
6641,CD30-Positive Neoplastic Cells Present,Primary cutaneous CD30+ T-cell lymphoproliferative disorder
6642,Recurrent disease,Recurrent Childhood Burkitt Lymphoma
6643,Recurrent disease,Recurrent Spinal Cord Neoplasm
6644,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland
6645,Epithelial Component Present,Stage 0 Renal Pelvis Cancer AJCC v7
6646,Epithelial Component Present,Endolymphatic sac tumor
6647,Recurrent disease,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent
6648,Epithelial Component Present,Undifferentiated carcinoma of stomach
6649,Presence of a Hormonal Syndrome,Functioning Pancreatic Neuroendocrine Tumor G2
6650,Koilocytotic atypia,Vulvar Warty Carcinoma
6651,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myelomonocytic leukemia with abnormal eosinophils
6652,Hemorrhagic,Mediastinal Angiosarcoma
6653,Lymphoplasmacytic Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis
6654,Carcinomatous Component Present,Cervical Large Cell Neuroendocrine Carcinoma
6655,Exophytic Polypoid Lesion,Colon Juvenile Polyp
6656,Epithelial Component Present,Schneiderian carcinoma
6657,Carcinomatous Component Present,Stage I Prostate Cancer AJCC v7
6658,Carcinomatous Component Present,Stage II Prostate Cancer AJCC v7
6659,Severe cytologic atypia,Recurrent Pancreatic Neuroendocrine Carcinoma
6660,Intraosseous Lesion,Follicular ameloblastoma
6661,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral"
6662,Metastatic Lesion,Extraskeletal osteosarcoma metastatic
6663,Acquired Lesion,Acquired keratoderma
6664,Mixed Cellular Population,Adenosarcoma of cervix uteri
6665,Peripheral Nuclear Palisading,Cervical Basaloid Carcinoma
6666,Well Developed Rough Endoplasmic Reticulum Present,Sparsely Granulated Lactotroph Adenoma
6667,Pagetoid Proliferation,Stage IV Superficial Spreading Melanoma AJCC v6 and v7
6668,Cutaneous Involvement,Skin Metatypical Carcinoma
6669,Papillary Pattern,Clear Cell Papillary Cystadenoma
6670,Papillary Pattern,Papillary mucinous cystadenocarcinoma
6671,Metastatic/Recurrent Disease,Alveolar soft part sarcoma metastatic
6672,Diffuse Lesion,Intraductal Breast Papillomatosis
6673,Hyperplastic Tissue Present,Endometrial cystic hyperplasia
6674,Tubular Structures Present,Fetal Lung Adenocarcinoma
6675,Epithelial Component Present,High Grade Corneal Intraepithelial Neoplasia
6676,Vascular Channel Formation,Breast Epithelioid Hemangioma
6677,Carcinomatous Component Present,Nasopharyngeal cancer recurrent
6678,Epithelial Component Present,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
6679,Epithelial Component Present,Biliary Intraepithelial Neoplasia-3
6680,Dysplasia,Biliary Intraepithelial Neoplasia-3
6681,Biphasic Pattern,Uterine Corpus Carcinofibroma
6682,Dysplasia,adenomatous polyp of stomach
6683,Epithelial Component Present,Ovarian Cancer by FIGO Stage
6684,Recurrent disease,Recurrent Non-Hodgkin Lymphoma
6685,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
6686,Neuroendocrine Differentiation,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7
6687,Pregnancy Complications,Hypertension associated disorders of pregnancy
6688,Biphasic Pattern,Adenosarcoma
6689,Metastatic Lesion,Secondary malignant neoplasm of nervous system
6690,Epithelial Component Present,Hereditary Leiomyomatosis and Renal Cell Cancer
6691,High Grade Lesion,Vulvar Alveolar Rhabdomyosarcoma
6692,Diffuse Pattern,Childhood Brain Anaplastic Astrocytoma
6693,Multinodular Mass,"Dermatofibrosarcoma Protuberans, Myxoid"
6694,Cutaneous Involvement,Stage I Superficial Spreading Melanoma AJCC v7
6695,Adnexal Differentiation,Trichoepithelioma
6696,Immunologic Deficiency Syndromes,AIDS-Related Enterocolitis
6697,Papillary Pattern,Verrucous carcinoma of the oral cavity recurrent
6698,Junctional Proliferation,Epithelioid and spindle cell nevus
6699,Pushing Tumor Margin,Endometrial stromal nodule
6700,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Microadenoma
6701,Carcinomatous Component Present,Pleomorphic carcinoma
6702,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant"
6703,Well-Circumscribed Lesion,Mixed cell adenoma
6704,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Polyp
6705,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity recurrent
6706,Carcinomatous Component Present,TSH-Producing Pituitary Gland Carcinoma
6707,Osteoid formation,Adult Extraskeletal Osteosarcoma
6708,Systemic disease,Systemic EBV positive T-cell lymphoproliferative disease of childhood
6709,Osseous Differentiation,Osteosarcoma
6710,Well-Circumscribed Lesion,Colon Adenoma with Severe Dysplasia
6711,Chromogranin A Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell"
6712,Exophytic Papillary Lesion,Verrucous carcinoma
6713,Epithelial Component Present,Gastric Cancer by AJCC v7 Stage
6714,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v7
6715,Epithelial Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
6716,Diffuse Pattern,large B-cell diffuse lymphoma of kidney
6717,Epithelial Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type"
6718,Childhood Lesion,Childhood Pilocytic Astrocytoma
6719,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
6720,Epithelial Component Present,Large cell lung cancer stage IV
6721,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma
6722,Epithelial Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
6723,Well-Circumscribed Lesion,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
6724,Necrotic changes (finding),large cell neuroendocrine carcinoma of anal canal
6725,Vascular Channel Formation,Kaposi's sarcoma of extrahepatic bile duct
6726,Carcinomatous Component Present,Type 1 Papillary Renal Cell Carcinoma
6727,Carcinomatous Component Present,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
6728,Multifocal Lesion,HIV lipodystrophy
6729,Perivascular Arrangement of Tumor Cells,Venous Angioleiomyoma
6730,Microcystic Change,Sclerosing Polycystic Adenosis
6731,Epithelial Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
6732,Childhood Lesion,Childhood Neuroblastoma
6733,Lytic lesion,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone
6734,Carcinomatous Component Present,Stage IA1 Cervical Cancer
6735,Cutaneous Involvement,Precancerous skin lesion
6736,Epidermal Involvement,Compound nevus of skin
6737,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Acute Promyelocytic Leukemia
6738,Epithelial Component Present,Adenocarcinoma of lung (disorder)
6739,Invasive Lesion,Prolactin-Producing Pituitary Gland Carcinoma
6740,Epithelial Component Present,Labia Minora Carcinoma
6741,Vascular Channel Formation,Diffuse Pulmonary Lymphangiomatosis
6742,Lymphoplasmacytic Infiltrate,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
6743,Cutaneous Involvement,Cutaneous Mantle Cell Lymphoma
6744,Infiltrative Growth Pattern,Glioblastoma by Gene Expression Profile
6745,Diffuse Pattern,Childhood Oligodendroglioma
6746,Lytic lesion,Solitary Osseous Plasmacytoma
6747,Therapy-Related Toxicity,Treatment related secondary malignancy
6748,Carcinomatous Component Present,Squamous cell carcinoma with horn formation
6749,Adulthood Lesion,Stage IV Adult Soft Tissue Sarcoma AJCC v7
6750,Cutaneous Involvement,Malignant melanoma in junctional nevus
6751,Carcinomatous Component Present,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
6752,Nuclear Grooves,Oncocytic Variant Thyroid Gland Papillary Carcinoma
6753,Carcinomatous Component Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma
6754,Carcinomatous Component Present,Stage IIB Ovarian Cancer AJCC v6 and v7
6755,Pseudostratified Tumor Cells Present,"Endocervical Adenocarcinoma, Usual Type"
6756,Carcinomatous Component Present,Stage IA Lung Adenocarcinoma AJCC v7
6757,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
6758,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
6759,Peripheral Nuclear Palisading,Nasopharyngeal Basaloid Squamous Cell Carcinoma
6760,Carcinomatous Component Present,Paget Disease Extramammary
6761,Low Mitotic Activity,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
6762,Epithelial Component Present,Stage IV Penile Cancer AJCC v7
6763,Carcinomatous Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v7
6764,Epithelial Component Present,Invasive Mixed Breast Carcinoma
6765,Epithelial Component Present,Soft Palate Pleomorphic Adenoma
6766,Childhood Lesion,Stage IV Childhood Hodgkin Lymphoma
6767,Benign Cellular Infiltrate,Benign neoplasm of gallbladder
6768,Recurrent disease,Recurrent Childhood Spinal Cord Neoplasm
6769,Recurrent disease,Mycosis fungoides/Sezary syndrome recurrent
6770,Carcinomatous Component Present,Fallopian Tube Gestational Choriocarcinoma
6771,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage IV
6772,Invasive Lesion,Metastatic Dermatofibrosarcoma Protuberans
6773,High Grade Lesion,"Glioblastoma, IDH-Mutant"
6774,Well-Circumscribed Lesion,Adult Pineocytoma
6775,Epithelial Component Present,Stage 0 Cervical Cancer AJCC v6
6776,Primary Lesion,Recurrent Childhood Cerebellar Astrocytoma
6777,Epithelial Component Present,Stage IIA Cervical Cancer AJCC v6
6778,Childhood Lesion,Childhood Myelodysplastic Syndrome
6779,Epithelial Component Present,Gallbladder adenoma
6780,Primary Lesion,Osteoblastic Osteosarcoma
6781,Hypokalemia,Malignant Pancreatic Vipoma
6782,Nuclear pleomorphism,Choroid Plexus Carcinoma
6783,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
6784,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
6785,Calcitonin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
6786,Adulthood Lesion,Refractory Adult Acute Lymphoblastic Leukemia
6787,Carcinomatous Component Present,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation
6788,Squamous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation
6789,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7
6790,Pregnancy Complications,"Placenta, Retained"
6791,Epithelial Component Present,Squamous cell carcinoma of the nasal cavity
6792,Cellular Pleomorphism,Malignant Testicular Sertoli Cell Tumor
6793,Slow Growing Mass,Adult Ganglioglioma
6794,Metastatic Lesion,Metastases to adrenals
6795,Carcinomatous Component Present,Gastric Hepatoid Adenocarcinoma
6796,Mesenchymal Component Present,Vulvar Ectopic Fibroadenoma
6797,Primary Lesion,Adult Brain Medulloblastoma
6798,Well-Circumscribed Lesion,Hibernoma
6799,Infiltrative Growth Pattern,Adult Brain Glioblastoma
6800,Adulthood Lesion,Adult Brain Glioblastoma
6801,Cutaneous Involvement,Benign Pilar-Associated Mesenchyme Neoplasm
6802,Chronic lymphocytic inflammation,Lymphohistiocytoid Mesothelioma
6803,Splenomegaly,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
6804,Papillary Pattern,Pedunculated conjunctival papilloma
6805,Invasive Lesion,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant"
6806,Neuroendocrine Differentiation,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
6807,Well Differentiated Lesion,Well Differentiated Ovarian Steroid Cell Tumor
6808,Secondary Lesion,Secondary malignant neoplasm of brain stem
6809,Epithelial Component Present,Epithelial tumor of ovary
6810,Carcinomatous Component Present,Stage IIIB Breast Carcinoma
6811,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1
6812,Chronic lymphocytic inflammation,"Thymoma, type B1, malignant"
6813,Epithelial Component Present,"Thymoma, type B3"
6814,Carcinomatous Component Present,Ameloblastic Carcinoma
6815,Epithelial Component Present,Bladder transitional cell carcinoma stage III
6816,Nuclear Pseudoinclusion,Childhood Thyroid Gland Papillary Carcinoma
6817,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v6
6818,Severe dysplasia,Carcinoma in situ of ampulla of Vater
6819,Cutaneous Involvement,Intermediate Cutaneous Fibrohistiocytic Neoplasm
6820,Collagenous Stroma Formation,Sclerosing thymoma
6821,Chronic Inflammatory Infiltrate,Adult Mixed Cellularity Classical Hodgkin Lymphoma
6822,Well Differentiated Hyaline Cartilage Present,mesenchymal chondrosarcoma of bone
6823,Neuroectodermal Differentiation,Neuroblastoma recurrent
6824,Non-Hereditary Lesion,Poorly Cohesive Gastric Carcinoma
6825,Borderline Lesion,Borderline Ovarian Clear Cell Adenofibroma
6826,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular Monophasic Choriocarcinoma
6827,Pseudopapillary Pattern,Central Nervous System Embryonal Carcinoma
6828,Acanthosis,Urethral Verrucous Carcinoma
6829,Mixed Cellular Population,Borderline Ovarian Clear Cell Cystadenofibroma
6830,atypia morphology,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
6831,Increased Cellularity Present,Pineal parenchymal tumor of intermediate differentiation
6832,Tissue of Mullerian Origin Present,Ovarian Clear Cell Adenofibroma
6833,Regional Disease,Crohn's disease of the ileum
6834,Epithelial Component Present,Metastatic Ductal Breast Carcinoma
6835,Bone Marrow Dysplasia Present,Refractory Cytopenia of Childhood
6836,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Neoplasm
6837,Multinodular Mass,Metastatic angiosarcoma
6838,Epithelial Component Present,Gastric Fundus Carcinoma
6839,Epithelial Component Present,Borderline Breast Phyllodes Tumor
6840,Epithelial Component Present,Inverted Papilloma
6841,Mesenchymal Component Present,Pleomorphic adenoma of parotid gland
6842,Vascular Channel Formation,Epithelioid hemangioendothelioma
6843,Serrated Glandular Architecture,Sessile Serrated Adenoma/Polyp
6844,Nuclear Atypia,Diencephalic Glioblastoma
6845,Epithelial Component Present,Vulvar Eccrine Porocarcinoma
6846,Epithelial Component Present,Ureter Carcinoma
6847,Nuclear Pseudoinclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
6848,Anaplasia,gliosarcoma
6849,Papillary Pattern,Glottis Verrucous Carcinoma
6850,Tubular Structures Present,Benign mixed epithelial and stromal tumor of kidney
6851,Carcinomatous Component Present,Thymic Adenosquamous Carcinoma
6852,Epithelial Component Present,Papillary craniopharyngioma
6853,Antoni A Pattern,Trigeminal schwannoma
6854,Epithelial Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
6855,Absence of Stromal Invasion,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor
6856,Tissue of Mullerian Origin Present,Borderline Ovarian Mucinous Adenofibroma
6857,Epithelial Component Present,mucoepidermoid carcinoma of accessory sinus
6858,Epithelial Component Present,Recurrent Extrahepatic Bile Duct Carcinoma
6859,Carcinomatous Component Present,Sporadic Breast Carcinoma
6860,High Grade Lesion,Rhabdomyosarcoma
6861,Immunologic Deficiency Syndromes,Acute GVH disease
6862,Carcinomatous Component Present,"Carcinoma, Basal Cell"
6863,Vascular Channel Formation,Endemic African Kaposi Sarcoma
6864,Dysplasia,Stage 0 Esophageal Cancer AJCC v7
6865,Metastatic Lesion,Small intestine adenocarcinoma metastatic NOS
6866,High Grade Lesion,Fusion-Positive Alveolar Rhabdomyosarcoma
6867,Monoclonal Cellular Population Present,Thyroid Gland Mucinous Follicular Adenoma
6868,Capillary Sized Vascular Channel Formation,Trichodiscoma
6869,Well Differentiated Lesion,Laryngeal verrucous carcinoma recurrent
6870,Carcinomatous Component Present,Noninfiltrating Intraductal Carcinoma
6871,Pseudoglandular Pattern,Moderately Differentiated Hepatocellular Carcinoma
6872,Chromogranin A Positive Neoplastic Cells Present,Colon Neuroendocrine Tumor G1
6873,High Grade Lesion,Stage I Lung Small Cell Carcinoma AJCC v7
6874,Epithelial Component Present,Acinic Cell Breast Carcinoma
6875,Cystic Change,Ovarian Mucinous Cystic Tumor with Mural Nodules
6876,Malignant Cellular Infiltrate,Non-Gestational Ovarian Choriocarcinoma
6877,Cutaneous Involvement,Sebaceous Breast Carcinoma
6878,High Grade Lesion,Fusion-Positive Rhabdomyosarcoma
6879,High Grade Lesion,Stage IIB Lung Small Cell Carcinoma AJCC v7
6880,Organoid Pattern,Alveolar Soft Part Sarcoma
6881,Systemic disease,Lipoid dermatoarthritis
6882,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
6883,Epithelial Component Present,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma
6884,High Mitotic Activity,Embryonal Carcinoma
6885,Fibrovascular Septa Present,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
6886,In Situ Lesion,Adenocarcinoma in situ in a polyp
6887,Hyperplastic Tissue Present,Simple Endometrial Hyperplasia with Atypia
6888,Diffuse Lesion,Juvenile papillomatosis of breast
6889,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Gene Mutation
6890,High Mitotic Activity,Rectal Small Cell Neuroendocrine Carcinoma
6891,Mature Schwannian Stroma Present,Mature Ganglioneuroma
6892,Abnormal Eosinophilic Granules Present,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
6893,Congenital Lesion,Congenital spondylolysis of lumbosacral region
6894,Adulthood Lesion,Stage I Adult Liver Cancer AJCC v7
6895,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell"
6896,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell"
6897,Edema,Inflammatory carcinoma of breast stage IV
6898,Hemorrhagic,Angiosarcoma Associated with Lymphedema
6899,Deep Lesion,"Vaginal Deep ""Aggressive"" Angiomyxoma"
6900,Epithelial Component Present,tubulovillous adenoma of stomach
6901,Childhood Lesion,Childhood Oligoastrocytoma
6902,Vascular Channel Formation,Kasabach-Merritt syndrome
6903,Dysplasia,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
6904,Immunosuppression-Related Post-Transplant Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
6905,Hereditary Lesion,Turcot Syndrome Type 2
6906,Childhood Lesion,Childhood Favorable Prognosis Hodgkin Lymphoma
6907,Epithelial Component Present,Stage IVB Vaginal Cancer AJCC v6 and v7
6908,Papillary Pattern,Common wart
6909,Hereditary Lesion,"Pancreatic carcinoma, familial"
6910,Sebaceous Differentiation,Sebaceous adenoma
6911,Carcinomatous Component Present,adenocarcinoma of urethra
6912,Carcinomatous Component Present,Recurrent Adult Hepatocellular Carcinoma
6913,Cutaneous Involvement,Diaper Rash
6914,Metastatic Lesion,Secondary malignant neoplasm of lymph node
6915,Epithelial Component Present,Ceruminous adenocarcinoma
6916,Epithelial Component Present,Lung Pleomorphic Adenoma
6917,Adulthood Lesion,BCLC Stage C Adult Hepatocellular Carcinoma
6918,Carcinomatous Component Present,Intrahepatic cholangiocarcinoma recurrent
6919,Childhood Lesion,Infant T Acute Lymphoblastic Leukemia
6920,Immunologic Deficiency Syndromes,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
6921,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Alkylating Agent-Related Myelodysplastic Syndrome
6922,Local disease,Lipoma of external auditory meatus
6923,Cutaneous Involvement,Stage II Acral Lentiginous Melanoma AJCC v6 and v7
6924,Neuronal Differentiation,Glioblastoma with Primitive Neuronal Component
6925,Invasive Lesion,Infiltrating Urothelial Carcinoma
6926,Carcinomatous Component Present,Infiltrating Urothelial Carcinoma
6927,Epithelial Component Present,Adenocarcinoma of the prostate stage II
6928,Epithelial Component Present,Parotid Gland Warthin Tumor
6929,Epithelial Component Present,Stage IIIC Eyelid Carcinoma AJCC v7
6930,Myxoid Stroma Formation,Chondroid lipoma
6931,Epithelial Component Present,Stage IV Eyelid Carcinoma AJCC v7
6932,Childhood Lesion,Childhood Anaplastic Oligoastrocytoma
6933,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma
6934,Tissue Differentiation Uncertain,Desmoplastic Small Round Cell Tumor
6935,Carcinomatous Component Present,Adenocarcinoma of pancreas
6936,High Mitotic Activity,undifferentiated sarcoma of ovary
6937,Dysplasia,Vaginal Tubular Adenoma
6938,Well-Circumscribed Lesion,Pleomorphic Rhabdomyosarcoma
6939,Monoclonal Cellular Population Present,Indolent Systemic Mastocytosis
6940,Childhood Lesion,Childhood Acute Megakaryoblastic Leukemia
6941,Alcohol Toxicity,Alcohol-Related Hepatocellular Carcinoma
6942,Carcinomatous Component Present,Transitional cell carcinoma urethra
6943,Well Differentiated Lesion,Grade 1 Colon Adenocarcinoma
6944,Nodular Pattern,Recurrent Grade 3 Follicular Lymphoma
6945,Epithelial Component Present,Clear cell odontogenic carcinoma
6946,Dilated Vascular Space Formation,Hereditary Glomangioma
6947,Neuroendocrine Differentiation,Pancreatic Vipoma
6948,Childhood Lesion,Childhood Cerebral Anaplastic Astrocytoma
6949,Carcinomatous Component Present,Grade 2 Colon Adenocarcinoma
6950,High Mitotic Activity,Intestinal Neuroendocrine Carcinoma
6951,Intraductal Lesion,Central Breast Papilloma
6952,Sclerotic Pattern,Sclerosing rhabdomyosarcoma
6953,Epithelial Component Present,Bile duct carcinoma
6954,Carcinomatous Component Present,Paget's disease of penis
6955,Acanthosis,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
6956,Papillary Pattern,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
6957,Non-Invasive Lesion,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7
6958,Necrotic changes (finding),Stage IV Lung Small Cell Carcinoma AJCC v7
6959,Glandular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor
6960,Cutaneous Involvement,Chest Wall Plexiform Fibrohistiocytic Neoplasm
6961,Diffuse Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
6962,Epithelial Component Present,Adenocarcinoma in tubulovillous adenoma
6963,Cutaneous Involvement,Skin Abnormalities
6964,Epithelial Component Present,Stage I Esophageal Cancer AJCC v7
6965,Preserved Nuclear Polarity,Inverted urothelial papilloma
6966,Chronic Inflammatory Infiltrate,"lymphomatoid papulosis, type A"
6967,Indolent Clinical Course,Solitary Osteochondroma
6968,Neuroendocrine Differentiation,Minor Salivary Gland Small Cell Carcinoma
6969,Exophytic Polypoid Lesion,Colon Traditional Serrated Adenoma
6970,Poorly Differentiated Lesion,Skin Sarcomatoid Basal Cell Carcinoma
6971,High Mitotic Activity,Pancreatic Endocrine Carcinoma
6972,Myxoid Stroma Formation,Dedifferentiated chordoma
6973,Antoni A Pattern,Peripheral Nerve Schwannoma
6974,Cartilaginous Differentiation,Enchondroma
6975,Indolent Clinical Course,Left atrial myxoma
6976,Cutaneous Involvement,Cutaneous Mature B-Cell Neoplasm
6977,Carcinomatous Component Present,Breast Carcinoma with Chondroid Metaplasia
6978,Multifocal Lesion,Enchondromatosis
6979,Cutaneous Involvement,Pure Cutaneous Mastocytosis
6980,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Tumor
6981,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation
6982,Secondary Lesion,Secondary Peripheral Chondrosarcoma
6983,Rapidly Enlarging Mass,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
6984,Diffuse Pattern,Stage I Adult Immunoblastic Lymphoma
6985,In Situ Lesion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
6986,Pushing Tumor Margin,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
6987,Well-Circumscribed Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma
6988,Epithelial Component Present,Low Grade Esophageal Glandular Intraepithelial Neoplasia
6989,Epithelial Component Present,Colorectal Serrated Adenocarcinoma
6990,Serrated Glandular Architecture,Colorectal Serrated Adenocarcinoma
6991,Epithelial Component Present,Sparsely Granulated Lactotroph Adenoma
6992,Carcinomatous Component Present,Pharyngeal Carcinoma by AJCC v7 Stage
6993,Epithelial Component Present,Bladder Squamous Cell Carcinoma
6994,Childhood Lesion,Infant Acute Lymphoblastic Leukemia
6995,Epithelial Component Present,Serous adenofibroma
6996,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma recurrent
6997,Carcinomatous Component Present,signet ring cell carcinoma of gallbladder
6998,Benign Cellular Infiltrate,benign neurofibroma of gallbladder
6999,Adnexal Differentiation,Primary Cutaneous Mucinous Carcinoma
7000,Secondary Lesion,Metastatic Carcinoma in the Adrenal Cortex
7001,Papillary Pattern,Intracystic papillary adenoma
7002,Carcinomatous Component Present,Stage I Penile Cancer AJCC v6
7003,Epithelial Component Present,Relapsed Hypopharynx Carcinoma
7004,HMB-45-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis of skin
7005,Hyperkeratosis,Upper Gingival Verrucous Carcinoma
7006,"Amorphus, Eosinophilic, and Acellular Deposit",Thyroid Gland Medullary Carcinoma with Amyloid Stroma
7007,Epithelial Component Present,Breast adenocarcinoma
7008,Myxoid Stroma Formation,Metastatic Extraskeletal Myxoid Chondrosarcoma
7009,Epithelial Component Present,Stage IVC Appendix Carcinoma AJCC v7
7010,Cutaneous Involvement,Benign neoplasm of scrotum
7011,Epithelial Component Present,Thyroid Gland Paraganglioma
7012,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma
7013,Neuroendocrine Differentiation,Non functioning pancreatic endocrine tumor
7014,Mild cytologic atypia,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
7015,Epithelial Component Present,Lung Acinar Adenocarcinoma
7016,Lipomatous Metaplasia,Uterine Corpus Lipoleiomyoma
7017,Increased Cellularity Present,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
7018,Indolent Clinical Course,"Hemangioma, Cavernous, Central Nervous System"
7019,Pregnancy Complications,Recurrent Gestational Trophoblastic Tumor
7020,Mixed Cellular Population,"Phyllodes tumor, benign"
7021,Vascular Channel Formation,Tufted angioma of skin
7022,Aggressive Clinical Course,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor
7023,Honeycomb Pattern,Oligodendroglioma of spinal cord
7024,Indolent Clinical Course,Hemangioma of subcutaneous tissue
7025,Anaplasia,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
7026,Epithelial Component Present,Colorectal Cancer by AJCC v7 Stage
7027,Low Cellularity Present,Childhood Pilocytic Astrocytoma
7028,Aggressive Clinical Course,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM"
7029,Epithelial Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
7030,Carcinomatous Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
7031,Diffuse Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma
7032,Cystic Lesion,Childhood Craniopharyngioma
7033,Hereditary Lesion,TUBEROUS SCLEROSIS 2 (disorder)
7034,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells
7035,Pregnancy Complications,Gestational Ovarian Choriocarcinoma
7036,Metastatic Lesion,Breast Carcinoma Metastatic in the Brain
7037,Plasma cell inflammation,Inflammatory pseudotumor of liver
7038,Severe dysplasia,Stage 0 Rectal Cancer AJCC v6 and v7
7039,Childhood Lesion,Childhood Supratentorial Ependymoma
7040,Papillary Pattern,papillomatosis of extrahepatic bile duct
7041,Epithelial Component Present,Stage IA Cervical Cancer AJCC v6 and v7
7042,Epithelial Component Present,Stage IIIB Lung Cancer AJCC v7
7043,Carcinomatous Component Present,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor
7044,Carcinomatous Component Present,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
7045,Carcinomatous Component Present,Stage IIB Lung Adenocarcinoma AJCC v7
7046,Metastatic/Recurrent Disease,Cardiac Biphasic Synovial Sarcoma
7047,Epithelial Component Present,Atypical Ductal Breast Hyperplasia
7048,Rapidly Enlarging Mass,rhabdomyosarcoma of prostate
7049,Primary Lesion,Primary Systemic Mastocytosis
7050,Melanin Pigment Present,Melanotic neurofibroma
7051,Necrotic changes (finding),Prostate Stromal Sarcoma
7052,Hyalinized Stroma Formation,malignant epithelioid hemangioendothelioma of liver
7053,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrioid adenoma, borderline malignancy"
7054,Fibrotic Stroma Formation,clear cell adenocarcinofibroma of ovary
7055,High Grade Lesion,embryonal rhabdomyosarcoma of prostate
7056,Non-Invasive Lesion,Low-grade intraurothelial neoplasia
7057,Neuroendocrine Differentiation,Pancreatic Delta Cell Neoplasm
7058,Diffuse Pattern,Neural Glioblastoma
7059,Anaplasia,Adult Anaplastic Oligodendroglioma
7060,Neuroendocrine Differentiation,Neuroendocrine neoplasm of appendix
7061,Ground Glass Nuclear Inclusion,Clear Cell Variant Thyroid Gland Papillary Carcinoma
7062,Cutaneous Involvement,GIANT PIGMENTED HAIRY NEVUS
7063,Carcinomatous Component Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
7064,Primary Lesion,Primary leiomyosarcoma
7065,Peripheral Blood Involvement,Chronic Adult T-Cell Leukemia/Lymphoma
7066,Carcinomatous Component Present,"Endocervical Adenocarcinoma, Usual Type"
7067,Monoclonal Eosinophils Present,"Leukemia, Eosinophilic, Acute"
7068,Indolent Clinical Course,Lipoma of breast
7069,Immunologic Deficiency Syndromes,Ann Arbor Stage III AIDS-Related Lymphoma
7070,Neuroendocrine Differentiation,Metastatic Adrenal Gland Pheochromocytoma
7071,Carcinomatous Component Present,Colorectal Mucinous Adenocarcinoma
7072,Epithelial Component Present,Stage II Carcinoma of Penis
7073,Epithelial Component Present,Stage IIA Lung Adenocarcinoma AJCC v7
7074,Carcinomatous Component Present,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
7075,Cutaneous Involvement,alopecia congenita
7076,Necrotic changes (finding),Colorectal Small Cell Neuroendocrine Carcinoma
7077,Epithelial Component Present,carcinosarcoma of fallopian tube
7078,Striated Muscle Component Present,Medullomyoblastoma
7079,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome recurrent
7080,Adulthood Lesion,Adult Cardiac Cellular Rhabdomyoma
7081,Multiple Tumor Masses,"Meningiomas, Multiple"
7082,Epithelial Component Present,"Lung Large Cell Carcinoma, Clear Cell Variant"
7083,Anaplasia,Giant Cell Glioblastoma
7084,Epithelial Component Present,Filiform Serrated Adenoma
7085,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements
7086,Well-Circumscribed Lesion,Vaginal Rhabdomyoma
7087,Carcinomatous Component Present,Secondary carcinoma
7088,Neuroendocrine Differentiation,Childhood Adrenal Gland Pheochromocytoma
7089,Intramucosal Lesion,Colon Intramucosal Adenocarcinoma
7090,Carcinomatous Component Present,Childhood Rectal Carcinoma
7091,Slow Growing Mass,Hypothalamic Gangliocytoma
7092,Vascular Channel Formation,Cavernous hemangioma of the face
7093,Epithelial Component Present,adenocarcinoma of ureter
7094,Carcinomatous Component Present,epithelial-myoepithelial carcinoma of salivary gland
7095,Cartilaginous Differentiation,Chondrosarcoma metastatic
7096,Metastatic Lesion,Metastatic Carcinoma
7097,Nodular Pattern,"Lymphoma, Mixed-Cell, Follicular"
7098,Epithelial Component Present,Neoplasm of aortic body
7099,Follicular Cell Differentiation,Follicular thyroid carcinoma
7100,Skin nodule,Balloon cell malignant melanoma
7101,Composite Lesion,Composite Lymphoma
7102,Carcinomatous Component Present,Adenocarcinoma of lacrimal gland
7103,Cutaneous Involvement,Neuronevus
7104,Presence of a Hormonal Syndrome,Functioning Endocrine Neoplasm
7105,Vascular Channel Formation,Intermediate Blood Vessel Neoplasm
7106,Epithelial Component Present,FIGO Stage IIIA1 Ovarian Cancer
7107,Rapidly Enlarging Mass,Rhabdomyosarcoma of the orbit
7108,Atypical Mitotic Figures,Classic Type Atypical Fibroxanthoma
7109,Retiform Structures Comprise 90% or More of the Tumor,Ovarian Retiform Sertoli-Leydig Cell Tumor
7110,Epithelial Component Present,"Malignant Mixed Tumor, Not Otherwise Specified"
7111,Metastatic Lesion,Metastatic Carcinoma in the Lung
7112,Secondary Lesion,"Squamous cell carcinoma, metastatic"
7113,Tissue Differentiation Uncertain,"Phosphaturic mesenchymal tumor, malignant"
7114,Carcinomatous Component Present,High Grade Salivary Gland Carcinoma
7115,High Mitotic Activity,pleomorphic carcinoma of breast
7116,CD30-Positive Neoplastic Cells Present,Stage II Anaplastic Large Cell Lymphoma
7117,Mild dysplasia,Appendix Low Grade Intraepithelial Neoplasia
7118,Locally Aggressive Lesion,Intermediate Cutaneous Fibrohistiocytic Neoplasm
7119,Carcinomatous Component Present,Small intestine carcinoma recurrent
7120,Follicular Cell Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
7121,Epithelial Component Present,Clear cell hidradenoma
7122,Epithelial Component Present,Stage 0 Bladder Carcinoma
7123,Carcinomatous Component Present,Stage 0 Bladder Carcinoma
7124,Congenital Lesion,Small Congenital Melanocytic Nevus
7125,Primary Site Unknown,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
7126,Perivascular Arrangement of Tumor Cells,Sclerosing PEComa
7127,Epithelial Component Present,Adenoid cystic carcinoma of trachea
7128,Local disease,Cerebral Hemisphere Lipoma
7129,Dysplasia,Vulval intraepithelial neoplasia grade 2
7130,Increased Cellularity Present,Anaplastic Diencephalic Astrocytoma
7131,Carcinomatous Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma
7132,Cellular Pleomorphism,Malignant Testicular Sex Cord-Stromal Tumor
7133,Epithelial Component Present,Bartholin Gland Adenomyoma
7134,Juvenile Lesion,Rectal Juvenile Polyp
7135,Carcinomatous Component Present,Recurrent Cancer of Gallbladder
7136,Cutaneous Involvement,Primary Cutaneous Meningioma
7137,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage III
7138,Mucoid Stroma Formation,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
7139,Pregnancy Complications,Non-Metastatic Gestational Trophoblastic Tumor
7140,Immunologic Deficiency Syndromes,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder
7141,Dysplasia,Appendix High Grade Intraepithelial Neoplasia
7142,Epithelial Component Present,Human Papillomavirus-Related Carcinoma
7143,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Chordoid Glioma of the Third Ventricle
7144,Recurrent disease,Lymphoplasmacytoid lymphoma/immunocytoma recurrent
7145,Epithelial Component Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma
7146,Nodular lesions,Macrofollicular adenoma
7147,Indolent Clinical Course,Fibroid Tumor
7148,Syncytial Pattern,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
7149,Recurrent disease,Inflammatory carcinoma of breast recurrent
7150,Carcinomatous Component Present,Colorectal Undifferentiated Carcinoma
7151,Favorable Clinical Outcome,Biliary Adenofibroma
7152,Well-Circumscribed Lesion,Heavily Pigmented Adrenal Cortical Adenoma
7153,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma
7154,Anastomosing Strands of Tumor Cells Present,Odontoameloblastoma
7155,Carcinomatous Component Present,Colorectal Large Cell Neuroendocrine Carcinoma
7156,Benign Cellular Infiltrate,Colon Lipoma
7157,Carcinomatous Component Present,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
7158,Epidermotropic Lymphocytic Infiltrate,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
7159,Papillary Pattern,Papillary Renal Cell Carcinoma
7160,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Mucinous Follicular Adenoma
7161,Acanthosis,Laryngeal verrucous carcinoma recurrent
7162,Dysplasia,Noninfiltrating Intraductal Carcinoma
7163,Low Mitotic Activity,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
7164,Nuclear Molding,Stage I Lung Small Cell Carcinoma AJCC v7
7165,Plexiform Growth Pattern,Gastric Plexiform Fibromyxoma
7166,Carcinomatous Component Present,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
7167,Indolent Clinical Course,Strawberry nevus of skin
7168,Below the Diaphragm Disease,Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
7169,Carcinomatous Component Present,Stage II Rectal Cancer
7170,Poorly Differentiated Lesion,Sarcomatoid Renal Cell Carcinoma
7171,Acinar Cell Differentiation,Acinar Prostate Mucinous Adenocarcinoma
7172,Epithelial Component Present,Colorectal Neuroendocrine Neoplasm
7173,Blasts 5-19 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-2
7174,Peripheral Nuclear Palisading,Stage IIB Lung Small Cell Carcinoma AJCC v7
7175,Tissue Differentiation Uncertain,Alveolar Soft Part Sarcoma
7176,Immunosuppression-Related Post-Transplant Toxicity,Hyperacute allograft rejection
7177,Epithelial Component Present,Stage IV Rectosigmoid Cancer AJCC v6
7178,Osseous Differentiation,Fibroblastic osteosarcoma
7179,Epithelial Component Present,Anogenital papillomaviral intraepithelial neoplasia
7180,Carcinomatous Component Present,Stage 0 Esophageal Cancer AJCC v6
7181,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
7182,Carcinomatous Component Present,large cell neuroendocrine carcinoma of ovary
7183,Indolent Clinical Course,Bone Epithelioid Hemangioma
7184,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
7185,Immunologic Deficiency Syndromes,Transplant-Related Lung Carcinoma
7186,Cystic Change,Papillary cystic tumor
7187,Whorling Growth Pattern,Transitional Meningioma
7188,Cutaneous Involvement,Cutaneous Lipomatous Neoplasm
7189,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage I
7190,Carcinomatous Component Present,Small cell carcinoma of prostate
7191,Epithelial Component Present,Non-small cell lung cancer stage I
7192,Well-Circumscribed Lesion,Gastric hyperplastic polyp
7193,Neuroendocrine Differentiation,Intestinal Gangliocytic Paraganglioma
7194,Diffuse Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
7195,Neuroendocrine Differentiation,Intermediate Grade Lung Neuroendocrine Neoplasm
7196,Solitary mass,Plasmacytoma
7197,In Situ Lesion,Carcinoma in situ of skin
7198,Severe dysplasia,Intraductal Cribriform Breast Adenocarcinoma
7199,No Identifiable Line of Differentiation,Adult Undifferentiated Pleomorphic Sarcoma
7200,Neuronal Differentiation,Ganglioneuroma
7201,Local disease,Lipoblastoma
7202,Vascular Channel Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma"
7203,Pseudopapillary Pattern,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
7204,Indolent Clinical Course,Brain Hemangioma
7205,Hyperplastic Tissue Present,Atypical Adenomatous Lung Hyperplasia
7206,Diffuse Pattern,Stage III Diffuse Large B-Cell Lymphoma
7207,Epithelial Component Present,Bladder Papillary Clear Cell Adenocarcinoma
7208,Low Cellularity Present,Desmoplastic fibroblastoma
7209,Epithelial Component Present,adenoid cystic carcinoma of lung
7210,Carcinomatous Component Present,Bladder Diffuse Clear Cell Adenocarcinoma
7211,Immunosuppression-Related Post-Transplant Toxicity,EBV-Related Post-Transplant Lymphoproliferative Disorder
7212,Carcinomatous Component Present,Sweat gland carcinoma
7213,Cutaneous Involvement,Sweat gland carcinoma
7214,Childhood Lesion,Childhood Ovarian Germ Cell Tumor
7215,Immature Granulocytes in Peripheral Blood Under 10 Percent,"Leukemia, Myelomonocytic, Chronic"
7216,Epithelial Component Present,Benign Ovarian Mucinous Tumor
7217,Perineural spread,Posterior Tongue Adenoid Cystic Carcinoma
7218,Enamel Formation (finding),"Fibro-odontoma, Ameloblastic"
7219,Carcinomatous Component Present,Stage IB Lung Adenosquamous Carcinoma AJCC v7
7220,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Smoldering myeloma
7221,Epithelial Component Present,Carcinoma in situ of middle ear
7222,Dysplasia,tubular adenoma of gallbladder
7223,Malignant Cellular Infiltrate,Ovarian Embryonal Carcinoma
7224,IDH Gene Family Mutation Status Unknown,Glioblastoma
7225,Epithelial Component Present,Secretory breast carcinoma
7226,Rapidly Enlarging Mass,Childhood Embryonal Rhabdomyosarcoma
7227,Carcinomatous Component Present,Anal margin Paget's disease
7228,Epidermal Involvement,Hidroacanthoma simplex
7229,Adnexal Differentiation,Benign Hair Follicle Neoplasm
7230,Cystic Change,Parotid Gland Warthin Tumor
7231,Dysplasia,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
7232,Infiltrative Growth Pattern,Childhood Protoplasmic Astrocytoma
7233,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage I site unspecified
7234,Stromal Invasion,Invasive intraductal papillary-mucinous carcinoma of pancreas
7235,Pregnancy Complications,Complete hydatidiform mole
7236,Carcinomatous Component Present,small cell carcinoma of kidney
7237,Eccrine Differentiation,Syringofibroadenoma
7238,Alternative Fascicle (Bundle) Pattern,Gastric Leiomyoma
7239,Carcinomatous Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
7240,Papillary Pattern,"Transitional cell papilloma, inverted"
7241,White blood cell count increased (lab result),Acute promyelocytic leukemia - hypogranular variant
7242,Epithelial Component Present,Bladder Papillary Urothelial Neoplasm
7243,Tissue Differentiation Uncertain,Adult Clear Cell Sarcoma of Soft Parts
7244,Neuroendocrine Differentiation,small cell carcinoma of larynx
7245,CD30-Positive Neoplastic Cells Present,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma
7246,Endobronchial Lesion,Respiratory papilloma
7247,Childhood Lesion,Postsurgical Stage II Hepatoblastoma
7248,Indolent Clinical Course,Benign neoplasm of endometrium
7249,Lymphoplasmacytic Infiltrate,Localized Castleman Disease
7250,Epithelial Component Present,Adenomatous Polyps
7251,Exophytic Polypoid Lesion,Cervical Fibroepithelial Polyp
7252,Epithelial Component Present,"Carcinoma, Neuroendocrine"
7253,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with abnormal marrow eosinophils
7254,Infiltrative Growth Pattern,Childhood Cerebral Anaplastic Astrocytoma
7255,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myeloid Leukemia with Minimal Differentiation
7256,Cystic Change,Childhood Multilocular Cystic Renal Neoplasm
7257,Cutaneous Involvement,Grade 2 Cutaneous Follicular Lymphoma
7258,Perivascular Arrangement of Tumor Cells,Subungual glomus tumor
7259,Metaplasia,"Vulvar Adenocarcinoma, Intestinal-Type"
7260,Indolent Clinical Course,Nasopharyngeal Angiofibroma
7261,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic
7262,Carcinomatous Component Present,Small Intestinal Mixed Adenoneuroendocrine Carcinoma
7263,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma AJCC v7
7264,Severe dysplasia,Adenocarcinoma in situ in tubulovillous adenoma
7265,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of intestine
7266,Juvenile Lesion,Juvenile rheumatoid arthritis
7267,Vascular Channel Formation,Lymphangiomatosis
7268,Metaplasia,Bladder squamous cell carcinoma stage III
7269,Adulthood Lesion,Localized Resectable Adult Liver Carcinoma
7270,Carcinomatous Component Present,Gastric Squamous Cell Carcinoma
7271,Metastatic Lesion,Secondary malignant neoplasm of rectum
7272,Thyroglobulin Positive Neoplastic Cells Present,Papillary thyroid carcinoma
7273,Extracutaneous Dissemination of Disease,Mycosis fungoides stage IV
7274,Recurrent disease,Precursor B-lymphoblastic lymphoma recurrent
7275,Slow Growing Mass,Childhood Ependymoma
7276,Epithelial Component Present,"Carcinoma, Lobular"
7277,Carcinomatous Component Present,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
7278,Epithelial Component Present,Gallbladder Tubular Carcinoid
7279,Secondary Lesion,Secondary Central Chondrosarcoma
7280,Osteoid formation,Breast Extraskeletal Osteosarcoma
7281,Carcinomatous Component Present,Bile duct cystadenocarcinoma
7282,Adulthood Lesion,Stage I Adult Hodgkin Lymphoma
7283,Epithelial Component Present,Biliary Intraepithelial Neoplasia
7284,Microinvasive tumor,Ductal Carcinoma In Situ with Microinvasion
7285,Hyperkeratosis,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
7286,Adulthood Lesion,Adult Acute Megakaryoblastic Leukemia
7287,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis
7288,Osteoid formation,Extraskeletal osteosarcoma metastatic
7289,Monomorphic Cellular Infiltrate,"Adenoma, Basal Cell"
7290,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v7
7291,Recurrent Genetic Abnormalities Present,Childhood Acute Promyelocytic Leukemia with PML-RARA
7292,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Childhood Acute Promyelocytic Leukemia with PML-RARA
7293,Indolent Clinical Course,Benign chondrogenic neoplasm
7294,High Mitotic Activity,Dedifferentiated Solitary Fibrous Tumor
7295,Pain,Mesenchymal Chondrosarcoma
7296,Hyalinized Stroma Formation,Peritoneal Solitary Fibrous Tumor
7297,Epithelial Component Present,Solid Lung Adenocarcinoma
7298,Organoid Pattern,Alveolar soft part sarcoma metastatic
7299,Adnexal Differentiation,Germinative Follicular Epithelium Neoplasm
7300,Vascular Channel Formation,Polymorphus Hemangioendothelioma
7301,Epithelial Component Present,Ureter Inverted Papilloma
7302,Increased Cellularity Present,Juvenile fibroadenoma of breast
7303,"Undifferentiated ""Fetal-Type"" Tissues Present",Malignant teratoma of testis
7304,Carcinomatous Component Present,Stage IV Major Salivary Gland Carcinoma with Metastasis
7305,Epithelial Component Present,Stage I Penile Cancer AJCC v6
7306,Perivascular fibrosis,Grade I Nodular Sclerosis Hodgkin's Lymphoma
7307,Epithelial Component Present,Meningeal Carcinomatosis
7308,CD30-Positive Neoplastic Cells Present,Recurrent Anaplastic Large Cell Lymphoma
7309,Cutaneous Involvement,"Acanthoma, Pilar Sheath"
7310,Tissue of Mullerian Origin Present,Carcinosarcoma of cervix uteri
7311,Well-Circumscribed Lesion,"Gastric Adenoma, Gastric-Type"
7312,Severe cytologic atypia,Anal Canal Small Cell Neuroendocrine Carcinoma
7313,Low Mitotic Activity,Pancreatic Neuroendocrine Microadenoma
7314,Borderline Lesion,Borderline epithelial tumor of ovary
7315,Well-Circumscribed Lesion,Anal Canal Squamous Papilloma
7316,'Starry-sky' pattern,African Burkitt's lymphoma
7317,Anaplasia,Pulmonary Blastoma
7318,Exophytic Polypoid Lesion,Polyp of vocal cord
7319,Cutaneous Involvement,Dedifferentiated Dermatofibrosarcoma Protuberans
7320,Microvascular Proliferation,Supratentorial Glioblastoma
7321,Neuroectodermal Differentiation,"Childhood Ganglioneuroblastoma, Nodular"
7322,Radial Growth Phase,Stage III Superficial Spreading Melanoma AJCC v7
7323,Anaplasia,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
7324,Tissue of Mullerian Origin Present,Cystadenofibroma of fallopian tube
7325,Cutaneous Involvement,Cutaneous Leiomyosarcoma
7326,Carcinomatous Component Present,Adenocarcinoma of Skene Gland Origin
7327,Pseudorosette Formation,malignant gastrinoma of pancreas
7328,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity recurrent
7329,Cutaneous Involvement,Cercarial Dermatitis
7330,High Grade Lesion,Pleural Synovial Sarcoma
7331,Epithelial Component Present,Occult Lung Carcinoma
7332,Apocrine Differentiation,Apocrine breast carcinoma
7333,Nuclear Molding,Small cell carcinoma of lung
7334,Epithelial Component Present,Villous adenoma of rectum
7335,Drug Exposure,Chemotherapy-Related Leukemia
7336,Indolent Clinical Course,Pyogenic granuloma of oral mucosa
7337,Childhood Lesion,Childhood Brain Stem Glioma
7338,Diffuse Pattern,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
7339,Epithelial Component Present,Lung squamous cell carcinoma stage III
7340,Apocrine Differentiation,Malignant Apocrine Neoplasm
7341,Pseudopapillary Pattern,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
7342,Epithelial Component Present,Ovarian Insular Carcinoid Tumor
7343,Metastatic Lesion,Breast Carcinoma Metastatic in the Liver
7344,Dysplasia,Cervical high grade squamous intraepithelial lesion
7345,Malignant Germinomatous Cellular Infiltrate,Extragonadal Seminoma
7346,Carcinomatous Component Present,Stage II Renal Pelvis Cancer AJCC v7
7347,Cystic Change,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
7348,Acinar Proliferation,Breast Sclerosing Adenosis
7349,Macrofollicular Structures Present,Juvenile granulosa cell tumor
7350,Absence of Invasion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
7351,Epithelial Component Present,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
7352,Lobulated Growth Pattern,Pyogenic granuloma of skin and subcutaneous tissue
7353,Radiation Sickness,Enteritis due to radiation
7354,Epithelial Component Present,Ovarian Endometrioid Cystadenoma
7355,Metastatic/Recurrent Disease,Cardiac Monophasic Synovial Sarcoma
7356,Epithelial Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
7357,Dysplasia,tubular adenoma of extrahepatic bile duct
7358,Severe dysplasia,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
7359,Epithelial Component Present,Squamous cell carcinoma of vulva
7360,Absence of Invasion,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8"
7361,Recurrent disease,Recurrent Digestive System Carcinoma
7362,Stromal Invasion,Clear cell adenocarcinoma of ovary
7363,Epithelial Component Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter
7364,Carcinomatous Component Present,Carcinoma of bladder
7365,Well-Circumscribed Lesion,Benign phyllodes neoplasm of breast
7366,Cutaneous Involvement,Precancerous melanosis
7367,Cutaneous Involvement,Skin tumor of neural origin
7368,Benign Cellular Infiltrate,Polyp of esophagus
7369,Epithelial Component Present,FIGO Stage IIIB Ovarian Cancer
7370,Well-Circumscribed Lesion,Nodular tenosynovitis
7371,Borderline Lesion,Borderline serous tumor of ovary
7372,Abundance of Small Lymphocytes,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma
7373,Osteogenesis,Fibrodysplasia Ossificans Progressiva
7374,Carcinomatous Component Present,Stage IB Lung Adenocarcinoma AJCC v7
7375,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Testicular Choriocarcinoma
7376,Absence of Invasion,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
7377,Immunologic Deficiency Syndromes,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
7378,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,benign endometrioid tumor of ovary
7379,Increased Cellularity Present,Anaplastic astrocytoma
7380,Fibrotic Stroma Formation,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
7381,Carcinomatous Component Present,Cervical Cancer by AJCC v6 Stage
7382,Epithelial Component Present,mucinous adenocarcinoma of anus
7383,Papillary Pattern,Bladder papilloma
7384,Neuroendocrine Differentiation,insulinoma
7385,Adulthood Lesion,Adult Acute Monoblastic Leukemia
7386,Carcinomatous Component Present,Stage IA Fallopian Tube Cancer AJCC v6 and v7
7387,Carcinomatous Component Present,Uterine Ligament Mucinous Adenocarcinoma
7388,Epithelial Component Present,Salivary Gland Oncocytic Carcinoma
7389,Childhood Lesion,Recurrent Childhood Cerebellar Astrocytoma
7390,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
7391,Carcinomatous Component Present,Stage IIB Colorectal Cancer AJCC v7
7392,Cutaneous Involvement,Reactive Cutaneous Fibrous Lesion
7393,Secondary Lesion,Secondary malignant neoplasm of ciliary body
7394,Superficial Lesion,Dupuytren Contracture
7395,Malignant Germinomatous Cellular Infiltrate,"Seminoma, anaplastic"
7396,Perivascular Pseudorosette Formation,Anaplastic Astroblastoma
7397,Epithelial Component Present,Esophageal Neuroendocrine Neoplasm
7398,High Mitotic Activity,Medullary carcinoma of breast
7399,Childhood Lesion,Childhood Salivary Gland Carcinoma
7400,Childhood Lesion,Childhood Central Nervous System Yolk Sac Tumor
7401,Epithelial Component Present,Metastatic Carcinoma
7402,Epithelial Component Present,Undifferentiated carcinoma
7403,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage I
7404,Dysplasia,Low Grade Corneal Intraepithelial Neoplasia
7405,Immunoglobulin Heavy Chain Deposition,Heavy Chain Deposition Disease
7406,Epithelial Component Present,Epiglottic carcinoma
7407,Primary Lesion,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
7408,Anaplasia,Adult Systemic Anaplastic Large Cell Lymphoma
7409,Papillary Pattern,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
7410,Mixed Cellular Population,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
7411,Recurrent disease,Recurrent Childhood Lymphoblastic Lymphoma
7412,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
7413,Lymphoplasmacytic Infiltrate,Childhood Central Nervous System Germinoma
7414,Cystic Change,Anal Papillary Hidradenoma
7415,Lobular Pattern,Trichilemmocarcinoma
7416,Mass of body structure,Cardiac Myeloid Sarcoma
7417,Epithelial Component Present,Carcinoma of glottis
7418,Microcystic Change,Ovarian Microcystic Stromal Tumor
7419,Pseudopapillary Pattern,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
7420,Epithelial Component Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
7421,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v7
7422,Papillary Pattern,Condylomata Acuminata
7423,Locally Aggressive Lesion,Intermediate Vascular Neoplasm
7424,Epithelial Component Present,Stage IV Merkel Cell Carcinoma AJCC v7
7425,Neuroendocrine Differentiation,Stage IB Merkel Cell Carcinoma AJCC v7
7426,Rapidly Enlarging Mass,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
7427,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7
7428,Neuroendocrine Differentiation,Stage IIC Merkel Cell Carcinoma AJCC v7
7429,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Adenofibroma
7430,Epithelial Component Present,Childhood Lung Non-Small Cell Carcinoma
7431,Solid Growth Pattern,Solid Papillary Breast Carcinoma
7432,Well Differentiated Lesion,Urethral Verrucous Carcinoma
7433,Biphasic Pattern,Juvenile Pilocytic Astrocytoma
7434,Epithelial Component Present,Skin Nodular Solid Basal Cell Carcinoma
7435,Vascular Channel Formation,Cavernous Angioleiomyoma
7436,Infiltrative Growth Pattern,Anaplastic Diencephalic Astrocytoma
7437,Ineffective hematopoiesis,Refractory Neutropenia
7438,Mixed Cellular Population,Submandibular Gland Carcinoma ex Pleomorphic Adenoma
7439,Macrofollicular Structures Present,Juvenile Type Testicular Granulosa Cell Tumor
7440,Acanthosis,Verrucous carcinoma of oral cavity
7441,Carcinomatous Component Present,Oral Cavity Carcinoma
7442,Epithelial Component Present,Acantholytic squamous cell carcinoma of skin
7443,Cutaneous Involvement,Sebaceous Adenocarcinoma
7444,Infiltrative Growth Pattern,Diencephalic Glioblastoma
7445,Epithelial Component Present,Adenomatous polyp of colon
7446,Precise Histogenesis Unknown,Hemangioblastoma
7447,Carcinomatous Component Present,Bladder Mixed Adenocarcinoma
7448,Epithelial Component Present,Human Papillomavirus-Related Cervical Carcinoma
7449,Trabecular Pattern,Microfollicular adenoma
7450,Childhood Lesion,Childhood Leukemia
7451,Pseudoglandular Pattern,Extragonadal primary embryonal carcinoma
7452,Hypertensive disease,Juxtaglomerular tumor
7453,Carcinomatous Component Present,Pancreatic Large Cell Neuroendocrine Carcinoma
7454,Fibrous Septa Present,Childhood Ovarian Dysgerminoma
7455,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7
7456,Mitotic Activity,Testicular yolk sac tumor stage I
7457,Childhood Lesion,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma
7458,Carcinomatous Component Present,Adenocarcinoma Of Esophagus
7459,Necrotic changes (finding),Malignant Testicular Leydig Cell Tumor
7460,Perivascular Arrangement of Tumor Cells,Cerebellar Papillary Meningioma
7461,Chronic Inflammatory Infiltrate,Angiocentric immunoproliferative lesion grade 2
7462,Epithelial Component Present,Spindle cell squamous cell carcinoma
7463,progesterone receptor negative,Triple-Negative Breast Carcinoma
7464,Epithelial Component Present,Transitional cell cancer of renal pelvis and ureter metastatic
7465,Epithelial Component Present,Paget's disease of vulva
7466,Necrotic changes (finding),Colorectal Large Cell Neuroendocrine Carcinoma
7467,High Mitotic Activity,Tall Cell Variant Thyroid Gland Papillary Carcinoma
7468,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,choriocarcinoma of mediastinum
7469,Anaplasia,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype"
7470,Cutaneous Involvement,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
7471,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma stage IV
7472,Epithelial Component Present,"Carcinoma, Basosquamous"
7473,Acinar Cell Differentiation,Pancreatic Acinar Cell Cystadenoma
7474,Mixed Cellular Population,Invasive Ductal and Lobular Carcinoma
7475,Pushing Tumor Margin,Laryngeal verrucous carcinoma recurrent
7476,Severe cytologic atypia,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
7477,Epithelial Component Present,Colorectal Traditional Serrated Adenoma
7478,Carcinomatous Component Present,Carcinoma of Male Breast
7479,Epithelial Component Present,Poorly Differentiated Hepatocellular Carcinoma
7480,Intraductal Lesion,Intraductal papilloma of breast
7481,Recurrent disease,Recurrent tumors of the Ewing's family
7482,Carcinomatous Component Present,Small Intestinal Adenosquamous Carcinoma
7483,Dysplasia,Colorectal Adenomatous Polyp
7484,Bone Marrow Dysplasia Present,Chronic Myelomonocytic Leukemia-2
7485,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-2
7486,Dysplasia,Rectal Tubular Adenoma
7487,Nodular Pattern,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic
7488,Epithelial Component Present,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
7489,Stromal Invasion,Hereditary Ovarian Carcinoma
7490,Epithelial Component Present,Ovarian Neuroendocrine Neoplasm
7491,Carcinomatous Component Present,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
7492,Carcinomatous Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
7493,Epithelial Component Present,Non-Functioning Endocrine Neoplasm
7494,Exophytic Papillary Lesion,Condyloma acuminata of vagina
7495,Epithelial Component Present,Eccrine porocarcinoma
7496,Hyperplastic Tissue Present,Complex endometrial hyperplasia without atypia
7497,Neuroectodermal Differentiation,Stage 4S neuroblastoma
7498,Carcinomatous Component Present,Urothelial cancer of renal pelvis
7499,Unifocal Disease,Mastocytoma
7500,Geographic Necrosis,Teratocarcinoma
7501,Carcinomatous Component Present,Squamous cell carcinoma of rectum
7502,Desmoplastic Stroma Formation,Desmoplastic melanoma
7503,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
7504,Metastatic Lesion,Medulloblastoma with Leptomeningeal Spread
7505,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Solid Pattern"
7506,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, t(16;16)(p13;q22)"
7507,Acinar Cell Differentiation,Minor Salivary Gland Acinic Cell Carcinoma
7508,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity stage II
7509,Carcinomatous Component Present,Carcinoma
7510,Indolent Clinical Course,"Vaginal Deep ""Aggressive"" Angiomyxoma"
7511,Tricholemmal Differentiation,Desmoplastic trichilemmoma
7512,Epithelial Component Present,Familial Paraganglioma
7513,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
7514,Schwannian Stroma Predominant Component of the Tumor Volume,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
7515,Anaplasia,Childhood Giant Cell Glioblastoma
7516,Childhood Lesion,Childhood Giant Cell Glioblastoma
7517,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic-Phase"
7518,Metastatic Lesion,"Neoplasms, Unknown Primary"
7519,Severe dysplasia,Stage 0 Pancreatic Cancer AJCC v6 and v7
7520,Infiltrative Growth Pattern,Childhood Diffuse Astrocytoma
7521,Neuroendocrine Differentiation,Malignant Cardiac Paraganglioma
7522,Increased Cellularity Present,Vulvar Cellular Angiofibroma
7523,Adulthood Lesion,Adult Primary Melanocytic Lesion of Meninges
7524,Epithelial Component Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
7525,Cellular Stratification,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
7526,More than 5 Mitoses per 50HPF,Gastrointestinal Stromal Sarcoma
7527,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type"
7528,Histiocytosis,T-cell/histiocyte rich large B-cell lymphoma
7529,Papillary Pattern,Childhood Myxopapillary Ependymoma
7530,Borderline Lesion,Serous papillary cystic tumor of borderline malignancy
7531,Epithelial Component Present,Moderate epithelial dysplasia
7532,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Tumor G2
7533,Mesenchymal Component Present,Lung Pleomorphic Adenoma
7534,Indolent Clinical Course,Ovarian Adenomatoid Tumor
7535,Childhood Lesion,Childhood Burkitt Leukemia
7536,Well-Circumscribed Lesion,"Serous cystadenoma, borderline malignancy"
7537,Carcinomatous Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
7538,Less than 2 Mitoses per 10HPF,Thymic Typical Carcinoid Tumor
7539,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma
7540,Intracanalicular Growth Pattern,"Phyllodes tumor, borderline"
7541,Carcinomatous Component Present,Adenocarcinoma of salivary gland
7542,S-100-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
7543,Exophytic Polypoid Lesion,tubular adenoma of gallbladder
7544,Indolent Clinical Course,Intravenous leiomyomatosis
7545,Indolent Clinical Course,Lumbosacral Lipoma
7546,Smooth Muscle Component Present,Epithelioid Type Angiomyolipoma
7547,Biphasic Pattern,Ovarian Adenosarcoma
7548,Cysts Containing Proteinaceous Fluid Present,Serous cystadenocarcinoma of pancreas
7549,Thick-Walled Hyalinized Vessels Present,Benign Cardiac Schwannoma
7550,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Choriocarcinoma
7551,Carcinomatous Component Present,Minor Salivary Gland Adenocarcinoma
7552,Hereditary Lesion,Hereditary Non-Polyposis Colon Cancer Type 2
7553,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1
7554,Adnexal Differentiation,Malignant Eccrine Neoplasm
7555,Epithelial Component Present,Stage 0a Urethral Cancer AJCC v7
7556,Carcinomatous Component Present,Stage II Colorectal Cancer AJCC v7
7557,Organoid Pattern,"Thymoma, type B1"
7558,Metastatic Lesion,Testicular cancer metastatic
7559,Intestinal metaplasia,Vaginal Adenoma
7560,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor
7561,Low Mitotic Activity,insulinoma
7562,'Starry-sky' pattern,Stage II Burkitt Lymphoma
7563,Mitotic Activity,Adult Giant Cell Glioblastoma
7564,Cutaneous Involvement,Dermoid cyst of skin
7565,atypia morphology,Childhood Grade III Lymphomatoid Granulomatosis
7566,Rapidly Enlarging Mass,Vulvar Keratoacanthoma
7567,Carcinomatous Component Present,Childhood Thyroid Gland Carcinoma
7568,Papillary Pattern,Skin Papilloma
7569,Cutaneous Involvement,Carcinoma Metastatic to the Skin
7570,Secondary Lesion,Secondary malignant neoplasm of neck
7571,Carcinomatous Component Present,signet ring cell carcinoma of pancreas
7572,More than 10 Mitoses per 10HPF,Stage IIIA Lung Small Cell Carcinoma AJCC v7
7573,Carcinomatous Component Present,Squamous cell carcinoma of the parotid gland
7574,Epithelial Component Present,Thymus Lipofibroadenoma
7575,Pushing Tumor Margin,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
7576,Childhood Lesion,Hepatoblastoma non-resectable
7577,Primary Lesion,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology"
7578,Cystic Change,Mucoepidermoid carcinoma of skin
7579,Epithelial Component Present,Hereditary Prostate Carcinoma
7580,Epithelial Component Present,Thymoma malignant recurrent
7581,Non-Malignant Cellular Infiltrate,Mesenteric Lymphadenitis
7582,Papillary Pattern,sialadenoma papilliferum of salivary gland
7583,Epithelial Component Present,Grade 4 Clear Cell Renal Cell Carcinoma
7584,Epithelial Component Present,Central Nervous System Paraganglioma
7585,Adnexal Differentiation,Hidrocystoma
7586,Carcinomatous Component Present,Renal Cell Cancer by AJCC v7 Stage
7587,Osseous Differentiation,Stage IIA Osteosarcoma AJCC v7
7588,Carcinomatous Component Present,Papillary thyroid carcinoma
7589,Nuclear Pseudoinclusion,Papillary thyroid carcinoma
7590,Lobulated Growth Pattern,Dedifferentiated chordoma
7591,Neutral Epithelial Mucin Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
7592,Neuroendocrine Differentiation,Functioning Pancreatic Neuroendocrine Tumor G2
7593,Defective Alpha Heavy Chain Present,Immunoproliferative Small Intestinal Disease
7594,Low Mitotic Activity,Carcinoid tumor of the duodenum
7595,Well Differentiated Lesion,Early Hepatocellular Carcinoma
7596,Multinodular Mass,Poorly Differentiated Angiosarcoma
7597,Epithelial Component Present,Lung Squamous Cell Papilloma
7598,Carcinomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma
7599,Dysplasia,Tubular adenoma of colon
7600,Thick-Walled Vessels Present,Angiomyolipoma
7601,Carcinomatous Component Present,"Carcinoma bladder stage I, without cancer in situ"
7602,Carcinomatous Component Present,Stage I Anal Canal Cancer AJCC v6 and v7
7603,Secondary Lesion,Benzene-Related Acute Myeloid Leukemia
7604,Crystal deposition,Alveolar soft part sarcoma metastatic
7605,Proliferation of High Endothelial Venules Present,Angioimmunoblastic Lymphadenopathy
7606,Epithelial Component Present,Major Salivary Gland Adenocarcinoma
7607,Juvenile Lesion,Juvenile fibroadenoma of breast
7608,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Ovarian Teratoma
7609,Mixed Cellular Population,Mixed Cell Type Kidney Wilms Tumor
7610,Vascular Channel Formation,Lymphangioma
7611,Epithelial Component Present,Upper Gingival Verrucous Carcinoma
7612,Adnexal Differentiation,"Acanthoma, Pilar Sheath"
7613,Immunologic Deficiency Syndromes,Immunodeficiency-Related Neoplasm
7614,Severe dysplasia,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
7615,Gastric-Type Epithelial Differentiation,"Gastric Adenoma, Gastric-Type"
7616,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
7617,Sarcomatous Component Present,Vaginal Carcinosarcoma
7618,Mixed Cellular Population,Vaginal Carcinosarcoma
7619,Malignant Germinomatous Cellular Infiltrate,Dysgerminoma
7620,Epithelial Component Present,Basaloid squamous cell carcinoma
7621,Carcinomatous Component Present,Stage 0 Vaginal Cancer AJCC v7
7622,Poorly Differentiated Lesion,Pulmonary Blastoma
7623,Cavernous Vascular Space Formation,"Hemangioma, Cavernous"
7624,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Hyperplasia of the Breast
7625,Cutaneous Involvement,Nevus comedonicus
7626,Dysplasia,High Grade Glandular Intraepithelial Neoplasia
7627,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity recurrent
7628,Rapidly Enlarging Mass,"Myositis, Proliferative"
7629,Low Cellularity Present,Pilocytic astrocytoma of cerebellum
7630,Primary Lesion,Primary Cutaneous Anaplastic Large Cell Lymphoma
7631,Mixed Cellular Population,Giant fibroadenoma of breast
7632,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage I
7633,Low Mitotic Activity,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
7634,Negative Peripheral Blood,Aleukemic Acute Lymphoblastic Leukemia Cutis
7635,Papillary Pattern,Bladder Papillary Urothelial Carcinoma
7636,Fibrotic Stroma Formation,Low-grade fibromyxoid sarcoma
7637,Epithelial Component Present,Ectopic hamartomatous thymoma
7638,Epithelial Component Present,Malignant basal cell tumor
7639,Invasive Lesion,Pituitary carcinoma
7640,Myxoid Stroma Formation,Ameloblastic fibroma
7641,Carcinomatous Component Present,Large cell lung cancer stage I
7642,Neoplastic Plasma Cells Present in Bone Marrow,Osteosclerotic Plasma Cell Myeloma
7643,Invasive Lesion,Invasive Cribriform Breast Carcinoma
7644,Cutaneous Involvement,Eccrine Neoplasm
7645,Epithelial Component Present,Adenocarcinoma with apocrine metaplasia
7646,Metastatic Lesion,Metastasizing Chondroblastoma
7647,Neuroendocrine Differentiation,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
7648,Diffuse Pattern,Recurrent Childhood Oligodendroglioma
7649,Monomorphic Cellular Infiltrate,Recurrent Childhood Oligodendroglioma
7650,Locally Aggressive Lesion,Inflammatory pseudotumor of liver
7651,Tissue Differentiation Uncertain,Childhood Synovial Sarcoma
7652,Precise Histogenesis Unknown,Cerebellar hemangioblastoma
7653,Indolent Clinical Course,Airway Hemangioma
7654,High Grade Lesion,Combined Lung Small Cell and Squamous Cell Carcinoma
7655,Increased Cellularity Present,Stage 2 Neuroblastoma
7656,Well Differentiated Lesion,verrucous carcinoma of vagina
7657,Neuroendocrine Differentiation,Small Intestinal Small Cell Neuroendocrine Carcinoma
7658,Mixed Cellular Population,Ovarian Seromucinous Cystadenoma
7659,Epithelial Component Present,"Adenocarcinoma of lung, stage II"
7660,Epithelial Component Present,Carcinoma of bladder
7661,Chromogranin A Positive Neoplastic Cells Present,Extrahepatic Bile Duct Carcinoid Tumor
7662,Pseudoencapsulated Mass,Melanotic malignant nerve sheath tumor
7663,Koilocytotic atypia,Cervical Warty Carcinoma
7664,Adulthood Lesion,Recurrent Adult Soft Tissue Sarcoma
7665,Malignant Germinomatous Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma
7666,Gastric-Type Epithelial Differentiation,"Cervical Mucinous Adenocarcinoma, Gastric Type"
7667,Tissue of Mullerian Origin Present,Uterine Corpus Atypical Polypoid Adenomyoma
7668,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Homologous Type"
7669,Metastatic Lesion,Liposarcoma metastatic
7670,Biphasic Pattern,Myofibromatosis
7671,Carcinomatous Component Present,Paget's Disease of the Nipple
7672,Mitotic Activity,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
7673,Infiltrative Growth Pattern,Anaplastic astrocytoma
7674,Geographic Necrosis,Childhood Testicular Embryonal Carcinoma
7675,Non-Malignant Cellular Infiltrate,Axillary lymphadenitis
7676,Rapidly Enlarging Mass,Breast Rhabdomyosarcoma
7677,Epithelial Component Present,Cervical Cancer by AJCC v6 Stage
7678,Diffuse Pattern,Gemistocytic astrocytoma
7679,Carcinomatous Component Present,Bartholin Gland Transitional Cell Carcinoma
7680,Malignant Germinomatous Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7
7681,Fibrosarcomatous Component Present,Metastatic Dermatofibrosarcoma Protuberans
7682,Monoclonal Eosinophils Present,Childhood Acute Eosinophilic Leukemia
7683,Multifocal Lesion,Multifocal Glioblastomas
7684,Epithelial Component Present,Stage IB1 Cervical Cancer
7685,Slow Growing Mass,Buschke-Lowenstein Tumor
7686,Epithelial Component Present,Stage IV Vaginal Cancer AJCC v6 and v7
7687,Duct-Like Structures Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified"
7688,Anaplasia,Brain Glioblastoma
7689,S-100-Positive Neoplastic Cells Present,Lymphangiomyoma
7690,Well-Circumscribed Lesion,Soft tissue chondroma
7691,Lobulated Growth Pattern,Soft tissue chondroma
7692,Chromogranin A Positive Neoplastic Cells Present,Esophageal Neuroendocrine Tumor G1
7693,Epithelial Component Present,adenocarcinoma of extrahepatic bile duct
7694,Well-Circumscribed Lesion,Mediastinal Chondroma
7695,Carcinomatous Component Present,Posterior Pharyngeal Wall Squamous Cell Carcinoma
7696,Invasive Lesion,Metaplastic carcinoma of breast
7697,Monomorphic Cellular Infiltrate,Adult Oligodendroglioma
7698,Metastatic Lesion,Recurrent Carcinoma of Unknown Primary
7699,Epithelial Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7
7700,Necrotic changes (finding),Gastric Small Cell Carcinoma
7701,Locally Aggressive Lesion,Superficial fibromatosis
7702,Carcinomatous Component Present,High Grade Mucoepidermoid Breast Carcinoma
7703,Primary Lesion,Parosteal Osteosarcoma
7704,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage I
7705,Epithelial Component Present,Ductal Breast Carcinoma
7706,High Mitotic Activity,Childhood Choroid Plexus Carcinoma
7707,Papillary Pattern,Hereditary Papillary Renal Carcinoma
7708,Diffuse Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation
7709,Monoclonal Cellular Population Present,Skin Mastocytoma
7710,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage II
7711,Prominent Elastic Tissue Cores Present,Papillary fibroelastoma
7712,Epithelial Component Present,Combined Lung Carcinoma
7713,Epithelial Component Present,Endometrial Small Cell Carcinoma
7714,Primary Lesion,Cerebral Lymphoma in Immunocompetent Host
7715,Carcinomatous Component Present,Anaplastic adrenocortical carcinoma
7716,Recurrent disease,Recurrent Childhood Anaplastic Astrocytoma
7717,Diffuse Pattern,Recurrent Childhood Anaplastic Astrocytoma
7718,Dermal Involvement,Cellular Blue Nevus
7719,Adulthood Lesion,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
7720,atypia morphology,Borderline cystadenoma
7721,Carcinomatous Component Present,Breast Cancer by AJCC v6 Stage
7722,No Identifiable Line of Differentiation,Undifferentiated spindle cell sarcoma
7723,Epithelial Component Present,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
7724,Cutaneous Involvement,Cutaneous Melanoma by AJCC v6 Stage
7725,Tubular Pattern,Erosive Adenomatosis of the Nipple
7726,Cartilaginous Component Present,Chondroid Hamartoma
7727,Vascular proliferation,Angiofibroma
7728,Carcinomatous Component Present,Maxillary Sinus Adenoid Cystic Carcinoma
7729,Carcinomatous Component Present,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
7730,Vascular Channel Formation,Aortic Angiosarcoma
7731,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
7732,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
7733,Hemorrhagic,Uterine Angiosarcoma
7734,Epithelial Component Present,Neuroendocrine Tumors
7735,Mixed Cellular Population,Mixed epithelial tumor of ovary
7736,Epithelial Component Present,Liver carcinoma
7737,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v6 and v7
7738,Thyroglobulin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
7739,Epithelial Component Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma
7740,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
7741,Adnexal Differentiation,Carcinoma of apocrine gland
7742,Hyperplastic Tissue Present,Usual ductal hyperplasia of breast
7743,Cellular Pleomorphism,"Perivascular epithelioid tumor, malignant"
7744,Acinar Cell Differentiation,Acinic cell carcinoma of salivary gland
7745,Endophytic Tumor Growth,Lower Gingival Verrucous Carcinoma
7746,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage II
7747,In Situ Lesion,"Urinary bladder carcinoma stage I, with cancer in situ"
7748,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage II
7749,Epithelial Component Present,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
7750,Carcinomatous Component Present,Grade 1 Endometrial Endometrioid Adenocarcinoma
7751,Primary Lesion,Meningeal melanoma
7752,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage IV
7753,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH
7754,Invasive Lesion,Prostate Adenoid Cystic Carcinoma
7755,Dermal Involvement,Vulvar Eccrine Porocarcinoma
7756,Epithelial Component Present,Laryngeal verrucous carcinoma
7757,Cystic Change,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma
7758,Neuroendocrine Differentiation,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
7759,Hyperkeratosis,Glottis Verrucous Carcinoma
7760,Increased Cellularity Present,pineoblastoma
7761,Epithelial Component Present,Stage IC Eyelid Carcinoma AJCC v7
7762,Epithelial Component Present,Mixed Somatotroph and Lactotroph Adenoma
7763,Hyperkeratosis,Human Papillomavirus-Related Verrucous Carcinoma
7764,Epithelial Component Present,Adamantinous Craniopharyngioma
7765,Cystic Lesion,Adamantinous Craniopharyngioma
7766,Rapidly Enlarging Mass,Intravascular fasciitis
7767,Epithelial Component Present,Fallopian Tube Clear Cell Adenocarcinoma
7768,Epithelial Component Present,Adenocarcinoma Of Esophagus
7769,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma
7770,Mild cytologic atypia,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
7771,Extraosseous Lesion,Liver Extraskeletal Osteosarcoma
7772,Epithelial Component Present,Sporadic Breast Carcinoma
7773,Well-Circumscribed Lesion,Malignant Phyllodes Tumor of Prostate
7774,Hyperkeratosis,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
7775,Calcinosis,Testicular Large Cell Calcifying Sertoli Cell Tumor
7776,High Mitotic Activity,Colorectal Large Cell Neuroendocrine Carcinoma
7777,Benign Cellular Infiltrate,Pancreatic Macrocystic Serous Cystadenoma
7778,Vascular Channel Formation,Multiple Lobular Capillary Hemangiomas
7779,Carcinomatous Component Present,Pancreatic adenocarcinoma metastatic
7780,Pseudoglandular Pattern,embryonal carcinoma of mediastinum
7781,Carcinomatous Component Present,Invasive Ductal and Lobular Carcinoma
7782,Recurrent disease,Centroblastic lymphoma recurrent
7783,Carcinomatous Component Present,Stage IIB Lung Large Cell Carcinoma AJCC v7
7784,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant"
7785,Chromogranin A Positive Neoplastic Cells Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1"
7786,Carcinomatous Component Present,"Glycogen-Rich, Clear Cell Breast Carcinoma"
7787,Carcinomatous Component Present,Stage IVC Pharyngeal Carcinoma
7788,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Non-Gestational Ovarian Choriocarcinoma
7789,Neuroectodermal Differentiation,Recurrent tumors of the Ewing's family
7790,Epithelial Component Present,Colorectal Adenomatous Polyp
7791,Invasive Lesion,Dermatofibrosarcoma Protuberans
7792,Papillary Pattern,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
7793,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2
7794,Adnexal Differentiation,Eccrine carcinoma of skin
7795,Epithelial Component Present,Stage IV Prostate Carcinoma
7796,Eccrine Differentiation,Ductal Eccrine Carcinoma with Spindle Cell Elements
7797,Carcinomatous Component Present,Invasive Lobular Breast Carcinoma
7798,Metastatic Lesion,Metastatic Breast Carcinoid Tumor
7799,Mesenchymal Differentiation,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
7800,Epithelial Component Present,Adenosquamous cell lung cancer stage IIIA
7801,Benign Cellular Infiltrate,Benign neoplasm of mesothelial tissue of peritoneum
7802,Acanthosis,Condyloma acuminata of vagina
7803,Cutaneous Involvement,Scrotal Carcinoma
7804,Recurrent disease,Recurrent Lung Carcinoma Cell Type Unspecified
7805,Carcinomatous Component Present,Gallbladder adenosquamous carcinoma
7806,Exophytic Papillary Lesion,Exophytic Schneiderian Papilloma
7807,Epithelial Component Present,Glandular papilloma
7808,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
7809,Epithelial Component Present,Tonsillar Carcinoma
7810,Dysplasia,Intraepithelial Squamous Cell Carcinoma
7811,Exophytic Papillary Lesion,"Lung Squamous Cell Carcinoma, Papillary Variant"
7812,Well-Circumscribed Lesion,Oropharyngeal Polyp
7813,Refractory Disease,Plasma cell myeloma refractory
7814,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Signet Ring Cell Follicular Adenoma
7815,Follicular Structures Present,Thyroid Gland Signet Ring Cell Follicular Adenoma
7816,Slit-Like Vascular Channel Formation,Kaposiform Hemangioendothelioma
7817,Epithelial Component Present,Intermediate Grade Lung Neuroendocrine Neoplasm
7818,Epithelial Component Present,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation
7819,Epithelial Component Present,Ethmoid Sinus Squamous Cell Carcinoma
7820,Absence of Invasion or Limited Invasion Present,Peritoneal Well Differentiated Papillary Mesothelioma
7821,Rapidly Enlarging Mass,Childhood Pleomorphic Rhabdomyosarcoma
7822,Cutaneous Involvement,Squamous Cell Carcinoma of Anal Margin
7823,Slow Growing Mass,Ganglioneuroma
7824,Indolent Clinical Course,Vulvar Superficial Angiomyxoma
7825,Carcinomatous Component Present,Stage 0 Penile Cancer AJCC v6
7826,Exophytic Polypoid Lesion,Villous adenoma of duodenum
7827,Chronic Phase of Disease,"Leukemia, Myeloid, Chronic-Phase"
7828,Poorly Differentiated Lesion,Renal medullary carcinoma
7829,Carcinomatous Component Present,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
7830,Skin Papule,Desmoplastic trichoepithelioma
7831,Poorly Differentiated Lesion,Poorly Differentiated Prostate Adenocarcinoma
7832,Carcinomatous Component Present,Stage IA Esophageal Adenocarcinoma AJCC v7
7833,Non-Invasive Lesion,Ampulla of Vater Villous Adenoma
7834,Dysplasia,Ampulla of Vater Villous Adenoma
7835,Childhood Lesion,Childhood Acute Monoblastic and Monocytic Leukemia
7836,Lymphadenopathy,Multi-centric Castleman's Disease
7837,Childhood Lesion,Childhood Mesenchymal Chondrosarcoma
7838,Epithelial Component Present,Papillary mucinous cystadenoma
7839,Immunologic Deficiency Syndromes,Plasma Cell Post-Transplant Lymphoproliferative Disorder
7840,Cutaneous Involvement,Ceruminous adenocarcinoma
7841,Epithelial Component Present,Nasopharyngeal Paraganglioma
7842,Low Mitotic Activity,Pancreatic Gastrin-Producing Neuroendocrine Tumor
7843,Epithelial Component Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor
7844,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed
7845,Epithelial Component Present,"Papillary cystadenoma, borderline malignancy"
7846,Tubular Structures Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
7847,Adulthood Lesion,Adult Myxoid Chondrosarcoma
7848,Regional Disease,Locally Metastatic Malignant Neoplasm
7849,Infantile Lesion,"Neuroectodermal Tumor, Melanotic"
7850,Therapy-Related Toxicity,Alkylating Agent-Related Myelodysplastic Syndrome
7851,Epithelial Component Present,Ductal Breast Carcinoma with Squamous Metaplasia
7852,High Grade Lesion,Glioblastoma with Primitive Neuronal Component
7853,Fibrotic Stroma Formation,Ossifying Fibroma
7854,Carcinomatous Component Present,cloacogenic carcinoma of rectum
7855,Carcinomatous Component Present,Occult Lung Adenosquamous Carcinoma
7856,Slowly Progressive Clinical Course,Smoldering Systemic Mastocytosis
7857,Carcinomatous Component Present,Rectal Sarcomatoid Carcinoma
7858,Carcinomatous Component Present,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma
7859,Adulthood Lesion,Adult Glioblastoma
7860,Well-Circumscribed Lesion,Appendix Tubulovillous Adenoma
7861,Sebaceous Differentiation,Parotid Gland Sebaceous Lymphadenoma
7862,Epithelial Component Present,Intestinal Intraepithelial Neoplasia
7863,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v6
7864,Epithelial Component Present,Undifferentiated Carcinoma of Unknown Primary
7865,Dysplasia,Vaginal Tubulovillous Adenoma
7866,Neuroendocrine Differentiation,Benign Carotid Body Paraganglioma
7867,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myeloid leukemia with abnormal marrow eosinophils
7868,Epithelial Component Present,Breast Ductal Adenoma
7869,Recurrent Genetic Abnormalities Present,"Acute myeloid leukemia, t(8;21) (q22;q22)"
7870,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma
7871,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma
7872,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v7
7873,Vascular proliferation,Gingival Angiofibroma
7874,Diffuse Pattern,Childhood Brain Stem Gliosarcoma
7875,High Grade Lesion,Recurrent Childhood Glioblastoma
7876,Intraluminal Necrosis,Intermediate Grade Ductal Breast Carcinoma In Situ
7877,Adnexal Differentiation,Perifollicular fibroma
7878,Recurrent disease,Esophageal carcinoma recurrent
7879,Hereditary Lesion,"Hamartoma Syndrome, Multiple"
7880,Resectable Mass,Bile duct cancer resectable
7881,Neuroectodermal Differentiation,Mediastinal Neuroblastoma
7882,Absence of Invasion,Adenocarcinoma in situ in tubulovillous adenoma
7883,Borderline Lesion,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology"
7884,More than 10 Mitoses per 10HPF,Stage IV Lung Small Cell Carcinoma AJCC v7
7885,Recurrent disease,Recurrent Skin Carcinoma
7886,Mixed Cellular Population,carcinosarcoma of salivary gland
7887,Epithelial Component Present,Mucinous cystadenoma of ovary
7888,Epithelial Component Present,Cervix carcinoma
7889,Epithelial Component Present,cystadenoma of salivary gland
7890,Adulthood Lesion,Adult Ependymoma
7891,CD4-Positive Neoplastic Cells Present,Blastic plasmacytoid dendritic cell neoplasm
7892,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type A"
7893,Epithelial Component Present,Grade 3 Clear Cell Renal Cell Carcinoma
7894,Dysplasia,Stage 0 Renal Pelvis Cancer AJCC v7
7895,Monomorphic Cellular Infiltrate,Small cell glioblastoma
7896,Favorable Clinical Outcome,Type B Lymphomatoid Papulosis
7897,Multifocal Lesion,Bowenoid papulosis
7898,Therapy-Related Toxicity,Transplant-Related Kaposi Sarcoma
7899,Keratin pearl formation,Keratinizing Paranasal Sinus Squamous Cell Carcinoma
7900,Low Grade Lesion,Classic Congenital Mesoblastic Nephroma
7901,Epithelial Component Present,Cystic basal cell carcinoma
7902,Mesenchymal Metaplasia of Malignant Cells Present,Breast Carcinoma with Osseous Metaplasia
7903,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation
7904,Mucoid Stroma Formation,Bile duct mucinous adenocarcinoma
7905,Radiation Sickness,Cutaneous Radiation-Related Angiosarcoma
7906,Epithelial Component Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
7907,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma
7908,Mixed Cellular Population,Cervical Mixed Epithelial and Mesenchymal Neoplasm
7909,Locally Aggressive Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential
7910,Nodular Pattern,Medulloblastoma with extensive nodularity
7911,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma of Mucosa Site
7912,Mixed Cellular Population,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm
7913,Cutaneous Involvement,Acquired keratoderma
7914,Cribriform Pattern,Colon Cribriform Comedo-Type Adenocarcinoma
7915,Epithelial Component Present,Bladder squamous cell carcinoma recurrent
7916,Absence of a Hormonal Syndrome,Pituitary Gland Oncocytic Adenoma
7917,Epithelial Component Present,Major Salivary Gland Acinic Cell Carcinoma
7918,Five or Less Mitoses per 50HPF,Benign Gastric Gastrointestinal Stromal Tumor
7919,Increased Cellularity Present,Disseminated neuroblastoma
7920,Epithelial Component Present,Keratinizing Head and Neck Squamous Cell Carcinoma
7921,Papillary Pattern,Sphenoid Sinus Inverted Papilloma
7922,Secondary Lesion,Carcinomatosis of peritoneal cavity
7923,Neuroendocrine Differentiation,Adenocarcinoid tumor
7924,Epithelial Component Present,Gastrointestinal Carcinoid Tumor
7925,Well-Circumscribed Lesion,Central Nervous System Hemangioblastoma
7926,Eosinophilic inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor
7927,Tissues Derived from Two or Three Embryonic Layers Present,Mature Ovarian Teratoma
7928,Monomorphic Cellular Infiltrate,Adult Grade III Lymphomatoid Granulomatosis
7929,Glandular Differentiation,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma
7930,Defective Gamma Heavy Chain Present,gamma-Chain Disease
7931,Indolent Clinical Course,Benign vascular neoplasm
7932,Refractory Disease,Precursor T-lymphoblastic lymphoma/leukemia refractory
7933,Epithelial Component Present,High-Grade Squamous Intraepithelial Lesions
7934,Primary Lesion,Childhood Periosteal Osteosarcoma
7935,Peripheral Nuclear Palisading,Basaloid squamous cell carcinoma
7936,Storiform Growth Pattern,Dermatofibrosarcoma protuberans with myoid differentiation
7937,Mitotic Activity,Childhood Brain Anaplastic Astrocytoma
7938,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
7939,Dilated Terminal Duct Lobular Units Present,Columnar Cell Hyperplasia of the Breast
7940,Mild dysplasia,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia
7941,Carcinomatous Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
7942,Mitotic Activity,Supratentorial Glioblastoma
7943,Primary Lesion,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive"
7944,Carcinomatous Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7
7945,Cutaneous Involvement,Granulomatous dermatitis
7946,Lesion with Diameter of 10mm or Less,Non-Functioning Pituitary Gland Microadenoma
7947,Cystic Change,Dermoid Cyst of the Spinal Cord
7948,Dysplasia,Grade II Prostatic Intraepithelial Neoplasia
7949,Carcinomatous Component Present,Duodenal Cancer
7950,Carcinomatous Component Present,Stage IV Cervical Cancer AJCC v6 and v7
7951,Recurrent disease,Recurrent tumor
7952,Vascular Channel Formation,Blue rubber bleb nevus syndrome
7953,Hemorrhagic,hemangioendothelial sarcoma of bone
7954,Refractory Disease,Refractory Brain Neoplasm
7955,Plasma cell inflammation,Lung Inflammatory Myofibroblastic Tumor
7956,Cutaneous Involvement,Basal cell carcinoma - adamantinoid
7957,Spindle Cell Component Present,Pleural Biphasic Synovial Sarcoma
7958,Low Mitotic Activity,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
7959,Low Cellularity Present,Pilocytic Astrocytoma
7960,Epithelial Component Present,Adenocarcinoma with spindle cell metaplasia
7961,Cysts Containing Proteinaceous Fluid Present,"Cystadenoma, Serous"
7962,Secondary Lesion,Secondary Central Nervous System Lymphoma
7963,Adnexal Differentiation,Eccrine Neoplasm
7964,Carcinomatous Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma
7965,Malignant Germinomatous Cellular Infiltrate,Testicular Typical Seminoma
7966,Severe cytologic atypia,large cell neuroendocrine carcinoma of anal canal
7967,Necrotic changes (finding),Glioblastoma multiforme of spinal cord
7968,Multinodular Mass,Soft Tissue Angiosarcoma
7969,Exophytic Polypoid Lesion,Cyst of Skene's duct
7970,Carcinomatous Component Present,Lung squamous cell carcinoma stage III
7971,Metastatic/Recurrent Disease,Extrarenal rhabdoid tumor
7972,Recurrent disease,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
7973,Absence of Invasion,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
7974,Slow Growing Mass,Childhood Supratentorial Ependymoma
7975,Epithelial Component Present,Anal squamous cell carcinoma
7976,Chromogranin A Positive Neoplastic Cells Present,Ovarian Trabecular Carcinoid Tumor
7977,Neuroendocrine Differentiation,Vaginal Neuroendocrine Carcinoma
7978,Stromal Invasion,Stage I Ovarian Cancer AJCC v6 and v7
7979,Tissue Differentiation Uncertain,Clear Cell Sarcoma of Soft Tissue
7980,Epithelial Component Present,Sex Hormone-Producing Adrenal Cortex Adenoma
7981,In Situ Lesion,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
7982,High Mitotic Activity,Vaginal Large Cell Neuroendocrine Carcinoma
7983,Epithelial Component Present,Vagina Carcinoma
7984,In Situ Lesion,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8"
7985,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
7986,Hyperkeratosis,Plantar wart
7987,Cutaneous Involvement,Disseminated Juvenile Xanthogranuloma
7988,Cutaneous Involvement,Bullous pemphigoid
7989,Nuclear Pseudoinclusion,Oncocytic Variant Thyroid Gland Papillary Carcinoma
7990,Hereditary Lesion,"Amyloidosis, Familial"
7991,Vascular Channel Formation,Cardiac Epithelioid Hemangioendothelioma
7992,Pregnancy Complications,Placental infarct
7993,Vascular Channel Formation,Cardiac Kaposi's Sarcoma
7994,Increased Cellularity Present,Kadish Stage B Olfactory Neuroblastoma
7995,Epithelial Component Present,Stage IV Liver Cancer
7996,Epithelial Component Present,Pyloric Gland Adenoma
7997,Epithelial Component Present,Cervical Microglandular Polyp
7998,Epithelial Component Present,Gallbladder Cribriform Carcinoma
7999,Tissue of Mullerian Origin Present,"Uterine Carcinosarcoma, Heterologous Type"
8000,Increased Cellularity Present,"Anaplastic Astrocytoma, IDH-Mutant"
8001,Diffuse Pattern,"Anaplastic Astrocytoma, IDH-Mutant"
8002,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Testicular Mature Teratoma
8003,Childhood Lesion,Childhood Testicular Choriocarcinoma
8004,Carcinomatous Component Present,Adenosquamous cell lung cancer stage I
8005,Papillary Pattern,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
8006,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Villoglandular Endometrial Endometrioid Adenocarcinoma
8007,Carcinomatous Component Present,Low Grade Ovarian Serous Adenocarcinoma
8008,Junctional Proliferation,Spindle cell nevus of Reed
8009,Carcinomatous Component Present,Stage II Oropharyngeal Carcinoma
8010,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant"
8011,Immunosuppression-Related Post-Transplant Toxicity,Intestinal Graft Versus Host Disease
8012,Locally Aggressive Lesion,Atypical fibroxanthoma - spindle cell type
8013,High Grade Lesion,Metastatic Dermatofibrosarcoma Protuberans
8014,Mitotic Activity,"Glioblastoma, IDH-Mutant"
8015,Invasive Lesion,"Squamous Cell Breast Carcinoma, Acantholytic Variant"
8016,Adulthood Lesion,Adult Type Granulosa Cell Tumor
8017,Villous Projections of the Neoplastic Epithelium Present,Filiform Serrated Adenoma
8018,Epithelial Component Present,Stage II Anal Canal Cancer AJCC v6 and v7
8019,Hyperkeratosis,External Ear Actinic Keratosis
8020,Secondary Lesion,Secondary malignant neoplasm of choroid
8021,Anaplasia,Osteoblastic Osteosarcoma
8022,Tissue Differentiation Uncertain,Intermediate Soft Tissue Tumor of Uncertain Differentiation
8023,In Situ Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
8024,Severe cytologic atypia,Small cell carcinoma of esophagus
8025,Epithelial Component Present,Medullary carcinoma of breast
8026,Severe dysplasia,Stage 0 Gastric Cancer AJCC v6 and v7
8027,Hyperkeratosis,Supraglottic Verrucous Carcinoma
8028,Carcinomatous Component Present,Stage IVB Major Salivary Gland Cancer AJCC v7
8029,Storiform Growth Pattern,Giant Cell Fibrous Histiocytoma
8030,Primary Lesion,anaplastic large cell lymphoma of central nervous system
8031,Epithelial Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
8032,Adulthood Lesion,Adult Central Nervous System Immature Teratoma
8033,Cutaneous Involvement,Dermal Fibroma
8034,Favorable Clinical Outcome,Cutaneous Mastocytosis
8035,Neuroendocrine Differentiation,Neoplasm of aortic body
8036,Epithelial Component Present,Breast Carcinoma with Choriocarcinomatous Features
8037,Hereditary Lesion,Hereditary Papillary Renal Carcinoma
8038,Carcinomatous Component Present,Endometrial Transitional Cell Carcinoma
8039,Anaplasia,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
8040,Carcinomatous Component Present,Skin Basaloid Carcinoma
8041,Mixed Cellular Population,Combined Lung Carcinoma
8042,Intraductal Lesion,Intraductal Proliferative Lesion of the Breast
8043,Psammoma Body Formation,Calcifying Fibrous Pseudotumor
8044,Epithelial Component Present,Benign Ovarian Transitional Cell Tumor
8045,Non Lipogenic Sarcomatous Stroma Present,"Liposarcoma, Dedifferentiated"
8046,Cribriform Pattern,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
8047,Low Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v7
8048,Low Mitotic Activity,Duodenal Somatostatin-Producing Neuroendocrine Tumor
8049,Epithelial Component Present,Parathyroid mixed cell type adenoma
8050,Necrotic changes (finding),Cerebellar Glioblastoma
8051,Epithelial Component Present,Appendix Sessile Serrated Adenoma/Polyp
8052,Epithelial Component Present,Stage IVC Basal Cell Lip Carcinoma
8053,Epithelial Component Present,Stage I Lung Cancer AJCC v6
8054,Childhood Lesion,Recurrent Childhood Anaplastic Oligoastrocytoma
8055,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v7
8056,Increased Cellularity Present,Stage 2A Neuroblastoma
8057,Carcinomatous Component Present,Ethmoid Sinus Adenocarcinoma
8058,Anaplasia,Gingival Spindle Cell Carcinoma
8059,Edematous Stroma Formation,Vulvar Angiomyofibroblastoma
8060,Cutaneous Involvement,Stage IIC Cutaneous Melanoma AJCC v6 and v7
8061,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v7
8062,Follicular Cell Differentiation,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
8063,Hereditary Lesion,"Anemia, Hemolytic, Congenital"
8064,Cutaneous Involvement,Fibroepithelioma of Pinkus
8065,Thin Bands of Collagen Present,benign fibroma of liver
8066,Epithelial Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
8067,Tobacco Chewing Toxicity,Tobacco Chewing-Related Carcinoma
8068,Cystic Change,mucoepidermoid carcinoma of lung
8069,Epithelial Component Present,Atypical adenoma
8070,Cystic Change,Borderline Ovarian Clear Cell Cystadenofibroma
8071,Pregnancy Complications,Low lying placenta
8072,Carcinomatous Component Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
8073,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage I
8074,Well-Circumscribed Lesion,Pancreatic Solid Serous Adenoma
8075,Epithelial Component Present,Carcinoma of the Appendix
8076,Nodular Pattern,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites"
8077,Syncytial Pattern,Tonsillar Undifferentiated Carcinoma
8078,Indolent Clinical Course,Benign Glomus Tumor
8079,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 1 Endometrial Endometrioid Adenocarcinoma
8080,Submucosal Lesion,Submucosal Invasive Colon Adenocarcinoma
8081,Epithelial Component Present,Endometrial Squamous Cell Carcinoma
8082,Alternative Fascicle (Bundle) Pattern,Leiomyoma of esophagus
8083,Anaplasia,Stage II Childhood Anaplastic Large Cell Lymphoma
8084,CD30-Positive Neoplastic Cells Present,Stage III Childhood Anaplastic Large Cell Lymphoma
8085,Carcinomatous Component Present,Stage I Paranasal Sinus Cancer
8086,Epithelial Component Present,Neuroendocrine carcinoma of appendix
8087,Mixed Cellular Population,Benign mixed epithelial and stromal tumor of kidney
8088,Carcinomatous Component Present,Moderately Differentiated Prostate Adenocarcinoma
8089,Epithelial Component Present,undifferentiated carcinoma of extrahepatic bile duct
8090,Diffuse Pattern,Angioendotheliomatosis
8091,Mild dysplasia,Low Grade Anal Canal Squamous Intraepithelial Neoplasia
8092,Estrogen receptor negative,Triple-Negative Breast Carcinoma
8093,Negative Peripheral Blood,Aleukemic Lymphoid Leukemia
8094,High Grade Lesion,rhabdomyosarcoma of liver
8095,Indolent Clinical Course,Mucous Membrane Hemangioma
8096,Benign Cellular Infiltrate,Colon Leiomyoma
8097,Anaplasia,Stage I Childhood Anaplastic Large Cell Lymphoma
8098,Well-Circumscribed Lesion,Pancreatic Macrocystic Serous Cystadenoma
8099,Epithelial Component Present,Oxyphilic Adenoma
8100,Cystic Change,Pancreatic Acinar Cell Cystadenoma
8101,Perivascular Arrangement of Tumor Cells,Gastric Glomus Tumor
8102,Carcinomatous Component Present,Bronchioloalveolar Adenocarcinoma
8103,Osseous Differentiation,Osteosarcoma of bone
8104,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma
8105,Vascular Channel Formation,Senile angioma
8106,Epithelial Component Present,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7
8107,Diffuse Pattern,large B-cell diffuse lymphoma of spleen
8108,Epithelial Component Present,Carcinoma ex Eccrine Spiradenoma
8109,Recurrent disease,Rectosigmoid cancer recurrent
8110,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
8111,Fibrotic Stroma Formation,Posterior Tongue Mucoepidermoid Carcinoma
8112,Carcinomatous Component Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
8113,Carcinomatous Component Present,Carcinoma in situ of fallopian tube
8114,High Mitotic Activity,Stage IIA Lung Small Cell Carcinoma AJCC v7
8115,Epithelial Component Present,Paranasal Sinus Cancer
8116,Increased Cellularity Present,Cellular Schwannoma
8117,Epithelial Component Present,Stage 0 Esophageal Cancer AJCC v6
8118,Neuroendocrine Differentiation,Ovarian Neuroendocrine Neoplasm
8119,Childhood Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
8120,Childhood Lesion,Hepatoblastoma with Pure Fetal Epithelial Differentiation
8121,Epithelial Component Present,Small Intestinal VIP-Producing Neuroendocrine Tumor
8122,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
8123,Local disease,Solitary Adult Fibroma
8124,Granulocytes Increased in Bone Marrow,Prefibrotic/Early Primary Myelofibrosis
8125,Therapy-Related Toxicity,Transplant-Related Carcinoma
8126,In Situ Lesion,Carcinoma in situ of trachea
8127,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
8128,Metastatic Lesion,Secondary malignant neoplasm of mediastinum
8129,Epithelial Component Present,Colorectal Adenoma with Mild Dysplasia
8130,Mesenchymal Metaplasia,Adenocarcinoma with osseous metaplasia
8131,Ectopic Thyroid Tissue Present,Strumal carcinoid
8132,Secondary Lesion,Metastatic Malignant Solid Neoplasm
8133,Immunologic Deficiency Syndromes,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
8134,Peripheral Nuclear Palisading,Esophageal Basaloid Carcinoma
8135,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
8136,Epithelial Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
8137,Neuroectodermal Differentiation,Adrenal neuroblastoma
8138,Carcinomatous Component Present,Anal carcinoma
8139,Malignant Germinomatous Cellular Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7
8140,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Solid Pattern"
8141,Cutaneous Involvement,Carcinoma in situ of skin
8142,Tissue Differentiation Uncertain,Distal-Type Epithelioid Sarcoma
8143,Tubular Pattern,tubular adenoma of stomach
8144,Epithelial Component Present,Traditional Serrated Adenoma
8145,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic-Myeloproliferative Diseases
8146,Diffuse Lesion,Kasabach-Merritt syndrome
8147,Benign Cellular Infiltrate,Lipoma of small intestine
8148,Epithelial Component Present,Syringocystadenoma Papilliferum
8149,Low Grade Lesion,Lung Typical Carcinoid Tumor
8150,Alternative Fascicle (Bundle) Pattern,"Uterine Corpus Leiomyoma, Mitotically Active Variant"
8151,Intestinal metaplasia,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
8152,Mixture of Germ Cell Neoplastic Components Present,Mixed Germ Cell Tumor
8153,Mesenchymal Component Present,Breast Phyllodes Tumor
8154,Immunosuppression-Related Post-Transplant Toxicity,Plasma Cell Post-Transplant Lymphoproliferative Disorder
8155,Well-Circumscribed Lesion,Villous adenoma of colon
8156,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
8157,Childhood Lesion,Childhood Spinal Cord Neoplasm
8158,Well Differentiated Lesion,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type"
8159,Diffuse Pattern,Childhood Immunoblastic Lymphoma
8160,Epithelial Component Present,undifferentiated carcinoma of larynx
8161,Mixed Cellular Population,"Phyllodes tumor, borderline"
8162,Well-Circumscribed Lesion,"Phyllodes tumor, borderline"
8163,Epithelial Component Present,Lymphangitis carcinomatosa
8164,Therapy-Related Toxicity,Methotrexate-Associated Peripheral T-Cell Lymphoma
8165,Intraocular Lesion,Lymphoma of retina
8166,Epithelial Component Present,Adenocarcinoma of salivary gland
8167,Enterochromaffin Type Granules Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
8168,Carcinomatous Component Present,large cell neuroendocrine carcinoma of thymus
8169,Carcinomatous Component Present,Ampulla of Vater Adenosquamous Carcinoma
8170,Epithelial Component Present,Adult Hepatocellular Carcinoma
8171,Pseudostratified Neuroepithelial Tumor Cells Present,Malignant medulloepithelioma of ciliary body
8172,Squamous metaplasia of bladder,Bladder Urachal Squamous Cell Carcinoma
8173,Drug Exposure,Alkylating Agent-Related Acute Myeloid Leukemia
8174,Absence of Invasion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
8175,Severe dysplasia,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
8176,Radiation Sickness,Solar Radiation-Related Cutaneous Melanoma
8177,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
8178,Epithelial Component Present,Eccrine spiradenoma
8179,Severe dysplasia,Carcinoma in situ of small intestine
8180,Chromogranin A Positive Neoplastic Cells Present,Atypical carcinoid tumor
8181,Chronic lymphocytic inflammation,"Thymoma, type AB, malignant"
8182,Well-Circumscribed Lesion,Gardner Syndrome
8183,Epithelial Component Present,Invasive papillary breast carcinoma
8184,Mixture of Embryonal and Alveolar Features Present,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
8185,Severe dysplasia,Stage 0 Lung Cancer AJCC v6 and v7
8186,Epithelial Component Present,Stage 0 Lung Cancer AJCC v6 and v7
8187,Epithelial Component Present,Esophageal Neuroendocrine Tumor
8188,Metastatic Lesion,Secondary malignant neoplasm of large intestine
8189,Childhood Lesion,Childhood Central Nervous System Choriocarcinoma
8190,High Grade Lesion,rhabdomyosarcoma of mediastinum
8191,Well Differentiated Lesion,mucinous adenocarcinoma of lung
8192,Epithelial Component Present,Low Grade Ductal Breast Carcinoma In Situ
8193,Carcinomatous Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7
8194,Epithelial Component Present,Sporadic Cylindroma
8195,Monomorphic Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
8196,Peripheral Nuclear Palisading,Occult Lung Small Cell Carcinoma
8197,Epithelial Component Present,Eccrine mixed tumor of skin
8198,Stromal Invasion,mucinous adenocarcinoma of ovary
8199,Epithelial Component Present,Endometrial Dedifferentiated Carcinoma
8200,Epithelial Component Present,Hidrocystoma
8201,Metastatic Lesion,Carcinoma bone
8202,Tissue of Mullerian Origin Present,Uterine Ligament Adenosarcoma
8203,Mixed Cellular Population,Nephrogenic adenofibroma
8204,Hyperplastic Tissue Present,Mesonephric Hyperplasia
8205,Immunologic Deficiency Syndromes,AIDS-Related Pneumocystis Pneumonia
8206,Carcinomatous Component Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
8207,Carcinomatous Component Present,Vulvar Warty Carcinoma
8208,Intraductal Lesion,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm
8209,Lobulated Growth Pattern,Right atrial myxoma
8210,Epithelial Component Present,Hereditary Renal Cell Carcinoma
8211,Mild dysplasia,Mild esophageal dysplasia
8212,Secondary Lesion,Pericardial Carcinomatosis
8213,Extraosseous Lesion,Breast Extraskeletal Osteosarcoma
8214,Cutaneous Involvement,Cutaneous Radiation-Related Angiosarcoma
8215,Malignant Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma
8216,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v7
8217,Acanthosis,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
8218,Increased Cellularity Present,Adult Anaplastic Astrocytoma
8219,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
8220,Multifocal Lesion,Lymphangioleiomyomatosis
8221,Dysplasia,Pancreatic intraepithelial neoplasia
8222,Diffuse Pattern,Protoplasmic astrocytoma
8223,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma
8224,Benign Cellular Infiltrate,Colon Lymphangioma
8225,Biphasic Pattern,Benign Vaginal Mixed Tumor
8226,Epithelial Component Present,Rectosigmoid cancer
8227,Exophytic Polypoid Lesion,Polyp of nasal sinus
8228,Hyalinized Stroma Formation,Mediastinal Solitary Fibrous Tumor
8229,Squamous metaplasia of bladder,Bladder squamous cell carcinoma recurrent
8230,Epithelial Component Present,Gastric Papillary Adenocarcinoma
8231,Exophytic Polypoid Lesion,Appendix Villous Adenoma
8232,Carcinomatous Component Present,Solid Lung Adenocarcinoma
8233,Papillary Pattern,Papillary Ductal Breast Hyperplasia
8234,"Nodular, Reticulin-Free Zones Present",Desmoplastic Medulloblastoma
8235,Epithelial Component Present,High Grade Penile Intraepithelial Neoplasia
8236,More than 5 Mitoses per 50HPF,Malignant Gastric Gastrointestinal Stromal Tumor
8237,Alternative Fascicle (Bundle) Pattern,Leiomyoma of Gallbladder
8238,Biphasic Pattern,serous adenocarcinofibroma of ovary
8239,High Grade Lesion,"Synovial sarcoma, spindle cell"
8240,Angiocentric Pattern,Recurrent Childhood Lymphomatoid Granulomatosis
8241,Chronic Inflammatory Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis
8242,Cutaneous Involvement,Leukemic infiltration of skin
8243,Papillary Pattern,Frontal Sinus Inverted Papilloma
8244,Stromal Invasion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
8245,Epithelial Component Present,Stage II Penile Cancer AJCC v6
8246,Tissue of Mullerian Origin Present,Vaginal Adenosarcoma
8247,Rapidly Enlarging Mass,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
8248,Epithelial Component Present,FIGO Stage IC1 Ovarian Cancer
8249,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast
8250,Well-Circumscribed Lesion,Breast Myofibroblastoma
8251,Epithelial Component Present,Pharyngeal Carcinoma
8252,Epithelial Component Present,Gastric Mixed Adenocarcinoma
8253,Chronic lymphocytic inflammation,Recurrent Childhood Pleomorphic Xanthoastrocytoma
8254,Stromal Invasion,"Ovarian Small Cell Carcinoma, Hypercalcemic Type"
8255,Anaplasia,Infratentorial Glioblastoma
8256,Mucinous degeneration,Recurrent Childhood Protoplasmic Astrocytoma
8257,Absence of Invasion,Stage 0is Renal Pelvis Cancer AJCC v7
8258,Epithelial Component Present,FSH-Producing Gonadotroph Adenoma
8259,Exophytic Polypoid Lesion,Urethra Fibroepithelial Polyp
8260,Well-Circumscribed Lesion,Urethra Fibroepithelial Polyp
8261,Generalized illness,Leiomyomatosis peritonealis disseminata
8262,Carcinomatous Component Present,Stage IV Bladder Cancer AJCC v7
8263,Refractory Disease,Refractory Central Nervous System Neoplasm
8264,Mitotic Activity,Anaplastic Brain Stem Astrocytoma
8265,Hereditary Lesion,Dysplastic Nevus Syndrome
8266,Epithelial Component Present,Cholangiocarcinoma resectable
8267,Cutaneous Involvement,Neurodermatitis
8268,Carcinomatous Component Present,Large cell lung cancer recurrent
8269,Epithelial Component Present,Gastric Cardia Carcinoma
8270,Tissue Differentiation Uncertain,Pleural Biphasic Synovial Sarcoma
8271,Epithelial Component Present,Renal Pelvis Urothelial Papilloma
8272,Glomeruloid Vessels Present,Pilocytic Astrocytoma
8273,Mass of body structure,Prostate Myeloid Sarcoma
8274,Necrotic changes (finding),Mesenchymal Glioblastoma
8275,Vascular Channel Formation,Gastric Kaposi's Sarcoma
8276,Recurrent disease,Precursor T-lymphoblastic lymphoma/leukemia recurrent
8277,Indolent Clinical Course,Cardiac Cavernous Hemangioma
8278,Non-Hereditary Lesion,Sporadic Diffuse Gastric Adenocarcinoma
8279,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia B/myeloid
8280,Multifocal Lesion,Asynchronous Multifocal Osteosarcoma
8281,Recurrent disease,Recurrent Adult Non-Hodgkin Lymphoma
8282,Epithelial Component Present,Stage II Renal Pelvis Cancer AJCC v7
8283,Epithelial Component Present,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
8284,Collagenous Stroma Formation,Fibrous Meningioma
8285,Carcinomatous Component Present,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
8286,Well-Circumscribed Lesion,Intrahepatic Bile Duct Microcystic Adenoma
8287,Metastatic Lesion,Secondary malignant neoplasm of pituitary gland
8288,Vascular Channel Formation,Liver Lymphangiomatosis
8289,Well-Circumscribed Lesion,Androgen-Producing Adrenal Cortex Adenoma
8290,Adulthood Lesion,Adult T-cell lymphoma/leukemia refractory
8291,Carcinomatous Component Present,Adenocarcinoma of anal glands
8292,Epithelial Component Present,Parasite-Related Carcinoma
8293,Biphasic Pattern,Ovarian Seromucinous Adenofibroma
8294,High Grade Lesion,Alveolar rhabdomyosarcoma
8295,Epithelial Component Present,Vaginal adenocarcinoma
8296,Adulthood Lesion,Adult Acute Lymphocytic Leukemia
8297,Numerous Stromal Mast Cells Present,Vaginal Myofibroblastoma
8298,High Grade Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
8299,Osseous Component Present,Multiple hamartoma of lung
8300,Dilated Vascular Space Formation,Glomangioma
8301,Stromal Invasion,Stage IB Ovarian Cancer AJCC v6 and v7
8302,Tissue Differentiation Uncertain,Lung Monophasic Synovial Sarcoma
8303,Nuclear Grooves,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
8304,High Mitotic Activity,"Perineurioma, malignant"
8305,Stromal Invasion,FIGO Stage IIIA1(ii) Ovarian Cancer
8306,Epithelial Component Present,Localized Non-Resectable Adult Liver Carcinoma
8307,Unresectable Mass,Localized Non-Resectable Adult Liver Carcinoma
8308,Primary Lesion,Recurrent Childhood Brain Stem Astrocytoma
8309,Perineural spread,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
8310,Cutaneous Involvement,Recurrent Merkel Cell Carcinoma
8311,High Grade Lesion,Classical Glioblastoma
8312,Epithelial Component Present,Stage II Renal Cell Cancer
8313,Diffuse Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma
8314,Carcinomatous Component Present,hepatoid adenocarcinoma of gallbladder
8315,Carcinomatous Component Present,Sporadic Gastric Adenocarcinoma
8316,Extraosseous Lesion,Duodenal Extraskeletal Osteosarcoma
8317,Tissue of Mullerian Origin Present,"Cervical Adenomyoma, Endometrial Type"
8318,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern"
8319,Hyalinized Stroma Formation,Childhood Epithelioid Hemangioendothelioma
8320,Local disease,Lipoma of breast
8321,Indolent Clinical Course,lipoma of mediastinum
8322,Epithelial Component Present,Colorectal Mucinous Adenocarcinoma
8323,Recurrent disease,Pharyngeal cancer recurrent
8324,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma refractory
8325,Villous Pattern,Villoglandular Endometrial Endometrioid Adenocarcinoma
8326,Epithelial Component Present,Stage III Carcinoma of Penis
8327,Metastatic Lesion,Metastatic Malignant Neoplasm in the Iris
8328,Epithelial Component Present,Adrenal Cortical Adenoma
8329,Multilayered Rosette Formation,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
8330,Malignant Germinomatous Cellular Infiltrate,"Seminoma of testis, stage 1"
8331,Childhood Lesion,Childhood Cerebral Ependymoma
8332,Exophytic Polypoid Lesion,Polyp of small intestine
8333,Local disease,Pagetoid reticulosis
8334,Diffuse Pattern,"Glioblastoma, IDH-Mutant"
8335,Epithelial Component Present,Gastric Intestinal-Type Adenocarcinoma
8336,Carcinomatous Component Present,"Paget's Disease, Mammary"
8337,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
8338,Erythema,Inflammatory Breast Carcinoma
8339,Cellular Pleomorphism,Osteoblastic Osteosarcoma
8340,Epithelial Component Present,Stage IIIC Colorectal Cancer AJCC v7
8341,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuromatosis
8342,Epithelial Component Present,Stage II Fallopian Tube Cancer
8343,Epithelial Component Present,Grade 2 Endometrial Mucinous Adenocarcinoma
8344,Carcinomatous Component Present,Stage III Laryngeal Cancer AJCC v6 and v7
8345,Mixed Cellular Population,Metastasizing Pleomorphic Adenoma of the Salivary Gland
8346,Increased Cellularity Present,Differentiating Neuroblastoma
8347,Childhood Lesion,Recurrent Childhood Malignant Germ Cell Tumor
8348,Fibrotic Stroma Formation,High Grade Mucoepidermoid Breast Carcinoma
8349,Favorable Clinical Outcome,Skin Mastocytoma
8350,Childhood Lesion,Childhood Yolk Sac Tumor
8351,Biphasic Pattern,Uterine Corpus Adenosarcoma
8352,Carcinomatous Component Present,Stage I Ampulla of Vater Cancer AJCC v7
8353,Mixed Cellular Population,Pleomorphic adenoma of lacrimal gland
8354,Well-Circumscribed Lesion,Familial medullary thyroid carcinoma
8355,Hereditary Lesion,Familial medullary thyroid carcinoma
8356,Carcinomatous Component Present,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified"
8357,Absence of Invasion,Adenocarcinoma in situ in tubular adenoma
8358,Invasive Lesion,Breast Columnar Cell Mucinous Carcinoma
8359,Indolent Clinical Course,Chondromatosis
8360,Adnexal Differentiation,Trichilemmocarcinoma
8361,Chromogranin A Positive Neoplastic Cells Present,Colorectal Neuroendocrine Tumor G1
8362,Acanthosis,Common wart
8363,Storiform Growth Pattern,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8364,Carcinomatous Component Present,Stage IV Ovarian Cancer AJCC v6 and v7
8365,Epithelial Component Present,"Squamous cell carcinoma, metastatic"
8366,Smooth Muscle Component Present,Clear cell papillary renal cell carcinoma
8367,Epithelial Component Present,Condylomata Acuminata
8368,Indolent Clinical Course,Elastofibroma
8369,Carcinomatous Component Present,Stage I Prostate Carcinoma
8370,Cutaneous Involvement,Stage IV Merkel Cell Carcinoma AJCC v7
8371,Well Differentiated Lesion,Warty Carcinoma of the Penis
8372,Epithelial Component Present,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
8373,Carcinomatous Component Present,Bladder transitional cell carcinoma stage IV
8374,Neuroendocrine Differentiation,Descending Colon Neuroendocrine Tumor G1
8375,High Mitotic Activity,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
8376,Indolent Clinical Course,Histiocytoma
8377,Carcinomatous Component Present,Fibroepithelioma of Pinkus
8378,'Starry-sky' pattern,Burkitt lymphoma associated with AIDS
8379,Epithelial Component Present,bilateral breast cancer
8380,In Situ Lesion,Cervical Squamous Cell Carcinoma In Situ
8381,Recurrent disease,Recurrent Kaposi Sarcoma
8382,Cutaneous Involvement,Harlequin Fetus
8383,Carcinomatous Component Present,Skin Nodular Solid Basal Cell Carcinoma
8384,Solid Growth Pattern,Skin Nodular Solid Basal Cell Carcinoma
8385,Metastatic Lesion,Drop Metastasis in the Spinal Cord
8386,Epithelial Component Present,Squamous cell carcinoma of tonsil
8387,Increased NFkappaB Pathway Activation,Mediastinal (Thymic) Large B-Cell Lymphoma
8388,Secondary Lesion,Metastatic Ductal Breast Carcinoma
8389,Refractory Disease,Refractory cancer
8390,Ineffective hematopoiesis,Refractory Cytopenia of Childhood
8391,Rapidly Enlarging Mass,Gallbladder Rhabdomyosarcoma
8392,atypia morphology,Malignant Ovarian Granulosa Cell Tumor
8393,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage II
8394,Epithelial Component Present,Non-Functioning Pituitary Gland Neoplasm
8395,Metastatic/Recurrent Disease,Conventional Extraskeletal Myxoid Chondrosarcoma
8396,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage III
8397,Neuroectodermal Differentiation,Peripheral Primitive Neuroectodermal Tumor of the Kidney
8398,Cutaneous Involvement,"Adenoma, Sweat Gland"
8399,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Mammosomatotroph Adenoma
8400,Benign Cellular Infiltrate,Digestive System Hemangioma
8401,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v7
8402,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Solid Teratoma
8403,Epithelial Component Present,Borderline Ovarian Serous Cystadenofibroma
8404,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma refractory
8405,Perineural spread,adenoid cystic carcinoma of accessory sinus
8406,Pseudoglandular Pattern,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
8407,Immunosuppression-Related Post-Transplant Toxicity,Chronic graft-versus-host disease
8408,Regional Disease,Crohn's disease of small intestine
8409,Benign Cellular Infiltrate,Esophageal squamous papilloma
8410,Epithelial Component Present,Bladder adenocarcinoma stage I
8411,In Situ Lesion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
8412,Neuroendocrine Differentiation,"Glucagonoma, malignant"
8413,Cutaneous Involvement,Dermatologic disorders
8414,Carcinomatous Component Present,Cervical carcinoma stage II AJCC v7
8415,Low Grade Lesion,Low Grade Broad Ligament Serous Adenocarcinoma
8416,Exophytic Polypoid Lesion,Colonic tubulovillous adenoma
8417,Neuroendocrine Differentiation,Stage I Lung Small Cell Carcinoma AJCC v7
8418,Epithelial Component Present,Bladder Squamous Papilloma
8419,Epithelial Component Present,Barrett's Adenocarcinoma
8420,Red Papular Lesion,Senile angioma
8421,Epithelial Component Present,Metanephric adenoma
8422,Epithelial Component Present,Malignant Ovarian Endometrioid Tumor
8423,Invasive Lesion,Acinar Prostate Mucinous Adenocarcinoma
8424,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Mature Teratoma
8425,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia-1
8426,Well-Circumscribed Lesion,Rectal Tubular Adenoma
8427,Recurrent disease,Esophageal adenocarcinoma recurrent
8428,Metastatic/Recurrent Disease,Alveolar Soft Part Sarcoma
8429,Epithelial Component Present,Ductal Eccrine Carcinoma with Spindle Cell Elements
8430,Primary Lesion,Fibroblastic osteosarcoma
8431,Carcinomatous Component Present,Small Intestinal Medullary Carcinoma
8432,Epithelial Component Present,Hereditary Ovarian Carcinoma
8433,Indolent Clinical Course,Parotid Gland Lymphangioma
8434,Local disease,Pleural mesothelioma malignant localised
8435,Pseudoglandular Pattern,Laryngeal Acantholytic Squamous Cell Carcinoma
8436,Epithelial Component Present,Malignant neoplasm of endocrine gland
8437,VIP Positive Neoplastic Cells Present,Small Intestinal VIP-Producing Neuroendocrine Tumor
8438,Necrotic changes (finding),Stage III Lung Small Cell Carcinoma AJCC v7
8439,Mass of body structure,Monoblastic Sarcoma
8440,Carcinomatous Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v7
8441,Rapidly Enlarging Mass,Subcutaneous Nodular Fasciitis
8442,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
8443,Epithelial Component Present,Adenocarcinoma with cartilaginous metaplasia
8444,Hydropic Villous Change,"Hydatidiform Mole, Partial"
8445,Diffuse Lesion,Diffuse melanocytosis
8446,Locally Aggressive Lesion,Peyronie Disease
8447,Erythema,Inflammatory carcinoma of breast stage IV
8448,Malignant Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
8449,Pseudopapillary Pattern,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
8450,Exophytic Polypoid Lesion,Gallbladder Papillary Adenoma
8451,Diffuse Pattern,Childhood Glioblastoma
8452,Lymphadenopathy,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
8453,Tubular Pattern,tubulopapillary adenoma of gallbladder
8454,Solid Growth Pattern,"Prostate Ductal Adenocarcinoma, Solid Pattern"
8455,Epithelial Component Present,undifferentiated carcinoma of salivary gland
8456,Carcinomatous Component Present,Submandibular Gland Acinic Cell Carcinoma
8457,Plexiform Vasculature Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina
8458,Storiform Growth Pattern,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8459,Malignant Cellular Infiltrate,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
8460,Adulthood Lesion,Adult Spinal Cord Neoplasm
8461,Dysplasia,Traditional Serrated Adenoma
8462,Indolent Clinical Course,Hemangioma of retina
8463,Cutaneous Involvement,Urticaria Pigmentosa
8464,Antoni A Pattern,Benign Bone Schwannoma
8465,Mixed Cellular Population,Cystic Partially Differentiated Nephroblastoma
8466,Vascular Channel Formation,Hemangioma of intra-abdominal structure
8467,In Situ Lesion,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
8468,Epithelial Component Present,Stage 0 Pancreatic Cancer AJCC v6 and v7
8469,Carcinomatous Component Present,Stage 0 Pancreatic Cancer AJCC v6 and v7
8470,Epithelial Component Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma
8471,Epithelial Component Present,cystadenocarcinoma of salivary gland
8472,Gastrointestinal Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
8473,Cutaneous Involvement,Sezary Syndrome
8474,Alcohol Toxicity,Alcohol-Related Carcinoma
8475,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor
8476,Epithelial Component Present,Alcohol-Related Laryngeal Carcinoma
8477,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type"
8478,Infantile Lesion,Infant Acute Undifferentiated Leukemia
8479,Papillary Pattern,Lung Mixed Squamous Cell and Glandular Papilloma
8480,Congenital Lesion,Ectopia Lentis
8481,Diffuse Lesion,Papillomatosis
8482,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q13;q21)
8483,Bone Marrow Dysplasia Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome
8484,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of thymus
8485,Chronic Inflammatory Infiltrate,Pulmonary Lymphomatoid Granulomatosis
8486,Metastatic Lesion,Metastatic Urethral Carcinoma
8487,Spindle Cell Osteo-Fibrous Component Present,Adamantinoma
8488,Epithelial Component Present,Colorectal Adenoma with Severe Dysplasia
8489,Cutaneous Involvement,Dermatitis due to substances taken internally
8490,Childhood Lesion,Infant Leukemia
8491,Anaplasia,Childhood Anaplastic Oligoastrocytoma
8492,Mixed Cellular Population,Childhood Anaplastic Oligoastrocytoma
8493,Therapy-Related Toxicity,Therapy-related acute myeloid leukemia and myelodysplastic syndrome
8494,Nodular Pattern,Eccrine spiradenoma
8495,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(17;17)(q21;q21)
8496,Carcinomatous Component Present,Aflatoxins-Related Hepatocellular Carcinoma
8497,Diffuse Lesion,Breast Angiomatosis
8498,Childhood Lesion,Childhood Acute Basophilic Leukemia
8499,Epithelial Component Present,Pancreatic Somatostatinoma
8500,Carcinomatous Component Present,Invasive micropapillary carcinoma of breast
8501,Well-Circumscribed Lesion,Breast adenoma
8502,Epithelial Component Present,Alcohol-Related Hepatocellular Carcinoma
8503,Immunosuppression-Related Post-Transplant Toxicity,Graft-vs-Host Disease
8504,Mitotic Activity,Childhood Cerebral Anaplastic Astrocytoma
8505,Epithelial Component Present,Papillary adenoma
8506,Epithelial Component Present,Adult Salivary Gland Carcinoma
8507,Childhood Lesion,Childhood Brain Germinoma
8508,Exophytic Polypoid Lesion,Polyp of sphenoidal sinus
8509,Exophytic Polypoid Lesion,Tubular adenoma
8510,Carcinomatous Component Present,"Cystadenocarcinoma, Papillary"
8511,Cutaneous Involvement,Fibrous tissue neoplasm of skin
8512,Low Mitotic Activity,Gastric Carcinoid Tumor
8513,Carcinomatous Component Present,mucinous adenocarcinoma of lung
8514,Childhood Lesion,Recurrent Childhood Gliosarcoma
8515,Carcinomatous Component Present,Mesonephroma
8516,Mixed Cellular Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified"
8517,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma AJCC v7
8518,Epithelial Component Present,Prostate Cancer by AJCC v6 Stage
8519,Epithelial Component Present,Ancell-Spiegler cylindromas
8520,Carcinomatous Component Present,Minor Salivary Gland Undifferentiated Carcinoma
8521,Cutaneous Involvement,Type B Lymphomatoid Papulosis
8522,Epithelial Component Present,Stage II Cervical Cancer AJCC v6
8523,Carcinomatous Component Present,Stage IIIB Adult Liver Cancer AJCC v7
8524,Ineffective hematopoiesis,de novo Myelodysplastic Syndrome
8525,Invasive Lesion,Intraductal papillary adenocarcinoma with invasion
8526,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation
8527,Absence of Invasion,Intraductal carcinoma and lobular carcinoma in situ
8528,Indolent Clinical Course,Osteoblastoma
8529,Biphasic Pattern,Cervical Mixed Epithelial and Mesenchymal Neoplasm
8530,Monomorphic Cellular Infiltrate,Parotid monomorphic adenoma
8531,Lymphadenopathy,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma
8532,Pregnancy Complications,Severe pre-eclampsia
8533,Extraosseous Lesion,Extraskeletal osteosarcoma metastatic
8534,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma of Mucosa Site
8535,Borderline Lesion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
8536,Radial Growth Phase,Stage IV Superficial Spreading Melanoma AJCC v6 and v7
8537,Recurrent disease,Bladder squamous cell carcinoma recurrent
8538,Desmoplastic Stroma Formation,Peritoneal Desmoplastic Small Round Cell Tumor
8539,Carcinomatous Component Present,Gastric Papillary Adenocarcinoma
8540,Neuroectodermal Differentiation,Stage 3 Neuroblastoma
8541,Chromogranin A Positive Neoplastic Cells Present,Gallbladder Goblet Cell Carcinoid
8542,Vascular Channel Formation,Small Intestinal Kaposi Sarcoma
8543,Villous Pattern,Appendix Villous Adenoma
8544,Vascular Channel Formation,Gallbladder Angiosarcoma
8545,Carcinomatous Component Present,Primary Cutaneous Mucinous Carcinoma
8546,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Adenocarcinoma
8547,Numerous Stromal Mast Cells Present,Myofibroblastoma
8548,Alternative Fascicle (Bundle) Pattern,Appendix Leiomyoma
8549,Papillary Pattern,Maxillary Sinus Inverted Papilloma
8550,Pushing Tumor Margin,verrucous carcinoma of esophagus
8551,Tissue Differentiation Uncertain,Epithelioid sarcoma metastatic
8552,Epithelioid Component Present,"Synovial sarcoma, epithelioid cell"
8553,Cord-Like Pattern,Adenoid basal carcinoma of cervix uteri
8554,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v6
8555,Fibrotic Stroma Formation,Laryngeal Mucoepidermoid Carcinoma
8556,Ineffective hematopoiesis,Refractory anemia with excess blasts I
8557,Fibrous Septa Present,Dysgerminoma
8558,Cutaneous Involvement,Cutaneous myxoma
8559,Epithelial Component Present,Oral Cavity Monomorphic Adenoma
8560,Recurrent disease,Recurrent Childhood Pilomyxoid Astrocytoma
8561,Intermediate Grade Lesion,Childhood Periosteal Osteosarcoma
8562,Vascular Channel Formation,Malignant Blood Vessel Neoplasm
8563,Epithelial Component Present,Skin Nodular Basal Cell Carcinoma
8564,Severe dysplasia,Stage 0 Vaginal Cancer AJCC v7
8565,Epithelial Component Present,Lung Carcinoma Metastatic in the Brain
8566,Increased Cellularity Present,Familial Neuroblastoma
8567,Epithelial Component Present,Mucin-producing adenocarcinoma
8568,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage IV
8569,Malignant Cellular Infiltrate,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7
8570,Anaplasia,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive"
8571,Metastatic Lesion,Prostate Carcinoma Metastatic in the Bone
8572,Epithelial Component Present,Malignant Brenner Tumor
8573,Carcinomatous Component Present,Stage IVB Gallbladder Carcinoma
8574,Epithelial Component Present,Adenocarcinoma of Skene Gland Origin
8575,Myxoid Stroma Formation,Adult Extraskeletal Myxoid Chondrosarcoma
8576,Carcinomatous Component Present,Stage IIIC Rectal Cancer AJCC v7
8577,Epithelial Component Present,mucinous adenocarcinoma of gallbladder
8578,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
8579,Cutaneous Involvement,Aleukemic Acute Lymphoblastic Leukemia Cutis
8580,Breast Microcalcification,Oligodendroglioma of spinal cord
8581,Bilateral Disease,Bilateral Optic Nerve Meningioma
8582,High Grade Lesion,Pleural Monophasic Synovial Sarcoma
8583,Cutaneous Involvement,Acanthosis Nigricans
8584,Tissue Differentiation Uncertain,Ectopic hamartomatous thymoma
8585,Primary Lesion,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
8586,Alternative Fascicle (Bundle) Pattern,leiomyoma of extrahepatic bile duct
8587,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
8588,Encapsulated Mass,Encapsulated Thymoma
8589,Childhood Lesion,Small Cell Undifferentiated Hepatoblastoma
8590,Epithelial Component Present,Rectal Cancer by AJCC v7 Stage
8591,High Mitotic Activity,large cell neuroendocrine carcinoma of anal canal
8592,Adnexal Differentiation,Benign Eccrine Neoplasm
8593,Neuroendocrine Differentiation,Liver Neuroendocrine Neoplasm
8594,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
8595,Indolent Clinical Course,Giant Cell Lesion of Small Bones
8596,Carcinomatous Component Present,adenocarcinoma of renal pelvis
8597,Well-Circumscribed Lesion,Lactating adenoma
8598,Carcinomatous Component Present,Grade 2 Invasive Breast Carcinoma
8599,Secondary Lesion,Disseminated adenocarcinoma
8600,Neuroendocrine Differentiation,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
8601,Alternative Fascicle (Bundle) Pattern,Central Nervous System Leiomyoma
8602,Alternative Fascicle (Bundle) Pattern,Deep Leiomyoma
8603,Vascular Channel Formation,Skin Lymphangiosarcoma
8604,Carcinomatous Component Present,Prolactin-Producing Pituitary Gland Carcinoma
8605,Dysplasia,Cecum Villous Adenoma
8606,Congenital Lesion,Congenital anomaly of lens
8607,atypia morphology,Atypical Ductal Breast Hyperplasia
8608,Cystic Change,Benign Brenner Tumor
8609,Severe cytologic atypia,"Endometrial stromal sarcoma, high grade"
8610,Papillary Pattern,Plantar wart
8611,Exophytic Papillary Lesion,Plantar wart
8612,Absence of Stromal Invasion,Borderline Ovarian Endometrioid Cystadenofibroma
8613,Carcinomatous Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
8614,Exophytic Papillary Lesion,Cervical Verrucous Carcinoma
8615,Keratin pearl formation,Squamous cell carcinoma with horn formation
8616,Epithelial Component Present,Anterior Tongue Squamous Cell Carcinoma
8617,Epithelial Component Present,Vaginal Squamous Papilloma
8618,Tissue of Mullerian Origin Present,"Cervical Adenomyoma, Endocervical Type"
8619,Secondary Lesion,Secondary malignant neoplasm of pharynx
8620,Recurrent disease,Recurrent Hepatocellular Carcinoma
8621,Childhood Lesion,Benign Childhood Brain Neoplasm
8622,Diffuse Pattern,Primary mediastinal large B-cell lymphoma recurrent
8623,Secondary Lesion,Metastatic malignant neoplasm to nasopharynx
8624,Mitotic Activity,"Testicular Yolk Sac Tumor, Papillary Pattern"
8625,Neuroendocrine Differentiation,Thymic Carcinoid Tumor
8626,Carcinomatous Component Present,Stage III Carcinoma of Penis
8627,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage III
8628,Epithelial Component Present,Colorectal Adenosquamous Carcinoma
8629,Childhood Lesion,Childhood Colorectal Carcinoma
8630,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monoblastic Leukemia
8631,High Grade Lesion,"Glioblastoma, IDH-Wildtype"
8632,Epithelial Component Present,Stage IV Appendix Neuroendocrine Tumor AJCC v7
8633,Recurrent disease,Recurrent Adult Spinal Cord Neoplasm
8634,Acanthosis,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
8635,Carcinomatous Component Present,Stage 0 Cervical Cancer AJCC v6
8636,Emperipolesis,Giant cell carcinoma of lung
8637,Increased Cellularity Present,Anaplastic Oligodendroglioma
8638,Encapsulated Mass,Adenolymphoma
8639,Epithelial Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
8640,Well-Circumscribed Lesion,Childhood Choroid Plexus Papilloma
8641,Vascular Channel Formation,lymphangiosarcoma
8642,Microcystic Change,Adult Pilocytic Astrocytoma
8643,Lobulated Growth Pattern,Vertebral chordoma
8644,Carcinomatous Component Present,FIGO Stage III Carcinoma of the Fallopian Tube
8645,Carcinomatous Component Present,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
8646,Hemorrhagic,Angiosarcoma of liver
8647,Recurrent disease,Nasopharyngeal lymphoepithelioma recurrent
8648,Carcinomatous Component Present,Endometrial Adenosquamous Carcinoma
8649,Primary Lesion,Adult Brain Stem Astrocytoma
8650,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7
8651,Adulthood Lesion,Adult Infiltrating Astrocytoma
8652,Neuroendocrine Differentiation,Vipoma
8653,Carcinomatous Component Present,Stage IIIA Ovarian Carcinoma
8654,Carcinomatous Component Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
8655,Metaplasia,Pleomorphic adenoma of lacrimal gland
8656,Childhood Lesion,Childhood Embryonal Carcinoma
8657,Carcinomatous Component Present,Stage IB Vulvar Cancer AJCC v7
8658,Locally Aggressive Lesion,Intermediate Blood Vessel Neoplasm
8659,In Situ Lesion,Adenocarcinoma in situ in tubular adenoma
8660,Metastatic Lesion,Metastatic Kidney Carcinoma
8661,Exophytic Polypoid Lesion,Rectal Traditional Serrated Adenoma
8662,Indolent Clinical Course,Deep Lipoma
8663,Adulthood Lesion,Adult Burkitt Lymphoma
8664,Capillary Sized Vascular Channel Formation,Capillary hemangioma of orbit
8665,Local disease,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8666,Well-Circumscribed Lesion,Duodenal Adenoma
8667,Resectable Mass,Localized Resectable Adult Hepatocellular Carcinoma
8668,Epithelial Component Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
8669,Carcinomatous Component Present,Adenocarcinoma with metaplasia
8670,Cutaneous Involvement,apocrine adenocarcinoma of vulva
8671,Cystic Change,High Grade Salivary Gland Mucoepidermoid Carcinoma
8672,Carcinomatous Component Present,pleomorphic carcinoma of breast
8673,Cutaneous Involvement,Stage IB Merkel Cell Carcinoma AJCC v7
8674,Follicular Cell Differentiation,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
8675,Well-Circumscribed Lesion,Childhood Thyroid Gland Medullary Carcinoma
8676,Epithelial Component Present,Stage IIC Merkel Cell Carcinoma AJCC v7
8677,Dysplasia,Adenomatous polyp of rectum
8678,Epithelial Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7
8679,Cutaneous Involvement,Malignant melanoma in precancerous melanosis
8680,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with unilineage dysplasia
8681,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Ganglioneuroblastoma, Intermixed"
8682,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
8683,Carcinomatous Component Present,Gallbladder Cancer by AJCC v7 Stage
8684,Epithelial Component Present,"Schneiderian papilloma, inverted"
8685,Carcinomatous Component Present,Upper Gingival Squamous Cell Carcinoma
8686,Epithelial Component Present,Sporadic Thyroid Gland Micromedullary Carcinoma
8687,Cutaneous Involvement,Skin Nodular Solid Basal Cell Carcinoma
8688,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma
8689,Refractory Disease,Centroblastic lymphoma refractory
8690,Endophytic Tumor Growth,Buccal Mucosa Verrucous Carcinoma
8691,Oligodendroglial Component Present,Childhood Brain Oligodendroglioma
8692,Abundance of Small Lymphocytes,Lymphocyte Rich Classical Hodgkin Lymphoma
8693,Epithelial Component Present,Postcricoid Squamous Cell Carcinoma
8694,Myxoid Stroma Formation,Conventional Extraskeletal Myxoid Chondrosarcoma
8695,Diffuse Pattern,Primary cutaneous diffuse large cell B-cell lymphoma
8696,Carcinomatous Component Present,Ovarian Serous Adenocarcinoma
8697,Moderate dysplasia,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
8698,Mixed Cellular Population,Malignant phyllodes tumor of breast
8699,Epithelial Component Present,Bartholin's gland carcinoma
8700,Dystrophic calcification,Adamantinous Craniopharyngioma
8701,Epithelial Component Present,Carcinoma ex pleomorphic adenoma
8702,Giant Mitochondria Present,Acidophil Stem Cell Pituitary Gland Adenoma
8703,Epithelial Component Present,Tracheal Carcinoma
8704,Epithelial Component Present,Colon Adenosquamous Carcinoma
8705,Cutaneous Involvement,American cutaneous leishmaniasis
8706,Ground Glass Nuclear Inclusion,Tall Cell Variant Thyroid Gland Papillary Carcinoma
8707,Intraluminal Tumor Growth,Esophageal squamous papilloma
8708,Alternative Fascicle (Bundle) Pattern,Piloleiomyoma
8709,Carcinomatous Component Present,Stage IV Pancreatic Cancer AJCC v6 and v7
8710,Mitotic Activity,Glioblastoma
8711,Well-Circumscribed Lesion,Adenoma of large intestine
8712,Contiguous Disease,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma
8713,Recurrent disease,Laryngeal verrucous carcinoma recurrent
8714,Immunosuppression-Related Post-Transplant Toxicity,Renal Allograft Thrombosis
8715,Secondary Lesion,Secondary malignant neoplasm of ovary
8716,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Superficial Epithelioma with Sebaceous Differentiation
8717,Carcinomatous Component Present,Acinic Cell Breast Carcinoma
8718,Villous Pattern,Colorectal Tubulovillous Adenoma
8719,Hereditary Lesion,Roberts-SC phocomelia syndrome
8720,Cutaneous Involvement,Acral Skin Nevus
8721,Epithelial Component Present,Stage III Rectosigmoid Cancer AJCC v6
8722,Carcinomatous Component Present,Stage II Nasal Cavity Cancer AJCC v6 and v7
8723,Invasive Lesion,atypical medullary carcinoma of breast
8724,Intraluminal Tumor Growth,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
8725,Metastatic Lesion,Adenocarcinoma of the prostate stage IV
8726,Pseudorosette Formation,Gastrinoma
8727,Vascular Channel Formation,Rectal Kaposi Sarcoma
8728,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
8729,Carcinomatous Component Present,Gallbladder Neuroendocrine Carcinoma
8730,Intraosseous Lesion,Sternal Intraosseous Schwannoma
8731,Epithelial Component Present,Lung Micropapillary Adenocarcinoma
8732,Carcinomatous Component Present,Carcinoma in a polyp
8733,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
8734,Dysplasia,Glandular Cell Intraepithelial Neoplasia
8735,Absence of Invasion,Actinic keratosis
8736,Epithelial Component Present,AIDS-Related Anal Carcinoma
8737,Mitotic Activity,Teratocarcinoma
8738,Cellular Pleomorphism,Atypical neurofibroma
8739,Papillary Pattern,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia
8740,Borderline Lesion,Pancreatic Intraductal Papillary-Mucinous Adenoma
8741,Intraductal Lesion,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
8742,Carcinomatous Component Present,Transplant-Related Lung Carcinoma
8743,Carcinomatous Component Present,Prostatic Duct Urothelial Carcinoma
8744,Increased Cellularity Present,Adrenal neuroblastoma
8745,High Mitotic Activity,Small cell carcinoma of prostate
8746,Epithelial Component Present,Maxillary Sinus Squamous Cell Carcinoma
8747,Adulthood Lesion,Non-Hodgkin Lymphoma During Pregnancy
8748,Metastatic/Recurrent Disease,Proximal-Type Epithelioid Sarcoma
8749,Epithelial Component Present,small cell carcinoma of appendix
8750,Epithelial Component Present,Stage IIA Breast Carcinoma
8751,Non-Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm
8752,Nuclear Grooves,Papillary Thyroid Microcarcinoma
8753,Carcinomatous Component Present,Stage 0 Pharynx Carcinoma
8754,Follicular Cell Differentiation,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
8755,Pregnancy Complications,Hydatidiform Mole
8756,Epithelial Component Present,Ampulla of Vater Signet Ring Cell Carcinoma
8757,'Starry-sky' pattern,Sporadic Burkitt's lymphoma
8758,Indolent Clinical Course,Fibroma of prostate
8759,Carcinomatous Component Present,Pancreatic carcinoma recurrent
8760,Carcinomatous Component Present,Papillary carcinoma of the breast
8761,Well-Circumscribed Lesion,Adenoma of ampulla of Vater
8762,Neuroendocrine Differentiation,Lung Typical Carcinoid Tumor
8763,Mixed Cellular Population,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm
8764,Epithelial Component Present,Glomus Tympanicum Tumor
8765,Childhood Lesion,Childhood Gliomatosis Cerebri
8766,Carcinomatous Component Present,Stage IIA Rectal Cancer AJCC v7
8767,Indolent Clinical Course,Lipoma of axilla
8768,Moderate dysplasia,Moderate epithelial dysplasia
8769,Lymphoplasmacytic Infiltrate,Multi-centric Castleman's Disease
8770,Vascular Channel Formation,Malignant vascular tumor of skin
8771,Carcinomatous Component Present,papillary carcinoma of penis
8772,Secondary Lesion,Endometrioid adenocarcinoma metastatic
8773,Insular Pattern,Somatostatinoma
8774,Entrapped Respiratory Epithelium Present,Hamartoma of lung
8775,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
8776,Recurrent disease,Recurrent Non-Cutaneous Melanoma
8777,High Mitotic Activity,large cell neuroendocrine carcinoma of thymus
8778,Epithelial Component Present,Low Grade Lung Neuroendocrine Neoplasm
8779,Secondary Lesion,Metastatic Urethral Carcinoma
8780,Childhood Lesion,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8781,High Grade Lesion,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
8782,Epithelial Component Present,Thymic Sarcomatoid Carcinoma
8783,Monoclonal Cellular Population Present,Smoldering Systemic Mastocytosis
8784,Hyaline Cartilage Differentiation,Chondrosarcoma
8785,Carcinomatous Component Present,Large cell neuroendocrine carcinoma
8786,Epithelial Component Present,Minor Salivary Gland Adenocarcinoma
8787,Carcinomatous Component Present,Acinar cell cystadenocarcinoma
8788,Non-Invasive Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
8789,Chronic lymphocytic inflammation,Parotid Gland Sebaceous Lymphadenoma
8790,Hereditary Lesion,Hereditary Diffuse Gastric Adenocarcinoma
8791,Childhood Lesion,Recurrent Childhood Brain Stem Glioma
8792,Benign Cellular Infiltrate,Benign neoplasm of large intestine
8793,In Situ Lesion,Stage 0 Lung Cancer AJCC v6 and v7
8794,No Evidence of Metastatic Disease,Benign Carotid Body Paraganglioma
8795,Swelling,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone
8796,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6
8797,Local disease,Localized Adrenal Gland Pheochromocytoma
8798,Carcinomatous Component Present,Stage IV Colorectal Cancer AJCC v7
8799,Nuclear Atypia,Childhood Cerebral Anaplastic Astrocytoma
8800,Storiform Growth Pattern,Childhood Undifferentiated Pleomorphic Sarcoma
8801,Adnexal Differentiation,"Carcinoma, Skin Appendage"
8802,Cutaneous Involvement,Amelanotic Skin Melanoma
8803,High Grade Lesion,Childhood Brain Stem Gliosarcoma
8804,Epithelial Component Present,Intermediate Grade Ductal Breast Carcinoma In Situ
8805,Epithelial Component Present,"Cystadenocarcinoma, Serous"
8806,Absence of Stromal Invasion,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor
8807,Epithelial Component Present,Tubulovillous adenoma
8808,High Mitotic Activity,Stage IIIB Lung Small Cell Carcinoma AJCC v7
8809,Epithelial Component Present,Anal margin basal cell carcinoma
8810,Granuloma,Granulomatous slack skin disease
8811,Metastatic/Recurrent Disease,Intracranial Extraskeletal Myxoid Chondrosarcoma
8812,Diffuse Pattern,Stage IV Adult Immunoblastic Lymphoma
8813,Malignant Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor
8814,Carcinomatous Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v7
8815,Carcinomatous Component Present,Cervix carcinoma
8816,Epithelial Component Present,Non-Functioning Pituitary Gland Neoplasm
8817,Adulthood Lesion,Stage IV Adult Burkitt Lymphoma
8818,Adnexal Differentiation,Eccrine Poroma
8819,Infiltrative Growth Pattern,Small cell glioblastoma
8820,Diffuse Pattern,Gastric Diffuse Large B-Cell Lymphoma
8821,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage III
8822,Firm mass,Glandular malignant peripheral nerve sheath tumor
8823,Epithelial Component Present,Esophageal Moderately Differentiated Squamous Cell Carcinoma
8824,Mixed Cellular Population,Uterine Ligament Adenosarcoma
8825,Cartilaginous Differentiation,Grade II Chondrosarcoma
8826,Invasive Lesion,Breast Carcinoma with Chondroid Metaplasia
8827,Epithelial Component Present,Mucoepidermoid carcinoma of salivary gland
8828,Well-Circumscribed Lesion,Polyp of large intestine
8829,Cystic Change,Mucoepidermoid Carcinoma
8830,Favorable Clinical Outcome,Pure Cutaneous Mastocytosis
8831,Immunologic Deficiency Syndromes,AIDS-Related Toxoplasmosis
8832,Severe dysplasia,Intraductal carcinoma and lobular carcinoma in situ
8833,Collagenous Stroma Formation,Mammary-Type Myofibroblastoma
8834,Syncytial Pattern,Oropharyngeal lymphepithelioma
8835,Adulthood Lesion,Stage III Adult Hodgkin Lymphoma
8836,Carcinomatous Component Present,Basal cell carcinoma - keratotic
8837,Cutaneous Involvement,Basal cell carcinoma - keratotic
8838,Epithelial Component Present,adenocarcinoma of middle ear
8839,High Grade Lesion,Adult Anaplastic Astrocytoma
8840,Moderate cytologic atypia,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
8841,Fibrosis,Breast Blunt Duct Adenosis
8842,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory anemias
8843,Vascular Channel Formation,Kaposi Sarcoma NCI Grade 3
8844,Epithelial Component Present,Stage IIIA Gastric Carcinoma
8845,Epithelial Component Present,Grade 1 Clear Cell Renal Cell Carcinoma
8846,Monomorphic Cellular Infiltrate,Lung Basaloid Large Cell Carcinoma
8847,Mucocele of appendix,Appendix Mucinous Cystadenoma
8848,Multifocal Lesion,"Chondromatosis, Synovial"
8849,Non-Hereditary Lesion,Gastric Tubular Adenocarcinoma
8850,Epithelial Component Present,Urethral Inverted Papilloma
8851,Cutaneous Involvement,Pilar-Associated Mesenchyme Neoplasm
8852,Papillary Pattern,Papillary tumor of renal pelvis
8853,Hereditary Lesion,Hereditary Nonpolyposis Colorectal Cancer
8854,Carcinomatous Component Present,adenocarcinoma of oral cavity
8855,Vascular Channel Formation,Kaposi's sarcoma of skin
8856,Hereditary Lesion,Hereditary benign intraepithelial dyskeratosis
8857,Well Differentiated Lesion,Upper Gingival Verrucous Carcinoma
8858,Epithelial Component Present,"Gastric Adenoma, Gastric-Type"
8859,Indolent Clinical Course,Vulvar Lipoma
8860,Tissue Differentiation Uncertain,Cutaneous myxoma
8861,Tubular Structures Present,Benign Testicular Sertoli Cell Tumor
8862,Epithelial Component Present,Anal Canal Neuroendocrine Tumor G2
8863,Epithelial Component Present,Pancreatic Neuroendocrine Tumor G2
8864,Low Mitotic Activity,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
8865,Osseous Differentiation,Childhood Periosteal Osteosarcoma
8866,Carcinomatous Component Present,Basaloid squamous cell carcinoma
8867,Recurrent disease,Recurrent Adrenal Cortex Carcinoma
8868,Anaplasia,"Anaplastic large cell lymphoma, ALK negative"
8869,Infiltrative Growth Pattern,Supratentorial Glioblastoma
8870,Vascular Channel Formation,Hemangiosarcoma
8871,Epithelial Component Present,Prostate Carcinoma Metastatic in the Bone
8872,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Tumor G2
8873,Tissue Differentiation Uncertain,Atrial myxoma
8874,Nodular Pattern,Adenoameloblastoma
8875,Epithelial Component Present,Fallopian Tube Serous Adenofibroma
8876,Oligodendroglial Component Present,Anaplastic Oligodendroglioma
8877,Follicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
8878,Indolent Clinical Course,Oral Cavity Lipoma
8879,Cutaneous Involvement,Cockade nevus
8880,Epithelial Component Present,Esophageal Cancer by AJCC v7 Stage
8881,Epithelial Component Present,Large cell lung cancer recurrent
8882,Carcinomatous Component Present,carcinosarcoma of liver
8883,Low Grade Lesion,Pilocytic Astrocytoma
8884,Necrotic changes (finding),Adult Malignant Peripheral Nerve Sheath Tumor
8885,Indolent Clinical Course,leiomyoma of extrahepatic bile duct
8886,Lymphadenopathy,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma
8887,Peripheral Nuclear Palisading,Small cell carcinoma of lung
8888,Epithelial Component Present,Colon Cancer by AJCC v7 Stage
8889,Calcitonin Positive Neoplastic Cells Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
8890,Well Differentiated Lesion,Vaginal Papillary Carcinoma
8891,Carcinomatous Component Present,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
8892,Carcinomatous Component Present,Stage IVB Paranasal Sinus Cancer AJCC v7
8893,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
8894,Osseous Differentiation,Childhood Osteosarcoma
8895,Pregnancy Complications,Stage IV Gestational Trophoblastic Tumor AJCC v7
8896,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
8897,Melanosomes Present,Mediastinal Melanotic Schwannoma
8898,Carcinomatous Component Present,Anterior Tongue Mucoepidermoid Carcinoma
8899,Vascular Channel Formation,Cardiac Cavernous Hemangioma
8900,Carcinomatous Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
8901,Epithelial Component Present,Anterior Tongue Adenoid Cystic Carcinoma
8902,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v7 Stage
8903,Epithelial Component Present,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
8904,Papillary Pattern,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
8905,Carcinomatous Component Present,Helicobacter Pylori-Related Carcinoma
8906,Epithelial Component Present,Cervical Adenocarcinoma In Situ
8907,Epithelial Component Present,Stage IB Cervical Cancer AJCC v6 and v7
8908,Epithelial Component Present,Prolactin-Producing Pituitary Gland Carcinoma
8909,Cystic Change,Rete Ovarii Cystadenoma
8910,Junctional Proliferation,Vulvar Dysplastic Melanocytic Nevus
8911,Slow Growing Mass,Angiomyoma
8912,Indolent Clinical Course,Leiomyoma of lung
8913,Chronic lymphocytic inflammation,Benign Breast Eccrine Spiradenoma
8914,In Situ Lesion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8"
8915,In Situ Lesion,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
8916,Perivascular Arrangement of Tumor Cells,"Glomus tumor, malignant"
8917,Aggressive Clinical Course,"Endometrial stromal sarcoma, high grade"
8918,Epithelial Component Present,Breast Complex Fibroadenoma
8919,Cartilaginous Component Present,Multiple hamartoma of lung
8920,Indolent Clinical Course,Disseminated Juvenile Xanthogranuloma
8921,atypia morphology,Atypical hyperplasia of breast
8922,Honeycomb Pattern,Childhood Oligodendroglioma
8923,Carcinomatous Component Present,"Adenocarcinoma of lung, stage III"
8924,Cutaneous Involvement,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma
8925,Cutaneous Involvement,Ichthyoses
8926,Solitary mass,Cardiac Epithelioid Hemangioendothelioma
8927,High Grade Lesion,Neural Glioblastoma
8928,Slow Growing Mass,Kadish Stage A Olfactory Neuroblastoma
8929,Epithelial Component Present,Neuroendocrine neoplasm of appendix
8930,Thyroglobulin Positive Neoplastic Cells Present,Clear Cell Variant Thyroid Gland Papillary Carcinoma
8931,Epithelial Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7
8932,Non-Invasive Lesion,Papillary transitional cell neoplasm of low malignant potential
8933,Biphasic Pattern,Cystadenofibroma
8934,Well-Circumscribed Lesion,Polyp of esophagus
8935,Carcinomatous Component Present,Renal Pelvis Carcinoma
8936,Epithelial Component Present,Adenocarcinoma of anus
8937,Absence of Stromal Invasion,Borderline serous tumor of ovary
8938,Mixed Cellular Population,Cervical Atypical Polypoid Adenomyoma
8939,Recurrent Genetic Abnormalities Present,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
8940,Anaplasia,Anaplastic astrocytoma
8941,Pseudopapillary Pattern,Childhood Testicular Embryonal Carcinoma
8942,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7
8943,Carcinomatous Component Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma
8944,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma
8945,Recurrent Genetic Abnormalities Present,Adult Acute Promyelocytic Leukemia with PML-RARA
8946,Childhood Lesion,Childhood Cerebral Diffuse Astrocytoma
8947,Epithelial Component Present,Fallopian Tube Gestational Choriocarcinoma
8948,Nuclear Grooves,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
8949,Absence of Invasion,External Ear Actinic Keratosis
8950,Perivascular Arrangement of Tumor Cells,Lymphangiomyoma
8951,Adulthood Lesion,Aggressive Adult Non-Hodgkin Lymphoma
8952,Carcinomatous Component Present,adenoid cystic carcinoma of floor of mouth
8953,Carcinomatous Component Present,Gastric Adenocarcinoma
8954,Carcinomatous Component Present,"Adenocarcinoma, endocervical type"
8955,Necrotic changes (finding),Recurrent Glioblastoma
8956,Mitotic Activity,Pineal Region Yolk Sac Tumor
8957,Epithelial Component Present,Childhood Rectal Carcinoma
8958,Diffuse Pattern,Childhood Diffuse Large B-Cell Lymphoma
8959,Childhood Lesion,Childhood Nongerminomatous Germ Cell Tumor
8960,Epithelial Component Present,"Mucinous adenocarcinoma, endocervical type"
8961,Mitotic Activity,Adult Brain Stem Gliosarcoma
8962,Mixed Cellular Population,Anaplastic Kidney Wilms Tumor
8963,Carcinomatous Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
8964,Slow Growing Mass,Childhood Ganglioglioma
8965,Cutaneous Involvement,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin
8966,Metastatic Lesion,Metastatic Carcinoma to the Uterine Cervix
8967,Carcinomatous Component Present,Endometrial Mixed Cell Adenocarcinoma
8968,Thin-Walled Branching Vascular Pattern,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
8969,Childhood Lesion,Childhood Choriocarcinoma
8970,Epithelial Component Present,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
8971,Increased Cellularity Present,Childhood Anaplastic Ependymoma
8972,Tissue of Mullerian Origin Present,Uterine Corpus Adenosarcoma
8973,Papillary Pattern,Papillary fibroelastoma
8974,Neuroendocrine Differentiation,Endometrial Small Cell Carcinoma
8975,Mild dysplasia,Low Grade Conjunctival Intraepithelial Neoplasia
8976,Hemorrhagic,Anaplastic adrenocortical carcinoma
8977,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v7
8978,Dystrophic calcification,Calcifying Fibrous Pseudotumor
8979,Indolent Clinical Course,Uterine Corpus Adenomyoma
8980,Carcinomatous Component Present,Stage III Ampulla of Vater Cancer AJCC v7
8981,Ground Glass Nuclear Inclusion,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
8982,Stromal Invasion,FIGO Stage IIIA1 Ovarian Cancer
8983,Lobulated Growth Pattern,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
8984,Sclerotic Pattern,Sclerosing Breast Papilloma
8985,Metastatic Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
8986,Somatostatin Positive Neoplastic Cells Present,Pancreatic Somatostatinoma
8987,Serrated Glandular Architecture,Rectal Sessile Serrated Adenoma/Polyp
8988,Anaplasia,Recurrent Childhood Anaplastic Large Cell Lymphoma
8989,Epithelial Component Present,Duodenal Adenoma
8990,Carcinomatous Component Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells
8991,Benign Cellular Infiltrate,benign granular cell tumor of gallbladder
8992,Trabecular Pattern,Malignant Pancreatic Somatostatinoma
8993,Epithelial Component Present,Intestinal Neuroendocrine Tumor G2
8994,Cutaneous Involvement,Contact dermatitis due to solar radiation
8995,Epithelial Component Present,Verrucous carcinoma of penis
8996,Epithelial Component Present,Prostate Undifferentiated Carcinoma
8997,Carcinomatous Component Present,Childhood Thyroid Gland Medullary Carcinoma
8998,Rapidly Enlarging Mass,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
8999,Skin nodule,Fibroepithelioma of Pinkus
9000,Carcinomatous Component Present,Endometrial Carcinoma
9001,Storiform Growth Pattern,Deep histiocytoma
9002,Carcinomatous Component Present,bilateral breast cancer
9003,Odontogenic Cysts,Ameloblastic Carcinoma Derived From Odontogenic Cyst
9004,Mild cytologic atypia,Urethral Verrucous Carcinoma
9005,Monomorphic Cellular Infiltrate,Pineal parenchymal tumor of intermediate differentiation
9006,Epithelial Component Present,Verrucous carcinoma of oral cavity
9007,Exophytic Papillary Lesion,Verrucous carcinoma of oral cavity
9008,Diffuse Pattern,Centroblastic lymphoma refractory
9009,Low Mitotic Activity,Gallbladder Neuroendocrine Tumor G1
9010,Epithelial Component Present,Bladder cancer recurrent
9011,Low Mitotic Activity,Gallbladder Neuroendocrine Tumor G2
9012,Epithelial Component Present,Squamous Cell Neoplasms
9013,High Grade Lesion,High Grade Astrocytic Tumor
9014,Epithelial Component Present,basal cell adenocarcinoma of salivary gland
9015,Metastatic/Recurrent Disease,Extraskeletal Myxoid Chondrosarcoma
9016,Myxoid Stroma Formation,Dermal nerve sheath myxoma
9017,Dysplasia,Sessile Serrated Adenoma/Polyp
9018,Epithelial Component Present,Stage IB Vulvar Carcinoma AJCC v6
9019,Well-Circumscribed Lesion,Adenomatous polyp of colon
9020,Carcinomatous Component Present,Prostate Adenoid Cystic Carcinoma
9021,Capillary Sized Vascular Channel Formation,Hemangioblastoma
9022,Pushing Tumor Margin,Laryngeal verrucous carcinoma
9023,Fibrotic Stroma Formation,Thyroid Gland Mucoepidermoid Carcinoma
9024,Carcinomatous Component Present,Stage II Prostate Carcinoma
9025,Glomerular Hypertrophy,"Focal Segmental Glomerulosclerosis, Not Otherwise Specified"
9026,Cystic Change,Malignant Kidney Mixed Epithelial and Stromal Tumor
9027,Nuclear Palisading,Adamantinous Craniopharyngioma
9028,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage II
9029,Epithelial Component Present,Tobacco-Related Carcinoma
9030,Fibrotic Stroma Formation,Borderline Ovarian Serous Adenofibroma
9031,Mitotic Activity,Testicular yolk sac tumor stage II
9032,Acanthosis,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
9033,Secondary Lesion,Breast Carcinoma Metastatic in the Skin
9034,Carcinomatous Component Present,Metastatic Squamous Cell Breast Carcinoma
9035,Indolent Clinical Course,Colon Lipoma
9036,Lobulated Growth Pattern,Multiple Lobular Capillary Hemangiomas
9037,Multifocal Lesion,Multiple Lobular Capillary Hemangiomas
9038,Secondary Lesion,Secondary osteosarcoma
9039,Carcinomatous Component Present,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7
9040,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype"
9041,'Starry-sky' pattern,EBV-Related Burkitt Lymphoma
9042,Neuroendocrine Differentiation,Carotid Body Paraganglioma
9043,Papillary Pattern,Bladder Squamous Papilloma
9044,Indolent Clinical Course,Senile angioma
9045,Epithelial Component Present,Stage IV Nasal Cavity Carcinoma AJCC v7
9046,Epithelial Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
9047,High Mitotic Activity,Stage IIB Lung Small Cell Carcinoma AJCC v7
9048,Neuroendocrine Differentiation,Malignant neoplasm of carotid body
9049,Thick-Walled Hyalinized Vessels Present,Cellular Schwannoma
9050,Vascular Channel Formation,Parotid Gland Lymphangioma
9051,Low Mitotic Activity,Gastrinoma
9052,Follicular Cell Differentiation,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
9053,Cutaneous Involvement,Mycosis fungoides stage I
9054,"Amorphus, Eosinophilic, and Acellular Deposit",Reactive systemic amyloidosis
9055,Neuroendocrine Differentiation,combined small cell carcinoma of lung
9056,Peripheral Nuclear Palisading,combined small cell carcinoma of lung
9057,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm
9058,Alternative Fascicle (Bundle) Pattern,Rectal Leiomyoma
9059,Hereditary Lesion,Hereditary sideroblastic anemia
9060,Hereditary Lesion,Neurofibromatosis 2
9061,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
9062,Diffuse Pattern,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease
9063,Carcinomatous Component Present,Stage I Adult Liver Cancer AJCC v7
9064,Poorly Differentiated Lesion,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma
9065,Cellular Pseudostratification,cystic mucinous tumor of pancreas with moderate dysplasia
9066,Nuclear pleomorphism,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
9067,Well-Circumscribed Lesion,Uterine Corpus Adenomatoid Tumor
9068,Severe dysplasia,Lobular carcinoma in situ of breast
9069,Rhabdomyosarcomatous Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
9070,Mixture of Morphologic Patterns,Mixed Squamous Cell Carcinoma of the Penis
9071,Multifocal Lesion,Spinal Multifocal Clear Cell Meningioma
9072,Abnormal Eosinophilic Granules Present,"Acute myeloid leukemia, inv(16)(p13q22)"
9073,Juvenile Lesion,Gastric Juvenile Polyp
9074,Generalized Dysplasia,Traditional Serrated Adenoma
9075,Borderline Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm
9076,Tissue Differentiation Uncertain,Vulvar Angiomyxoma
9077,Vascular Channel Formation,Appendix Kaposi Sarcoma
9078,Epithelial Component Present,Lip Carcinoma
9079,HMB-45-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma
9080,Carcinomatous Component Present,Adenocarcinoma of prostate
9081,Epithelial Component Present,Ureteric cancer regional
9082,Adnexal Differentiation,Sweat gland carcinoma
9083,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Tumor G1
9084,Mild dysplasia,Mild epithelial dysplasia
9085,Endocervical Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
9086,Adulthood Lesion,Stage IA Adult Soft Tissue Sarcoma AJCC v7
9087,Glandular Pattern,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
9088,Follicular Structures Present,Follicular Variant Thyroid Gland Papillary Carcinoma
9089,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Chronic Neutrophilic Leukemia
9090,Cutaneous Involvement,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
9091,Cutaneous Involvement,Congenital hypotrichia
9092,Apocrine Differentiation,Ceruminous adenocarcinoma
9093,Pseudoalveolar Pattern,Adult Alveolar Soft Part Sarcoma
9094,Well-Circumscribed Lesion,Colorectal Inflammatory Polyp
9095,Carcinomatous Component Present,Ampulla of Vater Clear Cell Adenocarcinoma
9096,Adulthood Lesion,Adult Epithelioid Sarcoma
9097,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Solid Variant"
9098,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma
9099,Epithelial Component Present,Endocrine Gland Neoplasms
9100,Epithelial Component Present,Adenocarcinoma of cecum
9101,Epithelial Component Present,lymphoepithelial squamous cell carcinoma of salivary gland
9102,Carcinomatous Component Present,Bladder Urachal Carcinoma
9103,Epithelial Component Present,Condyloma acuminata of cervix
9104,Papillary Pattern,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
9105,Crystal deposition,Vulvar Alveolar Soft Part Sarcoma
9106,Cutaneous Involvement,Stage 0 Cutaneous Melanoma AJCC v6 and v7
9107,Chronic lymphocytic inflammation,Parotid Gland Warthin Tumor
9108,Ineffective hematopoiesis,Alkylating Agent-Related Acute Myeloid Leukemia
9109,Therapy-Related Toxicity,Alkylating Agent-Related Acute Myeloid Leukemia
9110,Intestinal metaplasia,Intestinal-Type Sinonasal Adenocarcinoma
9111,Indolent Clinical Course,Ureter Leiomyoma
9112,Well-Circumscribed Lesion,Stage V Kidney Wilms Tumor
9113,Metastatic Lesion,Secondary malignant neoplasm of esophagus
9114,Aggressive Clinical Course,Undifferentiated Stromal Sarcoma
9115,Epithelial Component Present,Carcinoma in situ of small intestine
9116,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone metastatic
9117,Papillary Pattern,Vaginal Mullerian Papilloma
9118,Cribriform Pattern,Rectal Cribriform Comedo-Type Adenocarcinoma
9119,Epithelial Component Present,Grade 2 Rectal Adenocarcinoma
9120,Exophytic Polypoid Lesion,Vaginal Tubulovillous Adenoma
9121,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Cervical Endometrioid Adenocarcinoma
9122,Presence of a Hormonal Syndrome,insulinoma
9123,Low Mitotic Activity,Pancreatic Vipoma
9124,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Adenofibroma
9125,Non-Invasive Lesion,Ampulla of Vater Tubulovillous Adenoma
9126,Well-Circumscribed Lesion,Flat adenoma
9127,Epithelial Component Present,Esophageal Neuroendocrine Tumor G2
9128,Immunoglobulin Deposition,Primary Systemic Amyloidosis
9129,Cutaneous Involvement,Hydroa Vacciniforme
9130,Cutaneous Involvement,Stevens-Johnson Syndrome
9131,Childhood Lesion,Childhood Grade I Meningioma
9132,Carcinomatous Component Present,"Cystadenocarcinoma, Mucinous"
9133,Benign Cellular Infiltrate,Benign neoplasm of stomach
9134,Intraductal Lesion,Atypical Breast Papilloma
9135,Microvascular Proliferation,Recurrent Childhood Glioblastoma
9136,Neuroendocrine Differentiation,Regional Digestive System Neuroendocrine Tumor G1
9137,Mesenchymal Differentiation,Recurrent Childhood Gliosarcoma
9138,Dysplasia,Tubulovillous adenoma
9139,Increased Cellularity Present,Mediastinal Neuroblastoma
9140,Cutaneous Involvement,Acute Generalized Exanthematous Pustulosis
9141,Carcinomatous Component Present,Adenoid cystic eccrine carcinoma
9142,Diffuse Pattern,Grade 2 Diffuse Follicular Lymphoma
9143,Lymphadenopathy,Nodal marginal zone B-cell lymphoma refractory
9144,Local disease,Fibromyxolipoma
9145,Low Mitotic Activity,Carcinoid tumor of intestine
9146,Mixed Cellular Population,Malignant Submandibular Gland Mixed Tumor
9147,Childhood Lesion,Hepatoblastoma recurrent
9148,Metaplasia,Bladder squamous cell carcinoma stage I
9149,Capillary Sized Vascular Channel Formation,Capillary hemangioma of eyelid
9150,Myxoid Stroma Formation,Chondromyxoid fibroma
9151,Epithelial Component Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
9152,Epithelial Component Present,Eccrine Poroma
9153,Carcinomatous Component Present,Gastric Adenosquamous Carcinoma
9154,Mitotic Activity,Small cell glioblastoma
9155,Epithelial Component Present,Colon Traditional Serrated Adenoma
9156,Dysplasia,Tubulovillous adenoma of rectum
9157,Indolent Clinical Course,Chondroma
9158,Hyperplastic Tissue Present,Stromal hyperplasia
9159,Epithelial Component Present,Invasive Prostate Carcinoma
9160,Neuroendocrine Differentiation,Hindgut Carcinoid Tumor
9161,Carcinomatous Component Present,Vaginal Cancer by AJCC v7 Stage
9162,Cutaneous Involvement,Vulvar Adenocarcinoma of Sweat Gland Type
9163,Necrotic changes (finding),High Grade Malignant Peripheral Nerve Sheath Tumor
9164,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation
9165,Epithelial Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
9166,Lymphadenopathy,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma
9167,Epithelial Component Present,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
9168,Epithelial Component Present,Sweat gland adenocarcinoma
9169,Epithelial Component Present,Colon cancer recurrent
9170,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor
9171,S-100-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis
9172,Multinodular Mass,Post-Radiotherapy Breast Angiosarcoma
9173,Cutaneous Involvement,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
9174,Mixed Cellular Population,Benign Vaginal Mixed Tumor
9175,Carcinomatous Component Present,Malignant Breast Eccrine Spiradenoma
9176,Epithelial Component Present,Urothelial Carcinoma
9177,Neuroendocrine Differentiation,Combined Lung Large Cell Neuroendocrine Carcinoma
9178,Squamous metaplasia of bladder,Bladder Squamous Cell Carcinoma
9179,Immunologic Deficiency Syndromes,AIDS-Related Cervical Kaposi Sarcoma
9180,Carcinomatous Component Present,Stage IIA2 Cervical Cancer AJCC v7
9181,Childhood Lesion,Recurrent Childhood Visual Pathway Glioma
9182,Cystic Change,Rete Ovarii Cystadenofibroma
9183,Hyperplastic Tissue Present,Pseudoangiomatous stromal hyperplasia
9184,Metastatic/Recurrent Disease,"Synovial sarcoma, spindle cell"
9185,Epithelial Component Present,Sphenoid Sinus Inverted Papilloma
9186,Tissues Derived from Two or Three Embryonic Layers Present,Immature Ovarian Teratoma
9187,Primary Lesion,Primary peritoneal carcinoma
9188,Refractory Disease,Refractory Mature B-Cell Non-Hodgkin Lymphoma
9189,Multilocular Lesion,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor
9190,Multifocal Lesion,Lymphangioleiomyomatosis of skin
9191,Mild cytologic atypia,Upper Gingival Verrucous Carcinoma
9192,Endophytic Tumor Growth,Upper Gingival Verrucous Carcinoma
9193,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma non-metastatic
9194,Follicular Differentiation,Pilomatrixoma
9195,Papillary Pattern,"Papilloma, Intraductal"
9196,Intraosseous Lesion,Primary Intraosseous Squamous Cell Carcinoma
9197,Mild dysplasia,Low Grade Squamous Intraepithelial Neoplasia
9198,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast
9199,Pseudoalveolar Pattern,Cervical Alveolar Soft Part Sarcoma
9200,Congenital Lesion,Congenital melanocytic nevus
9201,Slow Growing Mass,Ganglioglioma
9202,Childhood Lesion,Recurrent Childhood Pleomorphic Xanthoastrocytoma
9203,Epithelial Component Present,Lung Carcinoma Metastatic in the Bone
9204,Mitotic Activity,Anaplastic astrocytoma
9205,Primary Lesion,Cerebral Non-Hodgkin Lymphoma
9206,Necrotic changes (finding),Supratentorial Glioblastoma
9207,Epithelial Component Present,Water-clear cell adenoma
9208,Moderate dysplasia,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia
9209,Epithelial Component Present,Stage IIIA Rectal Cancer AJCC v7
9210,Intracanalicular Growth Pattern,Intracanalicular fibroadenoma
9211,Cystic Change,Cystadenofibroma of fallopian tube
9212,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity recurrent
9213,Carcinomatous Component Present,Gallbladder papillary adenocarcinoma
9214,Epithelial Component Present,carcinoma of eye
9215,Cutaneous Involvement,Primary Cutaneous Anaplastic Large Cell Lymphoma
9216,Primary Lesion,Childhood Brain Stem Mixed Glioma
9217,Carcinomatous Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
9218,Carcinomatous Component Present,Stage IIB Appendix Carcinoma AJCC v7
9219,Blue Bone Formation,"Bone Cysts, Aneurysmal"
9220,Solitary mass,Pleural Epithelioid Hemangioendothelioma
9221,Mesenchymal Component Present,"Phyllodes tumor, benign"
9222,Well-Circumscribed Lesion,Epithelial Predominant Kidney Wilms Tumor
9223,Malignant Germinomatous Cellular Infiltrate,Intracranial Germinoma
9224,Childhood Lesion,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation
9225,Epithelial Component Present,Cervical Intraepithelial Neoplasia
9226,In Situ Lesion,Stage 0is Ureter Cancer AJCC v7
9227,Indolent Clinical Course,Benign Extrahepatic Bile Duct Soft Tissue Neoplasm
9228,Perivascular Arrangement of Tumor Cells,Solid Angioleiomyoma
9229,Breast Microcalcification,Recurrent Childhood Oligodendroglioma
9230,Recurrent disease,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
9231,Nuclear Atypia,Glioblastoma multiforme of spinal cord
9232,Infiltrative Growth Pattern,Glioblastoma multiforme of spinal cord
9233,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
9234,Osseous Differentiation,Multifocal osteosarcoma
9235,Epithelial Component Present,Adenocarcinoma of the rete testis
9236,Epithelial Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
9237,Epithelial Component Present,Stage 0 Rectal Cancer AJCC v6 and v7
9238,Invasive Lesion,Grade 2 Invasive Breast Carcinoma
9239,Generalized illness,Disseminated adenocarcinoma
9240,Cutaneous Involvement,Granuloma Annulare
9241,Epithelial Component Present,Gallbladder squamous cell carcinoma
9242,Keratin pearl formation,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
9243,Epithelial Component Present,Adenocarcinoma of rete ovarii
9244,Follicular Structures Present,Thyroid Gland Follicular Adenoma
9245,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
9246,Epithelial Component Present,Stage IV Penile Cancer AJCC v6
9247,Locally Aggressive Lesion,Cardiac Inflammatory Myofibroblastic Tumor
9248,Epithelial Component Present,Rete Ovarii Cystadenoma
9249,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone recurrent
9250,Cartilaginous Differentiation,Dedifferentiated chondrosarcoma
9251,Indolent Clinical Course,Angiomyoma
9252,Vascular Channel Formation,Kaposi's sarcoma of liver
9253,Carcinomatous Component Present,Squamous cell carcinoma of skin
9254,Mixed Cellular Population,Salivary Gland Pleomorphic Adenoma
9255,Metastatic/Recurrent Disease,Lung Biphasic Synovial Sarcoma
9256,Macule,Mucosal lentiginous melanoma
9257,Absence of Invasion,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
9258,Exophytic Papillary Lesion,Cervical Papillary Squamous Cell Carcinoma
9259,Adulthood Lesion,Adult Classical Hodgkin Lymphoma
9260,Epithelial Component Present,Vaginal intraepithelial neoplasia grade 1
9261,Childhood Lesion,Stage IV Childhood Non-Hodgkin Lymphoma
9262,Pregnancy Complications,Eclampsia
9263,Epithelial Component Present,Colorectal Cancer by AJCC v6 Stage
9264,Carcinomatous Component Present,Bilateral Carcinoma
9265,Childhood Lesion,Childhood Infratentorial Neoplasm
9266,Indolent Clinical Course,Cellular Myxoma
9267,Fibrotic Stroma Formation,Clear cell cystadenofibroma
9268,Adulthood Lesion,Adult Langerhans Cell Histiocytosis
9269,Secondary Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
9270,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v7
9271,Malignant Germinomatous Cellular Infiltrate,Childhood Germinomatous Germ Cell Tumor
9272,Secondary Lesion,Secondary malignant neoplasm of larynx
9273,Diffuse Pattern,Anaplastic astrocytoma
9274,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage II supradiaphragmatic
9275,Microvascular Proliferation,Epithelioid glioblastoma
9276,Carcinomatous Component Present,Colorectal Small Cell Neuroendocrine Carcinoma
9277,Carcinomatous Component Present,carcinosarcoma of fallopian tube
9278,Pregnancy Complications,Placental aromatase deficiency
9279,Malignant Germinomatous Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7
9280,Sarcomatoid Stroma Formation,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
9281,Biphasic Pattern,Carcinosarcoma
9282,Fibrotic Stroma Formation,Broad Ligament Serous Adenofibroma
9283,Increased Cellularity Present,neuroblastoma of spinal cord
9284,Fibrotic Stroma Formation,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
9285,Mild cytologic atypia,Subglottic Verrucous Carcinoma
9286,Neuroendocrine Differentiation,small cell carcinoma of salivary gland
9287,Secondary Lesion,CNS metastases
9288,Childhood Lesion,Childhood Immature Teratoma
9289,Carcinomatous Component Present,Ductal Breast Carcinoma
9290,Well-Circumscribed Lesion,"Histiocytoma, Angiomatoid Fibrous"
9291,Mixed Cellular Population,Uterine Corpus Adenosarcoma
9292,Epithelial Component Present,Renal Adenoma
9293,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage III
9294,Systemic disease,Adult Systemic Anaplastic Large Cell Lymphoma
9295,Adulthood Lesion,Adult Systemic Anaplastic Large Cell Lymphoma
9296,In Situ Lesion,Adenocarcinoma in situ in adenomatous polyp
9297,Nuclear Pseudoinclusion,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
9298,Glandular Pattern,Pancreatic Somatostatinoma
9299,Biphasic Pattern,Ovarian serous cystadenofibroma
9300,Epithelial Component Present,Localized Resectable Adult Hepatocellular Carcinoma
9301,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
9302,Epithelial Component Present,Breast Cancer by AJCC v6 Stage
9303,Epithelial Component Present,BCLC Stage C Hepatocellular Carcinoma
9304,Epithelial Component Present,Anal Canal Squamous Intraepithelial Neoplasia
9305,Carcinomatous Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma
9306,Epithelial Component Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells
9307,Carcinomatous Component Present,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
9308,Poorly Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
9309,Well-Circumscribed Lesion,Angiofibroma
9310,Vascular Channel Formation,Angiosarcoma recurrent
9311,Epithelial Component Present,Childhood Thyroid Gland Follicular Carcinoma
9312,Cutaneous Involvement,Hutchinson's Melanotic Freckle
9313,Epithelial Component Present,Undifferentiated carcinoma of ovary
9314,Regional Disease,Malignant Neoplasm with Regional Lymph Node Involvement
9315,Carcinomatous Component Present,Poorly Cohesive Gastric Carcinoma
9316,Adulthood Lesion,Adult Central Nervous System Mature Teratoma
9317,Regional Disease,Crohn Disease
9318,Carcinomatous Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
9319,Exophytic Polypoid Lesion,Anal Inflammatory Cloacogenic Polyp
9320,Diffuse Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
9321,Secondary Lesion,Submandibular Gland Carcinoma ex Pleomorphic Adenoma
9322,Pseudopapillary Pattern,teratocarcinoma of mediastinum
9323,Dysplasia,Perianal Squamous Intraepithelial Neoplasia
9324,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
9325,Refractory Disease,Hodgkin's disease mixed cellularity refractory
9326,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Endometrioid Adenocarcinoma
9327,Antoni A Pattern,Plexiform Schwannoma
9328,Carcinomatous Component Present,Acantholytic squamous cell carcinoma of skin
9329,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v6 Stage
9330,Non-Invasive Lesion,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm
9331,Carcinomatous Component Present,eccrine adenocarcinoma of vulva
9332,Epithelial Component Present,Small Intestinal High Grade Intraepithelial Neoplasia
9333,Carcinomatous Component Present,Bladder Adenocarcinoma
9334,Indolent Clinical Course,Lipoma of pleura
9335,Slow Growing Mass,Subependymal Glioma
9336,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor
9337,Neuroectodermal Differentiation,Localized Peripheral Primitive Neuroectodermal Tumor
9338,Epithelial Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
9339,Rapidly Enlarging Mass,Rhabdomyosarcoma of cervix uteri
9340,Unresectable Mass,Unresectable Gallbladder Carcinoma
9341,Carcinomatous Component Present,Recurrent Vulvar Carcinoma
9342,Mild cytologic atypia,Human Papillomavirus-Related Verrucous Carcinoma
9343,High Grade Lesion,Anal Rhabdomyosarcoma
9344,Carcinomatous Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
9345,Secondary Lesion,Carcinoma ex pleomorphic adenoma
9346,Childhood Lesion,Childhood Acute Lymphoblastic Leukemia
9347,High Grade Lesion,Intracortical osteosarcoma
9348,Macrocystic Change,Congenital Cystic Hygroma
9349,Stromal Invasion,Mucinous cystadenocarcinoma of ovary
9350,Carcinomatous Component Present,Ovarian Dermoid Cyst with Adenocarcinoma
9351,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
9352,Epithelial Component Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia
9353,Bone marrow depression,Hypocellular Myelodysplastic Syndrome
9354,Epithelial Component Present,"Thymoma, type A, malignant"
9355,Epithelial Component Present,Malignant Pancreatic Insulinoma
9356,Necrotic changes (finding),large cell neuroendocrine carcinoma of lung
9357,Peripheral Nuclear Palisading,large cell neuroendocrine carcinoma of lung
9358,Low Mitotic Activity,"Glucagonoma, malignant"
9359,Perivascular Arrangement of Tumor Cells,Telangiectatic Glomangioma
9360,Anaplasia,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype"
9361,Recurrent disease,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
9362,Epithelial Component Present,Cervical carcinoma stage II AJCC v7
9363,Villous Pattern,Colonic tubulovillous adenoma
9364,Exophytic Polypoid Lesion,Colorectal Traditional Serrated Adenoma
9365,Carcinomatous Component Present,Non-Small Cell Lung Carcinoma
9366,Epithelial Component Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
9367,Childhood Lesion,Recurrent Childhood Central Nervous System Embryonal Neoplasm
9368,Capillary Sized Vascular Channel Formation,Senile angioma
9369,Absence of Basal Cell Layer,Acinar Prostate Mucinous Adenocarcinoma
9370,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v7
9371,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
9372,Carcinomatous Component Present,Stage IB Lung Small Cell Carcinoma AJCC v7
9373,Epithelial Component Present,Non-Small Cell Adenocarcinoma
9374,Exophytic Polypoid Lesion,Rectal Tubular Adenoma
9375,Anaplasia,Fibroblastic osteosarcoma
9376,Epithelial Component Present,Laryngeal Basaloid Carcinoma
9377,Absence of Stromal Invasion,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor
9378,Neuroendocrine Differentiation,Gallbladder Neuroendocrine Carcinoma
9379,Necrotic changes (finding),large cell neuroendocrine carcinoma of ovary
9380,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of ovary
9381,Nuclear Molding,combined small cell carcinoma of lung
9382,Exophytic Polypoid Lesion,Juvenile polyp
9383,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Skin Squamous Cell Carcinoma
9384,Epithelial Component Present,Pancreatic Foamy Gland Adenocarcinoma
9385,Dysplasia,Colorectal Intraepithelial Neoplasia
9386,Increased Cellularity Present,Cellular Neurofibroma
9387,Follicular Structures Present,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
9388,Mature Neutrophils Present,Differentiated Granulocytic Sarcoma
9389,Carcinomatous Component Present,Prostatic Urethra Urothelial Carcinoma
9390,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v7
9391,Carcinomatous Component Present,"Lung Squamous Cell Carcinoma, Papillary Variant"
9392,Immunologic Deficiency Syndromes,"Post-transplant lymphoproliferative disorder, polymorphic"
9393,High Mitotic Activity,Small cell lung cancer limited stage
9394,Carcinomatous Component Present,High Grade Ductal Breast Carcinoma In Situ
9395,Carcinomatous Component Present,small cell carcinoma of appendix
9396,Dysplasia,Intraductal Cribriform Breast Adenocarcinoma
9397,Well-Circumscribed Lesion,Childhood Pleomorphic Rhabdomyosarcoma
9398,Metaplasia,Nephrogenic metaplasia
9399,Epithelial Component Present,"Carcinoma of urinary bladder, superficial"
9400,Papillary Pattern,verrucous carcinoma of vulva
9401,Deep Lesion,"Vulvar Deep ""Aggressive"" Angiomyxoma"
9402,Infiltrative Growth Pattern,Childhood Gemistocytic Astrocytoma
9403,Epithelial Component Present,Papillary Thyroid Microcarcinoma
9404,Carcinomatous Component Present,Stage IIB Breast Carcinoma
9405,Neuroendocrine Differentiation,Cardiac Paraganglioma
9406,Epithelial Component Present,Stage 0 Penile Cancer AJCC v6
9407,Alternative Fascicle (Bundle) Pattern,Vulvar Leiomyoma
9408,Carcinomatous Component Present,Hepatitis B Virus-Related Hepatocellular Carcinoma
9409,Absence of Invasion,Adenoma of ampulla of Vater
9410,Immunologic Deficiency Syndromes,EBV-Related Post-Transplant Lymphoproliferative Disorder
9411,Acanthosis,Common wart
9412,Epithelial Component Present,Carcinosarcoma of ovary
9413,Indolent Clinical Course,Follicular Myxoma
9414,Epithelial Component Present,Squamous cell carcinoma
9415,Tubular Pattern,Ampulla of Vater Tubular Adenoma
9416,Adulthood Lesion,Adult Central Nervous System Neoplasm
9417,Carcinomatous Component Present,"Carcinoma, Spindle-Cell"
9418,Nuclear pleomorphism,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
9419,Local disease,Ovarian Adenomatoid Tumor
9420,Pseudopapillary Pattern,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma
9421,Myxoid Stroma Formation,Adult Myxoid Chondrosarcoma
9422,Epithelial Component Present,Prostate Neuroendocrine Neoplasm
9423,Diffuse Pattern,Glioblastoma
9424,Disease regression,regressing melanoma of skin
9425,Carcinomatous Component Present,carcinoma of pancreas with osteoclast-like giant cells
9426,Well-Circumscribed Lesion,Adamantinoma
9427,Necrotic changes (finding),Glioblastoma with Primitive Neuronal Component
9428,Epithelial Component Present,Carcinoid tumor of rectum
9429,Carcinomatous Component Present,Stage I Oral Cavity Cancer AJCC v6 and v7
9430,Epithelial Component Present,Intestinal-Type Sinonasal Adenocarcinoma
9431,Diffuse Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
9432,High Mitotic Activity,Gastric Large Cell Neuroendocrine Carcinoma
9433,Increased Cellularity Present,Cellular leiomyoma
9434,Eccrine Differentiation,Malignant Eccrine Neoplasm
9435,'Starry-sky' pattern,Childhood Burkitt Lymphoma
9436,Recurrent disease,Recurrent Grade 1 Follicular Lymphoma
9437,High Mitotic Activity,Testicular embryonal carcinoma
9438,Histiocytosis,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma
9439,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Basophilic Leukemia
9440,Epithelial Component Present,Mucinous adenocarcinoma of appendix
9441,Epithelial Component Present,Cervical Adenosquamous Carcinoma
9442,"Amorphus, Eosinophilic, and Acellular Deposit",Soft Tissue Amyloid Neoplasm
9443,Carcinomatous Component Present,Adenocarcinoma of the gastroesophageal junction
9444,Childhood Lesion,Recurrent Childhood Optic Nerve Glioma
9445,Nodular Pattern,Grade 2 Cutaneous Follicular Lymphoma
9446,Epithelial Component Present,Vaginal cancer recurrent
9447,Nodular Pattern,Grade 3b Follicular Lymphoma
9448,Cysts Containing Proteinaceous Fluid Present,"Cystadenocarcinoma, Serous"
9449,Borderline Lesion,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor
9450,Lesion with Diameter of 2cm or Less,Osteoid osteoma
9451,Biphasic Pattern,Recurrent Childhood Gliosarcoma
9452,Tubular Structures Present,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
9453,Carcinomatous Component Present,Endometrial Undifferentiated Carcinoma
9454,Non-Hereditary Lesion,Sporadic Cylindroma
9455,High Grade Lesion,Stage IV Lung Small Cell Carcinoma AJCC v7
9456,Epithelial Component Present,Adenocarcinoma in multiple adenomatous polyps
9457,Epithelial Component Present,Recurrent Skin Carcinoma
9458,Multinodular Pattern,Chest Wall Plexiform Fibrohistiocytic Neoplasm
9459,Epithelial Component Present,intestinal type adenocarcinoma of extrahepatic bile duct
9460,Recurrent disease,Nodal marginal zone B-cell lymphoma recurrent
9461,Stromal Invasion,adenosquamous carcinoma of ovary
9462,Mixed Cellular Population,Malignant Parotid Gland Mixed Tumor
9463,Epithelial Component Present,Invasive Ductal and Invasive Lobular Breast Carcinoma
9464,Rapidly Enlarging Mass,Central Nervous System Rhabdomyosarcoma
9465,Multifocal Lesion,Adenomatous Polyposis Coli
9466,Cutaneous Involvement,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
9467,Epithelial Component Present,Inverted urothelial papilloma
9468,Primary Lesion,"lymphomatoid papulosis, type A"
9469,Epithelial Component Present,Adenocarcinoma of colon
9470,High Grade Lesion,Endometrial Dedifferentiated Carcinoma
9471,Pseudoencapsulated Mass,Glandular malignant peripheral nerve sheath tumor
9472,Local disease,Localized Resectable Adult Liver Carcinoma
9473,Secondary Lesion,Secondary malignant neoplasm of rectum
9474,Secondary Lesion,Carcinoma bone
9475,Papillary Pattern,Papillary thyroid carcinoma
9476,Adulthood Lesion,Adult Myxopapillary Ependymoma
9477,Papillary Pattern,Adult Myxopapillary Ependymoma
9478,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ringed sideroblasts
9479,Childhood Lesion,Recurrent Childhood Ependymoma
9480,Carcinomatous Component Present,Hereditary Renal Cell Carcinoma
9481,Papillary Pattern,Cervical Mullerian Papilloma
9482,Epithelial Component Present,Stage I Prostate Cancer AJCC v7
9483,Recurrent disease,Adenosquamous cell lung cancer recurrent
9484,Osseous Differentiation,Ivory Exostosis
9485,Dysplasia,High Grade Esophageal Squamous Intraepithelial Neoplasia
9486,Exophytic Polypoid Lesion,papillary adenoma of extrahepatic bile duct
9487,Vascular Channel Formation,"Lymphangioma, Cystic"
9488,Adulthood Lesion,Stage I Adult Lymphoblastic Lymphoma
9489,Tissue of Mullerian Origin Present,Adenomyoma
9490,Vascular Channel Formation,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
9491,Epithelial Component Present,AIDS-related anal cancer recurrent
9492,Epithelial Component Present,Colon Cribriform Comedo-Type Adenocarcinoma
9493,atypia morphology,Complex Endometrial Hyperplasia with Atypia
9494,Dysplasia,Appendix Mucinous Cystadenoma
9495,Epithelial Component Present,Pituitary Gland Oncocytic Adenoma
9496,Cutaneous Involvement,Warty dyskeratoma
9497,Pseudoalveolar Pattern,Childhood Alveolar Soft Part Sarcoma
9498,Non-Hereditary Lesion,Gastric Papillary Adenocarcinoma
9499,Thin-Walled Branching Vascular Pattern,Peritoneal Solitary Fibrous Tumor
9500,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia
9501,Oligodendroglial Component Present,Anaplastic Oligoastrocytoma
9502,Carcinomatous Component Present,Major Salivary Gland Adenocarcinoma
9503,Indolent Clinical Course,Central Nervous System Hemangioma
9504,Epithelial Component Present,serous adenocarcinofibroma of ovary
9505,Adnexal Differentiation,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
9506,Angiocentric Pattern,Childhood Lymphomatoid Granulomatosis
9507,Tissue Differentiation Uncertain,Alveolar soft part sarcoma recurrent
9508,Epithelial Component Present,verrucous carcinoma of esophagus
9509,Chronic lymphocytic inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor
9510,Neuroendocrine Differentiation,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
9511,Skin nodule,Pilomatrixoma
9512,Numerous Stromal Mast Cells Present,Breast Myofibroblastoma
9513,Slow Growing Mass,Brain Stem Hemangioblastoma
9514,Epithelial Component Present,Early gastric cancer
9515,Osseous Differentiation,Childhood Parosteal Osteosarcoma
9516,Multinodular Mass,Hemangiosarcoma
9517,Cartilaginous Component Present,Osteochondromyxoma
9518,Epithelial Component Present,Fallopian Tube Papilloma
9519,Rare Lesion,estrogen-producing adrenal cortical adenoma
9520,Carcinomatous Component Present,Recurrent Salivary Gland Cancer
9521,Mesenchymal Component Present,Malignant Cystosarcoma Phyllodes
9522,Well-Circumscribed Lesion,Malignant Cystosarcoma Phyllodes
9523,Metastatic/Recurrent Disease,Pleural Monophasic Synovial Sarcoma
9524,Chronic lymphocytic inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor
9525,Epithelial Component Present,Stage IIIA Appendix Carcinoma AJCC v7
9526,Carcinomatous Component Present,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7
9527,Hereditary Lesion,Hereditary clear cell renal cell carcinoma
9528,Necrotic changes (finding),"Ovarian Small Cell Carcinoma, Pulmonary Type"
9529,Epithelial Component Present,Low Grade Fallopian Tube Serous Adenocarcinoma
9530,Mixed Cellular Population,Recurrent Childhood Oligoastrocytoma
9531,Carcinomatous Component Present,Stage IVA Paranasal Sinus Cancer AJCC v7
9532,Villous Pattern,Villous adenoma of rectum
9533,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells
9534,Neuroendocrine Differentiation,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
9535,Epithelial Component Present,Stage IVB Liver Cancer
9536,Neuroendocrine Differentiation,Primary hepatic neuroendocrine carcinoma
9537,Neuroendocrine Differentiation,Ovarian Insular Carcinoid Tumor
9538,Insular Pattern,Ovarian Insular Carcinoid Tumor
9539,Pregnancy Complications,Exaggerated placental site
9540,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
9541,Cutaneous Involvement,Sweat Gland Tubular Carcinoma
9542,Cutaneous Involvement,Psoriasis
9543,Primary Lesion,Intraosseous well differentiated osteosarcoma
9544,Indolent Clinical Course,Cavernous lymphangioma
9545,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland
9546,Non-Hereditary Lesion,Helicobacter Pylori-Related Gastric Adenocarcinoma
9547,Epithelial Component Present,Stage III Esophageal Cancer
9548,Hemorrhagic,Childhood Angiosarcoma
9549,In Situ Lesion,Stage 0 Oral Cavity Cancer AJCC v6 and v7
9550,Severe dysplasia,Stage 0 Oral Cavity Cancer AJCC v6 and v7
9551,Epithelial Component Present,Ovarian Seromucinous Adenofibroma
9552,Carcinomatous Component Present,Recurrent Female Reproductive System Carcinoma
9553,Neuroendocrine Differentiation,"Carcinoma, Small Cell"
9554,Monophasic Pattern,Cardiac Monophasic Synovial Sarcoma
9555,Mixed Cellular Population,Breast Pleomorphic Adenoma
9556,Epithelial Component Present,Recurrent Male Reproductive System Carcinoma
9557,Vascular Channel Formation,Spindle cell hemangioma
9558,Syncytial Pattern,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
9559,Pericanalicular Growth Pattern,Breast Complex Fibroadenoma
9560,High Grade Lesion,Lung Biphasic Synovial Sarcoma
9561,Breast Microcalcification,Childhood Oligodendroglioma
9562,Cutaneous Involvement,Skin carcinoma
9563,Alternative Fascicle (Bundle) Pattern,Vaginal Leiomyoma
9564,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7
9565,Collagenous Stroma Formation,Desmoplastic fibroma
9566,Hyperkeratosis,Cervical Squamotransitional Carcinoma
9567,Biphasic Pattern,Mucinous adenofibroma
9568,Mixed Cellular Population,Cystadenofibroma
9569,Epithelial Component Present,"Uterine Carcinosarcoma, Homologous Type"
9570,Epithelial Component Present,FIGO Stage IVA Ovarian Cancer
9571,Tissue of Mullerian Origin Present,Clear cell cystadenofibroma
9572,Carcinomatous Component Present,"Uterine Carcinosarcoma, Heterologous Type"
9573,Heterologous Elements Present,"Uterine Carcinosarcoma, Heterologous Type"
9574,Hyperplastic Tissue Present,Parathyroid chief-cell hyperplasia
9575,Childhood Lesion,Childhood Ovarian Embryonal Carcinoma
9576,Metastatic Lesion,Metastatic carcinoid tumor
9577,Neuroendocrine Differentiation,Colorectal Small Cell Neuroendocrine Carcinoma
9578,Carcinomatous Component Present,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
9579,Mixed Cellular Population,carcinosarcoma of fallopian tube
9580,Carcinomatous Component Present,Pancreatic Medullary Carcinoma
9581,Carcinomatous Component Present,Stage IVB Lip Cancer AJCC v6 and v7
9582,Adnexal Differentiation,Trichilemmoma
9583,Carcinomatous Component Present,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
9584,Calcitonin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
9585,Endophytic Tumor Growth,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
9586,Cutaneous Involvement,Porphyria Cutanea Tarda
9587,Lobulated Growth Pattern,Malignant myoepithelioma
9588,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma
9589,Secondary Lesion,Head and neck cancer metastatic
9590,Dentin formation,Ameloblastic fibrodentinoma
9591,Splenomegaly,Hairy Cell Leukemia
9592,Well-Circumscribed Lesion,"Leydig cell tumor, benign"
9593,Infiltrative Growth Pattern,Dupuytren Contracture
9594,Mixed Cellular Population,Broad Ligament Serous Cystadenofibroma
9595,Fibrotic Stroma Formation,Ovarian Stromal-Leydig Cell Tumor
9596,Diffuse Lesion,Ganglioneuromatosis
9597,Well Differentiated Lesion,Plantar Verrucous Skin Carcinoma
9598,Pushing Tumor Margin,Subglottic Verrucous Carcinoma
9599,Carcinomatous Component Present,Stage IVA Colorectal Cancer AJCC v7
9600,Epithelial Component Present,Childhood Salivary Gland Carcinoma
9601,Carcinomatous Component Present,"Mucinous adenocarcinoma, endocervical type"
9602,Mass of body structure,"Sarcoma, Myeloid"
9603,Hemorrhagic,Superior Vena Cava Angiosarcoma
9604,Cutaneous Involvement,Nodular melanoma
9605,Perivascular Arrangement of Tumor Cells,Malignant Uterine Corpus PEComa
9606,Epithelial Component Present,Polymorphous low grade adenocarcinoma of salivary gland
9607,Epithelial Component Present,Metastatic Carcinoma to the Uterine Cervix
9608,Storiform Growth Pattern,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
9609,Carcinomatous Component Present,FIGO Stage IC3 Ovarian Cancer
9610,Carcinomatous Component Present,Follicular thyroid carcinoma
9611,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage I
9612,Carcinomatous Component Present,"Basal cell carcinoma, micronodular"
9613,Carcinomatous Component Present,Epiglottic carcinoma
9614,Epithelial Component Present,Childhood Choroid Plexus Carcinoma
9615,Carcinomatous Component Present,Breast Carcinoma with Melanotic Features
9616,Carcinomatous Component Present,Adenoid cystic carcinoma of lacrimal gland
9617,Papillary Pattern,Ovarian Surface Papilloma
9618,Epithelial Component Present,Adenocarcinoma in situ in adenomatous polyp
9619,Necrotic changes (finding),Adult Brain Glioblastoma
9620,Myomatous Stroma Formation,Uterine Corpus Adenomyoma
9621,Storiform Growth Pattern,Inflammatory malignant fibrous histiocytoma
9622,Cellular Pleomorphism,Classic Type Atypical Fibroxanthoma
9623,Cribriform Pattern,"Testicular Seminoma, Cribriform Variant"
9624,Epithelial Component Present,Breast Columnar Cell Mucinous Carcinoma
9625,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL
9626,Tissue of Mullerian Origin Present,Ovarian serous cystadenofibroma
9627,Serrated Glandular Architecture,Colon Sessile Serrated Adenoma/Polyp
9628,Vascular Channel Formation,Capillary hemangioma of orbit
9629,Diffuse Pattern,Recurrent Childhood Anaplastic Oligoastrocytoma
9630,Childhood Lesion,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
9631,Carcinomatous Component Present,Fallopian Tube Serous Adenocarcinoma
9632,Multinodular Lesion,Plexiform Neurofibroma
9633,Epithelial Component Present,Stage II Ureter Cancer AJCC v7
9634,Low Mitotic Activity,Malignant Pancreatic Somatostatinoma
9635,Lymphoplasmacytic Infiltrate,Lymphoepithelial malignant thymoma
9636,Cytoplasmic Membrane-Bound Granules Present,Stage IB Merkel Cell Carcinoma AJCC v7
9637,Poorly Differentiated Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
9638,Follicular Cell Differentiation,Childhood Thyroid Gland Follicular Carcinoma
9639,Immunologic Deficiency Syndromes,AIDS-Related Primary Central Nervous System Lymphoma
9640,Epithelial Component Present,Pancreatic Neuroendocrine Tumor G1
9641,Epithelial Component Present,Stage I Carcinoma of Bladder
9642,High Mitotic Activity,Childhood Lung Small Cell Carcinoma
9643,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7
9644,Diffuse Pattern,Anaplastic Diencephalic Astrocytoma
9645,Indolent Clinical Course,"Perivascular epithelioid tumor, benign"
9646,Severe dysplasia,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
9647,Low Mitotic Activity,Lipofibromatosis
9648,Immunologic Deficiency Syndromes,Plasmacytic Hyperplasia Post-Transplant Lymphoproliferative Disorder
9649,Childhood Lesion,Childhood Brain Oligodendroglioma
9650,Fibrotic Stroma Formation,Ovarian Clear Cell Cystadenofibroma
9651,Mixture of Germ Cell Neoplastic Components Present,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor
9652,Immunosuppression-Related Post-Transplant Toxicity,Infectious mononucleosis-like post-transplant lymphoproliferative disorder
9653,Epithelial Component Present,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7
9654,Epithelial Component Present,"Urinary bladder carcinoma stage I, with cancer in situ"
9655,Mixed Cellular Population,Borderline Breast Phyllodes Tumor
9656,Adnexal Differentiation,Malignant Vulvar Sweat Gland Neoplasm
9657,Primary Lesion,Diencephalic Astrocytoma
9658,Focal dysplasia,Sessile Serrated Adenoma/Polyp
9659,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant"
9660,Papillary Pattern,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
9661,Vascular Channel Formation,Infantile hemangioma
9662,Indolent Clinical Course,Infantile hemangioma
9663,Microfollicular Structures Present,Microfollicular adenoma
9664,Adulthood Lesion,Adult Intracranial Germ Cell Tumor
9665,Primary Lesion,Adult Meningeal Melanoma
9666,Acanthosis,Glottis Verrucous Carcinoma
9667,Storiform Growth Pattern,benign fibrous histiocytoma of bone
9668,Cutaneous Involvement,Acne Vulgaris
9669,Borderline Lesion,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor
9670,Childhood Lesion,Stage IV Childhood Anaplastic Large Cell Lymphoma
9671,Epithelial Component Present,Mammosomatotroph Adenoma
9672,Severe cytologic atypia,Pancreatic Large Cell Neuroendocrine Carcinoma
9673,Carcinomatous Component Present,Carcinoma ex pleomorphic adenoma
9674,Neuronal Differentiation,Lhermitte-Duclos disease
9675,Immunologic Deficiency Syndromes,Post-transplant lymphoproliferative disorder
9676,Diffuse Lesion,"Retinoblastoma, diffuse"
9677,Epithelial Component Present,Clear Cell Adrenal Cortical Adenoma
9678,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,"Leukemia, Mast-Cell"
9679,Mitotic Activity,Testicular yolk sac tumor stage III
9680,Epithelial Component Present,Stage IIIC Gastric Cancer AJCC v7
9681,Tubular Structures Present,"Testicular Sertoli Cell Tumor, Lipid Rich Variant"
9682,Carcinomatous Component Present,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
9683,Epithelial Component Present,Breast Carcinoma Metastatic in the Skin
9684,Carcinomatous Component Present,Paget's disease of vulva
9685,Epithelial Component Present,Colorectal Large Cell Neuroendocrine Carcinoma
9686,Pineocytomatous Rosette Formation,Pineocytoma
9687,Geographic Necrosis,embryonal carcinoma of mediastinum
9688,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma
9689,Cutaneous Involvement,Dermatologic disorders
9690,Carcinomatous Component Present,Unclassified Renal Cell Carcinoma
9691,Carcinomatous Component Present,Barrett's Adenocarcinoma
9692,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia
9693,Well-Circumscribed Lesion,Seminal Vesicle Cystadenoma
9694,Epithelial Component Present,Stage IB Lung Small Cell Carcinoma AJCC v7
9695,Epithelial Component Present,Stage I Digestive System Neuroendocrine Tumor AJCC v7
9696,Carcinomatous Component Present,Eccrine ductal carcinoma
9697,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Biphasic or Triphasic Teratoma
9698,Epithelial Component Present,Vaginal Squamous Neoplasm
9699,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
9700,Epithelial Component Present,Metastatic Breast Carcinoid Tumor
9701,atypia morphology,Simple Endometrial Hyperplasia with Atypia
9702,Mixed Cellular Population,Benign Ovarian Seromucinous Tumor
9703,Epithelial Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
9704,Poorly Differentiated Lesion,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant"
9705,Tubular Pattern,Colorectal Tubular Adenoma
9706,Local disease,Lipoma of chest wall
9707,Epithelial Component Present,Adenocarcinoma of Accessory Sinus
9708,Carcinomatous Component Present,Recurrent Lung Carcinoma Cell Type Unspecified
9709,Juvenile Lesion,Juvenile Polyp of the Small Intestine
9710,Anaplasia,Esophageal Spindle Cell Carcinoma
9711,Carcinomatous Component Present,Stage II Colon Cancer AJCC v7
9712,Carcinomatous Component Present,Small intestine carcinoma
9713,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Renal Cell Carcinoma
9714,Primary Lesion,Diffuse melanocytosis
9715,Immunosuppression-Related Post-Transplant Toxicity,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
9716,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
9717,Glandular Pattern,"Adenocarcinoma, intestinal type"
9718,Cutaneous Involvement,Paget Disease of the Scrotum
9719,Well-Circumscribed Lesion,Gastric Cronkhite Canada Polyposis
9720,Well-Circumscribed Lesion,Polyp of middle ear
9721,Intraductal Lesion,Pancreatic Intraductal Neoplasms
9722,Intraductal Lesion,intraductal micropapillary carcinoma of breast
9723,HMB-45-Positive Neoplastic Cells Present,Clear-Cell Myomelanocytic Tumors
9724,Villous Pattern,Bladder Villous Adenoma
9725,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage II
9726,Thyroglobulin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
9727,Carcinomatous Component Present,Localized Carcinoma
9728,Hyperplastic Tissue Present,Adrenal hyperplasia
9729,Well-Circumscribed Lesion,Ampulla of Vater Villous Adenoma
9730,Exophytic Polypoid Lesion,Ampulla of Vater Villous Adenoma
9731,Epithelial Component Present,Stage IB Esophageal Adenocarcinoma AJCC v7
9732,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monoblastic and Monocytic Leukemia
9733,Cutaneous Involvement,"Dermatitis, Irritant"
9734,Skin nodule,Sebaceous adenoma
9735,Tissue Differentiation Uncertain,Adult Desmoplastic Small Round Cell Tumor
9736,Epithelial Component Present,Stage IIIA Esophageal Adenocarcinoma AJCC v7
9737,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Neoplasm
9738,Pain,Childhood Mesenchymal Chondrosarcoma
9739,Adulthood Lesion,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
9740,Dermal Involvement,Deep Penetrating Nevus
9741,Carcinomatous Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v7
9742,Anaplasia,"Carcinoma, Spindle-Cell"
9743,Vascular Channel Formation,Hemangioma of breast
9744,Epithelial Component Present,Thymic Typical Carcinoid Tumor
9745,Diffuse Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma
9746,Well-Circumscribed Lesion,Colorectal hyperplastic polyp
9747,Hereditary Lesion,Hereditary hemorrhagic telangiectasia
9748,Carcinomatous Component Present,Lymphangitis carcinomatosa
9749,Indolent Clinical Course,Prostate Leiomyoma
9750,Epithelial Component Present,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
9751,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell"
9752,Fibrotic Stroma Formation,Brenner Tumor
9753,Well-Circumscribed Lesion,Frontal sinus polyp
9754,Well-Circumscribed Lesion,Stage III Kidney Wilms Tumor
9755,Preserved Nuclear Polarity,Ureter Urothelial Papilloma
9756,Neuroendocrine Differentiation,Intestinal Neuroendocrine Neoplasm
9757,Recurrent disease,Recurrent Chronic Lymphoid Leukemia
9758,Indolent Clinical Course,Lipoblastomatosis
9759,Well-Circumscribed Lesion,Syringofibroadenoma
9760,Carcinomatous Component Present,Stage 0 Urethral Cancer AJCC v7
9761,Epithelial Component Present,Rectal Neuroendocrine Neoplasm
9762,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Tip Lesion Variant
9763,Bone Marrow Dysplasia Present,"Myelodysplastic syndrome, no ICD-O subtype"
9764,Epithelial Component Present,Papillary serous cystadenoma
9765,Trabecular Pattern,Pancreatic Somatostatinoma
9766,Non-Invasive Lesion,Bladder Urothelial Papilloma
9767,Carcinomatous Component Present,Undifferentiated Carcinoma of Unknown Primary
9768,High Grade Lesion,Anaplastic Embryonal Rhabdomyosarcoma
9769,Neuroendocrine Differentiation,Glomus Jugulare Tumor
9770,Monomorphic Cellular Infiltrate,Childhood Infratentorial Ependymoma
9771,Cutaneous Involvement,Cutaneous Malignant Melanoma 2
9772,Cutaneous Involvement,Sweat Gland Neoplasms
9773,Epithelial Component Present,HER2-positive carcinoma of breast
9774,Epithelial Component Present,Pancreatic Vipoma
9775,Epithelial Component Present,Stage III Urethral Cancer AJCC v7
9776,Chronic lymphocytic inflammation,"Thymoma, type B2, malignant"
9777,Carcinomatous Component Present,Anaplastic Carcinoma of the Rectum
9778,Epithelial Component Present,Flat adenoma
9779,Carcinomatous Component Present,Vaginal cancer recurrent
9780,Vascular proliferation,Nasopharyngeal Angiofibroma
9781,Well-Circumscribed Lesion,Osteoid osteoma
9782,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology"
9783,Low Mitotic Activity,Recurrent Digestive System Neuroendocrine Tumor G1
9784,Carcinomatous Component Present,Mucoepidermoid carcinoma of skin
9785,Plexiform Growth Pattern,Chest Wall Plexiform Fibrohistiocytic Neoplasm
9786,Slow Growing Mass,Chest Wall Plexiform Fibrohistiocytic Neoplasm
9787,Carcinomatous Component Present,intestinal type adenocarcinoma of extrahepatic bile duct
9788,'Starry-sky' pattern,Recurrent Childhood Burkitt Lymphoma
9789,CD30-Positive Neoplastic Cells Present,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
9790,Mucoid Stroma Formation,Minimally Invasive Mucinous Lung Adenocarcinoma
9791,Multifocal Lesion,Osteochondromatosis
9792,Epithelial Component Present,Gastric Adenosquamous Carcinoma
9793,High Grade Lesion,Small cell glioblastoma
9794,Epithelial Component Present,Bladder squamous cell carcinoma stage III
9795,Carcinomatous Component Present,Vulvar Non-Keratinizing Squamous Cell Carcinoma
9796,Oligodendroglial Component Present,oligodendroglioma
9797,Nodular lesions,Low Grade Liver Dysplastic Nodule
9798,Epithelial Component Present,Vulvar Adenocarcinoma of Mammary Gland Type
9799,High Mitotic Activity,Testicular embryonal carcinoma stage I
9800,Carcinomatous Component Present,Stage II Cervical Cancer AJCC v6
9801,Chromogranin A Positive Neoplastic Cells Present,Meckel Diverticulum Neuroendocrine Tumor G1
9802,Vascular Channel Formation,Small Intestinal Angiosarcoma
9803,Villous atrophy,Immunoproliferative Small Intestinal Disease
9804,Absence of Invasion,Lobular Neoplasia
9805,Prominent Intraductal Component Present,Intraductal papillary adenocarcinoma with invasion
9806,Extraosseous Lesion,Mediastinal Extraskeletal Osteosarcoma
9807,Papillary Pattern,Frontal Sinus Schneiderian Papilloma
9808,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic
9809,Adulthood Lesion,Adult Fibrosarcoma
9810,Carcinomatous Component Present,Invasive carcinoma of breast
9811,Diffuse Pattern,Breast Diffuse Large B-Cell Lymphoma
9812,Epithelial Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma
9813,Carcinomatous Component Present,Mucinous adenocarcinoma of colon
9814,Epithelial Component Present,Prolactin-producing pituitary tumor
9815,Diffuse Pattern,Diffuse follicle center lymphoma
9816,Hemorrhagic,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
9817,Epithelial Component Present,"Carcinoma bladder stage I, without cancer in situ"
9818,Well-Circumscribed Lesion,Polyp of nasal sinus
9819,Well-Circumscribed Lesion,Gingival fibroepithelial polyp
9820,Hereditary Lesion,Hereditary retinal dystrophy
9821,Necrotic changes (finding),Dedifferentiated Solitary Fibrous Tumor
9822,Increased Cellularity Present,Stage 3 Neuroblastoma
9823,Monomorphic Cellular Infiltrate,Head and Neck Basaloid Carcinoma
9824,Epithelial Component Present,AIDS-Related Cervical Carcinoma
9825,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Erythroleukemia (Erythroid/Myeloid)
9826,Neuroectodermal Differentiation,Disseminated neuroblastoma
9827,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Seminoma
9828,Necrotic changes (finding),Childhood Malignant Peripheral Nerve Sheath Tumor
9829,Mixed Cellular Population,Mixed Salivary Gland Tumor
9830,Exophytic Polypoid Lesion,Fibrous polyp
9831,Carcinomatous Component Present,Major Salivary Gland Carcinoma
9832,Glandular Differentiation,Adenocarcinoid tumor
9833,Nodular Pattern,Refractory Follicular Lymphoma
9834,Intestinal metaplasia of gastric mucosa,adenomatous polyp of stomach
9835,Biphasic Pattern,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma
9836,Recurrent disease,Extra-osseous Ewing's sarcoma recurrent
9837,Biphasic Pattern,Recurrent Childhood Pilocytic Astrocytoma
9838,Papillary Pattern,Papillary ependymoma
9839,Cutaneous Involvement,Desmoplastic Neurotropic Melanoma
9840,Dysplasia,High-Grade Squamous Intraepithelial Lesions
9841,Neuroendocrine Differentiation,Stage I Appendix Neuroendocrine Tumor AJCC v7
9842,Collagenous Stroma Formation,Breast Myofibroblastoma
9843,Ineffective hematopoiesis,Adult Myelodysplastic Syndrome
9844,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Brain
9845,Epithelial Component Present,Foveolar-Type Adenoma
9846,Pagetoid Proliferation,Stage I Superficial Spreading Melanoma AJCC v7
9847,Carcinomatous Component Present,Stage IV Gallbladder Cancer AJCC v6
9848,Non-Invasive Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
9849,Carcinomatous Component Present,Ovarian adenocarcinoma
9850,Carcinomatous Component Present,Primary Peritoneal High Grade Serous Adenocarcinoma
9851,Recurrent disease,Recurrent Adult Acute Lymphoblastic Leukemia
9852,Epithelial Component Present,Neck Carcinoma
9853,Pagetoid Proliferation,Stage III Superficial Spreading Melanoma AJCC v7
9854,Dysplasia,Vaginal high grade squamous intraepithelial lesion
9855,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of extrahepatic bile duct
9856,Poorly Differentiated Lesion,Pleomorphic carcinoma
9857,Pregnancy Complications,Morbidly adherent placenta (disorder)
9858,Fibrotic Stroma Formation,Fallopian Tube Serous Adenofibroma
9859,Hyaline Cartilage Differentiation,Juxtacortical chondroma
9860,Cartilaginous Differentiation,Intermediate Chondrogenic Neoplasm
9861,Carcinomatous Component Present,Stage II Hypopharyngeal Carcinoma AJCC v6 and v7
9862,Malignant Germinomatous Cellular Infiltrate,Recurrent Extragonadal Seminoma
9863,Diffuse Pattern,Plasmablastic lymphoma
9864,Epithelial Component Present,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
9865,Recurrent disease,Recurrent Fallopian Tube Carcinoma
9866,Early Stromal Invasion Present,Early Invasive Cervical Squamous Cell Carcinoma
9867,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
9868,Neuroendocrine Differentiation,Small cell neuroendocrine carcinoma of bladder
9869,Absence of Invasion,Stage 0is Ureter Cancer AJCC v7
9870,Epithelial Component Present,Stage III Fallopian Tube Cancer AJCC v7
9871,Dense Collagenized Tissue Present,Morpheic basal cell carcinoma
9872,Poorly Differentiated Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
9873,Nuclear Palisading,Palisaded Lymph Node Myofibroblastoma
9874,Microvascular Proliferation,Mesenchymal Glioblastoma
9875,Hemorrhagic,Giant Cell Lesion of Small Bones
9876,Epithelial Component Present,Primary hepatic neuroendocrine carcinoma
9877,Carcinomatous Component Present,Stage 0 Distal Bile Duct Cancer AJCC v7
9878,Epithelial Component Present,Papillary renal cell carcinoma type 2
9879,Pregnancy Complications,Placenta Disorders
9880,Absence of Invasion,Stage 0 Rectal Cancer AJCC v6 and v7
9881,Carcinomatous Component Present,Stage IA Cervical Cancer AJCC v6 and v7
9882,Borderline Lesion,Borderline Uterine Ligament Neoplasm
9883,Osseous Differentiation,Osteosarcoma recurrent
9884,Well-Circumscribed Lesion,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
9885,Epithelial Component Present,Recurrent Childhood Hepatocellular Carcinoma
9886,Local disease,PNET of bone localized
9887,Pushing Tumor Margin,verrucous carcinoma of vagina
9888,Epithelial Component Present,Stage IIIB Esophageal Cancer AJCC v7
9889,Epithelial Component Present,Ovarian Seromucinous Cystadenoma
9890,Absence of Invasion,Stage 0 Lip Carcinoma
9891,In Situ Lesion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
9892,Carcinomatous Component Present,Vaginal adenocarcinoma
9893,Exophytic Polypoid Lesion,tubular adenoma of extrahepatic bile duct
9894,Epithelial Component Present,Benign Breast Eccrine Spiradenoma
9895,Carcinomatous Component Present,Parotid Gland Carcinoma
9896,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx
9897,Myxoid Stroma Formation,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant"
9898,Carcinomatous Component Present,Diffuse Gastric Adenocarcinoma
9899,Epithelial Component Present,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
9900,Epithelial Component Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma
9901,Carcinomatous Component Present,Stage IIIA Anal Canal Cancer AJCC v6 and v7
9902,Carcinomatous Component Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
9903,High Mitotic Activity,Recurrent Merkel Cell Carcinoma
9904,Glomerular Hypertrophy,AIDS-Associated Nephropathy
9905,Carcinomatous Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7
9906,Solitary mass,Adult Epithelioid Hemangioendothelioma
9907,Lobulated Growth Pattern,Meningothelial meningioma
9908,Thin-Walled Branching Vascular Pattern,Epidural Spinal Canal Angiolipoma
9909,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Mutant"
9910,Mitotic Activity,"Testicular Yolk Sac Tumor, Macrocystic Pattern"
9911,Dysplasia,Serous Tubal Intraepithelial Carcinoma
9912,Epithelial Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7
9913,Carcinomatous Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7
9914,Cutaneous Involvement,Lichen Sclerosus et Atrophicus
9915,In Situ Lesion,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
9916,Carcinomatous Component Present,Pharyngeal cancer recurrent
9917,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v7 Stage
9918,Malignant Cellular Infiltrate,Childhood Ovarian Embryonal Carcinoma
9919,Epithelial Component Present,Stage I Oropharyngeal Carcinoma
9920,Neuroendocrine Differentiation,Metastatic carcinoid tumor
9921,Papillary Pattern,Nasopharyngeal Papillary Adenocarcinoma
9922,Carcinomatous Component Present,Nasopharyngeal Papillary Adenocarcinoma
9923,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage III
9924,Microcystic Change,Fibrillary Astrocytoma
9925,Epithelial Component Present,Childhood Colorectal Carcinoma
9926,Nuclear Palisading,calcifying aponeurotic fibroma
9927,Cutaneous Involvement,Epithelioid hemangioma of skin
9928,Storiform Growth Pattern,Metastatic Dermatofibrosarcoma Protuberans
9929,Locally Aggressive Lesion,Metastatic Dermatofibrosarcoma Protuberans
9930,Carcinomatous Component Present,Paget Disease of the Breast without Invasive Carcinoma
9931,Glandular Pattern,Gastric Intestinal-Type Adenocarcinoma
9932,Epithelial Component Present,undifferentiated carcinoma of gallbladder
9933,Childhood Lesion,Childhood Malignant Testicular Germ Cell Tumor
9934,Cutaneous Involvement,Moniliform hamartoma
9935,Epithelial Component Present,Adult Penile Carcinoma
9936,Cutaneous Involvement,keratoacanthoma
9937,Local disease,Intracranial lipoma
9938,High Grade Lesion,Osteoblastic Osteosarcoma
9939,Neuronal Differentiation,Hypothalamic Gangliocytoma
9940,High Mitotic Activity,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
9941,Epithelial Component Present,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
9942,Epithelial Component Present,Broad Ligament Serous Adenocarcinoma
9943,Pseudoglandular Pattern,Testicular embryonal carcinoma stage III
9944,Glial Differentiation,Anaplastic ganglioglioma
9945,Epithelial Component Present,Sympathetic paraganglioma
9946,Recurrent disease,Recurrent Carcinoma of Unknown Primary
9947,Primary Lesion,Adult Brain Stem Gliosarcoma
9948,Severe cytologic atypia,Gastric Small Cell Carcinoma
9949,Invasive Lesion,High Grade Mucoepidermoid Breast Carcinoma
9950,Epithelial Component Present,Endometrial Adenosquamous Carcinoma
9951,Epithelial Component Present,Stage IIIA Fallopian Tube Cancer AJCC v7
9952,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Childhood Acute Myeloid Leukemia with Maturation
9953,Intraocular Lesion,Intraocular Lymphoma
9954,Mixture of Germ Cell Neoplastic Components Present,Childhood Central Nervous System Mixed Germ Cell Tumor
9955,Intraosseous Lesion,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
9956,Adulthood Lesion,Adult Brain Medulloblastoma
9957,Carcinomatous Component Present,Combined Lung Carcinoma
9958,Epithelial Component Present,Human Papillomavirus-Related Penile Squamous Cell Carcinoma
9959,Slow Growing Mass,Subependymal Giant Cell Astrocytoma
9960,Slow Growing Mass,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
9961,Mesenchymal Component Present,Pleomorphic adenoma of lacrimal gland
9962,Epithelial Component Present,Grade 1 Colorectal Adenocarcinoma
9963,Carcinomatous Component Present,Stage IV Ampulla of Vater Cancer AJCC v7
9964,Low Mitotic Activity,Pancreatic Somatostatinoma
9965,Cystic Change,Ovarian serous cystadenofibroma
9966,Carcinomatous Component Present,Bartholin Gland Adenocarcinoma
9967,Adnexal Differentiation,Trichoadenoma
9968,Epithelial Component Present,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
9969,Epithelial Component Present,Pancreatic Intraductal Papillary Mucinous Neoplasm
9970,Geographic Necrosis,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
9971,Carcinomatous Component Present,Stage III Lung Cancer AJCC v6
9972,Low Mitotic Activity,Colorectal Neuroendocrine Tumor G2
9973,Monomorphic Cellular Infiltrate,basaloid carcinoma of penis
9974,Cellular Stratification,Nasopharyngeal Differentiated Carcinoma
9975,Epithelial Component Present,Vulvar Sebaceous Carcinoma
9976,Carcinomatous Component Present,Vulvar Sebaceous Carcinoma
9977,Necrotic changes (finding),Malignant Peripheral Nerve Sheath Tumor
9978,Neuroendocrine Differentiation,Stage IV Merkel Cell Carcinoma AJCC v7
9979,Absence of Basal Cell Layer,Prostate Acinar Adenocarcinoma
9980,Epithelial Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
9981,Odontogenic Cysts,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
9982,Erythema,Multifocal superficial basal cell carcinoma
9983,Primary Lesion,AIDS-Related Primary Central Nervous System Lymphoma
9984,Neuroendocrine Differentiation,Childhood Thyroid Gland Medullary Carcinoma
9985,Low Mitotic Activity,Jejunal Neuroendocrine Tumor G1
9986,Neuroendocrine Differentiation,Stage IIA Merkel Cell Carcinoma AJCC v7
9987,Childhood Lesion,Benign Childhood Germ Cell Tumor
9988,Epithelial Component Present,carcinoma ex pleomorphic adenoma of salivary gland
9989,Cigarette Smoking Toxicity,Cigarette Smoking-Related Carcinoma
9990,Epithelial Component Present,Endometrial Carcinoma
9991,Follicular Cell Differentiation,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
9992,Epithelial Component Present,epithelial-myoepithelial carcinoma of lung
9993,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
9994,Epithelial Component Present,Childhood Lung Small Cell Carcinoma
9995,High Mitotic Activity,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
9996,Skin nodule,Skin Nodular Solid Basal Cell Carcinoma
9997,Endophytic Tumor Growth,Verrucous carcinoma of oral cavity
9998,Neuroectodermal Differentiation,Recurrent Primitive Neuroectodermal Tumor
9999,Carcinomatous Component Present,Carcinoma of sublingual gland
10000,Epithelial Component Present,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma
10001,Whorling Growth Pattern,"Dendritic Cell Sarcoma, Interdigitating"
10002,Carcinomatous Component Present,"Urinary bladder carcinoma stage I, with cancer in situ"
10003,Epithelial Component Present,tubulopapillary adenoma of extrahepatic bile duct
10004,Endophytic Tumor Growth,Inverted Papilloma
10005,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 3 Endometrial Endometrioid Adenocarcinoma
10006,Carcinomatous Component Present,Vulvar Eccrine Porocarcinoma
10007,Epithelial Component Present,Carcinoma of base of tongue
10008,Epithelial Component Present,Prostate cancer stage C
10009,Follicular Cell Differentiation,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
10010,Carcinomatous Component Present,Sarcomatoid Intrahepatic Cholangiocarcinoma
10011,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage III
10012,Hereditary Lesion,"Corneal Dystrophy, Juvenile Epithelial of Meesmann"
10013,Epithelial Component Present,Pancreatic carcinoma non-resectable
10014,Epithelial Component Present,Compact Cell Adrenal Cortical Adenoma
10015,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Carcinoma
10016,'Starry-sky' pattern,Stage III Adult Burkitt Lymphoma
10017,Unifocal Disease,Benign Mastocytoma
10018,Epithelial Component Present,Borderline Ovarian Serous Adenofibroma
10019,High Mitotic Activity,Malignant Testicular Leydig Cell Tumor
10020,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma refractory
10021,Adnexal Differentiation,Paget's disease of vulva
10022,Angiocentric Pattern,Grade III Lymphomatoid Granulomatosis
10023,Epithelial Component Present,Ovarian mixed epithelial carcinoma
10024,Local disease,benign lipoma of gallbladder
10025,Immunosuppression-Related Post-Transplant Toxicity,Acute GVH disease
10026,Carcinomatous Component Present,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
10027,Exophytic Papillary Lesion,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
10028,Epithelial Component Present,lipid-rich carcinoma of breast
10029,Epithelial Component Present,Stage IV Rectal Carcinoma
10030,Epithelial Component Present,Colon Carcinoma Metastatic in the Lung
10031,High Mitotic Activity,Stage IA Lung Small Cell Carcinoma AJCC v7
10032,Epithelial Component Present,undifferentiated carcinoma of liver
10033,Perineural spread,Adenoid cystic carcinoma of parotid gland
10034,Carcinomatous Component Present,Adenoid cystic carcinoma of parotid gland
10035,Nuclear Molding,Stage IIB Lung Small Cell Carcinoma AJCC v7
10036,Epithelial Component Present,Invasive Lobular Breast Carcinoma
10037,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of parotid gland
10038,Biphasic Pattern,Pleural Biphasic Mesothelioma
10039,Epithelial Component Present,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
10040,Neuroendocrine Differentiation,Pancreatic Vipoma
10041,More than 10 Mitoses per 10HPF,Stage II Lung Small Cell Carcinoma AJCC v7
10042,Vascular Channel Formation,Scrotal Hemangioma
10043,Neuroendocrine Differentiation,Small Intestinal VIP-Producing Neuroendocrine Tumor
10044,Neuroendocrine Differentiation,Stage III Lung Small Cell Carcinoma AJCC v7
10045,Vascular Channel Formation,Angiosarcoma non-metastatic
10046,Epithelial Component Present,Anterior Tongue Carcinoma
10047,Scattered Collections of Differentiating Neuroblasts Present,Maturing Ganglioneuroma
10048,Epithelial Component Present,Condyloma acuminata of vagina
10049,Leukoerythroblastic Reaction,Overt Primary Myelofibrosis
10050,Carcinomatous Component Present,Scrotal Carcinoma
10051,High Grade Lesion,combined small cell carcinoma of lung
10052,Mitotic Activity,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
10053,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myelomonocytic Leukemia
10054,Metastatic Lesion,Secondary malignant neoplasm of lung
10055,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, minimal differentiation"
10056,Resectable Mass,Resectable Malignant Liver Neoplasm
10057,Mixture of Germ Cell Neoplastic Components Present,Teratocarcinoma
10058,Proliferation of Follicular Dendritic Cells Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma
10059,Non-Hereditary Lesion,Gastric Intramucosal Adenocarcinoma
10060,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1
10061,Mixed Cellular Population,Adenocarcinoma with cartilaginous metaplasia
10062,Carcinomatous Component Present,Clear cell squamous cell carcinoma of skin
10063,Well-Circumscribed Lesion,Small Intestinal Tubular Adenoma
10064,Primary Lesion,Meningeal melanomatosis
10065,Extensive Stage Lesion,Advanced Adult Hepatocellular Carcinoma
10066,Generalized illness,Disseminated squamous cell carcinoma
10067,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
10068,Necrotic changes (finding),Childhood Glioblastoma
10069,Diffuse Pattern,Recurrent Grade III Lymphomatoid Granulomatosis
10070,Intermediate Grade Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm
10071,Acinar Cell Differentiation,Parotid Gland Acinic Cell Carcinoma
10072,Epithelial Component Present,Human Papillomavirus-Related Squamous Cell Carcinoma
10073,Severe dysplasia,Stage 0 Breast Cancer AJCC v6 and v7
10074,Immunologic Deficiency Syndromes,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
10075,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
10076,Epithelial Component Present,Human Papillomavirus-Related Adenocarcinoma
10077,Multinodular Mass,Radiation-Related Angiosarcoma
10078,Well-Circumscribed Lesion,Lipoblastoma
10079,Epithelial Component Present,Fallopian Tube Serous Neoplasm
10080,Indolent Clinical Course,Vulvar Angiomyxoma
10081,Primary Lesion,Childhood Giant Cell Glioblastoma
10082,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Adult Pure Erythroid Leukemia
10083,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma
10084,Desmoplastic Stroma Formation,"Adenocarcinoma, Scirrhous"
10085,Biphasic Pattern,Adenocarcinofibroma
10086,Absence of Stromal Invasion,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
10087,Epithelial Component Present,Malignant Intrathoracic Paravertebral Paraganglioma
10088,Cutaneous Involvement,Verrucous epidermal nevus
10089,Epithelial Component Present,Malignant carcinoid tumor of lung
10090,Mixed Cellular Population,Carcinosarcoma of ovary
10091,Pregnancy Complications,Infection of amniotic cavity
10092,Epithelial Component Present,Parathyroid Gland Lipoadenoma
10093,Neuroendocrine Differentiation,Benign neuroendocrine tumor
10094,Epithelial Component Present,Adenoid cystic breast carcinoma
10095,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP E"
10096,Cystic Change,Brenner Tumor
10097,Osseous Differentiation,Childhood Extraskeletal Osteosarcoma
10098,Epithelial Component Present,Sarcomatoid Carcinoma of the Penis
10099,Epithelial Component Present,Stage IVB Oropharyngeal Carcinoma AJCC v7
10100,Aggressive Clinical Course,Adult Burkitt Leukemia
10101,Epithelial Component Present,Ampulla of Vater Mucinous Adenocarcinoma
10102,Intestinal metaplasia,Intestinal Metaplasia of Bladder Urothelium
10103,High Mitotic Activity,Thymic Small Cell Carcinoma
10104,Neuroendocrine Differentiation,Thymic Small Cell Carcinoma
10105,Neuroendocrine Differentiation,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
10106,Epithelial Component Present,Cystic Oncocytic Neoplasm
10107,Adulthood Lesion,Adult Hepatocellular Carcinoma
10108,Exophytic Papillary Lesion,Condyloma acuminata of cervix
10109,Epithelial Component Present,carcinoma of pancreas with osteoclast-like giant cells
10110,Carcinomatous Component Present,Ductal Breast Carcinoma with Squamous Metaplasia
10111,Nuclear Atypia,Glioblastoma with Primitive Neuronal Component
10112,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Acute Megakaryocytic Leukemias
10113,Local disease,Mesothelioma malignant localized
10114,High Mitotic Activity,Malignant medulloepithelioma of ciliary body
10115,Aberrant Thyroid Tissue Present,Struma Ovarii
10116,Epithelial Component Present,Ureter Urothelial Papilloma
10117,Epithelial Component Present,"Transitional cell papilloma, benign"
10118,Antoni A Pattern,Neurilemmoma
10119,Myxoid Stroma Formation,Chordoma
10120,Alternative Fascicle (Bundle) Pattern,Ureter Leiomyoma
10121,Neuroendocrine Differentiation,small cell carcinoma of kidney
10122,Dysplasia,High Grade Anal Canal Squamous Intraepithelial Neoplasia
10123,Carcinomatous Component Present,Laryngeal Cancer by AJCC v6 Stage
10124,Carcinomatous Component Present,Stage IIA Lung Squamous Cell Carcinoma AJCC v7
10125,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v6
10126,Epithelial Component Present,Vaginal Mullerian Papilloma
10127,Epithelial Component Present,Stage II Vulvar Cancer AJCC v7
10128,Low Mitotic Activity,"Somatostatinoma, malignant"
10129,'Starry-sky' pattern,Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma
10130,Exophytic Polypoid Lesion,Adenomatous Polyps
10131,Diffuse Pattern,Childhood Mixed Glioma
10132,Infiltrating Tumor Margins Present,Malignant Vulvar Phyllodes Tumor
10133,Epithelial Component Present,"Carcinoma, Skin Appendage"
10134,Carcinomatous Component Present,Grade 3 Colon Adenocarcinoma
10135,Ischemia,Acute vascular insufficiency of intestine (disorder)
10136,Cutaneous Involvement,Carcinoma of anal margin
10137,Epithelial Component Present,Mesonephroma
10138,Epithelial Component Present,Esophageal dysplasia
10139,Epithelial Component Present,Paget's disease of penis
10140,Hyaline Cartilage Differentiation,Chondrosarcoma recurrent
10141,Diffuse Pattern,Adult Immunoblastic Lymphoma
10142,Epithelial Component Present,Nasopharyngeal Carcinoma by AJCC v6 Stage
10143,Neuroendocrine Differentiation,Gastric Neuroendocrine Tumor G2
10144,Indolent Clinical Course,Myxoma of the Endocardium
10145,Adulthood Lesion,Adult Brain Stem Glioma
10146,Confluent Sheets of Anaplastic T-Lymphocytes Present,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
10147,Epithelial Component Present,inverted ductal papilloma of salivary gland
10148,Cutaneous Involvement,Exacerbation of acne
10149,Epithelial Component Present,Hormone secreting pituitary neoplasms
10150,Epithelial Component Present,Digital papillary eccrine carcinoma of skin
10151,Metaplasia,Bladder squamous cell carcinoma stage IV
10152,Epithelial Component Present,Carcinoma bone
10153,Well-Circumscribed Lesion,Unclassified Hepatocellular Adenoma
10154,Carcinomatous Component Present,Invasive Prostate Carcinoma
10155,Solitary mass,Dedifferentiated chordoma
10156,Epithelial Component Present,Skin Clear Cell Basal Cell Carcinoma
10157,Cutaneous Involvement,Skin Clear Cell Basal Cell Carcinoma
10158,Neuroendocrine Differentiation,Apudoma
10159,Epithelial Component Present,Transitional cell carcinoma of ureter
10160,Carcinomatous Component Present,Papillary serous cystadenocarcinoma
10161,Mild dysplasia,Cervical intraepithelial neoplasia grade 1
10162,Immunologic Deficiency Syndromes,AIDS-Related Pelvic Inflammatory Disease
10163,Eosinophil count raised (finding),Chronic eosinophilic leukemia
10164,Recurrent disease,Colon cancer recurrent
10165,Exophytic Papillary Lesion,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
10166,Neuronal Differentiation,Medulloblastoma with extensive nodularity
10167,Osseous Differentiation,Extraskeletal osteosarcoma metastatic
10168,Biphasic Pattern,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm
10169,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma
10170,Epithelial Component Present,High Grade Gastric Intraepithelial Neoplasia
10171,Carcinomatous Component Present,Cervical Non-Keratinizing Squamous Cell Carcinoma
10172,Cutaneous Involvement,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C"
10173,Carcinomatous Component Present,Rectosigmoid cancer
10174,Epithelial Component Present,Carcinoma of Cowper Glands
10175,Carcinomatous Component Present,Stage I Vulvar Carcinoma
10176,Mixed Cellular Population,Serous adenofibroma
10177,Malignant Germinomatous Cellular Infiltrate,Germinomatous Germ Cell Tumor
10178,Epithelial Component Present,Carcinoma in situ of vagina
10179,Carcinomatous Component Present,"Carcinoma, diffuse type"
10180,Locally Aggressive Lesion,Polymorphus Hemangioendothelioma
10181,Adulthood Lesion,Adult Pineal Gland Astrocytoma
10182,Monomorphic Cellular Infiltrate,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
10183,Antoni A Pattern,Mediastinal Schwannoma
10184,Carcinomatous Component Present,Major Salivary Gland Adenoid Cystic Carcinoma
10185,High Grade Lesion,Gastric Synovial Sarcoma
10186,Vascular Channel Formation,Central Nervous System Kaposi Sarcoma
10187,Carcinomatous Component Present,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
10188,Fibrotic Stroma Formation,Uterine Corpus Carcinofibroma
10189,Anaplasia,Ki-1+ Anaplastic Large Cell Lymphoma
10190,Primary Lesion,Ethmoid Sinus Primary Ectopic Meningioma
10191,Epithelial Component Present,Stage IV Digestive System Neuroendocrine Tumor AJCC v7
10192,Invasive Lesion,"Dermatofibrosarcoma Protuberans, Myxoid"
10193,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage IV
10194,Recurrent disease,Recurrent Childhood Protoplasmic Astrocytoma
10195,Stromal Invasion,Ovarian adenocarcinoma
10196,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Gastric Teratoma
10197,Composite Lesion,Combined Thymic Epithelial Neoplasm
10198,High Mitotic Activity,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
10199,Oligodendroglial Component Present,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
10200,Fibrotic Stroma Formation,Signet Ring Cell Intrahepatic Cholangiocarcinoma
10201,Epithelial Component Present,Stage IV Bladder Cancer AJCC v7
10202,Ground Glass Nuclear Inclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
10203,Epithelial Component Present,Giant fibroadenoma of breast
10204,Epithelial Component Present,Stage IVA Colon Cancer AJCC v7
10205,Carcinomatous Component Present,Cholangiocarcinoma resectable
10206,Bone Marrow Dysplasia Present,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
10207,Increased Cellularity Present,Juxta-Articular Myxoma
10208,Systemic disease,Childhood Systemic Anaplastic Large Cell Lymphoma
10209,Carcinomatous Component Present,Stage IVA Appendix Carcinoma AJCC v7
10210,Cutaneous Involvement,Benign Eccrine Neoplasm
10211,Epithelial Component Present,Lung squamous cell carcinoma stage II
10212,Childhood Lesion,Childhood Meningioma
10213,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells
10214,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gestational Ovarian Choriocarcinoma
10215,Vascular Channel Formation,"Neoplasms, Vascular Tissue"
10216,Indolent Clinical Course,HIV lipodystrophy
10217,Epithelial Component Present,Ovarian Mucinous Carcinoid Tumor
10218,Carcinomatous Component Present,Stage IIIA Lung Cancer AJCC v7
10219,Epithelial Component Present,Thyroid Gland Follicular Adenoma
10220,Peripheral Nuclear Palisading,Combined Lung Small Cell and Squamous Cell Carcinoma
10221,Epithelial Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland
10222,Capillary Sized Vascular Channel Formation,Pyogenic granuloma of skin and subcutaneous tissue
10223,Childhood Lesion,Pediatric Intraocular Retinoblastoma
10224,Hyperkeratosis,verrucous carcinoma of vagina
10225,Benign Cellular Infiltrate,Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm
10226,Carcinomatous Component Present,Vaginal Large Cell Neuroendocrine Carcinoma
10227,Vascular Channel Formation,Childhood Angiosarcoma
10228,Villous Pattern,Cecum Villous Adenoma
10229,Well-Circumscribed Lesion,Ovarian Seromucinous Cystadenoma
10230,Radiation Sickness,Radiation-Related Non-Neoplastic Disorder
10231,Carcinomatous Component Present,Proximal Urethral Carcinoma
10232,Hyperplastic Epithelial Tissue Present,Atypical Ductal Breast Hyperplasia
10233,Cystic Change,Ovarian Clear Cell Cystadenocarcinoma
10234,Tissue Differentiation Uncertain,Cardiac Monophasic Synovial Sarcoma
10235,Carcinomatous Component Present,Well Differentiated Adrenal Cortex Carcinoma
10236,Spindle Cell Component Present,Lung Biphasic Synovial Sarcoma
10237,Cutaneous Involvement,Plantar wart
10238,Smooth Muscle Component Present,Multiple hamartoma of lung
10239,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrioid adenoma, borderline malignancy"
10240,Epithelial Component Present,Borderline Ovarian Endometrioid Cystadenofibroma
10241,Ground Glass Nuclear Inclusion,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
10242,Papillary Pattern,Cervical Warty Carcinoma
10243,Exophytic Papillary Lesion,Cervical Warty Carcinoma
10244,Carcinomatous Component Present,FIGO Stage IIIA1(ii) Ovarian Cancer
10245,Low Grade Lesion,Adult Epithelioid Hemangioendothelioma
10246,Cutaneous Involvement,Sarcoma of skin
10247,Cutaneous Involvement,Vulvar Seborrheic Keratosis
10248,Biphasic Pattern,Papillary adenofibroma
10249,Collagenous Stroma Formation,"Fibromatosis, Abdominal"
10250,Well-Circumscribed Lesion,Vulvar Fibroepithelial Stromal Polyp
10251,Cartilage-Like Elements Present,Clivus Chondroid Chordoma
10252,Necrotic changes (finding),Brain Stem Glioblastoma
10253,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7
10254,Epithelial Component Present,"Squamous cell carcinoma, large cell, nonkeratinizing"
10255,Mixture of Germ Cell Neoplastic Components Present,Childhood Ovarian Mixed Germ Cell Tumor
10256,Epithelial Component Present,Colorectal Squamous Cell Carcinoma
10257,Nodular lesions,Giant Cell Tumor of Soft Tissue
10258,Painless Mass,Giant Cell Tumor of Soft Tissue
10259,Microvascular Proliferation,"Glioblastoma, IDH-Wildtype"
10260,Epithelial Component Present,Vulvar Merkel Cell Carcinoma
10261,Epithelial Component Present,Gallbladder adenocarcinoma
10262,Mixed Cellular Population,Cellular Pleomorphic Adenoma
10263,Acanthosis,Melanoacanthoma
10264,Villous Projections of the Neoplastic Epithelium Present,Colorectal Filiform Serrated Adenoma
10265,Dilated Thin-Walled Vascular Space Formation,Vaginal Rhabdomyoma
10266,Recurrent disease,Recurrent Aggressive Adult Non-Hodgkin Lymphoma
10267,Epithelial Component Present,Stage IIC Colorectal Cancer AJCC v7
10268,Serrated Glandular Architecture,Colorectal Sessile Serrated Adenoma/Polyp
10269,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
10270,Epithelial Component Present,BCLC Stage 0 Adult Hepatocellular Carcinoma
10271,Adulthood Lesion,Adult Medulloblastoma
10272,Epithelial Component Present,Adenolymphoma
10273,Cystic Change,Adenolymphoma
10274,Carcinomatous Component Present,Stage IIIA Colorectal Cancer AJCC v7
10275,Spontaneous Regression,keratoacanthoma
10276,Carcinomatous Component Present,adenocarcinoma of gallbladder with squamous metaplasia
10277,Monomorphic Cellular Infiltrate,Cellular Ependymoma
10278,Non-Malignant Cellular Infiltrate,Histiocytic Necrotizing Lymphadenitis
10279,Childhood Lesion,Childhood Lymphoma
10280,Indolent Clinical Course,Fibroma of lung
10281,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma recurrent
10282,Epithelial Component Present,Endometrioid carcinoma of prostate
10283,Refractory Disease,Refractory Adult Acute Lymphoblastic Leukemia
10284,Carcinomatous Component Present,Undifferentiated carcinoma
10285,Indolent Clinical Course,Benign neoplasm of lymph vessels
10286,Epithelial Component Present,FIGO Stage II Ovarian Cancer
10287,Endophytic Tumor Growth,Inverting papilloma of the nasal cavity
10288,Cutaneous Involvement,Skin Basaloid Carcinoma
10289,High Mitotic Activity,Anaplastic adrenocortical carcinoma
10290,Tissue of Mullerian Origin Present,Uterine Corpus Adenofibroma
10291,Curvilinear Thin-Walled Vascular Pattern,Fibromyxosarcoma
10292,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7
10293,Epithelial Component Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
10294,Carcinomatous Component Present,Grade 1 Colorectal Adenocarcinoma
10295,Neuroendocrine Differentiation,Carcinoid Tumor
10296,Childhood Lesion,Childhood Central Nervous System Germinoma
10297,Diffuse Pattern,Lymphohistiocytoid Mesothelioma
10298,Cutaneous Involvement,Vulvar Lichen Sclerosus
10299,Secondary Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
10300,Neuroendocrine Differentiation,Pancreatic Somatostatinoma
10301,Carcinomatous Component Present,Stage IV Esophageal Cancer AJCC v7
10302,Cutaneous Involvement,Kaposi's sarcoma classical type
10303,Primary Lesion,Primary Effusion Lymphoma
10304,Myxoid Stroma Formation,Neurothekeoma
10305,Recurrent disease,Epithelioid sarcoma recurrent
10306,Fibrotic Stroma Formation,Pancreatic Well Differentiated Ductal Adenocarcinoma
10307,Epithelial Component Present,"Thymoma, type B1, malignant"
10308,Carcinomatous Component Present,apocrine adenocarcinoma of vulva
10309,Neuroectodermal Differentiation,Stage 2A Neuroblastoma
10310,Epithelial Component Present,Stage IVA Basal Cell Lip Carcinoma
10311,Indolent Clinical Course,Lymphangioendothelioma
10312,Fibrotic Stroma Formation,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
10313,Carcinomatous Component Present,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
10314,Presence of a Hormonal Syndrome,Malignant Pancreatic Somatostatinoma
10315,High Mitotic Activity,Stage IV Merkel Cell Carcinoma AJCC v7
10316,Carcinomatous Component Present,Stage IV Merkel Cell Carcinoma AJCC v7
10317,Tubular Structures Present,Ovarian Sertoli Cell Tumor
10318,Epithelial Component Present,Central Nervous System Carcinoma
10319,In Situ Lesion,Carcinoma in situ of ampulla of Vater
10320,Cytoplasmic Membrane-Bound Granules Present,Stage IIC Merkel Cell Carcinoma AJCC v7
10321,Secondary Lesion,Secondary malignant neoplasm of vulva
10322,Neuroendocrine Differentiation,Stage IIB Merkel Cell Carcinoma AJCC v7
10323,Well-Circumscribed Lesion,"Cystadenoma, Mucinous"
10324,Koilocytotic atypia,HPV positive oropharyngeal squamous cell carcinoma
10325,Adulthood Lesion,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
10326,Ground Glass Nuclear Inclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
10327,Calcitonin Positive Neoplastic Cells Present,Sporadic Thyroid Gland Micromedullary Carcinoma
10328,Epithelial Component Present,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
10329,HMB-45-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, benign"
10330,Perivascular Arrangement of Tumor Cells,"Perivascular epithelioid tumor, benign"
10331,Hemosiderin pigmentation,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
10332,Mild cytologic atypia,Lower Gingival Verrucous Carcinoma
10333,Immunologic Deficiency Syndromes,Infectious mononucleosis-like post-transplant lymphoproliferative disorder
10334,Keratin pearl formation,Acantholytic squamous cell carcinoma of skin
10335,Carcinomatous Component Present,Neuroendocrine cervical carcinoma
10336,Cystic Change,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm
10337,Myxoid Changes Present,Dermal nerve sheath myxoma
10338,Necrotic changes (finding),Diencephalic Glioblastoma
10339,Absence of Invasion,Skin Squamous Cell Carcinoma In Situ
10340,Well Differentiated Lesion,Laryngeal verrucous carcinoma
10341,Mucoid Stroma Formation,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
10342,Glial Differentiation,gliosarcoma
10343,Epithelial Component Present,Nasal cavity carcinoma
10344,High Plasma Renin Activity,Juxtaglomerular tumor
10345,Epithelial Component Present,Malignant Ovarian Surface Epithelial-Stromal Tumor
10346,High Mitotic Activity,large cell neuroendocrine carcinoma of appendix
10347,Epithelial Component Present,Multicentric Thyroid Gland Papillary Carcinoma
10348,Epithelial Component Present,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor
10349,Unresectable Mass,Unresectable Extrahepatic Bile Duct Carcinoma
10350,Cutaneous Involvement,Eccrine hidrocystoma
10351,Endophytic Tumor Growth,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
10352,Spontaneous Regression,"Retinoblastoma, spontaneously regressed"
10353,Invasive Lesion,Intramuscular lipoma
10354,Epithelial Component Present,Carcinoma of upper gum
10355,Epithelial Component Present,Neuroendocrine neoplasm of lung
10356,Osseous Differentiation,Secondary osteosarcoma
10357,High Grade Lesion,Secondary osteosarcoma
10358,Intracanalicular Growth Pattern,Benign Prostate Phyllodes Tumor
10359,Epithelial Component Present,Invasive Ductal and Lobular Carcinoma
10360,Invasive Lesion,Invasive Cutaneous Melanoma
10361,Diffuse Pattern,Glioblastoma
10362,Exophytic Polypoid Lesion,Colorectal Mucin Poor Hyperplastic Polyp
10363,Carcinomatous Component Present,Bladder adenocarcinoma stage III
10364,Epithelial Component Present,Islet Cell Tumor
10365,Exophytic Polypoid Lesion,Colorectal Tubulovillous Adenoma
10366,Invasive Lesion,Thymoma malignant invasive
10367,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Ovarian Choriocarcinoma
10368,Carcinomatous Component Present,Mucoepidermoid carcinoma of parotid gland
10369,High Grade Lesion,Synovial sarcoma metastatic
10370,Carcinomatous Component Present,Stage IIA Lung Small Cell Carcinoma AJCC v7
10371,Anaplasia,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
10372,Carcinomatous Component Present,Stage 0 Colon Cancer AJCC v6 and v7
10373,Diffuse Lesion,Recurrent respiratory papillomatosis
10374,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of peritoneum
10375,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
10376,NRBC - Nucleated red blood cell present result,Overt Primary Myelofibrosis
10377,Mixed Cellular Population,combined small cell carcinoma of lung
10378,Epithelial Component Present,Adenoma of lung
10379,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
10380,Nuclear Atypia,Atypical neurofibroma
10381,Poorly Differentiated Lesion,Esophageal Spindle Cell Carcinoma
10382,Neoplastic Plasma Cells Present in Bone Marrow,DS Stage II Plasma Cell Myeloma
10383,Superficial Lesion,Peyronie Disease
10384,In Situ Lesion,Intraepithelial Squamous Cell Carcinoma
10385,Sebaceous Differentiation,Ocular Sebaceous Carcinoma
10386,Lymphadenopathy,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
10387,Neoplastic Plasma Cells Present in Bone Marrow,Plasma cell myeloma refractory
10388,Carcinomatous Component Present,Prostate Basal Cell Carcinoma
10389,Neuroendocrine Differentiation,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation
10390,Papillary Pattern,Pancreatic Intraepithelial Neoplasia-1B
10391,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with Variant MLL Translocations
10392,High Mitotic Activity,small cell carcinoma of appendix
10393,Myxoid Stroma Formation,Skull Base Chordoma
10394,Edematous Stroma Formation,Superficial angiomyxoma
10395,Refractory Disease,Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
10396,Carcinomatous Component Present,Human Papillomavirus-Related Adenocarcinoma
10397,Blasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic-Myeloproliferative Diseases
10398,Epithelial Component Present,ENSAT Stage II Adrenal Cortex Carcinoma
10399,Diffuse Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor
10400,High Grade Lesion,embryonal rhabdomyosarcoma of orbit
10401,Dense Collagenized Tissue Present,Pleural Desmoplastic Mesothelioma
10402,Secondary Lesion,"Neoplasms, Unknown Primary"
10403,Pseudoglandular Pattern,Adult Central Nervous System Embryonal Carcinoma
10404,Epithelial Component Present,Cecum Carcinoma
10405,Regional Disease,Ureteric cancer regional
10406,Adnexal Differentiation,Sebaceous adenoma
10407,Mixed Cellular Population,Breast Phyllodes Tumor
10408,Adulthood Lesion,Adult Central Nervous System Choriocarcinoma
10409,Epithelial Component Present,Apocrine adenoma
10410,Villous Pattern,Villous adenoma of colon
10411,Hereditary Lesion,"Elliptocytosis, Hereditary"
10412,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor G1
10413,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor
10414,Metastatic/Recurrent Disease,Adult Epithelioid Sarcoma
10415,Epithelial Component Present,Benign Ovarian Serous Tumor
10416,Smooth Muscle Component Present,Hamartoma of lung
10417,Poorly Differentiated Lesion,Sarcomatoid Carcinoma of the Penis
10418,Cartilaginous Differentiation,Childhood Myxoid Chondrosarcoma
10419,Epithelial Component Present,Intrahepatic cholangiocarcinoma recurrent
10420,Carcinomatous Component Present,Ampulla of Vater Squamous Cell Carcinoma
10421,Epithelial Component Present,Bladder Urachal Carcinoma
10422,Dysplasia,Large Cell Dysplasia
10423,Hydropic degeneration,Uterine Corpus Hydropic Leiomyoma
10424,Carcinomatous Component Present,Bladder Urachal Urothelial Carcinoma
10425,Childhood Lesion,Calcifying Nested Epithelial Stromal Tumor of the Liver
10426,Carcinomatous Component Present,Recurrent Thyroid Carcinoma
10427,Adnexal Differentiation,Classic Type Trichilemmoma
10428,Slow Growing Mass,Ependymoma of spinal cord
10429,Recurrent Genetic Abnormalities Present,Hypergranular promyelocytic leukemia
10430,Dense Collagenized Tissue Present,Syringoma
10431,Epithelial Component Present,Laryngeal Cancer by AJCC v6 Stage
10432,CD30-Positive Neoplastic Cells Present,Common Variant Anaplastic Large Cell Lymphoma
10433,Splenomegaly,Splenic diffuse red pulp small B-cell lymphoma
10434,Intraluminal Tumor Growth,Giant Fibrovascular Esophageal Polyp
10435,Slow Growing Mass,Childhood Infratentorial Ependymoma
10436,Epithelial Component Present,Vaginal Tubulovillous Adenoma
10437,Carcinomatous Component Present,Stage IVC Oral Cavity Cancer AJCC v6 and v7
10438,Non-Invasive Lesion,Inverted papilloma of urinary bladder
10439,Epithelial Component Present,Luminal B Breast Carcinoma
10440,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v7
10441,Diffuse Pattern,Recurrent Childhood Gemistocytic Astrocytoma
10442,Angiocentric Pattern,Childhood Grade III Lymphomatoid Granulomatosis
10443,Endophytic Tumor Growth,Vulvar Keratoacanthoma
10444,Neuroendocrine Differentiation,Esophageal Neuroendocrine Carcinoma
10445,Epithelial Component Present,Acinar Cell Carcinoma
10446,Local disease,Localized Digestive System Neuroendocrine Tumor G1
10447,Epithelial Component Present,"Cystadenocarcinoma, Papillary"
10448,Carcinomatous Component Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
10449,Nodular Pattern,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic
10450,Peripheral Nuclear Palisading,Stage IV Lung Small Cell Carcinoma AJCC v7
10451,Biphasic Pattern,carcinosarcoma of salivary gland
10452,Lesion with Diameter Greater than 15mm,Medium/Large Size Posterior Uveal Melanoma
10453,Lymphadenopathy,Nodal marginal zone B-cell lymphoma recurrent
10454,Carcinomatous Component Present,adenosquamous carcinoma of ovary
10455,Well-Circumscribed Lesion,Adult Pleomorphic Rhabdomyosarcoma
10456,Adulthood Lesion,Stage IV Adult Lymphoblastic Lymphoma
10457,Childhood Lesion,Recurrent Childhood Burkitt Lymphoma
10458,Unicystic Lesion,intraductal papilloma of salivary gland
10459,Epithelial Component Present,Colorectal Villous Adenoma
10460,Indolent Clinical Course,Colorectal Leiomyoma
10461,Cutaneous Involvement,Mycosis fungoides stage IV
10462,Epithelial Component Present,Conjunctival intraepithelial neoplasia
10463,Collagenous Stroma Formation,Classic Congenital Mesoblastic Nephroma
10464,Indolent Clinical Course,Hemangioma of gingiva
10465,In Situ Lesion,Intraductal carcinoma and lobular carcinoma in situ
10466,Cauliflower-Like Mass,Lung Squamous Cell Papilloma
10467,Cystic Change,Vaginal Dermoid Cyst
10468,Epithelial Component Present,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7
10469,Carcinomatous Component Present,Colon cancer recurrent
10470,Carcinomatous Component Present,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
10471,Hemorrhagic,Angiosarcoma of spleen
10472,Lymphoplasmacytic Infiltrate,Recurrent Oropharyngeal Undifferentiated Carcinoma
10473,Fibrosis,"Breast Fibrocystic Change, Proliferative Type"
10474,Adulthood Lesion,Stage IB Adult Soft Tissue Sarcoma AJCC v7
10475,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage III
10476,Carcinomatous Component Present,Stage III Primary Peritoneal Cancer AJCC v7
10477,Benign Cellular Infiltrate,Benign Gastric Soft Tissue Neoplasm
10478,Well Differentiated Lesion,"Papillary squamous cell carcinoma, non-invasive"
10479,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Erythroleukemia (Erythroid/Myeloid)
10480,Glandular Differentiation,Gallbladder Goblet Cell Carcinoid
10481,Adnexal Differentiation,Malignant Hair Follicle Neoplasm
10482,Deep Lesion,Pelvic Fibromatosis
10483,Nuclear pleomorphism,Salivary duct carcinoma
10484,Fascicles of Spindly Tumor Cells Present,Tanycytic ependymoma
10485,Keratin pearl formation,Keratinizing Head and Neck Squamous Cell Carcinoma
10486,Carcinomatous Component Present,Carcinomatosis of peritoneal cavity
10487,Chromogranin A Positive Neoplastic Cells Present,Gastrointestinal Carcinoid Tumor
10488,Rapidly Enlarging Mass,Vaginal Rhabdomyosarcoma
10489,Indolent Clinical Course,Lymphangioma
10490,Chronic Inflammatory Infiltrate,Adult Grade III Lymphomatoid Granulomatosis
10491,Alternative Fascicle (Bundle) Pattern,Bladder Leiomyoma
10492,Cutaneous Involvement,Tumor of follicular infundibulum
10493,Epithelial Component Present,Parathyroid Gland Oncocytic Adenoma
10494,Low Mitotic Activity,Anal Canal Neuroendocrine Tumor G1
10495,Carcinomatous Component Present,FIGO Stage IC1 Ovarian Cancer
10496,Metastatic Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma
10497,Neuroendocrine Differentiation,Stage IV Digestive System Neuroendocrine Tumor AJCC v7
10498,Adulthood Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
10499,Glial Differentiation,Ganglioglioma
10500,Epithelial Component Present,Grade II Glandular Intraepithelial Neoplasia
10501,Hyperplastic Tissue Present,Columnar Cell Hyperplasia of the Breast
10502,Slow Growing Mass,Olfactory Neuroblastoma
10503,Epithelial Component Present,Stage IIIC Breast Cancer AJCC v6
10504,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Carcinoma
10505,Carcinomatous Component Present,Stage IVA Gallbladder Carcinoma
10506,Cutaneous Involvement,Dermatophytosis of groin and perianal area
10507,Epithelial Component Present,Blepharal carcinoma
10508,Recurrent disease,Mucoepidermoid carcinoma of the oral cavity recurrent
10509,Carcinomatous Component Present,ACTH-Producing Pituitary Gland Carcinoma
10510,Microcystic Change,Pilocytic astrocytoma of cerebellum
10511,Intraductal Lesion,Intraductal papillary breast neoplasm
10512,Vascular Channel Formation,"Hemangioma, Cavernous, Central Nervous System"
10513,Cutaneous Involvement,Aleukemic Monocytic Leukemia Cutis
10514,Tissue Differentiation Uncertain,Pleural Synovial Sarcoma
10515,Cutaneous Involvement,Cervical Blue Nevus
10516,Myxoid Stroma Formation,Chondroid chordoma
10517,Pushing Tumor Margin,Verrucous carcinoma
10518,Tissue Differentiation Uncertain,Ossifying fibromyxoid tumor
10519,Mesenchymal Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
10520,Adulthood Lesion,Adult Lymphoma
10521,Carcinomatous Component Present,Stage IA Lung Cancer AJCC v7
10522,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
10523,Epithelial Component Present,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7
10524,Childhood Lesion,Childhood Carcinoid Tumor
10525,Carcinomatous Component Present,Stage IIA Appendix Carcinoma AJCC v7
10526,Diffuse Pattern,Recurrent Childhood Oligoastrocytoma
10527,Carcinomatous Component Present,Stage III Colon Cancer
10528,High Grade Lesion,Mesenchymal Glioblastoma
10529,High Grade Lesion,Glioblastoma multiforme of spinal cord
10530,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
10531,Carcinomatous Component Present,Basophilic Adenocarcinoma
10532,Severe dysplasia,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
10533,Intraductal Lesion,papillomatosis of extrahepatic bile duct
10534,Epithelial Component Present,Rectal Cancer by AJCC v6 Stage
10535,Epithelial Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma
10536,Firm mass,Cardiac Malignant Peripheral Nerve Sheath Tumor
10537,Carcinomatous Component Present,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
10538,Trabecular Pattern,Well Differentiated Hepatocellular Carcinoma
10539,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v6 and v7
10540,Rare Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma
10541,Well-Circumscribed Lesion,Angiomyoma
10542,Benign Cellular Infiltrate,Benign Non-Epithelial Gallbladder Neoplasm
10543,Epithelial Component Present,Androgen-Producing Adrenal Cortex Adenoma
10544,Dysplasia,Stage 0 Ureter Cancer AJCC v7
10545,Epithelial Component Present,"Carcinoma, Small Cell"
10546,Benign Cellular Infiltrate,Benign neoplasm of colon
10547,Epithelial Component Present,Benign Brenner Tumor
10548,Epithelial Component Present,Laryngeal Squamous Cell Carcinoma
10549,Borderline Lesion,"Endometrioid adenoma, borderline malignancy"
10550,High Grade Lesion,Lung Monophasic Synovial Sarcoma
10551,Macrofollicular Structures Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
10552,Thick-Walled Hyalinized Vessels Present,Benign Esophageal Schwannoma
10553,Osteoid formation,Extraskeletal osteosarcoma recurrent
10554,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,MYELODYSPLASTIC SYNDROME
10555,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v7
10556,Vascular Channel Formation,Benign Cutaneous Vascular Neoplasm
10557,Mixed Cellular Population,Malignant Mixed Mesodermal (Mullerian) Tumor
10558,Epithelial Component Present,Stage IIIA Anal Canal Cancer AJCC v6 and v7
10559,Carcinomatous Component Present,Recurrent Merkel Cell Carcinoma
10560,Carcinomatous Component Present,Clear Cell Variant Thyroid Gland Papillary Carcinoma
10561,Nuclear Pseudoinclusion,Clear Cell Variant Thyroid Gland Papillary Carcinoma
10562,Neuroectodermal Differentiation,Kadish Stage B Olfactory Neuroblastoma
10563,Osteoid formation,Duodenal Extraskeletal Osteosarcoma
10564,Epithelial Component Present,Renal cell carcinoma recurrent
10565,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Homologous Type"
10566,Solitary mass,Childhood Epithelioid Hemangioendothelioma
10567,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with a Variant RARA Translocation
10568,Carcinomatous Component Present,Stage 0 Merkel Cell Carcinoma AJCC v7
10569,Cutaneous Involvement,Bullous Dermatitis
10570,High Mitotic Activity,Childhood Testicular Embryonal Carcinoma
10571,Adnexal Differentiation,External Auditory Canal Ceruminous Adenoma
10572,Cutaneous Involvement,"Xeroderma Pigmentosum, Complementation Group D"
10573,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage III Immature Testicular Teratoma AJCC v6 and v7
10574,Carcinomatous Component Present,Fallopian Tube Papillary Adenocarcinoma
10575,Epithelial Component Present,Uterine Ligament Serous Adenocarcinoma
10576,Infiltrative Growth Pattern,"Glioblastoma, IDH-Wildtype"
10577,Mitotic Activity,"Glioblastoma, IDH-Wildtype"
10578,Carcinomatous Component Present,"Gallbladder Adenocarcinoma, Biliary Type"
10579,Mixed Cellular Population,Anaplastic Oligoastrocytoma
10580,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage IV
10581,Childhood Lesion,Refractory Childhood Spinal Cord Neoplasm
10582,Epithelial Component Present,Uterine Ligament Endometrioid Adenocarcinoma
10583,Carcinomatous Component Present,Head and neck cancer metastatic
10584,Necrotic changes (finding),Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
10585,Nerve palsy,Facial Nerve Palsy Related to Trauma
10586,Mitotic Activity,Cerebral Glioblastoma
10587,Epithelial Component Present,Stage III Nasopharyngeal Carcinoma
10588,Slow Growing Mass,Cellular Ependymoma
10589,Epithelial Component Present,Metastatic non-small cell lung cancer
10590,Carcinomatous Component Present,small cell carcinoma of breast
10591,Nested Pattern,Ovarian gonadoblastoma
10592,Cystic Change,Pleuropulmonary blastoma type I
10593,Glomerular Hypertrophy,Chronic rejection of renal transplant
10594,Carcinomatous Component Present,Malignant neoplasm of stomach stage IV
10595,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
10596,Epithelial Component Present,Distal 1/3 of the Common Bile Duct Adenocarcinoma
10597,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma
10598,Slow Growing Mass,Giant Cell Angioblastoma
10599,Epithelial Component Present,small cell carcinoma of salivary gland
10600,Metastatic Lesion,Secondary malignant neoplasm of vagina
10601,Indolent Clinical Course,chondroma of lung
10602,Hyperkeratosis,Vulvar Inverted Follicular Keratosis
10603,Cutaneous Involvement,"Basal cell carcinoma, infundibulocystic"
10604,Epithelial Component Present,Cauda Equina Paraganglioma
10605,Cutaneous Involvement,Skin Mastocytoma
10606,Melanoma Cells Present,Breast Carcinoma with Melanotic Features
10607,Indolent Clinical Course,Congenital hemangioma
10608,Neuroendocrine Differentiation,Digestive System Neuroendocrine Neoplasm
10609,Adnexal Differentiation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
10610,Diffuse Pattern,Adult Brain Glioblastoma
10611,Lymphoplasmacytic Infiltrate,Calcifying Fibrous Pseudotumor
10612,Papillary Pattern,Sclerosing Breast Papilloma
10613,Hypercellular bone marrow,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
10614,Epithelial Component Present,Pedunculated conjunctival papilloma
10615,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
10616,Acute inflammation,Myxoinflammatory fibroblastic sarcoma
10617,Epithelial Component Present,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
10618,Well-Circumscribed Lesion,Rectal Sessile Serrated Adenoma/Polyp
10619,Papillary Pattern,Common wart
10620,Epithelial Component Present,Malignant Ovarian Mucinous Tumor
10621,Nuclear pleomorphism,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
10622,Cutaneous Involvement,Benign epithelial neoplasm of skin
10623,Indolent Clinical Course,Vaginal Angiomyofibroblastoma
10624,Lymphoplasmacytic Infiltrate,Nasopharyngeal Differentiated Carcinoma
10625,Cutaneous Involvement,Epithelial neoplasm of skin
10626,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v7
10627,Bead-Like Arrangement of Elastic Fibers,Elastofibroma
10628,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7
10629,Vascular Channel Formation,Lymphangioma of skin
10630,Hemorrhagic,Angiosarcoma recurrent
10631,Epithelial Component Present,Bladder transitional cell carcinoma stage IV
10632,Metastatic Lesion,Endometrial adenocarcinoma metastatic
10633,Carcinomatous Component Present,Paget Disease of the Anus
10634,Cutaneous Involvement,Head and Neck Nevus
10635,Alternative Fascicle (Bundle) Pattern,Liver Leiomyoma
10636,Biphasic Pattern,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
10637,Epithelial Component Present,Mixed Cell Adrenal Cortical Adenoma
10638,Carcinomatous Component Present,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
10639,Epithelial Component Present,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
10640,Papillary Pattern,Urethral Verrucous Carcinoma
10641,Cervical Glandular Dysplasia,High grade cervical glandular intraepithelial neoplasia
10642,Cutaneous Involvement,Plexiform fibrohistiocytic tumor
10643,Epithelial Component Present,Papilloma of buccal mucosa
10644,Carcinomatous Component Present,Adenoid cystic carcinoma of trachea
10645,Firm mass,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
10646,Melanosomes Present,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
10647,Hyperkeratosis,Verrucous carcinoma of oral cavity
10648,Secondary Lesion,Secondary malignant neoplasm of bone
10649,Recurrent disease,Hodgkin's disease mixed cellularity recurrent
10650,Storiform Growth Pattern,"Dendritic Cell Sarcoma, Follicular"
10651,Epithelial Component Present,Lip basal cell carcinoma
10652,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Grade 3 Endometrial Endometrioid Adenocarcinoma
10653,Epithelial Component Present,Subglottic Squamous Cell Carcinoma
10654,In Situ Lesion,Skin Squamous Cell Carcinoma In Situ
10655,Adnexal Differentiation,Vulvar Eccrine Porocarcinoma
10656,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant"
10657,Collagenous Stroma Formation,Benign mixed epithelial and stromal tumor of kidney
10658,Lymphoplasmacytic Infiltrate,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
10659,Carcinomatous Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
10660,Mitotic Activity,"Testicular Yolk Sac Tumor, Hepatoid Pattern"
10661,Chronic Inflammatory Infiltrate,Childhood Ovarian Dysgerminoma
10662,Epithelial Component Present,Stage II Eyelid Carcinoma AJCC v7
10663,Carcinomatous Component Present,Tobacco-Related Carcinoma
10664,Metastatic Lesion,Metastatic Signet Ring Cell Breast Carcinoma
10665,HER2/Neu Negative,Triple-Negative Breast Carcinoma
10666,Epithelial Component Present,Carcinoma of supraglottis
10667,Benign Cellular Infiltrate,Pancreatic Serous Adenoma
10668,Invasive Lesion,Squamous cell breast carcinoma
10669,Angiodestructive Pattern,Grade III Lymphomatoid Granulomatosis
10670,Severe dysplasia,Bladder adenocarcinoma stage 0
10671,Carcinomatous Component Present,Contralateral Breast Carcinoma
10672,High Grade Lesion,Radiation-Related Osteosarcoma
10673,Carcinomatous Component Present,Carcinoma of extrahepatic bile duct
10674,Epithelial Component Present,Bronchogenic Carcinoma
10675,Epithelial Component Present,Adenoma of large intestine
10676,Tubular Pattern,Colonic tubulovillous adenoma
10677,Well Differentiated Lesion,verrucous carcinoma of bladder
10678,Carcinomatous Component Present,Stage I Rectal Cancer AJCC v6 and v7
10679,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Ovarian Immature Teratoma
10680,Multifocal Multisystem Disease,Letterer-Siwe Disease
10681,Carcinomatous Component Present,Poorly Differentiated Hepatocellular Carcinoma
10682,High Grade Lesion,Poorly Differentiated Fibrosarcoma
10683,Cutaneous Involvement,Ductal Eccrine Carcinoma with Spindle Cell Elements
10684,Carcinomatous Component Present,Vaginal Keratinizing Squamous Cell Carcinoma
10685,Adnexal Differentiation,Ductal Eccrine Carcinoma with Squamous Metaplasia
10686,Nuclear Molding,Stage II Lung Small Cell Carcinoma AJCC v7
10687,Invasive Lesion,Adenocarcinoma of the prostate stage IV
10688,Papillary Pattern,papillary squamous cell carcinoma of larynx
10689,Epithelial Component Present,Large cell acanthoma
10690,Cutaneous Involvement,Large cell acanthoma
10691,Epithelial Component Present,Carcinoma in situ in a polyp
10692,Malignant Germinomatous Cellular Infiltrate,Germinoma
10693,Preserved Nuclear Polarity,Renal Pelvis Inverted Papilloma
10694,Carcinomatous Component Present,Stage IV Lip Basal Cell Carcinoma
10695,Epithelial Component Present,Transplant-Related Bladder Urothelial Carcinoma
10696,Epithelial Component Present,Urothelial cancer of renal pelvis
10697,Secondary Lesion,Secondary malignant neoplasm of mediastinum
10698,Epithelial Component Present,Gallbladder adenosquamous carcinoma
10699,Epithelial Component Present,Squamous cell carcinoma of rectum
10700,Multicentric Lesion,Multicentric Breast Carcinoma
10701,Antoni B Pattern,Acoustic Neuroma
10702,Indolent Clinical Course,Benign Smooth Muscle Neoplasm
10703,Exophytic Polypoid Lesion,Small Intestinal Villous Adenoma
10704,Recurrent disease,B-cell lymphoma recurrent
10705,Benign Cellular Infiltrate,Leiomyoma of small intestine
10706,Unresectable Mass,Unresectable Solid Neoplasm
10707,Refractory Disease,B-cell lymphoma refractory
10708,Multinodular Mass,Central Nervous System Angiosarcoma
10709,Epithelial Component Present,Inflammatory carcinoma of breast stage IV
10710,Exophytic Polypoid Lesion,Oropharyngeal Polyp
10711,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis
10712,Tubular Pattern,Small Intestinal Tubulovillous Adenoma
10713,Papillary Pattern,Gallbladder Papillary Adenoma
10714,Absence of Invasion,Lobular carcinoma in situ of breast
10715,Diffuse Pattern,Diffuse large B-cell lymphoma recurrent
10716,Ganglion Cell-Like Elements Present,Ampulla of Vater Gangliocytic Paraganglioma
10717,Well-Circumscribed Lesion,tubulopapillary adenoma of gallbladder
10718,Metaplasia,"Adenocarcinoma, intestinal type"
10719,Solitary mass,Chest Wall Solitary Plasmacytoma
10720,High Mitotic Activity,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
10721,Acanthosis,verrucous carcinoma of vulva
10722,Intestinal metaplasia of gastric mucosa,tubular adenoma of stomach
10723,Myxoid Stroma Formation,Vulvar Superficial Angiomyxoma
10724,Invasive Lesion,Mucinous carcinoma of breast
10725,Neuroendocrine Differentiation,Extra-Adrenal Retroperitoneal Paraganglioma
10726,Epithelial Component Present,Appendix Tubular Carcinoid
10727,Epithelial Component Present,Lung Mucous Gland Adenoma
10728,Epithelial Component Present,Stage IIB Breast Carcinoma
10729,Diffuse Pattern,Stage IV Diffuse Large B-Cell Lymphoma
10730,In Situ Lesion,Stage 0 Pancreatic Cancer AJCC v6 and v7
10731,Necrotic changes (finding),Intraocular Malignant Peripheral Nerve Sheath Tumor
10732,Carcinomatous Component Present,Anaplastic thyroid carcinoma
10733,Cutaneous Involvement,Cutaneous Precursor Lymphoid Neoplasm
10734,Secondary Lesion,Osteosarcoma Arising in Paget Disease of Bone
10735,Epithelial Component Present,Common wart
10736,Indolent Clinical Course,Myolipoma
10737,Epithelial Component Present,Benign neuroendocrine tumor
10738,Lytic lesion,Cranial Nodular Fasciitis
10739,Cystic Change,Adult cystic teratoma
10740,Exophytic Papillary Lesion,Urethral Condyloma Acuminatum
10741,Hemorrhagic,Uterine Corpus Apoplectic Leiomyoma
10742,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Carcinoma
10743,Epithelial Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v7
10744,Epithelial Component Present,Ampulla of Vater Intestinal-Type Adenocarcinoma
10745,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Myxoid Leiomyoma
10746,Epithelial Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7
10747,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Carcinoma, Endometrioid"
10748,Epithelial Component Present,Seborrheic keratosis of eyelid
10749,Metastatic/Recurrent Disease,"Sarcoma, Epithelioid"
10750,Serotonin Positive Neoplastic Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
10751,Pseudopapillary Pattern,Ovarian Embryonal Carcinoma
10752,Infiltrative Growth Pattern,Glioblastoma
10753,Exophytic Polypoid Lesion,Frontal sinus polyp
10754,HMB-45-Positive Neoplastic Cells Present,Epithelioid Type Angiomyolipoma
10755,Intraosseous Lesion,Ossifying Fibroma
10756,Childhood Lesion,Childhood Alveolar Rhabdomyosarcoma
10757,Papillary Pattern,Parotid Gland Warthin Tumor
10758,Solitary mass,Chordoma
10759,Epithelial Component Present,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
10760,Exophytic Papillary Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
10761,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monoblastic and Monocytic Leukemia
10762,Microcystic Change,Childhood Protoplasmic Astrocytoma
10763,Low Cellularity Present,Childhood Protoplasmic Astrocytoma
10764,Nuclei of Various Sizes and Shapes Present,Lobular Neoplasia Type B
10765,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of the prostate
10766,Indolent Clinical Course,Ovarian Myxoma
10767,High Mitotic Activity,Undifferentiated Stromal Sarcoma
10768,Epithelial Component Present,Aflatoxins-Related Hepatocellular Carcinoma
10769,Papillary Pattern,Bladder Papillary Urothelial Neoplasm
10770,Dysplasia,Intestinal Intraepithelial Neoplasia
10771,Epithelial Component Present,small cell carcinoma of larynx
10772,Comedo Necrosis,Rectal Cribriform Comedo-Type Adenocarcinoma
10773,Tubular Pattern,"Somatostatinoma, malignant"
10774,Papillary Pattern,Bladder Urothelial Papilloma
10775,Anaplasia,Anaplastic small cell lymphoma
10776,Well Differentiated Lesion,Grade 1 Rectal Adenocarcinoma
10777,Hyperplastic Tissue Present,Neuroendocrine cell hyperplasia of infancy
10778,Low Mitotic Activity,Intestinal Neuroendocrine Tumor
10779,Carcinomatous Component Present,Normal Breast-Like Subtype of Breast Carcinoma
10780,Absence of Stromal Invasion,Borderline Ovarian Endometrioid Adenofibroma
10781,Tubular Pattern,Ampulla of Vater Tubulovillous Adenoma
10782,Tubular Structures Present,Ovarian gynandroblastoma
10783,Cystic Change,Dermoid cyst of skin
10784,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myeloid leukemia with multilineage dysplasia
10785,Epithelial Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)
10786,Epithelial Component Present,Peripheral Breast Papilloma
10787,High Grade Lesion,Spindle Cell/Sclerosing Rhabdomyosarcoma
10788,Recurrent disease,Recurrent Childhood Giant Cell Glioblastoma
10789,Metastatic Lesion,Secondary malignant neoplasm of neck
10790,Carcinomatous Component Present,Stage IV Bladder Cancer AJCC v6
10791,Tubular Structures Present,Benign Sertoli Cell Tumor
10792,Epithelial Component Present,Carcinoma of anal margin
10793,Recurrent disease,Bladder adenocarcinoma recurrent
10794,Cartilaginous Differentiation,Grade I Chondrosarcoma
10795,Low Mitotic Activity,Duodenal Gastrin-Producing Neuroendocrine Tumor
10796,Dermal Involvement,Classical Poroma
10797,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,adenosquamous carcinoma of ovary
10798,Squamous Differentiation,adenosquamous carcinoma of ovary
10799,Biphasic Pattern,sialadenoma papilliferum of salivary gland
10800,Moderately Differentiated Lesion,Esophageal Moderately Differentiated Squamous Cell Carcinoma
10801,Immunologic Deficiency Syndromes,AIDS-Related Herpes Zoster
10802,Diffuse Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor
10803,Indolent Clinical Course,Cardiac fibroma
10804,Mesenchymal Component Present,Nephrogenic adenofibroma
10805,Epithelial Component Present,Nephrogenic adenofibroma
10806,Carcinomatous Component Present,Nonencapsulated sclerosing tumor
10807,Benign Cellular Infiltrate,lipoma of large intestine
10808,Cartilaginous Differentiation,Enchondromatosis
10809,Absence of Invasion,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
10810,Epithelial Component Present,Breast Carcinoma with Osseous Metaplasia
10811,Alternative Fascicle (Bundle) Pattern,Oral Cavity Leiomyoma
10812,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of the duodenum
10813,Carcinomatous Component Present,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7
10814,Polymorphic Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis
10815,Epithelial Component Present,Stage IIIB Adult Liver Cancer AJCC v7
10816,Epithelial Component Present,Intraductal papillary adenocarcinoma with invasion
10817,High Grade Lesion,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation
10818,Lymphoplasmacytic Infiltrate,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
10819,Neuroendocrine Differentiation,Small Intestinal Gangliocytic Paraganglioma
10820,Exophytic Papillary Lesion,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
10821,Adulthood Lesion,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma
10822,Extraosseous Lesion,Extraskeletal osteosarcoma non-metastatic
10823,Monomorphic Cellular Infiltrate,Cervical Basaloid Carcinoma
10824,Metastatic/Recurrent Disease,Childhood Alveolar Soft Part Sarcoma
10825,Childhood Lesion,Childhood Rhabdomyosarcoma
10826,Dense Intercellular Reticulin Network Present,Desmoplastic Medulloblastoma
10827,Epithelial Component Present,Stage I Vaginal Cancer AJCC v6 and v7
10828,Intraductal Lesion,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
10829,Indolent Clinical Course,Breast Capillary Hemangioma
10830,Cartilaginous Differentiation,Primary chondrosarcoma of bone
10831,Papillary Pattern,verrucous carcinoma of esophagus
10832,Endophytic Tumor Growth,Sphenoid Sinus Inverted Papilloma
10833,HMB-45-Positive Neoplastic Cells Present,Uterine Corpus PEComa
10834,Lesion with Diameter Greater than 2cm,Cementoma
10835,Cutaneous Involvement,Lymphangioleiomyomatosis of skin
10836,Nodular lesions,Thyroid Gland Hyperfunctioning Adenoma
10837,Epithelial Component Present,Pilomatrixoma
10838,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
10839,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
10840,Bone Marrow Dysplasia Present,Refractory anemia with excess blasts I
10841,In Situ Lesion,Stage 0 Appendix Carcinoma AJCC v7
10842,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts II
10843,Vascular Channel Formation,Hemangioendothelioma
10844,Secondary Lesion,Breast Carcinoma Metastatic in the Bone
10845,Cystic Change,Gallbladder Mucinous Cystic Neoplasm
10846,Carcinomatous Component Present,Type II Endometrial Adenocarcinoma
10847,Invasive Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans
10848,Alternative Fascicle (Bundle) Pattern,Cutaneous leiomyoma
10849,Stable Disease,Indolent multiple myeloma
10850,Gastrin Positive Neoplastic Cells Present,malignant gastrinoma of pancreas
10851,Low Mitotic Activity,Low Grade Endometrial Stromal Sarcoma
10852,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma
10853,Epithelial Component Present,TSH-Producing Pituitary Gland Carcinoma
10854,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Endometrioid Tumor
10855,Epithelial Component Present,Ovarian Endometrioid Tumor
10856,Well-Circumscribed Lesion,Cortisol-Producing Adrenal Cortex Adenoma
10857,Carcinomatous Component Present,"Carcinoma, Large Cell"
10858,Whorling Growth Pattern,Low-grade fibromyxoid sarcoma
10859,Dysplasia,Cervical Intraepithelial Neoplasia
10860,Metaplasia of Malignant Cells Present,Adenocarcinoma with spindle cell metaplasia
10861,Low Grade Lesion,Low Grade Fallopian Tube Serous Adenocarcinoma
10862,Carcinomatous Component Present,Stage IV Distal Bile Duct Cancer AJCC v7
10863,Cutaneous Involvement,Primary Cutaneous Intravascular Large B-Cell Lymphoma
10864,Malignant Component Present,Ovarian Dermoid Cyst with Angiosarcoma
10865,Childhood Lesion,Recurrent Childhood Oligodendroglioma
10866,Secondary Lesion,Secondary malignant neoplasm of epididymis
10867,Well-Circumscribed Lesion,adenoma of extrahepatic bile duct
10868,Osseous Differentiation,Synchronous Multifocal Osteosarcoma
10869,Parakeratinized Stratified Squamous Epithelium Present,Keratocystic Odontogenic Tumor
10870,Neuroectodermal Differentiation,Childhood Ganglioneuroblastoma
10871,Epithelial Component Present,Oropharyngeal Poorly Differentiated Carcinoma
10872,Cutaneous Involvement,Grade 3 Cutaneous Follicular Lymphoma
10873,Exophytic Polypoid Lesion,adenoma of intrahepatic bile duct
10874,Antoni A Pattern,Pleural Schwannoma
10875,Epithelial Component Present,Sweat Gland Tubular Carcinoma
10876,Indolent Clinical Course,Pyogenic granuloma of skin and subcutaneous tissue
10877,Cutaneous Involvement,Pemphigoid Gestationis
10878,Hereditary Lesion,Basal Cell Nevus Syndrome
10879,Adulthood Lesion,Adult T-Cell Lymphoma/Leukemia
10880,Epithelial Component Present,Parotid Gland Carcinoma
10881,Severe dysplasia,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8"
10882,Cystic Change,Hard Palate Mucoepidermoid Carcinoma
10883,Carcinomatous Component Present,Clear cell adenocarcinoma of ovary
10884,Mixed Cellular Population,Borderline Ovarian Endometrioid Cystadenofibroma
10885,Extraosseous Lesion,Extraskeletal osteosarcoma recurrent
10886,Adulthood Lesion,Localized Non-Resectable Adult Liver Carcinoma
10887,Primary Lesion,Primary Carcinoma Unspecified Site
10888,Carcinomatous Component Present,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
10889,atypia morphology,Recurrent Adult Grade III Lymphomatoid Granulomatosis
10890,Monomorphic Cellular Infiltrate,Recurrent Adult Grade III Lymphomatoid Granulomatosis
10891,Nuclear pleomorphism,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder
10892,Sarcomatous Component Present,Testicular Spermatocytic Seminoma with Sarcoma
10893,Pregnancy Complications,Pre-Eclampsia
10894,Myomatous Stroma Formation,Uterine Corpus Atypical Polypoid Adenomyoma
10895,Gastrin Positive Neoplastic Cells Present,Gastric Gastrin-Producing Neuroendocrine Tumor
10896,Perivascular Arrangement of Tumor Cells,Myofibromatosis
10897,Mitotic Activity,"Testicular Yolk Sac Tumor, Solid Pattern"
10898,Mesenchymal Component Present,Fibroadenoma of breast
10899,Epithelial Component Present,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
10900,Abnormal alveolar pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
10901,Carcinomatous Component Present,Bartholin Gland Adenoid Cystic Carcinoma
10902,Multifocal Lesion,Multiple Endocrine Neoplasia
10903,atypia morphology,Atypical fibroxanthoma - spindle cell type
10904,Tubular Structures Present,"Gallbladder Adenocarcinoma, Biliary Type"
10905,Indolent Clinical Course,calcifying aponeurotic fibroma
10906,Calcinosis,calcifying aponeurotic fibroma
10907,Slow Growing Mass,Adult Pineocytoma
10908,Mitotic Activity,Giant Cell Glioblastoma
10909,Cutaneous Involvement,Stage I Skin Cancer
10910,Acanthosis,Buschke-Lowenstein Tumor
10911,Epithelial Component Present,Giant cell carcinoma of lung
10912,Childhood Lesion,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma
10913,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
10914,Epithelial Component Present,Stage III Anal Canal Cancer AJCC v6 and v7
10915,Epithelial Component Present,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
10916,Carcinomatous Component Present,Hepatoid adenocarcinoma
10917,High Mitotic Activity,"Leydig cell tumor, malignant"
10918,Mixed Cellular Population,Carcinosarcoma
10919,Villous Pattern,"Adenoma, Villous"
10920,Favorable Clinical Outcome,Ganglioneuromatosis
10921,Carcinomatous Component Present,Oropharyngeal cancer recurrent
10922,Slow Growing Mass,Vertebral chordoma
10923,Lobulated Growth Pattern,chondroma of lung
10924,Chronic Inflammatory Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7
10925,Cutaneous Involvement,Pityriasis Lichenoides
10926,Indolent Clinical Course,Hibernoma
10927,Childhood Lesion,Stage III Childhood Hodgkin Lymphoma
10928,Inflammatory infiltrate,Malignant tenosynovial giant cell tumor
10929,Well-Circumscribed Lesion,Calcifying Fibrous Pseudotumor
10930,Papillary Pattern,Anal Papillary Hidradenoma
10931,Cystic Change,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
10932,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor G1
10933,Carcinomatous Component Present,Stage I Gastric Carcinoma
10934,Osseous Differentiation,Childhood Conventional Osteosarcoma
10935,Cutaneous Involvement,Neoplasm of scrotum
10936,Pseudoglandular Pattern,"Testicular Seminoma, Pseudoglandular Variant"
10937,Low Grade Lesion,Myxoinflammatory fibroblastic sarcoma
10938,Severe dysplasia,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
10939,Metastatic Lesion,Secondary malignant neoplasm of prostate
10940,Epithelial Component Present,High Grade Salivary Gland Carcinoma
10941,Recurrent disease,Recurrent Childhood Brain Neoplasm
10942,Cutaneous Involvement,Vulvar Sebaceous Carcinoma
10943,Single Cell Necrosis,Stage IV Merkel Cell Carcinoma AJCC v7
10944,CD30-Positive Neoplastic Cells Present,Stage III Anaplastic Large Cell Lymphoma
10945,Epithelial Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
10946,Swelling,mesenchymal chondrosarcoma of bone
10947,High Mitotic Activity,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
10948,Metastatic Lesion,Secondary malignant neoplasm of vulva
10949,Localized Lesion,Plasmacytoma
10950,Carcinomatous Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7
10951,Vascular Channel Formation,Hemangioma acquired
10952,Hereditary Lesion,MUTYH-Associate Polyposis
10953,Borderline Lesion,Borderline Ovarian Clear Cell Cystadenofibroma
10954,Peripheral Nuclear Palisading,Childhood Lung Small Cell Carcinoma
10955,Childhood Lesion,Childhood Hodgkin Lymphoma
10956,Bone Marrow Dysplasia Present,Refractory Neutropenia
10957,Juvenile Lesion,Juvenile Type Testicular Granulosa Cell Tumor
10958,Recurrent disease,Recurrent Primitive Neuroectodermal Tumor
10959,Hyalinized Stroma Formation,Intraneural perineurioma
10960,Epithelial Component Present,Colorectal Low Grade Intraepithelial Neoplasia
10961,Perivascular Arrangement of Tumor Cells,"Perivascular epithelioid tumor, malignant"
10962,High Mitotic Activity,Malignant Testicular Sex Cord-Stromal Tumor
10963,Epithelial Component Present,Colorectal High Grade Intraepithelial Neoplasia
10964,Epithelial Component Present,canalicular adenoma of salivary gland
10965,Canalicular Pattern,canalicular adenoma of salivary gland
10966,Intraductal Lesion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
10967,Carcinomatous Component Present,Grade 3 Endometrial Endometrioid Adenocarcinoma
10968,Diffuse Pattern,Diencephalic Glioblastoma
10969,Recurrent disease,Recurrent Hematologic Malignancy
10970,Epithelial Component Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
10971,Carcinomatous Component Present,Glottis Verrucous Carcinoma
10972,Chronic Inflammatory Infiltrate,benign fibrous histiocytoma of bone
10973,Indolent Clinical Course,Angiomyofibroblastoma
10974,Geographic Necrosis,Extragonadal primary embryonal carcinoma
10975,Mesenchymal Component Present,Malignant phyllodes tumor of breast
10976,atypia morphology,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor
10977,Carcinomatous Component Present,Bartholin's gland carcinoma
10978,Epithelial Component Present,Oncocytic Neoplasm
10979,Primary Lesion,Intracortical osteosarcoma
10980,Pushing Tumor Margin,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
10981,Carcinomatous Component Present,Colon Adenosquamous Carcinoma
10982,Carcinomatous Component Present,carcinosarcoma of lung
10983,Intracanalicular Growth Pattern,Malignant Phyllodes Tumor of Prostate
10984,Carcinomatous Component Present,Large cell lung cancer stage II
10985,Low Mitotic Activity,Colorectal Neuroendocrine Tumor
10986,Exophytic Polypoid Lesion,Colon Serrated Polyposis
10987,Well-Circumscribed Lesion,Esophageal squamous papilloma
10988,Carcinomatous Component Present,Cervical Adenocarcinoma
10989,Adnexal Differentiation,Piloleiomyoma
10990,Cystic Change,Nipple Syringomatous Adenoma
10991,Microvascular Proliferation,Glioblastoma
10992,Squamous metaplasia of bladder,verrucous carcinoma of bladder
10993,Non-Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
10994,Chromogranin A Positive Neoplastic Cells Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
10995,Dysplasia,Colorectal Tubulovillous Adenoma
10996,Carcinomatous Component Present,Esophageal squamous cell carcinoma recurrent
10997,High Grade Lesion,Stage IA Lung Small Cell Carcinoma AJCC v7
10998,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
10999,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
11000,More than 10 Mitoses per 10HPF,Stage IB Lung Small Cell Carcinoma AJCC v7
11001,Epithelial Component Present,Stage IIA Lung Adenosquamous Carcinoma AJCC v7
11002,Tubular Pattern,Rectal Tubular Adenoma
11003,Metastatic Lesion,Secondary malignant neoplasm of vertebral column
11004,Secondary Lesion,Secondary malignant neoplasm of vertebral column
11005,Invasive Lesion,Invasive Lobular Breast Carcinoma
11006,Indolent Clinical Course,Giant cell angiofibroma
11007,Nuclear Molding,Stage IIA Lung Small Cell Carcinoma AJCC v7
11008,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
11009,Metastatic Lesion,Small intestine carcinoma metastatic
11010,Carcinomatous Component Present,Tubular breast carcinoma
11011,Absence of Invasion,Stage 0 Colon Cancer AJCC v6 and v7
11012,Epithelial Component Present,squamous cell carcinoma of the thyroid gland
11013,Epithelial Component Present,Borderline Fallopian Tube Mucinous Tumor
11014,Secondary Lesion,Secondary malignant neoplasm of female breast
11015,Secondary Lesion,Secondary malignant neoplasm of lung
11016,Epithelial Component Present,Bladder transitional cell carcinoma stage 0
11017,Glial Differentiation,Dysembryoplastic neuroepithelial tumor
11018,Eosinophilic inflammation,Central Nervous System Inflammatory Myofibroblastic Tumor
11019,Non-Invasive Lesion,Urethral Urothelial Papilloma
11020,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
11021,Neoplastic Plasma Cells Present in Bone Marrow,DS Stage III Plasma Cell Myeloma
11022,Hemorrhagic,Central Nervous System Angiosarcoma
11023,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant"
11024,Somatostatin Positive Neoplastic Cells Present,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
11025,Monoclonal Cellular Population Present,Thyroid Gland Signet Ring Cell Follicular Adenoma
11026,Dysplasia,Lobular carcinoma in situ of breast
11027,Childhood Lesion,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation
11028,Immunosuppression-Related Post-Transplant Toxicity,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
11029,Nodular Pattern,Distal-Type Epithelioid Sarcoma
11030,Severe cytologic atypia,small cell carcinoma of appendix
11031,Glandular Pattern,intestinal type adenocarcinoma of gallbladder
11032,Intraductal Lesion,Intraductal Cribriform Breast Adenocarcinoma
11033,Nuclear Atypia,Childhood Fibrillary Astrocytoma
11034,Epithelial Component Present,Minor Salivary Gland Acinic Cell Carcinoma
11035,Unclassifiable Lesion,"Peripheral T-Cell Lymphoma, Unclassifiable"
11036,Epithelial Component Present,clear cell adenocarcinoma of gallbladder
11037,Perineural spread,Adenoid cystic carcinoma of salivary gland
11038,In Situ Lesion,Carcinoma in situ of prostate
11039,CD56-Positive Neoplastic Cells Present,"NK-Cell Lymphoma, Unclassifiable"
11040,Carcinomatous Component Present,Stage IIB Colon Cancer AJCC v7
11041,Epithelial Component Present,Lung Typical Carcinoid Tumor
11042,Biphasic Pattern,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm
11043,Chronic Inflammatory Infiltrate,Inflammatory liposarcoma
11044,Increased Cellularity Present,Uterine Corpus Cellular Leiomyoma
11045,Well Differentiated Hyaline Cartilage Present,Childhood Mesenchymal Chondrosarcoma
11046,Carcinomatous Component Present,undifferentiated carcinoma of urethra
11047,Carcinomatous Component Present,Stage IIIB Esophageal Adenocarcinoma AJCC v7
11048,Adulthood Lesion,Adult Central Nervous System Teratoma
11049,Carcinomatous Component Present,Ovarian Cystadenocarcinoma
11050,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7
11051,Adulthood Lesion,Stage III Adult Non-Hodgkin Lymphoma
11052,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
11053,Vascular Channel Formation,Liver Cavernous Hemangioma
11054,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor
11055,Cystic Change,Lung Mucinous Cystadenoma
11056,Glandular Pattern,Ampulla of Vater Intestinal-Type Adenocarcinoma
11057,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma
11058,Chronic Inflammatory Infiltrate,Dysgerminoma of ovary
11059,Borderline Lesion,"Phyllodes tumor, borderline"
11060,Carcinomatous Component Present,Cervical Villoglandular Adenocarcinoma
11061,Epithelial Component Present,Colloid Carcinoma of the Pancreas
11062,Epithelial Component Present,Ovarian Cancer by AJCC v6 and v7 Stage
11063,Geographic Necrosis,Ovarian Embryonal Carcinoma
11064,Carcinomatous Component Present,Stage IIB Esophageal Carcinoma
11065,Sebaceous Differentiation,sebaceous adenoma of salivary gland
11066,Myxoid Stroma Formation,Classic Rhabdomyoma
11067,Dysplasia,Colorectal Adenoma with Severe Dysplasia
11068,Firm mass,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
11069,High Mitotic Activity,Large cell neuroendocrine carcinoma
11070,Carcinomatous Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
11071,Secondary Lesion,Therapy-related acute myeloid leukemia and myelodysplastic syndrome
11072,Neuroendocrine Differentiation,Neuroendocrine neoplasm of larynx
11073,Well-Circumscribed Lesion,Recurrent Kidney Wilms Tumor
11074,Anaplasia,Common Variant Anaplastic Large Cell Lymphoma
11075,Refractory Disease,Refractory Hodgkin Lymphoma
11076,Epithelial Component Present,Intraepithelial Neoplasia in Barrett Esophagus
11077,Carcinomatous Component Present,Stage 0a Urethral Cancer AJCC v7
11078,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic syndrome, no ICD-O subtype"
11079,Undifferentiated Lesion,undifferentiated sarcoma of ovary
11080,Epithelial Component Present,Mucinous adenocarcinoma gastric
11081,Non-Invasive Lesion,"Ampullary Flat Intraepithelial Neoplasia, High Grade"
11082,Indolent Clinical Course,Subglottic Hemangioma
11083,Neuroendocrine Differentiation,insulinoma
11084,Recurrent disease,Recurrent Childhood Diffuse Astrocytoma
11085,Epithelial Component Present,"Adenocarcinoma, Tubular"
11086,Neuroendocrine Differentiation,Esophageal Neuroendocrine Tumor
11087,HMB-45-Positive Neoplastic Cells Present,Childhood Kidney Angiomyolipoma
11088,Adulthood Lesion,Stage I Adult Non-Hodgkin Lymphoma
11089,Epithelial Component Present,Metastatic Carcinoma in the Liver
11090,Dysplasia,Ampulla of Vater Tubulovillous Adenoma
11091,Adulthood Lesion,Stage IIIC Adult Liver Cancer AJCC v7
11092,Carcinomatous Component Present,Fibrolamellar Hepatocellular Carcinoma
11093,Spontaneous Regression,Vulvar Keratoacanthoma
11094,Carcinomatous Component Present,Esophageal Neuroendocrine Carcinoma
11095,Rapidly Enlarging Mass,Sclerosing rhabdomyosarcoma
11096,Hereditary Lesion,Von Hippel-Lindau Syndrome
11097,Dysplasia,Intermediate Grade Ductal Breast Carcinoma In Situ
11098,Epithelial Component Present,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor
11099,Carcinomatous Component Present,Bile duct cancer resectable
11100,Carcinomatous Component Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
11101,Insular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor
11102,Epithelial Component Present,Duodenal Gastrin-Producing Neuroendocrine Tumor
11103,Neuroendocrine Differentiation,Carcinoid tumor of intestine
11104,Immunologic Deficiency Syndromes,Immunodeficiency-Related Disorder
11105,Epithelial Component Present,Gastric Neuroendocrine Tumor G2
11106,Papillary Pattern,Inverted urothelial papilloma
11107,Epithelial Component Present,Esophageal Well Differentiated Squamous Cell Carcinoma
11108,Lobulated Growth Pattern,Chondromyxoid fibroma
11109,Storiform Growth Pattern,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
11110,Severe dysplasia,Bowenoid papulosis
11111,Recurrent disease,Larynx carcinoma recurrent
11112,Diffuse Pattern,oligodendroglioma
11113,Carcinomatous Component Present,Adenocarcinoma in situ in villous adenoma
11114,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ringed sideroblasts
11115,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory anemia with ringed sideroblasts
11116,Low Mitotic Activity,Gallbladder Tubular Carcinoid
11117,Carcinomatous Component Present,small cell carcinoma of extrahepatic bile duct
11118,Local disease,Localized Bone Ewing Sarcoma
11119,Papillary Pattern,Intraductal papillary adenocarcinoma with invasion
11120,Metastatic Lesion,Metastatic Ewing's Sarcoma
11121,Non-Malignant Cellular Infiltrate,Submandibular lymphadenitis
11122,Carcinomatous Component Present,Villous adenocarcinoma
11123,Cutaneous Involvement,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm
11124,S-100-Positive Neoplastic Cells Present,Angiomyolipoma
11125,Mucoid Stroma Formation,Mucinous adenocarcinoma of colon
11126,Cutaneous Involvement,Cutaneous Mature T-Cell and NK-Cell Neoplasm
11127,Carcinomatous Component Present,Rectal Serrated Adenocarcinoma
11128,Epithelial Component Present,Stage I Major Salivary Gland Cancer AJCC v7
11129,Tissue Differentiation Uncertain,Alveolar soft part sarcoma metastatic
11130,Cutaneous Involvement,Germinative Follicular Epithelium Neoplasm
11131,Cutaneous Involvement,Benign Dermal Schwannoma
11132,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v7
11133,Papillary Pattern,Intraductal Breast Papillomatosis
11134,Cutaneous Involvement,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
11135,Moderate dysplasia,Biliary Intraepithelial Neoplasia-2
11136,Secondary Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread"
11137,Epithelial Differentiation,Papillary tumor of the pineal region
11138,Carcinomatous Component Present,Adenocarcinoid tumor
11139,Carcinomatous Component Present,Stage IVA Vaginal Cancer AJCC v6 and v7
11140,Lymphoplasmacytic Infiltrate,Lung Lymphoepithelioma-Like Carcinoma
11141,Cystic Lesion,Intracerebral Cystic Meningioma
11142,Cutaneous Involvement,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7
11143,Absence of Invasion,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
11144,Myxoid Stroma Formation,Myxoma
11145,Vascular Channel Formation,Benign vascular neoplasm
11146,Plexiform Vasculature Present,Low Grade Endometrioid Stromal Sarcoma of the Cervix
11147,Myxoid Stroma Formation,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
11148,Collagenous Stroma Formation,Vulvar Superficial Myofibroblastoma
11149,Immunologic Deficiency Syndromes,Hairy leukoplakia of tongue
11150,Myxoid Stroma Formation,Intramuscular Myxoma
11151,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Myeloid Leukemia (AML-M2)
11152,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
11153,Well-Circumscribed Lesion,Foveolar-Type Adenoma
11154,Slow Growing Mass,Recurrent Olfactory Neuroblastoma
11155,Mitotic Activity,Infratentorial Glioblastoma
11156,Infiltrative Growth Pattern,Infratentorial Glioblastoma
11157,Diffuse Pattern,Recurrent Childhood Protoplasmic Astrocytoma
11158,Locally Aggressive Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans
11159,Carcinomatous Component Present,Stage 0is Renal Pelvis Cancer AJCC v7
11160,Carcinomatous Component Present,Renal Cell Cancer by AJCC v6 Stage
11161,Epithelial Component Present,Prostatic Adenoma
11162,Cutaneous Involvement,Dartoic myoma
11163,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
11164,Epithelial Component Present,large cell neuroendocrine carcinoma of extrahepatic bile duct
11165,Well-Circumscribed Lesion,Anal polyp
11166,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant"
11167,Vascular Channel Formation,Hemolymphangioma
11168,Well-Circumscribed Lesion,Pituicytoma
11169,Monomorphic Cellular Infiltrate,"Trophoblastic tumor, epithelioid"
11170,Carcinomatous Component Present,basal cell carcinoma of penis
11171,Biphasic Pattern,Malignant Cystosarcoma Phyllodes
11172,Monomorphic Cellular Infiltrate,Oligodendroglioma of spinal cord
11173,Epithelioid Component Present,Pleural Biphasic Synovial Sarcoma
11174,Epithelial Component Present,Gastric Pylorus Carcinoma
11175,Local disease,Infiltrating angiolipoma
11176,Benign Cellular Infiltrate,Benign Extrahepatic Bile Duct Soft Tissue Neoplasm
11177,Dysplasia,adenoma of extrahepatic bile duct
11178,Epithelial Component Present,Prolactinoma
11179,Secondary Lesion,Chemotherapy-Related Leukemia
11180,High Grade Lesion,Adult Synovial Sarcoma
11181,Juvenile Lesion,Juvenile cataract
11182,Epithelial Component Present,Sporadic Diffuse Gastric Adenocarcinoma
11183,Epithelial Component Present,Stage IA1 Cervical Cancer
11184,Diffuse Pattern,Colorectal Diffuse Large B-Cell Lymphoma
11185,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma
11186,Congenital Abnormality,Vulvar Congenital Melanocytic Nevus
11187,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Glycogen-rich carcinoma
11188,Vascular Channel Formation,Pyogenic granuloma of skin and subcutaneous tissue
11189,Carcinomatous Component Present,verrucous carcinoma of vagina
11190,Carcinomatous Component Present,Stage IIIC Esophageal Cancer AJCC v7
11191,Hemorrhagic,Conventional Angiosarcoma
11192,Adulthood Lesion,Adult Leiomyosarcoma
11193,Carcinomatous Component Present,Adenosquamous cell lung cancer stage III
11194,Epithelial Component Present,Transitional cell cancer of the renal pelvis and ureter localized
11195,Rapidly Enlarging Mass,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
11196,atypia morphology,Borderline Ovarian Endometrioid Cystadenofibroma
11197,Carcinomatous Component Present,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7
11198,Ineffective hematopoiesis,MYELODYSPLASTIC SYNDROME
11199,Acanthosis,Cervical Warty Carcinoma
11200,Negative Peripheral Blood,Aleukemic Chronic Lymphocytic Leukemia
11201,Microvascular Proliferation,Neural Glioblastoma
11202,Epithelial Component Present,Cervical Papillary Squamous Cell Carcinoma
11203,Adulthood Lesion,Benign Adult Cerebral Neoplasm
11204,Edematous Stroma Formation,Spermatocytic seminoma
11205,Lobulated Growth Pattern,Cellular Myxoma
11206,Indolent Clinical Course,Kidney Fibroma
11207,Pregnancy Complications,Subacute Placental Infarction
11208,Increased Cellularity Present,Secondary Supratentorial Anaplastic Astrocytoma
11209,Neuroendocrine Differentiation,Sporadic Thyroid Gland Medullary Carcinoma
11210,Osseous Differentiation,High grade surface osteosarcoma
11211,Severe dysplasia,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
11212,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma stage II
11213,Apocrine Differentiation,External Auditory Canal Ceruminous Adenoma
11214,Adulthood Lesion,Stage II Indolent Adult Non-Hodgkin Lymphoma
11215,Pseudopapillary Pattern,Childhood Ovarian Embryonal Carcinoma
11216,Epithelial Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v7
11217,Childhood Lesion,Childhood Acute Monocytic Leukemia
11218,Oligodendroglial Component Present,Brain Oligodendroglioma
11219,Epithelial Component Present,Unresectable Hepatocellular Carcinoma
11220,Well-Circumscribed Lesion,Adult Cardiac Cellular Rhabdomyoma
11221,Carcinomatous Component Present,Bartholin Gland Small Cell Carcinoma
11222,Infantile Lesion,Neonatal leukemia
11223,Single Cell Necrosis,Vulvar Merkel Cell Carcinoma
11224,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Endometrioid Adenocarcinoma
11225,Nuclear Atypia,Giant Cell Glioblastoma
11226,High Grade Lesion,Cerebral Glioblastoma
11227,Epithelial Component Present,Papillary adenocarcinoma
11228,Nuclear Atypia,Brain Glioblastoma
11229,Presence of a Hormonal Syndrome,Malignant Pancreatic Vipoma
11230,Architectural Distortion,Anaplastic Astroblastoma
11231,Adulthood Lesion,Adult Pilocytic Astrocytoma
11232,Chronic Clinical Course,"Thrombocythemia, Essential"
11233,Epithelial Component Present,Esophageal Neuroendocrine Tumor G1
11234,Myxoid Stroma Formation,Vertebral chordoma
11235,Syncytial Pattern,Medullary carcinoma of breast
11236,Antoni A Pattern,Microcystic/Reticular Schwannoma
11237,Recurrent disease,Oropharyngeal squamous cell carcinoma recurrent
11238,Acinar Cell Differentiation,Acinar cell carcinoma of pancreas
11239,Well-Circumscribed Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
11240,Malignant Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7
11241,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
11242,Epithelial Component Present,FIGO Stage IC3 Ovarian Cancer
11243,Absence of Invasion,Stage 0 Gallbladder Cancer AJCC v6 and v7
11244,Epithelial Component Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
11245,Fibrotic Stroma Formation,Mucinous cystadenofibroma
11246,Epithelial Component Present,Stage 0 Vulvar Cancer
11247,Papulovesicular Lesion,Hydroa vacciniforme-like lymphoma
11248,Follicular Cell Differentiation,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
11249,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
11250,Locally Aggressive Lesion,Extra-abdominal fibromatosis
11251,Histiocytoid Differentiation,Lymphohistiocytoid Mesothelioma
11252,Tubular Pattern,Pancreatic Somatostatinoma
11253,Carcinomatous Component Present,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
11254,Low Mitotic Activity,Colorectal Neuroendocrine Tumor G1
11255,Fibrotic Stroma Formation,Ovarian serous cystadenofibroma
11256,Indolent Clinical Course,"Hemangioma, Intramuscular"
11257,Carcinomatous Component Present,"Malignant Mixed Tumor, Not Otherwise Specified"
11258,Osseous Differentiation,Metastatic osteosarcoma
11259,Absence of Invasion,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
11260,Epithelial Component Present,Ovarian cancer stage III
11261,Carcinomatous Component Present,Lung Cancer by AJCC v7 Stage
11262,Tubular Pattern,"Testicular Seminoma, Tubular Variant"
11263,Tissue Differentiation Uncertain,Epithelioid sarcoma recurrent
11264,Neuroendocrine Differentiation,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
11265,Well-Circumscribed Lesion,Appendix Hyperplastic Polyp
11266,Monoclonal Gammapathies,Waldenstrom's macroglobulinemia recurrent
11267,Diffuse Pattern,Sarcomatoid Mesothelioma
11268,High Grade Lesion,Diffuse Blastoid B-Cell Lymphoma
11269,Diffuse Pattern,Malignant Peripheral Nerve Sheath Tumor
11270,Neuroendocrine Differentiation,Carcinoid tumor of ileum
11271,Low Mitotic Activity,Ascending Colon Neuroendocrine Tumor G1
11272,Exophytic Papillary Lesion,Warty Carcinoma of the Penis
11273,Dysplasia,Pancreatic Intraepithelial Neoplasia-1A
11274,Perineural spread,Maxillary Sinus Adenoid Cystic Carcinoma
11275,No Identifiable Line of Differentiation,Malignant Fibrous Histiocytoma
11276,Cutaneous Involvement,Stage IIC Merkel Cell Carcinoma AJCC v7
11277,Pseudoglandular Pattern,Central Nervous System Embryonal Carcinoma
11278,Well-Circumscribed Lesion,Deep histiocytoma
11279,Deep Lesion,Deep histiocytoma
11280,Extraosseous Lesion,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
11281,Junctional Proliferation,Epithelioid cell nevus
11282,Cutaneous Involvement,Cutaneous neurofibroma
11283,Hemorrhagic Neuroblastic Nodules Present,"Ganglioneuroblastoma, Nodular"
11284,Borderline Lesion,"Gastrointestinal stromal tumor, uncertain malignant potential"
11285,Carcinomatous Component Present,Metastatic Penile Cancer
11286,Recurrent disease,Peritoneal mesothelioma malignant recurrent
11287,Indolent Clinical Course,Cavernous Angioleiomyoma
11288,Absence of Invasion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
11289,Childhood Lesion,Refractory Cytopenia of Childhood
11290,Well-Circumscribed Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma
11291,Intracanalicular Growth Pattern,Borderline Breast Phyllodes Tumor
11292,Epithelial Component Present,Glottic Squamous Cell Carcinoma
11293,High Grade Lesion,Diencephalic Glioblastoma
11294,Skin Papule,Vulvar Trichoepithelioma
11295,Epithelial Component Present,Stage III Prostate Carcinoma
11296,Carcinomatous Component Present,Stage IB Vulvar Carcinoma AJCC v6
11297,Polarization of Nuclei Towards the Glandular Lumen,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant"
11298,Carcinomatous Component Present,Carcinoma of base of tongue
11299,Biphasic Pattern,gliosarcoma
11300,Carcinomatous Component Present,Stage II Hilar Cholangiocarcinoma AJCC v7
11301,Epithelial Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7
11302,Well-Circumscribed Lesion,Malignant phyllodes tumor of breast
11303,Epithelial Component Present,Somatotroph/Lactotroph Adenoma
11304,Recurrent disease,Recurrent Vulvar Carcinoma
11305,Carcinomatous Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
11306,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma
11307,Carcinomatous Component Present,Rectosigmoid Mucinous Adenocarcinoma
11308,Well-Circumscribed Lesion,Otic polyp
11309,Anaplasia,Lung Pleomorphic Carcinoma
11310,Borderline Lesion,Borderline Ovarian Mucinous Adenofibroma
11311,Anaplasia,Intracortical osteosarcoma
11312,Borderline Lesion,Borderline Ovarian Serous Cystadenofibroma
11313,atypia morphology,Angiocentric immunoproliferative lesion grade 2
11314,Splenomegaly,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia
11315,Carcinomatous Component Present,mucoepidermoid carcinoma of esophagus
11316,Mixed Cellular Population,Childhood Kidney Wilms Tumor
11317,Severe cytologic atypia,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
11318,White blood cell count increased (lab result),"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
11319,Enterochromaffin-Like Type Granules Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
11320,Malignant Cellular Infiltrate,polyembryoma of ovary
11321,Epithelial Component Present,Thyroid Gland Lipoadenoma
11322,Childhood Lesion,Childhood Ovarian Mature Teratoma
11323,Thin Bands of Collagen Present,Thymus Solitary Fibrous Tumor
11324,Epithelial Component Present,Esophageal adenocarcinoma recurrent
11325,Syncytial Pattern,atypical medullary carcinoma of breast
11326,Epithelial Component Present,Ovarian Transitional Cell Tumor
11327,Epithelial Component Present,Laryngeal Giant Cell Carcinoma
11328,Geographic Necrosis,Embryonal Carcinoma
11329,Epithelial Component Present,Gastrinoma
11330,Poorly Differentiated Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
11331,Adulthood Lesion,Stage III Adult Immunoblastic Lymphoma
11332,Bone Marrow Dysplasia Present,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
11333,Metastatic/Recurrent Disease,Synovial sarcoma recurrent
11334,Non-Invasive Lesion,Renal Pelvis Inverted Papilloma
11335,Epithelial Component Present,Oncocytic Schneiderian papilloma
11336,Epithelial Component Present,Scrotal Carcinoma
11337,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
11338,Epithelial Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia
11339,Well-Circumscribed Lesion,Juvenile Polyp of the Small Intestine
11340,atypia morphology,Actinic keratosis
11341,Carcinomatous Component Present,Transplant-Related Skin Squamous Cell Carcinoma
11342,Favorable Clinical Outcome,HNF1alpha-Inactivated Hepatocellular Adenoma
11343,Epithelial Component Present,Stage II Colon Cancer AJCC v7
11344,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v7
11345,Indolent Clinical Course,Lipoma of the tongue
11346,Villous Pattern,Small Intestinal Tubulovillous Adenoma
11347,Vascular Channel Formation,Endovascular papillary angioendothelioma
11348,Carcinomatous Component Present,"Adenocarcinoma, intestinal type"
11349,Immunologic Deficiency Syndromes,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
11350,Malignant Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7
11351,Chronic Inflammatory Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7
11352,Epithelial Component Present,Submandibular Gland Acinic Cell Carcinoma
11353,Carcinomatous Component Present,intestinal type adenocarcinoma of gallbladder
11354,Recurrent Genetic Abnormalities Present,"Acute myeloid leukemia, t(16;16)(p13;q22)"
11355,Epithelial Component Present,Intraductal Cribriform Breast Adenocarcinoma
11356,Myxoid Stroma Formation,Superficial angiomyxoma
11357,Gastric dysplasia,tubular adenoma of stomach
11358,Dysplasia,tubular adenoma of stomach
11359,Radiation Sickness,Radiation-Related Angiosarcoma
11360,Chronic Inflammatory Infiltrate,Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma
11361,Epithelial Component Present,"Vulvar Intraepithelial Neoplasia, Differentiated Type"
11362,Geographic Necrosis,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
11363,Intraductal Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm
11364,In Situ Lesion,Stage 0 Pharynx Carcinoma
11365,Epithelial Component Present,Fallopian Tube Transitional Cell Carcinoma
11366,Biphasic Pattern,Vaginal Mixed Epithelial and Mesenchymal Neoplasm
11367,Epithelial Component Present,Carcinoma of unknown primary
11368,Cystic Change,Mucoepidermoid carcinoma of the oral cavity stage I
11369,Dysplasia,Squamous intraepithelial neoplasia grade 2
11370,Five or Less Mitoses per 50HPF,"Gastrointestinal stromal tumor, benign"
11371,Primary Lesion,Childhood Gliosarcoma
11372,Drug Exposure,Steroid Lipomatosis
11373,Carcinomatous Component Present,Stage I Colon Cancer AJCC v6 and v7
11374,Epithelial Component Present,Ampulla of Vater Neuroendocrine Neoplasm
11375,Dysplasia,Moderate epithelial dysplasia
11376,Cystic Change,Dermoid Cyst
11377,Carcinomatous Component Present,Adenoid cystic breast carcinoma
11378,Hereditary Lesion,fanconi anemia complementation group g
11379,Pain,Adult Mesenchymal Chondrosarcoma
11380,Tissue Differentiation Uncertain,Acral Fibromyxoma
11381,Carcinomatous Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
11382,atypia morphology,"Papillary cystadenoma, borderline malignancy"
11383,Epithelial Component Present,BCLC Stage D Adult Hepatocellular Carcinoma
11384,Biphasic Pattern,"Phyllodes tumor, borderline"
11385,Recurrent disease,Melanoma recurrent
11386,Slow Growing Mass,Intravascular Angioleiomyoma
11387,Immunologic Deficiency Syndromes,HIV Encephalopathy
11388,Metastatic Lesion,Distantly Metastatic Malignant Neoplasm
11389,Neuroendocrine Differentiation,Low Grade Lung Neuroendocrine Neoplasm
11390,Neuroectodermal Differentiation,"Neuroectodermal Tumor, Primitive"
11391,Macule,Stage II Acral Lentiginous Melanoma AJCC v6 and v7
11392,Poorly Differentiated Lesion,Rectal Sarcomatoid Carcinoma
11393,Chemotherapeutic Agent Toxicity,Alkylating Agent-Related Acute Myeloid Leukemia
11394,Well-Circumscribed Lesion,Spindle cell lipoma
11395,Carcinomatous Component Present,Adenocarcinoma of the prostate stage III
11396,Hyperkeratosis,Classic Type Trichilemmoma
11397,Cutaneous Involvement,Syringofibroadenoma
11398,Desmoplastic Stroma Formation,Desmoplastic Small Round Cell Tumor
11399,Epithelial Component Present,Cervical Mesonephric Adenocarcinoma
11400,Well-Circumscribed Lesion,Adenomatoid Tumor
11401,Indolent Clinical Course,Bizarre leiomyoma
11402,Fibrovascular Stroma Formation,Giant Fibrovascular Esophageal Polyp
11403,Low Mitotic Activity,Pancreatic Somatostatinoma
11404,Dysplasia,Stage 0a Ureter Cancer AJCC v7
11405,Carcinomatous Component Present,Luminal A Breast Carcinoma
11406,Epithelial Component Present,Klatskin Tumor
11407,Carcinomatous Component Present,malignant neoplasm of large intestine stage IV
11408,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)
11409,Primary Lesion,Adult Gliosarcoma
11410,'Starry-sky' pattern,Recurrent Adult Burkitt Lymphoma
11411,Low Mitotic Activity,Esophageal Neuroendocrine Tumor G2
11412,Metastatic Lesion,Disseminated carcinoma
11413,Adulthood Lesion,Stage IV Adult Liver Cancer AJCC v7
11414,Epithelial Component Present,Lip and Oral Cavity Carcinoma
11415,Diffuse Pattern,Childhood Grade III Lymphomatoid Granulomatosis
11416,Necrotic changes (finding),Small Intestinal Large Cell Neuroendocrine Carcinoma
11417,Childhood Lesion,Childhood Brain Stem Gliosarcoma
11418,Metastatic/Recurrent Disease,Mediastinal Synovial Sarcoma
11419,Metastatic Lesion,Carcinoma Metastatic to the Skin
11420,Hyperkeratosis,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
11421,Thyroglobulin Positive Neoplastic Cells Present,Familial Nonmedullary Thyroid Gland Carcinoma
11422,Well Differentiated Lesion,Grade I Chondrosarcoma
11423,Well-Circumscribed Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma
11424,Multinodular Pattern,Ancell-Spiegler cylindromas
11425,Necrotic changes (finding),Occult Lung Small Cell Carcinoma
11426,Fibrotic Stroma Formation,Minor Salivary Gland Mucoepidermoid Carcinoma
11427,Neuroendocrine Differentiation,Central Nervous System Paraganglioma
11428,Dysplasia,Colorectal Villous Adenoma
11429,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage IV
11430,Villous Pattern,Tubulovillous adenoma of rectum
11431,Carcinomatous Component Present,Vulvar Cancer by AJCC v7 Stage
11432,Angiodestructive Pattern,Recurrent Grade I Lymphomatoid Granulomatosis
11433,Tubular Pattern,Gallbladder Tubular Carcinoid
11434,High Mitotic Activity,Cellular Congenital Mesoblastic Nephroma
11435,Epithelial Component Present,Cervical intraepithelial neoplasia grade 1
11436,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
11437,Cutaneous Involvement,Infiltrating basal cell carcinoma
11438,Necrotic changes (finding),Cervical Malignant Peripheral Nerve Sheath Tumor
11439,Lymphadenopathy,Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma
11440,Epithelial Component Present,Sphenoid Sinus Schneiderian Papilloma
11441,Lymphatic Spread,Inflammatory carcinoma of breast stage III
11442,Recurrent disease,Recurrent Extraskeletal Myxoid Chondrosarcoma
11443,'Starry-sky' pattern,Burkitt's lymphoma of breast
11444,Adulthood Lesion,Stage IV Adult Hodgkin Lymphoma
11445,Radiation Sickness,Post-Radiotherapy Breast Angiosarcoma
11446,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemias
11447,Thin-Walled Branching Vascular Pattern,Dedifferentiated Solitary Fibrous Tumor
11448,Carcinomatous Component Present,Carcinoma of Cowper Glands
11449,Carcinomatous Component Present,Major Salivary Gland Acinic Cell Carcinoma
11450,Carcinomatous Component Present,Head and Neck Basaloid Carcinoma
11451,Carcinomatous Component Present,Laryngeal Cancer by AJCC v7 Stage
11452,Exophytic Polypoid Lesion,Fundic gland polyp
11453,Dysplasia,Biliary Intraepithelial Neoplasia-1
11454,Dysplasia,High Grade Conjunctival Intraepithelial Neoplasia
11455,Pregnancy Complications,"Pregnancy, Cornual"
11456,Epithelial Component Present,Noninfiltrating intraductal papillary adenocarcinoma
11457,Endophytic Tumor Growth,Maxillary Sinus Inverted Papilloma
11458,Mixed Cellular Population,Stromal Predominant Kidney Wilms Tumor
11459,Metastatic Lesion,Extra-osseous Ewing's sarcoma metastatic
11460,Carcinomatous Component Present,adenosquamous carcinoma of esophagus
11461,Contiguous Disease,Ann Arbor Stage II Contiguous Mantle Cell Lymphoma
11462,Epithelial Component Present,Carcinosarcoma of cervix uteri
11463,Epithelial Component Present,Stage III Penile Cancer AJCC v6
11464,Mitotic Activity,malignant myoepithelioma of breast
11465,Carcinomatous Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma
11466,Cutaneous Involvement,Acanthoma
11467,Severe cytologic atypia,Undifferentiated Endocervical Sarcoma
11468,Lobulated Growth Pattern,Intramuscular Myxoma
11469,Metastatic Lesion,Secondary Central Nervous System Hodgkin Lymphoma
11470,Invasive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation
11471,Carcinomatous Component Present,Rectal Medullary Carcinoma
11472,CD30-Positive Neoplastic Cells Present,alk-positive anaplastic large cell lymphoma
11473,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Fallopian Tube Endometrioid Tumor
11474,Acinar Pattern,Lung Acinar Adenocarcinoma
11475,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Neuroendocrine Tumor G2
11476,Epithelial Component Present,Stage IVA Gallbladder Carcinoma
11477,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Tumor
11478,Nodular lesions,"Childhood Ganglioneuroblastoma, Nodular"
11479,Osseous Component Present,Osteochondromyxoma
11480,Carcinomatous Component Present,Carcinoma duodenum resectable
11481,Locally Aggressive Lesion,Intermediate (Locally Aggressive) Blood Vessel Neoplasm
11482,Eosinophilic inflammation,Lung Inflammatory Myofibroblastic Tumor
11483,Mixed Cellular Population,Epithelial Predominant Kidney Wilms Tumor
11484,Recurrent disease,Testis cancer recurrent
11485,Indolent Clinical Course,Intracranial cavernous hemangioma
11486,High Mitotic Activity,"Ovarian Small Cell Carcinoma, Pulmonary Type"
11487,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma
11488,Epithelial Component Present,Stage I Appendix Carcinoma AJCC v7
11489,Mitotic Activity,Metastasizing Chondroblastoma
11490,Epithelial Component Present,Stage IVB Paranasal Sinus Cancer AJCC v7
11491,Carcinomatous Component Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
11492,Cystic Change,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
11493,Metastatic Lesion,Secondary malignant neoplasm of axilla
11494,Epithelial Component Present,Lymphoepithelioma-Like Hepatocellular Carcinoma
11495,Diffuse Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor
11496,Epithelial Component Present,Colorectal Sarcomatoid Carcinoma
11497,Recurrent disease,Recurrent Follicular Lymphoma
11498,Fibrotic Stroma Formation,Breast Sclerosing Adenosis
11499,Diffuse Pattern,Diffuse large B-cell lymphoma of central nervous system
11500,Junctional Proliferation,Compound nevus of skin
11501,Epithelial Component Present,Colorectal Carcinoma
11502,Neuroectodermal Differentiation,Stage 2 Neuroblastoma
11503,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma
11504,Necrotic changes (finding),Vaginal Large Cell Neuroendocrine Carcinoma
11505,Carcinomatous Component Present,Stage 0 Oral Cavity Cancer AJCC v6 and v7
11506,Indolent Clinical Course,Endobronchial Leiomyoma
11507,Squamous metaplasia of bladder,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
11508,High Grade Lesion,Embryonal Rhabdomyosarcoma
11509,Childhood Lesion,Childhood Breast Carcinoma
11510,Carcinomatous Component Present,Small cell carcinoma of the cervix
11511,Lymphoplasmacytic Infiltrate,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
11512,Follicular Cell Differentiation,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
11513,Neuroendocrine Differentiation,Extrahepatic Bile Duct Carcinoid Tumor
11514,Hyperplastic Tissue Present,Benign Prostatic Hyperplasia
11515,Carcinomatous Component Present,Non-small cell lung cancer stage IIIB
11516,Epithelial Component Present,Papillary transitional cell neoplasm of low malignant potential
11517,Epithelial Component Present,Vulvar Seborrheic Keratosis
11518,Follicular Cell Differentiation,Clear Cell Variant Thyroid Gland Follicular Carcinoma
11519,Argentaffin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
11520,Mitotic Activity,"Testicular Yolk Sac Tumor, Microcystic Pattern"
11521,Epithelial Component Present,Recurrent Hepatocellular Carcinoma
11522,Carcinomatous Component Present,Serous Tubal Intraepithelial Carcinoma
11523,Carcinomatous Component Present,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
11524,Epithelial Component Present,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
11525,Carcinomatous Component Present,squamous cell carcinoma of middle ear
11526,Epithelial Component Present,Bartholin Gland Squamous Cell Carcinoma
11527,IDH Gene Family Mutation Status Unknown,Anaplastic astrocytoma
11528,Cutaneous Involvement,Superficial spreading malignant melanoma of skin
11529,Radial Growth Phase,Superficial spreading malignant melanoma of skin
11530,Epithelial Component Present,Colorectal Signet Ring Cell Carcinoma
11531,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage II
11532,Necrotic changes (finding),Epithelioid glioblastoma
11533,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Erythroid Leukemia
11534,Primary Lesion,Periosteal Osteosarcoma
11535,Recurrent disease,Squamous cell carcinoma of the hypopharynx recurrent
11536,Nodular Pattern,"Lymphoma, Follicular, Grade 1"
11537,Carcinomatous Component Present,Malignant myoepithelioma
11538,Nuclear Molding,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
11539,Epithelial Component Present,BCLC Stage D Hepatocellular Carcinoma
11540,Adulthood Lesion,Adult Craniopharyngioma
11541,Myxoid Stroma Formation,Epithelioid hemangioendothelioma of lung
11542,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP J"
11543,Primary Lesion,Primary Carcinoma
11544,Cauliflower-Like Mass,Childhood Choroid Plexus Papilloma
11545,Epithelial Component Present,Gastric Adenocarcinoma
11546,Cutaneous Involvement,External Ear Basal Cell Carcinoma
11547,Neuroendocrine Differentiation,Esophageal Neuroendocrine Tumor G1
11548,Carcinomatous Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
11549,Epithelial Component Present,FIGO Stage III Carcinoma of the Fallopian Tube
11550,Acanthosis,Supraglottic Verrucous Carcinoma
11551,Fibrous Septa Present,Stage I Ovarian Dysgerminoma AJCC v6 and v7
11552,Infiltrative Growth Pattern,Malignant Uterine Corpus PEComa
11553,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7
11554,Secondary Lesion,Metastatic Carcinoma to the Uterine Cervix
11555,Cutaneous Involvement,Familial benign pemphigus
11556,Carcinomatous Component Present,Squamous cell carcinoma of the paranasal sinus
11557,Mixture of Germ Cell Neoplastic Components Present,Adult Central Nervous System Mixed Germ Cell Tumor
11558,Biphasic Pattern,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
11559,Indolent Clinical Course,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
11560,Lesion with Diameter of 4mm or More,Dysplastic Nevus
11561,Carcinomatous Component Present,Stage IV Rectosigmoid Cancer AJCC v7
11562,Epithelial Component Present,Hepatocellular Carcinoma by BCLC Stage
11563,Carcinomatous Component Present,Stage IIIA Breast Carcinoma
11564,High Mitotic Activity,Vulvar Small Cell Carcinoma
11565,Follicular Cell Differentiation,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
11566,Fibrotic Stroma Formation,Ovarian Serous Adenofibroma
11567,Secondary Lesion,Secondary Cerebral Hodgkin Lymphoma
11568,Focal dysplasia,Colon Sessile Serrated Adenoma/Polyp
11569,Anaplasia,Recurrent Childhood Anaplastic Astrocytoma
11570,Cutaneous Involvement,Common wart
11571,Diffuse Pattern,Cerebellar Glioblastoma
11572,High Grade Lesion,Cerebellar Glioblastoma
11573,Dysplasia,Appendix Sessile Serrated Adenoma/Polyp
11574,Carcinomatous Component Present,Uterine Carcinosarcoma
11575,Fibrotic Stroma Formation,mucinous adenocarcinofibroma of ovary
11576,Epithelial Component Present,Localized Unresectable Adult Hepatocellular Carcinoma
11577,Carcinomatous Component Present,"Squamous cell carcinoma, keratinizing"
11578,Carcinomatous Component Present,basaloid carcinoma of penis
11579,Epithelial Component Present,Glandular cell neoplasm
11580,Neuroendocrine Differentiation,Malignant Pancreatic Somatostatinoma
11581,Carcinomatous Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
11582,Carcinomatous Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
11583,Cutaneous Involvement,Stage IIA Merkel Cell Carcinoma AJCC v7
11584,Carcinomatous Component Present,Stage IIA Merkel Cell Carcinoma AJCC v7
11585,Fenestrating Pattern,Fibroepithelioma of Pinkus
11586,Mixed Cellular Population,carcinoma ex pleomorphic adenoma of salivary gland
11587,Epithelial Component Present,Mixed epithelial tumor of ovary
11588,Inconspicuous Syncytiotrophoblastic Cell Component,Testicular Monophasic Choriocarcinoma
11589,Immunologic Deficiency Syndromes,Burkitt lymphoma associated with AIDS
11590,Alternative Fascicle (Bundle) Pattern,Pericardial Leiomyoma
11591,High Mitotic Activity,Central Nervous System Embryonal Carcinoma
11592,Metastatic Lesion,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
11593,Fibrotic Stroma with Finger-Like Projections Present,Solid Papillary Breast Carcinoma
11594,Childhood Lesion,Refractory Childhood Acute Lymphoblastic Leukemia
11595,Secondary Lesion,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma
11596,Mesenchymal Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma
11597,Papillary Pattern,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
11598,Cavernous Vascular Space Formation,Cavernous Angioleiomyoma
11599,Epithelial Component Present,Stage IV Anal Canal Cancer AJCC v6 and v7
11600,Epithelial Component Present,Buccal Mucosa Verrucous Carcinoma
11601,Exophytic Polypoid Lesion,Rectal Juvenile Polyp
11602,Childhood Lesion,Rhabdoid Tumor of the Kidney
11603,Mixed Cellular Population,Phyllodes Tumor
11604,Carcinomatous Component Present,Spindle cell squamous cell carcinoma
11605,Severe dysplasia,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
11606,Secondary Lesion,Krukenberg Tumor
11607,Epithelial Component Present,Densely Granulated Somatotroph Adenoma
11608,Edematous Stroma Formation,Microfollicular adenoma
11609,Collagenous Stroma Formation,Benign mixed epithelial and stromal tumor of kidney
11610,Moderately Differentiated Lesion,Moderately Differentiated Prostate Adenocarcinoma
11611,Alternative Fascicle (Bundle) Pattern,Bone Leiomyoma
11612,Infiltrating Tumor Margins Present,Malignant phyllodes tumor of breast
11613,CD30-Positive Neoplastic Cells Present,Stage IV Childhood Anaplastic Large Cell Lymphoma
11614,Epithelial Component Present,Stage III Lung Cancer AJCC v7
11615,Epithelial Component Present,Sarcomatoid carcinoma of the lung
11616,Indolent Clinical Course,Hemangioma of liver
11617,Non-Invasive Lesion,Preinvasive Neoplasm of the Ampullary Region
11618,Biphasic Pattern,Borderline Ovarian Serous Adenofibroma
11619,Secondary Lesion,Metastatic Signet Ring Cell Breast Carcinoma
11620,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma refractory
11621,BRAF V600E Mutation Present,Splenic Manifestation of Hairy Cell Leukemia
11622,Epithelial Component Present,Fallopian Tube Squamous Cell Carcinoma
11623,In Situ Lesion,Bladder adenocarcinoma stage 0
11624,Epithelial Component Present,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7
11625,Epithelial Component Present,"Carcinoma, Basal Cell"
11626,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Hematologic Malignancy
11627,Low Mitotic Activity,Malignant Pancreatic Insulinoma
11628,Epithelial Component Present,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
11629,Adulthood Lesion,Adult Central Nervous System Germ Cell Tumor
11630,Biphasic Pattern,Ovarian Mucinous Adenofibroma
11631,Neuroendocrine Differentiation,Malignant Vipoma
11632,Lipomatous Component Present,Thymolipoma
11633,Childhood Lesion,Childhood Ovarian Immature Teratoma
11634,Capillary Sized Vascular Channel Formation,Strawberry nevus of skin
11635,Carcinomatous Component Present,Stage IV Rectal Carcinoma
11636,Nerve palsy,Facial paralysis
11637,Cutaneous Involvement,Carcinoma ex Eccrine Spiradenoma
11638,Well-Circumscribed Lesion,Skin tag
11639,Refractory Disease,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
11640,Adnexal Differentiation,Papillary Eccrine Carcinoma
11641,Carcinomatous Component Present,Small Intestinal Squamous Cell Carcinoma
11642,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of submandibular gland
11643,Secondary Lesion,Metastatic Malignant Neoplasm to the Cervix
11644,Osteoid formation,Fibroblastic osteosarcoma
11645,Carcinomatous Component Present,Stage I Nasal Cavity Cancer AJCC v6 and v7
11646,'Starry-sky' pattern,Burkitt Lymphoma with Plasmacytoid Differentiation
11647,Epithelial Component Present,Stage IVA Laryngeal Cancer AJCC v7
11648,Secondary Lesion,Metastatic Non-Cutaneous Melanoma
11649,Absence of Stromal Invasion,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor
11650,Well Differentiated Lesion,papillary squamous cell carcinoma of larynx
11651,Epithelial Component Present,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor
11652,Biphasic Pattern,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
11653,Large Neoplastic Glands with Branching and Papillary Infolding Present,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
11654,Carcinomatous Component Present,"Papillary transitional cell carcinoma, non-invasive"
11655,Epidermal Involvement,Eccrine porocarcinoma
11656,Indolent Clinical Course,"Synovioma, benign"
11657,Carcinomatous Component Present,Stage IVA Hepatocellular Carcinoma AJCC v7
11658,Exophytic Polypoid Lesion,Polyp of vulva
11659,Epithelial Component Present,Stage IIIB Colon Cancer AJCC v7
11660,Epithelial Component Present,Transplant-Related Renal Cell Carcinoma
11661,Dysplasia,solid type ductal carcinoma in situ of breast
11662,Epithelial Component Present,Stage I Esophageal Adenocarcinoma AJCC v7
11663,Pseudoglandular Pattern,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
11664,Invasive Lesion,Small cell carcinoma of prostate
11665,Low Mitotic Activity,Intestinal Gangliocytic Paraganglioma
11666,Bone Marrow Eosinophilia,"Acute myeloid leukemia, inv(16)(p13q22)"
11667,Well-Circumscribed Lesion,Adult Kidney Wilms Tumor
11668,Thin Bands of Collagen Present,Malignant Solitary Fibrous Tumor
11669,High Mitotic Activity,Malignant Solitary Fibrous Tumor
11670,Tissue Differentiation Uncertain,"Vaginal Deep ""Aggressive"" Angiomyxoma"
11671,Severe dysplasia,Pancreatic Intraductal Tubulopapillary Neoplasm
11672,Ganglioneuroma Component Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
11673,Rapidly Enlarging Mass,embryonal rhabdomyosarcoma of orbit
11674,Epithelial Component Present,Oropharyngeal Carcinoma by AJCC v7 Stage
11675,Epithelial Component Present,Hepatitis B Virus-Related Hepatocellular Carcinoma
11676,Osseous Differentiation,Metachronous Osteosarcoma
11677,Metastatic Lesion,Metachronous Osteosarcoma
11678,Papillary Pattern,Syringocystadenoma Papilliferum
11679,Diffuse Pattern,Childhood Gliosarcoma
11680,Sarcomatous Component Present,Carcinosarcoma of ovary
11681,Monocytosis,"Leukemia, Myelomonocytic, Chronic"
11682,Epithelial Component Present,Virus-Related Carcinoma
11683,Moderate dysplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia
11684,Multifocal Lesion,Multiple endocrine neoplasia Type 2
11685,Carcinomatous Component Present,Endometrial Large Cell Neuroendocrine Carcinoma
11686,Rapidly Enlarging Mass,Cranial Nodular Fasciitis
11687,Epithelial Component Present,Adenoma of the Colon with Intramucosal Adenocarcinoma
11688,Epithelial Component Present,Parathyroid Gland Adenocarcinoma
11689,Carcinomatous Component Present,Endometrioid adenocarcinoma metastatic
11690,Local disease,Lipoma of spinal cord
11691,Secondary Lesion,Alkylating Agent-Related Myelodysplastic Syndrome
11692,Epithelial Component Present,Bladder Urachal Adenocarcinoma
11693,Epithelial Component Present,Cystadenocarcinoma of pancreas
11694,In Situ Lesion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
11695,Carcinomatous Component Present,Stage IV Eyelid Carcinoma AJCC v7
11696,Anastomosing Strands of Tumor Cells Present,Syringofibroadenoma
11697,Indolent Clinical Course,Diffuse Lipomatosis
11698,Benign Cellular Infiltrate,Gastric Leiomyoma
11699,Neuroendocrine Differentiation,Colon Neuroendocrine Neoplasm
11700,Severe cytologic atypia,undifferentiated sarcoma of ovary
11701,Trabecular Pattern,"Somatostatinoma, malignant"
11702,Presence of a Hormonal Syndrome,Pancreatic ACTH-Producing Neuroendocrine Tumor
11703,Systemic disease,Indolent Systemic Mastocytosis
11704,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Megakaryoblastic Leukemia
11705,Cutaneous Involvement,Epidermolysis Bullosa Acquisita
11706,Papillary Pattern,Serous surface papillary carcinoma
11707,Epithelial Component Present,Localized Adrenal Gland Pheochromocytoma
11708,Well-Circumscribed Lesion,Cervical Rhabdomyoma
11709,Carcinomatous Component Present,"Carcinoma, Signet Ring Cell"
11710,Lytic lesion,Benign Osteoclastic Giant Cell-Rich Tumor of Bone
11711,Neuroendocrine Differentiation,Esophageal Neuroendocrine Tumor G2
11712,Severe cytologic atypia,Digestive System Neuroendocrine Carcinoma
11713,Well Differentiated Lesion,Anal Verrucous Carcinoma
11714,Diffuse Pattern,Recurrent Childhood Giant Cell Glioblastoma
11715,Papillary Pattern,Atypical Breast Papilloma
11716,Primary Lesion,Childhood Brain Stem Gliosarcoma
11717,Cutaneous Involvement,Malignant fibrous histiocytoma of skin
11718,Benign Cellular Infiltrate,Benign neoplasm of duodenum
11719,Perineural spread,Adenoid cystic eccrine carcinoma
11720,Carcinomatous Component Present,Adenocarcinoma in situ in tubulovillous adenoma
11721,Carcinomatous Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
11722,Epithelial Component Present,Bile duct adenoma
11723,Recurrent disease,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
11724,Childhood Lesion,Childhood Liver and Intrahepatic Bile Duct Neoplasm
11725,Lobulated Growth Pattern,Myxoma of the Endocardium
11726,Carcinomatous Component Present,Bladder transitional cell carcinoma stage I
11727,Neuroendocrine Differentiation,Urinary System Paraganglioma
11728,Local disease,Appendix Lipoma
11729,Pseudoglandular Pattern,Testicular embryonal carcinoma stage II
11730,Hyaline Cartilage Differentiation,Grade II Chondrosarcoma
11731,Epithelial Component Present,Pleural Carcinomatosis
11732,Papillary Pattern,Sphenoid Sinus Schneiderian Papilloma
11733,Metastatic/Recurrent Disease,Epithelioid Sarcoma NCI Grade 3
11734,Nodular Pattern,Ann Arbor Stage II Grade 1 Follicular Lymphoma
11735,Carcinomatous Component Present,Stage IIB Prostate Cancer AJCC v7
11736,Well Differentiated Lesion,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
11737,Carcinomatous Component Present,Cervical Keratinizing Squamous Cell Carcinoma
11738,Cutaneous Involvement,Cutaneous B Lymphoblastic Leukemia/Lymphoma
11739,Indolent Clinical Course,Colon Lymphangioma
11740,Carcinomatous Component Present,carcinosarcoma of gallbladder
11741,High Grade Lesion,Conventional Alveolar Rhabdomyosarcoma
11742,Cartilaginous Differentiation,"Chondromatosis, Synovial"
11743,Exophytic Polypoid Lesion,Hamartomatous polyp
11744,Cutaneous Involvement,Mycosis Fungoides Variant
11745,Epithelial Component Present,Hereditary Kidney Oncocytoma
11746,Cystic Change,Papillary mucinous cystadenocarcinoma
11747,Locally Aggressive Lesion,Pelvic Fibromatosis
11748,Pseudoalveolar Pattern,Alveolar soft part sarcoma non-metastatic
11749,Non-Invasive Lesion,Ureter Inverted Papilloma
11750,Childhood Lesion,Childhood Lymphomatoid Granulomatosis
11751,Recurrent disease,Small cell lung cancer recurrent
11752,Epithelial Component Present,Major Salivary Gland Mucoepidermoid Carcinoma
11753,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
11754,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
11755,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
11756,Epithelial Component Present,Stage III Vaginal Cancer AJCC v6 and v7
11757,Low Mitotic Activity,Anal Canal Neuroendocrine Tumor
11758,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma metastatic
11759,Carcinomatous Component Present,Adenoid basal carcinoma of cervix uteri
11760,Dysplasia,Esophageal Squamous Intraepithelial Neoplasia
11761,Neuroendocrine Differentiation,Bladder Paraganglioma
11762,Cutaneous Involvement,Senile hemangioma of lip
11763,Tissue Differentiation Uncertain,Intramuscular Myxoma
11764,Absence of Invasion,Stage 0 Vaginal Cancer AJCC v7
11765,Cutaneous Involvement,Staphylococcal Scalded Skin Syndrome
11766,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Pulmonary Blastoma
11767,Cystic Change,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
11768,Anaplasia,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
11769,Epithelial Component Present,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
11770,Multinodular Mass,Dedifferentiated Dermatofibrosarcoma Protuberans
11771,Epithelial Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7
11772,Hemorrhagic Neuroblastic Nodules Present,"Childhood Ganglioneuroblastoma, Nodular"
11773,Exophytic Papillary Lesion,Verrucous carcinoma of the oral cavity recurrent
11774,Biphasic Pattern,Cystadenofibroma of fallopian tube
11775,Epithelial Component Present,Stage IIIB Rectal Cancer AJCC v7
11776,1p/19q Codeletion Status Unknown,Anaplastic Oligodendroglioma
11777,Well-Circumscribed Lesion,Adrenal Cortex Oncocytic Adenoma
11778,Multilocular Lesion,Cystadenocarcinoma of kidney
11779,Acquired Lesion,Naevus spider acquired
11780,Rarely Metastasizing Lesion,Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm
11781,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage II
11782,S-100-Positive Neoplastic Cells Present,Eosinophilic Granuloma
11783,Epithelial Component Present,Malignant Cystosarcoma Phyllodes
11784,Infiltrating Tumor Margins Present,Malignant Cystosarcoma Phyllodes
11785,Serotonin Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell"
11786,Cutaneous Involvement,Bullous pemphigoid
11787,Microvascular Proliferation,Pilocytic Astrocytoma
11788,Carcinomatous Component Present,High Grade Fallopian Tube Serous Adenocarcinoma
11789,Epithelial Component Present,Stage 0is Ureter Cancer AJCC v7
11790,Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other"
11791,Vascular Channel Formation,Cerebral hemangioma
11792,Biphasic Pattern,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
11793,Anaplasia,Glioblastoma multiforme of spinal cord
11794,Epithelial Component Present,Childhood Craniopharyngioma
11795,Recurrent disease,Lung adenocarcinoma recurrent
11796,Multifocal Lesion,Multifocal osteosarcoma
11797,Carcinomatous Component Present,Adenocarcinoma of the rete testis
11798,Carcinomatous Component Present,Localized Parathyroid Gland Carcinoma
11799,Papillary Pattern,Papillary renal cell carcinoma type 2
11800,Secondary Lesion,Breast Carcinoma Metastatic in the Liver
11801,Chronic Inflammatory Infiltrate,Cutaneous Fibrous Histiocytoma
11802,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
11803,Epithelial Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
11804,Epithelial Component Present,Pharyngeal cancer stage I
11805,Hyperplastic Tissue Present,Atypical Breast Myoepitheliosis
11806,Carcinomatous Component Present,Adenocarcinoma of rete ovarii
11807,Carcinomatous Component Present,Glycogen-rich carcinoma
11808,Dysplasia,Cervical intraepithelial neoplasia grade 2
11809,Epithelial Component Present,Stage I Ovarian Cancer AJCC v6 and v7
11810,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type"
11811,Vascular Channel Formation,Cavernous lymphangioma
11812,Epithelial Component Present,Intrahepatic Bile Duct Microcystic Adenoma
11813,Benign Cellular Infiltrate,Colorectal Perineurioma
11814,Eosinophilic inflammation,Cardiac Inflammatory Myofibroblastic Tumor
11815,Papillary Pattern,verrucous carcinoma of vagina
11816,Epithelial Component Present,Adenocarcinoma of lung stage IIIB
11817,Extraocular Dissemination of Disease,Pediatric Extraocular Retinoblastoma
11818,Chronic lymphocytic inflammation,Breast Inflammatory Myofibroblastic Tumor
11819,Non-Invasive Lesion,Stage 0 Ureter Cancer AJCC v7
11820,High Grade Lesion,Cardiac Biphasic Synovial Sarcoma
11821,Tissue of Mullerian Origin Present,Ovarian Seromucinous Adenofibroma
11822,In Situ Lesion,Stage 0 Lip Carcinoma
11823,Well Differentiated Lesion,Well Differentiated Adrenal Cortex Carcinoma
11824,Carcinomatous Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
11825,High Grade Lesion,Lung Synovial Sarcoma
11826,Cystic Change,cystadenoma of extrahepatic bile duct
11827,Intracanalicular Growth Pattern,Breast Complex Fibroadenoma
11828,Tissue of Mullerian Origin Present,Ovarian Endometrioid Cystadenofibroma
11829,Vascular Channel Formation,malignant epithelioid hemangioendothelioma of liver
11830,Epithelial Component Present,Vulval intraepithelial neoplasia
11831,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
11832,Carcinomatous Component Present,Cervical Verrucous Carcinoma
11833,Well Differentiated Lesion,Cervical Verrucous Carcinoma
11834,Splenomegaly,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
11835,Intracanalicular Growth Pattern,Benign phyllodes neoplasm of breast
11836,Thyroglobulin Positive Neoplastic Cells Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma
11837,Papillary Pattern,Oncocytic Variant Thyroid Gland Papillary Carcinoma
11838,Fibrotic Stroma Formation,Female Reproductive System Adenofibroma
11839,Epithelial Component Present,Clear Cell Variant Thyroid Gland Papillary Carcinoma
11840,Koilocytotic atypia,Cervical Papillary Squamous Cell Carcinoma
11841,Tissue of Mullerian Origin Present,Cystadenofibroma
11842,Carcinomatous Component Present,FIGO Stage IVA Ovarian Cancer
11843,Recurrent disease,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
11844,Biphasic Pattern,"Neoplasms, Fibroepithelial"
11845,Adulthood Lesion,Recurrent Indolent Adult Non-Hodgkin Lymphoma
11846,Carcinomatous Component Present,Cervical Cancer by AJCC v7 Stage
11847,Neuroendocrine Differentiation,Stage 0 Merkel Cell Carcinoma AJCC v7
11848,Metastatic Lesion,Metastatic malignant neoplasm to nasopharynx
11849,Papillary Pattern,"Testicular Yolk Sac Tumor, Papillary Pattern"
11850,Immunologic Deficiency Syndromes,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
11851,Carcinomatous Component Present,Stage IIIB Gallbladder Cancer AJCC v7
11852,Diffuse Pattern,Epithelioid glioblastoma
11853,Carcinomatous Component Present,mucinous adenocarcinoma of anus
11854,Epithelial Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
11855,Carcinomatous Component Present,Stage IIC Fallopian Tube Cancer AJCC v6 and v7
11856,Cartilaginous Differentiation,Periosteal Osteosarcoma
11857,Carcinomatous Component Present,Pancreatic Hepatoid Adenocarcinoma
11858,Parakeratosis,Trichilemmoma
11859,Epithelial Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
11860,Primary Lesion,Childhood Cerebral Diffuse Astrocytoma
11861,Indolent Clinical Course,Encephalocraniocutaneous lipomatosis
11862,Pregnancy Complications,Fallopian Tube Gestational Choriocarcinoma
11863,Necrotic changes (finding),Multifocal Glioblastomas
11864,Vascular Channel Formation,Epithelioid hemangioendothelioma of lung
11865,Islands of Odontogenic Epithelium Present,Acanthomatous ameloblastoma
11866,Childhood Lesion,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma
11867,Epithelial Component Present,Primary Carcinoma
11868,Epithelial Component Present,Malignant Pancreatic Vipoma
11869,Polyvesicular Vitelline Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
11870,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
11871,Epithelial Component Present,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
11872,Primary Site Unknown,Recurrent Carcinoma of Unknown Primary
11873,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Differentiating Neuroblastoma
11874,Prominent Squamous Eddies Present,Vulvar Inverted Follicular Keratosis
11875,Carcinomatous Component Present,Squamous Cell Carcinoma In Situ of the Nipple
11876,Osseous Differentiation,Parosteal Osteosarcoma
11877,Carcinomatous Component Present,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
11878,Epithelial Component Present,Hereditary Papillary Renal Carcinoma
11879,Invasive Lesion,Breast Carcinoma with Melanotic Features
11880,Mixed Cellular Population,Mucinous cystadenofibroma
11881,Biphasic Pattern,Uterine Corpus Adenofibroma
11882,Epithelial Component Present,large cell neuroendocrine carcinoma of breast
11883,Cauliflower-Like Mass,Choroid Plexus Papilloma
11884,Epithelial Component Present,Grade 3 Colorectal Adenocarcinoma
11885,In Situ Lesion,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
11886,Splenomegaly,Hepatosplenic T-cell lymphoma
11887,Organoid Pattern,"Thymoma, type B1, malignant"
11888,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH
11889,Acanthosis,Warty Carcinoma of the Penis
11890,Metastatic Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
11891,Secondary Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
11892,Hyaline Cartilage Differentiation,mesenchymal chondrosarcoma of bone
11893,Hyperplastic Tissue Present,C-cell hyperplasia of thyroid
11894,Multilocular Lesion,Multilocular Thymic Cyst
11895,Cutaneous Involvement,Clear cell hidradenoma
11896,Hyperplastic Tissue Present,Neoplastic C-Cell Hyperplasia
11897,Carcinomatous Component Present,Childhood Lung Non-Small Cell Carcinoma
11898,Perineural spread,adenoid cystic carcinoma of pharynx
11899,Epithelial Component Present,Retromolar Trigone Squamous Cell Carcinoma
11900,Well-Circumscribed Lesion,Apocrine adenoma
11901,High Mitotic Activity,Stage IIIB Merkel Cell Carcinoma AJCC v7
11902,Nuclear pleomorphism,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
11903,Refractory Disease,Refractory Childhood Acute Lymphoblastic Leukemia
11904,Necrotic changes (finding),Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
11905,Stromal Invasion,squamous cell carcinoma of ovary
11906,Dysplasia,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
11907,Epithelial Component Present,Childhood Nasal Cavity Carcinoma
11908,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma recurrent
11909,Epithelial Component Present,Tonsillar Undifferentiated Carcinoma
11910,Fibrotic Stroma Formation,Pancreatic Ductal Adenocarcinoma
11911,Epithelial Component Present,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
11912,Carcinomatous Component Present,Laryngeal verrucous carcinoma
11913,Mild cytologic atypia,Laryngeal verrucous carcinoma
11914,Adnexal Differentiation,Malignant Outer Hair Sheath and Infundibulum Neoplasm
11915,Nodular lesions,Microfollicular adenoma
11916,Local disease,Localized Peripheral Primitive Neuroectodermal Tumor
11917,Microvascular Proliferation,gliosarcoma
11918,Epithelial Component Present,Prostate cancer stage B
11919,Carcinomatous Component Present,large cell neuroendocrine carcinoma of appendix
11920,Epithelial Component Present,Mucinous neoplasm
11921,Carcinomatous Component Present,squamous cell carcinoma of renal pelvis
11922,Edema,Inflammatory carcinoma of breast recurrent
11923,Adulthood Lesion,Stage III Adult Burkitt Lymphoma
11924,Anaplasia,Spindle cell squamous cell carcinoma
11925,High Mitotic Activity,Colorectal Neuroendocrine Carcinoma
11926,Epithelial Component Present,Squamous cell breast carcinoma
11927,Cutaneous Involvement,Erythema multiforme minor
11928,Vascular Channel Formation,Iatrogenic Kaposi Sarcoma
11929,Carcinomatous Component Present,Carcinoma of lower gum
11930,Carcinomatous Component Present,Renal Cell Carcinoma Associated with Neuroblastoma
11931,Exophytic Polypoid Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp
11932,Cutaneous Involvement,Telangiectatic Glomangioma
11933,Pseudorosette Formation,"Gastrinoma, malignant"
11934,Primary Lesion,Stage IVA Osteosarcoma AJCC v7
11935,Well-Circumscribed Lesion,Serous cystadenoma of pancreas
11936,Adnexal Differentiation,Trichodiscoma
11937,Ischemia,Vascular insufficiency of intestine
11938,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
11939,In Situ Lesion,Noninfiltrating Intraductal Carcinoma
11940,Secondary Lesion,Secondary malignant neoplasm of colon
11941,Mural Nodule,Ovarian Mucinous Cystic Tumor with Mural Nodules
11942,Nodular Pattern,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
11943,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia with Eosinophilia
11944,Pseudoencapsulated Mass,Metastatic Malignant Peripheral Nerve Sheath Tumor
11945,Recurrent disease,Colorectal cancer recurrent
11946,Nodular Pattern,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma
11947,Pseudoencapsulated Mass,Recurrent Malignant Peripheral Nerve Sheath Tumor
11948,Carcinomatous Component Present,Sebaceous Breast Carcinoma
11949,Blasts Under 5 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1
11950,High Grade Lesion,Stage IB Lung Small Cell Carcinoma AJCC v7
11951,Storiform Growth Pattern,Dermatofibrosarcoma Protuberans
11952,Intraluminal Tumor Growth,Intracystic papillary neoplasm with low grade intraepithelial neoplasia
11953,Epithelial Component Present,Adenoid cystic carcinoma of parotid gland
11954,Dysplasia,villous adenoma of stomach
11955,Rapidly Enlarging Mass,Fusion-Negative Rhabdomyosarcoma
11956,Cutaneous Involvement,Senile nevus
11957,Epithelial Component Present,Vaginal Keratinizing Squamous Cell Carcinoma
11958,Diffuse Pattern,Pleural Biphasic Mesothelioma
11959,Epithelial Component Present,papillary squamous cell carcinoma of larynx
11960,Ineffective hematopoiesis,Myelodysplastic Syndrome with Isolated del(5q)
11961,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
11962,Recurrent disease,Recurrent respiratory papillomatosis
11963,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Medulla
11964,Absence of Invasion,Carcinoma in situ of trachea
11965,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Overt Primary Myelofibrosis
11966,Mass of body structure,Granulocytic Sarcoma
11967,Nerve palsy,Oculomotor Nerve Paralysis
11968,Nodular Pattern,Hodgkin's disease nodular sclerosis stage IV
11969,Carcinomatous Component Present,Papillary transitional cell carcinoma
11970,Papillary Pattern,Primary serous papillary carcinoma of peritoneum
11971,Monomorphic Cellular Infiltrate,Esophageal Basaloid Carcinoma
11972,Epithelial Component Present,Stage III Adult Liver Cancer AJCC v7
11973,Indolent Clinical Course,Central Nervous System Lipoma
11974,Mesenchymal Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
11975,Carcinomatous Component Present,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation
11976,Chronic lymphocytic inflammation,"Thymoma, type AB"
11977,Exophytic Papillary Lesion,Condyloma Acuminatum with Dysplasia
11978,Below the Diaphragm Disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic
11979,Refractory Disease,Diffuse large B-cell lymphoma refractory
11980,Pseudopapillary Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
11981,Carcinomatous Component Present,clear cell adenocarcinoma of gallbladder
11982,Mixed Cellular Population,Atypical polypoid adenomyoma
11983,Edematous Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma"
11984,Pseudoglandular Pattern,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
11985,Well-Circumscribed Lesion,tubulovillous adenoma of stomach
11986,Non-Contiguous Disease,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma
11987,Composite Lesion,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
11988,Adnexal Differentiation,Malignant Proliferating Pilar Tumor
11989,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma
11990,Deep Lesion,Aggressive angiomyxoma
11991,S-100-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma
11992,Concentric Perivascular Arrangement of Tumor Cells,Myopericytoma
11993,Carcinomatous Component Present,Hepatitis C Virus-Related Hepatocellular Carcinoma
11994,Indolent Clinical Course,Steroid Lipomatosis
11995,Nodular lesions,Malignant carcinoid tumor of lung
11996,Carcinomatous Component Present,Breast Solid Neuroendocrine Carcinoma
11997,Neuroendocrine Differentiation,Breast Solid Neuroendocrine Carcinoma
11998,Absence of Stromal Invasion,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
11999,Papillary Pattern,Follicular Variant Thyroid Gland Papillary Carcinoma
12000,Cysts Containing Proteinaceous Fluid Present,Serous papillary cystic tumor of borderline malignancy
12001,Epithelial Component Present,Stage I Colon Cancer AJCC v6 and v7
12002,Indolent Clinical Course,Uterine Corpus Epithelioid Leiomyoma
12003,Immature Granulocytes in Peripheral Blood Increased,Juvenile Myelomonocytic Leukemia
12004,Perineural spread,Cervical Adenoid Cystic Carcinoma
12005,Neuroendocrine Differentiation,Uterine Corpus Carcinoid Tumor
12006,Therapy-Related Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
12007,Carcinomatous Component Present,"Carcinoma, Ovarian Epithelial"
12008,Fibrous Septa Present,Dysgerminoma of ovary
12009,Malignant Cellular Infiltrate,Endodermal sinus tumor of ovary
12010,Epithelial Component Present,Recurrent Urethral Cancer
12011,Absence of Invasion,Lobular Neoplasia Type B
12012,Carcinomatous Component Present,Duodenal carcinoma recurrent
12013,Recurrent disease,Lentigo maligna recurrent
12014,Ineffective hematopoiesis,Therapy-related acute myeloid leukemia and myelodysplastic syndrome
12015,Epithelial Component Present,Colon Neuroendocrine Neoplasm
12016,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type C"
12017,Epithelial Component Present,Appendix Traditional Serrated Adenoma
12018,Cervical lymphadenopathy,Sinus histiocytosis
12019,Hereditary Lesion,Gardner Syndrome
12020,Carcinomatous Component Present,Stage III Vulvar Cancer AJCC v7
12021,Carcinomatous Component Present,Invasive papillary breast carcinoma
12022,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v6
12023,Epithelial Component Present,Vaginal Villous Adenoma
12024,Epithelial Component Present,Cervical Clear Cell Adenocarcinoma
12025,Epithelial Component Present,Glucagonoma
12026,Infiltrative Growth Pattern,Adult Gliosarcoma
12027,Cutaneous Involvement,Benign neoplasm of sebaceous gland
12028,Anaplasia,Childhood Cerebral Anaplastic Astrocytoma
12029,Childhood Lesion,Childhood Acute Myeloid Leukemia with Minimal Differentiation
12030,Epithelial Component Present,Ampulla of Vater Tubulovillous Adenoma
12031,Exophytic Polypoid Lesion,Polyp of maxillary sinus
12032,Mild cytologic atypia,Anal Verrucous Carcinoma
12033,Glial Differentiation,Childhood Brain Stem Gliosarcoma
12034,Epithelial Component Present,Adrenal Gland Pheochromocytoma
12035,Diffuse Pattern,Low Grade Malignant Peripheral Nerve Sheath Tumor
12036,Secondary Lesion,Secondary malignant neoplasm of spinal cord
12037,Hyaline Cartilage Differentiation,Grade I Chondrosarcoma
12038,Neuroendocrine Differentiation,Duodenal Gastrin-Producing Neuroendocrine Tumor
12039,Tissue Differentiation Uncertain,Myxoma of the Endocardium
12040,Cutaneous Involvement,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder
12041,Carcinomatous Component Present,Localized Resectable Adult Liver Carcinoma
12042,Exophytic Polypoid Lesion,Rectal Adenoma with Severe Dysplasia
12043,Nuclear Grooves,Nonencapsulated sclerosing tumor
12044,Monomorphic Cellular Infiltrate,oligodendroglioma
12045,Alternative Fascicle (Bundle) Pattern,Myxoid leiomyoma
12046,Epithelial Component Present,Functioning Pituitary Gland Macroadenoma
12047,Cystic Change,Cystic Neoplasm
12048,Monoclonal Cellular Population Present,Pure Cutaneous Mastocytosis
12049,Cartilaginous Differentiation,Grade III Chondrosarcoma
12050,Hyperchromatism,Hepatocellular Small Cell Change
12051,Neuroendocrine Differentiation,Gallbladder Tubular Carcinoid
12052,Epithelial Component Present,Small Intestinal Neuroendocrine Tumor
12053,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion
12054,Osteoid formation,Mediastinal Extraskeletal Osteosarcoma
12055,Carcinomatous Component Present,Stage IV Breast Cancer AJCC v6 and v7
12056,Malignant Component Present,Ovarian Dermoid Cyst with Melanoma
12057,Immunologic Deficiency Syndromes,"Leukoplakia, Hairy"
12058,Collagenous Stroma Formation,Alveolar adenoma
12059,Epithelial Component Present,Recurrent Pancreatic Neuroendocrine Carcinoma
12060,Carcinomatous Component Present,Cloacogenic carcinoma
12061,Monoclonal Eosinophils Present,Chronic eosinophilic leukemia
12062,Adulthood Lesion,Adult Acute Basophilic Leukemia
12063,Carcinomatous Component Present,Oropharyngeal lymphepithelioma
12064,Monomorphic Cellular Infiltrate,basaloid carcinoma of anus
12065,Cutaneous Involvement,"Cicatrix, Hypertrophic"
12066,Carcinomatous Component Present,Cervical Basaloid Carcinoma
12067,Folliculotropic Lymphocytic Infiltrate,Follicular mycosis fungoides
12068,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of the cecum
12069,Carcinomatous Component Present,Lung Basaloid Large Cell Carcinoma
12070,Thin Bands of Collagen Present,Dedifferentiated Solitary Fibrous Tumor
12071,Exophytic Polypoid Lesion,Peutz Jehgers polyp
12072,Absence of Invasion,Pre-Malignant Skin Epithelial Lesion
12073,Well-Circumscribed Lesion,Clear Cell Papillary Cystadenoma
12074,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage
12075,Radiation Sickness,Radiation damage to artery
12076,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia
12077,Peripheral Blood Involvement,Leukemic Phase of Non-Hodgkin's Lymphoma
12078,Keratin pearl formation,Lung Basaloid Squamous Cell Carcinoma
12079,Childhood Lesion,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement
12080,Hyperplastic Tissue Present,Papillary Ductal Breast Hyperplasia
12081,Dysplasia,High Grade Penile Intraepithelial Neoplasia
12082,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma
12083,Epithelial Component Present,Salivary duct carcinoma
12084,Carcinomatous Component Present,Salivary duct carcinoma
12085,Epithelial Component Present,Multiple Endocrine Neoplasia Type 2b
12086,Metastatic/Recurrent Disease,Epithelioid sarcoma non-metastatic
12087,Stromal Invasion,Small cell carcinoma of ovary
12088,Metastatic/Recurrent Disease,Gastric Synovial Sarcoma
12089,In Situ Lesion,Biliary Intraepithelial Neoplasia-3
12090,Epithelial Component Present,Thymic Papillary Adenocarcinoma
12091,Locally Aggressive Lesion,Urinary Bladder Inflammatory Myofibroblastic Tumor
12092,Recurrent disease,Recurrent Anaplastic Large Cell Lymphoma
12093,Monomorphic Cellular Infiltrate,Papillary ependymoma
12094,Childhood Lesion,Childhood Periosteal Osteosarcoma
12095,Indolent Clinical Course,Intramuscular Myxoma
12096,Bone Marrow Dysplasia Present,Adult Myelodysplastic Syndrome
12097,Tissue Differentiation Uncertain,Malignant Soft Tissue Tumor of Uncertain Differentiation
12098,Foveolar-Type Epithelium Present,Foveolar-Type Adenoma
12099,Carcinomatous Component Present,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
12100,Indolent Clinical Course,Benign Cutaneous Fibroblastic Neoplasm
12101,Tissue Differentiation Uncertain,Myxoma
12102,Cartilaginous Differentiation,Juxtacortical chondroma
12103,Indolent Clinical Course,Hemolymphangioma
12104,Indolent Clinical Course,Subungual exostoses
12105,Cartilaginous Differentiation,Central Nervous System Chondroma
12106,Myxoid Stroma Formation,Myxoid chondrosarcoma
12107,Congenital Lesion,Blue rubber bleb nevus syndrome
12108,Hyalinized Stroma Formation,Pleural Epithelioid Hemangioendothelioma
12109,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Aleukemic Monocytic Leukemia Cutis
12110,Secondary Lesion,Secondary malignant neoplasm of chest wall
12111,Acanthosis,Verrucous carcinoma
12112,Epithelial Component Present,Apocrine Breast Carcinoma In Situ
12113,Epithelial Component Present,Stage IB Esophageal Cancer AJCC v7
12114,Squamous Metaplasia of Malignant Cells Present,Adenocarcinoma with squamous metaplasia
12115,Carcinomatous Component Present,Undifferentiated Carcinoma of Colon
12116,Carcinomatous Component Present,Stage IIIB Appendix Carcinoma AJCC v7
12117,Anaplasia,Systemic Anaplastic Large Cell Lymphoma
12118,High Grade Lesion,Small cell carcinoma of lung
12119,Infiltrative Growth Pattern,Morpheic basal cell carcinoma
12120,Calcitonin serum level increased,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
12121,Dysplasia,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia
12122,Chromogranin A Positive Neoplastic Cells Present,Ovarian Insular Carcinoid Tumor
12123,Composite Lesion,Recurrent Combined Thymic Epithelial Neoplasm
12124,Carcinomatous Component Present,"Carcinoma, Cribriform"
12125,Epithelial Component Present,"Adenocarcinoma of lung, stage I"
12126,Adulthood Lesion,Recurrent Adult Non-Hodgkin Lymphoma
12127,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia T/myeloid
12128,Indolent Clinical Course,Cardiac Intramuscular Hemangioma
12129,Unresectable Mass,Localized Unresectable Neuroblastoma
12130,Childhood Lesion,Childhood Extragonadal Malignant Germ Cell Tumor
12131,Diffuse Pattern,Pyothorax-Associated Lymphoma
12132,Carcinomatous Component Present,Labia Majora Carcinoma
12133,Well-Circumscribed Lesion,Nephroblastoma
12134,Epithelial Component Present,Tubular adenoma of breast
12135,Carcinomatous Component Present,Colon Carcinoma
12136,Carcinomatous Component Present,Esophageal Cancer by AJCC v6 Stage
12137,Metastatic/Recurrent Disease,Liver Synovial Sarcoma
12138,Cutaneous Involvement,Squamous cell carcinoma of skin
12139,Herringbone Growth Pattern,Conventional Fibrosarcoma
12140,Multifocal Lesion,Multiple hamartoma of lung
12141,Secondary Lesion,Secondary Malignant Neoplasm
12142,Hyperplastic Tissue Present,Atypical hyperplasia of breast
12143,Cystic Change,Borderline Ovarian Endometrioid Cystadenofibroma
12144,Epithelial Component Present,Transitional Cell Intraepithelial Neoplasia
12145,Epithelial Component Present,clear cell adenocarcinofibroma of ovary
12146,Papillary Pattern,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
12147,Papillary Pattern,Condyloma anal
12148,Adulthood Lesion,Adult Atypical Meningioma
12149,Carcinomatous Component Present,Malignant Mixed Mesodermal (Mullerian) Tumor
12150,Carcinomatous Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
12151,Myxoid Stroma Formation,Adult Epithelioid Hemangioendothelioma
12152,Carcinomatous Component Present,Stage IV Liver Cancer
12153,Carcinomatous Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7
12154,Vascular Channel Formation,Kaposi's sarcoma of penis
12155,Primary Lesion,Pineal Gland Astrocytoma
12156,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Heterologous Type"
12157,Fibrosis,Primary mediastinal large B-cell lymphoma recurrent
12158,Pseudoglandular Pattern,Childhood Ovarian Embryonal Carcinoma
12159,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage II
12160,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma stage III
12161,Carcinomatous Component Present,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
12162,Chronic lymphocytic inflammation,Pleomorphic Xanthoastrocytoma
12163,Slow Growing Painless Mass,calcifying aponeurotic fibroma
12164,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
12165,Infiltrative Growth Pattern,Multifocal Glioblastomas
12166,Epithelial Component Present,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
12167,Hereditary Lesion,"Anemia, Diamond-Blackfan"
12168,Epithelial Component Present,Head and neck cancer metastatic
12169,Carcinomatous Component Present,Stage III Carcinoma of Stomach
12170,Carcinomatous Component Present,Stage IV Vaginal Cancer AJCC v6 and v7
12171,Carcinomatous Component Present,Tubulocystic renal cell carcinoma
12172,Exophytic Polypoid Lesion,Colorectal Sporadic Serrated Polyp
12173,Carcinomatous Component Present,Squamous cell carcinoma of conjunctiva
12174,Osteoid formation,Osteoblastic Osteosarcoma
12175,Absence of Invasion,Carcinoma in situ of penis
12176,Indolent Clinical Course,Mediastinal Lymphangioma
12177,Epithelial Component Present,Childhood Adrenal Gland Pheochromocytoma
12178,Acanthosis,Subglottic Verrucous Carcinoma
12179,Epithelial Component Present,Small cell carcinoma of esophagus
12180,Carcinomatous Component Present,Grade 2 Endometrial Mucinous Adenocarcinoma
12181,Localized Lesion,Chondrosarcoma localised
12182,Epithelial Component Present,Oropharyngeal squamous cell carcinoma recurrent
12183,Pseudoglandular Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern"
12184,Primary Lesion,lymphoma of spinal cord
12185,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma recurrent
12186,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage I
12187,In Situ Lesion,Squamous Cell Carcinoma In Situ of the Nipple
12188,Immunoglobulin Deposition,Heavy Chain Deposition Disease
12189,Epithelial Component Present,"Basal cell carcinoma, micronodular"
12190,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage III
12191,Well-Circumscribed Lesion,Fibroma of tendon sheath
12192,Subcutaneous Involvement,"Histiocytoma, Angiomatoid Fibrous"
12193,Cutaneous Involvement,Skin Pseudovascular Squamous Cell Carcinoma
12194,Epithelial Component Present,Skin Pseudovascular Squamous Cell Carcinoma
12195,Epithelial Component Present,Familial medullary thyroid carcinoma
12196,Epithelial Component Present,BCLC Stage 0 Hepatocellular Carcinoma
12197,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v7
12198,Cystic Change,Breast Mucinous Cystadenocarcinoma
12199,Epithelial Component Present,Stage IA Vulvar Cancer AJCC v7
12200,High Grade Lesion,"Liposarcoma, Dedifferentiated"
12201,Cutaneous Involvement,Cutaneous Melanoma by AJCC v7 Stage
12202,Epithelial Component Present,Grade 3 Rectal Adenocarcinoma
12203,Carcinomatous Component Present,Localized Resectable Adult Hepatocellular Carcinoma
12204,Epithelial Component Present,Metaplastic carcinoma
12205,Low Mitotic Activity,Transverse Colon Neuroendocrine Tumor G1
12206,Dysplasia,Appendix Intraepithelial Neoplasia
12207,Carcinomatous Component Present,Bladder transitional cell carcinoma stage III
12208,Chromogranin A Positive Neoplastic Cells Present,Ascending Colon Neuroendocrine Tumor G1
12209,Collagenous Stroma Formation,Vulvar Angiomyofibroblastoma
12210,Carcinomatous Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
12211,Epithelial Component Present,Stage IV Ureter Cancer AJCC v7
12212,Secondary Lesion,Endometrial adenocarcinoma metastatic
12213,Epithelial Component Present,Cystadenocarcinoma
12214,Childhood Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement
12215,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
12216,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with unilineage dysplasia
12217,Neuroectodermal Differentiation,"Ganglioneuroblastoma, Nodular"
12218,Hemorrhagic,Thyroid Angiosarcoma
12219,Radiation Sickness,Radiation-Induced Cerebritis
12220,Tissue Differentiation Uncertain,"Perivascular epithelioid tumor, malignant"
12221,Exophytic Papillary Lesion,Buccal Mucosa Verrucous Carcinoma
12222,Dense Collagenized Tissue Present,Desmoplastic mesothelioma
12223,Adulthood Lesion,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma
12224,Whorling Growth Pattern,"Dendritic Cell Sarcoma, Follicular"
12225,Perivascular Arrangement of Tumor Cells,Benign Glomus Tumor
12226,Capillary Sized Vascular Channel Formation,canalicular adenoma of salivary gland
12227,Epithelial Component Present,Sebaceous Adenocarcinoma
12228,Secondary Lesion,Metastatic Lobular Breast Carcinoma
12229,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Grade 1 Endometrial Endometrioid Adenocarcinoma
12230,Exophytic Polypoid Lesion,Colon Hyperplastic Polyp
12231,Carcinomatous Component Present,Human Papillomavirus-Related Carcinoma
12232,Anaplasia,Diencephalic Glioblastoma
12233,Eosinophil count raised (finding),B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH
12234,Adulthood Lesion,Adult Germ Cell Tumor
12235,Thyroglobulin Positive Neoplastic Cells Present,Microfollicular adenoma
12236,Mitotic Activity,gliosarcoma
12237,Cutaneous Involvement,Acral Lentiginous Malignant Melanoma
12238,Recurrent disease,Recurrent tumors of the Ewing's family
12239,Well Differentiated Lesion,"Retinoblastoma, differentiated"
12240,Neuroectodermal Differentiation,Recurrent Peripheral Primitive Neuroectodermal Tumor
12241,Lymphatic Spread,Inflammatory carcinoma of breast recurrent
12242,Childhood Lesion,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
12243,Concentric Aggregates of Intermediate Filaments Present,Acidophil Stem Cell Pituitary Gland Adenoma
12244,Carcinomatous Component Present,CARCINOMA OF VULVA
12245,Epithelial Component Present,Stage IV Paranasal Sinus Cancer AJCC v7
12246,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage I
12247,Cystic Change,Borderline Ovarian Serous Cystadenofibroma
12248,Childhood Lesion,Childhood Mixed Cellularity Classic Hodgkin Lymphoma
12249,Epithelial Component Present,Undifferentiated Fallopian Tube Carcinoma
12250,Epithelial Component Present,Stage IIA Gastric Cancer AJCC v7
12251,Sarcomatous Component Present,carcinosarcoma of lung
12252,Well-Circumscribed Lesion,Rhabdomyoma
12253,Epithelial Component Present,Rectal Adenosquamous Carcinoma
12254,Macrocystic Change,Pancreatic Macrocystic Serous Cystadenoma
12255,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor
12256,Epithelial Component Present,Hepatocellular Adenoma
12257,Epithelial Component Present,Contralateral Breast Carcinoma
12258,Epithelial Component Present,Renal Cell Carcinoma Associated with Neuroblastoma
12259,Pseudopapillary Pattern,embryonal carcinoma of mediastinum
12260,Papillary Pattern,"Papillary renal cell carcinoma, sporadic"
12261,Epithelial Component Present,Stage IV Pancreatic Cancer AJCC v6 and v7
12262,Epithelial Component Present,Carcinoma of soft palate
12263,Carcinomatous Component Present,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions
12264,Epithelial Component Present,Carcinoma of submandibular gland
12265,Hyperkeratosis,Laryngeal verrucous carcinoma recurrent
12266,Carcinomatous Component Present,Stage IIIB Lung Large Cell Carcinoma AJCC v7
12267,Neuroendocrine Differentiation,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
12268,Carcinomatous Component Present,lipid-rich carcinoma of breast
12269,Recurrent disease,Esophageal squamous cell carcinoma recurrent
12270,Collagenous Stroma Formation,Chest Wall Fibromatosis
12271,Carcinomatous Component Present,Prostate Adenosquamous Carcinoma
12272,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v7
12273,Epithelial Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7
12274,Trabecular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
12275,Primary Lesion,Stage I Osteosarcoma AJCC v7
12276,Well-Circumscribed Lesion,Cervix adenomatous polyp
12277,Neuroendocrine Differentiation,Neuroendocrine neoplasm of gallbladder
12278,Rapidly Enlarging Mass,Ovarian Rhabdomyosarcoma
12279,atypia morphology,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor
12280,Severe dysplasia,Bowen's Disease
12281,Immunologic Deficiency Syndromes,Ann Arbor Stage IV AIDS-Related Lymphoma
12282,atypia morphology,Borderline Fallopian Tube Mucinous Tumor
12283,Carcinomatous Component Present,Stage III Renal Cell Cancer AJCC v7
12284,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
12285,Papillary Pattern,Oncocytic Schneiderian papilloma
12286,Koilocytotic atypia,Vaginal Warty Carcinoma
12287,Dysplasia,Colorectal Adenoma with Moderate Dysplasia
12288,Carcinomatous Component Present,Multifocal breast carcinoma
12289,Epithelial Component Present,Recurrent Lung Carcinoma Cell Type Unspecified
12290,Cutaneous Involvement,Erythema toxicum neonatorum
12291,Hereditary Lesion,Hereditary Female Breast Carcinoma
12292,Osseous Differentiation,Stage IA Osteosarcoma AJCC v7
12293,Carcinomatous Component Present,Transplant-Related Renal Cell Carcinoma
12294,Epithelial Component Present,Papillary serous cystadenocarcinoma
12295,Epithelial Component Present,Intraepithelial Squamous Cell Carcinoma
12296,Absence of Invasion,Intraepithelial Squamous Cell Carcinoma
12297,Epithelial Component Present,Stage II Rectosigmoid Cancer AJCC v7
12298,Carcinomatous Component Present,Stage II Rectosigmoid Cancer AJCC v7
12299,Glandular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
12300,Well Differentiated Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
12301,Epithelial Component Present,Undifferentiated carcinoma of nasopharynx
12302,Carcinomatous Component Present,Vaginal Adenoid Cystic Carcinoma
12303,Necrotic changes (finding),Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
12304,Monomorphic Cellular Infiltrate,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation
12305,In Situ Lesion,High Grade Ductal Breast Carcinoma In Situ
12306,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
12307,Microcystic Change,Childhood Fibrillary Astrocytoma
12308,Geographic Necrosis,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
12309,High Mitotic Activity,Vaginal Undifferentiated Sarcoma
12310,Papillary Pattern,intraductal micropapillary carcinoma of breast
12311,Serrated Glandular Architecture,Traditional Serrated Adenoma
12312,Diffuse Pattern,Pleural Epithelioid Mesothelioma
12313,Myxoid Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma"
12314,In Situ Lesion,Carcinoma in Situ
12315,Mitotic Activity,Childhood Giant Cell Glioblastoma
12316,Recurrent disease,Malignant neoplasm of stomach recurrent
12317,Epithelial Component Present,ENSAT Stage III Adrenal Cortex Carcinoma
12318,Childhood Lesion,Childhood Diffuse Astrocytoma
12319,Neuroectodermal Differentiation,Neuroblastoma
12320,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Adult Erythroleukemia
12321,Exophytic Papillary Lesion,Common wart
12322,Villous Pattern,Ampulla of Vater Villous Adenoma
12323,Chromogranin A Positive Neoplastic Cells Present,Malignant carcinoid tumor of lung
12324,Carcinomatous Component Present,Carcinosarcoma of ovary
12325,Indolent Clinical Course,fibroma of testis
12326,Cystic Change,Papillary mucinous cystadenoma
12327,Epithelial Component Present,Uterine Corpus Carcinoid Tumor
12328,Adulthood Lesion,Adult Subependymoma
12329,Epithelial Component Present,Ovarian Carcinoid Tumor
12330,Neuroendocrine Differentiation,Thymic Typical Carcinoid Tumor
12331,Well-Circumscribed Lesion,"Papillary mucinous cystadenoma, borderline malignancy"
12332,Carcinomatous Component Present,Laryngeal Adenosquamous Carcinoma
12333,Invasive Lesion,"Hydatidiform Mole, Invasive"
12334,Alternative Fascicle (Bundle) Pattern,Prostate Leiomyoma
12335,Epithelial Component Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
12336,Cellular Pleomorphism,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
12337,Perivascular Arrangement of Tumor Cells,Epithelioid Type Angiomyolipoma
12338,Diffuse Pattern,Glioblastoma with Primitive Neuronal Component
12339,Carcinomatous Component Present,Occult Lung Large Cell Carcinoma
12340,Squamous metaplasia,Parotid Gland Warthin Tumor
12341,Infiltrating Tumor Margins Present,Ovarian Low Grade Endometrioid Stromal Sarcoma
12342,Carcinomatous Component Present,Recurrent Urethral Cancer
12343,Necrotic changes (finding),Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
12344,Carcinomatous Component Present,Solar Radiation-Related Skin Squamous Cell Carcinoma
12345,Indolent Clinical Course,Cellular leiomyoma
12346,Hypercellular bone marrow,"Myeloid Leukemia, Chronic"
12347,Monoclonal Cellular Population Present,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease"
12348,Neuroendocrine Differentiation,Rectal Neuroendocrine Neoplasm
12349,Generalized Dysplasia,Appendix Traditional Serrated Adenoma
12350,Papillary Pattern,Papillary serous cystadenoma
12351,Epithelial Component Present,Minor Salivary Gland Squamous Cell Carcinoma
12352,Carcinomatous Component Present,Grade 1 Rectal Adenocarcinoma
12353,Indolent Clinical Course,Gastric Lipoma
12354,Vascular Channel Formation,AIDS-Related Gastric Kaposi Sarcoma
12355,Primary Lesion,Childhood Cerebellar Anaplastic Astrocytoma
12356,Alternative Fascicle (Bundle) Pattern,Laryngeal Leiomyoma
12357,Epithelial Component Present,Serous surface papillary carcinoma
12358,Carcinomatous Component Present,Grade 1 Colon Adenocarcinoma
12359,Childhood Lesion,Childhood Kidney Angiomyolipoma
12360,Neuroendocrine Differentiation,Localized Adrenal Gland Pheochromocytoma
12361,'Starry-sky' pattern,Stage I Burkitt Lymphoma
12362,Biphasic Pattern,Adult Gliosarcoma
12363,Villous Pattern,Ampulla of Vater Tubulovillous Adenoma
12364,Myxoid Stroma Formation,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
12365,Epithelial Component Present,Growth Hormone-Secreting Pituitary Adenoma
12366,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Carcinoma
12367,Severe dysplasia,Intermediate Grade Ductal Breast Carcinoma In Situ
12368,Mixed Cellular Population,Testicular gonadoblastoma
12369,Nidus Formation,Osteoid osteoma
12370,Carcinomatous Component Present,Familial Nonmedullary Thyroid Gland Carcinoma
12371,Adnexal Differentiation,Adenoid cystic eccrine carcinoma
12372,Neuroendocrine Differentiation,Orbit Paraganglioma
12373,Epithelial Component Present,Skin Basal Cell Carcinoma with Sebaceous Differentiation
12374,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of extrahepatic bile duct
12375,More than 10 Mitoses per 10HPF,Occult Lung Small Cell Carcinoma
12376,Epithelial Component Present,Minor Salivary Gland Mucoepidermoid Carcinoma
12377,'Starry-sky' pattern,Gastric Burkitt Lymphoma
12378,Epithelial Component Present,Larynx carcinoma recurrent
12379,Carcinomatous Component Present,Skin Sarcomatoid Basal Cell Carcinoma
12380,Epithelial Component Present,Transitional Cell Neoplasm
12381,Invasive Lesion,Invasive Prostate Carcinoma
12382,Low Grade Lesion,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
12383,Carcinomatous Component Present,Stage IB Gastric Carcinoma
12384,Exophytic Polypoid Lesion,Polyp of large intestine
12385,Vascular Channel Formation,Mediastinal Angiosarcoma
12386,In Situ Lesion,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
12387,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis
12388,Carcinomatous Component Present,Pleural Carcinomatosis
12389,Recurrent disease,Recurrent Childhood Visual Pathway Astrocytoma
12390,Epithelial Component Present,Infiltrating basal cell carcinoma
12391,Epithelial Component Present,Stage IV Breast Cancer AJCC v6 and v7
12392,Trabecular Pattern,Thyroid Hyalinizing Trabecular Adenoma
12393,Invasive Lesion,Invasive carcinoma of breast
12394,Indolent Clinical Course,Mammary-Type Myofibroblastoma
12395,Indolent Clinical Course,Bone island
12396,Epithelial Component Present,Cervical Keratinizing Squamous Cell Carcinoma
12397,Borderline Lesion,Pancreatic intraepithelial neoplasia
12398,Exophytic Polypoid Lesion,Gingival fibroepithelial polyp
12399,Epithelial Component Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
12400,Carcinomatous Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v7
12401,Epithelial Component Present,Stage I Anal Canal Cancer AJCC v6 and v7
12402,Carcinomatous Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v7
12403,Hyperkeratosis,"Papillary squamous cell carcinoma, non-invasive"
12404,CD56-Positive Neoplastic Cells Present,Monomorphic epitheliotropic intestinal T-cell lymphoma
12405,Crystal deposition,Childhood Alveolar Soft Part Sarcoma
12406,Cystic Change,Clear Cell Papillary Cystadenoma
12407,Papillary Pattern,Inverted Squamous Cell Papilloma
12408,Antoni A Pattern,Benign Dermal Schwannoma
12409,Carcinomatous Component Present,Stage IA Breast Cancer AJCC v7
12410,Metastatic/Recurrent Disease,Alveolar soft part sarcoma non-metastatic
12411,Epithelial Component Present,Biliary Intraepithelial Neoplasia-1
12412,Epithelial Component Present,Thyroid Gland Adenocarcinoma
12413,Indolent Clinical Course,Uterine Corpus Diffuse Leiomyomatosis
12414,Epithelial Component Present,Stage II Vaginal Cancer AJCC v6 and v7
12415,Diffuse Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
12416,Fibrotic Stroma Formation,Major Salivary Gland Mucoepidermoid Carcinoma
12417,High Grade Lesion,Alveolar soft part sarcoma recurrent
12418,Childhood Lesion,Childhood Small Intestinal Carcinoma
12419,Metastatic/Recurrent Disease,"Synovial sarcoma, epithelioid cell"
12420,Adulthood Lesion,Adult T-cell lymphoma/leukemia recurrent
12421,Encapsulated Mass,Thyroid Gland Hyperfunctioning Adenoma
12422,Papillary Pattern,Upper Gingival Verrucous Carcinoma
12423,Epithelial Component Present,Sinonasal undifferentiated carcinoma
12424,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
12425,Cambium Layer,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
12426,Vascular Channel Formation,Hemangioma
12427,Dysplasia,Dysplasia of anus
12428,Primary Lesion,Cerebellar Astrocytoma
12429,Epithelial Component Present,Low Grade Gastric Intraepithelial Neoplasia
12430,Cutaneous Involvement,Recurrent Lip Basal Cell Carcinoma
12431,High Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Carcinoma
12432,Anaplasia,Anaplastic astrocytoma
12433,Primary Lesion,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative"
12434,Recurrent disease,Recurrent Lip and Oral Cavity Carcinoma
12435,Biphasic Pattern,Intracanalicular fibroadenoma
12436,Pregnancy Complications,Cesarean Scar Pregnancy
12437,Hyaline Cartilage Differentiation,Myxoid chondrosarcoma
12438,Infiltrative Growth Pattern,Anaplastic Brain Stem Astrocytoma
12439,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v7
12440,Papillary Pattern,Intraductal papillomatosis
12441,Cutaneous Involvement,Tufted angioma of skin
12442,Submucosal Tumor Growth,"Carcinoid, Goblet Cell"
12443,Primary Lesion,Anaplastic Brain Stem Glioma
12444,Childhood Lesion,Childhood Germ Cell Tumor
12445,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v7
12446,Local disease,lipoma of extrahepatic bile duct
12447,Epithelial Component Present,High Grade Fallopian Tube Serous Adenocarcinoma
12448,Carcinomatous Component Present,Small cell neuroendocrine carcinoma of bladder
12449,Metastatic Lesion,Secondary malignant neoplasm of lip
12450,Minimally Invasive Lesion,Minimally Invasive Thymoma
12451,Stromal Invasion,"Ovarian Small Cell Carcinoma, Pulmonary Type"
12452,Carcinomatous Component Present,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7
12453,Cutaneous Involvement,Skin disorder arising from mental factors
12454,Carcinomatous Component Present,Invasive Cribriform Breast Carcinoma
12455,Multinodular Mass,Prostate Angiosarcoma
12456,Carcinomatous Component Present,large cell neuroendocrine carcinoma of anal canal
12457,Epithelial Component Present,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
12458,Well-Circumscribed Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
12459,Primary Lesion,Childhood Brain Stem Glioma
12460,Cutaneous Involvement,Apocrine Neoplasm
12461,Angiocentric Pattern,Angiocentric glioma
12462,Epithelial Component Present,Stage II Breast Cancer AJCC v6 and v7
12463,Multifocal Lesion,Synchronous Multifocal Osteosarcoma
12464,Epithelial Component Present,Stage IIIB Cervical Cancer AJCC v6 and v7
12465,Epithelial Component Present,Recurrent Adult Liver Carcinoma
12466,Metastatic Lesion,Pseudomyxoma Peritonei
12467,Epithelial Component Present,Wolffian tumor
12468,Carcinomatous Component Present,Stage IA2 Cervical Cancer
12469,Epithelial Component Present,Chief cell adenoma
12470,Neuroectodermal Differentiation,PNET of bone localized
12471,Carcinomatous Component Present,Stage IB Cervical Cancer AJCC v6 and v7
12472,Epithelial Component Present,verrucous carcinoma of vagina
12473,Hyaline Cartilage Differentiation,Dedifferentiated chondrosarcoma
12474,Carcinomatous Component Present,Stage 0 Ureter Cancer AJCC v7
12475,Cystic Change,Ovarian Endometrioid Cystadenoma
12476,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,"Leukemia, Prolymphocytic, B-Cell"
12477,Cutaneous Involvement,Benign Breast Eccrine Spiradenoma
12478,Indolent Clinical Course,Genital rhabdomyoma
12479,Epithelial Component Present,Esophageal Cancer by AJCC v6 Stage
12480,Epithelial Component Present,Stage IA Ovarian Cancer
12481,Microinvasive tumor,"Squamous cell carcinoma, microinvasive"
12482,Increased Cellularity Present,Grade III Childhood Astrocytoma
12483,Solitary mass,Solitary Osseous Plasmacytoma
12484,Indolent Clinical Course,Extrahepatic Bile Duct Fibroma
12485,Increased Cellularity Present,"Perineurioma, malignant"
12486,Oligodendroglial Component Present,Adult Anaplastic Oligodendroglioma
12487,Carcinomatous Component Present,Stage III Distal Bile Duct Cancer AJCC v7
12488,Preserved Nuclear Polarity,Papillary transitional cell neoplasm of low malignant potential
12489,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with hyperdiploidy
12490,Epithelial Component Present,Urethral Carcinoma
12491,Carcinomatous Component Present,Urethral Carcinoma
12492,Exophytic Polypoid Lesion,Cervical Microglandular Polyp
12493,Indolent Clinical Course,Kidney Lipoma
12494,Refractory Disease,Lymphoplasmacytoid lymphoma/immunocytoma refractory
12495,Argentaffin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
12496,Carcinomatous Component Present,Colorectal Squamous Cell Carcinoma
12497,Recurrent disease,Recurrent Adult Lymphoblastic Lymphoma
12498,Carcinomatous Component Present,Unresectable Hepatocellular Carcinoma
12499,Hereditary Lesion,Shwachman syndrome
12500,Epithelial Component Present,Stage I Skin Cancer
12501,Carcinomatous Component Present,BCLC Stage D Hepatocellular Carcinoma
12502,Follicular Cell Differentiation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
12503,Bone Marrow Dysplasia Present,Childhood Myelodysplastic Syndrome
12504,Low Grade Lesion,Epithelioid hemangioendothelioma of lung
12505,Epithelial Component Present,Perihilar Intrahepatic Cholangiocarcinoma
12506,Cutaneous Involvement,Eruptive collagenoma
12507,Endophytic Tumor Growth,keratoacanthoma
12508,Carcinomatous Component Present,Malignant neoplasm of stomach stage III
12509,Microvascular Proliferation,Adult Pilocytic Astrocytoma
12510,Epithelial Component Present,Non-small cell lung cancer stage III
12511,Epithelial Component Present,"Adenoma, Villous"
12512,Malignant Germinomatous Cellular Infiltrate,Pineal germinoma
12513,Malignant Cellular Infiltrate,Ovarian Primitive Germ Cell Tumor
12514,Carcinomatous Component Present,Uterine Corpus Carcinosarcoma
12515,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma
12516,Well-Circumscribed Lesion,Nonanaplastic Kidney Wilms Tumor
12517,Mixed Cellular Population,Nonanaplastic Kidney Wilms Tumor
12518,Locally Aggressive Lesion,Giant Cell Angioblastoma
12519,Metastatic Lesion,Metastasizing Pleomorphic Adenoma of the Salivary Gland
12520,Junctional Proliferation,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin
12521,Childhood Lesion,Childhood Atypical Choroid Plexus Papilloma
12522,Epithelial Component Present,Stage II Ampulla of Vater Cancer AJCC v7
12523,Mitotic Activity,Adult Brain Glioblastoma
12524,Indolent Clinical Course,Calcifying Fibrous Pseudotumor
12525,Necrotic changes (finding),"Liposarcoma, Dedifferentiated"
12526,Indolent Clinical Course,Pigmented villonodular synovitis
12527,Secondary Lesion,Metastatic osteosarcoma
12528,Secondary Lesion,Metastatic Carcinoma in the Lung
12529,In Situ Lesion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
12530,Epithelial Component Present,Non-small cell lung cancer recurrent
12531,Recurrent Genetic Abnormalities Present,Hyperdiploid B Acute Lymphoblastic Leukemia
12532,Dilated Vascular Space Formation,Hobnail Hemangioma
12533,Cutaneous Involvement,Telogen effluvium
12534,Carcinomatous Component Present,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
12535,Follicular Cell Differentiation,Childhood Thyroid Gland Papillary Carcinoma
12536,Epithelial Component Present,Lymphoepithelial carcinoma
12537,Carcinomatous Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
12538,High Mitotic Activity,Stage IIC Merkel Cell Carcinoma AJCC v7
12539,Epithelial Component Present,Cigarette Smoking-Related Carcinoma
12540,atypia morphology,Borderline Ovarian Clear Cell Adenofibroma
12541,Carcinomatous Component Present,Stage III Merkel Cell Carcinoma AJCC v7
12542,Cystic Change,"Cystadenoma, Mucinous"
12543,Locally Aggressive Lesion,Plexiform fibrohistiocytic tumor
12544,Epithelial Component Present,Stage III Colorectal Cancer
12545,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Cystadenofibroma
12546,Dysplasia,High Grade Intraepithelial Neoplasia
12547,Storiform Growth Pattern,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
12548,Indolent Clinical Course,Cerebral Hemisphere Lipoma
12549,Childhood Lesion,Childhood Testicular Neoplasm
12550,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Mature Teratoma
12551,Secondary Lesion,Drop Metastasis in the Spinal Cord
12552,Carcinomatous Component Present,Verrucous carcinoma of oral cavity
12553,Metastatic Lesion,Secondary malignant neoplasm of bone
12554,Infiltrative Growth Pattern,"Perivascular epithelioid tumor, malignant"
12555,Lymphoplasmacytic Infiltrate,Tonsillar Undifferentiated Carcinoma
12556,Poorly Differentiated Lesion,Spindle cell squamous cell carcinoma
12557,Carcinomatous Component Present,Acinic cell carcinoma of salivary gland
12558,Monomorphic Cellular Infiltrate,canalicular adenoma of salivary gland
12559,Storiform Growth Pattern,"Dendritic Cell Sarcoma, Interdigitating"
12560,Vascular Channel Formation,Metastatic angiosarcoma
12561,Well-Circumscribed Lesion,Borderline Breast Phyllodes Tumor
12562,Immunologic Deficiency Syndromes,Renal transplant rejection
12563,Carcinomatous Component Present,Glottic Squamous Cell Carcinoma
12564,Dense Collagenized Tissue Present,Vulvar Syringoma
12565,Local disease,Infiltrating Intramuscular Lipoma
12566,Carcinomatous Component Present,"Adenocarcinoma, Oxyphilic"
12567,Mitotic Activity,Diencephalic Glioblastoma
12568,Childhood Lesion,Childhood Meningeal Melanoma
12569,Borderline Lesion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
12570,High Grade Lesion,gliosarcoma
12571,Epithelial Component Present,Pancreatic Large Cell Neuroendocrine Carcinoma
12572,atypia morphology,Borderline Ovarian Serous Tumor with Microinvasion
12573,atypia morphology,Borderline Ovarian Mucinous Adenofibroma
12574,Indolent Clinical Course,Congenital Cystic Hygroma
12575,Cutaneous Involvement,Skin-associated lymphoid tissue lymphoma
12576,Epithelial Component Present,adenoid cystic carcinoma of esophagus
12577,Epithelial Component Present,Carcinoma ex pleomorphic adenoma of parotid gland
12578,Indolent Clinical Course,benign lipoma of gallbladder
12579,Papillary Pattern,Laryngeal verrucous carcinoma stage IV
12580,Tissue of Mullerian Origin Present,Ovarian Mucinous Adenofibroma
12581,Dysplasia,Colonic tubulovillous adenoma
12582,Epithelial Component Present,Bladder adenocarcinoma stage III
12583,Below the Diaphragm Disease,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb
12584,Pushing Tumor Margin,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
12585,Epithelial Component Present,Ovarian Mucinous Cystic Tumor with Mural Nodules
12586,Well-Circumscribed Lesion,Colorectal Hamartoma
12587,Invasive Lesion,Squamous cell carcinoma of prostate
12588,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia with Eosinophilia
12589,Encapsulated Mass,Thyroid Gland Lipoadenoma
12590,Well-Circumscribed Lesion,Hamartomatous polyposis
12591,Indolent Clinical Course,"Lipomatosis, Multiple Symmetrical"
12592,Absence of a Hormonal Syndrome,Null Cell Pituitary Gland Adenoma
12593,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2
12594,Epithelial Component Present,Salivary gland carcinoma
12595,Severe dysplasia,Carcinoma in situ of fallopian tube
12596,Epithelial Component Present,Stage IVB Laryngeal Cancer AJCC v7
12597,Carcinomatous Component Present,atypical medullary carcinoma of breast
12598,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic
12599,Epithelial Component Present,Stage IIIA Small Intestinal Cancer AJCC v7
12600,Cellular Pleomorphism,Fibroblastic osteosarcoma
12601,Absence of Invasion,Adenocarcinoma in situ in a polyp
12602,Severe dysplasia,Carcinoma in situ in a polyp
12603,Invasive Lesion,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
12604,Epithelial Component Present,Renal Pelvis Inverted Papilloma
12605,Papillary Pattern,Renal Pelvis Inverted Papilloma
12606,Favorable Clinical Outcome,Mature Ganglioneuroma
12607,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
12608,Poorly Differentiated Lesion,"Transitional cell carcinoma, spindle cell"
12609,Cutaneous Involvement,Actinic keratosis
12610,Biphasic Pattern,Tibial adamantinoma
12611,Vascular Channel Formation,Parotid Gland Hemangioma
12612,Mixed Cellular Population,Adenocarcinoma with osseous metaplasia
12613,Metastatic Lesion,Secondary malignant neoplasm of small intestine
12614,Epithelial Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7
12615,Invasive Lesion,Inflammatory carcinoma of breast stage IV
12616,Tubular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
12617,Nuclear Molding,Small cell lung cancer limited stage
12618,Syncytial Pattern,Undifferentiated carcinoma of nasopharynx
12619,Carcinomatous Component Present,Stage I Lung Cancer AJCC v7
12620,Slow Growing Mass,Childhood Subependymal Giant Cell Astrocytoma
12621,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
12622,Epithelial Component Present,Adenoid cystic carcinoma of salivary gland
12623,Indolent Clinical Course,Hemangioma of intracranial structure
12624,Micropapillary Pattern,intraductal micropapillary carcinoma of breast
12625,Perivascular Arrangement of Tumor Cells,Clear-Cell Myomelanocytic Tumors
12626,Epithelial Component Present,Fallopian Tube Mucinous Adenocarcinoma
12627,Adnexal Differentiation,Desmoplastic trichilemmoma
12628,Exophytic Polypoid Lesion,Malignant lymphomatous polyposis
12629,Childhood Lesion,childhood nasal type extranodal NK/T-cell lymphoma
12630,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage I
12631,Epithelial Component Present,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
12632,Carcinomatous Component Present,Poorly Differentiated Prostate Adenocarcinoma
12633,Childhood Lesion,Childhood Unfavorable Prognosis Hodgkin Lymphoma
12634,Compartmentalized Pattern,Sebaceous adenoma
12635,Desmoplastic Stroma Formation,Adult Desmoplastic Small Round Cell Tumor
12636,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1"
12637,Carcinomatous Component Present,Stage II Esophageal Adenocarcinoma AJCC v7
12638,Epithelial Component Present,Carcinoma of lung
12639,Severe dysplasia,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia
12640,Papillary Pattern,"Papilloma, Squamous Cell"
12641,Mixed Neoplastic Glandular and Squamous Cell Population,Lung Mixed Squamous Cell and Glandular Papilloma
12642,Mucoid Stroma Formation,Ampulla of Vater Mucinous Adenocarcinoma
12643,Carcinomatous Component Present,Thymic Small Cell Carcinoma
12644,Perivascular Arrangement of Tumor Cells,Intravascular Angioleiomyoma
12645,Fibrotic Stroma Formation,Proliferating Brenner Tumor
12646,Swelling,Adamantinoma
12647,Well-Circumscribed Lesion,Adenoma of rectum
12648,Epithelial Component Present,Stage I Oral Cavity Cancer AJCC v6 and v7
12649,Antoni A Pattern,Benign Intraocular Schwannoma
12650,Carcinomatous Component Present,Stage II Esophageal Cancer AJCC v7
12651,Encapsulated Mass,Parotid Gland Warthin Tumor
12652,Metaplasia,Intestinal-Type Sinonasal Adenocarcinoma
12653,Local disease,Chondroid lipoma
12654,Epithelial Component Present,Duodenal carcinoma recurrent
12655,Epithelial Component Present,Acinar cell cystadenocarcinoma
12656,Childhood Lesion,Postsurgical Stage IV Hepatoblastoma
12657,Dysplasia,Appendix Traditional Serrated Adenoma
12658,Well-Circumscribed Lesion,Papillary serous cystadenoma
12659,Insular Pattern,Pancreatic Somatostatinoma
12660,Epithelial Component Present,Stage III Rectal Cancer AJCC v7
12661,Epithelial Component Present,Merkel cell carcinoma
12662,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Central Nervous System Choriocarcinoma
12663,Carcinomatous Component Present,Small Intestinal Neuroendocrine Carcinoma
12664,Secondary Lesion,Secondary malignant neoplasm of testis
12665,Secondary Lesion,Carcinoma Metastatic to the Skin
12666,Indolent Clinical Course,Osteoma
12667,Cutaneous Involvement,Benign neoplasm of adnexa of skin
12668,Lipomatous Component Present,Thymus Lipofibroadenoma
12669,Mesenchymal Component Present,Thymus Lipofibroadenoma
12670,Carcinomatous Component Present,Prostate cancer recurrent
12671,Diffuse Pattern,Recurrent Childhood Gliomatosis Cerebri
12672,atypia morphology,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
12673,Adulthood Lesion,Stage IV Adult Immunoblastic Lymphoma
12674,Invasive Lesion,Bladder transitional cell carcinoma stage I
12675,Vascular Channel Formation,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma
12676,Epithelial Component Present,Grade 2 Clear Cell Renal Cell Carcinoma
12677,High Grade Lesion,Adult Pleomorphic Rhabdomyosarcoma
12678,Cutaneous Involvement,Blastic plasmacytoid dendritic cell neoplasm
12679,Aggressive Clinical Course,NUT midline carcinoma
12680,Adnexal Differentiation,Digital papillary eccrine carcinoma of skin
12681,Epithelial Component Present,Infiltrating Cervical Carcinoma
12682,Poorly Differentiated Lesion,Pancreatic Endocrine Carcinoma
12683,Epithelial Component Present,Unclassified Hepatocellular Adenoma
12684,Thick-Walled Hyalinized Vessels Present,Peripheral Nerve Schwannoma
12685,Epithelial Component Present,Papillary serous cystadenocarcinoma
12686,Immature Myeloid Cells Increased in Bone Marrow,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
12687,Dysplasia,Hepatocellular Small Cell Change
12688,Osseous Metaplasia of Malignant Cells Present,Breast Carcinoma with Osseous Metaplasia
12689,Epithelial Component Present,Distal Urethral Carcinoma
12690,Papillary Pattern,Ethmoid Sinus Schneiderian Papilloma
12691,Cystic Change,Bile duct cystadenocarcinoma
12692,Epithelial Component Present,Squamous cell carcinoma of mouth
12693,Monoclonal Eosinophils Present,Adult Acute Eosinophilic Leukemia
12694,Rapidly Enlarging Mass,Botryoid-Type Embryonal Rhabdomyosarcoma
12695,Well Differentiated Lesion,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
12696,Epithelial Component Present,Maxillary Sinus Schneiderian Papilloma
12697,Well-Circumscribed Lesion,papillary adenoma of extrahepatic bile duct
12698,Extraosseous Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma
12699,Carcinomatous Component Present,Carcinoma Arising in Nasal Papillomatosis
12700,Well-Circumscribed Lesion,Epulides
12701,Epithelial Component Present,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
12702,Epithelial Component Present,Rectal Serrated Adenocarcinoma
12703,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia with Atypia
12704,Primary Lesion,Stage IIIB Primary Peritoneal Cancer AJCC v7
12705,Cutaneous Involvement,Eyelid Xanthoma
12706,Acantholysis,Warty dyskeratoma
12707,atypia morphology,Pre-Malignant Skin Epithelial Lesion
12708,Dysplasia,Grade II Penile Intraepithelial Neoplasia
12709,More than 10 Mitoses per 10HPF,Combined Lung Large Cell Neuroendocrine Carcinoma
12710,Swelling,Osteoclastic Giant Cell-Rich Tumor of Bone
12711,Ineffective hematopoiesis,Refractory cytopenia with multilineage dysplasia
12712,Absence of Invasion,Carcinoma in situ of vagina
12713,Hereditary Lesion,Bloom Syndrome
12714,Carcinomatous Component Present,Thyroid Gland Adenocarcinoma
12715,Epithelial Component Present,High Grade Conjunctival Intraepithelial Neoplasia
12716,Childhood Lesion,Childhood Epithelioid Sarcoma
12717,Solitary mass,Bone Epithelioid Hemangioendothelioma
12718,Adnexal Differentiation,Hair Follicle Neoplasm
12719,Childhood Lesion,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
12720,Epithelial Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma
12721,Vascular Channel Formation,Senile hemangioma of lip
12722,Severe dysplasia,Carcinoma in situ of cecum
12723,In Situ Lesion,Carcinoma in situ of cecum
12724,Indolent Clinical Course,Benign Soft Tissue Tumor of Uncertain Differentiation
12725,Cartilaginous Differentiation,Childhood Periosteal Osteosarcoma
12726,Nodular Pattern,Skin Nodular Basal Cell Carcinoma
12727,Anaplasia,Childhood Brain Anaplastic Astrocytoma
12728,Microvascular Proliferation,Infratentorial Glioblastoma
12729,Infiltrative Growth Pattern,Recurrent Childhood Protoplasmic Astrocytoma
12730,Hyperplastic Tissue Present,Columnar Cell Hyperplasia of the Breast with Atypia
12731,Storiform Growth Pattern,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
12732,Presence of a Hormonal Syndrome,malignant gastrinoma of pancreas
12733,Exophytic Polypoid Lesion,Anal polyp
12734,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v6
12735,Epithelial Component Present,Stage IIIC Rectal Cancer AJCC v7
12736,Lytic lesion,"Bone Cysts, Aneurysmal"
12737,Well-Circumscribed Lesion,"Phyllodes tumor, benign"
12738,Indolent Clinical Course,Benign Extraskeletal Cartilaginous and Osseous Neoplasm
12739,Metastatic/Recurrent Disease,Pleural Synovial Sarcoma
12740,Cutaneous Involvement,Common blue nevus of skin
12741,Cutaneous Involvement,Primary cutaneous lymphoma
12742,Low Grade Lesion,Classical Low Grade Fibromyxoid Sarcoma
12743,Secondary Lesion,Advanced cancer
12744,Myxoid Stroma Formation,Low-grade fibromyxoid sarcoma
12745,Endophytic Tumor Growth,Verrucous carcinoma
12746,Epithelial Component Present,carcinosarcoma of liver
12747,Secondary Lesion,Secondary malignant neoplasm of lip
12748,Delicate Vascular Network Formation,Hereditary clear cell renal cell carcinoma
12749,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
12750,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
12751,Locally Aggressive Lesion,Metastasizing Chondroblastoma
12752,Adulthood Lesion,Glioblastoma multiforme of spinal cord
12753,Therapy-Related Toxicity,Chemotherapy-Related Leukemia
12754,Cutaneous Involvement,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
12755,Epithelial Component Present,Grade 1 Invasive Breast Carcinoma
12756,Epithelial Component Present,Benign Apocrine Neoplasm
12757,Carcinomatous Component Present,"Adenocarcinoma of lung, stage I"
12758,Carcinomatous Component Present,Sporadic Diffuse Gastric Adenocarcinoma
12759,Metastatic Lesion,Metastatic Parathyroid Gland Carcinoma
12760,Epithelial Component Present,Lipid-rich carcinoma
12761,Childhood Lesion,Recurrent Childhood Central Nervous System Neoplasm
12762,Severe dysplasia,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
12763,Epithelial Component Present,Cervical intraepithelial neoplasia grade 2
12764,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor
12765,Proliferation of Small Ducts Present,Intrahepatic Bile Duct Microcystic Adenoma
12766,Secondary Lesion,Carcinoma ex pleomorphic adenoma of lacrimal gland
12767,Epithelial Component Present,Stage IIB Lung Adenocarcinoma AJCC v7
12768,Indolent Clinical Course,Liver Lymphangioma
12769,Epithelial Component Present,Vaginal intraepithelial neoplasia
12770,Benign Cellular Infiltrate,Infantile hemangioma of liver
12771,Rare Lesion,Androgen-Producing Adrenal Cortex Adenoma
12772,Locally Aggressive Lesion,Breast Inflammatory Myofibroblastic Tumor
12773,Epithelial Component Present,Stage 0 Oral Cavity Cancer AJCC v6 and v7
12774,Epithelial Component Present,Stage 0is Urethral Cancer AJCC v7
12775,Mixed Cellular Population,Ovarian Seromucinous Adenofibroma
12776,Tissue Differentiation Uncertain,"Ossifying fibromyxoid tumor, malignant"
12777,Locally Aggressive Lesion,"Ossifying fibromyxoid tumor, malignant"
12778,Well-Circumscribed Lesion,tubular adenoma of extrahepatic bile duct
12779,Biphasic Pattern,Lung Biphasic Synovial Sarcoma
12780,Cutaneous Involvement,Mycosis Fungoides
12781,Carcinomatous Component Present,Stage IB Ovarian Cancer AJCC v6 and v7
12782,Epithelial Component Present,"Adenocarcinoma of lung, stage IV"
12783,Secondary Lesion,Secondary malignant neoplasm of liver
12784,Metastatic Lesion,Secondary malignant neoplasm of liver
12785,Solid Growth Pattern,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
12786,Exophytic Polypoid Lesion,Pyloric Gland Adenoma
12787,Stromal Invasion,FIGO Stage IIIB Ovarian Cancer
12788,Epithelial Component Present,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
12789,Enterochromaffin Type Granules Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
12790,Solid Growth Pattern,"Testicular Yolk Sac Tumor, Solid Pattern"
12791,Well-Circumscribed Lesion,Colonic Polyps
12792,Diffuse Pattern,Primary mediastinal large B-cell lymphoma refractory
12793,Carcinomatous Component Present,Stage IIIA Gallbladder Cancer AJCC v7
12794,Invasive Lesion,Invasive Mixed Breast Carcinoma
12795,Childhood Lesion,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
12796,Cutaneous Involvement,"Keratoderma, Palmoplantar"
12797,Epithelial Component Present,Trichilemmoma
12798,Diffuse Pattern,Brain Oligodendroglioma
12799,Cystic Change,Melanoacanthoma
12800,Neuroendocrine Differentiation,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
12801,Bone Marrow Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
12802,Epithelial Component Present,Stage IIB Colorectal Cancer AJCC v7
12803,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v6
12804,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
12805,Epithelial Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7
12806,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v6
12807,Cutaneous Involvement,Circumscribed storiform collagenoma
12808,Neuronal Differentiation,Pituitary Gland Gangliocytoma
12809,Metaplasia of Malignant Cells Present,adenocarcinoma of breast with squamous metaplasia
12810,Painless Mass,Mediastinal Chondroma
12811,Severe cytologic atypia,Colon Small Cell Neuroendocrine Carcinoma
12812,Secondary Lesion,Secondary malignant neoplasm of orbit
12813,Pseudoglandular Pattern,Childhood Central Nervous System Embryonal Carcinoma
12814,Breast Microcalcification,Adult Oligodendroglioma
12815,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Poorly Differentiated Neuroblastoma
12816,Carcinomatous Component Present,adenocarcinoma of ureter
12817,Unifocal Disease at Presentation,Extracutaneous Mastocytoma
12818,Epithelial Component Present,Childhood Atypical Choroid Plexus Papilloma
12819,Epithelial Component Present,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
12820,Epithelial Component Present,Adenocarcinoma of ampulla of Vater
12821,Childhood Lesion,Stage II Childhood Hodgkin Lymphoma
12822,Epithelial Component Present,Breast Carcinoma with Melanotic Features
12823,Epithelial Component Present,Adenocarcinoma in tubular adenoma
12824,"Undifferentiated ""Fetal-Type"" Tissues Present",Central Nervous System Immature Teratoma
12825,Ground Glass Nuclear Inclusion,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
12826,Carcinomatous Component Present,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
12827,Carcinomatous Component Present,Stage I Vulvar Cancer
12828,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v7
12829,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
12830,Carcinomatous Component Present,Metastatic Kidney Carcinoma
12831,Locally Aggressive Lesion,Classic Type Atypical Fibroxanthoma
12832,Oligodendroglial Component Present,Adult Brain Oligodendroglioma
12833,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant"
12834,Epithelial Component Present,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant"
12835,Childhood Lesion,Childhood Conventional Osteosarcoma
12836,Carcinomatous Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
12837,Multifocal Lesion,Sarcomatosis
12838,Carcinomatous Component Present,Stage II Ureter Cancer AJCC v7
12839,Vascular Channel Formation,Intra-Abdominal Lymphangioma
12840,Low Mitotic Activity,Intestinal Neuroendocrine Tumor G2
12841,Thyroglobulin Positive Neoplastic Cells Present,Childhood Thyroid Gland Follicular Carcinoma
12842,Mild cytologic atypia,Verrucous carcinoma of penis
12843,Epithelial Component Present,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
12844,Neuroendocrine Differentiation,Stage II Merkel Cell Carcinoma AJCC v7
12845,Epithelial Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
12846,Neuroendocrine Differentiation,Adenocarcinoma with neuroendocrine differentiation
12847,Poorly Cohesive Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma
12848,Refractory Disease,Non-Hodgkin's lymphoma refractory
12849,Metastatic Lesion,Secondary Neoplasm
12850,Cystic Change,"Cystadenoma, Papillary"
12851,Neuroendocrine Differentiation,Stage IIIB Merkel Cell Carcinoma AJCC v7
12852,Necrotic changes (finding),Childhood Lung Small Cell Carcinoma
12853,Low Cellularity Present,Juvenile Pilocytic Astrocytoma
12854,Perineural spread,Adenoid cystic carcinoma of trachea
12855,Bilateral Disease,Retinoblastoma bilateral
12856,Epithelial Component Present,Perianal Squamous Intraepithelial Neoplasia
12857,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity recurrent
12858,Adnexal Differentiation,Malignant eccrine spiradenoma
12859,Papillary Pattern,Papilloma of eyelid
12860,Childhood Lesion,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
12861,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity
12862,Carcinomatous Component Present,basal cell adenocarcinoma of salivary gland
12863,Epithelial Component Present,Prostate Adenoid Cystic Carcinoma
12864,Local disease,Localized Askin Tumor
12865,Papillary Pattern,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
12866,Syncytial Pattern,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
12867,Epithelial Component Present,Sparsely Granulated Somatotroph Adenoma
12868,Cytoplasmic Membrane-Bound Granules Present,Stage IA Merkel Cell Carcinoma AJCC v7
12869,Well-Circumscribed Lesion,Angiomyofibroblastoma
12870,Pushing Tumor Margin,Human Papillomavirus-Related Verrucous Carcinoma
12871,Unresectable Mass,Pancreatic carcinoma non-resectable
12872,Tissue Differentiation Uncertain,Epithelioid Sarcoma NCI Grade 2
12873,Osteoid formation,Ossifying Renal Tumor of Infancy
12874,Immunosuppression-Related Post-Transplant Toxicity,Bone Marrow Transplantation Nephropathy
12875,atypia morphology,Borderline Ovarian Serous Adenofibroma
12876,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage III
12877,Nuclear pleomorphism,Lung Pleomorphic Carcinoma
12878,Chronic lymphocytic inflammation,Salivary Gland Sebaceous Lymphadenoma
12879,Malignant Component Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma
12880,Fibrotic Stroma Formation,mucoepidermoid carcinoma of accessory sinus
12881,Cutaneous Involvement,Cutaneous diphtheria
12882,atypia morphology,Borderline Ovarian Serous Cystadenofibroma
12883,Calcinosis,"Retinoblastoma, spontaneously regressed"
12884,Metastatic Lesion,Secondary malignant neoplasm of pleura
12885,Malignant Cellular Infiltrate,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
12886,Rapidly Enlarging Mass,Rhabdomyosarcoma
12887,Pregnancy Complications,Placental Choriocarcinoma
12888,Well-Circumscribed Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp
12889,Endophytic Tumor Growth,Laryngeal verrucous carcinoma stage IV
12890,Secondary Lesion,Small intestine adenocarcinoma metastatic NOS
12891,Glandular Pattern,Nipple Syringomatous Adenoma
12892,Epithelial Component Present,Thymic epithelial tumor
12893,Acanthosis,verrucous carcinoma of bladder
12894,Primary Lesion,Childhood Cerebellar Astrocytoma
12895,Cysts Containing Proteinaceous Fluid Present,Serous cystadenoma of pancreas
12896,Cystic Change,Apocrine cystadenoma
12897,Carcinomatous Component Present,High Grade Broad Ligament Serous Adenocarcinoma
12898,Low Mitotic Activity,Malignant Vipoma
12899,Squamous metaplasia of bladder,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
12900,Epithelial Component Present,Thymoma
12901,Polymorphic Cellular Infiltrate,Letterer-Siwe Disease
12902,Varicosity,Disorder of vein
12903,Monoclonal Cellular Population Present,Thyroid Gland Clear Cell Follicular Adenoma
12904,Exophytic Polypoid Lesion,Colorectal Cowden-Associated Polyp
12905,Nuclear Pseudoinclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
12906,Rapidly Enlarging Mass,Recurrent Rhabdomyosarcoma
12907,Well Differentiated Lesion,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
12908,Metastatic Lesion,Synovial sarcoma metastatic
12909,Epithelial Component Present,Stage IIA Lung Small Cell Carcinoma AJCC v7
12910,Skin Papule,Lipoid dermatoarthritis
12911,Epithelial Component Present,Neuroendocrine neoplasm of gallbladder
12912,Epithelial Component Present,Small intestine carcinoma metastatic
12913,Epithelial Component Present,Stage II Renal Cell Cancer AJCC v7
12914,Tissues Derived from Two or Three Embryonic Layers Present,Malignant Ovarian Teratoma
12915,Epithelial Component Present,Adenocarcinoma of nasal cavity
12916,Primary Lesion,Angiosarcoma non-metastatic
12917,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Adult Acute Myeloid Leukemia with Maturation
12918,Papillary Pattern,Condyloma acuminata of vagina
12919,Carcinomatous Component Present,Eccrine porocarcinoma
12920,Epithelial Component Present,Stage IIC Rectal Cancer AJCC v7
12921,Carcinomatous Component Present,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
12922,Dysplasia,Colorectal Adenoma with Mild Dysplasia
12923,Pseudoglandular Pattern,Teratocarcinoma
12924,Pain,Juxtacortical chondrosarcoma
12925,Papillary Pattern,Glandular papilloma
12926,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage IV
12927,Carcinomatous Component Present,Stage IVB Hepatocellular Carcinoma AJCC v7
12928,Well-Circumscribed Lesion,Gastrointestinal polyps
12929,Local disease,Lipoma of the tongue
12930,Epithelial Component Present,Esophageal Basaloid Carcinoma
12931,Recurrent disease,Mycosis fungoides recurrent
12932,Carcinomatous Component Present,Stage III Adult Liver Cancer AJCC v7
12933,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage I
12934,Anaplasia,Childhood Glioblastoma
12935,Perineural spread,Vaginal Adenoid Cystic Carcinoma
12936,Recurrent disease,Plasma cell myeloma recurrent
12937,Rapidly Enlarging Mass,Cardiac Rhabdomyosarcoma
12938,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, inv(16)(p13q22)"
12939,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-1B
12940,Epithelial Component Present,Intraductal Non-Comedo Breast Adenocarcinoma
12941,Indolent Clinical Course,Inner Ear Lipoma
12942,Epithelial Component Present,Stage III Colorectal Cancer AJCC v7
12943,Mesenchymal Component Present,Oral Cavity Pleomorphic Adenoma
12944,Solitary mass,Skull Base Chordoma
12945,Indolent Clinical Course,Superficial angiomyxoma
12946,Absence of Invasion,Stage 0 Breast Cancer AJCC v6 and v7
12947,Epithelial Component Present,Mucinous carcinoma of breast
12948,Carcinomatous Component Present,Thymic Undifferentiated Carcinoma
12949,Epithelial Component Present,Gallbladder Biliary Intraepithelial Neoplasia
12950,Epithelial Component Present,Atrial Paraganglioma
12951,Carcinomatous Component Present,Carcinoma in Situ
12952,Tissue Differentiation Uncertain,Hepatic Angiomyolipoma
12953,Neuroendocrine Differentiation,Intrathoracic Paravertebral Paraganglioma
12954,Epithelial Component Present,Anaplastic thyroid carcinoma
12955,Dysplasia,Precancerous Polyp
12956,Acantholysis,Acantholytic acanthoma
12957,Carcinomatous Component Present,Ureteric cancer regional
12958,Nuclear Pseudoinclusion,Follicular Variant Thyroid Gland Papillary Carcinoma
12959,Systemic disease,Multi-centric Castleman's Disease
12960,Adulthood Lesion,Stage II Adult Non-Hodgkin Lymphoma
12961,Therapy-Related Toxicity,Plasma Cell Post-Transplant Lymphoproliferative Disorder
12962,Well Differentiated Hyaline Cartilage Present,Adult Mesenchymal Chondrosarcoma
12963,Childhood Lesion,Infant Acute Undifferentiated Leukemia
12964,Adulthood Lesion,Stage IV Adult Non-Hodgkin Lymphoma
12965,Somatostatin Positive Neoplastic Cells Present,Somatostatinoma
12966,Carcinomatous Component Present,undifferentiated carcinoma of larynx
12967,Chemotherapeutic Agent Toxicity,Epipodophyllotoxin-Related Myelodysplastic Syndrome
12968,Adulthood Lesion,Adult Grade II Meningioma
12969,Low Mitotic Activity,Gastric Neuroendocrine Tumor
12970,Macule,Stage III Acral Lentiginous Melanoma AJCC v7
12971,Carcinomatous Component Present,Cystadenocarcinoma of pancreas
12972,Cystic Change,Cystadenocarcinoma of pancreas
12973,Preserved Nuclear Polarity,"Transitional cell papilloma, benign"
12974,Absence of Invasion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
12975,Carcinomatous Component Present,Pharyngeal Carcinoma by AJCC v6 Stage
12976,High Grade Lesion,Adult Glioblastoma
12977,Recurrent disease,Recurrent Kidney Wilms Tumor
12978,Secondary Lesion,Peripheral neuroepithelioma of bone metastatic
12979,Epithelial Component Present,Stage IVB Oral Cavity Cancer AJCC v6 and v7
12980,Cutaneous Involvement,Melanoma recurrent
12981,Pregnancy Complications,Disorder of pregnancy
12982,Neuroendocrine Differentiation,Glucagonoma
12983,Tubular Structures Present,"Adenocarcinoma, Tubular"
12984,Rosenthal Fibers Present,Rosette-forming glioneuronal tumor of the fourth ventricle
12985,Smooth Muscle Component Present,Childhood Kidney Angiomyolipoma
12986,Diffuse Pattern,Esophageal Diffuse Large B-Cell Lymphoma
12987,Recurrent disease,Recurrent Childhood Gemistocytic Astrocytoma
12988,Intraductal Lesion,Intermediate Grade Ductal Breast Carcinoma In Situ
12989,Osseous Differentiation,Osteoid osteoma
12990,Hereditary Lesion,Familial Nonmedullary Thyroid Gland Carcinoma
12991,Carcinomatous Component Present,Stage IIA Esophagus Carcinoma
12992,Follicular Cell Differentiation,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
12993,Childhood Lesion,Stage III Childhood Burkitt Lymphoma
12994,Childhood Lesion,Stage IV Childhood Burkitt Lymphoma
12995,Cystic Change,Minor Salivary Gland Mucoepidermoid Carcinoma
12996,Rapidly Enlarging Mass,Solid Alveolar Rhabdomyosarcoma
12997,Epithelial Component Present,Parotid Gland Undifferentiated Carcinoma
12998,Cartilaginous Differentiation,Solitary Osteochondroma
12999,Necrotic changes (finding),Minor Salivary Gland Small Cell Carcinoma
13000,Primary Lesion,Gastric T-Cell Non-Hodgkin Lymphoma
13001,Carcinomatous Component Present,Stage IB Breast Cancer AJCC v7
13002,Chromogranin A Positive Neoplastic Cells Present,Midgut Carcinoid Tumor
13003,Severe cytologic atypia,Pancreatic Endocrine Carcinoma
13004,Ground Glass Nuclear Inclusion,Nonencapsulated sclerosing tumor
13005,Indolent Clinical Course,benign neoplasm of lower jaw bone
13006,Monomorphic Cellular Infiltrate,Childhood Ependymoma
13007,Dysplasia,Conjunctival intraepithelial neoplasia
13008,Epithelial Component Present,Stage IB Pancreatic Cancer AJCC v6 and v7
13009,Adnexal Differentiation,Vulvar Adenocarcinoma of Sweat Gland Type
13010,Juvenile Lesion,Colon Juvenile Polyp
13011,Epithelial Component Present,Cervical Mullerian Papilloma
13012,Epithelial Component Present,clear cell adenocarcinoma of bladder
13013,Epithelial Component Present,Bile duct cystadenocarcinoma
13014,Fibrotic Stroma Formation,Fibrolipoma
13015,Favorable Clinical Outcome,Class 1a Uveal Melanoma
13016,Childhood Lesion,Childhood Medulloblastoma
13017,Adulthood Lesion,Stage I Adult Immunoblastic Lymphoma
13018,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Basophilic Leukemia
13019,Adnexal Differentiation,Sweat gland adenocarcinoma
13020,Primary Lesion,Stage IIIA Primary Peritoneal Cancer AJCC v7
13021,Storiform Growth Pattern,Non-Ossifying Fibroma
13022,Epithelial Component Present,Colorectal Cribriform Comedo-Type Adenocarcinoma
13023,Childhood Lesion,Childhood Leiomyosarcoma
13024,Metastatic Lesion,Alveolar soft part sarcoma metastatic
13025,Epithelial Component Present,Fundic gland polyp
13026,Hemorrhagic,Gallbladder Angiosarcoma
13027,Well-Circumscribed Lesion,Blastema Predominant Kidney Wilms Tumor
13028,Mixed Cellular Population,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
13029,Hyaline Cartilage Differentiation,Primary chondrosarcoma of bone
13030,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
13031,Carcinomatous Component Present,Small cell carcinoma of ovary
13032,Carcinomatous Component Present,Stage II Penile Cancer AJCC v6
13033,Diffuse Lesion,Meningeal Carcinomatosis
13034,Adulthood Lesion,Adult Grade III Lymphomatoid Granulomatosis
13035,Vascular Channel Formation,Kaposi's sarcoma of lung
13036,Intraductal Lesion,"Papilloma, Intraductal"
13037,Neuroendocrine Differentiation,Anal Canal Small Cell Neuroendocrine Carcinoma
13038,Indolent Clinical Course,Myxoma
13039,Indolent Clinical Course,Fibrous Hamartoma of Infancy
13040,Chromogranin A Positive Neoplastic Cells Present,Anal Canal Neuroendocrine Tumor G1
13041,Capillary Sized Vascular Channel Formation,Senile hemangioma of lip
13042,Epithelial Component Present,Hypopharyngeal Carcinoma
13043,Tissue of Mullerian Origin Present,Adenosarcoma
13044,Absence of Stromal Invasion,Borderline epithelial tumor of ovary
13045,Metastatic Lesion,Metastatic Neoplasm to the Gallbladder
13046,Carcinomatous Component Present,Skin Nodular Basal Cell Carcinoma
13047,Diffuse Cellular Infiltrate,Gastric Mixed Adenocarcinoma
13048,High Grade Lesion,Infratentorial Glioblastoma
13049,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Bone
13050,Epithelial Component Present,cystadenocarcinoma of intrahepatic bile duct
13051,Well-Circumscribed Lesion,Hyperplastic Polyp
13052,Carcinomatous Component Present,Superficial basal cell carcinoma
13053,Serum phosphate concentration below normal,Oncogenic osteomalacia
13054,Epithelial Component Present,Cholangiolocellular Carcinoma
13055,Invasive Lesion,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
13056,Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade
13057,Cystic Change,Mucoepidermoid carcinoma of the oral cavity recurrent
13058,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity recurrent
13059,Resectable Mass,Carcinoma duodenum resectable
13060,Epithelial Component Present,serous surface papillary carcinoma of ovary
13061,Lesion with Diameter of 10mm or Less,Functioning Pituitary Gland Microadenoma
13062,Hereditary Lesion,Cobb's syndrome
13063,Hyaline Cartilage Differentiation,Central Nervous System Chondroma
13064,Epithelial Component Present,Stage IIB Appendix Carcinoma AJCC v7
13065,High Grade Lesion,Anaplastic Brain Stem Astrocytoma
13066,Abundance of Small Lymphocytes,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma
13067,Radiation Sickness,Mucositis following radiation therapy
13068,Carcinomatous Component Present,Stage IIIB Ovarian Cancer AJCC v6 and v7
13069,Epithelial Component Present,"Oncocytoma, renal"
13070,Indolent Clinical Course,Juxta-Articular Myxoma
13071,Low Grade Lesion,Low-grade fibromyxoid sarcoma
13072,Lobulated Growth Pattern,Chondroid chordoma
13073,Serotonin Positive Neoplastic Cells Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
13074,Recurrent disease,Large cell lung cancer recurrent
13075,Indolent Clinical Course,Ectopic hamartomatous thymoma
13076,Adnexal Differentiation,Apocrine Breast Carcinoma In Situ
13077,Cutaneous Involvement,Basal cell nevus with comedones
13078,Indolent Clinical Course,lipoma of extrahepatic bile duct
13079,Cystic Change,"Cystadenoma, Serous"
13080,Childhood Lesion,Recurrent Childhood Oligoastrocytoma
13081,Disease regression,Regressing nevus
13082,Epithelial Component Present,Stage IA Ampulla of Vater Cancer AJCC v7
13083,Well-Circumscribed Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
13084,Carcinomatous Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
13085,Epithelial Component Present,Breast Carcinoma Metastatic in the Liver
13086,Epithelial Component Present,Clear cell adenoma
13087,Secondary Lesion,Secondary malignant neoplasm of axilla
13088,Well-Circumscribed Lesion,Cerebellar hemangioblastoma
13089,Epithelial Component Present,"Carcinoma, Granular Cell"
13090,Neuroectodermal Differentiation,Stage 1 Neuroblastoma
13091,Vascular Channel Formation,Cardiac Intramuscular Hemangioma
13092,Osteoid formation,Intraosseous well differentiated osteosarcoma
13093,Severe dysplasia,Cervical Adenocarcinoma In Situ
13094,Mild dysplasia,Cervical Squamous Intraepithelial Neoplasia 1
13095,Epithelial Component Present,Proximal Urethral Carcinoma
13096,Vascular Channel Formation,Conventional Angiosarcoma
13097,Cutaneous Involvement,Microcystic adnexal carcinoma
13098,Calcinosis,"Ossifying fibromyxoid tumor, malignant"
13099,Infiltrating Tumor Margins Present,Endometrial Stromal Sarcoma
13100,Solitary mass,malignant epithelioid hemangioendothelioma of liver
13101,Malignant Component Present,Dermoid cyst with secondary tumor
13102,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm
13103,Carcinomatous Component Present,FIGO Stage IIIC Ovarian Cancer
13104,Locally Aggressive Lesion,"Fibromatosis, Abdominal"
13105,Metastatic Lesion,Secondary malignant neoplasm of pharynx
13106,Indolent Clinical Course,Epidural Spinal Canal Angiolipoma
13107,Adulthood Lesion,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma
13108,Non-Hereditary Lesion,Sporadic Thyroid Gland Medullary Carcinoma
13109,Cystic Change,"Testicular Yolk Sac Tumor, Macrocystic Pattern"
13110,Epithelial Component Present,Metastatic Adrenal Gland Pheochromocytoma
13111,Keratin pearl formation,Nasopharyngeal Basaloid Squamous Cell Carcinoma
13112,Epithelial Component Present,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
13113,Increased Cellularity Present,Retinoblastoma
13114,High Mitotic Activity,Colorectal Small Cell Neuroendocrine Carcinoma
13115,Epithelial Component Present,"Gallbladder Adenocarcinoma, Biliary Type"
13116,Mitotic Activity,Multifocal Glioblastomas
13117,High Grade Lesion,Multifocal Glioblastomas
13118,Epithelial Component Present,Stage II Gastric Carcinoma
13119,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
13120,Infiltrative Growth Pattern,Adult Diffuse Astrocytoma
13121,Inflammatory infiltrate,Giant cell carcinoma of lung
13122,Prominent Stromal Reaction,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
13123,Epithelial Component Present,External Ear Actinic Keratosis
13124,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
13125,Epithelial Component Present,Carcinoma of ampulla of Vater
13126,High Mitotic Activity,small cell carcinoma of breast
13127,Increased megakaryocytes (bone marrow),"Thrombocythemia, Essential"
13128,Papillary Pattern,Subglottic Verrucous Carcinoma
13129,Lymphoplasmacytic Infiltrate,Medullary carcinoma of breast
13130,Thick-Walled Hyalinized Vessels Present,Microcystic/Reticular Schwannoma
13131,Endophytic Tumor Growth,Supraglottic Verrucous Carcinoma
13132,Cytokeratin Positive Neoplastic Cells Present,Fibroblastic reticular cell tumor
13133,Necrotic changes (finding),Adult Brain Stem Gliosarcoma
13134,Painless Mass,chondroma of lung
13135,Epithelial Component Present,Stage II Liver Cancer
13136,High Grade Lesion,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
13137,Epithelial Component Present,Stage 0 Gallbladder Cancer AJCC v6 and v7
13138,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid carcinoma ovary
13139,Painless Mass,Fibroma of tendon sheath
13140,Carcinomatous Component Present,Adenocarcinoma of ampulla of Vater
13141,Carcinomatous Component Present,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
13142,Tissue of Mullerian Origin Present,Mucinous cystadenofibroma
13143,Dysplasia,Stage 0 Vulvar Cancer
13144,Neuroendocrine Differentiation,Breast Neuroendocrine Neoplasm
13145,Dysplasia,Low Grade Conjunctival Intraepithelial Neoplasia
13146,Indolent Clinical Course,Uterine Corpus Adenofibroma
13147,Mixture of Germ Cell Neoplastic Components Present,Childhood Mixed Germ Cell Tumor
13148,Carcinomatous Component Present,Adenocarcinoma of rectum
13149,Pseudoglandular Pattern,Childhood Embryonal Carcinoma
13150,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma
13151,Mixed Cellular Population,Uterine Corpus Adenomyoma
13152,Childhood Lesion,Non-Metastatic Childhood Soft Tissue Sarcoma
13153,Breast Microcalcification,Adult Brain Oligodendroglioma
13154,Honeycomb Pattern,Adult Brain Oligodendroglioma
13155,Carcinomatous Component Present,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma
13156,Low Grade Lesion,Low grade myofibroblastic sarcoma
13157,Carcinomatous Component Present,Grade 3 Colorectal Adenocarcinoma
13158,Nerve palsy,Progressive bulbar palsy
13159,Carcinomatous Component Present,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
13160,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity
13161,Carcinomatous Component Present,Breast Cancer by AJCC v7 Stage
13162,No Evidence of Metastatic Disease,"Phosphaturic mesenchymal tumor, benign"
13163,Cutaneous Involvement,Stage IVC Basal Cell Lip Carcinoma
13164,Epithelial Component Present,Stage IV Ovarian Cancer AJCC v6 and v7
13165,Carcinomatous Component Present,Non-small cell lung cancer recurrent
13166,Bone Marrow Involvement,Waldenstrom's macroglobulinemia recurrent
13167,Edematous Stroma Formation,Vaginal Angiomyofibroblastoma
13168,Epithelial Component Present,Lymphoepithelial malignant thymoma
13169,Resectable Mass,Localized Resectable Neuroblastoma
13170,Carcinomatous Component Present,Stage IB Merkel Cell Carcinoma AJCC v7
13171,Childhood Lesion,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT"
13172,atypia morphology,Primary ameloblastic carcinoma
13173,Carcinomatous Component Present,Pancreatic Small Cell Neuroendocrine Carcinoma
13174,Low Mitotic Activity,Digestive System Neuroendocrine Tumor G2
13175,Invasive Lesion,Prostate Undifferentiated Carcinoma
13176,Absence of Invasion,Carcinoma in situ of ampulla of Vater
13177,Carcinomatous Component Present,Carcinoma in situ of ampulla of Vater
13178,Diffuse Pattern,Immunoblastic lymphoma associated with AIDS
13179,Carcinomatous Component Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
13180,Severe dysplasia,Cervical Squamous Cell Carcinoma In Situ
13181,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
13182,Epithelial Component Present,Malignant neoplasm of stomach stage I
13183,Recurrent disease,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
13184,Neuroendocrine Differentiation,Gallbladder Neuroendocrine Tumor G1
13185,Metastatic Lesion,Metastatic Ductal Breast Carcinoma
13186,Carcinomatous Component Present,Stage IV Anal Canal Cancer AJCC v6 and v7
13187,Breast Microcalcification,Childhood Brain Oligodendroglioma
13188,Carcinomatous Component Present,Bladder cancer recurrent
13189,Mesenchymal Component Present,Phyllodes Tumor
13190,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Excess Blasts and Fibrosis
13191,Epithelial Component Present,Papilloma of eyelid
13192,Carcinomatous Component Present,Lower Gingival Verrucous Carcinoma
13193,Adnexal Differentiation,Sebaceous Adenocarcinoma
13194,Biphasic Pattern,Borderline Breast Phyllodes Tumor
13195,Epithelial Component Present,Maxillary Sinus Carcinoma
13196,Vascular Channel Formation,Angiomatosis
13197,Cutaneous Involvement,Vulvar Trichoepithelioma
13198,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphoepithelioma stage I
13199,Epithelial Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
13200,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
13201,Hereditary Lesion,Familial Paraganglioma-Pheochromocytoma Syndrome
13202,Epithelial Component Present,Stage IA Merkel Cell Carcinoma AJCC v7
13203,Indolent Clinical Course,Gardner Fibroma
13204,Follicular Cell Differentiation,Multicentric Thyroid Gland Papillary Carcinoma
13205,Cutaneous Involvement,Precancerous Dermatitis
13206,Cystic Change,mucoepidermoid carcinoma of accessory sinus
13207,Epithelial Component Present,Metastatic Signet Ring Cell Breast Carcinoma
13208,Childhood Lesion,Refractory Childhood Hodgkin Lymphoma
13209,Keratin pearl formation,Spindle cell squamous cell carcinoma
13210,Ineffective hematopoiesis,Hypocellular Myelodysplastic Syndrome
13211,Childhood Lesion,Stage III Childhood Lymphoblastic Lymphoma
13212,Diffuse Pattern,"Trophoblastic Tumor, Placental Site"
13213,Secondary Lesion,Transitional cell cancer of renal pelvis and ureter metastatic
13214,Epithelial Component Present,EBV-Related Carcinoma
13215,bone marrow fibrosis,Acute panmyelosis with myelofibrosis
13216,Carcinomatous Component Present,Bladder adenocarcinoma stage 0
13217,Immunosuppression-Related Post-Transplant Toxicity,Acute humoral allograft nephropathy
13218,Secondary Lesion,Pancreatic adenocarcinoma metastatic
13219,Cutaneous Involvement,Fibrofolliculoma
13220,Carcinomatous Component Present,Stage IB Lung Large Cell Carcinoma AJCC v7
13221,Carcinomatous Component Present,Carcinoma of hard palate
13222,Carcinomatous Component Present,Lung Hilum Carcinoma
13223,Well-Circumscribed Lesion,Pineocytoma
13224,Epithelial Component Present,Laryngeal verrucous carcinoma stage IV
13225,Epithelial Component Present,Stage IIB Lung Large Cell Carcinoma AJCC v7
13226,Neuroendocrine Differentiation,Gastroesophageal Junction Neuroendocrine Carcinoma
13227,Carcinomatous Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
13228,Adulthood Lesion,Stage IIIA Adult Liver Cancer AJCC v7
13229,Epithelial Component Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
13230,Invasive Lesion,lipid-rich carcinoma of breast
13231,Thin Bands of Collagen Present,Solitary fibrous tumor
13232,Metaplasia,Barrett's Adenocarcinoma
13233,Intestinal metaplasia,Barrett's Adenocarcinoma
13234,Carcinomatous Component Present,Stage IV Nasal Cavity Carcinoma AJCC v7
13235,Carcinomatous Component Present,Stage IIA Lung Large Cell Carcinoma AJCC v7
13236,Epithelial Component Present,Rectosigmoid cancer recurrent
13237,Papillary Pattern,Papillary Eccrine Carcinoma
13238,More than 10 Mitoses per 10HPF,Stage IIB Lung Small Cell Carcinoma AJCC v7
13239,Well-Circumscribed Lesion,villous adenoma of stomach
13240,High Grade Lesion,Stage IIA Lung Small Cell Carcinoma AJCC v7
13241,Epithelial Component Present,Supraglottic Squamous Cell Carcinoma
13242,Carcinomatous Component Present,papillary squamous cell carcinoma of larynx
13243,Indolent Clinical Course,Leiomyoma of ciliary body
13244,Epithelial Component Present,Vaginal Basaloid Carcinoma
13245,Follicular Cell Differentiation,Thyroid Hurthle Cell Carcinoma
13246,Epithelial Component Present,Stage III Renal Cell Cancer AJCC v7
13247,Carcinomatous Component Present,Transplant-Related Bladder Urothelial Carcinoma
13248,Cutaneous Involvement,Eccrine porocarcinoma
13249,Dysplasia,Bladder transitional cell carcinoma stage 0
13250,Well-Circumscribed Lesion,Juvenile polyp
13251,Carcinomatous Component Present,"Transitional cell carcinoma, micropapillary"
13252,Epithelial Component Present,Glandular Cell Intraepithelial Neoplasia
13253,Swelling,Tibial adamantinoma
13254,Carcinomatous Component Present,Stage IIIA Colon Cancer AJCC v7
13255,Osseous metaplasia,Adenocarcinoma with osseous metaplasia
13256,Cutaneous Involvement,Hamartoma of skin appendage
13257,Progressive Clinical Course,Rapidly progressive glomerulonephritis
13258,Adulthood Lesion,Cutaneous Adult T-Cell Leukemia/Lymphoma
13259,Pregnancy Complications,"Hydatidiform Mole, Partial"
13260,Neuroendocrine Differentiation,Primary malignant neoplasm of glomus jugulare
13261,Carcinomatous Component Present,Vaginal Adenosquamous Carcinoma
13262,Cutaneous Involvement,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
13263,Epithelial Component Present,Eccrine dermal cylindroma
13264,Refractory Disease,Mycosis fungoides refractory
13265,Epithelial Component Present,Stage I Lung Cancer AJCC v7
13266,Infiltrating Tumor Margins Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina
13267,Exophytic Polypoid Lesion,Polyp of middle ear
13268,Epithelial hyperplasia of skin,Verrucous keratotic hemangioma
13269,Exophytic Polypoid Lesion,Traditional Serrated Adenoma
13270,Indolent Clinical Course,Lipoblastoma
13271,Low Mitotic Activity,Appendix Tubular Carcinoid
13272,Tubular Pattern,Appendix Tubular Carcinoid
13273,Epithelial Component Present,Desmoplastic trichilemmoma
13274,Severe dysplasia,Carcinoma in Situ
13275,Cutaneous Involvement,Stage III Lip Basal Cell Carcinoma
13276,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity stage I
13277,Local disease,Localized Carcinoma
13278,Carcinomatous Component Present,adenoid cystic carcinoma of lung
13279,Geographic Necrosis,Adult Central Nervous System Embryonal Carcinoma
13280,Pseudoencapsulated Mass,Intraocular Malignant Peripheral Nerve Sheath Tumor
13281,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
13282,Secondary Lesion,Metachronous Osteosarcoma
13283,Nested Pattern,Sclerosing Epithelioid Fibrosarcoma
13284,Calcitonin Positive Neoplastic Cells Present,Medullary carcinoma of thyroid
13285,Epithelial Component Present,Hepatitis C Virus-Related Hepatocellular Carcinoma
13286,Microvascular Proliferation,Childhood Gliosarcoma
13287,Indolent Clinical Course,"Uterine Corpus Leiomyoma, Mitotically Active Variant"
13288,Cystic Change,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia
13289,Metaplasia,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
13290,Carcinomatous Component Present,Stage IIIA Esophageal Adenocarcinoma AJCC v7
13291,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP F"
13292,Cystic Change,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia
13293,Alcohol Toxicity,Alcohol-Related Laryngeal Carcinoma
13294,Carcinomatous Component Present,Parathyroid Gland Adenocarcinoma
13295,Carcinomatous Component Present,Squamous cell carcinoma of cornea
13296,Low Mitotic Activity,Somatostatinoma
13297,Local disease,Lipoma of skin
13298,Well-Circumscribed Lesion,Intravascular Angioleiomyoma
13299,Carcinomatous Component Present,Colloid Carcinoma of the Pancreas
13300,Borderline Lesion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
13301,High Grade Lesion,Glioblastoma
13302,atypia morphology,Proliferating Brenner Tumor
13303,Thick-Walled Vessels Present,Epithelioid Type Angiomyolipoma
13304,Carcinomatous Component Present,Intracystic Papillary Breast Carcinoma
13305,Glomerular Hypertrophy,Obesity Related Glomerulopathy
13306,Neuroectodermal Differentiation,malignant ganglioneuroblastoma of adrenal gland
13307,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v6 Stage
13308,Confluent Sheets of Anaplastic T-Lymphocytes Present,"lymphomatoid papulosis, type C"
13309,Dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
13310,Local disease,Adenomatoid Tumor
13311,Carcinomatous Component Present,"Glandular intraepithelial neoplasia, grade III"
13312,Carcinomatous Component Present,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7
13313,Benign Cellular Infiltrate,Giant Fibrovascular Esophageal Polyp
13314,Papillary Pattern,Respiratory papilloma
13315,Non-Hereditary Lesion,Mucinous adenocarcinoma gastric
13316,Carcinomatous Component Present,undifferentiated carcinoma of appendix
13317,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma refractory
13318,Vascular Channel Formation,Adrenal Gland Angiosarcoma
13319,Multinodular Mass,Adrenal Gland Angiosarcoma
13320,Carcinomatous Component Present,Alcohol-Related Hepatocellular Carcinoma
13321,Refractory Disease,Burkitt's lymphoma refractory
13322,Carcinomatous Component Present,mucinous adenocarcinoma of rectum
13323,High Mitotic Activity,Merkel cell carcinoma
13324,Myxoid Stroma Formation,Cervical Rhabdomyoma
13325,Well-Circumscribed Lesion,Malignant Vulvar Phyllodes Tumor
13326,Epithelial Component Present,Malignant Vulvar Phyllodes Tumor
13327,Severe dysplasia,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8"
13328,Epithelial Component Present,BCLC Stage A Adult Hepatocellular Carcinoma
13329,atypia morphology,High Grade Liver Dysplastic Nodule
13330,Epithelial Component Present,Stage IV Adult Liver Cancer AJCC v7
13331,Carcinomatous Component Present,Adenocarcinoma of anal canal
13332,Neuroendocrine Differentiation,Adrenal Gland Pheochromocytoma
13333,Chromogranin A Positive Neoplastic Cells Present,Regional Digestive System Neuroendocrine Tumor G1
13334,Nuclear Molding,Stage IIIA Lung Small Cell Carcinoma AJCC v7
13335,Epithelial Component Present,Bladder adenocarcinoma recurrent
13336,Chromogranin A Positive Neoplastic Cells Present,Gastric Carcinoid Tumor
13337,Exophytic Polypoid Lesion,Tubulovillous adenoma
13338,Tubular Pattern,Tubulovillous adenoma
13339,Villous Pattern,Tubulovillous adenoma
13340,Epithelial Component Present,Stage IIIB Lung Small Cell Carcinoma AJCC v7
13341,Storiform Growth Pattern,Malignant fibrous histiocytoma of skin
13342,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma of skin
13343,Cellular Pleomorphism,Malignant fibrous histiocytoma of skin
13344,Angiocentric Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
13345,Epithelial Component Present,Dermal Duct Tumor
13346,Presence of a Hormonal Syndrome,Hormone secreting pituitary neoplasms
13347,Cartilaginous Differentiation,Osteochondromatosis
13348,Carcinomatous Component Present,Esophageal Well Differentiated Squamous Cell Carcinoma
13349,Carcinomatous Component Present,Digital papillary eccrine carcinoma of skin
13350,Carcinomatous Component Present,Esophageal Large Cell Neuroendocrine Carcinoma
13351,Epithelial Component Present,Bladder squamous cell carcinoma stage IV
13352,Diffuse Lesion,Nonencapsulated sclerosing tumor
13353,Carcinomatous Component Present,Sublingual Gland Adenocarcinoma
13354,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile ganglioglioma
13355,Geographic Necrosis,Testicular embryonal carcinoma stage I
13356,Presence of a Hormonal Syndrome,Functioning Pituitary Gland Macroadenoma
13357,Papillary Pattern,Papillary serous cystadenocarcinoma
13358,Carcinomatous Component Present,Cystic basal cell carcinoma
13359,Micropapillary Pattern,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
13360,Hyaline Cartilage Differentiation,Secondary Central Chondrosarcoma
13361,Epithelial Component Present,Recurrent Inverted Schneiderian Papilloma
13362,Vascular Channel Formation,Cutaneous Radiation-Related Angiosarcoma
13363,Immunologic Deficiency Syndromes,AIDS-Related Isosporiasis
13364,Recurrent disease,Ewing's sarcoma recurrent
13365,Indolent Clinical Course,Angiolipoma
13366,Keratin pearl formation,Cervical Keratinizing Squamous Cell Carcinoma
13367,Epithelial Component Present,Lung Basaloid Large Cell Carcinoma
13368,Cystic Change,Appendix Mucinous Cystadenoma
13369,Indolent Clinical Course,Non-Ossifying Fibroma
13370,Carcinomatous Component Present,Carcinoma Arising from Craniopharyngioma
13371,Carcinomatous Component Present,Gallbladder Goblet Cell Carcinoid
13372,Multifocal Lesion,Multiple Endocrine Neoplasia Type 1
13373,Vascular Channel Formation,Composite hemangioendothelioma
13374,Primary Lesion,Alveolar soft part sarcoma non-metastatic
13375,Epithelial Component Present,Gastrointestinal Intraepithelial Neoplasia
13376,Multifocal Lesion,Uterine Corpus Diffuse Leiomyomatosis
13377,Tissue Differentiation Uncertain,"Synovial sarcoma, epithelioid cell"
13378,Mass of body structure,Intracranial Myeloid Sarcoma
13379,Well-Circumscribed Lesion,adenomatous polyp of stomach
13380,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
13381,Epithelial Component Present,Vaginal Carcinosarcoma
13382,Ineffective hematopoiesis,Refractory anemia with excess blasts II
13383,Intramucosal Lesion,Intramucosal Adenocarcinoma
13384,Exophytic Polypoid Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
13385,Mild cytologic atypia,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
13386,Indolent Clinical Course,Vulvar Superficial Myofibroblastoma
13387,Extensive Stage Lesion,Advanced Unfavorable Hodgkin Lymphoma
13388,Epithelial Component Present,Recurrent Oral Cavity Carcinoma
13389,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Hyperplasia of the Breast with Atypia
13390,Epithelial Component Present,Primary Peritoneal High Grade Serous Adenocarcinoma
13391,Infiltrative Growth Pattern,Anaplastic astrocytoma
13392,Primary Lesion,Cerebral Astrocytoma
13393,Embryoid Bodies Present,Stage I Ovarian Polyembryoma AJCC v6 and v7
13394,Pregnancy Complications,Deciduoma
13395,Epithelial Component Present,Recurrent Lip and Oral Cavity Carcinoma
13396,Tubular Structures Present,Adenoameloblastoma
13397,Mixed Cellular Population,Pericanalicular fibroadenoma
13398,Carcinomatous Component Present,carcinoma of eye
13399,Childhood Lesion,Childhood Brain Neoplasm
13400,Perineural spread,Adenoid cystic carcinoma of the oral cavity recurrent
13401,Well-Circumscribed Lesion,Cystadenocarcinoma of kidney
13402,Epithelial Component Present,Cholangiocarcinoma recurrent
13403,Epithelial Component Present,Cortisol-Producing Adrenal Cortex Adenoma
13404,Chronic lymphocytic inflammation,Lung Inflammatory Myofibroblastic Tumor
13405,Neuroendocrine Differentiation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
13406,Epithelial Component Present,Bladder Papillary Urothelial Carcinoma
13407,Oligodendroglial Component Present,Oligodendroglioma of spinal cord
13408,Epithelial Component Present,Stage IIIB Small Intestinal Cancer AJCC v7
13409,Carcinomatous Component Present,Stage IB Esophageal Cancer AJCC v7
13410,Whorling Growth Pattern,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
13411,Diffuse Pattern,Adult Malignant Peripheral Nerve Sheath Tumor
13412,Firm mass,Adult Malignant Peripheral Nerve Sheath Tumor
13413,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of pleura
13414,Carcinomatous Component Present,Recurrent Primary Peritoneal Carcinoma
13415,Secondary Lesion,Secondary malignant neoplasm of pancreas
13416,Geographic Necrosis,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
13417,Epithelial Component Present,Lactating adenoma
13418,Neuroendocrine Differentiation,Ovarian Mucinous Carcinoid Tumor
13419,Carcinomatous Component Present,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
13420,Cutaneous Involvement,furuncle
13421,Epithelial Component Present,Stage II Pharynx Carcinoma
13422,Nuclear Molding,Combined Lung Small Cell and Squamous Cell Carcinoma
13423,Childhood Lesion,Recurrent Childhood Hepatocellular Carcinoma
13424,Osseous Differentiation,Intraosseous well differentiated osteosarcoma
13425,Necrotic changes (finding),Small Intestinal Small Cell Neuroendocrine Carcinoma
13426,Carcinomatous Component Present,Esophageal carcinoma
13427,Peripheral Nuclear Palisading,Small cell lung cancer extensive stage
13428,Necrotic changes (finding),"Carcinoma, Small Cell"
13429,Refractory Disease,Anaplastic large cell lymphoma T- and null-cell types refractory
13430,Tubular Pattern,tubular adenoma of extrahepatic bile duct
13431,Epithelial Component Present,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
13432,Epithelial Component Present,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
13433,Entrapped Respiratory Epithelium Present,Endobronchial Hamartoma
13434,Severe dysplasia,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
13435,Follicular Cell Differentiation,Oncocytic Variant Thyroid Gland Papillary Carcinoma
13436,Carcinomatous Component Present,Cervical Warty Carcinoma
13437,Acanthosis,Vulvar Seborrheic Keratosis
13438,Stromal Invasion,Stage IIC Ovarian Carcinoma
13439,CD4-Positive Neoplastic Cells Present,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder
13440,Cutaneous Involvement,"Ichthyosis, X-Linked"
13441,Hereditary Lesion,Lynch Syndrome
13442,Microglandular Pattern,Cervical Microglandular Polyp
13443,Desmoplastic Stroma Formation,Desmoplastic ameloblastoma
13444,Carcinomatous Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7
13445,Diffuse Pattern,Secondary Supratentorial Anaplastic Astrocytoma
13446,Secondary Lesion,Secondary Myelodysplastic Syndrome
13447,Undifferentiated Lesion,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
13448,Vascular Channel Formation,Colorectal Kaposi Sarcoma
13449,Dysplasia,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
13450,Epithelial Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma
13451,Epithelial Component Present,Pancreatic carcinoma resectable
13452,Melanin Pigment Present,Spindle cell nevus of Reed
13453,Childhood Lesion,Childhood Mediastinal Neurogenic Neoplasm
13454,Fibrosis,Primary mediastinal large B-cell lymphoma stage III
13455,Recurrent disease,Recurrent Childhood Hodgkin Lymphoma
13456,Anaplasia,"Glioblastoma, IDH-Wildtype"
13457,Increased Cellularity Present,Anaplastic Oligoastrocytoma
13458,Well-Circumscribed Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
13459,Anaplasia,Multifocal Glioblastomas
13460,Indolent Clinical Course,Cardiac hemangioma
13461,Anaplasia,Giant cell carcinoma of lung
13462,Intraosseous Lesion,Acanthomatous ameloblastoma
13463,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
13464,Carcinomatous Component Present,BCLC Stage 0 Adult Hepatocellular Carcinoma
13465,Carcinomatous Component Present,Carcinoma in situ of penis
13466,Recurrent disease,Recurrent Glioblastoma
13467,Carcinomatous Component Present,Stage I Fallopian Tube Cancer
13468,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage III
13469,Mild cytologic atypia,Plantar Verrucous Skin Carcinoma
13470,Well Differentiated Lesion,Subglottic Verrucous Carcinoma
13471,Solitary mass,Vertebral chordoma
13472,Tissue Differentiation Uncertain,Benign Uterine Corpus PEComa
13473,Anaplasia,Anaplastic Kidney Wilms Tumor
13474,Mild dysplasia,Low Grade Corneal Intraepithelial Neoplasia
13475,Indolent Clinical Course,Benign Connective and Soft Tissue Neoplasm
13476,Carcinomatous Component Present,Stage I Carcinoma of Penis
13477,Stromal Invasion,Endometrioid carcinoma ovary
13478,Carcinomatous Component Present,Breast Carcinoma with Choriocarcinomatous Features
13479,atypia morphology,Dysplastic Nevus
13480,Epithelial Component Present,Stage IV Rectosigmoid Cancer AJCC v7
13481,Epithelial Component Present,Gastric Carcinoma with Lymphoid Stroma
13482,Dermal Involvement,Neuronevus
13483,Low Grade Lesion,Subependymal Giant Cell Astrocytoma
13484,High Mitotic Activity,Malignant tenosynovial giant cell tumor
13485,Microvascular Proliferation,Adult Brain Glioblastoma
13486,Indolent Clinical Course,Capillary hemangioma of retina
13487,Local disease,Pleomorphic Lipoma
13488,Epithelial Component Present,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
13489,Carcinomatous Component Present,Renal carcinoma
13490,Epithelial Component Present,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma
13491,Carcinomatous Component Present,Renal Cell Carcinoma
13492,Infiltrative Growth Pattern,Pigmented villonodular synovitis
13493,Poorly Differentiated Lesion,Grade 3 Colorectal Adenocarcinoma
13494,CD30-Positive Neoplastic Cells Present,Recurrent Childhood Anaplastic Large Cell Lymphoma
13495,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Carcinosarcoma
13496,Serotonin Positive Neoplastic Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
13497,Melanosomes Present,Melanotic Schwannoma
13498,Recurrent disease,Non-small cell lung cancer recurrent
13499,Indolent Clinical Course,Hemangioma of Peripheral Nerve
13500,Dysplasia,High Grade Cervical Intraepithelial Neoplasia
13501,Epithelial Component Present,Trabecular adenocarcinoma
13502,Epithelial Component Present,Ascending Colon Neuroendocrine Tumor G1
13503,Regional Disease,Regional Neuroblastoma
13504,Cutaneous Involvement,Flexural Skin Nevus
13505,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable"
13506,Tobacco Toxicity,Cigarette Smoking-Related Carcinoma
13507,Epithelial Component Present,Non-Functioning Pancreatic Neuroendocrine Tumor G1
13508,Cutaneous Involvement,Contact Dermatitis
13509,Follicular Cell Differentiation,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
13510,One Germ Layer Present,Monodermal Testicular Teratoma
13511,Mixed Cellular Population,Mixed Cell Adrenal Cortical Adenoma
13512,Carcinomatous Component Present,large cell neuroendocrine carcinoma of gallbladder
13513,Endophytic Tumor Growth,Urethral Verrucous Carcinoma
13514,Mitotic Activity,Anaplastic Hemispheric Astrocytoma
13515,Nodular lesions,"Ganglioneuroblastoma, Nodular"
13516,Juvenile Lesion,Juvenile Pilocytic Astrocytoma
13517,Cutaneous Involvement,Small plaque parapsoriasis
13518,Epithelial Component Present,Pituitary Gland Microadenoma
13519,Lesion with Diameter of 10mm or Less,Pituitary Gland Microadenoma
13520,Thick-Walled Hyalinized Vessels Present,Schwannomatosis
13521,Well Differentiated Lesion,Verrucous carcinoma of oral cavity
13522,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
13523,Epithelial Component Present,Ovarian Clear Cell Adenofibroma
13524,Epithelial Component Present,Vaginal Glandular Neoplasm
13525,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Thrombocytopenia
13526,Hyperkeratosis,Buccal Mucosa Verrucous Carcinoma
13527,Carcinomatous Component Present,Small Intestinal Signet Ring Cell Carcinoma
13528,Thick-Walled Hyalinized Vessels Present,Plexiform Schwannoma
13529,Adnexal Differentiation,Vulvar Nodular Hidradenoma
13530,Eccrine Differentiation,Vulvar Syringoma
13531,Cutaneous Involvement,Malignant Outer Hair Sheath and Infundibulum Neoplasm
13532,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia
13533,Epithelial Component Present,Microfollicular adenoma
13534,Hyperplastic Tissue Present,Prostatic Basal Cell Hyperplasia
13535,Epithelial Component Present,Macrofollicular adenoma
13536,Cutaneous Involvement,Malignant Sebaceous Neoplasm
13537,Stromal Invasion,Malignant Ovarian Surface Epithelial-Stromal Tumor
13538,Epithelial Component Present,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor
13539,Mixed Cellular Population,Borderline Ovarian Serous Adenofibroma
13540,Carcinomatous Component Present,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
13541,Sarcomatous or Carcinomatous Component Present,Testicular Teratoma with Somatic-Type Malignancy
13542,Osteoid formation,Liver Extraskeletal Osteosarcoma
13543,Mast Cells 10 Percent or More of Peripheral Blood White Cells,"Leukemia, Mast-Cell"
13544,Secondary Lesion,Secondary malignant neoplasm of trachea
13545,Pregnancy Complications,Chorioangioma
13546,Increased Cellularity Present,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System
13547,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma of parotid gland
13548,Therapy-Related Toxicity,Iatrogenic Kaposi Sarcoma
13549,Well-Circumscribed Lesion,Colon Serrated Polyposis
13550,Epithelial Component Present,Colorectal Mixed Adenoneuroendocrine Carcinoma
13551,Juvenile Lesion,Juvenile type ovarian granulosa cell tumor
13552,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma
13553,Epithelial Component Present,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions
13554,Superficial Lesion,"Fibromatosis, Plantar"
13555,Multinodular Pattern,Gastric Plexiform Fibromyxoma
13556,Secondary Lesion,Carcinoma ex Eccrine Spiradenoma
13557,Exophytic Polypoid Lesion,Colorectal Adenomatous Polyp
13558,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
13559,Epithelial Component Present,Anal cancer recurrent
13560,Epithelial Component Present,Mucoepidermoid carcinoma of parotid gland
13561,Alternative Fascicle (Bundle) Pattern,Uterine Fibroids
13562,Cutaneous Involvement,basal cell carcinoma of scrotum
13563,Eccrine Differentiation,Ductal Eccrine Carcinoma with Squamous Metaplasia
13564,Tubular Structures Present,Tubular breast carcinoma
13565,atypia morphology,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor
13566,Anaplasia,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant"
13567,Increased Cellularity Present,Ovarian Cellular Fibroma
13568,Dysplasia,Colorectal Tubular Adenoma
13569,Well Differentiated Lesion,Vaginal Warty Carcinoma
13570,Exophytic Papillary Lesion,Vaginal Warty Carcinoma
13571,Epithelial Component Present,"Papillary transitional cell carcinoma, non-invasive"
13572,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
13573,Chronic lymphocytic inflammation,Central Nervous System Inflammatory Myofibroblastic Tumor
13574,Papillary Pattern,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
13575,Cutaneous Involvement,Paraganglioma-Like Dermal Melanocytic Tumor
13576,Indolent Clinical Course,Adrenal Cortex Adenomatoid Tumor
13577,High Mitotic Activity,Langerhans Cell Sarcoma
13578,Generalized illness,Disseminated Malignant Neoplasm
13579,Carcinomatous Component Present,Stage IIB Lung Adenosquamous Carcinoma AJCC v7
13580,Diffuse Lesion,Meningeal melanomatosis
13581,Cystic Change,cystic mucinous tumor of pancreas with moderate dysplasia
13582,Carcinomatous Component Present,Disseminated squamous cell carcinoma
13583,Epithelial Component Present,Prostate Basal Cell Carcinoma
13584,Carcinomatous Component Present,Bile duct signet-ring cell carcinoma
13585,Epithelial Component Present,Stage III Esophageal Adenocarcinoma AJCC v7
13586,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1B
13587,Mixed Cellular Population,Oral Cavity Pleomorphic Adenoma
13588,Localized Lesion,Chest Wall Solitary Plasmacytoma
13589,Hyalinized Stroma Formation,Malignant Solitary Fibrous Tumor
13590,S-100-Positive Neoplastic Cells Present,Pulmonary lymphangioleiomyomatosis
13591,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis
13592,Low Grade Lesion,Mixed Congenital Mesoblastic Nephroma
13593,Epithelial Component Present,Appendix Mixed Adenoneuroendocrine Carcinoma
13594,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
13595,Nuclear pleomorphism,Childhood Pleomorphic Rhabdomyosarcoma
13596,Vascular Channel Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma"
13597,Carcinomatous Component Present,Papillary Thyroid Microcarcinoma
13598,Villous Pattern,tubulovillous adenoma of stomach
13599,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells
13600,Multifocal Lesion,Atypical Adenomatous Lung Hyperplasia
13601,Absence of Invasion,Carcinoma in Situ
13602,Diffuse Pattern,Pleural Desmoplastic Mesothelioma
13603,Carcinomatous Component Present,Invasive Apocrine Breast Carcinoma
13604,Carcinomatous Component Present,Stage IVB Vaginal Cancer AJCC v6 and v7
13605,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity stage III
13606,Indolent Clinical Course,Pericardial Adenomatoid Tumor
13607,Mixed Cellular Population,Adenocarcinofibroma
13608,Chromogranin A Positive Neoplastic Cells Present,Metastatic Digestive System Neuroendocrine Tumor G1
13609,Peripheral Blood Involvement,Sezary Syndrome
13610,Lymphoplasmacytic Infiltrate,"Castleman Disease, Plasma Cell Type"
13611,Compartmentalized Pattern,Sebaceous hyperplasia
13612,No Evidence of Metastatic Disease,Benign neuroendocrine tumor
13613,Myxoid Stroma Formation,"Fibro-odontoma, Ameloblastic"
13614,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor
13615,White blood cell count increased (lab result),Juvenile Myelomonocytic Leukemia
13616,Cutaneous Involvement,Bullous lichen planus
13617,Epithelial Component Present,"Papillary mucinous cystadenoma, borderline malignancy"
13618,Childhood Lesion,Infant Acute Biphenotypic Leukemia
13619,Epithelial Component Present,BCLC Stage C Adult Hepatocellular Carcinoma
13620,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Bizarre Leiomyoma
13621,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
13622,Monoclonal Langerhans Cells Present,"Histiocytosis, Langerhans-Cell"
13623,Epithelial Component Present,tubular adenoma of gallbladder
13624,Necrotic changes (finding),Glioblastoma
13625,Anaplasia,Glioblastoma
13626,Indolent Clinical Course,Classic Rhabdomyoma
13627,Cutaneous Involvement,Anal margin Paget's disease
13628,High Mitotic Activity,Gastric Neuroendocrine Carcinoma
13629,Cutaneous Involvement,Cutaneous schistosomiasis
13630,Mixed Cellular Population,Adult Mixed Glioma
13631,Carcinomatous Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7
13632,Neuroendocrine Differentiation,Thymic Atypical Carcinoid Tumor
13633,Hereditary Lesion,Neurofibromatoses
13634,Epithelial Component Present,Stage IVC Oral Cavity Cancer AJCC v6 and v7
13635,Low Mitotic Activity,Glucagonoma
13636,Epithelial Component Present,malignant neoplasm of large intestine stage IV
13637,Carcinomatous Component Present,Metastatic Carcinoma in the Liver
13638,Adulthood Lesion,BCLC Stage A Adult Hepatocellular Carcinoma
13639,High Grade Lesion,Adult Giant Cell Glioblastoma
13640,Malignant Germinomatous Cellular Infiltrate,Childhood Brain Germinoma
13641,High Mitotic Activity,Esophageal Neuroendocrine Carcinoma
13642,Cutaneous Involvement,Hair nevus
13643,Absence of Stromal Invasion,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor
13644,Epithelial Component Present,Small Intestinal Mixed Adenoneuroendocrine Carcinoma
13645,Necrotic changes (finding),Low Grade Malignant Peripheral Nerve Sheath Tumor
13646,Metastatic Lesion,Secondary malignant neoplasm of spinal cord
13647,Epithelial Component Present,"Carcinoma, Giant Cell"
13648,Biphasic Pattern,Thymus Lipofibroadenoma
13649,Sarcomatous Component Present,carcinosarcoma of extrahepatic bile duct
13650,Cystic Change,Mucinous cystadenoma of ovary
13651,Exophytic Polypoid Lesion,Tubulovillous adenoma of rectum
13652,Papillary Pattern,Digital papillary eccrine carcinoma of skin
13653,Necrotic changes (finding),Esophageal Large Cell Neuroendocrine Carcinoma
13654,Hyperplastic Tissue Present,Squamous Hyperplasia
13655,Invasive Lesion,Glomangiomatosis
13656,1p/19q Codeletion Status Unknown,oligodendroglioma
13657,Intermediate Grade Lesion,Grade II Chondrosarcoma
13658,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v6 and v7
13659,Adulthood Lesion,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
13660,High Grade Lesion,Grade III Chondrosarcoma
13661,Nodular lesions,Carcinoid tumor of lung
13662,Bone Marrow Dysplasia Present,de novo Myelodysplastic Syndrome
13663,Carcinomatous Component Present,clear cell adenocarcinoma of bladder
13664,Nodular Pattern,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic
13665,Osseous Differentiation,Osteoblastoma
13666,Epithelial Component Present,Cloacogenic carcinoma
13667,Well-Circumscribed Lesion,Cystadenoma of pancreas
13668,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor
13669,Acinar Cell Differentiation,Acinar cell tumor
13670,Mild cytologic atypia,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
13671,Peau d'orange surface of breast,Inflammatory carcinoma of breast stage III
13672,Epithelial Component Present,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
13673,Intravascular Fibrin Thrombus Formation,Angiolipoma
13674,High Grade Lesion,Angiosarcoma NCI Grade 3
13675,Exophytic Polypoid Lesion,Epulides
13676,Non-Invasive Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
13677,Mixed Cellular Population,carcinosarcoma of gallbladder
13678,Cord-Like Pattern,Clear cell sarcoma of kidney
13679,Moderate dysplasia,Grade II Penile Intraepithelial Neoplasia
13680,Papillary Pattern,Gastric Papillary Adenocarcinoma
13681,Epithelial Component Present,Head and Neck Basaloid Carcinoma
13682,Biphasic Pattern,Serous adenofibroma
13683,IDH Gene Family Mutation Status Unknown,Anaplastic Oligoastrocytoma
13684,Carcinomatous Component Present,Carcinoma in situ of vagina
13685,Infiltrating Tumor Margins Present,Uterine Corpus High Grade Endometrial Stromal Sarcoma
13686,Mixed Cellular Population,Juvenile fibroadenoma of breast
13687,High Mitotic Activity,Small cell lung cancer recurrent
13688,Metastatic Lesion,Epithelioid sarcoma metastatic
13689,Epithelial Component Present,Anal Canal Neuroendocrine Tumor
13690,Epithelial Component Present,Early Invasive Cervical Adenocarcinoma
13691,Mixed Cellular Population,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
13692,Carcinomatous Component Present,Carcinosarcoma of cervix uteri
13693,Epithelial Component Present,Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
13694,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Monodermal and Highly Specialized Teratoma
13695,Epithelial Component Present,Primary Intraosseous Squamous Cell Carcinoma
13696,Tissue Differentiation Uncertain,Metastatic Extraskeletal Myxoid Chondrosarcoma
13697,Low Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v7
13698,Indolent Clinical Course,Breast Myofibroblastoma
13699,Secondary Lesion,Secondary malignant neoplasm of nervous system
13700,Carcinomatous Component Present,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
13701,Humoral hypercalcemia of malignancy (disorder),"Ovarian Small Cell Carcinoma, Hypercalcemic Type"
13702,Epithelial Component Present,Recurrent Ureter Carcinoma
13703,Well-Circumscribed Lesion,"Polyposis, Gastric"
13704,Secondary Lesion,Lung Carcinoma Metastatic in the Bone
13705,Epithelial Component Present,Benign Epithelioma
13706,Neuroendocrine Differentiation,Non-Functioning Pancreatic Neuroendocrine Tumor G2
13707,Low Grade Lesion,Primary Peritoneal Low Grade Serous Adenocarcinoma
13708,Mild cytologic atypia,Verrucous carcinoma of the oral cavity recurrent
13709,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia
13710,Cutaneous Involvement,melanoma of scrotum
13711,Nuclear Clearing,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
13712,Well Differentiated Lesion,Papillary squamous cell carcinoma
13713,Vascular Channel Formation,Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm
13714,Carcinomatous Component Present,Stage III Adrenal Cortex Carcinoma AJCC v7
13715,Polymorphic Cellular Infiltrate,Eosinophilic Granuloma
13716,Chronic Inflammatory Infiltrate,Pleomorphic hyalinizing angiectatic tumor of soft tissue
13717,Lobulated Growth Pattern,Pleomorphic hyalinizing angiectatic tumor of soft tissue
13718,Epithelial Component Present,Stage IVA Rectal Cancer AJCC v7
13719,Cavernous Vascular Space Formation,Intracranial cavernous hemangioma
13720,High Mitotic Activity,Small cell neuroendocrine carcinoma of bladder
13721,Macrotrabecular Pattern,Macrotrabecular Hepatoblastoma
13722,Biphasic Pattern,Childhood Pilocytic Astrocytoma
13723,Anaplasia,Anaplastic Ependymoma
13724,Sarcomatous Component Present,Ovarian Dermoid Cyst with Angiosarcoma
13725,Epithelial Component Present,adenosquamous carcinoma of skin
13726,Carcinomatous Component Present,Hard Palate Squamous Cell Carcinoma
13727,High Mitotic Activity,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
13728,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
13729,Recurrent disease,Recurrent Combined Thymic Epithelial Neoplasm
13730,Epithelial Component Present,"Carcinoma, Cribriform"
13731,Epithelial Component Present,Stage IIIA Cervical Carcinoma
13732,Carcinomatous Component Present,Pharyngeal cancer stage I
13733,Intraosseous Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor
13734,Cystic Change,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
13735,Local disease,Localized Unresectable Neuroblastoma
13736,Cystic Change,Telangiectatic osteosarcoma
13737,Cutaneous Involvement,Pyogenic granuloma of skin and subcutaneous tissue
13738,Dermal Involvement,Vulvar Blue Nevus
13739,Cutaneous Involvement,Contact dermatitis due to acid
13740,Epithelial Component Present,Clitoral Carcinoma
13741,Capillary Sized Vascular Channel Formation,Infantile hemangioma of liver
13742,Benign Cellular Infiltrate,Gastric Lymphangioma
13743,Nuclear Molding,Small cell lung cancer extensive stage
13744,Neuroendocrine Differentiation,Small cell lung cancer extensive stage
13745,Epithelial Component Present,Adenocarcinoma of lung stage IIIA
13746,High Grade Lesion,Cardiac Synovial Sarcoma
13747,Epithelial Component Present,Squamous cell carcinoma of lip
13748,Carcinomatous Component Present,Adenosquamous cell lung cancer stage II
13749,Cellular Pleomorphism,Prostate Stromal Sarcoma
13750,Benign Cellular Infiltrate,Esophageal Fibroma
13751,Carcinomatous Component Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter
13752,Primary Lesion,Childhood Brain Stem Astrocytoma
13753,Increased Cellularity Present,Adult Anaplastic Oligodendroglioma
13754,Dysplasia,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
13755,Epithelial Component Present,Stage III Distal Bile Duct Cancer AJCC v7
13756,Carcinomatous Component Present,Stage II Renal Cell Cancer
13757,Moderate dysplasia,Vaginal intraepithelial neoplasia grade 2
13758,Exophytic Papillary Lesion,Cervical Squamotransitional Carcinoma
13759,Well-Circumscribed Lesion,Cervical Microglandular Polyp
13760,Biphasic Pattern,"Uterine Carcinosarcoma, Homologous Type"
13761,Glucagon-Like Peptide Positive Neoplastic Cells Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
13762,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage II
13763,Adulthood Lesion,Adult Acute Erythroid Leukemia
13764,Epithelial Component Present,insulinoma
13765,Childhood Lesion,Recurrent Childhood Spinal Cord Neoplasm
13766,Carcinomatous Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
13767,Carcinomatous Component Present,Pilomatrix carcinoma of skin
13768,Absence of Invasion,Stage 0 Cervical Cancer AJCC v6
13769,Hereditary Lesion,Neurofibromatosis aggravated
13770,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma
13771,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma
13772,Anaplasia,Anaplastic Oligodendroglioma
13773,Papillary Pattern,Papillary adenocarcinoma
13774,Cystic Lesion,Adult Craniopharyngioma
13775,Follicular Structures Present,Atypical follicular adenoma
13776,Metastatic Lesion,Secondary malignant neoplasm of ciliary body
13777,Epithelial Component Present,Stage IIIA Colorectal Cancer AJCC v7
13778,Well-Circumscribed Lesion,Broad Ligament Serous Cystadenoma
13779,Epithelial Component Present,small cell carcinoma of breast
13780,Epithelial Component Present,Stage II Pancreatic Cancer AJCC v6 and v7
13781,Epithelial Component Present,Subglottic Verrucous Carcinoma
13782,Carcinomatous Component Present,Superior Sulcus Lung Carcinoma
13783,Dysplasia,Corneal intraepithelial neoplasia
13784,Carcinomatous Component Present,Stage IV Lip Cancer AJCC v6 and v7
13785,Infiltrative Growth Pattern,"Fibromatosis, Aggressive"
13786,Adnexal Differentiation,Vulvar Papillary Hidradenoma
13787,Diffuse Lesion,Carcinomatosis
13788,Epithelial Component Present,Recurrent Carcinoma
13789,Nuclear pleomorphism,Childhood Choroid Plexus Carcinoma
13790,Radiation Sickness,Solar Radiation-Related Malignant Neoplasm
13791,Perivascular Pseudorosette Formation,Childhood Anaplastic Ependymoma
13792,Vascular Channel Formation,Giant Hemangioma
13793,Indolent Clinical Course,Giant Hemangioma
13794,VIP Positive Neoplastic Cells Present,Vipoma
13795,Carcinomatous Component Present,BCLC Stage 0 Hepatocellular Carcinoma
13796,Papillary Pattern,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
13797,Metastatic Lesion,Secondary Cerebral Hodgkin Lymphoma
13798,Mixed Cellular Population,Ovarian serous cystadenofibroma
13799,Well-Circumscribed Lesion,Nasal Polyps
13800,Stromal Invasion,Ovarian epithelial cancer stage II
13801,Local disease,Tendon Sheath Lipoma
13802,Epithelial Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7
13803,Papillary Pattern,Pancreatic Intraductal Papillary Mucinous Neoplasm
13804,Infiltrative Growth Pattern,Cerebellar Glioblastoma
13805,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligoastrocytoma
13806,Malignant Cellular Infiltrate,"Phosphaturic mesenchymal tumor, malignant"
13807,Epithelial Component Present,Nasopharyngeal Differentiated Carcinoma
13808,atypia morphology,Ameloblastic Carcinoma
13809,Vascular Channel Formation,Intermediate Vascular Neoplasm
13810,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7
13811,Epithelial Component Present,Warty Carcinoma of the Penis
13812,Indolent Clinical Course,Angiofibroma
13813,Local disease,Localized Lymphoma
13814,Epithelial Component Present,Digestive System Neuroendocrine Tumor G2
13815,Bone Marrow Involvement,mu-Chain Disease
13816,Infantile Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement
13817,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
13818,Dysplasia,intraepithelial glandular neoplasia of cervix
13819,Epithelial Component Present,Cystadenoma
13820,Epithelial Component Present,Poorly Differentiated Thyroid Carcinoma
13821,Single Cell Necrosis,Stage III Merkel Cell Carcinoma AJCC v7
13822,High Mitotic Activity,large cell neuroendocrine carcinoma of gallbladder
13823,Dysplasia,Cervical Squamous Cell Carcinoma In Situ
13824,Hyperkeratosis,Urethral Verrucous Carcinoma
13825,Secondary Lesion,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma
13826,Radiation Sickness,Radiation sickness syndrome
13827,S-100-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, benign"
13828,Epithelial Component Present,Throat cancer
13829,"Undifferentiated ""Fetal-Type"" Tissues Present",Pineal Region Immature Teratoma
13830,Increased Cellularity Present,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
13831,Epithelial Component Present,Type I Endometrial Adenocarcinoma
13832,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 2 Endometrial Endometrioid Adenocarcinoma
13833,Lymphoplasmacytic Infiltrate,Chordoid Glioma of the Third Ventricle
13834,Papillary Pattern,Laryngeal verrucous carcinoma
13835,Carcinomatous Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7
13836,Encapsulated Mass,Macrofollicular adenoma
13837,Carcinomatous Component Present,undifferentiated carcinoma of extrahepatic bile duct
13838,Hyperplastic Tissue Present,Follicular Lymph Node Hyperplasia
13839,Hypokalemia,Juxtaglomerular tumor
13840,Epithelial Component Present,Benign Germinative Follicular Epithelium Neoplasm
13841,Indolent Clinical Course,Digestive System Hemangioma
13842,Lymphoplasmacytic Infiltrate,Lung Spindle Cell Carcinoma
13843,Exophytic Polypoid Lesion,Otic polyp
13844,Tissue of Mullerian Origin Present,Borderline Ovarian Serous Adenofibroma
13845,Carcinomatous Component Present,Stage IV Paranasal Sinus Cancer AJCC v7
13846,Lymphoplasmacytic Infiltrate,Grade I Lymphomatoid Granulomatosis
13847,Adnexal Differentiation,Eccrine hidrocystoma
13848,Epithelial Component Present,Mediastinal Thymoma
13849,Biphasic Pattern,Borderline Ovarian Serous Cystadenofibroma
13850,Pseudopapillary Pattern,Cerebellar Papillary Meningioma
13851,Malignant Component Present,Ovarian Dermoid Cyst with Adenocarcinoma
13852,Bone Marrow Dysplasia Present,Hypocellular Myelodysplastic Syndrome
13853,Epithelial Component Present,Stage IIB Gastric Cancer AJCC v7
13854,Severe cytologic atypia,Colorectal Large Cell Neuroendocrine Carcinoma
13855,Nuclear Pseudoinclusion,Tall Cell Variant Thyroid Gland Papillary Carcinoma
13856,Neuroendocrine Differentiation,Malignant Pancreatic Insulinoma
13857,Childhood Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
13858,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v7
13859,Sarcomatoid Features,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype"
13860,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant"
13861,Metaplasia,verrucous carcinoma of bladder
13862,Severe dysplasia,Noninfiltrating Intraductal Carcinoma
13863,Metaplasia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
13864,Epithelial Component Present,Oncocytic Breast Carcinoma
13865,Lymphoplasmacytic Infiltrate,Lymphoplasmacyte-rich meningioma
13866,Cutaneous Involvement,Papillary Eccrine Carcinoma
13867,No Identifiable Line of Differentiation,Undifferentiated Epithelioid Sarcoma
13868,Lymphoplasmacytic Infiltrate,Laryngeal Lymphoepithelial Carcinoma
13869,Epithelial Component Present,Carcinoma in situ of fallopian tube
13870,Acantholysis,Laryngeal Acantholytic Squamous Cell Carcinoma
13871,Gastrin Positive Neoplastic Cells Present,Gastrinoma
13872,Gyriform Trabecular Pattern,Gastrinoma
13873,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
13874,Monomorphic Cellular Infiltrate,Vaginal Basaloid Carcinoma
13875,Hemorrhagic,Angiosarcoma non-metastatic
13876,Papillary Pattern,Vaginal Warty Carcinoma
13877,Acanthosis,Vaginal Warty Carcinoma
13878,Cavernous Vascular Space Formation,Colon Cavernous Hemangioma
13879,Adnexal Differentiation,Eccrine porocarcinoma
13880,Dermal Involvement,Eccrine porocarcinoma
13881,Favorable Clinical Outcome,Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm
13882,Diffuse Lesion,Melanomatosis
13883,Mild dysplasia,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia
13884,Epithelial Component Present,Transplant-Related Lung Carcinoma
13885,Neoplastic Plasma Cells Present in Bone Marrow,DS Stage I Plasma Cell Myeloma
13886,Varicosity,Infective Phlebitis
13887,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
13888,Cutaneous Involvement,Acne Keloid
13889,Epithelial Component Present,Primary serous papillary carcinoma of peritoneum
13890,'Starry-sky' pattern,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
13891,Multifocal Lesion,Meningeal sarcomatosis
13892,Exophytic Polypoid Lesion,Small Intestinal Tubulovillous Adenoma
13893,Carcinomatous Component Present,Lobular carcinoma in situ of breast
13894,Necrotic changes (finding),Small cell lung cancer limited stage
13895,Exophytic Polypoid Lesion,tubulopapillary adenoma of gallbladder
13896,Dysplasia,Gastric adenoma
13897,Undifferentiated Lesion,Vaginal Undifferentiated Sarcoma
13898,Neuroendocrine Differentiation,Appendix Tubular Carcinoid
13899,Epithelial Component Present,Frontal Sinus Squamous Cell Carcinoma
13900,Dysplasia,"Vulvar Intraepithelial Neoplasia, Differentiated Type"
13901,Cutaneous Involvement,Urticaria
13902,Follicular Cell Differentiation,Papillary Thyroid Microcarcinoma
13903,Papillary Pattern,Papillary Thyroid Microcarcinoma
13904,Hyperplastic Tissue Present,Atypical hyperplasia
13905,Desmoplastic Stroma Formation,Malignant Proliferating Pilar Tumor
13906,Cystic Change,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
13907,Basophilia (finding),"Leukemia, Myeloid, Chronic-Phase"
13908,Carcinomatous Component Present,Nipple Carcinoma
13909,Recurrent disease,Pancreatic carcinoma recurrent
13910,Rapidly Enlarging Mass,alveolar rhabdomyosarcoma of orbit
13911,Non-Invasive Lesion,Ampulla of Vater Tubular Adenoma
13912,Carcinomatous Component Present,Squamous cell carcinoma of lung
13913,Cutaneous Involvement,"Acanthoma, Clear Cell"
13914,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7
13915,Epithelial Component Present,Anterior Pituitary Gland Endocrine Neoplasm
13916,Monocytosis,Juvenile Myelomonocytic Leukemia
13917,Carcinomatous Component Present,Cervical Adenoid Cystic Carcinoma
13918,Increased Cellularity Present,Uterine Corpus Apoplectic Leiomyoma
13919,Aggressive Clinical Course,Childhood Burkitt Leukemia
13920,Papillary Pattern,papillary carcinoma of penis
13921,Epithelial Component Present,Endometrioid adenocarcinoma metastatic
13922,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma metastatic
13923,Metastatic Lesion,Lymphangitis carcinomatosa
13924,Absence of Invasion,Carcinoma in situ of middle ear
13925,Carcinomatous Component Present,Mucinous Adenocarcinoma
13926,Metastatic Lesion,Metastatic Ureter Carcinoma
13927,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
13928,Epithelial Component Present,sebaceous adenoma of salivary gland
13929,Carcinomatous Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v7
13930,Biphasic Pattern,Adamantinoma
13931,Carcinomatous Component Present,Adenocarcinoma of the prostate stage I
13932,Nuclear pleomorphism,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
13933,Carcinomatous Component Present,Serous cystadenocarcinoma of pancreas
13934,Cutaneous Involvement,Fox Fordyce disease
13935,Carcinomatous Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas
13936,Secondary Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
13937,Neuroendocrine Differentiation,Carcinoid tumor of the prostate
13938,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Hypergranular promyelocytic leukemia
13939,Superficial Lesion,Atypical Lipoma
13940,Preserved Nuclear Polarity,"Transitional cell papilloma, inverted"
13941,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage
13942,Cystic Change,Papillary serous cystadenoma
13943,Childhood Lesion,Childhood Kidney Neoplasm
13944,Tubular Pattern,Vaginal Tubulovillous Adenoma
13945,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor
13946,Childhood Lesion,Childhood B Lymphoblastic Lymphoma
13947,Microvascular Proliferation,Adult Gliosarcoma
13948,Borderline Lesion,Borderline Ovarian Endometrioid Adenofibroma
13949,Lytic lesion,Giant Cell Tumor of Bone
13950,Carcinomatous Component Present,Stage IVA Vulvar Cancer AJCC v7
13951,Follicular Cell Differentiation,minimally invasive follicular carcinoma of the thyroid gland
13952,Minimal Invasion Present,minimally invasive follicular carcinoma of the thyroid gland
13953,Primary Lesion,Recurrent Childhood Giant Cell Glioblastoma
13954,Epithelial Component Present,Regional Digestive System Neuroendocrine Tumor G1
13955,Breast Microcalcification,Well Differentiated Oligodendroglioma
13956,Multinodular Pattern,Sporadic Cylindroma
13957,Refractory Disease,Nodal marginal zone B-cell lymphoma refractory
13958,Delicate Vascular Network Formation,Grade 2 Clear Cell Renal Cell Carcinoma
13959,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Neoplasm
13960,Epithelial Component Present,Bladder squamous cell carcinoma stage I
13961,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage I
13962,CD56-Positive Neoplastic Cells Present,Blastic plasmacytoid dendritic cell neoplasm
13963,Cutaneous Involvement,"Skin Diseases, Infectious"
13964,Fibrotic Stroma Formation,Nonencapsulated sclerosing tumor
13965,Vascular Channel Formation,AIDS with Kaposi's sarcoma
13966,Epithelial Component Present,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
13967,Well-Circumscribed Lesion,Pseudopolyposis of colon
13968,Angiodestructive Pattern,Recurrent Grade II Lymphomatoid Granulomatosis
13969,Diffuse Lesion,Pericardial Carcinomatosis
13970,Myxoid Stroma Formation,Uterine Corpus Myxoid Leiomyosarcoma
13971,Unfavorable Clinical Outcome,Class 2 Uveal Melanoma
13972,Syncytial Pattern,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
13973,Mild dysplasia,Low Grade Esophageal Glandular Intraepithelial Neoplasia
13974,Carcinomatous Component Present,Skin Basal Cell Carcinoma with Adnexal Differentiation
13975,Indolent Clinical Course,Benign Gastric Soft Tissue Neoplasm
13976,Cutaneous Involvement,Stage IV Superficial Spreading Melanoma AJCC v6 and v7
13977,Recurrent disease,Recurrent Meningioma
13978,Carcinomatous Component Present,Skin Metatypical Carcinoma
13979,Skin nodule,Nodulo-ulcerative basal cell carcinoma
13980,Polymorphic Cellular Infiltrate,Childhood Langerhans Cell Histiocytosis
13981,Multinodular Mass,Gallbladder Angiosarcoma
13982,Carcinomatous Component Present,Stage III Major Salivary Gland Cancer AJCC v7
13983,Dysplasia,Gastrointestinal Intraepithelial Neoplasia
13984,Cribriform Pattern,Salivary duct carcinoma
13985,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
13986,Recurrent disease,Mesothelioma malignant recurrent
13987,Hyperplastic Tissue Present,Foveolar hyperplasia
13988,Carcinomatous Component Present,Relapsed Hypopharynx Carcinoma
13989,High Grade Lesion,Vaginal Rhabdomyosarcoma
13990,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Disorder
13991,Papillary Pattern,Ethmoid Sinus Inverted Papilloma
13992,Carcinomatous Component Present,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant"
13993,Epithelial Component Present,adenomatous polyp of stomach
13994,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
13995,Biphasic Pattern,Vaginal Carcinosarcoma
13996,Dilated Terminal Duct Lobular Units Present,Columnar Cell Lesion of the Breast
13997,Local disease,Vulvar Fibrolipoma
13998,Epithelial Component Present,Carcinoma in situ of cecum
13999,Tissue Differentiation Uncertain,Benign Soft Tissue Tumor of Uncertain Differentiation
14000,Crystal deposition,Cervical Alveolar Soft Part Sarcoma
14001,Cutaneous Involvement,Congenital melanocytic nevus
14002,Multinodular Mass,Dermatofibrosarcoma protuberans with myoid differentiation
14003,Neuroectodermal Differentiation,Olfactory Neuroblastoma
14004,Recurrent disease,Recurrent Olfactory Neuroblastoma
14005,Diffuse Pattern,Infratentorial Glioblastoma
14006,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v6
14007,Primary Lesion,Primary Peritoneal Low Grade Serous Adenocarcinoma
14008,Epithelial Component Present,Growth Hormone-Producing Pituitary Gland Carcinoma
14009,Epithelial Component Present,Papillary serous endometrial carcinoma
14010,Fibrotic Stroma Formation,Cystadenofibroma of fallopian tube
14011,Low Mitotic Activity,malignant gastrinoma of pancreas
14012,Invasive Lesion,Microinvasive Malignant Neoplasm
14013,Hereditary Lesion,Fanconi Anemia
14014,Epithelial Component Present,Cholangiocarcinoma non-resectable
14015,Epithelial Component Present,Stage II Hypopharyngeal Carcinoma AJCC v6 and v7
14016,Carcinomatous Component Present,Papillary squamous cell carcinoma
14017,Fibrotic Stroma Formation,Scirrhous carcinoma of breast
14018,Capillary Sized Vascular Channel Formation,Tufted angioma of skin
14019,CD1a-Positive Neoplastic Cells Present,Eosinophilic Granuloma
14020,Rapidly Enlarging Mass,Spindle cell rhabdomyosarcoma
14021,Preserved Nuclear Polarity,Renal Pelvis Urothelial Papilloma
14022,Adulthood Lesion,Adult Malignant Peripheral Nerve Sheath Tumor
14023,Benign Cellular Infiltrate,leiomyoma of extrahepatic bile duct
14024,Local disease,Benign neoplasm of mesothelial tissue of pleura
14025,Neuroendocrine Differentiation,Childhood Carcinoid Tumor
14026,Mesenchymal Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
14027,Carcinomatous Component Present,adenosquamous carcinoma of skin
14028,Carcinomatous Component Present,Carcinoma breast stage I
14029,Adnexal Differentiation,Apocrine Neoplasm
14030,Childhood Lesion,Extrarenal rhabdoid tumor
14031,Monomorphic Cellular Infiltrate,Childhood Supratentorial Ependymoma
14032,Pregnancy Complications,Metastatic Neoplasm to the Placenta
14033,Pregnancy Complications,Placenta Previa
14034,Anaplasia,Colorectal Sarcomatoid Carcinoma
14035,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm
14036,Cutaneous Involvement,Skin tumor of smooth muscle origin
14037,Multifocal Lesion,Atypical Breast Myoepitheliosis
14038,Epithelial Component Present,Stage III Renal Pelvis Cancer AJCC v7
14039,Metastatic Lesion,Secondary Heart Lymphoma
14040,Secondary Lesion,Secondary Heart Lymphoma
14041,Chronic lymphocytic inflammation,Cardiac Inflammatory Myofibroblastic Tumor
14042,Carcinomatous Component Present,Squamous cell carcinoma of buccal mucosa
14043,Multinodular Mass,Childhood Angiosarcoma
14044,Adnexal Differentiation,Microcystic adnexal carcinoma
14045,Alternative Fascicle (Bundle) Pattern,Anal Leiomyoma
14046,Perineural spread,Hard Palate Adenoid Cystic Carcinoma
14047,Carcinomatous Component Present,Recurrent Male Reproductive System Carcinoma
14048,High Grade Lesion,rhabdomyosarcoma of extrahepatic bile duct
14049,Cambium Layer,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
14050,Epithelioid Component Present,Lung Biphasic Synovial Sarcoma
14051,Epithelial Component Present,Plantar wart
14052,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant"
14053,Tissue of Mullerian Origin Present,clear cell adenocarcinofibroma of ovary
14054,Epithelial Component Present,FIGO Stage IIIA1(ii) Ovarian Cancer
14055,Cutaneous Involvement,Stage III Skin Cancer
14056,Stromal Invasion,Stage IIA Ovarian Cancer AJCC V6 and v7
14057,Adulthood Lesion,Recurrent Adult Grade III Lymphomatoid Granulomatosis
14058,Papillary Pattern,ductal papilloma of salivary gland
14059,Well-Circumscribed Lesion,Pyloric Gland Adenoma
14060,Epithelial Component Present,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7
14061,Epithelial Component Present,Cervical Squamotransitional Carcinoma
14062,Recurrent disease,Renal cell carcinoma recurrent
14063,Epithelial Component Present,Cervical Squamous Neoplasm
14064,Epithelial Component Present,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
14065,Secondary Lesion,Secondary Supratentorial Anaplastic Astrocytoma
14066,Stromal Invasion,FIGO Stage IVB Ovarian Cancer
14067,Epithelial Component Present,adenosquamous carcinoma of breast
14068,Anaplasia,Adult Anaplastic (Malignant) Meningioma
14069,Cutaneous Involvement,Stage 0 Merkel Cell Carcinoma AJCC v7
14070,Anaplasia,Brain Stem Glioblastoma
14071,Glucagon-Like Peptide Positive Neoplastic Cells Present,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
14072,Childhood Lesion,Childhood Germinomatous Germ Cell Tumor
14073,Nuclear Atypia,Epithelioid glioblastoma
14074,Anaplasia,Epithelioid glioblastoma
14075,Epithelial Component Present,Small intestine carcinoma stage III
14076,Hyperplastic Tissue Present,Parathyroid Clear Cell Hyperplasia
14077,Carcinomatous Component Present,Bartholin Gland Adenosquamous Carcinoma
14078,Indolent Clinical Course,Endometrial Polyp
14079,Vascular Channel Formation,Lymphangioma circumscriptum
14080,Vascular Channel Formation,Epithelioid hemangioma of skin
14081,Epithelial Component Present,Large cell carcinoma of lung
14082,Metaplasia,Gastric Intestinal-Type Adenocarcinoma
14083,Epithelial Component Present,Stage IIA Colorectal Cancer AJCC v7
14084,Epithelial Component Present,Epithelioma
14085,Fried-Egg Appearance of the Bone Marrow,Hairy Cell Leukemia
14086,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma
14087,Fibromyxoid Stroma Formation,Myxofibroma
14088,Increased Cellularity Present,Stage 2B Neuroblastoma
14089,Metaplasia of Malignant Cells Present,adenocarcinoma of gallbladder with squamous metaplasia
14090,Cutaneous Involvement,Squamous cell carcinoma of scrotum
14091,Metastatic Lesion,Secondary malignant neoplasm of choroid
14092,Carcinomatous Component Present,Metastatic non-small cell lung cancer
14093,Carcinomatous Component Present,Peripheral Intrahepatic Cholangiocarcinoma
14094,Carcinomatous Component Present,Stage I Laryngeal Cancer AJCC v6 and v7
14095,Epithelial Component Present,Stage III Oropharyngeal Carcinoma AJCC v6
14096,Microcystic Change,Microcystic/Reticular Schwannoma
14097,Epithelial Component Present,Stage III Lip Cancer AJCC v6 and v7
14098,Hyaline Cartilage Differentiation,Chondrosarcoma localised
14099,Secondary Lesion,Secondary malignant neoplasm of parathyroid gland
14100,Mesenchymal Component Present,Metastasizing Pleomorphic Adenoma of the Salivary Gland
14101,Diffuse Pattern,Adult Brain Stem Gliosarcoma
14102,Glial Differentiation,Childhood Ganglioglioma
14103,Carcinomatous Component Present,Stage II Liver Cancer
14104,Acinar Cell Differentiation,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
14105,Adulthood Lesion,Adult Fibrolamellar Carcinoma
14106,Chronic Inflammatory Infiltrate,Diffuse large B-cell lymphoma associated with chronic inflammation
14107,Childhood Lesion,Childhood Acute Myeloid Leukemia with Maturation
14108,Epithelial Component Present,Inverting papilloma of the nasal cavity
14109,Myxoid Stroma Formation,"Leiomyosarcoma, Myxoid"
14110,Neuroendocrine Differentiation,Vulvar Small Cell Carcinoma
14111,Mixed Cellular Population,Ovarian Serous Adenofibroma
14112,Diffuse Pattern,Adult Brain Oligodendroglioma
14113,Papillary Pattern,Choroid Plexus Papilloma
14114,Cutaneous Involvement,Porokeratosis
14115,Inflammatory infiltrate,Pigmented villonodular synovitis
14116,Primary Lesion,Childhood Conventional Osteosarcoma
14117,Focal dysplasia,Rectal Sessile Serrated Adenoma/Polyp
14118,High Mitotic Activity,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
14119,Carcinomatous Component Present,Stage IVC Basal Cell Lip Carcinoma
14120,Local disease,Localized Resectable Adult Hepatocellular Carcinoma
14121,Borderline Lesion,Borderline cystadenoma
14122,Stromal Invasion,mucinous adenocarcinofibroma of ovary
14123,Acanthosis,Condyloma acuminata of vulva
14124,Epithelial Component Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma
14125,Invasive Lesion,pleomorphic carcinoma of breast
14126,Chromogranin A Positive Neoplastic Cells Present,Transverse Colon Neuroendocrine Tumor G1
14127,Slow Growing Mass,Elastofibroma
14128,Carcinomatous Component Present,Gingival Spindle Cell Carcinoma
14129,Vascular Channel Formation,Hemangioma of Peripheral Nerve
14130,Severe cytologic atypia,Vulvar Proximal-Type Epithelioid Sarcoma
14131,Hyperkeratosis,Verrucous carcinoma of penis
14132,Papillary Pattern,Verrucous carcinoma of penis
14133,Hemorrhagic,Aortic Angiosarcoma
14134,Cytoplasmic Membrane-Bound Granules Present,Stage II Merkel Cell Carcinoma AJCC v7
14135,Indolent Clinical Course,Benign fibrohistiocytic neoplasm
14136,Multinodular Mass,Uterine Angiosarcoma
14137,Neuroendocrine Differentiation,Jejunal Neuroendocrine Tumor G1
14138,Immunologic Deficiency Syndromes,Immunoblastic lymphoma associated with AIDS
14139,Carcinomatous Component Present,Tobacco Chewing-Related Carcinoma
14140,Bilateral Disease,bilateral breast cancer
14141,Papillary Pattern,Papilloma of buccal mucosa
14142,Exophytic Polypoid Lesion,Neoplastic Polyp
14143,Mixed Cellular Population,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma
14144,Cutaneous Involvement,"Nevus, Spindle Cell"
14145,Tissue Differentiation Uncertain,"Perivascular epithelioid tumor, benign"
14146,Papillary Pattern,Verrucous carcinoma of oral cavity
14147,Infiltrative Growth Pattern,Lipofibromatosis
14148,Immunosuppression-Related Post-Transplant Toxicity,Plasmacytic Hyperplasia Post-Transplant Lymphoproliferative Disorder
14149,Carcinomatous Component Present,Carcinoma of the Appendix
14150,Absence of Invasion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7
14151,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Grade 2 Endometrial Endometrioid Adenocarcinoma
14152,Hemorrhagic,Metastatic angiosarcoma
14153,Epithelial Component Present,mucoepidermoid carcinoma of floor of mouth
14154,Hyalinized Stroma Formation,Epithelioid hemangioendothelioma
14155,Dysplasia,Small Intestinal High Grade Intraepithelial Neoplasia
14156,Non-Specific Glandular Pattern,Bladder Adenocarcinoma
14157,Eccrine Differentiation,Vulvar Eccrine Porocarcinoma
14158,Monoclonal Cellular Population Present,Microfollicular adenoma
14159,Low Mitotic Activity,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
14160,Pushing Tumor Margin,Glottis Verrucous Carcinoma
14161,Primary Lesion,Meningeal melanocytoma
14162,Cutaneous Involvement,Spongiotic dermatitis
14163,Epithelial Component Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor
14164,Collagenous Stroma Formation,Malignant Kidney Mixed Epithelial and Stromal Tumor
14165,Absence of Invasion,Preinvasive Neoplasm of the Ampullary Region
14166,Low Grade Lesion,Borderline Ovarian Serous Tumor with Microinvasion
14167,Chronic Inflammatory Infiltrate,Lymphomatoid Granulomatosis
14168,Borderline Lesion,Borderline Ovarian Serous Adenofibroma
14169,Epithelial Component Present,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
14170,Absence of Stromal Invasion,Borderline Ovarian Mucinous Adenofibroma
14171,Cystic Change,Mucinous cystadenocarcinoma of ovary
14172,Chronic Inflammatory Infiltrate,Grade III Lymphomatoid Granulomatosis
14173,Exophytic Papillary Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
14174,Tubular Structures Present,Testicular Large Cell Calcifying Sertoli Cell Tumor
14175,Invasive Lesion,Metastatic Squamous Cell Breast Carcinoma
14176,Thyroglobulin Positive Neoplastic Cells Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma
14177,Adulthood Lesion,Adult Type Ovarian Granulosa Cell Tumor
14178,Carcinomatous Component Present,Exocervical Carcinoma
14179,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Neoplasm
14180,Gastrin Positive Neoplastic Cells Present,"Gastrinoma, malignant"
14181,Well-Circumscribed Lesion,Colonic tubulovillous adenoma
14182,Acinar Cell Differentiation,Acinic Cell Breast Carcinoma
14183,Benign Cellular Infiltrate,Gastric Plexiform Fibromyxoma
14184,Tubular Pattern,Colorectal Tubulovillous Adenoma
14185,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Mature Teratoma
14186,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-1
14187,Rapidly Enlarging Mass,Fusion-Positive Rhabdomyosarcoma
14188,Epithelial Component Present,Breast Carcinoid Tumor
14189,Epithelial Component Present,basal cell carcinoma of scrotum
14190,Skin nodule,Lipoid dermatoarthritis
14191,Neuroendocrine Differentiation,Metastatic Breast Carcinoid Tumor
14192,Monomorphic Cellular Infiltrate,Laryngeal Basaloid Carcinoma
14193,Rapidly Enlarging Mass,Laryngeal Basaloid Carcinoma
14194,Acanthosis,Bowen's Disease
14195,Borderline Lesion,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor
14196,Carcinomatous Component Present,Vaginal Basaloid Carcinoma
14197,Mixed Cellular Population,Infiltrating duct and lobular carcinoma
14198,High Mitotic Activity,Gallbladder Neuroendocrine Carcinoma
14199,Absence of Stromal Invasion,Borderline Fallopian Tube Mucinous Tumor
14200,Multifocal Lesion,Recurrent respiratory papillomatosis
14201,Well-Circumscribed Lesion,Benign neoplasm of mesothelial tissue of peritoneum
14202,Carcinomatous Component Present,Transplant-Related Hepatocellular Carcinoma
14203,Papillary Pattern,Exophytic Schneiderian Papilloma
14204,Low Grade Lesion,Tibial adamantinoma
14205,Splenomegaly,Splenic Manifestation of Chronic Lymphocytic Leukemia
14206,Carcinomatous Component Present,AIDS-Related Anal Carcinoma
14207,Preserved Nuclear Polarity,Urethral Urothelial Papilloma
14208,Epithelial Component Present,Oropharyngeal Basaloid Carcinoma
14209,Well-Circumscribed Lesion,Appendix adenoma
14210,Indolent Clinical Course,Spindle Cell/Pleomorphic Lipoma
14211,Childhood Lesion,Myeloid leukemia associated with Down Syndrome
14212,Severe dysplasia,Adenocarcinoma in Situ
14213,Adulthood Lesion,Stage II Adult Liver Cancer AJCC v7
14214,Secondary Lesion,Disseminated Malignant Neoplasm
14215,Acute inflammation,Acute lymphadenitis
14216,Carcinomatous Component Present,Maxillary Sinus Adenocarcinoma
14217,Carcinomatous Component Present,Inflammatory carcinoma of breast stage IV
14218,Necrotic changes (finding),Small cell carcinoma of prostate
14219,Indolent Clinical Course,Venous hemangioma
14220,Angiocentric Pattern,Recurrent Grade III Lymphomatoid Granulomatosis
14221,Cutaneous Involvement,Basal cell carcinoma of vulva
14222,Therapy-Related Toxicity,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
14223,Neuroendocrine Differentiation,High Grade Lung Neuroendocrine Neoplasm
14224,Metaplasia,intestinal type adenocarcinoma of gallbladder
14225,Adulthood Lesion,Adult Rhabdomyosarcoma
14226,Multifocal Lesion,Pulmonary lymphangioleiomyomatosis
14227,Myxoid Stroma Formation,Undifferentiated (Embryonal) Sarcoma
14228,Adulthood Lesion,Adult Undifferentiated Pleomorphic Sarcoma
14229,Aggressive Clinical Course,Vaginal Undifferentiated Sarcoma
14230,Childhood Lesion,Childhood Gemistocytic Astrocytoma
14231,Carcinomatous Component Present,Recurrent Head and Neck Carcinoma
14232,Mixed Cellular Population,Vaginal Mixed Epithelial and Mesenchymal Neoplasm
14233,Epithelial Component Present,Adenosquamous cell lung cancer
14234,Neuroendocrine Differentiation,Glomus vagale tumor
14235,Epithelial Component Present,Female Breast Carcinoma
14236,Adnexal Differentiation,Desmoplastic trichoepithelioma
14237,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
14238,Papillary Pattern,Papillary carcinoma of the breast
14239,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity stage III
14240,Mixed Cellular Population,Mixed parotid tumor
14241,Epithelial Component Present,Sweat gland carcinoma
14242,Carcinomatous Component Present,Stage IB Esophageal Adenocarcinoma AJCC v7
14243,Well-Circumscribed Lesion,Prostate Phyllodes Tumor
14244,Local disease,Myolipoma
14245,Carcinomatous Component Present,Squamous cell carcinoma
14246,Cellular Stratification,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
14247,Indolent Clinical Course,Benign Notochordal Cell Tumor
14248,Papillary Pattern,Bronchial adenoma
14249,Epithelial Component Present,undifferentiated carcinoma of urethra
14250,Childhood Lesion,recurrent childhood acute myeloid leukemia
14251,Crystal deposition,Adult Alveolar Soft Part Sarcoma
14252,Cutaneous Involvement,Atrophic lichen planus
14253,Severe cytologic atypia,Ampulla of Vater Neuroendocrine Carcinoma
14254,Neuroendocrine Differentiation,Ovarian Carcinoid Tumor
14255,Cystic Change,"Serous cystadenoma, borderline malignancy"
14256,Carcinomatous Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7
14257,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
14258,Carcinomatous Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma
14259,Carcinomatous Component Present,adenosquamous carcinoma of salivary gland
14260,Secondary Lesion,Metastatic Ureter Carcinoma
14261,Zonal Pattern,Adamantinoma
14262,Nodular Pattern,Glioblastoma with Primitive Neuronal Component
14263,'Starry-sky' pattern,Stage I Adult Burkitt Lymphoma
14264,Poorly Differentiated Lesion,Thymic Sarcomatoid Carcinoma
14265,Epithelial Component Present,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
14266,Non-Invasive Lesion,Ureter Urothelial Papilloma
14267,Epithelial Component Present,Paget disease of anal canal
14268,Epithelial Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage
14269,Lymphoplasmacytic Infiltrate,Waldenstrom Macroglobulinemia
14270,Epithelial Component Present,Transitional cell carcinoma in situ
14271,Epithelial Component Present,Large cell neuroendocrine carcinoma
14272,Epithelial Component Present,small cell carcinoma of kidney
14273,Epithelial Component Present,Hurthle Cell Tumor
14274,Diffuse Pattern,Adult Mixed Glioma
14275,Cystic Change,Acinar cell cystadenocarcinoma
14276,Epithelial Component Present,Vaginal Mesonephric Adenocarcinoma
14277,Epithelial Component Present,Stage 0a Renal Pelvis Cancer AJCC v7
14278,Epithelial Component Present,Stage I Urethral Cancer AJCC v7
14279,Epithelial Component Present,Stage II Urethral Cancer AJCC v7
14280,Mixed Cellular Population,Borderline Ovarian Endometrioid Adenofibroma
14281,Metastatic Lesion,Metastatic Carcinoma in the Liver
14282,Carcinomatous Component Present,BCLC Stage A Adult Hepatocellular Carcinoma
14283,Epithelial Component Present,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
14284,Epithelial Component Present,Submandibular Gland Adenocarcinoma
14285,Nuclear Atypia,Childhood Brain Stem Gliosarcoma
14286,Indolent Clinical Course,Lipoma of spermatic cord
14287,Carcinomatous Component Present,Intermediate Grade Ductal Breast Carcinoma In Situ
14288,Benign Cellular Infiltrate,Benign neoplasm of rectum
14289,Schwannian Stroma Predominant Component of the Tumor Volume,Colon Ganglioneuroma
14290,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic
14291,Metastatic Lesion,Metastatic Neoplasm to the Bladder
14292,Severe dysplasia,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
14293,Sarcomatous Component Present,carcinosarcoma of salivary gland
14294,Epithelial Component Present,Small Intestinal Carcinoid Tumor
14295,Carcinomatous Component Present,Oropharyngeal Carcinoma by AJCC v6 Stage
14296,Epithelial Component Present,carcinosarcoma of extrahepatic bile duct
14297,Low Mitotic Activity,Esophageal Well Differentiated Squamous Cell Carcinoma
14298,'Starry-sky' pattern,Stage IV Adult Burkitt Lymphoma
14299,High Mitotic Activity,Minor Salivary Gland Small Cell Carcinoma
14300,Generalized Dysplasia,Colon Traditional Serrated Adenoma
14301,Cutaneous Involvement,Exfoliative dermatitis
14302,Carcinomatous Component Present,Skin Signet Ring Cell Basal Cell Carcinoma
14303,Hyaline Cartilage Differentiation,Chondroma
14304,Epithelial Component Present,Minor Salivary Gland Carcinoma
14305,Epithelial Component Present,Adenocarcinoma in situ in villous adenoma
14306,Epithelial Component Present,Sublingual Gland Adenocarcinoma
14307,Epithelial Component Present,Vulvar Warty Carcinoma
14308,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of salivary gland
14309,Tubular Pattern,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
14310,Alternative Fascicle (Bundle) Pattern,Intravenous leiomyomatosis
14311,Epithelial Component Present,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type"
14312,Carcinomatous Component Present,Stage IB Pancreatic Cancer AJCC v6 and v7
14313,Neuroendocrine Differentiation,Carcinoid tumor of the duodenum
14314,Papillary Pattern,Paranasal Sinus Schneiderian Papilloma
14315,Carcinomatous Component Present,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7
14316,Hypercellular bone marrow,Chronic eosinophilic leukemia
14317,Papillary Pattern,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
14318,Nodular Pattern,Hodgkin's disease nodular sclerosis stage II
14319,CD56-Positive Neoplastic Cells Present,adult nasal type extranodal NK/T-cell lymphoma
14320,Epithelial Component Present,Oropharyngeal lymphepithelioma
14321,Papillary Pattern,papillary adenoma of extrahepatic bile duct
14322,Multinodular Mass,Angiosarcoma NCI Grade 2
14323,Multinodular Pattern,Recurrent Extraskeletal Myxoid Chondrosarcoma
14324,Diffuse Pattern,Adult Anaplastic Astrocytoma
14325,Hyperplastic Tissue Present,Atypical Lobular Breast Hyperplasia
14326,Carcinomatous Component Present,Colorectal Serrated Adenocarcinoma
14327,Epithelial Component Present,Stage IIIB Gastric Carcinoma
14328,Recurrent disease,AIDS-related anal cancer recurrent
14329,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory anemias
14330,Cutaneous Involvement,Granuloma annulare aggravated
14331,Storiform Growth Pattern,"Histiocytoma, Benign Fibrous"
14332,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Seminoma
14333,Benzene Exposure,Benzene-Related Acute Myeloid Leukemia
14334,Well-Circumscribed Lesion,Multiple polyps
14335,Carcinomatous Component Present,Postcricoid cancer
14336,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary
14337,Necrotic changes (finding),Small cell lung cancer recurrent
14338,Epithelial Component Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7
14339,Hyperkeratosis,verrucous carcinoma of esophagus
14340,Carcinomatous Component Present,Childhood Small Intestinal Carcinoma
14341,Tubular Pattern,Adenoma of the nipple
14342,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
14343,Follicular Differentiation,"Acanthoma, Pilar Sheath"
14344,Monomorphic Cellular Infiltrate,Oral Cavity Monomorphic Adenoma
14345,Cutaneous Involvement,Dermatofibrosarcoma protuberans with myoid differentiation
14346,Metastatic Lesion,Lung Carcinoma Metastatic in the Brain
14347,Intracellular Accumulation of Lipids,Recurrent Childhood Pleomorphic Xanthoastrocytoma
14348,Epithelial Component Present,Non functioning pancreatic endocrine tumor
14349,Carcinomatous Component Present,Recurrent Lip Basal Cell Carcinoma
14350,Epithelial Component Present,Primary Peritoneal Low Grade Serous Adenocarcinoma
14351,Carcinomatous Component Present,Stage III Cervical Cancer AJCC v6 and v7
14352,Invasive Lesion,ACTH-Producing Pituitary Gland Carcinoma
14353,Microinvasive tumor,Microinvasive Malignant Neoplasm
14354,Epithelial Component Present,Duodenal Cancer
14355,Epithelial Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma
14356,Necrotic changes (finding),Suppurative lymphadenopathy
14357,Vascular Channel Formation,Intermediate (Locally Aggressive) Blood Vessel Neoplasm
14358,Cutaneous Involvement,Herpes zoster dermatitis of eyelid
14359,Biphasic Pattern,Giant fibroadenoma of breast
14360,Papillary Pattern,Papilloma of nasal vestibule
14361,Epithelial Component Present,Stage IA Esophageal Cancer AJCC v7
14362,Islands of Odontogenic Epithelium Present,Central odontogenic fibroma
14363,Lipomatous Component Present,Ectopic hamartomatous thymoma
14364,Indolent Clinical Course,Hemangioma of spleen
14365,Multifocal Lesion,Bowenoid papulosis of penis
14366,Epithelial Component Present,Adenocarcinoma with squamous metaplasia
14367,Heterologous Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
14368,CD30-Positive Neoplastic Cells Present,Systemic Anaplastic Large Cell Lymphoma
14369,Chromogranin A Positive Neoplastic Cells Present,Childhood Carcinoid Tumor
14370,Invasive Lesion,Infiltrating angiolipoma
14371,CD30-Positive Neoplastic Cells Present,Childhood Systemic Anaplastic Large Cell Lymphoma
14372,Epithelial Component Present,Stage IVA Appendix Carcinoma AJCC v7
14373,Epithelial Component Present,Benign Eccrine Neoplasm
14374,Metastatic Lesion,Secondary malignant neoplasm of epididymis
14375,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
14376,Recurrent disease,Recurrent Childhood Subependymal Giant Cell Astrocytoma
14377,Well-Circumscribed Lesion,Venous Angioleiomyoma
14378,Ependymal Differentiation,Angiocentric glioma
14379,Carcinomatous Component Present,Grade 1 Invasive Breast Carcinoma
14380,Diffuse Pattern,Primary Cutaneous Plasmablastic Lymphoma
14381,Epithelial Component Present,Disseminated adenocarcinoma
14382,High Grade Lesion,Childhood Synovial Sarcoma
14383,Thin-Branching Papillae Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type"
14384,Pseudoencapsulated Mass,Cardiac Malignant Peripheral Nerve Sheath Tumor
14385,Cystic Change,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
14386,Carcinomatous Component Present,Well Differentiated Hepatocellular Carcinoma
14387,Recurrent disease,Recurrent Parathyroid Gland Carcinoma
14388,Carcinomatous Component Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma
14389,Primary Site Unknown,Squamous Cell Carcinoma of Unknown Primary
14390,Deep Lesion,Cardiac Intramuscular Hemangioma
14391,Dermal Involvement,Compound nevus of skin
14392,Carcinomatous Component Present,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
14393,Cytoplasmic Membrane-Bound Granules Present,Stage I Merkel Cell Carcinoma AJCC v7
14394,Cutaneous Involvement,Vulvar Blue Nevus
14395,Epithelial Component Present,Small Intestinal Small Cell Neuroendocrine Carcinoma
14396,Diffuse Pattern,Mixed Oligodendroglioma-Astrocytoma
14397,Vascular Channel Formation,Vascular Breast Neoplasm
14398,Absence of Invasion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8"
14399,Biphasic Pattern,endometrioid adenofibroma of ovary
14400,Epithelial Component Present,Stomach Carcinoma
14401,Carcinomatous Component Present,Vagina Carcinoma
14402,Papillary Pattern,Squamous Papilloma of the Nasopharynx
14403,Carcinomatous Component Present,"Squamous cell carcinoma, microinvasive"
14404,Childhood Lesion,Childhood Oligodendroglioma
14405,Single Cell Necrosis,Recurrent Merkel Cell Carcinoma
14406,Intraosseous Lesion,Basal Cell Ameloblastoma
14407,Koilocytotic atypia,Cervical Squamotransitional Carcinoma
14408,Epithelial Component Present,adenocarcinoma of breast with spindle cell metaplasia
14409,Cystic Change,Clear cell cystadenofibroma
14410,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma refractory
14411,Precocious Puberty,McCune-Albright Syndrome
14412,Mixed Cellular Population,"Neoplasms, Fibroepithelial"
14413,Osteoid formation,High grade surface osteosarcoma
14414,Epithelial Component Present,squamous cell carcinoma of middle ear
14415,Epithelial Component Present,Stage 0 Merkel Cell Carcinoma AJCC v7
14416,Diffuse Pattern,"Anaplastic Astrocytoma, IDH-Wildtype"
14417,Epithelial Component Present,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
14418,Epithelial Component Present,Adenocarcinoma of large intestine
14419,Epithelial Component Present,Metastatic carcinoid tumor
14420,Epithelial Component Present,Nasopharyngeal Papillary Adenocarcinoma
14421,Well-Circumscribed Lesion,Adrenal Cortical Adenoma
14422,Syncytial Pattern,Pancreatic Medullary Carcinoma
14423,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Acute monoblastic leukemia
14424,Primary Lesion,"Glioblastoma, IDH-Wildtype"
14425,Diffuse Pattern,Anaplastic Oligoastrocytoma
14426,Bone Marrow and Blood Involvement,Burkitt Leukemia
14427,Neuroectodermal Differentiation,Peripheral neuroblastoma
14428,Refractory Disease,Refractory Childhood Spinal Cord Neoplasm
14429,More than 10 Mitoses per 10HPF,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
14430,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP I"
14431,Epithelial Component Present,Tubulocystic renal cell carcinoma
14432,High Mitotic Activity,"Seminoma, anaplastic"
14433,Epithelial Component Present,Peripheral Intrahepatic Cholangiocarcinoma
14434,Absence of Malignant Features,Childhood Choroid Plexus Papilloma
14435,Perineural spread,adenoid cystic carcinoma of floor of mouth
14436,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Adenocarcinoma, endocervical type"
14437,Low Cellularity Present,Adult Pilocytic Astrocytoma
14438,Carcinomatous Component Present,Choroid Plexus Carcinoma
14439,Epithelial Component Present,Hereditary Fallopian Tube Carcinoma
14440,Cystic Change,mucoepidermoid carcinoma of lacrimal gland
14441,Vascular Channel Formation,Pyogenic granuloma
14442,Metaplasia of Malignant Cells Present,Metaplastic carcinoma of breast
14443,Carcinomatous Component Present,Stage III Lip Cancer AJCC v6 and v7
14444,Cavernous Vascular Space Formation,Cavernous hemangioma of the face
14445,Indolent Clinical Course,Cavernous hemangioma of the face
14446,Epithelial Component Present,Grade 3 Endometrial Mucinous Adenocarcinoma
14447,Necrotic changes (finding),small cell carcinoma of gallbladder
14448,Metastatic Lesion,Chondrosarcoma metastatic
14449,Hyaline Cartilage Differentiation,Chondrosarcoma metastatic
14450,Childhood Lesion,Recurrent Childhood Liver Cancer
14451,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern"
14452,High Mitotic Activity,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
14453,Epithelial Component Present,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
14454,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v7
14455,Micronodular Pattern,"Basal cell carcinoma, micronodular"
14456,Carcinomatous Component Present,Low Grade Mucoepidermoid Breast Carcinoma
14457,CD30-Positive Neoplastic Cells Present,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
14458,Cutaneous Involvement,Pityriasis Rubra Pilaris
14459,Well-Circumscribed Lesion,Pleomorphic Lipoma
14460,Lymphoplasmacytic Infiltrate,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
14461,Carcinomatous Component Present,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
14462,Metastatic/Recurrent Disease,synovial sarcoma
14463,Adnexal Differentiation,Anal Papillary Hidradenoma
14464,High Grade Lesion,Recurrent Childhood Anaplastic Astrocytoma
14465,Exophytic Polypoid Lesion,Rectal Sessile Serrated Adenoma/Polyp
14466,Carcinomatous Component Present,BCLC Stage C Hepatocellular Carcinoma
14467,Adnexal Differentiation,Vulvar Clear Cell Hidradenocarcinoma
14468,Epithelial Component Present,Recurrent ovarian cancer
14469,Infantile Lesion,Infantile fibrosarcoma
14470,Thyroglobulin Positive Neoplastic Cells Present,Childhood Thyroid Gland Papillary Carcinoma
14471,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1A
14472,Recurrent disease,Angiosarcoma recurrent
14473,Carcinomatous Component Present,Prostate Undifferentiated Carcinoma
14474,Juvenile Lesion,Osteochondritis juvenilis
14475,Anaplasia,Anaplastic (Malignant) Intracranial Meningioma
14476,Carcinomatous Component Present,Anal cancer metastatic
14477,Low Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G1
14478,Cutaneous Involvement,Stage IIIA Merkel Cell Carcinoma AJCC v7
14479,Adnexal Differentiation,Eccrine acrospiroma
14480,Well-Circumscribed Lesion,Eccrine acrospiroma
14481,Increased Cellularity Present,Extracranial Neuroblastoma
14482,Epithelial Component Present,High grade cervical glandular intraepithelial neoplasia
14483,Local disease,Localized Primitive Neuroectodermal Tumor
14484,Pseudoencapsulated Mass,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
14485,Slow Growing Mass,Cavernous Angioleiomyoma
14486,Pseudoglandular Pattern,teratocarcinoma of mediastinum
14487,Vascular Channel Formation,Pulmonary Artery Angiosarcoma
14488,Multinodular Mass,Pulmonary Artery Angiosarcoma
14489,Mixed Cellular Population,Ovarian Clear Cell Adenofibroma
14490,Mixed Cellular Population,Ovarian Clear Cell Cystadenofibroma
14491,Cutaneous Involvement,Acantholytic squamous cell carcinoma of skin
14492,Multinodular Pattern,Conventional Extraskeletal Myxoid Chondrosarcoma
14493,Exophytic Polypoid Lesion,tubulopapillary adenoma of extrahepatic bile duct
14494,Pregnancy Complications,Good Prognosis Metastatic Gestational Trophoblastic Tumor
14495,Carcinomatous Component Present,Oropharyngeal lymphoepithelioma stage I
14496,Cystic Change,Thyroid Gland Mucoepidermoid Carcinoma
14497,Epithelial Component Present,Well Differentiated Prostate Adenocarcinoma
14498,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage II
14499,Carcinomatous Component Present,Inflammatory carcinoma of breast recurrent
14500,Exophytic Papillary Lesion,Human Papillomavirus-Related Verrucous Carcinoma
14501,Dysplasia,Preinvasive Neoplasm of the Ampullary Region
14502,Poorly Differentiated Lesion,Lung Spindle Cell Carcinoma
14503,Borderline Lesion,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor
14504,Epithelial Component Present,Acidophil Stem Cell Pituitary Gland Adenoma
14505,Cutaneous Involvement,"Mastocytosis, Diffuse Cutaneous"
14506,Alternative Fascicle (Bundle) Pattern,Colon Leiomyoma
14507,Mesenchymal Component Present,Benign Prostate Phyllodes Tumor
14508,Acanthosis,Laryngeal verrucous carcinoma stage IV
14509,Therapy-Related Toxicity,Radiation-Related Osteosarcoma
14510,High Mitotic Activity,Gastroesophageal Junction Neuroendocrine Carcinoma
14511,Gyriform Trabecular Pattern,"Gastrinoma, malignant"
14512,Mixed Cellular Population,Ovarian Mucinous Cystadenofibroma
14513,Biphasic Pattern,Ovarian Mucinous Cystadenofibroma
14514,Fibrotic Stroma Formation,Ovarian Mucinous Cystadenofibroma
14515,Epithelial Component Present,Stage IVA Pharyngeal Carcinoma
14516,High Grade Lesion,Fusion-Negative Alveolar Rhabdomyosarcoma
14517,Cutaneous Involvement,Skin Neoplasms
14518,Papillary Pattern,Intraductal papilloma of breast
14519,Epithelial Component Present,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei
14520,Recurrent disease,Recurrent Malignant Peripheral Nerve Sheath Tumor
14521,Epithelial Component Present,Small Intestinal Adenosquamous Carcinoma
14522,Epithelial Component Present,Eccrine carcinoma of skin
14523,Delicate Arborizing Vascular Channel Formation,Ovarian Myxoid Liposarcoma
14524,Locally Aggressive Lesion,Hemosiderotic Fibrolipomatous Tumor
14525,Insular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
14526,Leukoerythroblastic Reaction,Post polycythaemia vera myelofibrosis
14527,Tissue Differentiation Uncertain,Synovial sarcoma non-metastatic
14528,High Grade Lesion,Synovial sarcoma non-metastatic
14529,Epithelial Component Present,Bowen's Disease
14530,Antoni A Pattern,Cellular Schwannoma
14531,Hyperkeratosis,papillary squamous cell carcinoma of larynx
14532,Epithelial Component Present,Small intestine carcinoma non-resectable
14533,Cutaneous Involvement,Cutaneous sarcoidosis
14534,Epithelial Component Present,Transplant-Related Carcinoma
14535,Non-Invasive Lesion,"Papillary transitional cell carcinoma, non-invasive"
14536,Benign Cellular Infiltrate,Colon Cavernous Hemangioma
14537,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Primary amyloidosis
14538,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm
14539,Indolent Clinical Course,Parotid Gland Hemangioma
14540,Pseudopapillary Pattern,Teratocarcinoma
14541,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
14542,Epithelial Component Present,Primary malignant neoplasm of glomus jugulare
14543,Keratin pearl formation,Clear cell squamous cell carcinoma of skin
14544,Micropapillary Pattern,Papillary serous cystadenocarcinoma
14545,Carcinomatous Component Present,solid type ductal carcinoma in situ of breast
14546,Metastatic Lesion,Disseminated Malignant Neoplasm
14547,Epithelial Component Present,Prostatic Duct Urothelial Carcinoma
14548,Epithelial Component Present,Gallbladder Papillary Adenoma
14549,In Situ Lesion,Lobular carcinoma in situ of breast
14550,Epithelial Component Present,Adenoid cystic carcinoma of oropharynx
14551,Immunologic Deficiency Syndromes,AIDS-Related Human Papillomavirus Infection
14552,Indolent Clinical Course,Tonsillar Lipoma
14553,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
14554,Epithelial Component Present,tubulopapillary adenoma of gallbladder
14555,Intraductal Lesion,Intraductal Non-Comedo Breast Adenocarcinoma
14556,Intestinal metaplasia,"Adenocarcinoma, intestinal type"
14557,Increased megakaryocytes (bone marrow),Primary Myelofibrosis
14558,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Primary Myelofibrosis
14559,atypia morphology,Malignant Solitary Fibrous Tumor
14560,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, t(16;16)(p13;q22)"
14561,Well Differentiated Lesion,Peritoneal Well Differentiated Papillary Mesothelioma
14562,Above the Diaphragm Disease,Hodgkin's disease mixed cellularity stage I supradiaphragmatic
14563,Therapy-Related Toxicity,Radiation-Related Angiosarcoma
14564,Epithelial Component Present,Malignant Adrenal Gland Composite Pheochromocytoma
14565,Hereditary Lesion,Familial Paraganglioma
14566,Infiltrative Growth Pattern,Diffuse neurofibroma
14567,Carcinomatous Component Present,Endometrial Clear Cell Adenocarcinoma
14568,Multifocal Lesion,Pelvic lipomatosis
14569,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma
14570,Epithelial Component Present,Sebaceous adenoma
14571,Osseous Differentiation,Osteogenic Neoplasm
14572,Adulthood Lesion,Adult Unfavorable Prognosis Hodgkin Lymphoma
14573,Melanin-Forming Neuroepithelial Cells Present,Melanotic medulloblastoma
14574,Epithelial Component Present,Stage IVB Vulvar Cancer AJCC v6 and v7
14575,Fibrotic Stroma Formation,Testicular Brenner Tumor
14576,Fibromyxoid Stroma Formation,Acral Fibromyxoma
14577,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adult Subependymoma
14578,Indolent Clinical Course,Hemangioma of breast
14579,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type"
14580,Endobronchial Lesion,Lung Mixed Squamous Cell and Glandular Papilloma
14581,Well-Circumscribed Lesion,Lung Mucinous Cystadenoma
14582,Cystic Change,"Papillary cystadenoma, borderline malignancy"
14583,Childhood Lesion,Childhood Immunoblastic Lymphoma
14584,Carcinomatous Component Present,Ampulla of Vater Mucinous Adenocarcinoma
14585,Bone Marrow Dysplasia Present,Refractory anaemia with excess blasts
14586,No Evidence of Metastatic Disease,Benign Adrenal Gland Composite Pheochromocytoma
14587,S-100-Positive Neoplastic Cells Present,Lung Clear Cell Tumor
14588,Diffuse Pattern,Childhood Protoplasmic Astrocytoma
14589,Invasive Lesion,Adenocarcinoma of the prostate stage III
14590,Intraductal Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas
14591,Monomorphic Cellular Infiltrate,Ependymoma of spinal cord
14592,Adnexal Differentiation,Syringofibroadenoma
14593,Cystic Change,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma
14594,Dysplasia,Pancreatic Intraepithelial Neoplasia-1
14595,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)"
14596,Mediastinal mass,Thymic Hodgkin Lymphoma
14597,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Leiomyosarcoma
14598,Carcinomatous Component Present,Stage II Vulvar Cancer AJCC v7
14599,Tubular Pattern,Pancreatic Somatostatinoma
14600,Papillary Pattern,Inverted papilloma of urinary bladder
14601,Pain,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone
14602,Epithelial Component Present,Colon Micropapillary Adenocarcinoma
14603,Presence of a Hormonal Syndrome,Glucagonoma
14604,Multilocular Lesion,"Mesothelioma, Cystic"
14605,Tissue of Mullerian Origin Present,Borderline Ovarian Endometrioid Adenofibroma
14606,Immunologic Deficiency Syndromes,Graft-vs-Host Disease
14607,Low Mitotic Activity,Gastro-enteropancreatic neuroendocrine tumor
14608,Adulthood Lesion,Recurrent Adult Burkitt Lymphoma
14609,Ulcer,Esophageal Neuroendocrine Tumor G2
14610,Papillary Pattern,Central Breast Papilloma
14611,High Grade Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
14612,Carcinomatous Component Present,Digestive System Neuroendocrine Carcinoma
14613,Angiodestructive Pattern,Childhood Grade III Lymphomatoid Granulomatosis
14614,Mesenchymal Differentiation,Childhood Brain Stem Gliosarcoma
14615,Epithelial Component Present,Bile duct adenocarcinoma
14616,Nuclear Atypia,Recurrent Childhood Gliosarcoma
14617,Dysplasia,Moderate pancreatic duct dysplasia
14618,Absence of Invasion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
14619,Locally Aggressive Lesion,Chest Wall Plexiform Fibrohistiocytic Neoplasm
14620,Carcinomatous Component Present,carcinosarcoma of salivary gland
14621,Childhood Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
14622,Recurrent disease,Recurrent Uveal Melanoma
14623,Prominent Keratin Formation,Esophageal Well Differentiated Squamous Cell Carcinoma
14624,Immunologic Deficiency Syndromes,AIDS-Related Diffuse Large B-cell Lymphoma
14625,Osseous Differentiation,Stage IIB Osteosarcoma AJCC v7
14626,Favorable Clinical Outcome,Unclassified Hepatocellular Adenoma
14627,In Situ Lesion,Adenocarcinoma in situ in villous adenoma
14628,Exophytic Papillary Lesion,Vulvar Warty Carcinoma
14629,Indolent Clinical Course,Right atrial myxoma
14630,Epithelial Component Present,Mucoepidermoid Carcinoma
14631,Dysplasia,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
14632,Carcinomatous Component Present,Breast Carcinoma with Osseous Metaplasia
14633,Indolent Clinical Course,Oral Cavity Leiomyoma
14634,Mallory Bodies,Acute alcoholic liver disease
14635,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
14636,Plexiform Growth Pattern,Schneiderian carcinoma
14637,Primary Site Unknown,Adenocarcinoma of Unknown Primary
14638,Well-Circumscribed Lesion,Colorectal Peutz-Jeghers Polyp
14639,Absence of Invasion,Gastrointestinal carcinoma in situ
14640,Hyalinized Stroma Formation,Thyroid Hyalinizing Trabecular Adenoma
14641,Vascular Channel Formation,Lymphatic Vessel Tumors
14642,Epithelial Component Present,Cystadenoma of pancreas
14643,Absence of Invasion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
14644,Epithelial Component Present,High Grade Esophageal Squamous Intraepithelial Neoplasia
14645,Pseudoencapsulated Mass,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
14646,Papillary Pattern,Maxillary Sinus Schneiderian Papilloma
14647,Well-Circumscribed Lesion,Tubular adenoma of colon
14648,Hyperkeratosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
14649,Cutaneous Involvement,Solar lentigo
14650,Myomatous Stroma Formation,Adenomyoma
14651,Epithelial Component Present,Cervical Non-Keratinizing Squamous Cell Carcinoma
14652,Cutaneous Involvement,Cutis Laxa
14653,Intraductal Lesion,Papillary Ductal Breast Hyperplasia
14654,Non-Invasive Lesion,Urethral Inverted Papilloma
14655,Mucoid Stroma Formation,Primary Cutaneous Mucinous Carcinoma
14656,Epithelial Component Present,Postcricoid cancer
14657,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
14658,Unresectable Mass,Non-Resectable Malignant Liver Neoplasm
14659,Monomorphic Cellular Infiltrate,Tanycytic ependymoma
14660,Childhood Lesion,Recurrent Childhood Lymphomatoid Granulomatosis
14661,Indolent Clinical Course,Breast Epithelioid Hemangioma
14662,Chronic lymphocytic inflammation,Breast Epithelioid Hemangioma
14663,Epithelial Component Present,Cervical Glandular Neoplasm
14664,Extraosseous Lesion,Extra-osseous Ewing's sarcoma metastatic
14665,Epithelial Component Present,Laryngeal Adenoid Cystic Carcinoma
14666,Early Stromal Invasion Present,Early Invasive Cervical Adenocarcinoma
14667,Biphasic Pattern,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
14668,Carcinomatous Component Present,Meningeal Carcinomatosis
14669,Follicular Structures Present,Thyroid Gland Hyperfunctioning Adenoma
14670,Myxoid Stroma Formation,Chordoid meningioma
14671,Nuclear Atypia,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
14672,Malignant Cellular Infiltrate,Ovarian germ cell tumor mixed
14673,Low Mitotic Activity,Non functioning pancreatic endocrine tumor
14674,Dysplasia,Penile intraepithelial neoplasia
14675,Epithelial Component Present,Colon Medullary Carcinoma
14676,Epithelial Component Present,"Glandular intraepithelial neoplasia, low grade"
14677,Dysplasia,Stage 0is Renal Pelvis Cancer AJCC v7
14678,Mild dysplasia,Low Grade Gastric Intraepithelial Neoplasia
14679,Primary Lesion,Primary Peritoneal High Grade Serous Adenocarcinoma
14680,Recurrent disease,Verrucous carcinoma of the oral cavity recurrent
14681,Invasive Lesion,Growth Hormone-Producing Pituitary Gland Carcinoma
14682,Biphasic Pattern,Fallopian Tube Serous Adenofibroma
14683,Indolent Clinical Course,Juxtacortical chondroma
14684,Hyperplastic Tissue Present,Breast hyperplasia
14685,Osseous Differentiation,Adult Extraskeletal Osteosarcoma
14686,Epithelial Component Present,Basal cell carcinoma - adamantinoid
14687,Epithelial Component Present,malignant neoplasm of breast stage I
14688,Neuroendocrine Differentiation,Testicular Carcinoid Tumor
14689,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuroma of mediastinum
14690,Cutaneous Involvement,Morpheic basal cell carcinoma
14691,Childhood Lesion,Childhood Systemic Anaplastic Large Cell Lymphoma
14692,Well-Circumscribed Lesion,Solid Angioleiomyoma
14693,Carcinomatous Component Present,Rectal Cancer by AJCC v7 Stage
14694,Honeycomb Pattern,Recurrent Childhood Oligodendroglioma
14695,Epithelial Component Present,Liver Neuroendocrine Neoplasm
14696,Single Type of Tissue Derived from One Embryonic Layer Present,Benign Struma Ovarii
14697,Adulthood Lesion,Adult Cholangiocarcinoma
14698,Epithelial Component Present,Hard Palate Squamous Cell Carcinoma
14699,Pseudopapillary Pattern,Papillary glioneuronal tumor
14700,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Lipid-rich carcinoma
14701,Indolent Clinical Course,Cardiac Capillary Hemangioma
14702,Epithelial Component Present,Cervical high grade squamous intraepithelial lesion
14703,Carcinomatous Component Present,Stage I Esophageal Cancer
14704,Epithelial Component Present,Aldosterone-Producing Adrenal Cortex Adenoma
14705,Epithelial Component Present,Vaginal Neuroendocrine Carcinoma
14706,Well-Circumscribed Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma
14707,Neuroectodermal Differentiation,"Childhood Ganglioneuroblastoma, Intermixed"
14708,Exophytic Papillary Lesion,verrucous carcinoma of vagina
14709,Indolent Clinical Course,Infantile hemangioma of liver
14710,Pregnancy Complications,Stage I Gestational Trophoblastic Tumor AJCC v7
14711,Metastatic/Recurrent Disease,"Ossifying fibromyxoid tumor, malignant"
14712,Epithelial Component Present,Breast Pleomorphic Adenoma
14713,Osseous Component Present,Endobronchial Hamartoma
14714,High Grade Lesion,Liver Synovial Sarcoma
14715,Carcinomatous Component Present,Stomach Carcinoma
14716,Epithelial Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
14717,Local disease,Transitional cell cancer of the renal pelvis and ureter localized
14718,Carcinomatous Component Present,Hard Palate Mucoepidermoid Carcinoma
14719,Indolent Clinical Course,Intermediate Rhabdomyoma
14720,Epithelial Component Present,Recurrent Digestive System Carcinoma
14721,Perivascular Arrangement of Tumor Cells,Glomangioma
14722,Indolent Clinical Course,Esophageal Fibroma
14723,Mixed Cellular Population,clear cell adenocarcinofibroma of ovary
14724,Epithelial Component Present,Pancreatic Delta Cell Neoplasm
14725,Carcinomatous Component Present,Stage IV Rectal Cancer AJCC v7
14726,Cutaneous Involvement,Melanoma Arising in Giant Congenital Nevus
14727,Biphasic Pattern,Uterine Corpus Atypical Polypoid Adenomyoma
14728,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Neoplasm
14729,Melanin-Pigmented Dendritic Cells Present,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
14730,Absence of Invasion,Serous Tubal Intraepithelial Carcinoma
14731,High Grade Lesion,High grade surface osteosarcoma
14732,High Mitotic Activity,Stage 0 Merkel Cell Carcinoma AJCC v7
14733,Metastatic Lesion,Metastatic Adrenal Gland Pheochromocytoma
14734,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage II
14735,Carcinomatous Component Present,Pancreatic carcinoma resectable
14736,Sarcomatous Component Present,carcinosarcoma of fallopian tube
14737,Mixed Cellular Population,Stage I Kidney Wilms Tumor
14738,Epithelial Component Present,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
14739,Breast Microcalcification,Brain Oligodendroglioma
14740,Epithelial Component Present,"Squamous Cell Breast Carcinoma, Acantholytic Variant"
14741,Nuclear Atypia,Cerebral Glioblastoma
14742,Carcinomatous Component Present,Stage IA Lung Non-Small Cell Carcinoma AJCC v7
14743,Ineffective hematopoiesis,Childhood Myelodysplastic Syndrome
14744,Slow Growing Mass,Adult Craniopharyngioma
14745,Necrotic changes (finding),Brain Glioblastoma
14746,Hereditary Lesion,Carney Complex
14747,Carcinomatous Component Present,External Ear Carcinoma
14748,Biphasic Pattern,Adult Pilocytic Astrocytoma
14749,Metastatic Lesion,Secondary malignant neoplasm of orbit
14750,Epithelial Component Present,Ear carcinoma
14751,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma
14752,In Situ Lesion,Stage 0 Gastric Cancer AJCC v6 and v7
14753,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
14754,Primary Lesion,Adult Brain Stem Mixed Glioma
14755,Epithelial Component Present,Adult Pleomorphic Hepatocellular Carcinoma
14756,Non-Hereditary Lesion,Gastric Hepatoid Adenocarcinoma
14757,Childhood Lesion,Childhood Central Nervous System Mixed Germ Cell Tumor
14758,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
14759,Epithelial Component Present,Ovarian Papillary Cystadenoma
14760,Anaplasia,Childhood Anaplastic Ependymoma
14761,High Grade Lesion,Combined Lung Carcinoma
14762,Epithelial Component Present,Adenocarcinoma of lacrimal gland
14763,Carcinomatous Component Present,Stage IV Laryngeal Cancer AJCC v7
14764,Vascular Channel Formation,Malignant Vascular Neoplasm
14765,High Mitotic Activity,Childhood Embryonal Carcinoma
14766,Indolent Clinical Course,Pleomorphic Lipoma
14767,Indolent Clinical Course,Benign Pilar-Associated Mesenchyme Neoplasm
14768,Well-Circumscribed Lesion,Choroid Plexus Papilloma
14769,Diffuse Pattern,Low grade myofibroblastic sarcoma
14770,Cutaneous Involvement,Chronic Bullous Disease of Childhood
14771,Epithelial Component Present,Trichoadenoma
14772,Glucagon-Like Peptide Positive Neoplastic Cells Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
14773,High Grade Lesion,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
14774,Secondary Lesion,Secondary malignant neoplasm of prostate
14775,Carcinomatous Component Present,Metaplastic carcinoma
14776,'Starry-sky' pattern,Burkitt-like lymphoma
14777,Locally Aggressive Lesion,Intermediate Fibroblastic Neoplasm
14778,Carcinomatous Component Present,Squamous cell carcinoma of the head and neck
14779,Acanthosis,Condylomata Acuminata
14780,Cutaneous Involvement,Contact dermatitis due to dichromate
14781,Adulthood Lesion,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma
14782,Carcinomatous Component Present,Primary ameloblastic carcinoma
14783,Dysplasia,Appendix Low Grade Intraepithelial Neoplasia
14784,Epithelial Component Present,Stage I Colorectal Cancer AJCC v6 and v7
14785,Secondary Lesion,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)
14786,Carcinomatous Component Present,mucoepidermoid carcinoma of lung
14787,Serotonin Positive Neoplastic Cells Present,Carcinoid tumor of pancreas
14788,Dysplasia,High grade cervical glandular intraepithelial neoplasia
14789,Well-Circumscribed Lesion,"Cystadenoma, Papillary"
14790,Microvascular Proliferation,Juvenile Pilocytic Astrocytoma
14791,Glomeruloid Vessels Present,Juvenile Pilocytic Astrocytoma
14792,Borderline Lesion,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
14793,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Neutropenia
14794,Mixture of Germ Cell Neoplastic Components Present,teratocarcinoma of mediastinum
14795,Mild dysplasia of colon,Colorectal Low Grade Intraepithelial Neoplasia
14796,Epithelial Component Present,Ovarian Cystadenoma
14797,Cutaneous Involvement,Vulvar Neoplasm of Skin Appendage Origin
14798,Epithelial Component Present,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm
14799,Adnexal Differentiation,Neoplasm of skin with adnexal differentiation
14800,Carcinomatous Component Present,Stage II Rectosigmoid Cancer AJCC v6
14801,Follicular Structures Present,Microfollicular adenoma
14802,Anaplasia,Anaplastic (Malignant) Intraspinal Meningioma
14803,Biphasic Pattern,Malignant phyllodes tumor of breast
14804,Non-Malignant Cellular Infiltrate,Lymphadenitis
14805,Epithelial Component Present,squamous cell carcinoma of renal pelvis
14806,Childhood Lesion,Childhood Ovarian Dysgerminoma
14807,Acanthosis,Human Papillomavirus-Related Verrucous Carcinoma
14808,Carcinomatous Component Present,Human Papillomavirus-Related Verrucous Carcinoma
14809,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v7
14810,Papillary Pattern,Squamous Papilloma of the Larynx
14811,Indolent Clinical Course,Intramuscular lipoma
14812,Local disease,Intramuscular lipoma
14813,Carcinomatous Component Present,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
14814,Monoclonal Cellular Population Present,Mast-Cell Sarcoma
14815,High Grade Lesion,Mast-Cell Sarcoma
14816,Non-Hereditary Lesion,Sporadic Breast Carcinoma
14817,Carcinomatous Component Present,Squamous cell breast carcinoma
14818,Vascular Channel Formation,Mucous Membrane Hemangioma
14819,Absence of Invasion,Bladder adenocarcinoma stage 0
14820,Childhood Lesion,Childhood Central Nervous System Embryonal Neoplasm
14821,Precise Histogenesis Unknown,Neoplasm of Uncertain Histogenesis
14822,Negative Bone Marrow and Peripheral Blood,Splenic Small Lymphocytic Lymphoma
14823,Well-Circumscribed Lesion,Pancreatic Acinar Cell Cystadenoma
14824,Hypercellular bone marrow,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
14825,Intraluminal Masses of Mucin Present,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant"
14826,Hyperkeratosis,verrucous carcinoma of bladder
14827,Carcinomatous Component Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
14828,Primary Lesion,Stage IVB Osteosarcoma AJCC v7
14829,Epithelial Component Present,Seminal Vesicle Adenocarcinoma
14830,Stromal Invasion,Malignant Ovarian Endometrioid Tumor
14831,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
14832,Cutaneous Involvement,Sebaceoma
14833,Epithelial Component Present,Sebaceous Breast Carcinoma
14834,Epithelial Component Present,Null Cell Pituitary Gland Adenoma
14835,Therapy-Related Toxicity,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm
14836,Carcinomatous Component Present,Non-Small Cell Adenocarcinoma
14837,Neuroendocrine Differentiation,Stage IIB Lung Small Cell Carcinoma AJCC v7
14838,Cystic Change,Mucoepidermoid carcinoma of parotid gland
14839,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
14840,Well-Circumscribed Lesion,Gliomatosis Cerebri Type II
14841,Epithelial Component Present,Pancreatic Vipoma
14842,Absence of Invasion,Bowen's Disease
14843,Carcinomatous Component Present,Laryngeal Acantholytic Squamous Cell Carcinoma
14844,Necrotic changes (finding),combined small cell carcinoma of lung
14845,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
14846,Necrotic changes (finding),Rectal Small Cell Neuroendocrine Carcinoma
14847,Cutaneous Involvement,Hepatoerythropoietic Porphyria
14848,Neutral Epithelial Mucin Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
14849,Mild dysplasia,Pancreatic Intraductal Papillary-Mucinous Adenoma
14850,Eosinophilic inflammation,Gastric Inflammatory Myofibroblastic Tumor
14851,Epithelial Component Present,Pancreatic Acinar Cell Neoplasm
14852,Acinar Cell Differentiation,Pancreatic Acinar Cell Neoplasm
14853,Carcinomatous Component Present,Primary serous papillary carcinoma of peritoneum
14854,Well-Circumscribed Lesion,Adrenal Cortex Adenomatoid Tumor
14855,Insular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
14856,Below the Diaphragm Disease,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
14857,Primary Lesion,AIDS-Related Primary Effusion Lymphoma
14858,Polymorphic Cellular Infiltrate,"Post-transplant lymphoproliferative disorder, polymorphic"
14859,Capillary Sized Vascular Channel Formation,Kaposiform Hemangioendothelioma
14860,Epithelial Component Present,signet ring cell carcinoma of appendix
14861,Childhood Lesion,Childhood Fibrillary Astrocytoma
14862,Pleural effusion disorder,Pulmonary lymphangioleiomyomatosis
14863,Therapy-Related Toxicity,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
14864,Diffuse Pattern,Childhood Oligoastrocytoma
14865,Cutaneous Involvement,Malignant Proliferating Pilar Tumor
14866,Thick-Walled Vessels Present,Hepatic Angiomyolipoma
14867,Carcinomatous Component Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma
14868,Invasive Lesion,Adenocarcinoma of prostate
14869,Childhood Lesion,Recurrent Childhood Cerebral Astrocytoma
14870,Primary Lesion,Recurrent Childhood Cerebral Astrocytoma
14871,Carcinomatous Component Present,"Adenocarcinoma, Scirrhous"
14872,Intracanalicular Growth Pattern,Prostate Phyllodes Tumor
14873,Invasive Lesion,Breast Solid Neuroendocrine Carcinoma
14874,Cutaneous Involvement,Parapsoriasis
14875,Epithelial Component Present,Testicular Brenner Tumor
14876,Bone Marrow and Blood Involvement,Childhood Burkitt Leukemia
14877,Absence of Stromal Invasion,"Papillary mucinous cystadenoma, borderline malignancy"
14878,Epithelial Component Present,Superior and Inferior Paraaortic Paraganglioma
14879,Papillary Pattern,Squamous cell papilloma of eyelid
14880,Pseudoglandular Pattern,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma
14881,Stromal Invasion,"Carcinoma, Ovarian Epithelial"
14882,Cutaneous Involvement,Erythrokeratodermia variabilis
14883,Carcinomatous Component Present,Comedocarcinoma
14884,Metastatic Lesion,Locally Metastatic Malignant Neoplasm
14885,Hereditary Lesion,Turcot syndrome (disorder)
14886,Infiltrative Growth Pattern,Glioblastoma with Primitive Neuronal Component
14887,Locally Aggressive Lesion,Intermediate Soft Tissue Tumor
14888,Papillary Pattern,Intracystic Papillary Breast Carcinoma
14889,Non-Invasive Lesion,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
14890,Exophytic Papillary Lesion,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
14891,Primary Lesion,Astrocytoma of brain
14892,Dense Intercellular Reticulin Network Present,Childhood Pleomorphic Xanthoastrocytoma
14893,Lytic lesion,Chondroblastoma
14894,Glandular Pattern,Intestinal-Type Sinonasal Adenocarcinoma
14895,Epithelial Component Present,Adenocarcinoma of the prostate stage III
14896,Carcinomatous Component Present,Occult Lung Squamous Cell Carcinoma
14897,Mixed Cellular Population,Recurrent Kidney Wilms Tumor
14898,Tubular Pattern,Syringoma
14899,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
14900,Endophytic Tumor Growth,"Transitional cell papilloma, inverted"
14901,Childhood Lesion,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement
14902,Indolent Clinical Course,Adenomatoid Tumor
14903,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Gastric Teratoma
14904,Well-Circumscribed Lesion,Giant Fibrovascular Esophageal Polyp
14905,Morphologic Overlap,"Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
14906,Dysplasia,"Ampullary Flat Intraepithelial Neoplasia, High Grade"
14907,Carcinomatous Component Present,squamous cell carcinoma of urethra
14908,Micropapillary Pattern,Colorectal Micropapillary Adenocarcinoma
14909,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v6
14910,Carcinomatous Component Present,Cervical Adenosquamous Carcinoma
14911,Epithelial Component Present,Mammary Analog Secretory Carcinoma of Salivary Gland
14912,Regional Disease,Locally Advanced Malignant Neoplasm
14913,Intestinal metaplasia,Vaginal Villous Adenoma
14914,Anaplasia,Childhood Anaplastic Oligodendroglioma
14915,Diffuse Pattern,Childhood Anaplastic Oligodendroglioma
14916,Congenital Lesion,Pulmonary Subvalvular Stenosis
14917,Adulthood Lesion,Adult Salivary Gland Carcinoma
14918,Childhood Lesion,Childhood Multilocular Cystic Renal Neoplasm
14919,Secondary Lesion,Disseminated carcinoma
14920,Metastatic Lesion,Metastatic malignant neoplasm to oropharynx
14921,Epithelial Component Present,"Vulvar Adenocarcinoma, Intestinal-Type"
14922,Therapy-Related Toxicity,Treatment related leukaemia
14923,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)
14924,Hereditary Lesion,Familial Waldenstrom's Macroglobulinaemia
14925,Fibrotic Stroma Formation,signet ring cell carcinoma of pancreas
14926,Carcinomatous Component Present,Stage IIIA Lung Small Cell Carcinoma AJCC v7
14927,Firm mass,Low Grade Malignant Peripheral Nerve Sheath Tumor
14928,Infiltrative Growth Pattern,Recurrent Childhood Gliosarcoma
14929,Neuroendocrine Differentiation,Stage IIIB Lung Small Cell Carcinoma AJCC v7
14930,Metastatic Lesion,Secondary malignant neoplasm of eye
14931,Epithelial Component Present,Multiple adenomatous polyps
14932,Cartilaginous Differentiation,Chondrosarcoma recurrent
14933,Ground Glass Nuclear Inclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
14934,Epithelial Component Present,Recurrent Digestive System Neuroendocrine Tumor G1
14935,Epithelial Component Present,Ovarian mucinous tumor
14936,Mixed Cellular Population,Invasive Ductal and Invasive Lobular Breast Carcinoma
14937,Epithelial Component Present,Urinary System Paraganglioma
14938,Diffuse Lesion,Lymphangiomatosis
14939,Benign Cellular Infiltrate,Appendix Lipoma
14940,Delicate Vascular Network Formation,Grade 4 Clear Cell Renal Cell Carcinoma
14941,Cutaneous Involvement,Hidrocystoma
14942,High Mitotic Activity,Esophageal Large Cell Neuroendocrine Carcinoma
14943,Well Differentiated Lesion,Vulvar Warty Carcinoma
14944,Carcinomatous Component Present,Vulvar Adenocarcinoma of Mammary Gland Type
14945,Horny Masses of Keratin Present,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type"
14946,Carcinomatous Component Present,Cervix carcinoma recurrent
14947,Metastatic Lesion,Pericardial Carcinomatosis
14948,Immunologic Deficiency Syndromes,AIDS-Related Oropharyngeal Candidiasis
14949,High Grade Lesion,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
14950,Carcinomatous Component Present,Stage IIIa Penile Cancer AJCC v7
14951,Epithelial Component Present,Parotid monomorphic adenoma
14952,Metaplasia,Bladder squamous cell carcinoma stage II
14953,Tissue Differentiation Uncertain,Recurrent Extraskeletal Myxoid Chondrosarcoma
14954,Infiltrating Tumor Margins Present,Uterine Corpus Endometrial Stromal Sarcoma
14955,Neuroendocrine Differentiation,neuroendocrine carcinoma of anal canal
14956,Epithelial Component Present,Pancreatic intraepithelial neoplasia
14957,Epithelial Component Present,Stage IV Major Salivary Gland Carcinoma without Metastasis
14958,Carcinomatous Component Present,Grade 1 Clear Cell Renal Cell Carcinoma
14959,Cartilaginous Differentiation,Benign chondrogenic neoplasm
14960,atypia morphology,Dedifferentiated Solitary Fibrous Tumor
14961,High Grade Lesion,Dedifferentiated Solitary Fibrous Tumor
14962,Immunoglobulin Deposition,Immunoglobulin deposition disease
14963,High Grade Lesion,Combined Lung Large Cell Neuroendocrine Carcinoma
14964,High Mitotic Activity,Combined Lung Large Cell Neuroendocrine Carcinoma
14965,Hyperplastic Tissue Present,Tubal Epithelial Hyperplasia
14966,Tubular Structures Present,Gastric Tubular Adenocarcinoma
14967,Cutaneous Involvement,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7
14968,Vascular Channel Formation,Kaposi's sarcoma of conjunctiva
14969,Pseudoencapsulated Mass,Childhood Malignant Peripheral Nerve Sheath Tumor
14970,Biphasic Pattern,Rete Ovarii Cystadenofibroma
14971,Peripheral Nuclear Palisading,Small cell lung cancer recurrent
14972,Borderline Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential
14973,Mucoid Stroma Formation,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
14974,Epithelial Component Present,Nasopharyngeal cancer recurrent
14975,Epithelial Component Present,Stage IV Major Salivary Gland Carcinoma with Metastasis
14976,S-100-Positive Neoplastic Cells Present,Uterine Corpus PEComa
14977,Epithelial Component Present,Primary peritoneal carcinoma
14978,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Carcinoma
14979,Neoplastic Growth or Spread,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
14980,Cutaneous Involvement,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7
14981,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts I
14982,High Mitotic Activity,Anal Canal Small Cell Neuroendocrine Carcinoma
14983,Absence of a Hormonal Syndrome,Pancreatic Neuroendocrine Microadenoma
14984,Low Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Cervix
14985,Low Mitotic Activity,Anal Canal Neuroendocrine Tumor G2
14986,Carcinomatous Component Present,Anal Canal Mixed Adenoneuroendocrine Carcinoma
14987,Neoplastic Plasma Cells Present in Bone Marrow,Multiple Myeloma
14988,Carcinomatous Component Present,Pulmonary Blastoma
14989,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma
14990,Epithelial Component Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2
14991,Fibrotic Stroma Formation,Malignant Brenner Tumor
14992,Carcinomatous Component Present,Stage I Cervical Cancer AJCC v6 and v7
14993,Myxoid Changes Present,Osteochondromyxoma
14994,Hereditary Lesion,Hereditary Malignant Neoplasm
14995,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v7
14996,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
14997,Mixed Cellular Population,Malignant Cystosarcoma Phyllodes
14998,Aggressive Clinical Course,ALK positive large B-cell lymphoma
14999,Severe dysplasia,Bowenoid papulosis of penis
15000,Monoclonal Paraproteinemia,Osteosclerotic Plasma Cell Myeloma
15001,Neuroendocrine Differentiation,Small cell carcinoma of lung
15002,Rapidly Enlarging Mass,Recurrent Childhood Rhabdomyosarcoma
15003,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
15004,Epithelial Component Present,Vaginal Papillary Carcinoma
15005,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type"
15006,Adulthood Lesion,Adult Synovial Sarcoma
15007,Cutaneous Involvement,Malignant Apocrine Neoplasm
15008,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Mediastinal Teratoma
15009,Calcitonin Positive Neoplastic Cells Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
15010,Epithelial Component Present,Unresectable Esophageal Carcinoma
15011,Hyperplastic Tissue Present,Circumferential Endothelial Hyperplasia
15012,Carcinomatous Component Present,Carcinoma of larynx
15013,Fibrotic Stroma Formation,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
15014,Epithelial Component Present,Recurrent Parathyroid Gland Carcinoma
15015,Congenital Lesion,Vulvar Congenital Melanocytic Nevus
15016,Carcinomatous Component Present,Combined Lung Small Cell and Squamous Cell Carcinoma
15017,Exophytic Polypoid Lesion,Cecum Villous Adenoma
15018,Diffuse Lesion,Liver Lymphangiomatosis
15019,Carcinomatous Component Present,Stage 0is Urethral Cancer AJCC v7
15020,Exophytic Polypoid Lesion,Polyp in nasopharynx
15021,Neuroendocrine Differentiation,"Pheochromocytoma, malignant"
15022,Epithelial Component Present,Hard Palate Adenoid Cystic Carcinoma
15023,Epithelial Component Present,Malignant Ovarian Clear Cell Tumor
15024,Neuroendocrine Differentiation,Small cell carcinoma of the cervix
15025,Cartilaginous Differentiation,Chondrogenic Neoplasm
15026,Increased Cellularity Present,Prostate Stromal Sarcoma
15027,Epithelial Component Present,Clear cell adenocarcinoma of ovary
15028,Entrapped Respiratory Epithelium Present,Multiple hamartoma of lung
15029,Acanthosis,Condyloma anal
15030,Tissue of Mullerian Origin Present,Malignant Mixed Mesodermal (Mullerian) Tumor
15031,Cutaneous Involvement,Xeroderma
15032,Solitary mass,Chordoma of clivus
15033,Hyperkeratosis,Cervical Papillary Squamous Cell Carcinoma
15034,Cutaneous Involvement,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder
15035,Papillary Pattern,Vestibular Papilloma
15036,Locally Aggressive Lesion,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
15037,Cellular Pleomorphism,High grade surface osteosarcoma
15038,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma recurrent
15039,Epithelial Component Present,Squamous cell carcinoma of tongue
15040,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Wildtype"
15041,Epithelial Component Present,Pharyngeal cancer recurrent
15042,Stromal Invasion,Low Grade Ovarian Serous Adenocarcinoma
15043,Childhood Lesion,Childhood Ovarian Mixed Germ Cell Tumor
15044,Epithelial Component Present,Multiple Endocrine Neoplasia
15045,Epithelial Component Present,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
15046,Vascular proliferation,Giant Cell Tumor of Soft Tissue
15047,Hypercellular bone marrow,"Polycythemia Vera, Polycythemic Phase"
15048,Neuroendocrine Differentiation,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
15049,High Mitotic Activity,Vulvar Merkel Cell Carcinoma
15050,Mixed Cellular Population,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
15051,Carcinomatous Component Present,Stage I Skin Cancer
15052,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
15053,Cutaneous Involvement,"Lymphoma, T-Cell, Cutaneous"
15054,Mucoid Stroma Formation,Low grade appendiceal mucinous neoplasm
15055,Microvascular Proliferation,Cerebral Glioblastoma
15056,Hyalinized Stroma Formation,Epithelioid hemangioendothelioma of lung
15057,Chronic lymphocytic inflammation,Adenolymphoma
15058,Epithelial Component Present,Endometrioid tumor
15059,Neuroendocrine Differentiation,small cell carcinoma of breast
15060,Refractory Disease,Precursor B-lymphoblastic lymphoma refractory
15061,High Grade Lesion,Recurrent Glioblastoma
15062,Reinke Crystals Formation,Ovarian Stromal-Leydig Cell Tumor
15063,Hemorrhagic,Peripheral Intraneural Angiosarcoma
15064,Carcinomatous Component Present,Squamous cell carcinoma of oropharynx
15065,Epithelial Component Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
15066,Secondary Lesion,Recurrent Carcinoma of Unknown Primary
15067,Epithelial Component Present,Supraglottic Verrucous Carcinoma
15068,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change
15069,Fibrotic Stroma Formation,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
15070,Epithelial Component Present,Low Grade Corneal Intraepithelial Neoplasia
15071,Cutaneous Involvement,Vulvar Papillary Hidradenoma
15072,Papillary Pattern,Vulvar Papillary Hidradenoma
15073,Lamellar Pattern,Adult Fibrolamellar Carcinoma
15074,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage I
15075,Cutaneous Involvement,Balloon cell malignant melanoma
15076,Epithelial Component Present,Gastric Hepatoid Adenocarcinoma
15077,Carcinomatous Component Present,Adenocarcinoma in tubular adenoma
15078,CD8-Positive Neoplastic Cells Present,Hydroa vacciniforme-like lymphoma
15079,Follicular Cell Differentiation,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
15080,Primary Lesion,Cerebral Hodgkin Lymphoma
15081,Ineffective hematopoiesis,Therapy-related myelodysplastic syndrome
15082,Pregnancy Complications,"Pregnancy, Ovarian"
15083,Invasive Lesion,large cell neuroendocrine carcinoma of breast
15084,Absence of Malignant Features,Choroid Plexus Papilloma
15085,High Grade Lesion,Childhood Conventional Osteosarcoma
15086,Epithelial Component Present,mucinous adenocarcinoma of salivary gland
15087,Carcinomatous Component Present,Stage IVB Colorectal Cancer AJCC v7
15088,Epithelial Component Present,Recurrent Liver Carcinoma
15089,Absence of Invasion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
15090,Epithelial Component Present,Adenocarcinoma with metaplasia
15091,Hereditary Lesion,Tuberous Sclerosis
15092,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
15093,Mitotic Activity,Childhood Ovarian Yolk Sac Tumor
15094,Neuroectodermal Differentiation,Regional Neuroblastoma
15095,Carcinomatous Component Present,Cystadenocarcinoma
15096,Carcinomatous Component Present,squamous cell carcinoma of ureter
15097,Cutaneous Involvement,Congenital Nonbullous Ichthyosiform Erythroderma
15098,Epithelial Component Present,Adult Liver Carcinoma
15099,Epithelial Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
15100,Well-Circumscribed Lesion,Clear cell hidradenoma
15101,Carcinomatous Component Present,Lower Gingival Squamous Cell Carcinoma
15102,Epithelial Component Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
15103,Nodular Pattern,Eccrine acrospiroma
15104,Cutaneous Involvement,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7
15105,Locally Aggressive Lesion,"Gastrointestinal stromal tumor, uncertain malignant potential"
15106,Adulthood Lesion,Malignant Adult Brain Neoplasm
15107,Epithelial Component Present,Vulval intraepithelial neoplasia grade 2
15108,Well-Circumscribed Lesion,Phyllodes Tumor
15109,No Identifiable Line of Differentiation,undifferentiated sarcoma of soft tissue
15110,Epithelial Component Present,Oral Cavity Carcinoma
15111,Aggressive Clinical Course,Malignant mastocytosis
15112,Indolent Clinical Course,Cervical Leiomyoma
15113,Carcinomatous Component Present,High Grade Appendix Mucinous Adenocarcinoma
15114,Low Mitotic Activity,Appendix Neuroendocrine Tumor G2
15115,Carcinomatous Component Present,Fallopian Tube Carcinoma
15116,Cutaneous Involvement,Contact dermatitis due to alkali
15117,Adnexal Differentiation,Malignant Sebaceous Neoplasm
15118,Necrotic changes (finding),large cell neuroendocrine carcinoma of appendix
15119,Vascular Channel Formation,Hemangioma of liver
15120,Epithelial Component Present,Malignant Ovarian Serous Tumor
15121,Carcinomatous Component Present,Squamous cell carcinoma of esophagus
15122,Malignant Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma
15123,Biphasic Pattern,Borderline Ovarian Mucinous Adenofibroma
15124,Aggressive Clinical Course,Mast-Cell Sarcoma
15125,Primary Lesion,"Leukemia, Mast-Cell"
15126,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
15127,Epithelial Component Present,Serous Neoplasm
15128,Epithelial Component Present,Pancreatic carcinoma
15129,Immunosuppression-Related Post-Transplant Toxicity,Allograft Thrombosis
15130,Carcinomatous Component Present,Carcinoma of soft palate
15131,Endophytic Tumor Growth,verrucous carcinoma of bladder
15132,Elastin Fibers Present,Trichodiscoma
15133,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
15134,Carcinomatous Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7
15135,Carcinomatous Component Present,Stage IIIA Adult Liver Cancer AJCC v7
15136,Carcinomatous Component Present,Stage IVB Pharyngeal Carcinoma
15137,Well-Circumscribed Lesion,Colorectal Tubulovillous Adenoma
15138,Necrotic changes (finding),Recurrent Malignant Peripheral Nerve Sheath Tumor
15139,Sebaceous Differentiation,Sebaceous Breast Carcinoma
15140,Nuclear Molding,Stage IB Lung Small Cell Carcinoma AJCC v7
15141,Neuroendocrine Differentiation,Stage II Lung Small Cell Carcinoma AJCC v7
15142,Immunologic Deficiency Syndromes,Transplant-Related Malignant Neoplasm
15143,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with Maturation
15144,Hyperplastic Tissue Present,Atypical Mesothelial Hyperplasia
15145,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
15146,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myelomonocytic Leukemia
15147,"Amorphus, Eosinophilic, and Acellular Deposit",Primary amyloidosis
15148,Cutaneous Involvement,"Keratoderma, Palmoplantar, Diffuse"
15149,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
15150,Diffuse Lesion,Diffuse Intrinsic Pontine Glioma
15151,Absence of Invasion of the Muscularis Externa,Gastric Intramucosal Adenocarcinoma
15152,Epithelial Component Present,Transplant-Related Skin Squamous Cell Carcinoma
15153,Carcinomatous Component Present,Palate carcinoma
15154,Favorable Clinical Outcome,Beta-Catenin-Activated Hepatocellular Adenoma
15155,Solid Growth Pattern,solid type ductal carcinoma in situ of breast
15156,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa
15157,Epithelial Component Present,Anal carcinoma
15158,High Grade Lesion,Small cell lung cancer limited stage
15159,Carcinomatous Component Present,Undifferentiated carcinoma of nasopharynx
15160,Carcinomatous Component Present,Stage III Esophageal Adenocarcinoma AJCC v7
15161,Locally Aggressive Lesion,Prostate Stromal Proliferation of Uncertain Malignant Potential
15162,Carcinomatous Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
15163,Metastatic/Recurrent Disease,Distal-Type Epithelioid Sarcoma
15164,Necrotic changes (finding),small cell carcinoma of appendix
15165,Cribriform Pattern,Intraductal Cribriform Breast Adenocarcinoma
15166,Neuroendocrine Differentiation,Paraganglioma of head and neck
15167,Cystic Change,Mucoepidermoid carcinoma of the oral cavity stage II
15168,Carcinomatous Component Present,Squamous Cell Carcinoma of Anal Margin
15169,Carcinomatous Component Present,Stage I Lip Basal Cell Carcinoma
15170,Exophytic Polypoid Lesion,Bladder Villous Adenoma
15171,Edematous Stroma Formation,Vulvar Angiomyxoma
15172,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells
15173,Intraductal Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
15174,Primary Site Unknown,"Neoplasms, Unknown Primary"
15175,Tartrate Resistant Acid Phosphatase Positive Cells Present,Progressive Hairy Cell Leukemia Initial Treatment
15176,Less than 2 Mitoses per 10HPF,Lung Typical Carcinoid Tumor
15177,Cystic Change,Mucoepidermoid carcinoma of the oral cavity stage III
15178,Deep Lesion,Inflammatory liposarcoma
15179,Epithelial Component Present,"Pancreatic carcinoma, familial"
15180,Mitotic Activity,"Uterine Corpus Leiomyoma, Mitotically Active Variant"
15181,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma
15182,Neoplastic Plasma Cells Present in Bone Marrow,Smoldering myeloma
15183,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7
15184,Hereditary Lesion,Anemia due to membrane defect
15185,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia
15186,Epithelial Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma
15187,Fibrotic Stroma Formation,Intrahepatic cholangiocarcinoma recurrent
15188,Epithelial Component Present,adenosquamous carcinoma of pancreas
15189,Fibrotic Stroma Formation,Colloid Carcinoma of the Pancreas
15190,Recurrent disease,Recurrent Rectal Cancer
15191,Epithelial Component Present,Adenocarcinoma of the prostate stage I
15192,High Mitotic Activity,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
15193,Neuroendocrine Differentiation,Benign Adrenal Gland Composite Pheochromocytoma
15194,Epithelial Component Present,Hidroacanthoma simplex
15195,Schwannian Stroma More than 50 Percent of the Tumor Volume,malignant ganglioneuroblastoma of adrenal gland
15196,Increased Cellularity Present,Adult Pineoblastoma
15197,Splenomegaly,"Leukemia, Myeloid, Accelerated Phase"
15198,Secondary Lesion,Secondary malignant neoplasm of esophagus
15199,Primary Lesion,"lymphomatoid papulosis, type C"
15200,Cutaneous Involvement,Solar Radiation-Related Skin Squamous Cell Carcinoma
15201,In Situ Lesion,Carcinoma in situ of small intestine
15202,Dysplasia,Intraepithelial Neoplasia in Barrett Esophagus
15203,Primary Lesion,Recurrent Childhood Brain Stem Glioma
15204,Absence of Invasion,"Ampullary Flat Intraepithelial Neoplasia, High Grade"
15205,Epithelial Component Present,Gardner Syndrome
15206,Epithelial Component Present,squamous cell carcinoma of urethra
15207,Carcinomatous Component Present,Stage II Urethral Cancer AJCC v7
15208,Bone Marrow Eosinophilia,Acute myeloid leukemia with abnormal marrow eosinophils
15209,Borderline Lesion,"Mesothelioma, Cystic"
15210,High Grade Lesion,Adult Gliosarcoma
15211,In Situ Lesion,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8"
15212,Childhood Lesion,Malignant Childhood Central Nervous System Neoplasm
15213,Multifocal Lesion,Breast Myoepitheliosis
15214,Exophytic Polypoid Lesion,Polyp of ethmoidal sinus
15215,Dysplasia,Tubular adenoma
15216,Neuroendocrine Differentiation,Stage IIIA Lung Small Cell Carcinoma AJCC v7
15217,Diffuse Pattern,Recurrent Childhood Gliosarcoma
15218,Epithelial Component Present,Endometrial Undifferentiated Carcinoma
15219,Neuroendocrine Differentiation,Recurrent Digestive System Neuroendocrine Tumor G1
15220,Mixed Cellular Population,carcinosarcoma of extrahepatic bile duct
15221,Primary Lesion,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder
15222,Hereditary Lesion,Adenomatous Polyposis Coli
15223,Endophytic Tumor Growth,Inverted urothelial papilloma
15224,Cutaneous Involvement,Necrobiosis Lipoidica
15225,Cutaneous Involvement,Skin Signet Ring Cell Basal Cell Carcinoma
15226,Epithelial Component Present,Basal cell carcinoma - adenoid
15227,Pseudoglandular Pattern,Testicular embryonal carcinoma stage I
15228,Epithelial Component Present,Apudoma
15229,Myxoid Stroma Formation,Right atrial myxoma
15230,Therapy-Related Toxicity,Treatment related acute myeloid leukaemia
15231,High Mitotic Activity,small cell carcinoma of extrahepatic bile duct
15232,Non-Invasive Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
15233,Cartilaginous Differentiation,Secondary Peripheral Chondrosarcoma
15234,Osteoid formation,Bone island
15235,Invasive Lesion,Inflammatory carcinoma of breast stage III
15236,Exophytic Polypoid Lesion,Tubular adenoma of colon
15237,Mixed Cellular Population,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm
15238,Epithelial Component Present,High Grade Esophageal Glandular Intraepithelial Neoplasia
15239,Epithelial Component Present,Malignant Breast Eccrine Spiradenoma
15240,Epithelial Component Present,Appendix Mucinous Cystadenoma
15241,Intraductal Lesion,Noninfiltrating intraductal papillary adenocarcinoma
15242,Cutaneous Involvement,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7
15243,Metastatic/Recurrent Disease,Alveolar soft part sarcoma recurrent
15244,Metastatic Lesion,Metastatic Carcinoma in the Adrenal Cortex
15245,Tissue Differentiation Uncertain,Epithelioid sarcoma non-metastatic
15246,Papillary Pattern,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
15247,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v6 and v7
15248,Slow Growing Mass,Central Nervous System Hemangioblastoma
15249,Secondary Lesion,Meningeal Carcinomatosis
15250,Nodular Pattern,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma
15251,Carcinomatous Component Present,Stage III Penile Cancer AJCC v6
15252,In Situ Lesion,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
15253,Epithelial Component Present,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7
15254,Cutaneous Involvement,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7
15255,Aggressive Clinical Course,Undifferentiated Endocervical Sarcoma
15256,Epithelial Component Present,Esophageal Glandular Intraepithelial Neoplasia
15257,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Tumor G2
15258,Numerous Stromal Mast Cells Present,Vulvar Superficial Myofibroblastoma
15259,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Adult Myelodysplastic Syndrome
15260,Recurrent disease,Recurrent Childhood Pleomorphic Xanthoastrocytoma
15261,Non-Hereditary Lesion,Early gastric cancer
15262,Borderline Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor
15263,Well-Circumscribed Lesion,Adult Extracardiac Rhabdomyoma
15264,Epithelial Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
15265,Carcinomatous Component Present,Cholangiolocellular Carcinoma
15266,Cutaneous Involvement,Epithelioid and spindle cell nevus
15267,Epithelial Component Present,LH-Producing Gonadotroph Adenoma
15268,Cutaneous Involvement,Benign Cutaneous Fibroblastic Neoplasm
15269,Carcinomatous Component Present,large cell neuroendocrine carcinoma of extrahepatic bile duct
15270,Neoplastic Plasma Cells Present in Bone Marrow,Indolent multiple myeloma
15271,Metastatic/Recurrent Disease,Adult Extraskeletal Myxoid Chondrosarcoma
15272,Cartilaginous Differentiation,Subungual exostoses
15273,Extraosseous Lesion,Adult Extraskeletal Osteosarcoma
15274,Carcinomatous Component Present,Stage IIC Appendix Carcinoma AJCC v7
15275,Mitotic Activity,Tufted angioma of skin
15276,Monoclonal Langerhans Cells Present,Eosinophilic Granuloma
15277,Unifocal Lesion,Eosinophilic Granuloma
15278,Exophytic Polypoid Lesion,Colon Adenoma with Severe Dysplasia
15279,Epithelial Component Present,Liver and Intrahepatic Biliary Tract Carcinoma
15280,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage III
15281,Low Mitotic Activity,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
15282,Epithelial Component Present,Stage IV Oropharyngeal Carcinoma
15283,Low Grade Lesion,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
15284,Epithelial Component Present,Stage IIIC Breast Cancer AJCC v7
15285,Fibromyxoid Stroma Formation,Nonossifying Fibromyxoid Tumor
15286,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Halo nevus
15287,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
15288,Splenomegaly,Refractory Hairy Cell Leukemia
15289,Eccrine Differentiation,Benign Eccrine Neoplasm
15290,Carcinomatous Component Present,Stage IIA Lung Cancer AJCC v7
15291,Carcinomatous Component Present,Lung squamous cell carcinoma stage II
15292,Vascular Channel Formation,Venous Angioleiomyoma
15293,Fibrotic Stroma Formation,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
15294,Tissue Differentiation Uncertain,Adult Synovial Sarcoma
15295,Epithelial Component Present,Ovarian Papillary Tumor
15296,'Starry-sky' pattern,Colorectal Burkitt Lymphoma
15297,Childhood Lesion,Childhood Ganglioneuroblastoma
15298,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Neoplasm
15299,Recurrent disease,Recurrent Burkitt Lymphoma
15300,Carcinomatous Component Present,Stage II Nasopharyngeal Carcinoma AJCC v6
15301,Carcinomatous Component Present,Vaginal Neuroendocrine Carcinoma
15302,Epithelial Component Present,Labia Majora Carcinoma
15303,Indolent Clinical Course,Benign Skeletal Muscle Neoplasm
15304,Monomorphic Cellular Infiltrate,Atypical Ductal Breast Hyperplasia
15305,Alternative Fascicle (Bundle) Pattern,Leiomyomatosis
15306,Tissue Differentiation Uncertain,Cardiac Synovial Sarcoma
15307,Pregnancy Complications,Stage IA Gestational Trophoblastic Tumor AJCC v7
15308,Macrocystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
15309,Nodular Pattern,Benign Breast Eccrine Spiradenoma
15310,Epithelial Component Present,Squamous Papilloma of the Nasopharynx
15311,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant"
15312,Osseous Differentiation,Extraskeletal Osteosarcoma
15313,Epithelial Component Present,Extrahepatic Bile Duct Carcinoid Tumor
15314,Antoni A Pattern,Benign Esophageal Schwannoma
15315,Hyperchromatism,"Perineurioma, malignant"
15316,Adulthood Lesion,Stage III Indolent Adult Non-Hodgkin Lymphoma
15317,Epithelial Component Present,Cervical Warty Carcinoma
15318,Epithelioid Differentiation,"Epithelioid mesothelioma, malignant"
15319,Epithelial Component Present,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
15320,Carcinomatous Component Present,Cervical Papillary Squamous Cell Carcinoma
15321,Chronic Inflammatory Infiltrate,Recurrent Adult Grade III Lymphomatoid Granulomatosis
15322,Carcinomatous Component Present,Stage I Renal Cell Carcinoma
15323,Malignant Germinomatous Cellular Infiltrate,Spermatocytic seminoma
15324,Carcinomatous Component Present,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7
15325,Epithelial Component Present,Renal Pelvis Carcinoma
15326,Epithelial Component Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
15327,Cutaneous Involvement,Local infection skin/subcut tissue NOS
15328,Immunologic Deficiency Syndromes,Ann Arbor Stage II AIDS-Related Lymphoma
15329,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I
15330,Epithelial Component Present,Squamous cell carcinoma of palate
15331,Mitotic Activity,Brain Stem Glioblastoma
15332,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage II
15333,Indolent Clinical Course,Skin Cavernous Hemangioma
15334,Invasive Lesion,Invasive Malignant Neoplasm
15335,Epithelial Component Present,Sarcomatoid Hepatocellular Carcinoma
15336,Epithelial Component Present,Colorectal Small Cell Neuroendocrine Carcinoma
15337,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage III
15338,Follicular Differentiation,Trichofolliculoma
15339,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Acute monoblastic leukemia
15340,Immunologic Deficiency Syndromes,AIDS-Related Retinopathy
15341,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Erythroid Leukemia
15342,Capillary Sized Vascular Channel Formation,Epithelioid hemangioma of skin
15343,Increased Cellularity Present,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
15344,Adulthood Lesion,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
15345,Microvascular Proliferation,Multifocal Glioblastomas
15346,Carcinomatous Component Present,Vulvar Merkel Cell Carcinoma
15347,Acanthosis,inverted follicular keratosis
15348,Increased Cellularity Present,Cellular Pleomorphic Adenoma
15349,Carcinomatous Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
15350,Edema,Inflammatory Breast Carcinoma
15351,Intraosseous Lesion,Plexiform ameloblastoma
15352,Epithelial Component Present,Adult Craniopharyngioma
15353,Adulthood Lesion,Adult Penile Carcinoma
15354,Childhood Lesion,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q
15355,Epithelial Component Present,"Adenocarcinoma, endocervical type"
15356,Anaplasia,Recurrent Glioblastoma
15357,Childhood Lesion,Childhood Seminoma
15358,Carcinomatous Component Present,Stage IIIC Ovarian Cancer
15359,Pseudo-Psammoma Body Formation,Secretory meningioma
15360,Cartilaginous Differentiation,Chondrosarcoma localised
15361,Increased Cellularity Present,Poorly Differentiated Neuroblastoma
15362,Carcinomatous Component Present,Stage III renal cell cancer
15363,Epithelial Component Present,Stage III renal cell cancer
15364,Recurrent disease,Nasopharyngeal squamous cell carcinoma recurrent
15365,Epithelial Component Present,Vulvar Inverted Follicular Keratosis
15366,Cystic Change,Vulvar Inverted Follicular Keratosis
15367,Carcinomatous Component Present,Serous Endometrial Intraepithelial Carcinoma
15368,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma recurrent
15369,Epithelial Component Present,Stage III Liver Cancer
15370,Intraosseous Lesion,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
15371,Stromal Invasion,FIGO Stage II Ovarian Cancer
15372,Epithelial Component Present,Low Grade Mucoepidermoid Breast Carcinoma
15373,Recurrent Genetic Abnormalities Present,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities
15374,Cystic Change,Ovarian Papillary Cystadenoma
15375,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage II
15376,Adnexal Differentiation,Malignant Germinative Follicular Epithelium Neoplasm
15377,Carcinomatous Component Present,squamous cell carcinoma of salivary gland
15378,Ground Glass Nuclear Inclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
15379,Cutaneous Involvement,Eczema
15380,Heterologous Elements Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements
15381,Well-Circumscribed Lesion,Rectal Traditional Serrated Adenoma
15382,atypia morphology,Borderline Ovarian Transitional Cell Tumor
15383,Epithelial Component Present,Endometrial intraepithelial neoplasia
15384,Anaplasia,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
15385,Adulthood Lesion,Localized Resectable Adult Hepatocellular Carcinoma
15386,Anaplasia,Recurrent Childhood Anaplastic Oligoastrocytoma
15387,Carcinomatous Component Present,Localized Unresectable Adult Hepatocellular Carcinoma
15388,Pseudoencapsulated Mass,Malignant Peripheral Nerve Sheath Tumor
15389,Neuroendocrine Differentiation,Ascending Colon Neuroendocrine Tumor G1
15390,Epithelial Component Present,Maxillary Sinus Adenoid Cystic Carcinoma
15391,Well Differentiated Lesion,Verrucous carcinoma of penis
15392,Calcitonin serum level increased,Childhood Thyroid Gland Medullary Carcinoma
15393,Epithelial Component Present,squamous cell carcinoma of ureter
15394,Well-Circumscribed Lesion,Adenomatous polyp of rectum
15395,Vacuolated Plasma Cells in the Bone Marrow,mu-Chain Disease
15396,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma
15397,Biphasic Pattern,Borderline Ovarian Clear Cell Adenofibroma
15398,Epithelial Component Present,Ampulla of Vater Hepatoid Adenocarcinoma
15399,Necrotic changes (finding),large cell neuroendocrine carcinoma of gallbladder
15400,Duct-Like Structures Present,epithelial-myoepithelial carcinoma of lung
15401,Carcinomatous Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma
15402,Immunologic Deficiency Syndromes,AIDS-Related Malignant Cervical Neoplasm
15403,Perivascular Arrangement of Tumor Cells,Cavernous Angioleiomyoma
15404,Chromogranin A Positive Neoplastic Cells Present,Gallbladder Neuroendocrine Tumor G1
15405,High Mitotic Activity,"Perivascular epithelioid tumor, malignant"
15406,Epithelial Component Present,Ovarian Clear Cell Cystadenofibroma
15407,Primary Lesion,Primary Lung Meningioma
15408,Carcinomatous Component Present,Endometrial Mucinous Adenocarcinoma
15409,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Excess Blasts and Fibrosis
15410,Metastatic Lesion,Metastatic Lobular Breast Carcinoma
15411,Carcinomatous Component Present,Gastric Body Carcinoma
15412,Carcinomatous Component Present,mucoepidermoid carcinoma of floor of mouth
15413,Epithelial Component Present,Bladder Adenocarcinoma
15414,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
15415,Carcinomatous Component Present,mucinous adenocarcinoma of bladder
15416,Mucoid Stroma Formation,mucinous adenocarcinoma of bladder
15417,Hereditary Lesion,Familial Colorectal Cancer Type X
15418,Capillary Sized Vascular Channel Formation,Infantile hemangioma
15419,Fibrotic Stroma Formation,Sarcomatoid Intrahepatic Cholangiocarcinoma
15420,Neuroendocrine Differentiation,Stage IA Merkel Cell Carcinoma AJCC v7
15421,Carcinomatous Component Present,Human Papillomavirus-Related Endocervical Adenocarcinoma
15422,Slow Growing Mass,Papillary craniopharyngioma
15423,In Situ Lesion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
15424,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Dysgerminoma
15425,Benign Cellular Infiltrate,Hemangioma of liver
15426,Eosinophil count raised (finding),Hypereosinophilic syndrome
15427,Cutaneous Involvement,Mycosis fungoides stage II
15428,Indolent Clinical Course,Proliferative fasciitis
15429,Carcinomatous Component Present,Carcinoma of subglottis
15430,Fried-Egg Appearance of the Bone Marrow,Splenic Manifestation of Hairy Cell Leukemia
15431,Pancytopenia,Acute panmyelosis with myelofibrosis
15432,Neuroendocrine Differentiation,Neuroendocrine neoplasm of lung
15433,Epithelial Component Present,Pancreatic Macrocystic Serous Cystadenoma
15434,Metastatic Lesion,Metastatic melanoma
15435,Severe dysplasia,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
15436,More than 10 Mitoses per 10HPF,large cell neuroendocrine carcinoma of lung
15437,Pushing Tumor Margin,Laryngeal verrucous carcinoma stage IV
15438,Lymphoplasmacytic Infiltrate,Splenic Lymphoplasmacytic Lymphoma
15439,Carcinomatous Component Present,Low Grade Broad Ligament Serous Adenocarcinoma
15440,Intraductal Lesion,Noninfiltrating Intraductal Carcinoma
15441,VIP Positive Neoplastic Cells Present,Malignant Vipoma
15442,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor G1
15443,Invasive Lesion,Acinic Cell Breast Carcinoma
15444,Epithelial Component Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1"
15445,Carcinomatous Component Present,Stage III Nasal Cavity Cancer AJCC v6 and v7
15446,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,M5b Acute differentiated monocytic leukemia
15447,Dysplasia,Carcinoma in situ of fallopian tube
15448,Increased Cellularity Present,Cellular angiofibroma
15449,In Situ Lesion,Bowen's Disease
15450,Carcinomatous Component Present,Adenocarcinoma in situ in a polyp
15451,Epithelial Component Present,Adenocarcinoma in situ in a polyp
15452,Carcinomatous Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant"
15453,Therapy-Related Toxicity,Radiation-Related Sarcoma
15454,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
15455,Hereditary Lesion,Hereditary Male Breast Carcinoma
15456,Epithelial Component Present,Pancreatic Serous Neoplasm
15457,Well-Circumscribed Lesion,Tibial adamantinoma
15458,Plasma cell inflammation,Central Nervous System Inflammatory Myofibroblastic Tumor
15459,Epithelial Component Present,Pancreatic Intraductal Papillary-Mucinous Adenoma
15460,Hyaline Cartilage Differentiation,Juxtacortical chondrosarcoma
15461,Favorable Clinical Outcome,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
15462,Epithelial Component Present,Cerebellar Paraganglioma
15463,Plasma cell inflammation,Gastric Inflammatory Myofibroblastic Tumor
15464,Tubular Pattern,Small Intestinal Tubular Adenoma
15465,Primary Lesion,Mycosis fungoides recurrent
15466,Carcinomatous Component Present,Intraepithelial Squamous Cell Carcinoma
15467,Exophytic Polypoid Lesion,Gastric Non-Neoplastic Polyp
15468,Microvascular Proliferation,Childhood Glioblastoma
15469,Cutaneous Involvement,Extraocular Cutaneous Sebaceous Carcinoma
15470,Low Mitotic Activity,Ampulla of Vater Gangliocytic Paraganglioma
15471,Blasts of Mixed Phenotype Present,Acute bilineal leukemia
15472,Invasive Lesion,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation
15473,Dysplasia,Condyloma Acuminatum with Dysplasia
15474,Epithelial Component Present,Adenosquamous Bile Duct Carcinoma
15475,Vascular Channel Formation,Superficial angiomyxoma
15476,Carcinomatous Component Present,Stage 0 Breast Cancer AJCC v6 and v7
15477,In Situ Lesion,Stage 0 Breast Cancer AJCC v6 and v7
15478,Cutaneous Involvement,Desmoplastic trichilemmoma
15479,Myxoid Stroma Formation,Vulvar Angiomyxoma
15480,Favorable Clinical Outcome,Urticaria Pigmentosa
15481,Immunologic Deficiency Syndromes,Immunodeficiency-associated Burkitt's lymphoma
15482,Nuclear Atypia,Childhood Giant Cell Glioblastoma
15483,Hereditary Lesion,Familial Isolated Hyperparathyroidism
15484,Diffuse Lesion,"Diffuse midline glioma, point mutation K27M in histone H3"
15485,Intermediate Grade Lesion,Malignant carcinoid tumor of lung
15486,atypia morphology,Serous papillary cystic tumor of borderline malignancy
15487,Carcinomatous Component Present,Stage IVB Vulvar Cancer AJCC v6 and v7
15488,Epithelial Component Present,Recurrent Adult Hepatocellular Carcinoma
15489,Cystic Change,Testicular Brenner Tumor
15490,Intramucosal Lesion,Adenoma of the Colon with Intramucosal Adenocarcinoma
15491,Epithelial Component Present,Pigmented Basal Cell Carcinoma
15492,Carcinomatous Component Present,Ceruminous adenocarcinoma
15493,Exophytic Polypoid Lesion,Villous adenoma of colon
15494,Adulthood Lesion,Adult Teratoma
15495,Carcinomatous Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v7
15496,Epithelial Component Present,Squamous cell carcinoma of cornea
15497,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Carcinoma, Endometrioid"
15498,Nuclear pleomorphism,Uterine Corpus Bizarre Leiomyoma
15499,Low Mitotic Activity,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
15500,Neuroendocrine Differentiation,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
15501,Secondary Lesion,Adenocarcinoma of the prostate metastatic
15502,Epithelial Component Present,Anal Extramucosal (Perianal) Adenocarcinoma
15503,Tissue Differentiation Uncertain,Perivascular Epithelioid Cell Neoplasms
15504,Diffuse Pattern,"Malignant lymphoma centroblastic, diffuse"
15505,Epithelial Component Present,Brenner Tumor
15506,Primary Lesion,Brain Stem Intraparenchymal Clear Cell Meningioma
15507,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia
15508,'Starry-sky' pattern,Methotrexate-Associated Burkitt Lymphoma
15509,Tissue Differentiation Uncertain,Vulvar Alveolar Soft Part Sarcoma
15510,Recurrent disease,Recurrent Childhood Non-Hodgkin Lymphoma
15511,Carcinomatous Component Present,Gastric Neuroendocrine Carcinoma
15512,Low Mitotic Activity,Ovarian Low Grade Endometrioid Stromal Sarcoma
15513,Oligodendroglial Component Present,Childhood Anaplastic Oligoastrocytoma
15514,Metastatic Lesion,Peripheral neuroepithelioma of bone metastatic
15515,Metastatic/Recurrent Disease,Desmoplastic Small Round Cell Tumor
15516,Epithelial Component Present,"Transitional cell papilloma, inverted"
15517,Metastatic/Recurrent Disease,Adult Clear Cell Sarcoma of Soft Parts
15518,Papillary Pattern,Stage 0a Renal Pelvis Cancer AJCC v7
15519,Moderately Differentiated Lesion,Grade 2 Rectal Adenocarcinoma
15520,Carcinomatous Component Present,Mucinous adenocarcinoma of appendix
15521,Dysplasia,Gardner Syndrome
15522,Recurrent disease,Melanoma recurrent
15523,Childhood Lesion,Childhood Infratentorial Ependymoma
15524,Epithelial Component Present,Colorectal Micropapillary Adenocarcinoma
15525,Epithelial Component Present,Grade 1 Rectal Adenocarcinoma
15526,Epithelial Component Present,Benign Carotid Body Paraganglioma
15527,Dysplasia,Flat Ductal Epithelial Atypia of the Breast
15528,Epithelial Component Present,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8"
15529,Childhood Lesion,Childhood Grade III Lymphomatoid Granulomatosis
15530,Cutaneous Involvement,Epidermodysplasia Verruciformis
15531,Hyperplastic Tissue Present,Parathyroid hyperplasia
15532,Immunologic Deficiency Syndromes,AIDS-Related Idiopathic Thrombocytopenic Purpura
15533,Honeycomb Pattern,Well Differentiated Oligodendroglioma
15534,Well Differentiated Lesion,Gastric Carcinoid Tumor
15535,Anaplasia,Recurrent Childhood Gliosarcoma
15536,Epithelial Component Present,Moderate pancreatic duct dysplasia
15537,Recurrent disease,Chondrosarcoma recurrent
15538,Cutaneous Involvement,Herpes simplex dermatitis
15539,Carcinomatous Component Present,Submandibular Gland Squamous Cell Carcinoma
15540,Primary Lesion,Childhood Cerebral Astrocytoma
15541,Non-Invasive Lesion,Inverted urothelial papilloma
15542,Cutaneous Involvement,Atrophic condition of skin
15543,Vascular Channel Formation,Capillary hemangioma of eyelid
15544,Diffuse Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
15545,Obesity,Inflammatory Hepatocellular Adenoma
15546,Primary Lesion,Stage IIB Osteosarcoma AJCC v7
15547,Nuclear Grooves,Papillary thyroid carcinoma
15548,Bone Marrow Dysplasia Present,Refractory anemia with ringed sideroblasts
15549,Hyaline Cartilage Differentiation,Enchondromatosis
15550,Secondary Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
15551,Nuclear pleomorphism,Hepatocellular Small Cell Change
15552,Epithelial Component Present,Basal cell carcinoma - follicular
15553,Carcinomatous Component Present,Pericardial Carcinomatosis
15554,Osseous Differentiation,Breast Extraskeletal Osteosarcoma
15555,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation
15556,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Melanocytic Nevus
15557,Severe dysplasia,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
15558,Epithelial Component Present,Acinar cell tumor
15559,Epithelial Component Present,Stage IIIb Penile Cancer AJCC v7
15560,Adulthood Lesion,adult nasal type extranodal NK/T-cell lymphoma
15561,Epithelial Component Present,Stage IIB Prostate Cancer AJCC v7
15562,atypia morphology,Atypical Lobular Breast Hyperplasia
15563,Epithelial Component Present,Adenosquamous carcinoma
15564,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v7 Stage
15565,Papillary Pattern,Papillary Lung Adenocarcinoma
15566,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma
15567,Epithelial Component Present,"Carcinoma, diffuse type"
15568,Mixed Cellular Population,Malignant Mixed Tumor of the Major Salivary Gland
15569,Epithelial Component Present,Stage IIA1 Cervical Cancer AJCC v7
15570,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis
15571,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7
15572,Adnexal Differentiation,Pilar-Associated Mesenchyme Neoplasm
15573,Nodular Pattern,Ann Arbor Stage I Follicular Lymphoma
15574,Childhood Lesion,Recurrent Childhood Pilocytic Astrocytoma
15575,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Microadenoma
15576,Tissue Differentiation Uncertain,Cervical Alveolar Soft Part Sarcoma
15577,Papillary Pattern,Anal Canal Squamous Papilloma
15578,Epithelial Component Present,Penile intraepithelial neoplasia
15579,Stromal Invasion,Malignant Brenner Tumor
15580,Epithelial Component Present,Stage I Cervical Cancer AJCC v6 and v7
15581,Infiltrating Tumor Margins Present,Low Grade Endometrial Stromal Sarcoma
15582,Well-Circumscribed Lesion,Central Nervous System Rhabdomyoma
15583,Swelling,Subungual exostoses
15584,Carcinomatous Component Present,mucinous adenocarcinoma of gallbladder
15585,Antoni A Pattern,Sympathetic Schwannoma
15586,Carcinomatous Component Present,Bladder Papillary Urothelial Carcinoma
15587,Papillary Pattern,Renal Pelvis Urothelial Papilloma
15588,Nodular lesions,Focal nodular hyperplasia of liver
15589,In Situ Lesion,Stage 0 Oropharyngeal Carcinoma
15590,Carcinomatous Component Present,mucinous adenocarcinoma of cervix
15591,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma with spindle cell metaplasia
15592,Microvascular Proliferation,Childhood Pilocytic Astrocytoma
15593,Epithelial Component Present,Type 1 Papillary Renal Cell Carcinoma
15594,Pregnancy Complications,Placenta Accreta
15595,Pregnancy Complications,Benign neoplasm of placenta
15596,Neuroendocrine Differentiation,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
15597,Synchronous Lesion,Synchronous Multifocal Osteosarcoma
15598,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma
15599,Adulthood Lesion,Recurrent Adult Liver Carcinoma
15600,Capillary Sized Vascular Channel Formation,Cerebellar hemangioblastoma
15601,Recurrent disease,Recurrent Childhood Kidney Neoplasm
15602,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monoblastic Leukemia
15603,Multilocular Lesion,Juvenile granulosa cell tumor
15604,Carcinomatous Component Present,Crohn Disease-Associated Colorectal Adenocarcinoma
15605,Carcinomatous Component Present,Squamous cell carcinoma of floor of mouth
15606,Epithelial Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing"
15607,Epithelial Component Present,Ovarian Clear Cell Cystadenocarcinoma
15608,Splenomegaly,"Leukemia, Prolymphocytic, B-Cell"
15609,Epithelial Component Present,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
15610,Epithelial Component Present,"Squamous cell carcinoma, microinvasive"
15611,Anaplasia,Grade III Childhood Astrocytoma
15612,High Grade Lesion,Glioblastoma by Gene Expression Profile
15613,Diffuse Pattern,Glioblastoma by Gene Expression Profile
15614,Junctional Proliferation,Junctional nevus
15615,Osseous Differentiation,Extraskeletal osteosarcoma recurrent
15616,Ground Glass Nuclear Inclusion,Oncocytic Variant Thyroid Gland Papillary Carcinoma
15617,Hereditary Lesion,Rhabdoid tumor predisposition syndrome
15618,Gastric-Type Epithelial Differentiation,Pyloric Gland Adenoma
15619,Lytic lesion,Desmoplastic fibroma
15620,Adulthood Lesion,Adult Subependymal Giant Cell Astrocytoma
15621,Low Grade Lesion,Childhood Epithelioid Hemangioendothelioma
15622,Nuclear Atypia,Secondary Supratentorial Anaplastic Astrocytoma
15623,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Heterologous Type"
15624,Bone Marrow Dysplasia Present,Secondary Myelodysplastic Syndrome
15625,Adulthood Lesion,Adult Anaplastic (Malignant) Meningioma
15626,Carcinomatous Component Present,Rectosigmoid Adenocarcinoma
15627,Anaplasia,High grade surface osteosarcoma
15628,Infiltrative Growth Pattern,"Anaplastic Astrocytoma, IDH-Wildtype"
15629,Slow Growing Mass,Clivus Chondroid Chordoma
15630,Cutaneous Involvement,Porokeratotic eccrine ostial and dermal duct nevus
15631,Metastatic Lesion,Secondary malignant neoplasm of kidney
15632,Childhood Lesion,Childhood Testicular Embryonal Carcinoma
15633,Pagetoid Proliferation,Superficial spreading malignant melanoma of skin
15634,Primary Lesion,Ependymoma of brain stem
15635,Infiltrative Growth Pattern,Gemistocytic astrocytoma
15636,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,carcinosarcoma of fallopian tube
15637,Epithelial Component Present,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
15638,Intracellular Accumulation of Lipids,Pleomorphic Xanthoastrocytoma
15639,Childhood Lesion,Childhood Acute Erythroid Leukemia
15640,Multifocal Lesion,Encephalocraniocutaneous lipomatosis
15641,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Acantholytic Variant"
15642,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Endometrioid Adenocarcinoma
15643,Metastatic Lesion,Head and neck cancer metastatic
15644,Necrotic changes (finding),Giant Cell Glioblastoma
15645,Indolent Clinical Course,Vaginal Rhabdomyoma
15646,Fibrosis,Breast Fibrocystic Disease
15647,Epithelial Component Present,Hepatoid adenocarcinoma
15648,Epithelial Component Present,External Ear Carcinoma
15649,Epithelial Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
15650,Epithelial Component Present,Posterior Pharyngeal Wall Squamous Cell Carcinoma
15651,Childhood Lesion,Childhood Rectal Carcinoma
15652,Geographic Necrosis,Childhood Central Nervous System Embryonal Carcinoma
15653,Geographic Necrosis,Testicular embryonal carcinoma stage III
15654,Epithelial Component Present,epithelial-myoepithelial carcinoma of salivary gland
15655,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern"
15656,Childhood Lesion,Childhood Ovarian Nongerminomatous Germ Cell Tumor
15657,Secondary Lesion,Metastatic Carcinoma
15658,Carcinomatous Component Present,Gastric Small Cell Carcinoma
15659,Thick-Walled Hyalinized Vessels Present,Jugular Foramen Schwannoma
15660,Indolent Clinical Course,Lipoma
15661,Secondary Lesion,Metastases to adrenals
15662,Koilocytotic atypia,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
15663,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
15664,Severe dysplasia,Adenocarcinoma in situ in adenomatous polyp
15665,Epithelial Component Present,Stage IB Vulvar Cancer AJCC v7
15666,Therapy-Related Toxicity,Therapy-related myelodysplastic syndrome
15667,CD30-Positive Neoplastic Cells Present,Adult Anaplastic Large Cell Lymphoma
15668,Cutaneous Involvement,Angioma serpiginosum
15669,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
15670,Epithelial Component Present,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
15671,Multilocular Lesion,Peritoneal cystic mesothelioma
15672,Epithelial Component Present,Borderline Ovarian Transitional Cell Tumor
15673,Carcinomatous Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
15674,Carcinomatous Component Present,BCLC Stage A Hepatocellular Carcinoma
15675,Epithelial Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
15676,Vascular Channel Formation,"Hemangioma, Intramuscular"
15677,Stromal Invasion,Malignant Ovarian Transitional Cell Tumor
15678,Epithelial Component Present,Prostatic Intraepithelial Neoplasias
15679,Diffuse Pattern,Anaplastic large B-cell lymphoma
15680,Mitotic Activity,Cerebellar Glioblastoma
15681,Therapy-Related Toxicity,Kaposi Sarcoma Related to Immunosuppressive Treatment
15682,Unresectable Mass,Localized Unresectable Adult Hepatocellular Carcinoma
15683,Recurrent disease,Recurrent Childhood Anaplastic Oligodendroglioma
15684,Monomorphic Cellular Infiltrate,Undifferentiated round cell sarcoma
15685,Adulthood Lesion,Stage II Adult Burkitt Lymphoma
15686,Epithelial Component Present,Appendix Intraepithelial Neoplasia
15687,Single Cell Necrosis,Stage IB Merkel Cell Carcinoma AJCC v7
15688,Cutaneous Involvement,Benign fibrohistiocytic neoplasm of skin
15689,Tissue Differentiation Uncertain,Vulvar Proximal-Type Epithelioid Sarcoma
15690,Exophytic Papillary Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
15691,Carcinomatous Component Present,Synchronous Bilateral Breast Carcinoma
15692,Epithelial Component Present,Stage II Lip Cancer AJCC v6 and v7
15693,Non-Malignant Cellular Infiltrate,Benign Lymphoproliferative Disorder
15694,Indolent Clinical Course,Epicardial Lipoma
15695,Childhood Lesion,Childhood Gastric Carcinoma
15696,Indolent Clinical Course,Liver Leiomyoma
15697,Carcinomatous Component Present,Clear Cell Hepatocellular Carcinoma
15698,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Cystadenofibroma
15699,Congenital Lesion,Congenital kyphosis
15700,Tissue Differentiation Uncertain,Sclerosing PEComa
15701,Diffuse Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma
15702,Extensive Stage Lesion,Pleural mesothelioma malignant advanced
15703,Ineffective hematopoiesis,Refractory Thrombocytopenia
15704,High Mitotic Activity,Malignant Ovarian Granulosa Cell Tumor
15705,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II
15706,Epithelial Component Present,Krukenberg Tumor
15707,Widely Invasive Lesion,Widely Invasive Thymoma
15708,Dysplasia,Small Intestinal Low Grade Intraepithelial Neoplasia
15709,Neuroendocrine Differentiation,Neuroendocrine cervical carcinoma
15710,Dysplasia,Adenomatous polyp of colon
15711,Metastatic Lesion,Poor Prognosis Metastatic Gestational Trophoblastic Tumor
15712,Acanthosis,Laryngeal verrucous carcinoma
15713,Necrotic changes (finding),gliosarcoma
15714,Epithelial Component Present,Small intestine carcinoma stage IV
15715,Recurrent disease,Recurrent Peripheral Primitive Neuroectodermal Tumor
15716,Thick-Walled Hyalinized Vessels Present,Trigeminal schwannoma
15717,Increased Cellularity Present,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
15718,Carcinomatous Component Present,Spindle cell squamous cell carcinoma
15719,Pseudopapillary Pattern,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
15720,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Acute Erythroblastic Leukemia
15721,Well Differentiated Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
15722,Carcinomatous Component Present,Laryngeal squamous cell carcinoma recurrent
15723,Carcinomatous Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma
15724,Mesenchymal Metaplasia of Malignant Cells Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma
15725,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
15726,Hyalinized Stroma Formation,Solitary fibrous tumor
15727,Diffuse Lesion,Breast Papillomatosis
15728,Nodular Pattern,follicular lymphoma of spleen
15729,Monocytosis,Chronic Myelomonocytic Leukemia with Eosinophilia
15730,Nodular lesions,Thyroid Gland Lipoadenoma
15731,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
15732,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic
15733,Metastatic Lesion,Metastatic Malignant Neoplasm to the Cervix
15734,Epithelial Component Present,Rectal Tubular Adenoma
15735,Immunologic Deficiency Syndromes,Hyperacute allograft rejection
15736,Papillary Pattern,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
15737,Chromogranin A Positive Neoplastic Cells Present,Metastatic Breast Carcinoid Tumor
15738,Borderline Lesion,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor
15739,Carcinomatous Component Present,Small Intestinal Undifferentiated Carcinoma
15740,Epithelial Component Present,Ectopic Cervical Thymoma
15741,High Grade Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
15742,Exophytic Papillary Lesion,papillary squamous cell carcinoma of larynx
15743,Hyperplastic Tissue Present,Simple Endometrial Hyperplasia without Atypia
15744,Therapy-Related Toxicity,Transplant-Related Bladder Urothelial Carcinoma
15745,Carcinomatous Component Present,Stage IV Renal Cell Cancer AJCC v7
15746,Dysplasia,Adenoma of small intestine
15747,Neuronal Differentiation,Dysembryoplastic neuroepithelial tumor
15748,Epithelial Component Present,Stage IIIA Colon Cancer AJCC v7
15749,Encapsulated Mass,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
15750,Epithelial Component Present,Adenocarcinoma with osseous metaplasia
15751,Neuroendocrine Differentiation,Strumal carcinoid
15752,Recurrent disease,Recurrent Gastrointestinal Stromal Tumor
15753,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
15754,Carcinomatous Component Present,Oropharyngeal Basaloid Carcinoma
15755,Localized Hydropic Villous Change,"Hydatidiform Mole, Partial"
15756,Increased Cellularity Present,Neuroblastoma of brain
15757,Carcinomatous Component Present,"Carcinoma, Transitional Cell"
15758,Severe dysplasia,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
15759,Epithelial Component Present,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
15760,Dual Population of Bone Marrow Blasts Present,Acute bilineal leukemia
15761,Papillary Pattern,tubulopapillary adenoma of gallbladder
15762,Epithelial Component Present,Thymoma malignant noninvasive
15763,Chronic lymphocytic inflammation,Histiocytoid hemangioma
15764,Slow Growing Mass,Skull Base Chordoma
15765,Carcinomatous Component Present,Human Papillomavirus-Related Squamous Cell Carcinoma
15766,Cutaneous Involvement,Epidermolysis Bullosa
15767,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
15768,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
15769,Complex Glandular Pattern,Atypical polypoid adenomyoma
15770,S-100-Positive Neoplastic Cells Present,Clear-Cell Myomelanocytic Tumors
15771,Severe dysplasia,Carcinoma in situ of prostate
15772,Unclassifiable Lesion,"NK-Cell Lymphoma, Unclassifiable"
15773,Hyperkeratosis,Desmoplastic trichilemmoma
15774,Ground Glass Nuclear Inclusion,Papillary Thyroid Microcarcinoma
15775,Ground Glass Nuclear Inclusion,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
15776,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells
15777,Monoclonal Cellular Population Present,Urticaria Pigmentosa
15778,Hydropic Villous Change,Hydatidiform Mole
15779,Epithelial Component Present,Squamous intraepithelial neoplasia grade 2
15780,Fibrovascular Stalks Present,Gallbladder Papillary Biliary Intraepithelial Neoplasia
15781,"Amorphus, Eosinophilic, and Acellular Deposit",Amyloidosis
15782,Dysplasia,Mild epithelial dysplasia
15783,Well-Circumscribed Lesion,Sebaceous adenoma
15784,Cutaneous Involvement,Old Burn Scar-Related Cutaneous Melanoma
15785,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma
15786,Dysplasia,Villous adenoma of colon
15787,Epithelial Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v7
15788,Organoid Pattern,Adult Alveolar Soft Part Sarcoma
15789,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome
15790,Cutaneous Involvement,Non-neoplastic nevus of skin
15791,Immunosuppression-Related Post-Transplant Toxicity,Delayed Graft Function
15792,Invasive Lesion,Secretory breast carcinoma
15793,Storiform Growth Pattern,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
15794,Adulthood Lesion,Stage I Adult Burkitt Lymphoma
15795,Tubular Pattern,Appendix Tubular Adenoma
15796,Therapy-Related Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
15797,Epithelial Component Present,Hereditary Diffuse Gastric Adenocarcinoma
15798,Perivascular fibrosis,Hodgkin's disease nodular sclerosis recurrent
15799,Mucoid Stroma Formation,Mucinous adenocarcinoma gastric
15800,Epithelial Component Present,Cervical Squamous Papilloma
15801,Low Mitotic Activity,Pancreatic ACTH-Producing Neuroendocrine Tumor
15802,Refractory Disease,Hodgkin's disease nodular sclerosis refractory
15803,Carcinomatous Component Present,Mixed Ductal-Endocrine Carcinoma
15804,Adulthood Lesion,Adult Acute Myeloid Leukemia with Minimal Differentiation
15805,Carcinomatous Component Present,"Adenocarcinoma, Tubular"
15806,Pseudorosette Formation,Rosette-forming glioneuronal tumor of the fourth ventricle
15807,Carcinomatous Component Present,Merkel cell carcinoma
15808,Single Cell Necrosis,Merkel cell carcinoma
15809,Fibrotic Stroma Formation,Borderline Ovarian Endometrioid Adenofibroma
15810,Epithelial Component Present,Small Intestinal Neuroendocrine Carcinoma
15811,Epithelial Component Present,Anal Verrucous Carcinoma
15812,Exophytic Papillary Lesion,Anal Verrucous Carcinoma
15813,Carcinomatous Component Present,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
15814,Carcinomatous Component Present,Small Intestinal Large Cell Neuroendocrine Carcinoma
15815,Epithelial Component Present,Small Intestinal Large Cell Neuroendocrine Carcinoma
15816,Biphasic Pattern,Childhood Brain Stem Gliosarcoma
15817,Childhood Lesion,Recurrent Childhood Glioblastoma
15818,High Grade Lesion,Stage IIIA Lung Small Cell Carcinoma AJCC v7
15819,Epithelial Component Present,Esophageal carcinoma recurrent
15820,Epithelial Component Present,Small Intestinal Neuroendocrine Tumor G2
15821,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Tumor G2
15822,Carcinomatous Component Present,Anal margin basal cell carcinoma
15823,In Situ Lesion,Adenocarcinoma in situ in tubulovillous adenoma
15824,Cutaneous Involvement,"Dermatitis, Allergic Contact"
15825,Exophytic Polypoid Lesion,Skin tag
15826,Cutaneous Involvement,Mucoepidermoid carcinoma of skin
15827,'Starry-sky' pattern,Stage III Childhood Burkitt Lymphoma
15828,Epithelial Component Present,Bladder squamous cell carcinoma stage 0
15829,Carcinomatous Component Present,Invasive Ductal and Invasive Lobular Breast Carcinoma
15830,Childhood Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
15831,Primary Lesion,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent
15832,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage IV
15833,Recurrent disease,B-cell small lymphocytic lymphoma recurrent
15834,Perivascular Arrangement of Tumor Cells,Glomangiomatosis
15835,Epithelial Component Present,Functioning Pancreatic Neuroendocrine Tumor
15836,Dysplasia,Squamous Lung Dysplasia
15837,Neuronal Differentiation,Desmoplastic infantile ganglioglioma
15838,Indolent Clinical Course,Esophageal hemangioma
15839,Cutaneous Involvement,Stage III Cutaneous Melanoma AJCC v6
15840,Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia
15841,Low Mitotic Activity,Classic Congenital Mesoblastic Nephroma
15842,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
15843,Low Mitotic Activity,Small Intestinal Neuroendocrine Tumor
15844,Ineffective hematopoiesis,Treatment related acute myeloid leukaemia
15845,Secondary Lesion,Pleural Carcinomatosis
15846,Matrical Differentiation,Basal cell carcinoma - follicular
15847,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,de novo Myelodysplastic Syndrome
15848,Epithelial Component Present,Bile duct mucinous adenocarcinoma
15849,Metastatic Lesion,Adenocarcinoma of Unknown Primary
15850,Carcinomatous Component Present,Stage IIB Pancreatic Cancer AJCC v6 and v7
15851,Carcinomatous Component Present,Gastrointestinal carcinoma in situ
15852,Carcinomatous Component Present,Sweat gland adenocarcinoma
15853,Erythema,Inflammatory carcinoma of breast stage III
15854,Epithelial Component Present,Mucinous adenocarcinoma of colon
15855,Epithelial Component Present,Cervical Basaloid Carcinoma
15856,Adulthood Lesion,Stage IIB Adult Soft Tissue Sarcoma AJCC v7
15857,Indolent Clinical Course,Conventional Lipoma
15858,Exophytic Polypoid Lesion,Appendix Mucinous Cystadenoma
15859,Tissue Differentiation Uncertain,Peritoneal Desmoplastic Small Round Cell Tumor
15860,Mixed Cellular Population,Mixed Oligodendroglioma-Astrocytoma
15861,Dyskeratosis,Warty dyskeratoma
15862,Metastatic/Recurrent Disease,Intimal sarcoma
15863,Anaplasia,Anaplastic Oligoastrocytoma
15864,Nuclear Molding,Small cell lung cancer recurrent
15865,Dysplasia,High Grade Corneal Intraepithelial Neoplasia
15866,Spindle Cell Component Present,"Synovial sarcoma, spindle cell"
15867,Papillary Pattern,Thymic Papillary Adenocarcinoma
15868,Neuronal Differentiation,Cerebellar Liponeurocytoma
15869,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Ovarian Teratoma
15870,Extensive Stage Lesion,Advanced Favorable Hodgkin Lymphoma
15871,Rapidly Enlarging Mass,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
15872,Infiltrating Tumor Margins Present,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
15873,Epithelial Component Present,Bile Duct Biliary Intraepithelial Neoplasia
15874,Epithelial Component Present,Dysplasia of anus
15875,Neuroendocrine Differentiation,Malignant Bladder Paraganglioma
15876,Epithelial Component Present,Recurrent Adrenal Cortex Carcinoma
15877,Mitotic Activity,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7
15878,Indolent Clinical Course,Fetal rhabdomyoma
15879,Epithelial Component Present,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7
15880,Skin Papule,Trichoepithelioma
15881,Increased Cellularity Present,Anaplastic astrocytoma
15882,Adulthood Lesion,Adult T Acute Lymphoblastic Leukemia
15883,Carcinomatous Component Present,Blepharal carcinoma
15884,Stromal Invasion,serous surface papillary carcinoma of ovary
15885,Mixed Cellular Population,Fallopian Tube Serous Adenofibroma
15886,Splenomegaly,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
15887,Mixed Cellular Population,Mixed cell adenoma
15888,Recurrent disease,Recurrent Central Nervous System Neoplasm
15889,Primary Lesion,Pilocytic astrocytoma of cerebellum
15890,Carcinomatous Component Present,Ghost Cell Odontogenic Carcinoma
15891,Cartilaginous Differentiation,Bizarre parosteal osteochondromatous proliferation
15892,CD56-Positive Neoplastic Cells Present,Nasal Type Extranodal NK/T-Cell Lymphoma
15893,Tissue Differentiation Uncertain,Pleomorphic hyalinizing angiectatic tumor of soft tissue
15894,Epithelial Component Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
15895,Carcinomatous Component Present,Stage IVA Rectal Cancer AJCC v7
15896,Slow Growing Mass,Pilocytic Astrocytoma
15897,Carcinomatous Component Present,Low Grade Fallopian Tube Serous Adenocarcinoma
15898,Carcinomatous Component Present,Stage III Oropharyngeal Carcinoma AJCC v7
15899,Fried-Egg Appearance of the Bone Marrow,Refractory Hairy Cell Leukemia
15900,Secondary Lesion,Breast Carcinoma Metastatic in the Lung
15901,Hemorrhagic,Soft Tissue Angiosarcoma
15902,Epithelial Component Present,Carcinoma breast stage I
15903,Lobulated Growth Pattern,Pyogenic granuloma of oral mucosa
15904,Pain,Giant Cell Lesion of Small Bones
15905,Swelling,Giant Cell Lesion of Small Bones
15906,Pseudostratified Tumor Cells Present,Papillary renal cell carcinoma type 2
15907,Carcinomatous Component Present,Stage II Breast Cancer AJCC v6 and v7
15908,Cystic Change,Anterior Tongue Mucoepidermoid Carcinoma
15909,Metastatic Lesion,Metastatic Neoplasm to the Placenta
15910,Osseous Differentiation,Asynchronous Multifocal Osteosarcoma
15911,Recurrent disease,Osteosarcoma recurrent
15912,Epithelial Component Present,Stage I Esophageal Cancer
15913,Malignant Germinomatous Cellular Infiltrate,Seminoma
15914,Non-Hereditary Lesion,Vulvar Acquired Melanocytic Nevus
15915,Epithelial Component Present,Stage I Merkel Cell Carcinoma AJCC v7
15916,Hyaline Cartilage Differentiation,"Chondrosarcoma, Clear Cell"
15917,Well Differentiated Hyaline Cartilage Present,"Chondrosarcoma, Clear Cell"
15918,Epithelial Component Present,Stage IV Esophagus Carcinoma
15919,Refractory Disease,Adult T-cell lymphoma/leukemia refractory
15920,High Mitotic Activity,Small cell lung cancer extensive stage
15921,Epithelial Component Present,Stage I Adrenal Cortex Carcinoma AJCC v7
15922,Well-Circumscribed Lesion,Tubular adenoma of breast
15923,Indolent Clinical Course,Anal Leiomyoma
15924,Radiation Sickness,Radiation-induced disorder
15925,Mixed Cellular Population,Breast Complex Fibroadenoma
15926,Adulthood Lesion,Adult Liposarcoma
15927,Carcinomatous Component Present,Stage IB Distal Bile Duct Cancer AJCC v7
15928,Adulthood Lesion,Stage III Adult Soft Tissue Sarcoma AJCC v7
15929,Pregnancy Complications,Stage IIA Gestational Trophoblastic Tumor AJCC v7
15930,Carcinomatous Component Present,Stage IIA Distal Bile Duct Cancer AJCC v7
15931,Absence of Invasion,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
15932,Low Grade Lesion,Cardiac Epithelioid Hemangioendothelioma
15933,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7
15934,Infiltrative Growth Pattern,Diffuse Astrocytoma
15935,Secondary Lesion,Secondary malignant neoplasm of ureter
15936,Indolent Clinical Course,Nodular tenosynovitis
15937,Hyalinized Stroma Formation,Nodular tenosynovitis
15938,Recurrent disease,Malignant neoplasm of duodenum recurrent
15939,Infiltrative Growth Pattern,"Fibromatosis, Abdominal"
15940,Complex Glandular Pattern,Uterine Corpus Atypical Polypoid Adenomyoma
15941,Epithelial Component Present,Gastric Gastrin-Producing Neuroendocrine Tumor
15942,Spindle Cell Metaplasia of Malignant Cells Present,adenocarcinoma of breast with spindle cell metaplasia
15943,Epithelial Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7
15944,Monophasic Pattern,Monophasic Synovial Sarcoma
15945,Multinodular Mass,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
15946,Refractory Disease,Splenic marginal zone lymphoma refractory
15947,Adulthood Lesion,Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma
15948,Solitary mass,Clivus Chondroid Chordoma
15949,Epithelial Component Present,benign endometrioid tumor of ovary
15950,Monomorphic Cellular Infiltrate,Ependymoma of brain stem
15951,High Grade Lesion,Breast Rhabdomyosarcoma
15952,Non-Invasive Lesion,Bladder papilloma
15953,Well-Circumscribed Lesion,Stage I Kidney Wilms Tumor
15954,Carcinomatous Component Present,Stage I Hilar Cholangiocarcinoma AJCC v7
15955,Epithelial Component Present,Thyroid carcinoma
15956,Fibrotic Stroma Formation,Pancreatic Hepatoid Adenocarcinoma
15957,Exophytic Polypoid Lesion,Endometrial Polyp
15958,Carcinomatous Component Present,Uterine Ligament Serous Adenocarcinoma
15959,Low Mitotic Activity,Stage IV Appendix Neuroendocrine Tumor AJCC v7
15960,Epithelial Component Present,Uterine Ligament Mucinous Adenocarcinoma
15961,Tissue Differentiation Uncertain,Ventricular myxoma
15962,Carcinomatous Component Present,Giant cell carcinoma of lung
15963,Indolent Clinical Course,Benign Mediastinal Soft Tissue Neoplasm
15964,Splenomegaly,"T-Cell Prolymphocytic Leukemia, Small Cell Variant"
15965,Squamoid Differentiation,Acanthomatous ameloblastoma
15966,Tissue Differentiation Uncertain,Lymphangiomyoma
15967,Slow Growing Mass,Adult Pilocytic Astrocytoma
15968,Carcinomatous Component Present,Hereditary Fallopian Tube Carcinoma
15969,Sarcomatous Component Present,Pleuropulmonary blastoma type II
15970,Papillary Pattern,Plantar Verrucous Skin Carcinoma
15971,Epithelial Component Present,Superior Sulcus Lung Carcinoma
15972,Anaplasia,Adult Brain Stem Gliosarcoma
15973,Cystic Change,Mucoepidermoid Breast Carcinoma
15974,Metastatic/Recurrent Disease,Malignant Uterine Corpus PEComa
15975,Desmoplastic Stroma Formation,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin
15976,Regional Disease,Regional Adrenal Gland Pheochromocytoma
15977,Nuclear pleomorphism,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
15978,Dysplasia,Squamous Cell Carcinoma In Situ of the Nipple
15979,Glandular Differentiation,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation
15980,Epithelial Component Present,Stage I Carcinoma of Penis
15981,Cutaneous Involvement,"Basal cell carcinoma, micronodular"
15982,Cystic Change,Low Grade Mucoepidermoid Breast Carcinoma
15983,Cutaneous Involvement,Dysplastic Nevus
15984,Low Mitotic Activity,Well Differentiated Pancreatic Endocrine Tumor
15985,Childhood Lesion,Stage I Childhood Hodgkin Lymphoma
15986,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma
15987,Childhood Lesion,Recurrent Childhood Lymphoblastic Lymphoma
15988,Indolent Clinical Course,Angioma serpiginosum
15989,Skin Red Dot,Angioma serpiginosum
15990,Carcinomatous Component Present,Vulvar Large Cell Neuroendocrine Carcinoma
15991,Mixture of Germ Cell Neoplastic Components Present,Central Nervous System Mixed Germ Cell Tumor
15992,Exophytic Polypoid Lesion,Colon Sessile Serrated Adenoma/Polyp
15993,Carcinomatous Component Present,Ovarian epithelial cancer stage II
15994,Inflammatory infiltrate,Fibrous histiocytoma of tendon sheath
15995,Dysplasia,Prostatic Intraepithelial Neoplasias
15996,Hepatomegaly,Hepatosplenic T-cell lymphoma
15997,Epithelial Component Present,Stage I Nasopharyngeal Carcinoma AJCC v7
15998,Focal dysplasia,Appendix Sessile Serrated Adenoma/Polyp
15999,Vascular Channel Formation,Cavernous hemangioma of orbit
16000,Keratin pearl formation,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
16001,Epithelial Component Present,basaloid carcinoma of penis
16002,Dermal Involvement,"Nevus, Intradermal"
16003,Epithelial Component Present,Stage I Prostate Carcinoma
16004,Pushing Tumor Margin,Verrucous carcinoma of penis
16005,Secondary Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
16006,Primary Lesion,Bone Surface (Peripheral) Osteosarcoma
16007,Carcinomatous Component Present,Cholangiocarcinoma
16008,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Tumor
16009,Epithelial Component Present,Paget Disease of the Anus
16010,Mesenchymal Component Present,carcinoma ex pleomorphic adenoma of salivary gland
16011,Secondary Lesion,Secondary Neoplasm
16012,Epithelial Component Present,Tobacco Chewing-Related Carcinoma
16013,Cystic Lesion,Craniopharyngioma
16014,Neuroendocrine Differentiation,Carcinoid tumor of pancreas
16015,Glomerular Hypertrophy,Focal glomerulosclerosis
16016,Hypercellular bone marrow,Philadelphia chromosome negative chronic myelogenous leukemia
16017,atypia morphology,Neoplastic C-Cell Hyperplasia
16018,Cutaneous Involvement,Small Congenital Melanocytic Nevus
16019,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
16020,Plexiform Growth Pattern,Plexiform fibrohistiocytic tumor
16021,Hyperplastic Tissue Present,Reactive C-Cell Hyperplasia
16022,Follicular Structures Present,Thyroid Gland Oncocytic Adenoma
16023,Indolent Clinical Course,Lipoma of corpus callosum
16024,Cutaneous Involvement,Carcinoma of apocrine gland
16025,Carcinomatous Component Present,Stage IV Colorectal Cancer
16026,Slow Growing Painless Mass,Lipofibromatosis
16027,Diffuse Pattern,Childhood Brain Oligodendroglioma
16028,Benign Cellular Infiltrate,Pancreatic Solid Serous Adenoma
16029,Acanthosis,Lower Gingival Verrucous Carcinoma
16030,Juvenile Lesion,Juvenile osteochondrosis of tibial tubercle
16031,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage IV
16032,Exophytic Polypoid Lesion,Sessile Serrated Adenoma/Polyp
16033,Pregnancy Complications,Poor Prognosis Metastatic Gestational Trophoblastic Tumor
16034,Epithelial Component Present,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
16035,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent
16036,Epithelial Component Present,hepatoid adenocarcinoma of bladder
16037,Primary Lesion,gliosarcoma
16038,Cystic Change,Thymic Mucoepidermoid Carcinoma
16039,Carcinomatous Component Present,Thymic Adenocarcinoma
16040,Epithelial Component Present,Squamous cell carcinoma of colon
16041,"Undifferentiated ""Fetal-Type"" Tissues Present",Extragonadal primary malignant teratoma
16042,Intraosseous Lesion,Odontogenic myxofibroma
16043,Epithelial Component Present,Carcinoma of lower gum
16044,Malignant Germinomatous Cellular Infiltrate,germinoma of brain
16045,Epithelial Component Present,Small intestine adenocarcinoma metastatic NOS
16046,Non-Hereditary Lesion,"Papillary renal cell carcinoma, sporadic"
16047,Antoni A Pattern,Gastric Schwannoma
16048,Carcinomatous Component Present,Carcinoma of submandibular gland
16049,Epithelial Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7
16050,Epithelial Component Present,Stage I Lung Small Cell Carcinoma AJCC v7
16051,Carcinomatous Component Present,Stage I Lung Small Cell Carcinoma AJCC v7
16052,Necrotic changes (finding),Stage I Lung Small Cell Carcinoma AJCC v7
16053,Secondary Lesion,Colon Carcinoma Metastatic in the Lung
16054,Localized Lesion,Well-differentiated papillary mesothelioma
16055,Papillary Pattern,Well-differentiated papillary mesothelioma
16056,Metastatic Lesion,Metastatic signet ring cell carcinoma
16057,Epithelial Component Present,Prostate Adenosquamous Carcinoma
16058,Carcinomatous Component Present,Salivary gland carcinoma
16059,High Mitotic Activity,Classical Burkitt Lymphoma
16060,Neuroendocrine Differentiation,Breast Carcinoid Tumor
16061,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
16062,Epithelial Component Present,Stage I Nasal Cavity Cancer AJCC v6 and v7
16063,Vascular proliferation,Giant cell angiofibroma
16064,Diffuse Pattern,Plasmablastic Lymphoma of the Oral Mucosa
16065,High Grade Lesion,Ovarian Rhabdomyosarcoma
16066,Carcinomatous Component Present,ENSAT Stage IV Adrenal Cortex Carcinoma
16067,Squamous metaplasia,Ductal Eccrine Carcinoma with Squamous Metaplasia
16068,Epithelial Component Present,Small Intestinal Undifferentiated Carcinoma
16069,Carcinomatous Component Present,Paranasal Sinus Cancer
16070,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Isolated del(5q)
16071,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage III
16072,Nuclear Molding,Stage III Lung Small Cell Carcinoma AJCC v7
16073,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Prefibrotic/Early Primary Myelofibrosis
16074,Adulthood Lesion,Adult Acute Myeloid Leukemia with Maturation
16075,Epithelial Component Present,Infiltrating duct and lobular carcinoma
16076,atypia morphology,Atypical Mesothelial Hyperplasia
16077,Ineffective hematopoiesis,Myelodysplastic Syndrome with Gene Mutation
16078,Cutaneous Involvement,Cutaneous Angioimmunoblastic T-Cell Lymphoma
16079,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
16080,Cutaneous Involvement,Mycosis fungoides recurrent
16081,Ganglion Cell-Like Elements Present,Intestinal Gangliocytic Paraganglioma
16082,Diffuse Pattern,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
16083,Malignant Cellular Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7
16084,Acanthosis,Condyloma Acuminatum with Dysplasia
16085,Carcinomatous Component Present,Stage II Lung Cancer AJCC v7
16086,Tissue Differentiation Uncertain,Superficial angiomyxoma
16087,Mild cytologic atypia,verrucous carcinoma of vulva
16088,Myomatous Stroma Formation,Atypical polypoid adenomyoma
16089,Dysplasia,Gallbladder Biliary Intraepithelial Neoplasia
16090,Thyroglobulin Positive Neoplastic Cells Present,Papillary Thyroid Microcarcinoma
16091,Intestinal metaplasia of gastric mucosa,tubulovillous adenoma of stomach
16092,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
16093,Epithelial Component Present,Villous adenoma of duodenum
16094,Well-Circumscribed Lesion,Mediastinal Rhabdomyoma
16095,Firm mass,Intraocular Malignant Peripheral Nerve Sheath Tumor
16096,Diffuse Pattern,Intraocular Malignant Peripheral Nerve Sheath Tumor
16097,High Mitotic Activity,Anaplastic thyroid carcinoma
16098,Fibrosis,"Fibrocystic change, proliferative type with atypia"
16099,Cutaneous Involvement,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7
16100,Multifocal Lesion,mediastinal lipomatosis
16101,Dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7
16102,Slow Growing Mass,Acral Fibromyxoma
16103,Epithelial Component Present,Benign neoplasm of sweat gland
16104,Borderline Lesion,"Serous cystadenoma, borderline malignancy"
16105,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant"
16106,Neuroendocrine Differentiation,Somatostatinoma
16107,Carcinomatous Component Present,Adenocarcinoma of cecum
16108,Acanthosis,Seborrheic keratosis of eyelid
16109,Carcinomatous Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7
16110,Epithelial Component Present,Comedocarcinoma
16111,Diffuse Pattern,Diffuse malignant mesothelioma
16112,Carcinomatous Component Present,Anal Extramucosal (Perianal) Adenocarcinoma
16113,Neuroectodermal Differentiation,"Neuroectodermal Tumor, Melanotic"
16114,Carcinomatous Component Present,Anal Adenocarcinoma within Anorectal Fistula
16115,Childhood Lesion,Childhood Pilomyxoid Astrocytoma
16116,Cystic Change,Intracystic Papillary Breast Carcinoma
16117,Epithelial Component Present,Stage IIIB Eyelid Carcinoma AJCC v7
16118,Carcinomatous Component Present,Paget disease of anal canal
16119,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7
16120,Immature Myeloid Cells Increased in Bone Marrow,Alkylating Agent-Related Acute Myeloid Leukemia
16121,Therapy-Related Toxicity,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
16122,Granuloma,Lymphoepithelioid lymphoma (clinical)
16123,'Starry-sky' pattern,Colon Burkitt Lymphoma
16124,Necrotic changes (finding),small cell carcinoma of larynx
16125,Multifocal Lesion,Gardner Syndrome
16126,Severe cytologic atypia,Anaplastic Embryonal Rhabdomyosarcoma
16127,Mesenchymal Component Present,Malignant Vulvar Phyllodes Tumor
16128,Absence of Invasion,Ampulla of Vater Tubulovillous Adenoma
16129,Necrotic changes (finding),Esophageal Neuroendocrine Tumor G2
16130,Neuroendocrine Differentiation,Intestinal Neuroendocrine Carcinoma
16131,Lamellar Pattern,Fibrolamellar Hepatocellular Carcinoma
16132,Nodular lesions,High Grade Liver Dysplastic Nodule
16133,Intraductal Lesion,Peripheral Breast Papilloma
16134,Lymphoplasmacytic Infiltrate,Childhood Brain Germinoma
16135,Childhood Lesion,Congenital Mesoblastic Nephroma
16136,Regional Disease,Regional Digestive System Neuroendocrine Tumor G1
16137,Metastatic Lesion,Secondary malignant neoplasm of skin
16138,Secondary Lesion,Secondary malignant neoplasm of skin
16139,Favorable Clinical Outcome,Colon Ganglioneuroma
16140,Recurrent disease,Recurrent Childhood Gliosarcoma
16141,Intraductal Lesion,Low Grade Ductal Breast Carcinoma In Situ
16142,Hyperkeratosis,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
16143,Nodular Pattern,"Hodgkin lymphoma, nodular sclerosis, cellular phase"
16144,Dermal Involvement,Dermal Duct Tumor
16145,Cutaneous Involvement,Classical Poroma
16146,Neuroendocrine Differentiation,Small Intestinal Carcinoid Tumor
16147,Childhood Lesion,Childhood Cerebral Astrocytoma
16148,Biphasic Pattern,Parotid Gland Carcinosarcoma
16149,Epithelial Component Present,Bladder transitional cell carcinoma stage I
16150,Carcinomatous Component Present,Chromophobe Renal Cell Carcinoma
16151,Locally Aggressive Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma
16152,Epithelial Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma
16153,Nuclear pleomorphism,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
16154,Cutaneous Involvement,Digital papillary eccrine carcinoma of skin
16155,Poorly Differentiated Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma
16156,Vascular Channel Formation,Gallbladder Kaposi's Sarcoma
16157,Neuroendocrine Differentiation,Meckel Diverticulum Neuroendocrine Tumor G1
16158,Neuroendocrine Differentiation,small cell carcinoma of extrahepatic bile duct
16159,Epithelial Component Present,Stage IV Colon Carcinoma
16160,Carcinomatous Component Present,Stage IV Colon Carcinoma
16161,Recurrent disease,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
16162,Epithelial Component Present,Stage II Prostate Cancer AJCC v7
16163,Indolent Clinical Course,Ivory Exostosis
16164,Multilocular Lesion,Alveolar adenoma
16165,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma
16166,Epithelial Component Present,Low Grade Esophageal Squamous Intraepithelial Neoplasia
16167,Photosensitivity of skin,Rothmund-Thomson syndrome
16168,Serrated Glandular Architecture,Colon Serrated Adenocarcinoma
16169,Moderate cytologic atypia,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
16170,Bone Marrow Dysplasia Present,Refractory anemias
16171,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma
16172,Biphasic Pattern,Mesenchymal Chondrosarcoma
16173,IDH Gene Family Mutation Status Unknown,Mixed Oligodendroglioma-Astrocytoma
16174,Tissue Differentiation Uncertain,Childhood Alveolar Soft Part Sarcoma
16175,Pregnancy Complications,Placental Non-Neoplastic Disorder
16176,Recurrent disease,Malignant fibrous histiocytoma recurrent
16177,Infiltrative Growth Pattern,Pelvic Fibromatosis
16178,Epithelial Component Present,Carcinoma of anal canal
16179,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia
16180,Chronic Inflammatory Infiltrate,Childhood Lymphomatoid Granulomatosis
16181,Anaplasia,Anaplastic Pleomorphic Xanthoastrocytoma
16182,Epithelial Component Present,Lepidic Predominant Adenocarcinoma
16183,Carcinomatous Component Present,Undifferentiated carcinoma of esophagus
16184,Dysplasia,"Gastric Adenoma, Gastric-Type"
16185,Childhood Lesion,Childhood Anaplastic Large Cell Lymphoma
16186,Carcinomatous Component Present,Breast adenocarcinoma
16187,Carcinomatous Component Present,Vaginal Carcinosarcoma
16188,High Grade Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
16189,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast with Atypia
16190,Dysplasia,Low Grade Gastric Intraepithelial Neoplasia
16191,Recurrent disease,Recurrent Malignant Extragonadal Germ Cell Tumor
16192,Carcinomatous Component Present,Growth Hormone-Producing Pituitary Gland Carcinoma
16193,Carcinomatous Component Present,Stage IIIA Rectal Cancer AJCC v7
16194,Fibrotic Stroma Formation,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
16195,Mixed Cellular Population,Intracanalicular fibroadenoma
16196,Nuclear pleomorphism,Pleomorphic carcinoma
16197,Epithelial Component Present,ACTH-Producing Pituitary Gland Carcinoma
16198,Biphasic Pattern,Pilocytic astrocytoma of cerebellum
16199,Hereditary Lesion,Familial meningioma
16200,Hyperplastic Epithelial Tissue Present,Breast hyperplasia
16201,Lobulated Growth Pattern,Central Nervous System Chondroma
16202,Cartilaginous Differentiation,Myxoid chondrosarcoma
16203,Thin-Walled Branching Vascular Pattern,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
16204,Vascular Channel Formation,Pleural Epithelioid Hemangioendothelioma
16205,Pushing Tumor Margin,"Phyllodes tumor, benign"
16206,Slow Growing Mass,Pleomorphic hyalinizing angiectatic tumor of soft tissue
16207,Monophasic Pattern,Pleural Monophasic Synovial Sarcoma
16208,Slow Growing Mass,Ependymoma
16209,Neuroendocrine Differentiation,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
16210,Epithelial Component Present,Adenocarcinoma of duodenum
16211,Mixed Cellular Population,carcinosarcoma of liver
16212,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
16213,Carcinomatous Component Present,Stage IIIA Esophageal Cancer AJCC v7
16214,Metastatic Lesion,Secondary malignant neoplasm of pancreas
16215,Diffuse Pattern,Mesenchymal Glioblastoma
16216,Childhood Lesion,Childhood Osteosarcoma
16217,Epithelial Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
16218,Carcinomatous Component Present,Stage IVB Appendix Carcinoma AJCC v7
16219,Carcinomatous Component Present,Stage IVC Paranasal Sinus Cancer AJCC v7
16220,Neuroectodermal Differentiation,Childhood Neuroblastoma
16221,Cribriform Pattern,"Carcinoma, Cribriform"
16222,Carcinomatous Component Present,Stage IIB Ampulla of Vater Cancer AJCC v7
16223,atypia morphology,Atypical Breast Myoepitheliosis
16224,Indolent Clinical Course,Deep Leiomyoma
16225,Calcinosis,Psammomatous Meningioma
16226,Vascular Channel Formation,Angiomatous Meningioma
16227,Secondary Lesion,Secondary malignant neoplasm of pituitary gland
16228,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Mutant"
16229,Epithelial Component Present,Small cell lung cancer extensive stage
16230,Necrotic changes (finding),Small cell lung cancer extensive stage
16231,Carcinomatous Component Present,Squamous cell carcinoma of lip
16232,High Grade Lesion,rhabdomyosarcoma of prostate
16233,Infiltrative Growth Pattern,"Gemistocytic Astrocytoma, IDH-Mutant"
16234,Carcinomatous Component Present,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
16235,Mesenchymal Component Present,Breast Complex Fibroadenoma
16236,Well-Circumscribed Lesion,Intermediate Rhabdomyoma
16237,Low Grade Lesion,malignant epithelioid hemangioendothelioma of liver
16238,Diffuse Pattern,Grade III Childhood Astrocytoma
16239,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
16240,Childhood Lesion,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
16241,Mesenchymal Component Present,Benign phyllodes neoplasm of breast
16242,Mixed Cellular Population,Benign phyllodes neoplasm of breast
16243,Necrotic changes (finding),Proneural Glioblastoma
16244,Microvascular Proliferation,Proneural Glioblastoma
16245,Stromal Invasion,FIGO Stage IIIA2 Ovarian Cancer
16246,Biphasic Pattern,Cervical Adenomyoma
16247,Epithelial Component Present,Lung squamous cell carcinoma stage I
16248,Adulthood Lesion,Smoldering Adult T-Cell Leukemia/Lymphoma
16249,Carcinomatous Component Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
16250,Neuroendocrine Differentiation,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
16251,Recurrent disease,Marginal zone lymphoma recurrent
16252,Hereditary Lesion,Familial Retinoblastoma
16253,Mixed Cellular Population,Clear cell cystadenofibroma
16254,Carcinomatous Component Present,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
16255,Progressive Clinical Course,"Leukoencephalopathy, Progressive Multifocal"
16256,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v7
16257,Anaplasia,"Anaplastic Astrocytoma, IDH-Mutant"
16258,Childhood Lesion,Childhood Testicular Yolk Sac Tumor
16259,Anaplasia,"Anaplastic Astrocytoma, IDH-Wildtype"
16260,High Grade Lesion,Brain Stem Glioblastoma
16261,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage I
16262,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma
16263,Epithelial Component Present,Stage IVB Lip Cancer AJCC v6 and v7
16264,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage III
16265,Neuronal Differentiation,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor
16266,Diffuse Pattern,Fibrillary Astrocytoma
16267,Alternative Fascicle (Bundle) Pattern,Fallopian tube leiomyoma
16268,Well-Circumscribed Lesion,Stage II Kidney Wilms Tumor
16269,Carcinomatous Component Present,Nasopharyngeal Nonkeratinizing Carcinoma
16270,Carcinomatous Component Present,Childhood Colorectal Carcinoma
16271,Cutaneous Involvement,Seborrheic keratosis
16272,Eosinophilic inflammation,Epithelioid hemangioma of skin
16273,Carcinomatous Component Present,Gastric Intestinal-Type Adenocarcinoma
16274,Cytoplasmic Membrane-Bound Granules Present,Vulvar Merkel Cell Carcinoma
16275,Generalized Dysplasia,Filiform Serrated Adenoma
16276,High Mitotic Activity,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
16277,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma
16278,Oligodendroglial Component Present,Anaplastic Oligodendroglioma
16279,Exophytic Polypoid Lesion,Vaginal Rhabdomyoma
16280,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v6
16281,Cystic Change,Broad Ligament Serous Cystadenoma
16282,HMB-45-Positive Neoplastic Cells Present,Lymphangiomyoma
16283,Painless Mass,Soft tissue chondroma
16284,Low Mitotic Activity,Malignant Pancreatic Vipoma
16285,Carcinomatous Component Present,Stage IIIB Colorectal Cancer AJCC v7
16286,Invasive Lesion,small cell carcinoma of breast
16287,Epithelial Component Present,Colon Intramucosal Adenocarcinoma
16288,Carcinomatous Component Present,adenocarcinoma of extrahepatic bile duct
16289,Perivascular Arrangement of Tumor Cells,Solitary Myofibromatosis
16290,Severe dysplasia,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
16291,Acanthosis,Plantar Verrucous Skin Carcinoma
16292,Necrotic changes (finding),Small cell carcinoma of esophagus
16293,Epithelial Component Present,squamous cell carcinoma of lacrimal gland
16294,Neuronal Differentiation,Anaplastic ganglioglioma
16295,Mitotic Activity,"Ovarian Yolk Sac Tumor, Glandular Pattern"
16296,Pregnancy Complications,Funisitis (disorder)
16297,Infundibular-Like Structures Present,"Basal cell carcinoma, infundibulocystic"
16298,Recurrent disease,Recurrent Childhood Liver Cancer
16299,Neuroendocrine Differentiation,Regional Adrenal Gland Pheochromocytoma
16300,Adulthood Lesion,Adult Ganglioglioma
16301,Cutaneous Involvement,"Skin Diseases, Vascular"
16302,Collagenous Stroma Formation,Nuchal-type fibroma
16303,Epithelial Component Present,Stage I Ampulla of Vater Cancer AJCC v7
16304,Epithelial Component Present,Stage I Hepatocellular Carcinoma AJCC v6 and v7
16305,Slow Growing Mass,Myxopapillary ependymoma
16306,Mitotic Activity,Adult Yolk Sac Tumor
16307,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of breast
16308,Keratin pearl formation,Squamous cell carcinoma of nasopharynx
16309,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7
16310,Dysplasia,Colon Sessile Serrated Adenoma/Polyp
16311,Deep Lesion,"Hemangioma, Intramuscular"
16312,Carcinomatous Component Present,Stage IV Pharynx Carcinoma
16313,Metastatic Lesion,Secondary malignant neoplasm of brain stem
16314,Intraductal Lesion,Pancreatic Intraductal Papillary Mucinous Neoplasm
16315,Well-Circumscribed Lesion,Parathyroid mixed cell type adenoma
16316,Sarcomatous Component Present,Uterine Carcinosarcoma
16317,Stromal Invasion,Stage IV Ovarian Cancer AJCC v6 and v7
16318,Well Differentiated Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma
16319,Dermal Involvement,"Nevus, Blue"
16320,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Uterine Corpus Choriocarcinoma
16321,Vascular Channel Formation,Hobnail Hemangioma
16322,Trabecular Pattern,Trabecular adenocarcinoma
16323,Carcinomatous Component Present,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
16324,Severe cytologic atypia,Pancreatic Small Cell Neuroendocrine Carcinoma
16325,Epithelial Component Present,Pancreatic Small Cell Neuroendocrine Carcinoma
16326,Epithelial Component Present,Stage I Lip Carcinoma
16327,Epithelial Component Present,Multifocal superficial basal cell carcinoma
16328,High Mitotic Activity,Stage IIA Merkel Cell Carcinoma AJCC v7
16329,Neuroendocrine Differentiation,Non-Functioning Pancreatic Neuroendocrine Tumor G1
16330,Thyroglobulin Positive Neoplastic Cells Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
16331,Cervical Glandular Dysplasia,intraepithelial glandular neoplasia of cervix
16332,Childhood Lesion,Childhood Ovarian Teratoma
16333,atypia morphology,Atypical adenoma
16334,Epithelial Component Present,"Cystadenoma, Mucinous"
16335,Epithelial Component Present,Stage III Breast Cancer AJCC v6
16336,Neuroendocrine Differentiation,Stage IIIA Merkel Cell Carcinoma AJCC v7
16337,Absence of Invasion,Cervical Squamous Cell Carcinoma In Situ
16338,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Cystadenofibroma
16339,Single Cell Necrosis,Stage IIIB Merkel Cell Carcinoma AJCC v7
16340,Extensive Stage Lesion,Peritoneal mesothelioma malignant advanced
16341,Recurrent Malignant Neoplasm,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
16342,Nuclear Grooves,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
16343,Pushing Tumor Margin,Verrucous carcinoma of oral cavity
16344,Epithelial Component Present,Stage III Bladder Cancer AJCC v6 and v7
16345,Fibrosis,Mediastinal (Thymic) Large B-Cell Lymphoma
16346,Exophytic Polypoid Lesion,Rectal hyperplastic polyp
16347,Mesenchymal Component Present,Borderline Breast Phyllodes Tumor
16348,Epithelial Component Present,Neuroendocrine cervical carcinoma
16349,Adnexal Differentiation,eccrine adenocarcinoma of vulva
16350,Epithelial Component Present,Sessile Serrated Adenoma/Polyp
16351,Carcinomatous Component Present,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
16352,Vascular Channel Formation,Digestive System Hemangioma
16353,Epithelial Component Present,Stage IIIA Eyelid Carcinoma AJCC v7
16354,Angiodestructive Pattern,Lymphomatoid Granulomatosis
16355,Carcinomatous Component Present,Unresectable Extrahepatic Bile Duct Carcinoma
16356,Aggressive Clinical Course,"Leukemia, Mast-Cell"
16357,Epithelial Component Present,Triple-Negative Breast Carcinoma
16358,Carcinomatous Component Present,Rectal Adenosquamous Carcinoma
16359,Epithelial Component Present,Colorectal Neuroendocrine Carcinoma
16360,Epithelial Component Present,Pancreatic Serous Adenoma
16361,Stromal Invasion,Ovarian mixed epithelial carcinoma
16362,Epithelial Component Present,Large cell lung cancer stage II
16363,Severe dysplasia,Stage 0 Colorectal Cancer AJCC v6 and v7
16364,Cystic Change,Pancreatic Macrocystic Serous Cystadenoma
16365,Metastatic Lesion,Secondary malignant neoplasm of heart
16366,Epithelial Component Present,Cervical Squamous Cell Carcinoma
16367,Recurrent disease,Recurrent Lymphomatoid Granulomatosis
16368,Slow Growing Mass,Pineocytoma
16369,Osteoid formation,Radiation-Related Osteosarcoma
16370,Osseous Differentiation,Stage IVA Osteosarcoma AJCC v7
16371,Cystic Change,Serous cystadenoma of pancreas
16372,Mild dysplasia,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
16373,Serrated Glandular Architecture,Colorectal Traditional Serrated Adenoma
16374,Epithelial Component Present,Stage I Rectal Cancer AJCC v6 and v7
16375,Papillary Pattern,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
16376,Embryoid Bodies Present,polyembryoma of ovary
16377,Progressive Disease,Metastatic Malignant Peripheral Nerve Sheath Tumor
16378,Neuroendocrine Differentiation,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7
16379,Epithelial Component Present,Sebaceoma
16380,Eccrine Differentiation,Papillary Eccrine Carcinoma
16381,Mucoid Stroma Formation,Microcystic meningioma
16382,Epithelial Component Present,Stage IVC Laryngeal Cancer AJCC v7
16383,Lobulated Growth Pattern,Sternal Chondromyxoid Fibroma
16384,Eccrine Differentiation,Eccrine ductal carcinoma
16385,Epithelial Component Present,Posterior Tongue Mucoepidermoid Carcinoma
16386,Carcinomatous Component Present,Posterior Tongue Mucoepidermoid Carcinoma
16387,Non-Encapsulated Neoplasm,Hemosiderotic Fibrolipomatous Tumor
16388,Carcinomatous Component Present,Hereditary Ovarian Carcinoma
16389,Carcinomatous Component Present,Supraglottic Squamous Cell Carcinoma
16390,Absence of Invasion,Carcinoma in situ in a polyp
16391,Cutaneous Involvement,Acrodermatitis
16392,Neuroendocrine Differentiation,Rectal Small Cell Neuroendocrine Carcinoma
16393,Epithelial Component Present,carcinoma of gingiva
16394,Stromal Invasion,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
16395,Mass of body structure,Blastic Granulocytic Sarcoma
16396,Nodular lesions,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
16397,Carcinomatous Component Present,Unilateral Breast Carcinoma
16398,Epithelial Component Present,Tongue Carcinoma
16399,Vertical Growth Phase,Desmoplastic melanoma
16400,Epithelial Component Present,Beta-Catenin-Activated Hepatocellular Adenoma
16401,Neuroendocrine Differentiation,Cerebellar Paraganglioma
16402,CD1a-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
16403,Moderate dysplasia,cystic mucinous tumor of pancreas with moderate dysplasia
16404,Low Mitotic Activity,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
16405,Epithelial Component Present,Thyroid Gland Signet Ring Cell Follicular Adenoma
16406,Well-Circumscribed Lesion,Gastric Non-Neoplastic Polyp
16407,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue
16408,Epithelial Component Present,Small Intestinal Tubulovillous Adenoma
16409,Epithelial Component Present,Extraocular Cutaneous Sebaceous Carcinoma
16410,Recurrent Genetic Abnormalities Present,"Acute myeloid leukemia, inv(16)(p13q22)"
16411,Absence of Invasion or Limited Invasion Present,Pleural Well Differentiated Papillary Mesothelioma
16412,Recurrent disease,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
16413,Vascular Channel Formation,Histiocytoid hemangioma
16414,Childhood Lesion,Mixed Congenital Mesoblastic Nephroma
16415,Papillary Pattern,Peritoneal Well Differentiated Papillary Mesothelioma
16416,Monoclonal Cellular Population Present,Mastocytosis
16417,Cystic Change,Pancreatic Intraductal Neoplasms
16418,Epithelial Component Present,intraductal micropapillary carcinoma of breast
16419,Hemorrhagic,Radiation-Related Angiosarcoma
16420,Oligodendroglial Component Present,Adult Oligodendroglial Tumor
16421,Diffuse Pattern,Pleural Sarcomatoid Mesothelioma
16422,Epithelial Component Present,Stage IIA Colon Cancer AJCC v7
16423,Adulthood Lesion,Adult Central Nervous System Embryonal Carcinoma
16424,Pseudopapillary Pattern,Adult Central Nervous System Embryonal Carcinoma
16425,Adulthood Lesion,Adult Favorable Prognosis Hodgkin Lymphoma
16426,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Amyloidosis
16427,Carcinomatous Component Present,Medullary carcinoma of thyroid
16428,Exophytic Polypoid Lesion,Precancerous Polyp
16429,Adulthood Lesion,Adult Central Nervous System Germinoma
16430,Solid Growth Pattern,Breast Solid Neuroendocrine Carcinoma
16431,Well-Circumscribed Lesion,Breast Phyllodes Tumor
16432,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Adult Central Nervous System Choriocarcinoma
16433,Adulthood Lesion,Recurrent Adult Hepatocellular Carcinoma
16434,Indolent Clinical Course,Parotid Gland Lipoma
16435,Secondary Lesion,Secondary malignant neoplasm of thymus
16436,Epithelial Component Present,Stage II Esophageal Adenocarcinoma AJCC v7
16437,Refractory Disease,Intestinal T-cell lymphoma refractory
16438,Adulthood Lesion,Adult Mesenchymal Chondrosarcoma
16439,Chromogranin A Positive Neoplastic Cells Present,Ampulla of Vater Neuroendocrine Tumor G1
16440,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Apoplectic Leiomyoma
16441,Epithelial Component Present,Stage IIB Esophageal Carcinoma
16442,Hyperchromatism,Large Cell Dysplasia
16443,Microvascular Proliferation,Glioblastoma with Primitive Neuronal Component
16444,High Grade Lesion,Childhood Alveolar Rhabdomyosarcoma
16445,Childhood Lesion,Childhood Pleomorphic Xanthoastrocytoma
16446,Lobulated Growth Pattern,Ovarian Myxoma
16447,Myxoid Stroma Formation,Ovarian Myxoma
16448,Mitotic Activity,Adult Glioblastoma
16449,Acinar Cell Differentiation,Acinar cell cystadenocarcinoma
16450,Solar Radiation Toxicity,Solar Radiation-Related Skin Squamous Cell Carcinoma
16451,Chronic lymphocytic inflammation,Eccrine spiradenoma
16452,Epithelial Component Present,Stage 0 Urethral Cancer AJCC v7
16453,Aggressive Clinical Course,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease"
16454,Pseudoglandular Pattern,Testicular embryonal carcinoma
16455,Epithelial Component Present,Stage IVA Oral Cavity Cancer AJCC v6 and v7
16456,Fever,Sinus histiocytosis
16457,Carcinomatous Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
16458,High Grade Lesion,Pleomorphic Rhabdomyosarcoma
16459,Epithelial Component Present,Stage II Colorectal Cancer AJCC v7
16460,Epithelial Component Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade"
16461,Carcinomatous Component Present,Stage 0a Ureter Cancer AJCC v7
16462,Carcinomatous Component Present,Metastatic urothelial carcinoma
16463,Epithelial Component Present,"Thymoma, type B1"
16464,Cutaneous Involvement,Primary Cutaneous Follicle Center Lymphoma
16465,'Starry-sky' pattern,Burkitt's lymphoma refractory
16466,Childhood Lesion,Childhood Mixed Glioma
16467,Nodular Pattern,Hodgkin's disease nodular sclerosis stage I
16468,Mixed Cellular Population,Malignant Vulvar Phyllodes Tumor
16469,Carcinomatous Component Present,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8"
16470,Pain,Giant Cell Tumor of Bone
16471,Childhood Lesion,Childhood Pineal Parenchymal Cell Neoplasm
16472,Recurrent disease,Recurrent Childhood Fibrillary Astrocytoma
16473,Intestinal metaplasia,"Vulvar Adenocarcinoma, Intestinal-Type"
16474,Benign Cellular Infiltrate,Benign neoplasm of esophagus
16475,High Mitotic Activity,Small Intestinal Neuroendocrine Carcinoma
16476,Anaplasia,Childhood Brain Stem Gliosarcoma
16477,Necrotic changes (finding),Recurrent Childhood Glioblastoma
16478,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyposis coli
16479,Low Grade Lesion,Gastric Carcinoid Tumor
16480,Childhood Lesion,"Optic Nerve Glioma, Childhood"
16481,Carcinomatous Component Present,Low Grade Ductal Breast Carcinoma In Situ
16482,Deep Lesion,"Liposarcoma, well differentiated"
16483,Cellular Changes Resembling Foveolar Epithelium Cells,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
16484,Benign Cellular Infiltrate,Benign neoplasm of extrahepatic bile ducts
16485,Childhood Lesion,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
16486,Epithelial Component Present,Cervical Intraepithelial Neoplasia Grade 2/3
16487,Epithelial Component Present,Vulvar Non-Keratinizing Squamous Cell Carcinoma
16488,Neuroendocrine Differentiation,Esophageal Large Cell Neuroendocrine Carcinoma
16489,Epithelial Component Present,Endocervical Carcinoma
16490,Carcinomatous Component Present,Undifferentiated carcinoma of stomach
16491,Indolent Clinical Course,Enchondroma
16492,Hyperkeratosis,Vulvar Warty Carcinoma
16493,Carcinomatous Component Present,Stage IA Pancreatic Cancer AJCC v6 and v7
16494,Cystic Change,Central Nervous System Dermoid Cyst
16495,Mucoid Stroma Formation,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm
16496,High Grade Lesion,Esophageal Synovial Sarcoma
16497,atypia morphology,Recurrent Grade II Lymphomatoid Granulomatosis
16498,Epithelial Component Present,Localized Gallbladder Carcinoma
16499,Dysplasia,Intraductal carcinoma and lobular carcinoma in situ
16500,Papillary Pattern,Recurrent Inverted Schneiderian Papilloma
16501,Epithelial Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
16502,Benign Cellular Infiltrate,Cystadenoma of pancreas
16503,Epithelial Component Present,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
16504,Carcinomatous Component Present,basaloid carcinoma of anus
16505,Fibrotic Stroma Formation,Follicular ameloblastoma
16506,Unilineage Dysplasia Present,Refractory anemias
16507,Mixed Cellular Population,Anaplastic Oligoastrocytoma
16508,Epithelial Component Present,Differentiated Thyroid Gland Carcinoma
16509,Epithelial Component Present,Primary Cutaneous Mucinous Carcinoma
16510,Childhood Lesion,Childhood Malignant Peripheral Nerve Sheath Tumor
16511,Organoid Pattern,Alveolar soft part sarcoma non-metastatic
16512,Epithelial Component Present,Multiple Endocrine Neoplasia Type 2a
16513,Polymorphic Cellular Infiltrate,Polymorphus Hemangioendothelioma
16514,Preserved Nuclear Polarity,Ureter Inverted Papilloma
16515,Cystic Change,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
16516,Epithelial Component Present,Intraductal Breast Papillomatosis
16517,Tissue of Mullerian Origin Present,Rete Ovarii Cystadenofibroma
16518,Nodular Pattern,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma
16519,Carcinomatous Component Present,Metastatic Carcinoma in the Adrenal Cortex
16520,Cystic Change,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
16521,Carcinomatous Component Present,verrucous carcinoma of esophagus
16522,Metastatic Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread"
16523,High Grade Lesion,"Synovial sarcoma, epithelioid cell"
16524,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Carcinoma
16525,Carcinomatous Component Present,Thymic Papillary Adenocarcinoma
16526,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis of skin
16527,Rapidly Enlarging Mass,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant"
16528,Carcinomatous Component Present,Stage IVC Appendix Carcinoma AJCC v7
16529,Low Mitotic Activity,Pancreatic Neuroendocrine Tumor G2
16530,Epithelial Component Present,Stage I Appendix Neuroendocrine Tumor AJCC v7
16531,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Bone
16532,High Grade Lesion,Cervical Alveolar Soft Part Sarcoma
16533,Secondary Lesion,Secondary Central Nervous System Hodgkin Lymphoma
16534,atypia morphology,Columnar Cell Change of the Breast with Atypia
16535,Increased Cellularity Present,Olfactory Neuroblastoma
16536,Epithelial Component Present,Stage 0is Renal Pelvis Cancer AJCC v7
16537,Indolent Clinical Course,Adult Extracardiac Rhabdomyoma
16538,Metastatic Lesion,Lung Carcinoma Metastatic in the Liver
16539,Epithelial Component Present,Fallopian Tube Endometrioid Tumor
16540,Adnexal Differentiation,Pilar tumor
16541,Vascular Channel Formation,Myxoma
16542,Epithelial Component Present,Vulvar Cancer by AJCC v6 Stage
16543,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage I
16544,Myxoid Stroma Formation,Myxosarcoma
16545,Epithelial Component Present,estrogen-producing adrenal cortical adenoma
16546,Epithelial Component Present,Lipoadenoma
16547,Pregnancy Complications,"Trophoblastic tumor, epithelioid"
16548,Anaplasia,Anaplastic Brain Stem Glioma
16549,Metastatic/Recurrent Disease,Extrarenal Rhabdoid Tumor of the Liver
16550,Epithelial Component Present,Pituitary carcinoma
16551,Vascular Channel Formation,Intracranial cavernous hemangioma
16552,Indolent Clinical Course,Cerebral hemangioma
16553,Carcinomatous Component Present,Large cell lung cancer stage IV
16554,Biphasic Pattern,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
16555,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Brain
16556,Carcinomatous Component Present,Primary hepatic neuroendocrine carcinoma
16557,Childhood Lesion,Childhood Fibrosarcoma
16558,Cutaneous Involvement,Primary Cutaneous Plasmablastic Lymphoma
16559,Metastatic/Recurrent Disease,Childhood Synovial Sarcoma
16560,Metastatic Lesion,Secondary malignant neoplasm of extrahepatic bile ducts
16561,Carcinomatous Component Present,Gallbladder squamous cell carcinoma
16562,Carcinomatous Component Present,Recurrent Adult Liver Carcinoma
16563,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Acute Monoblastic Leukemia
16564,Carcinomatous Component Present,Rectosigmoid Cancer by AJCC v6 Stage
16565,Secondary Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor
16566,Well-Circumscribed Lesion,Aldosterone-Producing Adrenal Cortex Adenoma
16567,High Mitotic Activity,Combined Lung Small Cell and Squamous Cell Carcinoma
16568,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
16569,Multifocal Lesion,Periductal Breast Myoepitheliosis
16570,Vascular Channel Formation,Liver Lymphangioma
16571,Epithelial Component Present,Squamous cell carcinoma of buccal mucosa
16572,Cystic Change,Ovarian Seromucinous Cystadenoma
16573,Pregnancy Complications,Stage IB Gestational Trophoblastic Tumor AJCC v7
16574,Indolent Clinical Course,Spindle cell hemangioma
16575,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
16576,Hereditary Lesion,Multiple fibrofolliculomas
16577,Epithelial Component Present,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7
16578,Carcinomatous Component Present,Stage IC Ovarian Cancer AJCC v6 and v7
16579,Diffuse Pattern,"Perineurioma, malignant"
16580,Necrotic changes (finding),"Perineurioma, malignant"
16581,Well Differentiated Lesion,Cervical Warty Carcinoma
16582,Diffuse Pattern,"Epithelioid mesothelioma, malignant"
16583,"Amorphus, Eosinophilic, and Acellular Deposit","Amyloidosis, Familial"
16584,Low Mitotic Activity,Pancreatic Delta Cell Neoplasm
16585,Epithelial Component Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
16586,Necrotic changes (finding),Neural Glioblastoma
16587,Increased Cellularity Present,Kadish Stage A Olfactory Neuroblastoma
16588,In Situ Lesion,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
16589,Follicular Cell Differentiation,Clear Cell Variant Thyroid Gland Papillary Carcinoma
16590,Adulthood Lesion,Adult Acute Monocytic Leukemia
16591,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Adult Acute Monocytic Leukemia
16592,Refractory Disease,Hodgkin's disease lymphocyte depletion type refractory
16593,Localized Lesion,Nodular tenosynovitis
16594,Biphasic Pattern,Cystadenofibroma
16595,High Grade Lesion,Secondary Supratentorial Anaplastic Astrocytoma
16596,Mixed Cellular Population,"Uterine Carcinosarcoma, Heterologous Type"
16597,High Grade Lesion,rhabdomyosarcoma of testis
16598,Primary Lesion,Primary mediastinal large B-cell lymphoma recurrent
16599,Childhood Lesion,Childhood Testicular Mature Teratoma
16600,Single Cell Necrosis,Stage 0 Merkel Cell Carcinoma AJCC v7
16601,High Grade Lesion,"Anaplastic Astrocytoma, IDH-Wildtype"
16602,Low Grade Lesion,Low Grade Ovarian Serous Adenocarcinoma
16603,Carcinomatous Component Present,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
16604,Neuroectodermal Differentiation,Retinoblastoma
16605,Epithelial Component Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma
16606,Carcinomatous Component Present,Stage IV Penile Cancer AJCC v7
16607,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant"
16608,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx recurrent
16609,Epithelial Component Present,Stage IIB Fallopian Tube Cancer AJCC v6 and v7
16610,Epithelial Component Present,Paget Disease of the Breast without Invasive Carcinoma
16611,In Situ Lesion,Stage 0 Cervical Cancer AJCC v6
16612,Exophytic Polypoid Lesion,Filiform Serrated Adenoma
16613,Papillary Pattern,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
16614,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
16615,Multihormonal Immunoreactivity Present,Plurihormonal Pituitary Gland Adenoma
16616,Epithelial Component Present,Carcinoma in situ of penis
16617,Epithelial Component Present,adenoid cystic carcinoma of floor of mouth
16618,Epithelial Component Present,Colon Small Cell Neuroendocrine Carcinoma
16619,Epithelial Component Present,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
16620,Carcinomatous Component Present,Broad Ligament Serous Adenocarcinoma
16621,Carcinomatous Component Present,Subglottic Verrucous Carcinoma
16622,Sarcomatous Component Present,Pleuropulmonary blastoma type III
16623,atypia morphology,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
16624,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma recurrent
16625,Necrotic changes (finding),small cell carcinoma of salivary gland
16626,Epithelial Component Present,Stage 0 Penile Cancer AJCC v7
16627,Vascular Channel Formation,Angiosarcoma of liver
16628,Fibrotic Stroma Formation,Mucoepidermoid Breast Carcinoma
16629,Epithelial Component Present,Follicular thyroid carcinoma
16630,Carcinomatous Component Present,Recurrent Carcinoma
16631,Perineural spread,Adenoid cystic carcinoma of lacrimal gland
16632,Absence of Invasion,Stage 0 Vulvar Cancer
16633,Epithelial Component Present,Rectal Carcinoma
16634,Epithelial Component Present,Malignant Germinative Follicular Epithelium Neoplasm
16635,Nuclear pleomorphism,Anaplastic adrenocortical carcinoma
16636,Vascular Channel Formation,Perineural Hemangioma
16637,Epithelial Component Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
16638,Neuroendocrine Differentiation,Familial medullary thyroid carcinoma
16639,Capillary Sized Vascular Channel Formation,Capillary hemangioma of retina
16640,Vascular Channel Formation,Angioma serpiginosum
16641,No Identifiable Line of Differentiation,Inflammatory malignant fibrous histiocytoma
16642,Tissue of Mullerian Origin Present,Ovarian Serous Adenofibroma
16643,Epithelial Component Present,Sclerosing Breast Papilloma
16644,Epithelial Component Present,Anal Papillary Hidradenoma
16645,Carcinomatous Component Present,Carcinoma of glottis
16646,Epithelial Component Present,Lung Cancer by AJCC v7 Stage
16647,Epithelial Component Present,Uterine Carcinosarcoma
16648,Recurrent disease,Recurrent Liver Carcinoma
16649,Carcinomatous Component Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma
16650,Epithelial Component Present,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
16651,Epithelial Component Present,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
16652,Sebaceous Differentiation,Vulvar Sebaceous Carcinoma
16653,Carcinomatous Component Present,Trabecular adenocarcinoma
16654,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor G2
16655,Increased Cellularity Present,Undifferentiated Neuroblastoma
16656,CD30-Positive Neoplastic Cells Present,Stage IV Anaplastic Large Cell Lymphoma
16657,Local disease,Epicardial Lipoma
16658,Carcinomatous Component Present,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)
16659,Bilateral Mass,bilateral breast cancer
16660,atypia morphology,Borderline Ovarian Clear Cell Cystadenofibroma
16661,Carcinomatous Component Present,Stage IIIB Merkel Cell Carcinoma AJCC v7
16662,Cutaneous Involvement,Proliferative dermal lesion in congenital nevus
16663,Well-Circumscribed Lesion,Neoplastic Polyp
16664,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
16665,Carcinomatous Component Present,squamous cell carcinoma of ovary
16666,Negative Peripheral Blood,Aleukemic Leukemia Cutis
16667,Cutaneous Involvement,Aleukemic Leukemia Cutis
16668,Secondary Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma
16669,Cystic Change,Ovarian Cystadenoma
16670,Necrotic changes (finding),"Perivascular epithelioid tumor, malignant"
16671,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v7
16672,Epithelial Component Present,Malignant eccrine spiradenoma
16673,Solid Growth Pattern,Pancreatic Solid Serous Adenoma
16674,Exophytic Papillary Lesion,Lower Gingival Verrucous Carcinoma
16675,Increased Cellularity Present,Childhood Central Nervous System Neuroblastoma
16676,Well-Circumscribed Lesion,tubulopapillary adenoma of extrahepatic bile duct
16677,Epithelial Component Present,Grade 1 Endometrial Endometrioid Adenocarcinoma
16678,Epithelial Component Present,"Squamous Cell Carcinoma of the Penis, Usual Type"
16679,Epithelial Component Present,Vulvar Syringoma
16680,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
16681,Refractory Disease,Refractory Hematologic Malignancy
16682,Exophytic Polypoid Lesion,Adenomatous polyp of colon
16683,Deep Lesion,leiomyosarcoma of retroperitoneum
16684,Epithelial Component Present,Bladder Mixed Adenocarcinoma
16685,Epithelial Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7
16686,Cutaneous Involvement,"Adenoma, Sweat Gland"
16687,Necrotic changes (finding),Pancreatic Large Cell Neuroendocrine Carcinoma
16688,Invasive Lesion,Metastatic Signet Ring Cell Breast Carcinoma
16689,Carcinomatous Component Present,Metastatic Signet Ring Cell Breast Carcinoma
16690,Indolent Clinical Course,Chorioangioma
16691,Monomorphic Cellular Infiltrate,"Trophoblastic Tumor, Placental Site"
16692,Perineural spread,adenoid cystic carcinoma of esophagus
16693,Biphasic Pattern,Malignant Phyllodes Tumor of Prostate
16694,Acanthosis,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
16695,Mixed Cellular Population,Ovarian Mucinous Adenofibroma
16696,Exophytic Papillary Lesion,verrucous carcinoma of bladder
16697,Cutaneous Involvement,Apocrine cystadenoma
16698,High Grade Lesion,High Grade Broad Ligament Serous Adenocarcinoma
16699,Vascular Channel Formation,Ovarian Angiosarcoma
16700,Epithelial Component Present,Stage 0 Eyelid Carcinoma AJCC v7
16701,Exophytic Polypoid Lesion,Colorectal Hamartoma
16702,Epithelial Component Present,Squamous cell carcinoma of penis
16703,Carcinomatous Component Present,"Carcinoma, Papillary"
16704,Carcinomatous Component Present,Sarcomatoid Renal Cell Carcinoma
16705,Epithelial Component Present,Acinar Prostate Mucinous Adenocarcinoma
16706,Carcinomatous Component Present,Stage IIB Small Intestinal Cancer AJCC v7
16707,Glandular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
16708,Indolent Clinical Course,Uterine Fibroids
16709,Absence of Stromal Invasion,Borderline Fallopian Tube Neoplasm
16710,Cellular Pleomorphism,Chondroblastic osteosarcoma
16711,Cartilaginous Component Present,Chondroblastic osteosarcoma
16712,High Grade Lesion,Stage II Lung Small Cell Carcinoma AJCC v7
16713,Cutaneous Involvement,Scrotal Hemangioma
16714,Invasive Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
16715,Low Mitotic Activity,Small Intestinal VIP-Producing Neuroendocrine Tumor
16716,Carcinomatous Component Present,Adenocarcinoma of nasal cavity
16717,High Grade Lesion,Stage III Lung Small Cell Carcinoma AJCC v7
16718,Secondary Lesion,Reactive systemic amyloidosis
16719,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
16720,Dysplasia,Carcinoma in situ of trachea
16721,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Gene Mutation
16722,Juvenile Lesion,Juvenile polyp
16723,Eosinophilic inflammation,Bone Epithelioid Hemangioma
16724,Papillary Pattern,"Transitional cell carcinoma, micropapillary"
16725,Carcinomatous Component Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
16726,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
16727,Immunologic Deficiency Syndromes,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease
16728,Monoclonal Langerhans Cells Present,"Histiocytosis, Langerhans-Cell"
16729,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma
16730,Carcinomatous Component Present,Pyriform Fossa Carcinoma
16731,Epithelial Component Present,cystic mucinous tumor of pancreas with moderate dysplasia
16732,Mitotic Activity,cystic mucinous tumor of pancreas with moderate dysplasia
16733,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
16734,Epithelial Component Present,Bile duct signet-ring cell carcinoma
16735,Immunoglobulin Light Chain Deposition,Light chain disease
16736,Keratin pearl formation,"Lung Squamous Cell Carcinoma, Clear Cell Variant"
16737,Nodular Pattern,Ann Arbor Stage III Grade 2 Follicular Lymphoma
16738,Epithelial Component Present,Squamous cell carcinoma of vagina
16739,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, inv(16)(p13q22)"
16740,Locally Aggressive Lesion,Retiform hemangioendothelioma
16741,Arborizing Vascular Channel Formation,Retiform hemangioendothelioma
16742,Papillary Pattern,Condyloma Acuminatum with Dysplasia
16743,Well-Circumscribed Lesion,Adenomatoid tumor of epididymis
16744,High Mitotic Activity,Vaginal Small Cell Carcinoma
16745,Epithelial Component Present,Stage III Colon Cancer AJCC v7
16746,Secondary Lesion,Secondary Prostate Urothelial Carcinoma
16747,Mucoid Stroma Formation,Mucinous carcinoma of breast
16748,Epithelial Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm
16749,Lymphadenopathy,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma
16750,Recurrent disease,Angiocentric lymphoma recurrent
16751,Epithelial Component Present,Desmoplastic trichoepithelioma
16752,Adnexal Differentiation,Syringocystadenoma Papilliferum
16753,Cutaneous Involvement,Stage IIIB Cutaneous Melanoma AJCC v7
16754,Nodular lesions,Lung Typical Carcinoid Tumor
16755,Bilateral Disease,Bilateral Malignant Neoplasm
16756,Osseous Differentiation,Osteosarcoma Arising in Paget Disease of Bone
16757,Tissue Differentiation Uncertain,Childhood Desmoplastic Small Round Cell Tumor
16758,Carcinomatous Component Present,Alcohol-Related Carcinoma
16759,Recurrent disease,Recurrent Adult Hepatocellular Carcinoma
16760,Neutrophilia (finding),Chronic Neutrophilic Leukemia
16761,Papillary Pattern,Papillary mucinous cystadenoma
16762,Resectable Mass,Hepatoma resectable
16763,Epithelial Component Present,Ovarian Cystadenocarcinoma
16764,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7
16765,Carcinomatous Component Present,Alcohol-Related Laryngeal Carcinoma
16766,High Grade Lesion,Adult Alveolar Soft Part Sarcoma
16767,Epithelial Component Present,Lung Glandular Papilloma
16768,Negative Bone Marrow and Peripheral Blood,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
16769,Epithelial Component Present,"Papilloma, Squamous Cell"
16770,Immunosuppression-Related Post-Transplant Toxicity,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
16771,Diffuse Lesion,Lymphangitis carcinomatosa
16772,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
16773,Carcinomatous Component Present,undifferentiated carcinoma of pancreas
16774,Diffuse Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma
16775,Severe dysplasia,Colorectal Adenoma with Severe Dysplasia
16776,Antoni A Pattern,Benign Cardiac Schwannoma
16777,Dysplasia,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
16778,Indolent Clinical Course,Chondroblastoma
16779,Nested Pattern,Calcifying Nested Epithelial Stromal Tumor of the Liver
16780,Infantile Lesion,Infant Leukemia
16781,Lobulated Growth Pattern,Chordoma
16782,Non-Invasive Lesion,Non-Invasive Urothelial Neoplasm
16783,Epithelial Component Present,Gastric Neuroendocrine Carcinoma
16784,Intestinal metaplasia,Intestinal Metaplasia of Bladder Urachal Epithelium
16785,Childhood Lesion,PRETEXT Stage 4 Hepatoblastoma
16786,Epithelial Component Present,Appendix Tubulovillous Adenoma
16787,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage IV
16788,Pseudopapillary Pattern,Adult Papillary Meningioma
16789,Carcinomatous Component Present,Bladder Signet Ring Cell Adenocarcinoma
16790,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
16791,Absence of Invasion,"Glandular intraepithelial neoplasia, grade III"
16792,Geographic Necrosis,Testicular embryonal carcinoma
16793,Epithelial Component Present,"Thymoma, type AB, malignant"
16794,Primary Site Unknown,Undifferentiated Carcinoma of Unknown Primary
16795,Gastrin Positive Neoplastic Cells Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor
16796,Edematous Stroma Formation,Cervical Rhabdomyoma
16797,Biphasic Pattern,Borderline Ovarian Endometrioid Adenofibroma
16798,Carcinomatous Component Present,Rectal Micropapillary Adenocarcinoma
16799,Cutaneous Involvement,Malignant tumor of dermis
16800,Poorly Differentiated Lesion,Grade 3 Colon Adenocarcinoma
16801,Monoclonal Gammapathies,Familial Waldenstrom's Macroglobulinaemia
16802,Dome-Shaped Lesion,Vulvar Keratoacanthoma
16803,Lobulated Growth Pattern,Solid pseudopapillary tumor of the pancreas
16804,Carcinomatous Component Present,Carcinoma of anal margin
16805,Cutaneous Involvement,Secondary malignant neoplasm of skin
16806,Epithelial Component Present,mucinous adenocarcinoma of lung
16807,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma AJCC v7
16808,Carcinomatous Component Present,Carcinoma of the Floor of the Mouth
16809,Carcinomatous Component Present,carcinoma of lacrimal gland
16810,Borderline Lesion,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder
16811,Carcinomatous Component Present,NUT midline carcinoma
16812,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v7
16813,Keratin pearl formation,keratinizing squamous cell carcinoma of vulva
16814,Well-Circumscribed Lesion,Tubulovillous adenoma of rectum
16815,Pseudoencapsulated Mass,Epithelioid Malignant Peripheral Nerve Sheath Tumor
16816,Honeycomb Pattern,Basal cell carcinoma - adenoid
16817,Nuclear Pseudoinclusion,Nonencapsulated sclerosing tumor
16818,Absence of Invasion,Adenocarcinoma in situ in villous adenoma
16819,Indolent Clinical Course,lipoma of large intestine
16820,Indolent Clinical Course,Enchondromatosis
16821,Epithelial Component Present,Mixed Acinar-Ductal Carcinoma of the Pancreas
16822,Endophytic Tumor Growth,Recurrent Inverted Schneiderian Papilloma
16823,HMB-45-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis
16824,Hyperplastic Epithelial Tissue Present,Atypical Lobular Breast Hyperplasia
16825,Nodular Pattern,Ann Arbor Stage III Follicular Lymphoma
16826,Cutaneous Involvement,Keratoderma
16827,Cutaneous Involvement,Skin Basal Cell Carcinoma with Adnexal Differentiation
16828,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
16829,Fibrovascular Septa Present,Clear cell sarcoma of kidney
16830,Exophytic Papillary Lesion,"Papillary squamous cell carcinoma, non-invasive"
16831,Cutaneous Involvement,Pre-Malignant Skin Epithelial Lesion
16832,Metaplasia,Bladder Squamous Cell Carcinoma
16833,Tissue Differentiation Uncertain,Intimal sarcoma
16834,Squamoid Corpuscle,Pancreatoblastoma
16835,Epithelial Component Present,Carcinoma of Littre Glands
16836,Epithelial Component Present,Bladder Adenocarcinoma
16837,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma
16838,High Grade Lesion,Uterine Corpus High Grade Endometrial Stromal Sarcoma
16839,Hyperplastic Tissue Present,Lobular Endocervical Glandular Hyperplasia
16840,Cutaneous Involvement,Mycosis fungoides stage III
16841,Mixed Cellular Population,Rete Ovarii Cystadenofibroma
16842,Locally Aggressive Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential
16843,Slow Growing Mass,Tanycytic ependymoma
16844,Intraductal Lesion,Intracystic papillary adenoma
16845,Papillary Pattern,Papillary neoplasm
16846,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Hyperfunctioning Adenoma
16847,Perivascular fibrosis,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma
16848,Adnexal Differentiation,Pilomatrixoma
16849,Mixed Cellular Population,Carcinosarcoma of cervix uteri
16850,High Grade Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
16851,Carcinomatous Component Present,Intramucosal Adenocarcinoma
16852,Childhood Lesion,Recurrent Childhood Pilomyxoid Astrocytoma
16853,Carcinomatous Component Present,Carcinoma in situ of cecum
16854,Childhood Lesion,Recurrent Childhood Pineoblastoma
16855,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast with Atypia
16856,Neuronal Differentiation,Ganglioglioma
16857,Childhood Lesion,Childhood Brain Anaplastic Astrocytoma
16858,Erythema,Superficial basal cell carcinoma
16859,Epithelial Component Present,Invasive Breast Carcinoma by Histologic Grade
16860,Carcinomatous Component Present,Periampullary Adenocarcinoma
16861,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
16862,White blood cell count increased (lab result),"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
16863,Epithelial Component Present,Pericanalicular fibroadenoma
16864,Hyalinized Vessels Present,Pilocytic astrocytoma of cerebellum
16865,Increased Cellularity Present,Anaplastic Brain Stem Astrocytoma
16866,Epithelial Component Present,Adenocarcinoma of small intestine
16867,Pseudorosette Formation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
16868,Dermal Involvement,Common blue nevus of skin
16869,Vascular Channel Formation,Hemangioma of subcutaneous tissue
16870,In Situ Lesion,Apocrine Breast Carcinoma In Situ
16871,Hemorrhagic,Skin Angiosarcoma
16872,Sarcomatous Component Present,carcinosarcoma of liver
16873,Hyalinized Vessels Present,Pilocytic Astrocytoma
16874,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
16875,Epithelial Component Present,Large cell lung cancer stage I
16876,Epithelial Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma
16877,Anaplasia,Childhood Systemic Anaplastic Large Cell Lymphoma
16878,Immunosuppression-Related Post-Transplant Toxicity,Engraftment syndrome
16879,Diffuse Pattern,Glioblastoma multiforme of spinal cord
16880,Local disease,Localized Parathyroid Gland Carcinoma
16881,Primary Lesion,Synchronous Multifocal Osteosarcoma
16882,Carcinomatous Component Present,Anal squamous cell carcinoma
16883,Epithelial Component Present,Stage I Renal Pelvis Cancer AJCC v7
16884,Well-Circumscribed Lesion,Central Nervous System Hibernoma
16885,Childhood Lesion,Childhood Acute Monoblastic Leukemia
16886,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Neoplasm
16887,Epithelial Component Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma
16888,Childhood Lesion,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified"
16889,Carcinomatous Component Present,Stage IVB Cervical Cancer AJCC v6 and v7
16890,Epithelial Component Present,Helicobacter Pylori-Related Gastric Adenocarcinoma
16891,Childhood Lesion,Pediatric Extraocular Retinoblastoma
16892,Perivascular Arrangement of Tumor Cells,Angiomyoma
16893,Childhood Lesion,Childhood Extracranial Germ Cell Tumor
16894,Epithelial Component Present,"Adenoma, Microcystic"
16895,Intraductal Lesion,Atypical Ductal Breast Hyperplasia
16896,Carcinomatous Component Present,Microcystic adnexal carcinoma
16897,Lipomatous Component Present,Angiomyolipoma of kidney
16898,Epithelial Component Present,"Pheochromocytoma, malignant"
16899,Carcinomatous Component Present,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
16900,Borderline Lesion,Borderline Ovarian Endometrioid Cystadenofibroma
16901,Papillary Pattern,Oropharyngeal squamous papilloma
16902,Epithelial Component Present,Condyloma anal
16903,Perivascular Arrangement of Tumor Cells,Glomangiomyoma
16904,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with recurrent genetic abnormality
16905,Childhood Lesion,Recurrent Childhood Brain Stem Astrocytoma
16906,Epithelial Component Present,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
16907,Perineural spread,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
16908,Cystic Change,Cystadenofibroma
16909,Nuclear Grooves,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
16910,Carcinomatous Component Present,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
16911,Cutaneous Involvement,Ichthyosis Vulgaris
16912,Bilateral Disease,Bilateral Carcinoma
16913,Carcinomatous Component Present,Colon Cancer by AJCC v6 Stage
16914,Epithelial Component Present,Small Intestinal Neuroendocrine Neoplasm
16915,Recurrent disease,Recurrent Medulloblastoma
16916,Hereditary Lesion,Hereditary Kidney Wilms Tumor
16917,Cutaneous Involvement,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor)
16918,Primary Lesion,High grade surface osteosarcoma
16919,Carcinomatous Component Present,Small intestine carcinoma stage I
16920,Infiltrative Growth Pattern,Fibromatosis colli
16921,Cutaneous Involvement,Lentigo maligna melanoma
16922,Tubular Structures Present,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
16923,Carcinomatous Component Present,Nasopharyngeal Basaloid Squamous Cell Carcinoma
16924,Epithelial Component Present,Paget Disease Extramammary
16925,Epithelial Component Present,Low Grade Ovarian Serous Adenocarcinoma
16926,Childhood Lesion,Childhood Choroid Plexus Neoplasm
16927,Infiltrative Growth Pattern,Epithelioid glioblastoma
16928,Mitotic Activity,Epithelioid glioblastoma
16929,High Grade Lesion,Epithelioid glioblastoma
16930,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage II Immature Testicular Teratoma AJCC v6 and v7
16931,Mucoid Stroma Formation,mucinous adenocarcinoma of anus
16932,Carcinomatous Component Present,Accessory Urethral Gland Carcinoma
16933,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Adult Acute Promyelocytic Leukemia with PML-RARA
16934,Indolent Clinical Course,Lymphangioma circumscriptum
16935,Carcinomatous Component Present,"Lung Large Cell Carcinoma, Clear Cell Variant"
16936,Pineocytomatous Rosette Formation,Adult Pineocytoma
16937,Epithelial Component Present,Squamous papillomatosis
16938,Papillary Pattern,Squamous papillomatosis
16939,Invasive Lesion,Invasive Carcinoma
16940,Carcinomatous Component Present,Stage IIC Colorectal Cancer AJCC v7
16941,Solitary mass,Epithelioid hemangioendothelioma of lung
16942,Extraosseous Lesion,Extramedullary Plasmacytoma
16943,Epithelial Component Present,Broad Ligament Serous Cystadenoma
16944,Well Differentiated Lesion,keratoacanthoma
16945,Well-Circumscribed Lesion,Gallbladder adenoma
16946,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v6 and v7
16947,Indolent Clinical Course,Soft tissue chondroma
16948,Cartilaginous Differentiation,Mediastinal Chondroma
16949,Recurrent disease,Urothelial carcinoma bladder recurrent
16950,Neuroendocrine Differentiation,Esophageal Neuroendocrine Neoplasm
16951,Epithelial Component Present,Acinar cell carcinoma of pancreas
16952,Alternative Fascicle (Bundle) Pattern,Mediastinal Leiomyoma
16953,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change
16954,Well-Circumscribed Lesion,chondroma of lung
16955,Carcinomatous Component Present,Stage 0 Penile Cancer AJCC v7
16956,Epithelial Component Present,Stage IC Fallopian Tube Cancer AJCC v6 and v7
16957,Mitotic Activity,Malignant Ovarian Luteinized Thecoma
16958,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
16959,Stromal Invasion,FIGO Stage IC3 Ovarian Cancer
16960,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage I Immature Testicular Teratoma AJCC v6 and v7
16961,Carcinomatous Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
16962,Cutaneous Involvement,Nuchal-type fibroma
16963,Carcinomatous Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma
16964,Keratin pearl formation,Skin Basaloid Carcinoma
16965,atypia morphology,Classic Type Atypical Fibroxanthoma
16966,Benign Cellular Infiltrate,Anal Papillary Hidradenoma
16967,Diffuse Pattern,Primary Effusion Lymphoma
16968,Stromal Invasion,Ovarian cancer stage III
16969,Exophytic Polypoid Lesion,Appendix Sessile Serrated Adenoma/Polyp
16970,Epithelial Component Present,Stage IIIB Breast Carcinoma
16971,Increased Cellularity Present,Recurrent Childhood Anaplastic Oligoastrocytoma
16972,Local disease,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
16973,Radiation Sickness,Radiation Anemia
16974,Carcinomatous Component Present,Vulvar Clear Cell Hidradenocarcinoma
16975,Cutaneous Involvement,Vulvar Clear Cell Hidradenocarcinoma
16976,Local disease,Localized Unresectable Adult Hepatocellular Carcinoma
16977,Stromal Invasion,Recurrent ovarian cancer
16978,Intraosseous Lesion,Primary solid type intraosseous squamous cell carcinoma
16979,Apocrine Differentiation,apocrine adenocarcinoma of vulva
16980,Numerous Stromal Mast Cells Present,Vaginal Angiomyofibroblastoma
16981,Poorly Differentiated Lesion,Gingival Spindle Cell Carcinoma
16982,Neuroendocrine Differentiation,Intestinal Neuroendocrine Tumor G2
16983,Respiratory distress,"Respiratory Distress Syndrome, Newborn"
16984,Carcinomatous Component Present,Warty Carcinoma of the Penis
16985,Well Differentiated Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
16986,Increased Cellularity Present,Regional Neuroblastoma
16987,Carcinomatous Component Present,Stage II Merkel Cell Carcinoma AJCC v7
16988,Indolent Clinical Course,Cardiac Lipoma
16989,Exophytic Polypoid Lesion,Adenomatous polyp of rectum
16990,Single Cell Necrosis,Stage IIIA Merkel Cell Carcinoma AJCC v7
16991,Bone Marrow Dysplasia Present,Refractory cytopenia with unilineage dysplasia
16992,Epithelial Component Present,adenoid cystic carcinoma of pharynx
16993,Papillary Pattern,Solid Papillary Breast Carcinoma
16994,Epithelial Component Present,Apocrine adenoma
16995,Epithelial Component Present,Ovarian Squamous Cell Tumor
16996,Epithelial Component Present,Gallbladder Neuroendocrine Tumor G1
16997,Carcinomatous Component Present,Malignant neoplasm of stomach stage II
16998,Plexiform Growth Pattern,Plexiform Schwannoma
16999,Immunologic Deficiency Syndromes,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
17000,Moderately Differentiated Lesion,"Squamous Cell Carcinoma of the Penis, Usual Type"
17001,Epithelial Component Present,Gallbladder Mixed Adenoneuroendocrine Carcinoma
17002,Cystic Change,Dermoid cyst of ovary
17003,Epithelial Component Present,eccrine adenocarcinoma of vulva
17004,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged
17005,Childhood Lesion,Stage II Childhood Anaplastic Large Cell Lymphoma
17006,Epithelial Component Present,Stage II Rectosigmoid Cancer AJCC v6
17007,Epithelial Component Present,"Breast Cancer, Familial"
17008,Invasive Lesion,Moderately Differentiated Prostate Adenocarcinoma
17009,Carcinomatous Component Present,Sarcomatoid carcinoma of the lung
17010,Splenomegaly,T-Cell Large Granular Lymphocyte Leukemia
17011,Well Differentiated Lesion,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
17012,Papillary Pattern,Borderline Ovarian Serous Cystadenofibroma
17013,Carcinomatous Component Present,Colorectal Neuroendocrine Carcinoma
17014,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Hypocellular Myelodysplastic Syndrome
17015,Splenomegaly,Splenic Manifestation of Leukemia
17016,Epithelial Component Present,mucoepidermoid carcinoma of esophagus
17017,Multifocal Lesion,Colon Serrated Polyposis
17018,Immunologic Deficiency Syndromes,Chronic graft-versus-host disease
17019,Carcinomatous Component Present,"Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8"
17020,Carcinomatous Component Present,Laryngeal verrucous carcinoma stage IV
17021,Carcinomatous Component Present,Small intestine adenocarcinoma metastatic NOS
17022,Huge Vascular Channel Formation,Telangiectatic Glomangioma
17023,Necrotic changes (finding),Glioblastoma
17024,Epithelial Component Present,"Gastrinoma, malignant"
17025,Low Mitotic Activity,"Gastrinoma, malignant"
17026,Neuroendocrine Differentiation,"Gastrinoma, malignant"
17027,Metaplasia of Malignant Cells Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma
17028,Childhood Lesion,Childhood Cerebellar Astrocytoma
17029,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia
17030,Intraductal Lesion,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
17031,Nodular Pattern,Ann Arbor Stage III Grade 3 Follicular Lymphoma
17032,Epithelial Component Present,Adenoid cystic carcinoma of submandibular gland
17033,Bone Marrow Dysplasia Present,Chronic Myelomonocytic Leukemia-1
17034,Well-Circumscribed Lesion,Colorectal Cowden-Associated Polyp
17035,Poikilocytosis,Post polycythaemia vera myelofibrosis
17036,Adnexal Differentiation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
17037,High Grade Lesion,Synovial sarcoma recurrent
17038,High Mitotic Activity,Stage III Lung Small Cell Carcinoma AJCC v7
17039,Hypercellular bone marrow,Prefibrotic/Early Primary Myelofibrosis
17040,Epithelial Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant"
17041,Epithelial Component Present,Gallbladder Neuroendocrine Carcinoma
17042,Stromal Invasion,large cell neuroendocrine carcinoma of ovary
17043,Papillary Pattern,"Papillary transitional cell carcinoma, non-invasive"
17044,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
17045,Immunologic Deficiency Syndromes,AIDS-Related Anal Carcinoma
17046,Epithelial Component Present,Hereditary Female Breast Carcinoma
17047,Cutaneous Involvement,Dermatitis
17048,Cartilaginous Differentiation,Juxtacortical chondrosarcoma
17049,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v7
17050,Carcinomatous Component Present,Multicentric Breast Carcinoma
17051,Mass of body structure,Immature Granulocytic Sarcoma
17052,Carcinomatous Component Present,Early-Stage Breast Carcinoma
17053,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
17054,Epithelial Component Present,Adenocarcinoma in Situ
17055,Infiltrative Growth Pattern,Peyronie Disease
17056,Neuroendocrine Differentiation,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
17057,Diffuse Pattern,AIDS-Related Primary Effusion Lymphoma
17058,Epithelial Component Present,Benign oncocytoma of salivary gland
17059,Carcinomatous Component Present,Vulvar adenocarcinoma
17060,Epithelial Component Present,Small cell carcinoma of prostate
17061,Carcinomatous Component Present,Non-small cell lung cancer stage I
17062,Angiodestructive Pattern,Recurrent Grade III Lymphomatoid Granulomatosis
17063,Carcinomatous Component Present,Mixed Squamous Cell Carcinoma of the Penis
17064,Severe cytologic atypia,Proximal-Type Epithelioid Sarcoma
17065,Epithelial Component Present,Parotid Gland Acinic Cell Carcinoma
17066,High Grade Lesion,Cardiac Rhabdomyosarcoma
17067,Dysplasia,Pancreatic Intraepithelial Neoplasia-1B
17068,Dysplasia,Intraductal Non-Comedo Breast Adenocarcinoma
17069,Low Grade Lesion,Childhood Subependymal Giant Cell Astrocytoma
17070,HMB-45-Positive Neoplastic Cells Present,Pulmonary lymphangioleiomyomatosis
17071,Lesion with Diameter of 10mm or Less,Papillary Thyroid Microcarcinoma
17072,Vascular Channel Formation,Vulvar Angiomyxoma
17073,High Grade Lesion,alveolar rhabdomyosarcoma of orbit
17074,Increased Cellularity Present,Neuroblastoma
17075,Local disease,Pericardial Adenomatoid Tumor
17076,Cutaneous Involvement,Acantholytic acanthoma
17077,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type"
17078,Neuroendocrine Differentiation,Malignant carcinoid tumor of lung
17079,Cutaneous Involvement,Old Burn Scar-Related Skin Squamous Cell Carcinoma
17080,Malignant Germinomatous Cellular Infiltrate,Adult Central Nervous System Germinoma
17081,Lobulated Growth Pattern,Apocrine adenoma
17082,Slow Growing Mass,Adult Subependymoma
17083,Well-Circumscribed Lesion,Ovarian Adenomatoid Tumor
17084,Papillary Pattern,"Papillary mucinous cystadenoma, borderline malignancy"
17085,Indolent Clinical Course,Uterine Corpus Bizarre Leiomyoma
17086,Epithelial Component Present,Mucinous Adenocarcinoma
17087,Cystic Change,Benign cystic nephroma
17088,Mixed Cellular Population,Mixed Neoplasm
17089,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Hydropic Leiomyoma
17090,Epithelial Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v7
17091,Exophytic Polypoid Lesion,Colorectal Adenoma with Severe Dysplasia
17092,Cementum Formation,Ossifying Fibroma
17093,Epithelial Component Present,Occult Lung Adenosquamous Carcinoma
17094,HMB-45-Positive Neoplastic Cells Present,Lung Clear Cell Tumor
17095,Carcinomatous Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7
17096,Mixed Cellular Population,Stage V Kidney Wilms Tumor
17097,High Mitotic Activity,small cell carcinoma of kidney
17098,Borderline Lesion,"lymphomatoid papulosis, type C"
17099,Radiation Sickness,Solar Radiation-Related Skin Squamous Cell Carcinoma
17100,Necrotic changes (finding),Nasal Cavity and Paranasal Sinus Small Cell Carcinoma
17101,Splenomegaly,"Myeloid Leukemia, Chronic"
17102,Aggressive Clinical Course,undifferentiated sarcoma of ovary
17103,Papillary Pattern,Stage 0a Ureter Cancer AJCC v7
17104,Nested Pattern,Childhood Clear Cell Sarcoma of Soft Parts
17105,Low Mitotic Activity,Pancreatic Gastrin-Producing Neuroendocrine Tumor
17106,Adulthood Lesion,Adult Solid Neoplasm
17107,Increased Cellularity Present,Childhood Cerebellar Anaplastic Astrocytoma
17108,Epithelial Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)
17109,High Grade Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
17110,Recurrent disease,Recurrent Childhood Optic Nerve Glioma
17111,Epithelial Component Present,Disseminated carcinoma
17112,High Grade Lesion,High Grade Liver Dysplastic Nodule
17113,Infiltrative Growth Pattern,Recurrent Childhood Gemistocytic Astrocytoma
17114,Childhood Lesion,Childhood Thyroid Gland Carcinoma
17115,Epithelial Component Present,Localized Digestive System Neuroendocrine Tumor G1
17116,Absence of Invasion,Intermediate Grade Ductal Breast Carcinoma In Situ
17117,Mucoid Stroma Formation,mucinous adenocarcinoma of lung
17118,Hyperplastic Tissue Present,Simple Endometrial Hyperplasia
17119,Carcinomatous Component Present,"Carcinoma, Giant Cell"
17120,Recurrent disease,Prostate cancer recurrent
17121,Well-Circumscribed Lesion,Bile duct adenoma
17122,Epithelial Component Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor
17123,Malignant Component Present,Ovarian Dermoid Cyst with Secondary Sarcoma
17124,Non-Hereditary Lesion,Signet-ring cell adenocarcinoma gastric
17125,High Mitotic Activity,Occult Lung Small Cell Carcinoma
17126,Recurrent disease,Hepatoblastoma recurrent
17127,Severe dysplasia,Bladder squamous cell carcinoma stage 0
17128,Carcinomatous Component Present,Grade 2 Clear Cell Renal Cell Carcinoma
17129,Exophytic Polypoid Lesion,Adenomatous Polyposis Coli
17130,Epithelial Component Present,mucinous adenocarcinoma of ovary
17131,Presence of a Hormonal Syndrome,Functioning Pancreatic Neuroendocrine Tumor
17132,Biphasic Pattern,Nephrogenic adenofibroma
17133,Pseudopapillary Pattern,Testicular embryonal carcinoma stage II
17134,IDH Gene Family Mutation Status Unknown,oligodendroglioma
17135,Epithelial Component Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
17136,Epithelial Component Present,Breast Carcinoma with Chondroid Metaplasia
17137,Epithelial Component Present,Vaginal Cancer by AJCC v7 Stage
17138,Monomorphic Cellular Infiltrate,Recurrent Childhood Ependymoma
17139,Indolent Clinical Course,Benign Metastasizing Leiomyoma of the Uterine Corpus
17140,Severe cytologic atypia,small cell carcinoma of extrahepatic bile duct
17141,Epithelial Component Present,Vulvar Adenocarcinoma of Sweat Gland Type
17142,Hyperplastic Tissue Present,Epithelial hyperplasia of skin
17143,Epithelial Component Present,Stage IIA Pancreatic Cancer AJCC v6 and v7
17144,Well-Circumscribed Lesion,Colon Juvenile Polyp
17145,Pseudoencapsulated Mass,Cervical Malignant Peripheral Nerve Sheath Tumor
17146,Carcinomatous Component Present,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
17147,Endophytic Tumor Growth,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
17148,Epithelial Component Present,Villous adenocarcinoma
17149,Epithelial Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral"
17150,Hyperplastic Tissue Present,Papillary Urothelial Hyperplasia
17151,Dysplasia,High Grade Gastric Intraepithelial Neoplasia
17152,Carcinomatous Component Present,Hypopharyngeal Carcinoma by AJCC v7 Stage
17153,Epithelial Component Present,Hypopharyngeal Carcinoma by AJCC v7 Stage
17154,Well-Circumscribed Lesion,Appendix Mucinous Cystadenoma
17155,Cartilaginous Differentiation,Mesenchymal Chondrosarcoma
17156,Monomorphic Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma
17157,Carcinomatous Component Present,Combined Lung Large Cell Neuroendocrine Carcinoma
17158,Epithelial Component Present,Nodulo-ulcerative basal cell carcinoma
17159,Epithelial Component Present,Laryngeal Cancer by AJCC v7 Stage
17160,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Seminoma
17161,Benign Cellular Infiltrate,Leiomyoma of Gallbladder
17162,Primary Lesion,Adult Pineal Gland Astrocytoma
17163,Endophytic Tumor Growth,verrucous carcinoma of esophagus
17164,Carcinomatous Component Present,Primary peritoneal carcinoma
17165,High Grade Lesion,"Synovial sarcoma, biphasic"
17166,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma non-metastatic
17167,Shadow Cells Present,Pilomatrixoma
17168,Biphasic Pattern,Carcinosarcoma of cervix uteri
17169,Gastric dysplasia,adenomatous polyp of stomach
17170,CD30-Positive Neoplastic Cells Present,Ki-1+ Anaplastic Large Cell Lymphoma
17171,Epithelial Component Present,Tumor of follicular infundibulum
17172,Carcinomatous Component Present,Stage 0 Appendix Carcinoma AJCC v7
17173,Indolent Clinical Course,Vulvar Fibrolipoma
17174,Biphasic Pattern,"Mixed Tumor, Mullerian"
17175,Exophytic Polypoid Lesion,Anal Canal Squamous Papilloma
17176,Diffuse Pattern,Supratentorial Glioblastoma
17177,Indolent Clinical Course,Uterine Corpus Lipoleiomyoma
17178,Systemic disease,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative"
17179,Intraluminal Tumor Growth,Gallbladder papillary adenocarcinoma
17180,Refractory Disease,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
17181,Increased Cellularity Present,Anaplastic Oligodendroglioma
17182,Mixed Cellular Population,Childhood Brain Stem Mixed Glioma
17183,Invasive Lesion,TSH-Producing Pituitary Gland Carcinoma
17184,Cutaneous Involvement,Hemangioendothelioma of skin
17185,Adulthood Lesion,Adult Extraskeletal Osteosarcoma
17186,Osseous Component Present,Bizarre parosteal osteochondromatous proliferation
17187,Lytic lesion,Malignant Giant Cell Tumor of Bone
17188,Epithelial Component Present,"Adenoma, Trabecular"
17189,Epithelial Component Present,Colon Adenoma with Severe Dysplasia
17190,Intracanalicular Growth Pattern,Malignant Cystosarcoma Phyllodes
17191,Tissue Differentiation Uncertain,Extrarenal Rhabdoid Tumor of the Liver
17192,Cartilage-Like Elements Present,Chondroid chordoma
17193,Islands of Odontogenic Epithelium Present,Peripheral Odontogenic Fibroma
17194,Fibrotic Stroma Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
17195,Epithelial Component Present,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7
17196,Mediastinal mass,Mediastinal T Acute Lymphoblastic Leukemia
17197,Necrotic changes (finding),Small cell neuroendocrine carcinoma of bladder
17198,Nuclear Molding,"Ovarian Small Cell Carcinoma, Pulmonary Type"
17199,Pregnancy Complications,Stage IIIA Gestational Trophoblastic Tumor AJCC v7
17200,Epithelial Component Present,Lung adenocarcinoma recurrent
17201,Neuroectodermal Differentiation,olfactory neuroblastoma of nasal cavity
17202,Epithelial Component Present,Stage IVB Appendix Carcinoma AJCC v7
17203,Slow Growing Mass,Venous Angioleiomyoma
17204,Monomorphic Cellular Infiltrate,Angiocentric glioma
17205,Metastatic/Recurrent Disease,Adult Synovial Sarcoma
17206,Adnexal Differentiation,Malignant Apocrine Neoplasm
17207,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v7
17208,Indolent Clinical Course,Cutaneous Fibrous Histiocytoma
17209,Childhood Lesion,Childhood Synovial Sarcoma
17210,Juvenile Lesion,Juvenile granulosa cell tumor
17211,Primary Lesion,Diffuse large B-cell lymphoma of central nervous system
17212,Dysplasia,Cervical Adenocarcinoma In Situ
17213,Carcinomatous Component Present,Cervical Adenocarcinoma In Situ
17214,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma of lacrimal gland
17215,Tubular Pattern,Tubular adenoma of breast
17216,Thick-Walled Vessels Present,Angiomyolipoma of kidney
17217,Tissue Differentiation Uncertain,Angiomyolipoma of kidney
17218,S-100-Positive Neoplastic Cells Present,Angiomyolipoma of kidney
17219,Well-Circumscribed Lesion,Genital rhabdomyoma
17220,Keratin pearl formation,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
17221,Absence of Invasion,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
17222,Indolent Clinical Course,Benign Cutaneous Vascular Neoplasm
17223,In Situ Lesion,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
17224,Sarcomatous Component Present,Malignant Mixed Mesodermal (Mullerian) Tumor
17225,Epithelial Component Present,Papillary Urothelial Neoplasm
17226,Recurrent disease,Recurrent Merkel Cell Carcinoma
17227,Slow Growing Mass,Chordoma of clivus
17228,Carcinomatous Component Present,Oropharyngeal Carcinoma
17229,Mild dysplasia,Vaginal intraepithelial neoplasia grade 1
17230,Tubular Structures Present,Pyloric Gland Adenoma
17231,Enterochromaffin Type Granules Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
17232,Non-Hereditary Lesion,Sporadic Gastric Adenocarcinoma
17233,Islands of Neuropil-Like Matrix Present,Glioneuronal Tumor with Neuropil-Like Islands
17234,Sarcomatous Component Present,"Uterine Carcinosarcoma, Homologous Type"
17235,Intravascular Fibrin Thrombus Formation,Epidural Spinal Canal Angiolipoma
17236,Epithelial Component Present,Sporadic Thyroid Gland Medullary Carcinoma
17237,Sarcomatous Component Present,"Uterine Carcinosarcoma, Heterologous Type"
17238,Vascular Channel Formation,Colorectal Angiosarcoma
17239,Lobulated Growth Pattern,Clivus Chondroid Chordoma
17240,Childhood Lesion,Benign Childhood Supratentorial Neoplasm
17241,Favorable Clinical Outcome,Retroperitoneal Ganglioneuroma
17242,Epithelial Component Present,Recurrent Adrenal Gland Pheochromocytoma
17243,Neuroendocrine Differentiation,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
17244,Biphasic Pattern,carcinosarcoma of fallopian tube
17245,Hereditary Lesion,Cherubism
17246,Mixed Cellular Population,Nephroblastoma
17247,Epithelial Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
17248,"Undifferentiated ""Fetal-Type"" Tissues Present","Teratoma, Malignant"
17249,Epithelial Component Present,Buschke-Lowenstein Tumor
17250,Exophytic Papillary Lesion,Buschke-Lowenstein Tumor
17251,Epithelial Component Present,Adenocarcinoma
17252,Peau d'orange surface of breast,Inflammatory Breast Carcinoma
17253,Fibrotic Stroma Formation,Tubulocystic renal cell carcinoma
17254,Infiltrative Growth Pattern,Brain Glioblastoma
17255,Dysplasia,Colorectal Sessile Serrated Adenoma/Polyp
17256,Mixed Cellular Population,Mixed Salivary Gland Tumor
17257,Tubular Structures Present,Sertoli Cell Tumor
17258,Severe dysplasia,Carcinoma in situ of penis
17259,Cartilaginous Differentiation,Soft tissue chondroma
17260,Diarrhea,Malignant Pancreatic Vipoma
17261,Necrotic changes (finding),small cell carcinoma of breast
17262,Glomeruloid Vessels Present,Adult Pilocytic Astrocytoma
17263,Hereditary Lesion,Hereditary Breast and Ovarian Cancer Syndrome
17264,High Mitotic Activity,Childhood Central Nervous System Embryonal Carcinoma
17265,Carcinomatous Component Present,squamous cell carcinoma of lacrimal gland
17266,Epithelial Component Present,Stage I Liver Carcinoma
17267,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
17268,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Choriocarcinoma
17269,Locally Aggressive Lesion,"Histiocytoma, Angiomatoid Fibrous"
17270,Epithelial Component Present,Stage IIIB Fallopian Tube Cancer AJCC v7
17271,'Starry-sky' pattern,Stage I Childhood Burkitt Lymphoma
17272,High Mitotic Activity,Classic Type Atypical Fibroxanthoma
17273,High Mitotic Activity,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
17274,Vascular Channel Formation,Childhood Conventional Osteosarcoma
17275,Sebaceous Differentiation,Sebaceous Gland Neoplasms
17276,Cystic Change,Pancreatic Intraductal Papillary Mucinous Neoplasm
17277,Tubular Structures Present,Malignant Sertoli Cell Tumor
17278,Epithelial Component Present,Benign epithelial neoplasm of skin
17279,Epithelial Component Present,Acantholytic squamous cell carcinoma
17280,Diffuse Pattern,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly
17281,Epithelial Component Present,Microscopic Thymoma
17282,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1A
17283,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal bone tumor
17284,Antoni A Pattern,Schwannoma of the Twelfth Cranial Nerve
17285,Recurrent disease,Neuroblastoma recurrent
17286,Mild dysplasia,Low Grade Prostatic Intraepithelial Neoplasia
17287,Thyroglobulin Positive Neoplastic Cells Present,Poorly Differentiated Thyroid Carcinoma
17288,Carcinomatous Component Present,Ampulla of Vater Hepatoid Adenocarcinoma
17289,Ineffective hematopoiesis,Refractory cytopenia with unilineage dysplasia
17290,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
17291,Cytoplasmic Membrane-Bound Granules Present,Stage IIIB Merkel Cell Carcinoma AJCC v7
17292,Epithelial Component Present,Stage IIIB Merkel Cell Carcinoma AJCC v7
17293,Epithelial Component Present,Gallbladder Cancer by AJCC v7 Stage
17294,Adulthood Lesion,Adult Type Testicular Granulosa Cell Tumor
17295,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
17296,Adulthood Lesion,Lymphomatous Adult T-Cell Leukemia/Lymphoma
17297,Lymphadenopathy,Lymphomatous Adult T-Cell Leukemia/Lymphoma
17298,Epithelial Component Present,Childhood Bladder Carcinoma
17299,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ganglioneuroblastoma
17300,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood
17301,Mild cytologic atypia,Buccal Mucosa Verrucous Carcinoma
17302,Perivascular fibrosis,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites"
17303,Neuronal Differentiation,Central Neurocytoma
17304,Well Differentiated Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma
17305,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity
17306,Epithelial Component Present,Benign tumor of choroid plexus
17307,Cord-Like Pattern,Vulvar Syringoma
17308,Epithelial Component Present,Appendix Neuroendocrine Tumor G2
17309,Slow Growing Painless Mass,Palisaded encapsulated neuroma
17310,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma
17311,Encapsulated Mass,Microfollicular adenoma
17312,Carcinomatous Component Present,Thyroid Gland Mucoepidermoid Carcinoma
17313,Absence of Invasion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
17314,Koilocytotic atypia,Human Papillomavirus-Related Verrucous Carcinoma
17315,Thyroglobulin Positive Neoplastic Cells Present,Multicentric Thyroid Gland Papillary Carcinoma
17316,Tobacco Toxicity,Tobacco-Related Carcinoma
17317,Childhood Lesion,Stage I Childhood Lymphoblastic Lymphoma
17318,Polymorphic Cellular Infiltrate,Grade I Lymphomatoid Granulomatosis
17319,Multilayered Rosette Formation,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
17320,Vascular Channel Formation,Intracortical osteosarcoma
17321,Carcinomatous Component Present,EBV-Related Carcinoma
17322,Invasive Lesion,Low Grade Adenosquamous Breast Carcinoma
17323,Nodular lesions,Thyroid Gland Mucinous Follicular Adenoma
17324,Infiltrative Growth Pattern,"Fibromatosis, Plantar"
17325,Multinodular Mass,Ovarian Angiosarcoma
17326,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Endometrioid Tumor
17327,Infiltrative Growth Pattern,Chest Wall Fibromatosis
17328,Diffuse Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor
17329,Invasive Lesion,Sebaceous Breast Carcinoma
17330,Cutaneous Involvement,Dermatofibrosarcoma Protuberans
17331,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Spindle Cell Elements
17332,Metastatic/Recurrent Disease,Synovial sarcoma metastatic
17333,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7
17334,VIP Positive Neoplastic Cells Present,Pancreatic Vipoma
17335,In Situ Lesion,Stage 0 Esophageal Cancer AJCC v6
17336,Carcinomatous Component Present,Small intestine carcinoma non-resectable
17337,Epithelial Component Present,Stage 0 Colon Cancer AJCC v6 and v7
17338,Carcinomatous Component Present,Anterior Tongue Carcinoma
17339,Epithelial Component Present,Juvenile papillomatosis of breast
17340,Adulthood Lesion,Adult Acute Myelomonocytic Leukemia
17341,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Hepatocellular Carcinoma
17342,Epithelial Component Present,"Transitional cell carcinoma, micropapillary"
17343,Hyperplastic Tissue Present,Lymphoid hyperplasia
17344,Epithelial Component Present,Stage II Lung Cancer AJCC v6
17345,Immunologic Deficiency Syndromes,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation
17346,Cystic Change,Pancreatic Intraductal Papillary-Mucinous Adenoma
17347,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
17348,Carcinomatous Component Present,Stage IIIB Colon Cancer AJCC v7
17349,Epithelial Component Present,Esophageal Spindle Cell Carcinoma
17350,Cutaneous Involvement,Dermatosis Papulosa Nigra
17351,Epithelial Component Present,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
17352,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Lung Carcinoma
17353,Thick-Walled Hyalinized Vessels Present,Acoustic Neuroma
17354,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
17355,Mass of body structure,Differentiated Granulocytic Sarcoma
17356,Indolent Clinical Course,Leiomyoma of small intestine
17357,High Mitotic Activity,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
17358,Epithelial Component Present,Basal cell carcinoma of vulva
17359,Epithelial Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
17360,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Solid Pattern"
17361,Necrotic changes (finding),Malignant Solitary Fibrous Tumor
17362,Diffuse Pattern,Childhood Fibrillary Astrocytoma
17363,Well-Circumscribed Lesion,Gastric adenoma
17364,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage I supradiaphragmatic
17365,Well-Circumscribed Lesion,Renal Pelvis Fibroepithelial Polyp
17366,Malignant Cellular Infiltrate,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
17367,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
17368,Childhood Lesion,Cystic Partially Differentiated Nephroblastoma
17369,Necrotic changes (finding),Esophageal Malignant Peripheral Nerve Sheath Tumor
17370,Vascular Channel Formation,Aggressive angiomyxoma
17371,Cutaneous Involvement,Invasive Apocrine Breast Carcinoma
17372,Cutaneous Involvement,Syringocystadenoma Papilliferum
17373,Cutaneous Involvement,Follicular Myxoma
17374,Lobulated Growth Pattern,Follicular Myxoma
17375,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
17376,Biphasic Pattern,Childhood Mesenchymal Chondrosarcoma
17377,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q23;q21)
17378,Moderately Differentiated Lesion,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
17379,Therapy-Related Toxicity,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
17380,Gastrin Positive Neoplastic Cells Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor
17381,Low Grade Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant"
17382,Nodular Pattern,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma
17383,Geographic Necrosis,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma
17384,Hyaline Cartilage Differentiation,Childhood Myxoid Chondrosarcoma
17385,Cutaneous Involvement,Seborrheic keratosis of eyelid
17386,Hyaline Cartilage Differentiation,Adult Myxoid Chondrosarcoma
17387,Stromal Invasion,Ovarian Cancer by AJCC v6 and v7 Stage
17388,Atypical Mitotic Figures,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
17389,S-100-Positive Neoplastic Cells Present,Perivascular Epithelioid Cell Neoplasms
17390,Epithelial Component Present,Adamantinoma
17391,Epithelial Component Present,Ampulla of Vater Undifferentiated Carcinoma
17392,Absence of Invasion,Lobular Neoplasia Type A
17393,Recurrent disease,Recurrent Thyroid Carcinoma
17394,Malignant Germinomatous Cellular Infiltrate,Testicular Seminoma with Syncytiotrophoblastic Cells
17395,Childhood Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6
17396,Alternative Fascicle (Bundle) Pattern,Cellular leiomyoma
17397,Chromogranin A Positive Neoplastic Cells Present,Laryngeal Carcinoid Tumor
17398,Adulthood Lesion,Adult Clear Cell Sarcoma of Soft Parts
17399,Epithelial Component Present,Stage I Gallbladder Cancer AJCC v6
17400,Well-Circumscribed Lesion,Appendix Traditional Serrated Adenoma
17401,Sarcomatous Component Present,Ovarian Dermoid Cyst with Leiomyosarcoma
17402,Epithelial Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
17403,Carcinomatous Component Present,mixed acinar-endocrine carcinoma of pancreas
17404,Refractory Disease,B-cell small lymphocytic lymphoma refractory
17405,Perivascular fibrosis,Hodgkin's disease nodular sclerosis refractory
17406,Childhood Lesion,Childhood Central Nervous System Teratoma
17407,Epithelial Component Present,insulinoma
17408,Epithelial Component Present,mucinous adenocarcinoma of rectum
17409,Intraductal Lesion,Flat Ductal Epithelial Atypia of the Breast
17410,Epithelial Component Present,Borderline Ovarian Endometrioid Adenofibroma
17411,Carcinomatous Component Present,Stage III Urethral Cancer AJCC v7
17412,Epithelial Component Present,Intestinal Neuroendocrine Carcinoma
17413,Secondary Lesion,Secondary malignant neoplasm of bone marrow
17414,Epithelial Component Present,"Cystadenocarcinoma, Mucinous"
17415,Epithelial Component Present,Childhood Renal Cell Carcinoma
17416,Childhood Lesion,Childhood Visual Pathway Astrocytoma
17417,Anaplasia,Recurrent Childhood Glioblastoma
17418,Neuroendocrine Differentiation,Gastric Carcinoid Tumor
17419,Pushing Tumor Margin,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
17420,High Grade Lesion,Recurrent Childhood Gliosarcoma
17421,Epithelial Component Present,Familial Nonmedullary Thyroid Gland Carcinoma
17422,Cutaneous Involvement,Anal margin basal cell carcinoma
17423,Therapy-Related Toxicity,"Neoplasms, Therapy-Associated"
17424,Dysplasia,Bile duct adenoma
17425,Carcinomatous Component Present,Occult Lung Small Cell Carcinoma
17426,Carcinomatous Component Present,carcinosarcoma of extrahepatic bile duct
17427,Neuroendocrine Differentiation,Carcinoid tumor of appendix
17428,Epithelial Component Present,NUT midline carcinoma
17429,Epithelial Component Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12)
17430,Carcinomatous Component Present,"Bronchiolo-alveolar carcinoma, non-mucinous"
17431,Carcinomatous Component Present,Carcinoma bone
17432,Indolent Clinical Course,Glomangiomatosis
17433,Dysplasia,Rectal Adenoma with Severe Dysplasia
17434,Desmoplastic Stroma Formation,Desmoplastic infantile ganglioglioma
17435,Infantile Lesion,Desmoplastic infantile ganglioglioma
17436,Immunologic Deficiency Syndromes,AIDS with Kaposi's sarcoma
17437,Myxoid Stroma Formation,Left atrial myxoma
17438,Carcinomatous Component Present,Vulvar Adenocarcinoma of Sweat Gland Type
17439,Epithelial Component Present,Pericardial Carcinomatosis
17440,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation
17441,Epithelial Component Present,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7
17442,Epithelial Component Present,Gastrointestinal carcinoma in situ
17443,In Situ Lesion,Gastrointestinal carcinoma in situ
17444,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic
17445,Epithelial Component Present,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
17446,Invasive Lesion,Ductal Carcinoma In Situ with Microinvasion
17447,Osseous Differentiation,Bone island
17448,Locally Aggressive Lesion,Intermediate Osteogenic Neoplasm
17449,Vascular Channel Formation,Post-Radiotherapy Breast Angiosarcoma
17450,Tissue Differentiation Uncertain,Angiomyolipoma
17451,Epithelial Component Present,Benign epithelial tumor of ovary
17452,Cutaneous Involvement,Cutaneous T Lymphoblastic Leukemia/Lymphoma
17453,Childhood Lesion,Childhood Liposarcoma
17454,High Grade Lesion,Sarcoma NCI Grade 3
17455,Fibrovascular Septa Present,Conventional Alveolar Rhabdomyosarcoma
17456,Cribriform Pattern,Colorectal Cribriform Comedo-Type Adenocarcinoma
17457,Epithelial Component Present,Clear Cell Papillary Cystadenoma
17458,Peripheral Nuclear Palisading,Combined Lung Large Cell Neuroendocrine Carcinoma
17459,Carcinomatous Component Present,Bladder Squamous Cell Carcinoma
17460,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage
17461,Epithelial Component Present,Mucinous cystadenocarcinoma appendix
17462,Well-Circumscribed Lesion,Hamartomatous polyp
17463,Pseudoalveolar Pattern,Alveolar soft part sarcoma metastatic
17464,Childhood Lesion,Childhood Langerhans Cell Histiocytosis
17465,Hyperplastic Epithelial Tissue Present,Papillary Ductal Breast Hyperplasia
17466,Rarely Metastasizing Lesion,Composite hemangioendothelioma
17467,Exophytic Polypoid Lesion,Multiple polyps
17468,Diffuse Pattern,Diffuse Glioma
17469,Epithelial Component Present,Germinative Follicular Epithelium Neoplasm
17470,Firm mass,Childhood Malignant Peripheral Nerve Sheath Tumor
17471,Thick-Walled Hyalinized Vessels Present,Benign Dermal Schwannoma
17472,Multifocal Lesion,Multiple Endocrine Neoplasia Type 2a
17473,Capillary Sized Vascular Channel Formation,Breast Capillary Hemangioma
17474,Honeycomb Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
17475,Epithelial Component Present,Fetal Lung Adenocarcinoma
17476,Necrotic changes (finding),small cell carcinoma of ureter
17477,Monophasic Pattern,"Synovial sarcoma, epithelioid cell"
17478,atypia morphology,Adult Grade III Lymphomatoid Granulomatosis
17479,Diffuse Pattern,Adult Grade III Lymphomatoid Granulomatosis
17480,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of cervix uteri
17481,Diffuse Pattern,Gliomatosis cerebri
17482,Mixed Cellular Population,Uterine Corpus Carcinofibroma
17483,Biphasic Pattern,Vaginal Adenosarcoma
17484,Increased Cellularity Present,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma
17485,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma recurrent
17486,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell tumor mixed
17487,Increased Cellularity Present,Recurrent Childhood Pineoblastoma
17488,In Situ Lesion,Stage 0 Vaginal Cancer AJCC v7
17489,Precise Histogenesis Unknown,Brain Stem Hemangioblastoma
17490,Carcinomatous Component Present,Recurrent Adrenal Cortex Carcinoma
17491,Epithelial Component Present,Renal Cell Cancer by AJCC v6 Stage
17492,Diffuse Pattern,Anaplastic astrocytoma
17493,Koilocytotic atypia,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma
17494,Indolent Clinical Course,Osteochondromyxoma
17495,Carcinomatous Component Present,Papillary serous endometrial carcinoma
17496,Myxoid Stroma Formation,Atrial myxoma
17497,Edematous Stroma Formation,Myxoma
17498,CD30-Positive Neoplastic Cells Present,Primary Cutaneous Anaplastic Large Cell Lymphoma
17499,Slow Growing Mass,Pituicytoma
17500,Rubbery Skin Lesion,Blue rubber bleb nevus syndrome
17501,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v6 and v7
17502,Sinusoidal Growth Pattern,ALK positive large B-cell lymphoma
17503,Enterochromaffin Type Granules Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
17504,Cutaneous Involvement,Pemphigus
17505,Carcinomatous Component Present,Adenocarcinoma with spindle cell metaplasia
17506,Osteosclerotic Lesion,Osteosclerotic Plasma Cell Myeloma
17507,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
17508,Vascular Channel Formation,Blood Vessel Tumors
17509,Pregnancy Complications,Stage IIIB Gestational Trophoblastic Tumor AJCC v7
17510,Childhood Lesion,Recurrent Childhood Subependymal Giant Cell Astrocytoma
17511,Primary Lesion,Multifocal osteosarcoma
17512,Carcinomatous Component Present,Stage IVB Liver Cancer
17513,Epithelial Component Present,Adult Cholangiocarcinoma
17514,Epithelial Component Present,Ovarian Trabecular Carcinoid Tumor
17515,Tubular Pattern,Wolffian tumor
17516,Recurrent disease,Liposarcoma recurrent
17517,Cutaneous Involvement,Vulvar Congenital Melanocytic Nevus
17518,Splenomegaly,Prolymphocytic Leukemia
17519,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Tumor
17520,Carcinomatous Component Present,Colorectal Carcinoma
17521,Microcystic Change,Intrahepatic Bile Duct Microcystic Adenoma
17522,Carcinomatous Component Present,Stage IV Penile Cancer AJCC v6
17523,Papillary Pattern,Papilloma
17524,Perivascular Arrangement of Tumor Cells,Papillary Meningioma
17525,Childhood Lesion,Childhood Teratoma
17526,Recurrent disease,Recurrent Malignant Endocervical Neoplasm
17527,Microcystic Change,"Adenoma, Microcystic"
17528,Epithelial Component Present,Hard Palate Pleomorphic Adenoma
17529,High Grade Lesion,Cardiac Monophasic Synovial Sarcoma
17530,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v7
17531,Microcystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
17532,Tissue of Mullerian Origin Present,endometrioid adenofibroma of ovary
17533,Biphasic Pattern,Ovarian Endometrioid Cystadenofibroma
17534,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Wildtype"
17535,Primary Lesion,Astrocytoma of brain stem
17536,Pregnancy Complications,Stage IIB Gestational Trophoblastic Tumor AJCC v7
17537,Epithelial Component Present,Malignant Mixed Mesodermal (Mullerian) Tumor
17538,Cutaneous Involvement,Hair Diseases
17539,High Mitotic Activity,Adult Anaplastic Oligodendroglioma
17540,Negative Peripheral Blood,Aleukemic Acute Lymphoblastic Leukemia
17541,Mixed Cellular Population,Cystadenofibroma
17542,Cutaneous Involvement,Aplasia Cutis Congenita
17543,Thick-Walled Hyalinized Vessels Present,Cerebellopontine Angle Schwannoma
17544,Epithelial Component Present,Stage IIC Ovarian Carcinoma
17545,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v7
17546,Cutaneous Involvement,Abscess of skin AND/OR subcutaneous tissue
17547,Well-Circumscribed Lesion,Cervical Wilms Tumor
17548,Biphasic Pattern,Clear cell cystadenofibroma
17549,Invasive Lesion,adenosquamous carcinoma of breast
17550,Nuclear Atypia,Brain Stem Glioblastoma
17551,Epithelial Component Present,External Auditory Canal Ceruminous Adenoma
17552,Myxoid Stroma Formation,"Testicular Yolk Sac Tumor, Myxomatous Pattern"
17553,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage II
17554,Preserved Nuclear Polarity,Bladder papilloma
17555,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage III
17556,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx recurrent
17557,Keratin pearl formation,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
17558,Carcinomatous Component Present,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
17559,Multilayered Rosette Formation,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
17560,Indolent Clinical Course,Adult Cardiac Cellular Rhabdomyoma
17561,Perivascular Pseudorosette Formation,Astroblastoma
17562,Serrated Glandular Architecture,Colorectal Filiform Serrated Adenoma
17563,Vascular Channel Formation,Cardiac hemangioma
17564,Cutaneous Involvement,Eccrine angiomatous hamartoma
17565,Carcinomatous Component Present,Prostate Cancer by AJCC v7 Stage
17566,Well-Circumscribed Lesion,Colorectal Sporadic Serrated Polyp
17567,Carcinomatous Component Present,Adult Penile Carcinoma
17568,Carcinomatous Component Present,Stage II Pancreatic Cancer AJCC v6 and v7
17569,Epithelial Component Present,Stage I Fallopian Tube Cancer
17570,Immunologic Deficiency Syndromes,Chronic Allograft Arteriopathy
17571,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
17572,Epithelial Component Present,Stage III Pancreatic Cancer AJCC v6 and v7
17573,High Grade Lesion,Rhabdomyosarcoma with ganglionic differentiation
17574,Carcinomatous Component Present,Salivary Gland Myoepithelial Carcinoma
17575,Epithelial Component Present,Gastrointestinal carcinoma
17576,Oligodendroglial Component Present,Adult Oligodendroglioma
17577,Concentric Perivascular Arrangement of Tumor Cells,Giant Cell Angioblastoma
17578,Malignant Germinomatous Cellular Infiltrate,Mediastinal seminoma
17579,Epithelial Component Present,Stage IB Fallopian Tube Cancer AJCC v6 and v7
17580,Epithelial Component Present,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
17581,Glial Differentiation,Adult Brain Stem Gliosarcoma
17582,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple
17583,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Testicular Immature Teratoma
17584,Epithelial Component Present,High Grade Mucoepidermoid Breast Carcinoma
17585,Severe dysplasia,Stage 0 Gallbladder Cancer AJCC v6 and v7
17586,Epithelial Component Present,Endometrial Mixed Cell Adenocarcinoma
17587,Keratin pearl formation,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
17588,Mixed Cellular Population,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
17589,Carcinomatous Component Present,Stage IIIA Fallopian Tube Cancer AJCC v7
17590,High Grade Lesion,Adult Brain Glioblastoma
17591,Encapsulated Mass,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
17592,Tissue Differentiation Uncertain,Classic Type Atypical Fibroxanthoma
17593,High Mitotic Activity,large cell neuroendocrine carcinoma of breast
17594,Perivascular Arrangement of Tumor Cells,Pericytic Neoplasm
17595,Cutaneous Involvement,Giant Cell Fibroblastoma
17596,Glandular Pattern,Duodenal Somatostatin-Producing Neuroendocrine Tumor
17597,'Starry-sky' pattern,Adult Burkitt Lymphoma
17598,Cutaneous Involvement,Sebaceous Gland Neoplasms
17599,Melanin Pigment Present,Cellular Blue Nevus
17600,Parakeratosis,Common wart
17601,Poorly Differentiated Lesion,Grade 3 Rectal Adenocarcinoma
17602,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v7
17603,Small Lesion,Luteoma
17604,Papillary Pattern,Gallbladder Papillomatosis
17605,Metaplasia of Malignant Cells Present,Adenocarcinoma with metaplasia
17606,Epithelial Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma
17607,Adulthood Lesion,Localized Unresectable Adult Hepatocellular Carcinoma
17608,Childhood Lesion,Recurrent Childhood Anaplastic Oligodendroglioma
17609,Cutaneous Involvement,"Nevus, Blue"
17610,Epithelial Component Present,Stage II Merkel Cell Carcinoma AJCC v7
17611,atypia morphology,Borderline Ovarian Clear Cell Tumor
17612,Intraosseous Lesion,Odontogenic myxoma
17613,Epithelial Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
17614,Diffuse Pattern,Anaplastic Hemispheric Astrocytoma
17615,More than 10 Mitoses per 10HPF,Childhood Lung Small Cell Carcinoma
17616,Papillary Pattern,"Schneiderian papilloma, inverted"
17617,Epithelial Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
17618,Negative Peripheral Blood,Lymphomatous Adult T-Cell Leukemia/Lymphoma
17619,Carcinomatous Component Present,Stage III Bladder Cancer AJCC v6 and v7
17620,Lesion with Diameter Greater than 10mm,Pituitary Gland Macroadenoma
17621,Recurrent disease,Recurrent Cancer of Gallbladder
17622,Acantholysis,Acantholytic squamous cell carcinoma of skin
17623,Carcinomatous Component Present,Stage III Prostate Carcinoma
17624,Carcinomatous Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
17625,Therapy-Related Toxicity,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
17626,Adulthood Lesion,Adult Meningeal Melanoma
17627,Serotonin Positive Neoplastic Cells Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
17628,Cystic Change,Benign mixed epithelial and stromal tumor of kidney
17629,Polyvesicular Vitelline Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
17630,Osseous Differentiation,Small cell osteosarcoma
17631,Nuclear Pseudoinclusion,Multicentric Thyroid Gland Papillary Carcinoma
17632,Extracutaneous Dissemination of Disease,Mycosis fungoides stage II
17633,Extensive Stage Lesion,Advanced Favorable Non-Hodgkin Lymphoma
17634,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Adenocarcinoma
17635,Refractory Disease,Angioimmunoblastic T-cell lymphoma refractory
17636,Cutaneous Involvement,Paget's disease of vulva
17637,Monomorphic Cellular Infiltrate,Grade III Lymphomatoid Granulomatosis
17638,Mixed Cellular Population,Ovarian mixed epithelial carcinoma
17639,Secondary Lesion,Carcinoma ex pleomorphic adenoma of parotid gland
17640,Indolent Clinical Course,Multiple Lobular Capillary Hemangiomas
17641,Necrotic changes (finding),Tall Cell Variant Thyroid Gland Papillary Carcinoma
17642,Invasive Lesion,Invasive Ductal and Lobular Carcinoma
17643,Epithelial Component Present,Papillary Renal Cell Carcinoma
17644,Exophytic Polypoid Lesion,Colorectal Microvesicular Hyperplastic Polyp
17645,Peripheral Nuclear Palisading,Stage I Lung Small Cell Carcinoma AJCC v7
17646,Papillary Pattern,Breast Papillomatosis
17647,Epithelial Component Present,Esophageal squamous cell carcinoma recurrent
17648,Cutaneous Involvement,Senile angioma
17649,Epithelial Component Present,Stage IIA Lung Large Cell Carcinoma AJCC v7
17650,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Clear Cell Follicular Adenoma
17651,Carcinomatous Component Present,Stage III Rectal Cancer AJCC v6
17652,Carcinomatous Component Present,Papillary Eccrine Carcinoma
17653,Dysplasia,Colon adenoma
17654,Carcinomatous Component Present,Stage IIA Lung Adenosquamous Carcinoma AJCC v7
17655,Mitotic Activity,Malignant Ovarian Thecoma
17656,High Grade Lesion,Recurrent Rhabdomyosarcoma
17657,Chromogranin A Positive Neoplastic Cells Present,Breast Carcinoid Tumor
17658,Gastric dysplasia,villous adenoma of stomach
17659,Borderline Lesion,Borderline Fallopian Tube Neoplasm
17660,Carcinomatous Component Present,Stage II Lung Small Cell Carcinoma AJCC v7
17661,Cutaneous Involvement,Bowen's Disease
17662,Borderline Lesion,Borderline Fallopian Tube Mucinous Tumor
17663,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Fetiform Teratoma
17664,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Cystic Teratoma
17665,Epithelial Component Present,Stage IV Lip Basal Cell Carcinoma
17666,Epithelial Component Present,Stage IIIA Hepatocellular Carcinoma AJCC v7
17667,More than 10 Mitoses per 10HPF,combined small cell carcinoma of lung
17668,Carcinomatous Component Present,combined small cell carcinoma of lung
17669,Hereditary Lesion,Neurofibromatosis 1
17670,Benign Cellular Infiltrate,Rectal Leiomyoma
17671,Carcinomatous Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia
17672,Intraductal Lesion,Pancreatic Intraductal Papillary-Mucinous Adenoma
17673,Cutaneous Involvement,Desmoplastic melanoma
17674,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma
17675,Cutaneous Involvement,Pilosebaceous Hamartoma
17676,Carcinomatous Component Present,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma
17677,Vascular Channel Formation,Central Nervous System Angiosarcoma
17678,Peau d'orange surface of breast,Inflammatory carcinoma of breast stage IV
17679,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Papillary Variant"
17680,Hyperkeratosis,"Lung Squamous Cell Carcinoma, Papillary Variant"
17681,Firm mass,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
17682,Carcinomatous Component Present,Squamous cell carcinoma of vagina
17683,Epithelial Component Present,Oral Cavity Pleomorphic Adenoma
17684,Epithelial Component Present,Condyloma Acuminatum with Dysplasia
17685,Biphasic Pattern,Atypical polypoid adenomyoma
17686,Metastatic Lesion,Secondary Prostate Urothelial Carcinoma
17687,Cystic Change,Pancreatic Intraductal Tubulopapillary Neoplasm
17688,Epithelial Component Present,Hepatitis Virus-Related Hepatocellular Carcinoma
17689,Indolent Clinical Course,Kasabach-Merritt syndrome
17690,Cellular Changes Resembling Foveolar Epithelium Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type"
17691,BRAF V600E Mutation Present,Progressive Hairy Cell Leukemia Initial Treatment
17692,Hereditary Lesion,PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA
17693,Adulthood Lesion,Adult Erythroleukemia
17694,Mixed Cellular Population,Metachronous Wilms Tumor
17695,Indolent Clinical Course,Extracardiac Rhabdomyoma
17696,Absence of Invasion,Ampulla of Vater Villous Adenoma
17697,Sheets of Interfollicular Plasma Cells Present,"Castleman Disease, Plasma Cell Type"
17698,Cutaneous Involvement,Stage IIIC Cutaneous Melanoma AJCC v7
17699,Cutaneous Involvement,Apocrine adenoma
17700,Mixed Cellular Population,Infiltrating duct and lobular carcinoma
17701,Cutaneous Involvement,Primary cutaneous gamma-delta T-cell lymphoma
17702,Swelling,Adult Mesenchymal Chondrosarcoma
17703,Poorly Differentiated Lesion,"Carcinoma, Spindle-Cell"
17704,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor G1
17705,Epithelial Component Present,Ampulla of Vater Clear Cell Adenocarcinoma
17706,Cysts Containing Proteinaceous Fluid Present,"Serous cystadenoma, borderline malignancy"
17707,Absence of Stromal Invasion,"Serous cystadenoma, borderline malignancy"
17708,Epithelial Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
17709,Carcinomatous Component Present,Ampulla of Vater Intestinal-Type Adenocarcinoma
17710,Myxoid Stroma Formation,Uterine Corpus Myxoid Leiomyoma
17711,Borderline Lesion,"Papillary cystadenoma, borderline malignancy"
17712,Indolent Clinical Course,Intravascular Angioleiomyoma
17713,Epithelial Component Present,Ampulla of Vater Squamous Cell Carcinoma
17714,Cutaneous Involvement,Post-kala-azar dermal leishmaniasis
17715,Carcinomatous Component Present,Adult Hepatocellular Carcinoma
17716,Epithelial Component Present,Serous cystadenocarcinoma of pancreas
17717,Indolent Clinical Course,Spindle cell lipoma
17718,Neuroendocrine Differentiation,Gastric Neuroendocrine Carcinoma
17719,Epithelial Component Present,Submandibular Gland Undifferentiated Carcinoma
17720,Recurrent disease,Recurrent Urethral Cancer
17721,Absence of Invasion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
17722,Exophytic Papillary Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
17723,Increased Cellularity Present,Childhood Anaplastic Oligoastrocytoma
17724,Pregnancy Complications,Clinical Chorioamnionitis
17725,Microvascular Proliferation,Acinar cell cystadenocarcinoma
17726,Secondary Lesion,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
17727,Aflatoxins Toxicity,Aflatoxins-Related Hepatocellular Carcinoma
17728,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v7
17729,Serrated Glandular Architecture,Appendix Traditional Serrated Adenoma
17730,Neuroendocrine Differentiation,Pancreatic ACTH-Producing Neuroendocrine Tumor
17731,Hyperplastic Tissue Present,Intraductal Hyperplasia
17732,Apocrine metaplasia,Breast Apocrine Adenoma
17733,Oligodendroglial Component Present,Childhood Anaplastic Oligodendroglioma
17734,Neuroendocrine Differentiation,Glucagonoma
17735,Biphasic Pattern,Malignant Vulvar Phyllodes Tumor
17736,Microvascular Proliferation,Adult Giant Cell Glioblastoma
17737,Secondary Lesion,Treatment related leukaemia
17738,High Grade Lesion,Rectal Rhabdomyosarcoma
17739,Papillary Pattern,"Cystadenocarcinoma, Papillary"
17740,Dysplasia,Esophageal dysplasia
17741,Moderate dysplasia,Moderate pancreatic duct dysplasia
17742,Nuclear Molding,Stage IV Lung Small Cell Carcinoma AJCC v7
17743,Elastophagocytosis,Granulomatous slack skin disease
17744,Cutaneous Involvement,Skin Basal Cell Carcinoma with Sebaceous Differentiation
17745,'Starry-sky' pattern,Stage IV Childhood Burkitt Lymphoma
17746,Epithelial Component Present,Classical Poroma
17747,Carcinomatous Component Present,mucinous adenocarcinoma of ovary
17748,Well-Circumscribed Lesion,Retinal hemangioblastoma
17749,Skin nodule,Blastic plasmacytoid dendritic cell neoplasm
17750,High Mitotic Activity,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
17751,Adulthood Lesion,Adult Meningioma
17752,Diffuse Pattern,Small cell glioblastoma
17753,Carcinomatous Component Present,Grade 4 Clear Cell Renal Cell Carcinoma
17754,Carcinomatous Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma
17755,Carcinomatous Component Present,Stage IA Gastric Carcinoma
17756,atypia morphology,Low Grade Liver Dysplastic Nodule
17757,Low Grade Lesion,Low Grade Liver Dysplastic Nodule
17758,Bile Pigment Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
17759,Epithelial Component Present,Functioning Pancreatic Neuroendocrine Tumor G2
17760,Pseudopapillary Pattern,Testicular embryonal carcinoma stage I
17761,Ineffective hematopoiesis,Refractory anemia with ringed sideroblasts
17762,Cystic Change,Papillary serous cystadenocarcinoma
17763,Carcinomatous Component Present,Mixed Acinar-Ductal Carcinoma of the Pancreas
17764,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Macroadenoma
17765,Recurrent disease,Recurrent Bone Ewing Sarcoma
17766,Glandular Differentiation,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation
17767,Angiocentric Pattern,Recurrent Grade II Lymphomatoid Granulomatosis
17768,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
17769,Cambium Layer,Botryoid-Type Embryonal Rhabdomyosarcoma
17770,Carcinomatous Component Present,Ductal Carcinoma In Situ with Microinvasion
17771,Epithelial Component Present,Adenocarcinoma in villous adenoma
17772,Edema,Inflammatory carcinoma of breast stage III
17773,Metastatic/Recurrent Disease,Recurrent Extraskeletal Myxoid Chondrosarcoma
17774,Villous Pattern,Villous adenocarcinoma
17775,Microcystic Change,Protoplasmic astrocytoma
17776,Adnexal Differentiation,Skin Basal Cell Carcinoma with Adnexal Differentiation
17777,Well-Circumscribed Lesion,Conventional Lipoma
17778,Biphasic Pattern,carcinosarcoma of gallbladder
17779,Chronic Inflammatory Infiltrate,Non-Ossifying Fibroma
17780,Carcinomatous Component Present,Stage I Major Salivary Gland Cancer AJCC v7
17781,Hyperplastic Tissue Present,Cervical Microglandular Hyperplasia
17782,Mesenchymal Component Present,Juvenile fibroadenoma of breast
17783,Epithelial Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
17784,Epithelial Component Present,Small cell lung cancer recurrent
17785,Cystic Change,Major Salivary Gland Mucoepidermoid Carcinoma
17786,Epithelial Component Present,Childhood Small Intestinal Carcinoma
17787,Endophytic Tumor Growth,Frontal Sinus Inverted Papilloma
17788,Exophytic Papillary Lesion,Upper Gingival Verrucous Carcinoma
17789,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
17790,Poorly Differentiated Lesion,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant"
17791,Local disease,Vulvar Lipoma
17792,Microcystic Change,Recurrent Childhood Pilocytic Astrocytoma
17793,Hyalinized Vessels Present,Recurrent Childhood Pilocytic Astrocytoma
17794,Diffuse Pattern,Grade 1 Diffuse Follicular Lymphoma
17795,Epithelial Component Present,Stage 0 Appendix Carcinoma AJCC v7
17796,Lesion Less than 5mm in Diameter,Pancreatic Neuroendocrine Microadenoma
17797,Adulthood Lesion,Adult Myelodysplastic Syndrome
17798,Dysplasia,Grade II Glandular Intraepithelial Neoplasia
17799,Myxoid Stroma Formation,"Dermatofibrosarcoma Protuberans, Myxoid"
17800,Mild dysplasia,"Glandular intraepithelial neoplasia, low grade"
17801,Fenestrated Pattern,Trichoepithelioma
17802,Cutaneous Involvement,Superficial basal cell carcinoma
17803,Well Differentiated Lesion,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor
17804,Carcinomatous Component Present,Distal Bile Duct Carcinoma
17805,Epithelial Component Present,Stage IVB Gallbladder Carcinoma
17806,Indolent Clinical Course,"Myositis, Proliferative"
17807,Fibromyxoid Stroma Formation,Ossifying fibromyxoid tumor
17808,Epithelial Component Present,Stage IIIB Appendix Carcinoma AJCC v7
17809,Dysplasia,Stage 0is Ureter Cancer AJCC v7
17810,Microcystic Change,Childhood Pilocytic Astrocytoma
17811,Delicate Vascular Network Formation,Non-Hereditary Clear Cell Renal Cell Carcinoma
17812,Carcinomatous Component Present,Stage III Childhood Hepatocellular Carcinoma AJCC v7
17813,Cutaneous Involvement,Regressing nevus
17814,Increased Cellularity Present,olfactory neuroblastoma of nasal cavity
17815,Histiocytosis,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
17816,Cutaneous Involvement,Benign Apocrine Neoplasm
17817,Nodular Pattern,"Follicle center lymphoma, follicular grade I, II, III stage IV"
17818,Epithelial Component Present,Grade 2 Invasive Breast Carcinoma
17819,Congenital Lesion,Airway Hemangioma
17820,Secondary Lesion,Squamous Cell Carcinoma of Unknown Primary
17821,Epithelial Component Present,Squamous Cell Carcinoma of Unknown Primary
17822,Neuroendocrine Differentiation,Combined Lung Small Cell and Squamous Cell Carcinoma
17823,Malignant Germinomatous Cellular Infiltrate,Stage 0 Testicular Seminoma AJCC v6 and v7
17824,Adnexal Differentiation,Skin appendage adenoma
17825,Carcinomatous Component Present,Labia Minora Carcinoma
17826,Syncytial Pattern,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
17827,Cutaneous Involvement,Cutaneous Chronic Lymphocytic Leukemia
17828,Epithelial Component Present,Squamous cell carcinoma in situ with questionable stromal invasion
17829,Carcinomatous Component Present,Squamous cell carcinoma in situ with questionable stromal invasion
17830,Epithelial Component Present,Adenosquamous cell lung cancer stage II
17831,Epithelial Component Present,Parathyroid Adenoma
17832,Parakeratosis,Plantar wart
17833,Cutaneous Involvement,Vitiligo
17834,Myxoid Stroma Formation,malignant epithelioid hemangioendothelioma of liver
17835,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IV
17836,Epithelial Component Present,Adenosquamous cell lung cancer stage IV
17837,Anaplasia,Glioblastoma by Gene Expression Profile
17838,Epithelial Component Present,Non-small cell lung cancer stage IIIA
17839,Metastatic/Recurrent Disease,Lung Monophasic Synovial Sarcoma
17840,Pushing Tumor Margin,Cervical Verrucous Carcinoma
17841,Biphasic Pattern,Benign phyllodes neoplasm of breast
17842,Epithelial Component Present,Squamous cell carcinoma with horn formation
17843,Carcinomatous Component Present,Gastric Cancer by AJCC v6 Stage
17844,Papillary Pattern,Clear Cell Variant Thyroid Gland Papillary Carcinoma
17845,Carcinomatous Component Present,FIGO Stage IIIA2 Ovarian Cancer
17846,Recurrent disease,Recurrent Adult Grade III Lymphomatoid Granulomatosis
17847,Carcinomatous Component Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma
17848,Edematous Stroma Formation,Testicular Spermatocytic Seminoma with Sarcoma
17849,Epithelial Component Present,Vestibular Papilloma
17850,Mixed Cellular Population,"Cervical Adenomyoma, Endometrial Type"
17851,Tissue of Mullerian Origin Present,Cervical Atypical Polypoid Adenomyoma
17852,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mixed Germ Cell Tumor
17853,Indolent Clinical Course,Myofibromatosis
17854,Mitotic Activity,Secondary Supratentorial Anaplastic Astrocytoma
17855,Tissue Differentiation Uncertain,Monophasic Synovial Sarcoma
17856,High Grade Lesion,High Grade Ovarian Serous Adenocarcinoma
17857,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Villoglandular Endometrial Endometrioid Adenocarcinoma
17858,Carcinomatous Component Present,Small intestine carcinoma stage III
17859,Secondary Lesion,Metastatic Malignant Neoplasm in the Iris
17860,Tissue of Mullerian Origin Present,Fallopian Tube Adenosarcoma
17861,Increased Cellularity Present,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
17862,Epithelial Component Present,Pancreatic Medullary Carcinoma
17863,Tissue Differentiation Uncertain,Atypical fibroxanthoma - spindle cell type
17864,Intracytoplasmic Eosinophilic Spherical Inclusion,Infantile digital fibromatosis
17865,Neuroendocrine Differentiation,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
17866,Carcinomatous Component Present,Gallbladder Carcinoma
17867,Adnexal Differentiation,Pilomatrix carcinoma of skin
17868,Heterologous Elements Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
17869,Epithelial Component Present,Stage IB2 Cervical Cancer
17870,Epithelial Component Present,Invasive Carcinoma
17871,Carcinomatous Component Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified"
17872,Carcinomatous Component Present,Stage III Anal Canal Cancer AJCC v6 and v7
17873,Schwannian Stroma More than 50 Percent of the Tumor Volume,Peripheral Ganglioneuroblastoma
17874,Secondary Lesion,Secondary carcinoma
17875,Tumor Vascular Invasion,"Leydig cell tumor, malignant"
17876,Tissue of Mullerian Origin Present,Broad Ligament Serous Cystadenofibroma
17877,Epithelial Component Present,Malignant neoplasm of stomach stage IV
17878,Borderline Lesion,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor
17879,Diffuse Pattern,Recurrent Glioblastoma
17880,Lobulated Growth Pattern,Mediastinal Chondroma
17881,Capillary Sized Vascular Channel Formation,Pyogenic granuloma
17882,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
17883,Childhood Lesion,Childhood Central Nervous System Embryonal Carcinoma
17884,Carcinomatous Component Present,Small cell carcinoma of esophagus
17885,Diffuse Pattern,Adult Oligodendroglioma
17886,Papillary Pattern,Vestibular Micropapillomatosis
17887,Epithelial Component Present,Vestibular Micropapillomatosis
17888,Exophytic Polypoid Lesion,Placental polyp
17889,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma recurrent
17890,Glial Differentiation,Adult Ganglioglioma
17891,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7
17892,Carcinomatous Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7
17893,Neuroendocrine Differentiation,Cauda Equina Paraganglioma
17894,Cutaneous Involvement,Malignant Germinative Follicular Epithelium Neoplasm
17895,Carcinomatous Component Present,Human Papillomavirus-Related Penile Squamous Cell Carcinoma
17896,Anaplasia,Adult Brain Glioblastoma
17897,Primary Lesion,Adult Brain Glioblastoma
17898,Epithelial Component Present,Functioning Endocrine Neoplasm
17899,Well Differentiated Lesion,Grade 1 Colorectal Adenocarcinoma
17900,Low Cellularity Present,Calcifying Fibrous Pseudotumor
17901,Carcinomatous Component Present,Vulvar Small Cell Carcinoma
17902,Locally Aggressive Lesion,Giant Cell Fibroblastoma
17903,Carcinomatous Component Present,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
17904,Epithelial Component Present,Lip and Oral Cavity Squamous Cell Carcinoma
17905,Carcinomatous Component Present,Breast Columnar Cell Mucinous Carcinoma
17906,Epithelial Component Present,Renal Cell Carcinoma
17907,Absence of Stromal Invasion,Borderline Ovarian Transitional Cell Tumor
17908,Exophytic Polypoid Lesion,Nasal Polyps
17909,Stromal Invasion,Malignant Ovarian Mucinous Tumor
17910,Nuclear pleomorphism,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
17911,Carcinomatous Component Present,Recurrent Liver Carcinoma
17912,Papillary Pattern,Condyloma acuminata of vulva
17913,Epithelial Component Present,Stage IVB Basal Cell Lip Carcinoma
17914,Intraluminal Tumor Growth,Gallbladder Papillomatosis
17915,Increased Cellularity Present,Recurrent Childhood Anaplastic Oligodendroglioma
17916,Dysplastic Dentin Formation,Dentinogenic Ghost Cell Tumor
17917,Vascular Channel Formation,Lymphangioendothelioma
17918,Glandular Pattern,Malignant Pancreatic Somatostatinoma
17919,Insular Pattern,Malignant Pancreatic Somatostatinoma
17920,Carcinomatous Component Present,Lymphoepithelial carcinoma
17921,Bilateral Mass,Synchronous Bilateral Breast Carcinoma
17922,Cutaneous Involvement,Stage II Merkel Cell Carcinoma AJCC v7
17923,Carcinomatous Component Present,Undifferentiated carcinoma of ovary
17924,Chromogranin A Positive Neoplastic Cells Present,Jejunal Neuroendocrine Tumor G1
17925,Epithelial Component Present,Poorly Cohesive Gastric Carcinoma
17926,Neuroectodermal Differentiation,Kadish Stage C Olfactory Neuroblastoma
17927,Dysplasia,Low Grade Prostatic Intraepithelial Neoplasia
17928,Locally Aggressive Lesion,Intermediate Fibrohistiocytic Neoplasm
17929,High Mitotic Activity,Stage IIB Merkel Cell Carcinoma AJCC v7
17930,Epithelial Component Present,Lower Gingival Squamous Cell Carcinoma
17931,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage IV
17932,Local disease,Lipoma of corpus callosum
17933,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma
17934,Apocrine Differentiation,Carcinoma of apocrine gland
17935,Epithelial Component Present,Stage IV Colorectal Cancer
17936,Geographic Necrosis,teratocarcinoma of mediastinum
17937,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage I
17938,Honeycomb Pattern,Childhood Brain Oligodendroglioma
17939,Cystic Change,Ovarian Clear Cell Cystadenofibroma
17940,Carcinomatous Component Present,Prostate Cancer by Whitmore-Jewett Stage
17941,Epithelial Component Present,Vaginal Endometrioid Adenocarcinoma
17942,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Endometrioid Adenocarcinoma
17943,Childhood Lesion,Childhood Paranasal Sinus Carcinoma
17944,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage II
17945,Diffuse Pattern,Centroblastic lymphoma stage II
17946,Carcinomatous Component Present,Childhood Parathyroid Gland Carcinoma
17947,Epithelial Component Present,Vulvar Nodular Hidradenoma
17948,Epithelial Component Present,Pancreatic Ductal Adenocarcinoma
17949,Carcinomatous Component Present,Endometrial Squamous Cell Carcinoma
17950,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Subependymal Glioma
17951,Carcinomatous Component Present,Ureter Carcinoma
17952,Mesenchymal Differentiation,gliosarcoma
17953,Carcinomatous Component Present,Colorectal Medullary Carcinoma
17954,Carcinomatous Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7
17955,Well-Circumscribed Lesion,Juxtaglomerular tumor
17956,Osseous Differentiation,Intracortical osteosarcoma
17957,Rapidly Enlarging Mass,Proliferative fasciitis
17958,Non-Malignant Cellular Infiltrate,Follicular Bronchitis/Bronchiolitis
17959,Carcinomatous Component Present,Stage IIA Gastric Cancer AJCC v7
17960,Poorly Differentiated Lesion,carcinosarcoma of lung
17961,Biphasic Pattern,carcinosarcoma of lung
17962,Dysplasia,Low Grade Anal Canal Squamous Intraepithelial Neoplasia
17963,Epithelial Component Present,Malignant Phyllodes Tumor of Prostate
17964,Neuroectodermal Differentiation,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System
17965,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma of parotid gland
17966,Cystic Change,mucoepidermoid carcinoma of esophagus
17967,Angiocentric Pattern,Recurrent Lymphomatoid Granulomatosis
17968,Papillary Pattern,Esophageal squamous papilloma
17969,Severe dysplasia,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
17970,Recurrent disease,Recurrent Childhood Soft Tissue Sarcoma
17971,Well-Circumscribed Lesion,Colorectal Mucin Poor Hyperplastic Polyp
17972,Malignant Germinomatous Cellular Infiltrate,Seminoma
17973,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype"
17974,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant"
17975,Neuroendocrine Differentiation,"Cervical Low Grade Neuroendocrine Tumor, Grade 1"
17976,Carcinomatous Component Present,Recurrent Uterine Corpus Carcinoma
17977,Monoclonal Cellular Population Present,Thyroid Gland Lipoadenoma
17978,Follicular Structures Present,Thyroid Gland Clear Cell Follicular Adenoma
17979,Cribriform Pattern,Cribriform Neuroepithelial Tumor
17980,Epithelial Component Present,Small Intestinal Squamous Cell Carcinoma
17981,Carcinomatous Component Present,Laryngeal Lymphoepithelial Carcinoma
17982,Carcinomatous Component Present,Mucoepidermoid carcinoma of submandibular gland
17983,Cystic Change,Posterior Tongue Mucoepidermoid Carcinoma
17984,"Undifferentiated ""Fetal-Type"" Tissues Present",Grade 1 Ovarian Teratoma
17985,Keratin pearl formation,Vaginal Keratinizing Squamous Cell Carcinoma
17986,No Identifiable Line of Differentiation,"Undifferentiated Sarcoma, Not Otherwise Specified"
17987,Carcinomatous Component Present,Laryngeal Basaloid Carcinoma
17988,Epithelial Component Present,Ductal Eccrine Carcinoma with Squamous Metaplasia
17989,Indolent Clinical Course,Myoma
17990,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
17991,Tissue Differentiation Uncertain,Synovial sarcoma recurrent
17992,High Mitotic Activity,large cell neuroendocrine carcinoma of ovary
17993,Papillary Pattern,Lung Micropapillary Adenocarcinoma
17994,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
17995,Immunologic Deficiency Syndromes,Transplant-Related Bladder Urothelial Carcinoma
17996,Therapy-Related Toxicity,Transplant-Related Skin Squamous Cell Carcinoma
17997,Cystic Change,Cystic teratoma
17998,Nuclear Pseudoinclusion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
17999,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
18000,S-100-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell"
18001,Epithelial Component Present,"Mesonephroma, benign"
18002,Absence of Invasion,Adenocarcinoma in Situ
18003,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
18004,Cribriform Pattern,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
18005,Severe dysplasia,Intraepithelial Squamous Cell Carcinoma
18006,Indolent Clinical Course,Uterine Corpus Adenomatoid Tumor
18007,Perineural spread,Adenoid cystic carcinoma of oropharynx
18008,Severe dysplasia,Intraductal Non-Comedo Breast Adenocarcinoma
18009,Severe dysplasia,High Grade Ductal Breast Carcinoma In Situ
18010,Low Grade Lesion,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
18011,Smooth Muscle Component Present,Pulmonary lymphangioleiomyomatosis
18012,Multinodular Mass,Angiosarcoma Associated with Lymphedema
18013,Immunosuppression-Related Post-Transplant Toxicity,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
18014,Primary Site Unknown,Carcinoma of unknown primary
18015,Decreased platelet count,Kasabach-Merritt syndrome
18016,Epithelial Component Present,Renal medullary carcinoma
18017,Carcinomatous Component Present,Retroperitoneal Carcinoma
18018,High Grade Lesion,Childhood Gliosarcoma
18019,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type"
18020,Intracanalicular Growth Pattern,Breast Phyllodes Tumor
18021,Epithelial Component Present,Follicular Variant Thyroid Gland Papillary Carcinoma
18022,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma
18023,Tissue Differentiation Uncertain,Soft Tissue Tumor of Uncertain Differentiation
18024,Nodular Pattern,Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma
18025,Papillary Pattern,Urethral Condyloma Acuminatum
18026,Cutaneous Involvement,Scrotal Infection
18027,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma metastatic
18028,Mitotic Activity,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma
18029,Lymphatic Spread,Lymphangitis carcinomatosa
18030,Childhood Lesion,Childhood Hepatocellular Carcinoma
18031,Epithelial Component Present,large cell neuroendocrine carcinoma of thymus
18032,Chemotherapeutic Agent Toxicity,Alkylating Agent-Related Myelodysplastic Syndrome
18033,Nuclear pleomorphism,carcinoma of pancreas with osteoclast-like giant cells
18034,Epithelial Component Present,Anal Adenocarcinoma within Anorectal Fistula
18035,Adulthood Lesion,Adult Grade I Meningioma
18036,Epithelial Component Present,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
18037,Carcinomatous Component Present,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
18038,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage
18039,Epithelial Component Present,Stage III Esophageal Cancer AJCC v7
18040,Generalized Hydropic Villous Change,Complete hydatidiform mole
18041,Immature Myeloid Cells Increased in Bone Marrow,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
18042,Dysplasia,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia
18043,Exophytic Polypoid Lesion,Appendix Tubulovillous Adenoma
18044,Monoclonal Myeloid or Lymphoid Cells Present,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease"
18045,Epithelial Component Present,Gastric Cardia Adenocarcinoma
18046,Adulthood Lesion,Adult Angiosarcoma
18047,Mucoid Stroma Formation,Mucinous adenocarcinoma of appendix
18048,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
18049,Carcinomatous Component Present,Cervical Endometrioid Adenocarcinoma
18050,Presence of a Hormonal Syndrome,Pancreatic Gastrin-Producing Neuroendocrine Tumor
18051,Papillary Pattern,Invasive papillary breast carcinoma
18052,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
18053,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage I
18054,Cytoplasmic Membrane-Bound Granules Present,Merkel cell carcinoma
18055,Mesenchymal Differentiation,Adult Gliosarcoma
18056,Intracanalicular Growth Pattern,Malignant Vulvar Phyllodes Tumor
18057,Nuclear Atypia,Recurrent Childhood Fibrillary Astrocytoma
18058,Moderately Differentiated Lesion,Grade 2 Colon Adenocarcinoma
18059,Hereditary Lesion,Familial Testicular Germ Cell Tumor
18060,Multilayered Rosette Formation,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
18061,Adulthood Lesion,BCLC Stage B Adult Hepatocellular Carcinoma
18062,Bone Marrow Involvement,Familial Waldenstrom's Macroglobulinaemia
18063,Cutaneous Involvement,Skin Papilloma
18064,Neuroendocrine Differentiation,Localized Digestive System Neuroendocrine Tumor G1
18065,Secondary Lesion,Secondary malignant neoplasm of eye
18066,Carcinomatous Component Present,Adenocarcinoma in multiple adenomatous polyps
18067,Gastrin Positive Neoplastic Cells Present,Duodenal Gastrin-Producing Neuroendocrine Tumor
18068,Extensive Stage Lesion,Mesothelioma malignant advanced
18069,In Situ Lesion,Bladder squamous cell carcinoma stage 0
18070,Cutaneous Involvement,Eccrine mixed tumor of skin
18071,Carcinomatous Component Present,Grade 3 Clear Cell Renal Cell Carcinoma
18072,Epithelial Component Present,Bowenoid papulosis
18073,Cartilaginous Differentiation,Chondroma
18074,Epithelial Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma
18075,Monomorphic Cellular Infiltrate,basaloid squamous cell carcinoma of vulva
18076,Epithelial Component Present,basaloid squamous cell carcinoma of vulva
18077,Mesenchymal Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia
18078,Acinar Cell Differentiation,Mixed Acinar-Ductal Carcinoma of the Pancreas
18079,Epithelial Component Present,Ethmoid Sinus Schneiderian Papilloma
18080,Local disease,Fibrolipoma
18081,Hereditary Lesion,Rothmund-Thomson syndrome
18082,Epithelial Component Present,"Adenoma, Basal Cell"
18083,Epithelial Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v7
18084,Metaplasia,Bladder squamous cell carcinoma recurrent
18085,Epithelial Component Present,Gallbladder Goblet Cell Carcinoid
18086,Papillary Pattern,Urethral Inverted Papilloma
18087,Embryoid Bodies Present,Stage II Ovarian Polyembryoma AJCC v6 and v7
18088,Carcinomatous Component Present,Stage I Vaginal Cancer AJCC v6 and v7
18089,Papillary Pattern,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm
18090,Lobulated Growth Pattern,Primary chondrosarcoma of bone
18091,Acanthosis,verrucous carcinoma of esophagus
18092,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor
18093,Recurrent disease,Relapsed Hypopharynx Carcinoma
18094,Immunologic Deficiency Syndromes,Transplant-Related Disorder
18095,Tissue Differentiation Uncertain,"Synovial sarcoma, biphasic"
18096,Pushing Tumor Margin,Upper Gingival Verrucous Carcinoma
18097,Mixed Cellular Population,Vaginal Adenosarcoma
18098,Exophytic Polypoid Lesion,"Gastric Adenoma, Gastric-Type"
18099,Lobulated Growth Pattern,malignant myoepithelioma of breast
18100,Carcinomatous Component Present,malignant myoepithelioma of breast
18101,Slow Growing Mass,Recurrent Childhood Pilocytic Astrocytoma
18102,Epithelial Component Present,Bladder Paraganglioma
18103,Metastatic/Recurrent Disease,Metastatic Extraskeletal Myxoid Chondrosarcoma
18104,Extraosseous Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma
18105,Infiltrative Growth Pattern,Childhood Brain Anaplastic Astrocytoma
18106,Epithelial Component Present,Anal Canal Squamous Papilloma
18107,Exophytic Polypoid Lesion,"Polyposis, Gastric"
18108,Annular Tubules Present,Ovarian Sex Cord Tumor with Annular Tubules
18109,Epithelial Component Present,Lung Carcinoma Metastatic in the Liver
18110,Secondary Lesion,Lung Carcinoma Metastatic in the Liver
18111,Fibroblastoma-Like Differentiation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation
18112,Carcinomatous Component Present,Verrucous carcinoma of the oral cavity recurrent
18113,Plexiform Vasculature Present,Endometrial stromal nodule
18114,Secondary Lesion,Colon Carcinoma Metastatic in the Liver
18115,Anaplasia,Pleomorphic carcinoma
18116,Well-Circumscribed Lesion,Adult Extraskeletal Myxoid Chondrosarcoma
18117,Hemorrhagic,Hemolymphangioma
18118,Pain,Subungual exostoses
18119,Adulthood Lesion,Adult Non-Hodgkin Lymphoma
18120,Locally Aggressive Lesion,Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm
18121,Carcinomatous Component Present,Adenocarcinoma of small intestine
18122,Absence of a Hormonal Syndrome,Non-Functioning Adrenal Cortex Adenoma
18123,Perivascular fibrosis,Nodular Sclerosis Classical Hodgkin Lymphoma
18124,Apocrine Differentiation,Apocrine Breast Carcinoma In Situ
18125,Metastatic/Recurrent Disease,Pleural Biphasic Synovial Sarcoma
18126,Epithelial Component Present,Stage IVB Rectal Cancer AJCC v7
18127,Locally Aggressive Lesion,Ossifying fibromyxoid tumor
18128,Epithelial Component Present,Small cell neuroendocrine carcinoma of bladder
18129,Refractory Disease,Refractory T Lymphoblastic Lymphoma
18130,Collagenous Stroma Formation,Palisaded Lymph Node Myofibroblastoma
18131,BRAF V600E Mutation Present,Refractory Hairy Cell Leukemia
18132,Carcinomatous Component Present,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
18133,Carcinomatous Component Present,Disseminated adenocarcinoma
18134,Carcinomatous Component Present,Lymphoepithelioma-Like Hepatocellular Carcinoma
18135,Epithelial Component Present,Ovarian Serous Tumor
18136,Local disease,Central Nervous System Hibernoma
18137,Necrotic changes (finding),Cardiac Malignant Peripheral Nerve Sheath Tumor
18138,Carcinomatous Component Present,Pseudomyxoma Peritonei
18139,Carcinomatous Component Present,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
18140,Childhood Lesion,Childhood Supratentorial Neoplasm
18141,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma
18142,Epithelial Component Present,Glycogen-rich carcinoma
18143,Deep Lesion,Deep Leiomyoma
18144,Alternative Fascicle (Bundle) Pattern,Degeneration of uterine fibroid
18145,Single Cell Necrosis,Stage I Merkel Cell Carcinoma AJCC v7
18146,Epithelial Component Present,Crohn Disease-Associated Colorectal Adenocarcinoma
18147,Carcinomatous Component Present,Adenocarcinoma of lung stage IIIB
18148,Dysplasia,Atypical Ductal Breast Hyperplasia
18149,Well-Circumscribed Lesion,Polyp in nasopharynx
18150,Cutaneous Involvement,Incontinentia Pigmenti Achromians
18151,Carcinomatous Component Present,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8"
18152,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx
18153,Monoclonal Cellular Population Present,Primary Systemic Mastocytosis
18154,Acanthosis,Plantar wart
18155,Juvenile Lesion,Disseminated Juvenile Xanthogranuloma
18156,Necrotic changes (finding),Glioblastoma by Gene Expression Profile
18157,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuroma
18158,Thyroglobulin Positive Neoplastic Cells Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
18159,Epithelial Component Present,"Adenocarcinoma of lung, stage III"
18160,Bone Marrow Dysplasia Present,MYELODYSPLASTIC SYNDROME
18161,Firm mass,"Perineurioma, malignant"
18162,Slow Growing Mass,Benign Meningioma
18163,CD56-Positive Neoplastic Cells Present,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma
18164,Diffuse Pattern,Diffuse Astrocytoma
18165,Cutaneous Involvement,Ichthyosis Bullosa of Siemens
18166,Childhood Lesion,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma
18167,Epithelial Component Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
18168,Childhood Lesion,Childhood Testicular Teratoma
18169,Biphasic Pattern,Cervical Atypical Polypoid Adenomyoma
18170,Childhood Lesion,Childhood Epithelioid Hemangioendothelioma
18171,Adulthood Lesion,Benign Adult Brain Stem Neoplasm
18172,Calcitonin Positive Neoplastic Cells Present,Sporadic Thyroid Gland Medullary Carcinoma
18173,CD1a-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis
18174,Exophytic Polypoid Lesion,Colonic Polyps
18175,Thin-Walled Branching Vascular Pattern,Pericardial Solitary Fibrous Tumor
18176,Well-Circumscribed Lesion,External Auditory Canal Ceruminous Adenoma
18177,Fibrotic Stroma Formation,Pancreatic Medullary Carcinoma
18178,Monomorphic Cellular Infiltrate,Childhood Cerebral Ependymoma
18179,Fibrotic Stroma Formation,Endometrial Polyp
18180,Calcitonin serum level increased,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
18181,Monomorphic Cellular Infiltrate,Brain Oligodendroglioma
18182,Carcinomatous Component Present,Breast Carcinoma with Osteoclastic Giant Cells
18183,Multinodular Mass,Metastatic Dermatofibrosarcoma Protuberans
18184,Well Differentiated Lesion,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
18185,Carcinomatous Component Present,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
18186,Cystic Change,Dermoid cyst of orbit
18187,Papillary Pattern,Adenolymphoma
18188,Epithelial Component Present,adenocarcinoma of gallbladder with squamous metaplasia
18189,Epithelial Component Present,Non-small cell lung cancer stage II
18190,Cytologic atypia,Anaplastic Astroblastoma
18191,atypia morphology,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor
18192,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation
18193,Epithelial Component Present,Thymoma Type B
18194,Honeycomb Pattern,Adult Oligodendroglioma
18195,Carcinomatous Component Present,Medullary carcinoma of breast
18196,Indolent Clinical Course,Benign Uterine Corpus PEComa
18197,Carcinomatous Component Present,Acinar cell carcinoma of pancreas
18198,Indolent Clinical Course,Mediastinal Leiomyoma
18199,Cutaneous Involvement,Indeterminate dendritic cell tumor
18200,Calcitonin serum level increased,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
18201,S-100-Positive Neoplastic Cells Present,Malignant Uterine Corpus PEComa
18202,Well-Circumscribed Lesion,Placental polyp
18203,Collagenous Stroma Formation,"Fibromatosis, Aggressive"
18204,Childhood Lesion,Childhood Testicular Non-Seminomatous Germ Cell Tumor
18205,High Mitotic Activity,Gastric Small Cell Carcinoma
18206,Mixed Cellular Population,Adult Brain Stem Mixed Glioma
18207,Infiltrative Growth Pattern,Superficial fibromatosis
18208,Adulthood Lesion,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
18209,Epithelial Component Present,Squamous cell carcinoma of the paranasal sinus
18210,Cutaneous Involvement,Dermatophytosis
18211,Carcinomatous Component Present,undifferentiated carcinoma of ureter
18212,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Mature Teratoma
18213,Epithelial Component Present,Vipoma
18214,Low Mitotic Activity,Vipoma
18215,Epithelial Component Present,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
18216,Calcitonin serum level increased,Familial medullary thyroid carcinoma
18217,Epithelial Component Present,Ovarian Serous Adenofibroma
18218,Necrotic changes (finding),Vulvar Large Cell Neuroendocrine Carcinoma
18219,Exophytic Polypoid Lesion,Peutz-Jeghers Polyp of the Stomach
18220,Epithelial Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7
18221,Epithelial Component Present,Choroid Plexus Papilloma
18222,Cutaneous Involvement,Malignant blue nevus of skin
18223,Edematous Stroma Formation,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
18224,Enterochromaffin Type Granules Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
18225,Epithelial Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
18226,Cutaneous Involvement,Stage IVB Basal Cell Lip Carcinoma
18227,Epithelial Component Present,Stage I Ureter Cancer AJCC v7
18228,Epithelial Component Present,pleomorphic carcinoma of breast
18229,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7
18230,Exophytic Polypoid Lesion,Anal skin tag
18231,Intraosseous Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
18232,Epithelial Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
18233,Low Grade Lesion,Low Grade Astrocytic Tumor
18234,Carcinomatous Component Present,Poorly Differentiated Thyroid Carcinoma
18235,Transformed Phase of Disease,Non-Hodgkin's lymphoma transformed recurrent
18236,High Mitotic Activity,Stage III Merkel Cell Carcinoma AJCC v7
18237,Intraepithelial Neoplasia,Malignant melanoma in precancerous melanosis
18238,Epithelial Component Present,Craniopharyngioma
18239,Geographic Necrosis,Central Nervous System Embryonal Carcinoma
18240,atypia morphology,Ameloblastic Carcinoma Derived From Odontogenic Cyst
18241,Carcinomatous Component Present,Solid Papillary Breast Carcinoma
18242,Nuclear Grooves,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
18243,Monoclonal Cellular Population Present,Thyroid Gland Oncocytic Adenoma
18244,Encapsulated Mass,Thyroid Gland Oncocytic Adenoma
18245,Collagenous Stroma Formation,Sclerosing PEComa
18246,Neuronal Differentiation,Plexosarcoma
18247,Neuroendocrine Differentiation,Sporadic Thyroid Gland Micromedullary Carcinoma
18248,Nodular Pattern,Skin Nodular Solid Basal Cell Carcinoma
18249,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage IV
18250,Carcinomatous Component Present,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
18251,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
18252,Primary Lesion,Primary Cutaneous Meningioma
18253,Carcinomatous Component Present,Sebaceous Adenocarcinoma
18254,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage III
18255,Alternative Fascicle (Bundle) Pattern,Cervical Leiomyoma
18256,Immunologic Deficiency Syndromes,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
18257,Epithelial Component Present,mucinous adenocarcinoma of bladder
18258,Cutaneous Involvement,Stage IB Cutaneous Melanoma AJCC v7
18259,Peripheral Nuclear Palisading,Thymic Basaloid Carcinoma
18260,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
18261,Lymphoplasmacytic Infiltrate,Oropharyngeal lymphoepithelioma stage III
18262,Epithelial Component Present,Micronodular thymoma with lymphoid stroma
18263,Sebaceous Differentiation,Malignant Sebaceous Neoplasm
18264,Carcinomatous Component Present,Prostate cancer stage B
18265,Intracanalicular Growth Pattern,Malignant phyllodes tumor of breast
18266,Carcinomatous Component Present,Stage IIIA Eyelid Carcinoma AJCC v7
18267,Carcinomatous Component Present,Lung Spindle Cell Carcinoma
18268,Misplaced Exocytosis Present,Acidophil Stem Cell Pituitary Gland Adenoma
18269,Sebaceous Differentiation,Salivary Gland Sebaceous Lymphadenoma
18270,Monoclonal Cellular Population Present,"Mastocytosis, Diffuse Cutaneous"
18271,Exophytic Papillary Lesion,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
18272,Epithelial Component Present,Rectosigmoid Signet Ring Cell Carcinoma
18273,Epithelial Component Present,Mucinous cystadenocarcinoma of ovary
18274,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Hypocellular Myelodysplastic Syndrome
18275,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7
18276,Carcinomatous Component Present,Pancreatic carcinoma
18277,Splenomegaly,Splenic Manifestation of T-Cell Prolymphocytic Leukemia
18278,Carcinomatous Component Present,"Papillary renal cell carcinoma, sporadic"
18279,Regional Disease,Crohn's disease of large bowel
18280,Adulthood Lesion,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma
18281,Papillary Pattern,Laryngeal verrucous carcinoma recurrent
18282,Epithelial Component Present,Stage IIIB Lung Large Cell Carcinoma AJCC v7
18283,Metastatic Lesion,Colon Carcinoma Metastatic in the Lung
18284,Metastatic Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor
18285,Deep Lesion,Chest Wall Fibromatosis
18286,Carcinomatous Component Present,Carcinoma ex Eccrine Spiradenoma
18287,Cutaneous Involvement,Eccrine ductal carcinoma
18288,Secondary Lesion,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm
18289,Borderline Lesion,Borderline Exocrine Pancreatic Neoplasm
18290,Epithelial Component Present,ENSAT Stage IV Adrenal Cortex Carcinoma
18291,Mixed Cellular Population,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor
18292,Windblown Appearance of Atypical Keratinocytes,Bowen's Disease
18293,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Hurthle Cell Carcinoma
18294,Indolent Clinical Course,Ovarian Cellular Fibroma
18295,Thick-Walled Hyalinized Vessels Present,Sternal Intraosseous Schwannoma
18296,Epithelial Component Present,Colorectal Tubular Adenoma
18297,Cutaneous Involvement,Stage IV Lip Basal Cell Carcinoma
18298,Slow Growing Mass,Olfactory Neuroblastoma
18299,Juvenile Lesion,Scheuermann's Disease
18300,Vascular Channel Formation,Bone Epithelioid Hemangioma
18301,Diffuse Pattern,Diffuse Intrinsic Pontine Glioma
18302,Indolent Clinical Course,Subcutaneous Nodular Fasciitis
18303,Carcinomatous Component Present,Pancreatic Foamy Gland Adenocarcinoma
18304,Epithelial Component Present,Multicentric Breast Carcinoma
18305,Papillary Pattern,Biliary papillomatosis
18306,Absence of Invasion,solid type ductal carcinoma in situ of breast
18307,Lymphatic Spread,Inflammatory carcinoma of breast stage IV
18308,Vascular Channel Formation,Venous hemangioma
18309,Local disease,Central Nervous System Lipoma
18310,High Grade Lesion,High Grade Lung Neuroendocrine Neoplasm
18311,Epithelial Component Present,Carcinoma in situ of skin
18312,Low Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Vagina
18313,Adulthood Lesion,Adult Ependymal Tumor
18314,Carcinomatous Component Present,"Carcinoma of urinary bladder, superficial"
18315,Carcinomatous Component Present,Soft Palate Squamous Cell Carcinoma
18316,Exophytic Polypoid Lesion,tubular adenoma of stomach
18317,Carcinomatous Component Present,"Cystadenocarcinoma, Serous"
18318,Epithelial Component Present,Extra-Adrenal Retroperitoneal Paraganglioma
18319,Local disease,Paratesticular Lipoma
18320,Hereditary Lesion,BRCA1 Syndrome
18321,Carcinomatous Component Present,Carcinoma of unknown primary
18322,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma recurrent
18323,Lipomatous Component Present,Hepatic Angiomyolipoma
18324,Epithelial Component Present,Intrathoracic Paravertebral Paraganglioma
18325,Epithelial Component Present,Intrahepatic Cholangiocarcinoma
18326,Recurrent disease,Recurrent Childhood Cerebral Astrocytoma
18327,Neuroendocrine Differentiation,Medullary carcinoma of thyroid
18328,Diffuse Pattern,"Diffuse midline glioma, point mutation K27M in histone H3"
18329,Epithelial Component Present,Acantholytic acanthoma
18330,Carcinomatous Component Present,Old Burn Scar-Related Skin Squamous Cell Carcinoma
18331,Diffuse Pattern,Childhood Gliomatosis Cerebri
18332,Borderline Lesion,Borderline Ovarian Mucinous Tumor
18333,Carcinomatous Component Present,Cervical Serous Adenocarcinoma
18334,Congenital Lesion,Congenital Epulides
18335,Tubular Pattern,Apocrine adenoma
18336,Epithelial Component Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7
18337,High Mitotic Activity,Endometrial Large Cell Neuroendocrine Carcinoma
18338,Hypercellular bone marrow,Chronic Neutrophilic Leukemia
18339,Epithelial Component Present,undifferentiated carcinoma of cervix
18340,Indolent Clinical Course,Acral Fibromyxoma
18341,Epithelial Component Present,Lung Mucinous Cystadenoma
18342,atypia morphology,"Papillary mucinous cystadenoma, borderline malignancy"
18343,Well-Circumscribed Lesion,"Papillary cystadenoma, borderline malignancy"
18344,Mitotic Activity,Yolk Sac Tumor
18345,Lymphoplasmacytic Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland
18346,Epithelial Component Present,recurrent gastric cancer
18347,Premalignant Lesion,Pulmonary Lymphomatoid Granulomatosis
18348,Carcinomatous Component Present,Secretory breast carcinoma
18349,Epithelial Component Present,Ampulla of Vater Adenosquamous Carcinoma
18350,Epithelial Component Present,Stage IVC Lip Cancer AJCC v6 and v7
18351,Perivascular Arrangement of Tumor Cells,Lung Clear Cell Tumor
18352,Epithelial Component Present,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
18353,Intracellular Accumulation of Lipids,Childhood Pleomorphic Xanthoastrocytoma
18354,Mixed Cellular Population,Stage IV Kidney Wilms Tumor
18355,Slow Growing Mass,Chordoma
18356,Cutaneous Involvement,Lentigo maligna recurrent
18357,Non-Invasive Lesion,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
18358,Microvascular Proliferation,Adult Glioblastoma
18359,Favorable Clinical Outcome,"lymphomatoid papulosis, type C"
18360,Epithelial Component Present,High Grade Anal Canal Squamous Intraepithelial Neoplasia
18361,Severe cytologic atypia,Undifferentiated Stromal Sarcoma
18362,Diffuse Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma
18363,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Childhood Acute Myelomonocytic Leukemia
18364,Primary Lesion,Aggressive Systemic Mastocytosis
18365,Epithelial Component Present,Breast Carcinoma by Gene Expression Profile
18366,Non-Invasive Lesion,Stage 0a Ureter Cancer AJCC v7
18367,Hemorrhagic,Adrenal Gland Angiosarcoma
18368,Recurrent disease,Hodgkin's disease lymphocyte depletion type recurrent
18369,Metastatic/Recurrent Disease,Childhood Clear Cell Sarcoma of Soft Parts
18370,Fascicular Pattern,Childhood Clear Cell Sarcoma of Soft Parts
18371,Epithelial Component Present,Vaginal Adenoma
18372,Epithelial Component Present,Glucagonoma
18373,Secondary Lesion,Locally Advanced Malignant Neoplasm
18374,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Adenofibroma
18375,Anaplasia,Adult Giant Cell Glioblastoma
18376,Adulthood Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
18377,Acanthosis,Anal Verrucous Carcinoma
18378,Benign Cellular Infiltrate,Benign neoplasm of cecum
18379,Borderline Lesion,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor
18380,Nuclear Atypia,Recurrent Childhood Glioblastoma
18381,Recurrent disease,Recurrent Childhood Glioblastoma
18382,Epithelial Component Present,Parotid Gland Adenocarcinoma
18383,Acanthosis,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
18384,Immunologic Deficiency Syndromes,New Onset Diabetes After Transplant
18385,Carcinomatous Component Present,Penile Cancer by AJCC v6 Stage
18386,Stromal Invasion,Ovarian Transitional Cell Carcinoma
18387,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Prolactin Secreting Adenoma
18388,Hyperplastic Tissue Present,Endometrial Hyperplasia without Atypia
18389,Gyriform Trabecular Pattern,Duodenal Gastrin-Producing Neuroendocrine Tumor
18390,Perivascular fibrosis,"Hodgkin lymphoma, nodular sclerosis, cellular phase"
18391,Radiation Sickness,Radiation-Induced Cancer
18392,Epithelial Component Present,Solid carcinoma
18393,Carcinomatous Component Present,Hereditary Prostate Carcinoma
18394,Epithelial Component Present,intraductal papilloma of salivary gland
18395,Epithelial Component Present,sialadenoma papilliferum of salivary gland
18396,Carcinomatous Component Present,Endometrial Dedifferentiated Carcinoma
18397,Resectable Mass,Localized Resectable Adult Liver Carcinoma
18398,Carcinomatous Component Present,Bladder squamous cell carcinoma stage IV
18399,Firm mass,Epithelioid Malignant Peripheral Nerve Sheath Tumor
18400,Neuroendocrine Differentiation,Functioning Pancreatic Neuroendocrine Tumor
18401,Carcinomatous Component Present,Esophageal Mixed Adenoneuroendocrine Carcinoma
18402,Severe dysplasia,Adenocarcinoma in situ in villous adenoma
18403,Hereditary Lesion,Ataxia Telangiectasia
18404,Benign Cellular Infiltrate,Esophageal hemangioma
18405,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia with abnormal eosinophils
18406,Defective Heavy Chain Present,Immunoproliferative Small Intestinal Disease
18407,Carcinomatous Component Present,Stage II Colon Cancer
18408,Epithelial Component Present,keratinizing squamous cell carcinoma of nasal cavity
18409,Secondary Lesion,Treatment related acute myeloid leukaemia
18410,Cutaneous Involvement,Basal cell carcinoma - follicular
18411,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of lung
18412,Diffuse Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor
18413,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
18414,Lymphoplasmacytic Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis
18415,Carcinomatous Component Present,Squamous cell carcinoma of mouth
18416,atypia morphology,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous"
18417,HMB-45-Positive Neoplastic Cells Present,Angiomyolipoma
18418,atypia morphology,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
18419,Micropapillary Pattern,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma
18420,Adulthood Lesion,Adult Spinal Cord Ependymoma
18421,Carcinomatous Component Present,Signet-ring cell adenocarcinoma of colon
18422,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemias
18423,Cutaneous Involvement,Malignant Breast Eccrine Spiradenoma
18424,Carcinomatous Component Present,Urothelial Carcinoma
18425,Epithelial Component Present,Grade II Penile Intraepithelial Neoplasia
18426,Epithelial Component Present,Stage I Vulvar Carcinoma
18427,Osteoid formation,Central Nervous System Extraskeletal Osteosarcoma
18428,Dysplasia,Appendix Villous Adenoma
18429,Carcinomatous Component Present,Stage IIA1 Cervical Cancer AJCC v7
18430,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma
18431,Stromal Invasion,serous adenocarcinofibroma of ovary
18432,Cystic Change,Bile duct cystadenoma
18433,Tissue Differentiation Uncertain,Gastric Synovial Sarcoma
18434,Metastatic Lesion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
18435,Carcinomatous Component Present,Early Invasive Cervical Adenocarcinoma
18436,Acanthosis,Upper Gingival Verrucous Carcinoma
18437,Childhood Lesion,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
18438,Anaplasia,Recurrent Anaplastic Large Cell Lymphoma
18439,Carcinomatous Component Present,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
18440,Childhood Lesion,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
18441,Chronic Inflammatory Infiltrate,Dysgerminoma
18442,Nerve palsy,Congenital facial nerve palsy
18443,Epithelial Component Present,Stage IV Oropharyngeal Carcinoma AJCC v7
18444,Epithelial Component Present,Malignant Bladder Paraganglioma
18445,Metastatic/Recurrent Disease,Malignant Soft Tissue Tumor of Uncertain Differentiation
18446,Carcinomatous Component Present,"Ovarian Small Cell Carcinoma, Hypercalcemic Type"
18447,Poorly Differentiated Lesion,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
18448,Endophytic Tumor Growth,Verrucous carcinoma of the oral cavity recurrent
18449,Pushing Tumor Margin,Verrucous carcinoma of the oral cavity recurrent
18450,Epithelial Component Present,Periampullary Adenocarcinoma
18451,Cutaneous Involvement,Radiation-Induced Dermatitis
18452,Carcinomatous Component Present,Stage IIIB Rectal Cancer AJCC v7
18453,Cavernous Vascular Space Formation,"Hemangioma, Cavernous, Central Nervous System"
18454,Indolent Clinical Course,Bizarre parosteal osteochondromatous proliferation
18455,Epithelial Component Present,"Phyllodes tumor, benign"
18456,Trabecular Pattern,"Adenoma, Trabecular"
18457,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage III
18458,Mediastinal mass,Mediastinal T Lymphoblastic Leukemia/Lymphoma
18459,Carcinomatous Component Present,Apocrine Breast Carcinoma In Situ
18460,Prominent Collagen Rosette Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
18461,Biphasic Pattern,Pleural Biphasic Synovial Sarcoma
18462,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
18463,Epithelial Component Present,mucinous adenocarcinoma of cervix
18464,Carcinomatous Component Present,Small cell carcinoma of lung
18465,More than 10 Mitoses per 10HPF,Small cell carcinoma of lung
18466,Epithelial Component Present,Stage IIA Appendix Carcinoma AJCC v7
18467,Eccrine Differentiation,Eccrine Neoplasm
18468,Recurrent disease,Recurrent Childhood Oligoastrocytoma
18469,Indolent Clinical Course,Palisaded Lymph Node Myofibroblastoma
18470,Well-Circumscribed Lesion,Palisaded Lymph Node Myofibroblastoma
18471,Carcinomatous Component Present,Stage I Appendix Carcinoma AJCC v7
18472,Chronic lymphocytic inflammation,Regressing nevus
18473,Tartrate Resistant Acid Phosphatase Positive Cells Present,Refractory Hairy Cell Leukemia
18474,Refractory Disease,Refractory Hairy Cell Leukemia
18475,Childhood Lesion,Mixed epithelial-mesenchymal hepatoblastoma
18476,Apocrine Differentiation,Apocrine Neoplasm
18477,Biphasic Pattern,Papillary glioneuronal tumor
18478,Recurrent disease,Recurrent Adult Liver Carcinoma
18479,Epithelial Component Present,Metastatic Parathyroid Gland Carcinoma
18480,Encapsulated Mass,Thyroid Gland Follicular Adenoma
18481,Epithelial Component Present,adenoma of intrahepatic bile duct
18482,Epithelial Component Present,Combined Lung Small Cell and Squamous Cell Carcinoma
18483,Schwannian Stroma More than 50 Percent of the Tumor Volume,Childhood Central Nervous System Ganglioneuroblastoma
18484,Keratin pearl formation,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
18485,Carcinomatous Component Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
18486,Absence of Invasion,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
18487,Neuroendocrine Differentiation,Stage I Merkel Cell Carcinoma AJCC v7
18488,Carcinomatous Component Present,Stage 0 Vulvar Carcinoma
18489,Epithelioid Component Present,Cardiac Biphasic Synovial Sarcoma
18490,Carcinomatous Component Present,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
18491,Severe dysplasia,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
18492,Metaplasia,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
18493,Pregnancy Complications,Abruptio Placentae
18494,High Mitotic Activity,"Endometrial stromal sarcoma, high grade"
18495,Necrotic changes (finding),Small cell carcinoma of the cervix
18496,Hyperplastic Epithelial Tissue Present,Atypical hyperplasia of breast
18497,Chronic Inflammatory Infiltrate,Cutaneous Lymphomatoid Granulomatosis
18498,Epithelial Component Present,Non-small cell lung cancer stage IIIB
18499,Refractory Disease,Refractory Plasma Cell Neoplasm
18500,Epithelial Component Present,Skin carcinoma
18501,Benign Cellular Infiltrate,neurofibroma of esophagus
18502,Mixed Cellular Population,Female Reproductive System Adenofibroma
18503,Papillary Pattern,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
18504,Epithelial Component Present,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
18505,Recurrent disease,Oral neoplasm malignant recurrent
18506,Mixed Cellular Population,Mixed Astrocytoma-Ependymoma-Oligodendroglioma
18507,Carcinomatous Component Present,Stage IIB Cervical Cancer AJCC v6 and v7
18508,Metaplasia of Malignant Cells Present,adenocarcinoma of breast with spindle cell metaplasia
18509,Epithelial Component Present,"Uterine Carcinosarcoma, Heterologous Type"
18510,Epithelial Component Present,Stage IB Lung Adenocarcinoma AJCC v7
18511,Epithelial Component Present,"Neoplasms, Fibroepithelial"
18512,Epithelial Component Present,Rectosigmoid Adenocarcinoma
18513,Cytoplasmic Membrane-Bound Granules Present,Stage 0 Merkel Cell Carcinoma AJCC v7
18514,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
18515,Childhood Lesion,Childhood Mature Teratoma
18516,Epithelial Component Present,Fallopian Tube Adenocarcinoma
18517,Cavernous Vascular Space Formation,Skin Cavernous Hemangioma
18518,Geographic Necrosis,Childhood Ovarian Embryonal Carcinoma
18519,Recurrent disease,Recurrent Malignant Neoplasm
18520,Carcinomatous Component Present,Adenocarcinoma of large intestine
18521,Perineural spread,Bartholin Gland Adenoid Cystic Carcinoma
18522,Slow Growing Mass,Childhood Cerebral Ependymoma
18523,Mixed Cellular Population,Stage II Kidney Wilms Tumor
18524,Epithelial Component Present,Seborrheic keratosis
18525,Invasive Lesion,Breast Carcinoma with Osteoclastic Giant Cells
18526,Non-Hereditary Lesion,Sporadic Retinoblastoma
18527,Nuclear Atypia,Multifocal Glioblastomas
18528,Carcinomatous Component Present,Stage II Gastric Carcinoma
18529,Well-Circumscribed Lesion,Gastrointestinal tract adenoma
18530,Increased Cellularity Present,Peripheral neuroblastoma
18531,Epithelial Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
18532,Carcinomatous Component Present,Penile Cancer by AJCC v7 Stage
18533,Neuroectodermal Differentiation,Peripheral Ganglioneuroblastoma
18534,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v6
18535,Immunosuppression-Related Post-Transplant Toxicity,Chronic rejection of renal transplant
18536,Carcinomatous Component Present,External Ear Basal Cell Carcinoma
18537,Epithelial Component Present,adenocarcinoma of breast with squamous metaplasia
18538,Mixed Cellular Population,Broad Ligament Serous Adenofibroma
18539,Exophytic Polypoid Lesion,"Adenoma, Villous"
18540,Cutaneous Involvement,External Ear Squamous Cell Carcinoma
18541,High Mitotic Activity,Small cell carcinoma of esophagus
18542,Glandular cell atypia,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
18543,Carcinomatous Component Present,small cell carcinoma of gallbladder
18544,Absence of Invasion,Squamous Cell Carcinoma In Situ of the Nipple
18545,Epithelial Component Present,Vulvar Glandular Neoplasm
18546,Epithelial Component Present,Carcinomatosis
18547,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Breast Carcinoma with Choriocarcinomatous Features
18548,Nodular Pattern,Balloon cell malignant melanoma
18549,Adulthood Lesion,Adult Brain Stem Astrocytoma
18550,Carcinomatous Component Present,Rectal Carcinoma
18551,Cavernous Vascular Space Formation,Giant Hemangioma
18552,Necrotic changes (finding),Anaplastic adrenocortical carcinoma
18553,'Starry-sky' pattern,Burkitt Lymphoma
18554,Carcinomatous Component Present,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
18555,Carcinomatous Component Present,FIGO Stage IIIA1 Ovarian Cancer
18556,Monomorphic Cellular Infiltrate,Adult Brain Oligodendroglioma
18557,Adulthood Lesion,Adult Brain Oligodendroglioma
18558,Infiltrative Growth Pattern,Extra-abdominal fibromatosis
18559,Syncytial Pattern,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion"
18560,Carcinomatous Component Present,Lip and Oral Cavity Squamous Cell Carcinoma
18561,Cutaneous Involvement,Trichilemmocarcinoma
18562,Vascular Channel Formation,Kaposi's sarcoma classical type
18563,Pseudoglandular Pattern,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
18564,Diffuse Pattern,Centroblastic lymphoma stage III
18565,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia
18566,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v7
18567,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7
18568,Syncytial Pattern,Lymphoepithelial carcinoma
18569,Metastatic/Recurrent Disease,Vulvar Proximal-Type Epithelioid Sarcoma
18570,Carcinomatous Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
18571,Carcinomatous Component Present,Childhood Thyroid Gland Follicular Carcinoma
18572,Mixed Cellular Population,Hybrid nerve sheath tumor
18573,Single Cell Necrosis,Stage IIC Merkel Cell Carcinoma AJCC v7
18574,Recurrent disease,T-cell lymphoma recurrent
18575,Metastatic Lesion,Metastatic Malignant Neoplasm in the Adult Brain
18576,Carcinomatous Component Present,Retromolar Trigone Squamous Cell Carcinoma
18577,High Grade Lesion,Anaplastic Diencephalic Astrocytoma
18578,Absence of Stromal Invasion,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
18579,Epithelial Component Present,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
18580,Epithelial Component Present,Adenoma of Minor Vestibular Glands
18581,S-100-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, malignant"
18582,Well-Circumscribed Lesion,Benign Mixed Tumor of the Vulva
18583,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity refractory
18584,Carcinomatous Component Present,Childhood Paranasal Sinus Carcinoma
18585,Epithelial Component Present,Lower Gingival Verrucous Carcinoma
18586,Polymorphic Cellular Infiltrate,Infectious mononucleosis-like post-transplant lymphoproliferative disorder
18587,Epithelial Component Present,Small Intestinal Intraepithelial Neoplasia
18588,Sebaceous Differentiation,Sebaceous Adenocarcinoma
18589,Tissue Differentiation Uncertain,Conventional Extraskeletal Myxoid Chondrosarcoma
18590,Borderline Lesion,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm
18591,Primary Lesion,Childhood Meningeal Melanoma
18592,Cutaneous Involvement,Scar Tissue
18593,Epithelial Component Present,High Grade Appendix Mucinous Adenocarcinoma
18594,Epithelial Component Present,"Adenoma, Sweat Gland"
18595,CD30-Positive Neoplastic Cells Present,Stage II Childhood Anaplastic Large Cell Lymphoma
18596,Monomorphic Cellular Infiltrate,Thymic Basaloid Carcinoma
18597,Epithelial Component Present,Appendix Neuroendocrine Tumor
18598,High Mitotic Activity,Neuroendocrine carcinoma of appendix
18599,Edematous Stroma Formation,Angiomyofibroblastoma
18600,Epithelial Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
18601,Borderline Lesion,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor
18602,Immunologic Deficiency Syndromes,Bone Marrow Transplantation Nephropathy
18603,Cellular Stratification,Borderline Ovarian Mucinous Adenofibroma
18604,Carcinomatous Component Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma
18605,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
18606,Neuroendocrine Differentiation,Colorectal Neuroendocrine Carcinoma
18607,Epithelial Component Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma
18608,Carcinomatous Component Present,large cell neuroendocrine carcinoma of lung
18609,In Situ Lesion,Stage 0 Esophageal Cancer AJCC v7
18610,Infiltrative Growth Pattern,Glioblastoma
18611,Recurrent disease,Laryngeal squamous cell carcinoma recurrent
18612,Epithelial Component Present,Colonic tubulovillous adenoma
18613,Neuroendocrine Differentiation,Islet Cell Tumor
18614,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia with Eosinophilia
18615,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Lipoadenoma
18616,Carcinomatous Component Present,Colorectal cancer recurrent
18617,Contiguous Disease,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma
18618,Carcinomatous Component Present,Stage III Rectosigmoid Cancer AJCC v6
18619,Local disease,Localized tumors of the Ewing's family
18620,Epithelial Component Present,Stage II Nasal Cavity Cancer AJCC v6 and v7
18621,Neoplastic Promonocytes in Bone Marrow Markedly Increased,M5b Acute differentiated monocytic leukemia
18622,Thin-Walled Branching Vascular Pattern,Thymus Solitary Fibrous Tumor
18623,Pseudoalveolar Pattern,Alveolar Soft Part Sarcoma
18624,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
18625,Carcinomatous Component Present,squamous cell carcinoma of the thyroid gland
18626,Exophytic Polypoid Lesion,Juvenile Polyp of the Small Intestine
18627,Pale Eosinophilic Stroma Formation,Dysembryoplastic neuroepithelial tumor
18628,Carcinomatous Component Present,Stage II Lung Cancer AJCC v6
18629,Epithelial Component Present,Unilateral Breast Carcinoma
18630,Peripheral Nuclear Palisading,Oropharyngeal Basaloid Carcinoma
18631,Follicular Cell Differentiation,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
18632,Fascicular Pattern,Transitional Meningioma
18633,Diffuse Pattern,Diffuse Large B-Cell Lymphoma
18634,Adulthood Lesion,Stage III Adult Liver Cancer AJCC v7
18635,Cutaneous Involvement,Eccrine dermal cylindroma
18636,Monomorphic Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis
18637,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1B
18638,Nuclear pleomorphism,High Grade Ductal Breast Carcinoma In Situ
18639,Localized Lesion,Pleural Well Differentiated Papillary Mesothelioma
18640,Well Differentiated Lesion,Pleural Well Differentiated Papillary Mesothelioma
18641,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage I subdiaphragmatic
18642,Indolent Clinical Course,Histiocytoid hemangioma
18643,Superficial Lesion,Superficial angiomyxoma
18644,Severe cytologic atypia,Vaginal Undifferentiated Sarcoma
18645,Immunologic Deficiency Syndromes,AIDS Dementia Complex
18646,Well-Circumscribed Lesion,tubular adenoma of stomach
18647,Diffuse Pattern,Childhood Gemistocytic Astrocytoma
18648,Tissue Differentiation Uncertain,Vulvar Superficial Angiomyxoma
18649,Carcinomatous Component Present,Mucinous carcinoma of breast
18650,Vascular Channel Formation,Brain Hemangioma
18651,Hyperplastic Tissue Present,Ductal Breast Hyperplasia
18652,Recurrent disease,Recurrent Head and Neck Carcinoma
18653,Tubular Pattern,Pancreatic Intraductal Tubulopapillary Neoplasm
18654,Recurrent disease,Malignant neoplasm of hypopharynx recurrent
18655,Epithelial Component Present,Cardiac Paraganglioma
18656,Carcinomatous Component Present,Female Breast Carcinoma
18657,Neuroendocrine Differentiation,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma
18658,Osteoid formation,Osteosarcoma Arising in Paget Disease of Bone
18659,Fibrotic Stroma Formation,Adenocarcinofibroma
18660,Epithelial Component Present,Papillary Epithelial Neoplasm
18661,Refractory Disease,Refractory Neoplasm
18662,Carcinomatous Component Present,Virus-Related Carcinoma
18663,Local disease,Parotid Gland Lipoma
18664,Hypergammaglobulinemia,Multi-centric Castleman's Disease
18665,Epithelial Component Present,Bronchial adenoma
18666,Carcinomatous Component Present,Pigmented Basal Cell Carcinoma
18667,Endobronchial Lesion,Lung Glandular Papilloma
18668,Non-Contiguous Disease,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma
18669,Neuroendocrine Differentiation,Nasopharyngeal Paraganglioma
18670,Solid Growth Pattern,"Invasive Lobular Breast Carcinoma, Solid Variant"
18671,Anaplasia,Sarcomatoid Carcinoma of the Penis
18672,Low Mitotic Activity,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
18673,Severe dysplasia,Carcinoma in situ of middle ear
18674,Nuclear Atypia,Glioblastoma
18675,Deep Lesion,Lumbosacral Lipoma
18676,Carcinomatous Component Present,Metastatic Prostate Carcinoma
18677,Indolent Clinical Course,Uterine Corpus Hydropic Leiomyoma
18678,Carcinomatous Component Present,Thymic Sarcomatoid Carcinoma
18679,Adnexal Differentiation,Hidroacanthoma simplex
18680,Epithelial Component Present,Non-Invasive Urothelial Neoplasm
18681,Exophytic Polypoid Lesion,Appendix Tubular Adenoma
18682,Pseudoencapsulated Mass,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
18683,Invasive Lesion,Invasive micropapillary carcinoma of breast
18684,Epithelial Component Present,"Thymoma, type B2"
18685,Locally Aggressive Lesion,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone
18686,Recurrent disease,Recurrent Retinoblastoma
18687,Perivascular Arrangement of Tumor Cells,Hereditary Glomangioma
18688,Presence of a Hormonal Syndrome,Pancreatic Vipoma
18689,Severe cytologic atypia,Intestinal Neuroendocrine Carcinoma
18690,Cambium Layer,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
18691,Metastatic Lesion,Metastatic Jugulotympanic Paraganglioma
18692,Monomorphic Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis
18693,High Mitotic Activity,Small Intestinal Large Cell Neuroendocrine Carcinoma
18694,Chromogranin A Positive Neoplastic Cells Present,Localized Digestive System Neuroendocrine Tumor G1
18695,atypia morphology,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor
18696,Necrotic changes (finding),Solid pseudopapillary tumor of the pancreas
18697,Carcinomatous Component Present,Penis carcinoma recurrent
18698,Epithelial Component Present,Penis carcinoma recurrent
18699,Indolent Clinical Course,Perifollicular fibroma
18700,'Starry-sky' pattern,Stage IV Burkitt Lymphoma
18701,Somatostatin Positive Neoplastic Cells Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor
18702,Sebaceous Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation
18703,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage 0
18704,Rapidly Enlarging Mass,Adult Pleomorphic Rhabdomyosarcoma
18705,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of appendix
18706,High Grade Lesion,Solid Alveolar Rhabdomyosarcoma
18707,Epithelial Component Present,Squamous cell carcinoma of pharynx
18708,Intraductal Lesion,intraductal papilloma of salivary gland
18709,Epithelial Component Present,Renal Cell Cancer by AJCC v7 Stage
18710,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Choriocarcinoma of ovary
18711,Epithelial Component Present,Gastric Squamous Cell Carcinoma
18712,Carcinomatous Component Present,Larynx carcinoma recurrent
18713,Cartilaginous Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia
18714,Epithelial Component Present,Meckel Diverticulum Neuroendocrine Tumor G1
18715,Papillary Pattern,Infiltrating papillary adenocarcinoma
18716,Epithelial Component Present,small cell carcinoma of extrahepatic bile duct
18717,Childhood Lesion,Juvenile astrocytoma
18718,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
18719,Vascular Channel Formation,Poorly Differentiated Angiosarcoma
18720,Myxoid Stroma Formation,Recurrent Extraskeletal Myxoid Chondrosarcoma
18721,Locally Aggressive Lesion,Intermediate Bone Neoplasm
18722,Absence of Invasion,Atypical Lobular Breast Hyperplasia
18723,Multinodular Mass,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
18724,Tissue of Mullerian Origin Present,Adenosarcoma of cervix uteri
18725,Carcinomatous Component Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
18726,Carcinomatous Component Present,Papillary carcinoma in situ
18727,Carcinomatous Component Present,Colon Cribriform Comedo-Type Adenocarcinoma
18728,Epithelial Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v7
18729,Comedo Necrosis,Colorectal Cribriform Comedo-Type Adenocarcinoma
18730,Nuclear Atypia,Anaplastic Oligoastrocytoma
18731,High Mitotic Activity,Anaplastic Oligoastrocytoma
18732,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis
18733,Indolent Clinical Course,Leiomyoma of Gallbladder
18734,Vascular Channel Formation,Breast Capillary Hemangioma
18735,Dysplasia,Biliary Intraepithelial Neoplasia-2
18736,Primary Lesion,Epithelioid sarcoma non-metastatic
18737,Squamous Differentiation,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
18738,Eosinophilic inflammation,Breast Epithelioid Hemangioma
18739,Epithelial Component Present,Adenoma of the nipple
18740,Perineural spread,Laryngeal Adenoid Cystic Carcinoma
18741,Invasive Lesion,Invasive Ductal Breast Carcinoma
18742,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma
18743,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I
18744,Malignant Germinomatous Cellular Infiltrate,Central Nervous System Germinoma
18745,Stromal Invasion,FIGO Stage IC1 Ovarian Cancer
18746,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Cervix
18747,High Mitotic Activity,Pleomorphic Variant Mantle Cell Lymphoma
18748,Epithelial Component Present,Borderline epithelial tumor of ovary
18749,Recurrent disease,Pericardial mesothelioma malignant recurrent
18750,Indolent Clinical Course,Hemangioma
18751,Carcinomatous Component Present,Pharyngeal Carcinoma
18752,Non-Invasive Lesion,Stage 0is Renal Pelvis Cancer AJCC v7
18753,Papillary Pattern,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
18754,Cystic Change,Malignant Brenner Tumor
18755,Antoni A Pattern,Conventional Schwannoma
18756,Hyperkeratosis,Verrucous carcinoma of the oral cavity recurrent
18757,Duct-Like Structures Present,Adenoameloblastoma
18758,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
18759,Metastatic Lesion,Advanced cancer
18760,Well Differentiated Lesion,Verrucous carcinoma
18761,Desmoplastic Stroma Formation,Desmoplastic Nevus
18762,Neuroendocrine Differentiation,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
18763,Glucagon-Like Peptide Positive Neoplastic Cells Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
18764,Epithelial Component Present,Stage IIIA Esophageal Cancer AJCC v7
18765,Severe dysplasia,Stage 0is Ureter Cancer AJCC v7
18766,Well-Circumscribed Lesion,"Cystadenoma, Serous"
18767,Chronic lymphocytic inflammation,Halo nevus
18768,Childhood Lesion,Rare Childhood Malignant Neoplasm
18769,Metaplasia of Malignant Cells Present,Adenocarcinoma with apocrine metaplasia
18770,Infiltrative Growth Pattern,Mesenchymal Glioblastoma
18771,Cutaneous Involvement,Pityriasis Rosea
18772,Mediastinal mass,Hodgkin's lymphoma of mediastinum
18773,Recurrent disease,Recurrent Ovarian Germ Cell Tumor
18774,Carcinomatous Component Present,Rectosigmoid Cancer by AJCC v7 Stage
18775,New bone formation (morphologic abnormality),Giant Cell Lesion of Small Bones
18776,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma
18777,Fibrosis,"Breast Fibrocystic Change, Proliferative Type without Atypia"
18778,Epithelial Component Present,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7
18779,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v7 Stage
18780,Schwannian Stroma More than 50 Percent of the Tumor Volume,Childhood Ganglioneuroblastoma
18781,More than 10 Mitoses per 10HPF,Combined Lung Small Cell and Squamous Cell Carcinoma
18782,Antoni A Pattern,Colorectal Schwannoma
18783,Hyperplastic Epithelial Tissue Present,Intraductal Breast Myoepitheliosis
18784,Mesenchymal Component Present,Breast Fibroepithelial Neoplasm
18785,Vascular Channel Formation,Gastric Lymphangioma
18786,Recurrent disease,Recurrent Female Reproductive System Carcinoma
18787,Epithelial Component Present,Hard Palate Mucoepidermoid Carcinoma
18788,Pregnancy Complications,Stage II Gestational Trophoblastic Tumor AJCC v7
18789,Carcinomatous Component Present,Stage IA Ovarian Cancer
18790,Epithelial Component Present,Extra-Adrenal Paraganglioma
18791,Exophytic Papillary Lesion,Condyloma anal
18792,Epithelial Component Present,Stage IIB Distal Bile Duct Cancer AJCC v7
18793,Local disease,Localized Non-Resectable Adult Liver Carcinoma
18794,Epithelial Component Present,Adrenocortical carcinoma
18795,Mixed Cellular Population,Cervical Adenofibroma
18796,Thyroglobulin Positive Neoplastic Cells Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
18797,Serotonin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
18798,Biphasic Pattern,"Cervical Adenomyoma, Endometrial Type"
18799,Indolent Clinical Course,Uterine Corpus Atypical Polypoid Adenomyoma
18800,Calcitonin serum level increased,Sporadic Thyroid Gland Medullary Carcinoma
18801,Childhood Lesion,Childhood Hematopoietic Neoplasm
18802,Neuroendocrine Differentiation,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
18803,Chromogranin A Positive Neoplastic Cells Present,Thymic Carcinoid Tumor
18804,Cutaneous Involvement,Spindle cell nevus of Reed
18805,Mixed Cellular Population,Soft Palate Pleomorphic Adenoma
18806,Osseous Differentiation,Periosteal Osteosarcoma
18807,Epithelial Component Present,Nasopharyngeal Nonkeratinizing Carcinoma
18808,Unresectable Mass,Unresectable Hepatocellular Carcinoma
18809,Hyperkeratosis,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
18810,Mild cytologic atypia,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
18811,Acantholysis,"Squamous Cell Breast Carcinoma, Acantholytic Variant"
18812,Epithelial Component Present,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
18813,Adulthood Lesion,Adult Diffuse Astrocytoma
18814,Carcinomatous Component Present,Uterine Ligament Clear Cell Adenocarcinoma
18815,Non-Specific Glandular Pattern,"Salivary Gland Adenocarcinoma, Not Otherwise Specified"
18816,Nuclear Atypia,Atypical follicular adenoma
18817,Increased Cellularity Present,Cellular Ependymoma
18818,Localized Lesion,Extramedullary Plasmacytoma
18819,Carcinomatous Component Present,Perihilar Intrahepatic Cholangiocarcinoma
18820,Hyaline Cartilage Differentiation,Soft tissue chondroma
18821,Biphasic Pattern,Broad Ligament Serous Cystadenofibroma
18822,Carcinomatous Component Present,Urothelial carcinoma bladder recurrent
18823,Exophytic Papillary Lesion,Plantar Verrucous Skin Carcinoma
18824,Epithelial Component Present,Metaplastic carcinoma of breast
18825,Sarcomatous Component Present,Uterine Corpus Carcinosarcoma
18826,Biphasic Pattern,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
18827,Unifocal Disease,Extracutaneous Mastocytoma
18828,Recurrent disease,Recurrent Adult Hodgkin Lymphoma
18829,Invasive Lesion,Endometrioid carcinoma of prostate
18830,Epithelial Component Present,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
18831,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma stage I
18832,Carcinomatous Component Present,Adult Fibrolamellar Carcinoma
18833,Angiosarcoma-Like Areas Present,Skin Pseudovascular Squamous Cell Carcinoma
18834,Neuroectodermal Differentiation,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
18835,Cysts Containing Proteinaceous Fluid Present,Ovarian Papillary Cystadenoma
18836,Vascular Channel Formation,Synovial Hemangioma
18837,Epithelial Component Present,undifferentiated carcinoma of ureter
18838,Epithelial Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma
18839,Koilocytotic atypia,Human Papillomavirus-Related Penile Squamous Cell Carcinoma
18840,Neuroendocrine Differentiation,Vulvar Neuroendocrine Carcinoma
18841,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
18842,Carcinomatous Component Present,Adenocarcinoma in situ in tubular adenoma
18843,Dysplasia,Rectal Traditional Serrated Adenoma
18844,Moderately Differentiated Lesion,Grade 2 Colorectal Adenocarcinoma
18845,Epithelial Component Present,Breast cancer recurrent
18846,Epithelial Component Present,Pancreatic Somatostatinoma
18847,Nodular Pattern,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion"
18848,Microvascular Proliferation,Cerebellar Glioblastoma
18849,Cystic Change,Borderline cystadenoma
18850,Low Mitotic Activity,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
18851,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma
18852,Mixed Cellular Population,Infiltrating duct and lobular carcinoma
18853,Cutaneous Involvement,Stage IVA Basal Cell Lip Carcinoma
18854,Plexiform Growth Pattern,Plexiform Neurofibroma
18855,Biphasic Pattern,Metaplastic thymoma
18856,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of ileum
18857,Increased Cellularity Present,Localized Resectable Neuroblastoma
18858,Epithelial Component Present,Refractory Carcinoma
18859,Epithelial Component Present,Descending Colon Neuroendocrine Tumor G1
18860,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intracranial Meningioma
18861,Epithelial Component Present,Small intestine carcinoma recurrent
18862,Epithelial Component Present,mucoepidermoid carcinoma of lung
18863,Unilineage Dysplasia Present,Refractory cytopenia with unilineage dysplasia
18864,Extensive Stage Lesion,Pericardial mesothelioma malignant advanced
18865,Vascular Channel Formation,Deep Hemangioma
18866,Carcinomatous Component Present,Urethral Verrucous Carcinoma
18867,Cutaneous Involvement,Retiform parapsoriasis
18868,Congenital Lesion,Proliferative dermal lesion in congenital nevus
18869,Childhood Lesion,Childhood Lung Small Cell Carcinoma
18870,Carcinomatous Component Present,Sporadic Thyroid Gland Micromedullary Carcinoma
18871,Psammoma Body Formation,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
18872,Junctional Proliferation,"Nevus, Spindle Cell"
18873,Mesenchymal Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma
18874,Mitotic Activity,teratocarcinoma of mediastinum
18875,Nuclear pleomorphism,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
18876,Carcinomatous Component Present,Squamous cell carcinoma of tonsil
18877,Multiple Tumor Masses,Multiple Intraspinal Meningiomas
18878,Carcinomatous Component Present,Renal Pelvis and Ureter Urothelial Carcinoma
18879,Epithelial Component Present,Spindle cell squamous cell carcinoma
18880,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Excess Blasts and Fibrosis
18881,Epithelial Component Present,Childhood Parathyroid Gland Carcinoma
18882,Epithelial Component Present,"Thymoma, type A"
18883,Epithelial Component Present,Grade 3 Endometrial Endometrioid Adenocarcinoma
18884,Fibrotic Stroma Formation,mucoepidermoid carcinoma of floor of mouth
18885,Cutaneous Involvement,"Mucinosis, Follicular"
18886,Epithelial Component Present,Bladder transitional cell carcinoma stage II
18887,Carcinomatous Component Present,Submucosal Invasive Colon Adenocarcinoma
18888,Indolent Clinical Course,Leiomyoma of esophagus
18889,Intraductal Lesion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
18890,Carcinomatous Component Present,Well Differentiated Prostate Adenocarcinoma
18891,Well Differentiated Lesion,Well Differentiated Prostate Adenocarcinoma
18892,Childhood Lesion,Stage III Childhood Anaplastic Large Cell Lymphoma
18893,Carcinomatous Component Present,"Breast Cancer, Familial"
18894,Carcinomatous Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
18895,Epithelial Component Present,large cell neuroendocrine carcinoma of appendix
18896,Epithelial Component Present,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
18897,Epithelial Component Present,Colorectal Undifferentiated Carcinoma
18898,Indolent Clinical Course,Intravascular fasciitis
18899,Intravascular Spread,Intravascular fasciitis
18900,Epithelial Component Present,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
18901,Epithelial Component Present,Paget Disease
18902,Ineffective hematopoiesis,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
18903,Severe cytologic atypia,Colorectal Neuroendocrine Carcinoma
18904,Epithelial Component Present,Glomerulosa Cell Adrenal Cortical Adenoma
18905,Cutaneous Involvement,Breast Carcinoma Metastatic in the Skin
18906,Carcinomatous Component Present,Fallopian Tube Squamous Cell Carcinoma
18907,Metastatic Lesion,Metastatic Malignant Neoplasm in the Soft Tissues
18908,Mixed Cellular Population,Malignant Phyllodes Tumor of Prostate
18909,Mild cytologic atypia,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
18910,Childhood Lesion,Pediatric Neoplasm
18911,Well-Circumscribed Lesion,Childhood Kidney Wilms Tumor
18912,Therapy-Related Toxicity,Transplant-Related Hematologic Malignancy
18913,Carcinomatous Component Present,Stage 0 Esophageal Cancer AJCC v7
18914,Cutaneous Involvement,Piloleiomyoma
18915,Epithelial Component Present,Cervical Neuroendocrine Neoplasm
18916,Benign Cellular Infiltrate,Serous cystadenoma of pancreas
18917,Epithelial Component Present,Carotid Body Paraganglioma
18918,Carcinomatous Component Present,Stage IVA Pharyngeal Carcinoma
18919,Absence of Invasion,Noninfiltrating Intraductal Carcinoma
18920,Poorly Differentiated Lesion,Poorly Differentiated Hepatocellular Carcinoma
18921,Below the Diaphragm Disease,Hodgkin's disease of intrapelvic lymph nodes
18922,Cutaneous Involvement,Skin tag
18923,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-1
18924,Well-Circumscribed Lesion,Colon adenoma
18925,High Mitotic Activity,Stage IB Lung Small Cell Carcinoma AJCC v7
18926,Indolent Clinical Course,Sternal Chondromyxoid Fibroma
18927,Hereditary Lesion,BRCA2 Syndrome
18928,High Grade Lesion,Fibroblastic osteosarcoma
18929,Slow Growing Mass,Hemosiderotic Fibrolipomatous Tumor
18930,Epithelial Component Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
18931,Epithelial Component Present,Adenocarcinoma of the prostate stage IV
18932,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IIIB
18933,Epithelial Component Present,Stage IV Renal Cell Cancer AJCC v7
18934,Epithelial Differentiation,"Transitional cell carcinoma, spindle cell"
18935,Abnormal Eosinophilic Granules Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
18936,Perivascular Arrangement of Tumor Cells,Solid Glomus Tumor
18937,Secondary Lesion,Medulloblastoma with Leptomeningeal Spread
18938,Therapy-Related Toxicity,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
18939,Exophytic Polypoid Lesion,Small Intestinal Tubular Adenoma
18940,Epithelial Component Present,"Adenocarcinoma, metastatic"
18941,Hyperplastic Tissue Present,Senile Sebaceous Hyperplasia
18942,Chronic Inflammatory Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis
18943,Cutaneous Involvement,Mycosis fungoides refractory
18944,Chronic Inflammatory Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7
18945,In Situ Lesion,Intraductal Non-Comedo Breast Adenocarcinoma
18946,Comedo Necrosis,High Grade Ductal Breast Carcinoma In Situ
18947,Carcinomatous Component Present,Squamous Cell Bile Duct Carcinoma
18948,Papillary Pattern,Pleural Well Differentiated Papillary Mesothelioma
18949,Localized Lesion,Plasmacytoma
18950,Epithelial Component Present,Intra-Abdominal Paraganglioma
18951,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7
18952,Severe dysplasia,Carcinoma in situ of skin
18953,Adulthood Lesion,Adult Kidney Wilms Tumor
18954,Bone Marrow Eosinophilia,"Acute myeloid leukemia, t(16;16)(p13;q22)"
18955,Carcinomatous Component Present,Stage III Colon Cancer AJCC v7
18956,Secondary Lesion,Secondary Chondrosarcoma
18957,Epithelial Component Present,Stage 0 Breast Cancer AJCC v6 and v7
18958,Epithelial Component Present,Pancreatic Intraductal Neoplasms
18959,Carcinomatous Component Present,Vaginal Undifferentiated Carcinoma
18960,Absence of Invasion,Carcinoma in situ of prostate
18961,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage II
18962,Villous Pattern,Villous adenoma of duodenum
18963,Dysplasia,Villous adenoma of duodenum
18964,Epithelial Component Present,Localized Carcinoma
18965,Epithelial Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
18966,Granulocytes Increased in Bone Marrow,"Leukemia, Myeloid, Chronic-Phase"
18967,Epithelial Component Present,Malignant Cardiac Paraganglioma
18968,"Hyperkeratosis, Epidermolytic",Epidermolytic acanthoma
18969,Well-Circumscribed Lesion,Syringocystadenoma Papilliferum
18970,Vascular proliferation,Vulvar Cellular Angiofibroma
18971,Chromogranin A Positive Neoplastic Cells Present,Lung Typical Carcinoid Tumor
18972,Childhood Lesion,"Diffuse midline glioma, point mutation K27M in histone H3"
18973,Mitotic Activity,Childhood Gliosarcoma
18974,atypia morphology,"Borderline Ovarian Mucinous Tumor, Intestinal Type"
18975,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of ovary
18976,atypia morphology,Borderline Ovarian Mucinous Tumor
18977,Epithelial Component Present,Uterine Corpus Neuroendocrine Neoplasm
18978,Epithelial Component Present,Cervical Serous Adenocarcinoma
18979,Absence of Invasion,Ampulla of Vater Tubular Adenoma
18980,Seminomatous Component Present,Mixed Germ Cell Tumor
18981,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Neutrophilic Leukemia
18982,Epithelial Component Present,Stage IIIB Esophageal Adenocarcinoma AJCC v7
18983,Broad Fibrous Bands Formation,Parathyroid Gland Atypical Adenoma
18984,Blasts Under 20 Percent of Peripheral Blood White Cells,Juvenile Myelomonocytic Leukemia
18985,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7
18986,Diffuse Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease
18987,Epithelial Component Present,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
18988,Adnexal Differentiation,Benign neoplasm of sweat gland
18989,Immunologic Deficiency Syndromes,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
18990,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type"
18991,Malignant Cellular Infiltrate,Dysgerminoma of ovary
18992,Epithelial Component Present,large cell carcinoma of salivary gland
18993,Nuclear pleomorphism,undifferentiated carcinoma of pancreas
18994,Epithelial Component Present,Mucin-producing adenocarcinoma
18995,Well-Circumscribed Lesion,Ossifying Fibroma
18996,Mixed Cellular Population,Ovarian Adenosarcoma
18997,Primary Lesion,Smoldering Systemic Mastocytosis
18998,Papillary Pattern,Invasive intraductal papillary-mucinous carcinoma of pancreas
18999,Cutaneous Involvement,Solar Radiation-Related Cutaneous Melanoma
19000,Epithelial Component Present,Gastric Large Cell Neuroendocrine Carcinoma
19001,Nodular lesions,Liver Dysplastic Nodule
19002,Carcinomatous Component Present,Large cell carcinoma with rhabdoid phenotype
19003,Cutaneous Involvement,Syringoma
19004,Diffuse Pattern,Splenic diffuse red pulp small B-cell lymphoma
19005,Epithelial Component Present,Stage IIA Lung Squamous Cell Carcinoma AJCC v7
19006,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
19007,Epithelial Component Present,"Somatostatinoma, malignant"
19008,Epithelial Component Present,mixed acinar-endocrine carcinoma of pancreas
19009,Recurrent disease,Recurrent Grade 2 Follicular Lymphoma
19010,Carcinomatous Component Present,Stage II Gallbladder Cancer AJCC v6
19011,Carcinomatous Component Present,Stage I Urethral Cancer AJCC v7
19012,Indolent Clinical Course,Indolent Systemic Mastocytosis
19013,Adnexal Differentiation,Sweat Gland Neoplasms
19014,Carcinomatous Component Present,Stage III Rectosigmoid Cancer AJCC v7
19015,Carcinomatous Component Present,Serous surface papillary carcinoma
19016,Epithelial Component Present,Grade 1 Colon Adenocarcinoma
19017,Primary Lesion,Childhood Cerebral Anaplastic Astrocytoma
19018,Neuroendocrine Differentiation,Gastro-enteropancreatic neuroendocrine tumor
19019,Cutaneous Involvement,Subungual glomus tumor
19020,Secondary Lesion,Metastatic malignant neoplasm to oropharynx
19021,Neuroendocrine Differentiation,Digestive System Neuroendocrine Carcinoma
19022,Primary Lesion,Primary Systemic Amyloidosis
19023,Lymphoplasmacytic Infiltrate,Familial Waldenstrom's Macroglobulinaemia
19024,Exophytic Papillary Lesion,Vulvar Keratoacanthoma
19025,Carcinomatous Component Present,Childhood Renal Cell Carcinoma
19026,Nuclear Atypia,Recurrent Childhood Giant Cell Glioblastoma
19027,Low Mitotic Activity,Localized Digestive System Neuroendocrine Tumor G1
19028,atypia morphology,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor
19029,Primary Lesion,Recurrent Childhood Gliosarcoma
19030,Dysplasia,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
19031,High Mitotic Activity,Stage IV Lung Small Cell Carcinoma AJCC v7
19032,Multinodular Pattern,Intracranial Extraskeletal Myxoid Chondrosarcoma
19033,Mixed Cellular Population,Mixed germ cell-sex cord-stromal tumor
19034,Carcinomatous Component Present,Adenocarcinoma in tubulovillous adenoma
19035,Solid Growth Pattern,Solid Alveolar Rhabdomyosarcoma
19036,Endophytic Tumor Growth,inverted ductal papilloma of salivary gland
19037,Epithelial Component Present,Foregut Carcinoid Tumor
19038,Biphasic Pattern,Uterine Ligament Adenosarcoma
19039,Cutaneous Involvement,Basal cell carcinoma - adenoid
19040,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage I
19041,Geographic Necrosis,Testicular embryonal carcinoma stage II
19042,Breast Microcalcification,oligodendroglioma
19043,Honeycomb Pattern,oligodendroglioma
19044,Epithelial Component Present,Keratinizing Paranasal Sinus Squamous Cell Carcinoma
19045,Epithelial Component Present,Stage IB Gastric Carcinoma
19046,Epithelial Component Present,Stage II Colon Cancer
19047,High Grade Lesion,Esophageal Rhabdomyosarcoma
19048,Carcinomatous Component Present,keratinizing squamous cell carcinoma of nasal cavity
19049,Necrotic changes (finding),Cervical Large Cell Neuroendocrine Carcinoma
19050,Neuroendocrine Differentiation,Cervical Large Cell Neuroendocrine Carcinoma
19051,Osseous Differentiation,Mediastinal Extraskeletal Osteosarcoma
19052,Cutaneous plaque,Infiltrating basal cell carcinoma
19053,Hyperplastic Tissue Present,Pseudoepitheliomatous hyperplasia
19054,Carcinomatous Component Present,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter
19055,Pregnancy Complications,"Non-Neoplastic, Non-Molar Trophoblastic Disorder"
19056,Cutaneous Involvement,Folliculitis
19057,Nuclear Atypia,Adult Anaplastic Astrocytoma
19058,Epithelial Component Present,Head and Neck Carcinoma
19059,Peripheral Nuclear Palisading,Lung Basaloid Large Cell Carcinoma
19060,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
19061,Childhood Lesion,Clear cell sarcoma of kidney
19062,Peripheral Nuclear Palisading,Head and Neck Basaloid Carcinoma
19063,Cellular Pleomorphism,Malignant fibrous histiocytoma recurrent
19064,Epithelial Component Present,Carcinoma Arising from Craniopharyngioma
19065,Well-Circumscribed Lesion,Appendix Villous Adenoma
19066,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma
19067,Locally Aggressive Lesion,Composite hemangioendothelioma
19068,Vascular Channel Formation,Central Nervous System Hemangioma
19069,Mild dysplasia,Biliary Intraepithelial Neoplasia-1
19070,Endophytic Tumor Growth,Ureter Inverted Papilloma
19071,Fibrotic Stroma Formation,Rete Ovarii Cystadenofibroma
19072,Exophytic Polypoid Lesion,Rectal polyp
19073,Tissue Differentiation Uncertain,Uterine Corpus PEComa
19074,S-100-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis of skin
19075,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis of skin
19076,Epithelial Component Present,Thyroid Gland Hyperfunctioning Adenoma
19077,Polymorphic Cellular Infiltrate,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
19078,Defective Heavy Chain Present,gamma-Chain Disease
19079,Pregnancy Complications,Placental Site Nodule or Plaque
19080,Vascular Channel Formation,Benign neoplasm of blood vessel
19081,Indolent Clinical Course,Cutaneous myxoma
19082,Carcinomatous Component Present,FIGO Stage IC2 Ovarian Cancer
19083,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Adult Myelodysplastic Syndrome
19084,Cutaneous Involvement,Mongolian Spot
19085,Childhood Lesion,Recurrent Childhood Protoplasmic Astrocytoma
19086,Recurrent disease,recurrent adult acute myeloid leukemia
19087,Carcinomatous Component Present,Primary Peritoneal Low Grade Serous Adenocarcinoma
19088,Carcinomatous Component Present,Invasive Breast Carcinoma by Histologic Grade
19089,Recurrent disease,Recurrent Adult Brain Neoplasm
19090,Epithelial Component Present,Intracanalicular fibroadenoma
19091,Presence of a Hormonal Syndrome,Functioning Pituitary Gland Microadenoma
19092,Vascular Channel Formation,Hemangioendothelioma of skin
19093,Large Mass,Giant fibroadenoma of breast
19094,Indolent Clinical Course,Blue rubber bleb nevus syndrome
19095,Well-Circumscribed Lesion,Non-Functioning Adrenal Cortex Adenoma
19096,Extensive Stage Lesion,Advanced cancer
19097,Childhood Lesion,Childhood T Lymphoblastic Leukemia/Lymphoma
19098,Biphasic Pattern,carcinosarcoma of liver
19099,Calcinosis,Ossifying fibromyxoid tumor
19100,Epithelial Component Present,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
19101,Well-Circumscribed Lesion,Cyst of Skene's duct
19102,Childhood Lesion,Childhood Acute Myeloid Leukemia
19103,Tissue Differentiation Uncertain,Extrarenal rhabdoid tumor
19104,Carcinomatous Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma
19105,Calcitonin serum level increased,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
19106,Nodular lesions,Thyroid Gland Follicular Adenoma
19107,Dysplasia,adenoma of intrahepatic bile duct
19108,Cutaneous Involvement,Ganglioneuroma of skin
19109,Increased Cellularity Present,Localized Unresectable Neuroblastoma
19110,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type"
19111,Epithelial Component Present,Stage II Esophageal Cancer
19112,Absence of Invasion,Cervical Adenocarcinoma In Situ
19113,Cutaneous Involvement,Contact dermatitis due to arnica
19114,Primary Lesion,Telangiectatic osteosarcoma
19115,Epithelial Component Present,Benign squamous cell tumor
19116,Epithelial Component Present,Skin appendage adenoma
19117,Childhood Lesion,Childhood Angiosarcoma
19118,Severe dysplasia,Stage 0 Vulvar Carcinoma
19119,Dysplasia,Stage 0 Vulvar Carcinoma
19120,Radiation Sickness,Cataract associated with radiation
19121,Spindle Cell Component Present,Cardiac Biphasic Synovial Sarcoma
19122,Low Grade Lesion,Microcystic adnexal carcinoma
19123,Carcinomatous Component Present,Adenocarcinoma of lung stage IIIA
19124,Epithelial Component Present,tubular adenoma of extrahepatic bile duct
19125,Invasive Lesion,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
19126,Epithelial Component Present,"Endometrioid adenoma, borderline malignancy"
19127,Endophytic Tumor Growth,Cervical Verrucous Carcinoma
19128,Necrotic changes (finding),Melanotic malignant nerve sheath tumor
19129,Nuclear Grooves,Clear Cell Variant Thyroid Gland Papillary Carcinoma
19130,Angiocentric Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis
19131,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma
19132,Slow Growing Mass,Kadish Stage B Olfactory Neuroblastoma
19133,Fibrotic Stroma Formation,Cystadenofibroma
19134,Unicystic Lesion,Unicystic ameloblastoma
19135,Fibrotic Stroma Formation,Papillary adenofibroma
19136,Mixed Cellular Population,Uterine Corpus Atypical Polypoid Adenomyoma
19137,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Secondary Myelodysplastic Syndrome
19138,Epithelial Component Present,Paget's Disease of the Nipple
19139,Endodermal Sinus Pattern,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern"
19140,Biphasic Pattern,Fibroadenoma of breast
19141,Mucoid Stroma Formation,Colorectal Mucinous Adenocarcinoma
19142,Stromal Invasion,High Grade Ovarian Serous Adenocarcinoma
19143,Monomorphic Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma
19144,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage II
19145,Carcinomatous Component Present,Stage I Oropharyngeal Carcinoma
19146,Immunologic Deficiency Syndromes,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
19147,Nerve palsy,Glossopharyngeal nerve paralysis
19148,Carcinomatous Component Present,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
19149,Locally Aggressive Lesion,Giant Cell Tumor of Soft Tissue
19150,Anaplasia,Anaplastic Oligoastrocytoma
19151,Desmoplastic Stroma Formation,Pilomatrix carcinoma of skin
19152,Geographic Necrosis,Pilomatrix carcinoma of skin
19153,Necrotic changes (finding),Bartholin Gland Small Cell Carcinoma
19154,Serrated Glandular Architecture,Filiform Serrated Adenoma
19155,Well Differentiated Lesion,Low grade appendiceal mucinous neoplasm
19156,Carcinomatous Component Present,undifferentiated carcinoma of gallbladder
19157,Cysts Containing Proteinaceous Fluid Present,Broad Ligament Serous Cystadenoma
19158,Rapidly Enlarging Mass,keratoacanthoma
19159,Epithelial Component Present,Plurihormonal Pituitary Gland Adenoma
19160,Epithelial Component Present,Squamous cell carcinoma of scrotum
19161,Osseous Differentiation,Osteoblastic Osteosarcoma
19162,Vascular Channel Formation,Osteoblastic Osteosarcoma
19163,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v7
19164,Epithelial Component Present,Childhood Choroid Plexus Papilloma
19165,Absence of Stromal Invasion,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor
19166,Fibrotic Stroma Formation,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
19167,Stromal Invasion,Stage IIIC Ovarian Cancer
19168,Biphasic Pattern,Solitary Myofibromatosis
19169,Lobulated Growth Pattern,Pyogenic granuloma
19170,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
19171,Anaplasia,Anaplastic ganglioglioma
19172,Severe cytologic atypia,small cell carcinoma of gallbladder
19173,Secondary Lesion,Secondary malignant neoplasm of vagina
19174,High Grade Lesion,Adult Brain Stem Gliosarcoma
19175,Neuroendocrine Differentiation,Middle Ear Paraganglioma
19176,Marked Nuclear Atypia Present,Malignant Uterine Corpus PEComa
19177,Carcinomatous Component Present,Squamous cell carcinoma of the nasal cavity
19178,Primary Lesion,Meningeal Lymphoma
19179,Carcinomatous Component Present,FIGO Stage II Ovarian Cancer
19180,Keratin pearl formation,Skin Pseudovascular Squamous Cell Carcinoma
19181,Nodular lesions,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
19182,Biphasic Pattern,Vulvar Ectopic Fibroadenoma
19183,Nests of Nevus Cells Resembling Nerve Bundles Present,Neuronevus
19184,Childhood Lesion,Childhood Mixed Germ Cell Tumor
19185,Local disease,Hibernoma
19186,Carcinomatous Component Present,Familial medullary thyroid carcinoma
19187,Secondary Lesion,Therapy-related myelodysplastic syndrome
19188,Carcinomatous Component Present,Grade 2 Colorectal Adenocarcinoma
19189,Deep Lesion,Deep Lipoma
19190,Infiltrative Growth Pattern,Recurrent Childhood Anaplastic Astrocytoma
19191,Deep Lesion,Tendon Sheath Lipoma
19192,Mixed Cellular Population,"Malignant Mixed Tumor, Not Otherwise Specified"
19193,Morphologic Overlap,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
19194,Epithelial Component Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
19195,Mitotic Activity,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
19196,Recurrent disease,Recurrent Childhood Anaplastic Oligoastrocytoma
19197,Exophytic Polypoid Lesion,Appendix Hyperplastic Polyp
19198,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Pulmonary Artery Choriocarcinoma
19199,Keratin pearl formation,"Squamous cell carcinoma, keratinizing"
19200,Storiform Growth Pattern,Malignant fibrous histiocytoma metastatic
19201,Epithelial Component Present,Metaplastic thymoma
19202,Invasive Lesion,Bladder transitional cell carcinoma stage III
19203,Cutaneous Involvement,Lymphangioma of skin
19204,atypia morphology,Atypical fibroxanthoma of skin
19205,Carcinomatous Component Present,Central Nervous System Carcinoma
19206,Carcinomatous Component Present,Verrucous carcinoma of penis
19207,Carcinomatous Component Present,Multifocal superficial basal cell carcinoma
19208,Adulthood Lesion,Adult Brain Neoplasm
19209,Actinic Damage,Hutchinson's Melanotic Freckle
19210,Epithelial Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
19211,Increased Cellularity Present,Neuroblastoma recurrent
19212,Hyalinized Stroma Formation,benign fibroma of liver
19213,Recurrent disease,Non-Hodgkin's lymphoma transformed recurrent
19214,Neuroendocrine Differentiation,Stage III Merkel Cell Carcinoma AJCC v7
19215,Epithelial Component Present,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)
19216,Neuroendocrine Differentiation,Adrenal Gland Composite Pheochromocytoma
19217,Chronic Inflammatory Infiltrate,Deep histiocytoma
19218,Indolent Clinical Course,Deep histiocytoma
19219,atypia morphology,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
19220,Mesenchymal Component Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma
19221,Papillary Pattern,"Cystadenoma, Papillary"
19222,Adnexal Differentiation,Apocrine adenoma
19223,Primary Lesion,Anaplastic Hemispheric Astrocytoma
19224,Epithelial Component Present,Upper Gingival Squamous Cell Carcinoma
19225,Neuroectodermal Differentiation,Localized Primitive Neuroectodermal Tumor
19226,Metastatic Lesion,Metastatic Penile Cancer
19227,Drop Metastasis,Drop Metastasis in the Spinal Cord
19228,Epithelial Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma
19229,Neuroectodermal Differentiation,Ganglioneuroblastoma
19230,Anaplasia,Spindle cell squamous cell carcinoma
19231,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage III
19232,Regional Disease,Ureteric cancer regional
19233,Epithelial Component Present,Vaginal Mucinous Adenocarcinoma
19234,Carcinomatous Component Present,Postcricoid Squamous Cell Carcinoma
19235,S-100-Positive Neoplastic Cells Present,"Dendritic Cell Sarcoma, Interdigitating"
19236,Carcinomatous Component Present,Lip basal cell carcinoma
19237,Borderline Lesion,Borderline Breast Phyllodes Tumor
19238,Borderline Lesion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia
19239,Invasive Lesion,Bladder transitional cell carcinoma stage II
19240,Hyperkeratosis,Laryngeal verrucous carcinoma
19241,Carcinomatous Component Present,Human Papillomavirus-Related Cervical Carcinoma
19242,Hereditary Lesion,Congenital Bone Marrow Failure Syndromes
19243,Osteoid formation,Small cell osteosarcoma
19244,Mitotic Activity,"Testicular Yolk Sac Tumor, Enteric Pattern"
19245,Well-Circumscribed Lesion,Compact Cell Adrenal Cortical Adenoma
19246,Carcinomatous Component Present,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
19247,Carcinomatous Component Present,Rectosigmoid Signet Ring Cell Carcinoma
19248,Fibrotic Stroma Formation,Borderline Ovarian Serous Cystadenofibroma
19249,Well-Circumscribed Lesion,Clear Cell Adrenal Cortical Adenoma
19250,Cutaneous Involvement,"Leishmaniasis, Cutaneous"
19251,Well-Circumscribed Lesion,Glomerulosa Cell Adrenal Cortical Adenoma
19252,Pushing Tumor Margin,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
19253,Cystic Change,Calcifying Odontogenic Cyst
19254,Dysplasia,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
19255,Carcinomatous Component Present,"Carcinoma, Basosquamous"
19256,Epithelial Component Present,"Papillary renal cell carcinoma, sporadic"
19257,Epithelial Component Present,verrucous carcinoma of bladder
19258,Dermal Nodule,Trichodiscoma
19259,Mild cytologic atypia,Laryngeal verrucous carcinoma recurrent
19260,Epithelial Component Present,"Glycogen-Rich, Clear Cell Breast Carcinoma"
19261,Epithelial Component Present,Stage IVC Pharyngeal Carcinoma
19262,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
19263,Mucoid Stroma Formation,Small Intestinal Mucinous Adenocarcinoma
19264,Eccrine Differentiation,Eccrine carcinoma of skin
19265,Crystal deposition,Alveolar Soft Part Sarcoma
19266,Low Mitotic Activity,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
19267,Osteoid formation,Chondroblastic osteosarcoma
19268,Vascular proliferation,Cellular angiofibroma
19269,Severe dysplasia,Stage 0 Esophageal Cancer AJCC v6
19270,Neuroendocrine Differentiation,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma
19271,Low Mitotic Activity,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma
19272,Pseudoglandular Pattern,Embryonal Carcinoma
19273,Epithelial Component Present,Tubular breast carcinoma
19274,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage III
19275,Endophytic Tumor Growth,Renal Pelvis Inverted Papilloma
19276,Hyperkeratosis,Vaginal Warty Carcinoma
19277,Metastatic Lesion,Secondary malignant neoplasm of female breast
19278,Exophytic Polypoid Lesion,Vaginal Fibroepithelial Polyp
19279,Epithelial Component Present,Strumal carcinoid
19280,Immunologic Deficiency Syndromes,AIDS-Related Hodgkin Lymphoma
19281,Metaplasia of Malignant Cells Present,Adenocarcinoma with cartilaginous metaplasia
19282,Cartilaginous metaplasia,Adenocarcinoma with cartilaginous metaplasia
19283,Embryoid Bodies Present,polyembryoma of testis
19284,Epithelial Component Present,Appendix adenoma
19285,Exophytic Polypoid Lesion,Appendix adenoma
19286,Antoni A Pattern,Acoustic Neuroma
19287,Intraductal Lesion,Biliary papillomatosis
19288,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Choriocarcinoma of the Testis
19289,Immunologic Deficiency Syndromes,Transplant-Related Renal Cell Carcinoma
19290,Metastatic Lesion,Metastatic Malignant Solid Neoplasm
19291,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Teratoma
19292,Cutaneous Involvement,Clear cell squamous cell carcinoma of skin
19293,Lymphadenopathy,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
19294,Epithelial Component Present,Human Papillomavirus-Related Adenosquamous Carcinoma
19295,Metastatic Lesion,"Adenocarcinoma, metastatic"
19296,Absence of Invasion,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
19297,Trabecular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
19298,Adulthood Lesion,Advanced Adult Hepatocellular Carcinoma
19299,Metastatic Lesion,Disseminated squamous cell carcinoma
19300,Extraosseous Lesion,Peripheral primitive neuroectodermal tumor of soft tissue
19301,Invasive Lesion,Prostate Basal Cell Carcinoma
19302,Dysplasia,Gallbladder Papillary Adenoma
19303,Adnexal Differentiation,Eccrine dermal cylindroma
19304,Epithelial Component Present,Ampulla of Vater Gangliocytic Paraganglioma
19305,Intraductal Lesion,High Grade Ductal Breast Carcinoma In Situ
19306,Immunosuppression-Related Post-Transplant Toxicity,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
19307,Epithelial Component Present,intestinal type adenocarcinoma of gallbladder
19308,Local disease,Adenomatoid tumor of epididymis
19309,Epithelial Component Present,Vaginal Small Cell Carcinoma
19310,Epithelial Component Present,Sphenoid Sinus Squamous Cell Carcinoma
19311,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-3
19312,Dysplasia,Pancreatic Intraepithelial Neoplasia-3
19313,Carcinomatous Component Present,AIDS-Related Carcinoma
19314,Adulthood Lesion,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma
19315,Adulthood Lesion,Adult Pure Erythroid Leukemia
19316,Absence of Invasion,Stage 0 Pancreatic Cancer AJCC v6 and v7
19317,Plasma cell inflammation,Syringocystadenoma Papilliferum
19318,Biphasic Pattern,Prostate Phyllodes Tumor
19319,Tissue of Mullerian Origin Present,Carcinosarcoma of ovary
19320,Cutaneous Involvement,Sebaceous adenoma
19321,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
19322,Epithelial Component Present,Parathyroid Gland Atypical Adenoma
19323,Hereditary Lesion,Juvenile polyposis syndrome
19324,Carcinomatous Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7
19325,Absence of Stromal Invasion,"Papillary cystadenoma, borderline malignancy"
19326,Carcinomatous Component Present,Sarcomatoid Carcinoma of the Penis
19327,Bone Marrow and Blood Involvement,Adult Burkitt Leukemia
19328,Indolent Clinical Course,Lipoma of skin
19329,Angiodestructive Pattern,Lymphomatoid Granulomatosis
19330,Carcinomatous Component Present,Carcinoma in situ of middle ear
19331,In Situ Lesion,Carcinoma in situ of middle ear
19332,Argentaffin Positive Neoplastic Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
19333,Diffuse Lesion,"Papillomatosis, glandular"
19334,Exophytic Polypoid Lesion,Polyp of external auditory meatus
19335,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
19336,Non-Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia
19337,Cystic Change,Proliferating Brenner Tumor
19338,Low Grade Lesion,Adamantinoma
19339,Rapidly Enlarging Mass,Childhood Alveolar Rhabdomyosarcoma
19340,Papillary Pattern,"Transitional cell papilloma, benign"
19341,Non-Invasive Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia
19342,Hyalinized Stroma Formation,Chondroid lipoma
19343,Carcinomatous Component Present,Stage III Oral Cavity Cancer AJCC v6 and v7
19344,Nuclear Atypia,Childhood Anaplastic Oligoastrocytoma
19345,Eccrine Differentiation,Syringoma
19346,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma
19347,High Mitotic Activity,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma
19348,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-1
19349,Multinodular Mass,Adult Angiosarcoma
19350,Carcinomatous Component Present,Rectal Cribriform Comedo-Type Adenocarcinoma
19351,Nuclear pleomorphism,Pleomorphic Rhabdomyosarcoma
19352,Metastatic Lesion,Metastatic urothelial carcinoma
19353,Hyperplastic Tissue Present,Adenomatous hyperplasia
19354,Cutaneous Involvement,Pityriasis Lichenoides et Varioliformis Acuta
19355,Multifocal Lesion,"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)"
19356,Immunologic Deficiency Syndromes,AIDS-Related Gastric Kaposi Sarcoma
19357,Mixed Cellular Population,Childhood Mixed Glioma
19358,Carcinomatous Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6
19359,Epithelial Component Present,Flat Ductal Epithelial Atypia of the Breast
19360,Hypokalemia,Pancreatic Vipoma
19361,Increased Cellularity Present,Childhood Cerebral Anaplastic Astrocytoma
19362,Adnexal Differentiation,Malignant tumor of epidermal appendage
19363,Infiltrative Growth Pattern,Recurrent Childhood Fibrillary Astrocytoma
19364,Exophytic Polypoid Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
19365,Epithelial Component Present,Vulvar Keratoacanthoma
19366,Infiltrative Growth Pattern,Childhood Brain Stem Gliosarcoma
19367,Hemorrhagic,Solid pseudopapillary tumor of the pancreas
19368,Adnexal Differentiation,Benign neoplasm of adnexa of skin
19369,Peripheral Nuclear Palisading,Stage IIIA Lung Small Cell Carcinoma AJCC v7
19370,Immunosuppression-Related Post-Transplant Toxicity,New Onset Diabetes After Transplant
19371,Epithelial Component Present,Adenocarcinoma in situ in tubulovillous adenoma
19372,Cutaneous Involvement,Granulomatous slack skin disease
19373,Cystic Change,Serous cystadenoma of ovary
19374,Carcinomatous Component Present,Occult Lung Non-Small Cell Carcinoma
19375,Epithelial Component Present,Thymoma malignant invasive
19376,Mixed Cellular Population,Eccrine mixed tumor of skin
19377,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage II
19378,Papillary Pattern,intraductal papilloma of salivary gland
19379,Neuroendocrine Differentiation,Foregut Carcinoid Tumor
19380,Vascular Channel Formation,Transplant-Related Kaposi Sarcoma
19381,Hyperplastic Tissue Present,Diffuse Laminar Endocervical Hyperplasia
19382,Carcinomatous Component Present,Endocervical Carcinoma
19383,Peripheral Nuclear Palisading,basaloid squamous cell carcinoma of vulva
19384,Epithelial Component Present,Papillary thyroid carcinoma
19385,Cystic Lesion,Desmoplastic infantile ganglioglioma
19386,Low Mitotic Activity,Functioning Pancreatic Neuroendocrine Tumor G2
19387,Lesion with Diameter Greater than 10mm,Functioning Pituitary Gland Macroadenoma
19388,Cystic Change,Cystic basal cell carcinoma
19389,Diffuse Lesion,Pleural Carcinomatosis
19390,Metastatic/Recurrent Disease,Esophageal Synovial Sarcoma
19391,Chronic Inflammatory Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis
19392,Epithelial Component Present,Intraductal carcinoma and lobular carcinoma in situ
19393,Epithelial Component Present,Adenocarcinoma of Unknown Primary
19394,Carcinomatous Component Present,Adenocarcinoma of Unknown Primary
19395,Epithelial Component Present,Acinar cell adenoma
19396,High Grade Lesion,Epithelioid Sarcoma NCI Grade 3
19397,Carcinomatous Component Present,Stage IIIb Penile Cancer AJCC v7
19398,Carcinomatous Component Present,"Hepatocellular carcinoma, scirrhous"
19399,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis
19400,Dysplasia,Low Grade Esophageal Glandular Intraepithelial Neoplasia
19401,Cellular Stratification,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
19402,Adnexal Differentiation,Malignant Breast Eccrine Spiradenoma
19403,Metastatic/Recurrent Disease,Peritoneal Desmoplastic Small Round Cell Tumor
19404,Indolent Clinical Course,"Histiocytoma, Benign Fibrous"
19405,Chronic Inflammatory Infiltrate,"Histiocytoma, Benign Fibrous"
19406,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Refractory cytopenia with multilineage dysplasia
19407,Secondary Lesion,Carcinoma Arising from Craniopharyngioma
19408,Carcinomatous Component Present,Bladder Adenocarcinoma
19409,High Grade Lesion,Alveolar soft part sarcoma metastatic
19410,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis
19411,Dysplasia,Fundic gland polyp
19412,Cutaneous Involvement,Primary Cutaneous Mucinous Carcinoma
19413,Carcinomatous Component Present,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
19414,Epithelial Component Present,Adenoid basal carcinoma of cervix uteri
19415,Cutaneous Involvement,Minimal Deviation Melanoma
19416,Biphasic Pattern,"Synovial sarcoma, biphasic"
19417,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v6
19418,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma recurrent
19419,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement
19420,Epithelial Component Present,Esophageal Squamous Intraepithelial Neoplasia
19421,Lymphoplasmacytic Infiltrate,Central Nervous System Germinoma
19422,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
19423,Neuroectodermal Differentiation,Recurrent Olfactory Neuroblastoma
19424,Recurrent disease,Recurrent Ureter Carcinoma
19425,Exophytic Polypoid Lesion,Hyperplastic Polyp
19426,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Superficial basal cell carcinoma
19427,Low Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G2
19428,Cartilaginous Differentiation,Osteochondromyxoma
19429,Well-Circumscribed Lesion,Fallopian Tube Endometrioid Polyp
19430,Epithelial Component Present,Adrenal Cortex Oncocytic Adenoma
19431,Diffuse Pattern,Childhood Brain Stem Mixed Glioma
19432,Carcinomatous Component Present,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma
19433,Cutaneous Involvement,Scleromyxedema
19434,Monomorphic Cellular Infiltrate,Ependymoma
19435,Argentaffin Positive Neoplastic Cells Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
19436,Papillary Pattern,Verrucous carcinoma
19437,Lesion with Diameter Greater than 2cm,Aggressive osteoblastoma
19438,Nidus Formation,Aggressive osteoblastoma
19439,Childhood Lesion,Childhood Small Intestinal Leiomyosarcoma
19440,Epithelial Component Present,Undifferentiated Carcinoma of Colon
19441,Carcinomatous Component Present,Apocrine breast carcinoma
19442,Epithelial Component Present,Hereditary clear cell renal cell carcinoma
19443,Well-Circumscribed Lesion,Benign neoplasm of mesothelial tissue of pleura
19444,Necrotic changes (finding),Small cell carcinoma of lung
19445,Hyalinized Vessels Present,Childhood Pilocytic Astrocytoma
19446,High Mitotic Activity,Anaplastic Ependymoma
19447,Slow Growing Mass,Childhood Craniopharyngioma
19448,Carcinomatous Component Present,Stage IA Ampulla of Vater Cancer AJCC v7
19449,Fibrosis,Giant Cell Lesion of Small Bones
19450,'Starry-sky' pattern,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma
19451,Trabecular Pattern,Ovarian Trabecular Carcinoid Tumor
19452,Carcinomatous Component Present,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7
19453,Vascular Channel Formation,Airway Hemangioma
19454,Diffuse Lesion,Pseudomyxoma Peritonei
19455,Poorly Differentiated Lesion,Oropharyngeal Poorly Differentiated Carcinoma
19456,Benign Cellular Infiltrate,Colorectal Schwannoma
19457,Diffuse Pattern,Colon Diffuse Large B-Cell Lymphoma
19458,Anaplasia,Anaplastic Malignant Neoplasm
19459,Epithelial Component Present,Choroid Plexus Neoplasms
19460,Anaplasia,Adult Anaplastic Ependymoma
19461,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v7
19462,Cutaneous Involvement,Pemphigus Vulgaris
19463,Carcinomatous Component Present,Small cell lung cancer extensive stage
19464,Histiocytosis haematophagic,Familial Hemophagocytic Lymphocytosis
19465,Epithelial Component Present,Occult Lung Adenocarcinoma
19466,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
19467,Carcinomatous Component Present,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8"
19468,Mixed Cellular Population,endometrioid adenofibroma of ovary
19469,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,endometrioid adenofibroma of ovary
19470,Epithelial Component Present,Renal papillary adenoma
19471,Epithelial Component Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential
19472,Nuclear Pseudoinclusion,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
19473,Hypercellular bone marrow,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
19474,Severe dysplasia,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
19475,Infiltrative Growth Pattern,Neural Glioblastoma
19476,Biphasic Pattern,Female Reproductive System Adenofibroma
19477,Myxoid Stroma Formation,Chordoma of clivus
19478,Papillary Pattern,Papillary transitional cell neoplasm of low malignant potential
19479,Epithelial Component Present,Stage IV Skin Cancer
19480,Carcinomatous Component Present,Cervical Lymphoepithelioma-Like Carcinoma
19481,Dysplasia,Vaginal intraepithelial neoplasia grade 1
19482,Intraluminal Tumor Growth,Polyp of esophagus
19483,Tissue of Mullerian Origin Present,Papillary adenofibroma
19484,Fibrotic Stroma Formation,Mucinous adenofibroma
19485,Epithelial Component Present,"Endocervical Adenocarcinoma, Usual Type"
19486,Neuroendocrine Differentiation,Gastric Gastrin-Producing Neuroendocrine Tumor
19487,Low Mitotic Activity,Gastric Gastrin-Producing Neuroendocrine Tumor
19488,Primary Lesion,Brain Stem Glioma
19489,Mitotic Activity,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern"
19490,Metastatic Lesion,Secondary malignant neoplasm of larynx
19491,Hereditary Lesion,Hereditary Melanoma
19492,Hyperkeratosis,Trichilemmoma
19493,Epithelial Component Present,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
19494,Indolent Clinical Course,Epithelioid hemangioma of skin
19495,Adulthood Lesion,Recurrent Adult Spinal Cord Neoplasm
19496,Epithelial Component Present,Stage III Carcinoma of Stomach
19497,Monomorphic Cellular Infiltrate,Cellular Ependymoma
19498,Fibrotic Stroma Formation,Broad Ligament Serous Cystadenofibroma
19499,Papillary Pattern,Childhood Choroid Plexus Papilloma
19500,Adulthood Lesion,Adult Diffuse Large B-Cell Lymphoma
19501,Carcinomatous Component Present,Stage II Laryngeal Cancer AJCC v6 and v7
19502,Epithelial Component Present,Plantar Verrucous Skin Carcinoma
19503,Carcinomatous Component Present,Gastrointestinal carcinoma
19504,High Mitotic Activity,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
19505,Neuroectodermal Differentiation,Poorly Differentiated Neuroblastoma
19506,Duct-Like Structures Present,epithelial-myoepithelial carcinoma of salivary gland
19507,Multifocal Lesion,Vestibular Micropapillomatosis
19508,Mild cytologic atypia,Supraglottic Verrucous Carcinoma
19509,Exophytic Papillary Lesion,Supraglottic Verrucous Carcinoma
19510,Carcinomatous Component Present,Metastatic Carcinoma
19511,Epithelial Component Present,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation
19512,Carcinomatous Component Present,Stage IC Fallopian Tube Cancer AJCC v6 and v7
19513,Tubular Structures Present,Malignant Testicular Sertoli Cell Tumor
19514,Carcinomatous Component Present,Hereditary Papillary Renal Carcinoma
19515,Fibrotic Stroma Formation,Low Grade Mucoepidermoid Breast Carcinoma
19516,'Starry-sky' pattern,Stage II Childhood Burkitt Lymphoma
19517,Childhood Lesion,Stage II Childhood Burkitt Lymphoma
19518,Adulthood Lesion,Adult Anaplastic Large Cell Lymphoma
19519,Epithelial Component Present,Carcinoid Tumor
19520,Acute inflammation,Inflammatory malignant fibrous histiocytoma
19521,High Mitotic Activity,Vulvar Large Cell Neuroendocrine Carcinoma
19522,Epithelial Component Present,Grade 2 Colorectal Adenocarcinoma
19523,Epithelial Component Present,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
19524,Vascular Channel Formation,Kaposi's sarcoma of palate
19525,Insular Pattern,Pancreatic Somatostatinoma
19526,Borderline Lesion,Borderline Ovarian Transitional Cell Tumor
19527,Epithelial Component Present,Parathyroid transitional clear cell adenoma
19528,Metastatic Lesion,Metastases to abdominal cavity
19529,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity
19530,Alternative Fascicle (Bundle) Pattern,leiomyoma of trachea
19531,Mixed Cellular Population,Uterine Carcinosarcoma
19532,Exophytic Polypoid Lesion,Endocervical polyp
19533,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor G2
19534,Cystic Change,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
19535,Eosinophilic inflammation,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
19536,Epithelial Component Present,Squamous cell carcinoma of the head and neck
19537,Peripheral Nuclear Palisading,basaloid carcinoma of penis
19538,Somatostatin Positive Neoplastic Cells Present,Malignant Pancreatic Somatostatinoma
19539,Cytoplasmic Membrane-Bound Granules Present,Stage IV Merkel Cell Carcinoma AJCC v7
19540,Carcinomatous Component Present,Prostate Acinar Adenocarcinoma
19541,Dilated Thin-Walled Vascular Space Formation,Vulvar Angiomyofibroblastoma
19542,Epithelial Component Present,Primary ameloblastic carcinoma
19543,Epithelial Component Present,Synchronous Bilateral Breast Carcinoma
19544,Epithelial Component Present,Endometrial adenocarcinoma metastatic
19545,Metastatic Lesion,Anal cancer metastatic
19546,Cytoplasmic Membrane-Bound Granules Present,Stage IIA Merkel Cell Carcinoma AJCC v7
19547,Defective Heavy Chain Present,mu-Chain Disease
19548,Cutaneous Involvement,Dermatitis Herpetiformis
19549,Mild dysplasia,Low grade cervical glandular intraepithelial neoplasia
19550,Carcinomatous Component Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst
19551,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
19552,Well-Circumscribed Lesion,Sporadic Thyroid Gland Micromedullary Carcinoma
19553,Immunologic Deficiency Syndromes,Non-Destructive Post-Transplant Lymphoproliferative Disorder
19554,In Situ Lesion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
19555,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma
19556,Acanthosis,Buccal Mucosa Verrucous Carcinoma
19557,Fibromuscular Stroma Formation,Bartholin Gland Adenomyoma
19558,Epithelial Component Present,Pancreatic Solid Serous Adenoma
19559,Invasive Lesion,Widely Invasive Thymoma
19560,Cutaneous Involvement,eccrine adenocarcinoma of vulva
19561,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v7
19562,Carcinomatous Component Present,Prostate cancer stage C
19563,Primary Lesion,Primary Melanocytic Lesion of Meninges
19564,Invasive Lesion,Well Differentiated Prostate Adenocarcinoma
19565,Endophytic Tumor Growth,Glottis Verrucous Carcinoma
19566,Exophytic Papillary Lesion,Glottis Verrucous Carcinoma
19567,Epithelial Component Present,Human Papillomavirus-Related Endocervical Adenocarcinoma
19568,Splenomegaly,Splenic Marginal Zone B-Cell Lymphoma
19569,Erythema,Inflammatory carcinoma of breast recurrent
19570,Nuclear Grooves,Multicentric Thyroid Gland Papillary Carcinoma
19571,Epithelial Component Present,Stage III Paranasal Sinus Cancer AJCC v6 and v7
19572,Glandular Pattern,"Testicular Yolk Sac Tumor, Enteric Pattern"
19573,Perineural spread,Adenoid Cystic Carcinoma
19574,Epithelial Component Present,Heavily Pigmented Adrenal Cortical Adenoma
19575,Malignant Component Present,Testicular Teratoma with Somatic-Type Malignancy
19576,Epithelial Component Present,Borderline Ovarian Mucinous Adenofibroma
19577,Osteoid formation,Intracortical osteosarcoma
19578,Mixed Cellular Population,Borderline Ovarian Serous Cystadenofibroma
19579,Carcinomatous Component Present,Recurrent Extrahepatic Bile Duct Carcinoma
19580,Poorly Differentiated Lesion,Spindle cell squamous cell carcinoma
19581,Cutaneous Involvement,Spindle cell squamous cell carcinoma
19582,Carcinomatous Component Present,Stage IIB Gastric Cancer AJCC v7
19583,In Situ Lesion,Stage 0 Colorectal Cancer AJCC v6 and v7
19584,Epithelial Component Present,Metastatic Squamous Cell Breast Carcinoma
19585,Papillary Pattern,Tall Cell Variant Thyroid Gland Papillary Carcinoma
19586,Childhood Lesion,Recurrent Childhood Soft Tissue Sarcoma
19587,Epithelial Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma
19588,Cutaneous Involvement,Erythematosquamous dermatosis
19589,Low Mitotic Activity,Colon Neuroendocrine Tumor G1
19590,Epithelial Component Present,Carcinoma of Male Breast
19591,Indolent Clinical Course,Gastric Plexiform Fibromyxoma
19592,Epithelial Component Present,Recurrent Uterine Corpus Carcinoma
19593,Carcinomatous Component Present,Colon Carcinoma Metastatic in the Lung
19594,Carcinomatous Component Present,Metastatic signet ring cell carcinoma
19595,Adnexal Differentiation,Carcinoma ex Eccrine Spiradenoma
19596,Papillary Pattern,Intracystic papillary neoplasm with low grade intraepithelial neoplasia
19597,Carcinomatous Component Present,Small Intestinal Mucinous Adenocarcinoma
19598,Hereditary Lesion,Familial Atypical Mole Melanoma Syndrome
19599,Somatostatin Positive Neoplastic Cells Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
19600,Cutaneous Involvement,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
19601,Carcinomatous Component Present,Small intestine carcinoma metastatic
19602,Low Mitotic Activity,Pancreatic Vipoma
19603,Metastatic/Recurrent Disease,Synovial sarcoma non-metastatic
19604,Carcinomatous Component Present,Bowen's Disease
19605,Refractory Disease,Refractory Malignant Testicular Germ Cell Tumor
19606,Therapy-Related Toxicity,Transplant-Related Malignant Neoplasm
19607,Cutaneous Involvement,Tinea
19608,Mixed Cellular Population,Gonadoblastoma
19609,Therapy-Related Toxicity,Transplant-Related Hepatocellular Carcinoma
19610,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v6
19611,Locally Aggressive Lesion,Central Nervous System Inflammatory Myofibroblastic Tumor
19612,Carcinomatous Component Present,Hereditary Female Breast Carcinoma
19613,Capillary Sized Vascular Channel Formation,Solid Glomus Tumor
19614,Lymphadenopathy,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
19615,Cutaneous Involvement,Eccrine Sweat Gland Hamartoma
19616,Severe dysplasia,Intraductal papillary neoplasm with high grade intraepithelial neoplasia
19617,Epithelial Component Present,adenocarcinoma of epididymis
19618,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant"
19619,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
19620,Therapy-Related Toxicity,Lymphoproliferative disorder caused by methotrexate
19621,Fibrous Septa Present,Stage IV Ovarian Dysgerminoma AJCC v6 and v7
19622,Hyaline Cartilage Differentiation,Secondary Chondrosarcoma
19623,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage II
19624,Hyperkeratosis,verrucous carcinoma of vulva
19625,Well Differentiated Lesion,verrucous carcinoma of vulva
19626,Immunosuppression-Related Post-Transplant Toxicity,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
19627,Epithelial Component Present,Carcinoma in situ of prostate
19628,Hyperplastic Tissue Present,Diffuse C-Cell Hyperplasia
19629,High Grade Lesion,Childhood Giant Cell Glioblastoma
19630,Non-Invasive Lesion,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
19631,Exophytic Polypoid Lesion,Gallbladder Hyperplastic Polyp
19632,Slow Growing Mass,Childhood Myxopapillary Ependymoma
19633,Absence of Stromal Invasion,Serous papillary cystic tumor of borderline malignancy
19634,Epithelial Component Present,Endometrial Large Cell Neuroendocrine Carcinoma
19635,Metastatic Lesion,Secondary malignant neoplasm of thymus
19636,Vascular Channel Formation,Hemangioma of skin
19637,Chromogranin A Positive Neoplastic Cells Present,Uterine Corpus Carcinoid Tumor
19638,Recurrent disease,Recurrent Nevus
19639,Cutaneous Involvement,Recurrent Nevus
19640,Cutaneous Involvement,Hypertrophic lichen planus
19641,Epithelial Component Present,Brenner Tumor
19642,Adulthood Lesion,Benign Adult Cerebellar Neoplasm
19643,Epithelial Component Present,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations
19644,Cutaneous Involvement,Vascular neoplasm of skin
19645,Recurrent Genetic Abnormalities Present,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
19646,Childhood Lesion,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
19647,Epithelial Component Present,"Papillomatosis, glandular"
19648,Mitotic Activity,Glioblastoma with Primitive Neuronal Component
19649,Neuroendocrine Differentiation,Carcinoid tumor of rectum
19650,Childhood Lesion,PRETEXT Stage 2 Hepatoblastoma
19651,Chronic lymphocytic inflammation,Childhood Pleomorphic Xanthoastrocytoma
19652,Dysplasia,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
19653,Tubular Pattern,Appendix Tubulovillous Adenoma
19654,Secondary Lesion,Metastatic Malignant Neoplasm to the Thyroid
19655,Cord-Like Pattern,Syringoma
19656,Absence of Invasion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
19657,Cysts Containing Proteinaceous Fluid Present,Papillary serous cystadenoma
19658,Vascular Channel Formation,Subglottic Hemangioma
19659,Epithelial Component Present,Cervical Endometrioid Adenocarcinoma
19660,Epithelial Component Present,Asbestos-Related Lung Carcinoma
19661,Hereditary Lesion,Hereditary Glomangioma
19662,Epithelial Component Present,Bladder Urothelial Carcinoma in Situ
19663,Non-Invasive Lesion,Bladder Urothelial Carcinoma in Situ
19664,Childhood Lesion,Recurrent Childhood Gemistocytic Astrocytoma
19665,Epithelial Component Present,Carcinoma Metastatic to the Skin
19666,Cystic Change,Solid pseudopapillary tumor of the pancreas
19667,Melanin Pigment Present,Melanocytic nevus of skin
19668,Severe dysplasia,Low Grade Ductal Breast Carcinoma In Situ
19669,Monomorphic Cellular Infiltrate,Low Grade Ductal Breast Carcinoma In Situ
19670,In Situ Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
19671,Childhood Lesion,Hepatoblastoma resectable
19672,Carcinomatous Component Present,Signet-ring cell adenocarcinoma gastric
19673,Sarcomatous Component Present,Parotid Gland Carcinosarcoma
19674,Well-Circumscribed Lesion,Mucinous cystadenoma of ovary
19675,Epithelial Component Present,Adenomatous Polyposis Coli
19676,Collagenous Stroma Formation,Cardiac fibroma
19677,Carcinomatous Component Present,Bladder Cancer by AJCC v7 Stage
19678,Malignant Cellular Infiltrate,Stage IV Ovarian Polyembryoma AJCC v6 and v7
19679,Severe dysplasia,Rectal Adenoma with Severe Dysplasia
19680,Epithelial Component Present,Nonencapsulated sclerosing tumor
19681,Myxoid Stroma Formation,Myxoid leiomyoma
19682,Tissue Differentiation Uncertain,Left atrial myxoma
19683,Low Grade Lesion,Cellular Congenital Mesoblastic Nephroma
19684,Epithelial Component Present,Mild esophageal dysplasia
19685,Dysplasia,Cervical intraepithelial neoplasia grade 1
19686,Carcinomatous Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
19687,Tissue Differentiation Uncertain,Epithelioid Sarcoma NCI Grade 3
19688,Pregnancy Complications,Toxemia of pregnancy
19689,Syncytial Pattern,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
19690,Smooth Muscle Component Present,Angiomyolipoma
19691,Mixed Cellular Population,Adenomyoma
19692,Carcinomatous Component Present,Colon Serrated Adenocarcinoma
19693,Epithelial Component Present,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor
19694,Acinar Pattern,Pancreatoblastoma
19695,Cutaneous Involvement,"NEVUS, EPIDERMAL (disorder)"
19696,Endophytic Tumor Growth,Inverted Squamous Cell Papilloma
19697,Increased Cellularity Present,Anaplastic Oligoastrocytoma
19698,Severe dysplasia,Carcinoma in situ of vagina
19699,In Situ Lesion,Carcinoma in situ of vagina
19700,Polymorphic Cellular Infiltrate,Angioimmunoblastic Lymphadenopathy
19701,Sarcomatoid Stroma Formation,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor
19702,Malignant Cellular Infiltrate,Stage II Ovarian Polyembryoma AJCC v6 and v7
19703,Delicate Vascular Network Formation,Conventional (Clear Cell) Renal Cell Carcinoma
19704,Eosinophilic inflammation,Abdominal Inflammatory Myofibroblastic Tumor
19705,Epithelial Component Present,Juvenile fibroadenoma of breast
19706,Benign Cellular Infiltrate,Appendix Leiomyoma
19707,Histiocytosis haematophagic,"Lymphohistiocytosis, Hemophagocytic"
19708,Metastatic/Recurrent Disease,Epithelioid sarcoma metastatic
19709,Stromal Invasion,Lepidic Predominant Adenocarcinoma
19710,Secondary Lesion,Extra-osseous Ewing's sarcoma metastatic
19711,Hot Nodule,Thyroid Gland Hyperfunctioning Adenoma
19712,Polymorphic Cellular Infiltrate,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement
19713,Cutaneous Involvement,Pilomatrixoma
19714,Sarcomatous Component Present,Carcinosarcoma of cervix uteri
19715,Stromal Invasion,Ovarian Cancer by FIGO Stage
19716,Epithelial Component Present,Low Grade Squamous Intraepithelial Neoplasia
19717,Desmoplastic Stroma Formation,Desmoplastic Neurotropic Melanoma
19718,Bone Marrow Dysplasia Present,Refractory anemia with excess blasts II
19719,Dysplasia,Bile Duct Biliary Intraepithelial Neoplasia
19720,Carcinomatous Component Present,Hereditary Leiomyomatosis and Renal Cell Cancer
19721,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma
19722,Storiform Growth Pattern,"Dermatofibrosarcoma Protuberans, Myxoid"
19723,Carcinomatous Component Present,cystadenocarcinoma of intrahepatic bile duct
19724,Absence of Stromal Invasion,Borderline Fallopian Tube Endometrioid Tumor
19725,Malignant Cellular Infiltrate,Stage I Ovarian Polyembryoma AJCC v6 and v7
19726,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Tumor G2
19727,Cutaneous Involvement,Dermatophytosis of scalp and beard
19728,Neuroendocrine Differentiation,malignant gastrinoma of pancreas
19729,Microvascular Proliferation,Pilocytic astrocytoma of cerebellum
19730,Osseous Component Present,Subungual exostoses
19731,Recurrent disease,Adenoid cystic carcinoma of the oral cavity recurrent
19732,Indolent Clinical Course,Central Nervous System Chondroma
19733,Epithelial Component Present,Fallopian Tube Metaplastic Papillary Tumor
19734,Severe dysplasia,Colon Adenoma with Severe Dysplasia
19735,Myxoid Stroma Formation,Classical Low Grade Fibromyxoid Sarcoma
19736,Somatostatin Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell"
19737,Carcinomatous Component Present,Stage IV Oropharyngeal Carcinoma
19738,Cutaneous Involvement,Skin Angiosarcoma
19739,Non-Invasive Lesion,Renal Pelvis Urothelial Papilloma
19740,Carcinomatous Component Present,Colon Cancer by AJCC v7 Stage
19741,Carcinomatous Component Present,Stage IB Lung Cancer AJCC v7
19742,Epithelial Component Present,Basal Cell Neoplasm
19743,Slow Growing Mass,Solid Angioleiomyoma
19744,Epithelial Component Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia
19745,Childhood Lesion,Mixed Hepatoblastoma with Teratoid Features
19746,In Situ Lesion,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
19747,Absence of Stromal Invasion,Borderline Uterine Ligament Neoplasm
19748,In Situ Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
19749,Childhood Lesion,Childhood Central Nervous System Ganglioneuroblastoma
19750,High Mitotic Activity,Adult Anaplastic Ependymoma
19751,Osteoid formation,Telangiectatic osteosarcoma
19752,Mass of pleura,Pyothorax-Associated Lymphoma
19753,Epithelial Component Present,Esophageal carcinoma
19754,Jaw Keratocyst,Basal Cell Nevus Syndrome
19755,Diffuse Pattern,large B-cell diffuse lymphoma of liver
19756,HMB-45-Positive Neoplastic Cells Present,Angiomyolipoma of kidney
19757,Malignant Cellular Infiltrate,Malignant Meningioma
19758,Epithelial Component Present,endometrioid adenofibroma of ovary
19759,Stromal Invasion,Malignant Ovarian Clear Cell Tumor
19760,Carcinomatous Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma
19761,Microvascular Proliferation,Glioblastoma by Gene Expression Profile
19762,Monophasic Pattern,Lung Monophasic Synovial Sarcoma
19763,Firm mass,Melanotic malignant nerve sheath tumor
19764,Cystic Change,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
19765,Childhood Lesion,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
19766,Fibrotic Stroma Formation,Cervical Adenofibroma
19767,Epithelial Component Present,FIGO Stage IIIA2 Ovarian Cancer
19768,Efferent Arteriolar Hyalinosis,Diabetic Nephropathy
19769,Epithelial Component Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
19770,Follicular Cell Differentiation,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
19771,Epithelial Component Present,Hepatic cancer stage IVA
19772,Mixed Cellular Population,Mucinous adenofibroma
19773,Carcinomatous Component Present,Gallbladder Cribriform Carcinoma
19774,Vascular Channel Formation,Anal Kaposi Sarcoma
19775,Low Mitotic Activity,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
19776,Mesenchymal Component Present,"Neoplasms, Fibroepithelial"
19777,Hyperplastic Tissue Present,Pseudolymphoma
19778,Vascular Channel Formation,High grade surface osteosarcoma
19779,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Neoplasm
19780,Low Mitotic Activity,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
19781,Indolent Clinical Course,Fibromatosis colli
19782,Recurrent disease,Mantle cell lymphoma recurrent
19783,Epithelial Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
19784,Epithelial Component Present,Adenosquamous cell lung cancer stage I
19785,Carcinomatous Component Present,Stage IIA Lung Adenocarcinoma AJCC v7
19786,Neuroendocrine Differentiation,Recurrent Adrenal Gland Pheochromocytoma
19787,Recurrent disease,Recurrent Adrenal Gland Pheochromocytoma
19788,Cutaneous Involvement,Skin Cavernous Hemangioma
19789,Diffuse Pattern,"Mesothelioma, biphasic, malignant"
19790,Epithelial Component Present,Fallopian Tube Papillary Adenocarcinoma
19791,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant"
19792,Indolent Clinical Course,Infantile digital fibromatosis
19793,Chronic lymphocytic inflammation,Epithelioid hemangioma of skin
19794,Carcinomatous Component Present,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
19795,Prominent Squamous Eddies Present,inverted follicular keratosis
19796,Epithelial Component Present,Low grade appendiceal mucinous neoplasm
19797,Epithelial Component Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
19798,Refractory Disease,Extranodal marginal zone B-cell lymphoma (MALT type) refractory
19799,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v6
19800,Childhood Lesion,Childhood Malignant Penile Neoplasm
19801,Epithelial Component Present,Malignant neoplasm of stomach stage III
19802,Epithelial Component Present,Adenoma
19803,High Mitotic Activity,Choroid Plexus Carcinoma
19804,Epithelial Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
19805,Fibrotic Stroma Formation,mucoepidermoid carcinoma of lacrimal gland
19806,Recurrent disease,Oropharyngeal cancer recurrent
19807,Vertical Growth Phase,Nodular melanoma
19808,Microvascular Proliferation,Adult Brain Stem Gliosarcoma
19809,Vascular Channel Formation,Benign neoplasm of lymph vessels
19810,Mitotic Activity,Childhood Yolk Sac Tumor
19811,Invasive Lesion,Low Grade Mucoepidermoid Breast Carcinoma
19812,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Dysplastic Nevus
19813,Severe dysplasia,Stage 0 Vulvar Cancer
19814,Chronic lymphocytic inflammation,Gastric Carcinoma with Lymphoid Stroma
19815,Fibrotic Stroma Formation,Uterine Corpus Adenofibroma
19816,Tissue of Mullerian Origin Present,Uterine Corpus Adenomyoma
19817,Epithelial Component Present,Vulvar Small Cell Carcinoma
19818,Malignant Component Present,Central Nervous System Teratoma with Malignant Transformation
19819,Cartilaginous Differentiation,Chondromatosis
19820,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
19821,Keratin pearl formation,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant"
19822,Nuclear Atypia,Recurrent Childhood Anaplastic Astrocytoma
19823,Mucoid Stroma Formation,mucinous adenocarcinoma of salivary gland
19824,Dysplasia,Endometrial intraepithelial neoplasia
19825,Cutaneous Involvement,Trichoadenoma
19826,Carcinomatous Component Present,Gallbladder Cancer by AJCC v6 Stage
19827,Recurrent disease,Recurrent Childhood Anaplastic Large Cell Lymphoma
19828,Bone Marrow Involvement,Hepatosplenic T-cell lymphoma
19829,Epithelial Component Present,BCLC Stage B Hepatocellular Carcinoma
19830,Epithelial Component Present,Colorectal Neuroendocrine Tumor G2
19831,Diffuse Pattern,Recurrent Childhood Anaplastic Oligodendroglioma
19832,Nodular Pattern,Ann Arbor Stage I Grade 1 Follicular Lymphoma
19833,Carcinomatous Component Present,Stage IVA Basal Cell Lip Carcinoma
19834,Epithelial Component Present,Stage IV Lung Cancer AJCC v6
19835,Epithelial Component Present,Stage III Ureter Cancer AJCC v7
19836,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7
19837,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Multifocal superficial basal cell carcinoma
19838,Epithelial Component Present,Anal cancer metastatic
19839,Epithelial Component Present,Stage IIA Merkel Cell Carcinoma AJCC v7
19840,Epithelial Component Present,Borderline Ovarian Clear Cell Tumor
19841,Carcinomatous Component Present,Adult Liver Carcinoma
19842,Epithelial Component Present,Lung Cancer by AJCC v6 Stage
19843,Thin-Walled Branching Vascular Pattern,benign fibroma of liver
19844,Epithelial Component Present,Stage III Merkel Cell Carcinoma AJCC v7
19845,Dysplasia,Low grade cervical glandular intraepithelial neoplasia
19846,"Undifferentiated ""Fetal-Type"" Tissues Present",Mediastinal Immature Teratoma
19847,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of gallbladder
19848,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Oncocytic Adenoma
19849,Slow Growing Mass,Juvenile Pilocytic Astrocytoma
19850,HMB-45-Positive Neoplastic Cells Present,Sclerosing PEComa
19851,Hereditary Lesion,"Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome"
19852,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
19853,Dysplasia,Colorectal Low Grade Intraepithelial Neoplasia
19854,Tissue of Mullerian Origin Present,Ovarian Clear Cell Cystadenofibroma
19855,Epithelial Component Present,Phyllodes Tumor
19856,Hyperkeratosis,Lower Gingival Verrucous Carcinoma
19857,Hereditary Lesion,"Optic Atrophies, Hereditary"
19858,Epithelial Component Present,Cervical Atypical Carcinoid Tumor
19859,Immunologic Deficiency Syndromes,Acute cellular allograft nephropathy
19860,Tubular Pattern,tubulopapillary adenoma of extrahepatic bile duct
19861,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage IV
19862,Papillary Pattern,Squamous cell papilloma of skin
19863,Epithelial Component Present,Skin Squamous Cell Carcinoma In Situ
19864,Cystic Change,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia
19865,Carcinomatous Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
19866,Unresectable Mass,Unresectable Malignant Neoplasm
19867,Carcinomatous Component Present,hepatoid adenocarcinoma of bladder
19868,Follicular Structures Present,Macrofollicular adenoma
19869,Poorly Differentiated Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
19870,Carcinomatous Component Present,Localized Extrahepatic Bile Duct Carcinoma
19871,Epithelial Component Present,CARCINOMA OF VULVA
19872,Perivascular fibrosis,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma
19873,Papillary Pattern,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
19874,Tissue of Mullerian Origin Present,Borderline Ovarian Serous Cystadenofibroma
19875,Monoclonal Cellular Population Present,"Leukemia, Mast-Cell"
19876,Anaplasia,carcinosarcoma of lung
19877,Cutaneous Involvement,Toxic Epidermal Necrolysis
19878,Indolent Clinical Course,Colon Leiomyoma
19879,High Mitotic Activity,large cell neuroendocrine carcinoma of lung
19880,Osseous Differentiation,Radiation-Related Osteosarcoma
19881,Invasive Lesion,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma
19882,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant"
19883,Endophytic Tumor Growth,Laryngeal verrucous carcinoma recurrent
19884,Acanthosis,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
19885,Recurrent disease,Recurrent Childhood Central Nervous System Embryonal Neoplasm
19886,Epithelial Component Present,Stage III Nasal Cavity Cancer AJCC v6 and v7
19887,Epithelial Component Present,Stage IIB Small Intestinal Cancer AJCC v7
19888,Carcinomatous Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
19889,Epithelial Component Present,Small Intestinal Mucinous Adenocarcinoma
19890,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia-2
19891,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
19892,Primary Lesion,Chondroblastic osteosarcoma
19893,Nodular Pattern,Ann Arbor Stage IV Grade 3 Follicular Lymphoma
19894,Epithelial Component Present,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
19895,Thrombocytosis,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
19896,Invasive Lesion,Infiltrating duct and lobular carcinoma
19897,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Reactive systemic amyloidosis
19898,Epithelial Component Present,Vaginal Warty Carcinoma
19899,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v7
19900,Chronic lymphocytic inflammation,Bone Epithelioid Hemangioma
19901,Primary Lesion,Fibrosarcoma non-metastatic
19902,Lesion with Diameter Less than 11mm,Small Size Posterior Uveal Melanoma
19903,Metaplasia of Malignant Cells Present,Adenocarcinoma with osseous metaplasia
19904,Mucoid Stroma Formation,Pancreatic Intraductal Papillary-Mucinous Adenoma
19905,Lobulated Growth Pattern,HNF1alpha-Inactivated Hepatocellular Adenoma
19906,Well-Circumscribed Lesion,Spindle Cell/Pleomorphic Lipoma
19907,Encapsulated Mass,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
19908,Epithelial Component Present,Stage IIB Lung Adenosquamous Carcinoma AJCC v7
19909,Non-Malignant Cellular Infiltrate,Acute lymphadenitis
19910,Epithelial Component Present,Vaginal clear cell adenocarcinoma
19911,Immunoglobulin Deposition,Light chain disease
19912,Carcinomatous Component Present,Maxillary Sinus Squamous Cell Carcinoma
19913,Cutaneous Involvement,Dermatitis acneiform
19914,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage II
19915,Neuroendocrine Differentiation,Malignant Adrenal Gland Composite Pheochromocytoma
19916,Lymphadenopathy,Nodular Lymphocyte Predominant Hodgkin Lymphoma
19917,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity stage I
19918,Painless Mass,Desmoplastic fibroblastoma
19919,Indolent Clinical Course,Mediastinal Rhabdomyoma
19920,Well-Circumscribed Lesion,Vulvar Cellular Angiofibroma
19921,Mixed Cellular Population,Prostate Phyllodes Tumor
19922,Epithelial Component Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like"
19923,Epithelial Component Present,adenocarcinoma of urethra
19924,Apocrine Differentiation,Apocrine adenoma
19925,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor G2
19926,Exposure to asbestos,Asbestos-Related Lung Disorder
19927,Cutaneous Involvement,Diaper candidiasis
19928,Epithelial Component Present,Villous adenoma of colon
19929,Cavernous Vascular Space Formation,Liver Cavernous Hemangioma
19930,Epithelial Component Present,Ampulla of Vater Neuroendocrine Carcinoma
19931,Childhood Lesion,Childhood Extraskeletal Osteosarcoma
19932,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy"
19933,Monoclonal Cellular Population Present,"Mastocytosis, Systemic"
19934,Epithelial Component Present,Vaginal adenocarcinoma metastatic
19935,Epithelial Component Present,Stage IVC Nasopharyngeal Carcinoma AJCC v7
19936,Carcinomatous Component Present,Childhood Hepatocellular Carcinoma
19937,Non-Malignant Cellular Infiltrate,Chronic Lymphoproliferative Disorder of NK-Cells
19938,Fibrotic Stroma Formation,undifferentiated carcinoma of pancreas
19939,Therapy-Related Toxicity,Methotrexate-Associated Diffuse Large B-Cell Lymphoma
19940,Microvascular Proliferation,Glioblastoma
19941,Therapy-Related Toxicity,Methotrexate-Associated Follicular Lymphoma
19942,Dysplasia,Adenoma of rectum
19943,Absence of Invasion,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type"
19944,Metastatic/Recurrent Disease,Vulvar Alveolar Soft Part Sarcoma
19945,Thick-Walled Hyalinized Vessels Present,Benign Intraocular Schwannoma
19946,Carcinomatous Component Present,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
19947,Mucoid Stroma Formation,Invasive intraductal papillary-mucinous carcinoma of pancreas
19948,Tissue Differentiation Uncertain,Ovarian Myxoma
19949,Hereditary Lesion,"Colorectal cancer, hereditary nonpolyposis, type 1"
19950,Multifocal Lesion,Lipoblastomatosis
19951,Cutaneous Involvement,Ceruminous Neoplasm
19952,Cutaneous Involvement,Stage II Lentigo Maligna Melanoma AJCC v6 and v7
19953,Exophytic Polypoid Lesion,Appendix Traditional Serrated Adenoma
19954,Indolent Clinical Course,Breast Angiomatosis
19955,Somatostatin Positive Neoplastic Cells Present,Pancreatic Somatostatinoma
19956,Secondary Lesion,Undifferentiated Carcinoma of Unknown Primary
19957,Epithelial Component Present,Glomus Jugulare Tumor
19958,Chronic lymphocytic inflammation,"Thymoma, type B1"
19959,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
19960,Mitotic Activity,Childhood Cerebellar Anaplastic Astrocytoma
19961,High Grade Lesion,Childhood Cerebellar Anaplastic Astrocytoma
19962,Indolent Clinical Course,Laryngeal Leiomyoma
19963,Childhood Lesion,Childhood Anaplastic Oligodendroglioma
19964,Primary Lesion,Adult Giant Cell Glioblastoma
19965,Neuroendocrine Differentiation,Metastatic Jugulotympanic Paraganglioma
19966,Recurrent disease,Vaginal cancer recurrent
19967,Epithelial Component Present,Childhood Thyroid Gland Carcinoma
19968,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage I Plasma Cell Myeloma
19969,Carcinomatous Component Present,Parotid Gland Adenocarcinoma
19970,Carcinomatous Component Present,Bile duct carcinoma
19971,Exophytic Papillary Lesion,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
19972,Multifocal Lesion,Multiple adenomatous polyps
19973,Endophytic Tumor Growth,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
19974,Fibrosis,"Breast Fibrocystic Change, Non-Proliferative Type"
19975,Absence of Invasion,Bladder squamous cell carcinoma stage 0
19976,Carcinomatous Component Present,Bladder squamous cell carcinoma stage 0
19977,Invasive Lesion,Invasive Ductal and Invasive Lobular Breast Carcinoma
19978,Perivascular Arrangement of Tumor Cells,Glomus Tumor of Uncertain Malignant Potential
19979,Mucoid Stroma Formation,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
19980,Rapidly Enlarging Mass,Esophageal Rhabdomyosarcoma
19981,Papillary Pattern,Lung Squamous Cell Papilloma
19982,Childhood Lesion,Childhood Malignant Kidney Neoplasm
19983,Neuroectodermal Differentiation,Central Nervous System Ganglioneuroblastoma
19984,Epithelial Component Present,Small Intestinal Gangliocytic Paraganglioma
19985,Epithelial Component Present,Ductal Carcinoma In Situ with Microinvasion
19986,Neuroectodermal Differentiation,ganglioneuroblastoma of mediastinum
19987,Mucinous degeneration,Protoplasmic astrocytoma
19988,Perivascular Arrangement of Tumor Cells,Angiomyolipoma
19989,Cutaneous Involvement,Erythema Multiforme
19990,Absence of Invasion,Papillary carcinoma in situ
19991,Papillary Pattern,Papillary carcinoma in situ
19992,Epithelial Component Present,Skin Metatypical Carcinoma
19993,Epithelial Component Present,Papillary Lung Adenocarcinoma
19994,Tissue of Mullerian Origin Present,Serous adenofibroma
19995,Extraosseous Lesion,Central Nervous System Extraskeletal Osteosarcoma
19996,Diffuse Pattern,Anaplastic Oligoastrocytoma
19997,Carcinomatous Component Present,clear cell adenocarcinoma of urethra
19998,High Grade Lesion,Childhood Rhabdomyosarcoma
19999,Diffuse Cellular Infiltrate,"Carcinoma, diffuse type"
20000,Vascular Channel Formation,AIDS-Related Cervical Kaposi Sarcoma
20001,Carcinomatous Component Present,Stage II Major Salivary Gland Cancer AJCC v7
20002,Immunologic Deficiency Syndromes,AIDS-Related Vulvovaginal Candidiasis
20003,Multifocal Lesion,Multiple polyps
20004,Adulthood Lesion,Adult Soft Tissue Sarcoma
20005,Childhood Lesion,Childhood Malignant Liver Neoplasm
20006,Severe dysplasia,Biliary Intraepithelial Neoplasia-3
20007,Carcinomatous Component Present,small cell carcinoma of ureter
20008,High Mitotic Activity,small cell carcinoma of ureter
20009,Hyalinized Stroma Formation,Bone Epithelioid Hemangioendothelioma
20010,Cutaneous Involvement,Hair Follicle Neoplasm
20011,Epithelial Component Present,Squamous intraepithelial lesion
20012,Carcinomatous Component Present,Primary Intraosseous Squamous Cell Carcinoma
20013,Epithelial Component Present,Anal Canal Neuroendocrine Tumor G1
20014,Dysplasia,Stage 0 Vaginal Cancer AJCC v7
20015,Vascular Channel Formation,"Hemangioma, Cavernous"
20016,Epithelial Component Present,Type II Endometrial Adenocarcinoma
20017,Microcystic Change,Recurrent Childhood Protoplasmic Astrocytoma
20018,Cystic Change,cystadenocarcinoma of intrahepatic bile duct
20019,atypia morphology,Borderline Fallopian Tube Endometrioid Tumor
20020,Primary Lesion,Benign neoplasm of brain stem
20021,Epithelial Component Present,Ovarian adenocarcinoma
20022,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Bone
20023,Epithelial Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma
20024,Cutaneous Involvement,Stage III Superficial Spreading Melanoma AJCC v7
20025,Papillary Pattern,Fallopian Tube Papilloma
20026,Epithelial Component Present,Mucin-Producing Intrahepatic Cholangiocarcinoma
20027,Epithelial Component Present,Mixed cell adenoma
20028,Biphasic Pattern,Pericanalicular fibroadenoma
20029,Epithelial Component Present,Functioning Pituitary Gland Microadenoma
20030,Mesenchymal Component Present,Giant fibroadenoma of breast
20031,Cartilaginous Component Present,Bizarre parosteal osteochondromatous proliferation
20032,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage I
20033,Negative Peripheral Blood,Aleukemic Monocytic Leukemia Cutis
20034,Immature Granulocytes in Peripheral Blood Increased,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
20035,Well-Circumscribed Lesion,Focal nodular hyperplasia of liver
20036,Cutaneous Involvement,Apocrine breast carcinoma
20037,Epithelial Component Present,Stage IA Lung Cancer AJCC v7
20038,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
20039,Peripheral Nuclear Palisading,"Ovarian Small Cell Carcinoma, Pulmonary Type"
20040,Epithelial Component Present,Recurrent Primary Peritoneal Carcinoma
20041,Recurrent disease,Recurrent Childhood Rhabdomyosarcoma
20042,Carcinomatous Component Present,Childhood Laryngeal Carcinoma
20043,Oligodendroglial Component Present,Recurrent Childhood Oligodendroglioma
20044,Mitotic Activity,Glioblastoma multiforme of spinal cord
20045,Epithelial Component Present,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
20046,High Mitotic Activity,Malignant Granulosa Cell Tumor
20047,Carcinomatous Component Present,Prostate cancer stage D
20048,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
20049,Cystic Change,Keratocystic Odontogenic Tumor
20050,Epithelial Component Present,Rectosigmoid Cancer by AJCC v6 Stage
20051,Neuronal Differentiation,Extraventricular neurocytoma
20052,Well-Circumscribed Lesion,adenoma of intrahepatic bile duct
20053,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v6 and v7
20054,Cutaneous Involvement,Compound nevus of skin
20055,Nested Pattern,Clear Cell Sarcoma of Soft Tissue
20056,Epithelial Component Present,Stage IVB Cervical Cancer AJCC v6 and v7
20057,Cutaneous Involvement,Impetigo
20058,Recurrent Genetic Abnormalities Present,Acute Promyelocytic Leukemia
20059,Dysplasia,Vulvar Dysplastic Melanocytic Nevus
20060,Microcystic Change,Microcystic adnexal carcinoma
20061,Epithelial Component Present,Adenocarcinoma of anal glands
20062,High Grade Lesion,Small cell lung cancer extensive stage
20063,Epithelial Component Present,Recurrent Female Reproductive System Carcinoma
20064,Epithelial Component Present,Colon Carcinoma
20065,Cystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
20066,Indolent Clinical Course,lipoma of esophagus
20067,Well-Circumscribed Lesion,Fallopian Tube Adenomatoid Tumor
20068,Well-Circumscribed Lesion,Cardiac rhabdomyoma
20069,Epithelial Component Present,Stage IB Distal Bile Duct Cancer AJCC v7
20070,Infiltrative Growth Pattern,Grade III Childhood Astrocytoma
20071,Mild dysplasia,Low-grade intraurothelial neoplasia
20072,Anaplasia,Proneural Glioblastoma
20073,Epithelial Component Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
20074,Hyperplastic Tissue Present,Adrenal Medullary Hyperplasia
20075,Mixed Cellular Population,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor
20076,Neuroendocrine Differentiation,Recurrent Merkel Cell Carcinoma
20077,Angiodestructive Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis
20078,Metastatic Lesion,Metastatic leiomyosarcoma
20079,Peripheral Blood Involvement,Smoldering Adult T-Cell Leukemia/Lymphoma
20080,Diffuse Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
20081,Infiltrative Growth Pattern,Secondary Supratentorial Anaplastic Astrocytoma
20082,High Grade Lesion,Monophasic Synovial Sarcoma
20083,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v7
20084,Mitotic Activity,"Anaplastic Astrocytoma, IDH-Wildtype"
20085,Carcinomatous Component Present,High Grade Ovarian Serous Adenocarcinoma
20086,Fibrosis,Primary mediastinal large B-cell lymphoma refractory
20087,Poorly Differentiated Lesion,Pancreatic Medullary Carcinoma
20088,Cutaneous Involvement,Trichofolliculoma
20089,Carcinomatous Component Present,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
20090,High Mitotic Activity,Bartholin Gland Small Cell Carcinoma
20091,Dysplasia,Gastrointestinal tract adenoma
20092,Cutaneous Involvement,Palmoplantar keratoderma with leukoplakia
20093,High Grade Lesion,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
20094,Diffuse Lesion,Squamous papillomatosis
20095,Epithelial Component Present,Colorectal Sessile Serrated Adenoma/Polyp
20096,Cutaneous Involvement,External Ear Actinic Keratosis
20097,Fibrotic Stroma Formation,Acanthomatous ameloblastoma
20098,Dysplasia,Gallbladder adenoma
20099,Clear Perinuclear Halo Present,Cellular Ependymoma
20100,Nuclear Atypia,Recurrent Glioblastoma
20101,Epithelial Component Present,External Ear Basal Cell Carcinoma
20102,Epithelial Component Present,Stage IIIC Ovarian Cancer
20103,Nuclear Atypia,Adult Brain Stem Gliosarcoma
20104,Biphasic Pattern,Adult Brain Stem Gliosarcoma
20105,Carcinomatous Component Present,Mucoepidermoid Breast Carcinoma
20106,Cysts Containing Proteinaceous Fluid Present,Serous cystadenocarcinoma ovary
20107,Epithelial Component Present,Serous Endometrial Intraepithelial Carcinoma
20108,Neuroendocrine Differentiation,Gastric Small Cell Carcinoma
20109,Epithelial Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8"
20110,Cutaneous Involvement,Cutaneous Mastocytosis
20111,Epithelial Component Present,Adult Fibrolamellar Carcinoma
20112,Childhood Lesion,Childhood Choroid Plexus Carcinoma
20113,Indolent Clinical Course,"Lipomatosis, Multiple Symmetrical"
20114,Solitary Skin Tumor,Skin Mastocytoma
20115,Hemorrhagic,"Histiocytoma, Angiomatoid Fibrous"
20116,Carcinomatous Component Present,Adult Pleomorphic Hepatocellular Carcinoma
20117,Papillary Pattern,Inverting papilloma of the nasal cavity
20118,Cutaneous Involvement,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
20119,Monomorphic Cellular Infiltrate,Skin Basaloid Carcinoma
20120,Childhood Lesion,Stage I Childhood Burkitt Lymphoma
20121,Childhood Lesion,Hydroa vacciniforme-like lymphoma
20122,Severe dysplasia,Adenocarcinoma in situ in tubular adenoma
20123,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
20124,Necrotic changes (finding),large cell neuroendocrine carcinoma of breast
20125,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
20126,Epithelial Component Present,Vulvar Large Cell Neuroendocrine Carcinoma
20127,Pregnancy Complications,"Pregnancy, Tubal"
20128,Local disease,Deep Lipoma
20129,Carcinomatous Component Present,Trichilemmocarcinoma
20130,Epithelial Component Present,Bartholin Gland Adenocarcinoma
20131,Epithelial Component Present,Ovarian epithelial cancer stage II
20132,Lobulated Growth Pattern,"Malignant Mixed Tumor, Not Otherwise Specified"
20133,In Situ Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7
20134,Carcinomatous Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7
20135,Epithelial Component Present,Rectal Sessile Serrated Adenoma/Polyp
20136,Exophytic Papillary Lesion,Common wart
20137,Mucoid Stroma Formation,Pancreatic Intraductal Papillary Mucinous Neoplasm
20138,Perineural spread,Adenoid cystic carcinoma of the oral cavity
20139,Well-Circumscribed Lesion,Appendix Sessile Serrated Adenoma/Polyp
20140,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage I
20141,Carcinomatous Component Present,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
20142,Hyperkeratosis,Warty Carcinoma of the Penis
20143,Childhood Lesion,Childhood Ovarian Yolk Sac Tumor
20144,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-1A
20145,Perivascular fibrosis,Adult Nodular Sclerosis Classical Hodgkin Lymphoma
20146,Epithelial Component Present,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
20147,Endophytic Tumor Growth,Verrucous carcinoma of penis
20148,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
20149,Anaplasia,Stage IV Anaplastic Large Cell Lymphoma
20150,Epithelial Component Present,Childhood Gastric Carcinoma
20151,Epithelial Component Present,Carcinoid tumor of pancreas
20152,Indolent Clinical Course,Pericardial Leiomyoma
20153,Refractory Disease,T-cell lymphoma refractory
20154,Epithelial Component Present,Low grade cervical glandular intraepithelial neoplasia
20155,High Grade Lesion,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
20156,Carcinomatous Component Present,Malignant neoplasm of stomach stage I
20157,Anaplasia,Anaplastic Diencephalic Astrocytoma
20158,Epithelial Component Present,squamous cell carcinoma of ovary
20159,Necrotic changes (finding),Necrotic intraocular melanoma
20160,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory Cytopenia of Childhood
20161,Recurrent disease,Pleural mesothelioma malignant recurrent
20162,Vascular Channel Formation,Lymphadenopathic Kaposi Sarcoma
20163,Childhood Lesion,Childhood Central Nervous System Neuroblastoma
20164,Epithelial Component Present,Squamous cell papilloma of skin
20165,Hyperplastic Tissue Present,Drug-induced gingival hyperplasia
20166,Concentric Aggregates of Intermediate Filaments Present,Sparsely Granulated Somatotroph Adenoma
20167,Epithelial Component Present,Thymic Mucoepidermoid Carcinoma
20168,Alternative Fascicle (Bundle) Pattern,Fibroid Tumor
20169,Epithelial Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
20170,Epithelial Component Present,"Adenoma, Sweat Gland"
20171,Rapidly Enlarging Mass,Anal Rhabdomyosarcoma
20172,Anaplasia,Lung Spindle Cell Carcinoma
20173,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Tumor
20174,Hereditary Lesion,Short Limb Dwarfism-Saddle Nose-Spinal Alterations-Metaphyseal Striation Syndrome
20175,Fibrotic Stroma Formation,Borderline Ovarian Mucinous Adenofibroma
20176,Extensive Stage Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma
20177,Secondary Lesion,Secondary malignant neoplasm of pleura
20178,Carcinomatous Component Present,adenoid cystic carcinoma of accessory sinus
20179,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Placental Choriocarcinoma
20180,Epithelial Component Present,Colorectal Neuroendocrine Tumor
20181,Primary Lesion,Primary Childhood Soft Tissue Sarcoma
20182,Epithelial Component Present,Bladder adenocarcinoma stage 0
20183,Immunologic Deficiency Syndromes,Transplant-Related Hematologic Malignancy
20184,Presence of a Hormonal Syndrome,Malignant Pancreatic Insulinoma
20185,CD8-Positive Neoplastic Cells Present,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
20186,Negative Peripheral Blood,Aleukemic leukemia
20187,High Grade Lesion,Glioblastoma
20188,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma
20189,Carcinomatous Component Present,Bronchogenic Carcinoma
20190,Follicular Structures Present,Thyroid Gland Mucinous Follicular Adenoma
20191,Benign Cellular Infiltrate,Benign neoplasm of intestinal tract
20192,Microcystic Change,Serous cystadenoma of pancreas
20193,Immunologic Deficiency Syndromes,Renal Allograft Thrombosis
20194,Generalized Dysplasia,Colorectal Traditional Serrated Adenoma
20195,Epithelial Component Present,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
20196,Varicosity,Congenital Vena Cava Abnormality
20197,Neuroendocrine Differentiation,Stage IB Lung Small Cell Carcinoma AJCC v7
20198,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans
20199,Cystic Change,Mucoepidermoid carcinoma of submandibular gland
20200,Epithelial Component Present,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7
20201,Carcinomatous Component Present,Esophageal adenocarcinoma recurrent
20202,Nodular Pattern,Ovarian Myxoid Liposarcoma
20203,Adnexal Differentiation,Ductal Eccrine Carcinoma with Spindle Cell Elements
20204,Carcinomatous Component Present,Stage IV Rectosigmoid Cancer AJCC v6
20205,Carcinomatous Component Present,Stage IIIA Small Intestinal Cancer AJCC v7
20206,Well-Circumscribed Lesion,Giant cell angiofibroma
20207,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
20208,Primary Lesion,Synovial sarcoma non-metastatic
20209,Pseudopapillary Pattern,Embryonal Carcinoma
20210,Unresectable Mass,Small intestine carcinoma non-resectable
20211,Epithelial Component Present,Benign Ovarian Seromucinous Tumor
20212,Severe dysplasia,Stage 0 Colon Cancer AJCC v6 and v7
20213,Resectable Mass,Small intestine carcinoma resectable
20214,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Fetiform Teratoma
20215,Vascular Channel Formation,Kaposi Sarcoma
20216,Radiation Sickness,Radiation-Related Sarcoma
20217,Indolent Clinical Course,Colon Cavernous Hemangioma
20218,Indolent Clinical Course,Lipoma of chest wall
20219,Anaplasia,"Transitional cell carcinoma, spindle cell"
20220,Hyperkeratosis,Actinic keratosis
20221,Proliferation of High Endothelial Venules Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma
20222,Carcinomatous Component Present,Adenocarcinoma with osseous metaplasia
20223,Moderate dysplasia,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia
20224,Epithelial Component Present,Clear cell squamous cell carcinoma of skin
20225,Epithelial Component Present,Small Intestinal Tubular Adenoma
20226,S-100-Positive Neoplastic Cells Present,Langerhans Cell Sarcoma
20227,Localized Lesion,Nodular amyloidosis
20228,Mitotic Activity,Childhood Glioblastoma
20229,Recurrent disease,Diffuse large B-cell lymphoma recurrent
20230,Increased Cellularity Present,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation
20231,Carcinomatous Component Present,Stage II Lip Basal Cell Carcinoma
20232,Cord-Like Pattern,Vaginal Adenoid Basal Carcinoma
20233,Carcinomatous Component Present,Vaginal Small Cell Carcinoma
20234,Carcinomatous Component Present,Adenosquamous Bile Duct Carcinoma
20235,Exophytic Polypoid Lesion,Gastric Cronkhite Canada Polyposis
20236,Storiform Growth Pattern,Adult Undifferentiated Pleomorphic Sarcoma
20237,Osseous Differentiation,Kidney Extraskeletal Osteosarcoma
20238,Childhood Lesion,Childhood Gonadal Germ Cell Tumor
20239,Edematous Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma"
20240,Carcinomatous Component Present,intraductal micropapillary carcinoma of breast
20241,Benign Cellular Infiltrate,Hemangioma of retina
20242,Primary Lesion,Hepatitis Virus-Related Hepatocellular Carcinoma
20243,Primary Lesion,Recurrent Adult Hepatocellular Carcinoma
20244,Primary Lesion,Hepatoma resectable
20245,Benign Cellular Infiltrate,Ovarian Adenomatoid Tumor
20246,Epithelial Component Present,Unresectable Thyroid Gland Carcinoma
20247,Benign Cellular Infiltrate,"Papilloma, Squamous Cell"
20248,Unfavorable Clinical Outcome,B-lymphoblastic leukemia lymphoma BCR-ABL1-like
20249,Multinodular and Vacuolated Pattern,Multinodular and Vacuolated Tumor of the Cerebrum
20250,Benign Cellular Infiltrate,Intravenous leiomyomatosis
20251,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage
20252,Carcinomatous Component Present,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20253,Hyalinized Stroma Formation,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma
20254,Benign Cellular Infiltrate,Syringoma
20255,Sinusoidal Vascular Channel Formation,Anastomosing Hemangioma
20256,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8
20257,Benign Cellular Infiltrate,Breast Ductal Adenoma
20258,C19MC Amplification,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
20259,Primary Lesion,BCLC Stage B Adult Hepatocellular Carcinoma
20260,Epithelial Component Present,Testicular gonadoblastoma
20261,Carcinomatous Component Present,Gingival Squamous Cell Carcinoma
20262,Epithelial Component Present,Gingival Squamous Cell Carcinoma
20263,Benign Cellular Infiltrate,Vaginal Blue Nevus
20264,Benign Cellular Infiltrate,inverted ductal papilloma of salivary gland
20265,Primary Lesion,Recurrent Uveal Melanoma
20266,Benign Cellular Infiltrate,intraductal papilloma of salivary gland
20267,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12)
20268,Secondary Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20269,Epithelial Component Present,Hormone refractory prostate cancer
20270,Benign Cellular Infiltrate,Hemangioma of gingiva
20271,Benign Cellular Infiltrate,Benign Cervical Soft Tissue Neoplasm
20272,Epithelial Component Present,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20273,Benign Cellular Infiltrate,Hereditary Kidney Oncocytoma
20274,Benign Cellular Infiltrate,"Odontogenic tumor, benign"
20275,Epithelial Component Present,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20276,Cutaneous Involvement,Fibrous Hamartoma of Infancy
20277,Biphasic Pattern,Recurrent Gliosarcoma
20278,Thin Bands of Collagen Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1"
20279,Benign Cellular Infiltrate,Water-clear cell adenoma
20280,Hereditary Lesion,"Pyknocytosis, infantile"
20281,Benign Cellular Infiltrate,Benign neoplasm of gum
20282,Benign Cellular Infiltrate,Endometrial stromal nodule
20283,Swelling,Central Nervous System Mesenchymal Chondrosarcoma
20284,Benign Cellular Infiltrate,Adenoameloblastoma
20285,Benign Cellular Infiltrate,Adrenal Cortex Oncocytic Adenoma
20286,Epithelial Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8
20287,Hyalinized Stroma Formation,Central Nervous System Epithelioid Hemangioendothelioma
20288,Hyalinized Stroma Formation,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20289,Benign Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma
20290,Epithelial Component Present,Leydig Cell Tumor
20291,Epithelial Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v8
20292,Carcinomatous Component Present,Stage III Lip and Oral Cavity Cancer AJCC v8
20293,Extensive Stage Lesion,Advanced Head and Neck Carcinoma
20294,Secondary Lesion,Advanced Head and Neck Carcinoma
20295,Carcinomatous Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v8
20296,High Mitotic Activity,Large Cell/Anaplastic Medulloblastoma
20297,Nuclear pleomorphism,Large Cell/Anaplastic Medulloblastoma
20298,Epithelial Component Present,Ovarian Sclerosing Stromal Tumor
20299,Benign Cellular Infiltrate,Benign Apocrine Neoplasm
20300,Epithelial Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v8
20301,Carcinomatous Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v8
20302,Epithelial Component Present,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20303,Benign Cellular Infiltrate,Adenoma of rete ovarii
20304,Benign Cellular Infiltrate,Sex Hormone-Producing Adrenal Cortex Adenoma
20305,Epithelial Component Present,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20306,Unresectable Mass,Unresectable Osteosarcoma
20307,Anaplasia,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive"
20308,Anaplasia,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative"
20309,Benign Cellular Infiltrate,Tubular adenoma of breast
20310,Benign Cellular Infiltrate,Squamous Papilloma of the Nasopharynx
20311,Carcinomatous Component Present,Stage II Major Salivary Gland Cancer AJCC v8
20312,Epithelial Component Present,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor
20313,Benign Cellular Infiltrate,Benign Adult Cerebral Neoplasm
20314,Increased Cellularity Present,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified"
20315,Carcinomatous Component Present,Urothelial carcinoma urethra recurrent
20316,Recurrent disease,Urothelial carcinoma urethra recurrent
20317,Epithelial Component Present,Stage IVB Major Salivary Gland Cancer AJCC v8
20318,Benign Cellular Infiltrate,Uterine Corpus Atypical Polypoid Adenomyoma
20319,Epithelial Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage
20320,Benign Cellular Infiltrate,External Auditory Canal Ceruminous Adenoma
20321,Carcinomatous Component Present,Stage I Lip and Oral Cavity Cancer AJCC v8
20322,C19MC Amplification,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
20323,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v8
20324,Primary Lesion,Unresectable Hepatocellular Carcinoma
20325,Primary Lesion,Stage III Hepatocellular Carcinoma AJCC v6
20326,Epithelial Component Present,"Leydig cell tumor, benign"
20327,Benign Cellular Infiltrate,Adenolymphoma
20328,Primary Site Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20329,Benign Cellular Infiltrate,Vestibular Micropapillomatosis
20330,Epithelial Component Present,Small Cell Adenocarcinoma
20331,Benign Cellular Infiltrate,Vulvar Inverted Follicular Keratosis
20332,Benign Cellular Infiltrate,Vulvar Papillary Hidradenoma
20333,Primary Lesion,Pleomorphic Hepatocellular Carcinoma
20334,Benign Cellular Infiltrate,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
20335,Primary Lesion,Adult Pleomorphic Hepatocellular Carcinoma
20336,Benign Cellular Infiltrate,Ovarian Surface Papilloma
20337,Benign Cellular Infiltrate,Pleomorphic adenoma of lacrimal gland
20338,Benign Cellular Infiltrate,Common wart
20339,Benign Cellular Infiltrate,Parathyroid mixed cell type adenoma
20340,Epithelial Component Present,Ovarian Microcystic Stromal Tumor
20341,Epithelial Component Present,Unresectable Digestive System Adenocarcinoma
20342,Benign Cellular Infiltrate,Erosive Adenomatosis of the Nipple
20343,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with iAMP21
20344,Indolent Clinical Course,Odontogenic myxoma
20345,Primary Lesion,Clear Cell Hepatocellular Carcinoma
20346,Indolent Clinical Course,Papilloma of buccal mucosa
20347,Secondary Lesion,Peritoneal mesothelioma malignant advanced
20348,Benign Cellular Infiltrate,Ovarian Clear Cell Adenofibroma
20349,Benign Cellular Infiltrate,Vulvar Nodular Hidradenoma
20350,Benign Cellular Infiltrate,Benign neoplasm of conjunctiva
20351,Benign Cellular Infiltrate,Benign neoplasm of cornea
20352,Benign Cellular Infiltrate,Cervical Leiomyoma
20353,Monomorphic Cellular Infiltrate,basaloid squamous cell carcinoma of floor of mouth
20354,Nuclear Expression of STAT6 Protein,Hemangiopericytoma of meninges
20355,Hyalinized Stroma Formation,Hemangiopericytoma of meninges
20356,Epithelial Component Present,Stromal tumor of ovary
20357,Multifocal Lesion,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor"
20358,Benign Cellular Infiltrate,Benign neoplasm of Bartholin's gland
20359,Benign Cellular Infiltrate,"Adenoma, Sweat Gland"
20360,Benign Cellular Infiltrate,Benign Germinative Follicular Epithelium Neoplasm
20361,Benign Cellular Infiltrate,Heavily Pigmented Adrenal Cortical Adenoma
20362,Benign Cellular Infiltrate,Squamous Papilloma of the Larynx
20363,Epithelial Component Present,"Testicular Sertoli Cell Tumor, Lipid Rich Variant"
20364,Epithelial Component Present,Testicular Large Cell Calcifying Sertoli Cell Tumor
20365,Nuclear Atypia,MGMT-Unmethylated Glioblastoma
20366,Cutaneous Involvement,Stage IA Mycosis Fungoides AJCC v7
20367,Epithelial Component Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
20368,Epithelial Component Present,Juvenile type ovarian granulosa cell tumor
20369,Primary Lesion,Recurrent Childhood Soft Tissue Sarcoma
20370,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions
20371,Childhood Lesion,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2
20372,Benign Cellular Infiltrate,Seminal Vesicle Cystadenoma
20373,Ventricular Involvement Only,Lateral Ventricle Ependymal Tumor
20374,Benign Cellular Infiltrate,Benign Ovarian Seromucinous Tumor
20375,Benign Cellular Infiltrate,Juvenile papillomatosis of breast
20376,Primary Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v7
20377,Primary Lesion,Stage IVA Hepatocellular Carcinoma AJCC v7
20378,Storiform Growth Pattern,Central Nervous System Undifferentiated Pleomorphic Sarcoma
20379,Benign Cellular Infiltrate,Benign neoplasm of the lip
20380,Indolent Clinical Course,Benign neoplasm of the lip
20381,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v8
20382,Epithelial Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8
20383,Benign Cellular Infiltrate,benign neoplasm of floor of mouth
20384,Indolent Clinical Course,Osteoma of skull
20385,Carcinomatous Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v8
20386,Primary Lesion,Childhood Pleomorphic Rhabdomyosarcoma
20387,Benign Cellular Infiltrate,Paratesticular Lipoma
20388,Benign Cellular Infiltrate,Epidermolytic acanthoma
20389,Epithelial Component Present,Tumor of the Thecoma/Fibroma Group
20390,Primary Lesion,Hepatitis C Virus-Related Hepatocellular Carcinoma
20391,Epithelial Component Present,Testicular Thecoma
20392,Benign Cellular Infiltrate,Lung Glandular Papilloma
20393,Benign Cellular Infiltrate,Lung Pleomorphic Adenoma
20394,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25)
20395,Primary Lesion,BCLC Stage D Adult Hepatocellular Carcinoma
20396,Epithelial Component Present,Ovarian Thecoma
20397,Epithelial Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage
20398,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like"
20399,Epithelial Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage
20400,Benign Cellular Infiltrate,Uterine Corpus Hydropic Leiomyoma
20401,Human Papillomavirus Positive,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20402,Carcinomatous Component Present,Transitional cell carcinoma metastatic
20403,Secondary Lesion,Transitional cell carcinoma metastatic
20404,Primary Lesion,Lentigo maligna recurrent
20405,Primary Lesion,Recurrent Kidney Wilms Tumor
20406,Hyalinized Stroma Formation,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20407,High Mitotic Activity,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20408,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2"
20409,Benign Cellular Infiltrate,Benign neoplasm of endometrium
20410,Eosinophil count raised (finding),Myeloid/Lymphoid Neoplasms with PCM1-JAK2
20411,Epithelial Component Present,Stage III Nasopharyngeal Carcinoma AJCC v8
20412,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified"
20413,Benign Cellular Infiltrate,Classical Poroma
20414,Benign Cellular Infiltrate,Eccrine mixed tumor of skin
20415,Human Papillomavirus Positive,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20416,Carcinomatous Component Present,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20417,Benign Cellular Infiltrate,Benign neoplasm of fallopian tube
20418,Benign Cellular Infiltrate,Oral Cavity Leiomyoma
20419,Castration Resistance,Hormone refractory prostate cancer
20420,Carcinomatous Component Present,Major Salivary Gland Cancer by AJCC v7 Stage
20421,Epithelial Component Present,Major Salivary Gland Cancer by AJCC v7 Stage
20422,Epithelial Component Present,Major Salivary Gland Cancer by AJCC v8 Stage
20423,Benign Cellular Infiltrate,Vaginal Dermoid Cyst
20424,Benign Cellular Infiltrate,Frontal Sinus Schneiderian Papilloma
20425,Nuclear Expression of STAT6 Protein,Dedifferentiated Solitary Fibrous Tumor
20426,Multilineage Dysplasia Present,Refractory cytopenia with multilineage dysplasia
20427,Carcinomatous Component Present,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20428,Epithelial Component Present,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor
20429,Indolent Clinical Course,"Odontogenic tumor, benign"
20430,Benign Cellular Infiltrate,Uterine Corpus Diffuse Leiomyomatosis
20431,Benign Cellular Infiltrate,Rete Ovarii Cystadenofibroma
20432,Benign Cellular Infiltrate,Maxillary Sinus Inverted Papilloma
20433,Benign Cellular Infiltrate,Thyroid Gland Hyperfunctioning Adenoma
20434,Carcinomatous Component Present,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20435,Benign Cellular Infiltrate,Benign neoplasm of prostate
20436,Benign Cellular Infiltrate,Pilomatrixoma
20437,Necrotic changes (finding),Recurrent Gliosarcoma
20438,Mesenchymal Differentiation,Recurrent Gliosarcoma
20439,Glial Differentiation,Recurrent Gliosarcoma
20440,Epithelial Component Present,Benign Testicular Sertoli Cell Tumor
20441,Secondary Lesion,Advanced Unfavorable Hodgkin Lymphoma
20442,Epithelial Component Present,Ovarian Sex Cord Tumor with Annular Tubules
20443,Epithelial Component Present,Hypopharyngeal Carcinoma by AJCC v8 Stage
20444,Myxoid Stroma Formation,Central Nervous System Epithelioid Hemangioendothelioma
20445,Thin Bands of Collagen Present,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20446,Necrotic changes (finding),"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20447,High Mitotic Activity,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20448,Nuclear Expression of STAT6 Protein,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20449,Benign Cellular Infiltrate,Papilloma of nasal vestibule
20450,Absence of Invasion,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20451,Benign Cellular Infiltrate,Benign neoplasm vagina
20452,Collagenous Stroma Formation,Central Nervous System Desmoid-Type Fibromatosis
20453,Infiltrative Growth Pattern,Central Nervous System Desmoid-Type Fibromatosis
20454,C19MC Amplification,Ependymoblastoma
20455,Primary Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7
20456,Benign Cellular Infiltrate,Benign Eccrine Neoplasm
20457,Primary Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
20458,Benign Cellular Infiltrate,Benign Breast Adenomyoepithelioma
20459,Primary Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
20460,Epithelial Component Present,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor
20461,Epithelial Component Present,Juvenile granulosa cell tumor
20462,Benign Cellular Infiltrate,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease
20463,Unclassifiable Lesion,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified"
20464,Human Papillomavirus Negative,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20465,Benign Cellular Infiltrate,Vulvar Blue Nevus
20466,Benign Cellular Infiltrate,"Adenoma, Monomorphic"
20467,Benign Cellular Infiltrate,Oropharyngeal squamous papilloma
20468,Carcinomatous Component Present,Stage IV Major Salivary Gland Cancer AJCC v8
20469,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified"
20470,Benign Cellular Infiltrate,Cystadenofibroma
20471,Benign Cellular Infiltrate,Vulvar Seborrheic Keratosis
20472,Carcinomatous Component Present,Stage IVB Major Salivary Gland Cancer AJCC v8
20473,Benign Cellular Infiltrate,Vestibular Papilloma
20474,Benign Cellular Infiltrate,"Cervical Adenomyoma, Endometrial Type"
20475,Benign Cellular Infiltrate,Cervical Microglandular Polyp
20476,Benign Cellular Infiltrate,Benign Adult Brain Stem Neoplasm
20477,Benign Cellular Infiltrate,Benign Childhood Brain Neoplasm
20478,Nuclear Expression of STAT6 Protein,Pericardial Solitary Fibrous Tumor
20479,Benign Cellular Infiltrate,Benign Supratentorial Neoplasms
20480,Epithelial Component Present,Stage I Lip and Oral Cavity Cancer AJCC v8
20481,Epithelial Component Present,Stage IVC Major Salivary Gland Cancer AJCC v8
20482,Erythroid hyperplasia,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
20483,Secondary Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20484,Benign Cellular Infiltrate,Intracranial lipoma
20485,Epithelial Component Present,Ovarian gonadoblastoma
20486,Carcinomatous Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v8
20487,Epithelial Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v8
20488,Epithelial Component Present,Malignant Ovarian Sex Cord-Stromal Tumor
20489,Epithelial Component Present,Benign Ovarian Thecoma
20490,Benign Cellular Infiltrate,Benign Ovarian Thecoma
20491,Benign Cellular Infiltrate,Uterine Corpus Adenofibroma
20492,Epithelial Component Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements
20493,Benign Cellular Infiltrate,Cavernous hemangioma of retina
20494,WNT Pathway Activated,"Medulloblastoma, WNT-Activated"
20495,Benign Cellular Infiltrate,Endocervical polyp
20496,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
20497,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type"
20498,Epithelial Component Present,Reproductive Endocrine Neoplasm
20499,Epithelial Component Present,Atypical Pituitary Gland Adenoma
20500,Benign Cellular Infiltrate,Odontogenic myxoma
20501,Primary Lesion,Liver carcinoma
20502,Epithelial Component Present,Testicular Tumor of the Thecoma/Fibroma Group
20503,Epithelial Component Present,Malignant Testicular Sex Cord-Stromal Tumor
20504,Benign Cellular Infiltrate,Bartholin Gland Adenomyoma
20505,Unclassifiable Lesion,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
20506,Benign Cellular Infiltrate,canalicular adenoma of salivary gland
20507,Diffuse Pattern,Triple hit lymphoma
20508,Epithelial Component Present,Sex Cord-Stromal Tumor
20509,Limited Early T-Cell Differentiation,Early T Acute Lymphoblastic Leukemia
20510,Recurrent disease,Recurrent Childhood T Acute Lymphoblastic Leukemia
20511,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v7
20512,Primary Lesion,Recurrent Peripheral Primitive Neuroectodermal Tumor
20513,Benign Cellular Infiltrate,Compact Cell Adrenal Cortical Adenoma
20514,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
20515,Epithelial Component Present,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20516,Epithelial Component Present,Ovarian Granulosa-Stromal Cell Tumor
20517,Benign Cellular Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor
20518,Epithelial Component Present,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20519,Mitotic Activity,MGMT-Unmethylated Glioblastoma
20520,Benign Cellular Infiltrate,Calcifying Odontogenic Cyst
20521,Primary Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
20522,High Grade Lesion,Burkitt-like lymphoma with 11q aberration
20523,Benign Cellular Infiltrate,Renal Pelvis Inverted Papilloma
20524,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7
20525,Benign Cellular Infiltrate,Exophytic Schneiderian Papilloma
20526,Benign Cellular Infiltrate,Urethral Urothelial Papilloma
20527,Primary Lesion,Stage IVB Hepatocellular Carcinoma AJCC v7
20528,Nuclear Expression of STAT6 Protein,Malignant Solitary Fibrous Tumor
20529,Benign Cellular Infiltrate,Lung Mucous Gland Adenoma
20530,Benign Cellular Infiltrate,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm
20531,Benign Cellular Infiltrate,Uterine Corpus Myxoid Leiomyoma
20532,Benign Cellular Infiltrate,Benign Ovarian Serous Tumor
20533,Benign Cellular Infiltrate,Benign Intracranial Meningioma
20534,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage
20535,Low Grade Lesion,Multinodular and Vacuolated Tumor of the Cerebrum
20536,Multifocal Lesion,"Cervical, Thoracic, and Lumbosacral Spinal Cord Ependymal Tumor"
20537,Metastatic Lesion,Transitional cell carcinoma metastatic
20538,Epithelial Component Present,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20539,Benign Cellular Infiltrate,Benign neoplasm of ciliary body
20540,Thin-Walled Branching Vascular Pattern,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma
20541,Epithelial Component Present,Nasopharyngeal Carcinoma by AJCC v8 Stage
20542,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)
20543,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma AJCC v8
20544,Recurrent disease,Recurrent Subsequent Malignant Neoplasm
20545,Benign Cellular Infiltrate,Benign neoplasm of body of uterus
20546,Primary Lesion,Recurrent Childhood Glioblastoma
20547,Epithelial Component Present,Benign Sertoli Cell Tumor
20548,Primary Lesion,Hepatoblastoma recurrent
20549,Primary Site Unknown,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20550,Primary Site Unknown,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20551,Benign Cellular Infiltrate,Adenoma of middle ear
20552,Benign Cellular Infiltrate,Benign Metastasizing Leiomyoma of the Uterine Corpus
20553,Benign Cellular Infiltrate,Paranasal Sinus Schneiderian Papilloma
20554,Benign Cellular Infiltrate,Recurrent Inverted Schneiderian Papilloma
20555,Benign Cellular Infiltrate,Alveolar adenoma
20556,Carcinomatous Component Present,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20557,Benign Cellular Infiltrate,Benign epithelial tumor of ovary
20558,Epithelial Component Present,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20559,Human Papillomavirus Positive,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20560,Benign Cellular Infiltrate,Urethral Inverted Papilloma
20561,Benign Cellular Infiltrate,Ureter Inverted Papilloma
20562,Epithelial Component Present,Ovarian Sertoli Cell Tumor with Lipid Storage
20563,Indolent Clinical Course,Oral Cavity Adenoma
20564,Carcinomatous Component Present,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20565,Benign Cellular Infiltrate,Benign neoplasm of testis
20566,Benign Cellular Infiltrate,Frontal Sinus Inverted Papilloma
20567,Epithelial Component Present,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor
20568,Human Papillomavirus Negative,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20569,Benign Cellular Infiltrate,Tumor of follicular infundibulum
20570,Microvascular Proliferation,Recurrent Gliosarcoma
20571,Hypocellular Tissue,Intramuscular Myxoma
20572,Benign Cellular Infiltrate,Benign neoplasm of oral cavity
20573,Benign Cellular Infiltrate,Benign neoplasm of brain stem
20574,Benign Cellular Infiltrate,Benign Epithelioma
20575,Benign Cellular Infiltrate,Fallopian Tube Papilloma
20576,Biphasic Pattern,Central Nervous System Mesenchymal Chondrosarcoma
20577,Low Grade Lesion,Central Nervous System Epithelioid Hemangioendothelioma
20578,Vascular Channel Formation,Central Nervous System Epithelioid Hemangioendothelioma
20579,Benign Cellular Infiltrate,Oral Cavity Lipoma
20580,Secondary Lesion,Metastatic Malignant Germ Cell Tumor
20581,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v8
20582,Benign Cellular Infiltrate,Cortisol-Producing Adrenal Cortex Adenoma
20583,Benign Cellular Infiltrate,"Oncocytoma, renal"
20584,Epithelial Component Present,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage
20585,Benign Cellular Infiltrate,Central odontogenic fibroma
20586,Carcinomatous Component Present,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20587,Severe dysplasia,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20588,Carcinomatous Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v8
20589,Carcinomatous Component Present,Advanced Head and Neck Carcinoma
20590,Recurrent disease,Recurrent Ependymal Tumor
20591,Indolent Clinical Course,Oral Cavity Benign Granular Cell Tumor
20592,Primary Lesion,Lymphoepithelioma-Like Hepatocellular Carcinoma
20593,Primary Lesion,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
20594,Primary Lesion,Hepatocellular Carcinoma by AJCC v7 Stage
20595,Human Papillomavirus Negative,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20596,Benign Cellular Infiltrate,Ovarian Seromucinous Cystadenoma
20597,Primary Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative"
20598,Epithelial Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8
20599,Benign Cellular Infiltrate,Ovarian Endometrioid Cystadenofibroma
20600,Birbeck Granules Present,Central Nervous System Langerhans Cell Histiocytosis
20601,Benign Cellular Infiltrate,Cervical Adenofibroma
20602,Benign Cellular Infiltrate,Cervical Adenomyoma
20603,Benign Cellular Infiltrate,Papillary adenofibroma
20604,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage
20605,Benign Cellular Infiltrate,Adrenal Cortical Adenoma
20606,Indolent Clinical Course,Soft Palate Pleomorphic Adenoma
20607,Indolent Clinical Course,Squamous odontogenic tumor
20608,Primary Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma
20609,Benign Cellular Infiltrate,Childhood Choroid Plexus Papilloma
20610,Primary Lesion,Recurrent Glioblastoma
20611,Epithelial Component Present,Hilus cell tumor of ovary
20612,Benign Cellular Infiltrate,Capillary hemangioma of retina
20613,Primary Lesion,Stage I Hepatocellular Carcinoma AJCC v6 and v7
20614,Primary Lesion,Stage II Hepatocellular Carcinoma AJCC v6 and v7
20615,Primary Lesion,Recurrent Childhood Anaplastic Astrocytoma
20616,Epithelial Component Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
20617,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-0
20618,Benign Cellular Infiltrate,Ovarian Microcystic Stromal Tumor
20619,Unilineage Dysplasia Present,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
20620,Hereditary Lesion,Constitutional Mismatch Repair Deficiency Syndrome
20621,Epithelial Component Present,Thecoma
20622,Benign Cellular Infiltrate,Vaginal Angiomyofibroblastoma
20623,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified"
20624,Benign Cellular Infiltrate,Benign Intracranial Neoplasm
20625,High Mitotic Activity,Atypical Pituitary Gland Adenoma
20626,Extensive Stage Lesion,Advanced Malignant Solid Neoplasm
20627,Primary Lesion,Neuroblastoma recurrent
20628,Benign Cellular Infiltrate,Clear cell hidradenoma
20629,Unresectable Mass,Unresectable Liposarcoma
20630,Secondary Lesion,Pericardial mesothelioma malignant advanced
20631,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated"
20632,Benign Cellular Infiltrate,Ovarian Cystadenoma
20633,Benign Cellular Infiltrate,Benign Mixed Tumor of the Vulva
20634,Benign Cellular Infiltrate,Benign neoplasm of lacrimal gland
20635,Primary Lesion,Stage III Hepatocellular Carcinoma AJCC v7
20636,Benign Cellular Infiltrate,Microfollicular adenoma
20637,Benign Cellular Infiltrate,Adamantinous Craniopharyngioma
20638,Benign Cellular Infiltrate,Borderline Ovarian Serous Adenofibroma
20639,Benign Cellular Infiltrate,Borderline Ovarian Serous Cystadenofibroma
20640,Benign Cellular Infiltrate,Clear Cell Adrenal Cortical Adenoma
20641,Secondary Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma
20642,Human Papillomavirus Positive,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20643,Necrotic changes (finding),MGMT-Unmethylated Glioblastoma
20644,Benign Cellular Infiltrate,Benign neoplasm of hard palate
20645,Childhood Lesion,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4
20646,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms"
20647,Primary Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
20648,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v6
20649,Nuclear Expression of STAT6 Protein,Pleural Solitary Fibrous Tumor
20650,Unclassifiable Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified"
20651,Metastatic Lesion,Advanced Adult Hepatocellular Carcinoma
20652,Benign Cellular Infiltrate,Benign neoplasm of tongue
20653,Epithelial Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v8
20654,Benign Cellular Infiltrate,Brain Hemangioma
20655,Benign Cellular Infiltrate,Hidradenoma Papilliferum
20656,Benign Cellular Infiltrate,Vulvar Cellular Angiofibroma
20657,Benign Cellular Infiltrate,"Benign neoplasm of eye, unspecified"
20658,Indolent Clinical Course,"Fibro-odontoma, Ameloblastic"
20659,Benign Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyoma
20660,Benign Cellular Infiltrate,Benign tumor of eyelid
20661,Benign Cellular Infiltrate,Squamous cell papilloma of eyelid
20662,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Soft Tissue
20663,Benign Cellular Infiltrate,Prostate Leiomyoma
20664,Primary Lesion,Adult Hepatocellular Carcinoma
20665,Recurrent Genetic Abnormalities Present,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like"
20666,Epithelial Component Present,Unresectable Transitional Cell Carcinoma
20667,Primary Lesion,Childhood Embryonal Rhabdomyosarcoma
20668,Benign Cellular Infiltrate,Ossifying Fibroma
20669,Benign Cellular Infiltrate,Classic Type Trichilemmoma
20670,Thin Bands of Collagen Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20671,Carcinomatous Component Present,Pharyngeal Carcinoma by AJCC v8 Stage
20672,Vascular Channel Formation,Anastomosing Hemangioma
20673,Hyalinized Stroma Formation,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2"
20674,Aggressive Clinical Course,Invasive micropapillary carcinoma of breast
20675,Primary Lesion,Melanoma recurrent
20676,Primary Lesion,Alcohol-Related Hepatocellular Carcinoma
20677,Epithelial Component Present,granulosa cell tumor
20678,Epithelial Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8
20679,Carcinomatous Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8
20680,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8
20681,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)
20682,Benign Cellular Infiltrate,Gingival Angiofibroma
20683,Benign Cellular Infiltrate,Skin Papilloma
20684,Childhood Lesion,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1
20685,Childhood Lesion,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A
20686,Benign Cellular Infiltrate,Serous cystadenoma of ovary
20687,Benign Cellular Infiltrate,Benign Vaginal Melanocytic Nevus
20688,Epithelial Component Present,Resectable Head and Neck Squamous Cell Carcinoma
20689,Benign Cellular Infiltrate,Capillary hemangioma of eyelid
20690,Metastatic Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20691,Secondary Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20692,Benign Cellular Infiltrate,Sphenoid Sinus Schneiderian Papilloma
20693,Benign Cellular Infiltrate,Parotid monomorphic adenoma
20694,Human Papillomavirus Positive,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20695,Benign Cellular Infiltrate,Adenomyoma
20696,Benign Cellular Infiltrate,Inverted Squamous Cell Papilloma
20697,Thin-Walled Branching Vascular Pattern,Central Nervous System Angiolipoma
20698,Benign Cellular Infiltrate,Intracystic papillary adenoma
20699,Cutaneous Involvement,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2"
20700,Unclassifiable Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread"
20701,Human Papillomavirus Negative,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20702,Benign Cellular Infiltrate,Ethmoid Sinus Inverted Papilloma
20703,Secondary Lesion,Advanced Favorable Hodgkin Lymphoma
20704,Metastatic Lesion,Advanced Favorable Hodgkin Lymphoma
20705,Carcinomatous Component Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20706,Diffuse Pattern,Recurrent Gliosarcoma
20707,High Grade Lesion,Recurrent Gliosarcoma
20708,Nuclear Atypia,Recurrent Gliosarcoma
20709,Well-Circumscribed Lesion,Intramuscular Myxoma
20710,Low Cellularity Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1"
20711,Primary Lesion,Recurrent Olfactory Neuroblastoma
20712,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v8
20713,In Situ Lesion,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20714,Indolent Clinical Course,Ameloblastic fibroma
20715,Metastatic Lesion,Advanced Head and Neck Carcinoma
20716,Primary Lesion,Recurrent Childhood Rhabdomyosarcoma
20717,Epithelial Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v8
20718,Unclassifiable Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
20719,Benign Cellular Infiltrate,Lactating adenoma
20720,Benign Cellular Infiltrate,Oral Cavity Benign Granular Cell Tumor
20721,Primary Lesion,Well Differentiated Hepatocellular Carcinoma
20722,Benign Cellular Infiltrate,Benign neoplasm of oral cavity
20723,Carcinomatous Component Present,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20724,Primary Lesion,Recurrent Childhood Hepatocellular Carcinoma
20725,Benign Cellular Infiltrate,Chief cell adenoma
20726,Primary Lesion,Peripheral neuroepithelioma of bone recurrent
20727,Benign Cellular Infiltrate,Skin appendage adenoma
20728,CD30-Positive Neoplastic Cells Present,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative"
20729,Benign Cellular Infiltrate,Ovarian Seromucinous Adenofibroma
20730,Indolent Clinical Course,Hard Palate Pleomorphic Adenoma
20731,In Situ Lesion,Stage 0 Major Salivary Gland Cancer AJCC v8
20732,Benign Cellular Infiltrate,Fallopian Tube Adenomatoid Tumor
20733,Benign Cellular Infiltrate,Vaginal Myofibroblastoma
20734,Benign Cellular Infiltrate,Plantar wart
20735,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v8
20736,Carcinomatous Component Present,Stage III Major Salivary Gland Cancer AJCC v8
20737,Unclassifiable Lesion,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified"
20738,Benign Cellular Infiltrate,Vaginal Leiomyoma
20739,Carcinomatous Component Present,Stage IVA Major Salivary Gland Cancer AJCC v8
20740,Diffuse Pattern,Double-Hit Lymphoma
20741,Benign Cellular Infiltrate,Bladder papilloma
20742,Benign Cellular Infiltrate,Soft Palate Pleomorphic Adenoma
20743,Benign Cellular Infiltrate,Fallopian tube leiomyoma
20744,Benign Cellular Infiltrate,Seborrheic keratosis
20745,Epithelial Component Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements
20746,Epithelial Component Present,"Leydig cell tumor, malignant"
20747,Benign Cellular Infiltrate,Broad Ligament Serous Adenofibroma
20748,Epithelial Component Present,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types
20749,Carcinomatous Component Present,Small Cell Adenocarcinoma
20750,Benign Cellular Infiltrate,Benign Reproductive System Neoplasm
20751,Primary Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
20752,Primary Lesion,Recurrent Childhood Liver Cancer
20753,Epithelial Component Present,Malignant Testicular Sertoli Cell Tumor
20754,Primary Lesion,Adult Fibrolamellar Carcinoma
20755,Thin Bands of Collagen Present,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20756,Well-Circumscribed Lesion,Central Nervous System Myofibroblastoma
20757,Benign Cellular Infiltrate,Ovarian Serous Adenofibroma
20758,Epithelial Component Present,Ovarian Retiform Sertoli-Leydig Cell Tumor
20759,Benign Cellular Infiltrate,Parathyroid transitional clear cell adenoma
20760,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated"
20761,Benign Cellular Infiltrate,Trichoadenoma
20762,Primary Lesion,BCLC Stage B Hepatocellular Carcinoma
20763,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia-0
20764,Primary Lesion,Recurrent Childhood Anaplastic Oligoastrocytoma
20765,Epithelial Component Present,Recurrent Endometrial Serous Adenocarcinoma
20766,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Adenofibroma
20767,Benign Cellular Infiltrate,Mixed Cell Adrenal Cortical Adenoma
20768,Epithelial Component Present,Testicular Sclerosing Sertoli Cell Tumor
20769,Benign Cellular Infiltrate,Testicular Sclerosing Sertoli Cell Tumor
20770,Benign Cellular Infiltrate,Thyroid Gland Oncocytic Adenoma
20771,Metastatic Lesion,Peritoneal mesothelioma malignant advanced
20772,Benign Cellular Infiltrate,"Schneiderian papilloma, inverted"
20773,Benign Cellular Infiltrate,Benign Adult Brain Neoplasm
20774,Metastatic Lesion,Pleural mesothelioma malignant advanced
20775,Unclassifiable Lesion,"Supratentorial Embryonal Tumor, Not Otherwise Specified"
20776,Benign Cellular Infiltrate,benign myoepithelioma of salivary gland
20777,Primary Lesion,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
20778,Benign Cellular Infiltrate,Benign Diencephalic Neoplasm
20779,Primary Lesion,Hepatocellular Carcinoma by AJCC v6 Stage
20780,Recurrent disease,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
20781,Childhood Lesion,Recurrent Childhood T Acute Lymphoblastic Leukemia
20782,Thin Bands of Collagen Present,Hemangiopericytoma of meninges
20783,Primary Lesion,Recurrent tumors of the Ewing's family
20784,Solitary mass,Sacral Chordoma
20785,Primary Lesion,Recurrent Childhood Medulloblastoma
20786,Benign Cellular Infiltrate,"Testicular Sertoli Cell Tumor, Lipid Rich Variant"
20787,Carcinomatous Component Present,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20788,Indolent Clinical Course,Odontogenic myxofibroma
20789,Diffuse Pattern,MGMT-Unmethylated Glioblastoma
20790,Epithelial Component Present,Adult Type Ovarian Granulosa Cell Tumor
20791,Benign Cellular Infiltrate,Benign Prostate Phyllodes Tumor
20792,Benign Cellular Infiltrate,Ovarian Mucinous Adenofibroma
20793,Benign Cellular Infiltrate,Thyroid Gland Lipoadenoma
20794,Benign Cellular Infiltrate,Benign neoplasm of base of tongue
20795,Ventricular Involvement Only,Fourth Ventricle Ependymal Tumor
20796,Benign Cellular Infiltrate,Large cell acanthoma
20797,Benign Cellular Infiltrate,Benign tumor of endocrine gland
20798,Cellular Pleomorphism,Central Nervous System Undifferentiated Pleomorphic Sarcoma
20799,Benign Cellular Infiltrate,Eccrine dermal cylindroma
20800,Benign Cellular Infiltrate,Benign neoplasm of pineal gland
20801,Benign Cellular Infiltrate,Oral Cavity Pleomorphic Adenoma
20802,Indolent Clinical Course,Oral Cavity Pleomorphic Adenoma
20803,Osteoid formation,Osteoma of skull
20804,Benign Cellular Infiltrate,Acantholytic acanthoma
20805,Benign Cellular Infiltrate,"Uterine Corpus Leiomyoma, Mitotically Active Variant"
20806,Benign Cellular Infiltrate,Parathyroid Gland Lipoadenoma
20807,Benign Cellular Infiltrate,Sebaceous adenoma
20808,Benign Cellular Infiltrate,Bronchial adenoma
20809,Metastatic Lesion,Prostate Carcinoma Metastatic in the Soft Tissue
20810,Primary Lesion,Melanoma recurrent
20811,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like
20812,Primary Lesion,Recurrent Non-Cutaneous Melanoma
20813,Benign Cellular Infiltrate,sebaceous adenoma of salivary gland
20814,Unresectable Mass,Unresectable Transitional Cell Carcinoma
20815,Benign Cellular Infiltrate,Benign male reproductive tract neoplasm
20816,Epithelial Component Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20817,Benign Cellular Infiltrate,Hidroacanthoma simplex
20818,Necrotic changes (finding),"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20819,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2"
20820,Benign Cellular Infiltrate,Vaginal Mullerian Papilloma
20821,Benign Cellular Infiltrate,Breast adenoma
20822,Benign Cellular Infiltrate,Breast Apocrine Adenoma
20823,Benign Cellular Infiltrate,Borderline Ovarian Endometrioid Adenofibroma
20824,Primary Lesion,BCLC Stage A Adult Hepatocellular Carcinoma
20825,Cutaneous Involvement,Stage IB Mycosis Fungoides AJCC v7
20826,Benign Cellular Infiltrate,Atypical Breast Papilloma
20827,Metastatic Lesion,Mesothelioma malignant advanced
20828,Recurrent disease,Recurrent Glioma
20829,Benign Cellular Infiltrate,Dermal Duct Tumor
20830,Secondary Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
20831,Primary Site Unknown,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
20832,Benign Cellular Infiltrate,cystadenoma of salivary gland
20833,Benign Cellular Infiltrate,Inverted urothelial papilloma
20834,Benign Cellular Infiltrate,Eccrine Poroma
20835,Cervical lymphadenopathy,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20836,Cervical lymphadenopathy,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20837,Metastatic Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20838,Benign Cellular Infiltrate,Uterine Corpus Dissecting Leiomyoma
20839,Primary Lesion,Early Hepatocellular Carcinoma
20840,Benign Cellular Infiltrate,Lung Squamous Cell Papilloma
20841,Carcinomatous Component Present,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20842,Unclassifiable Lesion,primitive neuroectodermal tumor (PNET) of spinal cord
20843,Benign Cellular Infiltrate,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm
20844,Benign Cellular Infiltrate,"Adenoma, Basal Cell"
20845,Nuclear Expression of STAT6 Protein,Mediastinal Solitary Fibrous Tumor
20846,Nuclear Expression of STAT6 Protein,Peritoneal Solitary Fibrous Tumor
20847,Benign Cellular Infiltrate,Intraductal Breast Papillomatosis
20848,Childhood Lesion,Acute Megakaryoblastic Leukemia with NUP98-KDM5A
20849,Benign Cellular Infiltrate,Oral Cavity Adenoma
20850,Benign Cellular Infiltrate,Intracranial Benign Fibrous Histiocytoma
20851,Benign Cellular Infiltrate,Hard Palate Monomorphic Adenoma
20852,Benign Cellular Infiltrate,Parathyroid Gland Oncocytic Adenoma
20853,Epithelial Component Present,Leydig cell neoplasm of testis
20854,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
20855,Primary Lesion,Childhood Spindle Cell Rhabdomyosarcoma
20856,Recurrent disease,Recurrent Gliosarcoma
20857,Mitotic Activity,Recurrent Gliosarcoma
20858,Benign Cellular Infiltrate,Prostatic Adenoma
20859,Epithelial Component Present,Ovarian Fibromata
20860,Indolent Clinical Course,Benign neoplasm of gum
20861,Benign Cellular Infiltrate,Cystadenofibroma of fallopian tube
20862,Carcinomatous Component Present,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage
20863,Human Papillomavirus Negative,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage
20864,Carcinomatous Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v8
20865,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage
20866,Epithelial Component Present,Malignant Granulosa Cell Tumor
20867,Human Papillomavirus Negative,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20868,Benign Cellular Infiltrate,Vulvar Congenital Melanocytic Nevus
20869,Primary Lesion,Central Nervous System Intravascular Large B-Cell Lymphoma
20870,Diffuse Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma
20871,Benign Cellular Infiltrate,Degeneration of uterine fibroid
20872,Absence of Invasion,Stage 0 Major Salivary Gland Cancer AJCC v8
20873,Carcinomatous Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8
20874,Severe dysplasia,Stage 0 Major Salivary Gland Cancer AJCC v8
20875,Benign Cellular Infiltrate,Benign Brenner Tumor
20876,Rosenthal Fibers Present,Rosette-forming glioneuronal neoplasm
20877,Polymorphic Cellular Infiltrate,Central Nervous System Langerhans Cell Histiocytosis
20878,Benign Cellular Infiltrate,Female Reproductive System Adenofibroma
20879,Epithelial Component Present,Stage IVA Major Salivary Gland Cancer AJCC v8
20880,Benign Cellular Infiltrate,"Cervical Adenomyoma, Endocervical Type"
20881,Benign Cellular Infiltrate,Mucinous adenofibroma
20882,Benign Cellular Infiltrate,Cervical Atypical Polypoid Adenomyoma
20883,Primary Lesion,Recurrent Hepatocellular Carcinoma
20884,Epithelial Component Present,Benign Ovarian Luteinized Thecoma
20885,Primary Lesion,Sarcomatoid Hepatocellular Carcinoma
20886,Benign Cellular Infiltrate,Trichilemmoma
20887,Benign Cellular Infiltrate,inverted follicular keratosis
20888,Epithelial Component Present,Ovarian Stromal-Leydig Cell Tumor
20889,Epithelial Component Present,Lipid cell tumor of ovary
20890,Epithelial Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v8
20891,High Mitotic Activity,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20892,Hyalinized Stroma Formation,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20893,Epithelial Component Present,Ovarian Stromal Tumor with Minor Sex Cord Elements
20894,Benign Cellular Infiltrate,Mucinous cystadenofibroma
20895,Primary Lesion,BCLC Stage 0 Hepatocellular Carcinoma
20896,Primary Lesion,BCLC Stage A Hepatocellular Carcinoma
20897,Epithelial Component Present,malignant steroid cell tumor of ovary
20898,Epithelial Component Present,Malignant Sertoli Cell Tumor
20899,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated, TP53-Wildtype"
20900,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
20901,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
20902,Ineffective hematopoiesis,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
20903,Benign Cellular Infiltrate,Vulvar Angiomyofibroblastoma
20904,Secondary Lesion,Advanced Malignant Solid Neoplasm
20905,Benign Cellular Infiltrate,Craniopharyngioma
20906,Benign Cellular Infiltrate,Eccrine acrospiroma
20907,Benign Cellular Infiltrate,Apocrine adenoma
20908,Benign Cellular Infiltrate,Lipoma of corpus callosum
20909,Benign Cellular Infiltrate,Papilloma of buccal mucosa
20910,Secondary Lesion,Pleural mesothelioma malignant advanced
20911,Benign Cellular Infiltrate,Ovarian Clear Cell Cystadenofibroma
20912,Benign Cellular Infiltrate,Benign Outer Hair Sheath and Infundibulum Neoplasm
20913,Carcinomatous Component Present,basaloid squamous cell carcinoma of floor of mouth
20914,Benign Cellular Infiltrate,Retinoma
20915,Secondary Lesion,Advanced Favorable Non-Hodgkin Lymphoma
20916,Benign Cellular Infiltrate,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis
20917,Human Papillomavirus Positive,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20918,Indolent Clinical Course,Benign neoplasm of hard palate
20919,Primary Lesion,Moderately Differentiated Hepatocellular Carcinoma
20920,Nuclear Expression of STAT6 Protein,Thymus Solitary Fibrous Tumor
20921,Benign Cellular Infiltrate,Uterine Fibroids
20922,Epithelial Component Present,Gonadoblastoma
20923,Benign Cellular Infiltrate,Thyroid Gland Signet Ring Cell Follicular Adenoma
20924,Carcinomatous Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8
20925,Benign Cellular Infiltrate,Desmoplastic trichilemmoma
20926,Epithelial Component Present,Sertoli cell tumor of testis
20927,Benign Cellular Infiltrate,Desmoplastic trichoepithelioma
20928,Benign Cellular Infiltrate,Syringocystadenoma Papilliferum
20929,Benign Cellular Infiltrate,"Fibro-odontoma, Ameloblastic"
20930,Benign Cellular Infiltrate,Benign neoplasm of sweat gland
20931,Unresectable Mass,Unresectable Thyroid Gland Carcinoma
20932,Benign Cellular Infiltrate,Lung Mucinous Cystadenoma
20933,Benign Cellular Infiltrate,Seborrheic keratosis of eyelid
20934,Benign Cellular Infiltrate,Benign neoplasm of uterus
20935,Primary Lesion,Childhood Hepatocellular Carcinoma
20936,Recurrent Genetic Abnormalities Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like
20937,Benign Cellular Infiltrate,Adrenal Rest Tumor
20938,Benign Cellular Infiltrate,Benign tumor of iris
20939,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage
20940,Carcinomatous Component Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20941,Primary Lesion,Childhood Alveolar Rhabdomyosarcoma
20942,Human Papillomavirus Positive,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20943,Benign Cellular Infiltrate,"Transitional cell papilloma, benign"
20944,Benign Cellular Infiltrate,Syringofibroadenoma
20945,Benign Cellular Infiltrate,Schneiderian papilloma
20946,atypia morphology,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20947,Benign Cellular Infiltrate,Eccrine spiradenoma
20948,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v8 Stage
20949,Indolent Clinical Course,Anastomosing Hemangioma
20950,Increased Cellularity Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2"
20951,Primary Lesion,Aflatoxins-Related Hepatocellular Carcinoma
20952,Benign Cellular Infiltrate,Respiratory papilloma
20953,Benign Cellular Infiltrate,Cervical Squamous Papilloma
20954,Benign Cellular Infiltrate,Bladder Urothelial Papilloma
20955,Benign Cellular Infiltrate,Inverted papilloma of urinary bladder
20956,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12)
20957,Benign Cellular Infiltrate,Cervical Rhabdomyoma
20958,Epithelial Component Present,Ovarian gynandroblastoma
20959,Benign Cellular Infiltrate,Central Breast Papilloma
20960,Recurrent disease,Recurrent Primary Malignant Neoplasm
20961,Benign Cellular Infiltrate,Lipoma of spermatic cord
20962,Benign Cellular Infiltrate,Ancell-Spiegler cylindromas
20963,Secondary Lesion,Mesothelioma malignant advanced
20964,Cervical lymphadenopathy,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
20965,Benign Cellular Infiltrate,Benign tumor of penis
20966,Secondary Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20967,Metastatic Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
20968,Primary Lesion,Recurrent Bone Ewing Sarcoma
20969,Carcinomatous Component Present,Major Salivary Gland Cancer by AJCC v8 Stage
20970,Human Papillomavirus Positive,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
20971,Benign Cellular Infiltrate,Maxillary Sinus Schneiderian Papilloma
20972,Benign Cellular Infiltrate,Benign Vaginal Mixed Tumor
20973,Benign Cellular Infiltrate,Benign Cerebellar Neoplasms
20974,Epithelial Component Present,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20975,Chronic Inflammatory Infiltrate,Intracranial Benign Fibrous Histiocytoma
20976,Benign Cellular Infiltrate,"Acanthoma, Pilar Sheath"
20977,Benign Cellular Infiltrate,"Papilloma, Intraductal"
20978,Epithelial Component Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20979,Primary Lesion,Extra-osseous Ewing's sarcoma recurrent
20980,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma with Bizarre Nuclei
20981,Epithelial Component Present,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome
20982,Hyalinized Stroma Formation,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1"
20983,Benign Cellular Infiltrate,Trichoepithelioma
20984,Benign Cellular Infiltrate,Pilocytic astrocytoma of cerebellum
20985,Solitary mass,Central Nervous System Epithelioid Hemangioendothelioma
20986,atypia morphology,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
20987,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8
20988,Indolent Clinical Course,Central odontogenic fibroma
20989,Epithelial Component Present,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20990,Human Papillomavirus Negative,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
20991,Epithelial Component Present,Stage II Lip and Oral Cavity Cancer AJCC v8
20992,Carcinomatous Component Present,Stage II Lip and Oral Cavity Cancer AJCC v8
20993,Benign Cellular Infiltrate,Intracranial cavernous hemangioma
20994,Epithelial Component Present,Stage III Lip and Oral Cavity Cancer AJCC v8
20995,Epithelial Component Present,Typical Ovarian Thecoma
20996,Benign Cellular Infiltrate,Cerebral hemangioma
20997,Epithelial Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v8
20998,Epithelial Component Present,Ovarian Signet Ring Stromal Tumor
20999,Benign Cellular Infiltrate,Childhood Craniopharyngioma
21000,Epithelial Component Present,Ovarian Sertoli-Stromal Cell Tumor
21001,Benign Cellular Infiltrate,Ovarian Sclerosing Stromal Tumor
21002,Benign Cellular Infiltrate,Aldosterone-Producing Adrenal Cortex Adenoma
21003,Epithelial Component Present,Benign Ovarian Sex Cord-Stromal Tumor
21004,Primary Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive"
21005,Benign Cellular Infiltrate,Ovarian Endometrioid Cystadenoma
21006,Benign Cellular Infiltrate,Hard Palate Pleomorphic Adenoma
21007,Benign Cellular Infiltrate,Benign Breast Eccrine Spiradenoma
21008,Benign Cellular Infiltrate,Benign Ovarian Neoplasm
21009,Monoclonal Langerhans Cells Present,Central Nervous System Langerhans Cell Histiocytosis
21010,Epithelial Component Present,Stage IV Major Salivary Gland Cancer AJCC v8
21011,Benign Cellular Infiltrate,ductal papilloma of salivary gland
21012,Benign Cellular Infiltrate,Vaginal Squamous Papilloma
21013,Unresectable Mass,Unresectable Ewing Sarcoma
21014,Well-Circumscribed Lesion,Cellular Myxoma
21015,Benign Cellular Infiltrate,Cystadenofibroma
21016,Primary Lesion,Stage IIIC Hepatocellular Carcinoma AJCC v7
21017,Benign Cellular Infiltrate,Clear cell cystadenofibroma
21018,Benign Cellular Infiltrate,Benign Childhood Supratentorial Neoplasm
21019,Benign Cellular Infiltrate,Benign Ovarian Luteinized Thecoma
21020,Benign Cellular Infiltrate,benign endometrioid tumor of ovary
21021,Benign Cellular Infiltrate,Benign Intraocular Teratoid Medulloepithelioma
21022,Epithelial Component Present,Stage I Major Salivary Gland Cancer AJCC v8
21023,Benign Cellular Infiltrate,Adult Pineocytoma
21024,Benign Cellular Infiltrate,Melanoacanthoma
21025,Epithelial Component Present,Adult Type Granulosa Cell Tumor
21026,Epithelial Component Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
21027,Multilineage Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
21028,Benign Cellular Infiltrate,Ameloblastic fibrodentinoma
21029,Indolent Clinical Course,Benign Ameloblastoma
21030,Benign Cellular Infiltrate,Benign Ameloblastoma
21031,Benign Cellular Infiltrate,Broad Ligament Serous Cystadenoma
21032,Benign Cellular Infiltrate,Broad Ligament Serous Cystadenofibroma
21033,Benign Cellular Infiltrate,Ovarian Stromal-Leydig Cell Tumor
21034,Ventricular Involvement Only,Ventricular Ependymal Tumor
21035,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor
21036,Carcinomatous Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v8
21037,Benign Cellular Infiltrate,Ovarian Papillary Cystadenoma
21038,Benign Cellular Infiltrate,Vulvar Ectopic Fibroadenoma
21039,Benign Cellular Infiltrate,Uterine Corpus Adenomyoma
21040,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-0
21041,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated, TP53-Mutant"
21042,Benign Cellular Infiltrate,Benign neoplasm of retina
21043,Primary Lesion,BCLC Stage C Hepatocellular Carcinoma
21044,Epithelial Component Present,Luteoma
21045,Benign Cellular Infiltrate,Benign neoplasm of choroid
21046,Unresectable Mass,Unresectable Digestive System Adenocarcinoma
21047,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
21048,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
21049,Benign Cellular Infiltrate,Benign epithelial neoplasm of skin
21050,Benign Cellular Infiltrate,Benign Female Reproductive System Neoplasm
21051,Recurrent disease,Recurrent Endometrial Serous Adenocarcinoma
21052,Metastatic Lesion,Advanced Malignant Solid Neoplasm
21053,Epithelial Component Present,Adult Type Testicular Granulosa Cell Tumor
21054,Epithelial Component Present,Juvenile Type Testicular Granulosa Cell Tumor
21055,Primary Lesion,Recurrent Primitive Neuroectodermal Tumor
21056,Benign Cellular Infiltrate,Papilloma of eyelid
21057,Benign Cellular Infiltrate,Benign tumor of choroid plexus
21058,Benign Cellular Infiltrate,"Adenoma, Sweat Gland"
21059,Benign Cellular Infiltrate,Macrofollicular adenoma
21060,Lobulated Growth Pattern,Sacral Chordoma
21061,Myxoid Stroma Formation,Sacral Chordoma
21062,C19MC Amplification,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
21063,Metastatic Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma
21064,Benign Cellular Infiltrate,Glomerulosa Cell Adrenal Cortical Adenoma
21065,Carcinomatous Component Present,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
21066,Anaplasia,MGMT-Unmethylated Glioblastoma
21067,Indolent Clinical Course,Calcifying Odontogenic Cyst
21068,Benign Cellular Infiltrate,Apocrine cystadenoma
21069,Indolent Clinical Course,Benign neoplasm of buccal mucosa
21070,Primary Lesion,Poorly Differentiated Hepatocellular Carcinoma
21071,Benign Cellular Infiltrate,Sebaceoma
21072,Epithelial Component Present,Ovarian Tumor of the Thecoma/Fibroma Group
21073,Benign Cellular Infiltrate,Leiomyoma of ciliary body
21074,Ventricular Involvement Only,Third Ventricle Ependymal Tumor
21075,Epithelial Component Present,Ovarian Cellular Fibroma
21076,Benign Cellular Infiltrate,Hemangioma of choroid
21077,Primary Lesion,Transplant-Related Hepatocellular Carcinoma
21078,Childhood Lesion,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10
21079,Benign Cellular Infiltrate,Glandular papilloma
21080,Benign Cellular Infiltrate,Lipoma of the tongue
21081,Benign Cellular Infiltrate,Benign Anterior Tongue Neoplasm
21082,Secondary Lesion,Advanced Adult Hepatocellular Carcinoma
21083,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v8
21084,Primary Lesion,Hepatitis B Virus-Related Hepatocellular Carcinoma
21085,Epithelial Component Present,fibroma of testis
21086,Benign Cellular Infiltrate,Apocrine adenoma
21087,Benign Cellular Infiltrate,"Acanthoma, Clear Cell"
21088,Benign Cellular Infiltrate,Uterine Corpus Apoplectic Leiomyoma
21089,Carcinomatous Component Present,Unresectable Thyroid Gland Carcinoma
21090,Diffuse Lesion,Diffuse leptomeningeal glioneuronal neoplasm
21091,Benign Cellular Infiltrate,Benign Adult Cerebellar Neoplasm
21092,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with BCR-ABL1
21093,Epithelial Component Present,Prostate Carcinoma Metastatic in the Soft Tissue
21094,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage
21095,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage
21096,Primary Lesion,Multinodular and Vacuolated Tumor of the Cerebrum
21097,Benign Cellular Infiltrate,Ureter Urothelial Papilloma
21098,Benign Cellular Infiltrate,Parotid Gland Warthin Tumor
21099,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
21100,Benign Cellular Infiltrate,"Transitional cell papilloma, inverted"
21101,Thin Bands of Collagen Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2"
21102,Staghorn Configuration,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2"
21103,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v8 Stage
21104,Benign Cellular Infiltrate,Serous surface papilloma
21105,Unclassifiable Lesion,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified"
21106,Primary Lesion,Fibrolamellar Hepatocellular Carcinoma
21107,Primary Lesion,Recurrent Primary Malignant Neoplasm
21108,Benign Cellular Infiltrate,Benign neoplasm of uterine cervix
21109,Benign Cellular Infiltrate,Sporadic Cylindroma
21110,Epithelial Component Present,Mixed germ cell-sex cord-stromal tumor
21111,Resectable Mass,Resectable Head and Neck Squamous Cell Carcinoma
21112,Benign Cellular Infiltrate,Mucinous cystadenoma of ovary
21113,Benign Cellular Infiltrate,sialadenoma papilliferum of salivary gland
21114,Epithelial Component Present,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
21115,Primary Site Unknown,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
21116,Benign Cellular Infiltrate,Hidrocystoma
21117,Carcinomatous Component Present,Hormone refractory prostate cancer
21118,Epithelial Component Present,Sex cord stromal tumor of testis
21119,Benign Cellular Infiltrate,Benign Uterine Ligament Neoplasm
21120,Epithelial Component Present,Sertoli-Leydig cell tumor of ovary
21121,Childhood Lesion,Childhood Melanoma
21122,Local disease,Central Nervous System Angiolipoma
21123,Intravascular Fibrin Thrombus Formation,Central Nervous System Angiolipoma
21124,Human Papillomavirus Negative,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8
21125,Benign Cellular Infiltrate,Adenoma of the nipple
21126,Benign Cellular Infiltrate,"Benign neoplasm of brain, unspecified"
21127,Benign Cellular Infiltrate,Benign neoplasm of epididymis
21128,Indolent Clinical Course,Hard Palate Monomorphic Adenoma
21129,Dermal Involvement,Fibrous Hamartoma of Infancy
21130,Benign Cellular Infiltrate,Senile hemangioma of lip
21131,Anaplasia,Recurrent Gliosarcoma
21132,Benign Cellular Infiltrate,Benign Testicular Sertoli Cell Tumor
21133,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1"
21134,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1"
21135,Benign Cellular Infiltrate,Uterine Corpus Lipoleiomyoma
21136,Cartilaginous Differentiation,Central Nervous System Mesenchymal Chondrosarcoma
21137,Indolent Clinical Course,Adenoameloblastoma
21138,Benign Cellular Infiltrate,Fallopian Tube Serous Adenofibroma
21139,Epithelial Component Present,Stage I Hypopharyngeal Carcinoma AJCC v8
21140,Carcinomatous Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8
21141,Recurrent disease,Recurrent Malignant Germ Cell Tumor
21142,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v8
21143,Indolent Clinical Course,Peripheral Odontogenic Fibroma
21144,Deep Lesion,Central Nervous System Desmoid-Type Fibromatosis
21145,Benign Cellular Infiltrate,Renal Pelvis Urothelial Papilloma
21146,Epithelial Component Present,Advanced Head and Neck Carcinoma
21147,Carcinomatous Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v8
21148,Epithelial Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v8
21149,Epithelial Component Present,"Thecoma, luteinized"
21150,Carcinomatous Component Present,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
21151,Epithelial Component Present,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
21152,Indolent Clinical Course,Benign neoplasm of oral cavity
21153,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma
21154,Carcinomatous Component Present,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8
21155,Benign Cellular Infiltrate,Papilloma
21156,Osseous Differentiation,Unresectable Osteosarcoma
21157,Benign Cellular Infiltrate,Androgen-Producing Adrenal Cortex Adenoma
21158,Benign Cellular Infiltrate,Breast Pleomorphic Adenoma
21159,Benign Cellular Infiltrate,endometrioid adenofibroma of ovary
21160,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
21161,Epithelial Component Present,Stage II Major Salivary Gland Cancer AJCC v8
21162,CD1a-Positive Neoplastic Cells Present,Central Nervous System Langerhans Cell Histiocytosis
21163,Hypocellular Tissue,Cellular Myxoma
21164,Primary Lesion,Recurrent Medulloblastoma
21165,Benign Cellular Infiltrate,Soft Palate Benign Granular Cell Tumor
21166,Benign Cellular Infiltrate,Benign Uveal Neoplasm
21167,Carcinomatous Component Present,Stage I Major Salivary Gland Cancer AJCC v8
21168,Benign Cellular Infiltrate,Endometrial Polyp
21169,Benign Cellular Infiltrate,Bartholin Gland Adenoma
21170,Primary Lesion,BCLC Stage D Hepatocellular Carcinoma
21171,Benign Cellular Infiltrate,Adult Craniopharyngioma
21172,Benign Cellular Infiltrate,Squamous odontogenic tumor
21173,Metastatic Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
21174,Epithelial Component Present,Ovarian Granulosa Cell Tumor
21175,Epithelial Component Present,Malignant Ovarian Luteinized Thecoma
21176,atypia morphology,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
21177,Necrotic changes (finding),"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
21178,Numerous Stromal Mast Cells Present,Central Nervous System Myofibroblastoma
21179,Collagenous Stroma Formation,Central Nervous System Myofibroblastoma
21180,Indolent Clinical Course,Central Nervous System Myofibroblastoma
21181,Unclassifiable Lesion,Cerebral Primitive Neuroectodermal Tumor
21182,Benign Cellular Infiltrate,Benign Ovarian Transitional Cell Tumor
21183,Benign Cellular Infiltrate,Sclerosing Breast Papilloma
21184,Benign Cellular Infiltrate,Pedunculated conjunctival papilloma
21185,Benign Cellular Infiltrate,Ovarian serous cystadenofibroma
21186,Bone Marrow Dysplasia Present,Chronic Myelomonocytic Leukemia-0
21187,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-0
21188,Carcinomatous Component Present,Unresectable Digestive System Adenocarcinoma
21189,Carcinomatous Component Present,Recurrent Endometrial Serous Adenocarcinoma
21190,Epithelial Component Present,Ovarian Sertoli Cell Tumor
21191,Unresectable Mass,Unresectable Leiomyosarcoma
21192,Nuclear Expression of STAT6 Protein,benign fibroma of liver
21193,Unclassifiable Lesion,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified"
21194,Metastatic Lesion,Pericardial mesothelioma malignant advanced
21195,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Cystadenofibroma
21196,Unclassifiable Lesion,"Intracranial Embryonal Tumor, Not Otherwise Specified"
21197,Benign Cellular Infiltrate,Cerebral Hemisphere Lipoma
21198,Benign Cellular Infiltrate,Benign Thalamic Neoplasm
21199,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21
21200,Epithelial Component Present,Malignant Ovarian Granulosa Cell Tumor
21201,Benign Cellular Infiltrate,Vulvar Syringoma
21202,Benign Cellular Infiltrate,Squamous cell papilloma of skin
21203,Benign Cellular Infiltrate,Vulvar Trichoepithelioma
21204,Peripheral Nuclear Palisading,basaloid squamous cell carcinoma of floor of mouth
21205,Benign Cellular Infiltrate,Eccrine hidrocystoma
21206,Benign Cellular Infiltrate,Borderline Ovarian Mucinous Adenofibroma
21207,Epithelial Component Present,Malignant Testicular Leydig Cell Tumor
21208,Epithelial Component Present,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis
21209,Unmethylated MGMT Gene Promoter,MGMT-Unmethylated Glioblastoma
21210,Benign Cellular Infiltrate,Thyroid Gland Mucinous Follicular Adenoma
21211,Benign Cellular Infiltrate,Ovarian Mucinous Cystadenofibroma
21212,Benign Cellular Infiltrate,Benign neoplasm of buccal mucosa
21213,Benign Cellular Infiltrate,Superficial Epithelioma with Sebaceous Differentiation
21214,Primary Lesion,Recurrent Childhood Central Nervous System Embryonal Neoplasm
21215,Nuclear Expression of STAT6 Protein,Solitary fibrous tumor
21216,Benign Cellular Infiltrate,Metanephric adenoma
21217,Benign Cellular Infiltrate,Intraductal papilloma of breast
21218,Benign Cellular Infiltrate,Thyroid Gland Clear Cell Follicular Adenoma
21219,Primary Lesion,Recurrent tumors of the Ewing's family
21220,Benign Cellular Infiltrate,Oncocytic Schneiderian papilloma
21221,Mass of body structure,Small Intestinal Myeloid Sarcoma
21222,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia
21223,No Identifiable Line of Differentiation,Central Nervous System Undifferentiated Pleomorphic Sarcoma
21224,Indolent Clinical Course,Benign Anterior Tongue Neoplasm
21225,Primary Lesion,Advanced Adult Hepatocellular Carcinoma
21226,Benign Cellular Infiltrate,Benign oncocytoma of salivary gland
21227,Benign Cellular Infiltrate,Uterine Corpus Adenomatoid Tumor
21228,Benign Cellular Infiltrate,Inverting papilloma of the paranasal sinus
21229,Benign Cellular Infiltrate,Inner Ear Lipoma
21230,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified"
21231,Indolent Clinical Course,benign neoplasm of floor of mouth
21232,Osseous Differentiation,Osteoma of skull
21233,Benign Cellular Infiltrate,Adenomatoid tumor of epididymis
21234,Benign Cellular Infiltrate,Hemangioma of intracranial structure
21235,Benign Cellular Infiltrate,Fibroma of prostate
21236,Benign Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma
21237,Benign Cellular Infiltrate,Benign Ovarian Mucinous Tumor
21238,Benign Cellular Infiltrate,Lung Mixed Squamous Cell and Glandular Papilloma
21239,Primary Lesion,BCLC Stage C Adult Hepatocellular Carcinoma
21240,Benign Cellular Infiltrate,Uterine Corpus Bizarre Leiomyoma
21241,Benign Cellular Infiltrate,Rete Testis Adenoma
21242,Epithelial Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage
21243,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage
21244,Unfavorable Clinical Outcome,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like"
21245,Carcinomatous Component Present,Unresectable Transitional Cell Carcinoma
21246,Indolent Clinical Course,Ossifying Fibroma
21247,Epithelial Component Present,Transitional cell carcinoma metastatic
21248,Benign Cellular Infiltrate,Benign Intraocular Schwannoma
21249,Nuclear Expression of STAT6 Protein,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma
21250,Thin Bands of Collagen Present,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma
21251,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
21252,Capillary Sized Vascular Channel Formation,Anastomosing Hemangioma
21253,Benign Cellular Infiltrate,Benign neoplasm of sebaceous gland
21254,Benign Cellular Infiltrate,Peripheral Breast Papilloma
21255,Carcinomatous Component Present,Resectable Head and Neck Squamous Cell Carcinoma
21256,Metastatic Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
21257,Cervical lymphadenopathy,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
21258,Epithelial Component Present,Malignant sex-cord stromal tumor
21259,Benign Cellular Infiltrate,Benign germ cell tumor of ovary
21260,Metastatic Lesion,Hormone refractory prostate cancer
21261,Benign Cellular Infiltrate,Cervical Mullerian Papilloma
21262,Benign Cellular Infiltrate,Ethmoid Sinus Schneiderian Papilloma
21263,Epithelial Component Present,Granulosa cell tumor of the testis
21264,Epithelial Component Present,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
21265,Primary Lesion,Ewing's sarcoma recurrent
21266,Primary Lesion,"Hepatocellular carcinoma, scirrhous"
21267,Benign Cellular Infiltrate,Warty dyskeratoma
21268,Benign Cellular Infiltrate,Serous adenofibroma
21269,Primary Lesion,Childhood Rhabdomyosarcoma
21270,Indolent Clinical Course,Central Nervous System Angiolipoma
21271,Benign Cellular Infiltrate,Sphenoid Sinus Inverted Papilloma
21272,Storiform Growth Pattern,Intracranial Benign Fibrous Histiocytoma
21273,Indolent Clinical Course,Intracranial Benign Fibrous Histiocytoma
21274,Benign Cellular Infiltrate,Cementoma
21275,Carcinomatous Component Present,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
21276,Epithelial Component Present,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
21277,Human Papillomavirus Negative,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
21278,Benign Cellular Infiltrate,Acanthoma
21279,Benign Cellular Infiltrate,Benign neoplasm of pituitary gland
21280,Infiltrative Growth Pattern,Recurrent Gliosarcoma
21281,Primary Lesion,Recurrent Gliosarcoma
21282,Indolent Clinical Course,Oral Cavity Monomorphic Adenoma
21283,Benign Cellular Infiltrate,Oral Cavity Monomorphic Adenoma
21284,Metastatic Lesion,Advanced Unfavorable Hodgkin Lymphoma
21285,Benign Cellular Infiltrate,Benign cerebral tumor
21286,Indolent Clinical Course,Benign neoplasm of oral cavity
21287,Benign Cellular Infiltrate,Ovarian Fibromata
21288,Epithelial Component Present,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor
21289,Carcinomatous Component Present,Hypopharyngeal Carcinoma by AJCC v8 Stage
21290,Well Differentiated Hyaline Cartilage Present,Central Nervous System Mesenchymal Chondrosarcoma
21291,Pain,Central Nervous System Mesenchymal Chondrosarcoma
21292,Hyaline Cartilage Differentiation,Central Nervous System Mesenchymal Chondrosarcoma
21293,Benign Cellular Infiltrate,Fallopian Tube Metaplastic Papillary Tumor
21294,Benign Cellular Infiltrate,estrogen-producing adrenal cortical adenoma
21295,Metastatic Lesion,Metastatic Malignant Germ Cell Tumor
21296,Benign Cellular Infiltrate,Cervical Blue Nevus
21297,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8
21298,Benign Cellular Infiltrate,Peripheral Odontogenic Fibroma
21299,Locally Aggressive Lesion,Central Nervous System Desmoid-Type Fibromatosis
21300,Benign Cellular Infiltrate,Benign neoplasm of vulva
21301,Benign Cellular Infiltrate,Ameloblastic fibroma
21302,Benign Cellular Infiltrate,Pyogenic granuloma of oral mucosa
21303,Epithelial Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage
21304,Primary Lesion,Recurrent Combined Thymic Epithelial Neoplasm
21305,Benign Cellular Infiltrate,Benign Ovarian Sex Cord-Stromal Tumor
21306,Benign Cellular Infiltrate,Vulvar Acquired Melanocytic Nevus
21307,Benign Cellular Infiltrate,Benign squamous cell tumor
21308,Benign Cellular Infiltrate,Rete Ovarii Cystadenoma
21309,CD30-Positive Neoplastic Cells Present,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive"
21310,Benign Cellular Infiltrate,Genital rhabdomyoma
21311,Benign Cellular Infiltrate,Borderline Ovarian Endometrioid Cystadenofibroma
21312,Pseudorosette Formation,Rosette-forming glioneuronal neoplasm
21313,S-100-Positive Neoplastic Cells Present,Central Nervous System Langerhans Cell Histiocytosis
21314,Multilayered Rosette Formation,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified"
21315,Epithelial Component Present,Urothelial carcinoma urethra recurrent
21316,Benign Cellular Infiltrate,Benign Childhood Cerebral Neoplasm
21317,Benign Cellular Infiltrate,Benign Intraocular Medulloepithelioma
21318,Heterologous Elements Present,Benign Intraocular Teratoid Medulloepithelioma
21319,Indolent Clinical Course,Soft Palate Benign Granular Cell Tumor
21320,Benign Cellular Infiltrate,Benign Infratentorial Neoplasms
21321,C19MC Amplification,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
21322,Indolent Clinical Course,Ameloblastic fibrodentinoma
21323,Benign Cellular Infiltrate,Vaginal Rhabdomyoma
21324,Skin Ulcer,Epstein Barr virus positive mucocutaneous ulcer
21325,Cervical lymphadenopathy,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
21326,Epithelial Component Present,Sertoli Cell Tumor
21327,Epithelial Component Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified"
21328,Nuclear Expression of STAT6 Protein,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
21329,Benign Cellular Infiltrate,Inverting papilloma of the nasal cavity
21330,Primary Lesion,Hepatocellular Carcinoma by BCLC Stage
21331,Benign Cellular Infiltrate,Choroid Plexus Papilloma
21332,Epithelial Component Present,Well Differentiated Ovarian Steroid Cell Tumor
21333,Monocytosis,Chronic Myelomonocytic Leukemia-0
21334,Blasts Under 20 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-0
21335,Primary Lesion,Localized Resectable Adult Hepatocellular Carcinoma
21336,Primary Lesion,Localized Unresectable Adult Hepatocellular Carcinoma
21337,Primary Lesion,Recurrent Childhood Anaplastic Oligodendroglioma
21338,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
21339,Erythroid hyperplasia,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
21340,Benign Cellular Infiltrate,Benign tumor of lacrimal drainage structure
21341,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition
21342,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma
21343,Benign Cellular Infiltrate,Benign Ovarian Clear Cell Tumor
21344,Benign Cellular Infiltrate,Adenoma of Minor Vestibular Glands
21345,Benign Cellular Infiltrate,Inverted Papilloma
21346,Epithelial Component Present,basaloid squamous cell carcinoma of floor of mouth
21347,Heterologous Elements Present,Intraocular Teratoid Medulloepithelioma
21348,Benign Cellular Infiltrate,Papillary craniopharyngioma
21349,C19MC Amplification,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
21350,Slow Growing Mass,Sacral Chordoma
21351,Metastatic Lesion,Advanced Favorable Non-Hodgkin Lymphoma
21352,Benign Cellular Infiltrate,Odontogenic myxofibroma
21353,Microvascular Proliferation,MGMT-Unmethylated Glioblastoma
21354,Infiltrative Growth Pattern,MGMT-Unmethylated Glioblastoma
21355,High Grade Lesion,MGMT-Unmethylated Glioblastoma
21356,Benign Cellular Infiltrate,Pineocytoma
21357,Benign Cellular Infiltrate,Breast Papillomatosis
21358,Benign Cellular Infiltrate,Bladder Squamous Papilloma
21359,Indolent Clinical Course,Benign neoplasm of base of tongue
21360,Epithelial Component Present,Malignant Ovarian Thecoma
21361,Benign Cellular Infiltrate,Ovarian Cellular Fibroma
21362,Benign Cellular Infiltrate,Adenoma of lung
21363,Indolent Clinical Course,Benign neoplasm of tongue
21364,Benign Cellular Infiltrate,Atypical polypoid adenomyoma
21365,Unfavorable Clinical Outcome,Ph-Like Acute Lymphoblastic Leukemia
21366,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage
21367,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8
21368,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8
21369,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8
21370,Epithelial Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8
21371,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8
21372,Vascular Channel Formation,Recurrent Breast Angiosarcoma
21373,Secondary Lesion,Locally Advanced Malignant Solid Neoplasm
21374,Carcinomatous Component Present,Stage IV Laryngeal Cancer AJCC v8
21375,Carcinomatous Component Present,Stage IVA Laryngeal Cancer AJCC v8
21376,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v8 Stage
21377,Clinical TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
21378,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
21379,Clinical TNM Finding,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
21380,Epithelial Component Present,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
21381,Carcinomatous Component Present,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
21382,Carcinomatous Component Present,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
21383,Epithelial Component Present,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
21384,Carcinomatous Component Present,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
21385,Epithelial Component Present,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
21386,Carcinomatous Component Present,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
21387,Pathologic TNM Finding,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
21388,Epithelial Component Present,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
21389,Pathologic TNM Finding,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
21390,Pathologic TNM Finding,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
21391,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
21392,Carcinomatous Component Present,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
21393,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
21394,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
21395,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
21396,Recurrent disease,Recurrent Atypical Teratoid/Rhabdoid Tumor
21397,Metastatic Lesion,Breast Carcinoma Metastatic in the Central Nervous System
21398,Secondary Lesion,Melanoma Metastatic in the Central Nervous System
21399,Epithelial Component Present,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
21400,Epithelial Component Present,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
21401,Carcinomatous Component Present,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
21402,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
21403,Epithelial Component Present,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
21404,Carcinomatous Component Present,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
21405,Pathologic TNM Finding,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
21406,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
21407,Dysplasia,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
21408,Clinical TNM Finding,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
21409,Clinical TNM Finding,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
21410,Epithelial Component Present,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
21411,Carcinomatous Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
21412,Clinical TNM Finding,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
21413,Pathologic TNM Finding,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
21414,Carcinomatous Component Present,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
21415,Epithelial Component Present,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
21416,Carcinomatous Component Present,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21417,Epithelial Component Present,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
21418,Carcinomatous Component Present,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
21419,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21420,Epithelial Component Present,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
21421,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
21422,Epithelial Component Present,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
21423,Epithelial Component Present,Clinical Stage II Gastric Cancer AJCC v8
21424,Epithelial Component Present,Clinical Stage IV Gastric Cancer AJCC v8
21425,Pathologic TNM Finding,Pathologic Stage I Gastric Cancer AJCC v8
21426,Pathologic TNM Finding,Pathologic Stage IA Gastric Cancer AJCC v8
21427,Carcinomatous Component Present,Pathologic Stage IA Gastric Cancer AJCC v8
21428,Epithelial Component Present,Pathologic Stage II Gastric Cancer AJCC v8
21429,Carcinomatous Component Present,Pathologic Stage III Gastric Cancer AJCC v8
21430,Carcinomatous Component Present,Pathologic Stage IIIA Gastric Cancer AJCC v8
21431,Pathologic TNM Finding,Pathologic Stage IIIC Gastric Cancer AJCC v8
21432,Epithelial Component Present,Pathologic Stage IIIC Gastric Cancer AJCC v8
21433,Carcinomatous Component Present,Pathologic Stage IIIC Gastric Cancer AJCC v8
21434,Carcinomatous Component Present,Pathologic Stage IV Gastric Cancer AJCC v8
21435,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
21436,Epithelial Component Present,Clinical Stage IIA Gastric Cancer AJCC v8
21437,Clinical TNM Finding,Clinical Stage IIB Gastric Cancer AJCC v8
21438,Carcinomatous Component Present,Clinical Stage IIB Gastric Cancer AJCC v8
21439,Carcinomatous Component Present,Recurrent Head and Neck Squamous Cell Carcinoma
21440,Refractory Disease,Refractory Classic Hodgkin Lymphoma
21441,Carcinomatous Component Present,Stage I Anal Cancer AJCC v8
21442,Epithelial Component Present,Stage IIA Anal Cancer AJCC v8
21443,Epithelial Component Present,Stage IIB Anal Cancer AJCC v8
21444,Carcinomatous Component Present,Stage IIB Anal Cancer AJCC v8
21445,Epithelial Component Present,Stage IV Anal Cancer AJCC v8
21446,Epithelial Component Present,Stage I Small Intestinal Adenocarcinoma AJCC v8
21447,Epithelial Component Present,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
21448,Carcinomatous Component Present,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
21449,Carcinomatous Component Present,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
21450,Well Differentiated Lesion,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
21451,Carcinomatous Component Present,Stage I Appendix Carcinoma AJCC v8
21452,Carcinomatous Component Present,Stage II Appendix Carcinoma AJCC v8
21453,Epithelial Component Present,Stage IIA Appendix Carcinoma AJCC v8
21454,Epithelial Component Present,Stage IIIA Appendix Carcinoma AJCC v8
21455,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v8
21456,Carcinomatous Component Present,Stage IVC Appendix Carcinoma AJCC v8
21457,Polymorphic Cellular Infiltrate,Recurrent Langerhans Cell Histiocytosis
21458,S-100-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis
21459,Polymorphic Cellular Infiltrate,Refractory Langerhans Cell Histiocytosis
21460,Refractory Disease,Refractory Langerhans Cell Histiocytosis
21461,S-100-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis
21462,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v8
21463,Epithelial Component Present,Stage IIB Colon Cancer AJCC v8
21464,Epithelial Component Present,Stage III Colon Cancer AJCC v8
21465,Carcinomatous Component Present,Stage I Rectal Cancer AJCC v8
21466,Epithelial Component Present,Stage IIB Rectal Cancer AJCC v8
21467,Carcinomatous Component Present,Stage IIIB Rectal Cancer AJCC v8
21468,Refractory Disease,Acute myeloid leukemia refractory
21469,Epithelial Component Present,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
21470,Epithelial Component Present,Stage IB Hepatocellular Carcinoma AJCC v8
21471,Primary Lesion,Stage III Hepatocellular Carcinoma AJCC v8
21472,Primary Lesion,Stage IVB Hepatocellular Carcinoma AJCC v8
21473,Epithelial Component Present,Stage IVB Hepatocellular Carcinoma AJCC v8
21474,Carcinomatous Component Present,Stage IVB Hepatocellular Carcinoma AJCC v8
21475,Epithelial Component Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
21476,Carcinomatous Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
21477,Epithelial Component Present,Stage II Intrahepatic Bile Duct Cancer AJCC v8
21478,Carcinomatous Component Present,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
21479,Epithelial Component Present,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
21480,In Situ Lesion,Stage 0 Gallbladder Cancer AJCC v8
21481,Absence of Invasion,Stage 0 Gallbladder Cancer AJCC v8
21482,Epithelial Component Present,Stage 0 Gallbladder Cancer AJCC v8
21483,Carcinomatous Component Present,Stage IIA Gallbladder Cancer AJCC v8
21484,Carcinomatous Component Present,Stage IIB Gallbladder Cancer AJCC v8
21485,Epithelial Component Present,Stage IVB Gallbladder Cancer AJCC v8
21486,Carcinomatous Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v8
21487,Epithelial Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
21488,Epithelial Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
21489,Epithelial Component Present,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
21490,Carcinomatous Component Present,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
21491,Fibrotic Stroma Formation,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
21492,Epithelial Component Present,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
21493,Carcinomatous Component Present,Distal Bile Duct Cancer by AJCC v8 Stage
21494,Epithelial Component Present,Stage I Distal Bile Duct Cancer AJCC v8
21495,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8
21496,Recurrent disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia
21497,Philadelphia chromosome negative,Refractory Ph-Like Acute Lymphoblastic Leukemia
21498,Refractory Disease,Refractory Ph-Like Acute Lymphoblastic Leukemia
21499,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v8
21500,Carcinomatous Component Present,Stage I Pancreatic Cancer AJCC v8
21501,Epithelial Component Present,Stage IB Pancreatic Cancer AJCC v8
21502,Carcinomatous Component Present,Stage IIB Pancreatic Cancer AJCC v8
21503,Carcinomatous Component Present,Non-squamous non-small cell lung cancer
21504,Neuroendocrine Differentiation,Gastric Neuroendocrine Tumor by AJCC v8 Stage
21505,Neuroendocrine Differentiation,Stage II Gastric Neuroendocrine Tumor AJCC v8
21506,Epithelial Component Present,Stage II Gastric Neuroendocrine Tumor AJCC v8
21507,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage
21508,Epithelial Component Present,Stage II Jejunal Neuroendocrine Tumor AJCC v8
21509,Neuroendocrine Differentiation,Stage IV Jejunal Neuroendocrine Tumor AJCC v8
21510,Low Mitotic Activity,Ileal Neuroendocrine Tumor by AJCC v8 Stage
21511,Neuroendocrine Differentiation,Stage I Ileal Neuroendocrine Tumor AJCC v8
21512,Low Mitotic Activity,Stage II Ileal Neuroendocrine Tumor AJCC v8
21513,Neuroendocrine Differentiation,Stage IV Ileal Neuroendocrine Tumor AJCC v8
21514,Epithelial Component Present,Digestive System Neuroendocrine Tumor by AJCC v7 Stage
21515,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v7 Stage
21516,Low Mitotic Activity,Stage IV Appendix Neuroendocrine Tumor AJCC v8
21517,Low Mitotic Activity,Stage I Colorectal Neuroendocrine Tumor AJCC v8
21518,Low Mitotic Activity,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8
21519,Low Mitotic Activity,Rectal Neuroendocrine Tumor
21520,Epithelial Component Present,Colon Neuroendocrine Tumor by AJCC v8 Stage
21521,Neuroendocrine Differentiation,Stage I Colon Neuroendocrine Tumor AJCC v8
21522,Low Mitotic Activity,Stage IIB Colon Neuroendocrine Tumor AJCC v8
21523,Neuroendocrine Differentiation,Stage IIIB Colon Neuroendocrine Tumor AJCC v8
21524,Neuroendocrine Differentiation,Rectal Neuroendocrine Tumor by AJCC v8 Stage
21525,Low Mitotic Activity,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage
21526,Epithelial Component Present,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage
21527,Epithelial Component Present,Stage III Pancreatic Neuroendocrine Tumor AJCC v8
21528,Low Mitotic Activity,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
21529,Metastatic Lesion,Rectal Carcinoma Metastatic in the Liver
21530,Secondary Lesion,Rectal Carcinoma Metastatic in the Liver
21531,Epithelial Component Present,Stage IA2 Lung Cancer AJCC v8
21532,Carcinomatous Component Present,Stage II Lung Cancer AJCC v8
21533,Epithelial Component Present,Stage IIB Lung Cancer AJCC v8
21534,Epithelial Component Present,Stage IV Lung Cancer AJCC v8
21535,High Mitotic Activity,Lung Small Cell Carcinoma by AJCC v7 Stage
21536,Recurrent disease,Recurrent Anaplastic Astrocytoma
21537,Increased Cellularity Present,Recurrent Anaplastic Astrocytoma
21538,Refractory Disease,Refractory Diffuse Intrinsic Pontine Glioma
21539,Epithelial Component Present,keratinizing squamous cell carcinoma of lung
21540,Absence of Invasion,Lung Non-Mucinous Adenocarcinoma In Situ
21541,Severe dysplasia,Lung Non-Mucinous Adenocarcinoma In Situ
21542,Lepidic Growth Pattern,Lung Mucinous Adenocarcinoma In Situ
21543,More than 5 Mitoses per 50HPF,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage"
21544,More than 5 Mitoses per 50HPF,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
21545,atypia morphology,Atypical Spitz Nevus
21546,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v7 Stage
21547,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Stage
21548,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
21549,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
21550,High Mitotic Activity,Clinical Stage I Merkel Cell Carcinoma AJCC v8
21551,Single Cell Necrosis,Clinical Stage I Merkel Cell Carcinoma AJCC v8
21552,Cutaneous Involvement,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
21553,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
21554,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
21555,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
21556,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
21557,Pathologic TNM Finding,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
21558,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
21559,Cutaneous Involvement,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
21560,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
21561,Cutaneous Involvement,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
21562,Neuroendocrine Differentiation,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
21563,Neuroendocrine Differentiation,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
21564,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
21565,Cutaneous Involvement,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
21566,Cutaneous Involvement,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
21567,Single Cell Necrosis,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
21568,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
21569,Unfavorable Clinical Outcome,Intermediate Atypical Prostate Carcinoma
21570,Metastatic Lesion,Intermediate Atypical Prostate Carcinoma
21571,Epithelial Component Present,Intermediate Atypical Prostate Carcinoma
21572,Clinical TNM Finding,Clinical Stage 0 Cutaneous Melanoma AJCC v8
21573,Cutaneous Involvement,Clinical Stage I Cutaneous Melanoma AJCC v8
21574,Cutaneous Involvement,Clinical Stage IA Cutaneous Melanoma AJCC v8
21575,Clinical TNM Finding,Clinical Stage IIA Cutaneous Melanoma AJCC v8
21576,Clinical TNM Finding,Clinical Stage IIB Cutaneous Melanoma AJCC v8
21577,Pathologic TNM Finding,Pathologic Stage II Cutaneous Melanoma AJCC v8
21578,Pathologic TNM Finding,Pathologic Stage IIB Cutaneous Melanoma AJCC v8
21579,Cutaneous Involvement,Pathologic Stage IIC Cutaneous Melanoma AJCC v8
21580,Refractory Disease,Refractory Anal Carcinoma
21581,Carcinomatous Component Present,Refractory Anal Carcinoma
21582,Severe cytologic atypia,Refractory Pancreatic Neuroendocrine Carcinoma
21583,Recurrent disease,Recurrent Extranodal Diffuse Large B-cell Lymphoma
21584,Refractory Disease,Refractory Extranodal Diffuse Large B-cell Lymphoma
21585,Recurrent disease,Recurrent Testicular Lymphoma
21586,Primary Lesion,Recurrent Testicular Lymphoma
21587,Refractory Disease,Refractory Testicular Lymphoma
21588,Refractory Disease,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
21589,Carcinomatous Component Present,Prostate Carcinoma by Gene Expression Profile
21590,Epithelial Component Present,Luminal B Prostate Carcinoma
21591,Carcinomatous Component Present,Luminal B Prostate Carcinoma
21592,Neuroendocrine Differentiation,Refractory Abdominal Neuroendocrine Neoplasm
21593,Diffuse Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
21594,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Double expressor lymphoma
21595,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Recurrent High Risk Myelodysplastic Syndrome
21596,Bone Marrow Dysplasia Present,Recurrent High Risk Myelodysplastic Syndrome
21597,Ineffective hematopoiesis,Refractory High Risk Myelodysplastic Syndrome
21598,Anaplasia,Breast implant-associated anaplastic large cell lymphoma
21599,Nuclear pleomorphism,Type D Lymphomatoid Papulosis
21600,Cutaneous Involvement,Primary cutaneous acral CD8 positive T-cell lymphoma
21601,Epithelial Component Present,Anal Ectopic Fibroadenoma
21602,Epithelial Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
21603,Mixed Cellular Population,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
21604,Epithelial Component Present,Prognostic Stage I Breast Cancer AJCC v8
21605,Carcinomatous Component Present,Prognostic Stage IB Breast Cancer AJCC v8
21606,Carcinomatous Component Present,Prognostic Stage II Breast Cancer AJCC v8
21607,Carcinomatous Component Present,Prognostic Stage IIIA Breast Cancer AJCC v8
21608,Carcinomatous Component Present,Stage II Vulvar Cancer AJCC v8
21609,Peribronchial and Lobular Septal Involvement Only,Follicular Bronchitis/Bronchiolitis
21610,Poorly Differentiated Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
21611,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma
21612,Increased red cell mass,"Polycythemia Vera, Polycythemic Phase"
21613,Extramedullary Hematopoiesis (disorder),Post polycythaemia vera myelofibrosis
21614,Splenomegaly,Overt Primary Myelofibrosis
21615,EBV-Positive Neoplastic Cells Present,Hydroa vacciniforme-like lymphoma
21616,Multifocal Lesion,Erdheim-Chester Disease
21617,Poorly Differentiated Lesion,Large cell lung cancer stage II
21618,Poorly Differentiated Lesion,Stage IA Lung Large Cell Carcinoma AJCC v7
21619,Poorly Differentiated Lesion,Stage IIA Lung Large Cell Carcinoma AJCC v7
21620,Complete Spontaneous Regression,Type B Lymphomatoid Papulosis
21621,Diffuse Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified"
21622,Monoclonal Cellular Population Present,Monoclonal B-Cell Lymphocytosis
21623,Secondary Lesion,Metastatic Adrenal Gland Pheochromocytoma
21624,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma recurrent
21625,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage III
21626,Poorly Differentiated Lesion,Large cell lung cancer recurrent
21627,Low Mitotic Activity,Stage IV Digestive System Neuroendocrine Tumor AJCC v7
21628,Intermediate Filaments Present,Extrarenal Rhabdoid Tumor of the Liver
21629,Clinical TNM Finding,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage
21630,Dysplasia,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
21631,Cutaneous Involvement,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
21632,Epithelial Component Present,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
21633,Clinical TNM Finding,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
21634,Clinical TNM Finding,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
21635,Carcinomatous Component Present,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
21636,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
21637,Absence of Invasion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
21638,Severe dysplasia,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
21639,Pathologic TNM Finding,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
21640,Carcinomatous Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
21641,Pathologic TNM Finding,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
21642,Carcinomatous Component Present,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
21643,Epithelial Component Present,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
21644,Epithelial Component Present,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
21645,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
21646,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
21647,Pathologic TNM Finding,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
21648,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
21649,Epithelial Component Present,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
21650,Carcinomatous Component Present,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
21651,Clinical TNM Finding,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
21652,Epithelial Component Present,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
21653,Epithelial Component Present,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
21654,Epithelial Component Present,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
21655,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
21656,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
21657,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
21658,Epithelial Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
21659,Epithelial Component Present,Breast Carcinoma Metastatic in the Central Nervous System
21660,Epithelial Component Present,Lung Carcinoma Metastatic in the Central Nervous System
21661,Pathologic TNM Finding,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
21662,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
21663,Pathologic TNM Finding,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
21664,Severe dysplasia,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
21665,Clinical TNM Finding,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
21666,Clinical TNM Finding,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21667,Epithelial Component Present,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21668,Pathologic TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
21669,Dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
21670,Pathologic TNM Finding,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
21671,Carcinomatous Component Present,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21672,Epithelial Component Present,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21673,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
21674,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
21675,Epithelial Component Present,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
21676,Clinical TNM Finding,Gastric Cancer by AJCC v8 Clinical Stage
21677,Epithelial Component Present,Gastric Cancer by AJCC v8 Clinical Stage
21678,Carcinomatous Component Present,Clinical Stage I Gastric Cancer AJCC v8
21679,Clinical TNM Finding,Clinical Stage II Gastric Cancer AJCC v8
21680,Carcinomatous Component Present,Clinical Stage II Gastric Cancer AJCC v8
21681,Carcinomatous Component Present,Pathologic Stage IB Gastric Cancer AJCC v8
21682,Pathologic TNM Finding,Pathologic Stage II Gastric Cancer AJCC v8
21683,Epithelial Component Present,Pathologic Stage IIA Gastric Cancer AJCC v8
21684,Epithelial Component Present,Pathologic Stage IIB Gastric Cancer AJCC v8
21685,Epithelial Component Present,Pathologic Stage III Gastric Cancer AJCC v8
21686,Pathologic TNM Finding,Pathologic Stage IV Gastric Cancer AJCC v8
21687,Epithelial Component Present,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
21688,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
21689,Epithelial Component Present,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
21690,Epithelial Component Present,Clinical Stage IIB Gastric Cancer AJCC v8
21691,Recurrent disease,Recurrent Head and Neck Squamous Cell Carcinoma
21692,Epithelial Component Present,Metastatic Paraganglioma
21693,Secondary Lesion,Locally Advanced Paraganglioma
21694,Carcinomatous Component Present,Small Intestinal Cancer by AJCC v7 Stage
21695,Refractory Disease,Refractory Primary Amyloidosis
21696,Immunoglobulin Deposition,Refractory Primary Amyloidosis
21697,Immunoglobulin Deposition,Recurrent Primary Amyloidosis
21698,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Recurrent Primary Amyloidosis
21699,Epithelial Component Present,Stage II Anal Cancer AJCC v8
21700,Secondary Lesion,Metastatic Digestive System Carcinoma
21701,Epithelial Component Present,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
21702,Carcinomatous Component Present,Stage 0 Appendix Carcinoma AJCC v8
21703,Epithelial Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
21704,Carcinomatous Component Present,Stage IIA Appendix Carcinoma AJCC v8
21705,Epithelial Component Present,Stage IIB Appendix Carcinoma AJCC v8
21706,Carcinomatous Component Present,Stage IIC Appendix Carcinoma AJCC v8
21707,Carcinomatous Component Present,Stage III Appendix Carcinoma AJCC v8
21708,Epithelial Component Present,Stage IV Appendix Carcinoma AJCC v8
21709,Refractory Disease,Refractory Neuroblastoma
21710,Recurrent disease,Recurrent Langerhans Cell Histiocytosis
21711,Birbeck Granules Present,Refractory Langerhans Cell Histiocytosis
21712,Absence of Invasion,Stage 0 Colorectal Cancer AJCC v8
21713,Severe dysplasia,Stage 0 Colorectal Cancer AJCC v8
21714,Epithelial Component Present,Stage I Colorectal Cancer AJCC v8
21715,Epithelial Component Present,Stage II Colorectal Cancer AJCC v8
21716,Carcinomatous Component Present,Stage II Colorectal Cancer AJCC v8
21717,Carcinomatous Component Present,Stage IIA Colorectal Cancer AJCC v8
21718,Carcinomatous Component Present,Stage III Colorectal Cancer AJCC v8
21719,Absence of Invasion,Stage 0 Colon Cancer AJCC v8
21720,Epithelial Component Present,Stage II Colon Cancer AJCC v8
21721,Carcinomatous Component Present,Stage IIB Colon Cancer AJCC v8
21722,Carcinomatous Component Present,Stage IIIB Colon Cancer AJCC v8
21723,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v8
21724,Carcinomatous Component Present,Stage IV Colon Cancer AJCC v8
21725,Carcinomatous Component Present,Stage IVA Colon Cancer AJCC v8
21726,Epithelial Component Present,Stage IVC Colon Cancer AJCC v8
21727,Epithelial Component Present,Stage IIIC Rectal Cancer AJCC v8
21728,Epithelial Component Present,Stage IVC Rectal Cancer AJCC v8
21729,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
21730,Primary Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v8
21731,Epithelial Component Present,Stage IIIA Hepatocellular Carcinoma AJCC v8
21732,Epithelial Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v8
21733,Carcinomatous Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v8
21734,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v8
21735,Carcinomatous Component Present,Stage IV Hepatocellular Carcinoma AJCC v8
21736,Carcinomatous Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8
21737,Epithelial Component Present,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
21738,Epithelial Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
21739,Carcinomatous Component Present,Stage II Intrahepatic Bile Duct Cancer AJCC v8
21740,Epithelial Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
21741,Severe dysplasia,Stage 0 Gallbladder Cancer AJCC v8
21742,Epithelial Component Present,Stage IIA Gallbladder Cancer AJCC v8
21743,Carcinomatous Component Present,Stage IVA Gallbladder Cancer AJCC v8
21744,Carcinomatous Component Present,Stage IVB Gallbladder Cancer AJCC v8
21745,Epithelial Component Present,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
21746,Carcinomatous Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v8
21747,Epithelial Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v8
21748,Carcinomatous Component Present,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
21749,Carcinomatous Component Present,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
21750,Carcinomatous Component Present,Distal Bile Duct Cancer by AJCC v7 Stage
21751,Epithelial Component Present,Stage IIIA Distal Bile Duct Cancer AJCC v8
21752,Carcinomatous Component Present,Stage IIIB Distal Bile Duct Cancer AJCC v8
21753,Epithelial Component Present,Eyelid Sebaceous Gland Carcinoma
21754,Sebaceous Differentiation,Eyelid Sebaceous Gland Carcinoma
21755,Adnexal Differentiation,Eyelid Sebaceous Gland Carcinoma
21756,BCR/ABL1 Fusion Negative,Recurrent Ph-Like Acute Lymphoblastic Leukemia
21757,Epithelial Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8
21758,Carcinomatous Component Present,Stage III Ampulla of Vater Cancer AJCC v8
21759,Epithelial Component Present,Stage IIIB Ampulla of Vater Cancer AJCC v8
21760,Epithelial Component Present,Stage IV Ampulla of Vater Cancer AJCC v8
21761,Epithelial Component Present,Pancreatic Cancer by AJCC v8 Stage
21762,Carcinomatous Component Present,Stage IB Pancreatic Cancer AJCC v8
21763,Epithelial Component Present,Stage IV Pancreatic Cancer AJCC v8
21764,Epithelial Component Present,Stage III Gastric Neuroendocrine Tumor AJCC v8
21765,Epithelial Component Present,Stage IV Gastric Neuroendocrine Tumor AJCC v8
21766,Epithelial Component Present,Stage II Duodenal Neuroendocrine Tumor AJCC v8
21767,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage
21768,Neuroendocrine Differentiation,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8
21769,Epithelial Component Present,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8
21770,Low Mitotic Activity,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8
21771,Epithelial Component Present,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8
21772,Low Mitotic Activity,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8
21773,Low Mitotic Activity,Stage II Jejunal Neuroendocrine Tumor AJCC v8
21774,Neuroendocrine Differentiation,Ileal Neuroendocrine Tumor by AJCC v8 Stage
21775,Epithelial Component Present,Ileal Neuroendocrine Tumor by AJCC v8 Stage
21776,Neuroendocrine Differentiation,Stage III Ileal Neuroendocrine Tumor AJCC v8
21777,Low Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v8 Stage
21778,Neuroendocrine Differentiation,Stage IV Appendix Neuroendocrine Tumor AJCC v8
21779,Epithelial Component Present,Stage IV Appendix Neuroendocrine Tumor AJCC v8
21780,Epithelial Component Present,Stage I Colorectal Neuroendocrine Tumor AJCC v8
21781,Low Mitotic Activity,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8
21782,Epithelial Component Present,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8
21783,Neuroendocrine Differentiation,Stage IV Colorectal Neuroendocrine Tumor AJCC v8
21784,Epithelial Component Present,Colon Neuroendocrine Tumor
21785,Epithelial Component Present,Rectal Neuroendocrine Tumor
21786,Epithelial Component Present,Stage IIA Rectal Neuroendocrine Tumor AJCC v8
21787,Low Mitotic Activity,Stage IV Rectal Neuroendocrine Tumor AJCC v8
21788,Epithelial Component Present,Occult Lung Cancer AJCC v8
21789,Epithelial Component Present,Stage IIA Lung Cancer AJCC v8
21790,Carcinomatous Component Present,Stage IIIC Lung Cancer AJCC v8
21791,Absence of Invasion,Lung Adenocarcinoma In Situ
21792,Multifocal Lesion,Refractory Erdheim-Chester Disease
21793,Carcinomatous Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage
21794,Primary Lesion,Refractory Diffuse Intrinsic Pontine Glioma
21795,Carcinomatous Component Present,Recurrent Cervical Adenocarcinoma
21796,Carcinomatous Component Present,Invasive Mucinous Lung Adenocarcinoma
21797,Glandular Pattern,Lung Enteric Adenocarcinoma
21798,In Situ Lesion,Lung Non-Mucinous Adenocarcinoma In Situ
21799,Carcinomatous Component Present,Lung Non-Mucinous Adenocarcinoma In Situ
21800,Epithelial Component Present,Lung Mucinous Adenocarcinoma In Situ
21801,More than 5 Mitoses per 50HPF,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
21802,Borderline Lesion,Atypical Spitz Nevus
21803,Clinical TNM Finding,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
21804,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
21805,Neuroendocrine Differentiation,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
21806,Single Cell Necrosis,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
21807,Neuroendocrine Differentiation,Clinical Stage III Merkel Cell Carcinoma AJCC v8
21808,Single Cell Necrosis,Clinical Stage III Merkel Cell Carcinoma AJCC v8
21809,Epithelial Component Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
21810,Cutaneous Involvement,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
21811,High Mitotic Activity,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
21812,Neuroendocrine Differentiation,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
21813,Neuroendocrine Differentiation,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
21814,Pathologic TNM Finding,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
21815,Single Cell Necrosis,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
21816,Recurrent disease,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma
21817,Aggressive Clinical Course,Intermediate Atypical Prostate Carcinoma
21818,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Clinical Stage
21819,Cutaneous Involvement,Pathologic Stage I Cutaneous Melanoma AJCC v8
21820,Cutaneous Involvement,Pathologic Stage IB Cutaneous Melanoma AJCC v8
21821,Pathologic TNM Finding,Pathologic Stage IIC Cutaneous Melanoma AJCC v8
21822,Pathologic TNM Finding,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
21823,Carcinomatous Component Present,Occult Breast Carcinoma
21824,Pathologic TNM Finding,Pathologic Stage IIID Cutaneous Melanoma AJCC v8
21825,Carcinomatous Component Present,Pleomorphic lobular carcinoma in situ of breast
21826,Recurrent disease,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
21827,Diffuse Pattern,Refractory Intravascular Large B-Cell Lymphoma
21828,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
21829,In Situ Lesion,In situ follicular neoplasia
21830,Diffuse Pattern,High grade B-cell lymphoma
21831,Diffuse Pattern,Double expressor lymphoma
21832,Aggressive Clinical Course,High Risk Myelodysplastic Syndrome
21833,Ineffective hematopoiesis,High Risk Myelodysplastic Syndrome
21834,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,Recurrent High Risk Myelodysplastic Syndrome
21835,Recurrent disease,Recurrent High Risk Myelodysplastic Syndrome
21836,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory High Risk Myelodysplastic Syndrome
21837,Bone Marrow Dysplasia Present,Refractory High Risk Myelodysplastic Syndrome
21838,Refractory Disease,Refractory High Risk Myelodysplastic Syndrome
21839,Neoplastic Cells with TFH Cell Phenotype Present,Nodal peripheral T-cell lymphoma with T follicular helper phenotype
21840,Complete Spontaneous Regression,Type D Lymphomatoid Papulosis
21841,Cutaneous Involvement,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement
21842,Immunologic Deficiency Syndromes,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder
21843,Carcinomatous Component Present,Breast Cancer by AJCC v8 Anatomic Stage
21844,Carcinomatous Component Present,Anatomic Stage 0 Breast Cancer AJCC v8
21845,Epithelial Component Present,Anatomic Stage II Breast Cancer AJCC v8
21846,Epithelial Component Present,Anatomic Stage IIIA Breast Cancer AJCC v8
21847,Absence of Invasion,Prognostic Stage 0 Breast Cancer AJCC v8
21848,Epithelial Component Present,Prognostic Stage IA Breast Cancer AJCC v8
21849,Carcinomatous Component Present,Prognostic Stage IA Breast Cancer AJCC v8
21850,Epithelial Component Present,Prognostic Stage III Breast Cancer AJCC v8
21851,Epithelial Component Present,Prognostic Stage IIIC Breast Cancer AJCC v8
21852,Carcinomatous Component Present,Prognostic Stage IIIC Breast Cancer AJCC v8
21853,Epithelial Component Present,Stage III Vulvar Cancer AJCC v8
21854,Epithelial Component Present,Stage IVB Vulvar Cancer AJCC v8
21855,Reactive Germinal Centers Present,Pulmonary nodular lymphoid hyperplasia
21856,Subcutaneous nodule,Subcutaneous panniculitis-like T-cell lymphoma
21857,Complete Spontaneous Regression,"lymphomatoid papulosis, type A"
21858,Minimal Invasion Present,"Bronchiolo-alveolar carcinoma, non-mucinous"
21859,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage I
21860,Diffuse Pattern,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified"
21861,Diffuse Immunoblastic Proliferation,Infectious Mononucleosis
21862,Epidermotropic Lymphocytic Infiltrate,Stage IA Mycosis Fungoides AJCC v7
21863,Pathologic TNM Finding,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage
21864,Clinical TNM Finding,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
21865,Pathologic TNM Finding,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
21866,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8
21867,Multinodular Mass,Recurrent Breast Angiosarcoma
21868,Regional Disease,Locally Advanced Malignant Solid Neoplasm
21869,Epithelial Component Present,Stage I Laryngeal Cancer AJCC v8
21870,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v8
21871,Metastatic Lesion,Metastatic Thyroid Gland Carcinoma
21872,Secondary Lesion,Metastatic Thyroid Gland Carcinoma
21873,Cutaneous Involvement,Cutaneous Squamous Cell Carcinoma of the Head and Neck
21874,Epithelial Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck
21875,Epithelial Component Present,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
21876,Clinical TNM Finding,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
21877,Epithelial Component Present,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
21878,Carcinomatous Component Present,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
21879,Clinical TNM Finding,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
21880,Epithelial Component Present,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
21881,Clinical TNM Finding,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
21882,In Situ Lesion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
21883,Epithelial Component Present,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
21884,Carcinomatous Component Present,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
21885,Epithelial Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
21886,Epithelial Component Present,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
21887,Carcinomatous Component Present,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
21888,Epithelial Component Present,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
21889,Carcinomatous Component Present,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
21890,Epithelial Component Present,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
21891,Epithelial Component Present,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
21892,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
21893,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
21894,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
21895,In Situ Lesion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
21896,Absence of Invasion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
21897,Severe dysplasia,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
21898,Clinical TNM Finding,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
21899,Clinical TNM Finding,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
21900,Carcinomatous Component Present,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
21901,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
21902,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
21903,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
21904,Metastatic Lesion,Lung Carcinoma Metastatic in the Central Nervous System
21905,Pathologic TNM Finding,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
21906,Pathologic TNM Finding,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
21907,Carcinomatous Component Present,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
21908,Epithelial Component Present,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
21909,Epithelial Component Present,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
21910,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
21911,Carcinomatous Component Present,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
21912,Epithelial Component Present,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
21913,Epithelial Component Present,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
21914,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
21915,Pathologic TNM Finding,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21916,Epithelial Component Present,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21917,Pathologic TNM Finding,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
21918,Epithelial Component Present,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
21919,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
21920,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
21921,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
21922,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
21923,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
21924,Epithelial Component Present,Clinical Stage 0 Gastric Cancer AJCC v8
21925,Epithelial Component Present,Clinical Stage I Gastric Cancer AJCC v8
21926,Carcinomatous Component Present,Clinical Stage IVB Gastric Cancer AJCC v8
21927,Epithelial Component Present,Pathologic Stage IB Gastric Cancer AJCC v8
21928,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
21929,Nerve palsy,Brown-Vialetto-Van Laere Syndrome 1
21930,Carcinomatous Component Present,Stage II Anal Cancer AJCC v8
21931,Carcinomatous Component Present,Stage IIIA Anal Cancer AJCC v8
21932,Epithelial Component Present,Stage IIIC Anal Cancer AJCC v8
21933,Metastatic Lesion,Metastatic Digestive System Carcinoma
21934,Carcinomatous Component Present,Stage I Small Intestinal Adenocarcinoma AJCC v8
21935,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v8
21936,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v8
21937,Epithelial Component Present,Stage III Appendix Carcinoma AJCC v8
21938,Carcinomatous Component Present,Stage IVB Appendix Carcinoma AJCC v8
21939,Recurrent disease,Recurrent Lymphoma
21940,Monoclonal Langerhans Cells Present,Recurrent Langerhans Cell Histiocytosis
21941,Epithelial Component Present,Stage IIB Colorectal Cancer AJCC v8
21942,Epithelial Component Present,Stage III Colorectal Cancer AJCC v8
21943,Epithelial Component Present,Stage IVB Colorectal Cancer AJCC v8
21944,Epithelial Component Present,Stage 0 Colon Cancer AJCC v8
21945,Carcinomatous Component Present,Stage IIIA Colon Cancer AJCC v8
21946,Epithelial Component Present,Stage IIIC Colon Cancer AJCC v8
21947,Epithelial Component Present,Stage II Rectal Cancer AJCC v8
21948,Epithelial Component Present,Stage IIA Rectal Cancer AJCC v8
21949,Epithelial Component Present,Stage IVA Rectal Cancer AJCC v8
21950,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v8 Stage
21951,Carcinomatous Component Present,Stage IB Hepatocellular Carcinoma AJCC v8
21952,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v8
21953,Carcinomatous Component Present,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
21954,Carcinomatous Component Present,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
21955,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v8
21956,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v8
21957,Epithelial Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v8
21958,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v8
21959,Carcinomatous Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
21960,Carcinomatous Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
21961,Epithelial Component Present,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
21962,Fibrotic Stroma Formation,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
21963,Epithelial Component Present,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
21964,Epithelial Component Present,Distal Bile Duct Cancer by AJCC v8 Stage
21965,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8
21966,Carcinomatous Component Present,Stage I Distal Bile Duct Cancer AJCC v8
21967,Carcinomatous Component Present,Stage II Distal Bile Duct Cancer AJCC v8
21968,Epithelial Component Present,Stage IIB Distal Bile Duct Cancer AJCC v8
21969,Carcinomatous Component Present,Stage IIB Distal Bile Duct Cancer AJCC v8
21970,Epithelial Component Present,Stage III Distal Bile Duct Cancer AJCC v8
21971,Epithelial Component Present,Stage IIIB Distal Bile Duct Cancer AJCC v8
21972,Carcinomatous Component Present,Eyelid Sebaceous Gland Carcinoma
21973,BCR/ABL1 Fusion Negative,Refractory Ph-Like Acute Lymphoblastic Leukemia
21974,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v8 Stage
21975,Carcinomatous Component Present,Stage IIIA Ampulla of Vater Cancer AJCC v8
21976,Carcinomatous Component Present,Pancreatic Cancer by AJCC v8 Stage
21977,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v8
21978,Low Mitotic Activity,Gastric Neuroendocrine Tumor by AJCC v8 Stage
21979,Epithelial Component Present,Stage I Gastric Neuroendocrine Tumor AJCC v8
21980,Neuroendocrine Differentiation,Duodenal Neuroendocrine Tumor
21981,Neuroendocrine Differentiation,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8
21982,Epithelial Component Present,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8
21983,Neuroendocrine Differentiation,Stage I Jejunal Neuroendocrine Tumor AJCC v8
21984,Epithelial Component Present,Stage III Jejunal Neuroendocrine Tumor AJCC v8
21985,Epithelial Component Present,Stage IV Jejunal Neuroendocrine Tumor AJCC v8
21986,Epithelial Component Present,Stage I Ileal Neuroendocrine Tumor AJCC v8
21987,Epithelial Component Present,Stage III Ileal Neuroendocrine Tumor AJCC v8
21988,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor by AJCC v7 Stage
21989,Low Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v7 Stage
21990,Low Mitotic Activity,Stage II Appendix Neuroendocrine Tumor AJCC v8
21991,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor by AJCC v8 Stage
21992,Neuroendocrine Differentiation,Stage I Colorectal Neuroendocrine Tumor AJCC v8
21993,Epithelial Component Present,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8
21994,Epithelial Component Present,Stage IIIB Colon Neuroendocrine Tumor AJCC v8
21995,Epithelial Component Present,Stage IV Colon Neuroendocrine Tumor AJCC v8
21996,Low Mitotic Activity,Rectal Neuroendocrine Tumor by AJCC v8 Stage
21997,Neuroendocrine Differentiation,Stage IIB Rectal Neuroendocrine Tumor AJCC v8
21998,Epithelial Component Present,Stage IIB Rectal Neuroendocrine Tumor AJCC v8
21999,Neuroendocrine Differentiation,Stage II Pancreatic Neuroendocrine Tumor AJCC v8
22000,Carcinomatous Component Present,Rectal Carcinoma Metastatic in the Liver
22001,Epithelial Component Present,Stage III Thymoma AJCC v8
22002,Epithelial Component Present,Stage IV Thymoma AJCC v8
22003,Epithelial Component Present,Stage IVA Thymoma AJCC v8
22004,Epithelial Component Present,Stage IA1 Lung Cancer AJCC v8
22005,Epithelial Component Present,Stage IB Lung Cancer AJCC v8
22006,Carcinomatous Component Present,Stage IIA Lung Cancer AJCC v8
22007,Carcinomatous Component Present,Stage III Lung Cancer AJCC v8
22008,Epithelial Component Present,Stage IIIA Lung Cancer AJCC v8
22009,Epithelial Component Present,Stage IIIB Lung Cancer AJCC v8
22010,Epithelial Component Present,Stage IVA Lung Cancer AJCC v8
22011,Carcinomatous Component Present,Stage IVA Lung Cancer AJCC v8
22012,High Grade Lesion,Lung Small Cell Carcinoma by AJCC v7 Stage
22013,Nuclear Atypia,Recurrent Anaplastic Astrocytoma
22014,Primary Lesion,Recurrent Anaplastic Astrocytoma
22015,Childhood Lesion,Recurrent Diffuse Intrinsic Pontine Glioma
22016,Primary Lesion,Osteosarcoma by AJCC v7 Stage
22017,Epithelial Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
22018,Carcinomatous Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
22019,Epithelial Component Present,Lung Enteric Adenocarcinoma
22020,Epithelial Component Present,Lung Non-Keratinizing Squamous Cell Carcinoma
22021,Absence of Invasion,Lung Squamous Cell Carcinoma In Situ
22022,Epithelial Component Present,Lung Squamous Cell Carcinoma In Situ
22023,More than 5 Mitoses per 50HPF,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
22024,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v7 Stage
22025,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
22026,Epithelial Component Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22027,Single Cell Necrosis,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22028,Single Cell Necrosis,Clinical Stage II Merkel Cell Carcinoma AJCC v8
22029,High Mitotic Activity,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
22030,Neuroendocrine Differentiation,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
22031,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
22032,Clinical TNM Finding,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
22033,Epithelial Component Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
22034,Clinical TNM Finding,Clinical Stage III Merkel Cell Carcinoma AJCC v8
22035,Carcinomatous Component Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8
22036,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8
22037,Neuroendocrine Differentiation,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
22038,Carcinomatous Component Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
22039,Pathologic TNM Finding,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
22040,Carcinomatous Component Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
22041,Single Cell Necrosis,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
22042,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
22043,Cutaneous Involvement,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
22044,Single Cell Necrosis,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
22045,High Mitotic Activity,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
22046,Carcinomatous Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
22047,Single Cell Necrosis,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
22048,High Mitotic Activity,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
22049,Epithelial Component Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
22050,Carcinomatous Component Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
22051,Low Mitotic Activity,Intermediate Atypical Prostate Carcinoma
22052,Castration Resistance,Intermediate Atypical Prostate Carcinoma
22053,Cutaneous Involvement,Clinical Stage IIA Cutaneous Melanoma AJCC v8
22054,Clinical TNM Finding,Clinical Stage IIC Cutaneous Melanoma AJCC v8
22055,Cutaneous Involvement,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
22056,Pathologic TNM Finding,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
22057,Absence of Invasion,Pleomorphic lobular carcinoma in situ of breast
22058,Poorly Differentiated Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
22059,Epithelial Component Present,Refractory Pancreatic Neuroendocrine Carcinoma
22060,Morphologic Overlap,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
22061,Diffuse Pattern,Refractory Extranodal Diffuse Large B-cell Lymphoma
22062,Primary Lesion,Recurrent Central Nervous System Lymphoma
22063,Refractory Disease,Refractory Central Nervous System Lymphoma
22064,Diffuse Pattern,Recurrent Intravascular Large B-Cell Lymphoma
22065,Primary Lesion,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
22066,Diffuse Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
22067,Diffuse Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion
22068,Aggressive Clinical Course,Recurrent High Risk Myelodysplastic Syndrome
22069,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent High Risk Myelodysplastic Syndrome
22070,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,Refractory High Risk Myelodysplastic Syndrome
22071,Favorable Clinical Outcome,Type D Lymphomatoid Papulosis
22072,Cutaneous Involvement,Type D Lymphomatoid Papulosis
22073,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis
22074,Favorable Clinical Outcome,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement
22075,Complete Spontaneous Regression,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement
22076,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract
22077,Immunosuppression-Related Post-Transplant Toxicity,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder
22078,Extensive Stage Lesion,Advanced Head and Neck Squamous Cell Carcinoma
22079,Secondary Lesion,Advanced Head and Neck Squamous Cell Carcinoma
22080,Carcinomatous Component Present,Anatomic Stage I Breast Cancer AJCC v8
22081,Carcinomatous Component Present,Anatomic Stage IB Breast Cancer AJCC v8
22082,Epithelial Component Present,Anatomic Stage III Breast Cancer AJCC v8
22083,Carcinomatous Component Present,Anatomic Stage III Breast Cancer AJCC v8
22084,Carcinomatous Component Present,Anatomic Stage IIIC Breast Cancer AJCC v8
22085,Biphasic Pattern,Anal Ectopic Fibroadenoma
22086,Benign Cellular Infiltrate,Anal Ectopic Fibroadenoma
22087,Epithelial Component Present,Prognostic Stage 0 Breast Cancer AJCC v8
22088,Severe dysplasia,Prognostic Stage 0 Breast Cancer AJCC v8
22089,Epithelial Component Present,Prognostic Stage II Breast Cancer AJCC v8
22090,Epithelial Component Present,Prognostic Stage IIIA Breast Cancer AJCC v8
22091,Epithelial Component Present,Prognostic Stage IV Breast Cancer AJCC v8
22092,Carcinomatous Component Present,Prognostic Stage IV Breast Cancer AJCC v8
22093,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v8
22094,Nodular Pattern,Pulmonary nodular lymphoid hyperplasia
22095,Erythroid hyperplasia,"Polycythemia Vera, Polycythemic Phase"
22096,Poorly Differentiated Lesion,Large cell carcinoma of lung
22097,Poorly Differentiated Lesion,Stage IIIA Lung Large Cell Carcinoma AJCC v7
22098,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage III
22099,Secondary Lesion,Small intestine carcinoma metastatic
22100,Poorly Differentiated Lesion,Large cell lung cancer stage IV
22101,Clinical TNM Finding,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
22102,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage
22103,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8
22104,Carcinomatous Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8
22105,Carcinomatous Component Present,Laryngeal Cancer by AJCC v8 Stage
22106,Cutaneous Involvement,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22107,Dysplasia,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
22108,Epithelial Component Present,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
22109,Clinical TNM Finding,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
22110,Carcinomatous Component Present,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
22111,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v7 Stage
22112,Dysplasia,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
22113,Pathologic TNM Finding,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
22114,Pathologic TNM Finding,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
22115,Pathologic TNM Finding,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
22116,Pathologic TNM Finding,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
22117,Epithelial Component Present,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
22118,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
22119,Carcinomatous Component Present,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
22120,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
22121,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
22122,Epithelial Component Present,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
22123,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
22124,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
22125,Epithelial Component Present,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
22126,Clinical TNM Finding,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
22127,Clinical TNM Finding,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
22128,Clinical TNM Finding,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
22129,Carcinomatous Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
22130,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
22131,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
22132,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
22133,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
22134,Nodular and Diffuse Pattern,Large B-cell lymphoma with IRF4 rearrangement
22135,Secondary Lesion,Breast Carcinoma Metastatic in the Central Nervous System
22136,Metastatic Lesion,Melanoma Metastatic in the Central Nervous System
22137,Absence of Invasion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
22138,Epithelial Component Present,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
22139,Carcinomatous Component Present,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
22140,Pathologic TNM Finding,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
22141,Carcinomatous Component Present,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
22142,Epithelial Component Present,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
22143,Pathologic TNM Finding,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
22144,Carcinomatous Component Present,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
22145,Clinical TNM Finding,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
22146,Clinical TNM Finding,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
22147,Absence of Invasion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
22148,Severe dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
22149,Carcinomatous Component Present,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
22150,Pathologic TNM Finding,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
22151,Carcinomatous Component Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
22152,Carcinomatous Component Present,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
22153,Pathologic TNM Finding,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
22154,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
22155,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
22156,Epithelial Component Present,Gastric Cancer by AJCC v8 Stage
22157,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Pathologic Stage
22158,Carcinomatous Component Present,Clinical Stage 0 Gastric Cancer AJCC v8
22159,Clinical TNM Finding,Clinical Stage IV Gastric Cancer AJCC v8
22160,Epithelial Component Present,Pathologic Stage 0 Gastric Cancer AJCC v8
22161,Epithelial Component Present,Pathologic Stage IA Gastric Cancer AJCC v8
22162,Carcinomatous Component Present,Pathologic Stage IIB Gastric Cancer AJCC v8
22163,Pathologic TNM Finding,Pathologic Stage III Gastric Cancer AJCC v8
22164,Pathologic TNM Finding,Pathologic Stage IIIA Gastric Cancer AJCC v8
22165,Epithelial Component Present,Pathologic Stage IIIA Gastric Cancer AJCC v8
22166,Epithelial Component Present,Small Intestinal Cancer by AJCC v7 Stage
22167,Carcinomatous Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage
22168,Carcinomatous Component Present,Stage IIIC Anal Cancer AJCC v8
22169,Absence of Invasion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
22170,Epithelial Component Present,Stage II Small Intestinal Adenocarcinoma AJCC v8
22171,Carcinomatous Component Present,Stage II Small Intestinal Adenocarcinoma AJCC v8
22172,Epithelial Component Present,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
22173,In Situ Lesion,Stage 0 Appendix Carcinoma AJCC v8
22174,Epithelial Component Present,Stage 0 Appendix Carcinoma AJCC v8
22175,Carcinomatous Component Present,Stage IVA Appendix Carcinoma AJCC v8
22176,Epithelial Component Present,Stage IVB Appendix Carcinoma AJCC v8
22177,Epithelial Component Present,Stage IVC Appendix Carcinoma AJCC v8
22178,Refractory Disease,Refractory Histiocytic and Dendritic Cell Neoplasm
22179,Birbeck Granules Present,Recurrent Langerhans Cell Histiocytosis
22180,Carcinomatous Component Present,Stage IIB Colorectal Cancer AJCC v8
22181,Epithelial Component Present,Stage IIIA Colorectal Cancer AJCC v8
22182,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v8
22183,Carcinomatous Component Present,Stage IIIB Colorectal Cancer AJCC v8
22184,Epithelial Component Present,Stage IV Colorectal Cancer AJCC v8
22185,Carcinomatous Component Present,Stage IVC Colorectal Cancer AJCC v8
22186,Epithelial Component Present,Colon Cancer by AJCC v8 Stage
22187,Epithelial Component Present,Rectal Cancer by AJCC v8 Stage
22188,Carcinomatous Component Present,Rectal Cancer by AJCC v8 Stage
22189,Carcinomatous Component Present,Stage II Colon Cancer AJCC v8
22190,Epithelial Component Present,Stage IIIB Colon Cancer AJCC v8
22191,Absence of Invasion,Stage 0 Rectal Cancer AJCC v8
22192,Carcinomatous Component Present,Stage 0 Rectal Cancer AJCC v8
22193,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v8
22194,Carcinomatous Component Present,Stage IIB Rectal Cancer AJCC v8
22195,Epithelial Component Present,Stage III Rectal Cancer AJCC v8
22196,Carcinomatous Component Present,Stage IIIC Rectal Cancer AJCC v8
22197,Carcinomatous Component Present,Stage IV Rectal Cancer AJCC v8
22198,Carcinomatous Component Present,Stage IVC Rectal Cancer AJCC v8
22199,Primary Lesion,Stage IB Hepatocellular Carcinoma AJCC v8
22200,Epithelial Component Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
22201,Epithelial Component Present,Stage III Intrahepatic Bile Duct Cancer AJCC v8
22202,Epithelial Component Present,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
22203,Carcinomatous Component Present,Stage II Gallbladder Cancer AJCC v8
22204,Epithelial Component Present,Stage IIB Gallbladder Cancer AJCC v8
22205,Epithelial Component Present,Stage II Hilar Cholangiocarcinoma AJCC v8
22206,Epithelial Component Present,Stage IV Hilar Cholangiocarcinoma AJCC v8
22207,Carcinomatous Component Present,Stage IV Hilar Cholangiocarcinoma AJCC v8
22208,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
22209,Carcinomatous Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
22210,Carcinomatous Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
22211,Fibrotic Stroma Formation,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
22212,Carcinomatous Component Present,Stage IIIA Distal Bile Duct Cancer AJCC v8
22213,Unfavorable Clinical Outcome,Recurrent Ph-Like Acute Lymphoblastic Leukemia
22214,In Situ Lesion,Stage 0 Ampulla of Vater Cancer AJCC v8
22215,Carcinomatous Component Present,Stage I Ampulla of Vater Cancer AJCC v8
22216,Carcinomatous Component Present,Stage II Ampulla of Vater Cancer AJCC v8
22217,Carcinomatous Component Present,Stage IV Ampulla of Vater Cancer AJCC v8
22218,Carcinomatous Component Present,Pancreatic Cancer by AJCC v6 and v7 Stage
22219,Carcinomatous Component Present,Stage IA Pancreatic Cancer AJCC v8
22220,Carcinomatous Component Present,Stage IV Pancreatic Cancer AJCC v8
22221,Epithelial Component Present,Non-squamous non-small cell lung cancer
22222,Epithelial Component Present,Gastric Neuroendocrine Tumor by AJCC v8 Stage
22223,Neuroendocrine Differentiation,Duodenal Neuroendocrine Tumor by AJCC v8 Stage
22224,Low Mitotic Activity,Stage I Duodenal Neuroendocrine Tumor AJCC v8
22225,Neuroendocrine Differentiation,Stage III Duodenal Neuroendocrine Tumor AJCC v8
22226,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage
22227,Neuroendocrine Differentiation,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8
22228,Epithelial Component Present,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8
22229,Low Mitotic Activity,Jejunal Neuroendocrine Tumor
22230,Low Mitotic Activity,Stage III Jejunal Neuroendocrine Tumor AJCC v8
22231,Low Mitotic Activity,Stage IV Ileal Neuroendocrine Tumor AJCC v8
22232,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v8 Stage
22233,Low Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v8
22234,Epithelial Component Present,Colorectal Neuroendocrine Tumor by AJCC v8 Stage
22235,Low Mitotic Activity,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8
22236,Neuroendocrine Differentiation,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8
22237,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor
22238,Neuroendocrine Differentiation,Rectal Neuroendocrine Tumor
22239,Low Mitotic Activity,Colon Neuroendocrine Tumor by AJCC v8 Stage
22240,Low Mitotic Activity,Stage IIA Colon Neuroendocrine Tumor AJCC v8
22241,Epithelial Component Present,Stage IIA Colon Neuroendocrine Tumor AJCC v8
22242,Low Mitotic Activity,Stage IIIA Colon Neuroendocrine Tumor AJCC v8
22243,Epithelial Component Present,Stage IIIA Colon Neuroendocrine Tumor AJCC v8
22244,Neuroendocrine Differentiation,Stage IV Colon Neuroendocrine Tumor AJCC v8
22245,Epithelial Component Present,Rectal Neuroendocrine Tumor by AJCC v8 Stage
22246,Epithelial Component Present,Stage I Rectal Neuroendocrine Tumor AJCC v8
22247,Low Mitotic Activity,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8
22248,Neuroendocrine Differentiation,Stage IV Rectal Neuroendocrine Tumor AJCC v8
22249,Low Mitotic Activity,Stage III Pancreatic Neuroendocrine Tumor AJCC v8
22250,Epithelial Component Present,Stage II Thymus Epithelial Neoplasm AJCC v8
22251,Epithelial Component Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8
22252,Epithelial Component Present,Stage IV Thymus Epithelial Neoplasm AJCC v8
22253,Epithelial Component Present,Stage IIIB Thymoma AJCC v8
22254,Cutaneous Involvement,Unresectable Head and Neck Squamous Cell Carcinoma
22255,Epithelial Component Present,Unresectable Head and Neck Squamous Cell Carcinoma
22256,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v8
22257,Carcinomatous Component Present,Stage I Lung Cancer AJCC v8
22258,Carcinomatous Component Present,Stage IA2 Lung Cancer AJCC v8
22259,Carcinomatous Component Present,Stage IIIB Lung Cancer AJCC v8
22260,Carcinomatous Component Present,Stage IVB Lung Cancer AJCC v8
22261,Carcinomatous Component Present,Lung Non-Small Cell Cancer by AJCC v7 Stage
22262,Epithelial Component Present,Lung Adenosquamous Carcinoma by AJCC v7 Stage
22263,Epithelial Component Present,Lung Squamous Cell Carcinoma by AJCC v7 Stage
22264,Peripheral Nuclear Palisading,Lung Small Cell Carcinoma by AJCC v7 Stage
22265,Anaplasia,Recurrent Anaplastic Astrocytoma
22266,Infiltrative Growth Pattern,Recurrent Anaplastic Astrocytoma
22267,Diffuse Lesion,Recurrent Diffuse Intrinsic Pontine Glioma
22268,Osseous Differentiation,Osteosarcoma by AJCC v7 Stage
22269,Invasive Lesion,Invasive Mucinous Lung Adenocarcinoma
22270,Carcinomatous Component Present,Lung Enteric Adenocarcinoma
22271,Carcinomatous Component Present,keratinizing squamous cell carcinoma of lung
22272,In Situ Lesion,Lung Mucinous Adenocarcinoma In Situ
22273,Carcinomatous Component Present,Lung Squamous Cell Carcinoma In Situ
22274,More than 5 Mitoses per 50HPF,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
22275,More than 5 Mitoses per 50HPF,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
22276,Cutaneous Involvement,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22277,Neuroendocrine Differentiation,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22278,Clinical TNM Finding,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22279,Carcinomatous Component Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22280,High Mitotic Activity,Clinical Stage II Merkel Cell Carcinoma AJCC v8
22281,Epithelial Component Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
22282,Epithelial Component Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8
22283,Neuroendocrine Differentiation,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
22284,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
22285,Epithelial Component Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
22286,High Mitotic Activity,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
22287,Pathologic TNM Finding,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
22288,Carcinomatous Component Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
22289,Cutaneous Involvement,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
22290,Pathologic TNM Finding,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
22291,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
22292,Epithelial Component Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
22293,Carcinomatous Component Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
22294,Epithelial Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
22295,Carcinomatous Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
22296,Cutaneous Involvement,Clinical Stage 0 Cutaneous Melanoma AJCC v8
22297,Clinical TNM Finding,Clinical Stage I Cutaneous Melanoma AJCC v8
22298,Cutaneous Involvement,Clinical Stage IB Cutaneous Melanoma AJCC v8
22299,Clinical TNM Finding,Clinical Stage II Cutaneous Melanoma AJCC v8
22300,Cutaneous Involvement,Clinical Stage IIB Cutaneous Melanoma AJCC v8
22301,Pathologic TNM Finding,Cutaneous Melanoma by AJCC v8 Pathologic Stage
22302,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Pathologic Stage
22303,Cutaneous Involvement,Pathologic Stage IIA Cutaneous Melanoma AJCC v8
22304,Cutaneous Involvement,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
22305,Refractory Disease,Refractory Pancreatic Neuroendocrine Carcinoma
22306,Morphologic Overlap,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
22307,Extranodal Extension,Refractory Extranodal Diffuse Large B-cell Lymphoma
22308,Recurrent disease,Recurrent Breast Lymphoma
22309,Refractory Disease,Refractory Breast Lymphoma
22310,Refractory Disease,Refractory Intravascular Large B-Cell Lymphoma
22311,Diffuse Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
22312,Epithelial Component Present,Refractory Abdominal Neuroendocrine Neoplasm
22313,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,High Risk Myelodysplastic Syndrome
22314,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory High Risk Myelodysplastic Syndrome
22315,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by ISS Stage
22316,Epidermotropic Lymphocytic Infiltrate,Type D Lymphomatoid Papulosis
22317,Indolent Clinical Course,Primary cutaneous acral CD8 positive T-cell lymphoma
22318,Epithelial Component Present,Advanced Head and Neck Squamous Cell Carcinoma
22319,In Situ Lesion,Anatomic Stage 0 Breast Cancer AJCC v8
22320,Epithelial Component Present,Anatomic Stage I Breast Cancer AJCC v8
22321,Epithelial Component Present,Anatomic Stage IB Breast Cancer AJCC v8
22322,Epithelial Component Present,Anatomic Stage IIA Breast Cancer AJCC v8
22323,Carcinomatous Component Present,Anatomic Stage IIA Breast Cancer AJCC v8
22324,Epithelial Component Present,Anatomic Stage IIIB Breast Cancer AJCC v8
22325,Carcinomatous Component Present,Anatomic Stage IIIB Breast Cancer AJCC v8
22326,Mesenchymal Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
22327,Carcinomatous Component Present,Prognostic Stage 0 Breast Cancer AJCC v8
22328,Epithelial Component Present,Prognostic Stage IIA Breast Cancer AJCC v8
22329,Carcinomatous Component Present,Prognostic Stage IIA Breast Cancer AJCC v8
22330,Carcinomatous Component Present,Prognostic Stage III Breast Cancer AJCC v8
22331,Epithelial Component Present,Stage IA Vulvar Cancer AJCC v8
22332,Carcinomatous Component Present,Stage III Vulvar Cancer AJCC v8
22333,Carcinomatous Component Present,Stage IIIB Vulvar Cancer AJCC v8
22334,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v8
22335,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v8
22336,Chronic lymphocytic inflammation,Follicular Bronchitis/Bronchiolitis
22337,Cutaneous Involvement,Lymphomatoid Papulosis
22338,Hepatomegaly,Overt Primary Myelofibrosis
22339,Poorly Differentiated Lesion,"Lung Large Cell Carcinoma, Clear Cell Variant"
22340,Poorly Differentiated Lesion,Stage IIB Lung Large Cell Carcinoma AJCC v7
22341,Subcutaneous Involvement,Subcutaneous panniculitis-like T-cell lymphoma
22342,Poorly Differentiated Lesion,Lung Basaloid Large Cell Carcinoma
22343,Minimal Invasion Present,Minimally Invasive Mucinous Lung Adenocarcinoma
22344,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage II
22345,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage IV
22346,Low Mitotic Activity,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7
22347,Low Mitotic Activity,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
22348,Intracytoplasmic Eosinophilic Inclusion,Extrarenal Rhabdoid Tumor of the Liver
22349,Bone Marrow Involvement,Acute Adult T-Cell Leukemia/Lymphoma
22350,Pautrier-Like Microabscess Present,Acute Adult T-Cell Leukemia/Lymphoma
22351,BCR/ABL1 Fusion Negative,Ph-Like Acute Lymphoblastic Leukemia
22352,Multifocal Lesion,Central Nervous System Erdheim-Chester Disease
22353,Epidermotropic Lymphocytic Infiltrate,Stage IB Mycosis Fungoides AJCC v7
22354,Clinical TNM Finding,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
22355,Clinical TNM Finding,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
22356,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8
22357,Recurrent disease,Recurrent Breast Angiosarcoma
22358,Metastatic Lesion,Locally Advanced Malignant Solid Neoplasm
22359,Immunologic Deficiency Syndromes,AIDS-Related Anal Canal Carcinoma
22360,Carcinomatous Component Present,Stage I Laryngeal Cancer AJCC v8
22361,Epithelial Component Present,Stage II Laryngeal Cancer AJCC v8
22362,Carcinomatous Component Present,Stage III Laryngeal Cancer AJCC v8
22363,Carcinomatous Component Present,Stage IVB Laryngeal Cancer AJCC v8
22364,Carcinomatous Component Present,Stage IVC Laryngeal Cancer AJCC v8
22365,Epithelial Component Present,Squamous non-small cell lung cancer
22366,Cutaneous Involvement,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22367,Cutaneous Involvement,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22368,Epithelial Component Present,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22369,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Stage
22370,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
22371,Epithelial Component Present,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
22372,Epithelial Component Present,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
22373,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
22374,Carcinomatous Component Present,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
22375,Epithelial Component Present,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
22376,Carcinomatous Component Present,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
22377,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
22378,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
22379,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
22380,Epithelial Component Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
22381,Intermediate Filaments Present,Recurrent Atypical Teratoid/Rhabdoid Tumor
22382,Pathologic TNM Finding,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
22383,Carcinomatous Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
22384,Clinical TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
22385,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
22386,In Situ Lesion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
22387,Epithelial Component Present,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
22388,Carcinomatous Component Present,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
22389,Clinical TNM Finding,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
22390,Carcinomatous Component Present,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
22391,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
22392,Pathologic TNM Finding,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
22393,Epithelial Component Present,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
22394,Carcinomatous Component Present,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
22395,Epithelial Component Present,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
22396,Epithelial Component Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
22397,Epithelial Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
22398,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
22399,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
22400,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
22401,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
22402,Pathologic TNM Finding,Gastric Cancer by AJCC v8 Pathologic Stage
22403,In Situ Lesion,Clinical Stage 0 Gastric Cancer AJCC v8
22404,Absence of Invasion,Clinical Stage 0 Gastric Cancer AJCC v8
22405,Severe dysplasia,Clinical Stage 0 Gastric Cancer AJCC v8
22406,Clinical TNM Finding,Clinical Stage III Gastric Cancer AJCC v8
22407,Clinical TNM Finding,Clinical Stage IVB Gastric Cancer AJCC v8
22408,Carcinomatous Component Present,Pathologic Stage IIA Gastric Cancer AJCC v8
22409,Carcinomatous Component Present,Pathologic Stage IIIB Gastric Cancer AJCC v8
22410,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
22411,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
22412,Epithelial Component Present,Recurrent Head and Neck Squamous Cell Carcinoma
22413,Epithelial Component Present,Locally Advanced Paraganglioma
22414,Epithelial Component Present,Stage 0 Anal Cancer AJCC v8
22415,Epithelial Component Present,Stage IIIA Anal Cancer AJCC v8
22416,Carcinomatous Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
22417,Carcinomatous Component Present,Stage IV Small Intestinal Adenocarcinoma AJCC v8
22418,Carcinomatous Component Present,Stage IIIB Appendix Carcinoma AJCC v8
22419,Epithelial Component Present,Stage IIIC Appendix Carcinoma AJCC v8
22420,Carcinomatous Component Present,Stage IV Appendix Carcinoma AJCC v8
22421,Epithelial Component Present,Stage IVA Appendix Carcinoma AJCC v8
22422,Monoclonal Langerhans Cells Present,Refractory Langerhans Cell Histiocytosis
22423,CD1a-Positive Neoplastic Cells Present,Refractory Langerhans Cell Histiocytosis
22424,In Situ Lesion,Stage 0 Colorectal Cancer AJCC v8
22425,Carcinomatous Component Present,Stage IVA Colorectal Cancer AJCC v8
22426,Carcinomatous Component Present,Stage IVB Colorectal Cancer AJCC v8
22427,Carcinomatous Component Present,Stage IIA Colon Cancer AJCC v8
22428,Epithelial Component Present,Stage IIIA Colon Cancer AJCC v8
22429,Epithelial Component Present,Stage IVB Colon Cancer AJCC v8
22430,Carcinomatous Component Present,Stage IVB Colon Cancer AJCC v8
22431,Severe dysplasia,Stage 0 Rectal Cancer AJCC v8
22432,Carcinomatous Component Present,Stage IIA Rectal Cancer AJCC v8
22433,Carcinomatous Component Present,Stage IVA Rectal Cancer AJCC v8
22434,Primary Lesion,Hepatocellular Carcinoma by AJCC v8 Stage
22435,Carcinomatous Component Present,Stage I Hepatocellular Carcinoma AJCC v8
22436,Epithelial Component Present,Stage IA Hepatocellular Carcinoma AJCC v8
22437,Carcinomatous Component Present,Stage IIIA Hepatocellular Carcinoma AJCC v8
22438,Carcinomatous Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
22439,Carcinomatous Component Present,Gallbladder Cancer by AJCC v8 Stage
22440,Carcinomatous Component Present,Stage IIIA Gallbladder Cancer AJCC v8
22441,Epithelial Component Present,Hilar Cholangiocarcinoma by AJCC v7 Stage
22442,Epithelial Component Present,Hilar Cholangiocarcinoma by AJCC v8 Stage
22443,Carcinomatous Component Present,Stage III Hilar Cholangiocarcinoma AJCC v8
22444,Carcinomatous Component Present,Stage IVB Hilar Cholangiocarcinoma AJCC v8
22445,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
22446,Epithelial Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
22447,Carcinomatous Component Present,Stage III Distal Bile Duct Cancer AJCC v8
22448,Epithelial Component Present,Stage IV Distal Bile Duct Cancer AJCC v8
22449,Carcinomatous Component Present,Stage IV Distal Bile Duct Cancer AJCC v8
22450,Cutaneous Involvement,Eyelid Sebaceous Gland Carcinoma
22451,Carcinomatous Component Present,Ampulla of Vater Cancer by AJCC v7 Stage
22452,Absence of Invasion,Stage 0 Ampulla of Vater Cancer AJCC v8
22453,Epithelial Component Present,Stage IIB Ampulla of Vater Cancer AJCC v8
22454,Epithelial Component Present,Stage III Ampulla of Vater Cancer AJCC v8
22455,Epithelial Component Present,Stage IIIA Ampulla of Vater Cancer AJCC v8
22456,Low Mitotic Activity,Stage I Gastric Neuroendocrine Tumor AJCC v8
22457,Neuroendocrine Differentiation,Stage I Gastric Neuroendocrine Tumor AJCC v8
22458,Low Mitotic Activity,Stage II Gastric Neuroendocrine Tumor AJCC v8
22459,Neuroendocrine Differentiation,Stage III Gastric Neuroendocrine Tumor AJCC v8
22460,Low Mitotic Activity,Stage IV Gastric Neuroendocrine Tumor AJCC v8
22461,Low Mitotic Activity,Duodenal Neuroendocrine Tumor by AJCC v8 Stage
22462,Epithelial Component Present,Duodenal Neuroendocrine Tumor by AJCC v8 Stage
22463,Low Mitotic Activity,Stage II Duodenal Neuroendocrine Tumor AJCC v8
22464,Low Mitotic Activity,Stage IV Duodenal Neuroendocrine Tumor AJCC v8
22465,Low Mitotic Activity,Duodenal Neuroendocrine Tumor
22466,Low Mitotic Activity,Ileal Neuroendocrine Tumor
22467,Neuroendocrine Differentiation,Ileal Neuroendocrine Tumor
22468,Neuroendocrine Differentiation,Jejunal Neuroendocrine Tumor by AJCC v8 Stage
22469,Neuroendocrine Differentiation,Stage III Jejunal Neuroendocrine Tumor AJCC v8
22470,Low Mitotic Activity,Stage I Ileal Neuroendocrine Tumor AJCC v8
22471,Epithelial Component Present,Stage II Ileal Neuroendocrine Tumor AJCC v8
22472,Epithelial Component Present,Stage IV Ileal Neuroendocrine Tumor AJCC v8
22473,Low Mitotic Activity,Digestive System Neuroendocrine Tumor by AJCC v7 Stage
22474,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v8
22475,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v8
22476,Neuroendocrine Differentiation,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8
22477,Neuroendocrine Differentiation,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8
22478,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor by AJCC v8 Stage
22479,Neuroendocrine Differentiation,Stage IIA Colon Neuroendocrine Tumor AJCC v8
22480,Neuroendocrine Differentiation,Stage IIIA Colon Neuroendocrine Tumor AJCC v8
22481,Low Mitotic Activity,Stage IIIB Colon Neuroendocrine Tumor AJCC v8
22482,Low Mitotic Activity,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8
22483,Epithelial Component Present,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8
22484,Neuroendocrine Differentiation,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8
22485,Epithelial Component Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8
22486,Hyperplastic Tissue Present,Hyperplasia of Brunner glands of duodenum
22487,Epithelial Component Present,Rectal Carcinoma Metastatic in the Liver
22488,Epithelial Component Present,Thymus Epithelial Neoplasm by AJCC v8 Stage
22489,Epithelial Component Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8
22490,Epithelial Component Present,Stage IIIA Thymoma AJCC v8
22491,Epithelial Component Present,Stage IVB Thymoma AJCC v8
22492,Carcinomatous Component Present,Occult Lung Cancer AJCC v8
22493,Epithelial Component Present,Stage 0 Lung Cancer AJCC v8
22494,Epithelial Component Present,Stage IA3 Lung Cancer AJCC v8
22495,Epithelial Component Present,Stage II Lung Cancer AJCC v8
22496,Epithelial Component Present,Stage III Lung Cancer AJCC v8
22497,Epithelial Component Present,Stage IIIC Lung Cancer AJCC v8
22498,In Situ Lesion,Lung Adenocarcinoma In Situ
22499,Carcinomatous Component Present,Lung Adenocarcinoma In Situ
22500,Refractory Disease,Refractory Erdheim-Chester Disease
22501,Epithelial Component Present,Lung Adenocarcinoma by AJCC v7 Stage
22502,Epithelial Component Present,Lung Small Cell Carcinoma by AJCC v7 Stage
22503,More than 10 Mitoses per 10HPF,Lung Small Cell Carcinoma by AJCC v7 Stage
22504,Diffuse Pattern,Recurrent Anaplastic Astrocytoma
22505,Diffuse Pattern,Recurrent Diffuse Intrinsic Pontine Glioma
22506,Diffuse Lesion,Refractory Diffuse Intrinsic Pontine Glioma
22507,Epithelial Component Present,Invasive Mucinous Lung Adenocarcinoma
22508,Lepidic Growth Pattern,Lung Non-Mucinous Adenocarcinoma In Situ
22509,Absence of Invasion,Lung Mucinous Adenocarcinoma In Situ
22510,Severe dysplasia,Lung Mucinous Adenocarcinoma In Situ
22511,More than 5 Mitoses per 50HPF,Gastrointestinal Stromal Tumor by AJCC v8 Stage
22512,More than 5 Mitoses per 50HPF,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
22513,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v7 Stage
22514,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Stage
22515,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v8 Stage
22516,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
22517,High Mitotic Activity,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22518,Cutaneous Involvement,Clinical Stage I Merkel Cell Carcinoma AJCC v8
22519,High Mitotic Activity,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
22520,Cutaneous Involvement,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
22521,Cutaneous Involvement,Clinical Stage III Merkel Cell Carcinoma AJCC v8
22522,High Mitotic Activity,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
22523,Carcinomatous Component Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
22524,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
22525,Single Cell Necrosis,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
22526,Neuroendocrine Differentiation,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
22527,High Mitotic Activity,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
22528,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
22529,Cutaneous Involvement,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
22530,High Mitotic Activity,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
22531,Abundance of Small Lymphocytes,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma
22532,Clinical TNM Finding,Clinical Stage IA Cutaneous Melanoma AJCC v8
22533,Cutaneous Involvement,Clinical Stage IIC Cutaneous Melanoma AJCC v8
22534,Cutaneous Involvement,Pathologic Stage 0 Cutaneous Melanoma AJCC v8
22535,Cutaneous Involvement,Pathologic Stage II Cutaneous Melanoma AJCC v8
22536,Pathologic TNM Finding,Pathologic Stage IIA Cutaneous Melanoma AJCC v8
22537,Pathologic TNM Finding,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
22538,Severe dysplasia,Pleomorphic lobular carcinoma in situ of breast
22539,Refractory Disease,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
22540,Diffuse Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma
22541,Recurrent disease,Recurrent Central Nervous System Lymphoma
22542,Cutaneous Involvement,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
22543,Refractory Disease,Refractory Abdominal Neuroendocrine Neoplasm
22544,Bone Marrow Dysplasia Present,High Risk Myelodysplastic Syndrome
22545,CD30-Positive Neoplastic Cells Present,Breast implant-associated anaplastic large cell lymphoma
22546,Cutaneous Involvement,Type E Lymphomatoid Papulosis
22547,Acral Lesion,Primary cutaneous acral CD8 positive T-cell lymphoma
22548,CD8-Positive Neoplastic Cells Present,Primary cutaneous acral CD8 positive T-cell lymphoma
22549,Epithelial Component Present,Breast Cancer by AJCC v8 Stage
22550,Severe dysplasia,Anatomic Stage 0 Breast Cancer AJCC v8
22551,Epithelial Component Present,Anatomic Stage IIIC Breast Cancer AJCC v8
22552,Epithelial Component Present,Anatomic Stage IV Breast Cancer AJCC v8
22553,Epithelial Component Present,Perineal Ectopic Fibroadenoma
22554,Carcinomatous Component Present,Prognostic Stage IIB Breast Cancer AJCC v8
22555,Epithelial Component Present,Prognostic Stage IIIB Breast Cancer AJCC v8
22556,Carcinomatous Component Present,Vulvar Cancer by AJCC v8 Stage
22557,Epithelial Component Present,Stage IB Vulvar Cancer AJCC v8
22558,Epithelial Component Present,Stage IIIB Vulvar Cancer AJCC v8
22559,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v8
22560,Diffuse Cellular Infiltrate,Lymphoid interstitial pneumonia
22561,Solitary mass,Bronchioloalveolar Adenocarcinoma
22562,Lymphoplasmacytic Infiltrate,Pulmonary nodular lymphoid hyperplasia
22563,Emperipolesis,Sinus histiocytosis
22564,Diffuse Pattern,Diffuse Blastoid B-Cell Lymphoma
22565,Neoplastic Cells with TFH Cell Phenotype Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma
22566,Intermediate Filaments Present,Extrarenal rhabdoid tumor
22567,Poorly Differentiated Lesion,Stage IB Lung Large Cell Carcinoma AJCC v7
22568,Intracytoplasmic Eosinophilic Inclusion,Childhood Atypical Teratoid/Rhabdoid Tumor
22569,Intracytoplasmic Eosinophilic Inclusion,Atypical Teratoid Rhabdoid Tumor
22570,Rimming of Adipose Tissue Cells Present,Subcutaneous panniculitis-like T-cell lymphoma
22571,Complete Spontaneous Regression,"lymphomatoid papulosis, type C"
22572,Solitary mass,Minimally Invasive Mucinous Lung Adenocarcinoma
22573,Solitary mass,"Bronchiolo-alveolar carcinoma, non-mucinous"
22574,Poorly Differentiated Lesion,Large cell lung cancer stage III
22575,Cutaneous Involvement,Acute Adult T-Cell Leukemia/Lymphoma
22576,Pathologic TNM Finding,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
22577,Epithelial Component Present,Lung Adenofibroma
22578,Mesenchymal Component Present,Lung Adenofibroma
22579,Epithelial Component Present,AIDS-Related Anal Canal Carcinoma
22580,Epithelial Component Present,Stage IVC Laryngeal Cancer AJCC v8
22581,Dysplasia,Oral Intraepithelial Neoplasia
22582,Cutaneous Involvement,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage
22583,Epithelial Component Present,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22584,Severe dysplasia,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22585,Carcinomatous Component Present,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22586,Carcinomatous Component Present,Esophageal Cancer by AJCC v8 Stage
22587,In Situ Lesion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
22588,Absence of Invasion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
22589,Carcinomatous Component Present,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
22590,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v7 Stage
22591,Carcinomatous Component Present,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
22592,Pathologic TNM Finding,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
22593,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
22594,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
22595,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
22596,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
22597,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
22598,Carcinomatous Component Present,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
22599,Epithelial Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
22600,Clinical TNM Finding,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
22601,Clinical TNM Finding,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
22602,Epithelial Component Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
22603,Epithelial Component Present,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
22604,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
22605,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
22606,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
22607,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Central Nervous System
22608,Dysplasia,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
22609,Pathologic TNM Finding,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
22610,Severe dysplasia,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
22611,Carcinomatous Component Present,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
22612,Epithelial Component Present,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
22613,Epithelial Component Present,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
22614,Carcinomatous Component Present,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
22615,Carcinomatous Component Present,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
22616,Epithelial Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
22617,Epithelial Component Present,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
22618,Pathologic TNM Finding,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
22619,Epithelial Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
22620,Carcinomatous Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
22621,Carcinomatous Component Present,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
22622,Epithelial Component Present,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
22623,Epithelial Component Present,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
22624,Carcinomatous Component Present,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
22625,Postneoadjuvant Therapy Pathologic TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
22626,Epithelial Component Present,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
22627,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
22628,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
22629,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
22630,Recurrent disease,Recurrent Classic Hodgkin Lymphoma
22631,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Clinical Stage
22632,Clinical TNM Finding,Clinical Stage I Gastric Cancer AJCC v8
22633,Carcinomatous Component Present,Clinical Stage IVA Gastric Cancer AJCC v8
22634,Epithelial Component Present,Clinical Stage IVB Gastric Cancer AJCC v8
22635,In Situ Lesion,Pathologic Stage 0 Gastric Cancer AJCC v8
22636,Absence of Invasion,Pathologic Stage 0 Gastric Cancer AJCC v8
22637,Severe dysplasia,Pathologic Stage 0 Gastric Cancer AJCC v8
22638,Epithelial Component Present,Pathologic Stage I Gastric Cancer AJCC v8
22639,Pathologic TNM Finding,Pathologic Stage IIA Gastric Cancer AJCC v8
22640,Pathologic TNM Finding,Pathologic Stage IIIB Gastric Cancer AJCC v8
22641,Epithelial Component Present,Pathologic Stage IV Gastric Cancer AJCC v8
22642,Secondary Lesion,Metastatic Paraganglioma
22643,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Refractory Primary Amyloidosis
22644,Refractory Disease,Refractory Malignant Solid Neoplasm
22645,Epithelial Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage
22646,Carcinomatous Component Present,Stage 0 Anal Cancer AJCC v8
22647,Carcinomatous Component Present,Stage IIA Anal Cancer AJCC v8
22648,Carcinomatous Component Present,Stage III Anal Cancer AJCC v8
22649,Epithelial Component Present,Stage IIIB Anal Cancer AJCC v8
22650,Epithelial Component Present,Small Intestinal Adenocarcinoma by AJCC v8 Stage
22651,Epithelial Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
22652,Carcinomatous Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
22653,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v8
22654,Epithelial Component Present,Stage IIIB Appendix Carcinoma AJCC v8
22655,Refractory Disease,Refractory Lymphoma
22656,CD1a-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis
22657,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v8
22658,Epithelial Component Present,Stage IIIC Colorectal Cancer AJCC v8
22659,Carcinomatous Component Present,Stage III Colon Cancer AJCC v8
22660,Epithelial Component Present,Stage IV Colon Cancer AJCC v8
22661,Epithelial Component Present,Stage IVA Colon Cancer AJCC v8
22662,Epithelial Component Present,Stage IIC Rectal Cancer AJCC v8
22663,Carcinomatous Component Present,Stage III Rectal Cancer AJCC v8
22664,Epithelial Component Present,Stage IIIA Rectal Cancer AJCC v8
22665,Epithelial Component Present,Stage IIIB Rectal Cancer AJCC v8
22666,Epithelial Component Present,Stage IV Rectal Cancer AJCC v8
22667,Epithelial Component Present,Stage IVB Rectal Cancer AJCC v8
22668,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v8
22669,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
22670,Primary Lesion,Stage I Hepatocellular Carcinoma AJCC v8
22671,Primary Lesion,Stage IA Hepatocellular Carcinoma AJCC v8
22672,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v8
22673,Primary Lesion,Stage IVA Hepatocellular Carcinoma AJCC v8
22674,Carcinomatous Component Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
22675,Carcinomatous Component Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
22676,Carcinomatous Component Present,Stage III Intrahepatic Bile Duct Cancer AJCC v8
22677,Epithelial Component Present,Gallbladder Cancer by AJCC v8 Stage
22678,Carcinomatous Component Present,Stage 0 Gallbladder Cancer AJCC v8
22679,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v8
22680,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v8
22681,Epithelial Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
22682,Carcinomatous Component Present,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
22683,Fibrotic Stroma Formation,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
22684,Fibrotic Stroma Formation,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
22685,Carcinomatous Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8
22686,Severe dysplasia,Stage 0 Ampulla of Vater Cancer AJCC v8
22687,Epithelial Component Present,Stage I Ampulla of Vater Cancer AJCC v8
22688,Epithelial Component Present,Stage IB Ampulla of Vater Cancer AJCC v8
22689,Carcinomatous Component Present,Stage IIA Ampulla of Vater Cancer AJCC v8
22690,In Situ Lesion,Stage 0 Pancreatic Cancer AJCC v8
22691,Carcinomatous Component Present,Stage IIA Pancreatic Cancer AJCC v8
22692,Carcinomatous Component Present,Stage III Pancreatic Cancer AJCC v8
22693,Low Mitotic Activity,Stage III Gastric Neuroendocrine Tumor AJCC v8
22694,Epithelial Component Present,Stage I Duodenal Neuroendocrine Tumor AJCC v8
22695,Epithelial Component Present,Duodenal Neuroendocrine Tumor
22696,Neuroendocrine Differentiation,Jejunal Neuroendocrine Tumor
22697,Low Mitotic Activity,Stage I Jejunal Neuroendocrine Tumor AJCC v8
22698,Epithelial Component Present,Stage I Jejunal Neuroendocrine Tumor AJCC v8
22699,Low Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v8
22700,Epithelial Component Present,Stage I Appendix Neuroendocrine Tumor AJCC v8
22701,Neuroendocrine Differentiation,Stage III Appendix Neuroendocrine Tumor AJCC v8
22702,Epithelial Component Present,Stage III Appendix Neuroendocrine Tumor AJCC v8
22703,Neuroendocrine Differentiation,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8
22704,Epithelial Component Present,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8
22705,Epithelial Component Present,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8
22706,Epithelial Component Present,Stage IV Colorectal Neuroendocrine Tumor AJCC v8
22707,Low Mitotic Activity,Colon Neuroendocrine Tumor
22708,Epithelial Component Present,Stage I Colon Neuroendocrine Tumor AJCC v8
22709,Neuroendocrine Differentiation,Stage IIB Colon Neuroendocrine Tumor AJCC v8
22710,Low Mitotic Activity,Stage IV Colon Neuroendocrine Tumor AJCC v8
22711,Neuroendocrine Differentiation,Stage I Rectal Neuroendocrine Tumor AJCC v8
22712,Neuroendocrine Differentiation,Stage IIA Rectal Neuroendocrine Tumor AJCC v8
22713,Neuroendocrine Differentiation,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8
22714,Epithelial Component Present,Stage I Pancreatic Neuroendocrine Tumor AJCC v8
22715,Neuroendocrine Differentiation,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
22716,Epithelial Component Present,Stage I Thymus Epithelial Neoplasm AJCC v8
22717,Epithelial Component Present,Stage IIIB Thymus Epithelial Neoplasm AJCC v8
22718,Epithelial Component Present,Stage IVA Thymus Epithelial Neoplasm AJCC v8
22719,Epithelial Component Present,Stage II Thymoma AJCC v8
22720,Carcinomatous Component Present,Unresectable Head and Neck Squamous Cell Carcinoma
22721,Epithelial Component Present,Lung Cancer by AJCC v8 Stage
22722,Carcinomatous Component Present,Stage IA1 Lung Cancer AJCC v8
22723,Carcinomatous Component Present,Stage IB Lung Cancer AJCC v8
22724,Carcinomatous Component Present,Stage IIIA Lung Cancer AJCC v8
22725,Severe dysplasia,Lung Adenocarcinoma In Situ
22726,Carcinomatous Component Present,Lung Adenosquamous Carcinoma by AJCC v7 Stage
22727,Epithelial Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage
22728,Carcinomatous Component Present,Lung Squamous Cell Carcinoma by AJCC v7 Stage
22729,Carcinomatous Component Present,Lung Small Cell Carcinoma by AJCC v7 Stage
22730,High Grade Lesion,Recurrent Anaplastic Astrocytoma
22731,Diffuse Pattern,Refractory Diffuse Intrinsic Pontine Glioma
22732,Childhood Lesion,Refractory Diffuse Intrinsic Pontine Glioma
22733,Carcinomatous Component Present,Lung Non-Keratinizing Squamous Cell Carcinoma
22734,Epithelial Component Present,Lung Non-Mucinous Adenocarcinoma In Situ
22735,Carcinomatous Component Present,Lung Mucinous Adenocarcinoma In Situ
22736,In Situ Lesion,Lung Squamous Cell Carcinoma In Situ
22737,More than 5 Mitoses per 50HPF,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
22738,More than 5 Mitoses per 50HPF,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
22739,Cutaneous Involvement,Atypical Spitz Nevus
22740,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v7 Stage
22741,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v8 Stage
22742,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v8 Stage
22743,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
22744,Clinical TNM Finding,Clinical Stage I Merkel Cell Carcinoma AJCC v8
22745,Epithelial Component Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8
22746,Carcinomatous Component Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8
22747,Epithelial Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8
22748,Carcinomatous Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8
22749,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8
22750,Clinical TNM Finding,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
22751,Epithelial Component Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
22752,Single Cell Necrosis,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
22753,Single Cell Necrosis,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
22754,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
22755,Neuroendocrine Differentiation,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
22756,Clinical TNM Finding,Cutaneous Melanoma by AJCC v8 Clinical Stage
22757,Clinical TNM Finding,Clinical Stage IB Cutaneous Melanoma AJCC v8
22758,Cutaneous Involvement,Pathologic Stage IA Cutaneous Melanoma AJCC v8
22759,Cutaneous Involvement,Pathologic Stage IIB Cutaneous Melanoma AJCC v8
22760,Epithelial Component Present,Occult Breast Carcinoma
22761,Cutaneous Involvement,Pathologic Stage IV Cutaneous Melanoma AJCC v8
22762,In Situ Lesion,Pleomorphic lobular carcinoma in situ of breast
22763,Dysplasia,Pleomorphic lobular carcinoma in situ of breast
22764,Epithelial Component Present,Refractory Anal Carcinoma
22765,Extranodal Extension,Recurrent Extranodal Diffuse Large B-cell Lymphoma
22766,Primary Lesion,Recurrent Breast Lymphoma
22767,Epithelial Component Present,Prostate Carcinoma by Gene Expression Profile
22768,Epithelial Component Present,Basal-Like Prostate Carcinoma
22769,Carcinomatous Component Present,Basal-Like Prostate Carcinoma
22770,Favorable Clinical Outcome,Duodenal-type follicular lymphoma
22771,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,High Risk Myelodysplastic Syndrome
22772,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,High Risk Myelodysplastic Syndrome
22773,Aggressive Clinical Course,Refractory High Risk Myelodysplastic Syndrome
22774,Refractory Disease,Refractory Soft Tissue Sarcoma
22775,Recurrent disease,Recurrent Soft Tissue Sarcoma
22776,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by DS Stage
22777,Angioinvasion,Type E Lymphomatoid Papulosis
22778,Cutaneous Involvement,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract
22779,EBV-Positive Neoplastic Cells Present,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
22780,Absence of Invasion,Anatomic Stage 0 Breast Cancer AJCC v8
22781,Carcinomatous Component Present,Anatomic Stage IA Breast Cancer AJCC v8
22782,Mesenchymal Component Present,Anal Ectopic Fibroadenoma
22783,Mesenchymal Component Present,Perineal Ectopic Fibroadenoma
22784,Biphasic Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
22785,Benign Cellular Infiltrate,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
22786,In Situ Lesion,Prognostic Stage 0 Breast Cancer AJCC v8
22787,Carcinomatous Component Present,Prognostic Stage I Breast Cancer AJCC v8
22788,Carcinomatous Component Present,Prognostic Stage IIIB Breast Cancer AJCC v8
22789,Carcinomatous Component Present,Stage IA Vulvar Cancer AJCC v8
22790,Epithelial Component Present,Stage IIIA Vulvar Cancer AJCC v8
22791,Carcinomatous Component Present,Stage IIIA Vulvar Cancer AJCC v8
22792,Carcinomatous Component Present,Stage IVA Vulvar Cancer AJCC v8
22793,Carcinomatous Component Present,Stage IVB Vulvar Cancer AJCC v8
22794,Chronic lymphocytic inflammation,Lymphoid interstitial pneumonia
22795,Minimal Invasion Present,Bronchioloalveolar Adenocarcinoma
22796,Nodular Pattern,Follicular Bronchitis/Bronchiolitis
22797,Plasma cell inflammation,Sinus histiocytosis
22798,Hepatomegaly,Post polycythaemia vera myelofibrosis
22799,Poorly Differentiated Lesion,Occult Lung Large Cell Carcinoma
22800,Lymphocyte count increased,Monoclonal B-Cell Lymphocytosis
22801,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides recurrent
22802,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor of the Kidney
22803,Poorly Differentiated Lesion,Large cell lung cancer stage I
22804,Low Mitotic Activity,Stage I Digestive System Neuroendocrine Tumor AJCC v7
22805,Diffuse Pattern,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified"
22806,Atypical Lymphocytes Present in Peripheral Blood,Infectious Mononucleosis
22807,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma
22808,Epithelial Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8
22809,Carcinomatous Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8
22810,Carcinomatous Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8
22811,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8
22812,Mixed Cellular Population,Lung Adenofibroma
22813,Hemorrhagic,Recurrent Breast Angiosarcoma
22814,Carcinomatous Component Present,AIDS-Related Anal Canal Carcinoma
22815,Epithelial Component Present,Laryngeal Cancer by AJCC v8 Stage
22816,Carcinomatous Component Present,Stage II Laryngeal Cancer AJCC v8
22817,Epithelial Component Present,Stage IV Laryngeal Cancer AJCC v8
22818,Epithelial Component Present,Stage IVA Laryngeal Cancer AJCC v8
22819,Epithelial Component Present,Oral Intraepithelial Neoplasia
22820,Epithelial Component Present,Metastatic Thyroid Gland Carcinoma
22821,Carcinomatous Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage
22822,Carcinomatous Component Present,Squamous non-small cell lung cancer
22823,In Situ Lesion,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22824,Carcinomatous Component Present,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22825,Carcinomatous Component Present,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22826,Cutaneous Involvement,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
22827,Epithelial Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
22828,Clinical TNM Finding,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
22829,Epithelial Component Present,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
22830,Pathologic TNM Finding,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
22831,Carcinomatous Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
22832,Carcinomatous Component Present,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
22833,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
22834,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
22835,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
22836,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
22837,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
22838,Epithelial Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
22839,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
22840,Postneoadjuvant Therapy Pathologic TNM Finding,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
22841,Carcinomatous Component Present,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
22842,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
22843,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
22844,Epithelial Component Present,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
22845,Intracytoplasmic Eosinophilic Inclusion,Recurrent Atypical Teratoid/Rhabdoid Tumor
22846,Carcinomatous Component Present,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
22847,Epithelial Component Present,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
22848,Absence of Invasion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
22849,Epithelial Component Present,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
22850,Carcinomatous Component Present,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
22851,Epithelial Component Present,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
22852,Carcinomatous Component Present,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
22853,Carcinomatous Component Present,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
22854,Pathologic TNM Finding,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
22855,Pathologic TNM Finding,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
22856,Carcinomatous Component Present,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
22857,Pathologic TNM Finding,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
22858,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
22859,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
22860,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Stage
22861,Epithelial Component Present,Gastric Cancer by AJCC v8 Pathologic Stage
22862,Epithelial Component Present,Clinical Stage III Gastric Cancer AJCC v8
22863,Carcinomatous Component Present,Clinical Stage III Gastric Cancer AJCC v8
22864,Clinical TNM Finding,Clinical Stage IVA Gastric Cancer AJCC v8
22865,Epithelial Component Present,Clinical Stage IVA Gastric Cancer AJCC v8
22866,Pathologic TNM Finding,Pathologic Stage 0 Gastric Cancer AJCC v8
22867,Carcinomatous Component Present,Pathologic Stage I Gastric Cancer AJCC v8
22868,Pathologic TNM Finding,Pathologic Stage IIB Gastric Cancer AJCC v8
22869,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
22870,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
22871,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
22872,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
22873,Clinical TNM Finding,Clinical Stage IIA Gastric Cancer AJCC v8
22874,Metastatic Lesion,Metastatic Paraganglioma
22875,Neuroendocrine Differentiation,Metastatic Paraganglioma
22876,Metastatic Lesion,Locally Advanced Paraganglioma
22877,"Amorphus, Eosinophilic, and Acellular Deposit",Refractory Primary Amyloidosis
22878,Fibrovascular Stroma Formation,Pterygium Of Conjunctiva And Cornea
22879,Benign Cellular Infiltrate,Pterygium Of Conjunctiva And Cornea
22880,Epithelial Component Present,Anal Cancer by AJCC v8 Stage
22881,Carcinomatous Component Present,Anal Cancer by AJCC v8 Stage
22882,In Situ Lesion,Stage 0 Anal Cancer AJCC v8
22883,Epithelial Component Present,Stage III Anal Cancer AJCC v8
22884,Carcinomatous Component Present,Stage IIIB Anal Cancer AJCC v8
22885,Epithelial Component Present,Metastatic Digestive System Carcinoma
22886,Carcinomatous Component Present,Small Intestinal Adenocarcinoma by AJCC v8 Stage
22887,Carcinomatous Component Present,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
22888,Severe dysplasia,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
22889,Carcinomatous Component Present,Appendix Carcinoma by AJCC v8 Stage
22890,Mucoid Stroma Formation,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
22891,Epithelial Component Present,Stage II Appendix Carcinoma AJCC v8
22892,Increased Cellularity Present,Refractory Neuroblastoma
22893,Neuroectodermal Differentiation,Refractory Neuroblastoma
22894,Recurrent disease,Recurrent Histiocytic and Dendritic Cell Neoplasm
22895,Carcinomatous Component Present,Stage 0 Colorectal Cancer AJCC v8
22896,Epithelial Component Present,Stage IIC Colorectal Cancer AJCC v8
22897,Carcinomatous Component Present,Stage IIIA Colorectal Cancer AJCC v8
22898,Epithelial Component Present,Stage IVC Colorectal Cancer AJCC v8
22899,In Situ Lesion,Stage 0 Colon Cancer AJCC v8
22900,Carcinomatous Component Present,Stage 0 Colon Cancer AJCC v8
22901,Epithelial Component Present,Stage I Colon Cancer AJCC v8
22902,Carcinomatous Component Present,Stage I Colon Cancer AJCC v8
22903,Epithelial Component Present,Stage IIC Colon Cancer AJCC v8
22904,Carcinomatous Component Present,Stage IIC Colon Cancer AJCC v8
22905,In Situ Lesion,Stage 0 Rectal Cancer AJCC v8
22906,Epithelial Component Present,Stage I Rectal Cancer AJCC v8
22907,Carcinomatous Component Present,Stage IIIA Rectal Cancer AJCC v8
22908,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v8 Stage
22909,Epithelial Component Present,Stage I Hepatocellular Carcinoma AJCC v8
22910,Primary Lesion,Stage II Hepatocellular Carcinoma AJCC v8
22911,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v8
22912,Carcinomatous Component Present,Stage III Hepatocellular Carcinoma AJCC v8
22913,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v8
22914,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8
22915,Epithelial Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8
22916,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v8
22917,Carcinomatous Component Present,Stage IIIB Gallbladder Cancer AJCC v8
22918,Carcinomatous Component Present,Stage IV Gallbladder Cancer AJCC v8
22919,Carcinomatous Component Present,Hilar Cholangiocarcinoma by AJCC v7 Stage
22920,Carcinomatous Component Present,Hilar Cholangiocarcinoma by AJCC v8 Stage
22921,Carcinomatous Component Present,Stage I Hilar Cholangiocarcinoma AJCC v8
22922,Epithelial Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
22923,Epithelial Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v8
22924,Carcinomatous Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
22925,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
22926,Epithelial Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
22927,Fibrotic Stroma Formation,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
22928,Fibrotic Stroma Formation,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
22929,Carcinomatous Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8
22930,Philadelphia chromosome negative,Recurrent Ph-Like Acute Lymphoblastic Leukemia
22931,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v7 Stage
22932,Epithelial Component Present,Stage IA Ampulla of Vater Cancer AJCC v8
22933,Carcinomatous Component Present,Stage IA Ampulla of Vater Cancer AJCC v8
22934,Carcinomatous Component Present,Stage IB Ampulla of Vater Cancer AJCC v8
22935,Carcinomatous Component Present,Stage IIB Ampulla of Vater Cancer AJCC v8
22936,Carcinomatous Component Present,Stage IIIB Ampulla of Vater Cancer AJCC v8
22937,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v8
22938,Carcinomatous Component Present,Stage II Pancreatic Cancer AJCC v8
22939,Epithelial Component Present,Stage IIA Pancreatic Cancer AJCC v8
22940,Epithelial Component Present,Stage IIB Pancreatic Cancer AJCC v8
22941,Epithelial Component Present,Stage III Pancreatic Cancer AJCC v8
22942,Neuroendocrine Differentiation,Stage IV Gastric Neuroendocrine Tumor AJCC v8
22943,Neuroendocrine Differentiation,Stage II Duodenal Neuroendocrine Tumor AJCC v8
22944,Neuroendocrine Differentiation,Stage IV Duodenal Neuroendocrine Tumor AJCC v8
22945,Low Mitotic Activity,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8
22946,Neuroendocrine Differentiation,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8
22947,Low Mitotic Activity,Colorectal Neuroendocrine Tumor by AJCC v8 Stage
22948,Low Mitotic Activity,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8
22949,Low Mitotic Activity,Stage IV Colorectal Neuroendocrine Tumor AJCC v8
22950,Low Mitotic Activity,Stage I Colon Neuroendocrine Tumor AJCC v8
22951,Low Mitotic Activity,Stage IIA Rectal Neuroendocrine Tumor AJCC v8
22952,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage
22953,Low Mitotic Activity,Stage I Pancreatic Neuroendocrine Tumor AJCC v8
22954,Neuroendocrine Differentiation,Stage I Pancreatic Neuroendocrine Tumor AJCC v8
22955,Epithelial Component Present,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
22956,Epithelial Component Present,Stage III Thymus Epithelial Neoplasm AJCC v8
22957,Epithelial Component Present,Thymoma by AJCC v8 Stage
22958,Epithelial Component Present,Stage I Thymoma AJCC v8
22959,Unresectable Mass,Unresectable Head and Neck Squamous Cell Carcinoma
22960,Carcinomatous Component Present,Lung Cancer by AJCC v8 Stage
22961,Carcinomatous Component Present,Stage IA3 Lung Cancer AJCC v8
22962,Carcinomatous Component Present,Stage IIB Lung Cancer AJCC v8
22963,Lepidic Growth Pattern,Lung Adenocarcinoma In Situ
22964,Epithelial Component Present,Lung Non-Small Cell Cancer by AJCC v7 Stage
22965,Poorly Differentiated Lesion,Lung Large Cell Carcinoma by AJCC v7 Stage
22966,Necrotic changes (finding),Lung Small Cell Carcinoma by AJCC v7 Stage
22967,Recurrent disease,Recurrent Diffuse Intrinsic Pontine Glioma
22968,Primary Lesion,Recurrent Diffuse Intrinsic Pontine Glioma
22969,Recurrent disease,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
22970,Recurrent disease,Recurrent Cervical Adenosquamous Carcinoma
22971,Epithelial Component Present,Recurrent Cervical Adenosquamous Carcinoma
22972,Carcinomatous Component Present,Recurrent Cervical Adenosquamous Carcinoma
22973,Recurrent disease,Recurrent Cervical Adenocarcinoma
22974,Dysplasia,Lung Squamous Cell Carcinoma In Situ
22975,Severe dysplasia,Lung Squamous Cell Carcinoma In Situ
22976,More than 5 Mitoses per 50HPF,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
22977,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Stage
22978,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
22979,Neuroendocrine Differentiation,Clinical Stage I Merkel Cell Carcinoma AJCC v8
22980,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8
22981,Neuroendocrine Differentiation,Clinical Stage II Merkel Cell Carcinoma AJCC v8
22982,Carcinomatous Component Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
22983,Cutaneous Involvement,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
22984,Clinical TNM Finding,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
22985,Single Cell Necrosis,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
22986,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
22987,Neuroendocrine Differentiation,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
22988,Carcinomatous Component Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
22989,Epithelial Component Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
22990,Pathologic TNM Finding,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
22991,Epithelial Component Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
22992,Pathologic TNM Finding,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
22993,Carcinomatous Component Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
22994,Single Cell Necrosis,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
22995,High Mitotic Activity,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
22996,Epithelial Component Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
22997,Pathologic TNM Finding,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
22998,Cutaneous Involvement,Clinical Stage III Cutaneous Melanoma AJCC v8
22999,Pathologic TNM Finding,Pathologic Stage I Cutaneous Melanoma AJCC v8
23000,Pathologic TNM Finding,Pathologic Stage IA Cutaneous Melanoma AJCC v8
23001,Pathologic TNM Finding,Pathologic Stage IB Cutaneous Melanoma AJCC v8
23002,Positive Axillary Lymph Node,Occult Breast Carcinoma
23003,Cutaneous Involvement,Pathologic Stage IIID Cutaneous Melanoma AJCC v8
23004,Neuroendocrine Differentiation,Refractory Pancreatic Neuroendocrine Carcinoma
23005,Carcinomatous Component Present,Refractory Pancreatic Neuroendocrine Carcinoma
23006,Primary Lesion,Refractory Central Nervous System Lymphoma
23007,Recurrent disease,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
23008,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
23009,Cutaneous Involvement,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
23010,Epithelial Component Present,Luminal A Prostate Carcinoma
23011,Epithelial Component Present,Recurrent Abdominal Neuroendocrine Neoplasm
23012,Favorable Clinical Outcome,Type E Lymphomatoid Papulosis
23013,Florid Follicular Hyperplasia,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder
23014,Epithelial Component Present,Breast Cancer by AJCC v8 Anatomic Stage
23015,Epithelial Component Present,Anatomic Stage IA Breast Cancer AJCC v8
23016,Epithelial Component Present,Anatomic Stage IIB Breast Cancer AJCC v8
23017,Carcinomatous Component Present,Anatomic Stage IIIA Breast Cancer AJCC v8
23018,Carcinomatous Component Present,Anatomic Stage IV Breast Cancer AJCC v8
23019,Biphasic Pattern,Perineal Ectopic Fibroadenoma
23020,Benign Cellular Infiltrate,Perineal Ectopic Fibroadenoma
23021,Mixed Cellular Population,Perineal Ectopic Fibroadenoma
23022,Papillary Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
23023,Adnexal Differentiation,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
23024,Epithelial Component Present,Breast Cancer by AJCC v8 Prognostic Stage
23025,Carcinomatous Component Present,Breast Cancer by AJCC v8 Prognostic Stage
23026,Epithelial Component Present,Prognostic Stage IIB Breast Cancer AJCC v8
23027,Epithelial Component Present,Vulvar Cancer by AJCC v8 Stage
23028,Epithelial Component Present,Stage I Vulvar Cancer AJCC v8
23029,Carcinomatous Component Present,Stage IB Vulvar Cancer AJCC v8
23030,Massive Sinusoidal Histiocytic Infiltrate,Sinus histiocytosis
23031,Intermediate Filaments Present,Rhabdoid Tumor
23032,Splenomegaly,Post polycythaemia vera myelofibrosis
23033,Secondary Lesion,Metastatic Jugulotympanic Paraganglioma
23034,Poorly Differentiated Lesion,Large cell carcinoma with rhabdoid phenotype
23035,Intermediate Filaments Present,Atypical Teratoid Rhabdoid Tumor
23036,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic Lymphadenopathy
23037,Neoplastic Cells with TFH Cell Phenotype Present,Follicular T-cell lymphoma
23038,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma refractory
23039,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage II
23040,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides refractory
23041,Intermediate Filaments Present,Rhabdoid Tumor of the Kidney
23042,Low Mitotic Activity,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7
23043,Splenomegaly,Infectious Mononucleosis
23044,White blood cell count increased (lab result),Acute Adult T-Cell Leukemia/Lymphoma
23045,Philadelphia chromosome negative,Ph-Like Acute Lymphoblastic Leukemia
23046,Pathologic TNM Finding,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
23047,Pathologic TNM Finding,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
23048,Carcinomatous Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8
23049,Epithelial Component Present,Stage IVB Laryngeal Cancer AJCC v8
23050,Carcinomatous Component Present,Metastatic Thyroid Gland Carcinoma
23051,Carcinomatous Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck
23052,Epithelial Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage
23053,Absence of Invasion,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
23054,Carcinomatous Component Present,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
23055,Epithelial Component Present,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
23056,Carcinomatous Component Present,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
23057,Epithelial Component Present,Esophageal Cancer by AJCC v8 Stage
23058,Carcinomatous Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
23059,Severe dysplasia,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
23060,Epithelial Component Present,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
23061,Carcinomatous Component Present,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
23062,Carcinomatous Component Present,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
23063,Clinical TNM Finding,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
23064,Pathologic TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
23065,Epithelial Component Present,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
23066,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
23067,Epithelial Component Present,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
23068,Pathologic TNM Finding,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
23069,Pathologic TNM Finding,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
23070,Epithelial Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
23071,Postneoadjuvant Therapy Pathologic TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
23072,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
23073,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
23074,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
23075,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
23076,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
23077,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
23078,Dysplasia,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
23079,Epithelial Component Present,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
23080,Epithelial Component Present,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
23081,Carcinomatous Component Present,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
23082,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
23083,Secondary Lesion,Lung Carcinoma Metastatic in the Central Nervous System
23084,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Central Nervous System
23085,In Situ Lesion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
23086,Carcinomatous Component Present,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
23087,Pathologic TNM Finding,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
23088,Epithelial Component Present,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
23089,Pathologic TNM Finding,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
23090,Epithelial Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
23091,Carcinomatous Component Present,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
23092,Carcinomatous Component Present,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
23093,Pathologic TNM Finding,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
23094,Epithelial Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
23095,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
23096,Carcinomatous Component Present,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
23097,Epithelial Component Present,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
23098,Clinical TNM Finding,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
23099,In Situ Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
23100,Pathologic TNM Finding,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
23101,Epithelial Component Present,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
23102,Carcinomatous Component Present,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
23103,Epithelial Component Present,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
23104,Pathologic TNM Finding,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
23105,Epithelial Component Present,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
23106,Pathologic TNM Finding,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
23107,Epithelial Component Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
23108,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
23109,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
23110,Clinical TNM Finding,Clinical Stage 0 Gastric Cancer AJCC v8
23111,Carcinomatous Component Present,Clinical Stage IV Gastric Cancer AJCC v8
23112,Carcinomatous Component Present,Pathologic Stage 0 Gastric Cancer AJCC v8
23113,Pathologic TNM Finding,Pathologic Stage IB Gastric Cancer AJCC v8
23114,Carcinomatous Component Present,Pathologic Stage II Gastric Cancer AJCC v8
23115,Epithelial Component Present,Pathologic Stage IIIB Gastric Cancer AJCC v8
23116,Epithelial Component Present,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
23117,Carcinomatous Component Present,Clinical Stage IIA Gastric Cancer AJCC v8
23118,Regional Disease,Locally Advanced Paraganglioma
23119,Neuroendocrine Differentiation,Locally Advanced Paraganglioma
23120,Recurrent disease,Recurrent Primary Amyloidosis
23121,"Amorphus, Eosinophilic, and Acellular Deposit",Recurrent Primary Amyloidosis
23122,Epithelial Component Present,Appendix Carcinoma by AJCC v7 Stage
23123,Carcinomatous Component Present,Appendix Carcinoma by AJCC v7 Stage
23124,Absence of Invasion,Stage 0 Anal Cancer AJCC v8
23125,Severe dysplasia,Stage 0 Anal Cancer AJCC v8
23126,Epithelial Component Present,Stage I Anal Cancer AJCC v8
23127,Carcinomatous Component Present,Stage IV Anal Cancer AJCC v8
23128,Carcinomatous Component Present,Metastatic Digestive System Carcinoma
23129,Cutaneous Involvement,Atrophoderma maculatum
23130,In Situ Lesion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
23131,Epithelial Component Present,Stage III Small Intestinal Adenocarcinoma AJCC v8
23132,Carcinomatous Component Present,Stage III Small Intestinal Adenocarcinoma AJCC v8
23133,Epithelial Component Present,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
23134,Carcinomatous Component Present,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
23135,Epithelial Component Present,Stage IV Small Intestinal Adenocarcinoma AJCC v8
23136,Epithelial Component Present,Appendix Carcinoma by AJCC v8 Stage
23137,Severe dysplasia,Stage 0 Appendix Carcinoma AJCC v8
23138,Epithelial Component Present,Stage I Appendix Carcinoma AJCC v8
23139,Carcinomatous Component Present,Stage IIB Appendix Carcinoma AJCC v8
23140,Epithelial Component Present,Colorectal Cancer by AJCC v8 Stage
23141,Carcinomatous Component Present,Colorectal Cancer by AJCC v8 Stage
23142,Epithelial Component Present,Stage IIA Colorectal Cancer AJCC v8
23143,Carcinomatous Component Present,Stage IIC Colorectal Cancer AJCC v8
23144,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v8
23145,Carcinomatous Component Present,Stage IV Colorectal Cancer AJCC v8
23146,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v8
23147,Carcinomatous Component Present,Colon Cancer by AJCC v8 Stage
23148,Severe dysplasia,Stage 0 Colon Cancer AJCC v8
23149,Epithelial Component Present,Stage IIA Colon Cancer AJCC v8
23150,Carcinomatous Component Present,Stage IVC Colon Cancer AJCC v8
23151,Epithelial Component Present,Stage 0 Rectal Cancer AJCC v8
23152,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v8
23153,Carcinomatous Component Present,Stage IA Hepatocellular Carcinoma AJCC v8
23154,Epithelial Component Present,Stage II Hepatocellular Carcinoma AJCC v8
23155,Carcinomatous Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8
23156,Epithelial Component Present,Stage I Gallbladder Cancer AJCC v8
23157,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v8
23158,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v8
23159,Epithelial Component Present,Stage IVA Gallbladder Cancer AJCC v8
23160,Carcinomatous Component Present,Stage II Hilar Cholangiocarcinoma AJCC v8
23161,Epithelial Component Present,Stage III Hilar Cholangiocarcinoma AJCC v8
23162,Epithelial Component Present,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
23163,Fibrotic Stroma Formation,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
23164,Epithelial Component Present,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
23165,Carcinomatous Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
23166,Carcinomatous Component Present,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
23167,Carcinomatous Component Present,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
23168,Epithelial Component Present,Distal Bile Duct Cancer by AJCC v7 Stage
23169,Epithelial Component Present,Stage II Distal Bile Duct Cancer AJCC v8
23170,Carcinomatous Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8
23171,Unfavorable Clinical Outcome,Refractory Ph-Like Acute Lymphoblastic Leukemia
23172,Carcinomatous Component Present,Ampulla of Vater Cancer by AJCC v8 Stage
23173,Epithelial Component Present,Stage II Ampulla of Vater Cancer AJCC v8
23174,Epithelial Component Present,Pancreatic Cancer by AJCC v6 and v7 Stage
23175,Absence of Invasion,Stage 0 Pancreatic Cancer AJCC v8
23176,Epithelial Component Present,Stage 0 Pancreatic Cancer AJCC v8
23177,Carcinomatous Component Present,Stage 0 Pancreatic Cancer AJCC v8
23178,Severe dysplasia,Stage 0 Pancreatic Cancer AJCC v8
23179,Epithelial Component Present,Stage II Pancreatic Cancer AJCC v8
23180,Neuroendocrine Differentiation,Stage I Duodenal Neuroendocrine Tumor AJCC v8
23181,Low Mitotic Activity,Stage III Duodenal Neuroendocrine Tumor AJCC v8
23182,Epithelial Component Present,Stage III Duodenal Neuroendocrine Tumor AJCC v8
23183,Epithelial Component Present,Stage IV Duodenal Neuroendocrine Tumor AJCC v8
23184,Low Mitotic Activity,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8
23185,Epithelial Component Present,Jejunal Neuroendocrine Tumor
23186,Epithelial Component Present,Ileal Neuroendocrine Tumor
23187,Low Mitotic Activity,Jejunal Neuroendocrine Tumor by AJCC v8 Stage
23188,Epithelial Component Present,Jejunal Neuroendocrine Tumor by AJCC v8 Stage
23189,Neuroendocrine Differentiation,Stage II Jejunal Neuroendocrine Tumor AJCC v8
23190,Low Mitotic Activity,Stage IV Jejunal Neuroendocrine Tumor AJCC v8
23191,Neuroendocrine Differentiation,Stage II Ileal Neuroendocrine Tumor AJCC v8
23192,Low Mitotic Activity,Stage III Ileal Neuroendocrine Tumor AJCC v8
23193,Epithelial Component Present,Appendix Neuroendocrine Tumor by AJCC v7 Stage
23194,Epithelial Component Present,Appendix Neuroendocrine Tumor by AJCC v8 Stage
23195,Neuroendocrine Differentiation,Stage I Appendix Neuroendocrine Tumor AJCC v8
23196,Epithelial Component Present,Stage IIB Colon Neuroendocrine Tumor AJCC v8
23197,Low Mitotic Activity,Stage I Rectal Neuroendocrine Tumor AJCC v8
23198,Low Mitotic Activity,Stage IIB Rectal Neuroendocrine Tumor AJCC v8
23199,Epithelial Component Present,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8
23200,Low Mitotic Activity,Stage II Pancreatic Neuroendocrine Tumor AJCC v8
23201,Epithelial Component Present,Stage II Pancreatic Neuroendocrine Tumor AJCC v8
23202,Neuroendocrine Differentiation,Stage III Pancreatic Neuroendocrine Tumor AJCC v8
23203,Epithelial Component Present,Stage I Lung Cancer AJCC v8
23204,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v8
23205,Epithelial Component Present,Stage IVB Lung Cancer AJCC v8
23206,Epithelial Component Present,Lung Adenocarcinoma In Situ
23207,Refractory Disease,Refractory Acute Lymphoblastic Leukemia
23208,Carcinomatous Component Present,Lung Adenocarcinoma by AJCC v7 Stage
23209,Neuroendocrine Differentiation,Lung Small Cell Carcinoma by AJCC v7 Stage
23210,Nuclear Molding,Lung Small Cell Carcinoma by AJCC v7 Stage
23211,Mitotic Activity,Recurrent Anaplastic Astrocytoma
23212,Epithelial Component Present,Recurrent Cervical Adenocarcinoma
23213,Metaplasia,Lung Enteric Adenocarcinoma
23214,Intestinal metaplasia,Lung Enteric Adenocarcinoma
23215,More than 5 Mitoses per 50HPF,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage
23216,More than 5 Mitoses per 50HPF,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
23217,More than 5 Mitoses per 50HPF,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
23218,More than 5 Mitoses per 50HPF,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
23219,More than 5 Mitoses per 50HPF,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
23220,More than 5 Mitoses per 50HPF,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
23221,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v7 Stage
23222,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v7 Stage
23223,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v7 Stage
23224,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Stage
23225,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
23226,Cutaneous Involvement,Clinical Stage II Merkel Cell Carcinoma AJCC v8
23227,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8
23228,Carcinomatous Component Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
23229,Single Cell Necrosis,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
23230,High Mitotic Activity,Clinical Stage III Merkel Cell Carcinoma AJCC v8
23231,Pathologic TNM Finding,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
23232,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
23233,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
23234,High Mitotic Activity,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
23235,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
23236,Cutaneous Involvement,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
23237,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
23238,Neuroendocrine Differentiation,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
23239,Pathologic TNM Finding,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
23240,High Mitotic Activity,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
23241,Carcinomatous Component Present,Intermediate Atypical Prostate Carcinoma
23242,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Stage
23243,Cutaneous Involvement,Clinical Stage II Cutaneous Melanoma AJCC v8
23244,Clinical TNM Finding,Clinical Stage III Cutaneous Melanoma AJCC v8
23245,Cutaneous Involvement,Clinical Stage IV Cutaneous Melanoma AJCC v8
23246,Clinical TNM Finding,Clinical Stage IV Cutaneous Melanoma AJCC v8
23247,Pathologic TNM Finding,Pathologic Stage 0 Cutaneous Melanoma AJCC v8
23248,Cutaneous Involvement,Pathologic Stage III Cutaneous Melanoma AJCC v8
23249,Pathologic TNM Finding,Pathologic Stage III Cutaneous Melanoma AJCC v8
23250,Cutaneous Involvement,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
23251,No Evidence of Radiologic Finding,Occult Breast Carcinoma
23252,Pathologic TNM Finding,Pathologic Stage IV Cutaneous Melanoma AJCC v8
23253,Nuclear pleomorphism,Pleomorphic lobular carcinoma in situ of breast
23254,Epithelial Component Present,Pleomorphic lobular carcinoma in situ of breast
23255,High Mitotic Activity,Refractory Pancreatic Neuroendocrine Carcinoma
23256,Recurrent disease,Recurrent Intravascular Large B-Cell Lymphoma
23257,Carcinomatous Component Present,Luminal A Prostate Carcinoma
23258,Recurrent disease,Recurrent Abdominal Neuroendocrine Neoplasm
23259,Neuroendocrine Differentiation,Recurrent Abdominal Neuroendocrine Neoplasm
23260,In Situ Lesion,In situ mantle cell neoplasia
23261,Peripheral Blood Involvement,Leukemic Nonnodal Mantle Cell Lymphoma
23262,Diffuse Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
23263,Ineffective hematopoiesis,Recurrent High Risk Myelodysplastic Syndrome
23264,Breast Implant-Related Lesion,Breast implant-associated anaplastic large cell lymphoma
23265,Metastatic Lesion,Advanced Head and Neck Squamous Cell Carcinoma
23266,Carcinomatous Component Present,Advanced Head and Neck Squamous Cell Carcinoma
23267,Carcinomatous Component Present,Breast Cancer by AJCC v8 Stage
23268,Epithelial Component Present,Anatomic Stage 0 Breast Cancer AJCC v8
23269,Carcinomatous Component Present,Anatomic Stage II Breast Cancer AJCC v8
23270,Carcinomatous Component Present,Anatomic Stage IIB Breast Cancer AJCC v8
23271,Mixed Cellular Population,Anal Ectopic Fibroadenoma
23272,Cystic Change,Vulvar Composite Papillary Hidradenoma and Fibroadenoma
23273,Epithelial Component Present,Prognostic Stage IB Breast Cancer AJCC v8
23274,Carcinomatous Component Present,Stage I Vulvar Cancer AJCC v8
23275,Epithelial Component Present,Stage II Vulvar Cancer AJCC v8
23276,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v8
23277,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor
23278,Extramedullary Hematopoiesis (disorder),Overt Primary Myelofibrosis
23279,Intracytoplasmic Eosinophilic Inclusion,Extrarenal rhabdoid tumor
23280,Poorly Differentiated Lesion,Stage IIIB Lung Large Cell Carcinoma AJCC v7
23281,Intermediate Filaments Present,Childhood Atypical Teratoid/Rhabdoid Tumor
23282,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage I
23283,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage IV
23284,EBV-Positive Neoplastic Cells Present,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood
23285,EBV-Positive Neoplastic Cells Present,Systemic EBV positive T-cell lymphoproliferative disease of childhood
23286,Low Mitotic Activity,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7
23287,Low Mitotic Activity,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7
23288,Polymorphic Cellular Infiltrate,Infectious Mononucleosis
23289,Epithelial Component Present,Hormone refractory breast cancer
23290,Epithelial Component Present,Stage I Vaginal Cancer AJCC v8
23291,Carcinomatous Component Present,Stage IIB Vaginal Cancer AJCC v8
23292,Epithelial Component Present,Cervical Cancer by AJCC v8 Stage
23293,Carcinomatous Component Present,Cervical Cancer by AJCC v8 Stage
23294,Epithelial Component Present,Stage IIA Cervical Cancer AJCC v8
23295,Carcinomatous Component Present,Stage IIA1 Cervical Cancer AJCC v8
23296,Epithelial Component Present,Stage IIA2 Cervical Cancer AJCC v8
23297,Epithelial Component Present,Stage IIB Cervical Cancer AJCC v8
23298,Epithelial Component Present,Stage IIIB Cervical Cancer AJCC v8
23299,Carcinomatous Component Present,Stage IVA Cervical Cancer AJCC v8
23300,Infiltrating Tumor Margins Present,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23301,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23302,Infiltrating Tumor Margins Present,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23303,Biphasic Pattern,Uterine Corpus Adenosarcoma by AJCC v8 Stage
23304,Biphasic Pattern,Stage IB Uterine Corpus Adenosarcoma AJCC v8
23305,Mixed Cellular Population,Stage IC Uterine Corpus Adenosarcoma AJCC v8
23306,Mixed Cellular Population,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
23307,Stromal Invasion,Ovarian Cancer by AJCC v8 Stage
23308,Stromal Invasion,Stage I Ovarian Cancer AJCC v8
23309,Epithelial Component Present,Stage IC Ovarian Cancer AJCC v8
23310,Stromal Invasion,Stage IIB Ovarian Cancer AJCC v8
23311,Stromal Invasion,Stage IIIA Ovarian Cancer AJCC v8
23312,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v8
23313,Stromal Invasion,Stage IIIA1 Ovarian Cancer AJCC v8
23314,Epithelial Component Present,Stage IIIA1 Ovarian Cancer AJCC v8
23315,Epithelial Component Present,Stage IV Ovarian Cancer AJCC v8
23316,Carcinomatous Component Present,Stage IV Ovarian Cancer AJCC v8
23317,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v8 Stage
23318,Epithelial Component Present,Stage IIA Fallopian Tube Cancer AJCC v8
23319,Epithelial Component Present,Stage IIIC Fallopian Tube Cancer AJCC v8
23320,Carcinomatous Component Present,Stage IVB Fallopian Tube Cancer AJCC v8
23321,Primary Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v8
23322,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v8
23323,Epithelial Component Present,Stage IV Primary Peritoneal Cancer AJCC v8
23324,Epithelial Component Present,Stage III Penile Cancer AJCC v8
23325,Carcinomatous Component Present,Stage III Penile Cancer AJCC v8
23326,Epithelial Component Present,Stage IIIA Penile Cancer AJCC v8
23327,Transformed Phase of Disease,Refractory Transformed Non-Hodgkin Lymphoma
23328,Epithelial Component Present,Prostate Cancer by AJCC v8 Stage
23329,Carcinomatous Component Present,Stage IIB Prostate Cancer AJCC v8
23330,Carcinomatous Component Present,Stage IIC Prostate Cancer AJCC v8
23331,Epithelial Component Present,Stage IVA Prostate Cancer AJCC v8
23332,Carcinomatous Component Present,Stage IVA Prostate Cancer AJCC v8
23333,Epithelial Component Present,Renal Pelvis and Ureter Cancer by AJCC v8 Stage
23334,Epithelial Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
23335,Non-Invasive Lesion,Stage 0a Renal Pelvis Cancer AJCC v8
23336,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v8
23337,Carcinomatous Component Present,Stage 0a Ureter Cancer AJCC v8
23338,Epithelial Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
23339,Absence of Invasion,Stage 0is Renal Pelvis Cancer AJCC v8
23340,Absence of Invasion,Stage 0is Ureter Cancer AJCC v8
23341,Epithelial Component Present,Stage 0is Ureter Cancer AJCC v8
23342,Epithelial Component Present,Stage I Ureter Cancer AJCC v8
23343,Carcinomatous Component Present,Stage II Ureter Cancer AJCC v8
23344,Epithelial Component Present,Bladder Cancer by AJCC v8 Stage
23345,Carcinomatous Component Present,Bladder Cancer by AJCC v8 Stage
23346,Carcinomatous Component Present,Stage III Bladder Cancer AJCC v8
23347,Carcinomatous Component Present,Urethral Cancer by AJCC v8 Stage
23348,Severe dysplasia,Stage 0is Urethral Cancer AJCC v8
23349,Carcinomatous Component Present,Stage II Urethral Cancer AJCC v8
23350,Carcinomatous Component Present,Stage IA Eyelid Carcinoma AJCC v8
23351,Pathologic TNM Finding,Pathologic Stage IV Retinoblastoma AJCC v8
23352,Follicular Cell Differentiation,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23353,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
23354,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
23355,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
23356,Carcinomatous Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
23357,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
23358,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23359,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23360,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23361,Papillary Pattern,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
23362,Nuclear Pseudoinclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
23363,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
23364,Nuclear Pseudoinclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
23365,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
23366,Papillary Pattern,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
23367,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
23368,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
23369,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
23370,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
23371,Epithelial Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
23372,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
23373,Epithelial Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
23374,Follicular Cell Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
23375,Carcinomatous Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
23376,Carcinomatous Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
23377,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
23378,High Mitotic Activity,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
23379,Calcitonin serum level increased,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
23380,Calcitonin serum level increased,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
23381,Neuroendocrine Differentiation,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
23382,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
23383,Carcinomatous Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
23384,Calcitonin serum level increased,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
23385,Epithelial Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
23386,Neuroendocrine Differentiation,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
23387,High Grade Lesion,Recurrent Extensive Stage Lung Small Cell Carcinoma
23388,More than 10 Mitoses per 10HPF,Recurrent Extensive Stage Lung Small Cell Carcinoma
23389,Neuroendocrine Differentiation,Refractory Extensive Stage Lung Small Cell Carcinoma
23390,Carcinomatous Component Present,Adrenal Cortex Carcinoma by AJCC v8 Stage
23391,Cutaneous Involvement,Mycosis Fungoides by AJCC v7 Stage
23392,Adulthood Lesion,Lugano Classification Adult Lymphoma by AJCC v8 Stage
23393,Adulthood Lesion,Lugano Classification Advanced Stage Adult Lymphoma AJCC v8
23394,Adulthood Lesion,Lugano Classification Stage IV Adult Lymphoma AJCC v8
23395,Adulthood Lesion,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage
23396,Childhood Lesion,Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage
23397,Adulthood Lesion,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8
23398,Adulthood Lesion,Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8
23399,Childhood Lesion,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage
23400,Childhood Lesion,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8
23401,Chronic Inflammatory Infiltrate,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage
23402,CD30-Positive Neoplastic Cells Present,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage
23403,Cutaneous Involvement,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
23404,S-100-Positive Neoplastic Cells Present,Lung PEComa
23405,Indolent Clinical Course,Benign Lung PEComa
23406,Refractory Disease,Refractory Pancreatic Carcinoma
23407,Recurrent disease,Recurrent B Acute Lymphoblastic Leukemia
23408,Indolent Clinical Course,Lung Myoepithelioma
23409,Lobulated Growth Pattern,Primary myoepithelial carcinoma of lung
23410,Epithelial Component Present,Primary myoepithelial carcinoma of lung
23411,Unifocal Lesion,Pulmonary Histiocytosis X
23412,Refractory Disease,Refractory Rhabdomyosarcoma
23413,Carcinomatous Component Present,Metastatic Microsatellite Stable Colorectal Carcinoma
23414,Microsatellite Stable,Advanced Microsatellite Stable Colorectal Carcinoma
23415,Extensive Stage Lesion,Advanced Microsatellite Stable Colorectal Carcinoma
23416,Abundance of Small Lymphocytes,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma
23417,Cutaneous Involvement,Skin squamous cell carcinoma recurrent
23418,Refractory Disease,Refractory Glioblastoma
23419,Myxoid Stroma Formation,Locally Advanced Epithelioid Hemangioendothelioma
23420,Myxoid Stroma Formation,Metastatic Epithelioid Hemangioendothelioma
23421,Low Grade Lesion,Metastatic Epithelioid Hemangioendothelioma
23422,Mixture of Germ Cell Neoplastic Components Present,Mediastinal Mixed Germ Cell Tumor
23423,Vascular Channel Formation,hemangioma of mediastinum
23424,Osteoid formation,Cardiac Extraskeletal Osteosarcoma
23425,Extraosseous Lesion,Cardiac Extraskeletal Osteosarcoma
23426,Nuclear pleomorphism,Cardiac Myxofibrosarcoma
23427,Vascular Channel Formation,Pericardial Angiosarcoma
23428,Refractory Disease,Refractory Ependymoma
23429,Recurrent disease,Recurrent Lymphoproliferative Disorder
23430,Nuclear Atypia,Childhood Brain Glioblastoma
23431,Primary Lesion,Central Nervous System B-Cell Non-Hodgkin Lymphoma
23432,Epithelial Component Present,BRCA-Mutated Ovarian Carcinoma
23433,Stromal Invasion,Recurrent BRCA-Mutated Ovarian Carcinoma
23434,Hereditary Lesion,Recurrent BRCA-Mutated Ovarian Carcinoma
23435,Cystic Lesion,Unresectable Craniopharyngioma
23436,Slow Growing Mass,Unresectable Craniopharyngioma
23437,Epithelial Component Present,Refractory Malignant Thymoma
23438,Benign Cellular Infiltrate,Pulmonary Sclerosing Hemangioma
23439,Epithelial Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v7
23440,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v7
23441,Aggressive Clinical Course,"Thymoma, type B1, malignant"
23442,Recurrent Lymphoma,Systemic EBV positive T-cell lymphoproliferative disease of childhood
23443,Epithelial Component Present,Masaoka-Koga Stage III
23444,Hormonal resistance,Hormone refractory breast cancer
23445,Carcinomatous Component Present,Hormone refractory breast cancer
23446,Recurrent Lymphoma,Childhood Grade III Lymphomatoid Granulomatosis
23447,Recurrent Lymphoma,Recurrent Adult Grade III Lymphomatoid Granulomatosis
23448,Epithelial Component Present,Vaginal Cancer by AJCC v8 Stage
23449,Carcinomatous Component Present,Stage IIA Vaginal Cancer AJCC v8
23450,Epithelial Component Present,Stage IV Vaginal Cancer AJCC v8
23451,Epithelial Component Present,Stage I Cervical Cancer AJCC v8
23452,Carcinomatous Component Present,Stage IB2 Cervical Cancer AJCC v8
23453,Carcinomatous Component Present,Stage IIB Cervical Cancer AJCC v8
23454,Carcinomatous Component Present,Stage III Cervical Cancer AJCC v8
23455,Carcinomatous Component Present,Stage IIIA Cervical Cancer AJCC v8
23456,Infiltrating Tumor Margins Present,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage
23457,Infiltrating Tumor Margins Present,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23458,Infiltrating Tumor Margins Present,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23459,Mixed Cellular Population,Uterine Corpus Adenosarcoma by AJCC v8 Stage
23460,Tissue of Mullerian Origin Present,Uterine Corpus Adenosarcoma by AJCC v8 Stage
23461,Tissue of Mullerian Origin Present,Stage I Uterine Corpus Adenosarcoma AJCC v8
23462,Biphasic Pattern,Stage IA Uterine Corpus Adenosarcoma AJCC v8
23463,Tissue of Mullerian Origin Present,Stage IA Uterine Corpus Adenosarcoma AJCC v8
23464,Tissue of Mullerian Origin Present,Stage IB Uterine Corpus Adenosarcoma AJCC v8
23465,Mixed Cellular Population,Stage II Uterine Corpus Adenosarcoma AJCC v8
23466,Biphasic Pattern,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
23467,Biphasic Pattern,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
23468,Biphasic Pattern,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
23469,Carcinomatous Component Present,Stage IB Ovarian Cancer AJCC v8
23470,Carcinomatous Component Present,Stage III Ovarian Cancer AJCC v8
23471,Carcinomatous Component Present,Stage IIIA2 Ovarian Cancer AJCC v8
23472,Stromal Invasion,Stage IIIC Ovarian Cancer AJCC v8
23473,Epithelial Component Present,Stage IVB Ovarian Cancer AJCC v8
23474,Carcinomatous Component Present,Stage IA Fallopian Tube Cancer AJCC v8
23475,Epithelial Component Present,Stage IB Fallopian Tube Cancer AJCC v8
23476,Carcinomatous Component Present,Stage IC Fallopian Tube Cancer AJCC v8
23477,Epithelial Component Present,Stage IV Fallopian Tube Cancer AJCC v8
23478,Carcinomatous Component Present,Stage IVA Fallopian Tube Cancer AJCC v8
23479,Epithelial Component Present,Stage II Primary Peritoneal Cancer AJCC v8
23480,Epithelial Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8
23481,Carcinomatous Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8
23482,Carcinomatous Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v8
23483,Epithelial Component Present,Stage IVB Primary Peritoneal Cancer AJCC v8
23484,Pregnancy Complications,Stage II Gestational Trophoblastic Neoplasm AJCC v8
23485,Epithelial Component Present,Penile Cancer by AJCC v8 Stage
23486,Epithelial Component Present,Stage 0 Penile Cancer AJCC v8
23487,Epithelial Component Present,Stage 0is Penile Cancer AJCC v8
23488,Carcinomatous Component Present,Stage 0is Penile Cancer AJCC v8
23489,Epithelial Component Present,Stage I Penile Cancer AJCC v8
23490,Carcinomatous Component Present,Stage II Penile Cancer AJCC v8
23491,Epithelial Component Present,Stage IIC Prostate Cancer AJCC v8
23492,Carcinomatous Component Present,Stage IIIB Prostate Cancer AJCC v8
23493,Carcinomatous Component Present,Stage IIIC Prostate Cancer AJCC v8
23494,Epithelial Component Present,Stage II Renal Cell Cancer AJCC v8
23495,Epithelial Component Present,Stage 0a Renal Pelvis Cancer AJCC v8
23496,Non-Invasive Lesion,Stage 0is Renal Pelvis Cancer AJCC v8
23497,Epithelial Component Present,Stage 0is Renal Pelvis Cancer AJCC v8
23498,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8
23499,Carcinomatous Component Present,Stage I Renal Pelvis Cancer AJCC v8
23500,Epithelial Component Present,Stage II Renal Pelvis Cancer AJCC v8
23501,Epithelial Component Present,Stage II Ureter Cancer AJCC v8
23502,Carcinomatous Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v8
23503,Epithelial Component Present,Stage IIIB Bladder Cancer AJCC v8
23504,Carcinomatous Component Present,Stage 0is Urethral Cancer AJCC v8
23505,Carcinomatous Component Present,Stage 0 Eyelid Carcinoma AJCC v8
23506,Carcinomatous Component Present,Stage IIA Eyelid Carcinoma AJCC v8
23507,Carcinomatous Component Present,Stage IIB Eyelid Carcinoma AJCC v8
23508,Clinical TNM Finding,Clinical Stage I Retinoblastoma AJCC v8
23509,Pathologic TNM Finding,Pathologic Stage I Retinoblastoma AJCC v8
23510,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
23511,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage
23512,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23513,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23514,Nuclear Pseudoinclusion,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23515,Epithelial Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage
23516,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
23517,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
23518,Carcinomatous Component Present,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
23519,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
23520,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
23521,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23522,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23523,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23524,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
23525,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23526,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23527,Carcinomatous Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
23528,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
23529,Epithelial Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
23530,Ground Glass Nuclear Inclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
23531,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
23532,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
23533,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
23534,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
23535,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
23536,Carcinomatous Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
23537,Epithelial Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
23538,Carcinomatous Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
23539,Epithelial Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
23540,Neuroendocrine Differentiation,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
23541,Epithelial Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v8
23542,Carcinomatous Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v8
23543,Neuroendocrine Differentiation,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage
23544,Neuroendocrine Differentiation,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
23545,Adulthood Lesion,Lugano Classification Stage II Adult Lymphoma AJCC v8
23546,Adulthood Lesion,Lugano Classification Stage IIE Adult Lymphoma AJCC v8
23547,Adulthood Lesion,Lugano Classification Stage III Adult Lymphoma AJCC v8
23548,Adulthood Lesion,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8
23549,Childhood Lesion,Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8
23550,Adulthood Lesion,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8
23551,Lymphadenopathy,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage
23552,CD56-Positive Neoplastic Cells Present,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage
23553,Cutaneous Involvement,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8
23554,Cutaneous Involvement,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
23555,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8
23556,Recurrent disease,acute biphenotypic leukemia in relapse
23557,Recurrent disease,acute undifferentiated leukemia in relapse
23558,Epithelial Component Present,Refractory Pancreatic Carcinoma
23559,Endobronchial Mass,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
23560,Monoclonal Langerhans Cells Present,Pulmonary Histiocytosis X
23561,CD1a-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X
23562,Intermediate Filaments Present,Recurrent Rhabdoid Tumor
23563,Refractory Disease,Refractory Ewing Sarcoma
23564,Childhood Lesion,Refractory Hepatoblastoma
23565,Intermediate Filaments Present,Refractory Rhabdoid Tumor
23566,Anaplasia,Recurrent Anaplastic Oligoastrocytoma
23567,Primary Lesion,Recurrent Anaplastic Oligoastrocytoma
23568,Microsatellite Stable,Metastatic Microsatellite Stable Colorectal Carcinoma
23569,Metastatic Lesion,Advanced Microsatellite Stable Colorectal Carcinoma
23570,Metastatic Lesion,Metastatic Bile Duct Carcinoma
23571,Secondary Lesion,Metastatic Bile Duct Carcinoma
23572,Epithelial Component Present,Metastatic Bile Duct Carcinoma
23573,Metastatic Lesion,Advanced Bile Duct Carcinoma
23574,Rapidly Enlarging Mass,Refractory Alveolar Rhabdomyosarcoma
23575,Secondary Lesion,Skin squamous cell carcinoma metastatic
23576,High Grade Lesion,Refractory Glioblastoma
23577,Infiltrative Growth Pattern,Refractory Glioblastoma
23578,Multinodular Mass,Locally Advanced Angiosarcoma
23579,Secondary Lesion,Locally Advanced Angiosarcoma
23580,Vascular Channel Formation,Locally Advanced Epithelioid Hemangioendothelioma
23581,Metastatic Lesion,Locally Advanced Epithelioid Hemangioendothelioma
23582,Primary Lesion,Recurrent Central Nervous System Non-Hodgkin Lymphoma
23583,Hemorrhagic,Pericardial Angiosarcoma
23584,High Grade Lesion,Pericardial Synovial Sarcoma
23585,Slow Growing Mass,Refractory Ependymoma
23586,Sonic Hedgehog/Patch Pathway Activated,"Refractory Medulloblastoma, SHH-Activated"
23587,Stromal Invasion,Platinum-Resistant Ovarian Carcinoma
23588,Recurrent disease,Recurrent EBV-Related Lymphoma
23589,Anaplasia,Childhood Brain Glioblastoma
23590,Infiltrative Growth Pattern,Childhood Brain Glioblastoma
23591,Carcinomatous Component Present,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
23592,Epithelial Component Present,Refractory Colorectal Carcinoma
23593,Carcinomatous Component Present,Refractory Gastric Carcinoma
23594,Hereditary Lesion,BRCA-Mutated Ovarian Carcinoma
23595,Childhood Lesion,Childhood Refractory Malignant Solid Neoplasm
23596,Childhood Lesion,Childhood Malignant Solid Neoplasm
23597,Benign Cellular Infiltrate,Recurrent Craniopharyngioma
23598,Indolent Clinical Course,benign myoepithelioma of salivary gland
23599,Capsular Invasion,"Thymoma, type A, malignant"
23600,Epithelial Component Present,Thymoma by Masaoka-Koga Stage
23601,Epithelial Component Present,Masaoka-Koga Stage I
23602,Epithelial Component Present,Hormone-Resistant Prostate Carcinoma
23603,Recurrent Lymphoma,Adult Grade III Lymphomatoid Granulomatosis
23604,Indolent Clinical Course,Ectomesenchymal Chondromyxoid Tumor
23605,Recurrent Lymphoma,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
23606,Epithelial Component Present,Stage IIA Vaginal Cancer AJCC v8
23607,Carcinomatous Component Present,Stage IVA Vaginal Cancer AJCC v8
23608,Epithelial Component Present,Stage IB Cervical Cancer AJCC v8
23609,Carcinomatous Component Present,Stage IB Cervical Cancer AJCC v8
23610,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v8
23611,Mixed Cellular Population,Stage IA Uterine Corpus Adenosarcoma AJCC v8
23612,Biphasic Pattern,Stage IC Uterine Corpus Adenosarcoma AJCC v8
23613,Mixed Cellular Population,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
23614,Tissue of Mullerian Origin Present,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
23615,Tissue of Mullerian Origin Present,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
23616,Mixed Cellular Population,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
23617,Epithelial Component Present,Stage I Ovarian Cancer AJCC v8
23618,Epithelial Component Present,Stage IA Ovarian Cancer AJCC v8
23619,Stromal Invasion,Stage IC Ovarian Cancer AJCC v8
23620,Stromal Invasion,Stage IIA Ovarian Cancer AJCC v8
23621,Epithelial Component Present,Stage IIIA Ovarian Cancer AJCC v8
23622,Epithelial Component Present,Stage IIIB Ovarian Cancer AJCC v8
23623,Carcinomatous Component Present,Stage IVB Ovarian Cancer AJCC v8
23624,Epithelial Component Present,Stage IC Fallopian Tube Cancer AJCC v8
23625,Epithelial Component Present,Stage III Fallopian Tube Cancer AJCC v8
23626,Epithelial Component Present,Stage IIA Primary Peritoneal Cancer AJCC v8
23627,Epithelial Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v8
23628,Primary Lesion,Stage IVB Primary Peritoneal Cancer AJCC v8
23629,Pregnancy Complications,Gestational Trophoblastic Tumor by AJCC v7 Stage
23630,Carcinomatous Component Present,Stage I Penile Cancer AJCC v8
23631,Carcinomatous Component Present,Stage IIB Penile Cancer AJCC v8
23632,Epithelial Component Present,Stage IV Penile Cancer AJCC v8
23633,Refractory Disease,Refractory Transformed Non-Hodgkin Lymphoma
23634,Carcinomatous Component Present,Stage IVB Prostate Cancer AJCC v8
23635,Epithelial Component Present,Renal Cell Cancer by AJCC v8 Stage
23636,Carcinomatous Component Present,Stage I Renal Cell Cancer AJCC v8
23637,Epithelial Component Present,Stage IV Renal Cell Cancer AJCC v8
23638,Neuroendocrine Differentiation,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
23639,Neuroendocrine Differentiation,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
23640,Papillary Pattern,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
23641,Dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
23642,Absence of Invasion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
23643,Carcinomatous Component Present,Stage 0is Renal Pelvis Cancer AJCC v8
23644,Epithelial Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v8
23645,Epithelial Component Present,Stage I Renal Pelvis Cancer AJCC v8
23646,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8
23647,Carcinomatous Component Present,Stage III Renal Pelvis Cancer AJCC v8
23648,Epithelial Component Present,Stage IV Renal Pelvis Cancer AJCC v8
23649,Carcinomatous Component Present,Renal Pelvis and Ureter Cancer by AJCC v7 Stage
23650,Epithelial Component Present,Stage I Bladder Cancer AJCC v8
23651,Carcinomatous Component Present,Stage IV Bladder Cancer AJCC v8
23652,Epithelial Component Present,Stage IVA Bladder Cancer AJCC v8
23653,Epithelial Component Present,Stage 0a Urethral Cancer AJCC v8
23654,Epithelial Component Present,Stage 0is Urethral Cancer AJCC v8
23655,Epithelial Component Present,Stage III Urethral Cancer AJCC v8
23656,Epithelial Component Present,Eyelid Carcinoma by AJCC v8 Stage
23657,Epithelial Component Present,Stage 0 Eyelid Carcinoma AJCC v8
23658,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v8
23659,Carcinomatous Component Present,Stage III Eyelid Carcinoma AJCC v8
23660,Clinical TNM Finding,Clinical Stage IV Retinoblastoma AJCC v8
23661,Pathologic TNM Finding,Pathologic Stage II Retinoblastoma AJCC v8
23662,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage
23663,Carcinomatous Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage
23664,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23665,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23666,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23667,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
23668,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
23669,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
23670,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
23671,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
23672,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
23673,Follicular Cell Differentiation,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
23674,Epithelial Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
23675,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
23676,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
23677,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
23678,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23679,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23680,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23681,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23682,Follicular Cell Differentiation,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
23683,Papillary Pattern,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
23684,Nuclear Grooves,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
23685,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
23686,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
23687,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
23688,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
23689,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
23690,Rapidly Enlarging Mass,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
23691,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
23692,Calcitonin Positive Neoplastic Cells Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
23693,Epithelial Component Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
23694,Calcitonin serum level increased,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
23695,Neuroendocrine Differentiation,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
23696,Well-Circumscribed Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
23697,High Mitotic Activity,Recurrent Extensive Stage Lung Small Cell Carcinoma
23698,Neuroendocrine Differentiation,Recurrent Extensive Stage Lung Small Cell Carcinoma
23699,Carcinomatous Component Present,Recurrent Extensive Stage Lung Small Cell Carcinoma
23700,Nuclear Molding,Recurrent Extensive Stage Lung Small Cell Carcinoma
23701,Carcinomatous Component Present,Adrenal Cortex Carcinoma by AJCC v7 Stage
23702,Carcinomatous Component Present,Stage III Adrenal Cortex Carcinoma AJCC v8
23703,Epithelial Component Present,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage
23704,Epithelial Component Present,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
23705,Epithelial Component Present,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
23706,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8
23707,Adulthood Lesion,Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8
23708,Childhood Lesion,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8
23709,Childhood Lesion,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8
23710,Adulthood Lesion,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8
23711,Adulthood Lesion,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8
23712,Perivascular fibrosis,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage
23713,Adulthood Lesion,Adult Hodgkin Lymphoma by Ann Arbor Stage
23714,Lymphoplasmacytic Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage
23715,Diffuse Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage
23716,CD30-Positive Neoplastic Cells Present,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage
23717,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage
23718,Cutaneous Involvement,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
23719,Cutaneous Involvement,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8
23720,Cutaneous Involvement,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8
23721,Cutaneous Involvement,"Xeroderma pigmentosum, variant type"
23722,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by RISS Stage
23723,Monoclonal Gammapathies,Waldenstrom's macroglobulinemia refractory
23724,Tissue Differentiation Uncertain,Lung PEComa
23725,Tissue Differentiation Uncertain,Benign Lung PEComa
23726,Metastatic/Recurrent Disease,Malignant Lung PEComa
23727,S-100-Positive Neoplastic Cells Present,Malignant Lung PEComa
23728,Recurrent disease,Acute lymphoblastic leukemia recurrent
23729,Refractory Disease,Refractory B Acute Lymphoblastic Leukemia
23730,Polymorphic Cellular Infiltrate,Pulmonary Histiocytosis X
23731,S-100-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X
23732,Refractory Disease,Refractory Osteosarcoma
23733,Diffuse Pattern,Recurrent Anaplastic Oligodendroglioma
23734,Metastatic Lesion,Metastatic Microsatellite Stable Colorectal Carcinoma
23735,Secondary Lesion,Advanced Microsatellite Stable Colorectal Carcinoma
23736,Extensive Stage Lesion,Advanced Bile Duct Carcinoma
23737,Refractory Disease,Refractory Primary Cutaneous Lymphoma
23738,High Grade Lesion,Recurrent Alveolar Rhabdomyosarcoma
23739,Recurrent disease,Recurrent Alveolar Rhabdomyosarcoma
23740,Splenomegaly,Recurrent Hairy Cell Leukemia
23741,BRAF V600E Mutation Present,Recurrent Hairy Cell Leukemia
23742,Refractory Disease,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma
23743,Metastatic Lesion,Skin squamous cell carcinoma metastatic
23744,Refractory Disease,Marginal zone lymphoma refractory
23745,atypia morphology,Atypical Type A Thymoma
23746,Carcinomatous Component Present,Mediastinal/Thymic NUT Carcinoma
23747,Diffuse Pattern,Refractory Glioblastoma
23748,Solitary mass,Metastatic Epithelioid Hemangioendothelioma
23749,Secondary Lesion,Metastatic Epithelioid Hemangioendothelioma
23750,Carcinomatous Component Present,Metastatic Genitourinary System Carcinoma
23751,Low Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma
23752,Diffuse Pattern,Childhood Brain Glioblastoma
23753,Necrotic changes (finding),Childhood Brain Glioblastoma
23754,Microvascular Proliferation,Childhood Brain Glioblastoma
23755,Extensive Stage Lesion,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
23756,Carcinomatous Component Present,Refractory Breast Carcinoma
23757,Carcinomatous Component Present,Refractory Colorectal Carcinoma
23758,Epithelial Component Present,Refractory Gastric Carcinoma
23759,Childhood Lesion,Childhood Recurrent Malignant Solid Neoplasm
23760,Recurrent disease,Recurrent WHO Grade III Glioma
23761,Secondary Lesion,Advanced B-Cell Neoplasm
23762,Refractory Disease,Refractory Malignant Thymoma
23763,Recurrent Lymphoma,EBV-Related Lymphoma
23764,Recurrent Lymphoma,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
23765,Carcinomatous Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v7
23766,Aggressive Clinical Course,"Thymoma, type A, malignant"
23767,Epithelial Component Present,Masaoka-Koga Stage IVb
23768,Hormonal resistance,Hormone-Resistant Prostate Carcinoma
23769,Epithelial Component Present,Masaoka-Koga Stage II
23770,Epithelial Component Present,Masaoka-Koga Stage IV
23771,Indolent Clinical Course,"Mixed Tumor, Not Otherwise Specified"
23772,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8
23773,Carcinomatous Component Present,Stage IVB Vaginal Cancer AJCC v8
23774,Epithelial Component Present,Stage IA Cervical Cancer AJCC v8
23775,Carcinomatous Component Present,Stage IB1 Cervical Cancer AJCC v8
23776,Epithelial Component Present,Stage IV Cervical Cancer AJCC v8
23777,Infiltrating Tumor Margins Present,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23778,Tissue of Mullerian Origin Present,Stage IC Uterine Corpus Adenosarcoma AJCC v8
23779,Biphasic Pattern,Stage II Uterine Corpus Adenosarcoma AJCC v8
23780,Biphasic Pattern,Stage III Uterine Corpus Adenosarcoma AJCC v8
23781,Biphasic Pattern,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
23782,Stromal Invasion,Stage IA Ovarian Cancer AJCC v8
23783,Epithelial Component Present,Stage IB Ovarian Cancer AJCC v8
23784,Epithelial Component Present,Stage II Ovarian Cancer AJCC v8
23785,Carcinomatous Component Present,Stage II Ovarian Cancer AJCC v8
23786,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC v8
23787,Stromal Invasion,Stage III Ovarian Cancer AJCC v8
23788,Carcinomatous Component Present,Stage IIIA1 Ovarian Cancer AJCC v8
23789,Epithelial Component Present,Stage IIIA2 Ovarian Cancer AJCC v8
23790,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v8
23791,Stromal Invasion,Stage IV Ovarian Cancer AJCC v8
23792,Carcinomatous Component Present,Stage IVA Ovarian Cancer AJCC v8
23793,Stromal Invasion,Stage IVB Ovarian Cancer AJCC v8
23794,Carcinomatous Component Present,Stage IIIA1 Fallopian Tube Cancer AJCC v8
23795,Carcinomatous Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8
23796,Epithelial Component Present,Primary Peritoneal Cancer by AJCC v7 Stage
23797,Primary Lesion,Primary Peritoneal Cancer by AJCC v8 Stage
23798,Epithelial Component Present,Primary Peritoneal Cancer by AJCC v8 Stage
23799,Primary Lesion,Stage II Primary Peritoneal Cancer AJCC v8
23800,Primary Lesion,Stage IIA Primary Peritoneal Cancer AJCC v8
23801,Primary Lesion,Stage III Primary Peritoneal Cancer AJCC v8
23802,Carcinomatous Component Present,Stage III Primary Peritoneal Cancer AJCC v8
23803,Primary Lesion,Stage IIIA Primary Peritoneal Cancer AJCC v8
23804,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v8
23805,Pregnancy Complications,Stage IV Gestational Trophoblastic Neoplasm AJCC v8
23806,Epithelial Component Present,Stage 0a Penile Cancer AJCC v8
23807,Epithelial Component Present,Stage II Penile Cancer AJCC v8
23808,Epithelial Component Present,Stage IIB Penile Cancer AJCC v8
23809,Carcinomatous Component Present,Stage IIIA Prostate Cancer AJCC v8
23810,Epithelial Component Present,Stage IVB Prostate Cancer AJCC v8
23811,Epithelial Component Present,Stage I Renal Cell Cancer AJCC v8
23812,Carcinomatous Component Present,Stage II Renal Cell Cancer AJCC v8
23813,Carcinomatous Component Present,Renal Pelvis and Ureter Cancer by AJCC v8 Stage
23814,Epithelial Component Present,Renal Pelvis Cancer by AJCC v8 Stage
23815,Carcinomatous Component Present,Renal Pelvis Cancer by AJCC v8 Stage
23816,Epithelial Component Present,Ureter Cancer by AJCC v8 Stage
23817,Non-Invasive Lesion,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
23818,Non-Invasive Lesion,Stage 0a Ureter Cancer AJCC v8
23819,Epithelial Component Present,Stage 0a Ureter Cancer AJCC v8
23820,In Situ Lesion,Stage 0is Renal Pelvis Cancer AJCC v8
23821,Dysplasia,Stage 0is Ureter Cancer AJCC v8
23822,Carcinomatous Component Present,Stage 0is Ureter Cancer AJCC v8
23823,Carcinomatous Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v8
23824,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8
23825,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v8
23826,Epithelial Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v8
23827,Epithelial Component Present,Renal Pelvis and Ureter Cancer by AJCC v7 Stage
23828,Epithelial Component Present,Ureter Cancer by AJCC v7 Stage
23829,Epithelial Component Present,Stage 0a Bladder Cancer AJCC v8
23830,Carcinomatous Component Present,Stage IIIA Bladder Cancer AJCC v8
23831,Carcinomatous Component Present,Stage 0a Urethral Cancer AJCC v8
23832,Epithelial Component Present,Stage IV Urethral Cancer AJCC v8
23833,Carcinomatous Component Present,Eyelid Carcinoma by AJCC v7 Stage
23834,Carcinomatous Component Present,Eyelid Carcinoma by AJCC v8 Stage
23835,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v8
23836,Carcinomatous Component Present,Stage IB Eyelid Carcinoma AJCC v8
23837,Epithelial Component Present,Stage IIIA Eyelid Carcinoma AJCC v8
23838,Epithelial Component Present,Stage IIIB Eyelid Carcinoma AJCC v8
23839,Clinical TNM Finding,Retinoblastoma by AJCC v8 Clinical Stage
23840,Clinical TNM Finding,Clinical Stage II Retinoblastoma AJCC v8
23841,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage
23842,Carcinomatous Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage
23843,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
23844,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
23845,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
23846,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
23847,Thyroglobulin Positive Neoplastic Cells Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
23848,Follicular Cell Differentiation,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8
23849,Epithelial Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8
23850,Carcinomatous Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8
23851,Nuclear Pseudoinclusion,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
23852,Nuclear Grooves,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
23853,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23854,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23855,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23856,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23857,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
23858,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23859,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23860,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
23861,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
23862,Epithelial Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
23863,Epithelial Component Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
23864,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
23865,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
23866,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
23867,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
23868,Epithelial Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
23869,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
23870,Calcitonin serum level increased,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
23871,Epithelial Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
23872,Refractory Disease,Refractory Lung Carcinoma
23873,Necrotic changes (finding),Recurrent Extensive Stage Lung Small Cell Carcinoma
23874,Epithelial Component Present,Recurrent Extensive Stage Lung Small Cell Carcinoma
23875,High Grade Lesion,Refractory Extensive Stage Lung Small Cell Carcinoma
23876,Epithelial Component Present,Refractory Extensive Stage Lung Small Cell Carcinoma
23877,Carcinomatous Component Present,Refractory Extensive Stage Lung Small Cell Carcinoma
23878,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8
23879,Adulthood Lesion,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8
23880,Adulthood Lesion,Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8
23881,Adulthood Lesion,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8
23882,Adulthood Lesion,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8
23883,Childhood Lesion,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8
23884,Childhood Lesion,Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage
23885,'Starry-sky' pattern,Burkitt Lymphoma by Ann Arbor Stage
23886,Anaplasia,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage
23887,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage
23888,Cutaneous Involvement,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8
23889,Blasts of Mixed Phenotype Present,acute biphenotypic leukemia in relapse
23890,Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia refractory
23891,High Mitotic Activity,Malignant Lung PEComa
23892,Peribronchial Proliferation of Neoplastic Cells Present,tumor miofibroblástico peribronquial congénito
23893,Tissue Differentiation Uncertain,Pulmonary Artery Intimal Sarcoma
23894,Carcinomatous Component Present,Primary myoepithelial carcinoma of lung
23895,Recurrent disease,Recurrent Malignant Glioma
23896,Recurrent disease,Recurrent Rhabdoid Tumor
23897,Refractory Disease,Refractory Peripheral Primitive Neuroectodermal Tumor
23898,Neuroectodermal Differentiation,Refractory Peripheral Primitive Neuroectodermal Tumor
23899,Rapidly Enlarging Mass,Refractory Rhabdomyosarcoma
23900,High Grade Lesion,Refractory Rhabdomyosarcoma
23901,Recurrent disease,Recurrent Anaplastic Oligodendroglioma
23902,Primary Lesion,Recurrent Anaplastic Oligodendroglioma
23903,Oligodendroglial Component Present,Recurrent Anaplastic Oligodendroglioma
23904,Carcinomatous Component Present,Metastatic Bile Duct Carcinoma
23905,Carcinomatous Component Present,Advanced Bile Duct Carcinoma
23906,Cutaneous Involvement,Recurrent Primary Cutaneous Lymphoma
23907,Epithelial Component Present,Refractory Thyroid Gland Carcinoma
23908,Hereditary Lesion,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas"
23909,Epithelial Component Present,Atypical Type A Thymoma
23910,Aggressive Clinical Course,Mediastinal/Thymic NUT Carcinoma
23911,Hemorrhagic,Locally Advanced Angiosarcoma
23912,Vascular Channel Formation,Locally Advanced Angiosarcoma
23913,Regional Disease,Locally Advanced Epithelioid Hemangioendothelioma
23914,Vascular Channel Formation,Metastatic Epithelioid Hemangioendothelioma
23915,Hyalinized Stroma Formation,Metastatic Epithelioid Hemangioendothelioma
23916,Metastatic Lesion,Metastatic Genitourinary System Carcinoma
23917,Hyalinized Stroma Formation,Mediastinal Epithelioid Hemangioendothelioma
23918,Mitotic Activity,Cardiac Yolk Sac Tumor
23919,Primary Lesion,"Recurrent Medulloblastoma, SHH-Activated"
23920,Mitotic Activity,Childhood Brain Glioblastoma
23921,High Grade Lesion,Childhood Brain Glioblastoma
23922,Childhood Lesion,Childhood Brain Glioblastoma
23923,Epithelial Component Present,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
23924,Carcinomatous Component Present,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
23925,Refractory Disease,Refractory Breast Carcinoma
23926,Refractory Disease,Refractory Melanoma
23927,Carcinomatous Component Present,Recurrent BRCA-Mutated Ovarian Carcinoma
23928,Benign Cellular Infiltrate,Unresectable Craniopharyngioma
23929,Epithelial Component Present,Pulmonary Sclerosing Hemangioma
23930,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia
23931,Epithelial Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v7
23932,Carcinomatous Component Present,Hormone-Resistant Prostate Carcinoma
23933,Carcinomatous Component Present,Stage I Cervical Cancer AJCC v8
23934,Epithelial Component Present,Stage IB1 Cervical Cancer AJCC v8
23935,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v8
23936,Carcinomatous Component Present,Stage IIA2 Cervical Cancer AJCC v8
23937,Infiltrating Tumor Margins Present,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23938,Infiltrating Tumor Margins Present,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
23939,Biphasic Pattern,Stage I Uterine Corpus Adenosarcoma AJCC v8
23940,Mixed Cellular Population,Stage IB Uterine Corpus Adenosarcoma AJCC v8
23941,Tissue of Mullerian Origin Present,Stage III Uterine Corpus Adenosarcoma AJCC v8
23942,Tissue of Mullerian Origin Present,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
23943,Tissue of Mullerian Origin Present,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
23944,Mixed Cellular Population,Stage IV Uterine Corpus Adenosarcoma AJCC v8
23945,Mixed Cellular Population,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
23946,Tissue of Mullerian Origin Present,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
23947,Stromal Invasion,Stage IB Ovarian Cancer AJCC v8
23948,Stromal Invasion,Stage II Ovarian Cancer AJCC v8
23949,Carcinomatous Component Present,Stage IIB Ovarian Cancer AJCC v8
23950,Stromal Invasion,Stage IIIA2 Ovarian Cancer AJCC v8
23951,Epithelial Component Present,Stage I Fallopian Tube Cancer AJCC v8
23952,Carcinomatous Component Present,Stage I Fallopian Tube Cancer AJCC v8
23953,Carcinomatous Component Present,Stage II Fallopian Tube Cancer AJCC v8
23954,Carcinomatous Component Present,Stage IIA Fallopian Tube Cancer AJCC v8
23955,Carcinomatous Component Present,Stage IIIA Fallopian Tube Cancer AJCC v8
23956,Epithelial Component Present,Stage IVA Fallopian Tube Cancer AJCC v8
23957,Carcinomatous Component Present,Stage II Primary Peritoneal Cancer AJCC v8
23958,Primary Lesion,Stage IIB Primary Peritoneal Cancer AJCC v8
23959,Primary Lesion,Stage IIIB Primary Peritoneal Cancer AJCC v8
23960,Carcinomatous Component Present,Penile Cancer by AJCC v8 Stage
23961,Carcinomatous Component Present,Stage 0 Penile Cancer AJCC v8
23962,Carcinomatous Component Present,Stage 0a Penile Cancer AJCC v8
23963,Carcinomatous Component Present,Stage IIIA Penile Cancer AJCC v8
23964,Epithelial Component Present,Stage II Prostate Cancer AJCC v8
23965,Epithelial Component Present,Stage III Renal Cell Cancer AJCC v8
23966,Extensive Stage Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
23967,Absence of a Hormonal Syndrome,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
23968,Papillary Pattern,Stage 0a Renal Pelvis Cancer AJCC v8
23969,Papillary Pattern,Stage 0a Ureter Cancer AJCC v8
23970,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v8
23971,Carcinomatous Component Present,Stage II Renal Pelvis Cancer AJCC v8
23972,Carcinomatous Component Present,Stage IVA Bladder Cancer AJCC v8
23973,In Situ Lesion,Stage 0is Urethral Cancer AJCC v8
23974,Carcinomatous Component Present,Stage I Urethral Cancer AJCC v8
23975,Carcinomatous Component Present,Urethral Cancer by AJCC v7 Stage
23976,Epithelial Component Present,Eyelid Carcinoma by AJCC v7 Stage
23977,Epithelial Component Present,Stage I Eyelid Carcinoma AJCC v8
23978,Carcinomatous Component Present,Stage IIIA Eyelid Carcinoma AJCC v8
23979,Carcinomatous Component Present,Stage IIIB Eyelid Carcinoma AJCC v8
23980,Carcinomatous Component Present,Stage IV Eyelid Carcinoma AJCC v8
23981,Nuclear Grooves,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
23982,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
23983,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
23984,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
23985,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
23986,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
23987,Follicular Cell Differentiation,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
23988,Carcinomatous Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
23989,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
23990,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23991,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23992,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23993,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23994,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23995,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
23996,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
23997,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23998,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
23999,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
24000,Follicular Cell Differentiation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
24001,Nuclear Pseudoinclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
24002,Epithelial Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
24003,Carcinomatous Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
24004,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
24005,Carcinomatous Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
24006,Carcinomatous Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
24007,Carcinomatous Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24008,Neuroendocrine Differentiation,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
24009,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
24010,Well-Circumscribed Lesion,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
24011,Well-Circumscribed Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
24012,Well-Circumscribed Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
24013,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
24014,Carcinomatous Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
24015,Neuroendocrine Differentiation,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
24016,Carcinomatous Component Present,Refractory Lung Carcinoma
24017,Peripheral Nuclear Palisading,Recurrent Extensive Stage Lung Small Cell Carcinoma
24018,High Mitotic Activity,Refractory Extensive Stage Lung Small Cell Carcinoma
24019,Necrotic changes (finding),Refractory Extensive Stage Lung Small Cell Carcinoma
24020,Refractory Disease,Refractory Extensive Stage Lung Small Cell Carcinoma
24021,Peripheral Nuclear Palisading,Refractory Extensive Stage Lung Small Cell Carcinoma
24022,Epithelial Component Present,Adrenal Cortex Carcinoma by AJCC v7 Stage
24023,Neuroendocrine Differentiation,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
24024,Adulthood Lesion,Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8
24025,Childhood Lesion,Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8
24026,Childhood Lesion,Childhood Lymphoma by AJCC v8 Stage
24027,Childhood Lesion,St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8
24028,Adulthood Lesion,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage
24029,Fibrosis,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage
24030,Adulthood Lesion,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage
24031,Cutaneous Involvement,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage
24032,Cutaneous Involvement,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
24033,Aggressive Clinical Course,Thoracic NUT Carcinoma
24034,Perivascular Arrangement of Tumor Cells,Malignant Lung PEComa
24035,Cellular Pleomorphism,Malignant Lung PEComa
24036,Marked Nuclear Atypia Present,Malignant Lung PEComa
24037,Carcinomatous Component Present,Refractory Pancreatic Carcinoma
24038,Myxoid Stroma Formation,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
24039,Mixed Cellular Population,Recurrent Anaplastic Oligoastrocytoma
24040,Oligodendroglial Component Present,Recurrent Anaplastic Oligoastrocytoma
24041,Anaplasia,Recurrent Anaplastic Oligodendroglioma
24042,Epithelial Component Present,Metastatic Microsatellite Stable Colorectal Carcinoma
24043,Carcinomatous Component Present,Advanced Microsatellite Stable Colorectal Carcinoma
24044,Primary Lesion,Recurrent Primary Cutaneous Lymphoma
24045,High Grade Lesion,Refractory Alveolar Rhabdomyosarcoma
24046,Tartrate Resistant Acid Phosphatase Positive Cells Present,Recurrent Hairy Cell Leukemia
24047,Fried-Egg Appearance of the Bone Marrow,Recurrent Hairy Cell Leukemia
24048,Recurrent disease,Skin squamous cell carcinoma recurrent
24049,Epithelial Component Present,Skin squamous cell carcinoma recurrent
24050,Inoperable Disease,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas"
24051,Epithelial Component Present,Mediastinal/Thymic NUT Carcinoma
24052,Microvascular Proliferation,Refractory Glioblastoma
24053,Mass of body structure,Mediastinal Granulocytic Sarcoma
24054,Myxoid Stroma Formation,Mediastinal Epithelioid Hemangioendothelioma
24055,Refractory Disease,Refractory Central Nervous System Non-Hodgkin Lymphoma
24056,Epithelial Component Present,Metastatic Well Differentiated Neuroendocrine Neoplasm
24057,Multinodular Mass,Hemangiosarcoma of heart
24058,Mitotic Activity,Pericardial Yolk Sac Tumor
24059,Refractory Disease,Refractory Glioma
24060,Immunologic Deficiency Syndromes,Steroid Refractory Graft Versus Host Disease
24061,Platinum Resistance,Platinum-Resistant Ovarian Carcinoma
24062,Epithelial Component Present,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
24063,Carcinomatous Component Present,BRCA-Mutated Ovarian Carcinoma
24064,Refractory Disease,Childhood Refractory Malignant Solid Neoplasm
24065,Epithelial Component Present,Unresectable Craniopharyngioma
24066,Cystic Lesion,Recurrent Craniopharyngioma
24067,Wheezing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia
24068,Carcinomatous Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v7
24069,Recurrent Lymphoma,Grade III Lymphomatoid Granulomatosis
24070,Epithelial Component Present,Masaoka-Koga Stage IIa
24071,Epithelial Component Present,Stage IA Vaginal Cancer AJCC v8
24072,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v8
24073,Epithelial Component Present,Stage IVB Vaginal Cancer AJCC v8
24074,Carcinomatous Component Present,Stage IA Cervical Cancer AJCC v8
24075,Carcinomatous Component Present,Stage IA2 Cervical Cancer AJCC v8
24076,Epithelial Component Present,Stage IB2 Cervical Cancer AJCC v8
24077,Epithelial Component Present,Stage II Cervical Cancer AJCC v8
24078,Epithelial Component Present,Stage III Cervical Cancer AJCC v8
24079,Carcinomatous Component Present,Stage IVB Cervical Cancer AJCC v8
24080,Infiltrating Tumor Margins Present,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
24081,Infiltrating Tumor Margins Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
24082,Mixed Cellular Population,Stage I Uterine Corpus Adenosarcoma AJCC v8
24083,Mixed Cellular Population,Stage III Uterine Corpus Adenosarcoma AJCC v8
24084,Biphasic Pattern,Stage IV Uterine Corpus Adenosarcoma AJCC v8
24085,Epithelial Component Present,Ovarian Cancer by AJCC v8 Stage
24086,Stromal Invasion,Stage IVA Ovarian Cancer AJCC v8
24087,Epithelial Component Present,Stage IA Fallopian Tube Cancer AJCC v8
24088,Epithelial Component Present,Stage II Fallopian Tube Cancer AJCC v8
24089,Carcinomatous Component Present,Stage III Fallopian Tube Cancer AJCC v8
24090,Epithelial Component Present,Stage IIIA Fallopian Tube Cancer AJCC v8
24091,Carcinomatous Component Present,Stage IIIB Fallopian Tube Cancer AJCC v8
24092,Epithelial Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v8
24093,Primary Lesion,Stage IVA Primary Peritoneal Cancer AJCC v8
24094,Epithelial Component Present,Stage IVA Primary Peritoneal Cancer AJCC v8
24095,Carcinomatous Component Present,Stage IVA Primary Peritoneal Cancer AJCC v8
24096,Carcinomatous Component Present,Stage IVB Primary Peritoneal Cancer AJCC v8
24097,Epithelial Component Present,Stage IIIB Penile Cancer AJCC v8
24098,Carcinomatous Component Present,Prostate Cancer by AJCC v8 Stage
24099,Epithelial Component Present,Stage I Prostate Cancer AJCC v8
24100,Epithelial Component Present,Stage IIA Prostate Cancer AJCC v8
24101,Carcinomatous Component Present,Stage IIA Prostate Cancer AJCC v8
24102,Epithelial Component Present,Stage IIB Prostate Cancer AJCC v8
24103,Epithelial Component Present,Stage III Prostate Cancer AJCC v8
24104,Epithelial Component Present,Stage IV Prostate Cancer AJCC v8
24105,Carcinomatous Component Present,Stage IV Renal Cell Cancer AJCC v8
24106,Secondary Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
24107,Secondary Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
24108,Non-Invasive Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
24109,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
24110,Severe dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
24111,Dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8
24112,In Situ Lesion,Stage 0is Ureter Cancer AJCC v8
24113,Severe dysplasia,Stage 0is Ureter Cancer AJCC v8
24114,Carcinomatous Component Present,Stage 0a Bladder Cancer AJCC v8
24115,Carcinomatous Component Present,Stage 0is Bladder Cancer AJCC v8
24116,Carcinomatous Component Present,Stage I Bladder Cancer AJCC v8
24117,Epithelial Component Present,Stage II Bladder Cancer AJCC v8
24118,Carcinomatous Component Present,Stage II Bladder Cancer AJCC v8
24119,Epithelial Component Present,Stage III Bladder Cancer AJCC v8
24120,Carcinomatous Component Present,Stage III Urethral Cancer AJCC v8
24121,Carcinomatous Component Present,Stage IV Urethral Cancer AJCC v8
24122,Epithelial Component Present,Urethral Cancer by AJCC v7 Stage
24123,Carcinomatous Component Present,Stage I Eyelid Carcinoma AJCC v8
24124,Epithelial Component Present,Stage IIA Eyelid Carcinoma AJCC v8
24125,Epithelial Component Present,Stage III Eyelid Carcinoma AJCC v8
24126,Pathologic TNM Finding,Pathologic Stage III Retinoblastoma AJCC v8
24127,Follicular Cell Differentiation,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
24128,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
24129,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
24130,Follicular Cell Differentiation,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
24131,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
24132,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
24133,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
24134,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
24135,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
24136,Epithelial Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
24137,Nuclear Grooves,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
24138,Carcinomatous Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
24139,Follicular Cell Differentiation,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
24140,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
24141,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
24142,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
24143,Carcinomatous Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
24144,Follicular Cell Differentiation,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
24145,High Mitotic Activity,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
24146,Rapidly Enlarging Mass,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
24147,Rapidly Enlarging Mass,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24148,Epithelial Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24149,Rapidly Enlarging Mass,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24150,Epithelial Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24151,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
24152,Calcitonin serum level increased,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
24153,Calcitonin serum level increased,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
24154,Carcinomatous Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
24155,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
24156,Carcinomatous Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
24157,Nuclear Molding,Refractory Extensive Stage Lung Small Cell Carcinoma
24158,More than 10 Mitoses per 10HPF,Refractory Extensive Stage Lung Small Cell Carcinoma
24159,Carcinomatous Component Present,Stage I Adrenal Cortex Carcinoma AJCC v8
24160,Neuroendocrine Differentiation,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
24161,Neuroendocrine Differentiation,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
24162,Adulthood Lesion,Lugano Classification Limited Stage Adult Lymphoma AJCC v8
24163,Adulthood Lesion,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8
24164,Childhood Lesion,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8
24165,Adulthood Lesion,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage
24166,Adulthood Lesion,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8
24167,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8
24168,Childhood Lesion,St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8
24169,Diffuse Pattern,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage
24170,Anaplasia,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage
24171,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage
24172,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage
24173,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage II Plasma Cell Myeloma
24174,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage III Plasma Cell Myeloma
24175,S-100-Positive Neoplastic Cells Present,Benign Lung PEComa
24176,Necrotic changes (finding),Malignant Lung PEComa
24177,HMB-45-Positive Neoplastic Cells Present,Malignant Lung PEComa
24178,Tissue Differentiation Uncertain,Malignant Lung PEComa
24179,Birbeck Granules Present,Pulmonary Histiocytosis X
24180,Primary Lesion,Recurrent Malignant Glioma
24181,Refractory Disease,Refractory Hepatoblastoma
24182,Refractory Disease,Refractory Medulloblastoma
24183,Osseous Differentiation,Refractory Osteosarcoma
24184,Intracytoplasmic Eosinophilic Inclusion,Refractory Rhabdoid Tumor
24185,Diffuse Pattern,Recurrent Anaplastic Oligoastrocytoma
24186,Secondary Lesion,Metastatic Microsatellite Stable Colorectal Carcinoma
24187,Cutaneous Involvement,Refractory Primary Cutaneous Lymphoma
24188,Recurrent disease,Recurrent Hairy Cell Leukemia
24189,Carcinomatous Component Present,Refractory Thyroid Gland Carcinoma
24190,Cutaneous Involvement,Skin squamous cell carcinoma metastatic
24191,Epithelial Component Present,Thymic Hepatoid Adenocarcinoma
24192,Metastatic Lesion,Locally Advanced Angiosarcoma
24193,Regional Disease,Locally Advanced Angiosarcoma
24194,Solitary mass,Locally Advanced Epithelioid Hemangioendothelioma
24195,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma
24196,Metastatic Lesion,Metastatic Epithelioid Hemangioendothelioma
24197,Secondary Lesion,Metastatic Genitourinary System Carcinoma
24198,Vascular Channel Formation,Mediastinal Epithelioid Hemangioendothelioma
24199,Solitary mass,Mediastinal Epithelioid Hemangioendothelioma
24200,Recurrent disease,Recurrent Central Nervous System Non-Hodgkin Lymphoma
24201,Osseous Differentiation,Cardiac Extraskeletal Osteosarcoma
24202,Secondary Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm
24203,Vascular Channel Formation,Hemangiosarcoma of heart
24204,Multinodular Mass,Pericardial Angiosarcoma
24205,Metastatic/Recurrent Disease,Pericardial Synovial Sarcoma
24206,Tissue Differentiation Uncertain,Pericardial Synovial Sarcoma
24207,Sonic Hedgehog/Patch Pathway Activated,"Recurrent Medulloblastoma, SHH-Activated"
24208,Primary Lesion,Childhood Brain Glioblastoma
24209,Refractory Disease,Refractory Colorectal Carcinoma
24210,Stromal Invasion,BRCA-Mutated Ovarian Carcinoma
24211,Primary Lesion,Recurrent WHO Grade III Glioma
24212,Extensive Stage Lesion,Advanced B-Cell Neoplasm
24213,Unresectable Mass,Unresectable Craniopharyngioma
24214,Slow Growing Mass,Recurrent Craniopharyngioma
24215,Recurrent Lymphoma,African Burkitt's lymphoma
24216,Recurrent Lymphoma,EBV-Related Hodgkin Lymphoma
24217,Recurrent Lymphoma,EBV-Related Non-Hodgkin Lymphoma
24218,Recurrent Lymphoma,EBV-Related Burkitt Lymphoma
24219,Carcinomatous Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7
24220,Secondary Lesion,Metastatic angiosarcoma
24221,Epithelial Component Present,Masaoka-Koga Stage IIb
24222,Carcinomatous Component Present,Vaginal Cancer by AJCC v8 Stage
24223,Epithelial Component Present,Stage IIB Vaginal Cancer AJCC v8
24224,Carcinomatous Component Present,Stage IV Vaginal Cancer AJCC v8
24225,Epithelial Component Present,Stage IVA Vaginal Cancer AJCC v8
24226,Epithelial Component Present,Stage IA2 Cervical Cancer AJCC v8
24227,Carcinomatous Component Present,Stage II Cervical Cancer AJCC v8
24228,Epithelial Component Present,Stage IVB Cervical Cancer AJCC v8
24229,Tissue of Mullerian Origin Present,Stage II Uterine Corpus Adenosarcoma AJCC v8
24230,Biphasic Pattern,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
24231,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v8
24232,Carcinomatous Component Present,Stage IA Ovarian Cancer AJCC v8
24233,Epithelial Component Present,Stage IIB Ovarian Cancer AJCC v8
24234,Epithelial Component Present,Stage III Ovarian Cancer AJCC v8
24235,Epithelial Component Present,Stage IIIC Ovarian Cancer AJCC v8
24236,Epithelial Component Present,Stage IVA Ovarian Cancer AJCC v8
24237,Carcinomatous Component Present,Stage IB Fallopian Tube Cancer AJCC v8
24238,Carcinomatous Component Present,Stage IIB Fallopian Tube Cancer AJCC v8
24239,Epithelial Component Present,Stage IIIA1 Fallopian Tube Cancer AJCC v8
24240,Epithelial Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8
24241,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v8
24242,Epithelial Component Present,Stage IVB Fallopian Tube Cancer AJCC v8
24243,Carcinomatous Component Present,Primary Peritoneal Cancer by AJCC v8 Stage
24244,Epithelial Component Present,Stage IIB Primary Peritoneal Cancer AJCC v8
24245,Epithelial Component Present,Stage III Primary Peritoneal Cancer AJCC v8
24246,Pregnancy Complications,Stage I Gestational Trophoblastic Neoplasm AJCC v8
24247,Carcinomatous Component Present,Stage IIA Penile Cancer AJCC v8
24248,Carcinomatous Component Present,Stage IV Penile Cancer AJCC v8
24249,Carcinomatous Component Present,Stage II Prostate Cancer AJCC v8
24250,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v8
24251,Epithelial Component Present,Stage IIIB Prostate Cancer AJCC v8
24252,Carcinomatous Component Present,Stage IV Prostate Cancer AJCC v8
24253,Carcinomatous Component Present,Renal Cell Cancer by AJCC v8 Stage
24254,Metastatic Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
24255,Metastatic Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
24256,Carcinomatous Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
24257,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v8
24258,Epithelial Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8
24259,Epithelial Component Present,Stage III Renal Pelvis Cancer AJCC v8
24260,Epithelial Component Present,Stage IV Ureter Cancer AJCC v8
24261,Epithelial Component Present,Renal Pelvis Cancer by AJCC v7 Stage
24262,Carcinomatous Component Present,Ureter Cancer by AJCC v7 Stage
24263,Epithelial Component Present,Stage 0is Bladder Cancer AJCC v8
24264,Epithelial Component Present,Stage IV Bladder Cancer AJCC v8
24265,Epithelial Component Present,Stage IVB Bladder Cancer AJCC v8
24266,Epithelial Component Present,Urethral Cancer by AJCC v8 Stage
24267,Epithelial Component Present,Stage II Eyelid Carcinoma AJCC v8
24268,Epithelial Component Present,Stage IIB Eyelid Carcinoma AJCC v8
24269,Epithelial Component Present,Stage IV Eyelid Carcinoma AJCC v8
24270,Epithelial Component Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
24271,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
24272,Epithelial Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage
24273,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
24274,Epithelial Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
24275,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
24276,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
24277,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
24278,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
24279,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
24280,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
24281,Carcinomatous Component Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
24282,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
24283,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
24284,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
24285,Carcinomatous Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
24286,Papillary Pattern,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
24287,Follicular Cell Differentiation,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
24288,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
24289,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
24290,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
24291,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
24292,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
24293,Follicular Cell Differentiation,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
24294,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
24295,High Mitotic Activity,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
24296,Epithelial Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24297,Carcinomatous Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24298,Carcinomatous Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24299,Neuroendocrine Differentiation,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
24300,Epithelial Component Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
24301,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
24302,Neuroendocrine Differentiation,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
24303,Calcitonin Positive Neoplastic Cells Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
24304,Calcitonin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
24305,Epithelial Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
24306,Calcitonin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
24307,Epithelial Component Present,Refractory Lung Carcinoma
24308,Recurrent disease,Recurrent Extensive Stage Lung Small Cell Carcinoma
24309,Epithelial Component Present,Stage I Adrenal Cortex Carcinoma AJCC v8
24310,Epithelial Component Present,Stage II Adrenal Cortex Carcinoma AJCC v8
24311,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v8
24312,Epithelial Component Present,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
24313,Cutaneous Involvement,Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage
24314,Adulthood Lesion,Lugano Classification Stage I Adult Lymphoma AJCC v8
24315,Adulthood Lesion,Lugano Classification Stage IE Adult Lymphoma AJCC v8
24316,Adulthood Lesion,Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8
24317,Childhood Lesion,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8
24318,Childhood Lesion,Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8
24319,Adulthood Lesion,Lugano Classification Stage I Adult Hodgkin Lymphoma AJCC v8
24320,Childhood Lesion,Childhood Hodgkin Lymphoma by Ann Arbor Stage
24321,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma by Ann Arbor Stage
24322,Diffuse Pattern,Centroblastic Lymphoma by Ann Arbor Stage
24323,Childhood Lesion,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage
24324,Cutaneous Involvement,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
24325,Cutaneous Involvement,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8
24326,Refractory Disease,Waldenstrom's macroglobulinemia refractory
24327,Bone Marrow Involvement,Waldenstrom's macroglobulinemia refractory
24328,Epithelial Component Present,Thoracic NUT Carcinoma
24329,Carcinomatous Component Present,Thoracic NUT Carcinoma
24330,HMB-45-Positive Neoplastic Cells Present,Lung PEComa
24331,Perivascular Arrangement of Tumor Cells,Benign Lung PEComa
24332,HMB-45-Positive Neoplastic Cells Present,Benign Lung PEComa
24333,Infiltrative Growth Pattern,Malignant Lung PEComa
24334,Intraluminal Tumor Growth,Pulmonary Artery Intimal Sarcoma
24335,Intracytoplasmic Eosinophilic Inclusion,Recurrent Rhabdoid Tumor
24336,Refractory Disease,Refractory Malignant Glioma
24337,Refractory Disease,Refractory Rhabdoid Tumor
24338,Recurrent disease,Recurrent Anaplastic Oligoastrocytoma
24339,Increased Cellularity Present,Recurrent Anaplastic Oligoastrocytoma
24340,High Mitotic Activity,Recurrent Anaplastic Oligodendroglioma
24341,Epithelial Component Present,Advanced Microsatellite Stable Colorectal Carcinoma
24342,Recurrent disease,Recurrent Primary Cutaneous Lymphoma
24343,Refractory Disease,Refractory Alveolar Rhabdomyosarcoma
24344,Bone marrow reticulin fibrosis,Recurrent Hairy Cell Leukemia
24345,Carcinomatous Component Present,Skin squamous cell carcinoma recurrent
24346,Carcinomatous Component Present,Skin squamous cell carcinoma metastatic
24347,Cafe-au-Lait Spots,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas"
24348,Hyalinized Stroma Formation,Locally Advanced Epithelioid Hemangioendothelioma
24349,Low Grade Lesion,Locally Advanced Epithelioid Hemangioendothelioma
24350,Indolent Clinical Course,hemangioma of mediastinum
24351,Metastatic Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm
24352,Neuroendocrine Differentiation,Metastatic Well Differentiated Neuroendocrine Neoplasm
24353,Hemorrhagic,Hemangiosarcoma of heart
24354,Recurrent disease,"Recurrent Medulloblastoma, SHH-Activated"
24355,Epithelial Component Present,Platinum-Resistant Ovarian Carcinoma
24356,Carcinomatous Component Present,Platinum-Resistant Ovarian Carcinoma
24357,Secondary Lesion,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
24358,Refractory Disease,Refractory Gastric Carcinoma
24359,Recurrent disease,Recurrent BRCA-Mutated Ovarian Carcinoma
24360,Epithelial Component Present,Recurrent BRCA-Mutated Ovarian Carcinoma
24361,Unresectable Mass,Unresectable Malignant Solid Neoplasm
24362,Recurrent disease,Recurrent WHO Grade II Glioma
24363,Metastatic Lesion,Advanced B-Cell Neoplasm
24364,Recurrent Lymphoma,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
24365,Aggressive Clinical Course,"Thymoma, type B2, malignant"
24366,Capsular Invasion,"Thymoma, type B2, malignant"
24367,Recurrent Lymphoma,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
24368,Indolent Clinical Course,Benign myoepithelioma
24369,Epithelial Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v7
24370,Recurrent Lymphoma,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly
24371,Epithelial Component Present,Masaoka-Koga Stage IVa
24372,Recurrent Lymphoma,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
24373,Carcinomatous Component Present,Stage I Vaginal Cancer AJCC v8
24374,Carcinomatous Component Present,Stage IA Vaginal Cancer AJCC v8
24375,Epithelial Component Present,Stage IB Vaginal Cancer AJCC v8
24376,Carcinomatous Component Present,Stage IB Vaginal Cancer AJCC v8
24377,Epithelial Component Present,Stage III Vaginal Cancer AJCC v8
24378,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v8
24379,Epithelial Component Present,Stage IA1 Cervical Cancer AJCC v8
24380,Carcinomatous Component Present,Stage IA1 Cervical Cancer AJCC v8
24381,Epithelial Component Present,Stage IIA1 Cervical Cancer AJCC v8
24382,Epithelial Component Present,Stage IIIA Cervical Cancer AJCC v8
24383,Carcinomatous Component Present,Stage IIIB Cervical Cancer AJCC v8
24384,Carcinomatous Component Present,Stage IV Cervical Cancer AJCC v8
24385,Infiltrating Tumor Margins Present,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
24386,Mixed Cellular Population,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
24387,Tissue of Mullerian Origin Present,Stage IV Uterine Corpus Adenosarcoma AJCC v8
24388,Carcinomatous Component Present,Ovarian Cancer by AJCC v8 Stage
24389,Carcinomatous Component Present,Stage IC Ovarian Cancer AJCC v8
24390,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC v8
24391,Carcinomatous Component Present,Stage IIIB Ovarian Cancer AJCC v8
24392,Carcinomatous Component Present,Stage IIIC Ovarian Cancer AJCC v8
24393,Epithelial Component Present,Fallopian Tube Cancer by AJCC v8 Stage
24394,Epithelial Component Present,Stage IIB Fallopian Tube Cancer AJCC v8
24395,Epithelial Component Present,Stage IIIB Fallopian Tube Cancer AJCC v8
24396,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v8
24397,Primary Lesion,Primary Peritoneal Cancer by AJCC v7 Stage
24398,Carcinomatous Component Present,Primary Peritoneal Cancer by AJCC v7 Stage
24399,Carcinomatous Component Present,Stage IIA Primary Peritoneal Cancer AJCC v8
24400,Carcinomatous Component Present,Stage IIB Primary Peritoneal Cancer AJCC v8
24401,Carcinomatous Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v8
24402,Pregnancy Complications,Gestational Trophoblastic Neoplasm by AJCC v8 Stage
24403,Pregnancy Complications,Stage III Gestational Trophoblastic Neoplasm AJCC v8
24404,Epithelial Component Present,Stage IIA Penile Cancer AJCC v8
24405,Carcinomatous Component Present,Stage IIIB Penile Cancer AJCC v8
24406,Carcinomatous Component Present,Stage I Prostate Cancer AJCC v8
24407,Epithelial Component Present,Stage IIIA Prostate Cancer AJCC v8
24408,Epithelial Component Present,Stage IIIC Prostate Cancer AJCC v8
24409,Carcinomatous Component Present,Stage III Renal Cell Cancer AJCC v8
24410,Absence of a Hormonal Syndrome,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
24411,Epithelial Component Present,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
24412,Epithelial Component Present,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
24413,Carcinomatous Component Present,Ureter Cancer by AJCC v8 Stage
24414,Dysplasia,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
24415,Dysplasia,Stage 0a Ureter Cancer AJCC v8
24416,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
24417,Non-Invasive Lesion,Stage 0is Ureter Cancer AJCC v8
24418,Carcinomatous Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8
24419,Epithelial Component Present,Stage III Ureter Cancer AJCC v8
24420,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v8
24421,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v8
24422,Carcinomatous Component Present,Renal Pelvis Cancer by AJCC v7 Stage
24423,Epithelial Component Present,Stage IIIA Bladder Cancer AJCC v8
24424,Carcinomatous Component Present,Stage IIIB Bladder Cancer AJCC v8
24425,Carcinomatous Component Present,Stage IVB Bladder Cancer AJCC v8
24426,Absence of Invasion,Stage 0is Urethral Cancer AJCC v8
24427,Epithelial Component Present,Stage I Urethral Cancer AJCC v8
24428,Epithelial Component Present,Stage II Urethral Cancer AJCC v8
24429,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v8
24430,Clinical TNM Finding,Clinical Stage III Retinoblastoma AJCC v8
24431,Pathologic TNM Finding,Retinoblastoma by AJCC v8 Pathologic Stage
24432,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage
24433,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
24434,Epithelial Component Present,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
24435,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8
24436,Follicular Cell Differentiation,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
24437,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
24438,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
24439,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
24440,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
24441,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
24442,Nuclear Pseudoinclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
24443,Follicular Cell Differentiation,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
24444,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
24445,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
24446,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
24447,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
24448,Epithelial Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
24449,Epithelial Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
24450,High Mitotic Activity,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24451,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
24452,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
24453,Epithelial Component Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
24454,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
24455,Carcinomatous Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
24456,Calcitonin Positive Neoplastic Cells Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
24457,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
24458,Carcinomatous Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
24459,Well-Circumscribed Lesion,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
24460,Epithelial Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
24461,Well-Circumscribed Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
24462,Calcitonin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
24463,Well-Circumscribed Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
24464,Epithelial Component Present,Adrenal Cortex Carcinoma by AJCC v8 Stage
24465,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v8
24466,Epithelial Component Present,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8
24467,Epidermotropic Lymphocytic Infiltrate,Mycosis Fungoides by AJCC v7 Stage
24468,Childhood Lesion,Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8
24469,Childhood Lesion,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8
24470,Nodular Pattern,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage
24471,Lymphadenopathy,Nodal Marginal Zone Lymphoma by Ann Arbor Stage
24472,Increased NFkappaB Pathway Activation,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage
24473,Cutaneous Involvement,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8
24474,Cutaneous Involvement,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
24475,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage I Plasma Cell Myeloma
24476,Perivascular Arrangement of Tumor Cells,Lung PEComa
24477,Metastatic/Recurrent Disease,Pulmonary Artery Intimal Sarcoma
24478,High Mitotic Activity,Recurrent Anaplastic Oligoastrocytoma
24479,Nuclear Atypia,Recurrent Anaplastic Oligoastrocytoma
24480,Increased Cellularity Present,Recurrent Anaplastic Oligodendroglioma
24481,Secondary Lesion,Advanced Bile Duct Carcinoma
24482,Epithelial Component Present,Advanced Bile Duct Carcinoma
24483,Rapidly Enlarging Mass,Recurrent Alveolar Rhabdomyosarcoma
24484,Refractory Disease,Refractory Thyroid Gland Carcinoma
24485,Epithelial Component Present,Skin squamous cell carcinoma metastatic
24486,Progressive Disease,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas"
24487,Carcinomatous Component Present,Thymic Hepatoid Adenocarcinoma
24488,Mitotic Activity,Refractory Glioblastoma
24489,Nuclear Atypia,Refractory Glioblastoma
24490,Anaplasia,Refractory Glioblastoma
24491,Necrotic changes (finding),Refractory Glioblastoma
24492,Epithelial Component Present,Metastatic Genitourinary System Carcinoma
24493,Primary Lesion,Refractory Central Nervous System Non-Hodgkin Lymphoma
24494,Myxoid Stroma Formation,Cardiac Myxofibrosarcoma
24495,Curvilinear Thin-Walled Vascular Pattern,Cardiac Myxofibrosarcoma
24496,Monomorphic Cellular Infiltrate,Refractory Ependymoma
24497,Refractory Disease,"Refractory Medulloblastoma, SHH-Activated"
24498,Immunosuppression-Related Post-Transplant Toxicity,Steroid Refractory Graft Versus Host Disease
24499,Recurrent Lymphoma,Recurrent EBV-Related Lymphoma
24500,Metastatic Lesion,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
24501,Epithelial Component Present,Refractory Breast Carcinoma
24502,Recurrent disease,Childhood Recurrent Malignant Solid Neoplasm
24503,Recurrent disease,Recurrent Craniopharyngioma
24504,Epithelial Component Present,Recurrent Craniopharyngioma
24505,Indolent Clinical Course,Lung Clear Cell Tumor
24506,Aggressive Clinical Course,"Thymoma, type AB, malignant"
24507,Capsular Invasion,"Thymoma, type AB, malignant"
24508,Recurrent Lymphoma,Recurrent Grade III Lymphomatoid Granulomatosis
24509,Coughing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia
24510,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7
24511,Capsular Invasion,"Thymoma, type B1, malignant"
24512,Unresectable Mass,Unresectable Thymic Carcinoma
24513,Recurrent disease,Recurrent Thymic Carcinoma
24514,Carcinomatous Component Present,Recurrent Thymic Carcinoma
24515,Metastatic Lesion,Locally Advanced Carcinoma
24516,Epithelial Component Present,Locally Advanced Carcinoma
24517,Carcinomatous Component Present,Locally Advanced Carcinoma
24518,Refractory Disease,Refractory Head and Neck Squamous Cell Carcinoma
24519,Epithelial Component Present,Refractory Head and Neck Squamous Cell Carcinoma
24520,Recurrent disease,Recurrent Grade 3a Follicular Lymphoma
24521,Refractory Disease,Refractory Stage 0 Bladder Cancer AJCC v6 and v7
24522,Refractory Disease,Refractory Leiomyosarcoma
24523,Refractory Disease,Refractory Synovial Sarcoma
24524,Well-Circumscribed Lesion,Refractory Myxoid Liposarcoma
24525,Recurrent disease,Recurrent Myelodysplastic Syndrome
24526,Refractory Disease,Refractory Laryngeal Squamous Cell Carcinoma
24527,Refractory Disease,Refractory Oropharyngeal Squamous Cell Carcinoma
24528,Epithelial Component Present,Refractory Oropharyngeal Squamous Cell Carcinoma
24529,Diffuse Pattern,MCD Diffuse Large B-Cell Lymphoma
24530,Diffuse Pattern,BN2 Diffuse Large B-Cell Lymphoma
24531,Epithelial Component Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
24532,Carcinomatous Component Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
24533,Refractory Disease,Refractory Mixed Phenotype Acute Leukemia
24534,Metastatic Lesion,Locally Advanced Melanoma
24535,Refractory Disease,Refractory Human Papillomavirus-Related Malignant Neoplasm
24536,Secondary Lesion,Advanced Uveal Melanoma
24537,Epithelial Component Present,Thoracic Esophagus Adenocarcinoma
24538,Carcinomatous Component Present,Thoracic Esophagus Adenocarcinoma
24539,Carcinomatous Component Present,Cervical Esophagus Adenocarcinoma
24540,Epithelial Component Present,Gastric Cardia Squamous Cell Carcinoma
24541,Refractory Disease,Refractory Chronic Leukemia
24542,Blasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Chronic Myelomonocytic Leukemia
24543,Bone Marrow Dysplasia Present,Recurrent Chronic Myelomonocytic Leukemia
24544,Refractory Disease,Refractory Chronic Myelomonocytic Leukemia
24545,Refractory Disease,Refractory Ovarian Carcinoma
24546,Epithelial Component Present,Refractory Ovarian Carcinoma
24547,Recurrent disease,Recurrent Ovarian Endometrioid Adenocarcinoma
24548,Refractory Disease,Refractory Endometrial Endometrioid Adenocarcinoma
24549,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Endometrial Endometrioid Adenocarcinoma
24550,Recurrent disease,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
24551,CD56-Positive Neoplastic Cells Present,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
24552,Secondary Lesion,Advanced Oral Cavity Squamous Cell Carcinoma
24553,Carcinomatous Component Present,Advanced Nasopharyngeal Squamous Cell Carcinoma
24554,Epithelial Component Present,Advanced Hypopharyngeal Squamous Cell Carcinoma
24555,Carcinomatous Component Present,Advanced Hypopharyngeal Squamous Cell Carcinoma
24556,Metastatic Lesion,Squamous cell carcinoma of the hypopharynx stage IV
24557,Bilateral Disease,Bilateral Synchronous Sporadic Renal Cell Carcinoma
24558,Focal Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma
24559,Lymphoplasmacytic Infiltrate,HHV8-Positive Multicentric Castleman Disease
24560,CD56-Positive Neoplastic Cells Present,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma
24561,Unclassifiable Lesion,"Intestinal T-Cell Lymphoma, Not Otherwise Specified"
24562,Refractory Disease,Refractory T Acute Lymphoblastic Leukemia
24563,Secondary Lesion,Metastatic Urethral Urothelial Carcinoma
24564,Carcinomatous Component Present,Metastatic Renal Pelvis Urothelial Carcinoma
24565,Epithelial Component Present,Urothelial carcinoma ureter recurrent
24566,Carcinomatous Component Present,Recurrent Renal Pelvis Urothelial Carcinoma
24567,Unresectable Mass,Unresectable Urothelial Carcinoma
24568,Refractory Disease,Refractory Malignant Pharyngeal Neoplasm
24569,Refractory Disease,Refractory Malignant Mesothelioma
24570,Refractory Disease,Refractory Cutaneous Melanoma
24571,Recurrent disease,Recurrent Malignant Skin Neoplasm
24572,Refractory Disease,Refractory Malignant Skin Neoplasm
24573,Invasive Lesion,Infiltrating Bladder Carcinoma
24574,Carcinomatous Component Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
24575,Carcinomatous Component Present,Metastatic Gastroesophageal Junction Adenocarcinoma
24576,Carcinomatous Component Present,Unresectable Adrenal Cortex Carcinoma
24577,Carcinomatous Component Present,Refractory Lung Small Cell Carcinoma
24578,Non Lipogenic Sarcomatous Stroma Present,Refractory Dedifferentiated Liposarcoma
24579,Necrotic changes (finding),Unresectable Dedifferentiated Liposarcoma
24580,Neuroectodermal Differentiation,Unresectable Neuroblastoma
24581,Therapy-Related Toxicity,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
24582,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Disseminated"
24583,Storiform Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
24584,Metastatic Lesion,Metastatic Gastrointestinal Stromal Tumor
24585,Metastatic Lesion,Refractory Metastatic Digestive System Carcinoma
24586,Epithelial Component Present,Refractory Metastatic Digestive System Carcinoma
24587,Aggressive Clinical Course,Recurrent Burkitt Leukemia
24588,Recurrent disease,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
24589,Rapidly Enlarging Mass,Pelvic Rhabdomyosarcoma
24590,High Grade Lesion,Abdominal Rhabdomyosarcoma
24591,High Grade Lesion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
24592,No Identifiable Line of Differentiation,Abdominal Undifferentiated Pleomorphic Sarcoma
24593,Epithelial Component Present,Locally Advanced Pancreatic Ductal Adenocarcinoma
24594,Epithelial Component Present,Distal Esophagus Adenocarcinoma
24595,Carcinomatous Component Present,Refractory Fallopian Tube Carcinoma
24596,Refractory Disease,Refractory Female Reproductive System Carcinoma
24597,High Grade Lesion,Unresectable Synovial Sarcoma
24598,Carcinomatous Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma
24599,Severe cytologic atypia,Unresectable Pancreatic Neuroendocrine Carcinoma
24600,Carcinomatous Component Present,Refractory Lung Non-Small Cell Carcinoma
24601,Metastatic Lesion,Advanced Renal Cell Carcinoma
24602,Carcinomatous Component Present,Advanced Renal Cell Carcinoma
24603,Extensive Stage Lesion,Advanced Lymphoma
24604,Secondary Lesion,Advanced Lymphoma
24605,High Grade Lesion,Advanced Synovial Sarcoma
24606,Tissue Differentiation Uncertain,Advanced Synovial Sarcoma
24607,Extensive Stage Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma
24608,Secondary Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma
24609,Carcinomatous Component Present,Metastatic Lung Carcinoma
24610,Metastatic Lesion,Advanced Lung Carcinoma
24611,Secondary Lesion,Advanced Lung Carcinoma
24612,"Amorphus, Eosinophilic, and Acellular Deposit",Senile cardiac amyloidosis
24613,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Senile cardiac amyloidosis
24614,Secondary Lesion,Metastatic Unresectable Carcinoma
24615,Lobulated Growth Pattern,Unresectable Chordoma
24616,Solitary mass,Unresectable Chordoma
24617,Slow Growing Mass,Unresectable Chordoma
24618,Recurrent disease,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
24619,Tissue of Mullerian Origin Present,Recurrent Ovarian Carcinosarcoma
24620,Refractory Disease,Refractory Liver Carcinoma
24621,Carcinomatous Component Present,Refractory Liver Carcinoma
24622,Metastatic Lesion,Locally Advanced Digestive System Carcinoma
24623,Epithelial Component Present,Locally Advanced Digestive System Carcinoma
24624,Recurrent disease,Recurrent Gastroesophageal Junction Adenocarcinoma
24625,Epithelial Component Present,Metastatic Cervical Adenocarcinoma
24626,Unresectable Mass,Locally Advanced Unresectable Bone Sarcoma
24627,Unresectable Mass,Locally Advanced Unresectable Soft Tissue Sarcoma
24628,Secondary Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma
24629,Carcinomatous Component Present,Recurrent Acinic Cell Breast Carcinoma
24630,Acinar Cell Differentiation,Recurrent Acinic Cell Breast Carcinoma
24631,Carcinomatous Component Present,Recurrent Pancreatic Acinar Cell Carcinoma
24632,Epithelial Component Present,Recurrent Prostate Acinar Adenocarcinoma
24633,Epithelial Component Present,Recurrent Parotid Gland Acinic Cell Carcinoma
24634,Recurrent disease,Recurrent Submandibular Gland Acinic Cell Carcinoma
24635,Recurrent disease,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type"
24636,Invasive Lesion,Recurrent Invasive Ductal Breast Carcinoma
24637,Epithelial Component Present,Recurrent Invasive Ductal Breast Carcinoma
24638,Recurrent disease,Recurrent Paget Disease of the Breast
24639,Epithelial Component Present,Recurrent Paget Disease of the Breast
24640,Recurrent disease,Recurrent Chromophobe Renal Cell Carcinoma
24641,High Mitotic Activity,Recurrent Salivary Duct Carcinoma
24642,Carcinomatous Component Present,Recurrent Ovarian Adenocarcinoma
24643,Recurrent disease,Recurrent Ovarian Mucinous Adenocarcinoma
24644,Nuclear Pseudoinclusion,Recurrent Thyroid Gland Papillary Carcinoma
24645,Carcinomatous Component Present,Recurrent Thyroid Gland Medullary Carcinoma
24646,Carcinomatous Component Present,Recurrent Parotid Gland Carcinoma
24647,Carcinomatous Component Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma
24648,Epithelial Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
24649,Mesenchymal Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
24650,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
24651,Epithelial Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma
24652,Recurrent disease,Recurrent Submandibular Gland Squamous Cell Carcinoma
24653,Carcinomatous Component Present,Recurrent Parotid Gland Undifferentiated Carcinoma
24654,Stromal Invasion,Recurrent Malignant Ovarian Transitional Cell Tumor
24655,Recurrent disease,Recurrent Ovarian Transitional Cell Carcinoma
24656,Recurrent disease,Recurrent Malignant Brain Neoplasm
24657,Refractory Disease,Refractory Malignant Brain Neoplasm
24658,Primary Lesion,Metastatic Fibrolamellar Carcinoma
24659,Carcinomatous Component Present,Recurrent Fibrolamellar Carcinoma
24660,Epithelial Component Present,Hepatic cancer metastatic
24661,Carcinomatous Component Present,Locally Advanced Squamous Cell Carcinoma
24662,Regional Disease,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
24663,Epithelial Component Present,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
24664,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
24665,Infiltrative Growth Pattern,MGMT-Methylated Glioblastoma
24666,Crooke Hyaline Change,Crooke Cell Adenoma
24667,Epithelial Component Present,Crooke Cell Adenoma
24668,Generalized illness,Letterer-Siwe Disease
24669,Primary Lesion,Diencephalic Glioblastoma
24670,Immunologic Deficiency Syndromes,Methotrexate-Associated Diffuse Large B-Cell Lymphoma
24671,Secondary Lesion,Liposarcoma metastatic
24672,Steatohepatitis,Inflammatory Hepatocellular Adenoma
24673,Epithelial Component Present,Recurrent Thymic Carcinoma
24674,Tissue Differentiation Uncertain,Refractory Synovial Sarcoma
24675,Recurrent disease,Recurrent Sarcoma
24676,Epithelial Component Present,Refractory Hypopharyngeal Squamous Cell Carcinoma
24677,Epithelial Component Present,Refractory Laryngeal Squamous Cell Carcinoma
24678,Carcinomatous Component Present,Refractory Oral Cavity Squamous Cell Carcinoma
24679,Carcinomatous Component Present,Refractory Oropharyngeal Squamous Cell Carcinoma
24680,Refractory Disease,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
24681,Recurrent disease,Recurrent Acute Leukemia
24682,Epithelial Component Present,Advanced Urothelial Carcinoma
24683,Extensive Stage Lesion,Advanced Uveal Melanoma
24684,Castration-Naive,Castration-Naive Prostate Carcinoma
24685,Recurrent disease,Recurrent Chronic Myelomonocytic Leukemia
24686,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent Chronic Myelomonocytic Leukemia
24687,Immature Granulocytes in Peripheral Blood Under 10 Percent,Refractory Chronic Myelomonocytic Leukemia
24688,Refractory Disease,Refractory Ovarian Endometrioid Adenocarcinoma
24689,Extensive Stage Lesion,Uveal Melanoma Metastatic in the Liver
24690,Metastatic Lesion,Uveal Melanoma Metastatic in the Liver
24691,Extensive Stage Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx
24692,Secondary Lesion,Metastatic Squamous Cell Carcinoma of the Oropharynx
24693,Metastatic Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma
24694,Secondary Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma
24695,Epithelial Component Present,Advanced Nasopharyngeal Squamous Cell Carcinoma
24696,Carcinomatous Component Present,Advanced Laryngeal Squamous Cell Carcinoma
24697,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Larynx
24698,Refractory Disease,Refractory Urothelial Carcinoma
24699,Lymphadenopathy,HHV8-Positive Multicentric Castleman Disease
24700,Tumor Mass,Extracavitary Primary Effusion Lymphoma
24701,Epithelial Component Present,Metastatic Urethral Urothelial Carcinoma
24702,Epithelial Component Present,Urothelial carcinoma ureter metastatic
24703,Carcinomatous Component Present,Urothelial carcinoma ureter metastatic
24704,Recurrent disease,Recurrent Renal Pelvis Urothelial Carcinoma
24705,Carcinomatous Component Present,Unresectable Urothelial Carcinoma
24706,Refractory Disease,Refractory Malignant Female Reproductive System Neoplasm
24707,Recurrent disease,Recurrent Malignant Neoplasm of Multiple Primary Sites
24708,Primary Lesion,Recurrent Malignant Neoplasm of Multiple Primary Sites
24709,Primary Lesion,Refractory Malignant Neoplasm of Multiple Primary Sites
24710,Refractory Disease,Refractory Malignant Neoplasm of Multiple Primary Sites
24711,Refractory Disease,Refractory Malignant Endocrine Neoplasm
24712,Epithelial Component Present,Refractory Malignant Endocrine Neoplasm
24713,Muscle Invasion,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
24714,Metastatic Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma
24715,Secondary Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma
24716,Epithelial Component Present,Metastatic Gastroesophageal Junction Adenocarcinoma
24717,Nodular Pattern,Recurrent Myxoid Liposarcoma
24718,Myxoid Stroma Formation,Recurrent Myxoid Liposarcoma
24719,Refractory Disease,Refractory Lung Small Cell Carcinoma
24720,Favorable Clinical Outcome,Testicular Follicular Lymphoma
24721,Metastatic Lesion,Metastatic Malignant Neoplasm in the Viscera
24722,Resectable Mass,Resectable Carcinoma
24723,Unresectable Mass,Unresectable Undifferentiated Pleomorphic Sarcoma
24724,Monoclonal Langerhans Cells Present,"Langerhans cell histiocytosis, unifocal"
24725,Generalized illness,"Langerhans Cell Histiocytosis, Disseminated"
24726,Lymphoplasmacytic Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
24727,Regional Disease,Locally Advanced Gastrointestinal Stromal Tumor
24728,Unresectable Mass,Unresectable Gastrointestinal Stromal Tumor
24729,Hereditary Lesion,Familial Acute Myeloid Leukemia with Mutated Cebpa
24730,Hereditary Lesion,Myeloid Neoplasms with Germline DDX41 Mutation
24731,Hereditary Lesion,Myeloid Neoplasms with Germline RUNX1 Mutation
24732,Refractory Disease,Refractory Head and Neck Carcinoma
24733,Carcinomatous Component Present,Refractory Head and Neck Carcinoma
24734,Hereditary Lesion,Myeloid Neoplasms with Germline ANKRD26 Mutation
24735,Secondary Lesion,Locally Advanced Bile Duct Carcinoma
24736,Recurrent disease,Recurrent Burkitt Leukemia
24737,Epithelial Component Present,Resectable Pancreatic Ductal Adenocarcinoma
24738,Carcinomatous Component Present,Resectable Pancreatic Ductal Adenocarcinoma
24739,Primary Lesion,Refractory Primary Peritoneal Carcinoma
24740,Unresectable Mass,Metastatic Unresectable Sarcoma
24741,Neuroendocrine Differentiation,Unresectable Carcinoid Tumor
24742,Chromogranin A Positive Neoplastic Cells Present,Unresectable Carcinoid Tumor
24743,Hepatomegaly,Recurrent Hepatosplenic T-Cell Lymphoma
24744,Splenomegaly,Recurrent Hepatosplenic T-Cell Lymphoma
24745,Recurrent disease,Recurrent Hepatosplenic T-Cell Lymphoma
24746,Bone Marrow Involvement,Refractory Hepatosplenic T-Cell Lymphoma
24747,Metastatic Lesion,Advanced Carcinoma
24748,Metastatic/Recurrent Disease,Advanced Synovial Sarcoma
24749,Secondary Lesion,Advanced Sarcoma
24750,Epithelial Component Present,Metastatic Lung Carcinoma
24751,Epithelial Component Present,Advanced Lung Carcinoma
24752,Regional Disease,Locally Advanced Head and Neck Carcinoma
24753,Carcinomatous Component Present,Locally Advanced Head and Neck Carcinoma
24754,Secondary Lesion,Colorectal Carcinoma Metastatic in the Lung
24755,Secondary Lesion,Metastatic gastric adenocarcinoma
24756,Carcinomatous Component Present,Metastatic gastric adenocarcinoma
24757,Lobulated Growth Pattern,Metastatic Chordoma
24758,Myxoid Stroma Formation,Metastatic Chordoma
24759,Myxoid Stroma Formation,Locally Advanced Chordoma
24760,Metastatic Lesion,Castration-Sensitive Prostate Carcinoma
24761,Recurrent disease,Recurrent Ovarian Carcinosarcoma
24762,Epithelial Component Present,Recurrent Ovarian Carcinosarcoma
24763,Sarcomatous Component Present,Recurrent Ovarian Carcinosarcoma
24764,Estrogen receptor negative,Metastatic Triple-Negative Breast Carcinoma
24765,progesterone receptor negative,Metastatic Triple-Negative Breast Carcinoma
24766,Carcinomatous Component Present,Refractory Small Intestinal Carcinoma
24767,Epithelial Component Present,Locally Advanced Small Intestinal Carcinoma
24768,Carcinomatous Component Present,Recurrent Gastroesophageal Junction Adenocarcinoma
24769,Secondary Lesion,Metastatic Cervical Carcinoma
24770,Secondary Lesion,Metastatic Cervical Adenocarcinoma
24771,Carcinomatous Component Present,Metastatic Cervical Adenocarcinoma
24772,Secondary Lesion,Metastatic Cervical Adenosquamous Carcinoma
24773,Epithelial Component Present,Metastatic Cervical Adenosquamous Carcinoma
24774,Absence of Basal Cell Layer,Recurrent Prostate Acinar Adenocarcinoma
24775,Acinar Cell Differentiation,Recurrent Submandibular Gland Acinic Cell Carcinoma
24776,Epithelial Component Present,Recurrent Anal Adenocarcinoma
24777,Recurrent disease,Recurrent Lobular Breast Carcinoma
24778,Epithelial Component Present,Recurrent Clear Cell Renal Cell Carcinoma
24779,Epithelial Component Present,Recurrent Chromophobe Renal Cell Carcinoma
24780,Nuclear pleomorphism,Recurrent Salivary Duct Carcinoma
24781,Carcinomatous Component Present,Recurrent Fallopian Tube Serous Adenocarcinoma
24782,Recurrent disease,Recurrent Ovarian Adenocarcinoma
24783,Recurrent disease,Recurrent Ovarian Clear Cell Adenocarcinoma
24784,Epithelial Component Present,Recurrent Pancreatic Ductal Adenocarcinoma
24785,Papillary Pattern,Recurrent Thyroid Gland Papillary Carcinoma
24786,Recurrent disease,Recurrent Thyroid Gland Papillary Carcinoma
24787,Neuroendocrine Differentiation,Recurrent Thyroid Gland Medullary Carcinoma
24788,Hemorrhagic,Recurrent Skin Angiosarcoma
24789,Epithelial Component Present,Recurrent Parotid Gland Carcinoma
24790,Recurrent disease,Recurrent Submandibular Gland Carcinoma
24791,Carcinomatous Component Present,Recurrent Appendix Carcinoma
24792,Mixed Cellular Population,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
24793,Recurrent disease,Recurrent Parotid Gland Mucoepidermoid Carcinoma
24794,Carcinomatous Component Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma
24795,Mixed Cellular Population,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
24796,Perineural spread,Recurrent Submandibular Gland Adenoid Cystic Carcinoma
24797,Secondary Lesion,Metastatic Fibrolamellar Carcinoma
24798,Epithelial Component Present,Metastatic Fibrolamellar Carcinoma
24799,Metastatic Lesion,Hepatic cancer metastatic
24800,Secondary Lesion,Metastatic hepatocellular carcinoma
24801,Epithelial Component Present,Metastatic hepatocellular carcinoma
24802,Carcinomatous Component Present,Unresectable Gastric Adenocarcinoma
24803,Metastatic Lesion,Locally Advanced Squamous Cell Carcinoma
24804,Regional Disease,Locally Advanced Squamous Cell Carcinoma
24805,Epithelial Component Present,Locally Advanced Squamous Cell Carcinoma
24806,High Grade Lesion,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
24807,Primary Lesion,Infratentorial Glioblastoma
24808,Primary Lesion,Supratentorial Glioblastoma
24809,Multifocal Lesion,"Histiocytosis, Langerhans-Cell"
24810,Secondary Lesion,Alveolar soft part sarcoma metastatic
24811,Unresectable Mass,Unresectable Carcinoma
24812,Nodular Pattern,Recurrent Grade 3a Follicular Lymphoma
24813,Refractory Disease,Refractory Sarcoma
24814,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent Myelodysplastic Syndrome
24815,Ineffective hematopoiesis,Recurrent Myelodysplastic Syndrome
24816,Epithelial Component Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma
24817,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes"
24818,Diffuse Pattern,N1 Diffuse Large B-Cell Lymphoma
24819,Diffuse Pattern,EZB Diffuse Large B-Cell Lymphoma
24820,Epithelial Component Present,Refractory Nasopharyngeal Carcinoma
24821,Carcinomatous Component Present,Advanced Urothelial Carcinoma
24822,Regional Disease,Locally Advanced Melanoma
24823,Recurrent disease,Recurrent Human Papillomavirus-Related Malignant Neoplasm
24824,Carcinomatous Component Present,Castration-Naive Prostate Carcinoma
24825,Carcinomatous Component Present,Distal Esophagus Squamous Cell Carcinoma
24826,Recurrent disease,Recurrent Chronic Leukemia
24827,Stromal Invasion,Refractory Ovarian Carcinoma
24828,Carcinomatous Component Present,Refractory Endometrial Carcinoma
24829,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma
24830,Carcinomatous Component Present,Refractory Endometrial Endometrioid Adenocarcinoma
24831,Carcinomatous Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx
24832,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Oropharynx
24833,Epithelial Component Present,Metastatic Oral Cavity Squamous Cell Carcinoma
24834,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Nasopharynx
24835,Metastatic Lesion,Metastatic Squamous Cell Carcinoma of the Larynx
24836,Carcinomatous Component Present,Bilateral Synchronous Sporadic Renal Cell Carcinoma
24837,Refractory Disease,Platinum-Resistant Urothelial Carcinoma
24838,Carcinomatous Component Present,Platinum-Resistant Urothelial Carcinoma
24839,Favorable Clinical Outcome,Fibrin-Associated Diffuse Large B-Cell Lymphoma
24840,Primary Lesion,Extracavitary Primary Effusion Lymphoma
24841,Diffuse Pattern,Body Cavity Primary Effusion Lymphoma
24842,Carcinomatous Component Present,Urothelial carcinoma ureter recurrent
24843,Recurrent disease,Recurrent Malignant Female Reproductive System Neoplasm
24844,Recurrent disease,Recurrent Malignant Soft Tissue Neoplasm
24845,Recurrent disease,Recurrent Malignant Thyroid Gland Neoplasm
24846,Cutaneous Involvement,Refractory Cutaneous Melanoma
24847,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,IgM monoclonal gammopathy of uncertain significance
24848,Carcinomatous Component Present,Infiltrating Bladder Carcinoma
24849,Unresectable Mass,Unresectable Gastroesophageal Junction Adenocarcinoma
24850,Well-Circumscribed Lesion,Recurrent Myxoid Liposarcoma
24851,Epithelial Component Present,Unresectable Adrenal Cortex Carcinoma
24852,Necrotic changes (finding),Refractory Lung Small Cell Carcinoma
24853,More than 10 Mitoses per 10HPF,Refractory Lung Small Cell Carcinoma
24854,Monoclonal Paraproteinemia Present in Lower than Myeloma Levels,Non-IgM Monoclonal Gammopathy of Undetermined Significance
24855,Monoclonal Gammapathies,Non-IgM Monoclonal Gammopathy of Undetermined Significance
24856,Necrotic changes (finding),Refractory Dedifferentiated Liposarcoma
24857,High Grade Lesion,Unresectable Dedifferentiated Liposarcoma
24858,Unresectable Mass,Unresectable Dedifferentiated Liposarcoma
24859,Cellular Pleomorphism,Unresectable Undifferentiated Pleomorphic Sarcoma
24860,Neuroectodermal Differentiation,Resectable Neuroblastoma
24861,Immunologic Deficiency Syndromes,Lymphoproliferative Disease Associated with Primary Immune Disorder
24862,Immunologic Deficiency Syndromes,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
24863,Polymorphic Cellular Infiltrate,"Langerhans Cell Histiocytosis, Polystotic"
24864,S-100-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated"
24865,More than 5 Mitoses per 50HPF,Locally Advanced Gastrointestinal Stromal Tumor
24866,Refractory Disease,Refractory Metastatic Digestive System Carcinoma
24867,Carcinomatous Component Present,Refractory Digestive System Carcinoma
24868,Hereditary Lesion,Myeloid Neoplasms with Germline GATA2 Mutation
24869,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders
24870,Unclassifiable Lesion,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified"
24871,Bone Marrow and Blood Involvement,Recurrent Burkitt Leukemia
24872,Diffuse Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
24873,High Grade Lesion,Pelvic Rhabdomyosarcoma
24874,Rapidly Enlarging Mass,Unresectable Rhabdomyosarcoma
24875,Storiform Growth Pattern,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
24876,Storiform Growth Pattern,Abdominal Undifferentiated Pleomorphic Sarcoma
24877,Refractory Disease,Refractory Primary Peritoneal Carcinoma
24878,Epithelial Component Present,Refractory Fallopian Tube Carcinoma
24879,Metastatic Lesion,Metastatic Unresectable Sarcoma
24880,Metastatic Lesion,"Sarcoma, metastatic"
24881,Metastatic Lesion,Locally Advanced Soft Tissue Sarcoma
24882,High Mitotic Activity,Metastatic Pancreatic Neuroendocrine Carcinoma
24883,Neuroendocrine Differentiation,Metastatic Pancreatic Neuroendocrine Carcinoma
24884,Unresectable Mass,Unresectable Carcinoid Tumor
24885,Resectable Mass,Resectable Soft Tissue Sarcoma
24886,Secondary Lesion,Advanced Carcinoma
24887,Epithelial Component Present,Advanced Carcinoma
24888,Metastatic Lesion,Advanced Synovial Sarcoma
24889,Metastatic Lesion,Locally Advanced Head and Neck Carcinoma
24890,Epithelial Component Present,Colorectal Carcinoma Metastatic in the Lung
24891,Carcinomatous Component Present,Breast Carcinoma Metastatic in Lymph Node
24892,Secondary Lesion,Metastatic Breast Carcinoma
24893,Epithelial Component Present,Metastatic Breast Carcinoma
24894,Unresectable Mass,Locally Advanced Unresectable Malignant Neoplasm
24895,Epithelial Component Present,Advanced Unresectable Gastric Adenocarcinoma
24896,Epithelial Component Present,Metastatic gastric adenocarcinoma
24897,Myxoid Stroma Formation,Unresectable Chordoma
24898,Diffuse Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
24899,Castration-Sensitive,Castration-Sensitive Prostate Carcinoma
24900,Carcinomatous Component Present,Recurrent Ovarian Carcinosarcoma
24901,Secondary Lesion,Metastatic Triple-Negative Breast Carcinoma
24902,Carcinomatous Component Present,Locally Advanced Digestive System Carcinoma
24903,Regional Disease,Locally Advanced Unresectable Bone Sarcoma
24904,Acinar Cell Differentiation,Recurrent Prostate Acinar Adenocarcinoma
24905,Epithelial Component Present,Recurrent Ampulla of Vater Adenocarcinoma
24906,Recurrent disease,Recurrent Anal Mucinous Adenocarcinoma
24907,Epithelial Component Present,Recurrent Anal Mucinous Adenocarcinoma
24908,Recurrent disease,Recurrent Appendix Mucinous Adenocarcinoma
24909,Delicate Vascular Network Formation,Recurrent Clear Cell Renal Cell Carcinoma
24910,Carcinomatous Component Present,Recurrent Minor Salivary Gland Adenocarcinoma
24911,Stromal Invasion,Recurrent Ovarian Cystadenocarcinoma
24912,Recurrent disease,Recurrent Ovarian Cystadenocarcinoma
24913,Epithelial Component Present,Recurrent Ovarian Cystadenocarcinoma
24914,Stromal Invasion,Recurrent Ovarian Clear Cell Adenocarcinoma
24915,Epithelial Component Present,Recurrent Ovarian Clear Cell Adenocarcinoma
24916,Carcinomatous Component Present,Recurrent Ovarian Clear Cell Adenocarcinoma
24917,Fibrotic Stroma Formation,Recurrent Pancreatic Ductal Adenocarcinoma
24918,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Follicular Carcinoma
24919,Well-Circumscribed Lesion,Recurrent Thyroid Gland Medullary Carcinoma
24920,Calcitonin serum level increased,Recurrent Thyroid Gland Medullary Carcinoma
24921,Epithelial Component Present,Recurrent Thyroid Gland Anaplastic Carcinoma
24922,Multinodular Mass,Recurrent Skin Angiosarcoma
24923,Fibrotic Stroma Formation,Recurrent Parotid Gland Mucoepidermoid Carcinoma
24924,Cystic Change,Recurrent Malignant Ovarian Brenner Tumor
24925,Carcinomatous Component Present,Recurrent Ovarian Transitional Cell Carcinoma
24926,Recurrent disease,Recurrent Malignant Central Nervous System Neoplasm
24927,Metastatic Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
24928,Secondary Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
24929,Poorly Differentiated Lesion,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
24930,Mitotic Activity,MGMT-Methylated Glioblastoma
24931,Immunologic Deficiency Syndromes,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma
24932,Monoclonal Gammapathies,Monoclonal Gammopathy of Undetermined Significance
24933,Immunologic Deficiency Syndromes,Methotrexate-Associated Peripheral T-Cell Lymphoma
24934,Immunologic Deficiency Syndromes,Methotrexate-Associated Burkitt Lymphoma
24935,Primary Lesion,Recurrent Childhood Gliomatosis Cerebri
24936,Neoplastic Cells with TFH Cell Phenotype Present,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
24937,Metastatic Lesion,Locally Advanced Thymic Carcinoma
24938,Epithelial Component Present,Metastatic thymic carcinoma
24939,Refractory Disease,Mycosis fungoides/Sezary syndrome refractory
24940,Secondary Lesion,Locally Advanced Carcinoma
24941,Carcinomatous Component Present,Refractory Head and Neck Squamous Cell Carcinoma
24942,Carcinomatous Component Present,Squamous cell carcinoma of head and neck metastatic
24943,Epithelial Component Present,Refractory Thymic Carcinoma
24944,Carcinomatous Component Present,Refractory Thymic Carcinoma
24945,Adulthood Lesion,Refractory Indolent Adult Non-Hodgkin Lymphoma
24946,Epithelial Component Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7
24947,Nodular Pattern,Refractory Myxoid Liposarcoma
24948,Myxoid Stroma Formation,Myxoid liposarcoma metastatic
24949,Bone Marrow Dysplasia Present,Refractory Myelodysplastic Syndrome
24950,Refractory Disease,Refractory Paranasal Sinus Squamous Cell Carcinoma
24951,Recurrent disease,Recurrent Paranasal Sinus Squamous Cell Carcinoma
24952,Recurrent disease,Recurrent Mixed Phenotype Acute Leukemia
24953,Blasts of Mixed Phenotype Present,Recurrent Mixed Phenotype Acute Leukemia
24954,Carcinomatous Component Present,Refractory Nasopharyngeal Carcinoma
24955,Monocytosis,Recurrent Chronic Myelomonocytic Leukemia
24956,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory Chronic Myelomonocytic Leukemia
24957,Carcinomatous Component Present,Refractory Ovarian Carcinoma
24958,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Endometrioid Adenocarcinoma
24959,Carcinomatous Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma
24960,Splenomegaly,Recurrent T-Cell Prolymphocytic Leukemia
24961,Metastatic Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx
24962,Epithelial Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx
24963,Extensive Stage Lesion,Advanced Oral Cavity Squamous Cell Carcinoma
24964,Epithelial Component Present,Advanced Oral Cavity Squamous Cell Carcinoma
24965,Carcinomatous Component Present,Advanced Oral Cavity Squamous Cell Carcinoma
24966,Extensive Stage Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma
24967,Extensive Stage Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma
24968,Secondary Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma
24969,Secondary Lesion,Advanced Laryngeal Squamous Cell Carcinoma
24970,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Larynx
24971,Refractory Disease,Refractory Bladder Carcinoma
24972,Synchronous Lesion,Bilateral Synchronous Sporadic Renal Cell Carcinoma
24973,Epithelial Component Present,Bilateral Synchronous Sporadic Renal Cell Carcinoma
24974,Platinum Resistance,Platinum-Resistant Urothelial Carcinoma
24975,Small Aggregates of Tumor Cells Present,Fibrin-Associated Diffuse Large B-Cell Lymphoma
24976,Hypergammaglobulinemia,HHV8-Positive Multicentric Castleman Disease
24977,Primary Lesion,Body Cavity Primary Effusion Lymphoma
24978,Secondary Lesion,Urothelial carcinoma ureter metastatic
24979,Refractory Disease,Refractory Malignant Oral Neoplasm
24980,Refractory Disease,Refractory Malignant Male Reproductive System Neoplasm
24981,Refractory Disease,Refractory Malignant Thyroid Gland Neoplasm
24982,Refractory Disease,Refractory Malignant Urinary System Neoplasm
24983,Monoclonal Gammapathies,IgM monoclonal gammopathy of uncertain significance
24984,Epithelial Component Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
24985,Carcinomatous Component Present,Unresectable Gastroesophageal Junction Adenocarcinoma
24986,High Grade Lesion,Recurrent Dedifferentiated Liposarcoma
24987,Epithelial Component Present,Metastatic Renal Cell Carcinoma
24988,Secondary Lesion,Metastatic Malignant Neoplasm in the Viscera
24989,Epithelial Component Present,Resectable Carcinoma
24990,Resectable Mass,Resectable Sarcoma
24991,Increased Cellularity Present,Resectable Neuroblastoma
24992,Increased Cellularity Present,Unresectable Neuroblastoma
24993,Immunologic Deficiency Syndromes,Methotrexate-Associated Lymphoma
24994,CD1a-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells
24995,Birbeck Granules Present,"Langerhans cell histiocytosis, unifocal"
24996,CD1a-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal"
24997,Monoclonal Langerhans Cells Present,"Langerhans Cell Histiocytosis, Polystotic"
24998,More than 5 Mitoses per 50HPF,Metastatic Gastrointestinal Stromal Tumor
24999,Metastatic Lesion,Locally Advanced Gastrointestinal Stromal Tumor
25000,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction
25001,Hereditary Lesion,Myeloid Neoplasms with Germline ETV6 Mutation
25002,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders
25003,Metastatic Lesion,Locally Advanced Bile Duct Carcinoma
25004,Nuclear pleomorphism,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
25005,Cellular Pleomorphism,Abdominal Undifferentiated Pleomorphic Sarcoma
25006,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
25007,Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
25008,Epithelial Component Present,Refractory Primary Peritoneal Carcinoma
25009,Refractory Disease,Refractory Fallopian Tube Carcinoma
25010,Recurrent disease,Recurrent Malignant Head and Neck Neoplasm
25011,Unresectable Mass,Unresectable Soft Tissue Sarcoma
25012,Metastatic Lesion,Locally Advanced Bone Sarcoma
25013,Secondary Lesion,Locally Advanced Bone Sarcoma
25014,Regional Disease,Locally Advanced Sarcoma
25015,Unresectable Mass,Unresectable Synovial Sarcoma
25016,Carcinomatous Component Present,Metastatic Pancreatic Neuroendocrine Carcinoma
25017,Poorly Differentiated Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
25018,Refractory Disease,Refractory Lung Non-Small Cell Carcinoma
25019,Epithelial Component Present,Refractory Lung Non-Small Cell Carcinoma
25020,Extensive Stage Lesion,Advanced Melanoma
25021,Metastatic Lesion,Advanced Melanoma
25022,Secondary Lesion,Advanced Renal Cell Carcinoma
25023,Recurrent disease,Recurrent Mediastinal Lymphoma
25024,Secondary Lesion,Locally Advanced Skin Squamous Cell Carcinoma
25025,Carcinomatous Component Present,Locally Advanced Skin Squamous Cell Carcinoma
25026,Metastatic Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
25027,Regional Disease,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
25028,Epithelial Component Present,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
25029,Epithelial Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma
25030,Extensive Stage Lesion,Advanced Lung Carcinoma
25031,Secondary Lesion,Breast Carcinoma Metastatic in Lymph Node
25032,Metastatic Lesion,Metastatic Breast Carcinoma
25033,Secondary Lesion,Metastatic Unresectable Malignant Neoplasm
25034,Refractory Disease,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
25035,Unresectable Mass,Metastatic Unresectable Carcinoma
25036,Carcinomatous Component Present,Metastatic Unresectable Gastric Adenocarcinoma
25037,Metastatic Lesion,Advanced Unresectable Gastric Adenocarcinoma
25038,Secondary Lesion,Advanced Unresectable Gastric Adenocarcinoma
25039,Secondary Lesion,Metastatic Gastric Carcinoma
25040,Slow Growing Mass,Metastatic Chordoma
25041,Unresectable Mass,Unresectable Chordoma
25042,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Carcinosarcoma
25043,Epithelial Component Present,Metastatic Triple-Negative Breast Carcinoma
25044,Carcinomatous Component Present,Refractory Colon Carcinoma
25045,Refractory Disease,Refractory Small Intestinal Carcinoma
25046,Metastatic Lesion,Metastatic Cervical Adenocarcinoma
25047,Carcinomatous Component Present,Metastatic Cervical Adenosquamous Carcinoma
25048,Metastatic Lesion,Locally Advanced Unresectable Sarcoma
25049,Epithelial Component Present,Recurrent Acinic Cell Breast Carcinoma
25050,Carcinomatous Component Present,Recurrent Ampulla of Vater Adenocarcinoma
25051,Epithelial Component Present,Recurrent Paget Disease of the Anal Canal
25052,Carcinomatous Component Present,Recurrent Appendix Mucinous Adenocarcinoma
25053,Recurrent disease,Recurrent Invasive Ductal Breast Carcinoma
25054,Carcinomatous Component Present,Recurrent Invasive Ductal Breast Carcinoma
25055,Recurrent disease,Recurrent Clear Cell Renal Cell Carcinoma
25056,Recurrent disease,Recurrent Fallopian Tube Serous Adenocarcinoma
25057,Carcinomatous Component Present,Recurrent Ovarian Cystadenocarcinoma
25058,Nuclear Grooves,Recurrent Thyroid Gland Papillary Carcinoma
25059,Recurrent disease,Recurrent Thyroid Gland Follicular Carcinoma
25060,Calcitonin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Medullary Carcinoma
25061,Epithelial Component Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma
25062,Epithelial Component Present,Recurrent Submandibular Gland Mucoepidermoid Carcinoma
25063,Epithelial Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma
25064,Recurrent disease,Recurrent Submandibular Gland Undifferentiated Carcinoma
25065,Secondary Lesion,Locally Advanced Squamous Cell Carcinoma
25066,Epithelial Component Present,Densely Granulated Corticotroph Adenoma
25067,Epithelial Component Present,Metastatic Ureter Carcinoma
25068,Secondary Lesion,Malignant fibrous histiocytoma metastatic
25069,Primary Lesion,Cerebellar Glioblastoma
25070,High Grade Lesion,Langerhans Cell Sarcoma
25071,Diffuse Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype
25072,Transformed Phase of Disease,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
25073,Carcinomatous Component Present,Unresectable Thymic Carcinoma
25074,Secondary Lesion,Locally Advanced Thymic Carcinoma
25075,Carcinomatous Component Present,Locally Advanced Thymic Carcinoma
25076,Metastatic Lesion,Metastatic thymic carcinoma
25077,Epithelial Component Present,Squamous cell carcinoma of head and neck metastatic
25078,Refractory Disease,Refractory Thymic Carcinoma
25079,Refractory Disease,Refractory Indolent Adult Non-Hodgkin Lymphoma
25080,Unresectable Mass,Unresectable Cutaneous Melanoma
25081,No Identifiable Line of Differentiation,Refractory Undifferentiated Pleomorphic Sarcoma
25082,Refractory Disease,Refractory Undifferentiated Pleomorphic Sarcoma
25083,Refractory Disease,Refractory Myxoid Liposarcoma
25084,Delicate Arborizing Vascular Channel Formation,Refractory Myxoid Liposarcoma
25085,Nodular Pattern,Myxoid liposarcoma metastatic
25086,Well-Circumscribed Lesion,Myxoid liposarcoma metastatic
25087,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Myelodysplastic Syndrome
25088,Bone Marrow Dysplasia Present,Recurrent Myelodysplastic Syndrome
25089,Carcinomatous Component Present,Refractory Hypopharyngeal Squamous Cell Carcinoma
25090,Carcinomatous Component Present,Refractory Laryngeal Squamous Cell Carcinoma
25091,Carcinomatous Component Present,Refractory Paranasal Sinus Squamous Cell Carcinoma
25092,Carcinomatous Component Present,Unresectable Intrahepatic Cholangiocarcinoma
25093,Extensive Stage Lesion,Advanced Urothelial Carcinoma
25094,Metastatic Lesion,Metastatic Uveal Melanoma
25095,Secondary Lesion,Metastatic Uveal Melanoma
25096,Epithelial Component Present,Cervical Esophagus Adenocarcinoma
25097,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Chronic Myelomonocytic Leukemia
25098,Carcinomatous Component Present,Refractory Uterine Corpus Carcinoma
25099,Epithelial Component Present,Recurrent Endometrial Cancer
25100,Carcinomatous Component Present,Recurrent Endometrial Cancer
25101,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Endometrioid Adenocarcinoma
25102,Epithelial Component Present,Refractory Ovarian Endometrioid Adenocarcinoma
25103,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Ovarian Endometrioid Adenocarcinoma
25104,Secondary Lesion,Uveal Melanoma Metastatic in the Liver
25105,Monomorphic Cellular Infiltrate,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
25106,Recurrent disease,Recurrent T-Cell Prolymphocytic Leukemia
25107,Secondary Lesion,Squamous cell carcinoma of the hypopharynx stage IV
25108,Epithelial Component Present,Refractory Urothelial Carcinoma
25109,Epithelial Component Present,Platinum-Resistant Urothelial Carcinoma
25110,Diffuse Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma
25111,Epithelial Component Present,Metastatic Bladder Urothelial Carcinoma
25112,Carcinomatous Component Present,Metastatic Bladder Urothelial Carcinoma
25113,Recurrent disease,Recurrent Malignant Bone Neoplasm
25114,Refractory Disease,Refractory Malignant Bone Neoplasm
25115,Multifocal Lesion,Recurrent Malignant Neoplasm of Multiple Primary Sites
25116,Refractory Disease,Refractory Malignant Soft Tissue Neoplasm
25117,Recurrent disease,Recurrent Malignant Endocrine Neoplasm
25118,Epithelial Component Present,Infiltrating Bladder Carcinoma
25119,Invasive Lesion,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
25120,Unresectable Mass,Unresectable Adrenal Cortex Carcinoma
25121,Epithelial Component Present,Refractory Lung Small Cell Carcinoma
25122,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Non-IgM Monoclonal Gammopathy of Undetermined Significance
25123,Refractory Disease,Refractory Dedifferentiated Liposarcoma
25124,Metastatic Lesion,Metastatic Renal Cell Carcinoma
25125,Resectable Mass,Resectable Liposarcoma
25126,High Grade Lesion,Resectable Dedifferentiated Liposarcoma
25127,Resectable Mass,Resectable Dedifferentiated Liposarcoma
25128,Resectable Mass,Resectable Neuroblastoma
25129,Unresectable Mass,Unresectable Neuroblastoma
25130,Therapy-Related Toxicity,Methotrexate-Associated Lymphoma
25131,S-100-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells
25132,S-100-Positive Neoplastic Cells Present,"Langerhans cell histiocytosis, unifocal"
25133,Multifocal Lesion,"Langerhans Cell Histiocytosis, Polystotic"
25134,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Polystotic"
25135,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated"
25136,Secondary Lesion,Metastatic Gastrointestinal Stromal Tumor
25137,Decreased platelet count,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders
25138,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders
25139,Decreased platelet count,Myeloid Neoplasms with Germline RUNX1 Mutation
25140,Recurrent disease,Recurrent Metastatic Digestive System Carcinoma
25141,Metastatic Lesion,Recurrent Metastatic Digestive System Carcinoma
25142,Carcinomatous Component Present,Recurrent Metastatic Digestive System Carcinoma
25143,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes
25144,Regional Disease,Locally Advanced Bile Duct Carcinoma
25145,Diffuse Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
25146,Refractory Disease,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
25147,High Mitotic Activity,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
25148,Regional Disease,Locally Advanced Pancreatic Ductal Adenocarcinoma
25149,Carcinomatous Component Present,Refractory Female Reproductive System Carcinoma
25150,Secondary Lesion,Metastatic Unresectable Sarcoma
25151,Secondary Lesion,Locally Advanced Soft Tissue Sarcoma
25152,Unresectable Mass,Unresectable Bone Sarcoma
25153,Metastatic/Recurrent Disease,Unresectable Synovial Sarcoma
25154,High Mitotic Activity,Unresectable Pancreatic Neuroendocrine Carcinoma
25155,Neuroendocrine Differentiation,Unresectable Pancreatic Neuroendocrine Carcinoma
25156,Epithelial Component Present,Unresectable Carcinoid Tumor
25157,Splenomegaly,Refractory Hepatosplenic T-Cell Lymphoma
25158,Refractory Disease,Refractory Hepatosplenic T-Cell Lymphoma
25159,Refractory Disease,Refractory Mediastinal Lymphoma
25160,Extensive Stage Lesion,Advanced Synovial Sarcoma
25161,Secondary Lesion,Advanced Synovial Sarcoma
25162,Extensive Stage Lesion,Advanced Sarcoma
25163,Carcinomatous Component Present,Advanced Lung Carcinoma
25164,Secondary Lesion,Locally Advanced Unresectable Malignant Neoplasm
25165,Unresectable Mass,Metastatic Unresectable Malignant Neoplasm
25166,Metastatic Lesion,Metastatic Unresectable Malignant Neoplasm
25167,Epithelial Component Present,Metastatic Unresectable Carcinoma
25168,Unresectable Mass,Metastatic Unresectable Gastric Adenocarcinoma
25169,Extensive Stage Lesion,Advanced Unresectable Gastric Adenocarcinoma
25170,Metastatic Lesion,Metastatic gastric adenocarcinoma
25171,Metastatic Lesion,Metastatic Gastric Carcinoma
25172,Carcinomatous Component Present,Metastatic Gastric Carcinoma
25173,Solitary mass,Metastatic Chordoma
25174,Secondary Lesion,Metastatic Chordoma
25175,Lobulated Growth Pattern,Locally Advanced Chordoma
25176,Metastatic Lesion,Locally Advanced Chordoma
25177,Slow Growing Mass,Locally Advanced Chordoma
25178,Regional Disease,Locally Advanced Chordoma
25179,Epithelial Component Present,Refractory Bile Duct Carcinoma
25180,Recurrent disease,Bile duct cancer recurrent
25181,Epithelial Component Present,Bile duct cancer recurrent
25182,Epithelial Component Present,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
25183,Metastatic Lesion,Locally Advanced Unresectable Bone Sarcoma
25184,Metastatic Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma
25185,Secondary Lesion,Locally Advanced Unresectable Sarcoma
25186,Regional Disease,Locally Advanced Unresectable Sarcoma
25187,Recurrent disease,Recurrent Pancreatic Acinar Cell Carcinoma
25188,Invasive Lesion,Recurrent Prostate Acinar Adenocarcinoma
25189,Recurrent disease,Recurrent Parotid Gland Acinic Cell Carcinoma
25190,Carcinomatous Component Present,Recurrent Parotid Gland Acinic Cell Carcinoma
25191,Acinar Cell Differentiation,Recurrent Parotid Gland Acinic Cell Carcinoma
25192,Epithelial Component Present,Recurrent Submandibular Gland Acinic Cell Carcinoma
25193,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma
25194,Mucoid Stroma Formation,Recurrent Anal Mucinous Adenocarcinoma
25195,Carcinomatous Component Present,Recurrent Paget Disease of the Anal Canal
25196,Epithelial Component Present,Recurrent Appendix Mucinous Adenocarcinoma
25197,Carcinomatous Component Present,Recurrent Lobular Breast Carcinoma
25198,Carcinomatous Component Present,Recurrent Paget Disease of the Breast
25199,Carcinomatous Component Present,Recurrent Clear Cell Renal Cell Carcinoma
25200,Carcinomatous Component Present,Recurrent Chromophobe Renal Cell Carcinoma
25201,Epithelial Component Present,Recurrent Minor Salivary Gland Adenocarcinoma
25202,Stromal Invasion,Recurrent Ovarian Adenocarcinoma
25203,Carcinomatous Component Present,Recurrent Ovarian Serous Adenocarcinoma
25204,Recurrent disease,Recurrent Pancreatic Cystadenocarcinoma
25205,Carcinomatous Component Present,Recurrent Pancreatic Cystadenocarcinoma
25206,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Papillary Carcinoma
25207,Follicular Cell Differentiation,Recurrent Thyroid Gland Papillary Carcinoma
25208,Carcinomatous Component Present,Recurrent Thyroid Gland Papillary Carcinoma
25209,Follicular Cell Differentiation,Recurrent Thyroid Gland Follicular Carcinoma
25210,Carcinomatous Component Present,Recurrent Thyroid Gland Follicular Carcinoma
25211,Secondary Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
25212,Recurrent disease,Recurrent Submandibular Gland Mucoepidermoid Carcinoma
25213,Carcinomatous Component Present,Recurrent Submandibular Gland Mucoepidermoid Carcinoma
25214,Recurrent disease,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
25215,Carcinomatous Component Present,Recurrent Submandibular Gland Undifferentiated Carcinoma
25216,Recurrent disease,Recurrent Parotid Gland Undifferentiated Carcinoma
25217,Epithelial Component Present,Recurrent Malignant Ovarian Brenner Tumor
25218,Stromal Invasion,Recurrent Ovarian Transitional Cell Carcinoma
25219,Metastatic Lesion,Metastatic Fibrolamellar Carcinoma
25220,Unresectable Mass,Unresectable Gastric Adenocarcinoma
25221,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
25222,Diffuse Pattern,MGMT-Methylated Glioblastoma
25223,Microvascular Proliferation,MGMT-Methylated Glioblastoma
25224,Carcinomatous Component Present,Metastatic Ureter Carcinoma
25225,Carcinomatous Component Present,Metastatic Urethral Carcinoma
25226,Immunologic Deficiency Syndromes,Lymphoproliferative disorder caused by methotrexate
25227,Carcinomatous Component Present,Unresectable Carcinoma
25228,Secondary Lesion,Metastatic thymic carcinoma
25229,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome refractory
25230,Secondary Lesion,Squamous cell carcinoma of head and neck metastatic
25231,Cutaneous Involvement,Unresectable Cutaneous Melanoma
25232,High Grade Lesion,Refractory Synovial Sarcoma
25233,Metastatic/Recurrent Disease,Refractory Synovial Sarcoma
25234,Ineffective hematopoiesis,Refractory Myelodysplastic Syndrome
25235,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Myelodysplastic Syndrome
25236,Refractory Disease,Refractory Hypopharyngeal Squamous Cell Carcinoma
25237,Refractory Disease,Refractory Oral Cavity Squamous Cell Carcinoma
25238,Recurrent disease,Leukemia recurrent
25239,Unresectable Mass,Unresectable Intrahepatic Cholangiocarcinoma
25240,Fibrotic Stroma Formation,Unresectable Intrahepatic Cholangiocarcinoma
25241,Metastatic Lesion,Castration-Naive Prostate Carcinoma
25242,Epithelial Component Present,Castration-Naive Prostate Carcinoma
25243,Epithelial Component Present,Thoracic Esophagus Squamous Cell Carcinoma
25244,Carcinomatous Component Present,Thoracic Esophagus Squamous Cell Carcinoma
25245,Carcinomatous Component Present,Gastric Cardia Squamous Cell Carcinoma
25246,Epithelial Component Present,Distal Esophagus Squamous Cell Carcinoma
25247,Immature Granulocytes in Peripheral Blood Under 10 Percent,Recurrent Chronic Myelomonocytic Leukemia
25248,Monocytosis,Refractory Chronic Myelomonocytic Leukemia
25249,Epithelial Component Present,Refractory Endometrial Carcinoma
25250,Epithelial Component Present,Recurrent Ovarian Endometrioid Adenocarcinoma
25251,Stromal Invasion,Refractory Ovarian Endometrioid Adenocarcinoma
25252,Epithelial Component Present,Refractory Endometrial Endometrioid Adenocarcinoma
25253,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Endometrial Endometrioid Adenocarcinoma
25254,Recurrent disease,Recurrent T Acute Lymphoblastic Leukemia
25255,Metastatic Lesion,Metastatic Squamous Cell Carcinoma of the Oropharynx
25256,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Oropharynx
25257,Metastatic Lesion,Advanced Oral Cavity Squamous Cell Carcinoma
25258,Extensive Stage Lesion,Advanced Laryngeal Squamous Cell Carcinoma
25259,Metastatic Lesion,Advanced Laryngeal Squamous Cell Carcinoma
25260,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage IV
25261,Secondary Lesion,Metastatic Squamous Cell Carcinoma of the Larynx
25262,Increased Cellularity Present,High-Risk Neuroblastoma
25263,Carcinomatous Component Present,Refractory Urothelial Carcinoma
25264,Fibrinous Material Present,Fibrin-Associated Diffuse Large B-Cell Lymphoma
25265,Systemic disease,HHV8-Positive Multicentric Castleman Disease
25266,effusion,Body Cavity Primary Effusion Lymphoma
25267,Metastatic Lesion,Metastatic Urethral Urothelial Carcinoma
25268,Secondary Lesion,Metastatic Renal Pelvis Urothelial Carcinoma
25269,Metastatic Lesion,Urothelial carcinoma ureter metastatic
25270,Recurrent disease,Urothelial carcinoma ureter recurrent
25271,Serum IgM Monoclonal Gammopathy of Less than 30g/L,IgM monoclonal gammopathy of uncertain significance
25272,Recurrent disease,Recurrent Myxoid Liposarcoma
25273,Peripheral Nuclear Palisading,Refractory Lung Small Cell Carcinoma
25274,Necrotic changes (finding),Recurrent Dedifferentiated Liposarcoma
25275,High Grade Lesion,Refractory Dedifferentiated Liposarcoma
25276,Secondary Lesion,Metastatic Renal Cell Carcinoma
25277,Non Lipogenic Sarcomatous Stroma Present,Unresectable Dedifferentiated Liposarcoma
25278,Necrotic changes (finding),Resectable Dedifferentiated Liposarcoma
25279,Storiform Growth Pattern,Unresectable Undifferentiated Pleomorphic Sarcoma
25280,No Identifiable Line of Differentiation,Resectable Undifferentiated Pleomorphic Sarcoma
25281,Resectable Mass,Resectable Undifferentiated Pleomorphic Sarcoma
25282,Cellular Pleomorphism,Resectable Undifferentiated Pleomorphic Sarcoma
25283,Immunologic Deficiency Syndromes,Immunodeficiency-Associated Lymphoproliferative Disorder
25284,Birbeck Granules Present,Tumors Derived from Langerhans Cells
25285,Polymorphic Cellular Infiltrate,"Langerhans Cell Histiocytosis, Disseminated"
25286,Monoclonal Langerhans Cells Present,"Langerhans Cell Histiocytosis, Disseminated"
25287,Whorling Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
25288,More than 5 Mitoses per 50HPF,Unresectable Gastrointestinal Stromal Tumor
25289,Carcinomatous Component Present,Refractory Metastatic Digestive System Carcinoma
25290,Epithelial Component Present,Recurrent Metastatic Digestive System Carcinoma
25291,Refractory Disease,Refractory Digestive System Carcinoma
25292,Decreased platelet count,Myeloid Neoplasms with Germline ANKRD26 Mutation
25293,Decreased platelet count,Myeloid Neoplasms with Germline ETV6 Mutation
25294,Transformed Phase of Disease,Transformed Non-Hodgkin Lymphoma
25295,Carcinomatous Component Present,Locally Advanced Bile Duct Carcinoma
25296,Rapidly Enlarging Mass,Abdominal Rhabdomyosarcoma
25297,Unresectable Mass,Unresectable Rhabdomyosarcoma
25298,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
25299,Secondary Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma
25300,Carcinomatous Component Present,Locally Advanced Pancreatic Ductal Adenocarcinoma
25301,Resectable Mass,Resectable Pancreatic Ductal Adenocarcinoma
25302,Fibrotic Stroma Formation,Resectable Pancreatic Ductal Adenocarcinoma
25303,Carcinomatous Component Present,Refractory Primary Peritoneal Carcinoma
25304,Epithelial Component Present,Refractory Female Reproductive System Carcinoma
25305,Regional Disease,Locally Advanced Soft Tissue Sarcoma
25306,Secondary Lesion,Locally Advanced Sarcoma
25307,Metastatic Lesion,Metastatic Bone Sarcoma
25308,Tissue Differentiation Uncertain,Unresectable Synovial Sarcoma
25309,Epithelial Component Present,Metastatic Pancreatic Neuroendocrine Carcinoma
25310,Severe cytologic atypia,Metastatic Pancreatic Neuroendocrine Carcinoma
25311,Epithelial Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma
25312,Sinusoidal Infiltration,Recurrent Hepatosplenic T-Cell Lymphoma
25313,Hepatomegaly,Refractory Hepatosplenic T-Cell Lymphoma
25314,Epithelial Component Present,Advanced Renal Cell Carcinoma
25315,Carcinomatous Component Present,Advanced Carcinoma
25316,Metastatic Lesion,Advanced Lymphoma
25317,Epithelial Component Present,Locally Advanced Skin Squamous Cell Carcinoma
25318,Carcinomatous Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma
25319,Secondary Lesion,Metastatic Lung Carcinoma
25320,Secondary Lesion,Locally Advanced Lung Carcinoma
25321,Regional Disease,Locally Advanced Lung Carcinoma
25322,Secondary Lesion,Locally Advanced Head and Neck Carcinoma
25323,Carcinomatous Component Present,Colorectal Carcinoma Metastatic in the Lung
25324,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Spine
25325,Epithelial Component Present,Breast Carcinoma Metastatic in Lymph Node
25326,Histiocytosis haematophagic,Recurrent Hemophagocytic Lymphohistiocytosis
25327,Histiocytosis haematophagic,Refractory Hemophagocytic Lymphohistiocytosis
25328,Metastatic Lesion,Metastatic Unresectable Carcinoma
25329,Epithelial Component Present,Metastatic Unresectable Gastric Adenocarcinoma
25330,Carcinomatous Component Present,Advanced Unresectable Gastric Adenocarcinoma
25331,Metastatic Lesion,Metastatic Chordoma
25332,Recurrent Lymphoma,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
25333,Refractory Disease,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
25334,Stromal Invasion,Recurrent Ovarian Carcinosarcoma
25335,Mixed Cellular Population,Recurrent Ovarian Carcinosarcoma
25336,Refractory Disease,Refractory Colon Carcinoma
25337,Epithelial Component Present,Refractory Colon Carcinoma
25338,Epithelial Component Present,Refractory Small Intestinal Carcinoma
25339,Carcinomatous Component Present,Locally Advanced Small Intestinal Carcinoma
25340,Metastatic Lesion,Metastatic Cervical Carcinoma
25341,Epithelial Component Present,Metastatic Cervical Carcinoma
25342,Carcinomatous Component Present,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
25343,Regional Disease,Locally Advanced Unresectable Soft Tissue Sarcoma
25344,Invasive Lesion,Recurrent Acinic Cell Breast Carcinoma
25345,Epithelial Component Present,Recurrent Pancreatic Acinar Cell Carcinoma
25346,Carcinomatous Component Present,Recurrent Prostate Acinar Adenocarcinoma
25347,Epithelial Component Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type"
25348,Recurrent disease,Recurrent Anal Adenocarcinoma
25349,Carcinomatous Component Present,Recurrent Anal Mucinous Adenocarcinoma
25350,Cribriform Pattern,Recurrent Salivary Duct Carcinoma
25351,Recurrent disease,Recurrent Minor Salivary Gland Adenocarcinoma
25352,Epithelial Component Present,Recurrent Ovarian Adenocarcinoma
25353,Carcinomatous Component Present,Recurrent Pancreatic Ductal Adenocarcinoma
25354,Recurrent disease,Recurrent Parotid Gland Adenoid Cystic Carcinoma
25355,Perineural spread,Recurrent Parotid Gland Adenoid Cystic Carcinoma
25356,Fibrotic Stroma Formation,Recurrent Submandibular Gland Mucoepidermoid Carcinoma
25357,Secondary Lesion,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
25358,Mesenchymal Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
25359,Epithelial Component Present,Recurrent Submandibular Gland Squamous Cell Carcinoma
25360,Carcinomatous Component Present,Recurrent Submandibular Gland Squamous Cell Carcinoma
25361,Epithelial Component Present,Recurrent Submandibular Gland Undifferentiated Carcinoma
25362,Recurrent disease,Recurrent Malignant Ovarian Brenner Tumor
25363,Refractory Disease,Refractory WHO Grade III Glioma
25364,Lamellar Pattern,Metastatic Fibrolamellar Carcinoma
25365,Carcinomatous Component Present,Metastatic Fibrolamellar Carcinoma
25366,Carcinomatous Component Present,Metastatic hepatocellular carcinoma
25367,Epithelial Component Present,Unresectable Gastric Adenocarcinoma
25368,Anaplasia,MGMT-Methylated Glioblastoma
25369,Necrotic changes (finding),MGMT-Methylated Glioblastoma
25370,Epithelial Component Present,Metastatic Urethral Carcinoma
25371,Immunologic Deficiency Syndromes,Methotrexate-Associated Hodgkin Lymphoma
25372,Steatohepatitis,HNF1alpha-Inactivated Hepatocellular Adenoma
25373,Nodular and Diffuse Pattern,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
25374,Epithelial Component Present,Locally Advanced Thymic Carcinoma
25375,Carcinomatous Component Present,Metastatic thymic carcinoma
25376,Regional Disease,Locally Advanced Carcinoma
25377,Metastatic Lesion,Squamous cell carcinoma of head and neck metastatic
25378,Myxoid Stroma Formation,Refractory Myxoid Liposarcoma
25379,Metastatic Lesion,Myxoid liposarcoma metastatic
25380,Secondary Lesion,Myxoid liposarcoma metastatic
25381,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Myelodysplastic Syndrome
25382,Epithelial Component Present,Refractory Paranasal Sinus Squamous Cell Carcinoma
25383,Carcinomatous Component Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma
25384,Refractory Disease,Refractory Leukemia
25385,Blasts of Mixed Phenotype Present,Refractory Mixed Phenotype Acute Leukemia
25386,Epithelial Component Present,Unresectable Intrahepatic Cholangiocarcinoma
25387,Metastatic Lesion,Advanced Uveal Melanoma
25388,Unresectable Mass,Unresectable Melanoma
25389,Refractory Disease,Refractory Uterine Corpus Carcinoma
25390,Recurrent disease,Recurrent Endometrial Cancer
25391,Carcinomatous Component Present,Recurrent Ovarian Endometrioid Adenocarcinoma
25392,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Ovarian Endometrioid Adenocarcinoma
25393,Carcinomatous Component Present,Metastatic Oral Cavity Squamous Cell Carcinoma
25394,Metastatic Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx
25395,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Nasopharynx
25396,Epithelial Component Present,Refractory Bladder Carcinoma
25397,Carcinomatous Component Present,Refractory Bladder Carcinoma
25398,Fever,HHV8-Positive Multicentric Castleman Disease
25399,Diffuse Pattern,Extracavitary Primary Effusion Lymphoma
25400,Monomorphic Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma
25401,Carcinomatous Component Present,Metastatic Urethral Urothelial Carcinoma
25402,Multifocal Lesion,Refractory Malignant Neoplasm of Multiple Primary Sites
25403,Recurrent disease,Recurrent Malignant Urinary System Neoplasm
25404,Cutaneous Involvement,Recurrent Malignant Skin Neoplasm
25405,Epithelial Component Present,Unresectable Gastroesophageal Junction Adenocarcinoma
25406,Delicate Arborizing Vascular Channel Formation,Recurrent Myxoid Liposarcoma
25407,High Mitotic Activity,Refractory Lung Small Cell Carcinoma
25408,Non Lipogenic Sarcomatous Stroma Present,Recurrent Dedifferentiated Liposarcoma
25409,Refractory Disease,Refractory Liposarcoma
25410,Carcinomatous Component Present,Metastatic Renal Cell Carcinoma
25411,No Identifiable Line of Differentiation,Unresectable Undifferentiated Pleomorphic Sarcoma
25412,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic"
25413,Secondary Lesion,Locally Advanced Gastrointestinal Stromal Tumor
25414,Secondary Lesion,Recurrent Metastatic Digestive System Carcinoma
25415,Epithelial Component Present,Refractory Digestive System Carcinoma
25416,Epithelial Component Present,Refractory Head and Neck Carcinoma
25417,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction
25418,Pre-existing condition,Myeloid Neoplasms with Germline GATA2 Mutation
25419,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes
25420,Aggressive Clinical Course,Refractory Burkitt Leukemia
25421,Refractory Disease,Refractory Burkitt Leukemia
25422,Refractory Disease,Refractory Lymphoblastic Lymphoma
25423,Fibrotic Stroma Formation,Locally Advanced Pancreatic Ductal Adenocarcinoma
25424,Metastatic Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma
25425,Carcinomatous Component Present,Distal Esophagus Adenocarcinoma
25426,Secondary Lesion,"Sarcoma, metastatic"
25427,Metastatic Lesion,Metastatic Soft Tissue Sarcoma
25428,Secondary Lesion,Metastatic Soft Tissue Sarcoma
25429,Metastatic Lesion,Locally Advanced Sarcoma
25430,Secondary Lesion,Metastatic Bone Sarcoma
25431,Metastatic Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
25432,Secondary Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
25433,Unresectable Mass,Unresectable Pancreatic Neuroendocrine Carcinoma
25434,Extensive Stage Lesion,Advanced Renal Cell Carcinoma
25435,Cutaneous Involvement,Locally Advanced Skin Squamous Cell Carcinoma
25436,Metastatic Lesion,Locally Advanced Skin Squamous Cell Carcinoma
25437,Metastatic Lesion,Advanced Sarcoma
25438,Metastatic Lesion,Metastatic Lung Carcinoma
25439,Metastatic Lesion,Breast Carcinoma Metastatic in the Spine
25440,Carcinomatous Component Present,Metastatic Breast Carcinoma
25441,Metastatic Lesion,Locally Advanced Unresectable Malignant Neoplasm
25442,Regional Disease,Locally Advanced Unresectable Malignant Neoplasm
25443,Carcinomatous Component Present,Metastatic Unresectable Carcinoma
25444,Metastatic Lesion,Metastatic Unresectable Gastric Adenocarcinoma
25445,Unresectable Mass,Advanced Unresectable Gastric Adenocarcinoma
25446,Epithelial Component Present,Metastatic Gastric Carcinoma
25447,Solitary mass,Locally Advanced Chordoma
25448,Epithelial Component Present,Castration-Sensitive Prostate Carcinoma
25449,Biphasic Pattern,Recurrent Ovarian Carcinosarcoma
25450,Refractory Disease,Refractory Bile Duct Carcinoma
25451,Carcinomatous Component Present,Refractory Bile Duct Carcinoma
25452,Metastatic Lesion,Locally Advanced Small Intestinal Carcinoma
25453,Secondary Lesion,Locally Advanced Small Intestinal Carcinoma
25454,Regional Disease,Locally Advanced Small Intestinal Carcinoma
25455,Regional Disease,Locally Advanced Digestive System Carcinoma
25456,Metastatic Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
25457,Secondary Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
25458,Recurrent disease,Recurrent Acinic Cell Breast Carcinoma
25459,Acinar Cell Differentiation,Recurrent Pancreatic Acinar Cell Carcinoma
25460,Recurrent disease,Recurrent Prostate Acinar Adenocarcinoma
25461,Carcinomatous Component Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type"
25462,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type"
25463,Carcinomatous Component Present,Recurrent Anal Adenocarcinoma
25464,Recurrent disease,Recurrent Paget Disease of the Anal Canal
25465,Epithelial Component Present,Recurrent Salivary Duct Carcinoma
25466,Carcinomatous Component Present,Recurrent Salivary Duct Carcinoma
25467,Epithelial Component Present,Recurrent Fallopian Tube Serous Adenocarcinoma
25468,Stromal Invasion,Recurrent Ovarian Serous Adenocarcinoma
25469,Cystic Change,Recurrent Ovarian Cystadenocarcinoma
25470,Ground Glass Nuclear Inclusion,Recurrent Thyroid Gland Papillary Carcinoma
25471,Epithelial Component Present,Recurrent Thyroid Gland Follicular Carcinoma
25472,Recurrent disease,Recurrent Thyroid Gland Medullary Carcinoma
25473,Epithelial Component Present,Recurrent Thyroid Gland Medullary Carcinoma
25474,Carcinomatous Component Present,Recurrent Thyroid Gland Anaplastic Carcinoma
25475,Recurrent disease,Recurrent Skin Angiosarcoma
25476,Cutaneous Involvement,Recurrent Skin Angiosarcoma
25477,Recurrent disease,Recurrent Parotid Gland Carcinoma
25478,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma
25479,Recurrent disease,Recurrent Appendix Carcinoma
25480,Epithelial Component Present,Recurrent Appendix Carcinoma
25481,Epithelial Component Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma
25482,Cystic Change,Recurrent Parotid Gland Mucoepidermoid Carcinoma
25483,Recurrent disease,Recurrent Submandibular Gland Adenoid Cystic Carcinoma
25484,Carcinomatous Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma
25485,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma
25486,Epithelial Component Present,Recurrent Parotid Gland Undifferentiated Carcinoma
25487,Epithelial Component Present,Recurrent Malignant Ovarian Transitional Cell Tumor
25488,Epithelial Component Present,Recurrent Ovarian Transitional Cell Carcinoma
25489,Primary Lesion,Recurrent Fibrolamellar Carcinoma
25490,Lamellar Pattern,Recurrent Fibrolamellar Carcinoma
25491,Secondary Lesion,Hepatic cancer metastatic
25492,Metastatic Lesion,Metastatic hepatocellular carcinoma
25493,Primary Lesion,Metastatic hepatocellular carcinoma
25494,Hyperplastic Tissue Present,Hyperplasia of pituitary gland
25495,Recurrent disease,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified"
25496,Epithelial Component Present,Sparsely Granulated Corticotroph Adenoma
25497,Immunologic Deficiency Syndromes,Methotrexate-Associated Follicular Lymphoma
25498,Secondary Lesion,Epithelioid sarcoma metastatic
25499,Secondary Lesion,Synovial sarcoma metastatic
25500,Primary Lesion,Recurrent Childhood Pineoblastoma
25501,Monomorphic Cellular Infiltrate,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
25502,Refractory Disease,Platinum-Resistant Ovarian Carcinoma
25503,CDKN2A-p16 Negative,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
25504,Epithelial Component Present,Unresectable Carcinoma
25505,Epithelial Component Present,Unresectable Thymic Carcinoma
25506,Regional Disease,Locally Advanced Thymic Carcinoma
25507,Carcinomatous Component Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7
25508,Storiform Growth Pattern,Refractory Undifferentiated Pleomorphic Sarcoma
25509,Cellular Pleomorphism,Refractory Undifferentiated Pleomorphic Sarcoma
25510,Delicate Arborizing Vascular Channel Formation,Myxoid liposarcoma metastatic
25511,Unresectable Mass,Unresectable Sarcoma
25512,Refractory Disease,Refractory Myelodysplastic Syndrome
25513,Epithelial Component Present,Refractory Oral Cavity Squamous Cell Carcinoma
25514,Recurrent disease,Recurrent Acute Myeloid Leukemia
25515,Refractory Disease,Refractory Acute Leukemia
25516,Refractory Disease,Refractory Nasopharyngeal Carcinoma
25517,Metastatic Lesion,Advanced Urothelial Carcinoma
25518,Secondary Lesion,Advanced Urothelial Carcinoma
25519,Secondary Lesion,Locally Advanced Melanoma
25520,Epithelial Component Present,Cervical Esophagus Squamous Cell Carcinoma
25521,Carcinomatous Component Present,Cervical Esophagus Squamous Cell Carcinoma
25522,Bone Marrow Dysplasia Present,Refractory Chronic Myelomonocytic Leukemia
25523,Epithelial Component Present,Refractory Uterine Corpus Carcinoma
25524,Refractory Disease,Refractory Endometrial Carcinoma
25525,Stromal Invasion,Recurrent Ovarian Endometrioid Adenocarcinoma
25526,Carcinomatous Component Present,Refractory Ovarian Endometrioid Adenocarcinoma
25527,Recurrent disease,Recurrent Endometrial Endometrioid Adenocarcinoma
25528,Epithelial Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma
25529,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma
25530,Secondary Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx
25531,Metastatic Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma
25532,Secondary Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma
25533,Secondary Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx
25534,Metastatic Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma
25535,Epithelial Component Present,Advanced Laryngeal Squamous Cell Carcinoma
25536,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage IV
25537,Neuroectodermal Differentiation,High-Risk Neuroblastoma
25538,Chronic Inflammatory Infiltrate,Fibrin-Associated Diffuse Large B-Cell Lymphoma
25539,Metastatic Lesion,Metastatic Bladder Urothelial Carcinoma
25540,Secondary Lesion,Metastatic Bladder Urothelial Carcinoma
25541,Metastatic Lesion,Metastatic Renal Pelvis Urothelial Carcinoma
25542,Epithelial Component Present,Metastatic Renal Pelvis Urothelial Carcinoma
25543,Epithelial Component Present,Recurrent Renal Pelvis Urothelial Carcinoma
25544,Epithelial Component Present,Unresectable Urothelial Carcinoma
25545,Recurrent disease,Recurrent Malignant Pharyngeal Neoplasm
25546,Recurrent disease,Recurrent Malignant Male Reproductive System Neoplasm
25547,Epithelial Component Present,Recurrent Malignant Endocrine Neoplasm
25548,Cutaneous Involvement,Refractory Malignant Skin Neoplasm
25549,High Grade Lesion,Refractory Lung Small Cell Carcinoma
25550,Neuroendocrine Differentiation,Refractory Lung Small Cell Carcinoma
25551,Nuclear Molding,Refractory Lung Small Cell Carcinoma
25552,Recurrent disease,Recurrent Dedifferentiated Liposarcoma
25553,Resectable Mass,Resectable Malignant Neoplasm
25554,Carcinomatous Component Present,Resectable Carcinoma
25555,Non Lipogenic Sarcomatous Stroma Present,Resectable Dedifferentiated Liposarcoma
25556,Storiform Growth Pattern,Resectable Undifferentiated Pleomorphic Sarcoma
25557,Unifocal Lesion,"Langerhans cell histiocytosis, unifocal"
25558,Polymorphic Cellular Infiltrate,"Langerhans cell histiocytosis, unifocal"
25559,S-100-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic"
25560,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction
25561,Secondary Lesion,Refractory Metastatic Digestive System Carcinoma
25562,Epithelial Component Present,Locally Advanced Bile Duct Carcinoma
25563,Bone Marrow and Blood Involvement,Refractory Burkitt Leukemia
25564,High Grade Lesion,Unresectable Rhabdomyosarcoma
25565,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present","Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
25566,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
25567,Refractory Disease,Refractory Malignant Head and Neck Neoplasm
25568,Regional Disease,Locally Advanced Bone Sarcoma
25569,Poorly Differentiated Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
25570,Bone Marrow Involvement,Recurrent Hepatosplenic T-Cell Lymphoma
25571,Sinusoidal Infiltration,Refractory Hepatosplenic T-Cell Lymphoma
25572,Secondary Lesion,Advanced Melanoma
25573,Extensive Stage Lesion,Advanced Carcinoma
25574,Regional Disease,Locally Advanced Skin Squamous Cell Carcinoma
25575,Secondary Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
25576,Carcinomatous Component Present,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
25577,Metastatic Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma
25578,Metastatic Lesion,Locally Advanced Lung Carcinoma
25579,Epithelial Component Present,Locally Advanced Lung Carcinoma
25580,Carcinomatous Component Present,Locally Advanced Lung Carcinoma
25581,Epithelial Component Present,Locally Advanced Head and Neck Carcinoma
25582,Metastatic Lesion,Colorectal Carcinoma Metastatic in the Lung
25583,Secondary Lesion,Breast Carcinoma Metastatic in the Spine
25584,Epithelial Component Present,Breast Carcinoma Metastatic in the Spine
25585,Metastatic Lesion,Breast Carcinoma Metastatic in Lymph Node
25586,Secondary Lesion,Metastatic Unresectable Gastric Adenocarcinoma
25587,Secondary Lesion,Locally Advanced Chordoma
25588,Recurrent Lymphoma,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
25589,Diffuse Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
25590,Carcinomatous Component Present,Castration-Sensitive Prostate Carcinoma
25591,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Carcinosarcoma
25592,Metastatic Lesion,Metastatic Triple-Negative Breast Carcinoma
25593,Carcinomatous Component Present,Metastatic Triple-Negative Breast Carcinoma
25594,HER2/Neu Negative,Metastatic Triple-Negative Breast Carcinoma
25595,Epithelial Component Present,Refractory Liver Carcinoma
25596,Secondary Lesion,Locally Advanced Digestive System Carcinoma
25597,Epithelial Component Present,Recurrent Gastroesophageal Junction Adenocarcinoma
25598,Carcinomatous Component Present,Bile duct cancer recurrent
25599,Carcinomatous Component Present,Metastatic Cervical Carcinoma
25600,Metastatic Lesion,Metastatic Cervical Adenosquamous Carcinoma
25601,Secondary Lesion,Locally Advanced Unresectable Bone Sarcoma
25602,Unresectable Mass,Locally Advanced Unresectable Sarcoma
25603,Microvascular Proliferation,Recurrent Pancreatic Acinar Cell Carcinoma
25604,Carcinomatous Component Present,Recurrent Submandibular Gland Acinic Cell Carcinoma
25605,Mucoid Stroma Formation,Recurrent Appendix Mucinous Adenocarcinoma
25606,Epithelial Component Present,Recurrent Lobular Breast Carcinoma
25607,Recurrent disease,Recurrent Salivary Duct Carcinoma
25608,Recurrent disease,Recurrent Ovarian Serous Adenocarcinoma
25609,Epithelial Component Present,Recurrent Ovarian Serous Adenocarcinoma
25610,Stromal Invasion,Recurrent Ovarian Mucinous Adenocarcinoma
25611,Epithelial Component Present,Recurrent Ovarian Mucinous Adenocarcinoma
25612,Carcinomatous Component Present,Recurrent Ovarian Mucinous Adenocarcinoma
25613,Recurrent disease,Recurrent Pancreatic Ductal Adenocarcinoma
25614,Cystic Change,Recurrent Pancreatic Cystadenocarcinoma
25615,Epithelial Component Present,Recurrent Pancreatic Cystadenocarcinoma
25616,Epithelial Component Present,Recurrent Thyroid Gland Papillary Carcinoma
25617,High Mitotic Activity,Recurrent Thyroid Gland Anaplastic Carcinoma
25618,Rapidly Enlarging Mass,Recurrent Thyroid Gland Anaplastic Carcinoma
25619,Recurrent disease,Recurrent Thyroid Gland Anaplastic Carcinoma
25620,Vascular Channel Formation,Recurrent Skin Angiosarcoma
25621,Epithelial Component Present,Recurrent Submandibular Gland Carcinoma
25622,Recurrent disease,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
25623,Carcinomatous Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
25624,Cystic Change,Recurrent Submandibular Gland Mucoepidermoid Carcinoma
25625,Epithelial Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
25626,Recurrent disease,Recurrent Parotid Gland Squamous Cell Carcinoma
25627,Recurrent disease,Recurrent Malignant Ovarian Transitional Cell Tumor
25628,Stromal Invasion,Recurrent Malignant Ovarian Brenner Tumor
25629,Fibrotic Stroma Formation,Recurrent Malignant Ovarian Brenner Tumor
25630,Refractory Disease,Refractory Malignant Central Nervous System Neoplasm
25631,Recurrent disease,Recurrent Fibrolamellar Carcinoma
25632,Epithelial Component Present,Recurrent Fibrolamellar Carcinoma
25633,Carcinomatous Component Present,Hepatic cancer metastatic
25634,Carcinomatous Component Present,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
25635,Nuclear Atypia,MGMT-Methylated Glioblastoma
25636,High Grade Lesion,MGMT-Methylated Glioblastoma
25637,Villous atrophy,Small Intestinal Enteropathy-Associated T-Cell Lymphoma
25638,Primary Lesion,Brain Glioblastoma
25639,Primary Lesion,Cerebral Glioblastoma
25640,Malignant Cellular Infiltrate,Stage 2B Neuroblastoma
25641,Malignant Cellular Infiltrate,Class 1 Uveal Melanoma
25642,Malignant Cellular Infiltrate,Neural Glioblastoma
25643,Malignant Cellular Infiltrate,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
25644,Malignant Cellular Infiltrate,Adult Favorable Prognosis Hodgkin Lymphoma
25645,Malignant Cellular Infiltrate,Mucosal Melanoma
25646,Malignant Cellular Infiltrate,Childhood Epithelioid Hemangioendothelioma
25647,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
25648,Malignant Cellular Infiltrate,Stage IIC Rectal Cancer AJCC v7
25649,Malignant Cellular Infiltrate,Stage IVA Rectal Cancer AJCC v7
25650,Malignant Cellular Infiltrate,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
25651,Malignant Cellular Infiltrate,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
25652,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
25653,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
25654,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
25655,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7
25656,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7
25657,Malignant Cellular Infiltrate,Stage III Primary Peritoneal Cancer AJCC v7
25658,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v7
25659,Malignant Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v7
25660,Malignant Cellular Infiltrate,BCLC Stage D Hepatocellular Carcinoma
25661,Malignant Cellular Infiltrate,Adult Grade III Lymphomatoid Granulomatosis
25662,Malignant Cellular Infiltrate,Adult Myelodysplastic Syndrome
25663,Bone Marrow Lymphoplasmacytic Infiltrate,Familial Waldenstrom's Macroglobulinaemia
25664,Well Differentiated Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Tumor G1
25665,Malignant Cellular Infiltrate,Non-Metastatic Childhood Soft Tissue Sarcoma
25666,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Astrocytoma
25667,Malignant Cellular Infiltrate,Recurrent Childhood Giant Cell Glioblastoma
25668,Malignant Cellular Infiltrate,Recurrent Childhood Non-Hodgkin Lymphoma
25669,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Germ Cell Tumor
25670,Malignant Cellular Infiltrate,Recurrent Merkel Cell Carcinoma
25671,Malignant Cellular Infiltrate,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
25672,Malignant Cellular Infiltrate,Refractory Childhood Hodgkin Lymphoma
25673,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma
25674,Malignant Cellular Infiltrate,Childhood Colorectal Carcinoma
25675,Malignant Cellular Infiltrate,Childhood Nasal Cavity Carcinoma
25676,Malignant Cellular Infiltrate,Adult Penile Carcinoma
25677,Malignant Cellular Infiltrate,Childhood Malignant Small Intestinal Neoplasm
25678,Malignant Cellular Infiltrate,Orbital Melanoma
25679,Malignant Cellular Infiltrate,Familial Nonmedullary Thyroid Gland Carcinoma
25680,Malignant Cellular Infiltrate,Familial Colorectal Cancer Type X
25681,Benign Cellular Infiltrate,Palisaded encapsulated neuroma
25682,Benign Cellular Infiltrate,Hybrid nerve sheath tumor
25683,Malignant Cellular Infiltrate,"Undifferentiated Sarcoma, Not Otherwise Specified"
25684,Malignant Cellular Infiltrate,Secondary Peripheral Chondrosarcoma
25685,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia Not Otherwise Specified
25686,Malignant Cellular Infiltrate,Hypocellular Myelodysplastic Syndrome
25687,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7
25688,Malignant Cellular Infiltrate,Lepidic Predominant Adenocarcinoma
25689,Malignant Cellular Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis
25690,Malignant Cellular Infiltrate,Childhood Periosteal Osteosarcoma
25691,Malignant Cellular Infiltrate,Fusion-Positive Rhabdomyosarcoma
25692,Malignant Cellular Infiltrate,Childhood Mixed Germ Cell Tumor
25693,Malignant Cellular Infiltrate,Infant Acute Biphenotypic Leukemia
25694,Malignant Cellular Infiltrate,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
25695,Malignant Cellular Infiltrate,Primary Peritoneal High Grade Serous Adenocarcinoma
25696,Malignant Cellular Infiltrate,High Grade Fallopian Tube Serous Adenocarcinoma
25697,Malignant Cellular Infiltrate,Low Grade Fallopian Tube Serous Adenocarcinoma
25698,Malignant Cellular Infiltrate,Endometrial Dedifferentiated Carcinoma
25699,Malignant Cellular Infiltrate,WHO Grade III Glioma
25700,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Mammary Gland Type
25701,Benign Cellular Infiltrate,Vulvar Superficial Myofibroblastoma
25702,Malignant Cellular Infiltrate,"Medulloblastoma, Not Otherwise Specified"
25703,Benign Cellular Infiltrate,Central Nervous System Myofibroblastoma
25704,Benign Cellular Infiltrate,Osteoma of skull
25705,Malignant Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive"
25706,Malignant Cellular Infiltrate,Acute myeloid leukemia with BCR-ABL1
25707,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated RUNX1
25708,Malignant Cellular Infiltrate,Early T Acute Lymphoblastic Leukemia
25709,Malignant Cellular Infiltrate,Recurrent Gliosarcoma
25710,Primary Lesion,Frontal Lobe Ependymal Tumor
25711,Primary Lesion,Cerebellar and Brain Stem Ependymal Tumor
25712,Malignant Cellular Infiltrate,Small Intestinal Myeloid Sarcoma
25713,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Cancer AJCC v8
25714,Malignant Cellular Infiltrate,Stage I Major Salivary Gland Cancer AJCC v8
25715,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v8
25716,Malignant Cellular Infiltrate,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
25717,Malignant Cellular Infiltrate,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
25718,Malignant Cellular Infiltrate,MGMT-Unmethylated Glioblastoma
25719,Malignant Cellular Infiltrate,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage
25720,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
25721,Malignant Cellular Infiltrate,Stage IVB Laryngeal Cancer AJCC v8
25722,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck
25723,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Carcinoma
25724,Malignant Cellular Infiltrate,Clinical Stage II Esophageal Adenocarcinoma AJCC v8
25725,Malignant Cellular Infiltrate,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
25726,Malignant Cellular Infiltrate,Clinical Stage III Esophageal Adenocarcinoma AJCC v8
25727,Malignant Cellular Infiltrate,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8
25728,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8
25729,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
25730,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8
25731,Malignant Cellular Infiltrate,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
25732,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
25733,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
25734,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8
25735,Malignant Cellular Infiltrate,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8
25736,Malignant Cellular Infiltrate,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
25737,Malignant Cellular Infiltrate,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
25738,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage
25739,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Pathologic Stage
25740,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage
25741,Malignant Cellular Infiltrate,Clinical Stage I Gastric Cancer AJCC v8
25742,Malignant Cellular Infiltrate,Pathologic Stage I Gastric Cancer AJCC v8
25743,Malignant Cellular Infiltrate,Pathologic Stage IB Gastric Cancer AJCC v8
25744,Malignant Cellular Infiltrate,Locally Advanced Paraganglioma
25745,Malignant Cellular Infiltrate,Refractory Classic Hodgkin Lymphoma
25746,Malignant Cellular Infiltrate,Anal Cancer by AJCC v8 Stage
25747,Malignant Cellular Infiltrate,Stage 0 Anal Cancer AJCC v8
25748,Malignant Cellular Infiltrate,Stage II Anal Cancer AJCC v8
25749,Malignant Cellular Infiltrate,Stage II Appendix Carcinoma AJCC v8
25750,Malignant Cellular Infiltrate,Stage IIB Appendix Carcinoma AJCC v8
25751,Malignant Cellular Infiltrate,Stage IIIC Appendix Carcinoma AJCC v8
25752,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v8 Stage
25753,Malignant Cellular Infiltrate,Stage IIA Colorectal Cancer AJCC v8
25754,Malignant Cellular Infiltrate,Stage I Colon Cancer AJCC v8
25755,Malignant Cellular Infiltrate,Stage IV Colon Cancer AJCC v8
25756,Malignant Cellular Infiltrate,Stage IIIB Rectal Cancer AJCC v8
25757,Malignant Cellular Infiltrate,Stage IVA Rectal Cancer AJCC v8
25758,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v8
25759,Malignant Cellular Infiltrate,Stage IIIB Hepatocellular Carcinoma AJCC v8
25760,Malignant Cellular Infiltrate,Stage 0 Gallbladder Cancer AJCC v8
25761,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v8
25762,Malignant Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v8
25763,Malignant Cellular Infiltrate,Hilar Cholangiocarcinoma by AJCC v8 Stage
25764,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v8 Stage
25765,Malignant Cellular Infiltrate,Stage 0 Ampulla of Vater Cancer AJCC v8
25766,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v8
25767,Malignant Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v8
25768,Well Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor by AJCC v8 Stage
25769,Well Differentiated Neuroendocrine Lesion,Stage II Duodenal Neuroendocrine Tumor AJCC v8
25770,Well Differentiated Neuroendocrine Lesion,Stage IV Duodenal Neuroendocrine Tumor AJCC v8
25771,Well Differentiated Neuroendocrine Lesion,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8
25772,Well Differentiated Neuroendocrine Lesion,Stage II Jejunal Neuroendocrine Tumor AJCC v8
25773,Well Differentiated Neuroendocrine Lesion,Stage III Ileal Neuroendocrine Tumor AJCC v8
25774,Well Differentiated Neuroendocrine Lesion,Stage IV Ileal Neuroendocrine Tumor AJCC v8
25775,Well Differentiated Neuroendocrine Lesion,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8
25776,Well Differentiated Neuroendocrine Lesion,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8
25777,Malignant Cellular Infiltrate,Lung Cancer by AJCC v8 Stage
25778,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v8
25779,Malignant Cellular Infiltrate,Stage IA2 Lung Cancer AJCC v8
25780,Malignant Cellular Infiltrate,Lung Non-Small Cell Cancer by AJCC v7 Stage
25781,Malignant Cellular Infiltrate,Stage IIA Bone Cancer AJCC v8
25782,Malignant Cellular Infiltrate,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
25783,Malignant Cellular Infiltrate,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
25784,Malignant Cellular Infiltrate,Stage II Retroperitoneal Sarcoma AJCC v8
25785,Malignant Cellular Infiltrate,Stage IIIA Retroperitoneal Sarcoma AJCC v8
25786,Malignant Cellular Infiltrate,Stage IV Retroperitoneal Sarcoma AJCC v8
25787,Malignant Cellular Infiltrate,Clinical Stage II Merkel Cell Carcinoma AJCC v8
25788,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage
25789,Malignant Cellular Infiltrate,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8
25790,Malignant Cellular Infiltrate,Pathologic Stage III Merkel Cell Carcinoma AJCC v8
25791,Malignant Cellular Infiltrate,Clinical Stage I Cutaneous Melanoma AJCC v8
25792,Malignant Cellular Infiltrate,Clinical Stage IIB Cutaneous Melanoma AJCC v8
25793,Malignant Cellular Infiltrate,Clinical Stage IIC Cutaneous Melanoma AJCC v8
25794,Malignant Cellular Infiltrate,Clinical Stage III Cutaneous Melanoma AJCC v8
25795,Malignant Cellular Infiltrate,Pathologic Stage IIA Cutaneous Melanoma AJCC v8
25796,Malignant Cellular Infiltrate,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
25797,Malignant Cellular Infiltrate,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
25798,Malignant Cellular Infiltrate,Basal-Like Prostate Carcinoma
25799,Malignant Cellular Infiltrate,Breast Cancer by AJCC v8 Stage
25800,Malignant Cellular Infiltrate,Breast Cancer by AJCC v8 Anatomic Stage
25801,Malignant Cellular Infiltrate,Anatomic Stage II Breast Cancer AJCC v8
25802,Malignant Cellular Infiltrate,Anatomic Stage IV Breast Cancer AJCC v8
25803,Malignant Cellular Infiltrate,Prognostic Stage 0 Breast Cancer AJCC v8
25804,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v8 Stage
25805,Malignant Cellular Infiltrate,Stage II Vaginal Cancer AJCC v8
25806,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v8
25807,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v8
25808,Malignant Cellular Infiltrate,Stage II Uterine Corpus Leiomyosarcoma AJCC v8
25809,Malignant Cellular Infiltrate,Stage III Uterine Corpus Leiomyosarcoma AJCC v8
25810,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8
25811,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
25812,Malignant Cellular Infiltrate,Stage IV Ovarian Cancer AJCC v8
25813,Malignant Cellular Infiltrate,Stage IVA Ovarian Cancer AJCC v8
25814,Malignant Cellular Infiltrate,Stage I Fallopian Tube Cancer AJCC v8
25815,Malignant Cellular Infiltrate,Stage IIIB Fallopian Tube Cancer AJCC v8
25816,Malignant Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v8
25817,Malignant Cellular Infiltrate,Stage IVB Primary Peritoneal Cancer AJCC v8
25818,Malignant Cellular Infiltrate,Stage IIA Prostate Cancer AJCC v8
25819,Malignant Cellular Infiltrate,Stage IIIA Prostate Cancer AJCC v8
25820,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v8
25821,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v8 Stage
25822,Malignant Cellular Infiltrate,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
25823,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v8
25824,Malignant Cellular Infiltrate,Ureter Cancer by AJCC v7 Stage
25825,Malignant Cellular Infiltrate,Pathologic Stage I Retinoblastoma AJCC v8
25826,Malignant Cellular Infiltrate,Pathologic Stage IV Retinoblastoma AJCC v8
25827,Malignant Cellular Infiltrate,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
25828,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage
25829,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma AJCC v8
25830,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
25831,Encapsulated Mass,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
25832,Malignant Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage
25833,Malignant Cellular Infiltrate,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage
25834,Malignant Cellular Infiltrate,Refractory Extensive Stage Lung Small Cell Carcinoma
25835,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8
25836,Malignant Cellular Infiltrate,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8
25837,Malignant Cellular Infiltrate,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8
25838,Malignant Cellular Infiltrate,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage
25839,Malignant Cellular Infiltrate,B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage
25840,Malignant Cellular Infiltrate,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage
25841,Malignant Cellular Infiltrate,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage
25842,Malignant Cellular Infiltrate,RISS Stage III Plasma Cell Myeloma
25843,Malignant Cellular Infiltrate,Acute lymphoblastic leukemia recurrent
25844,Malignant Cellular Infiltrate,Recurrent B Acute Lymphoblastic Leukemia
25845,Malignant Cellular Infiltrate,Stage I Malignant Mediastinal Germ Cell Tumor
25846,Malignant Cellular Infiltrate,Stage II Malignant Mediastinal Germ Cell Tumor
25847,Well Differentiated Neuroendocrine Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm
25848,Benign Cellular Infiltrate,Benign Pericardial Germ Cell Tumor
25849,Malignant Cellular Infiltrate,"Recurrent Medulloblastoma, SHH-Activated"
25850,Malignant Cellular Infiltrate,Childhood Brain Glioblastoma
25851,Malignant Cellular Infiltrate,Refractory Breast Carcinoma
25852,Malignant Cellular Infiltrate,BRCA-Mutated Ovarian Carcinoma
25853,Malignant Cellular Infiltrate,Unresectable Carcinoma
25854,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome refractory
25855,Malignant Cellular Infiltrate,Refractory Indolent Adult Non-Hodgkin Lymphoma
25856,Malignant Cellular Infiltrate,Refractory Leiomyosarcoma
25857,Malignant Cellular Infiltrate,EZB Diffuse Large B-Cell Lymphoma
25858,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia
25859,Malignant Cellular Infiltrate,Castration-Naive Prostate Carcinoma
25860,Malignant Cellular Infiltrate,Cervical Esophagus Adenocarcinoma
25861,Malignant Cellular Infiltrate,Refractory T Acute Lymphoblastic Leukemia
25862,Malignant Cellular Infiltrate,Unresectable Urothelial Carcinoma
25863,Malignant Cellular Infiltrate,Recurrent Malignant Endocrine Neoplasm
25864,Malignant Cellular Infiltrate,Metastatic Gastroesophageal Junction Adenocarcinoma
25865,Malignant Cellular Infiltrate,Unresectable Neuroblastoma
25866,Malignant Cellular Infiltrate,Metastatic Gastrointestinal Stromal Tumor
25867,Malignant Cellular Infiltrate,Familial Acute Myeloid Leukemia with Mutated Cebpa
25868,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline RUNX1 Mutation
25869,Malignant Cellular Infiltrate,Abdominal Rhabdomyosarcoma
25870,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified"
25871,Malignant Cellular Infiltrate,Unresectable Soft Tissue Sarcoma
25872,Malignant Cellular Infiltrate,Metastatic Soft Tissue Sarcoma
25873,Malignant Cellular Infiltrate,Refractory Mediastinal Lymphoma
25874,Malignant Cellular Infiltrate,Locally Advanced Lung Carcinoma
25875,Malignant Cellular Infiltrate,Locally Advanced Head and Neck Carcinoma
25876,Malignant Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Lung
25877,Malignant Cellular Infiltrate,Metastatic Unresectable Malignant Neoplasm
25878,Malignant Cellular Infiltrate,Metastatic Unresectable Gastric Adenocarcinoma
25879,Malignant Cellular Infiltrate,Metastatic Gastric Carcinoma
25880,Malignant Cellular Infiltrate,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
25881,Secondary Lesion,Castration-Sensitive Prostate Carcinoma
25882,Malignant Cellular Infiltrate,Refractory Bile Duct Carcinoma
25883,Malignant Cellular Infiltrate,Metastatic Cervical Adenosquamous Carcinoma
25884,Malignant Cellular Infiltrate,Recurrent Ampulla of Vater Adenocarcinoma
25885,Malignant Cellular Infiltrate,Recurrent Anal Adenocarcinoma
25886,Malignant Cellular Infiltrate,Recurrent Anal Mucinous Adenocarcinoma
25887,Malignant Cellular Infiltrate,Recurrent Thyroid Gland Anaplastic Carcinoma
25888,Malignant Cellular Infiltrate,Recurrent Parotid Gland Mucoepidermoid Carcinoma
25889,Malignant Cellular Infiltrate,Recurrent Fibrolamellar Carcinoma
25890,Malignant Cellular Infiltrate,Resectable Malignant Mesothelioma
25891,Malignant Cellular Infiltrate,Unresectable Pleural Malignant Mesothelioma
25892,Epithelial Component Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma
25893,Unresectable Mass,Unresectable Renal Cell Carcinoma
25894,Resectable Mass,Resectable Renal Cell Carcinoma
25895,Extensive Stage Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm
25896,Malignant Cellular Infiltrate,Digestive System Small Cell Neuroendocrine Carcinoma
25897,Neuroendocrine Differentiation,Digestive System Small Cell Neuroendocrine Carcinoma
25898,Secondary Lesion,Advanced Sarcoma of the Extremity
25899,Malignant Cellular Infiltrate,Locally Advanced Unresectable Renal Cell Carcinoma
25900,Epithelial Component Present,Pituitary Gland Paraganglioma
25901,Slow Growing Mass,Sellar Chordoma
25902,Hyalinized Stroma Formation,Sellar Solitary Fibrous Tumor/Hemangiopericytoma
25903,Thin Bands of Collagen Present,Sellar Solitary Fibrous Tumor/Hemangiopericytoma
25904,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Sellar Region
25905,Malignant Cellular Infiltrate,Malignant Skull Base Neoplasm
25906,Primary Lesion,Pituitary Gland Non-Hodgkin Lymphoma
25907,Malignant Cellular Infiltrate,Pituitary Gland Diffuse Large B-Cell Lymphoma
25908,Primary Lesion,Pituitary Gland Diffuse Large B-Cell Lymphoma
25909,Lymphoplasmacytic Infiltrate,Sellar Germinoma
25910,Lymphoplasmacytic Infiltrate,Suprasellar Germinoma
25911,Malignant Cellular Infiltrate,Sellar Choriocarcinoma
25912,Recurrent disease,Recurrent Endometrial Clear Cell Adenocarcinoma
25913,Epithelial Component Present,Recurrent Uterine Corpus Carcinosarcoma
25914,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Uterine Corpus Carcinosarcoma
25915,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Uterine Corpus Carcinosarcoma
25916,Recurrent disease,Recurrent Endometrial Mixed Cell Adenocarcinoma
25917,Metastatic Lesion,Metastatic Malignant Pancreatic Neoplasm
25918,Extensive Stage Lesion,Advanced Neuroendocrine Carcinoma
25919,Unresectable Mass,Unresectable Lung Non-Small Cell Carcinoma
25920,Malignant Cellular Infiltrate,Metastatic Lung Adenocarcinoma
25921,Poorly Differentiated Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
25922,Secondary Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
25923,Secondary Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma
25924,Regional Disease,Locally Advanced Digestive System Neuroendocrine Carcinoma
25925,Carcinomatous Component Present,Unresectable Digestive System Neuroendocrine Carcinoma
25926,Refractory Disease,Refractory Digestive System Neuroendocrine Carcinoma
25927,Malignant Cellular Infiltrate,Recurrent Digestive System Neuroendocrine Carcinoma
25928,Precise Histogenesis Unknown,Cerebral Hemangioblastoma
25929,Epithelial Component Present,Epididymal Papillary Cystadenoma
25930,Monoclonal Cellular Population Present,Thyroid Gland Spindle Cell Follicular Adenoma
25931,Epithelial Component Present,Thyroid Gland Spindle Cell Follicular Adenoma
25932,Diffuse Pattern,Refractory Malignant Peripheral Nerve Sheath Tumor
25933,Refractory Disease,Refractory Malignant Peripheral Nerve Sheath Tumor
25934,High Grade Lesion,Frontal Lobe Anaplastic Astrocytoma
25935,Anaplasia,Temporal Lobe Anaplastic Astrocytoma
25936,Low Grade Lesion,Third Ventricle Pilocytic Astrocytoma
25937,Microcystic Change,Third Ventricle Pilocytic Astrocytoma
25938,Hyalinized Vessels Present,Third Ventricle Pilocytic Astrocytoma
25939,Malignant Cellular Infiltrate,Third Ventricle Germinoma
25940,Dense Intercellular Reticulin Network Present,Supratentorial Pleomorphic Xanthoastrocytoma
25941,Nuclear Pseudoinclusion,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
25942,Epithelial Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma
25943,Epithelial Component Present,Metastatic Fallopian Tube Carcinoma
25944,Metastatic Lesion,Metastatic Endometrial Carcinoma
25945,Secondary Lesion,Metastatic Endometrial Carcinoma
25946,Epithelial Component Present,Metastatic Adrenal Cortex Carcinoma
25947,Cutaneous Involvement,Stage IV Skin Melanoma
25948,Secondary Lesion,Stage IV Esophageal Adenocarcinoma
25949,Secondary Lesion,Stage IV Esophageal Squamous Cell Carcinoma
25950,Carcinomatous Component Present,Stage IV Esophageal Squamous Cell Carcinoma
25951,Carcinomatous Component Present,Metastatic Nasopharyngeal Undifferentiated Carcinoma
25952,Carcinomatous Component Present,Stage IV Laryngeal Carcinoma
25953,Metastatic Lesion,Metastatic Lip and Oral Cavity Carcinoma
25954,Metastatic Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma
25955,Epithelial Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma
25956,Epithelial Component Present,Lung squamous cell carcinoma stage IV
25957,Epithelial Component Present,Metastatic Lung Non-Small Cell Carcinoma
25958,Carcinomatous Component Present,Metastatic Lung Non-Small Cell Carcinoma
25959,Metastatic Lesion,Metastatic Lung Small Cell Carcinoma
25960,Epithelial Component Present,Metastatic Colorectal Carcinoma
25961,Carcinomatous Component Present,Metastatic Colon Carcinoma
25962,Carcinomatous Component Present,Metastatic Rectal Carcinoma
25963,Skin nodule,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
25964,Malignant Cellular Infiltrate,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
25965,Malignant Cellular Infiltrate,Frontal Lobe Anaplastic Oligodendroglioma
25966,Widely Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
25967,Thyroglobulin Positive Neoplastic Cells Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
25968,Local disease,Localized Gastric Carcinoma
25969,Carcinomatous Component Present,Thyroid Gland Mucinous Carcinoma
25970,High Grade Lesion,Tongue Alveolar Soft Part Sarcoma'
25971,Tissue Differentiation Uncertain,Tongue Alveolar Soft Part Sarcoma'
25972,High Grade Lesion,Orbital Alveolar Soft Part Sarcoma
25973,High Grade Lesion,Bladder Alveolar Soft Part Sarcoma
25974,Metastatic/Recurrent Disease,Bladder Alveolar Soft Part Sarcoma
25975,Malignant Cellular Infiltrate,Scrotal Sarcoma
25976,Regional Disease,Locally Advanced Prostate Carcinoma
25977,Carcinomatous Component Present,Locally Advanced Prostate Carcinoma
25978,Secondary Lesion,Locally Advanced Unresectable Prostate Carcinoma
25979,Epithelial Component Present,Locally Advanced Unresectable Prostate Carcinoma
25980,Invasive Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma
25981,Extensive Stage Lesion,Advanced Cervical Carcinoma
25982,Epithelial Component Present,Advanced Cervical Carcinoma
25983,Regional Disease,Locally Advanced Cervical Carcinoma
25984,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Carcinoma
25985,Epithelial Component Present,Advanced Cervical Adenocarcinoma
25986,Thick-Walled Hyalinized Vessels Present,Thyroid Gland Schwannoma
25987,Benign Cellular Infiltrate,Thyroid Gland Benign Vascular Neoplasm
25988,Indolent Clinical Course,Thyroid Gland Cavernous Hemangioma
25989,Vascular Channel Formation,Thyroid Gland Lymphangioma
25990,Indolent Clinical Course,Thyroid Gland Lymphangioma
25991,Emperipolesis,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy
25992,Malignant Cellular Infiltrate,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
25993,Metastatic Lesion,Advanced Kaposi Sarcoma
25994,Epithelial Component Present,Metastatic Neuroendocrine Neoplasm
25995,Metastatic Lesion,Advanced Neuroendocrine Neoplasm
25996,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Neoplasm
25997,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Neoplasm
25998,Neuroendocrine Differentiation,Metastatic Gastric Neuroendocrine Carcinoma
25999,Severe cytologic atypia,Metastatic Gastric Neuroendocrine Carcinoma
26000,Malignant Cellular Infiltrate,Advanced Gastric Neuroendocrine Carcinoma
26001,High Mitotic Activity,Advanced Gastric Small Cell Neuroendocrine Carcinoma
26002,Metastatic Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma
26003,High Mitotic Activity,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
26004,Metastatic Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
26005,Secondary Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
26006,Epithelial Component Present,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
26007,Malignant Cellular Infiltrate,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
26008,Carcinomatous Component Present,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
26009,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Acute Myelomonocytic Leukemia
26010,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A
26011,Recurrent Genetic Abnormalities Present,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A
26012,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
26013,Malignant Cellular Infiltrate,Recurrent Acute Erythroid Leukemia
26014,Metastatic Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma
26015,Carcinomatous Component Present,Locally Advanced Microsatellite Stable Colorectal Carcinoma
26016,Malignant Cellular Infiltrate,Basal cell carcinoma
26017,Epithelial Component Present,Locally Advanced Basal Cell Carcinoma
26018,Malignant Cellular Infiltrate,Biochemically Recurrent Prostate Carcinoma
26019,Epithelial Component Present,Biliary Tract Carcinoma
26020,Malignant Cellular Infiltrate,Metastatic Unresectable Basal Cell Carcinoma
26021,Regional Disease,Locally Advanced Unresectable Basal Cell Carcinoma
26022,Carcinomatous Component Present,Pancreatic adenocarcinoma resectable
26023,Malignant Cellular Infiltrate,Resectable Intrahepatic Cholangiocarcinoma
26024,Epithelial Component Present,Resectable Intrahepatic Cholangiocarcinoma
26025,Carcinomatous Component Present,Resectable Intrahepatic Cholangiocarcinoma
26026,Epithelial Component Present,Resectable Digestive System Carcinoma
26027,Malignant Cellular Infiltrate,"Carcinoma, Spindle-Cell"
26028,Malignant Cellular Infiltrate,Intraepithelial Squamous Cell Carcinoma
26029,Malignant Cellular Infiltrate,Gastric Non-Hodgkin's Lymphoma
26030,Low Grade Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
26031,Benign Cellular Infiltrate,Cellular angiofibroma
26032,Malignant Cellular Infiltrate,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7
26033,Malignant Cellular Infiltrate,"Myeloproliferative Neoplasm, Unclassifiable"
26034,Malignant Cellular Infiltrate,Refractory Hematologic Malignancy
26035,Malignant Cellular Infiltrate,Adult Anaplastic Large Cell Lymphoma
26036,Malignant Cellular Infiltrate,Adult Clear Cell Sarcoma of Soft Parts
26037,Malignant Cellular Infiltrate,Metastatic Carcinoma in the Adrenal Cortex
26038,Malignant Cellular Infiltrate,Pericardial Carcinomatosis
26039,Malignant Cellular Infiltrate,Small cell carcinoma of ovary
26040,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma
26041,Malignant Cellular Infiltrate,Adenoma of the Colon with Intramucosal Adenocarcinoma
26042,Malignant Cellular Infiltrate,Malignant Gastric Soft Tissue Neoplasm
26043,Malignant Cellular Infiltrate,mantle cell lymphoma of stomach
26044,Well Differentiated Neuroendocrine Lesion,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
26045,Well Differentiated Neuroendocrine Lesion,Small Intestinal Gastrin-Producing Neuroendocrine Tumor
26046,Malignant Cellular Infiltrate,Disseminated carcinoma
26047,Malignant Cellular Infiltrate,Proximal-Type Epithelioid Sarcoma
26048,Benign Cellular Infiltrate,Lipoblastoma
26049,Benign Cellular Infiltrate,Glomangiomatosis
26050,Benign Cellular Infiltrate,Hobnail Hemangioma
26051,Benign Cellular Infiltrate,Lymphangioma of skin
26052,Malignant Cellular Infiltrate,Radiation-Related Angiosarcoma
26053,Benign Cellular Infiltrate,Desmoplastic fibroblastoma
26054,Malignant Cellular Infiltrate,Digital papillary eccrine carcinoma of skin
26055,Benign Cellular Infiltrate,Multiple Lobular Capillary Hemangiomas
26056,Malignant Cellular Infiltrate,Human Papillomavirus-Related Endocervical Adenocarcinoma
26057,Malignant Cellular Infiltrate,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
26058,Malignant Cellular Infiltrate,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma
26059,Malignant Cellular Infiltrate,Human Papillomavirus-Related Anal Squamous Cell Carcinoma
26060,Malignant Cellular Infiltrate,Therapy-related myelodysplastic syndrome
26061,Questionable Invasive Lesion,Atypical follicular adenoma
26062,Ground Glass Nuclear Inclusion,Atypical follicular adenoma
26063,Follicular Cell Differentiation,Atypical follicular adenoma
26064,Malignant Cellular Infiltrate,Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
26065,Malignant Cellular Infiltrate,Carcinoma in situ of penis
26066,Secondary Lesion,Metastatic Kidney Carcinoma
26067,Malignant Cellular Infiltrate,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion"
26068,Malignant Cellular Infiltrate,Malignant neoplasm of endometrium
26069,Malignant Cellular Infiltrate,Stage IIIC Breast Cancer AJCC v6
26070,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component
26071,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant"
26072,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells
26073,Malignant Cellular Infiltrate,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease
26074,Malignant Cellular Infiltrate,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
26075,Malignant Cellular Infiltrate,Unclassified Renal Cell Carcinoma
26076,Malignant Cellular Infiltrate,Localized Askin Tumor
26077,Malignant Cellular Infiltrate,Alcohol-Related Hepatocellular Carcinoma
26078,Malignant Cellular Infiltrate,Alcohol-Related Carcinoma
26079,Malignant Cellular Infiltrate,Carcinoma in Situ
26080,Malignant Cellular Infiltrate,"Carcinoma, Papillary"
26081,Malignant Cellular Infiltrate,Colorectal Carcinoma
26082,Malignant Cellular Infiltrate,Cystadenocarcinoma
26083,Malignant Cellular Infiltrate,Glioblastoma
26084,Malignant Cellular Infiltrate,Heavy Chain Disease
26085,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia
26086,Malignant Cellular Infiltrate,Childhood Acute Lymphoblastic Leukemia
26087,Malignant Cellular Infiltrate,"Leukemia, Mast-Cell"
26088,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
26089,Malignant Cellular Infiltrate,"Leukemia, Myelomonocytic, Chronic"
26090,Malignant Cellular Infiltrate,Chronic Neutrophilic Leukemia
26091,Malignant Cellular Infiltrate,Acute Promyelocytic Leukemia
26092,Malignant Cellular Infiltrate,Malignant neoplasm of retina
26093,Malignant Cellular Infiltrate,melanoma
26094,Malignant Cellular Infiltrate,Paget's Disease of the Nipple
26095,Malignant Cellular Infiltrate,Carcinosarcoma
26096,Benign Cellular Infiltrate,"Chondromatosis, Synovial"
26097,Benign Cellular Infiltrate,Juvenile Xanthogranuloma
26098,Benign Cellular Infiltrate,Pyogenic granuloma
26099,Malignant Cellular Infiltrate,Lip Carcinoma
26100,Malignant Cellular Infiltrate,Adenocarcinoma of lung (disorder)
26101,Malignant Cellular Infiltrate,Esophageal carcinoma
26102,Malignant Cellular Infiltrate,Mixed Cellularity Hodgkin Lymphoma
26103,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
26104,Malignant Cellular Infiltrate,Malignant tumour of parotid gland
26105,Malignant Cellular Infiltrate,Malignant Frontal Sinus Neoplasm
26106,Malignant Cellular Infiltrate,Malignant neoplasm of heart
26107,Malignant Cellular Infiltrate,Malignant Placental Neoplasm
26108,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
26109,Malignant Cellular Infiltrate,Tall Cell Variant Thyroid Gland Papillary Carcinoma
26110,Malignant Cellular Infiltrate,Malignant tumor of epididymis
26111,Malignant Cellular Infiltrate,Malignant neoplasm of brain stem
26112,Malignant Cellular Infiltrate,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7
26113,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pleura
26114,Malignant Cellular Infiltrate,Head and Neck Carcinoma
26115,Malignant Cellular Infiltrate,Bronchogenic Carcinoma
26116,Benign Cellular Infiltrate,Benign neoplasm of tonsil
26117,Malignant Cellular Infiltrate,Microinvasive Malignant Neoplasm
26118,Malignant Cellular Infiltrate,Intermediate Grade Malignant Neoplasm
26119,Malignant Cellular Infiltrate,Invasive micropapillary carcinoma of breast
26120,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva
26121,Benign Cellular Infiltrate,Benign neoplasm of scrotum
26122,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Bone
26123,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Bone
26124,Malignant Cellular Infiltrate,Secondary carcinoma
26125,Malignant Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v6
26126,Malignant Cellular Infiltrate,Stage 0 Colon Cancer AJCC v6 and v7
26127,Malignant Cellular Infiltrate,"Adenocarcinoma, Oxyphilic"
26128,Benign Cellular Infiltrate,"Hemangioma, Intramuscular"
26129,Benign Cellular Infiltrate,Pleomorphic Lipoma
26130,Malignant Cellular Infiltrate,"Liposarcoma, Pleomorphic"
26131,Malignant Cellular Infiltrate,Medullomyoblastoma
26132,Malignant Cellular Infiltrate,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB
26133,Malignant Cellular Infiltrate,Desmoplastic melanoma
26134,Malignant Cellular Infiltrate,Adenosquamous carcinoma
26135,Primitive Mesenchymal Stroma Formation,Pulmonary Blastoma
26136,Biphasic Pattern,Pulmonary Blastoma
26137,Malignant Cellular Infiltrate,Mesenchymal Chondrosarcoma
26138,Malignant Cellular Infiltrate,"Carcinoma, Skin Appendage"
26139,Malignant Cellular Infiltrate,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
26140,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)
26141,Malignant Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor
26142,Benign Cellular Infiltrate,"Nevus, Blue"
26143,Malignant Cellular Infiltrate,Carcinoma of unknown primary
26144,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to brain
26145,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Leptomeninges
26146,Malignant Cellular Infiltrate,Digestive System Non-Hodgkin Lymphoma
26147,Malignant Cellular Infiltrate,Pancreatic carcinoma
26148,Malignant Cellular Infiltrate,Submucosal Invasive Colon Adenocarcinoma
26149,Malignant Cellular Infiltrate,Carcinoma of ampulla of Vater
26150,Malignant Cellular Infiltrate,Ann Arbor Stage IIIA Hodgkin Lymphoma
26151,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation
26152,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements"
26153,Malignant Cellular Infiltrate,hepatoid adenocarcinoma of bladder
26154,Malignant Cellular Infiltrate,Infiltrating Urothelial Carcinoma
26155,Malignant Cellular Infiltrate,Carcinoma of Cowper Glands
26156,Malignant Cellular Infiltrate,Male Urethral Malignant Neoplasm
26157,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant"
26158,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Solid Pattern"
26159,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Microcystic Pattern"
26160,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
26161,Malignant Cellular Infiltrate,malignant steroid cell tumor of ovary
26162,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern"
26163,"Fully Differentiated ""Adult-Type"" Tissues Present",Grade 1 Ovarian Teratoma
26164,Malignant Cellular Infiltrate,Extramedullary Plasmacytoma
26165,Malignant Cellular Infiltrate,Ovarian Lymphoma
26166,Malignant Cellular Infiltrate,adenosquamous carcinoma of ovary
26167,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Serous"
26168,Malignant Cellular Infiltrate,Metastatic non-small cell lung cancer
26169,Malignant Cellular Infiltrate,Malignant Head and Neck Neoplasm
26170,Malignant Cellular Infiltrate,Uterine Ligament Adenocarcinoma
26171,Malignant Cellular Infiltrate,Grade 1 Endometrial Mucinous Adenocarcinoma
26172,Malignant Cellular Infiltrate,Endometrial Undifferentiated Carcinoma
26173,Malignant Cellular Infiltrate,Ductal Breast Carcinoma
26174,Malignant Cellular Infiltrate,Cervical Keratinizing Squamous Cell Carcinoma
26175,Malignant Cellular Infiltrate,Cervical Large Cell Neuroendocrine Carcinoma
26176,Malignant Cellular Infiltrate,Cervical Melanoma
26177,Malignant Cellular Infiltrate,Vaginal Basaloid Carcinoma
26178,Malignant Cellular Infiltrate,Vaginal Mucinous Adenocarcinoma
26179,Malignant Cellular Infiltrate,Cervical Mesonephric Adenocarcinoma
26180,Malignant Cellular Infiltrate,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
26181,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Vagina
26182,Malignant Cellular Infiltrate,Vaginal Adenosarcoma
26183,Malignant Cellular Infiltrate,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type"
26184,Malignant Cellular Infiltrate,Bartholin Gland Transitional Cell Carcinoma
26185,Malignant Cellular Infiltrate,Vulvar Clear Cell Hidradenocarcinoma
26186,Malignant Cellular Infiltrate,apocrine adenocarcinoma of vulva
26187,Malignant Cellular Infiltrate,Invasive Mixed Breast Carcinoma
26188,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Spindle Cell Variant"
26189,Malignant Cellular Infiltrate,adenocarcinoma of breast with spindle cell metaplasia
26190,Benign Cellular Infiltrate,Breast Myofibroblastoma
26191,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Pulmonary Type"
26192,Malignant Cellular Infiltrate,Ovarian Malignant Mesothelioma
26193,Malignant Cellular Infiltrate,AIDS-Related Malignant Neoplasm
26194,Malignant Cellular Infiltrate,Squamous cell carcinoma of vulva
26195,Malignant Cellular Infiltrate,Ann Arbor Stage IVA Hodgkin Lymphoma
26196,Malignant Cellular Infiltrate,"Malignant lymphoma centroblastic, diffuse"
26197,Malignant Cellular Infiltrate,"Testicular Seminoma, Pseudoglandular Variant"
26198,Malignant Cellular Infiltrate,"Squamous cell carcinoma, metastatic"
26199,Malignant Cellular Infiltrate,Overt Primary Myelofibrosis
26200,Malignant Cellular Infiltrate,Fibrolamellar Hepatocellular Carcinoma
26201,Malignant Cellular Infiltrate,Villous adenocarcinoma
26202,Benign Cellular Infiltrate,Peripheral Nerve Schwannoma
26203,Malignant Cellular Infiltrate,Intraductal carcinoma and lobular carcinoma in situ
26204,Malignant Cellular Infiltrate,Undifferentiated Neuroblastoma
26205,Malignant Cellular Infiltrate,"Ganglioneuroblastoma, Nodular"
26206,Malignant Cellular Infiltrate,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor"
26207,Benign Cellular Infiltrate,Balloon cell nevus
26208,Malignant Cellular Infiltrate,Malignant blue nevus of skin
26209,Malignant Cellular Infiltrate,Sarcomatosis
26210,Malignant Cellular Infiltrate,Mixed Liposarcoma
26211,Benign Cellular Infiltrate,Spindle cell lipoma
26212,Malignant Cellular Infiltrate,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
26213,Benign Cellular Infiltrate,Fetal rhabdomyoma
26214,Benign Cellular Infiltrate,Adult Extracardiac Rhabdomyoma
26215,Malignant Cellular Infiltrate,Acute Myelomonocytic Leukemia without Abnormal Eosinophils
26216,Malignant Cellular Infiltrate,"Struma ovarii, malignant"
26217,Malignant Cellular Infiltrate,Malignant Giant Cell Tumor of Bone
26218,Malignant Cellular Infiltrate,Ghost Cell Odontogenic Carcinoma
26219,Malignant Cellular Infiltrate,Giant Cell Glioblastoma
26220,Malignant Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma
26221,Malignant Cellular Infiltrate,Malignant Germinative Follicular Epithelium Neoplasm
26222,Malignant Cellular Infiltrate,Ocular Sebaceous Carcinoma
26223,Malignant Cellular Infiltrate,Skin Basal Cell Carcinoma with Sebaceous Differentiation
26224,Malignant Cellular Infiltrate,signet ring cell carcinoma of appendix
26225,Malignant Cellular Infiltrate,Rectosigmoid Signet Ring Cell Carcinoma
26226,Benign Cellular Infiltrate,Benign neoplasm of frontal sinus
26227,Malignant Cellular Infiltrate,Squamous cell carcinoma of trachea
26228,Malignant Cellular Infiltrate,Acantholytic squamous cell carcinoma of skin
26229,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of skin
26230,Malignant Cellular Infiltrate,Skin Lymphangiosarcoma
26231,Benign Cellular Infiltrate,Common blue nevus of skin
26232,Benign Cellular Infiltrate,Benign lipomatous tumor
26233,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v6 and v7
26234,Malignant Cellular Infiltrate,Sarcoma of kidney
26235,Malignant Cellular Infiltrate,Pituitary carcinoma
26236,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of lacrimal gland
26237,Malignant Cellular Infiltrate,Rhabdomyosarcoma of the orbit
26238,Malignant Cellular Infiltrate,mucinous adenocarcinoma of lung
26239,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lung
26240,Malignant Cellular Infiltrate,epithelial-myoepithelial carcinoma of lung
26241,Malignant Cellular Infiltrate,High Grade Lung Neuroendocrine Neoplasm
26242,Malignant Cellular Infiltrate,Pleural Biphasic Mesothelioma
26243,Malignant Cellular Infiltrate,Primary malignant neoplasm of pericardium
26244,Malignant Cellular Infiltrate,Pleural Epithelioid Hemangioendothelioma
26245,Malignant Cellular Infiltrate,Malignant tumor of epidermal appendage
26246,Malignant Cellular Infiltrate,Mediastinal T Lymphoblastic Leukemia/Lymphoma
26247,Benign Cellular Infiltrate,Cardiac Cavernous Hemangioma
26248,Benign Cellular Infiltrate,Cystic tumor of atrio-ventricular node
26249,Malignant Cellular Infiltrate,Cardiac Synovial Sarcoma
26250,Malignant Cellular Infiltrate,Kaposi's sarcoma of conjunctiva
26251,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G2
26252,Intermediate Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G2
26253,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v7
26254,Benign Cellular Infiltrate,Benign neoplasm of epiglottis
26255,Malignant Cellular Infiltrate,Macrofollicular Variant Thyroid Gland Papillary Carcinoma
26256,Malignant Cellular Infiltrate,Oncocytic Variant Thyroid Gland Papillary Carcinoma
26257,Malignant Cellular Infiltrate,Clear Cell Variant Thyroid Gland Papillary Carcinoma
26258,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma
26259,Malignant Cellular Infiltrate,Thyroid Gland Mixed Medullary and Papillary Carcinoma
26260,Benign Cellular Infiltrate,Lipoma of external auditory meatus
26261,Malignant Cellular Infiltrate,Breast Lymphoma
26262,Malignant Cellular Infiltrate,"Leukemia, Prolymphocytic, B-Cell"
26263,Malignant Cellular Infiltrate,Secondary malignant neoplasm of liver
26264,Malignant Cellular Infiltrate,Malignant neoplasm of major salivary gland
26265,Malignant Cellular Infiltrate,Malignant neoplasm of middle ear
26266,Malignant Cellular Infiltrate,Duodenal Cancer
26267,Malignant Cellular Infiltrate,Malignant odontogenic tumor
26268,Malignant Cellular Infiltrate,Squamous cell carcinoma of skin
26269,Malignant Cellular Infiltrate,Tonsillar Carcinoma
26270,Malignant Cellular Infiltrate,Transitional cell carcinoma of ureter
26271,Malignant Cellular Infiltrate,CARCINOMA OF VULVA
26272,Benign Cellular Infiltrate,Chorioangioma
26273,Benign Cellular Infiltrate,HIV lipodystrophy
26274,Benign Cellular Infiltrate,Benign neoplasm of adrenal medulla
26275,Malignant Cellular Infiltrate,Myxoinflammatory fibroblastic sarcoma
26276,Benign Cellular Infiltrate,Hemangioma of skin
26277,Benign Cellular Infiltrate,Conventional Cardiac Rhabdomyoma
26278,Malignant Cellular Infiltrate,Malignant neoplasm of nasal cavity
26279,Malignant Cellular Infiltrate,Stage 0 Pharynx Carcinoma
26280,Malignant Cellular Infiltrate,Primary malignant neoplasm of brain
26281,Malignant Cellular Infiltrate,Infratentorial Cancer
26282,Malignant Cellular Infiltrate,Childhood Leukemia
26283,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma refractory
26284,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma
26285,Malignant Cellular Infiltrate,Stage 0 Rectosigmoid Cancer AJCC v6 and v7
26286,Malignant Cellular Infiltrate,AIDS-Related Malignant Anal Neoplasm
26287,Malignant Cellular Infiltrate,Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma
26288,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic
26289,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage I
26290,Malignant Cellular Infiltrate,Splenic marginal zone lymphoma recurrent
26291,Benign Cellular Infiltrate,Kidney Lipoma
26292,Malignant Cellular Infiltrate,Malignant eccrine spiradenoma
26293,Malignant Cellular Infiltrate,Anaplastic Diencephalic Astrocytoma
26294,Malignant Cellular Infiltrate,Malignant Diencephalic Neoplasm
26295,Malignant Cellular Infiltrate,Diencephalic Glioblastoma
26296,Malignant Cellular Infiltrate,Intraductal Cribriform Breast Adenocarcinoma
26297,Malignant Cellular Infiltrate,Vertebral chordoma
26298,Malignant Cellular Infiltrate,lymphoma of spinal cord
26299,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma
26300,Malignant Cellular Infiltrate,pleomorphic carcinoma of breast
26301,Malignant Cellular Infiltrate,signet ring cell carcinoma of breast
26302,Malignant Cellular Infiltrate,Metastatic Squamous Cell Breast Carcinoma
26303,Malignant Cellular Infiltrate,Ovarian Angiosarcoma
26304,Benign Cellular Infiltrate,Ovarian Myxoma
26305,Malignant Cellular Infiltrate,anaplastic large cell lymphoma of central nervous system
26306,Malignant Cellular Infiltrate,Esophageal Leiomyosarcoma
26307,Malignant Cellular Infiltrate,sarcoma of esophagus
26308,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of esophagus
26309,Benign Cellular Infiltrate,Solitary Osteochondroma
26310,Malignant Cellular Infiltrate,Breast Carcinoma by Gene Expression Profile
26311,Malignant Cellular Infiltrate,Normal Breast-Like Subtype of Breast Carcinoma
26312,Malignant Cellular Infiltrate,Basal-Like Breast Carcinoma
26313,Malignant Cellular Infiltrate,Aortic Angiosarcoma
26314,Malignant Cellular Infiltrate,Angiosarcoma recurrent
26315,Benign Cellular Infiltrate,Solitary Adult Fibroma
26316,Malignant Cellular Infiltrate,Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma
26317,Benign Cellular Infiltrate,Sympathetic Schwannoma
26318,Malignant Cellular Infiltrate,Intracranial Germinoma
26319,Malignant Cellular Infiltrate,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor
26320,Malignant Cellular Infiltrate,Central nervous system leukemia
26321,Malignant Cellular Infiltrate,Malignant Childhood Central Nervous System Neoplasm
26322,Malignant Cellular Infiltrate,Prostate Kaposi Sarcoma
26323,Malignant Cellular Infiltrate,leiomyosarcoma of rectum
26324,Benign Cellular Infiltrate,Benign Dermal Schwannoma
26325,Malignant Cellular Infiltrate,Stage II Uveal Melanoma AJCC v7
26326,Benign Cellular Infiltrate,Benign Childhood Central Nervous System Neoplasm
26327,Malignant Cellular Infiltrate,mucinous adenocarcinoma of anus
26328,Malignant Cellular Infiltrate,Ann Arbor Stage IB Hodgkin Lymphoma
26329,Malignant Cellular Infiltrate,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma
26330,Malignant Cellular Infiltrate,Esophageal Hodgkin Lymphoma
26331,Malignant Cellular Infiltrate,Kaposi's sarcoma of esophagus
26332,Malignant Cellular Infiltrate,Stage III Childhood Hepatocellular Carcinoma AJCC v7
26333,Malignant Cellular Infiltrate,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7
26334,Malignant Cellular Infiltrate,undifferentiated carcinoma of pancreas
26335,Malignant Cellular Infiltrate,Stage IVB Gallbladder Carcinoma
26336,Malignant Cellular Infiltrate,Gallbladder papillary adenocarcinoma
26337,Benign Cellular Infiltrate,Liver Leiomyoma
26338,Malignant Cellular Infiltrate,Adult Central Nervous System Germinoma
26339,Malignant Cellular Infiltrate,Small intestine carcinoma stage I
26340,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mucoepidermoid Carcinoma
26341,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
26342,Malignant Cellular Infiltrate,Stage IVC Basal Cell Lip Carcinoma
26343,Malignant Cellular Infiltrate,Stage IVB Basal Cell Lip Carcinoma
26344,Malignant Cellular Infiltrate,Stage I Lip Carcinoma
26345,Malignant Cellular Infiltrate,Stage III Lip Cancer AJCC v6 and v7
26346,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Carcinoma without Metastasis
26347,Malignant Cellular Infiltrate,Major Salivary Gland Adenoid Cystic Carcinoma
26348,Malignant Cellular Infiltrate,Tonsillar Lymphoma
26349,Malignant Cellular Infiltrate,Malignant Submandibular Gland Mixed Tumor
26350,Malignant Cellular Infiltrate,Anaplastic Brain Stem Astrocytoma
26351,Malignant Cellular Infiltrate,Carcinoma of subglottis
26352,Malignant Cellular Infiltrate,Stage IVC Nasopharyngeal Carcinoma AJCC v7
26353,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v7
26354,Malignant Cellular Infiltrate,Stage III Nasal Cavity Cancer AJCC v6 and v7
26355,Malignant Cellular Infiltrate,Paranasal Sinus Cancer
26356,Malignant Cellular Infiltrate,Adenocarcinoma of nasal cavity
26357,Malignant Cellular Infiltrate,Olfactory Neuroblastoma
26358,Malignant Cellular Infiltrate,Laryngeal Leiomyosarcoma
26359,Malignant Cellular Infiltrate,small cell carcinoma of larynx
26360,Malignant Cellular Infiltrate,sarcoma of trachea
26361,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity recurrent
26362,Malignant Cellular Infiltrate,Ethmoid Sinus Squamous Cell Carcinoma
26363,Malignant Cellular Infiltrate,Nasal Cavity Lymphoma
26364,Malignant Cellular Infiltrate,squamous cell carcinoma of middle ear
26365,Malignant Cellular Infiltrate,Stage I Renal Pelvis Cancer AJCC v7
26366,Malignant Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v7
26367,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v7
26368,Benign Cellular Infiltrate,Ureter Schwannoma
26369,Malignant Cellular Infiltrate,Ureter Lymphoma
26370,Malignant Cellular Infiltrate,Orbital lymphoma
26371,Malignant Cellular Infiltrate,Anterior Tongue Mucoepidermoid Carcinoma
26372,Malignant Cellular Infiltrate,Anterior Tongue Adenoid Cystic Carcinoma
26373,Malignant Cellular Infiltrate,Fallopian Tube Clear Cell Adenocarcinoma
26374,Malignant Cellular Infiltrate,Undifferentiated Fallopian Tube Carcinoma
26375,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Cancer AJCC v7
26376,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vulva
26377,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Teratoma
26378,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma
26379,"Fully Differentiated ""Adult-Type"" Tissues Present",Malignant teratoma of testis
26380,Malignant Cellular Infiltrate,sarcoma of testis
26381,Malignant Cellular Infiltrate,Stage IIIB Testicular Cancer AJCC v6 and v7
26382,Malignant Cellular Infiltrate,basal cell carcinoma of scrotum
26383,Well Differentiated Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1
26384,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1
26385,Malignant Cellular Infiltrate,embryonal carcinoma of mediastinum
26386,Malignant Cellular Infiltrate,Stage IIA Bone Sarcoma AJCC v7
26387,Malignant Cellular Infiltrate,Intraosseous well differentiated osteosarcoma
26388,Benign Cellular Infiltrate,Hemangioma of bone
26389,Benign Cellular Infiltrate,Calcifying Fibrous Pseudotumor
26390,Benign Cellular Infiltrate,Chondroid lipoma
26391,Malignant Cellular Infiltrate,Sclerosing liposarcoma
26392,Benign Cellular Infiltrate,Deep Leiomyoma
26393,Malignant Cellular Infiltrate,"Neoplasm, malignant, uncertain whether primary or metastatic"
26394,Malignant Cellular Infiltrate,Papillary carcinoma in situ
26395,Malignant Cellular Infiltrate,"Papillary transitional cell carcinoma, non-invasive"
26396,Invasive Lesion,minimally invasive follicular carcinoma of the thyroid gland
26397,Benign Cellular Infiltrate,Benign neoplasm of lymph vessels
26398,Malignant Cellular Infiltrate,Childhood Testicular Mixed Germ Cell Tumor
26399,Malignant Cellular Infiltrate,Childhood Testicular Yolk Sac Tumor
26400,Malignant Cellular Infiltrate,Childhood Testicular Embryonal Carcinoma
26401,Benign Cellular Infiltrate,Cutaneous myxoma
26402,Benign Cellular Infiltrate,Intramuscular Myxoma
26403,Malignant Cellular Infiltrate,Peripheral Ganglioneuroblastoma
26404,Benign Cellular Infiltrate,Mediastinal Lymphangioma
26405,Malignant Cellular Infiltrate,Mediastinal Extraskeletal Osteosarcoma
26406,Malignant Cellular Infiltrate,rhabdomyosarcoma of mediastinum
26407,Malignant Cellular Infiltrate,Mediastinal Synovial Sarcoma
26408,Malignant Cellular Infiltrate,ganglioneuroblastoma of mediastinum
26409,Benign Cellular Infiltrate,Ganglioneuroma of mediastinum
26410,Malignant Cellular Infiltrate,Hodgkin's lymphoma of mediastinum
26411,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v7
26412,Malignant Cellular Infiltrate,Large cell lung cancer stage II
26413,Malignant Cellular Infiltrate,Stage IA Lung Large Cell Carcinoma AJCC v7
26414,Malignant Cellular Infiltrate,Stage IA Lung Adenosquamous Carcinoma AJCC v7
26415,Malignant Cellular Infiltrate,Non-small cell lung cancer stage I
26416,Malignant Cellular Infiltrate,Metastatic signet ring cell carcinoma
26417,Malignant Cellular Infiltrate,Mixed epithelioid and spindle cell melanoma
26418,Benign Cellular Infiltrate,Melanotic neurofibroma
26419,Malignant Cellular Infiltrate,Stage IIA Lung Adenocarcinoma AJCC v7
26420,Malignant Cellular Infiltrate,Stage I Bone Sarcoma AJCC v7
26421,Malignant Cellular Infiltrate,Stage IV Bone Sarcoma AJCC v7
26422,Benign Cellular Infiltrate,Pericardial Leiomyoma
26423,Well Differentiated Neuroendocrine Lesion,malignant gastrinoma of pancreas
26424,Malignant Cellular Infiltrate,Pulmonary Artery Angiosarcoma
26425,Benign Cellular Infiltrate,Benign Extragonadal Germ Cell Tumor
26426,Benign Cellular Infiltrate,Dermoid Cyst of the Spinal Cord
26427,Malignant Cellular Infiltrate,Mediastinal seminoma
26428,Malignant Cellular Infiltrate,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma
26429,Malignant Cellular Infiltrate,Choroid Spindle Cell Type A Melanoma
26430,Malignant Cellular Infiltrate,Oropharyngeal lymphepithelioma
26431,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
26432,Malignant Cellular Infiltrate,Childhood Malignant Ovarian Germ Cell Tumor
26433,Malignant Cellular Infiltrate,Unfavorable Hodgkin Lymphoma
26434,Malignant Cellular Infiltrate,Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma
26435,Malignant Cellular Infiltrate,Solid Papillary Breast Carcinoma
26436,Malignant Cellular Infiltrate,Childhood Myelodysplastic Syndrome
26437,Malignant Cellular Infiltrate,Papillary serous cystadenocarcinoma
26438,Malignant Cellular Infiltrate,Favorable Non-Hodgkin Lymphoma
26439,Malignant Cellular Infiltrate,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor
26440,Malignant Cellular Infiltrate,Childhood Classic Hodgkin Lymphoma
26441,Malignant Cellular Infiltrate,Acute bilineal leukemia
26442,Malignant Cellular Infiltrate,Retinoblastoma
26443,Malignant Cellular Infiltrate,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
26444,Malignant Cellular Infiltrate,"Squamous Cell Carcinoma of the Penis, Usual Type"
26445,Malignant Cellular Infiltrate,Primary malignant neoplasm of oculomotor nerve
26446,Malignant Cellular Infiltrate,Intracranial Myeloid Sarcoma
26447,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Immature Teratoma
26448,Malignant Cellular Infiltrate,Central Nervous System Teratoma with Malignant Transformation
26449,Malignant Cellular Infiltrate,Malignant Intracranial Neoplasms By Morphology
26450,Malignant Cellular Infiltrate,Precursor Lymphoid Neoplasm
26451,Malignant Cellular Infiltrate,Megakaryocytic Neoplasm
26452,Malignant Cellular Infiltrate,Recurrent Non-Cutaneous Melanoma
26453,Malignant Cellular Infiltrate,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation
26454,Benign Cellular Infiltrate,Mature Mediastinal Teratoma
26455,Malignant Cellular Infiltrate,Stage I Liver Carcinoma
26456,Malignant Cellular Infiltrate,PRETEXT Stage 1 Hepatoblastoma
26457,Malignant Cellular Infiltrate,PRETEXT Stage 2 Hepatoblastoma
26458,Malignant Cellular Infiltrate,PRETEXT Stage 3 Hepatoblastoma
26459,Benign Cellular Infiltrate,Benign Dermal Neoplasm
26460,Malignant Cellular Infiltrate,Aleukemic Chronic Lymphocytic Leukemia
26461,Borderline Lesion,B-Cell Proliferation of Uncertain Malignant Potential
26462,Borderline Lesion,"lymphomatoid papulosis, type A"
26463,Malignant Cellular Infiltrate,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
26464,Malignant Cellular Infiltrate,Malignant neoplasm of testis
26465,Malignant Cellular Infiltrate,Methotrexate-Associated Hodgkin Lymphoma
26466,Malignant Cellular Infiltrate,Nodular Lymphocyte Predominant Hodgkin Lymphoma
26467,Malignant Cellular Infiltrate,"Bronchiolo-alveolar carcinoma, non-mucinous"
26468,Malignant Cellular Infiltrate,Splenic Manifestation of Prolymphocytic Leukemia
26469,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Prolymphocytic Leukemia
26470,Malignant Cellular Infiltrate,Splenic Manifestation of B-Cell Prolymphocytic Leukemia
26471,Malignant Cellular Infiltrate,Splenic Lymphoplasmacytic Lymphoma
26472,Malignant Cellular Infiltrate,Ovarian Adenosarcoma
26473,Malignant Cellular Infiltrate,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7
26474,Malignant Cellular Infiltrate,Stage 0 Testicular Seminoma AJCC v6 and v7
26475,Malignant Cellular Infiltrate,Adult B Lymphoblastic Lymphoma
26476,Malignant Cellular Infiltrate,Bladder Papillary Urothelial Carcinoma
26477,Malignant Cellular Infiltrate,Malignant Vascular Neoplasm
26478,Malignant Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma
26479,Malignant Cellular Infiltrate,Malignant Vaginal Neoplasm
26480,Malignant Cellular Infiltrate,Secondary malignant neoplasm of rectum
26481,Benign Cellular Infiltrate,Strawberry nevus of skin
26482,Malignant Cellular Infiltrate,Secondary malignant neoplasm of anus
26483,Malignant Cellular Infiltrate,Anal margin basal cell carcinoma
26484,Malignant Cellular Infiltrate,Primary solid type intraosseous squamous cell carcinoma
26485,Malignant Cellular Infiltrate,Ameloblastic Carcinoma Derived From Odontogenic Cyst
26486,Malignant Cellular Infiltrate,Malignant neoplasm of vulva
26487,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Thyroid
26488,Malignant Cellular Infiltrate,Stage IV Renal Pelvis and Ureter Cancer AJCC v7
26489,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma
26490,Malignant Cellular Infiltrate,Malignant neoplasm of ureter
26491,Malignant Cellular Infiltrate,Malignant neoplasm of pharynx
26492,Malignant Cellular Infiltrate,Malignant neoplasm of penis
26493,Malignant Cellular Infiltrate,Prostate cancer stage C
26494,Malignant Cellular Infiltrate,Prostate cancer stage A
26495,Benign Cellular Infiltrate,Benign melanocytic nevus
26496,Malignant Cellular Infiltrate,Microcystic adnexal carcinoma
26497,Malignant Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid
26498,Benign Cellular Infiltrate,Halo nevus
26499,Malignant Cellular Infiltrate,Malignant Thymoma
26500,Malignant Cellular Infiltrate,Malignant mesothelioma of pericardium
26501,Malignant Cellular Infiltrate,Metastatic Ductal Breast Carcinoma
26502,Malignant Cellular Infiltrate,Metastatic Lobular Breast Carcinoma
26503,Malignant Cellular Infiltrate,Localized Gallbladder Carcinoma
26504,Malignant Cellular Infiltrate,Adenocarcinoma in adenomatous polyp
26505,Malignant Cellular Infiltrate,Adenocarcinoma in situ in adenomatous polyp
26506,Malignant Cellular Infiltrate,Invasive Ductal and Lobular Carcinoma
26507,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma
26508,Malignant Cellular Infiltrate,Childhood Non-Hodgkin Lymphoma
26509,Malignant Cellular Infiltrate,Cardiac Sarcoma
26510,Malignant Cellular Infiltrate,Pericarditis malignant
26511,Malignant Cellular Infiltrate,Carcinoma breast stage I
26512,Malignant Cellular Infiltrate,Stage II Gastric Carcinoma
26513,Malignant Cellular Infiltrate,Non-small cell lung cancer stage III
26514,Malignant Cellular Infiltrate,Stage IIIB Breast Carcinoma
26515,Malignant Cellular Infiltrate,Stage II Cervical Cancer AJCC v6
26516,Malignant Cellular Infiltrate,Recurrent Childhood Rhabdomyosarcoma
26517,Malignant Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland
26518,Malignant Cellular Infiltrate,Stage I Ovarian Cancer AJCC v6 and v7
26519,Malignant Cellular Infiltrate,Stage IV Childhood Hepatocellular Carcinoma AJCC v7
26520,Malignant Cellular Infiltrate,Stage I Vulvar Carcinoma
26521,Malignant Cellular Infiltrate,Adult Immunoblastic Lymphoma
26522,Malignant Cellular Infiltrate,Recurrent Adult Liver Carcinoma
26523,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia refractory
26524,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v6 and v7
26525,Malignant Cellular Infiltrate,Thymoma malignant recurrent
26526,Malignant Cellular Infiltrate,Recurrent Thyroid Carcinoma
26527,Malignant Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v6
26528,Malignant Cellular Infiltrate,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7
26529,Malignant Cellular Infiltrate,Adult Burkitt Leukemia
26530,Malignant Cellular Infiltrate,Childhood Acute Basophilic Leukemia
26531,Malignant Cellular Infiltrate,Endometrioid carcinoma ovary
26532,Malignant Cellular Infiltrate,Intermediate Cell Type Uveal Melanoma
26533,Benign Cellular Infiltrate,Benign Carotid Body Paraganglioma
26534,Malignant Cellular Infiltrate,Lip basal cell carcinoma
26535,Malignant Cellular Infiltrate,High Grade Salivary Gland Mucoepidermoid Carcinoma
26536,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH
26537,Malignant Cellular Infiltrate,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7
26538,Malignant Cellular Infiltrate,Stage I Childhood Hodgkin Lymphoma
26539,Malignant Cellular Infiltrate,Stage IV Childhood Hodgkin Lymphoma
26540,Malignant Cellular Infiltrate,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
26541,Malignant Cellular Infiltrate,Stage I Adult Lymphoblastic Lymphoma
26542,Malignant Cellular Infiltrate,Stage II Ovarian Germ Cell Tumor AJCC v6 and v7
26543,Malignant Cellular Infiltrate,Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7
26544,Malignant Cellular Infiltrate,Childhood Alveolar Soft Part Sarcoma
26545,Malignant Cellular Infiltrate,Recurrent Adult Non-Hodgkin Lymphoma
26546,Malignant Primitive Cellular Infiltrate,Endodermal sinus tumor of ovary
26547,Malignant Cellular Infiltrate,Ann Arbor Stage III Grade 3 Follicular Lymphoma
26548,Malignant Cellular Infiltrate,Stage IV Adult Immunoblastic Lymphoma
26549,Malignant Cellular Infiltrate,Stage IV Adult Lymphoblastic Lymphoma
26550,Malignant Cellular Infiltrate,Anterior Tongue Squamous Cell Carcinoma
26551,Malignant Cellular Infiltrate,Lower Gingival Verrucous Carcinoma
26552,Malignant Cellular Infiltrate,adenoid cystic carcinoma of floor of mouth
26553,Malignant Cellular Infiltrate,Squamous cell carcinoma of tonsil
26554,Malignant Cellular Infiltrate,Glottis Verrucous Carcinoma
26555,Malignant Cellular Infiltrate,Stage I Lip Basal Cell Carcinoma
26556,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage I
26557,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage III
26558,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity recurrent
26559,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage I
26560,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma recurrent
26561,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage I
26562,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma recurrent
26563,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage I
26564,Malignant Cellular Infiltrate,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7
26565,Malignant Cellular Infiltrate,Sarcoma of ovary
26566,Malignant Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma
26567,Malignant Cellular Infiltrate,Gastric Antrum Carcinoma In Situ AJCC v6 and v7
26568,Malignant Cellular Infiltrate,Stage 0 Cutaneous Melanoma AJCC v6 and v7
26569,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement
26570,Malignant Cellular Infiltrate,"Acute myeloid leukemia, minimal differentiation"
26571,Benign Cellular Infiltrate,"Hemangioma, Cavernous, Central Nervous System"
26572,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
26573,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Mantle Cell Lymphoma
26574,Malignant Cellular Infiltrate,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma
26575,Malignant Cellular Infiltrate,Hereditary Kidney Wilms Tumor
26576,Malignant Cellular Infiltrate,Indolent Non-Hodgkin Lymphoma
26577,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7
26578,Malignant Cellular Infiltrate,Stage II Colorectal Cancer
26579,Malignant Cellular Infiltrate,Stage II Hodgkin Lymphoma
26580,Malignant Cellular Infiltrate,Secondary malignant neoplasm of brain stem
26581,Malignant Cellular Infiltrate,Secondary malignant neoplasm of choroid
26582,Malignant Cellular Infiltrate,Stage IIA Soft Tissue Sarcoma AJCC v7
26583,Malignant Cellular Infiltrate,Stage III Soft Tissue Sarcoma AJCC v7
26584,Malignant Cellular Infiltrate,Stage IV Merkel Cell Carcinoma AJCC v7
26585,Malignant Cellular Infiltrate,Stage IA Cutaneous Melanoma AJCC v7
26586,Malignant Cellular Infiltrate,Stage IIC Cutaneous Melanoma AJCC v6 and v7
26587,Malignant Cellular Infiltrate,Stage IV Esophageal Adenocarcinoma AJCC v7
26588,Malignant Cellular Infiltrate,Rectosigmoid cancer recurrent
26589,Malignant Cellular Infiltrate,Hepatoblastoma resectable
26590,Malignant Cellular Infiltrate,"Myelodysplastic syndrome, no ICD-O subtype"
26591,Malignant Cellular Infiltrate,Stage III Anaplastic Large Cell Lymphoma
26592,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I
26593,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II
26594,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage IV
26595,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage IV
26596,Malignant Cellular Infiltrate,Mycosis fungoides refractory
26597,Malignant Cellular Infiltrate,Ann Arbor Stage I Mature T- and NK-Cell Lymphoma
26598,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia recurrent
26599,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage I
26600,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage II
26601,Malignant Cellular Infiltrate,HPV positive oropharyngeal squamous cell carcinoma
26602,Malignant Cellular Infiltrate,Pleural mesothelioma malignant advanced
26603,Malignant Cellular Infiltrate,Retinoblastoma bilateral
26604,Malignant Cellular Infiltrate,Stage IIIA Uterine Sarcoma AJCC v7
26605,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7
26606,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7
26607,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Polyembryoma AJCC v6 and v7
26608,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer recurrent
26609,Malignant Cellular Infiltrate,Large cell lung cancer stage IV
26610,Malignant Cellular Infiltrate,Pharyngeal cancer stage I
26611,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v6
26612,Malignant Cellular Infiltrate,Stage IIB Colorectal Cancer AJCC v7
26613,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v7
26614,Malignant Cellular Infiltrate,Stage IIIA Colorectal Cancer AJCC v7
26615,Malignant Cellular Infiltrate,Lentigo maligna recurrent
26616,Malignant Cellular Infiltrate,Stage I Lentigo Maligna Melanoma AJCC v7
26617,Malignant Cellular Infiltrate,Stage III Lentigo Maligna Melanoma AJCC v7
26618,Malignant Cellular Infiltrate,Alveolar soft part sarcoma metastatic
26619,Malignant Cellular Infiltrate,Alveolar soft part sarcoma recurrent
26620,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma non-metastatic
26621,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma metastatic
26622,Malignant Cellular Infiltrate,Stage IIA Distal Bile Duct Cancer AJCC v7
26623,Malignant Cellular Infiltrate,Stage IIB Pancreatic Cancer AJCC v6 and v7
26624,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma recurrent
26625,Malignant Cellular Infiltrate,Metastatic leiomyosarcoma
26626,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v7
26627,Malignant Cellular Infiltrate,Stage IIB Uveal Melanoma AJCC v7
26628,Malignant Cellular Infiltrate,Stage IIIB Uveal Melanoma AJCC v7
26629,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis refractory
26630,Malignant Cellular Infiltrate,B-cell lymphoma recurrent
26631,Malignant Cellular Infiltrate,B-cell lymphoma stage II
26632,Malignant Cellular Infiltrate,Stage III Burkitt Lymphoma
26633,Malignant Cellular Infiltrate,Refractory Follicular Lymphoma
26634,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage III
26635,Malignant Cellular Infiltrate,B Lymphoblastic Lymphoma
26636,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma refractory
26637,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage I
26638,Malignant Cellular Infiltrate,"Seminoma of testis, stage 1"
26639,Malignant Cellular Infiltrate,Stage I Carcinoma of Penis
26640,Malignant Cellular Infiltrate,Stage II Carcinoma of Penis
26641,Malignant Cellular Infiltrate,Stage III Carcinoma of Penis
26642,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage II
26643,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage IV
26644,Malignant Cellular Infiltrate,Stage 0 Vulvar Cancer
26645,Malignant Cellular Infiltrate,Stage I Vulvar Cancer
26646,Malignant Cellular Infiltrate,Adenocarcinoma of the prostate stage II
26647,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IIIB
26648,Malignant Cellular Infiltrate,Adenocarcinoma of the rete testis
26649,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v6
26650,Malignant Cellular Infiltrate,Parosteal Osteosarcoma
26651,Malignant Cellular Infiltrate,Stage II Colorectal Cancer AJCC v7
26652,Malignant Cellular Infiltrate,Stage II Colon Cancer AJCC v7
26653,Malignant Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v7
26654,Benign Cellular Infiltrate,Benign neoplasm of adrenal cortex
26655,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v7
26656,Malignant Cellular Infiltrate,Sarcoma by FNCLCC Grade
26657,Malignant Cellular Infiltrate,Stage I Adult Hodgkin Lymphoma
26658,Malignant Cellular Infiltrate,Metastatic Parathyroid Gland Carcinoma
26659,Malignant Cellular Infiltrate,Pediatric Extraocular Retinoblastoma
26660,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v6
26661,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v6 Stage
26662,Malignant Cellular Infiltrate,Recurrent Vulvar Carcinoma
26663,Malignant Cellular Infiltrate,Recurrent Uterine Corpus Carcinoma
26664,Malignant Cellular Infiltrate,Stage III Testicular Cancer AJCC v6 and v7
26665,Malignant Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
26666,Encapsulated Mass,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
26667,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7
26668,Malignant Cellular Infiltrate,Malignant melanoma of iris
26669,Malignant Cellular Infiltrate,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8"
26670,Malignant Cellular Infiltrate,Non-small cell lung cancer stage IIIA
26671,Malignant Cellular Infiltrate,Urethral Carcinoma
26672,Malignant Cellular Infiltrate,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
26673,Malignant Cellular Infiltrate,Pancreatic Ductal Adenocarcinoma
26674,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v7 Stage
26675,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v7 Stage
26676,Malignant Cellular Infiltrate,Adult Rhabdomyosarcoma
26677,Malignant Cellular Infiltrate,Mucinous carcinoma of breast
26678,Malignant Cellular Infiltrate,Papillary carcinoma of the breast
26679,Malignant Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia
26680,Malignant Cellular Infiltrate,Epithelial Predominant Kidney Wilms Tumor
26681,Malignant Cellular Infiltrate,Mixed Cell Type Kidney Wilms Tumor
26682,Malignant Cellular Infiltrate,Childhood Acute Monocytic Leukemia
26683,Malignant Cellular Infiltrate,undifferentiated carcinoma of gallbladder
26684,Malignant Cellular Infiltrate,Gallbladder squamous cell carcinoma
26685,Malignant Cellular Infiltrate,Stage IV Uterine Sarcoma AJCC v7
26686,Malignant Cellular Infiltrate,Carcinosarcoma of ovary
26687,Malignant Cellular Infiltrate,Stage II Esophageal Cancer
26688,Malignant Cellular Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v7
26689,Malignant Cellular Infiltrate,recurrent gastric cancer
26690,Malignant Cellular Infiltrate,Recurrent Rectal Cancer
26691,Malignant Cellular Infiltrate,Mesothelioma malignant localized
26692,Malignant Cellular Infiltrate,Salivary gland carcinoma
26693,Malignant Cellular Infiltrate,Metastatic Carcinoma in the Adrenal Medulla
26694,Malignant Cellular Infiltrate,AIDS-Related Hodgkin Lymphoma
26695,Malignant Cellular Infiltrate,Mediastinal (Thymic) Large B-Cell Lymphoma
26696,Malignant Cellular Infiltrate,Acute myeloid leukemia with multilineage dysplasia
26697,Malignant Cellular Infiltrate,Bone Sarcoma
26698,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx
26699,Malignant Cellular Infiltrate,Duodenal carcinoma recurrent
26700,Malignant Cellular Infiltrate,Malignant neoplasm of stomach recurrent
26701,Malignant Cellular Infiltrate,Hodgkin Disease
26702,Malignant Cellular Infiltrate,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma
26703,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Maturation
26704,Malignant Cellular Infiltrate,Leiomyosarcoma NCI Grade 3
26705,Malignant Cellular Infiltrate,Grade 2 Colon Adenocarcinoma
26706,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma
26707,Malignant Cellular Infiltrate,Childhood Systemic Anaplastic Large Cell Lymphoma
26708,Malignant Cellular Infiltrate,Stage II Adult Liver Cancer AJCC v7
26709,Malignant Cellular Infiltrate,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma
26710,Malignant Cellular Infiltrate,Stage III Childhood Non-Hodgkin Lymphoma
26711,Malignant Cellular Infiltrate,Ann Arbor Stage I AIDS-Related Lymphoma
26712,Benign Cellular Infiltrate,Soft tissue chondroma
26713,Benign Cellular Infiltrate,Myolipoma
26714,Malignant Cellular Infiltrate,Stage IIIC1 Uterine Corpus Cancer AJCC v7
26715,Well Differentiated Neuroendocrine Lesion,Gastro-enteropancreatic neuroendocrine tumor
26716,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1
26717,Low Grade Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G1
26718,Malignant Cellular Infiltrate,Esophageal Rhabdomyosarcoma
26719,Poorly Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Carcinoma
26720,Malignant Cellular Infiltrate,Gastric Synovial Sarcoma
26721,Malignant Cellular Infiltrate,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma
26722,Malignant Cellular Infiltrate,Ampulla of Vater Neuroendocrine Carcinoma
26723,Malignant Cellular Infiltrate,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
26724,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Gangliocytic Paraganglioma
26725,Malignant Cellular Infiltrate,Small Intestinal Diffuse Large B-Cell Lymphoma
26726,Well Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor
26727,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1
26728,Intermediate Grade Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2
26729,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2
26730,Poorly Differentiated Neuroendocrine Lesion,Neuroendocrine carcinoma of appendix
26731,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of appendix
26732,Malignant Cellular Infiltrate,Colon Serrated Adenocarcinoma
26733,Malignant Cellular Infiltrate,Colon Cribriform Comedo-Type Adenocarcinoma
26734,Malignant Cellular Infiltrate,Crohn Disease-Associated Colorectal Adenocarcinoma
26735,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor
26736,Intermediate Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2
26737,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of anal canal
26738,Malignant Cellular Infiltrate,Anal Canal Mixed Adenoneuroendocrine Carcinoma
26739,Malignant Cellular Infiltrate,Well Differentiated Hepatocellular Carcinoma
26740,Malignant Cellular Infiltrate,Perihilar Intrahepatic Cholangiocarcinoma
26741,Malignant Cellular Infiltrate,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
26742,Malignant Cellular Infiltrate,Gallbladder Neuroendocrine Carcinoma
26743,Intermediate Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G2
26744,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of extrahepatic bile duct
26745,Malignant Cellular Infiltrate,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
26746,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Lymphoma
26747,Malignant Cellular Infiltrate,Secondary malignant neoplasm of extrahepatic bile ducts
26748,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor G2
26749,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of extrahepatic bile duct
26750,Malignant Cellular Infiltrate,Gastrointestinal carcinoma
26751,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Gene Mutation
26752,Malignant Cellular Infiltrate,Breast Solid Neuroendocrine Carcinoma
26753,Malignant Cellular Infiltrate,High Grade Ovarian Serous Adenocarcinoma
26754,Malignant Cellular Infiltrate,Recurrent Childhood Central Nervous System Embryonal Neoplasm
26755,Malignant Cellular Infiltrate,Hormone refractory breast cancer
26756,Malignant Cellular Infiltrate,Secondary Central Nervous System Hodgkin Lymphoma
26757,Malignant Cellular Infiltrate,Adult Fibrolamellar Carcinoma
26758,Encapsulated Mass,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
26759,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7
26760,Malignant Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v7
26761,Malignant Cellular Infiltrate,Stage IVA Colon Cancer AJCC v7
26762,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
26763,Malignant Cellular Infiltrate,BCLC Stage 0 Hepatocellular Carcinoma
26764,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Large Cell Lymphoma
26765,Malignant Cellular Infiltrate,Recurrent Childhood Glioblastoma
26766,Poorly Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma
26767,Malignant Cellular Infiltrate,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
26768,Malignant Cellular Infiltrate,Plasmacytoma anaplastic
26769,Malignant Cellular Infiltrate,Childhood Laryngeal Carcinoma
26770,Malignant Cellular Infiltrate,Childhood Esophageal Carcinoma
26771,Malignant Cellular Infiltrate,Childhood Gastric Carcinoma
26772,Malignant Cellular Infiltrate,Childhood Lung Small Cell Carcinoma
26773,Malignant Cellular Infiltrate,Childhood Bladder Carcinoma
26774,Malignant Cellular Infiltrate,Childhood Rectal Carcinoma
26775,Malignant Cellular Infiltrate,Childhood Salivary Gland Carcinoma
26776,Malignant Cellular Infiltrate,Refractory cancer
26777,Benign Cellular Infiltrate,Infiltrating Intramuscular Lipoma
26778,Malignant Cellular Infiltrate,Spindle Cell/Sclerosing Rhabdomyosarcoma
26779,Malignant Cellular Infiltrate,undifferentiated sarcoma of soft tissue
26780,Benign Cellular Infiltrate,Ivory Exostosis
26781,Malignant Cellular Infiltrate,Bone Epithelioid Hemangioendothelioma
26782,Malignant Cellular Infiltrate,Acute Lymphoblastic Leukemia by ROSE Cluster
26783,Malignant Cellular Infiltrate,ROSE Cluster 2
26784,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia with MLL Rearrangement
26785,Malignant Cellular Infiltrate,Refractory Childhood Acute Lymphoblastic Leukemia
26786,Malignant Cellular Infiltrate,Fusion-Negative Rhabdomyosarcoma
26787,Malignant Cellular Infiltrate,Refractory Childhood Malignant Germ Cell Tumor
26788,Malignant Cellular Infiltrate,Refractory Malignant Germ Cell Tumor
26789,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Immature Teratoma
26790,Benign Cellular Infiltrate,Childhood Mature Teratoma
26791,Malignant Cellular Infiltrate,Childhood Seminoma
26792,Malignant Cellular Infiltrate,Childhood Thyroid Gland Papillary Carcinoma
26793,Malignant Cellular Infiltrate,Childhood Thyroid Gland Medullary Carcinoma
26794,Malignant Cellular Infiltrate,Childhood Small Intestinal Carcinoma
26795,Malignant Cellular Infiltrate,Childhood Neuroblastoma
26796,Malignant Cellular Infiltrate,"Childhood Ganglioneuroblastoma, Nodular"
26797,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor
26798,Malignant Cellular Infiltrate,Recurrent Malignant Solid Neoplasm
26799,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Gastric Type"
26800,Malignant Cellular Infiltrate,Cervical Yolk Sac Tumor
26801,Malignant Cellular Infiltrate,Vaginal Neuroendocrine Carcinoma
26802,Malignant Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer
26803,Malignant Cellular Infiltrate,FIGO Stage IIIA1(i) Ovarian Cancer
26804,Malignant Cellular Infiltrate,FIGO Stage IVB Ovarian Cancer
26805,Malignant Cellular Infiltrate,Vulvar Yolk Sac Tumor
26806,Malignant Cellular Infiltrate,Unresectable Esophageal Carcinoma
26807,Malignant Cellular Infiltrate,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
26808,Malignant Cellular Infiltrate,Intrahepatic cholangiocarcinoma recurrent
26809,Malignant Cellular Infiltrate,"Anaplastic Astrocytoma, IDH-Mutant"
26810,Malignant Cellular Infiltrate,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"
26811,Malignant Cellular Infiltrate,Large Cell/Anaplastic Medulloblastoma
26812,Malignant Cellular Infiltrate,"Medulloblastoma, Genetically Defined"
26813,Malignant Cellular Infiltrate,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified"
26814,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA
26815,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with iAMP21
26816,Malignant Cellular Infiltrate,Recurrent Primary Malignant Neoplasm
26817,Primary Lesion,Supratentorial Ependymal Tumor
26818,Malignant Cellular Infiltrate,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
26819,Malignant Cellular Infiltrate,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
26820,Malignant Cellular Infiltrate,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
26821,Malignant Cellular Infiltrate,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8
26822,Malignant Cellular Infiltrate,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
26823,Malignant Cellular Infiltrate,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
26824,Malignant Cellular Infiltrate,Stage II Hypopharyngeal Carcinoma AJCC v8
26825,Malignant Cellular Infiltrate,Stage IVA Hypopharyngeal Carcinoma AJCC v8
26826,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8
26827,Malignant Cellular Infiltrate,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
26828,Malignant Cellular Infiltrate,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
26829,Malignant Cellular Infiltrate,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
26830,Malignant Cellular Infiltrate,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
26831,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
26832,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage
26833,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage
26834,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
26835,Malignant Cellular Infiltrate,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
26836,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8
26837,Malignant Cellular Infiltrate,Large B-cell lymphoma with IRF4 rearrangement
26838,Malignant Cellular Infiltrate,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
26839,Malignant Cellular Infiltrate,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
26840,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
26841,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
26842,Malignant Cellular Infiltrate,Refractory Primary Amyloidosis
26843,Malignant Cellular Infiltrate,Recurrent Primary Amyloidosis
26844,Malignant Cellular Infiltrate,Stage IIB Anal Cancer AJCC v8
26845,Malignant Cellular Infiltrate,Stage IIIB Anal Cancer AJCC v8
26846,Malignant Cellular Infiltrate,Stage IIIC Anal Cancer AJCC v8
26847,Malignant Cellular Infiltrate,Stage 0 Small Intestinal Adenocarcinoma AJCC v8
26848,Malignant Cellular Infiltrate,Stage I Appendix Carcinoma AJCC v8
26849,Malignant Cellular Infiltrate,Stage IIIA Appendix Carcinoma AJCC v8
26850,Malignant Cellular Infiltrate,Stage IIIB Appendix Carcinoma AJCC v8
26851,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v8
26852,Malignant Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v8
26853,Malignant Cellular Infiltrate,Stage IIIC Colorectal Cancer AJCC v8
26854,Malignant Cellular Infiltrate,Stage IVC Colorectal Cancer AJCC v8
26855,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v8 Stage
26856,Malignant Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v8
26857,Malignant Cellular Infiltrate,Stage IVA Colon Cancer AJCC v8
26858,Malignant Cellular Infiltrate,Stage IIB Rectal Cancer AJCC v8
26859,Malignant Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v8 Stage
26860,Malignant Cellular Infiltrate,Stage IB Hepatocellular Carcinoma AJCC v8
26861,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v8
26862,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v8
26863,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v8
26864,Malignant Cellular Infiltrate,Stage IB Intrahepatic Bile Duct Cancer AJCC v8
26865,Malignant Cellular Infiltrate,Gallbladder Cancer by AJCC v8 Stage
26866,Malignant Cellular Infiltrate,Stage IVA Gallbladder Cancer AJCC v8
26867,Malignant Cellular Infiltrate,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8
26868,Malignant Cellular Infiltrate,Distal Bile Duct Cancer by AJCC v8 Stage
26869,Malignant Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v8
26870,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v7 Stage
26871,Malignant Cellular Infiltrate,Stage IB Ampulla of Vater Cancer AJCC v8
26872,Malignant Cellular Infiltrate,Stage IIA Ampulla of Vater Cancer AJCC v8
26873,Malignant Cellular Infiltrate,Stage IV Ampulla of Vater Cancer AJCC v8
26874,Malignant Cellular Infiltrate,Pancreatic Cancer by AJCC v8 Stage
26875,Malignant Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v8
26876,Malignant Cellular Infiltrate,Stage IIA Pancreatic Cancer AJCC v8
26877,Well Differentiated Neuroendocrine Lesion,Stage I Gastric Neuroendocrine Tumor AJCC v8
26878,Well Differentiated Neuroendocrine Lesion,Stage II Gastric Neuroendocrine Tumor AJCC v8
26879,Well Differentiated Neuroendocrine Lesion,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8
26880,Well Differentiated Neuroendocrine Lesion,Stage III Jejunal Neuroendocrine Tumor AJCC v8
26881,Well Differentiated Neuroendocrine Lesion,Stage I Ileal Neuroendocrine Tumor AJCC v8
26882,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v7 Stage
26883,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8
26884,Well Differentiated Neuroendocrine Lesion,Stage IIA Colon Neuroendocrine Tumor AJCC v8
26885,Well Differentiated Neuroendocrine Lesion,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8
26886,Well Differentiated Neuroendocrine Lesion,Stage IV Rectal Neuroendocrine Tumor AJCC v8
26887,Well Differentiated Neuroendocrine Lesion,Stage III Pancreatic Neuroendocrine Tumor AJCC v8
26888,Malignant Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8
26889,Malignant Cellular Infiltrate,Lung Adenocarcinoma by AJCC v7 Stage
26890,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v8
26891,Malignant Cellular Infiltrate,Stage IVA Bone Cancer AJCC v8
26892,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage
26893,Malignant Cellular Infiltrate,Recurrent Cervical Adenocarcinoma
26894,Malignant Cellular Infiltrate,Lung Non-Keratinizing Squamous Cell Carcinoma
26895,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v7 Stage
26896,Malignant Cellular Infiltrate,Intermediate Atypical Prostate Carcinoma
26897,Malignant Cellular Infiltrate,Clinical Stage IV Cutaneous Melanoma AJCC v8
26898,Malignant Cellular Infiltrate,Pathologic Stage IA Cutaneous Melanoma AJCC v8
26899,Malignant Cellular Infiltrate,Pathologic Stage IB Cutaneous Melanoma AJCC v8
26900,Malignant Cellular Infiltrate,Pathologic Stage IIB Cutaneous Melanoma AJCC v8
26901,Malignant Cellular Infiltrate,Pathologic Stage IIID Cutaneous Melanoma AJCC v8
26902,Malignant Cellular Infiltrate,Pathologic Stage IV Cutaneous Melanoma AJCC v8
26903,Poorly Differentiated Neuroendocrine Lesion,Refractory Pancreatic Neuroendocrine Carcinoma
26904,Malignant Cellular Infiltrate,Refractory Extranodal Diffuse Large B-cell Lymphoma
26905,Malignant Cellular Infiltrate,Refractory Testicular Lymphoma
26906,Malignant Cellular Infiltrate,Double expressor lymphoma
26907,Malignant Cellular Infiltrate,Anatomic Stage 0 Breast Cancer AJCC v8
26908,Malignant Cellular Infiltrate,Prognostic Stage IIIA Breast Cancer AJCC v8
26909,Malignant Cellular Infiltrate,Stage IIB Vaginal Cancer AJCC v8
26910,Malignant Cellular Infiltrate,Stage III Cervical Cancer AJCC v8
26911,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Cancer AJCC v8
26912,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Cancer AJCC v8
26913,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
26914,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma by AJCC v8 Stage
26915,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Adenosarcoma AJCC v8
26916,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Adenosarcoma AJCC v8
26917,Malignant Cellular Infiltrate,Stage III Uterine Corpus Adenosarcoma AJCC v8
26918,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8
26919,Malignant Cellular Infiltrate,Stage II Ovarian Cancer AJCC v8
26920,Malignant Cellular Infiltrate,Stage IIIA1 Ovarian Cancer AJCC v8
26921,Malignant Cellular Infiltrate,Stage IIIC Ovarian Cancer AJCC v8
26922,Malignant Cellular Infiltrate,Stage IA Fallopian Tube Cancer AJCC v8
26923,Malignant Cellular Infiltrate,Stage III Fallopian Tube Cancer AJCC v8
26924,Malignant Cellular Infiltrate,Stage I Testicular Cancer AJCC v8
26925,Malignant Cellular Infiltrate,Stage III Renal Cell Cancer AJCC v8
26926,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v8 Stage
26927,Malignant Cellular Infiltrate,Ureter Cancer by AJCC v8 Stage
26928,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
26929,Malignant Cellular Infiltrate,Stage IV Renal Pelvis Cancer AJCC v8
26930,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v7 Stage
26931,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v8
26932,Malignant Cellular Infiltrate,Stage IV Bladder Cancer AJCC v8
26933,Malignant Cellular Infiltrate,Stage IVB Bladder Cancer AJCC v8
26934,Malignant Cellular Infiltrate,Stage III Eyelid Carcinoma AJCC v8
26935,Malignant Cellular Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v8
26936,Malignant Cellular Infiltrate,Choroidal and Ciliary Body Melanoma by AJCC v8 Stage
26937,Malignant Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8
26938,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
26939,Malignant Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v8
26940,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
26941,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Lymphoma AJCC v8
26942,Malignant Cellular Infiltrate,Lugano Classification Stage I Hodgkin Lymphoma AJCC v8
26943,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8
26944,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8
26945,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8
26946,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Modified Rai Staging System
26947,Malignant Cellular Infiltrate,St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8
26948,Malignant Cellular Infiltrate,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8
26949,Malignant Cellular Infiltrate,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage
26950,Malignant Cellular Infiltrate,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage
26951,Malignant Cellular Infiltrate,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8
26952,Malignant Cellular Infiltrate,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8
26953,Malignant Cellular Infiltrate,RISS Stage I Plasma Cell Myeloma
26954,Malignant Cellular Infiltrate,Malignant Lung PEComa
26955,Malignant Cellular Infiltrate,Pulmonary Artery Intimal Sarcoma
26956,Malignant Cellular Infiltrate,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
26957,Malignant Cellular Infiltrate,Refractory Osteosarcoma
26958,Malignant Cellular Infiltrate,Advanced Bile Duct Carcinoma
26959,Malignant Cellular Infiltrate,Recurrent Hairy Cell Leukemia
26960,Malignant Cellular Infiltrate,Refractory Glioblastoma
26961,Malignant Cellular Infiltrate,Hemangiosarcoma of heart
26962,Malignant Cellular Infiltrate,Pericardial Yolk Sac Tumor
26963,Malignant Cellular Infiltrate,Recurrent WHO Grade III Glioma
26964,Malignant Cellular Infiltrate,Locally Advanced Thymic Carcinoma
26965,Malignant Cellular Infiltrate,Recurrent Thymic Carcinoma
26966,Malignant Cellular Infiltrate,Refractory Undifferentiated Pleomorphic Sarcoma
26967,Malignant Cellular Infiltrate,Refractory Myxoid Liposarcoma
26968,Malignant Cellular Infiltrate,Refractory Paranasal Sinus Squamous Cell Carcinoma
26969,Malignant Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes"
26970,Malignant Cellular Infiltrate,N1 Diffuse Large B-Cell Lymphoma
26971,Malignant Cellular Infiltrate,Refractory Acute Leukemia
26972,Malignant Cellular Infiltrate,Refractory Ovarian Endometrioid Adenocarcinoma
26973,Malignant Cellular Infiltrate,Uveal Melanoma Metastatic in the Liver
26974,Malignant Cellular Infiltrate,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
26975,Malignant Cellular Infiltrate,Advanced Hypopharyngeal Squamous Cell Carcinoma
26976,Malignant Cellular Infiltrate,Refractory Bladder Carcinoma
26977,Malignant Cellular Infiltrate,Body Cavity Primary Effusion Lymphoma
26978,Malignant Cellular Infiltrate,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma
26979,Malignant Cellular Infiltrate,"Intestinal T-Cell Lymphoma, Not Otherwise Specified"
26980,Malignant Cellular Infiltrate,Metastatic Renal Pelvis Urothelial Carcinoma
26981,Malignant Cellular Infiltrate,Recurrent Renal Pelvis Urothelial Carcinoma
26982,Malignant Cellular Infiltrate,Recurrent Malignant Bone Neoplasm
26983,Malignant Cellular Infiltrate,Refractory Malignant Bone Neoplasm
26984,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm of Multiple Primary Sites
26985,Malignant Cellular Infiltrate,Recurrent Malignant Pharyngeal Neoplasm
26986,Malignant Cellular Infiltrate,Recurrent Malignant Soft Tissue Neoplasm
26987,Malignant Cellular Infiltrate,Recurrent Malignant Urinary System Neoplasm
26988,Malignant Cellular Infiltrate,Recurrent Malignant Skin Neoplasm
26989,Malignant Cellular Infiltrate,Unresectable Gastroesophageal Junction Adenocarcinoma
26990,Malignant Cellular Infiltrate,Recurrent Myxoid Liposarcoma
26991,Borderline Lesion,Non-IgM Monoclonal Gammopathy of Undetermined Significance
26992,Malignant Cellular Infiltrate,Testicular Follicular Lymphoma
26993,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders
26994,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes
26995,Malignant Cellular Infiltrate,Abdominal Undifferentiated Pleomorphic Sarcoma
26996,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Ductal Adenocarcinoma
26997,Malignant Cellular Infiltrate,Locally Advanced Bone Sarcoma
26998,Malignant Cellular Infiltrate,Refractory Lung Non-Small Cell Carcinoma
26999,Malignant Cellular Infiltrate,Advanced Sarcoma
27000,Malignant Cellular Infiltrate,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
27001,Malignant Cellular Infiltrate,Metastatic Chordoma
27002,Malignant Cellular Infiltrate,Locally Advanced Chordoma
27003,Malignant Cellular Infiltrate,Castration-Sensitive Prostate Carcinoma
27004,Malignant Cellular Infiltrate,Recurrent Gastroesophageal Junction Adenocarcinoma
27005,Malignant Cellular Infiltrate,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
27006,Malignant Cellular Infiltrate,Recurrent Pancreatic Acinar Cell Carcinoma
27007,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Acinic Cell Carcinoma
27008,Malignant Cellular Infiltrate,Recurrent Lobular Breast Carcinoma
27009,Malignant Cellular Infiltrate,Recurrent Parotid Gland Squamous Cell Carcinoma
27010,Malignant Cellular Infiltrate,Metastatic hepatocellular carcinoma
27011,Absence of a Hormonal Syndrome,Densely Granulated Non-Functioning Corticotroph Adenoma
27012,Malignant Cellular Infiltrate,Unresectable Malignant Mesothelioma
27013,Anaplasia,Anaplastic Sarcoma of the Kidney
27014,Carcinomatous Component Present,Unresectable Renal Cell Carcinoma
27015,Metastatic Lesion,Recurrent Metastatic Malignant Neoplasm
27016,High Mitotic Activity,Digestive System Large Cell Neuroendocrine Carcinoma
27017,Severe cytologic atypia,Digestive System Large Cell Neuroendocrine Carcinoma
27018,Metastatic Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm
27019,Epithelial Component Present,Transplant-Related Squamous Cell Carcinoma
27020,Primary Lesion,Recurrent Cutaneous Melanoma of the Extremity
27021,Malignant Cellular Infiltrate,Sarcoma of the Extremity
27022,Unresectable Mass,Locally Advanced Unresectable Renal Cell Carcinoma
27023,Metastatic Lesion,Locally Advanced Unresectable Renal Cell Carcinoma
27024,Secondary Lesion,Locally Advanced Unresectable Renal Cell Carcinoma
27025,Carcinomatous Component Present,Pancreatic adenocarcinoma recurrent
27026,Neuroectodermal Differentiation,Sellar Neuroblastoma
27027,Primary Lesion,Sellar Ependymoma
27028,Antoni A Pattern,Sellar Schwannoma
27029,Thick-Walled Hyalinized Vessels Present,Sellar Schwannoma
27030,Solitary mass,Sellar Chondroid Chordoma
27031,Slow Growing Mass,Sellar Dedifferentiated Chordoma
27032,Thin-Walled Branching Vascular Pattern,Sellar Solitary Fibrous Tumor/Hemangiopericytoma
27033,Malignant Cellular Infiltrate,malignant neoplasm of skull
27034,Benign Cellular Infiltrate,Sellar Mature Teratoma
27035,Epithelial Component Present,Recurrent Endometrial Clear Cell Adenocarcinoma
27036,Recurrent disease,Recurrent Uterine Corpus Carcinosarcoma
27037,Tissue of Mullerian Origin Present,Recurrent Uterine Corpus Carcinosarcoma
27038,Secondary Lesion,Metastatic Malignant Pancreatic Neoplasm
27039,Metastatic Lesion,"Neuroendocrine carcinoma, metastatic"
27040,Neuroendocrine Differentiation,"Neuroendocrine carcinoma, metastatic"
27041,Recurrent disease,Recurrent Desmoid-Type Fibromatosis
27042,Locally Aggressive Lesion,Recurrent Desmoid-Type Fibromatosis
27043,Infiltrative Growth Pattern,Unresectable Desmoid-Type Fibromatosis
27044,Collagenous Stroma Formation,Unresectable Desmoid-Type Fibromatosis
27045,Carcinomatous Component Present,Unresectable Lung Non-Small Cell Carcinoma
27046,Secondary Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity
27047,High Mitotic Activity,Locally Advanced Pancreatic Neuroendocrine Carcinoma
27048,Regional Disease,Locally Advanced Pancreatic Neuroendocrine Carcinoma
27049,Malignant Cellular Infiltrate,Locally Advanced Digestive System Neuroendocrine Carcinoma
27050,Carcinomatous Component Present,Locally Advanced Digestive System Neuroendocrine Carcinoma
27051,High Mitotic Activity,Unresectable Digestive System Neuroendocrine Carcinoma
27052,Epithelial Component Present,Unresectable Digestive System Neuroendocrine Carcinoma
27053,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Carcinoma
27054,Poorly Differentiated Neuroendocrine Lesion,Refractory Digestive System Neuroendocrine Carcinoma
27055,High Mitotic Activity,Recurrent Digestive System Neuroendocrine Carcinoma
27056,Precise Histogenesis Unknown,Spinal hemangioblastoma
27057,Encapsulated Mass,Thyroid Gland Spindle Cell Follicular Adenoma
27058,Nodular lesions,Thyroid Gland Spindle Cell Follicular Adenoma
27059,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Spindle Cell Follicular Adenoma
27060,Cytoplasmic Accumulation of Black Pigment,Thyroid Gland Black Follicular Adenoma
27061,Monoclonal Cellular Population Present,Thyroid Gland Black Follicular Adenoma
27062,Lobulated Growth Pattern,Recurrent Chordoma
27063,Myxoid Stroma Formation,Recurrent Chordoma
27064,Hereditary Lesion,Refractory Neurofibromatosis Type 1
27065,Malignant Cellular Infiltrate,Refractory Malignant Peripheral Nerve Sheath Tumor
27066,Encapsulated Mass,Encapsulated Variant Thyroid Gland Papillary Carcinoma
27067,Nuclear Atypia,Frontal Lobe Anaplastic Astrocytoma
27068,Malignant Cellular Infiltrate,Frontal Lobe Anaplastic Astrocytoma
27069,Diffuse Pattern,Temporal Lobe Anaplastic Astrocytoma
27070,Microvascular Proliferation,Third Ventricle Pilocytic Astrocytoma
27071,Slow Growing Mass,Third Ventricle Pilocytic Astrocytoma
27072,Malignant Cellular Infiltrate,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
27073,Nuclear Grooves,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
27074,Epithelial Component Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
27075,Papillary Pattern,Hobnail Variant Thyroid Gland Papillary Carcinoma
27076,Malignant Cellular Infiltrate,Hobnail Variant Thyroid Gland Papillary Carcinoma
27077,Metastatic Lesion,Bladder cancer stage IV
27078,Metastatic Lesion,Metastatic Vaginal Carcinoma
27079,Epithelial Component Present,Metastatic Endometrial Carcinoma
27080,Carcinomatous Component Present,Metastatic Endometrial Carcinoma
27081,Epithelial Component Present,stage IV pancreatic cancer
27082,Metastatic Lesion,Metastatic Adrenal Cortex Carcinoma
27083,Secondary Lesion,Metastatic Adrenal Cortex Carcinoma
27084,Carcinomatous Component Present,Metastatic Adrenal Cortex Carcinoma
27085,Malignant Cellular Infiltrate,Stage IV adult soft tissue sarcoma
27086,Carcinomatous Component Present,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
27087,Metastatic Lesion,Metastatic Pharyngeal Carcinoma
27088,Secondary Lesion,Metastatic Pharyngeal Carcinoma
27089,Carcinomatous Component Present,Metastatic Pharyngeal Carcinoma
27090,Secondary Lesion,Metastatic Hypopharyngeal Carcinoma
27091,Carcinomatous Component Present,Metastatic Hypopharyngeal Carcinoma
27092,Secondary Lesion,Metastatic Oropharyngeal Carcinoma
27093,Secondary Lesion,Metastatic Lip Carcinoma
27094,Carcinomatous Component Present,Metastatic Oral Cavity Adenoid Cystic Carcinoma
27095,Cystic Change,Metastatic Oral Cavity Mucoepidermoid Carcinoma
27096,Secondary Lesion,Metastatic Lung Adenosquamous Carcinoma
27097,Malignant Cellular Infiltrate,Metastatic Colon Carcinoma
27098,Metastatic Lesion,Metastatic Rectal Carcinoma
27099,Malignant Cellular Infiltrate,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
27100,Skin nodule,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
27101,Cutaneous Involvement,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
27102,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
27103,Malignant Cellular Infiltrate,Localized Gastric Carcinoma
27104,Malignant Cellular Infiltrate,Thyroid Gland Mucinous Carcinoma
27105,Secondary Lesion,Locally Advanced Pancreatic Adenocarcinoma
27106,Pseudoalveolar Pattern,Orbital Alveolar Soft Part Sarcoma
27107,Benign Cellular Infiltrate,Cellular neurothekeoma
27108,Malignant Cellular Infiltrate,Colon Liposarcoma
27109,Malignant Cellular Infiltrate,Parotid Gland Sarcoma
27110,Epithelial Component Present,Advanced Prostate Carcinoma
27111,Carcinomatous Component Present,Advanced Prostate Carcinoma
27112,Extensive Stage Lesion,Advanced Prostate Adenocarcinoma
27113,Metastatic Lesion,Advanced Prostate Adenocarcinoma
27114,Carcinomatous Component Present,Advanced Prostate Adenocarcinoma
27115,Invasive Lesion,Locally Advanced Prostate Adenocarcinoma
27116,Epithelial Component Present,Locally Advanced Prostate Adenocarcinoma
27117,Metastatic Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma
27118,Regional Disease,Locally Advanced Unresectable Prostate Adenocarcinoma
27119,Secondary Lesion,Locally Advanced Cervical Adenocarcinoma
27120,Malignant Cellular Infiltrate,Locally Advanced Unresectable Cervical Adenocarcinoma
27121,Unresectable Mass,Locally Advanced Unresectable Cervical Adenocarcinoma
27122,Regional Disease,Locally Advanced Unresectable Cervical Adenocarcinoma
27123,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma
27124,Unresectable Mass,Locally Advanced Unresectable Cervical Carcinoma
27125,Storiform Growth Pattern,follicular dendritic cell sarcoma of thyroid gland
27126,Whorling Growth Pattern,follicular dendritic cell sarcoma of thyroid gland
27127,Malignant Cellular Infiltrate,follicular lymphoma of thyroid gland
27128,Recurrent disease,Recurrent Primary Peritoneal Serous Adenocarcinoma
27129,Low Grade Lesion,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
27130,Recurrent disease,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
27131,Malignant Cellular Infiltrate,Extrapulmonary Small Cell Carcinoma
27132,Neuroendocrine Differentiation,Extrapulmonary Small Cell Carcinoma
27133,Carcinomatous Component Present,Extrapulmonary Small Cell Carcinoma
27134,Malignant Cellular Infiltrate,"Kaposi's sarcoma, metastatic"
27135,Malignant Cellular Infiltrate,Advanced Kaposi Sarcoma
27136,Metastatic Lesion,Metastatic Neuroendocrine Neoplasm
27137,Secondary Lesion,Advanced Neuroendocrine Neoplasm
27138,Well Differentiated Neuroendocrine Lesion,Advanced Carcinoid Tumor
27139,Secondary Lesion,Advanced Carcinoid Tumor
27140,Malignant Cellular Infiltrate,Pancreatic neuroendocrine tumor metastatic
27141,Metastatic Lesion,Advanced Pancreatic Neuroendocrine Tumor
27142,Secondary Lesion,Advanced Pancreatic Neuroendocrine Tumor
27143,Secondary Lesion,Metastatic Digestive System Neuroendocrine Neoplasm
27144,Metastatic Lesion,Metastatic Breast Neuroendocrine Neoplasm
27145,Epithelial Component Present,Metastatic Breast Neuroendocrine Neoplasm
27146,Malignant Cellular Infiltrate,Metastatic Gastric Neuroendocrine Carcinoma
27147,Carcinomatous Component Present,Advanced Gastric Neuroendocrine Carcinoma
27148,Malignant Cellular Infiltrate,Advanced Gastric Large Cell Neuroendocrine Carcinoma
27149,Extensive Stage Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma
27150,Neuroendocrine Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma
27151,Epithelial Component Present,Advanced Gastric Large Cell Neuroendocrine Carcinoma
27152,Severe cytologic atypia,Advanced Gastric Large Cell Neuroendocrine Carcinoma
27153,Secondary Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma
27154,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma
27155,High Mitotic Activity,Advanced Small Intestinal Neuroendocrine Carcinoma
27156,Extensive Stage Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma
27157,Neuroendocrine Differentiation,Advanced Small Intestinal Neuroendocrine Carcinoma
27158,Secondary Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
27159,Diffuse Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
27160,Recurrent disease,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
27161,Malignant Cellular Infiltrate,Malignant Peritoneal and Retroperitoneal Neoplasm
27162,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Recurrent Acute Monoblastic and Monocytic Leukemia
27163,Malignant Cellular Infiltrate,Locally Advanced Microsatellite Stable Colorectal Carcinoma
27164,Regional Disease,Locally Advanced Microsatellite Stable Colorectal Carcinoma
27165,Epithelial Component Present,Locally Advanced Microsatellite Stable Colorectal Carcinoma
27166,Carcinomatous Component Present,Metastatic basal cell carcinoma
27167,PSA Failure,Biochemically Recurrent Prostate Carcinoma
27168,Resectable Mass,Pancreatic adenocarcinoma resectable
27169,Epithelial Component Present,Pancreatic adenocarcinoma resectable
27170,Resectable Mass,Resectable Pancreatic Acinar Cell Carcinoma
27171,Acinar Cell Differentiation,Resectable Pancreatic Acinar Cell Carcinoma
27172,Antoni A Pattern,Adrenal Gland Schwannoma
27173,Malignant Cellular Infiltrate,Refractory Hormone Receptor Positive Breast Carcinoma
27174,Malignant Cellular Infiltrate,African Burkitt's lymphoma
27175,Malignant Cellular Infiltrate,Disseminated adenocarcinoma
27176,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
27177,Malignant Cellular Infiltrate,Familial Adenomatous Polyposis Associated Medulloblastoma
27178,Malignant Cellular Infiltrate,Stage IVB Vulvar Cancer AJCC v6 and v7
27179,Malignant Cellular Infiltrate,Eccrine carcinoma of skin
27180,Malignant Cellular Infiltrate,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7
27181,Malignant Cellular Infiltrate,Unresectable Malignant Neoplasm
27182,Malignant Cellular Infiltrate,Meningeal Carcinomatosis
27183,Malignant Cellular Infiltrate,Vaginal Melanoma
27184,Benign Cellular Infiltrate,Adult Central Nervous System Mature Teratoma
27185,Malignant Cellular Infiltrate,Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma
27186,Malignant Cellular Infiltrate,Ampulla of Vater Intestinal-Type Adenocarcinoma
27187,Malignant Cellular Infiltrate,Ampulla of Vater Squamous Cell Carcinoma
27188,Well Differentiated Neuroendocrine Lesion,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
27189,Well Differentiated Neuroendocrine Lesion,Gastric Gastrin-Producing Neuroendocrine Tumor
27190,Malignant Cellular Infiltrate,Small Intestinal Small Cell Neuroendocrine Carcinoma
27191,Well Differentiated Neuroendocrine Lesion,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
27192,Well Differentiated Neuroendocrine Lesion,Pancreatic Vipoma
27193,Benign Cellular Infiltrate,lipoma of bone
27194,Benign Cellular Infiltrate,Pelvic lipomatosis
27195,Malignant Cellular Infiltrate,Lymphadenopathic Kaposi Sarcoma
27196,Malignant Cellular Infiltrate,Conventional Extraskeletal Myxoid Chondrosarcoma
27197,Vascular Channel Formation,Glomeruloid hemangioma
27198,Benign Cellular Infiltrate,Hemangioma of Peripheral Nerve
27199,Benign Cellular Infiltrate,Benign Hair Follicle Neoplasm
27200,Benign Cellular Infiltrate,Follicular Myxoma
27201,Malignant Cellular Infiltrate,Basal cell carcinoma - adenoid
27202,Malignant Cellular Infiltrate,Skin Clear Cell Basal Cell Carcinoma
27203,Malignant Cellular Infiltrate,Infiltrating basal cell carcinoma
27204,Malignant Cellular Infiltrate,Transplant-Related Lung Carcinoma
27205,Malignant Cellular Infiltrate,EBV-Related Hodgkin Lymphoma
27206,Malignant Cellular Infiltrate,Virus-Related Sarcoma
27207,Malignant Cellular Infiltrate,Stage IIB Cutaneous Melanoma AJCC v6 and v7
27208,Malignant Cellular Infiltrate,Tobacco Chewing-Related Carcinoma
27209,Toxic effect,Solar Radiation-Related Malignant Neoplasm
27210,Malignant Cellular Infiltrate,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
27211,Malignant Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7
27212,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change
27213,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component
27214,Malignant Cellular Infiltrate,Papillary renal cell carcinoma type 2
27215,Malignant Cellular Infiltrate,Localized Peripheral Primitive Neuroectodermal Tumor
27216,Malignant Cellular Infiltrate,Old Burn Scar-Related Cutaneous Melanoma
27217,Malignant Cellular Infiltrate,Solar Radiation-Related Skin Squamous Cell Carcinoma
27218,Malignant Cellular Infiltrate,Asbestos-Related Malignant Mesothelioma
27219,Malignant Cellular Infiltrate,Adenocarcinoma
27220,Malignant Cellular Infiltrate,Papillary adenocarcinoma
27221,Benign Cellular Infiltrate,Benign neoplasm of skin
27222,Malignant Cellular Infiltrate,"Carcinoma, Transitional Cell"
27223,Benign Cellular Infiltrate,Chondroblastoma
27224,Malignant Cellular Infiltrate,Dysgerminoma
27225,Malignant Cellular Infiltrate,gamma-Chain Disease
27226,Benign Cellular Infiltrate,"Hemangioma, Cavernous"
27227,Malignant Cellular Infiltrate,Krukenberg Tumor
27228,Malignant Cellular Infiltrate,leukemia
27229,Malignant Cellular Infiltrate,Myeloid Leukemia
27230,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Accelerated Phase"
27231,Benign Cellular Infiltrate,Lipoma
27232,Benign Cellular Infiltrate,Myxoma
27233,Benign Cellular Infiltrate,Cartilaginous exostosis
27234,Benign Cellular Infiltrate,Osteoma
27235,Malignant Cellular Infiltrate,Rhabdomyosarcoma
27236,Benign Cellular Infiltrate,Pigmented villonodular synovitis
27237,Malignant Cellular Infiltrate,"Thrombocythemia, Essential"
27238,Benign Cellular Infiltrate,benign neoplasm of lower jaw bone
27239,Malignant Cellular Infiltrate,T-Cell Lymphoma
27240,Malignant Cellular Infiltrate,"Lymphoma, T-Cell, Cutaneous"
27241,Malignant Cellular Infiltrate,Squamous cell carcinoma of lung
27242,Benign Cellular Infiltrate,Hamartoma of lung
27243,Malignant Cellular Infiltrate,Malignant neoplasm of upper third of esophagus
27244,Malignant Cellular Infiltrate,Malignant tumor of ethmoid sinus
27245,Benign Cellular Infiltrate,Lipoma of axilla
27246,Malignant Cellular Infiltrate,Malignant neoplasm of subglottis
27247,Malignant Cellular Infiltrate,Malignant neoplasm of exocervix
27248,Malignant Cellular Infiltrate,Non-Resectable Malignant Liver Neoplasm
27249,Malignant Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of breast
27250,Malignant Cellular Infiltrate,Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
27251,Malignant Cellular Infiltrate,Malignant neoplasm of carotid body
27252,Malignant Cellular Infiltrate,Epithelioid Cell Uveal Melanoma
27253,Malignant Cellular Infiltrate,Choroid Mixed Cell Melanoma
27254,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone
27255,Malignant Cellular Infiltrate,Cancer of lymph node
27256,Malignant Cellular Infiltrate,Monoblastic Sarcoma
27257,Malignant Cellular Infiltrate,"Hodgkin's disease, lymphocytic depletion of lymph nodes of multiple sites"
27258,Malignant Cellular Infiltrate,Grade 2 Clear Cell Renal Cell Carcinoma
27259,Benign Cellular Infiltrate,Benign neoplasm of pharynx
27260,Malignant Cellular Infiltrate,Grade 2 Malignant Neoplasm
27261,Malignant Cellular Infiltrate,Malignant Neoplasm by Grade
27262,Malignant Cellular Infiltrate,Grade 3b Malignant Neoplasm
27263,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-1
27264,Malignant Cellular Infiltrate,Klatskin Tumor
27265,Benign Cellular Infiltrate,Benign neoplasm of bladder
27266,Malignant Cellular Infiltrate,Non-Hereditary Clear Cell Renal Cell Carcinoma
27267,Malignant Cellular Infiltrate,Acute Adult T-Cell Leukemia/Lymphoma
27268,Benign Cellular Infiltrate,Benign neoplasm of parathyroid gland
27269,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Liver
27270,Malignant Cellular Infiltrate,Stage 0 Breast Cancer AJCC v6 and v7
27271,Borderline Lesion,Neoplastic disease of uncertain behavior
27272,Benign Cellular Infiltrate,Papillary fibroelastoma
27273,Malignant Cellular Infiltrate,"Sarcoma, Epithelioid"
27274,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
27275,Malignant Cellular Infiltrate,Malignant Kidney Mixed Epithelial and Stromal Tumor
27276,Malignant Cellular Infiltrate,Head and Neck Basaloid Carcinoma
27277,Malignant Cellular Infiltrate,"Sarcoma, Small Cell"
27278,Malignant Cellular Infiltrate,"Adenocarcinoma, Clear Cell"
27279,Malignant Cellular Infiltrate,"Carcinoma, Endometrioid"
27280,Malignant Cellular Infiltrate,"Carcinoma, Giant Cell"
27281,Malignant Cellular Infiltrate,"Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
27282,Malignant Cellular Infiltrate,Olfactory Neuroblastoma
27283,Malignant Cellular Infiltrate,Malignant neoplasm of salivary gland
27284,Malignant Cellular Infiltrate,Skin Signet Ring Cell Basal Cell Carcinoma
27285,Malignant Cellular Infiltrate,Primary amyloidosis
27286,Malignant Cellular Infiltrate,Gallbladder Carcinoma
27287,Benign Cellular Infiltrate,Benign neoplasm of female breast
27288,Malignant Cellular Infiltrate,Thyroid Gland Mucoepidermoid Carcinoma
27289,Benign Cellular Infiltrate,Fibrous Hamartoma of Infancy
27290,Malignant Cellular Infiltrate,"Glioblastoma, IDH-Wildtype"
27291,Malignant Cellular Infiltrate,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations
27292,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation
27293,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant"
27294,Malignant Cellular Infiltrate,Bladder Urachal Adenocarcinoma
27295,Malignant Cellular Infiltrate,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma
27296,Malignant Cellular Infiltrate,Carcinoma of Littre Glands
27297,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Oncocytic Variant"
27298,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Papillary Pattern"
27299,Malignant Cellular Infiltrate,Prostatic Duct Urothelial Carcinoma
27300,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma
27301,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Solid Pattern"
27302,Malignant Cellular Infiltrate,Mixed Squamous Cell Carcinoma of the Penis
27303,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern"
27304,Malignant Primitive Cellular Infiltrate,polyembryoma of ovary
27305,Malignant Cellular Infiltrate,Adenocarcinoma of rete ovarii
27306,Malignant Cellular Infiltrate,Primary peritoneal carcinoma
27307,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer
27308,Malignant Cellular Infiltrate,Malignant Ovarian Transitional Cell Tumor
27309,Malignant Cellular Infiltrate,Ovarian mixed epithelial carcinoma
27310,Malignant Cellular Infiltrate,leiomyosarcoma of fallopian tube
27311,Malignant Cellular Infiltrate,Grade 3 Endometrial Endometrioid Adenocarcinoma
27312,Malignant Cellular Infiltrate,Lobular carcinoma in situ of breast
27313,Malignant Cellular Infiltrate,Cervical Warty Carcinoma
27314,Malignant Cellular Infiltrate,Cervical Lymphoepithelioma-Like Carcinoma
27315,Malignant Cellular Infiltrate,Cervical Squamotransitional Carcinoma
27316,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type"
27317,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Intestinal-Type"
27318,Malignant Cellular Infiltrate,Adenoid basal carcinoma of cervix uteri
27319,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Cervix
27320,Benign Cellular Infiltrate,"Vaginal Deep ""Aggressive"" Angiomyxoma"
27321,Malignant Cellular Infiltrate,Cervical Squamous Cell Carcinoma
27322,Malignant Cellular Infiltrate,Vulvar Non-Keratinizing Squamous Cell Carcinoma
27323,Malignant Cellular Infiltrate,Bladder Adenocarcinoma
27324,Malignant Cellular Infiltrate,Papillary thyroid carcinoma
27325,Malignant Cellular Infiltrate,Breast Columnar Cell Mucinous Carcinoma
27326,Malignant Cellular Infiltrate,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma
27327,Malignant Cellular Infiltrate,lipid-rich carcinoma of breast
27328,Malignant Cellular Infiltrate,malignant myoepithelioma of breast
27329,Malignant Cellular Infiltrate,Squamous cell carcinoma of buccal mucosa
27330,Malignant Cellular Infiltrate,Ann Arbor Stage IIIB Hodgkin Lymphoma
27331,Malignant Cellular Infiltrate,Bile duct cystadenocarcinoma
27332,Malignant Cellular Infiltrate,Adenocarcinoma in adenomatous polyposis coli
27333,Malignant Cellular Infiltrate,Adenocarcinoma in multiple adenomatous polyps
27334,Malignant Cellular Infiltrate,Lipid-rich carcinoma
27335,Malignant Cellular Infiltrate,Carcinoma of apocrine gland
27336,Malignant Cellular Infiltrate,Nodular melanoma
27337,Benign Cellular Infiltrate,Neuronevus
27338,Malignant Cellular Infiltrate,"Spindle cell melanoma, type B"
27339,Malignant Cellular Infiltrate,"Liposarcoma, well differentiated"
27340,Malignant Cellular Infiltrate,Clear cell sarcoma of kidney
27341,Malignant Cellular Infiltrate,Pancreatoblastoma
27342,Benign Cellular Infiltrate,Histiocytoid hemangioma
27343,Malignant Cellular Infiltrate,Gliomatosis cerebri
27344,Malignant Cellular Infiltrate,Medulloepithelioma
27345,Malignant Cellular Infiltrate,Malignant Proliferating Pilar Tumor
27346,Malignant Cellular Infiltrate,Extraocular Cutaneous Sebaceous Carcinoma
27347,Malignant Cellular Infiltrate,Peripheral T-Cell Lymphoma
27348,Malignant Cellular Infiltrate,Acute panmyelosis with myelofibrosis
27349,Malignant Cellular Infiltrate,Small Intestinal Medullary Carcinoma
27350,Malignant Cellular Infiltrate,Small Intestinal Signet Ring Cell Carcinoma
27351,Benign Cellular Infiltrate,Polyp of external auditory meatus
27352,Benign Cellular Infiltrate,Benign neoplasm of subglottis
27353,Malignant Cellular Infiltrate,Stage 0 Gallbladder Cancer AJCC v6 and v7
27354,Benign Cellular Infiltrate,Benign neoplasm of retroperitoneum
27355,Benign Cellular Infiltrate,Perifollicular fibroma
27356,Benign Cellular Infiltrate,Nevus spilus
27357,Malignant Cellular Infiltrate,Primary cutaneous diffuse large cell B-cell lymphoma
27358,Malignant Cellular Infiltrate,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes
27359,Borderline Lesion,Cutaneous Lymphomatoid Granulomatosis
27360,Malignant Cellular Infiltrate,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype"
27361,Malignant Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma
27362,Malignant Cellular Infiltrate,Fetal Lung Adenocarcinoma
27363,Malignant Cellular Infiltrate,Sarcomatoid carcinoma of the lung
27364,Malignant Cellular Infiltrate,Malignant medulloepithelioma of ciliary body
27365,Malignant Cellular Infiltrate,Malignant melanoma of ciliary body
27366,Malignant Cellular Infiltrate,Chronic eosinophilic leukemia
27367,Malignant Cellular Infiltrate,Lung Biphasic Synovial Sarcoma
27368,Malignant Cellular Infiltrate,Combined Thymic Epithelial Neoplasm
27369,Malignant Cellular Infiltrate,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy
27370,Benign Cellular Infiltrate,Cardiac Intramuscular Hemangioma
27371,Malignant Cellular Infiltrate,Malignant neoplasm of thalamus
27372,Malignant Cellular Infiltrate,Stage 0 Lip Carcinoma
27373,Malignant Cellular Infiltrate,Stage 0 Oropharyngeal Carcinoma
27374,Benign Cellular Infiltrate,Benign neoplasm of middle ear
27375,Malignant Cellular Infiltrate,Clear Cell Variant Thyroid Gland Follicular Carcinoma
27376,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Micromedullary Carcinoma
27377,Benign Cellular Infiltrate,Lipoma of skin
27378,Malignant Cellular Infiltrate,Primary malignant neoplasm of glomus jugulare
27379,Malignant Cellular Infiltrate,Rhabdomyosarcoma with ganglionic differentiation
27380,Malignant Cellular Infiltrate,Non-Secretory Plasma Cell Myeloma
27381,Malignant Cellular Infiltrate,Melanotic malignant nerve sheath tumor
27382,Malignant Cellular Infiltrate,Malignant tumor of eye
27383,Benign Cellular Infiltrate,Benign neuroendocrine tumor
27384,Malignant Cellular Infiltrate,malignant neoplasm of epiglottis
27385,Malignant Cellular Infiltrate,Carcinoma of larynx
27386,Malignant Cellular Infiltrate,Invasive Cutaneous Melanoma
27387,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vertebral column
27388,Malignant Cellular Infiltrate,Malignant neoplasm of gastrointestinal tract
27389,Malignant Cellular Infiltrate,Carcinoma in situ of small intestine
27390,Benign Cellular Infiltrate,Benign neoplasm of urinary system
27391,Benign Cellular Infiltrate,Gardner Fibroma
27392,Malignant Cellular Infiltrate,Small cell carcinoma of lung
27393,Malignant Cellular Infiltrate,Malignant germ cell neoplasm
27394,Low Grade Neuroendocrine Lesion,Carcinoid tumor of ileum
27395,Malignant Cellular Infiltrate,Hepatic lymphoma
27396,Malignant Cellular Infiltrate,Malignant neoplasm of large intestine
27397,Malignant Cellular Infiltrate,Hodgkin's disease of intrapelvic lymph nodes
27398,Malignant Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v6
27399,Malignant Cellular Infiltrate,Stage II Esophageal Squamous Cell Carcinoma AJCC v7
27400,Malignant Cellular Infiltrate,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7
27401,Malignant Cellular Infiltrate,Cerebral Hodgkin Lymphoma
27402,Malignant Cellular Infiltrate,Secondary Cerebral Hodgkin Lymphoma
27403,Malignant Cellular Infiltrate,Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma
27404,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
27405,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
27406,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I subdiaphragmatic
27407,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV
27408,Benign Cellular Infiltrate,Kidney Fibroma
27409,Malignant Cellular Infiltrate,Anaplastic Hemispheric Astrocytoma
27410,Malignant Cellular Infiltrate,adenocarcinoma of breast with squamous metaplasia
27411,Malignant Cellular Infiltrate,Metastatic Breast Carcinoid Tumor
27412,Secondary Lesion,Metastatic Breast Carcinoid Tumor
27413,Malignant Cellular Infiltrate,fibrosarcoma of breast
27414,Malignant Cellular Infiltrate,Stage IB Ovarian Cancer AJCC v6 and v7
27415,Malignant Cellular Infiltrate,Stage IIA Ovarian Cancer AJCC V6 and v7
27416,Malignant Cellular Infiltrate,Stage IIB Ovarian Cancer AJCC v6 and v7
27417,Malignant Cellular Infiltrate,Ovarian Rhabdomyosarcoma
27418,Malignant Cellular Infiltrate,Gastric T-Cell Non-Hodgkin Lymphoma
27419,Benign Cellular Infiltrate,Mature Gastric Teratoma
27420,Malignant Cellular Infiltrate,Meningeal melanoma
27421,Malignant Cellular Infiltrate,sarcoma of small intestine
27422,Benign Cellular Infiltrate,Osteochondromatosis
27423,Benign Cellular Infiltrate,Intravascular Angioleiomyoma
27424,Malignant Cellular Infiltrate,Intimal sarcoma
27425,Malignant Cellular Infiltrate,Cardiac Lymphoma
27426,Malignant Cellular Infiltrate,Secondary osteosarcoma
27427,Malignant Cellular Infiltrate,Malignant Aortic Neoplasm
27428,Malignant Cellular Infiltrate,"Central Nervous System Embryonal Tumor, Not Otherwise Specified"
27429,Malignant Cellular Infiltrate,Undifferentiated Stromal Sarcoma
27430,Malignant Cellular Infiltrate,Region 17p13 Allelic Loss Associated Medulloblastoma
27431,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Carcinoma
27432,Malignant Cellular Infiltrate,Drop Metastasis in the Spinal Cord
27433,Malignant Cellular Infiltrate,Stage IIA Breast Carcinoma
27434,Malignant Cellular Infiltrate,Invasive Apocrine Breast Carcinoma
27435,Malignant Cellular Infiltrate,Central Nervous System Fibrosarcoma
27436,Malignant Cellular Infiltrate,Malignant Gastric Granular Cell Tumor
27437,Malignant Cellular Infiltrate,Colon Adenosquamous Carcinoma
27438,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1
27439,Low Grade Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1
27440,Benign Cellular Infiltrate,Central Nervous System Dermoid Cyst
27441,Malignant Cellular Infiltrate,rhabdomyosarcoma of prostate
27442,Malignant Cellular Infiltrate,Squamous cell carcinoma of prostate
27443,Low Grade Neuroendocrine Lesion,Carcinoid tumor of rectum
27444,Malignant Cellular Infiltrate,Stage I Skin Cancer
27445,Malignant Cellular Infiltrate,Anal Lymphoma
27446,Malignant Cellular Infiltrate,Anal Kaposi Sarcoma
27447,Malignant Cellular Infiltrate,Skin Nodular Solid Basal Cell Carcinoma
27448,Malignant Cellular Infiltrate,Stage IIA Esophagus Carcinoma
27449,Malignant Cellular Infiltrate,malignant lymphoma of pancreatic lymph nodes
27450,Malignant Cellular Infiltrate,mucinous adenocarcinoma of gallbladder
27451,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v6
27452,Malignant Cellular Infiltrate,Stage IVA Hepatocellular Carcinoma AJCC v7
27453,Malignant Cellular Infiltrate,Gallbladder Kaposi's Sarcoma
27454,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma
27455,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Carcinoid Tumor
27456,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
27457,Malignant Cellular Infiltrate,Stage II Lip Cancer AJCC v6 and v7
27458,Malignant Cellular Infiltrate,Stage IVB Lip Cancer AJCC v6 and v7
27459,Malignant Cellular Infiltrate,Stage I Oral Cavity Cancer AJCC v6 and v7
27460,Malignant Cellular Infiltrate,Stage IV Oral Cavity Cancer AJCC v6 and v7
27461,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v7
27462,Malignant Cellular Infiltrate,Major Salivary Gland Acinic Cell Carcinoma
27463,Malignant Cellular Infiltrate,sarcoma of oral cavity
27464,Malignant Cellular Infiltrate,Minor Salivary Gland Adenoid Cystic Carcinoma
27465,Malignant Cellular Infiltrate,Squamous cell carcinoma of the parotid gland
27466,Malignant Cellular Infiltrate,Minor Salivary Gland Carcinoma
27467,Malignant Cellular Infiltrate,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified"
27468,Malignant Cellular Infiltrate,Prolactin-Producing Pituitary Gland Carcinoma
27469,Malignant Cellular Infiltrate,Growth Hormone-Producing Pituitary Gland Carcinoma
27470,Malignant Cellular Infiltrate,TSH-Producing Pituitary Gland Carcinoma
27471,Benign Cellular Infiltrate,Otic polyp
27472,Malignant Cellular Infiltrate,Carcinoma of supraglottis
27473,Malignant Cellular Infiltrate,Major Salivary Gland Non-Hodgkin Lymphoma
27474,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7
27475,Malignant Cellular Infiltrate,Stage IVA Pharyngeal Carcinoma
27476,Malignant Cellular Infiltrate,Laryngeal Liposarcoma
27477,Benign Cellular Infiltrate,Subglottic Hemangioma
27478,Malignant Cellular Infiltrate,Secondary malignant neoplasm of larynx
27479,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8"
27480,Malignant Cellular Infiltrate,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
27481,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage IV
27482,Malignant Cellular Infiltrate,Rectal Small Cell Neuroendocrine Carcinoma
27483,Malignant Cellular Infiltrate,Rectal Medullary Carcinoma
27484,Malignant Cellular Infiltrate,Paranasal Sinus Lymphoma
27485,Malignant Cellular Infiltrate,carcinoma of eye
27486,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8"
27487,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
27488,Malignant Cellular Infiltrate,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation
27489,Malignant Cellular Infiltrate,Transitional cell carcinoma urethra
27490,Benign Cellular Infiltrate,Bladder Leiomyoma
27491,Malignant Cellular Infiltrate,Adult Kidney Wilms Tumor
27492,Malignant Cellular Infiltrate,Kidney Extraskeletal Osteosarcoma
27493,Malignant Cellular Infiltrate,Hard Palate Mucoepidermoid Carcinoma
27494,Malignant Cellular Infiltrate,Grade III Childhood Astrocytoma
27495,Malignant Cellular Infiltrate,Skin Nodular Basal Cell Carcinoma
27496,Malignant Cellular Infiltrate,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
27497,Malignant Cellular Infiltrate,Ethmoid Sinus Adenoid Cystic Carcinoma
27498,Benign Cellular Infiltrate,Hemangioma of orbit
27499,Malignant Cellular Infiltrate,Childhood Brain Anaplastic Astrocytoma
27500,Malignant Cellular Infiltrate,Fallopian Tube Adenocarcinoma
27501,Malignant Cellular Infiltrate,Stage IA Fallopian Tube Cancer AJCC v6 and v7
27502,Malignant Cellular Infiltrate,Stage IIA Fallopian Tube Cancer AJCC v6 and v7
27503,Malignant Cellular Infiltrate,germinoma of brain
27504,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma
27505,Malignant Cellular Infiltrate,Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and 7
27506,Malignant Cellular Infiltrate,Stage IIB Uterine Corpus Cancer AJCC v6
27507,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer
27508,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer
27509,Malignant Cellular Infiltrate,Stage IB2 Cervical Cancer
27510,Malignant Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v6 and v7
27511,Malignant Cellular Infiltrate,Leiomyosarcoma of uterus
27512,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma
27513,Malignant Cellular Infiltrate,Stage IS Testicular Cancer AJCC v6 and v7
27514,Malignant Cellular Infiltrate,Stage IIIA Testicular Cancer AJCC v6 and v7
27515,Malignant Cellular Infiltrate,Kaposi's sarcoma of penis
27516,Malignant Cellular Infiltrate,Vulvar adenocarcinoma
27517,Malignant Cellular Infiltrate,Malignant Bladder Paraganglioma
27518,Malignant Cellular Infiltrate,Recurrent Adrenal Cortex Carcinoma
27519,Well Differentiated Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1
27520,Malignant Cellular Infiltrate,choriocarcinoma of mediastinum
27521,Malignant Cellular Infiltrate,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor
27522,Malignant Cellular Infiltrate,Thymic Mucoepidermoid Carcinoma
27523,Malignant Cellular Infiltrate,Stage IIB Bone Sarcoma AJCC v7
27524,Malignant Cellular Infiltrate,Asynchronous Multifocal Osteosarcoma
27525,Benign Cellular Infiltrate,Dermal Fibroma
27526,Benign Cellular Infiltrate,Fibroma of tendon sheath
27527,Invasive Lesion,"Squamous cell carcinoma, microinvasive"
27528,Capsular Invasion,minimally invasive follicular carcinoma of the thyroid gland
27529,Malignant Cellular Infiltrate,Malignant Pericytic Neoplasm
27530,Malignant Cellular Infiltrate,Childhood Testicular Choriocarcinoma
27531,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Embryonal Carcinoma
27532,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Immature Teratoma
27533,Benign Cellular Infiltrate,Childhood Ovarian Mature Teratoma
27534,Benign Cellular Infiltrate,Schwannomatosis
27535,Malignant Cellular Infiltrate,Childhood Renal Cell Carcinoma
27536,Malignant Cellular Infiltrate,Childhood Osteosarcoma
27537,Malignant Cellular Infiltrate,Extrarenal rhabdoid tumor
27538,Benign Cellular Infiltrate,lipoma of mediastinum
27539,Malignant Cellular Infiltrate,Stage III Osteosarcoma AJCC v7
27540,Malignant Cellular Infiltrate,Recurrent Bone Ewing Sarcoma
27541,Malignant Cellular Infiltrate,Stage 2 Neuroblastoma
27542,Malignant Cellular Infiltrate,Stage IB Lung Large Cell Carcinoma AJCC v7
27543,Benign Cellular Infiltrate,Epithelioid cell nevus
27544,Malignant Cellular Infiltrate,Stage IIB Lung Small Cell Carcinoma AJCC v7
27545,Benign Cellular Infiltrate,Ossifying Renal Tumor of Infancy
27546,Malignant Cellular Infiltrate,Choriocarcinoma combined with other germ cell elements
27547,Benign Cellular Infiltrate,Sternal Chondromyxoid Fibroma
27548,Malignant Cellular Infiltrate,Stage IIA Esophageal Adenocarcinoma AJCC v7
27549,Malignant Cellular Infiltrate,Superior Vena Cava Leiomyosarcoma
27550,Malignant Cellular Infiltrate,Kaposi's sarcoma of palate
27551,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6
27552,Malignant Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma
27553,Malignant Cellular Infiltrate,Colon Small Cell Neuroendocrine Carcinoma
27554,Poorly Differentiated Neuroendocrine Lesion,Small cell carcinoma of esophagus
27555,Malignant Cellular Infiltrate,Small cell carcinoma of esophagus
27556,Malignant Cellular Infiltrate,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
27557,Malignant Cellular Infiltrate,Malignant neoplasm of skin of eyelid
27558,Malignant Cellular Infiltrate,Plantar Verrucous Skin Carcinoma
27559,Malignant Cellular Infiltrate,Anaplastic adrenocortical carcinoma
27560,Malignant Cellular Infiltrate,childhood nasal type extranodal NK/T-cell lymphoma
27561,Malignant Cellular Infiltrate,Adult Pure Erythroid Leukemia
27562,Malignant Cellular Infiltrate,Adult Erythroleukemia
27563,Malignant Cellular Infiltrate,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified"
27564,Malignant Cellular Infiltrate,mixed acinar-endocrine carcinoma of pancreas
27565,Malignant Cellular Infiltrate,Unfavorable Non-Hodgkin Lymphoma
27566,Malignant Cellular Infiltrate,Meningeal melanomatosis
27567,Benign Cellular Infiltrate,Cellular fibroma
27568,Malignant Cellular Infiltrate,Cystic Partially Differentiated Nephroblastoma
27569,Malignant Cellular Infiltrate,Chondroid chordoma
27570,Malignant Cellular Infiltrate,Rhabdoid meningioma
27571,Borderline Lesion,Recurrent Grade III Lymphomatoid Granulomatosis
27572,Malignant Cellular Infiltrate,Neuroblastic tumors
27573,Malignant Cellular Infiltrate,Intracranial Liposarcoma
27574,Malignant Cellular Infiltrate,Papillary Renal Cell Carcinoma
27575,Malignant Cellular Infiltrate,basaloid carcinoma of penis
27576,Malignant Cellular Infiltrate,Verrucous carcinoma of penis
27577,Malignant Cellular Infiltrate,Central Nervous System Leiomyosarcoma
27578,Malignant Cellular Infiltrate,Central Nervous System Yolk Sac Tumor
27579,Malignant Cellular Infiltrate,Trilateral Retinoblastoma
27580,Malignant Cellular Infiltrate,Paget Disease
27581,Malignant Cellular Infiltrate,Distal Bile Duct Carcinoma
27582,Malignant Cellular Infiltrate,Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm
27583,Malignant Cellular Infiltrate,Primary cutaneous lymphoma
27584,Malignant Cellular Infiltrate,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma
27585,Malignant Cellular Infiltrate,Refractory anemia with excess blasts II
27586,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma of central nervous system
27587,Malignant Cellular Infiltrate,Classical Burkitt Lymphoma
27588,Malignant Cellular Infiltrate,Burkitt Lymphoma with Plasmacytoid Differentiation
27589,Malignant Cellular Infiltrate,Hypopharyngeal Cancer
27590,Malignant Cellular Infiltrate,Grade 3b Follicular Lymphoma
27591,Malignant Cellular Infiltrate,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma
27592,Malignant Cellular Infiltrate,Childhood B Lymphoblastic Lymphoma
27593,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of small intestine
27594,Malignant Cellular Infiltrate,Methotrexate-Associated Burkitt Lymphoma
27595,Malignant Cellular Infiltrate,Diffuse follicle center lymphoma
27596,Malignant Cellular Infiltrate,Splenic Manifestation of Hairy Cell Leukemia
27597,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of spleen
27598,Malignant Cellular Infiltrate,Acute monocytic/monoblastic leukemia
27599,Malignant Cellular Infiltrate,Retroperitoneal Lymphoma
27600,Malignant Cellular Infiltrate,Gallbladder adenosquamous carcinoma
27601,Malignant Cellular Infiltrate,Scirrhous carcinoma of breast
27602,Invasive Lesion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
27603,Malignant Cellular Infiltrate,Hairy Cell Leukemia
27604,Malignant Cellular Infiltrate,Malignant neoplasm tonsil
27605,Malignant Cellular Infiltrate,Malignant tumor of exocrine pancreas
27606,Malignant Cellular Infiltrate,Anal canal squamous cell carcinoma
27607,Malignant Cellular Infiltrate,Anal Verrucous Carcinoma
27608,Malignant Cellular Infiltrate,Anal Adenocarcinoma within Anorectal Fistula
27609,Malignant Cellular Infiltrate,Secondary malignant neoplasm of esophagus
27610,Malignant Cellular Infiltrate,Cancer of Lip
27611,Malignant Cellular Infiltrate,Malignant tumor of nasal sinuses
27612,Malignant Cellular Infiltrate,Malignant neoplasm of urethra
27613,Malignant Cellular Infiltrate,Lymphoid leukemia
27614,Malignant Cellular Infiltrate,Retinoblastoma
27615,Malignant Cellular Infiltrate,Stage II Prostate Carcinoma
27616,Benign Cellular Infiltrate,Recurrent Nevus
27617,Malignant Cellular Infiltrate,liposarcoma of bone
27618,Malignant Cellular Infiltrate,Urethral cancer regional
27619,Malignant Cellular Infiltrate,Anterior Urethral Malignant Neoplasm
27620,Malignant Cellular Infiltrate,Inflammatory carcinoma of breast stage IV
27621,Malignant Cellular Infiltrate,Adult Liver Carcinoma
27622,Malignant Cellular Infiltrate,Small intestine carcinoma
27623,Malignant Cellular Infiltrate,Vaginal clear cell adenocarcinoma
27624,Malignant Cellular Infiltrate,Stage III Breast Cancer AJCC v6
27625,Malignant Cellular Infiltrate,Stage III Pancreatic Cancer AJCC v6 and v7
27626,Malignant Cellular Infiltrate,Adult Fibrosarcoma
27627,Malignant Cellular Infiltrate,Stage I Adult Soft Tissue Sarcoma AJCC v7
27628,Malignant Cellular Infiltrate,Stage III Kidney Wilms Tumor
27629,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v6 and v7
27630,Malignant Cellular Infiltrate,Vaginal cancer recurrent
27631,Well Differentiated Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Tumor G1
27632,Malignant Cellular Infiltrate,Mesothelioma malignant advanced
27633,Malignant Cellular Infiltrate,Prostate cancer recurrent
27634,Malignant Cellular Infiltrate,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant"
27635,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v6
27636,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v6
27637,Malignant Cellular Infiltrate,Invasive Lobular Breast Carcinoma
27638,Malignant Cellular Infiltrate,Adult Hepatocellular Carcinoma
27639,Malignant Cellular Infiltrate,Childhood Alveolar Rhabdomyosarcoma
27640,Malignant Cellular Infiltrate,Adult Acute Basophilic Leukemia
27641,Malignant Cellular Infiltrate,Childhood Acute Promyelocytic Leukemia with PML-RARA
27642,Malignant Cellular Infiltrate,adenocarcinoma of extrahepatic bile duct
27643,Malignant Cellular Infiltrate,Ovarian Clear Cell Cystadenocarcinoma
27644,Malignant Cellular Infiltrate,Necrotic intraocular melanoma
27645,Malignant Cellular Infiltrate,squamous cell carcinoma of salivary gland
27646,Malignant Cellular Infiltrate,"Thymoma, type B1, malignant"
27647,Malignant Cellular Infiltrate,"Thymoma, type B3"
27648,Malignant Cellular Infiltrate,Lymphoepithelial malignant thymoma
27649,Malignant Cellular Infiltrate,Primary Intestinal Follicular Lymphoma
27650,Malignant Cellular Infiltrate,Pediatric nodal marginal zone lymphoma
27651,Malignant Cellular Infiltrate,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities
27652,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
27653,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with hyperdiploidy
27654,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7
27655,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged
27656,Malignant Cellular Infiltrate,Stage I Laryngeal Cancer AJCC v6 and v7
27657,Malignant Cellular Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma
27658,Malignant Cellular Infiltrate,Chemotherapy-Related Leukemia
27659,Malignant Cellular Infiltrate,Stage I Adult Burkitt Lymphoma
27660,Malignant Cellular Infiltrate,Childhood Synovial Sarcoma
27661,Malignant Cellular Infiltrate,Childhood Epithelioid Sarcoma
27662,Malignant Cellular Infiltrate,Recurrent Adult Burkitt Lymphoma
27663,Malignant Cellular Infiltrate,Hard Palate Squamous Cell Carcinoma
27664,Malignant Cellular Infiltrate,Buccal Mucosa Verrucous Carcinoma
27665,Malignant Cellular Infiltrate,Supraglottic Verrucous Carcinoma
27666,Malignant Cellular Infiltrate,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
27667,Malignant Cellular Infiltrate,Verrucous carcinoma of the oral cavity recurrent
27668,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage III
27669,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage III
27670,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma recurrent
27671,Malignant Cellular Infiltrate,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT"
27672,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
27673,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx recurrent
27674,Malignant Cellular Infiltrate,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
27675,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage III
27676,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia recurrent
27677,Malignant Cellular Infiltrate,de novo Myelodysplastic Syndrome
27678,Malignant Cellular Infiltrate,Refractory cytopenia with unilineage dysplasia
27679,Malignant Cellular Infiltrate,Adult Cholangiocarcinoma
27680,Malignant Cellular Infiltrate,Adult Anaplastic Oligodendroglioma
27681,Benign Cellular Infiltrate,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin
27682,Malignant Cellular Infiltrate,Adult Pineoblastoma
27683,Malignant Cellular Infiltrate,Adenocarcinoma of pancreas
27684,Malignant Cellular Infiltrate,Duodenal Extraskeletal Osteosarcoma
27685,Malignant Cellular Infiltrate,Desmoplastic Small Round Cell Tumor
27686,Malignant Cellular Infiltrate,Lymphoma stage I
27687,Malignant Cellular Infiltrate,Carcinoma of lower gum
27688,Malignant Cellular Infiltrate,Carcinoma of soft palate
27689,Malignant Cellular Infiltrate,Malignant melanoma of breast
27690,Benign Cellular Infiltrate,Benign neoplasm of ear
27691,Malignant Cellular Infiltrate,Diffuse malignant mesothelioma
27692,Malignant Cellular Infiltrate,Invasive Malignant Neoplasm
27693,Malignant Cellular Infiltrate,Malignant Leptomeningeal Neoplasm
27694,Malignant Cellular Infiltrate,Stage IV Hodgkin Lymphoma
27695,Malignant Cellular Infiltrate,Secondary malignant neoplasm of chest wall
27696,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Placenta
27697,Malignant Cellular Infiltrate,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma
27698,Malignant Cellular Infiltrate,Infiltrating Cervical Carcinoma
27699,Malignant Cellular Infiltrate,Stage IA Breast Cancer AJCC v7
27700,Malignant Cellular Infiltrate,Stage 0 Merkel Cell Carcinoma AJCC v7
27701,Malignant Cellular Infiltrate,Stage IIIB Cutaneous Melanoma AJCC v7
27702,Malignant Cellular Infiltrate,Testicular choriocarcinoma stage II
27703,Malignant Cellular Infiltrate,Aggressive natural killer-cell leukemia
27704,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage III
27705,Malignant Cellular Infiltrate,Stage II Anaplastic Large Cell Lymphoma
27706,Malignant Cellular Infiltrate,Stage IV Anaplastic Large Cell Lymphoma
27707,Malignant Cellular Infiltrate,T-cell lymphoma stage II
27708,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage III
27709,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma refractory
27710,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage III
27711,Malignant Cellular Infiltrate,Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma
27712,Malignant Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v7
27713,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant advanced
27714,Malignant Cellular Infiltrate,Pleural mesothelioma malignant recurrent
27715,Malignant Cellular Infiltrate,Stage I Fallopian Tube Cancer
27716,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7
27717,Malignant Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7
27718,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7
27719,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7
27720,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage II
27721,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7
27722,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7
27723,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
27724,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage IV"
27725,Malignant Cellular Infiltrate,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7
27726,Malignant Cellular Infiltrate,Chondrosarcoma localised
27727,Malignant Cellular Infiltrate,Chondrosarcoma metastatic
27728,Malignant Cellular Infiltrate,Stage II Lentigo Maligna Melanoma AJCC v6 and v7
27729,Well Differentiated Neuroendocrine Lesion,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7
27730,Malignant Cellular Infiltrate,Stage II Intrahepatic Cholangiocarcinoma AJCC v7
27731,Malignant Cellular Infiltrate,Stage III Intrahepatic Cholangiocarcinoma AJCC v7
27732,Malignant Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v7
27733,Malignant Cellular Infiltrate,Stage II Hilar Cholangiocarcinoma AJCC v7
27734,Malignant Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v7
27735,Malignant Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v7
27736,Malignant Cellular Infiltrate,Stage 0 Distal Bile Duct Cancer AJCC v7
27737,Malignant Cellular Infiltrate,Stage III Distal Bile Duct Cancer AJCC v7
27738,Malignant Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v7
27739,Malignant Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v6 and v7
27740,Malignant Cellular Infiltrate,Stage IIIb Penile Cancer AJCC v7
27741,Malignant Cellular Infiltrate,Stage IIA Prostate Cancer AJCC v7
27742,Malignant Cellular Infiltrate,Stage IIIC Eyelid Carcinoma AJCC v7
27743,Malignant Cellular Infiltrate,Stage IIIC Uveal Melanoma AJCC v7
27744,Malignant Cellular Infiltrate,Ocular Adnexal Lymphoma
27745,Malignant Cellular Infiltrate,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7
27746,Malignant Cellular Infiltrate,Liposarcoma recurrent
27747,Malignant Cellular Infiltrate,Synovial sarcoma recurrent
27748,Malignant Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v7
27749,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma refractory
27750,Malignant Cellular Infiltrate,Stage III Diffuse Large B-Cell Lymphoma
27751,Malignant Cellular Infiltrate,Ann Arbor Stage II Follicular Lymphoma
27752,Malignant Cellular Infiltrate,Mantle cell lymphoma refractory
27753,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage IV
27754,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma recurrent
27755,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage III
27756,"Fully Differentiated ""Adult-Type"" Tissues Present",Extragonadal primary malignant teratoma
27757,Malignant Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma AJCC v7
27758,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v7
27759,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v7
27760,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage II
27761,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage III Immature Testicular Teratoma AJCC v6 and v7
27762,Malignant Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7
27763,Malignant Cellular Infiltrate,Stage II Prostate Cancer AJCC v7
27764,Malignant Cellular Infiltrate,Metastatic melanoma
27765,Malignant Cellular Infiltrate,Centroblastic lymphoma stage I
27766,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma metastatic
27767,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v7
27768,Malignant Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v7
27769,Malignant Cellular Infiltrate,Adenocarcinoma of the prostate stage IV
27770,Malignant Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v7
27771,Malignant Cellular Infiltrate,Stage II Uterine Corpus Cancer
27772,Malignant Cellular Infiltrate,Embryonal Rhabdomyosarcoma
27773,Malignant Cellular Infiltrate,Malignant Mixed Mesodermal (Mullerian) Tumor
27774,Malignant Cellular Infiltrate,Stage II Esophageal Cancer AJCC v7
27775,Malignant Cellular Infiltrate,Stage III Esophageal Cancer AJCC v7
27776,Malignant Cellular Infiltrate,Malignant mastocytosis
27777,Malignant Cellular Infiltrate,Stage III Colon Cancer AJCC v7
27778,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v7
27779,Malignant Cellular Infiltrate,"Acute myeloid leukemia, t(16;16)(p13;q22)"
27780,Malignant Cellular Infiltrate,Low Grade Malignant Peripheral Nerve Sheath Tumor
27781,Malignant Cellular Infiltrate,Cervix carcinoma
27782,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v6 Stage
27783,Malignant Cellular Infiltrate,Uterine Corpus Cancer by AJCC v6 Stage
27784,Malignant Cellular Infiltrate,Small cell lung cancer recurrent
27785,Malignant Cellular Infiltrate,Colon Cancer by AJCC v6 Stage
27786,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v6 Stage
27787,Malignant Cellular Infiltrate,Penile Cancer by AJCC v6 Stage
27788,Malignant Cellular Infiltrate,Bartholin's gland carcinoma
27789,Malignant Cellular Infiltrate,recurrent childhood acute myeloid leukemia
27790,Malignant Cellular Infiltrate,Kaposi Sarcoma
27791,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v7 Stage
27792,Malignant Cellular Infiltrate,Colon Cancer by AJCC v7 Stage
27793,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v7 Stage
27794,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v7 Stage
27795,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v7 Stage
27796,Malignant Cellular Infiltrate,Adult Nodular Sclerosis Classical Hodgkin Lymphoma
27797,Malignant Cellular Infiltrate,Osteosarcoma
27798,Malignant Cellular Infiltrate,Stromal Predominant Kidney Wilms Tumor
27799,Malignant Cellular Infiltrate,Diffuse Gastric Adenocarcinoma
27800,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia
27801,Malignant Cellular Infiltrate,Anal squamous cell carcinoma
27802,Malignant Cellular Infiltrate,Childhood Acute Monoblastic Leukemia
27803,Malignant Cellular Infiltrate,Gallbladder adenocarcinoma
27804,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma
27805,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma
27806,Malignant Cellular Infiltrate,Stage I Uterine Corpus Cancer AJCC v6
27807,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma
27808,Malignant Cellular Infiltrate,Hereditary Papillary Renal Carcinoma
27809,Malignant Cellular Infiltrate,Non-Hematologic Malignancy
27810,Malignant Cellular Infiltrate,Malignant tumor of colon
27811,Malignant Cellular Infiltrate,Recurrent Anaplastic Large Cell Lymphoma
27812,Malignant Cellular Infiltrate,Recurrent Non-Hodgkin Lymphoma
27813,Malignant Cellular Infiltrate,Oral neoplasm malignant recurrent
27814,Malignant Cellular Infiltrate,Recurrent Hepatocellular Carcinoma
27815,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx recurrent
27816,Malignant Cellular Infiltrate,Malignant neoplasm of floor of mouth
27817,Malignant Cellular Infiltrate,Maxillary Sinus Carcinoma
27818,Malignant Cellular Infiltrate,Malignant neoplasm of appendix
27819,Malignant Cellular Infiltrate,Peripheral T-cell lymphoma unspecified refractory
27820,Malignant Cellular Infiltrate,Precursor cell lymphoblastic lymphoma
27821,Malignant Cellular Infiltrate,Labia Majora Carcinoma
27822,Malignant Cellular Infiltrate,Labia Minora Carcinoma
27823,Malignant Cellular Infiltrate,Testis cancer recurrent
27824,Primary Lesion,Adult Brain Ependymoma
27825,Malignant Cellular Infiltrate,Well Differentiated Leiomyosarcoma
27826,Malignant Cellular Infiltrate,Kaposi Sarcoma NCI Grade 2
27827,Malignant Cellular Infiltrate,Kaposi Sarcoma NCI Grade 3
27828,Malignant Cellular Infiltrate,High Grade Sarcoma
27829,Malignant Cellular Infiltrate,AJCC Grade 3 Sarcoma
27830,Malignant Cellular Infiltrate,Grade 2 Rectal Adenocarcinoma
27831,Malignant Cellular Infiltrate,Grade 1 Colon Adenocarcinoma
27832,Malignant Cellular Infiltrate,Stage III Adult Liver Cancer AJCC v7
27833,Malignant Cellular Infiltrate,Stage IIIC Adult Liver Cancer AJCC v7
27834,Malignant Cellular Infiltrate,Hereditary Malignant Neoplasm
27835,Malignant Cellular Infiltrate,Ann Arbor Stage IV AIDS-Related Lymphoma
27836,Malignant Cellular Infiltrate,Thymoliposarcoma
27837,Malignant Cellular Infiltrate,Digestive System Neuroendocrine Carcinoma
27838,Benign Cellular Infiltrate,benign mature teratoma of pancreas
27839,Well Differentiated Neuroendocrine Lesion,Pancreatic Vipoma
27840,Malignant Cellular Infiltrate,Esophageal Poorly Differentiated Squamous Cell Carcinoma
27841,Malignant Cellular Infiltrate,Esophageal Neuroendocrine Carcinoma
27842,Malignant Cellular Infiltrate,Esophageal Large Cell Neuroendocrine Carcinoma
27843,Malignant Cellular Infiltrate,Gastric Large Cell Neuroendocrine Carcinoma
27844,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2
27845,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor
27846,Malignant Cellular Infiltrate,Colorectal Neuroendocrine Carcinoma
27847,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2
27848,Well Differentiated Neuroendocrine Lesion,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
27849,Malignant Cellular Infiltrate,Neuroendocrine carcinoma of appendix
27850,Malignant Cellular Infiltrate,Colorectal Cribriform Comedo-Type Adenocarcinoma
27851,Malignant Cellular Infiltrate,Colorectal Sarcomatoid Carcinoma
27852,Malignant Cellular Infiltrate,Ulcerative Colitis-Associated Colorectal Adenocarcinoma
27853,Malignant Cellular Infiltrate,Colorectal Hodgkin Lymphoma
27854,Malignant Cellular Infiltrate,Colorectal Leiomyosarcoma
27855,Poorly Differentiated Neuroendocrine Lesion,Anal Canal Small Cell Neuroendocrine Carcinoma
27856,Malignant Cellular Infiltrate,Anal Canal Small Cell Neuroendocrine Carcinoma
27857,Poorly Differentiated Neuroendocrine Lesion,Primary hepatic neuroendocrine carcinoma
27858,Malignant Cellular Infiltrate,Lymphoepithelioma-Like Hepatocellular Carcinoma
27859,Malignant Cellular Infiltrate,carcinosarcoma of gallbladder
27860,Well Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G1
27861,Malignant Cellular Infiltrate,Gallbladder Mixed Adenoneuroendocrine Carcinoma
27862,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor
27863,Malignant Cellular Infiltrate,Human Papillomavirus-Related Adenosquamous Carcinoma
27864,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Alveolar Variant"
27865,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
27866,Malignant Cellular Infiltrate,Stage 2A Neuroblastoma
27867,Malignant Primitive Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor
27868,Malignant Cellular Infiltrate,Classical Glioblastoma
27869,Malignant Cellular Infiltrate,Adult Undifferentiated Pleomorphic Sarcoma
27870,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma of central nervous system
27871,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma During Pregnancy
27872,Malignant Cellular Infiltrate,Childhood Pineoblastoma
27873,Malignant Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
27874,Malignant Cellular Infiltrate,Childhood Anaplastic Oligoastrocytoma
27875,Malignant Cellular Infiltrate,Adult Pleomorphic Hepatocellular Carcinoma
27876,Malignant Cellular Infiltrate,Stage IV Childhood Anaplastic Large Cell Lymphoma
27877,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7
27878,Malignant Cellular Infiltrate,Stage IIIB Rectal Cancer AJCC v7
27879,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v7
27880,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
27881,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
27882,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage I
27883,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage III
27884,Malignant Cellular Infiltrate,Recurrent Oropharyngeal Undifferentiated Carcinoma
27885,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Tumor G1
27886,Secondary Lesion,Metastatic Digestive System Neuroendocrine Tumor G1
27887,Malignant Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
27888,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome recurrent
27889,Malignant Cellular Infiltrate,Intestinal-Type Sinonasal Adenocarcinoma
27890,Malignant Cellular Infiltrate,Childhood Breast Carcinoma
27891,Malignant Cellular Infiltrate,Adult Salivary Gland Carcinoma
27892,Benign Cellular Infiltrate,"Myositis, Proliferative"
27893,Malignant Cellular Infiltrate,Sclerosing rhabdomyosarcoma
27894,Benign Cellular Infiltrate,Conventional Schwannoma
27895,Malignant Cellular Infiltrate,"Perivascular epithelioid tumor, malignant"
27896,Benign Cellular Infiltrate,Subungual exostoses
27897,Malignant Cellular Infiltrate,Primary Non-Hodgkin Lymphoma of Bone
27898,Malignant Cellular Infiltrate,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone
27899,Malignant Cellular Infiltrate,ROSE Cluster 4
27900,Malignant Cellular Infiltrate,ROSE Cluster 5
27901,Malignant Cellular Infiltrate,Infant Leukemia
27902,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia
27903,Malignant Cellular Infiltrate,"Childhood Ganglioneuroblastoma, Intermixed"
27904,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes
27905,Malignant Cellular Infiltrate,Small cell glioblastoma
27906,Malignant Cellular Infiltrate,Recurrent Glioblastoma
27907,Malignant Cellular Infiltrate,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma
27908,Malignant Cellular Infiltrate,Fallopian Tube Lymphoma
27909,Malignant Cellular Infiltrate,Head and neck cancer metastatic
27910,Malignant Cellular Infiltrate,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma
27911,Malignant Cellular Infiltrate,FIGO Stage IIIA1(ii) Ovarian Cancer
27912,Malignant Cellular Infiltrate,Ovarian Cancer by AJCC v6 and v7 Stage
27913,"Fully Differentiated ""Adult-Type"" Tissues Present",Vaginal Dermoid Cyst
27914,Malignant Cellular Infiltrate,Vulvar Merkel Cell Carcinoma
27915,Malignant Cellular Infiltrate,Vulvar Alveolar Rhabdomyosarcoma
27916,Malignant Cellular Infiltrate,"NK-Cell Lymphoma, Unclassifiable"
27917,Malignant Cellular Infiltrate,Anaplastic astrocytoma
27918,Malignant Cellular Infiltrate,Epithelioid glioblastoma
27919,Malignant Cellular Infiltrate,Anaplastic Oligodendroglioma
27920,Malignant Cellular Infiltrate,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
27921,Malignant Cellular Infiltrate,Central Nervous System Undifferentiated Pleomorphic Sarcoma
27922,Malignant Cellular Infiltrate,Unresectable Thyroid Gland Carcinoma
27923,Malignant Cellular Infiltrate,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like"
27924,Malignant Cellular Infiltrate,Advanced Head and Neck Carcinoma
27925,Secondary Lesion,Hormone refractory prostate cancer
27926,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides AJCC v7
27927,Primary Lesion,Temporal Lobe Ependymal Tumor
27928,Primary Lesion,Lateral Ventricle Ependymal Tumor
27929,Malignant Cellular Infiltrate,Burkitt-like lymphoma with 11q aberration
27930,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4
27931,Malignant Cellular Infiltrate,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
27932,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v8
27933,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage
27934,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v8 Stage
27935,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v8
27936,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma
27937,Malignant Cellular Infiltrate,Unresectable Osteosarcoma
27938,Malignant Cellular Infiltrate,Metastatic Malignant Germ Cell Tumor
27939,Secondary Lesion,Prostate Carcinoma Metastatic in the Soft Tissue
27940,Malignant Cellular Infiltrate,Stage III Hypopharyngeal Carcinoma AJCC v8
27941,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v8
27942,Malignant Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v8
27943,Malignant Cellular Infiltrate,AIDS-Related Anal Canal Carcinoma
27944,Malignant Cellular Infiltrate,Stage I Laryngeal Cancer AJCC v8
27945,Malignant Cellular Infiltrate,Stage IVA Laryngeal Cancer AJCC v8
27946,Malignant Cellular Infiltrate,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
27947,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v8 Stage
27948,Malignant Cellular Infiltrate,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8
27949,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
27950,Malignant Cellular Infiltrate,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
27951,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
27952,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
27953,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Central Nervous System
27954,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Central Nervous System
27955,Malignant Cellular Infiltrate,Melanoma Metastatic in the Central Nervous System
27956,Malignant Cellular Infiltrate,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
27957,Malignant Cellular Infiltrate,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
27958,Malignant Cellular Infiltrate,Recurrent Classic Hodgkin Lymphoma
27959,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Stage
27960,Malignant Cellular Infiltrate,Pathologic Stage 0 Gastric Cancer AJCC v8
27961,Malignant Cellular Infiltrate,Pathologic Stage III Gastric Cancer AJCC v8
27962,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
27963,Malignant Cellular Infiltrate,Stage I Anal Cancer AJCC v8
27964,Malignant Cellular Infiltrate,Stage III Anal Cancer AJCC v8
27965,Malignant Cellular Infiltrate,Stage IIA Small Intestinal Adenocarcinoma AJCC v8
27966,Malignant Cellular Infiltrate,Stage III Appendix Carcinoma AJCC v8
27967,Malignant Cellular Infiltrate,Refractory Neuroblastoma
27968,Malignant Cellular Infiltrate,Refractory Lymphoma
27969,Malignant Cellular Infiltrate,Stage IIIA Colorectal Cancer AJCC v8
27970,Malignant Cellular Infiltrate,Stage IVA Colorectal Cancer AJCC v8
27971,Malignant Cellular Infiltrate,Stage II Rectal Cancer AJCC v8
27972,Malignant Cellular Infiltrate,Stage IIC Rectal Cancer AJCC v8
27973,Malignant Cellular Infiltrate,Stage IVC Rectal Cancer AJCC v8
27974,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v8
27975,Malignant Cellular Infiltrate,Stage IIA Gallbladder Cancer AJCC v8
27976,Malignant Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v8
27977,Malignant Cellular Infiltrate,Stage IIIB Gallbladder Cancer AJCC v8
27978,Malignant Cellular Infiltrate,Stage IVB Gallbladder Cancer AJCC v8
27979,Malignant Cellular Infiltrate,Hilar Cholangiocarcinoma by AJCC v7 Stage
27980,Malignant Cellular Infiltrate,Stage I Hilar Cholangiocarcinoma AJCC v8
27981,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v8
27982,Malignant Cellular Infiltrate,Stage IVB Hilar Cholangiocarcinoma AJCC v8
27983,Malignant Cellular Infiltrate,Stage III Intrahepatic Cholangiocarcinoma AJCC v8
27984,Malignant Cellular Infiltrate,Pancreatic Cancer by AJCC v6 and v7 Stage
27985,Well Differentiated Neuroendocrine Lesion,Stage I Duodenal Neuroendocrine Tumor AJCC v8
27986,Well Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor
27987,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor by AJCC v8 Stage
27988,Well Differentiated Neuroendocrine Lesion,Stage I Jejunal Neuroendocrine Tumor AJCC v8
27989,Well Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor by AJCC v8 Stage
27990,Well Differentiated Neuroendocrine Lesion,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8
27991,Well Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Tumor
27992,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor by AJCC v8 Stage
27993,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colon Neuroendocrine Tumor AJCC v8
27994,Well Differentiated Neuroendocrine Lesion,Stage I Rectal Neuroendocrine Tumor AJCC v8
27995,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v8 Stage
27996,Malignant Cellular Infiltrate,Stage I Pleural Malignant Mesothelioma AJCC v8
27997,Malignant Cellular Infiltrate,Stage IIIA Pleural Malignant Mesothelioma AJCC v8
27998,Malignant Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v8
27999,Malignant Cellular Infiltrate,Stage IIB Lung Cancer AJCC v8
28000,Malignant Cellular Infiltrate,Stage IVA Lung Cancer AJCC v8
28001,Malignant Cellular Infiltrate,Lung Large Cell Carcinoma by AJCC v7 Stage
28002,Malignant Cellular Infiltrate,Bone Cancer by AJCC v8 Stage
28003,Malignant Cellular Infiltrate,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
28004,Malignant Cellular Infiltrate,Lung Non-Mucinous Adenocarcinoma In Situ
28005,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma In Situ
28006,Malignant Cellular Infiltrate,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage
28007,Malignant Cellular Infiltrate,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage"
28008,Malignant Cellular Infiltrate,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
28009,Malignant Cellular Infiltrate,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
28010,Malignant Cellular Infiltrate,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
28011,Malignant Cellular Infiltrate,Stage III Retroperitoneal Sarcoma AJCC v8
28012,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Clinical Stage
28013,Malignant Cellular Infiltrate,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8
28014,Malignant Cellular Infiltrate,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8
28015,Malignant Cellular Infiltrate,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8
28016,Malignant Cellular Infiltrate,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8
28017,Malignant Cellular Infiltrate,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
28018,Malignant Cellular Infiltrate,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8
28019,Malignant Cellular Infiltrate,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma
28020,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Pathologic Stage
28021,Malignant Cellular Infiltrate,Recurrent Central Nervous System Lymphoma
28022,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma
28023,Borderline Lesion,In situ mantle cell neoplasia
28024,Malignant Cellular Infiltrate,Plasma Cell Myeloma by DS Stage
28025,Malignant Cellular Infiltrate,Nodal peripheral T-cell lymphoma with T follicular helper phenotype
28026,Borderline Lesion,Type E Lymphomatoid Papulosis
28027,Borderline Lesion,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement
28028,Malignant Cellular Infiltrate,Anatomic Stage IB Breast Cancer AJCC v8
28029,Malignant Cellular Infiltrate,Anatomic Stage IIIC Breast Cancer AJCC v8
28030,Malignant Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v8
28031,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v8
28032,Malignant Cellular Infiltrate,Stage IV Vaginal Cancer AJCC v8
28033,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v8 Stage
28034,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer AJCC v8
28035,Malignant Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v8
28036,Malignant Cellular Infiltrate,Stage IIA2 Cervical Cancer AJCC v8
28037,Malignant Cellular Infiltrate,Stage IIIA Cervical Cancer AJCC v8
28038,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v8
28039,Malignant Cellular Infiltrate,Stage IIIC1 Uterine Corpus Cancer AJCC v8
28040,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v8
28041,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma by AJCC v8 Stage
28042,Malignant Cellular Infiltrate,Uterine Corpus Leiomyosarcoma by AJCC v8 Stage
28043,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8
28044,Malignant Cellular Infiltrate,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
28045,Malignant Cellular Infiltrate,Stage IC Uterine Corpus Adenosarcoma AJCC v8
28046,Malignant Cellular Infiltrate,Ovarian Cancer by AJCC v8 Stage
28047,Malignant Cellular Infiltrate,Stage IIB Ovarian Cancer AJCC v8
28048,Malignant Cellular Infiltrate,Stage IIIA1 Fallopian Tube Cancer AJCC v8
28049,Malignant Cellular Infiltrate,Stage IIIA2 Fallopian Tube Cancer AJCC v8
28050,Malignant Cellular Infiltrate,Stage IIA Primary Peritoneal Cancer AJCC v8
28051,Malignant Cellular Infiltrate,Stage IIB Primary Peritoneal Cancer AJCC v8
28052,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v8
28053,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v8
28054,Malignant Cellular Infiltrate,Stage IVA Prostate Cancer AJCC v8
28055,Malignant Cellular Infiltrate,Testicular Cancer by AJCC v8 Stage
28056,Malignant Cellular Infiltrate,Stage IS Testicular Cancer AJCC v8
28057,Malignant Cellular Infiltrate,Stage IIIA Testicular Cancer AJCC v8
28058,Malignant Cellular Infiltrate,Stage IIIB Testicular Cancer AJCC v8
28059,Malignant Cellular Infiltrate,Stage IIIC Testicular Cancer AJCC v8
28060,Malignant Cellular Infiltrate,Testicular Cancer by AJCC v6 and v7 Stage
28061,Malignant Cellular Infiltrate,Stage I Renal Cell Cancer AJCC v8
28062,Malignant Cellular Infiltrate,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
28063,Malignant Cellular Infiltrate,Stage 0is Ureter Cancer AJCC v8
28064,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v8
28065,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v8
28066,Malignant Cellular Infiltrate,Stage IIIB Bladder Cancer AJCC v8
28067,Malignant Cellular Infiltrate,Urethral Cancer by AJCC v8 Stage
28068,Malignant Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v8
28069,Malignant Cellular Infiltrate,Stage 0is Urethral Cancer AJCC v8
28070,Malignant Cellular Infiltrate,Stage I Urethral Cancer AJCC v8
28071,Malignant Cellular Infiltrate,Urethral Cancer by AJCC v7 Stage
28072,Malignant Cellular Infiltrate,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8
28073,Encapsulated Mass,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
28074,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage
28075,Encapsulated Mass,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
28076,Malignant Cellular Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage
28077,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
28078,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
28079,Malignant Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
28080,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
28081,Encapsulated Mass,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
28082,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
28083,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
28084,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Ann Arbor Stage
28085,Malignant Cellular Infiltrate,Hodgkin Lymphoma by Ann Arbor Stage
28086,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Adult Lymphoma AJCC v8
28087,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8
28088,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
28089,Malignant Cellular Infiltrate,Lugano Classification Stage III Hodgkin Lymphoma AJCC v8
28090,Malignant Cellular Infiltrate,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
28091,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8
28092,Malignant Cellular Infiltrate,Stage A Chronic Lymphocytic Leukemia
28093,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage
28094,Malignant Cellular Infiltrate,Mantle Cell Lymphoma by Ann Arbor Stage
28095,Malignant Cellular Infiltrate,Centroblastic Lymphoma by Ann Arbor Stage
28096,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
28097,Benign Cellular Infiltrate,Benign Lung PEComa
28098,Benign Cellular Infiltrate,Lung Myoepithelioma
28099,Malignant Cellular Infiltrate,Advanced Microsatellite Stable Colorectal Carcinoma
28100,Malignant Cellular Infiltrate,Skin squamous cell carcinoma metastatic
28101,Malignant Cellular Infiltrate,Mediastinal Epithelioid Hemangioendothelioma
28102,Malignant Cellular Infiltrate,Cardiac Yolk Sac Tumor
28103,Malignant Cellular Infiltrate,Pericardial Sarcoma
28104,Malignant Cellular Infiltrate,"Refractory Medulloblastoma, SHH-Activated"
28105,Malignant Cellular Infiltrate,Recurrent Grade 3a Follicular Lymphoma
28106,Malignant Cellular Infiltrate,Recurrent Sarcoma
28107,Malignant Cellular Infiltrate,Refractory Oral Cavity Squamous Cell Carcinoma
28108,Malignant Cellular Infiltrate,Recurrent Mixed Phenotype Acute Leukemia
28109,Malignant Cellular Infiltrate,Refractory Mixed Phenotype Acute Leukemia
28110,Malignant Cellular Infiltrate,Unresectable Intrahepatic Cholangiocarcinoma
28111,Malignant Cellular Infiltrate,Recurrent Human Papillomavirus-Related Malignant Neoplasm
28112,Malignant Cellular Infiltrate,Unresectable Melanoma
28113,Malignant Cellular Infiltrate,Cervical Esophagus Squamous Cell Carcinoma
28114,Malignant Cellular Infiltrate,Recurrent Chronic Myelomonocytic Leukemia
28115,Malignant Cellular Infiltrate,Refractory Chronic Myelomonocytic Leukemia
28116,Malignant Cellular Infiltrate,Refractory Uterine Corpus Carcinoma
28117,Malignant Cellular Infiltrate,Advanced Squamous Cell Carcinoma of the Oropharynx
28118,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage IV
28119,Malignant Cellular Infiltrate,Bilateral Synchronous Sporadic Renal Cell Carcinoma
28120,Malignant Cellular Infiltrate,Recurrent Malignant Female Reproductive System Neoplasm
28121,Malignant Cellular Infiltrate,Refractory Malignant Female Reproductive System Neoplasm
28122,Malignant Cellular Infiltrate,Refractory Malignant Mesothelioma
28123,Malignant Cellular Infiltrate,Metastatic Renal Cell Carcinoma
28124,Malignant Cellular Infiltrate,Unresectable Undifferentiated Pleomorphic Sarcoma
28125,Malignant Cellular Infiltrate,Unresectable Gastrointestinal Stromal Tumor
28126,Malignant Cellular Infiltrate,Refractory Metastatic Digestive System Carcinoma
28127,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction
28128,Malignant Cellular Infiltrate,Transformed Non-Hodgkin Lymphoma
28129,Malignant Cellular Infiltrate,"Sarcoma, metastatic"
28130,Malignant Cellular Infiltrate,Recurrent Malignant Head and Neck Neoplasm
28131,Malignant Cellular Infiltrate,Refractory Malignant Head and Neck Neoplasm
28132,Malignant Cellular Infiltrate,Metastatic Bone Sarcoma
28133,Malignant Cellular Infiltrate,Advanced Lymphoma
28134,Malignant Cellular Infiltrate,Unresectable Chordoma
28135,Malignant Cellular Infiltrate,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
28136,Malignant Cellular Infiltrate,Locally Advanced Unresectable Bone Sarcoma
28137,Malignant Cellular Infiltrate,Locally Advanced Unresectable Soft Tissue Sarcoma
28138,Malignant Cellular Infiltrate,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type"
28139,Malignant Cellular Infiltrate,Recurrent Invasive Ductal Breast Carcinoma
28140,Malignant Cellular Infiltrate,Recurrent Chromophobe Renal Cell Carcinoma
28141,Malignant Cellular Infiltrate,Recurrent Ovarian Adenocarcinoma
28142,Encapsulated Mass,Recurrent Thyroid Gland Follicular Carcinoma
28143,Malignant Cellular Infiltrate,Recurrent Thyroid Gland Follicular Carcinoma
28144,Malignant Cellular Infiltrate,Recurrent Skin Angiosarcoma
28145,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Squamous Cell Carcinoma
28146,Malignant Cellular Infiltrate,Refractory Malignant Brain Neoplasm
28147,Malignant Cellular Infiltrate,Refractory WHO Grade III Glioma
28148,MGMT Gene Promoter Methylation,MGMT-Methylated Glioblastoma
28149,Epithelial Component Present,Non-Functioning Corticotroph Adenoma
28150,Resectable Mass,Resectable Malignant Mesothelioma
28151,Unresectable Mass,Unresectable Malignant Mesothelioma
28152,Multihormonal Immunoreactivity Present,Monomorphous Plurihormonal Pituitary Gland Adenoma
28153,Multihormonal Immunoreactivity Present in Two or More Cell Types,Plurimorphous Plurihormonal Pituitary Gland Adenoma
28154,Epithelial Component Present,Pituitary Gland Double Adenomas
28155,Epithelial Component Present,Digestive System Large Cell Neuroendocrine Carcinoma
28156,Recurrent disease,Adenocarcinoma gastric recurrent
28157,High Mitotic Activity,Digestive System Small Cell Neuroendocrine Carcinoma
28158,Malignant Cellular Infiltrate,Pituitary Gland Blastoma
28159,Extensive Stage Lesion,Advanced Cutaneous Melanoma of the Extremity
28160,Recurrent disease,Recurrent Sarcoma of the Extremity
28161,Metastatic Lesion,Locally Advanced Unresectable Carcinoma
28162,Epithelial Component Present,Locally Advanced Unresectable Carcinoma
28163,Carcinomatous Component Present,Locally Advanced Unresectable Carcinoma
28164,Benign Cellular Infiltrate,Sellar Neurocytoma
28165,Lobulated Growth Pattern,Sellar Chondroid Chordoma
28166,Slow Growing Mass,Sellar Chondroid Chordoma
28167,Lobulated Growth Pattern,Sellar Dedifferentiated Chordoma
28168,Malignant Cellular Infiltrate,Sellar Dedifferentiated Chordoma
28169,Secondary Lesion,Metastatic Malignant Neoplasm in the Sellar Region
28170,Malignant Cellular Infiltrate,Sellar Germinoma
28171,Pseudoglandular Pattern,Sellar Embryonal Carcinoma
28172,Mixed Cellular Population,Recurrent Uterine Corpus Carcinosarcoma
28173,Epithelial Component Present,Recurrent Endometrial Mixed Cell Adenocarcinoma
28174,Malignant Cellular Infiltrate,Advanced Neuroendocrine Carcinoma
28175,Secondary Lesion,Advanced Neuroendocrine Carcinoma
28176,Malignant Cellular Infiltrate,Unresectable Lung Carcinoma
28177,Malignant Cellular Infiltrate,Unresectable Digestive System Carcinoma
28178,Secondary Lesion,Metastatic Lung Adenocarcinoma
28179,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Thoracic Cavity
28180,Metastatic Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma
28181,High Mitotic Activity,Metastatic Digestive System Neuroendocrine Carcinoma
28182,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Carcinoma
28183,Carcinomatous Component Present,Refractory Digestive System Neuroendocrine Carcinoma
28184,Neuroendocrine Differentiation,Recurrent Digestive System Neuroendocrine Carcinoma
28185,Primary Lesion,Medullary Hemangioblastoma
28186,Hereditary Lesion,Hereditary Malignant Urinary System Neoplasm
28187,Epithelial Component Present,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome
28188,Papillary Pattern,Broad Ligament Papillary Cystadenoma
28189,Benign Cellular Infiltrate,Epididymal Papillary Cystadenoma
28190,Black Discoloration,Thyroid Gland Black Follicular Adenoma
28191,Nodular lesions,Thyroid Gland Black Follicular Adenoma
28192,Follicular Structures Present,Thyroid Gland Black Follicular Adenoma
28193,Malignant Cellular Infiltrate,Recurrent Chordoma
28194,Slow Growing Mass,Recurrent Chordoma
28195,Borderline Lesion,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
28196,Follicular Cell Differentiation,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
28197,Diffuse Pattern,Frontal Lobe Anaplastic Astrocytoma
28198,Increased Cellularity Present,Frontal Lobe Anaplastic Astrocytoma
28199,Lymphoplasmacytic Infiltrate,Third Ventricle Germinoma
28200,Chronic lymphocytic inflammation,Supratentorial Pleomorphic Xanthoastrocytoma
28201,Chronic lymphocytic inflammation,Temporal Lobe Pleomorphic Xanthoastrocytoma
28202,Dense Intercellular Reticulin Network Present,Temporal Lobe Pleomorphic Xanthoastrocytoma
28203,Papillary Pattern,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
28204,Malignant Cellular Infiltrate,Metastatic Fallopian Tube Carcinoma
28205,Malignant Cellular Infiltrate,Metastatic Vaginal Carcinoma
28206,Secondary Lesion,Metastatic Vaginal Carcinoma
28207,Metastatic Lesion,stage IV pancreatic cancer
28208,Secondary Lesion,stage IV pancreatic cancer
28209,Epithelial Component Present,Metastatic Esophageal Carcinoma
28210,Keratin pearl formation,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
28211,Epithelial Component Present,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
28212,Secondary Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma
28213,Epithelial Component Present,Metastatic Oropharyngeal Carcinoma
28214,Malignant Cellular Infiltrate,Metastatic Lip and Oral Cavity Carcinoma
28215,Metastatic Lesion,Metastatic Oral Cavity Carcinoma
28216,Secondary Lesion,Metastatic Oral Cavity Carcinoma
28217,Epithelial Component Present,Metastatic Oral Cavity Adenoid Cystic Carcinoma
28218,Malignant Cellular Infiltrate,Metastatic Lung Adenosquamous Carcinoma
28219,High Grade Lesion,Metastatic Lung Small Cell Carcinoma
28220,Metastatic Lesion,Metastatic Colorectal Carcinoma
28221,Secondary Lesion,Metastatic Rectal Carcinoma
28222,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Follicular Carcinoma
28223,Metastatic Lesion,Metastatic Thyroid Gland Follicular Carcinoma
28224,Carcinomatous Component Present,Metastatic Thyroid Gland Follicular Carcinoma
28225,Metastatic Lesion,Metastatic Thyroid Gland Papillary Carcinoma
28226,Secondary Lesion,Metastatic Thyroid Gland Papillary Carcinoma
28227,Metastatic Lesion,Metastatic Neuroblastoma
28228,Increased Cellularity Present,Metastatic Neuroblastoma
28229,Neuroectodermal Differentiation,Metastatic Neuroblastoma
28230,CD4-Positive Neoplastic Cells Present,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
28231,CD56-Positive Neoplastic Cells Present,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
28232,Diffuse Pattern,Frontal Lobe Anaplastic Oligodendroglioma
28233,Local disease,Localized Gastroesophageal Junction Adenocarcinoma
28234,Malignant Cellular Infiltrate,Recurrent Aggressive Non-Hodgkin Lymphoma
28235,Recurrent disease,Recurrent Aggressive Non-Hodgkin Lymphoma
28236,Metastatic Lesion,Locally Advanced Pancreatic Adenocarcinoma
28237,Epithelial Component Present,Locally Advanced Pancreatic Adenocarcinoma
28238,Metastatic/Recurrent Disease,Tongue Alveolar Soft Part Sarcoma'
28239,Crystal deposition,Orbital Alveolar Soft Part Sarcoma
28240,Organoid Pattern,Bladder Alveolar Soft Part Sarcoma
28241,Extensive Stage Lesion,Advanced Prostate Carcinoma
28242,Epithelial Component Present,Locally Advanced Prostate Carcinoma
28243,Secondary Lesion,Advanced Prostate Adenocarcinoma
28244,Metastatic Lesion,Locally Advanced Prostate Adenocarcinoma
28245,Secondary Lesion,Locally Advanced Prostate Adenocarcinoma
28246,Malignant Cellular Infiltrate,Advanced Cervical Carcinoma
28247,Secondary Lesion,Advanced Cervical Carcinoma
28248,Carcinomatous Component Present,Advanced Cervical Carcinoma
28249,Secondary Lesion,Locally Advanced Cervical Carcinoma
28250,Epithelial Component Present,Locally Advanced Cervical Carcinoma
28251,Regional Disease,Locally Advanced Unresectable Cervical Carcinoma
28252,Carcinomatous Component Present,Advanced Cervical Adenocarcinoma
28253,Antoni A Pattern,Thyroid Gland Schwannoma
28254,Necrotic changes (finding),Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
28255,Vascular Channel Formation,Thyroid Gland Benign Vascular Neoplasm
28256,Alternative Fascicle (Bundle) Pattern,Thyroid Gland Leiomyoma
28257,Hyalinized Stroma Formation,Thyroid Gland Solitary Fibrous Tumor
28258,Thin Bands of Collagen Present,Thyroid Gland Solitary Fibrous Tumor
28259,Birbeck Granules Present,Thyroid Gland Langerhans Cell Histiocytosis
28260,Cervical lymphadenopathy,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy
28261,"Undifferentiated ""Fetal-Type"" Tissues Present",Grade 1 Teratoma
28262,Low Grade Lesion,Recurrent Low Grade Ovarian Serous Adenocarcinoma
28263,Epithelial Component Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma
28264,Epithelial Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
28265,Slow Growing Mass,Brain Ependymoma
28266,Extensive Stage Lesion,Advanced Kaposi Sarcoma
28267,Malignant Cellular Infiltrate,Genitourinary Cancer
28268,Neuroendocrine Differentiation,Metastatic Neuroendocrine Neoplasm
28269,Extensive Stage Lesion,Advanced Neuroendocrine Neoplasm
28270,Secondary Lesion,Pancreatic neuroendocrine tumor metastatic
28271,Extensive Stage Lesion,Advanced Gastric Neuroendocrine Carcinoma
28272,Poorly Differentiated Neuroendocrine Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma
28273,Secondary Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma
28274,Malignant Cellular Infiltrate,Advanced Gastric Small Cell Neuroendocrine Carcinoma
28275,Metastatic Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma
28276,Carcinomatous Component Present,Advanced Gastric Small Cell Neuroendocrine Carcinoma
28277,Severe cytologic atypia,Metastatic Small Intestinal Neuroendocrine Carcinoma
28278,Severe cytologic atypia,Advanced Small Intestinal Neuroendocrine Carcinoma
28279,Metastatic Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
28280,Benign Cellular Infiltrate,Benign Peritoneal and Retroperitoneal Neoplasm
28281,Malignant Cellular Infiltrate,Recurrent Acute Myelomonocytic Leukemia
28282,Recurrent disease,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A
28283,Ineffective hematopoiesis,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
28284,Metastatic Lesion,Advanced Digestive System Carcinoma
28285,Metastatic Lesion,Metastatic basal cell carcinoma
28286,Recurrent disease,Biochemically Recurrent Prostate Carcinoma
28287,Recurrent disease,Recurrent Biliary Tract Carcinoma
28288,Unresectable Mass,Metastatic Unresectable Basal Cell Carcinoma
28289,Carcinomatous Component Present,Metastatic Unresectable Basal Cell Carcinoma
28290,Epithelial Component Present,Locally Advanced Unresectable Basal Cell Carcinoma
28291,Immunosuppression-Related Post-Transplant Toxicity,Maternally Derived Graft Versus Host Disease
28292,Microvascular Proliferation,Resectable Pancreatic Acinar Cell Carcinoma
28293,Epithelial Component Present,Resectable Pancreatic Acinar Cell Carcinoma
28294,Carcinomatous Component Present,Resectable Digestive System Carcinoma
28295,Resectable Mass,Bile duct adenocarcinoma resectable
28296,Epithelial Component Present,Adrenal Cortex Sex Cord-Stromal Tumor
28297,Thick-Walled Hyalinized Vessels Present,Adrenal Gland Schwannoma
28298,Malignant Cellular Infiltrate,Adrenal Gland Lymphoma
28299,Hormone Receptor Positive,Hormone Receptor Positive Breast Carcinoma
28300,Carcinomatous Component Present,Refractory Hormone Receptor Positive Breast Carcinoma
28301,Malignant Cellular Infiltrate,Spindle cell squamous cell carcinoma
28302,Malignant Cellular Infiltrate,Histiocytic sarcoma
28303,Malignant Cellular Infiltrate,Childhood Clear Cell Sarcoma of Soft Parts
28304,Benign Cellular Infiltrate,Childhood Central Nervous System Mature Teratoma
28305,Malignant Cellular Infiltrate,Colon Mantle Cell Lymphoma
28306,Well Differentiated Neuroendocrine Lesion,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor
28307,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v6 and v7
28308,Malignant Cellular Infiltrate,Secondary Chondrosarcoma
28309,Benign Cellular Infiltrate,Conventional Lipoma
28310,Malignant Cellular Infiltrate,"Basal cell carcinoma, infundibulocystic"
28311,Malignant Cellular Infiltrate,Human Papillomavirus-Related Carcinoma
28312,Malignant Cellular Infiltrate,Hepatitis C Virus-Related Hepatocellular Carcinoma
28313,Malignant Cellular Infiltrate,Virus-Related Carcinoma
28314,Nuclear Grooves,Atypical follicular adenoma
28315,Malignant Cellular Infiltrate,Helicobacter Pylori-Related Non-Hodgkin Lymphoma
28316,Malignant Cellular Infiltrate,Parasite-Related Carcinoma
28317,Malignant Cellular Infiltrate,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma
28318,Malignant Cellular Infiltrate,Cigarette Smoking-Related Carcinoma
28319,Malignant Cellular Infiltrate,Metastatic Penile Cancer
28320,Malignant Cellular Infiltrate,Metastatic Kidney Carcinoma
28321,Malignant Cellular Infiltrate,Oxyphilic Endometrial Endometrioid Adenocarcinoma
28322,Malignant Cellular Infiltrate,Well Differentiated Prostate Adenocarcinoma
28323,Toxic effect,Solar Radiation-Related Cutaneous Melanoma
28324,Malignant Cellular Infiltrate,Squamous Cell Carcinoma In Situ of the Nipple
28325,Malignant Cellular Infiltrate,Refractory anemias
28326,Malignant Cellular Infiltrate,Burkitt Lymphoma
28327,Malignant Cellular Infiltrate,Chordoma
28328,Well Differentiated Neuroendocrine Lesion,Gastrinoma
28329,Benign Cellular Infiltrate,Fibroid Tumor
28330,Malignant Cellular Infiltrate,leiomyosarcoma
28331,Malignant Cellular Infiltrate,Acute Basophilic Leukemia
28332,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic-Phase"
28333,Malignant Cellular Infiltrate,Adult T-Cell Lymphoma/Leukemia
28334,Malignant Cellular Infiltrate,MYELODYSPLASTIC SYNDROME
28335,Malignant Cellular Infiltrate,Myxosarcoma
28336,Benign Cellular Infiltrate,Rhabdomyoma
28337,Well Differentiated Neuroendocrine Lesion,Somatostatinoma
28338,Malignant Cellular Infiltrate,synovial sarcoma
28339,Malignant Cellular Infiltrate,B-Cell Lymphomas
28340,Malignant Cellular Infiltrate,Malignant neoplasms of independent (primary) multiple sites
28341,Malignant Cellular Infiltrate,Granulomatous slack skin disease
28342,Malignant Cellular Infiltrate,Uterine Cancer
28343,Malignant Cellular Infiltrate,Malignant neoplasm of endocervix
28344,Malignant Cellular Infiltrate,Malignant neoplasm of brain
28345,Malignant Cellular Infiltrate,Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma
28346,Malignant Cellular Infiltrate,epithelial-myoepithelial carcinoma of salivary gland
28347,Malignant Cellular Infiltrate,"Cranial Nerve Neoplasms, Malignant"
28348,Malignant Cellular Infiltrate,Thymic Undifferentiated Carcinoma
28349,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7
28350,Benign Cellular Infiltrate,Metastasizing Pleomorphic Adenoma of the Salivary Gland
28351,Malignant Cellular Infiltrate,Pagetoid reticulosis
28352,Malignant Cellular Infiltrate,Parotid Gland Carcinosarcoma
28353,Malignant Cellular Infiltrate,Grade 1 Clear Cell Renal Cell Carcinoma
28354,Malignant Cellular Infiltrate,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone
28355,Malignant Cellular Infiltrate,Endemic African Kaposi Sarcoma
28356,Benign Cellular Infiltrate,Benign tumor of nasopharynx
28357,Benign Cellular Infiltrate,Benign neoplasm of larynx
28358,Malignant Cellular Infiltrate,High Grade Malignant Neoplasm
28359,Malignant Cellular Infiltrate,Undifferentiated Malignant Neoplasm
28360,Malignant Cellular Infiltrate,Well Differentiated Malignant Neoplasm
28361,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
28362,Malignant Cellular Infiltrate,Adult Botryoid-Type Embryonal Rhabdomyosarcoma
28363,Benign Cellular Infiltrate,Benign neoplasm of ureter
28364,Benign Cellular Infiltrate,Benign neoplasm of urethra
28365,Malignant Cellular Infiltrate,Hereditary clear cell renal cell carcinoma
28366,Benign Cellular Infiltrate,Benign neoplasm of adrenal gland
28367,Benign Cellular Infiltrate,benign neoplasm of lymph nodes
28368,Malignant Cellular Infiltrate,"Carcinoma, Granular Cell"
28369,Malignant Cellular Infiltrate,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive"
28370,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
28371,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation
28372,Malignant Cellular Infiltrate,Multicentric Thyroid Gland Papillary Carcinoma
28373,Malignant Cellular Infiltrate,Embryonal Carcinoma
28374,Malignant Cellular Infiltrate,Germinoma
28375,Benign Cellular Infiltrate,Adenomatoid Tumor
28376,Malignant Cellular Infiltrate,"Carcinoma, Signet Ring Cell"
28377,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Mucinous"
28378,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25)
28379,Malignant Cellular Infiltrate,Metachronous Wilms Tumor
28380,Benign Cellular Infiltrate,"Synovioma, benign"
28381,Malignant Cellular Infiltrate,Neonatal leukemia
28382,Malignant Cellular Infiltrate,Carcinoma of Male Breast
28383,Malignant Cellular Infiltrate,Composite Lymphoma
28384,Malignant Cellular Infiltrate,Fallopian Tube Carcinoma
28385,Malignant Cellular Infiltrate,mu-Chain Disease
28386,Malignant Cellular Infiltrate,Telangiectatic osteosarcoma
28387,Malignant Cellular Infiltrate,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant"
28388,Benign Cellular Infiltrate,Nephrogenic adenofibroma
28389,Malignant Cellular Infiltrate,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma
28390,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Giant Cells
28391,Malignant Cellular Infiltrate,Bladder Enteric Type Adenocarcinoma
28392,Malignant Cellular Infiltrate,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma
28393,Malignant Cellular Infiltrate,Urethral Verrucous Carcinoma
28394,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant"
28395,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant"
28396,Malignant Cellular Infiltrate,"Seminoma, anaplastic"
28397,Malignant Cellular Infiltrate,Spermatocytic seminoma
28398,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Myxomatous Pattern"
28399,Malignant Cellular Infiltrate,Testicular Monophasic Choriocarcinoma
28400,Malignant Cellular Infiltrate,Childhood Medulloblastoma
28401,Benign Cellular Infiltrate,Grade 1 Ovarian Teratoma
28402,Benign Cellular Infiltrate,Ovarian Fetiform Teratoma
28403,Malignant Cellular Infiltrate,Malignant Ovarian Clear Cell Tumor
28404,Malignant Cellular Infiltrate,Fallopian Tube Transitional Cell Carcinoma
28405,Malignant Cellular Infiltrate,Fallopian Tube Adenosarcoma
28406,Malignant Cellular Infiltrate,Endometrial Transitional Cell Carcinoma
28407,Borderline Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential
28408,Malignant Cellular Infiltrate,Cervical Non-Keratinizing Squamous Cell Carcinoma
28409,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type"
28410,Malignant Cellular Infiltrate,Cervical Alveolar Soft Part Sarcoma
28411,Malignant Cellular Infiltrate,Cervical Wilms Tumor
28412,Malignant Cellular Infiltrate,Vaginal Keratinizing Squamous Cell Carcinoma
28413,Malignant Cellular Infiltrate,Paget's disease of vulva
28414,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of vulva
28415,Malignant Cellular Infiltrate,Vulvar Warty Carcinoma
28416,Malignant Cellular Infiltrate,Vulvar Eccrine Porocarcinoma
28417,Malignant Cellular Infiltrate,Vulvar Alveolar Soft Part Sarcoma
28418,Benign Cellular Infiltrate,Vulvar Leiomyoma
28419,Malignant Cellular Infiltrate,Larynx carcinoma recurrent
28420,Malignant Cellular Infiltrate,Breast Carcinoma with Choriocarcinomatous Features
28421,Malignant Cellular Infiltrate,Breast Carcinoma with Melanotic Features
28422,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of breast
28423,Malignant Cellular Infiltrate,Sebaceous Breast Carcinoma
28424,Malignant Cellular Infiltrate,Burkitt's lymphoma of breast
28425,Malignant Cellular Infiltrate,Trabecular adenocarcinoma
28426,Malignant Cellular Infiltrate,Papillary squamous cell carcinoma
28427,Malignant Cellular Infiltrate,Acantholytic squamous cell carcinoma
28428,Malignant Cellular Infiltrate,Fibroepithelioma of Pinkus
28429,Malignant Cellular Infiltrate,Post polycythaemia vera myelofibrosis
28430,Malignant Cellular Infiltrate,Mucin-Producing Intrahepatic Cholangiocarcinoma
28431,Malignant Cellular Infiltrate,Sarcomatoid Intrahepatic Cholangiocarcinoma
28432,Malignant Cellular Infiltrate,Gliomatosis Cerebri Type I
28433,Malignant Cellular Infiltrate,Gliomatosis Cerebri Type II
28434,Malignant Cellular Infiltrate,Noninfiltrating intraductal papillary adenocarcinoma
28435,Malignant Cellular Infiltrate,Differentiating Neuroblastoma
28436,Malignant Cellular Infiltrate,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor"
28437,Malignant Cellular Infiltrate,Malignant Fibrous Histiocytoma
28438,Benign Cellular Infiltrate,Fibromyxolipoma
28439,Benign Cellular Infiltrate,Cellular leiomyoma
28440,Malignant Cellular Infiltrate,Pleomorphic Rhabdomyosarcoma
28441,Malignant Cellular Infiltrate,Malignant Cystosarcoma Phyllodes
28442,Malignant Cellular Infiltrate,"Synovial sarcoma, biphasic"
28443,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor
28444,Malignant Cellular Infiltrate,Ameloblastic fibrosarcoma
28445,Malignant Cellular Infiltrate,"Pancreatic carcinoma, familial"
28446,Benign Cellular Infiltrate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm
28447,Benign Cellular Infiltrate,Piloleiomyoma
28448,Malignant Cellular Infiltrate,Ductal Eccrine Carcinoma with Spindle Cell Elements
28449,Malignant Cellular Infiltrate,Small Intestinal Squamous Cell Carcinoma
28450,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of appendix
28451,Malignant Cellular Infiltrate,Appendix Mixed Adenoneuroendocrine Carcinoma
28452,Malignant Cellular Infiltrate,Malignant melanoma of eyelid
28453,Malignant Cellular Infiltrate,Rectosigmoid Adenocarcinoma
28454,Malignant Cellular Infiltrate,Colorectal Mucinous Adenocarcinoma
28455,Benign Cellular Infiltrate,"Lipomatosis, Multiple Symmetrical"
28456,Malignant Cellular Infiltrate,Malignant Adrenal Medulla Neoplasm
28457,Malignant Cellular Infiltrate,Cholangiocarcinoma
28458,Malignant Cellular Infiltrate,Carcinoma in situ of ampulla of Vater
28459,Malignant Cellular Infiltrate,"Lung Large Cell Carcinoma, Clear Cell Variant"
28460,Benign Cellular Infiltrate,Benign neoplasm of lung
28461,Malignant Cellular Infiltrate,Adenoid cystic eccrine carcinoma
28462,Benign Cellular Infiltrate,Tufted angioma of skin
28463,Benign Cellular Infiltrate,Benign neoplasm of mesothelial tissue of pleura
28464,Malignant Cellular Infiltrate,Malignant Lipomatous Neoplasm
28465,Malignant Cellular Infiltrate,Undifferentiated carcinoma of ovary
28466,Malignant Cellular Infiltrate,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma
28467,Benign Cellular Infiltrate,Intravenous leiomyomatosis
28468,Malignant Cellular Infiltrate,Primary Cutaneous Plasmablastic Lymphoma
28469,Malignant Cellular Infiltrate,Cutaneous Precursor Lymphoid Neoplasm
28470,Malignant Cellular Infiltrate,Cutaneous Mature B-Cell Neoplasm
28471,Malignant Cellular Infiltrate,Cutaneous Chronic Lymphocytic Leukemia
28472,Malignant Cellular Infiltrate,Cutaneous Adult T-Cell Leukemia/Lymphoma
28473,Benign Cellular Infiltrate,Ureteric polyp
28474,Malignant Cellular Infiltrate,Stage 0is Urethral Cancer AJCC v7
28475,Malignant Cellular Infiltrate,Malignant tumor of choroid plexus
28476,Malignant Cellular Infiltrate,Primary cutaneous gamma-delta T-cell lymphoma
28477,Malignant Cellular Infiltrate,Malignant neoplasm of acoustic nerve
28478,Malignant Cellular Infiltrate,Squamous cell carcinoma of cornea
28479,Malignant Cellular Infiltrate,Corneal Melanoma
28480,Malignant Cellular Infiltrate,Sarcomatoid Mesothelioma
28481,Malignant Cellular Infiltrate,Pyothorax-Associated Lymphoma
28482,Malignant Cellular Infiltrate,Pleural Synovial Sarcoma
28483,Malignant Cellular Infiltrate,Pleural Biphasic Synovial Sarcoma
28484,Malignant Cellular Infiltrate,Malignant tumor of endocardium
28485,Malignant Cellular Infiltrate,Mediastinal T Lymphoblastic Lymphoma
28486,Intermediate Grade Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2
28487,Malignant Cellular Infiltrate,Secondary malignant neoplasm of spinal cord
28488,Well Differentiated Neuroendocrine Lesion,Gastric Carcinoid Tumor
28489,Well Differentiated Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor
28490,Malignant Cellular Infiltrate,Squamous cell carcinoma of scrotum
28491,Benign Cellular Infiltrate,Trigeminal schwannoma
28492,Malignant Cellular Infiltrate,Spindle cell squamous cell carcinoma
28493,Malignant Cellular Infiltrate,Sarcoma of breast
28494,Benign Cellular Infiltrate,Cellular Schwannoma
28495,Benign Cellular Infiltrate,Spindle cell hemangioma
28496,Malignant Cellular Infiltrate,Malignant neoplasm of abdominal part of esophagus
28497,Benign Cellular Infiltrate,Benign neurologic neoplasms
28498,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v6 and v7
28499,Malignant Cellular Infiltrate,Minimal Deviation Melanoma
28500,Malignant Cellular Infiltrate,Malignant neoplasm of muscle
28501,Malignant Cellular Infiltrate,Colon Carcinoma
28502,Benign Cellular Infiltrate,Cavernous Angioleiomyoma
28503,Malignant Cellular Infiltrate,Carcinoma of bladder
28504,Malignant Cellular Infiltrate,Pyriform Fossa Squamous Cell Carcinoma
28505,Malignant Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant"
28506,Malignant Cellular Infiltrate,"Cancer, Supratentorial"
28507,Malignant Cellular Infiltrate,Adult Acute Lymphocytic Leukemia
28508,Malignant Cellular Infiltrate,Environment-Related Malignant Neoplasm
28509,Malignant Cellular Infiltrate,Pancreatic carcinoma non-resectable
28510,Malignant Cellular Infiltrate,sarcoma of extrahepatic bile duct
28511,Malignant Cellular Infiltrate,Fibrosarcoma non-metastatic
28512,Malignant Cellular Infiltrate,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
28513,Malignant Cellular Infiltrate,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
28514,Malignant Cellular Infiltrate,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
28515,Malignant Cellular Infiltrate,Stage IV Burkitt Lymphoma
28516,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage III
28517,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II supradiaphragmatic
28518,Malignant Cellular Infiltrate,Hereditary Leiomyomatosis and Renal Cell Cancer
28519,Malignant Cellular Infiltrate,Intraductal Non-Comedo Breast Adenocarcinoma
28520,Malignant Cellular Infiltrate,Malignant Breast Adenomyoepithelioma
28521,Benign Cellular Infiltrate,Spinal Cord Neurofibroma
28522,Malignant Cellular Infiltrate,Cerebral Glioblastoma
28523,Malignant Cellular Infiltrate,Metaplastic carcinoma of breast
28524,Malignant Cellular Infiltrate,liposarcoma of breast
28525,Malignant Cellular Infiltrate,Breast Extraskeletal Osteosarcoma
28526,Malignant Cellular Infiltrate,Malignant nipple neoplasm
28527,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer
28528,Malignant Cellular Infiltrate,fibrosarcoma of ovary
28529,Malignant Cellular Infiltrate,Mucinous adenocarcinoma gastric
28530,Malignant Cellular Infiltrate,Thyroid Lymphoma
28531,Malignant Cellular Infiltrate,Adult Meningeal Melanoma
28532,Benign Cellular Infiltrate,Microcystic/Reticular Schwannoma
28533,Well Differentiated Neuroendocrine Lesion,Intestinal Gangliocytic Paraganglioma
28534,Malignant Cellular Infiltrate,Advanced Unfavorable Non-Hodgkin Lymphoma
28535,Malignant Cellular Infiltrate,Luminal A Breast Carcinoma
28536,Benign Cellular Infiltrate,Cellular Myxoma
28537,Malignant Cellular Infiltrate,Cardiac Epithelioid Hemangioendothelioma
28538,Malignant Cellular Infiltrate,Malignant Pulmonary Vein Neoplasm
28539,Benign Cellular Infiltrate,Benign Atrial Neoplasm
28540,Benign Cellular Infiltrate,benign fibrous histiocytoma of bone
28541,Malignant Cellular Infiltrate,primitive neuroectodermal tumor (PNET) of spinal cord
28542,Malignant Cellular Infiltrate,Medulloblastoma with extensive nodularity
28543,Malignant Cellular Infiltrate,Central Nervous System T-Cell Non-Hodgkin Lymphoma
28544,Benign Cellular Infiltrate,Cerebellopontine Angle Schwannoma
28545,Benign Cellular Infiltrate,Pleural Schwannoma
28546,Malignant Cellular Infiltrate,Clivus Chondroid Chordoma
28547,Malignant Cellular Infiltrate,Ear carcinoma
28548,Malignant Cellular Infiltrate,Schneiderian carcinoma
28549,Malignant Cellular Infiltrate,Sinonasal undifferentiated carcinoma
28550,Malignant Cellular Infiltrate,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral"
28551,Benign Cellular Infiltrate,Schwannoma of the Twelfth Cranial Nerve
28552,Malignant Cellular Infiltrate,Nasopharyngeal Papillary Adenocarcinoma
28553,Malignant Cellular Infiltrate,Intracranial Melanoma
28554,Malignant Cellular Infiltrate,Childhood Anaplastic Oligodendroglioma
28555,Malignant Cellular Infiltrate,Stage IIB Breast Carcinoma
28556,Malignant Cellular Infiltrate,Signet Ring Melanoma
28557,Malignant Cellular Infiltrate,Basal cell carcinoma - keratotic
28558,Malignant Cellular Infiltrate,Stage IA Gastric Carcinoma
28559,Malignant Cellular Infiltrate,Stage IIIB Gastric Carcinoma
28560,Malignant Cellular Infiltrate,Gastric Adenosquamous Carcinoma
28561,Malignant Cellular Infiltrate,Appendix Lymphoma
28562,Malignant Cellular Infiltrate,Cecum Lymphoma
28563,Malignant Cellular Infiltrate,Prostate Leiomyosarcoma
28564,Malignant Cellular Infiltrate,Prostate Angiosarcoma
28565,Malignant Cellular Infiltrate,Prostate Lymphoma
28566,Malignant Cellular Infiltrate,Prostate Adenosquamous Carcinoma
28567,Malignant Cellular Infiltrate,sarcoma of rectum
28568,Malignant Cellular Infiltrate,Rectal Lymphoma
28569,Malignant Cellular Infiltrate,Eccrine porocarcinoma
28570,Malignant Cellular Infiltrate,Sarcoma of skin
28571,Malignant Cellular Infiltrate,Paget Disease of the Anus
28572,Malignant Cellular Infiltrate,Aleukemic Monocytic Leukemia Cutis
28573,Malignant Cellular Infiltrate,Ann Arbor Stage IVB Hodgkin Lymphoma
28574,Malignant Cellular Infiltrate,Lung Acinar Adenocarcinoma
28575,Malignant Cellular Infiltrate,Papillary Lung Adenocarcinoma
28576,Malignant Cellular Infiltrate,Stage IA Lung Non-Small Cell Carcinoma AJCC v7
28577,Malignant Cellular Infiltrate,Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
28578,Malignant Cellular Infiltrate,leiomyosarcoma of lung
28579,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of lung
28580,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma of lung
28581,Malignant Cellular Infiltrate,Esophageal Liposarcoma
28582,Malignant Cellular Infiltrate,signet ring cell carcinoma of pancreas
28583,Malignant Cellular Infiltrate,Invasive intraductal papillary-mucinous carcinoma of pancreas
28584,Malignant Cellular Infiltrate,Gallbladder Lymphoma
28585,Malignant Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v6
28586,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v6 and v7
28587,Malignant Cellular Infiltrate,Stage IIIB Hepatocellular Carcinoma AJCC v7
28588,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v7
28589,Malignant Cellular Infiltrate,Adenosquamous Bile Duct Carcinoma
28590,Malignant Cellular Infiltrate,Small intestine carcinoma stage IV
28591,Malignant Cellular Infiltrate,"Intracranial Embryonal Tumor, Not Otherwise Specified"
28592,Malignant Cellular Infiltrate,rhabdomyosarcoma of liver
28593,Malignant Cellular Infiltrate,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type"
28594,Malignant Cellular Infiltrate,leiomyosarcoma of extrahepatic bile duct
28595,Malignant Cellular Infiltrate,rhabdomyosarcoma of extrahepatic bile duct
28596,Malignant Cellular Infiltrate,Stage IVA Basal Cell Lip Carcinoma
28597,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of salivary gland
28598,Malignant Cellular Infiltrate,adenocarcinoma of oral cavity
28599,Malignant Cellular Infiltrate,Oral Cavity Mucosal Melanoma
28600,Malignant Cellular Infiltrate,Stage IIIB Anal Canal Cancer AJCC v6 and v7
28601,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of parotid gland
28602,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of submandibular gland
28603,Malignant Cellular Infiltrate,Malignant Parotid Gland Mixed Tumor
28604,Malignant Cellular Infiltrate,Parotid Gland Undifferentiated Carcinoma
28605,Malignant Cellular Infiltrate,Parotid Gland Non-Hodgkin Lymphoma
28606,Malignant Cellular Infiltrate,Minor Salivary Gland Mucoepidermoid Carcinoma
28607,Malignant Cellular Infiltrate,Sublingual Gland Adenocarcinoma
28608,Malignant Cellular Infiltrate,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma
28609,Malignant Cellular Infiltrate,cystadenocarcinoma of salivary gland
28610,Malignant Cellular Infiltrate,Stage IVC Oropharyngeal Carcinoma AJCC v7
28611,Malignant Cellular Infiltrate,Stage IVA Hypopharyngeal Carcinoma AJCC v7
28612,Malignant Cellular Infiltrate,Stage IVB Pharyngeal Carcinoma
28613,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of accessory sinus
28614,Benign Cellular Infiltrate,Laryngeal Leiomyoma
28615,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to oropharynx
28616,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to nasopharynx
28617,Malignant Cellular Infiltrate,Thyroid Sarcoma
28618,Malignant Cellular Infiltrate,Thyroid Diffuse Large B-Cell Lymphoma
28619,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
28620,Poorly Differentiated Neuroendocrine Lesion,Rectal Small Cell Neuroendocrine Carcinoma
28621,Malignant Cellular Infiltrate,Stage IVA Paranasal Sinus Cancer AJCC v7
28622,Malignant Cellular Infiltrate,Stage IVB Paranasal Sinus Cancer AJCC v7
28623,Malignant Cellular Infiltrate,Stage IVC Paranasal Sinus Cancer AJCC v7
28624,Malignant Cellular Infiltrate,Blepharal carcinoma
28625,Malignant Cellular Infiltrate,External Ear Squamous Cell Carcinoma
28626,Malignant Cellular Infiltrate,Choroid Epithelioid Cell Melanoma
28627,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Iris
28628,Malignant Cellular Infiltrate,Intermediate Cell Type Ciliary Body Melanoma
28629,Malignant Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v7
28630,Malignant Cellular Infiltrate,Testicular Typical Seminoma
28631,Malignant Cellular Infiltrate,Stage IV Renal Pelvis Cancer AJCC v7
28632,Malignant Cellular Infiltrate,papillary carcinoma of renal pelvis
28633,Malignant Cellular Infiltrate,Uterine Corpus Cancer
28634,Malignant Cellular Infiltrate,Bladder Lymphoma
28635,Malignant Cellular Infiltrate,undifferentiated carcinoma of urethra
28636,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage I
28637,Malignant Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v7
28638,Malignant Cellular Infiltrate,Stage III Urethral Cancer AJCC v7
28639,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v7
28640,Malignant Cellular Infiltrate,Hard Palate Adenoid Cystic Carcinoma
28641,Malignant Cellular Infiltrate,Salivary Gland Oncocytic Carcinoma
28642,Malignant Cellular Infiltrate,Tracheal Lymphoma
28643,Malignant Cellular Infiltrate,Malignant Ovarian Luteinized Thecoma
28644,Malignant Cellular Infiltrate,Fallopian Tube Papillary Adenocarcinoma
28645,Malignant Cellular Infiltrate,Stage IIIB Fallopian Tube Cancer AJCC v7
28646,Malignant Cellular Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v6 and v7
28647,Malignant Cellular Infiltrate,Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7
28648,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v7
28649,Malignant Cellular Infiltrate,Stage IB Cervical Cancer AJCC v6 and v7
28650,Malignant Cellular Infiltrate,Stage IA Vulvar Carcinoma AJCC v6
28651,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vagina
28652,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma
28653,Malignant Cellular Infiltrate,Stage IA Testicular Cancer AJCC v6 and v7
28654,Malignant Cellular Infiltrate,Stage IIC Testicular Cancer AJCC v6 and v7
28655,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the duodenum
28656,Low Grade Neuroendocrine Lesion,Carcinoid tumor of the duodenum
28657,Low Grade Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1
28658,Malignant Cellular Infiltrate,Metastatic carcinoid tumor
28659,Benign Cellular Infiltrate,Benign Mediastinal Germ Cell Tumor
28660,Benign Cellular Infiltrate,Benign germ cell neoplasm
28661,Malignant Cellular Infiltrate,Thymic Squamous Cell Carcinoma
28662,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of thymus
28663,Malignant Cellular Infiltrate,Dedifferentiated chondrosarcoma
28664,Malignant Cellular Infiltrate,hemangioendothelial sarcoma of bone
28665,Benign Cellular Infiltrate,Deep Lipoma
28666,Benign Cellular Infiltrate,Diffuse Lipomatosis
28667,Malignant Cellular Infiltrate,Malignant Smooth Muscle Neoplasm
28668,Benign Cellular Infiltrate,Intermediate Rhabdomyoma
28669,Tumor Vascular Invasion,Malignant Pancreatic Insulinoma
28670,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma AJCC v7
28671,Malignant Cellular Infiltrate,Stage II Soft Tissue Sarcoma AJCC v7
28672,Benign Cellular Infiltrate,Palisaded Lymph Node Myofibroblastoma
28673,Benign Cellular Infiltrate,Benign Soft Tissue Tumor of Uncertain Differentiation
28674,Malignant Cellular Infiltrate,Stage IB Osteosarcoma AJCC v7
28675,Malignant Cellular Infiltrate,Disseminated neuroblastoma
28676,Malignant Cellular Infiltrate,Stage IIIA Lung Large Cell Carcinoma AJCC v7
28677,Benign Cellular Infiltrate,Periosteal fibroma
28678,Benign Cellular Infiltrate,Hemolymphangioma
28679,Malignant Cellular Infiltrate,"Retinoblastoma, diffuse"
28680,Malignant Cellular Infiltrate,Stage IA Lung Squamous Cell Carcinoma AJCC v7
28681,Malignant Cellular Infiltrate,Stage IIA Lung Squamous Cell Carcinoma AJCC v7
28682,Malignant Cellular Infiltrate,Stage IB Lung Squamous Cell Carcinoma AJCC v7
28683,Malignant Cellular Infiltrate,"Hodgkin lymphoma, nodular sclerosis, cellular phase"
28684,Malignant Cellular Infiltrate,Peripheral Primitive Neuroectodermal Tumor of the Kidney
28685,Malignant Cellular Infiltrate,Chest Wall Hodgkin Lymphoma
28686,Malignant Cellular Infiltrate,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7
28687,Benign Cellular Infiltrate,Benign Glomus Tumor
28688,Benign Cellular Infiltrate,Pineal Region Mature Teratoma
28689,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
28690,Malignant Cellular Infiltrate,small cell carcinoma of breast
28691,Poorly Differentiated Neuroendocrine Lesion,Colon Small Cell Neuroendocrine Carcinoma
28692,Malignant Cellular Infiltrate,Gastric Small Cell Carcinoma
28693,Malignant Cellular Infiltrate,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
28694,Malignant Cellular Infiltrate,Malignant Apocrine Neoplasm
28695,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of lacrimal gland
28696,Malignant Cellular Infiltrate,Endometrioid carcinoma of prostate
28697,Malignant Cellular Infiltrate,adenocarcinoma of middle ear
28698,Malignant Cellular Infiltrate,Low Grade Paranasal Sinus Sarcoma
28699,Malignant Cellular Infiltrate,Kadish Stage B Olfactory Neuroblastoma
28700,Malignant Cellular Infiltrate,Primary Cutaneous Anaplastic Large Cell Lymphoma
28701,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
28702,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11
28703,Malignant Cellular Infiltrate,Adult Gliosarcoma
28704,Malignant Cellular Infiltrate,Adult Giant Cell Glioblastoma
28705,Malignant Cellular Infiltrate,Large cell medulloblastoma
28706,Malignant Cellular Infiltrate,Atypical Teratoid Rhabdoid Tumor
28707,Malignant Cellular Infiltrate,Subcutaneous panniculitis-like T-cell lymphoma
28708,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Anal Margin
28709,Malignant Cellular Infiltrate,Stromal sarcoma
28710,Malignant Cellular Infiltrate,Anaplastic Oligoastrocytoma
28711,Malignant Cellular Infiltrate,"Supratentorial Embryonal Tumor, Not Otherwise Specified"
28712,Malignant Cellular Infiltrate,Central Nervous System Extraskeletal Osteosarcoma
28713,Malignant Cellular Infiltrate,Central Nervous System Kaposi Sarcoma
28714,Malignant Cellular Infiltrate,Central Nervous System Choriocarcinoma
28715,Malignant Cellular Infiltrate,Plasma cell myeloma refractory
28716,Malignant Cellular Infiltrate,Mature B-Cell Non-Hodgkin Lymphoma
28717,Malignant Cellular Infiltrate,ISS Stage I Plasma Cell Myeloma
28718,Malignant Cellular Infiltrate,Leiomyosarcoma of small intestine
28719,Malignant Cellular Infiltrate,Gastrointestinal melanoma
28720,Malignant Cellular Infiltrate,Mixed epithelial-mesenchymal hepatoblastoma
28721,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Colon
28722,Malignant Cellular Infiltrate,Bone Surface (Peripheral) Osteosarcoma
28723,Malignant Cellular Infiltrate,Postsurgical Stage II Hepatoblastoma
28724,Malignant Cellular Infiltrate,Erythroleukemia (Erythroid/Myeloid)
28725,Malignant Cellular Infiltrate,Refractory anemia with excess blasts I
28726,Malignant Cellular Infiltrate,Acute myeloid leukemia with recurrent genetic abnormality
28727,Borderline Lesion,Type B Lymphomatoid Papulosis
28728,Malignant Cellular Infiltrate,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma
28729,Malignant Cellular Infiltrate,ALK positive large B-cell lymphoma
28730,Malignant Cellular Infiltrate,Monomorphic Post-Transplant Lymphoproliferative Disorder
28731,Malignant Cellular Infiltrate,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder
28732,Malignant Cellular Infiltrate,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
28733,Malignant Cellular Infiltrate,Thyroid Immunoblastic Lymphoma
28734,Malignant Cellular Infiltrate,Splenic Manifestation of Leukemia
28735,Malignant Cellular Infiltrate,Burkitt's tumor of spleen
28736,Malignant Cellular Infiltrate,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension
28737,Malignant Cellular Infiltrate,Extragonadal Seminoma
28738,Malignant Cellular Infiltrate,Endometrial adenocarcinoma
28739,Malignant Cellular Infiltrate,melanoma of scrotum
28740,Malignant Cellular Infiltrate,Nonencapsulated sclerosing tumor
28741,Malignant Cellular Infiltrate,Malignant neoplasm of ovary
28742,Malignant Cellular Infiltrate,Infiltrating papillary adenocarcinoma
28743,Malignant Cellular Infiltrate,Anaplastic Brain Stem Glioma
28744,Malignant Cellular Infiltrate,Lung Hilum Carcinoma
28745,Malignant Cellular Infiltrate,Acute Leukemia of Ambiguous Lineage
28746,Malignant Cellular Infiltrate,Malignant neoplasm of fallopian tube
28747,Malignant Cellular Infiltrate,Malignant neoplasm of gallbladder
28748,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Gallbladder
28749,Malignant Cellular Infiltrate,Ameloblastic Carcinoma
28750,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7
28751,Malignant Cellular Infiltrate,Malignant tumor of small intestine
28752,Malignant Cellular Infiltrate,Malignant tumor of renal pelvis
28753,Malignant Cellular Infiltrate,Pancoast Tumor
28754,Malignant Cellular Infiltrate,Askin's tumor
28755,Malignant Cellular Infiltrate,Secondary malignant neoplasm of kidney
28756,Malignant Cellular Infiltrate,Sporadic Breast Carcinoma
28757,Malignant Cellular Infiltrate,Malignant basal cell tumor
28758,Benign Cellular Infiltrate,Regressing nevus
28759,Malignant Cellular Infiltrate,Recurrent Digestive System Carcinoma
28760,Malignant Cellular Infiltrate,Pancreatic carcinoma recurrent
28761,Malignant Cellular Infiltrate,Malignant neoplasm of labium minus
28762,Malignant Cellular Infiltrate,Epipodophyllotoxin-Related Myelodysplastic Syndrome
28763,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Bladder
28764,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous metaplasia
28765,Well Differentiated Neuroendocrine Lesion,Gastrointestinal Carcinoid Tumor
28766,Malignant Cellular Infiltrate,Childhood Soft Tissue Sarcoma
28767,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Urothelial Carcinoma
28768,Malignant Cellular Infiltrate,Bartholin Gland Adenocarcinoma
28769,Benign Cellular Infiltrate,Mucous Membrane Hemangioma
28770,Malignant Cellular Infiltrate,Stage I Gastric Carcinoma
28771,Malignant Cellular Infiltrate,Stage II Anal Canal Cancer AJCC v6 and v7
28772,Malignant Cellular Infiltrate,Stage III Anal Canal Cancer AJCC v6 and v7
28773,Malignant Cellular Infiltrate,Non-small cell lung cancer stage II
28774,Malignant Cellular Infiltrate,Mycosis fungoides stage I
28775,Malignant Cellular Infiltrate,Stage IV Adult Soft Tissue Sarcoma AJCC v7
28776,Malignant Cellular Infiltrate,Regional Neuroblastoma
28777,Malignant Cellular Infiltrate,Recurrent Kidney Wilms Tumor
28778,Malignant Cellular Infiltrate,Intraocular retinoblastoma
28779,Malignant Cellular Infiltrate,DS Stage II Plasma Cell Myeloma
28780,Well Differentiated Neuroendocrine Lesion,Localized Digestive System Neuroendocrine Tumor G1
28781,Malignant Cellular Infiltrate,Localized Non-Resectable Adult Liver Carcinoma
28782,Malignant Cellular Infiltrate,recurrent adult acute myeloid leukemia
28783,Malignant Cellular Infiltrate,Stage 0 Bladder Carcinoma
28784,Malignant Cellular Infiltrate,Bladder cancer recurrent
28785,Malignant Cellular Infiltrate,Stage IV Bladder Cancer AJCC v6
28786,Malignant Cellular Infiltrate,Ocular Melanoma with Extraocular Extension
28787,Malignant Cellular Infiltrate,Adult Extraskeletal Myxoid Chondrosarcoma
28788,Malignant Cellular Infiltrate,Grade III Lymphomatoid Granulomatosis
28789,Malignant Cellular Infiltrate,Recurrent Kaposi Sarcoma
28790,Malignant Cellular Infiltrate,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma
28791,Malignant Cellular Infiltrate,Spindle Cell Type B Uveal Melanoma
28792,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of salivary gland
28793,Malignant Cellular Infiltrate,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly
28794,Malignant Cellular Infiltrate,Hypodiploid B Acute Lymphoblastic Leukemia
28795,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7
28796,Malignant Cellular Infiltrate,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood
28797,Malignant Cellular Infiltrate,Stage I Adult Immunoblastic Lymphoma
28798,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Unknown Primary
28799,"Fully Differentiated ""Adult-Type"" Tissues Present",Immature Ovarian Teratoma
28800,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 1 Follicular Lymphoma
28801,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage III
28802,Malignant Cellular Infiltrate,Stage III Adult Lymphoblastic Lymphoma
28803,Malignant Cellular Infiltrate,Stage III Adult Burkitt Lymphoma
28804,Malignant Cellular Infiltrate,Recurrent Grade 3 Follicular Lymphoma
28805,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity
28806,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of floor of mouth
28807,Malignant Cellular Infiltrate,Squamous cell carcinoma of oropharynx
28808,Malignant Cellular Infiltrate,Squamous cell carcinoma of the nasal cavity
28809,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage II
28810,Malignant Cellular Infiltrate,Stage III Lip Basal Cell Carcinoma
28811,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
28812,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia T/myeloid
28813,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage II
28814,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage IV
28815,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma recurrent
28816,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage IV
28817,Malignant Cellular Infiltrate,Treatment related acute myeloid leukaemia
28818,Malignant Cellular Infiltrate,Stage II Uterine Sarcoma AJCC v7
28819,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Excess Blasts and Fibrosis
28820,Malignant Cellular Infiltrate,Stage III Uterine Sarcoma AJCC v7
28821,Malignant Cellular Infiltrate,Adult Acute Monocytic Leukemia
28822,Malignant Cellular Infiltrate,AIDS-Related Lymphoblastic Lymphoma
28823,Malignant Cellular Infiltrate,Lymphoma stage II
28824,Malignant Cellular Infiltrate,Primary malignant neoplasm
28825,Malignant Cellular Infiltrate,Aggressive Adult Non-Hodgkin Lymphoma
28826,Malignant Cellular Infiltrate,Stage I Hodgkin Lymphoma
28827,Malignant Cellular Infiltrate,Secondary malignant neoplasm of neck
28828,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v6
28829,Benign Cellular Infiltrate,Benign neoplasm of epicardium
28830,Benign Cellular Infiltrate,Benign neoplasm of blood vessel
28831,Benign Cellular Infiltrate,Benign neoplasm of great vessels
28832,Malignant Cellular Infiltrate,Secondary malignant neoplasm of lip
28833,Malignant Cellular Infiltrate,Secondary malignant neoplasm of epididymis
28834,Malignant Cellular Infiltrate,Secondary malignant neoplasm of nervous system
28835,Malignant Cellular Infiltrate,Malignant Paraganglionic Neoplasm
28836,Malignant Cellular Infiltrate,malignant tumor of male genital organ
28837,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia
28838,Malignant Cellular Infiltrate,Stage IA Soft Tissue Sarcoma AJCC v7
28839,Malignant Cellular Infiltrate,Stage IB Merkel Cell Carcinoma AJCC v7
28840,Malignant Cellular Infiltrate,Postcricoid cancer
28841,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma recurrent
28842,Malignant Cellular Infiltrate,Stage IIIA Cutaneous Melanoma AJCC v7
28843,Malignant Cellular Infiltrate,Malignant hepatobiliary neoplasms
28844,Malignant Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v6
28845,Malignant Cellular Infiltrate,Hepatoblastoma non-resectable
28846,Malignant Cellular Infiltrate,Hepatoblastoma recurrent
28847,Malignant Cellular Infiltrate,Precursor B-cell lymphoblastic leukemia
28848,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 4
28849,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I
28850,Malignant Cellular Infiltrate,Anaplastic large cell lymphoma T- and null-cell types refractory
28851,Malignant Cellular Infiltrate,Stage I Anaplastic Large Cell Lymphoma
28852,Malignant Cellular Infiltrate,T-cell lymphoma recurrent
28853,Malignant Cellular Infiltrate,T-cell lymphoma refractory
28854,Malignant Cellular Infiltrate,T-cell lymphoma stage IV
28855,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent
28856,Malignant Cellular Infiltrate,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
28857,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma refractory
28858,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma transformed recurrent
28859,Malignant Cellular Infiltrate,Peritoneal mesothelioma malignant advanced
28860,Malignant Cellular Infiltrate,Stage IC Uterine Sarcoma AJCC v7
28861,Malignant Cellular Infiltrate,Ureteric cancer regional
28862,Malignant Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v7
28863,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7
28864,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Polyembryoma AJCC v6 and v7
28865,Malignant Cellular Infiltrate,Stage III Ovarian Teratoma AJCC v6 and v7
28866,Malignant Cellular Infiltrate,Stage III Mucosal Melanoma of the Head and Neck AJCC v7
28867,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7
28868,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7
28869,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage III"
28870,Malignant Cellular Infiltrate,Stage IB Esophageal Adenocarcinoma AJCC v7
28871,Malignant Cellular Infiltrate,Stage IIIB Esophageal Adenocarcinoma AJCC v7
28872,Malignant Cellular Infiltrate,Stage IIB Small Intestinal Cancer AJCC v7
28873,Malignant Cellular Infiltrate,Secondary Central Nervous System Lymphoma
28874,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma recurrent
28875,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma non-metastatic
28876,Malignant Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v7
28877,Malignant Cellular Infiltrate,Stage IIIa Penile Cancer AJCC v7
28878,Malignant Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v7
28879,Malignant Cellular Infiltrate,Stage IIIA Uveal Melanoma AJCC v7
28880,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7
28881,Malignant Cellular Infiltrate,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7
28882,Malignant Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7
28883,Malignant Cellular Infiltrate,Liposarcoma metastatic
28884,Malignant Cellular Infiltrate,Liposarcoma non-metastatic
28885,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity refractory
28886,Malignant Cellular Infiltrate,Refractory Hodgkin Lymphoma
28887,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage IV
28888,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v7
28889,Malignant Cellular Infiltrate,Monocytoid B-cell lymphoma
28890,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage III
28891,Malignant Cellular Infiltrate,Malignant Extragonadal Germ Cell Tumor
28892,Malignant Cellular Infiltrate,Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
28893,Malignant Cellular Infiltrate,Placental Choriocarcinoma
28894,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v7
28895,Malignant Cellular Infiltrate,"Urinary bladder carcinoma stage I, with cancer in situ"
28896,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage I
28897,Malignant Cellular Infiltrate,Stage III Hypopharyngeal Carcinoma AJCC v7
28898,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v7
28899,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage III
28900,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage I Immature Testicular Teratoma AJCC v6 and v7
28901,Malignant Cellular Infiltrate,Stage III Immature Testicular Teratoma AJCC v6 and v7
28902,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v7
28903,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage I
28904,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage III
28905,Malignant Cellular Infiltrate,Centroblastic lymphoma stage III
28906,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v7
28907,Malignant Cellular Infiltrate,Centroblastic lymphoma stage IV
28908,Malignant Cellular Infiltrate,Stage IV Bladder Cancer AJCC v7
28909,Malignant Cellular Infiltrate,Stage II Vulvar Cancer AJCC v7
28910,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v7
28911,Malignant Cellular Infiltrate,Stage IVA Vulvar Cancer AJCC v7
28912,Malignant Cellular Infiltrate,Metastatic Prostate Carcinoma
28913,Malignant Cellular Infiltrate,Adenocarcinoma of the prostate stage III
28914,Malignant Cellular Infiltrate,Stage III Fallopian Tube Cancer AJCC v7
28915,Malignant Cellular Infiltrate,Stage II Rectal Cancer AJCC v7
28916,Malignant Cellular Infiltrate,Stage III Colorectal Cancer AJCC v7
28917,Malignant Cellular Infiltrate,Stage IV Rectal Cancer AJCC v7
28918,Malignant Cellular Infiltrate,Malignant neoplasm of pancreas
28919,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor
28920,Benign Cellular Infiltrate,Mature Teratoma
28921,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v7
28922,Malignant Cellular Infiltrate,Stage II Adult Hodgkin Lymphoma
28923,Primary Lesion,Childhood Infratentorial Ependymoma
28924,Malignant Cellular Infiltrate,Stage II Vulva Cancer AJCC v6
28925,Malignant Cellular Infiltrate,Localized Unresectable Adult Hepatocellular Carcinoma
28926,Malignant Cellular Infiltrate,Recurrent Adult Hepatocellular Carcinoma
28927,Malignant Cellular Infiltrate,Stage II Testicular Cancer AJCC v6 and v7
28928,Malignant Cellular Infiltrate,Refractory Malignant Testicular Germ Cell Tumor
28929,Malignant Cellular Infiltrate,Childhood Immunoblastic Lymphoma
28930,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma AJCC v7
28931,Malignant Cellular Infiltrate,Childhood Burkitt Lymphoma
28932,Malignant Cellular Infiltrate,Stage IV Cutaneous Melanoma AJCC v6 and v7
28933,Malignant Cellular Infiltrate,Kaposi's sarcoma classical type
28934,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v7 Stage
28935,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
28936,Malignant Cellular Infiltrate,Uterine Corpus Cancer by AJCC v7 Stage
28937,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v7 Stage
28938,Malignant Cellular Infiltrate,Childhood Lymphoblastic Lymphoma
28939,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v7 Stage
28940,Malignant Cellular Infiltrate,Superficial spreading malignant melanoma of skin
28941,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Seminoma
28942,Malignant Cellular Infiltrate,Stage I Childhood Burkitt Lymphoma
28943,Malignant Cellular Infiltrate,Stage II Childhood Burkitt Lymphoma
28944,Malignant Cellular Infiltrate,AIDS-related anal cancer recurrent
28945,Malignant Cellular Infiltrate,Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma
28946,Malignant Cellular Infiltrate,Large cell lung cancer stage III
28947,Malignant Cellular Infiltrate,"Acute myeloid leukemia, t(8;21) (q22;q22)"
28948,Malignant Cellular Infiltrate,Cancer of Urinary Tract
28949,Malignant Cellular Infiltrate,Malignant tumor of cervix
28950,Malignant Cellular Infiltrate,Radiation-Related Sarcoma
28951,Malignant Cellular Infiltrate,Malignant neoplasm of adrenal cortex
28952,Malignant Cellular Infiltrate,Malignant neoplasm of stomach
28953,Malignant Cellular Infiltrate,Ewings sarcoma-primitive neuroectodermal tumor (PNET)
28954,Malignant Cellular Infiltrate,Mast-Cell Sarcoma
28955,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v6 and v7
28956,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia without Maturation
28957,Malignant Cellular Infiltrate,Rectal Carcinoma
28958,Malignant Cellular Infiltrate,Adenocarcinoma of rectum
28959,Malignant Cellular Infiltrate,Sarcoma by NCI Grade
28960,Malignant Cellular Infiltrate,Epithelioid Sarcoma NCI Grade 3
28961,Malignant Cellular Infiltrate,AJCC Grade 4 Sarcoma
28962,Malignant Cellular Infiltrate,Conventional Leiomyosarcoma
28963,Benign Cellular Infiltrate,Spindle Cell Oncocytoma of the Adenohypophysis
28964,Malignant Cellular Infiltrate,Systemic Anaplastic Large Cell Lymphoma
28965,Malignant Cellular Infiltrate,Anaplastic astrocytoma
28966,Malignant Cellular Infiltrate,Stage IIIA Adult Liver Cancer AJCC v7
28967,Malignant Cellular Infiltrate,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma
28968,Malignant Cellular Infiltrate,Stage IV Childhood Non-Hodgkin Lymphoma
28969,Malignant Cellular Infiltrate,Locally Recurrent Malignant Neoplasm
28970,Malignant Cellular Infiltrate,Primary Carcinoma
28971,Malignant Cellular Infiltrate,Stage 4S neuroblastoma
28972,Malignant Cellular Infiltrate,Intramucosal Adenocarcinoma
28973,Chromogranin A Positive Neoplastic Cells Present,Pancreatic Neuroendocrine Tumor G1
28974,Well Differentiated Neuroendocrine Lesion,Pancreatic Gastrin-Producing Neuroendocrine Tumor
28975,Malignant Cellular Infiltrate,Esophageal Moderately Differentiated Squamous Cell Carcinoma
28976,Intermediate Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2
28977,Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma
28978,Malignant Cellular Infiltrate,Gastric Choriocarcinoma
28979,Malignant Cellular Infiltrate,Malignant Gastric Gastrointestinal Stromal Tumor
28980,Malignant Cellular Infiltrate,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
28981,Malignant Cellular Infiltrate,Ampulla of Vater Hepatoid Adenocarcinoma
28982,Malignant Cellular Infiltrate,Small Intestinal B-Cell Non-Hodgkin Lymphoma
28983,Malignant Cellular Infiltrate,Small Intestinal Follicular Lymphoma
28984,Malignant Cellular Infiltrate,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified"
28985,Malignant Cellular Infiltrate,Small Intestinal Kaposi Sarcoma
28986,Poorly Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Carcinoma
28987,Malignant Cellular Infiltrate,Small Intestinal Neuroendocrine Carcinoma
28988,Malignant Cellular Infiltrate,Small Intestinal Large Cell Neuroendocrine Carcinoma
28989,Low Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1
28990,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor G2
28991,Malignant Cellular Infiltrate,Appendix Kaposi Sarcoma
28992,Malignant Cellular Infiltrate,Colorectal Micropapillary Adenocarcinoma
28993,Malignant Cellular Infiltrate,Colorectal Non-Hodgkin Lymphoma
28994,Malignant Cellular Infiltrate,Colorectal Diffuse Large B-Cell Lymphoma
28995,Malignant Cellular Infiltrate,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
28996,Malignant Cellular Infiltrate,"Gallbladder Adenocarcinoma, Biliary Type"
28997,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of gallbladder
28998,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of gallbladder
28999,Malignant Cellular Infiltrate,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type"
29000,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
29001,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Neuroendocrine Carcinoma
29002,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant"
29003,Malignant Cellular Infiltrate,Mixed Congenital Mesoblastic Nephroma
29004,Benign Cellular Infiltrate,Airway Hemangioma
29005,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
29006,Malignant Cellular Infiltrate,ENSAT Stage IV Adrenal Cortex Carcinoma
29007,Malignant Cellular Infiltrate,Low Grade Ovarian Serous Adenocarcinoma
29008,Malignant Cellular Infiltrate,Class 1b Uveal Melanoma
29009,Malignant Cellular Infiltrate,Mesenchymal Glioblastoma
29010,Malignant Cellular Infiltrate,Endometrial Adenosquamous Carcinoma
29011,Malignant Cellular Infiltrate,Adult Unfavorable Prognosis Hodgkin Lymphoma
29012,Malignant Cellular Infiltrate,Stage I Childhood Anaplastic Large Cell Lymphoma
29013,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
29014,Malignant Cellular Infiltrate,Stage IIB Rectal Cancer AJCC v7
29015,Malignant Cellular Infiltrate,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7
29016,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7
29017,Malignant Cellular Infiltrate,Stage IIIB Esophageal Cancer AJCC v7
29018,Malignant Cellular Infiltrate,BCLC Stage D Adult Hepatocellular Carcinoma
29019,Borderline Lesion,Adult Grade III Lymphomatoid Granulomatosis
29020,Malignant Cellular Infiltrate,Childhood Cerebral Anaplastic Astrocytoma
29021,Malignant Cellular Infiltrate,Proximal Urethral Carcinoma
29022,Malignant Cellular Infiltrate,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
29023,Malignant Cellular Infiltrate,Recurrent Childhood Gliosarcoma
29024,Malignant Cellular Infiltrate,Recurrent Childhood Gliomatosis Cerebri
29025,Malignant Cellular Infiltrate,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
29026,Malignant Cellular Infiltrate,small cell carcinoma of kidney
29027,Benign Cellular Infiltrate,Congenital Cystic Hygroma
29028,Malignant Cellular Infiltrate,Malignant Fibrohistiocytic Neoplasm
29029,Malignant Cellular Infiltrate,"Ossifying fibromyxoid tumor, malignant"
29030,Benign Cellular Infiltrate,Bone island
29031,Malignant Cellular Infiltrate,DDIT4L Acute Lymphoblastic Leukemia
29032,Malignant Cellular Infiltrate,Cytogenetically normal acute myeloid leukemia
29033,Malignant Cellular Infiltrate,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
29034,Malignant Cellular Infiltrate,Childhood Thyroid Gland Follicular Carcinoma
29035,Malignant Cellular Infiltrate,Gastroesophageal Junction Neuroendocrine Carcinoma
29036,Malignant Cellular Infiltrate,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
29037,Malignant Cellular Infiltrate,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA
29038,Malignant Cellular Infiltrate,Oropharyngeal Basaloid Carcinoma
29039,Malignant Cellular Infiltrate,Metastatic Malignant Solid Neoplasm
29040,Malignant Cellular Infiltrate,Waldenstrom's macroglobulinemia recurrent
29041,Malignant Cellular Infiltrate,Leiomyosarcoma of cervix uteri
29042,Malignant Cellular Infiltrate,Vaginal Large Cell Neuroendocrine Carcinoma
29043,Malignant Cellular Infiltrate,FIGO Stage IIIA1 Ovarian Cancer
29044,Malignant Cellular Infiltrate,Malignant Vulvar Phyllodes Tumor
29045,Malignant Cellular Infiltrate,Vulvar Neuroendocrine Carcinoma
29046,Benign Cellular Infiltrate,Vulvar Fibrolipoma
29047,Malignant Cellular Infiltrate,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
29048,Malignant Cellular Infiltrate,Anaplastic Oligoastrocytoma
29049,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 3"
29050,Malignant Cellular Infiltrate,Central Nervous System Mesenchymal Chondrosarcoma
29051,Malignant Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative"
29052,Malignant Cellular Infiltrate,B-lymphoblastic leukemia lymphoma BCR-ABL1-like
29053,Malignant Cellular Infiltrate,Gingival Squamous Cell Carcinoma
29054,Malignant Cellular Infiltrate,Sacral Chordoma
29055,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition
29056,Primary Lesion,Temporal Lobe and Parietal Lobe Ependymal Tumor
29057,Primary Lesion,Cerebellar and Ventricular Ependymal Tumor
29058,Malignant Cellular Infiltrate,Triple hit lymphoma
29059,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10
29060,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2
29061,Malignant Cellular Infiltrate,Stage III Lip and Oral Cavity Cancer AJCC v8
29062,Malignant Cellular Infiltrate,Stage IVB Lip and Oral Cavity Cancer AJCC v8
29063,Malignant Cellular Infiltrate,Stage 0 Major Salivary Gland Cancer AJCC v8
29064,Malignant Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma AJCC v8
29065,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v8
29066,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage
29067,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage
29068,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage
29069,Malignant Cellular Infiltrate,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
29070,Malignant Cellular Infiltrate,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
29071,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v8 Stage
29072,Malignant Cellular Infiltrate,Laryngeal Cancer by AJCC v8 Stage
29073,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v8
29074,Malignant Cellular Infiltrate,Squamous non-small cell lung cancer
29075,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Stage
29076,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
29077,Malignant Cellular Infiltrate,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
29078,Malignant Cellular Infiltrate,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
29079,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8
29080,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8
29081,Malignant Cellular Infiltrate,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8
29082,Malignant Cellular Infiltrate,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8
29083,Malignant Cellular Infiltrate,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
29084,Malignant Cellular Infiltrate,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
29085,Malignant Cellular Infiltrate,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
29086,Malignant Cellular Infiltrate,Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
29087,Malignant Cellular Infiltrate,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
29088,Malignant Cellular Infiltrate,Clinical Stage IVA Gastric Cancer AJCC v8
29089,Malignant Cellular Infiltrate,Pathologic Stage II Gastric Cancer AJCC v8
29090,Malignant Cellular Infiltrate,Pathologic Stage IIIA Gastric Cancer AJCC v8
29091,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8
29092,Malignant Cellular Infiltrate,Stage I Small Intestinal Adenocarcinoma AJCC v8
29093,Malignant Cellular Infiltrate,Stage II Small Intestinal Adenocarcinoma AJCC v8
29094,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v8
29095,Malignant Cellular Infiltrate,Stage II Colorectal Cancer AJCC v8
29096,Malignant Cellular Infiltrate,Colon Cancer by AJCC v8 Stage
29097,Malignant Cellular Infiltrate,Stage II Colon Cancer AJCC v8
29098,Malignant Cellular Infiltrate,Stage III Colon Cancer AJCC v8
29099,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v8
29100,Malignant Cellular Infiltrate,Stage I Rectal Cancer AJCC v8
29101,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v8
29102,Malignant Cellular Infiltrate,Stage IV Rectal Cancer AJCC v8
29103,Malignant Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v8
29104,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage
29105,Malignant Cellular Infiltrate,Stage I Intrahepatic Bile Duct Cancer AJCC v8
29106,Malignant Cellular Infiltrate,Stage II Intrahepatic Bile Duct Cancer AJCC v8
29107,Malignant Cellular Infiltrate,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
29108,Malignant Cellular Infiltrate,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
29109,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
29110,Malignant Cellular Infiltrate,Stage I Intrahepatic Cholangiocarcinoma AJCC v8
29111,Malignant Cellular Infiltrate,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
29112,Malignant Cellular Infiltrate,Stage I Distal Bile Duct Cancer AJCC v8
29113,Malignant Cellular Infiltrate,Stage IIIA Distal Bile Duct Cancer AJCC v8
29114,Malignant Cellular Infiltrate,Stage IIIB Distal Bile Duct Cancer AJCC v8
29115,Malignant Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v8
29116,Malignant Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v8
29117,Malignant Cellular Infiltrate,Stage IV Pancreatic Cancer AJCC v8
29118,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage
29119,Well Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8
29120,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor
29121,Well Differentiated Neuroendocrine Lesion,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8
29122,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor
29123,Well Differentiated Neuroendocrine Lesion,Stage I Colon Neuroendocrine Tumor AJCC v8
29124,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Neuroendocrine Tumor AJCC v8
29125,Well Differentiated Neuroendocrine Lesion,Stage IIB Rectal Neuroendocrine Tumor AJCC v8
29126,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v7 Stage
29127,Malignant Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v8
29128,Malignant Cellular Infiltrate,Stage IIA Lung Cancer AJCC v8
29129,Malignant Cellular Infiltrate,Lung Adenocarcinoma In Situ
29130,Malignant Cellular Infiltrate,Lung Small Cell Carcinoma by AJCC v7 Stage
29131,Malignant Cellular Infiltrate,Bone Cancer by AJCC v7 Stage
29132,Malignant Cellular Infiltrate,Stage I Bone Cancer AJCC v8
29133,Malignant Cellular Infiltrate,Stage III Bone Cancer AJCC v8
29134,Malignant Cellular Infiltrate,Osteosarcoma by AJCC v7 Stage
29135,Malignant Cellular Infiltrate,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
29136,Malignant Cellular Infiltrate,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
29137,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma by AJCC v7 Stage
29138,Malignant Cellular Infiltrate,Lung Enteric Adenocarcinoma
29139,Malignant Cellular Infiltrate,Stage IA Retroperitoneal Sarcoma AJCC v8
29140,Malignant Cellular Infiltrate,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8
29141,Malignant Cellular Infiltrate,Clinical Stage IB Cutaneous Melanoma AJCC v8
29142,Malignant Cellular Infiltrate,Clinical Stage II Cutaneous Melanoma AJCC v8
29143,Malignant Cellular Infiltrate,Pathologic Stage III Cutaneous Melanoma AJCC v8
29144,Malignant Cellular Infiltrate,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
29145,Malignant Cellular Infiltrate,Pleomorphic lobular carcinoma in situ of breast
29146,Malignant Cellular Infiltrate,Refractory Pancreatic Neuroendocrine Carcinoma
29147,Malignant Cellular Infiltrate,"Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma"
29148,Malignant Cellular Infiltrate,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
29149,Malignant Cellular Infiltrate,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
29150,Malignant Cellular Infiltrate,Anatomic Stage IIB Breast Cancer AJCC v8
29151,Malignant Cellular Infiltrate,Anatomic Stage IIIA Breast Cancer AJCC v8
29152,Malignant Cellular Infiltrate,Breast Cancer by AJCC v8 Prognostic Stage
29153,Malignant Cellular Infiltrate,Malignant Neoplasm of Lung - Multiple Primary Sites
29154,Malignant Cellular Infiltrate,Prognostic Stage IIIC Breast Cancer AJCC v8
29155,Malignant Cellular Infiltrate,Prognostic Stage IV Breast Cancer AJCC v8
29156,Malignant Cellular Infiltrate,Stage II Vulvar Cancer AJCC v8
29157,Malignant Cellular Infiltrate,Stage IIIB Vulvar Cancer AJCC v8
29158,Malignant Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v8
29159,Malignant Cellular Infiltrate,Stage IVA Vulvar Cancer AJCC v8
29160,Malignant Cellular Infiltrate,Stage IB Vaginal Cancer AJCC v8
29161,Malignant Cellular Infiltrate,Stage IIA Vaginal Cancer AJCC v8
29162,Malignant Cellular Infiltrate,Stage I Uterine Corpus Cancer AJCC v8
29163,Malignant Cellular Infiltrate,Stage II Uterine Corpus Cancer AJCC v8
29164,Malignant Cellular Infiltrate,Stage IIIC2 Uterine Corpus Cancer AJCC v8
29165,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8
29166,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
29167,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8
29168,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v8
29169,Malignant Cellular Infiltrate,Stage IIA Fallopian Tube Cancer AJCC v8
29170,Malignant Cellular Infiltrate,Stage IV Fallopian Tube Cancer AJCC v8
29171,Malignant Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v8
29172,Malignant Cellular Infiltrate,Stage IVA Primary Peritoneal Cancer AJCC v8
29173,Malignant Cellular Infiltrate,Stage IIIA Penile Cancer AJCC v8
29174,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v8
29175,Malignant Cellular Infiltrate,Stage IIC Testicular Cancer AJCC v8
29176,Well Differentiated Neuroendocrine Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm
29177,Malignant Cellular Infiltrate,Stage I Renal Pelvis Cancer AJCC v8
29178,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v7 Stage
29179,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8
29180,Malignant Cellular Infiltrate,Eyelid Carcinoma by AJCC v7 Stage
29181,Malignant Cellular Infiltrate,Stage IB Eyelid Carcinoma AJCC v8
29182,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v8
29183,Malignant Cellular Infiltrate,Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8
29184,Malignant Cellular Infiltrate,Clinical Stage III Retinoblastoma AJCC v8
29185,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Pathologic Stage
29186,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
29187,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
29188,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
29189,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8
29190,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
29191,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
29192,Malignant Cellular Infiltrate,Stage III Thyroid Gland Follicular Carcinoma AJCC v8
29193,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
29194,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
29195,Malignant Cellular Infiltrate,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage
29196,Malignant Cellular Infiltrate,Refractory Lung Carcinoma
29197,Malignant Cellular Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v8
29198,Malignant Cellular Infiltrate,Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage
29199,Malignant Cellular Infiltrate,Lugano Classification Adult Lymphoma by AJCC v8 Stage
29200,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Lymphoma AJCC v8
29201,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8
29202,Malignant Cellular Infiltrate,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8
29203,Malignant Cellular Infiltrate,Lugano Classification Hodgkin Lymphoma by AJCC v8 Stage
29204,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8
29205,Malignant Cellular Infiltrate,Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage
29206,Malignant Cellular Infiltrate,Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8
29207,Malignant Cellular Infiltrate,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8
29208,Malignant Cellular Infiltrate,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage
29209,Malignant Cellular Infiltrate,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage
29210,Malignant Cellular Infiltrate,Adult Hodgkin Lymphoma by Ann Arbor Stage
29211,Malignant Cellular Infiltrate,Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage
29212,Malignant Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage
29213,Malignant Cellular Infiltrate,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage
29214,Malignant Cellular Infiltrate,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
29215,Malignant Cellular Infiltrate,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
29216,Malignant Cellular Infiltrate,acute undifferentiated leukemia in relapse
29217,Bone Marrow Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia refractory
29218,Malignant Cellular Infiltrate,Refractory B Acute Lymphoblastic Leukemia
29219,Malignant Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma
29220,Malignant Cellular Infiltrate,Recurrent Primary Cutaneous Lymphoma
29221,Malignant Cellular Infiltrate,Refractory Thyroid Gland Carcinoma
29222,Malignant Cellular Infiltrate,Mediastinal/Thymic NUT Carcinoma
29223,Malignant Cellular Infiltrate,Stage IV Malignant Mediastinal Germ Cell Tumor
29224,Malignant Cellular Infiltrate,Locally Advanced Epithelioid Hemangioendothelioma
29225,Malignant Cellular Infiltrate,Mediastinal Mixed Germ Cell Tumor
29226,Malignant Cellular Infiltrate,Mediastinal Granulocytic Sarcoma
29227,Malignant Cellular Infiltrate,Metastatic Genitourinary System Carcinoma
29228,Malignant Cellular Infiltrate,Refractory Central Nervous System Non-Hodgkin Lymphoma
29229,Malignant Cellular Infiltrate,Malignant Pericardial Germ Cell Tumor
29230,Malignant Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma
29231,Malignant Cellular Infiltrate,Refractory Melanoma
29232,Malignant Cellular Infiltrate,Recurrent BRCA-Mutated Ovarian Carcinoma
29233,Malignant Cellular Infiltrate,Childhood Malignant Solid Neoplasm
29234,Malignant Cellular Infiltrate,Unresectable Malignant Solid Neoplasm
29235,Malignant Cellular Infiltrate,Locally Advanced Carcinoma
29236,Malignant Cellular Infiltrate,Refractory Myelodysplastic Syndrome
29237,Malignant Cellular Infiltrate,BN2 Diffuse Large B-Cell Lymphoma
29238,Malignant Cellular Infiltrate,Advanced Urothelial Carcinoma
29239,Malignant Cellular Infiltrate,Metastatic Uveal Melanoma
29240,Secondary Lesion,Castration-Naive Prostate Carcinoma
29241,Malignant Cellular Infiltrate,Thoracic Esophagus Adenocarcinoma
29242,Malignant Cellular Infiltrate,Recurrent Chronic Leukemia
29243,Malignant Cellular Infiltrate,Refractory Endometrial Carcinoma
29244,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Oropharynx
29245,Malignant Cellular Infiltrate,Advanced Oral Cavity Squamous Cell Carcinoma
29246,Malignant Cellular Infiltrate,Intestinal T-Cell Lymphoma
29247,Malignant Cellular Infiltrate,Metastatic Urethral Urothelial Carcinoma
29248,Malignant Cellular Infiltrate,Refractory Malignant Pharyngeal Neoplasm
29249,Malignant Cellular Infiltrate,Recurrent Malignant Thyroid Gland Neoplasm
29250,Malignant Cellular Infiltrate,Refractory Malignant Endocrine Neoplasm
29251,Malignant Cellular Infiltrate,Refractory Malignant Urinary System Neoplasm
29252,Malignant Cellular Infiltrate,Recurrent Dedifferentiated Liposarcoma
29253,Malignant Cellular Infiltrate,Refractory Dedifferentiated Liposarcoma
29254,Malignant Cellular Infiltrate,Resectable Malignant Neoplasm
29255,Malignant Cellular Infiltrate,Resectable Carcinoma
29256,Malignant Cellular Infiltrate,Methotrexate-Associated Lymphoma
29257,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction
29258,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline ANKRD26 Mutation
29259,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline ETV6 Mutation
29260,Malignant Cellular Infiltrate,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma
29261,Malignant Cellular Infiltrate,Refractory Primary Peritoneal Carcinoma
29262,Malignant Cellular Infiltrate,Refractory Fallopian Tube Carcinoma
29263,Malignant Cellular Infiltrate,Unresectable Bone Sarcoma
29264,Poorly Differentiated Neuroendocrine Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma
29265,Malignant Cellular Infiltrate,Recurrent Hepatosplenic T-Cell Lymphoma
29266,Malignant Cellular Infiltrate,Advanced Unresectable Gastric Adenocarcinoma
29267,Malignant Cellular Infiltrate,Locally Advanced Small Intestinal Carcinoma
29268,Malignant Cellular Infiltrate,Recurrent Paget Disease of the Breast
29269,Malignant Cellular Infiltrate,Recurrent Ovarian Mucinous Adenocarcinoma
29270,Malignant Cellular Infiltrate,Recurrent Ovarian Cystadenocarcinoma
29271,Malignant Cellular Infiltrate,Recurrent Thyroid Gland Papillary Carcinoma
29272,Malignant Cellular Infiltrate,Recurrent Parotid Gland Adenoid Cystic Carcinoma
29273,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Mucoepidermoid Carcinoma
29274,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma
29275,Malignant Cellular Infiltrate,Recurrent Malignant Ovarian Transitional Cell Tumor
29276,Malignant Cellular Infiltrate,Recurrent Malignant Central Nervous System Neoplasm
29277,Malignant Cellular Infiltrate,Unresectable Gastric Adenocarcinoma
29278,Malignant Cellular Infiltrate,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
29279,Malignant Cellular Infiltrate,Resectable Pleural Malignant Mesothelioma
29280,Carcinomatous Component Present,MiT Family Translocation-Associated Renal Cell Carcinoma
29281,Two Separate Tumor Masses Present in the Same Organ,Pituitary Gland Double Adenomas
29282,Epithelial Component Present,Pituitary Gland Multiple Adenomas
29283,Neuroendocrine Differentiation,Digestive System Large Cell Neuroendocrine Carcinoma
29284,Well Differentiated Neuroendocrine Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm
29285,Neuroendocrine Differentiation,Advanced Well Differentiated Neuroendocrine Neoplasm
29286,Epithelial Component Present,Advanced Well Differentiated Neuroendocrine Neoplasm
29287,Epithelial Component Present,Adenocarcinoma gastric recurrent
29288,Necrotic changes (finding),Digestive System Small Cell Neuroendocrine Carcinoma
29289,Epithelial Component Present,Digestive System Small Cell Neuroendocrine Carcinoma
29290,Malignant Cellular Infiltrate,Transplant-Related Squamous Cell Carcinoma
29291,Carcinomatous Component Present,Transplant-Related Squamous Cell Carcinoma
29292,Malignant Cellular Infiltrate,Cutaneous Melanoma of the Extremity
29293,Cutaneous Involvement,Cutaneous Melanoma of the Extremity
29294,Malignant Cellular Infiltrate,Locally Advanced Unresectable Carcinoma
29295,Malignant Cellular Infiltrate,Locally Advanced Unresectable Pancreatic Adenocarcinoma
29296,Unresectable Mass,Locally Advanced Unresectable Pancreatic Adenocarcinoma
29297,Epithelial Component Present,Pituitary Gland Mixed Gangliocytoma-Adenoma
29298,Monomorphic Cellular Infiltrate,Sellar Ependymoma
29299,Slow Growing Mass,Sellar Ependymoma
29300,Myxoid Stroma Formation,Sellar Dedifferentiated Chordoma
29301,Metastatic Lesion,Metastatic Malignant Neoplasm in the Sellar Region
29302,Malignant Germinomatous Cellular Infiltrate,Sellar Germinoma
29303,Recurrent disease,Recurrent Endometrial Undifferentiated Carcinoma
29304,Carcinomatous Component Present,Recurrent Endometrial Undifferentiated Carcinoma
29305,Carcinomatous Component Present,Recurrent Endometrial Mixed Cell Adenocarcinoma
29306,Epithelial Component Present,Advanced Neuroendocrine Carcinoma
29307,Epithelial Component Present,Locally Advanced Unresectable Gastric Adenocarcinoma
29308,Carcinomatous Component Present,Locally Advanced Unresectable Gastric Adenocarcinoma
29309,Infiltrative Growth Pattern,Recurrent Desmoid-Type Fibromatosis
29310,Unresectable Mass,Unresectable Desmoid-Type Fibromatosis
29311,Carcinomatous Component Present,Unresectable Lung Carcinoma
29312,Lymphoplasmacytic Infiltrate,Smoldering Waldenstrom Macroglobulinemia
29313,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Neuroendocrine Carcinoma
29314,Metastatic Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
29315,Neuroendocrine Differentiation,Locally Advanced Pancreatic Neuroendocrine Carcinoma
29316,Carcinomatous Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma
29317,Severe cytologic atypia,Locally Advanced Pancreatic Neuroendocrine Carcinoma
29318,Epithelial Component Present,Locally Advanced Digestive System Neuroendocrine Carcinoma
29319,Poorly Differentiated Neuroendocrine Lesion,Unresectable Digestive System Neuroendocrine Carcinoma
29320,Unresectable Mass,Unresectable Digestive System Neuroendocrine Carcinoma
29321,Neuroendocrine Differentiation,Unresectable Digestive System Neuroendocrine Carcinoma
29322,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Carcinoma
29323,High Mitotic Activity,Refractory Digestive System Neuroendocrine Carcinoma
29324,Severe cytologic atypia,Refractory Digestive System Neuroendocrine Carcinoma
29325,Capillary Sized Vascular Channel Formation,Spinal hemangioblastoma
29326,Carcinomatous Component Present,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome
29327,Refractory Disease,Refractory Visual Pathway Glioma
29328,Recurrent disease,Recurrent Neurofibromatosis Type 1
29329,Hereditary Lesion,Recurrent Neurofibromatosis Type 1
29330,Firm mass,Refractory Malignant Peripheral Nerve Sheath Tumor
29331,Epithelial Component Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma
29332,Anaplasia,Frontal Lobe Anaplastic Astrocytoma
29333,Primary Lesion,Temporal Lobe Anaplastic Astrocytoma
29334,Glomeruloid Vessels Present,Third Ventricle Pilocytic Astrocytoma
29335,Mitotic Activity,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma
29336,Intracellular Accumulation of Lipids,Supratentorial Pleomorphic Xanthoastrocytoma
29337,Intracellular Accumulation of Lipids,Temporal Lobe Pleomorphic Xanthoastrocytoma
29338,Ground Glass Nuclear Inclusion,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
29339,Thyroglobulin Positive Neoplastic Cells Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
29340,Carcinomatous Component Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
29341,Stromal Invasion,Stage IV Ovarian Carcinoma
29342,Metastatic Lesion,Metastatic Vulvar Carcinoma
29343,Secondary Lesion,Metastatic Vulvar Carcinoma
29344,Carcinomatous Component Present,Metastatic Vulvar Carcinoma
29345,Malignant Cellular Infiltrate,Metastatic Endometrial Carcinoma
29346,Metastatic Lesion,Stage IV adult soft tissue sarcoma
29347,Metastatic Lesion,Metastatic Esophageal Carcinoma
29348,Carcinomatous Component Present,Metastatic Esophageal Carcinoma
29349,Metastatic Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
29350,Epithelial Component Present,Metastatic Nasopharyngeal Undifferentiated Carcinoma
29351,Metastatic Lesion,Metastatic Hypopharyngeal Carcinoma
29352,Metastatic Lesion,Stage IV Laryngeal Carcinoma
29353,Epithelial Component Present,Stage IV Laryngeal Carcinoma
29354,Carcinomatous Component Present,Metastatic Oral Cavity Carcinoma
29355,Carcinomatous Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma
29356,Carcinomatous Component Present,Metastatic Lip Squamous Cell Carcinoma
29357,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage IV
29358,High Mitotic Activity,Metastatic Lung Small Cell Carcinoma
29359,Neuroendocrine Differentiation,Metastatic Lung Small Cell Carcinoma
29360,More than 10 Mitoses per 10HPF,Metastatic Lung Small Cell Carcinoma
29361,Secondary Lesion,Metastatic Colorectal Carcinoma
29362,Carcinomatous Component Present,Metastatic Colorectal Carcinoma
29363,Secondary Lesion,Metastatic Colon Carcinoma
29364,Epithelial Component Present,Metastatic Thyroid Gland Follicular Carcinoma
29365,High Mitotic Activity,Frontal Lobe Anaplastic Oligodendroglioma
29366,Angioinvasion,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
29367,Malignant Cellular Infiltrate,Localized Gastroesophageal Junction Adenocarcinoma
29368,Epithelial Component Present,Localized Gastric Carcinoma
29369,Malignant Cellular Infiltrate,Orbital Alveolar Soft Part Sarcoma
29370,Metastatic/Recurrent Disease,Orbital Alveolar Soft Part Sarcoma
29371,Tissue Differentiation Uncertain,Orbital Alveolar Soft Part Sarcoma
29372,Secondary Lesion,Locally Advanced Prostate Carcinoma
29373,Carcinomatous Component Present,Locally Advanced Prostate Adenocarcinoma
29374,Metastatic Lesion,Locally Advanced Unresectable Prostate Carcinoma
29375,Malignant Cellular Infiltrate,Locally Advanced Cervical Carcinoma
29376,Metastatic Lesion,Locally Advanced Cervical Adenocarcinoma
29377,Epithelial Component Present,Locally Advanced Cervical Adenocarcinoma
29378,Extensive Stage Lesion,Advanced Cervical Adenocarcinoma
29379,Secondary Lesion,Advanced Cervical Adenocarcinoma
29380,Firm mass,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
29381,Indolent Clinical Course,Thyroid Gland Hemangioma
29382,Polyclonal hypergammaglobulinemia,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy
29383,Cutaneous Involvement,Hallopeau-Siemens Disease
29384,Malignant Cellular Infiltrate,Recurrent Primary Peritoneal Serous Adenocarcinoma
29385,Primary Lesion,Recurrent Primary Peritoneal Serous Adenocarcinoma
29386,Epithelial Component Present,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
29387,Malignant Cellular Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma
29388,Carcinomatous Component Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma
29389,Epithelial Component Present,Extrapulmonary Small Cell Carcinoma
29390,Primary Lesion,Brain Ependymoma
29391,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma
29392,Epithelial Component Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma
29393,Carcinomatous Component Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma
29394,Refractory Disease,Refractory Kaposi Sarcoma
29395,Metastatic Lesion,"Kaposi's sarcoma, metastatic"
29396,Malignant Cellular Infiltrate,Metastatic Neuroendocrine Neoplasm
29397,Malignant Cellular Infiltrate,Advanced Carcinoid Tumor
29398,Epithelial Component Present,Advanced Carcinoid Tumor
29399,Chromogranin A Positive Neoplastic Cells Present,Advanced Carcinoid Tumor
29400,Low Mitotic Activity,Pancreatic neuroendocrine tumor metastatic
29401,Epithelial Component Present,Pancreatic neuroendocrine tumor metastatic
29402,Well Differentiated Neuroendocrine Lesion,Advanced Pancreatic Neuroendocrine Tumor
29403,Malignant Cellular Infiltrate,Advanced Pancreatic Neuroendocrine Tumor
29404,Extensive Stage Lesion,Advanced Pancreatic Neuroendocrine Tumor
29405,Carcinomatous Component Present,Metastatic Gastric Neuroendocrine Carcinoma
29406,High Mitotic Activity,Advanced Gastric Neuroendocrine Carcinoma
29407,Secondary Lesion,Advanced Gastric Neuroendocrine Carcinoma
29408,Neuroendocrine Differentiation,Advanced Gastric Neuroendocrine Carcinoma
29409,Severe cytologic atypia,Advanced Gastric Neuroendocrine Carcinoma
29410,High Mitotic Activity,Advanced Gastric Large Cell Neuroendocrine Carcinoma
29411,Extensive Stage Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma
29412,Epithelial Component Present,Advanced Gastric Small Cell Neuroendocrine Carcinoma
29413,Poorly Differentiated Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma
29414,Carcinomatous Component Present,Advanced Small Intestinal Neuroendocrine Carcinoma
29415,Carcinomatous Component Present,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
29416,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
29417,Recurrent Genetic Abnormalities Present,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
29418,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
29419,Recurrent disease,Recurrent Acute Monoblastic and Monocytic Leukemia
29420,Recurrent disease,Recurrent Acute Megakaryoblastic Leukemia
29421,Secondary Lesion,Advanced Digestive System Carcinoma
29422,Carcinomatous Component Present,Advanced Digestive System Carcinoma
29423,Carcinomatous Component Present,Basal cell carcinoma
29424,Secondary Lesion,Locally Advanced Basal Cell Carcinoma
29425,Carcinomatous Component Present,Biliary Tract Carcinoma
29426,Epithelial Component Present,Metastatic Unresectable Basal Cell Carcinoma
29427,Malignant Cellular Infiltrate,Locally Advanced Unresectable Basal Cell Carcinoma
29428,Metastatic Lesion,Locally Advanced Unresectable Basal Cell Carcinoma
29429,Carcinomatous Component Present,Locally Advanced Unresectable Basal Cell Carcinoma
29430,Malignant Cellular Infiltrate,Malignant neoplasm of bronchus
29431,Malignant Cellular Infiltrate,Resectable Extrahepatic Bile Duct Adenocarcinoma
29432,Malignant Cellular Infiltrate,Hormone Receptor Positive Breast Carcinoma
29433,Epithelial Component Present,Refractory Hormone Receptor Positive Breast Carcinoma
29434,Well Differentiated Neuroendocrine Lesion,Vipoma
29435,Toxic effect,Environment-Related Neoplasm
29436,Malignant Cellular Infiltrate,Adult Yolk Sac Tumor
29437,Malignant Cellular Infiltrate,Secondary Myelodysplastic Syndrome
29438,Malignant Cellular Infiltrate,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7
29439,Malignant Cellular Infiltrate,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7
29440,Malignant Cellular Infiltrate,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
29441,Malignant Cellular Infiltrate,Recurrent Hematologic Malignancy
29442,Malignant Cellular Infiltrate,Adult Mesenchymal Chondrosarcoma
29443,Malignant Cellular Infiltrate,Thyroid Gland Adenocarcinoma
29444,Malignant Cellular Infiltrate,Carcinoma Arising in Nasal Papillomatosis
29445,Malignant Cellular Infiltrate,Childhood Central Nervous System Mixed Germ Cell Tumor
29446,Well Differentiated Neuroendocrine Lesion,Duodenal Somatostatin-Producing Neuroendocrine Tumor
29447,Malignant Cellular Infiltrate,Ampulla of Vater Adenosquamous Carcinoma
29448,Malignant Cellular Infiltrate,verrucous carcinoma of esophagus
29449,Well Differentiated Neuroendocrine Lesion,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
29450,Well Differentiated Neuroendocrine Lesion,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
29451,Malignant Cellular Infiltrate,Conventional Alveolar Rhabdomyosarcoma
29452,Malignant Cellular Infiltrate,Angiosarcoma Associated with Lymphedema
29453,Malignant Cellular Infiltrate,Cystic basal cell carcinoma
29454,Malignant Cellular Infiltrate,"Basal cell carcinoma, micronodular"
29455,Malignant Cellular Infiltrate,Skin Pseudovascular Squamous Cell Carcinoma
29456,Malignant Cellular Infiltrate,Skin Basaloid Carcinoma
29457,Malignant Cellular Infiltrate,Transplant-Related Malignant Neoplasm
29458,Malignant Cellular Infiltrate,Transplant-Related Hematologic Malignancy
29459,Malignant Cellular Infiltrate,Human Papillomavirus-Related Adenocarcinoma
29460,Malignant Cellular Infiltrate,Hepatitis B Virus-Related Hepatocellular Carcinoma
29461,Malignant Cellular Infiltrate,Cutaneous Radiation-Related Angiosarcoma
29462,Well Differentiated Neuroendocrine Lesion,Well Differentiated Pancreatic Endocrine Tumor
29463,Malignant Cellular Infiltrate,Childhood Kidney Wilms Tumor
29464,Malignant Cellular Infiltrate,Solar Radiation-Related Malignant Neoplasm
29465,Malignant Cellular Infiltrate,Bile duct carcinoma
29466,Malignant Cellular Infiltrate,Invasive Breast Carcinoma by Histologic Grade
29467,Malignant Cellular Infiltrate,Sarcomatoid Renal Cell Carcinoma
29468,Borderline Lesion,T-Cell Proliferation of Uncertain Malignant Potential
29469,Malignant Cellular Infiltrate,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
29470,Malignant Cellular Infiltrate,Poorly Differentiated Prostate Adenocarcinoma
29471,Malignant Cellular Infiltrate,Nipple Carcinoma
29472,Malignant Cellular Infiltrate,"Carcinoma, Basal Cell"
29473,Malignant Cellular Infiltrate,"Adenocarcinoma, Scirrhous"
29474,Malignant Cellular Infiltrate,Squamous cell carcinoma
29475,Benign Cellular Infiltrate,Enchondroma
29476,Benign Cellular Infiltrate,Enchondromatosis
29477,Malignant Cellular Infiltrate,Yolk Sac Tumor
29478,Malignant Cellular Infiltrate,Fibrosarcoma
29479,Well Differentiated Neuroendocrine Lesion,Glucagonoma
29480,Malignant Cellular Infiltrate,Liver carcinoma
29481,Malignant Cellular Infiltrate,"Leukemia, Myelocytic, Acute"
29482,Malignant Cellular Infiltrate,Philadelphia-Positive Myelogenous Leukemia
29483,Malignant Cellular Infiltrate,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
29484,Malignant Cellular Infiltrate,liposarcoma
29485,Benign Cellular Infiltrate,Lymphangioendothelioma
29486,Malignant Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic
29487,Malignant Cellular Infiltrate,Multiple Myeloma
29488,Benign Cellular Infiltrate,Myoblastoma
29489,Benign Cellular Infiltrate,neurofibroma
29490,Malignant Cellular Infiltrate,"Lymphoma, Large-Cell, Follicular"
29491,Benign Cellular Infiltrate,Chondromatosis
29492,Malignant Cellular Infiltrate,Malignant neoplasm of sublingual gland
29493,Malignant Cellular Infiltrate,Malignant Hard Palate Neoplasm
29494,Malignant Cellular Infiltrate,Kaposi's sarcoma of skin
29495,Malignant Cellular Infiltrate,Throat cancer
29496,Malignant Cellular Infiltrate,Malignant neoplasm of clitoris
29497,Malignant Cellular Infiltrate,Malignant neoplasm of spermatic cord
29498,Malignant Cellular Infiltrate,Malignant Accessory Urethral Gland Neoplasm
29499,Malignant Cellular Infiltrate,small cell carcinoma of salivary gland
29500,Malignant Cellular Infiltrate,Malignant neoplasm of spinal cord
29501,Malignant Cellular Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland
29502,Malignant Cellular Infiltrate,Secondary malignant neoplasm of axilla
29503,Malignant Cellular Infiltrate,Malignant neoplasm of endocrine gland
29504,Benign Cellular Infiltrate,Benign neoplasm of axilla
29505,Malignant Cellular Infiltrate,Secondary malignant neoplasm of mediastinum
29506,Malignant Cellular Infiltrate,Mixed Cell Uveal Melanoma
29507,Malignant Cellular Infiltrate,Low Grade Malignant Neoplasm
29508,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q23;q21)
29509,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q13;q21)
29510,Malignant Cellular Infiltrate,Malignant Reproductive System Neoplasm
29511,Malignant Cellular Infiltrate,Carcinoma bone
29512,Malignant Cellular Infiltrate,mucinous adenocarcinoma of cervix
29513,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation
29514,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Bone
29515,Benign Cellular Infiltrate,Benign Neoplasm
29516,Malignant Cellular Infiltrate,basal cell adenocarcinoma of salivary gland
29517,Benign Cellular Infiltrate,Hibernoma
29518,Malignant Cellular Infiltrate,"Neuroectodermal Tumor, Melanotic"
29519,Malignant Cellular Infiltrate,"Anaplastic large cell lymphoma, ALK negative"
29520,Malignant Cellular Infiltrate,Colloid Carcinoma of the Pancreas
29521,Malignant Cellular Infiltrate,Pancreatic Foamy Gland Adenocarcinoma
29522,Benign Cellular Infiltrate,Benign mixed epithelial and stromal tumor of kidney
29523,Malignant Cellular Infiltrate,Acinar Cell Carcinoma
29524,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Endocrine Carcinoma
29525,Malignant Cellular Infiltrate,"Carcinoma, Lobular"
29526,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Serous"
29527,Malignant Cellular Infiltrate,Metachronous Malignant Neoplasm
29528,Benign Cellular Infiltrate,Kasabach-Merritt syndrome
29529,Benign Cellular Infiltrate,Chondromyxoid fibroma
29530,Malignant Cellular Infiltrate,Malignant ovarian cyst
29531,Benign Cellular Infiltrate,Dermoid cyst of ovary
29532,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid cyst of ovary
29533,Malignant Cellular Infiltrate,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
29534,Malignant Cellular Infiltrate,Mucosa-Associated Lymphoid Tissue Lymphoma
29535,Benign Cellular Infiltrate,Compound nevus of skin
29536,Malignant Cellular Infiltrate,"Carcinoma, Small Cell"
29537,Benign Cellular Infiltrate,Angioma serpiginosum
29538,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype"
29539,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with inv(X)(p11;q12)
29540,Malignant Cellular Infiltrate,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma
29541,Malignant Cellular Infiltrate,Bulbomembranous Urethral Malignant Neoplasm
29542,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Cribriform Pattern"
29543,Malignant Cellular Infiltrate,Seminal Vesicle Adenocarcinoma
29544,Malignant Cellular Infiltrate,AIDS with Kaposi's sarcoma
29545,Malignant Cellular Infiltrate,Stage II Colon Cancer
29546,Benign Cellular Infiltrate,fibroma of testis
29547,Malignant Primitive Cellular Infiltrate,Ovarian Primitive Germ Cell Tumor
29548,Malignant Primitive Cellular Infiltrate,Non-Gestational Ovarian Choriocarcinoma
29549,Malignant Cellular Infiltrate,Malignant Ovarian Surface Epithelial-Stromal Tumor
29550,Malignant Cellular Infiltrate,undifferentiated sarcoma of ovary
29551,Malignant Cellular Infiltrate,Small Intestinal Lymphoma
29552,Malignant Cellular Infiltrate,clear cell adenocarcinofibroma of ovary
29553,Malignant Cellular Infiltrate,Uterine Ligament Clear Cell Adenocarcinoma
29554,Malignant Cellular Infiltrate,Endometrial Mucinous Adenocarcinoma
29555,Malignant Cellular Infiltrate,Endometrial Mixed Cell Adenocarcinoma
29556,Malignant Cellular Infiltrate,Endometrial Small Cell Carcinoma
29557,Malignant Cellular Infiltrate,Malignant Bone Neoplasm
29558,Malignant Cellular Infiltrate,Uterine Corpus Carcinofibroma
29559,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type"
29560,Malignant Cellular Infiltrate,Chondroblastic osteosarcoma
29561,Malignant Cellular Infiltrate,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm
29562,Malignant Cellular Infiltrate,Adenosarcoma of cervix uteri
29563,Malignant Cellular Infiltrate,Small cell osteosarcoma
29564,Malignant Cellular Infiltrate,Vaginal Mesonephric Adenocarcinoma
29565,Malignant Cellular Infiltrate,Vaginal Adenoid Cystic Carcinoma
29566,Malignant Cellular Infiltrate,Vaginal Adenoid Basal Carcinoma
29567,Malignant Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina
29568,Malignant Cellular Infiltrate,Cervical Adenocarcinoma
29569,Malignant Cellular Infiltrate,Bartholin Gland Squamous Cell Carcinoma
29570,Malignant Cellular Infiltrate,Urothelial Carcinoma
29571,Benign Cellular Infiltrate,Superficial angiomyxoma
29572,Benign Cellular Infiltrate,Vulvar Superficial Angiomyxoma
29573,Malignant Cellular Infiltrate,Malignant melanoma of vulva
29574,Malignant Cellular Infiltrate,adenosquamous carcinoma of breast
29575,Malignant Cellular Infiltrate,Breast Diffuse Large B-Cell Lymphoma
29576,Benign Cellular Infiltrate,Breast Leiomyoma
29577,Malignant Cellular Infiltrate,Nephroblastoma
29578,Malignant Cellular Infiltrate,Gestational Ovarian Choriocarcinoma
29579,Malignant Cellular Infiltrate,Anaplastic Ependymoma
29580,Malignant Cellular Infiltrate,"Malignant tumor, giant cell type"
29581,Malignant Cellular Infiltrate,Multifocal superficial basal cell carcinoma
29582,Malignant Cellular Infiltrate,Transitional cell carcinoma in situ
29583,Malignant Cellular Infiltrate,Papillary transitional cell carcinoma
29584,Malignant Cellular Infiltrate,"Polycythemia Vera, Polycythemic Phase"
29585,Malignant Cellular Infiltrate,"Carcinoma, diffuse type"
29586,Low Grade Neuroendocrine Lesion,Carcinoid tumor of appendix
29587,Malignant Cellular Infiltrate,Chromophobe Renal Cell Carcinoma
29588,Malignant Cellular Infiltrate,Glycogen-rich carcinoma
29589,Malignant Cellular Infiltrate,Secretory breast carcinoma
29590,Malignant Cellular Infiltrate,Invasive Ductal Breast Carcinoma
29591,Malignant Cellular Infiltrate,"Pheochromocytoma, malignant"
29592,Malignant Cellular Infiltrate,"Malignant melanoma, regressing"
29593,Benign Cellular Infiltrate,Benign neoplasm of soft tissue
29594,Malignant Cellular Infiltrate,Infantile fibrosarcoma
29595,Benign Cellular Infiltrate,Elastofibroma
29596,Malignant Cellular Infiltrate,Sporadic Retinoblastoma
29597,Malignant Cellular Infiltrate,Low grade appendiceal mucinous neoplasm
29598,Benign Cellular Infiltrate,Juxtacortical chondroma
29599,Malignant Cellular Infiltrate,Myeloid leukemia associated with Down Syndrome
29600,Malignant Cellular Infiltrate,Eccrine ductal carcinoma
29601,Malignant Cellular Infiltrate,Ductal Eccrine Carcinoma with Squamous Metaplasia
29602,Malignant Cellular Infiltrate,Chronic myeloproliferative disorder
29603,Malignant Cellular Infiltrate,Small Intestinal Undifferentiated Carcinoma
29604,Well Differentiated Neuroendocrine Lesion,Appendix Tubular Carcinoid
29605,Malignant Cellular Infiltrate,Colorectal Signet Ring Cell Carcinoma
29606,Malignant Cellular Infiltrate,Rectosigmoid Mucinous Adenocarcinoma
29607,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder
29608,Malignant Cellular Infiltrate,Pleomorphic Hepatocellular Carcinoma
29609,Malignant Cellular Infiltrate,Sarcomatoid Hepatocellular Carcinoma
29610,Benign Cellular Infiltrate,Senile angioma
29611,Benign Cellular Infiltrate,Benign neoplasm of sphenoidal sinus
29612,Malignant Cellular Infiltrate,Angiosarcoma of liver
29613,Low Grade Neuroendocrine Lesion,Carcinoid tumor of pancreas
29614,Malignant Cellular Infiltrate,Clear cell squamous cell carcinoma of skin
29615,Benign Cellular Infiltrate,Dartoic myoma
29616,Malignant Cellular Infiltrate,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
29617,Malignant Cellular Infiltrate,Cervical Adenosquamous Carcinoma
29618,Malignant Cellular Infiltrate,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other"
29619,Malignant Cellular Infiltrate,Cutaneous T Lymphoblastic Leukemia/Lymphoma
29620,Malignant Cellular Infiltrate,Cutaneous Lymphomatoid Granulomatosis
29621,Malignant Cellular Infiltrate,Stage 0is Ureter Cancer AJCC v7
29622,Malignant Cellular Infiltrate,Hydroa vacciniforme-like lymphoma
29623,Malignant Cellular Infiltrate,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
29624,Malignant Cellular Infiltrate,Adenocarcinoma of lacrimal gland
29625,Malignant Cellular Infiltrate,Lung Lymphoepithelioma-Like Carcinoma
29626,Benign Cellular Infiltrate,chondroma of lung
29627,Malignant Cellular Infiltrate,Lung Synovial Sarcoma
29628,Malignant Cellular Infiltrate,Lung Melanoma
29629,Malignant Cellular Infiltrate,Pleural Epithelioid Mesothelioma
29630,Malignant Cellular Infiltrate,Malignant neoplasm of respiratory system
29631,Malignant Cellular Infiltrate,NUT midline carcinoma
29632,Malignant Cellular Infiltrate,Malignant tumor of dermis
29633,Benign Cellular Infiltrate,Ventricular myxoma
29634,Malignant Cellular Infiltrate,Cardiac Rhabdomyosarcoma
29635,Malignant Cellular Infiltrate,Secondary malignant neoplasm of peritoneum
29636,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Microadenoma
29637,Well Differentiated Neuroendocrine Lesion,Non functioning pancreatic endocrine tumor
29638,Well Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2
29639,Malignant Cellular Infiltrate,Pancreatic Mixed Adenoneuroendocrine Carcinoma
29640,Malignant Cellular Infiltrate,Secondary malignant neoplasm of eye
29641,Malignant Cellular Infiltrate,Stage 0 Oral Cavity Cancer AJCC v6 and v7
29642,Benign Cellular Infiltrate,Benign neoplasm of glottis
29643,Benign Cellular Infiltrate,Benign neoplasm of myocardium
29644,Malignant Cellular Infiltrate,Malignant neoplasm of meninges
29645,Benign Cellular Infiltrate,Dermoid cyst of skin
29646,Low Grade Neuroendocrine Lesion,Gastric Carcinoid Tumor
29647,Malignant Cellular Infiltrate,Malignant melanoma of anus
29648,Malignant Cellular Infiltrate,Brain Glioblastoma
29649,Benign Cellular Infiltrate,Lipoma of breast
29650,Malignant Cellular Infiltrate,Malignant tumor of external ear
29651,Malignant Cellular Infiltrate,Choroid Plexus Carcinoma
29652,Benign Cellular Infiltrate,Intravascular fasciitis
29653,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma
29654,Malignant Cellular Infiltrate,Malignant neoplasm of cervical part of esophagus
29655,Benign Cellular Infiltrate,Benign neoplasm of kidney
29656,Malignant Cellular Infiltrate,Malignant neoplasm of sweat gland
29657,Malignant Cellular Infiltrate,Thyroid carcinoma
29658,Benign Cellular Infiltrate,Adrenal Cortex Adenomatoid Tumor
29659,Malignant Cellular Infiltrate,Malignant neoplasm of soft tissue
29660,Malignant Cellular Infiltrate,Carcinoma of lung
29661,Benign Cellular Infiltrate,Benign neoplasm of pyriform sinus
29662,Malignant Cellular Infiltrate,Secondary malignant neoplasm of trachea
29663,Malignant Cellular Infiltrate,Malignant lymphoma of spleen
29664,Malignant Cellular Infiltrate,Secondary malignant neoplasm of heart
29665,Benign Cellular Infiltrate,Benign neoplasm of spleen
29666,Benign Cellular Infiltrate,Venous Angioleiomyoma
29667,Benign Cellular Infiltrate,Extracardiac Rhabdomyoma
29668,Malignant Cellular Infiltrate,Soft Palate Squamous Cell Carcinoma
29669,Malignant Cellular Infiltrate,Thyroid Hurthle Cell Carcinoma
29670,Malignant Cellular Infiltrate,Non-hodgkin lymphoma of colon
29671,Malignant Cellular Infiltrate,Desmoplastic Medulloblastoma
29672,Malignant Cellular Infiltrate,Bladder adenocarcinoma recurrent
29673,Malignant Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7
29674,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma
29675,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
29676,Malignant Cellular Infiltrate,Pancreatic carcinoma resectable
29677,Malignant Cellular Infiltrate,sarcoma of spinal cord
29678,Malignant Cellular Infiltrate,High Grade Mucoepidermoid Breast Carcinoma
29679,Malignant Cellular Infiltrate,Malignant Breast Eccrine Spiradenoma
29680,Malignant Cellular Infiltrate,Angiosarcoma of the breast
29681,Malignant Cellular Infiltrate,leiomyosarcoma of breast
29682,Malignant Cellular Infiltrate,Breast Rhabdomyosarcoma
29683,Malignant Cellular Infiltrate,Stage IIC Ovarian Carcinoma
29684,Malignant Cellular Infiltrate,Ovarian Transitional Cell Carcinoma
29685,Malignant Cellular Infiltrate,Gastric Cardia Adenocarcinoma
29686,Malignant Cellular Infiltrate,BALT lymphoma
29687,Malignant Cellular Infiltrate,Metastatic Meningioma
29688,Secondary Lesion,Metastatic Meningioma
29689,Malignant Cellular Infiltrate,Peripheral Intraneural Angiosarcoma
29690,Malignant Cellular Infiltrate,Early Unfavorable Non-Hodgkin Lymphoma
29691,Malignant Cellular Infiltrate,adenoid cystic carcinoma of esophagus
29692,Benign Cellular Infiltrate,Hemangioma of breast
29693,Malignant Cellular Infiltrate,HER2-positive carcinoma of breast
29694,Benign Cellular Infiltrate,Ectopic hamartomatous thymoma
29695,Malignant Cellular Infiltrate,Osteosarcoma of bone
29696,Benign Cellular Infiltrate,Parotid Gland Hemangioma
29697,Malignant Cellular Infiltrate,Medulloblastoma with Leptomeningeal Spread
29698,Malignant Cellular Infiltrate,Cerebellar Vermis Medulloblastoma
29699,Malignant Cellular Infiltrate,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified"
29700,Malignant Cellular Infiltrate,Chordoma of clivus
29701,Malignant Cellular Infiltrate,Basaloid squamous cell carcinoma
29702,Malignant Cellular Infiltrate,adenosquamous carcinoma of skin
29703,Malignant Cellular Infiltrate,Keratinizing Paranasal Sinus Squamous Cell Carcinoma
29704,Malignant Cellular Infiltrate,Clear cell odontogenic carcinoma
29705,Malignant Cellular Infiltrate,Laryngeal Giant Cell Carcinoma
29706,Malignant Cellular Infiltrate,Kadish Stage C Olfactory Neuroblastoma
29707,Malignant Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma
29708,Malignant Cellular Infiltrate,Meningeal Gliomatosis
29709,Malignant Cellular Infiltrate,Intracranial Extraskeletal Myxoid Chondrosarcoma
29710,Malignant Cellular Infiltrate,Stage IIIA Gastric Carcinoma
29711,Malignant Cellular Infiltrate,Colon Mucosa-Associated Lymphoid Tissue Lymphoma
29712,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma
29713,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Dermoid Cyst
29714,Malignant Cellular Infiltrate,Colon Kaposi Sarcoma
29715,Malignant Cellular Infiltrate,Cecum Non-Hodgkin Lymphoma
29716,Malignant Cellular Infiltrate,Prostate Stromal Sarcoma
29717,Malignant Cellular Infiltrate,Rectal Kaposi Sarcoma
29718,Malignant Cellular Infiltrate,Malignant Eccrine Neoplasm
29719,Malignant Cellular Infiltrate,leiomyosarcoma of anus
29720,Malignant Cellular Infiltrate,Adenocarcinoma of anal glands
29721,Secondary Lesion,Anal cancer metastatic
29722,Malignant Cellular Infiltrate,Cutaneous Liposarcoma
29723,Malignant Cellular Infiltrate,Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma
29724,Malignant Cellular Infiltrate,Childhood Anaplastic Large Cell Lymphoma
29725,Malignant Cellular Infiltrate,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
29726,Malignant Cellular Infiltrate,Gastric Hodgkin's Lymphoma
29727,Malignant Cellular Infiltrate,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
29728,Malignant Cellular Infiltrate,Esophageal Non-Hodgkin Lymphoma
29729,Malignant Cellular Infiltrate,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7
29730,Malignant Cellular Infiltrate,adenosquamous carcinoma of pancreas
29731,Malignant Cellular Infiltrate,Acinar cell cystadenocarcinoma
29732,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v6
29733,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v7
29734,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Adult Brain
29735,Malignant Cellular Infiltrate,Liver Extraskeletal Osteosarcoma
29736,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
29737,Malignant Cellular Infiltrate,Stage IV Lip Cancer AJCC v6 and v7
29738,Malignant Cellular Infiltrate,Stage IVA Lip Cancer AJCC v6 and v7
29739,Malignant Cellular Infiltrate,Stage II Oral Cavity Cancer AJCC v6 and v7
29740,Malignant Cellular Infiltrate,Stage III Oral Cavity Cancer AJCC v6 and v7
29741,Malignant Cellular Infiltrate,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7
29742,Malignant Cellular Infiltrate,Stage I Major Salivary Gland Cancer AJCC v7
29743,Malignant Cellular Infiltrate,Stage II Major Salivary Gland Cancer AJCC v7
29744,Malignant Cellular Infiltrate,Parotid Gland Kaposi Sarcoma
29745,Malignant Cellular Infiltrate,Minor Salivary Gland Squamous Cell Carcinoma
29746,Malignant Cellular Infiltrate,ACTH-Producing Pituitary Gland Carcinoma
29747,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal Carcinoma AJCC v7
29748,Benign Cellular Infiltrate,Oropharyngeal Polyp
29749,Malignant Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v7
29750,Malignant Cellular Infiltrate,Stage IVC Pharyngeal Carcinoma
29751,Malignant Cellular Infiltrate,Stage IVB Laryngeal Cancer AJCC v7
29752,Malignant Cellular Infiltrate,Stage I Paranasal Sinus Cancer
29753,Malignant Cellular Infiltrate,Stage IV Nasal Cavity Carcinoma AJCC v7
29754,Malignant Cellular Infiltrate,Secondary malignant neoplasm of hypopharynx
29755,Benign Cellular Infiltrate,leiomyoma of trachea
29756,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
29757,Malignant Cellular Infiltrate,Maxillary Sinus Squamous Cell Carcinoma
29758,Malignant Cellular Infiltrate,Iris Spindle Cell Melanoma
29759,Malignant Cellular Infiltrate,Choroid Spindle Cell Melanoma
29760,Malignant Cellular Infiltrate,Intermediate Cell Type Choroid Melanoma
29761,Malignant Cellular Infiltrate,Ciliary Body Epithelioid Cell Melanoma
29762,Malignant Cellular Infiltrate,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7
29763,Malignant Cellular Infiltrate,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7
29764,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
29765,Malignant Cellular Infiltrate,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
29766,Malignant Cellular Infiltrate,Renal Pelvis Carcinoma
29767,Malignant Cellular Infiltrate,Stage 0 Ureter Cancer AJCC v7
29768,Malignant Cellular Infiltrate,adenocarcinoma of urethra
29769,Benign Cellular Infiltrate,Urethral Leiomyoma
29770,Malignant Cellular Infiltrate,liposarcoma of kidney
29771,Malignant Cellular Infiltrate,Stage 0 Renal Pelvis Cancer AJCC v7
29772,Malignant Cellular Infiltrate,Collecting Duct Carcinoma of the Kidney
29773,Malignant Cellular Infiltrate,Stage 0a Ureter Cancer AJCC v7
29774,Malignant Cellular Infiltrate,"Salivary Gland Adenocarcinoma, Not Otherwise Specified"
29775,Malignant Cellular Infiltrate,Central Nervous System Carcinoma
29776,Malignant Cellular Infiltrate,embryonal rhabdomyosarcoma of orbit
29777,Malignant Cellular Infiltrate,Anterior Tongue Carcinoma
29778,Malignant Cellular Infiltrate,Bowen's Disease
29779,Malignant Cellular Infiltrate,Stage IIIC Ovarian Cancer
29780,Malignant Cellular Infiltrate,Fallopian Tube Squamous Cell Carcinoma
29781,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation"
29782,Malignant Cellular Infiltrate,Stage IA Cervical Cancer AJCC v6 and v7
29783,Malignant Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v6
29784,Malignant Cellular Infiltrate,Stage IIIA Cervical Carcinoma
29785,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v6 and v7
29786,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma
29787,Malignant Cellular Infiltrate,Cervical Clear Cell Adenocarcinoma
29788,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed
29789,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Seminoma
29790,Benign Cellular Infiltrate,Mature Testicular Teratoma
29791,Malignant Cellular Infiltrate,Scrotal Carcinoma
29792,Malignant Cellular Infiltrate,Malignant Intrathoracic Paravertebral Paraganglioma
29793,Well Differentiated Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1
29794,Low Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1
29795,Malignant Cellular Infiltrate,Thymic Basaloid Carcinoma
29796,Malignant Cellular Infiltrate,Thymic Clear Cell Carcinoma
29797,Malignant Cellular Infiltrate,Inflammatory malignant fibrous histiocytoma
29798,Benign Cellular Infiltrate,Benign Smooth Muscle Neoplasm
29799,Malignant Cellular Infiltrate,Squamous cell carcinoma in situ with questionable stromal invasion
29800,Well Differentiated Neuroendocrine Lesion,"Gastrinoma, malignant"
29801,Well Differentiated Neuroendocrine Lesion,"Somatostatinoma, malignant"
29802,Malignant Cellular Infiltrate,Parietal cell carcinoma
29803,Malignant Cellular Infiltrate,Papillary mucinous cystadenocarcinoma
29804,Benign Cellular Infiltrate,Synovial Hemangioma
29805,Malignant Cellular Infiltrate,Malignant Synovial Neoplasm
29806,Malignant Cellular Infiltrate,Malignant tenosynovial giant cell tumor
29807,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Choriocarcinoma
29808,Malignant Cellular Infiltrate,Glandular malignant peripheral nerve sheath tumor
29809,Benign Cellular Infiltrate,Myxoma
29810,Malignant Cellular Infiltrate,leiomyosarcoma of mediastinum
29811,Malignant Cellular Infiltrate,Mediastinal Neuroblastoma
29812,Malignant Cellular Infiltrate,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum
29813,Malignant Cellular Infiltrate,malignant lymphoma of mediastinum
29814,Benign Cellular Infiltrate,Benign Mediastinal Psammomatous Schwannoma
29815,Malignant Cellular Infiltrate,Stage 1 Neuroblastoma
29816,Malignant Cellular Infiltrate,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
29817,Malignant Cellular Infiltrate,Ampulla of Vater Signet Ring Cell Carcinoma
29818,Malignant Cellular Infiltrate,Stage IIB Lung Large Cell Carcinoma AJCC v7
29819,Malignant Cellular Infiltrate,Stage IB Lung Adenosquamous Carcinoma AJCC v7
29820,Malignant Cellular Infiltrate,Stage IIB Lung Adenosquamous Carcinoma AJCC v7
29821,Malignant Cellular Infiltrate,Adenocarcinoma with neuroendocrine differentiation
29822,Malignant Cellular Infiltrate,Gonadal Polyembryoma
29823,Malignant Cellular Infiltrate,Stage II Lung Small Cell Carcinoma AJCC v7
29824,Malignant Cellular Infiltrate,Stage III Lung Small Cell Carcinoma AJCC v7
29825,Malignant Cellular Infiltrate,"Retinoblastoma, undifferentiated"
29826,Malignant Cellular Infiltrate,"Perineurioma, malignant"
29827,Malignant Cellular Infiltrate,Stage IIB Lung Squamous Cell Carcinoma AJCC v7
29828,Malignant Cellular Infiltrate,Occult Lung Adenocarcinoma
29829,Malignant Cellular Infiltrate,Stage II Bone Sarcoma AJCC v7
29830,Malignant Cellular Infiltrate,Stage IVA Bone Sarcoma AJCC v7
29831,"Fully Differentiated ""Adult-Type"" Tissues Present",Benign Teratoma
29832,Malignant Cellular Infiltrate,Chest Wall Solitary Plasmacytoma
29833,Malignant Cellular Infiltrate,Sternal Lymphoma
29834,Malignant Cellular Infiltrate,Hereditary Non-Polyposis Colon Cancer Type 2
29835,Tumor Vascular Invasion,Malignant Pancreatic Somatostatinoma
29836,Malignant Cellular Infiltrate,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7
29837,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Vipoma
29838,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Immature Teratoma
29839,Malignant Cellular Infiltrate,Gastric Pylorus Carcinoma
29840,Benign Cellular Infiltrate,Cutaneous Fibrous Histiocytoma
29841,Benign Cellular Infiltrate,Benign Cutaneous Fibroblastic Neoplasm
29842,Malignant Cellular Infiltrate,sarcoma of accessory sinus
29843,Malignant Cellular Infiltrate,High Grade Paranasal Sinus Sarcoma
29844,Malignant Cellular Infiltrate,Choroid Spindle Cell Type B Melanoma
29845,Malignant Cellular Infiltrate,Early Unfavorable Hodgkin Lymphoma
29846,Malignant Cellular Infiltrate,Advanced Unfavorable Hodgkin Lymphoma
29847,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1
29848,Malignant Cellular Infiltrate,Anaplastic large B-cell lymphoma
29849,Malignant Cellular Infiltrate,Plasmacytoma
29850,Malignant Cellular Infiltrate,Sweat gland carcinoma
29851,Malignant Cellular Infiltrate,Nonanaplastic Kidney Wilms Tumor
29852,Malignant Cellular Infiltrate,Anaplastic Kidney Wilms Tumor
29853,Benign Cellular Infiltrate,Neurothekeoma
29854,Malignant Cellular Infiltrate,ISS Stage III Plasma Cell Myeloma
29855,Malignant Cellular Infiltrate,Mixed Hepatoblastoma with Teratoid Features
29856,Malignant Cellular Infiltrate,Adult Grade III Meningioma
29857,Malignant Cellular Infiltrate,Postsurgical Stage I Hepatoblastoma
29858,Malignant Cellular Infiltrate,Immunoglobulin deposition disease
29859,Malignant Cellular Infiltrate,Primary chondrosarcoma of bone
29860,Malignant Cellular Infiltrate,Grade I Nodular Sclerosis Hodgkin's Lymphoma
29861,Malignant Cellular Infiltrate,Triple-Negative Breast Carcinoma
29862,Malignant Cellular Infiltrate,Smoldering Adult T-Cell Leukemia/Lymphoma
29863,Malignant Cellular Infiltrate,Chronic Adult T-Cell Leukemia/Lymphoma
29864,Malignant Cellular Infiltrate,Lymphoepithelioid lymphoma (clinical)
29865,Malignant Cellular Infiltrate,Anaplastic small cell lymphoma
29866,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma with Variable Clinical Course
29867,Malignant Cellular Infiltrate,Grade 1 Cutaneous Follicular Lymphoma
29868,Malignant Cellular Infiltrate,Blastoid Variant Mantle Cell Lymphoma
29869,Malignant Cellular Infiltrate,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder
29870,Malignant Cellular Infiltrate,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma
29871,Malignant Cellular Infiltrate,Mantle cell lymphoma of spleen
29872,Malignant Cellular Infiltrate,Splenic T Lymphoblastic Lymphoma
29873,Malignant Cellular Infiltrate,Malignant Pleural Mesothelioma
29874,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma
29875,Malignant Cellular Infiltrate,Anal margin Paget's disease
29876,Malignant Cellular Infiltrate,Malignant neoplasm of larynx
29877,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Carcinoma
29878,Malignant Cellular Infiltrate,Stage II Renal Pelvis and Ureter Cancer AJCC v7
29879,Malignant Cellular Infiltrate,Angioimmunoblastic Lymphadenopathy
29880,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pharynx
29881,Malignant Cellular Infiltrate,Stage I Prostate Carcinoma
29882,Malignant Cellular Infiltrate,Renal medullary carcinoma
29883,Malignant Cellular Infiltrate,Secondary malignant neoplasm of urethra
29884,Malignant Cellular Infiltrate,Combined Lung Carcinoma
29885,Malignant Cellular Infiltrate,Stage IV Vaginal Cancer AJCC v6 and v7
29886,Malignant Cellular Infiltrate,Primary cerebral lymphoma
29887,Malignant Cellular Infiltrate,Recurrent Carcinoma
29888,Malignant Cellular Infiltrate,Localized Carcinoma
29889,Malignant Cellular Infiltrate,Intracystic Papillary Breast Carcinoma
29890,Malignant Cellular Infiltrate,malignant ganglioneuroblastoma of adrenal gland
29891,Malignant Cellular Infiltrate,Carcinoma in situ in a polyp
29892,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous and osseous metaplasia
29893,Malignant Cellular Infiltrate,Childhood Rhabdomyosarcoma
29894,Malignant Cellular Infiltrate,Squamous cell carcinoma of penis
29895,Malignant Cellular Infiltrate,Prostate Sarcoma
29896,Malignant Cellular Infiltrate,Choriocarcinoma of the Testis
29897,Malignant Cellular Infiltrate,Stage IIIA Breast Carcinoma
29898,Malignant Cellular Infiltrate,Superior Sulcus Lung Carcinoma
29899,Malignant Cellular Infiltrate,Stage 0 Gastric Cancer AJCC v6 and v7
29900,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v6
29901,Malignant Cellular Infiltrate,Mycosis fungoides stage III
29902,Malignant Cellular Infiltrate,Cervix carcinoma recurrent
29903,Malignant Cellular Infiltrate,Solitary Osseous Plasmacytoma
29904,Malignant Cellular Infiltrate,Adult Synovial Sarcoma
29905,Malignant Cellular Infiltrate,Recurrent Adult Soft Tissue Sarcoma
29906,Malignant Cellular Infiltrate,Recurrent ovarian cancer
29907,Malignant Cellular Infiltrate,Localized Resectable Neuroblastoma
29908,Well Differentiated Neuroendocrine Lesion,Regional Digestive System Neuroendocrine Tumor G1
29909,Malignant Cellular Infiltrate,Mesothelioma malignant recurrent
29910,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 2
29911,Malignant Cellular Infiltrate,Localized Resectable Adult Liver Carcinoma
29912,Malignant Cellular Infiltrate,Recurrent Adult Acute Lymphoblastic Leukemia
29913,Malignant Cellular Infiltrate,Localized Extrahepatic Bile Duct Carcinoma
29914,Malignant Cellular Infiltrate,Stage I Carcinoma of Bladder
29915,Malignant Cellular Infiltrate,Stage II Cutaneous Melanoma AJCC v6 and v7
29916,Borderline Lesion,Grade III Lymphomatoid Granulomatosis
29917,Borderline Lesion,Recurrent Lymphomatoid Granulomatosis
29918,Malignant Cellular Infiltrate,Paget Disease of the Breast with Invasive Ductal Carcinoma
29919,Malignant Cellular Infiltrate,Childhood Pleomorphic Rhabdomyosarcoma
29920,Malignant Cellular Infiltrate,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features
29921,Malignant Cellular Infiltrate,Childhood Acute Myelomonocytic Leukemia
29922,Malignant Cellular Infiltrate,Childhood Acute Megakaryoblastic Leukemia
29923,Malignant Cellular Infiltrate,mucinous adenocarcinoma of rectum
29924,Malignant Cellular Infiltrate,High Grade Salivary Gland Carcinoma
29925,Malignant Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
29926,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma associated with chronic inflammation
29927,Malignant Cellular Infiltrate,Plasmablastic Lymphoma of the Oral Mucosa
29928,Malignant Cellular Infiltrate,Pediatric follicular lymphoma
29929,Malignant Cellular Infiltrate,Refractory Hairy Cell Leukemia
29930,Malignant Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma
29931,Malignant Cellular Infiltrate,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified"
29932,Malignant Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7
29933,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged
29934,Malignant Cellular Infiltrate,Hyperdiploid B Acute Lymphoblastic Leukemia
29935,Malignant Cellular Infiltrate,Follicular T-cell lymphoma
29936,Malignant Cellular Infiltrate,Malignant Ovarian Sex Cord-Stromal Tumor
29937,Malignant Cellular Infiltrate,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma
29938,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage I
29939,Malignant Cellular Infiltrate,Recurrent Ovarian Germ Cell Tumor
29940,Malignant Cellular Infiltrate,Childhood Malignant Peripheral Nerve Sheath Tumor
29941,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Unknown Primary
29942,Malignant Cellular Infiltrate,Stage IV Adult Non-Hodgkin Lymphoma
29943,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage II
29944,Malignant Cellular Infiltrate,Stage II Adult Burkitt Lymphoma
29945,Malignant Cellular Infiltrate,Ann Arbor Stage III Grade 2 Follicular Lymphoma
29946,Malignant Cellular Infiltrate,Ann Arbor Stage IV Grade 2 Follicular Lymphoma
29947,Malignant Cellular Infiltrate,Recurrent Grade 1 Follicular Lymphoma
29948,Malignant Cellular Infiltrate,Recurrent Adult Immunoblastic Lymphoma
29949,Malignant Cellular Infiltrate,Lower Gingival Squamous Cell Carcinoma
29950,Malignant Cellular Infiltrate,Upper Gingival Squamous Cell Carcinoma
29951,Malignant Cellular Infiltrate,Posterior Tongue Squamous Cell Carcinoma
29952,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage I
29953,Malignant Cellular Infiltrate,Stage IV Lip Basal Cell Carcinoma
29954,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity recurrent
29955,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia B/myeloid
29956,Malignant Cellular Infiltrate,NK-lymphoblastic leukemia/lymphoma
29957,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage III
29958,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
29959,Malignant Cellular Infiltrate,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
29960,Malignant Cellular Infiltrate,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
29961,Malignant Cellular Infiltrate,basaloid carcinoma of anus
29962,Malignant Cellular Infiltrate,Refractory Neutropenia
29963,Malignant Cellular Infiltrate,Refractory anemia with ring sideroblasts associated with marked thrombocytosis
29964,Malignant Cellular Infiltrate,AIDS-Related Primary Central Nervous System Lymphoma
29965,Malignant Cellular Infiltrate,Immunoblastic lymphoma associated with AIDS
29966,Benign Cellular Infiltrate,Meyerson Nevus
29967,Malignant Cellular Infiltrate,Giant Cell Fibrous Histiocytoma
29968,Malignant Cellular Infiltrate,Malignant Ovarian Granulosa Cell Tumor
29969,Malignant Cellular Infiltrate,Carcinoma of base of tongue
29970,Malignant Cellular Infiltrate,"Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"
29971,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
29972,Malignant Cellular Infiltrate,Stage I Indolent Adult Non-Hodgkin Lymphoma
29973,Malignant Cellular Infiltrate,Mantle cell lymphoma stage III
29974,Malignant Cellular Infiltrate,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma
29975,Malignant Cellular Infiltrate,Stage IV Indolent Adult Non-Hodgkin Lymphoma
29976,Malignant Cellular Infiltrate,Recurrent Aggressive Adult Non-Hodgkin Lymphoma
29977,Malignant Cellular Infiltrate,Hereditary Melanoma
29978,Malignant Cellular Infiltrate,Malignant Neoplasm with Regional Lymph Node Involvement
29979,Malignant Cellular Infiltrate,Stage II Non-Hodgkin Lymphoma
29980,Malignant Cellular Infiltrate,Stage IV Non-Hodgkin Lymphoma
29981,Benign Cellular Infiltrate,Hemangioma of subcutaneous tissue
29982,Benign Cellular Infiltrate,Hemangioma of spleen
29983,Malignant Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland
29984,Malignant Cellular Infiltrate,"Neoplasms, Unknown Primary"
29985,Malignant Cellular Infiltrate,Stage IIA Adult Soft Tissue Sarcoma AJCC v7
29986,Malignant Cellular Infiltrate,Stage IIB Soft Tissue Sarcoma AJCC v7
29987,Malignant Cellular Infiltrate,Stage IA Merkel Cell Carcinoma AJCC v7
29988,Malignant Cellular Infiltrate,Stage IIIA Merkel Cell Carcinoma AJCC v7
29989,Malignant Cellular Infiltrate,Esophageal adenocarcinoma recurrent
29990,Malignant Cellular Infiltrate,Stage I Esophageal Adenocarcinoma AJCC v7
29991,Malignant Cellular Infiltrate,Small intestine carcinoma non-resectable
29992,Malignant Cellular Infiltrate,Small intestine carcinoma resectable
29993,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type recurrent
29994,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type refractory
29995,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma refractory
29996,Malignant Cellular Infiltrate,T-cell lymphoma stage I
29997,Malignant Cellular Infiltrate,T-cell lymphoma stage III
29998,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia refractory
29999,Malignant Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v7
30000,Malignant Cellular Infiltrate,Stage IB Uterine Sarcoma AJCC v7
30001,Malignant Cellular Infiltrate,Stage I Bone Cancer AJCC v7
30002,Malignant Cellular Infiltrate,Stage IIB Bone Cancer AJCC v7
30003,Malignant Cellular Infiltrate,Stage IVA Bone Cancer AJCC v7
30004,Malignant Cellular Infiltrate,Stage II Fallopian Tube Cancer
30005,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7
30006,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Polyembryoma AJCC v6 and v7
30007,Malignant Cellular Infiltrate,Stage I Ovarian Teratoma AJCC v6 and v7
30008,Malignant Cellular Infiltrate,Large cell lung cancer recurrent
30009,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
30010,Malignant Cellular Infiltrate,Stage 0 Lung Adenocarcinoma AJCC v6 and v7
30011,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage III
30012,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v6
30013,Malignant Cellular Infiltrate,Peripheral primitive neuroectodermal bone tumor
30014,Malignant Cellular Infiltrate,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7
30015,Malignant Cellular Infiltrate,Stage IIC Appendix Carcinoma AJCC v7
30016,Well Differentiated Neuroendocrine Lesion,Stage I Appendix Neuroendocrine Tumor AJCC v7
30017,Malignant Cellular Infiltrate,Stage I Acral Lentiginous Melanoma AJCC v7
30018,Malignant Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v7
30019,Malignant Cellular Infiltrate,Stage IVA Colorectal Cancer AJCC v7
30020,Malignant Cellular Infiltrate,Stage III Acral Lentiginous Melanoma AJCC v7
30021,Malignant Cellular Infiltrate,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7
30022,Malignant Cellular Infiltrate,Stage I Superficial Spreading Melanoma AJCC v7
30023,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma recurrent
30024,Malignant Cellular Infiltrate,Alveolar soft part sarcoma non-metastatic
30025,Well Differentiated Neuroendocrine Lesion,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7
30026,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7
30027,Malignant Cellular Infiltrate,Stage IIIA Gallbladder Cancer AJCC v7
30028,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v7
30029,Malignant Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v6 and v7
30030,Malignant Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v7
30031,Malignant Cellular Infiltrate,Stage IC Eyelid Carcinoma AJCC v7
30032,Malignant Cellular Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v7
30033,Malignant Cellular Infiltrate,Leukemic infiltration of skin
30034,Malignant Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7
30035,Malignant Cellular Infiltrate,Synovial sarcoma non-metastatic
30036,Malignant Cellular Infiltrate,malignant neoplasm of breast stage I
30037,Malignant Cellular Infiltrate,Stage IIIC Breast Cancer AJCC v7
30038,Malignant Cellular Infiltrate,B-cell lymphoma stage III
30039,Malignant Cellular Infiltrate,Stage II Diffuse Large B-Cell Lymphoma
30040,Malignant Cellular Infiltrate,Ann Arbor Stage I Follicular Lymphoma
30041,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage II
30042,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage I
30043,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage I
30044,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v7
30045,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v7
30046,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage IV
30047,Malignant Cellular Infiltrate,Testicular choriocarcinoma stage III
30048,Malignant Cellular Infiltrate,Stage III Oropharyngeal Carcinoma AJCC v7
30049,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v7
30050,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage IV
30051,Malignant Cellular Infiltrate,Testicular choriocarcinoma stage I
30052,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v7
30053,Malignant Cellular Infiltrate,Stage II Immature Testicular Teratoma AJCC v6 and v7
30054,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage II Immature Testicular Teratoma AJCC v6 and v7
30055,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v7
30056,Malignant Cellular Infiltrate,Stage III Renal Cell Cancer AJCC v7
30057,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma/leukemia
30058,Malignant Cellular Infiltrate,Endometrial adenocarcinoma metastatic
30059,Malignant Cellular Infiltrate,Vaginal adenocarcinoma metastatic
30060,Malignant Cellular Infiltrate,Stage IB Vulvar Cancer AJCC v7
30061,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v6
30062,Malignant Cellular Infiltrate,Stage I Uterine Corpus Cancer
30063,Malignant Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v7
30064,Malignant Cellular Infiltrate,Stage I Esophageal Cancer AJCC v7
30065,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage III
30066,Malignant Cellular Infiltrate,Ureter Carcinoma
30067,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v7
30068,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v7
30069,Malignant Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v7
30070,Malignant Cellular Infiltrate,Grade I Chondrosarcoma
30071,Malignant Cellular Infiltrate,High Grade Malignant Peripheral Nerve Sheath Tumor
30072,Malignant Cellular Infiltrate,Poorly Differentiated Angiosarcoma
30073,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v6 Stage
30074,Malignant Cellular Infiltrate,Pediatric Intraocular Retinoblastoma
30075,Malignant Cellular Infiltrate,Gallbladder Cancer by AJCC v6 Stage
30076,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v6 Stage
30077,Malignant Cellular Infiltrate,Oropharyngeal Carcinoma by AJCC v6 Stage
30078,Malignant Cellular Infiltrate,Laryngeal Cancer by AJCC v6 Stage
30079,Malignant Cellular Infiltrate,Stage III Childhood Lymphoblastic Lymphoma
30080,Well Differentiated Neuroendocrine Lesion,Pancreatic Gastrin-Producing Neuroendocrine Tumor
30081,Malignant Cellular Infiltrate,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
30082,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma AJCC v7
30083,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7
30084,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma AJCC v7
30085,Malignant Cellular Infiltrate,Sarcoma
30086,Malignant Cellular Infiltrate,Lung Cancer by AJCC v7 Stage
30087,Malignant Cellular Infiltrate,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma
30088,Malignant Cellular Infiltrate,combined small cell carcinoma of lung
30089,Malignant Cellular Infiltrate,Childhood Angiosarcoma
30090,Malignant Cellular Infiltrate,Stage IV Childhood Burkitt Lymphoma
30091,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma
30092,Malignant Cellular Infiltrate,Stage I Cervical Cancer AJCC v6 and v7
30093,Malignant Cellular Infiltrate,Stage IV Cervical Cancer AJCC v6 and v7
30094,Malignant Cellular Infiltrate,Stage II Uterine Corpus Cancer AJCC v6
30095,Malignant Cellular Infiltrate,Stage I Esophageal Cancer
30096,Malignant Cellular Infiltrate,Stage IV Esophagus Carcinoma
30097,Malignant Cellular Infiltrate,Stage I Adrenal Cortex Carcinoma AJCC v7
30098,Malignant Cellular Infiltrate,Esophageal Malignant Peripheral Nerve Sheath Tumor
30099,Malignant Cellular Infiltrate,Recurrent Childhood Malignant Germ Cell Tumor
30100,Malignant Cellular Infiltrate,Relapsed Hypopharynx Carcinoma
30101,Malignant Cellular Infiltrate,Inflammatory carcinoma of breast stage III
30102,Malignant Cellular Infiltrate,Recurrent Ureter Carcinoma
30103,Malignant Cellular Infiltrate,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
30104,Malignant Cellular Infiltrate,testicular leukemia
30105,Malignant Cellular Infiltrate,AIDS-Related Anal Carcinoma
30106,Malignant Cellular Infiltrate,"Dendritic Cell Sarcoma, Follicular"
30107,Malignant Cellular Infiltrate,"Dendritic Cell Sarcoma, Interdigitating"
30108,Malignant Cellular Infiltrate,Acute myeloid leukemia with abnormal marrow eosinophils
30109,Malignant Cellular Infiltrate,Acute Undifferentiated Leukemia
30110,Malignant Cellular Infiltrate,Malignant tumor of parathyroid gland
30111,Malignant Cellular Infiltrate,Malignant neoplasm of postcricoid region
30112,Malignant Cellular Infiltrate,pineoblastoma
30113,Malignant Cellular Infiltrate,Malignant neoplasm of tongue
30114,Malignant Cellular Infiltrate,Malignant neoplasm of hypopharynx recurrent
30115,Malignant Cellular Infiltrate,Ureteric cancer regional
30116,Malignant Cellular Infiltrate,Clitoral Carcinoma
30117,Malignant Cellular Infiltrate,Adult Brain Glioblastoma
30118,Malignant Cellular Infiltrate,Renal carcinoma
30119,Malignant Cellular Infiltrate,Sarcoma NCI Grade 1
30120,Malignant Cellular Infiltrate,Low Grade Sarcoma
30121,Malignant Cellular Infiltrate,Grade 1 Colorectal Adenocarcinoma
30122,Malignant Cellular Infiltrate,Grade 2 Colorectal Adenocarcinoma
30123,Malignant Cellular Infiltrate,Low Grade Ductal Breast Carcinoma In Situ
30124,Malignant Cellular Infiltrate,Laryngeal Adenoid Cystic Carcinoma
30125,Malignant Cellular Infiltrate,Adenosarcoma
30126,Malignant Cellular Infiltrate,Meningeal Lymphoma
30127,Malignant Cellular Infiltrate,Ann Arbor Stage III AIDS-Related Lymphoma
30128,Malignant Cellular Infiltrate,T-cell/histiocyte rich large B-cell lymphoma
30129,Poorly Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Carcinoma
30130,Malignant Cellular Infiltrate,Pancreatic Large Cell Neuroendocrine Carcinoma
30131,Well Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G1
30132,Chromogranin A Positive Neoplastic Cells Present,Non-Functioning Pancreatic Neuroendocrine Tumor G1
30133,Well Differentiated Neuroendocrine Lesion,Glucagonoma
30134,Malignant Cellular Infiltrate,Esophageal Mixed Adenoneuroendocrine Carcinoma
30135,Malignant Cellular Infiltrate,Esophageal Synovial Sarcoma
30136,Malignant Cellular Infiltrate,Gastric Neuroendocrine Carcinoma
30137,Malignant Cellular Infiltrate,Gastric Mixed Adenoneuroendocrine Carcinoma
30138,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor
30139,Intermediate Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2
30140,Well Differentiated Neuroendocrine Lesion,Small Intestinal Gangliocytic Paraganglioma
30141,Well Differentiated Neuroendocrine Lesion,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
30142,Intermediate Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2
30143,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor G2
30144,Intermediate Grade Neuroendocrine Lesion,Appendix Neuroendocrine Tumor G2
30145,Malignant Cellular Infiltrate,Colorectal Mantle Cell Lymphoma
30146,Malignant Cellular Infiltrate,Colorectal Sarcoma
30147,Low Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1
30148,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2
30149,Poorly Differentiated Neuroendocrine Lesion,neuroendocrine carcinoma of anal canal
30150,Malignant Cellular Infiltrate,undifferentiated carcinoma of liver
30151,Malignant Cellular Infiltrate,Kaposi's sarcoma of liver
30152,Malignant Cellular Infiltrate,Liver Synovial Sarcoma
30153,Malignant Cellular Infiltrate,Gallbladder Cribriform Carcinoma
30154,Malignant Cellular Infiltrate,Childhood Central Nervous System Neuroblastoma
30155,Malignant Cellular Infiltrate,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone
30156,Malignant Cellular Infiltrate,Hodgkin Lymphoma During Pregnancy
30157,Malignant Cellular Infiltrate,Adult Epithelioid Hemangioendothelioma
30158,Malignant Cellular Infiltrate,Secondary Central Nervous System Non-Hodgkin Lymphoma
30159,Malignant Cellular Infiltrate,Hodgkin's lymphoma of CNS
30160,Malignant Cellular Infiltrate,Stage II Childhood Anaplastic Large Cell Lymphoma
30161,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7
30162,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
30163,Malignant Cellular Infiltrate,Stage IIC Colon Cancer AJCC v7
30164,Malignant Cellular Infiltrate,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7
30165,Malignant Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v7
30166,Malignant Cellular Infiltrate,Stage IIIC Esophageal Cancer AJCC v7
30167,Malignant Cellular Infiltrate,BCLC Stage B Adult Hepatocellular Carcinoma
30168,Malignant Cellular Infiltrate,Distal Urethral Carcinoma
30169,Malignant Cellular Infiltrate,Recurrent Olfactory Neuroblastoma
30170,Malignant Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
30171,Malignant Cellular Infiltrate,Recurrent Combined Thymic Epithelial Neoplasm
30172,Malignant Cellular Infiltrate,Liver Adenosquamous Carcinoma
30173,Malignant Cellular Infiltrate,Childhood Malignant Penile Neoplasm
30174,Malignant Cellular Infiltrate,CIC-DUX Sarcoma
30175,Malignant Cellular Infiltrate,Malignant nipple neoplasm male
30176,Malignant Cellular Infiltrate,"Malignant neoplasm of kidney, except pelvis"
30177,Malignant Cellular Infiltrate,Soft Tissue Angiosarcoma
30178,Benign Cellular Infiltrate,"Perivascular epithelioid tumor, benign"
30179,Malignant Cellular Infiltrate,Grade II Chondrosarcoma
30180,Malignant Cellular Infiltrate,Grade III Chondrosarcoma
30181,Malignant Cellular Infiltrate,Secondary Central Chondrosarcoma
30182,Malignant Cellular Infiltrate,Acute Lymphoblastic Leukemia by Gene Expression Profile
30183,Malignant Cellular Infiltrate,ROSE Cluster 3
30184,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement
30185,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6
30186,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement
30187,Malignant Cellular Infiltrate,Childhood Spindle Cell Rhabdomyosarcoma
30188,Malignant Cellular Infiltrate,Fusion-Positive Alveolar Rhabdomyosarcoma
30189,Malignant Cellular Infiltrate,Childhood Choriocarcinoma
30190,Malignant Cellular Infiltrate,Childhood Embryonal Carcinoma
30191,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Mixed Germ Cell Tumor
30192,Malignant Cellular Infiltrate,Childhood Small Intestinal Leiomyosarcoma
30193,Malignant Cellular Infiltrate,Childhood Choroid Plexus Carcinoma
30194,Malignant Cellular Infiltrate,Double-Hit Lymphoma
30195,Malignant Cellular Infiltrate,Infant T Acute Lymphoblastic Leukemia
30196,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma
30197,Increased Cellularity Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
30198,Malignant Cellular Infiltrate,High Grade Broad Ligament Serous Adenocarcinoma
30199,Malignant Cellular Infiltrate,Oropharyngeal Poorly Differentiated Carcinoma
30200,Malignant Cellular Infiltrate,Uterine Corpus Rhabdomyosarcoma
30201,Malignant Cellular Infiltrate,"Endocervical Adenocarcinoma, Usual Type"
30202,Malignant Cellular Infiltrate,Vaginal Rhabdomyosarcoma
30203,Malignant Cellular Infiltrate,FIGO Stage II Ovarian Cancer
30204,Malignant Cellular Infiltrate,FIGO Stage IIIA2 Ovarian Cancer
30205,Malignant Cellular Infiltrate,Vulvar Small Cell Carcinoma
30206,Benign Cellular Infiltrate,Cutaneous neurofibroma
30207,Malignant Cellular Infiltrate,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative"
30208,Malignant Cellular Infiltrate,Cutaneous Malignant Melanoma 2
30209,Malignant Cellular Infiltrate,Glioblastoma
30210,Malignant Cellular Infiltrate,Glioblastoma with Primitive Neuronal Component
30211,Malignant Cellular Infiltrate,Small Cell Adenocarcinoma
30212,Malignant Cellular Infiltrate,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
30213,Malignant Cellular Infiltrate,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
30214,Malignant Cellular Infiltrate,Transitional cell carcinoma metastatic
30215,Malignant Cellular Infiltrate,Urothelial carcinoma urethra recurrent
30216,Primary Lesion,Ventricular Ependymal Tumor
30217,Primary Lesion,Ventricular and Brain Stem Ependymal Tumor
30218,Primary Lesion,"Occipital Lobe, Parietal Lobe, and Ventricular Ependymal Tumor"
30219,Primary Lesion,Third Ventricle Ependymal Tumor
30220,Primary Lesion,Fourth Ventricle and Brain Stem Ependymal Tumor
30221,Benign Cellular Infiltrate,Anastomosing Hemangioma
30222,Malignant Cellular Infiltrate,Unresectable Liposarcoma
30223,Malignant Cellular Infiltrate,Recurrent Endometrial Serous Adenocarcinoma
30224,Malignant Cellular Infiltrate,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
30225,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v8
30226,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v8
30227,Malignant Cellular Infiltrate,Stage IVC Major Salivary Gland Cancer AJCC v8
30228,Malignant Cellular Infiltrate,Recurrent Malignant Germ Cell Tumor
30229,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
30230,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v8
30231,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8
30232,Malignant Cellular Infiltrate,Locally Advanced Malignant Solid Neoplasm
30233,Malignant Cellular Infiltrate,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
30234,Malignant Cellular Infiltrate,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
30235,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage
30236,Malignant Cellular Infiltrate,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8
30237,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
30238,Malignant Cellular Infiltrate,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
30239,Malignant Cellular Infiltrate,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8
30240,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage
30241,Malignant Cellular Infiltrate,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
30242,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
30243,Malignant Cellular Infiltrate,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8
30244,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8
30245,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8
30246,Malignant Cellular Infiltrate,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8
30247,Malignant Cellular Infiltrate,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
30248,Malignant Cellular Infiltrate,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
30249,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
30250,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
30251,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Clinical Stage
30252,Malignant Cellular Infiltrate,Clinical Stage IV Gastric Cancer AJCC v8
30253,Malignant Cellular Infiltrate,Recurrent Head and Neck Squamous Cell Carcinoma
30254,Malignant Cellular Infiltrate,Small Intestinal Cancer by AJCC v7 Stage
30255,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v7 Stage
30256,Malignant Cellular Infiltrate,Stage IIIA Anal Cancer AJCC v8
30257,Malignant Cellular Infiltrate,Small Intestinal Adenocarcinoma by AJCC v8 Stage
30258,Malignant Cellular Infiltrate,Stage IIB Small Intestinal Adenocarcinoma AJCC v8
30259,Malignant Cellular Infiltrate,Stage III Small Intestinal Adenocarcinoma AJCC v8
30260,Malignant Cellular Infiltrate,Stage IV Small Intestinal Adenocarcinoma AJCC v8
30261,Malignant Cellular Infiltrate,Stage III Colorectal Cancer AJCC v8
30262,Malignant Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v8
30263,Malignant Cellular Infiltrate,Stage IVA Hepatocellular Carcinoma AJCC v8
30264,Malignant Cellular Infiltrate,Stage IV Intrahepatic Bile Duct Cancer AJCC v8
30265,Malignant Cellular Infiltrate,Stage IIIA Gallbladder Cancer AJCC v8
30266,Malignant Cellular Infiltrate,Stage II Hilar Cholangiocarcinoma AJCC v8
30267,Malignant Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v8
30268,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage
30269,Malignant Cellular Infiltrate,Stage 0 Distal Bile Duct Cancer AJCC v8
30270,Malignant Cellular Infiltrate,Stage III Distal Bile Duct Cancer AJCC v8
30271,Malignant Cellular Infiltrate,Stage IV Distal Bile Duct Cancer AJCC v8
30272,Malignant Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v8
30273,Malignant Cellular Infiltrate,Stage II Ampulla of Vater Cancer AJCC v8
30274,Well Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor
30275,Well Differentiated Neuroendocrine Lesion,Stage IV Colon Neuroendocrine Tumor AJCC v8
30276,Well Differentiated Neuroendocrine Lesion,Stage IIA Rectal Neuroendocrine Tumor AJCC v8
30277,Well Differentiated Neuroendocrine Lesion,Stage I Pancreatic Neuroendocrine Tumor AJCC v8
30278,Malignant Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v8
30279,Malignant Cellular Infiltrate,Unresectable Head and Neck Squamous Cell Carcinoma
30280,Malignant Cellular Infiltrate,Stage IA1 Lung Cancer AJCC v8
30281,Malignant Cellular Infiltrate,Stage IB Lung Cancer AJCC v8
30282,Malignant Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v8
30283,Malignant Cellular Infiltrate,Lung Adenosquamous Carcinoma by AJCC v7 Stage
30284,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
30285,Malignant Cellular Infiltrate,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
30286,Malignant Cellular Infiltrate,Gastrointestinal Stromal Tumor by AJCC v8 Stage
30287,Malignant Cellular Infiltrate,Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
30288,Malignant Cellular Infiltrate,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
30289,Malignant Cellular Infiltrate,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
30290,Malignant Cellular Infiltrate,Retroperitoneal Sarcoma by AJCC v8 Stage
30291,Malignant Cellular Infiltrate,Stage IIIB Retroperitoneal Sarcoma AJCC v8
30292,Malignant Cellular Infiltrate,Clinical Stage I Merkel Cell Carcinoma AJCC v8
30293,Malignant Cellular Infiltrate,Clinical Stage III Merkel Cell Carcinoma AJCC v8
30294,Malignant Cellular Infiltrate,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8
30295,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Stage
30296,Malignant Cellular Infiltrate,Pathologic Stage I Cutaneous Melanoma AJCC v8
30297,Malignant Cellular Infiltrate,Refractory Anal Carcinoma
30298,Malignant Cellular Infiltrate,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
30299,Malignant Cellular Infiltrate,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
30300,Malignant Cellular Infiltrate,High grade B-cell lymphoma
30301,Malignant Cellular Infiltrate,High Risk Myelodysplastic Syndrome
30302,Malignant Cellular Infiltrate,Breast implant-associated anaplastic large cell lymphoma
30303,Borderline Lesion,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract
30304,Malignant Cellular Infiltrate,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
30305,Malignant Cellular Infiltrate,Anatomic Stage IIIB Breast Cancer AJCC v8
30306,Malignant Cellular Infiltrate,Prognostic Stage I Breast Cancer AJCC v8
30307,Malignant Cellular Infiltrate,Prognostic Stage IB Breast Cancer AJCC v8
30308,Malignant Cellular Infiltrate,Prognostic Stage IIB Breast Cancer AJCC v8
30309,Malignant Cellular Infiltrate,Prognostic Stage III Breast Cancer AJCC v8
30310,Malignant Cellular Infiltrate,Stage I Vulvar Cancer AJCC v8
30311,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v8
30312,Malignant Cellular Infiltrate,Stage IVB Vulvar Cancer AJCC v8
30313,Malignant Cellular Infiltrate,Stage IA Vaginal Cancer AJCC v8
30314,Malignant Cellular Infiltrate,Stage IA Cervical Cancer AJCC v8
30315,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer AJCC v8
30316,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Cancer AJCC v8
30317,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Cancer AJCC v8
30318,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8
30319,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8
30320,Malignant Cellular Infiltrate,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
30321,Malignant Cellular Infiltrate,Stage I Uterine Corpus Adenosarcoma AJCC v8
30322,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Adenosarcoma AJCC v8
30323,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Adenosarcoma AJCC v8
30324,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer AJCC v8
30325,Malignant Cellular Infiltrate,Stage IIIA2 Ovarian Cancer AJCC v8
30326,Malignant Cellular Infiltrate,Stage IVB Ovarian Cancer AJCC v8
30327,Malignant Cellular Infiltrate,Stage II Fallopian Tube Cancer AJCC v8
30328,Malignant Cellular Infiltrate,Stage IIIA Fallopian Tube Cancer AJCC v8
30329,Malignant Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v8
30330,Malignant Cellular Infiltrate,Stage III Penile Cancer AJCC v8
30331,Malignant Cellular Infiltrate,Refractory Transformed Non-Hodgkin Lymphoma
30332,Malignant Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v8
30333,Malignant Cellular Infiltrate,Stage IB Testicular Cancer AJCC v8
30334,Malignant Cellular Infiltrate,Stage III Testicular Cancer AJCC v8
30335,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8
30336,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v8
30337,Well Differentiated Neuroendocrine Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm
30338,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v8
30339,Malignant Cellular Infiltrate,Stage I Bladder Cancer AJCC v8
30340,Malignant Cellular Infiltrate,Stage III Urethral Cancer AJCC v8
30341,Malignant Cellular Infiltrate,Eyelid Carcinoma by AJCC v8 Stage
30342,Malignant Cellular Infiltrate,Uveal Melanoma by AJCC v7 Stage
30343,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Clinical Stage
30344,Malignant Cellular Infiltrate,Clinical Stage I Retinoblastoma AJCC v8
30345,Malignant Cellular Infiltrate,Clinical Stage IV Retinoblastoma AJCC v8
30346,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
30347,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8
30348,Malignant Cellular Infiltrate,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
30349,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
30350,Malignant Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v8
30351,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8
30352,Malignant Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma AJCC v8
30353,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8
30354,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8
30355,Malignant Cellular Infiltrate,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8
30356,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8
30357,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8
30358,Malignant Cellular Infiltrate,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8
30359,Malignant Cellular Infiltrate,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8
30360,Malignant Cellular Infiltrate,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage
30361,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8
30362,Malignant Cellular Infiltrate,Childhood Hodgkin Lymphoma by Ann Arbor Stage
30363,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage
30364,Malignant Cellular Infiltrate,Marginal Zone Lymphoma by Ann Arbor Stage
30365,Malignant Cellular Infiltrate,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
30366,Malignant Cellular Infiltrate,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8
30367,Malignant Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8
30368,Malignant Cellular Infiltrate,RISS Stage II Plasma Cell Myeloma
30369,Malignant Cellular Infiltrate,Recurrent Rhabdoid Tumor
30370,Malignant Cellular Infiltrate,Refractory Hepatoblastoma
30371,Malignant Cellular Infiltrate,Refractory Medulloblastoma
30372,Malignant Cellular Infiltrate,Metastatic Bile Duct Carcinoma
30373,Malignant Cellular Infiltrate,Refractory Alveolar Rhabdomyosarcoma
30374,Malignant Cellular Infiltrate,Thymic Hepatoid Adenocarcinoma
30375,Malignant Cellular Infiltrate,Metastatic Well Differentiated Neuroendocrine Neoplasm
30376,Malignant Cellular Infiltrate,Refractory Gastric Carcinoma
30377,Malignant Cellular Infiltrate,Childhood Refractory Malignant Solid Neoplasm
30378,Malignant Cellular Infiltrate,Advanced B-Cell Neoplasm
30379,Malignant Cellular Infiltrate,Refractory Head and Neck Squamous Cell Carcinoma
30380,Malignant Cellular Infiltrate,Refractory Stage 0 Bladder Cancer AJCC v6 and v7
30381,Malignant Cellular Infiltrate,Refractory Synovial Sarcoma
30382,Malignant Cellular Infiltrate,MCD Diffuse Large B-Cell Lymphoma
30383,Malignant Cellular Infiltrate,Recurrent Acute Leukemia
30384,Malignant Cellular Infiltrate,Locally Advanced Melanoma
30385,Malignant Cellular Infiltrate,Advanced Uveal Melanoma
30386,Malignant Cellular Infiltrate,Thoracic Esophagus Squamous Cell Carcinoma
30387,Malignant Cellular Infiltrate,Distal Esophagus Squamous Cell Carcinoma
30388,Malignant Cellular Infiltrate,Advanced Laryngeal Squamous Cell Carcinoma
30389,Malignant Cellular Infiltrate,Platinum-Resistant Urothelial Carcinoma
30390,Malignant Cellular Infiltrate,Metastatic Bladder Urothelial Carcinoma
30391,Malignant Cellular Infiltrate,Refractory Malignant Male Reproductive System Neoplasm
30392,Malignant Cellular Infiltrate,Refractory Cutaneous Melanoma
30393,Borderline Lesion,IgM monoclonal gammopathy of uncertain significance
30394,Malignant Cellular Infiltrate,Resectable Liposarcoma
30395,Malignant Cellular Infiltrate,Resectable Dedifferentiated Liposarcoma
30396,Malignant Cellular Infiltrate,Resectable Neuroblastoma
30397,Malignant Cellular Infiltrate,Locally Advanced Bile Duct Carcinoma
30398,Malignant Cellular Infiltrate,Refractory Burkitt Leukemia
30399,Malignant Cellular Infiltrate,Resectable Pancreatic Ductal Adenocarcinoma
30400,Malignant Cellular Infiltrate,Metastatic Unresectable Sarcoma
30401,Malignant Cellular Infiltrate,Advanced Carcinoma
30402,Malignant Cellular Infiltrate,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
30403,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Spine
30404,Malignant Cellular Infiltrate,Refractory Liver Carcinoma
30405,Malignant Cellular Infiltrate,Refractory Small Intestinal Carcinoma
30406,Malignant Cellular Infiltrate,Metastatic Cervical Carcinoma
30407,Malignant Cellular Infiltrate,Recurrent Prostate Acinar Adenocarcinoma
30408,Malignant Cellular Infiltrate,Recurrent Paget Disease of the Anal Canal
30409,Malignant Cellular Infiltrate,Recurrent Salivary Duct Carcinoma
30410,Malignant Cellular Infiltrate,Recurrent Ovarian Clear Cell Adenocarcinoma
30411,Malignant Cellular Infiltrate,Recurrent Pancreatic Cystadenocarcinoma
30412,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma
30413,Malignant Cellular Infiltrate,Refractory Malignant Central Nervous System Neoplasm
30414,Malignant Cellular Infiltrate,Locally Advanced Squamous Cell Carcinoma
30415,Malignant Cellular Infiltrate,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified"
30416,Metastatic Lesion,Melanoma of Unknown Primary
30417,Secondary Lesion,Melanoma of Unknown Primary
30418,Primary Site Unknown,Melanoma of Unknown Primary
30419,Multihormonal Immunoreactivity Present in a Single Cell Type,Monomorphous Plurihormonal Pituitary Gland Adenoma
30420,Multihormonal Immunoreactivity Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma
30421,Epithelial Component Present,Resectable Renal Cell Carcinoma
30422,Malignant Cellular Infiltrate,Digestive System Large Cell Neuroendocrine Carcinoma
30423,Carcinomatous Component Present,Digestive System Large Cell Neuroendocrine Carcinoma
30424,Malignant Cellular Infiltrate,Advanced Well Differentiated Neuroendocrine Neoplasm
30425,Poorly Differentiated Neuroendocrine Lesion,Digestive System Small Cell Neuroendocrine Carcinoma
30426,Therapy-Related Toxicity,Transplant-Related Squamous Cell Carcinoma
30427,Recurrent disease,Recurrent Cutaneous Melanoma of the Extremity
30428,Metastatic Lesion,Advanced Cutaneous Melanoma of the Extremity
30429,Malignant Cellular Infiltrate,Recurrent Sarcoma of the Extremity
30430,Unresectable Mass,Locally Advanced Unresectable Carcinoma
30431,Secondary Lesion,Locally Advanced Unresectable Carcinoma
30432,Regional Disease,Locally Advanced Unresectable Carcinoma
30433,Epithelial Component Present,Locally Advanced Unresectable Renal Cell Carcinoma
30434,Metastatic Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma
30435,Mixed Cellular Population,Pituitary Gland Mixed Gangliocytoma-Adenoma
30436,Neuronal Differentiation,Sellar Neurocytoma
30437,Lobulated Growth Pattern,Sellar Chordoma
30438,Malignant Cellular Infiltrate,Sellar Chordoma
30439,High Grade Lesion,Sellar Dedifferentiated Chordoma
30440,Solitary mass,Sellar Dedifferentiated Chordoma
30441,Malignant Cellular Infiltrate,Sellar Yolk Sac Tumor
30442,"Fully Differentiated ""Adult-Type"" Tissues Present",Sellar Immature Teratoma
30443,"Undifferentiated ""Fetal-Type"" Tissues Present",Sellar Immature Teratoma
30444,Malignant Component Present,Sellar Teratoma with Malignant Transformation
30445,Malignant Cellular Infiltrate,Recurrent Endometrial Clear Cell Adenocarcinoma
30446,Carcinomatous Component Present,Recurrent Endometrial Clear Cell Adenocarcinoma
30447,Sarcomatous Component Present,Recurrent Uterine Corpus Carcinosarcoma
30448,Malignant Cellular Infiltrate,"Neuroendocrine carcinoma, metastatic"
30449,Carcinomatous Component Present,Advanced Neuroendocrine Carcinoma
30450,Unresectable Mass,Locally Advanced Unresectable Gastric Adenocarcinoma
30451,Regional Disease,Locally Advanced Unresectable Gastric Adenocarcinoma
30452,Collagenous Stroma Formation,Recurrent Desmoid-Type Fibromatosis
30453,Bone Marrow Lymphoplasmacytic Infiltrate,Smoldering Waldenstrom Macroglobulinemia
30454,Monoclonal Gammapathies,Smoldering Waldenstrom Macroglobulinemia
30455,Severe cytologic atypia,Unresectable Digestive System Neuroendocrine Carcinoma
30456,Secondary Lesion,Metastatic Digestive System Neuroendocrine Carcinoma
30457,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Carcinoma
30458,Carcinomatous Component Present,Metastatic Digestive System Neuroendocrine Carcinoma
30459,Poorly Differentiated Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Carcinoma
30460,Slow Growing Mass,Cerebral Hemangioblastoma
30461,Capillary Sized Vascular Channel Formation,Cerebral Hemangioblastoma
30462,Well-Circumscribed Lesion,Spinal hemangioblastoma
30463,Capillary Sized Vascular Channel Formation,Medullary Hemangioblastoma
30464,Malignant Cellular Infiltrate,Hereditary Malignant Urinary System Neoplasm
30465,Papillary Pattern,Epididymal Papillary Cystadenoma
30466,Recurrent disease,Recurrent Chordoma
30467,Solitary mass,Recurrent Chordoma
30468,Encapsulated Mass,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
30469,Papillary Pattern,Encapsulated Variant Thyroid Gland Papillary Carcinoma
30470,Nuclear Pseudoinclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma
30471,Mitotic Activity,Temporal Lobe Anaplastic Astrocytoma
30472,Infiltrative Growth Pattern,Temporal Lobe Anaplastic Astrocytoma
30473,Malignant Germinomatous Cellular Infiltrate,Third Ventricle Germinoma
30474,Thyroglobulin Positive Neoplastic Cells Present,Hobnail Variant Thyroid Gland Papillary Carcinoma
30475,Follicular Cell Differentiation,Hobnail Variant Thyroid Gland Papillary Carcinoma
30476,Secondary Lesion,Metastatic Fallopian Tube Carcinoma
30477,Carcinomatous Component Present,Stage IV Ovarian Carcinoma
30478,Epithelial Component Present,Metastatic Vaginal Carcinoma
30479,Carcinomatous Component Present,Metastatic Vaginal Carcinoma
30480,Carcinomatous Component Present,stage IV pancreatic cancer
30481,Secondary Lesion,Stage IV adult soft tissue sarcoma
30482,Malignant Cellular Infiltrate,Stage IV Skin Melanoma
30483,Secondary Lesion,Stage IV Skin Melanoma
30484,Metastatic Lesion,Stage IV Esophageal Adenocarcinoma
30485,Metastatic Lesion,Stage IV Nasopharyngeal Carcinoma
30486,Malignant Cellular Infiltrate,Metastatic Hypopharyngeal Carcinoma
30487,Metastatic Lesion,Metastatic Oropharyngeal Carcinoma
30488,Carcinomatous Component Present,Metastatic Oropharyngeal Carcinoma
30489,Metastatic Lesion,Metastatic Lip Carcinoma
30490,Perineural spread,Metastatic Oral Cavity Adenoid Cystic Carcinoma
30491,Malignant Cellular Infiltrate,Metastatic Oral Cavity Mucoepidermoid Carcinoma
30492,Secondary Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma
30493,Carcinomatous Component Present,Lung squamous cell carcinoma stage IV
30494,Malignant Cellular Infiltrate,Metastatic Lung Non-Small Cell Carcinoma
30495,Epithelial Component Present,Metastatic Colon Carcinoma
30496,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Papillary Carcinoma
30497,Epithelial Component Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
30498,Epithelial Component Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
30499,Mucoid Stroma Formation,Thyroid Gland Mucinous Carcinoma
30500,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Adenocarcinoma
30501,Crystal deposition,Tongue Alveolar Soft Part Sarcoma'
30502,Malignant Cellular Infiltrate,Tongue Alveolar Soft Part Sarcoma'
30503,Organoid Pattern,Orbital Alveolar Soft Part Sarcoma
30504,Malignant Cellular Infiltrate,Bladder Alveolar Soft Part Sarcoma
30505,Malignant Cellular Infiltrate,Scrotal Liposarcoma
30506,Secondary Lesion,Advanced Prostate Carcinoma
30507,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Adenocarcinoma
30508,Unresectable Mass,Locally Advanced Unresectable Prostate Adenocarcinoma
30509,Secondary Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma
30510,Epithelial Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma
30511,Carcinomatous Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma
30512,Secondary Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma
30513,Malignant Cellular Infiltrate,Locally Advanced Unresectable Cervical Carcinoma
30514,Metastatic Lesion,Locally Advanced Unresectable Cervical Carcinoma
30515,Epithelial Component Present,Locally Advanced Unresectable Cervical Carcinoma
30516,Vascular Channel Formation,Thyroid Gland Hemangioma
30517,Vascular Channel Formation,Thyroid Gland Cavernous Hemangioma
30518,Benign Cellular Infiltrate,Thyroid Gland Cavernous Hemangioma
30519,Indolent Clinical Course,Thyroid Gland Leiomyoma
30520,Primary Lesion,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
30521,Carcinomatous Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
30522,Necrotic changes (finding),Extrapulmonary Small Cell Carcinoma
30523,Malignant Cellular Infiltrate,Refractory Kaposi Sarcoma
30524,Secondary Lesion,Advanced Kaposi Sarcoma
30525,Benign Cellular Infiltrate,Benign Genitourinary System Neoplasm
30526,Secondary Lesion,Metastatic Neuroendocrine Neoplasm
30527,Neuroendocrine Differentiation,Advanced Neuroendocrine Neoplasm
30528,Well Differentiated Neuroendocrine Lesion,Pancreatic neuroendocrine tumor metastatic
30529,Metastatic Lesion,Pancreatic neuroendocrine tumor metastatic
30530,Neuroendocrine Differentiation,Pancreatic neuroendocrine tumor metastatic
30531,Epithelial Component Present,Advanced Pancreatic Neuroendocrine Tumor
30532,Neuroendocrine Differentiation,Metastatic Breast Neuroendocrine Neoplasm
30533,Metastatic Lesion,Metastatic Gastric Neuroendocrine Carcinoma
30534,Poorly Differentiated Neuroendocrine Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma
30535,High Mitotic Activity,Metastatic Small Intestinal Neuroendocrine Carcinoma
30536,Malignant Cellular Infiltrate,Metastatic Small Intestinal Neuroendocrine Carcinoma
30537,Epithelial Component Present,Metastatic Small Intestinal Neuroendocrine Carcinoma
30538,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
30539,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
30540,Necrotic changes (finding),Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
30541,Severe cytologic atypia,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
30542,Malignant Cellular Infiltrate,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
30543,Malignant Cellular Infiltrate,Malignant Abdominal Neoplasm
30544,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia Not Otherwise Specified
30545,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Acute Myelomonocytic Leukemia
30546,Recurrent disease,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
30547,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Erythroid Leukemia
30548,Malignant Cellular Infiltrate,Advanced Digestive System Carcinoma
30549,Extensive Stage Lesion,Advanced Digestive System Carcinoma
30550,Secondary Lesion,Metastatic basal cell carcinoma
30551,Epithelial Component Present,Metastatic basal cell carcinoma
30552,Epithelial Component Present,Biochemically Recurrent Prostate Carcinoma
30553,Unresectable Mass,Locally Advanced Unresectable Basal Cell Carcinoma
30554,Secondary Lesion,Locally Advanced Unresectable Basal Cell Carcinoma
30555,Immunologic Deficiency Syndromes,Maternally Derived Graft Versus Host Disease
30556,Metastatic Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm
30557,Carcinomatous Component Present,Resectable Pancreatic Acinar Cell Carcinoma
30558,Fibrotic Stroma Formation,Resectable Intrahepatic Cholangiocarcinoma
30559,Epithelial Component Present,Bile duct adenocarcinoma resectable
30560,Carcinomatous Component Present,Bile duct adenocarcinoma resectable
30561,Resectable Mass,Resectable Extrahepatic Bile Duct Adenocarcinoma
30562,Refractory Disease,Refractory Hormone Receptor Positive Breast Carcinoma
30563,Malignant Cellular Infiltrate,Secondary Acute Myeloid Leukemia
30564,Malignant Cellular Infiltrate,"Sarcoma, Spindle Cell"
30565,Benign Cellular Infiltrate,Benign Cutaneous Vascular Neoplasm
30566,Malignant Cellular Infiltrate,Morpheic basal cell carcinoma
30567,Malignant Cellular Infiltrate,Glioblastoma multiforme of spinal cord
30568,Malignant Cellular Infiltrate,Radiation-Induced Cancer
30569,Malignant Cellular Infiltrate,Uterine Corpus Choriocarcinoma
30570,Benign Cellular Infiltrate,Cranial Nodular Fasciitis
30571,Malignant Cellular Infiltrate,Myelodysplastic-Myeloproliferative Diseases
30572,Malignant Cellular Infiltrate,Lymphoma stage
30573,Malignant Cellular Infiltrate,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
30574,Malignant Cellular Infiltrate,B-cell lymphoma stage I
30575,Malignant Cellular Infiltrate,Periampullary Adenocarcinoma
30576,Malignant Cellular Infiltrate,Carcinoma duodenum resectable
30577,Malignant Cellular Infiltrate,Unresectable Hepatocellular Carcinoma
30578,Malignant Cellular Infiltrate,Peripheral neuroepithelioma of bone recurrent
30579,Malignant Cellular Infiltrate,Adult Systemic Anaplastic Large Cell Lymphoma
30580,Malignant Cellular Infiltrate,Adult Desmoplastic Small Round Cell Tumor
30581,Malignant Cellular Infiltrate,Childhood Myxoid Chondrosarcoma
30582,Malignant Cellular Infiltrate,Adult Myxoid Chondrosarcoma
30583,Malignant Cellular Infiltrate,Metastatic Carcinoma in the Lung
30584,Malignant Cellular Infiltrate,Ampulla of Vater Mucinous Adenocarcinoma
30585,Malignant Cellular Infiltrate,adenosquamous carcinoma of esophagus
30586,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Small Cell Neuroendocrine Carcinoma
30587,Malignant Cellular Infiltrate,Distal-Type Epithelioid Sarcoma
30588,Malignant Cellular Infiltrate,"Carcinoma of urinary bladder, superficial"
30589,Benign Cellular Infiltrate,Nasopharyngeal Angiofibroma
30590,Benign Cellular Infiltrate,mediastinal lipomatosis
30591,Malignant Cellular Infiltrate,Solid Alveolar Rhabdomyosarcoma
30592,Malignant Cellular Infiltrate,Transplant-Related Carcinoma
30593,Malignant Cellular Infiltrate,Transplant-Related Bladder Urothelial Carcinoma
30594,Malignant Cellular Infiltrate,Transplant-Related Skin Squamous Cell Carcinoma
30595,Malignant Cellular Infiltrate,Transplant-Related Renal Cell Carcinoma
30596,Malignant Cellular Infiltrate,Transplant-Related Kaposi Sarcoma
30597,Malignant Cellular Infiltrate,Hepatitis Virus-Related Hepatocellular Carcinoma
30598,Malignant Cellular Infiltrate,EBV-Related Lymphoma
30599,Malignant Cellular Infiltrate,Virus-Related Lymphoma
30600,Malignant Cellular Infiltrate,Non-Small Cell Adenocarcinoma
30601,Malignant Cellular Infiltrate,Acute promyelocytic leukemia - hypogranular variant
30602,Malignant Cellular Infiltrate,Papillary serous endometrial carcinoma
30603,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant"
30604,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma
30605,Malignant Cellular Infiltrate,leiomyosarcoma of retroperitoneum
30606,Malignant Cellular Infiltrate,Moderately Differentiated Prostate Adenocarcinoma
30607,Malignant Cellular Infiltrate,Immunodeficiency-associated Burkitt's lymphoma
30608,Malignant Cellular Infiltrate,Solar Radiation-Related Cutaneous Melanoma
30609,Toxic effect,Solar Radiation-Related Skin Squamous Cell Carcinoma
30610,Toxic effect,Aflatoxins-Related Hepatocellular Carcinoma
30611,Malignant Cellular Infiltrate,Asbestos-Related Lung Carcinoma
30612,Malignant Cellular Infiltrate,Benzene-Related Acute Myeloid Leukemia
30613,Malignant Cellular Infiltrate,Advanced Adult Hepatocellular Carcinoma
30614,Well Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor
30615,Well Differentiated Neuroendocrine Lesion,Pancreatic Delta Cell Neoplasm
30616,Malignant Cellular Infiltrate,Skin Squamous Cell Carcinoma In Situ
30617,Malignant Cellular Infiltrate,Non-Small Cell Lung Carcinoma
30618,Malignant Cellular Infiltrate,Adenoid Cystic Carcinoma
30619,Malignant Cellular Infiltrate,Prolymphocytic Leukemia
30620,Malignant Cellular Infiltrate,"Lymphoma, Follicular"
30621,Malignant Cellular Infiltrate,Medulloblastoma
30622,Malignant Cellular Infiltrate,"Acute Myeloid Leukemia, M1"
30623,Benign Cellular Infiltrate,Acoustic Neuroma
30624,Benign Cellular Infiltrate,Osteoid osteoma
30625,Malignant Cellular Infiltrate,Paget Disease Extramammary
30626,Malignant Cellular Infiltrate,Polycythemia Vera
30627,Malignant Cellular Infiltrate,"Lymphoma, Follicular, Grade 1"
30628,Malignant Cellular Infiltrate,"Lymphoma, AIDS-Related"
30629,Malignant Cellular Infiltrate,Primary Malignant Liver Neoplasm
30630,Benign Cellular Infiltrate,Atrial myxoma
30631,Malignant Cellular Infiltrate,Gastrointestinal carcinoma in situ
30632,Malignant Cellular Infiltrate,Malignant tumor of peritoneum
30633,Malignant Cellular Infiltrate,Malignant neoplasm of glottis
30634,Malignant Cellular Infiltrate,Malignant tumor of mediastinum
30635,Malignant Cellular Infiltrate,Kaposi's sarcoma of lung
30636,Malignant Cellular Infiltrate,Malignant neoplasm of scrotum
30637,Malignant Cellular Infiltrate,Malignant neoplasm of lacrimal duct
30638,Malignant Cellular Infiltrate,Malignant neoplasm of gallbladder localized
30639,Malignant Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v7
30640,Malignant Cellular Infiltrate,Stage IVC Major Salivary Gland Cancer AJCC v7
30641,Malignant Cellular Infiltrate,Epiglottic carcinoma
30642,Malignant Cellular Infiltrate,Polymorphous low grade adenocarcinoma of salivary gland
30643,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7
30644,Malignant Cellular Infiltrate,Malignant neoplasm of thorax
30645,Malignant Cellular Infiltrate,Secondary malignant neoplasm of lung
30646,Malignant Cellular Infiltrate,Ciliary Body Mixed Cell Melanoma
30647,Malignant Cellular Infiltrate,Granulocytic Sarcoma
30648,Malignant Cellular Infiltrate,Blastic Granulocytic Sarcoma
30649,Malignant Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm
30650,Malignant Cellular Infiltrate,Anaplastic Malignant Neoplasm
30651,Malignant Cellular Infiltrate,Grade 1 Malignant Neoplasm
30652,Malignant Cellular Infiltrate,Grade 4 Malignant Neoplasm
30653,Benign Cellular Infiltrate,benign neoplasm of heart
30654,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(5;17)(q35;q21)
30655,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-2
30656,Malignant Cellular Infiltrate,Peripheral neuroepithelioma of bone metastatic
30657,Malignant Cellular Infiltrate,Activated B-cell type diffuse large B-cell lymphoma
30658,Benign Cellular Infiltrate,Testicular Dermoid Cyst
30659,Malignant Cellular Infiltrate,Hereditary Ovarian Carcinoma
30660,Benign Cellular Infiltrate,Hemangioma of intra-abdominal structure
30661,Malignant Cellular Infiltrate,"Neuroectodermal Tumor, Primitive"
30662,Malignant Cellular Infiltrate,alk-positive anaplastic large cell lymphoma
30663,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
30664,Epithelial Component Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB
30665,Malignant Cellular Infiltrate,Pulmonary Blastoma
30666,Malignant Cellular Infiltrate,Clear Cell Sarcoma of Soft Tissue
30667,Malignant Cellular Infiltrate,Alveolar rhabdomyosarcoma
30668,Malignant Cellular Infiltrate,Pancreatic Endocrine Carcinoma
30669,Malignant Cellular Infiltrate,"Carcinoma, Neuroendocrine"
30670,Malignant Cellular Infiltrate,"Cystadenocarcinoma, Papillary"
30671,Malignant Cellular Infiltrate,"Carcinoma, Large Cell"
30672,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)
30673,Malignant Cellular Infiltrate,Ganglioneuroblastoma
30674,Malignant Cellular Infiltrate,Plasmablastic Lymphoma of Mucosa Site
30675,Malignant Cellular Infiltrate,Gastrointestinal lymphoma
30676,Malignant Cellular Infiltrate,Neoplasm malignant aggravated
30677,Malignant Cellular Infiltrate,Lymphangitis carcinomatosa
30678,Malignant Cellular Infiltrate,Ann Arbor Stage IA Hodgkin Lymphoma
30679,Malignant Cellular Infiltrate,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma
30680,Malignant Cellular Infiltrate,Hereditary Renal Cell Carcinoma
30681,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
30682,Malignant Cellular Infiltrate,mucinous adenocarcinoma of bladder
30683,Malignant Cellular Infiltrate,Bladder Urachal Carcinoma
30684,Malignant Cellular Infiltrate,Bladder Urachal Squamous Cell Carcinoma
30685,Malignant Cellular Infiltrate,Female Urethral Malignant Neoplasm
30686,Malignant Cellular Infiltrate,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma
30687,Malignant Cellular Infiltrate,Prostatic Urethra Urothelial Carcinoma
30688,Malignant Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma
30689,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Macrocystic Pattern"
30690,Malignant Cellular Infiltrate,Stage IV Colon Carcinoma
30691,Malignant Cellular Infiltrate,Malignant Testicular Sex Cord-Stromal Tumor
30692,Malignant Cellular Infiltrate,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements"
30693,Malignant Cellular Infiltrate,Colon cancer recurrent
30694,Malignant Cellular Infiltrate,Malignant Ovarian Teratoma
30695,Malignant Cellular Infiltrate,Stage 0 Cervical Cancer AJCC v6
30696,Malignant Cellular Infiltrate,Inflammatory Breast Carcinoma
30697,Malignant Cellular Infiltrate,Malignant Ovarian Mucinous Tumor
30698,Malignant Cellular Infiltrate,Malignant Childhood Neoplasm
30699,Malignant Cellular Infiltrate,Fallopian Tube Serous Adenocarcinoma
30700,Malignant Cellular Infiltrate,Fallopian Tube Mucinous Adenocarcinoma
30701,Malignant Cellular Infiltrate,Carcinoma in situ of fallopian tube
30702,Malignant Cellular Infiltrate,carcinosarcoma of fallopian tube
30703,Malignant Cellular Infiltrate,Uterine Ligament Serous Adenocarcinoma
30704,Malignant Cellular Infiltrate,Uterine Ligament Mucinous Adenocarcinoma
30705,Malignant Cellular Infiltrate,Grade 3 Endometrial Mucinous Adenocarcinoma
30706,Malignant Cellular Infiltrate,Uterine Corpus Myxoid Leiomyosarcoma
30707,Malignant Cellular Infiltrate,Fibroblastic osteosarcoma
30708,Malignant Cellular Infiltrate,Acral Lentiginous Malignant Melanoma
30709,Malignant Cellular Infiltrate,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm
30710,Malignant Cellular Infiltrate,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells
30711,Malignant Cellular Infiltrate,Malignant Vulvar Sweat Gland Neoplasm
30712,Malignant Cellular Infiltrate,Bladder Squamous Cell Carcinoma
30713,Benign Cellular Infiltrate,Vulvar Angiomyxoma
30714,Malignant Cellular Infiltrate,Breast Carcinoma with Osteoclastic Giant Cells
30715,Malignant Cellular Infiltrate,Acinic Cell Breast Carcinoma
30716,Malignant Cellular Infiltrate,"Glycogen-Rich, Clear Cell Breast Carcinoma"
30717,Malignant Cellular Infiltrate,follicular malignant lymphoma of breast
30718,Malignant Cellular Infiltrate,carcinoma ex pleomorphic adenoma of salivary gland
30719,Malignant Cellular Infiltrate,Squamous cell carcinoma of lip
30720,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Hypercalcemic Type"
30721,Malignant Cellular Infiltrate,Laryngeal Squamous Cell Carcinoma
30722,Malignant Cellular Infiltrate,Pleomorphic carcinoma
30723,Malignant Cellular Infiltrate,"Squamous cell carcinoma, keratinizing"
30724,Malignant Cellular Infiltrate,"Transitional cell carcinoma, spindle cell"
30725,Malignant Cellular Infiltrate,Prefibrotic/Early Primary Myelofibrosis
30726,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of appendix
30727,Malignant Cellular Infiltrate,Basophilic Adenocarcinoma
30728,Malignant Cellular Infiltrate,Cholangiolocellular Carcinoma
30729,Benign Cellular Infiltrate,Juxtaglomerular tumor
30730,Malignant Cellular Infiltrate,Comedocarcinoma
30731,Malignant Cellular Infiltrate,Epithelial-myoepithelial carcinoma
30732,Benign Cellular Infiltrate,Maturing Ganglioneuroma
30733,Malignant Cellular Infiltrate,"Glomus tumor, malignant"
30734,Benign Cellular Infiltrate,Lipoblastomatosis
30735,"Fully Differentiated ""Adult-Type"" Tissues Present","Teratoma, Malignant"
30736,Malignant Cellular Infiltrate,Malignant Hair Follicle Neoplasm
30737,Malignant Cellular Infiltrate,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
30738,Malignant Cellular Infiltrate,Marginal Zone B-Cell Lymphoma
30739,Malignant Cellular Infiltrate,Sporadic Diffuse Gastric Adenocarcinoma
30740,Poorly Differentiated Neuroendocrine Lesion,Colorectal Small Cell Neuroendocrine Carcinoma
30741,Benign Cellular Infiltrate,Benign neoplasm of maxillary sinus
30742,Malignant Cellular Infiltrate,Gastric Body Carcinoma In Situ AJCC v6 and v7
30743,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of pancreas
30744,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of pancreas
30745,Benign Cellular Infiltrate,Cutaneous leiomyoma
30746,High Mitotic Activity,Cutaneous Leiomyosarcoma
30747,atypia morphology,Cutaneous Leiomyosarcoma
30748,Benign Cellular Infiltrate,Blue rubber bleb nevus syndrome
30749,Malignant Cellular Infiltrate,Malignant phyllodes tumor of breast
30750,Malignant Cellular Infiltrate,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type"
30751,Malignant Cellular Infiltrate,Cervical Adenocarcinoma In Situ
30752,Malignant Cellular Infiltrate,Low-grade fibromyxoid sarcoma
30753,Malignant Cellular Infiltrate,Classical Low Grade Fibromyxoid Sarcoma
30754,Malignant Cellular Infiltrate,Cutaneous B Lymphoblastic Leukemia/Lymphoma
30755,Benign Cellular Infiltrate,Benign Accessory Urethral Gland Neoplasm
30756,Benign Cellular Infiltrate,Dermoid cyst of orbit
30757,Malignant Cellular Infiltrate,Squamous cell carcinoma of conjunctiva
30758,Malignant Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Papillary Variant"
30759,Malignant Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Clear Cell Variant"
30760,Malignant Cellular Infiltrate,Lung Spindle Cell Carcinoma
30761,Malignant Cellular Infiltrate,Lung Monophasic Synovial Sarcoma
30762,Benign Cellular Infiltrate,Benign neoplasm of thorax
30763,Malignant Cellular Infiltrate,Pleural Desmoplastic Mesothelioma
30764,Malignant Cellular Infiltrate,Mediastinal T Acute Lymphoblastic Leukemia
30765,Malignant Cellular Infiltrate,Mediastinal Myeloid Sarcoma
30766,Benign Cellular Infiltrate,Adult Cardiac Cellular Rhabdomyoma
30767,Malignant Cellular Infiltrate,Malignant neoplasm of great vessels
30768,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pericardium
30769,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum
30770,Malignant Cellular Infiltrate,Secondary malignant neoplasm of testis
30771,Malignant Cellular Infiltrate,Papillary Thyroid Microcarcinoma
30772,Malignant Cellular Infiltrate,squamous cell carcinoma of the thyroid gland
30773,Malignant Cellular Infiltrate,Unilateral Breast Carcinoma
30774,Benign Cellular Infiltrate,Benign neoplasm of endocardium
30775,Encapsulated Mass,Clear Cell Variant Thyroid Gland Follicular Carcinoma
30776,Benign Cellular Infiltrate,Benign neoplasm of adnexa of skin
30777,Malignant Cellular Infiltrate,Amelanotic Skin Melanoma
30778,Low Grade Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor
30779,Malignant Cellular Infiltrate,Squamous cell carcinoma of tongue
30780,Malignant Cellular Infiltrate,Splenic Marginal Zone B-Cell Lymphoma
30781,Malignant Cellular Infiltrate,Adenocarcinoma with metaplasia
30782,Malignant Cellular Infiltrate,Malignant neoplasm of ciliary body
30783,Malignant Cellular Infiltrate,Paget Disease of the Breast without Invasive Carcinoma
30784,Benign Cellular Infiltrate,Fibromatosis colli
30785,Malignant Cellular Infiltrate,Malignant Glioma
30786,Malignant Cellular Infiltrate,Mucosal lentiginous melanoma
30787,Benign Cellular Infiltrate,Myoma
30788,Malignant Cellular Infiltrate,Dedifferentiated chordoma
30789,Malignant Cellular Infiltrate,Sclerosing Epithelioid Fibrosarcoma
30790,Malignant Cellular Infiltrate,Secondary malignant neoplasm of thymus
30791,Malignant Cellular Infiltrate,Cerebral Primitive Neuroectodermal Tumor
30792,Benign Cellular Infiltrate,Perineurioma
30793,Malignant Cellular Infiltrate,Recurrent Follicular Lymphoma
30794,Malignant Cellular Infiltrate,Lung squamous cell carcinoma recurrent
30795,Malignant Cellular Infiltrate,Stage I Rectosigmoid Cancer AJCC v6 and v7
30796,Malignant Cellular Infiltrate,Stage III Esophageal Squamous Cell Carcinoma AJCC v7
30797,Malignant Cellular Infiltrate,Cerebral Lymphoma in Immunocompetent Host
30798,Benign Cellular Infiltrate,Endobronchial lipoma
30799,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II
30800,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) refractory
30801,Malignant Cellular Infiltrate,Splenic marginal zone lymphoma refractory
30802,Malignant Cellular Infiltrate,Pharyngeal cancer recurrent
30803,Malignant Cellular Infiltrate,Malignant Intracranial Neoplasm
30804,Malignant Cellular Infiltrate,sarcoma of central nervous system
30805,Malignant Cellular Infiltrate,Spinal Cord Melanoma
30806,Malignant Cellular Infiltrate,Childhood Lymphoma
30807,Malignant Cellular Infiltrate,Mucoepidermoid Breast Carcinoma
30808,Malignant Cellular Infiltrate,Low Grade Mucoepidermoid Breast Carcinoma
30809,Malignant Cellular Infiltrate,Non-Hodgkin Breast Lymphoma
30810,Malignant Cellular Infiltrate,Stage IC Ovarian Cancer AJCC v6 and v7
30811,Malignant Cellular Infiltrate,leiomyosarcoma of ovary
30812,Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric
30813,"Fully Differentiated ""Adult-Type"" Tissues Present",Immature Gastric Teratoma
30814,Malignant Cellular Infiltrate,Early Favorable Non-Hodgkin Lymphoma
30815,Malignant Cellular Infiltrate,fibrosarcoma of small intestine
30816,Malignant Cellular Infiltrate,Hodgkin's lymphoma of small intestine
30817,Benign Cellular Infiltrate,Chondroma
30818,Benign Cellular Infiltrate,Benign Cardiac Germ Cell Tumor
30819,Malignant Cellular Infiltrate,Cardiac Fibrosarcoma
30820,Malignant Cellular Infiltrate,Superior Vena Cava Angiosarcoma
30821,Malignant Cellular Infiltrate,Malignant Pulmonary Artery Neoplasm
30822,Malignant Cellular Infiltrate,Renal Vein Leiomyosarcoma
30823,Malignant Cellular Infiltrate,Malignant Cardiac Paraganglioma
30824,Benign Cellular Infiltrate,Bone Leiomyoma
30825,Malignant Cellular Infiltrate,Malignant Central Nervous System Germ Cell Tumor
30826,Malignant Cellular Infiltrate,Secondary Supratentorial Anaplastic Astrocytoma
30827,Malignant Cellular Infiltrate,papillary squamous cell carcinoma of larynx
30828,Malignant Cellular Infiltrate,Laryngeal Acantholytic Squamous Cell Carcinoma
30829,Malignant Cellular Infiltrate,Extracranial Neuroblastoma
30830,Benign Cellular Infiltrate,Central Nervous System Lipoma
30831,Malignant Cellular Infiltrate,Sweat gland adenocarcinoma
30832,Malignant Cellular Infiltrate,Gastric Tubular Adenocarcinoma
30833,Malignant Cellular Infiltrate,Gastric Squamous Cell Carcinoma
30834,Malignant Cellular Infiltrate,Malignant Gastric Germ Cell Tumor
30835,Malignant Cellular Infiltrate,Colon Leiomyosarcoma
30836,Malignant Cellular Infiltrate,Colon Sarcoma
30837,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the cecum
30838,Malignant Cellular Infiltrate,Mucinous cystadenocarcinoma appendix
30839,Malignant Cellular Infiltrate,Prostate Myeloid Sarcoma
30840,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant"
30841,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Signet Ring Variant"
30842,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of rectum
30843,Malignant Cellular Infiltrate,Stage I Uveal Melanoma AJCC v7
30844,Malignant Cellular Infiltrate,Stage III Uveal Melanoma AJCC v7
30845,Malignant Cellular Infiltrate,Stage IV Skin Cancer
30846,Malignant Cellular Infiltrate,Anal Rhabdomyosarcoma
30847,Malignant Cellular Infiltrate,AIDS-Related Gastric Kaposi Sarcoma
30848,Malignant Cellular Infiltrate,Rectal Rhabdomyosarcoma
30849,Malignant Cellular Infiltrate,Stage IA Lung Cancer AJCC v7
30850,Malignant Cellular Infiltrate,Stage IIIA Lung Cancer AJCC v7
30851,Malignant Cellular Infiltrate,Solid Lung Adenocarcinoma
30852,Malignant Cellular Infiltrate,Stage IB Non-Small Cell Lung Carcinoma AJCC v7
30853,Benign Cellular Infiltrate,Multiple hamartoma of lung
30854,Malignant Cellular Infiltrate,Esophageal Melanoma
30855,Malignant Cellular Infiltrate,Pancreatic sarcoma
30856,Malignant Cellular Infiltrate,Gallbladder Melanoma
30857,Malignant Cellular Infiltrate,Gallbladder Sarcoma
30858,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v6
30859,Malignant Cellular Infiltrate,Stage IVA Gallbladder Carcinoma
30860,Malignant Cellular Infiltrate,Squamous Cell Bile Duct Carcinoma
30861,Malignant Cellular Infiltrate,Small intestine carcinoma stage III
30862,Malignant Cellular Infiltrate,Gallbladder Rhabdomyosarcoma
30863,Malignant Cellular Infiltrate,small cell carcinoma of extrahepatic bile duct
30864,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
30865,Malignant Cellular Infiltrate,Stage III Major Salivary Gland Cancer AJCC v7
30866,Secondary Lesion,Stage IV Major Salivary Gland Carcinoma with Metastasis
30867,Malignant Cellular Infiltrate,Malignant Mixed Tumor of the Major Salivary Gland
30868,Malignant Cellular Infiltrate,Submandibular Gland Undifferentiated Carcinoma
30869,Malignant Cellular Infiltrate,Minor Salivary Gland Adenocarcinoma
30870,Malignant Cellular Infiltrate,Minor Salivary Gland Undifferentiated Carcinoma
30871,Benign Cellular Infiltrate,Tonsillar Lipoma
30872,Malignant Cellular Infiltrate,Posterior Tongue Adenoid Cystic Carcinoma
30873,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v7
30874,Malignant Cellular Infiltrate,Stage IVA Laryngeal Cancer AJCC v7
30875,Malignant Cellular Infiltrate,Stage II Paranasal Sinus Cancer AJCC v6 and v7
30876,Malignant Cellular Infiltrate,Stage I Nasal Cavity Cancer AJCC v6 and v7
30877,Benign Cellular Infiltrate,Polyp in nasopharynx
30878,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8"
30879,Malignant Cellular Infiltrate,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
30880,Malignant Cellular Infiltrate,Thyroid Non-Hodgkin's Lymphoma
30881,Malignant Cellular Infiltrate,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
30882,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage I
30883,Malignant Cellular Infiltrate,Frontal Sinus Squamous Cell Carcinoma
30884,Malignant Cellular Infiltrate,External Ear Carcinoma
30885,Malignant Cellular Infiltrate,Sarcoma of orbit
30886,Malignant Cellular Infiltrate,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7
30887,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7
30888,Malignant Cellular Infiltrate,Stage III Thyroid Gland Medullary Carcinoma AJCC v7
30889,Malignant Cellular Infiltrate,adenocarcinoma of renal pelvis
30890,Malignant Cellular Infiltrate,Bladder Signet Ring Cell Adenocarcinoma
30891,Malignant Cellular Infiltrate,squamous cell carcinoma of urethra
30892,Malignant Cellular Infiltrate,Stage I Urethral Cancer AJCC v7
30893,Malignant Cellular Infiltrate,Stage IV Urethral Cancer AJCC v7
30894,Malignant Cellular Infiltrate,Childhood Central Nervous System Choriocarcinoma
30895,Malignant Cellular Infiltrate,Childhood Central Nervous System Embryonal Carcinoma
30896,Malignant Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified"
30897,Malignant Cellular Infiltrate,Maxillary Sinus Adenocarcinoma
30898,Malignant Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v6 and v7
30899,Malignant Cellular Infiltrate,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7
30900,Malignant Cellular Infiltrate,Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7
30901,Malignant Cellular Infiltrate,Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7
30902,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Cancer AJCC v7
30903,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Cancer AJCC v7
30904,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v6 and v7
30905,Malignant Cellular Infiltrate,leiomyosarcoma of vagina
30906,Malignant Cellular Infiltrate,Testicular embryonal carcinoma
30907,Malignant Cellular Infiltrate,Lymphoma of kidney
30908,Malignant Cellular Infiltrate,Stage IIB Testicular Cancer AJCC v6 and v7
30909,Malignant Cellular Infiltrate,Vaginal Yolk Sac Tumor
30910,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Cervix
30911,Malignant Cellular Infiltrate,Invasive Ductal and Invasive Lobular Breast Carcinoma
30912,Well Differentiated Neuroendocrine Lesion,Ascending Colon Neuroendocrine Tumor G1
30913,Malignant Cellular Infiltrate,Malignant Mediastinal Non-Seminomatous Germ Cell Tumor
30914,Malignant Cellular Infiltrate,Multifocal osteosarcoma
30915,Malignant Cellular Infiltrate,Synchronous Multifocal Osteosarcoma
30916,Malignant Cellular Infiltrate,Fibromyxosarcoma
30917,Benign Cellular Infiltrate,Tendon Sheath Lipoma
30918,Intermediate Grade Neuroendocrine Lesion,"Glucagonoma, malignant"
30919,Well Differentiated Neuroendocrine Lesion,Malignant Vipoma
30920,Tumor Vascular Invasion,"Somatostatinoma, malignant"
30921,Benign Cellular Infiltrate,Perineural Hemangioma
30922,Benign Cellular Infiltrate,Benign Pericytic Neoplasm
30923,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor
30924,Benign Cellular Infiltrate,Deep Hemangioma
30925,Benign Cellular Infiltrate,Degenerated Schwannoma
30926,Benign Cellular Infiltrate,Juxta-Articular Myxoma
30927,Malignant Cellular Infiltrate,Childhood Conventional Osteosarcoma
30928,Benign Cellular Infiltrate,Benign Mediastinal Soft Tissue Neoplasm
30929,Benign Cellular Infiltrate,Mediastinal Rhabdomyoma
30930,Malignant Cellular Infiltrate,Stage IIA Osteosarcoma AJCC v7
30931,Malignant Cellular Infiltrate,Stage IIB Osteosarcoma AJCC v7
30932,Malignant Cellular Infiltrate,Metastatic Bone Ewing Sarcoma
30933,Malignant Cellular Infiltrate,malignant peripheral nerve sheath tumor (MPNST) of mediastinum
30934,Benign Cellular Infiltrate,Mediastinal Neurofibroma
30935,Malignant Cellular Infiltrate,Stage I Ampulla of Vater Cancer AJCC v7
30936,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Small Cell Neuroendocrine Carcinoma
30937,Malignant Cellular Infiltrate,Stage IIA Lung Adenosquamous Carcinoma AJCC v7
30938,Malignant Cellular Infiltrate,Stage I Lung Small Cell Carcinoma AJCC v7
30939,Malignant Cellular Infiltrate,Stage IB Lung Small Cell Carcinoma AJCC v7
30940,Malignant Cellular Infiltrate,Stage IIA Lung Small Cell Carcinoma AJCC v7
30941,Malignant Cellular Infiltrate,Stage IIIA Lung Small Cell Carcinoma AJCC v7
30942,Malignant Cellular Infiltrate,Stage IV Lung Small Cell Carcinoma AJCC v7
30943,Malignant Cellular Infiltrate,Skin Metatypical Carcinoma
30944,Malignant Cellular Infiltrate,Stage IA Lung Adenocarcinoma AJCC v7
30945,Malignant Cellular Infiltrate,serous adenocarcinofibroma of ovary
30946,Benign Cellular Infiltrate,Benign Teratoma
30947,Benign Cellular Infiltrate,Lipoma of chest wall
30948,Malignant Cellular Infiltrate,Malignant Chest Wall Bone Neoplasm
30949,Malignant Cellular Infiltrate,Stage IIB Esophageal Adenocarcinoma AJCC v7
30950,Benign Cellular Infiltrate,Cardiac Lipoma
30951,Malignant Cellular Infiltrate,Biliary Intraepithelial Neoplasia-3
30952,Malignant Cellular Infiltrate,Gastric Mixed Adenocarcinoma
30953,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
30954,Benign Cellular Infiltrate,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm"
30955,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of gallbladder
30956,Malignant Cellular Infiltrate,Gastric Cardia Carcinoma
30957,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Isolated del(5q)
30958,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v6
30959,Malignant Cellular Infiltrate,Stage IV Anal Canal Cancer AJCC v6 and v7
30960,Malignant Cellular Infiltrate,Large cell carcinoma with rhabdoid phenotype
30961,Malignant Cellular Infiltrate,"Thymoma, type AB, malignant"
30962,Benign Cellular Infiltrate,Intraneural perineurioma
30963,Malignant Cellular Infiltrate,Lymphocyte Rich Classical Hodgkin Lymphoma
30964,Malignant Cellular Infiltrate,Precursor T-cell lymphoblastic lymphoma
30965,Malignant Cellular Infiltrate,Malignant Ovarian Thecoma
30966,Benign Cellular Infiltrate,Cardiac fibroma
30967,Malignant Cellular Infiltrate,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System
30968,Malignant Cellular Infiltrate,Warty Carcinoma of the Penis
30969,Malignant Cellular Infiltrate,Central Nervous System Embryonal Neoplasm
30970,Benign Cellular Infiltrate,Central Nervous System Hibernoma
30971,Benign Cellular Infiltrate,Cavernous hemangioma of the face
30972,Malignant Cellular Infiltrate,Erythroid Neoplasm
30973,Malignant Cellular Infiltrate,Secondary malignant neoplasm of prostate
30974,Malignant Cellular Infiltrate,regressing melanoma of skin
30975,Malignant Cellular Infiltrate,Regressing Non-Cutaneous Melanoma
30976,Malignant Cellular Infiltrate,Macrotrabecular Hepatoblastoma
30977,Malignant Cellular Infiltrate,Small Cell Undifferentiated Hepatoblastoma
30978,Malignant Cellular Infiltrate,Prostate cancer stage D
30979,Malignant Cellular Infiltrate,Stage II Liver Cancer
30980,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma
30981,Malignant Cellular Infiltrate,Smoldering myeloma
30982,Malignant Cellular Infiltrate,leiomyosarcoma of bone
30983,Malignant Cellular Infiltrate,Classical Hodgkin's Lymphoma
30984,Malignant Cellular Infiltrate,Primary Cutaneous Follicle Center Lymphoma
30985,Malignant Cellular Infiltrate,Adult T Lymphoblastic Lymphoma
30986,Malignant Cellular Infiltrate,Refractory T Lymphoblastic Lymphoma
30987,Malignant Cellular Infiltrate,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder
30988,Malignant Cellular Infiltrate,Plasma Cell Post-Transplant Lymphoproliferative Disorder
30989,Malignant Cellular Infiltrate,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder
30990,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
30991,Malignant Cellular Infiltrate,Methotrexate-Associated Peripheral T-Cell Lymphoma
30992,Malignant Cellular Infiltrate,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma
30993,Malignant Cellular Infiltrate,Hodgkin's disease of spleen
30994,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia
30995,Malignant Cellular Infiltrate,Splenic B Lymphoblastic Lymphoma
30996,Malignant Cellular Infiltrate,Cervical Squamous Cell Carcinoma In Situ
30997,Malignant Cellular Infiltrate,Juxtacortical chondrosarcoma
30998,Malignant Cellular Infiltrate,Nasopharyngeal Nonkeratinizing Carcinoma
30999,Malignant Cellular Infiltrate,Malignant neoplasm of prostate
31000,Benign Cellular Infiltrate,Benign vascular neoplasm
31001,Malignant Cellular Infiltrate,Rectosigmoid cancer
31002,Malignant Cellular Infiltrate,AIDS-Related Cervical Carcinoma
31003,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma of the Cervix
31004,Malignant Cellular Infiltrate,Acute myelomonocytic leukemia
31005,Malignant Cellular Infiltrate,Pure Erythroid Leukemia
31006,Malignant Cellular Infiltrate,Anal Extramucosal (Perianal) Adenocarcinoma
31007,Malignant Cellular Infiltrate,Paget disease of anal canal
31008,Malignant Cellular Infiltrate,Secondary malignant neoplasm of female breast
31009,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7
31010,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ureter
31011,Malignant Cellular Infiltrate,Stage III Prostate Carcinoma
31012,Malignant Cellular Infiltrate,Endometrial Carcinoma
31013,Malignant Cellular Infiltrate,Basal cell carcinoma - adamantinoid
31014,Malignant Cellular Infiltrate,Malignant myoepithelioma
31015,Malignant Cellular Infiltrate,Recurrent Urinary System Carcinoma
31016,Malignant Cellular Infiltrate,Malignant neoplasm of labium majus
31017,Malignant Cellular Infiltrate,Posterior Urethral Malignant Neoplasm
31018,Malignant Cellular Infiltrate,Alkylating Agent-Related Myelodysplastic Syndrome
31019,Malignant Cellular Infiltrate,Primary serous papillary carcinoma of peritoneum
31020,Malignant Cellular Infiltrate,Squamous cell carcinoma of vagina
31021,Malignant Cellular Infiltrate,sarcoma of vagina
31022,Malignant Cellular Infiltrate,Stage I Rectal Cancer AJCC v6 and v7
31023,Malignant Cellular Infiltrate,Refractory Plasma Cell Neoplasm
31024,Malignant Cellular Infiltrate,Adult Malignant Peripheral Nerve Sheath Tumor
31025,Malignant Cellular Infiltrate,Stage I Renal Cell Carcinoma
31026,Malignant Cellular Infiltrate,Recurrent Parathyroid Gland Carcinoma
31027,Malignant Cellular Infiltrate,Stage IV Ovarian Cancer AJCC v6 and v7
31028,Malignant Cellular Infiltrate,Stage I Kidney Wilms Tumor
31029,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 0
31030,Malignant Cellular Infiltrate,Stage III Penile Cancer AJCC v6
31031,Malignant Cellular Infiltrate,Adenocarcinoma of small intestine
31032,Malignant Cellular Infiltrate,Adenocarcinoma of duodenum
31033,Malignant Cellular Infiltrate,Unresectable Gallbladder Carcinoma
31034,Malignant Cellular Infiltrate,Thymoma malignant invasive
31035,Malignant Cellular Infiltrate,Adult Alveolar Soft Part Sarcoma
31036,Malignant Cellular Infiltrate,Adult Epithelioid Sarcoma
31037,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Maturation
31038,Malignant Cellular Infiltrate,Mucinous adenocarcinoma of colon
31039,Malignant Cellular Infiltrate,Acinar cell carcinoma of pancreas
31040,Malignant Cellular Infiltrate,Serous cystadenocarcinoma ovary
31041,Malignant Cellular Infiltrate,"Epithelioid mesothelioma, malignant"
31042,Malignant Cellular Infiltrate,Spindle Cell Type A Uveal Melanoma
31043,Malignant Cellular Infiltrate,Squamous cell carcinoma of nasopharynx
31044,Malignant Cellular Infiltrate,Carcinoma Arising from Craniopharyngioma
31045,Malignant Cellular Infiltrate,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma
31046,Malignant Cellular Infiltrate,Low Grade Salivary Gland Mucoepidermoid Carcinoma
31047,Malignant Cellular Infiltrate,Progressive Hairy Cell Leukemia Initial Treatment
31048,Malignant Cellular Infiltrate,"High Grade B-Cell Lymphoma, Not Otherwise Specified"
31049,Malignant Cellular Infiltrate,"Splenic B-Cell Lymphoma/Leukemia, Unclassifiable"
31050,Malignant Cellular Infiltrate,Systemic EBV positive T-cell lymphoproliferative disease of childhood
31051,Malignant Cellular Infiltrate,Stage II Hypopharyngeal Carcinoma AJCC v6 and v7
31052,Malignant Cellular Infiltrate,Stage III Laryngeal Cancer AJCC v6 and v7
31053,Malignant Cellular Infiltrate,Stage III Oropharyngeal Carcinoma AJCC v6
31054,Encapsulated Mass,Follicular thyroid carcinoma
31055,Malignant Cellular Infiltrate,Metastatic Childhood Soft Tissue Sarcoma
31056,Malignant Cellular Infiltrate,Recurrent Childhood Soft Tissue Sarcoma
31057,Malignant Cellular Infiltrate,Childhood Leiomyosarcoma
31058,Malignant Primitive Cellular Infiltrate,Ovarian Embryonal Carcinoma
31059,Malignant Primitive Cellular Infiltrate,Ovarian germ cell tumor mixed
31060,Malignant Cellular Infiltrate,Ann Arbor Stage III Grade 1 Follicular Lymphoma
31061,Malignant Cellular Infiltrate,Ann Arbor Stage IV Grade 3 Follicular Lymphoma
31062,Malignant Cellular Infiltrate,Transitional cell cancer of the renal pelvis and ureter localized
31063,Malignant Cellular Infiltrate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter
31064,Malignant Cellular Infiltrate,Glottic Squamous Cell Carcinoma
31065,Malignant Cellular Infiltrate,Subglottic Squamous Cell Carcinoma
31066,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma
31067,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage III
31068,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage IV
31069,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma stage II
31070,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage II
31071,Malignant Cellular Infiltrate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL
31072,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Gene Mutations
31073,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage II
31074,Malignant Cellular Infiltrate,Recurrent Uterine Corpus Sarcoma
31075,Malignant Cellular Infiltrate,Adult Papillary Meningioma
31076,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Minimal Differentiation
31077,Malignant Cellular Infiltrate,Lymphoma stage IV
31078,Malignant Cellular Infiltrate,Carcinoma of upper gum
31079,Malignant Cellular Infiltrate,Carcinoma of sublingual gland
31080,Malignant Cellular Infiltrate,Gastric Fundus Carcinoma
31081,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma
31082,Malignant Cellular Infiltrate,Recurrent Indolent Adult Non-Hodgkin Lymphoma
31083,Malignant Cellular Infiltrate,Mantle cell lymphoma recurrent
31084,Malignant Cellular Infiltrate,Indolent Adult Non-Hodgkin Lymphoma
31085,Malignant Cellular Infiltrate,Refractory Carcinoma
31086,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer
31087,Benign Cellular Infiltrate,Benign neoplasm of accessory sinus
31088,Benign Cellular Infiltrate,Benign neoplasm of pericardium
31089,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ciliary body
31090,Malignant Cellular Infiltrate,Secondary malignant neoplasm of retina
31091,Malignant Cellular Infiltrate,Stage IA Adult Soft Tissue Sarcoma AJCC v7
31092,Malignant Cellular Infiltrate,Stage II Merkel Cell Carcinoma AJCC v7
31093,Malignant Cellular Infiltrate,Stage IIA Merkel Cell Carcinoma AJCC v7
31094,Malignant Cellular Infiltrate,Stage IIB Merkel Cell Carcinoma AJCC v7
31095,Malignant Cellular Infiltrate,Malignant melanoma of retina
31096,Malignant Cellular Infiltrate,Stage IIIC Cutaneous Melanoma AJCC v7
31097,Malignant Cellular Infiltrate,Inflammatory carcinoma of breast recurrent
31098,Malignant Cellular Infiltrate,Metastases to adrenals
31099,Malignant Cellular Infiltrate,Small intestine carcinoma metastatic
31100,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage II
31101,Malignant Cellular Infiltrate,Mycosis fungoides recurrent
31102,Malignant Cellular Infiltrate,Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma
31103,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage III
31104,Malignant Cellular Infiltrate,Non-Cutaneous Melanoma
31105,Malignant Cellular Infiltrate,Stage IVA Uterine Sarcoma AJCC v7
31106,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v7
31107,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v7
31108,Malignant Cellular Infiltrate,Stage III Bone Cancer AJCC v7
31109,Malignant Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v7
31110,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7
31111,Malignant Cellular Infiltrate,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7
31112,Malignant Cellular Infiltrate,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8"
31113,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7
31114,Malignant Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7
31115,Malignant Cellular Infiltrate,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7
31116,Malignant Cellular Infiltrate,Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7
31117,Malignant Cellular Infiltrate,Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7
31118,Malignant Cellular Infiltrate,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7
31119,Malignant Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7
31120,Malignant Cellular Infiltrate,Large cell lung cancer stage I
31121,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage I"
31122,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage I
31123,Malignant Cellular Infiltrate,Stage II Pharynx Carcinoma
31124,Malignant Cellular Infiltrate,Stage III Pharynx Carcinoma
31125,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v6
31126,Malignant Cellular Infiltrate,Stage IA Esophageal Adenocarcinoma AJCC v7
31127,Malignant Cellular Infiltrate,Stage IIIA Esophageal Adenocarcinoma AJCC v7
31128,Malignant Cellular Infiltrate,Stage IIA Small Intestinal Cancer AJCC v7
31129,Malignant Cellular Infiltrate,Stage IIIA Small Intestinal Cancer AJCC v7
31130,Malignant Cellular Infiltrate,Stage IIIC Colorectal Cancer AJCC v7
31131,Malignant Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v7
31132,Well Differentiated Neuroendocrine Lesion,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7
31133,Well Differentiated Neuroendocrine Lesion,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7
31134,Malignant Cellular Infiltrate,Metastatic Extraskeletal Myxoid Chondrosarcoma
31135,Malignant Cellular Infiltrate,Stage IIIC Hepatocellular Carcinoma AJCC v7
31136,Malignant Cellular Infiltrate,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
31137,Malignant Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v7
31138,Malignant Cellular Infiltrate,Extraskeletal Osteosarcoma
31139,Malignant Cellular Infiltrate,Stage II Eyelid Carcinoma AJCC v7
31140,Malignant Cellular Infiltrate,Leiomyosarcoma recurrent
31141,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7
31142,Malignant Cellular Infiltrate,Metastatic Malignant Peripheral Nerve Sheath Tumor
31143,Secondary Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor
31144,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity recurrent
31145,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I site unspecified
31146,Malignant Cellular Infiltrate,Stage III Breast Cancer AJCC v7
31147,Malignant Cellular Infiltrate,B-cell lymphoma refractory
31148,Malignant Cellular Infiltrate,Stage I Burkitt Lymphoma
31149,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma recurrent
31150,Malignant Cellular Infiltrate,Ann Arbor Stage III Follicular Lymphoma
31151,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage IV
31152,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage II
31153,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage 0
31154,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage III
31155,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7
31156,Malignant Cellular Infiltrate,Pancreatic adenocarcinoma metastatic
31157,Malignant Cellular Infiltrate,Small intestine adenocarcinoma metastatic NOS
31158,Malignant Cellular Infiltrate,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
31159,Malignant Cellular Infiltrate,Adenocarcinoma of the prostate stage I
31160,Malignant Cellular Infiltrate,Stage 0 Vaginal Cancer AJCC v7
31161,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IIIA
31162,Malignant Cellular Infiltrate,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7
31163,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Cancer
31164,Benign Cellular Infiltrate,Lymphangioma
31165,Malignant Cellular Infiltrate,Colon Carcinoma Metastatic in the Lung
31166,Benign Cellular Infiltrate,Dermoid Cyst
31167,Malignant Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa
31168,Malignant Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v7
31169,Malignant Cellular Infiltrate,FNCLCC Sarcoma Grade 1
31170,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v6 Stage
31171,Malignant Cellular Infiltrate,Gastric carcinoma stage IV
31172,Malignant Cellular Infiltrate,Adult Angiosarcoma
31173,Malignant Cellular Infiltrate,Recurrent Childhood Hepatocellular Carcinoma
31174,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v6 Stage
31175,Malignant Cellular Infiltrate,Breast Cancer by AJCC v6 Stage
31176,Malignant Cellular Infiltrate,Stage I Childhood Lymphoblastic Lymphoma
31177,Malignant Cellular Infiltrate,Adult Burkitt Lymphoma
31178,Malignant Cellular Infiltrate,Localized Resectable Adult Hepatocellular Carcinoma
31179,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
31180,Malignant Cellular Infiltrate,Melanoma recurrent
31181,Malignant Cellular Infiltrate,Blast Phase
31182,Malignant Cellular Infiltrate,Medullary carcinoma of breast
31183,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v7 Stage
31184,Malignant Cellular Infiltrate,Penile Cancer by AJCC v7 Stage
31185,Malignant Cellular Infiltrate,Laryngeal Cancer by AJCC v7 Stage
31186,Malignant Cellular Infiltrate,Adult Mixed Cellularity Classical Hodgkin Lymphoma
31187,Malignant Cellular Infiltrate,Adult Acute Myeloblastic Leukemia
31188,Malignant Cellular Infiltrate,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3"
31189,Malignant Cellular Infiltrate,Stage III Childhood Burkitt Lymphoma
31190,Malignant Cellular Infiltrate,Stage III Esophageal Cancer
31191,Malignant Cellular Infiltrate,Juvenile Myelomonocytic Leukemia
31192,Malignant Cellular Infiltrate,Nasopharyngeal cancer recurrent
31193,Malignant Cellular Infiltrate,Malignant neoplasm of duodenum recurrent
31194,Malignant Cellular Infiltrate,Malignant neoplasm of bladder recurrent
31195,Malignant Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm
31196,Malignant Cellular Infiltrate,Advanced cancer
31197,Malignant Cellular Infiltrate,"Hodgkin lymphoma, lymphocyte depletion"
31198,Malignant Cellular Infiltrate,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease"
31199,Malignant Cellular Infiltrate,Primary central nervous system lymphoma
31200,Malignant Cellular Infiltrate,Lip and Oral Cavity Carcinoma
31201,Malignant Cellular Infiltrate,Malignant neoplasm of mouth
31202,Malignant Cellular Infiltrate,Malignant neoplasm of cecum
31203,Malignant Cellular Infiltrate,Carcinoma of the Appendix
31204,Malignant Cellular Infiltrate,Cancer of Ear
31205,Malignant Cellular Infiltrate,Adrenal Cancer
31206,Malignant Cellular Infiltrate,Tracheal Carcinoma
31207,Malignant Cellular Infiltrate,Stage I Colon Cancer AJCC v6 and v7
31208,Malignant Cellular Infiltrate,Adult Lymphoblastic Lymphoma
31209,Malignant Cellular Infiltrate,Angiosarcoma NCI Grade 2
31210,Malignant Cellular Infiltrate,Sarcoma by AJCC Grade
31211,Malignant Cellular Infiltrate,AJCC Grade 1 Sarcoma
31212,Malignant Cellular Infiltrate,Pharyngeal Carcinoma
31213,Malignant Cellular Infiltrate,Ann Arbor Stage II AIDS-Related Lymphoma
31214,Malignant Cellular Infiltrate,Melanotic medulloblastoma
31215,Malignant Cellular Infiltrate,Melanomatosis
31216,Malignant Cellular Infiltrate,Thymic Hodgkin Lymphoma
31217,Malignant Cellular Infiltrate,Stage IIIC2 Uterine Corpus Cancer AJCC v7
31218,Malignant Cellular Infiltrate,Pancreatic Small Cell Neuroendocrine Carcinoma
31219,Well Differentiated Neuroendocrine Lesion,Pancreatic Somatostatinoma
31220,Malignant Cellular Infiltrate,Second Primary Cancers
31221,Malignant Cellular Infiltrate,Esophageal Well Differentiated Squamous Cell Carcinoma
31222,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2
31223,Malignant Cellular Infiltrate,Gastric Carcinoma with Lymphoid Stroma
31224,Malignant Cellular Infiltrate,Ampulla of Vater Invasive Papillary Adenocarcinoma
31225,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor
31226,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Large Cell Neuroendocrine Carcinoma
31227,Malignant Cellular Infiltrate,Rectal Serrated Adenocarcinoma
31228,Malignant Cellular Infiltrate,Rectal Cribriform Comedo-Type Adenocarcinoma
31229,Malignant Cellular Infiltrate,neuroendocrine carcinoma of anal canal
31230,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of anal canal
31231,Malignant Cellular Infiltrate,Moderately Differentiated Hepatocellular Carcinoma
31232,Malignant Cellular Infiltrate,Poorly Differentiated Hepatocellular Carcinoma
31233,Malignant Cellular Infiltrate,carcinosarcoma of liver
31234,Well Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G2
31235,Malignant Cellular Infiltrate,cystadenocarcinoma of intrahepatic bile duct
31236,Malignant Cellular Infiltrate,Kaposi's sarcoma of extrahepatic bile duct
31237,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant"
31238,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Solid Variant"
31239,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with Neuroblastoma
31240,Malignant Cellular Infiltrate,Hereditary Prostate Carcinoma
31241,Malignant Cellular Infiltrate,ENSAT Stage III Adrenal Cortex Carcinoma
31242,Malignant Cellular Infiltrate,Class 2 Uveal Melanoma
31243,Malignant Cellular Infiltrate,Class 1a Uveal Melanoma
31244,Malignant Cellular Infiltrate,"Uterine Carcinosarcoma, Heterologous Type"
31245,Malignant Cellular Infiltrate,Childhood Unfavorable Prognosis Hodgkin Lymphoma
31246,Malignant Cellular Infiltrate,Hormone-Resistant Prostate Carcinoma
31247,Malignant Cellular Infiltrate,Malignant Cardiovascular Neoplasm
31248,Malignant Cellular Infiltrate,Childhood Gliosarcoma
31249,Malignant Cellular Infiltrate,Stage III Childhood Anaplastic Large Cell Lymphoma
31250,Encapsulated Mass,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7
31251,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
31252,Malignant Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v7
31253,Malignant Cellular Infiltrate,Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
31254,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
31255,Malignant Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
31256,Malignant Cellular Infiltrate,Stage IB Esophageal Cancer AJCC v7
31257,Malignant Cellular Infiltrate,Stage IIA Uterine Sarcoma AJCC v7
31258,Malignant Cellular Infiltrate,Stage IIB Uterine Sarcoma AJCC v7
31259,Malignant Cellular Infiltrate,BCLC Stage B Hepatocellular Carcinoma
31260,Malignant Cellular Infiltrate,BCLC Stage C Adult Hepatocellular Carcinoma
31261,Malignant Cellular Infiltrate,Childhood Cerebellar Anaplastic Astrocytoma
31262,Malignant Cellular Infiltrate,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
31263,Borderline Lesion,Childhood Grade III Lymphomatoid Granulomatosis
31264,Malignant Cellular Infiltrate,Recurrent Fallopian Tube Carcinoma
31265,Malignant Cellular Infiltrate,Recurrent Primary Peritoneal Carcinoma
31266,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma
31267,Malignant Cellular Infiltrate,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
31268,Benign Cellular Infiltrate,Mammary-Type Myofibroblastoma
31269,Malignant Cellular Infiltrate,Leiomyosarcoma of Deep Soft Tissue
31270,Benign Cellular Infiltrate,Dermal nerve sheath myxoma
31271,Benign Cellular Infiltrate,Acral Fibromyxoma
31272,Benign Cellular Infiltrate,Osteochondromyxoma
31273,Benign Cellular Infiltrate,Non-Ossifying Fibroma
31274,Malignant Cellular Infiltrate,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM"
31275,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q
31276,Malignant Cellular Infiltrate,Mammary Analog Secretory Carcinoma of Salivary Gland
31277,Benign Cellular Infiltrate,Childhood Testicular Mature Teratoma
31278,Malignant Cellular Infiltrate,Childhood Ganglioneuroblastoma
31279,Malignant Cellular Infiltrate,Childhood Central Nervous System Ganglioneuroblastoma
31280,Malignant Cellular Infiltrate,Childhood Anaplastic Ependymoma
31281,Malignant Cellular Infiltrate,Metastatic urothelial carcinoma
31282,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma
31283,Malignant Cellular Infiltrate,Warthin-Like Variant Thyroid Gland Papillary Carcinoma
31284,Malignant Cellular Infiltrate,Broad Ligament Serous Adenocarcinoma
31285,Malignant Cellular Infiltrate,Endometrial Large Cell Neuroendocrine Carcinoma
31286,Malignant Cellular Infiltrate,Malignant Uterine Corpus PEComa
31287,Malignant Cellular Infiltrate,FIGO Stage IC2 Ovarian Cancer
31288,Malignant Cellular Infiltrate,FIGO Stage III Ovarian Cancer
31289,Malignant Cellular Infiltrate,Stage IIIA Ovarian Carcinoma
31290,Malignant Cellular Infiltrate,FIGO Stage IVA Ovarian Cancer
31291,Malignant Cellular Infiltrate,"Vulvar Adenocarcinoma, Intestinal-Type"
31292,Malignant Cellular Infiltrate,Vulvar Large Cell Neuroendocrine Carcinoma
31293,Benign Cellular Infiltrate,Vulvar Lipoma
31294,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Wildtype"
31295,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 4"
31296,Malignant Cellular Infiltrate,Unresectable Transitional Cell Carcinoma
31297,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia
31298,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1
31299,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A
31300,Primary Lesion,Parietal Lobe and Occipital Lobe Ependymal Tumor
31301,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with NUP98-KDM5A
31302,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v8 Stage
31303,Malignant Cellular Infiltrate,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
31304,Malignant Cellular Infiltrate,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
31305,Malignant Cellular Infiltrate,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
31306,Malignant Cellular Infiltrate,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8
31307,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8
31308,Malignant Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8
31309,Malignant Cellular Infiltrate,Recurrent Breast Angiosarcoma
31310,Malignant Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v8
31311,Malignant Cellular Infiltrate,Stage III Laryngeal Cancer AJCC v8
31312,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck by AJCC v7 Stage
31313,Malignant Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck
31314,Malignant Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage
31315,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v7 Stage
31316,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage
31317,Malignant Cellular Infiltrate,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8
31318,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage
31319,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8
31320,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage
31321,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage
31322,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
31323,Malignant Cellular Infiltrate,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
31324,Malignant Cellular Infiltrate,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
31325,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
31326,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage
31327,Malignant Cellular Infiltrate,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
31328,Malignant Cellular Infiltrate,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
31329,Malignant Cellular Infiltrate,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
31330,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
31331,Malignant Cellular Infiltrate,Clinical Stage II Gastric Cancer AJCC v8
31332,Malignant Cellular Infiltrate,Clinical Stage III Gastric Cancer AJCC v8
31333,Malignant Cellular Infiltrate,Clinical Stage IVB Gastric Cancer AJCC v8
31334,Malignant Cellular Infiltrate,Pathologic Stage IIIB Gastric Cancer AJCC v8
31335,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
31336,Malignant Cellular Infiltrate,Clinical Stage IIA Gastric Cancer AJCC v8
31337,Malignant Cellular Infiltrate,Refractory Malignant Solid Neoplasm
31338,Malignant Cellular Infiltrate,Anal Canal Cancer by AJCC v6 and v7 Stage
31339,Malignant Cellular Infiltrate,Metastatic Digestive System Carcinoma
31340,Malignant Cellular Infiltrate,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8
31341,Malignant Cellular Infiltrate,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
31342,Malignant Cellular Infiltrate,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8
31343,Malignant Cellular Infiltrate,Stage IV Appendix Carcinoma AJCC v8
31344,Malignant Cellular Infiltrate,Stage IVA Appendix Carcinoma AJCC v8
31345,Malignant Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v8
31346,Malignant Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v8
31347,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v8
31348,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v8
31349,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v8
31350,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v8
31351,Malignant Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v8
31352,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v8
31353,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8
31354,Malignant Cellular Infiltrate,Stage III Intrahepatic Bile Duct Cancer AJCC v8
31355,Malignant Cellular Infiltrate,Stage IIB Gallbladder Cancer AJCC v8
31356,Malignant Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v8
31357,Malignant Cellular Infiltrate,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
31358,Malignant Cellular Infiltrate,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
31359,Malignant Cellular Infiltrate,Distal Bile Duct Cancer by AJCC v7 Stage
31360,Malignant Cellular Infiltrate,Stage IIA Distal Bile Duct Cancer AJCC v8
31361,Malignant Cellular Infiltrate,Eyelid Sebaceous Gland Carcinoma
31362,Malignant Cellular Infiltrate,Stage IIB Pancreatic Cancer AJCC v8
31363,Well Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8
31364,Well Differentiated Neuroendocrine Lesion,Stage III Duodenal Neuroendocrine Tumor AJCC v8
31365,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor by AJCC v7 Stage
31366,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colon Neuroendocrine Tumor AJCC v8
31367,Well Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Tumor by AJCC v8 Stage
31368,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage
31369,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v8
31370,Malignant Cellular Infiltrate,Stage IA3 Lung Cancer AJCC v8
31371,Malignant Cellular Infiltrate,Refractory Acute Lymphoblastic Leukemia
31372,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v8
31373,Malignant Cellular Infiltrate,Stage IIB Bone Cancer AJCC v8
31374,Malignant Cellular Infiltrate,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified"
31375,Malignant Cellular Infiltrate,Recurrent Cervical Adenosquamous Carcinoma
31376,Malignant Cellular Infiltrate,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
31377,Malignant Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v7 Stage
31378,Malignant Cellular Infiltrate,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
31379,Malignant Cellular Infiltrate,Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
31380,Malignant Cellular Infiltrate,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
31381,Malignant Cellular Infiltrate,Stage I Retroperitoneal Sarcoma AJCC v8
31382,Malignant Cellular Infiltrate,Stage IB Retroperitoneal Sarcoma AJCC v8
31383,Malignant Cellular Infiltrate,Pathologic Stage I Merkel Cell Carcinoma AJCC v8
31384,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Clinical Stage
31385,Malignant Cellular Infiltrate,Pathologic Stage IIC Cutaneous Melanoma AJCC v8
31386,Malignant Cellular Infiltrate,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
31387,Malignant Cellular Infiltrate,Prostate Carcinoma by Gene Expression Profile
31388,Malignant Cellular Infiltrate,Luminal A Prostate Carcinoma
31389,Malignant Cellular Infiltrate,Luminal B Prostate Carcinoma
31390,Borderline Lesion,In situ follicular neoplasia
31391,Malignant Cellular Infiltrate,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified"
31392,Malignant Cellular Infiltrate,Refractory High Risk Myelodysplastic Syndrome
31393,Borderline Lesion,Type D Lymphomatoid Papulosis
31394,Malignant Cellular Infiltrate,Prognostic Stage IIIB Breast Cancer AJCC v8
31395,Malignant Cellular Infiltrate,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
31396,Malignant Cellular Infiltrate,Stage I Cervical Cancer AJCC v8
31397,Malignant Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v8
31398,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Cancer AJCC v8
31399,Malignant Cellular Infiltrate,Stage I Uterine Corpus Leiomyosarcoma AJCC v8
31400,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8
31401,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
31402,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Adenosarcoma AJCC v8
31403,Malignant Cellular Infiltrate,Stage IIA Ovarian Cancer AJCC v8
31404,Malignant Cellular Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v8
31405,Malignant Cellular Infiltrate,Stage IVA Fallopian Tube Cancer AJCC v8
31406,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v7 Stage
31407,Malignant Cellular Infiltrate,Stage III Primary Peritoneal Cancer AJCC v8
31408,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v8
31409,Malignant Cellular Infiltrate,Stage II Penile Cancer AJCC v8
31410,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v8
31411,Malignant Cellular Infiltrate,Stage IVB Prostate Cancer AJCC v8
31412,Malignant Cellular Infiltrate,Stage 0a Ureter Cancer AJCC v8
31413,Malignant Cellular Infiltrate,Stage II Renal Pelvis and Ureter Cancer AJCC v8
31414,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v8
31415,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v8
31416,Malignant Cellular Infiltrate,Stage IV Urethral Cancer AJCC v8
31417,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v8
31418,Malignant Cellular Infiltrate,Stage I Eyelid Carcinoma AJCC v8
31419,Malignant Cellular Infiltrate,Stage IIB Eyelid Carcinoma AJCC v8
31420,Malignant Cellular Infiltrate,Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8
31421,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Stage
31422,Malignant Cellular Infiltrate,Clinical Stage II Retinoblastoma AJCC v8
31423,Malignant Cellular Infiltrate,Pathologic Stage II Retinoblastoma AJCC v8
31424,Malignant Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage
31425,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8
31426,Malignant Cellular Infiltrate,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
31427,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma AJCC v8
31428,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8
31429,Encapsulated Mass,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8
31430,Encapsulated Mass,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
31431,Malignant Cellular Infiltrate,Stage III Thyroid Gland Medullary Carcinoma AJCC v8
31432,Malignant Cellular Infiltrate,Adrenal Cortex Carcinoma by AJCC v8 Stage
31433,Malignant Cellular Infiltrate,Stage III Adrenal Cortex Carcinoma AJCC v8
31434,Malignant Cellular Infiltrate,Lymphoma by Ann Arbor Stage
31435,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Lymphoma AJCC v8
31436,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8
31437,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8
31438,Malignant Cellular Infiltrate,Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8
31439,Malignant Cellular Infiltrate,Lugano Classification Stage I Adult Hodgkin Lymphoma AJCC v8
31440,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8
31441,Malignant Cellular Infiltrate,St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8
31442,Malignant Cellular Infiltrate,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage
31443,Malignant Cellular Infiltrate,Nodal Marginal Zone Lymphoma by Ann Arbor Stage
31444,Malignant Cellular Infiltrate,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage
31445,Malignant Cellular Infiltrate,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage
31446,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8
31447,Malignant Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8
31448,Malignant Cellular Infiltrate,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
31449,Malignant Cellular Infiltrate,acute biphenotypic leukemia in relapse
31450,Malignant Cellular Infiltrate,Waldenstrom's macroglobulinemia refractory
31451,Malignant Cellular Infiltrate,Primary myoepithelial carcinoma of lung
31452,Malignant Cellular Infiltrate,Refractory Rhabdomyosarcoma
31453,Malignant Cellular Infiltrate,Refractory Ewing Sarcoma
31454,Malignant Cellular Infiltrate,Refractory Malignant Glioma
31455,Malignant Cellular Infiltrate,Refractory Rhabdoid Tumor
31456,Malignant Cellular Infiltrate,Recurrent Alveolar Rhabdomyosarcoma
31457,Malignant Cellular Infiltrate,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group
31458,Malignant Cellular Infiltrate,Cardiac Extraskeletal Osteosarcoma
31459,Malignant Cellular Infiltrate,Pericardial Angiosarcoma
31460,Malignant Cellular Infiltrate,Pericardial Synovial Sarcoma
31461,Malignant Cellular Infiltrate,Platinum-Resistant Ovarian Carcinoma
31462,Malignant Cellular Infiltrate,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
31463,Malignant Cellular Infiltrate,Central Nervous System B-Cell Non-Hodgkin Lymphoma
31464,Malignant Cellular Infiltrate,Childhood Recurrent Malignant Solid Neoplasm
31465,Malignant Cellular Infiltrate,Unresectable Thymic Carcinoma
31466,Malignant Cellular Infiltrate,Metastatic thymic carcinoma
31467,Malignant Cellular Infiltrate,Squamous cell carcinoma of head and neck metastatic
31468,Malignant Cellular Infiltrate,Unresectable Sarcoma
31469,Malignant Cellular Infiltrate,Recurrent Myelodysplastic Syndrome
31470,Malignant Cellular Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma
31471,Malignant Cellular Infiltrate,Refractory Oropharyngeal Squamous Cell Carcinoma
31472,Malignant Cellular Infiltrate,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
31473,Malignant Cellular Infiltrate,Leukemia recurrent
31474,Malignant Cellular Infiltrate,Refractory Nasopharyngeal Carcinoma
31475,Malignant Cellular Infiltrate,Recurrent Ovarian Endometrioid Adenocarcinoma
31476,Malignant Cellular Infiltrate,Refractory Endometrial Endometrioid Adenocarcinoma
31477,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Nasopharynx
31478,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Larynx
31479,Malignant Cellular Infiltrate,Urothelial carcinoma ureter metastatic
31480,Malignant Cellular Infiltrate,Urothelial carcinoma ureter recurrent
31481,Malignant Cellular Infiltrate,Refractory Malignant Oral Neoplasm
31482,Malignant Cellular Infiltrate,Refractory Malignant Thyroid Gland Neoplasm
31483,Malignant Cellular Infiltrate,Refractory Malignant Skin Neoplasm
31484,Malignant Cellular Infiltrate,Infiltrating Bladder Carcinoma
31485,Malignant Cellular Infiltrate,Resectable Undifferentiated Pleomorphic Sarcoma
31486,Malignant Cellular Infiltrate,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified"
31487,Malignant Cellular Infiltrate,Refractory Lymphoblastic Lymphoma
31488,Malignant Cellular Infiltrate,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
31489,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified"
31490,Malignant Cellular Infiltrate,Refractory Female Reproductive System Carcinoma
31491,Malignant Cellular Infiltrate,Locally Advanced Soft Tissue Sarcoma
31492,Poorly Differentiated Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma
31493,Malignant Cellular Infiltrate,Advanced Renal Cell Carcinoma
31494,Malignant Cellular Infiltrate,Recurrent Mediastinal Lymphoma
31495,Malignant Cellular Infiltrate,Advanced Synovial Sarcoma
31496,Malignant Cellular Infiltrate,Advanced Lung Non-Small Cell Squamous Carcinoma
31497,Malignant Cellular Infiltrate,Recurrent Ovarian Carcinosarcoma
31498,Malignant Cellular Infiltrate,Metastatic Triple-Negative Breast Carcinoma
31499,Malignant Cellular Infiltrate,Metastatic Cervical Adenocarcinoma
31500,Malignant Cellular Infiltrate,Recurrent Parotid Gland Acinic Cell Carcinoma
31501,Malignant Cellular Infiltrate,Recurrent Appendix Mucinous Adenocarcinoma
31502,Malignant Cellular Infiltrate,Recurrent Pancreatic Ductal Adenocarcinoma
31503,Malignant Cellular Infiltrate,Recurrent Thyroid Gland Medullary Carcinoma
31504,Malignant Cellular Infiltrate,Recurrent Parotid Gland Carcinoma
31505,Malignant Cellular Infiltrate,Recurrent Appendix Carcinoma
31506,Malignant Cellular Infiltrate,Recurrent Ovarian Transitional Cell Carcinoma
31507,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
31508,Malignant Cellular Infiltrate,MGMT-Methylated Glioblastoma
31509,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma
31510,Resectable Mass,Resectable Pleural Malignant Mesothelioma
31511,Unresectable Mass,Unresectable Pleural Malignant Mesothelioma
31512,Malignant Cellular Infiltrate,Anaplastic Sarcoma of the Kidney
31513,Malignant Cellular Infiltrate,Resectable Renal Cell Carcinoma
31514,Recurrent disease,Recurrent Metastatic Malignant Neoplasm
31515,Secondary Lesion,Recurrent Metastatic Malignant Neoplasm
31516,Necrotic changes (finding),Digestive System Large Cell Neuroendocrine Carcinoma
31517,Carcinomatous Component Present,Digestive System Small Cell Neuroendocrine Carcinoma
31518,Malignant Cellular Infiltrate,Recurrent Cutaneous Melanoma of the Extremity
31519,Cutaneous Involvement,Advanced Cutaneous Melanoma of the Extremity
31520,Recurrent disease,Pancreatic adenocarcinoma recurrent
31521,Secondary Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma
31522,Epithelial Component Present,Locally Advanced Unresectable Pancreatic Adenocarcinoma
31523,Carcinomatous Component Present,Locally Advanced Unresectable Pancreatic Adenocarcinoma
31524,Diffuse Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma
31525,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Sellar Choriocarcinoma
31526,"Fully Differentiated ""Adult-Type"" Tissues Present",Sellar Mature Teratoma
31527,Mixture of Germ Cell Neoplastic Components Present,Sellar Mixed Germ Cell Tumor
31528,Epithelial Component Present,Recurrent Endometrial Undifferentiated Carcinoma
31529,Malignant Cellular Infiltrate,Recurrent Uterine Corpus Carcinosarcoma
31530,Unresectable Mass,Unresectable Low Grade Glioma
31531,Secondary Lesion,"Neuroendocrine carcinoma, metastatic"
31532,Secondary Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma
31533,Locally Aggressive Lesion,Unresectable Desmoid-Type Fibromatosis
31534,Epithelial Component Present,Unresectable Lung Carcinoma
31535,Unresectable Mass,Unresectable Digestive System Carcinoma
31536,Epithelial Component Present,Metastatic Lung Adenocarcinoma
31537,Carcinomatous Component Present,Metastatic Lung Adenocarcinoma
31538,Poorly Differentiated Neuroendocrine Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma
31539,Severe cytologic atypia,Locally Advanced Digestive System Neuroendocrine Carcinoma
31540,Malignant Cellular Infiltrate,Unresectable Digestive System Neuroendocrine Carcinoma
31541,Poorly Differentiated Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Carcinoma
31542,Severe cytologic atypia,Metastatic Digestive System Neuroendocrine Carcinoma
31543,Malignant Cellular Infiltrate,Refractory Digestive System Neuroendocrine Carcinoma
31544,Neuroendocrine Differentiation,Refractory Digestive System Neuroendocrine Carcinoma
31545,Epithelial Component Present,Refractory Digestive System Neuroendocrine Carcinoma
31546,Carcinomatous Component Present,Recurrent Digestive System Neuroendocrine Carcinoma
31547,Cystic Change,Broad Ligament Papillary Cystadenoma
31548,Cystic Change,Epididymal Papillary Cystadenoma
31549,Benign Cellular Infiltrate,Thyroid Gland Spindle Cell Follicular Adenoma
31550,Epithelial Component Present,Thyroid Gland Black Follicular Adenoma
31551,Questionable Invasive Lesion,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
31552,Follicular Structures Present,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
31553,Recurrent disease,Recurrent Visual Pathway Glioma
31554,Carcinomatous Component Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma
31555,Mitotic Activity,Frontal Lobe Anaplastic Astrocytoma
31556,Primary Lesion,Frontal Lobe Anaplastic Astrocytoma
31557,Nuclear Atypia,Temporal Lobe Anaplastic Astrocytoma
31558,Malignant Cellular Infiltrate,Temporal Lobe Anaplastic Astrocytoma
31559,High Grade Lesion,Temporal Lobe Anaplastic Astrocytoma
31560,Increased Cellularity Present,Temporal Lobe Anaplastic Astrocytoma
31561,Spindle Cell Metaplasia,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
31562,Malignant Cellular Infiltrate,Bladder cancer stage IV
31563,Secondary Lesion,Bladder cancer stage IV
31564,Epithelial Component Present,Bladder cancer stage IV
31565,Secondary Lesion,Stage IV Ovarian Carcinoma
31566,Epithelial Component Present,Metastatic Vulvar Carcinoma
31567,Malignant Cellular Infiltrate,stage IV pancreatic cancer
31568,Malignant Cellular Infiltrate,Metastatic Adrenal Cortex Carcinoma
31569,Metastatic Lesion,Stage IV Skin Melanoma
31570,Malignant Cellular Infiltrate,Metastatic Esophageal Carcinoma
31571,Epithelial Component Present,Stage IV Esophageal Squamous Cell Carcinoma
31572,Syncytial Pattern,Metastatic Nasopharyngeal Undifferentiated Carcinoma
31573,Malignant Cellular Infiltrate,Metastatic Nasopharyngeal Undifferentiated Carcinoma
31574,Metastatic Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma
31575,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma
31576,Epithelial Component Present,Metastatic Hypopharyngeal Carcinoma
31577,Malignant Cellular Infiltrate,Metastatic Oropharyngeal Carcinoma
31578,Epithelial Component Present,Metastatic Lip and Oral Cavity Carcinoma
31579,Malignant Cellular Infiltrate,Metastatic Oral Cavity Carcinoma
31580,Secondary Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma
31581,Metastatic Lesion,Metastatic Lung Non-Small Cell Carcinoma
31582,Malignant Cellular Infiltrate,Metastatic Lung Small Cell Carcinoma
31583,Epithelial Component Present,Metastatic Lung Small Cell Carcinoma
31584,Carcinomatous Component Present,Metastatic Lung Small Cell Carcinoma
31585,Malignant Cellular Infiltrate,Metastatic Rectal Carcinoma
31586,Epithelial Component Present,Metastatic Thyroid Gland Papillary Carcinoma
31587,Carcinomatous Component Present,Metastatic Thyroid Gland Papillary Carcinoma
31588,Recurrent disease,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
31589,CD4-Positive Neoplastic Cells Present,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
31590,Malignant Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
31591,Thyroglobulin Positive Neoplastic Cells Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
31592,Carcinomatous Component Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
31593,Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
31594,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
31595,Carcinomatous Component Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
31596,Carcinomatous Component Present,Localized Gastroesophageal Junction Adenocarcinoma
31597,Malignant Cellular Infiltrate,Refractory Aggressive Non-Hodgkin Lymphoma
31598,Carcinomatous Component Present,Locally Advanced Pancreatic Adenocarcinoma
31599,Pseudoalveolar Pattern,Tongue Alveolar Soft Part Sarcoma'
31600,Malignant Cellular Infiltrate,sarcoma of tongue
31601,Crystal deposition,Bladder Alveolar Soft Part Sarcoma
31602,Metastatic Lesion,Advanced Prostate Carcinoma
31603,Metastatic Lesion,Locally Advanced Prostate Carcinoma
31604,Epithelial Component Present,Advanced Prostate Adenocarcinoma
31605,Malignant Cellular Infiltrate,Locally Advanced Prostate Adenocarcinoma
31606,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Carcinoma
31607,Regional Disease,Locally Advanced Unresectable Prostate Carcinoma
31608,Metastatic Lesion,Locally Advanced Cervical Carcinoma
31609,Carcinomatous Component Present,Locally Advanced Cervical Carcinoma
31610,Malignant Cellular Infiltrate,Locally Advanced Cervical Adenocarcinoma
31611,Carcinomatous Component Present,Locally Advanced Cervical Adenocarcinoma
31612,Diffuse Pattern,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
31613,Cavernous Vascular Space Formation,Thyroid Gland Cavernous Hemangioma
31614,Benign Cellular Infiltrate,Thyroid Gland Leiomyoma
31615,Polymorphic Cellular Infiltrate,Thyroid Gland Langerhans Cell Histiocytosis
31616,Fever,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy
31617,Plasma cell inflammation,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy
31618,Massive Sinusoidal Histiocytic Infiltrate,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy
31619,Benign Cellular Infiltrate,Grade 1 Teratoma
31620,Epithelial Component Present,Recurrent Primary Peritoneal Serous Adenocarcinoma
31621,Recurrent disease,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
31622,Stromal Invasion,Recurrent Low Grade Ovarian Serous Adenocarcinoma
31623,Low Mitotic Activity,Recurrent Low Grade Ovarian Serous Adenocarcinoma
31624,Monomorphic Cellular Infiltrate,Brain Ependymoma
31625,Secondary Lesion,"Kaposi's sarcoma, metastatic"
31626,Vascular Channel Formation,Advanced Kaposi Sarcoma
31627,Extensive Stage Lesion,Advanced Carcinoid Tumor
31628,Neuroendocrine Differentiation,Advanced Carcinoid Tumor
31629,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Neoplasm
31630,Malignant Cellular Infiltrate,Metastatic Breast Neuroendocrine Neoplasm
31631,Secondary Lesion,Metastatic Breast Neuroendocrine Neoplasm
31632,Secondary Lesion,Metastatic Gastric Neuroendocrine Carcinoma
31633,Poorly Differentiated Neuroendocrine Lesion,Advanced Gastric Neuroendocrine Carcinoma
31634,Metastatic Lesion,Advanced Gastric Neuroendocrine Carcinoma
31635,Severe cytologic atypia,Advanced Gastric Small Cell Neuroendocrine Carcinoma
31636,Neuroendocrine Differentiation,Metastatic Small Intestinal Neuroendocrine Carcinoma
31637,Malignant Cellular Infiltrate,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
31638,Necrotic changes (finding),Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
31639,Severe cytologic atypia,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
31640,High Mitotic Activity,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
31641,Histiocytosis,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
31642,Recurrent disease,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
31643,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Megakaryoblastic Leukemia
31644,Microsatellite Stable,Locally Advanced Microsatellite Stable Colorectal Carcinoma
31645,Benign Cellular Infiltrate,Benign Parathyroid Gland Adenoma
31646,Epithelial Component Present,Benign Parathyroid Gland Adenoma
31647,Malignant Cellular Infiltrate,Locally Advanced Basal Cell Carcinoma
31648,Regional Disease,Locally Advanced Basal Cell Carcinoma
31649,Carcinomatous Component Present,Locally Advanced Basal Cell Carcinoma
31650,Malignant Cellular Infiltrate,Recurrent Biliary Tract Carcinoma
31651,Metastatic Lesion,Metastatic Unresectable Basal Cell Carcinoma
31652,Malignant Cellular Infiltrate,Metastatic Human Papillomavirus-Related Malignant Neoplasm
31653,Secondary Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm
31654,Malignant Cellular Infiltrate,Resectable Pancreatic Acinar Cell Carcinoma
31655,Resectable Mass,Resectable Intrahepatic Cholangiocarcinoma
31656,Epithelial Component Present,Resectable Extrahepatic Bile Duct Adenocarcinoma
31657,Benign Cellular Infiltrate,Adrenal Gland Schwannoma
31658,Hormone Receptor Positive,Refractory Hormone Receptor Positive Breast Carcinoma
31659,Secondary Lesion,Testicular cancer metastatic
31660,Malignant Cellular Infiltrate,"Leukemia, Radiation-Induced"
31661,Benign Cellular Infiltrate,Epithelioid and spindle cell nevus
31662,Malignant Cellular Infiltrate,Leiomyosarcoma of stomach
31663,Benign Cellular Infiltrate,Giant cell angiofibroma
31664,Malignant Cellular Infiltrate,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7
31665,Malignant Cellular Infiltrate,Cholangiocarcinoma recurrent
31666,Malignant Cellular Infiltrate,Childhood Yolk Sac Tumor
31667,Malignant Cellular Infiltrate,Mucin-producing adenocarcinoma
31668,Malignant Cellular Infiltrate,Carcinomatosis of peritoneal cavity
31669,Malignant Cellular Infiltrate,"Hepatocellular carcinoma, scirrhous"
31670,Malignant Cellular Infiltrate,Ampulla of Vater Undifferentiated Carcinoma
31671,Well Differentiated Neuroendocrine Lesion,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
31672,Malignant Cellular Infiltrate,Disseminated Malignant Neoplasm
31673,Benign Cellular Infiltrate,Classic Rhabdomyoma
31674,Malignant Cellular Infiltrate,Spindle cell liposarcoma
31675,Malignant Cellular Infiltrate,Granular Cell Leiomyosarcoma
31676,Benign Cellular Infiltrate,Angiomatosis
31677,Indolent Clinical Course,Glomeruloid hemangioma
31678,Benign Cellular Infiltrate,Glomeruloid hemangioma
31679,Benign Cellular Infiltrate,Intra-Abdominal Lymphangioma
31680,Malignant Cellular Infiltrate,Human Papillomavirus-Related Cervical Carcinoma
31681,Malignant Cellular Infiltrate,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
31682,Malignant Cellular Infiltrate,Human Papillomavirus-Related Penile Squamous Cell Carcinoma
31683,Malignant Cellular Infiltrate,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder
31684,Malignant Cellular Infiltrate,AIDS-Related Carcinoma
31685,Malignant Cellular Infiltrate,Hypergranular promyelocytic leukemia
31686,Malignant Cellular Infiltrate,Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
31687,Malignant Cellular Infiltrate,Helicobacter Pylori-Related Carcinoma
31688,Malignant Cellular Infiltrate,Bile duct adenocarcinoma
31689,Malignant Cellular Infiltrate,Paget's disease of penis
31690,Malignant Cellular Infiltrate,Metastatic Urethral Carcinoma
31691,Malignant Cellular Infiltrate,Grade 2 Invasive Breast Carcinoma
31692,Malignant Cellular Infiltrate,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation
31693,Malignant Cellular Infiltrate,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease
31694,Malignant Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma
31695,Malignant Cellular Infiltrate,Classic Variant of Chromophobe Renal Cell Carcinoma
31696,Malignant Cellular Infiltrate,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma
31697,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions
31698,Malignant Cellular Infiltrate,Recurrent tumors of the Ewing's family
31699,Malignant Cellular Infiltrate,Recurrent tumors of the Ewing's family
31700,Malignant Cellular Infiltrate,Sporadic Burkitt's lymphoma
31701,Malignant Cellular Infiltrate,Old Burn Scar-Related Skin Squamous Cell Carcinoma
31702,Malignant Cellular Infiltrate,Aflatoxins-Related Hepatocellular Carcinoma
31703,Malignant Cellular Infiltrate,Alcohol-Related Laryngeal Carcinoma
31704,Malignant Cellular Infiltrate,Ionizing Radiation-Related Malignant Neoplasm
31705,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Skin
31706,Malignant Cellular Infiltrate,Endocervical Carcinoma
31707,Malignant Cellular Infiltrate,Carcinoma
31708,Malignant Cellular Infiltrate,Female Breast Carcinoma
31709,Malignant Cellular Infiltrate,Malignant neoplasm of skin
31710,Malignant Cellular Infiltrate,"Carcinoma, Basosquamous"
31711,Malignant Cellular Infiltrate,Immunoproliferative Small Intestinal Disease
31712,Well Differentiated Neuroendocrine Lesion,insulinoma
31713,Malignant Cellular Infiltrate,lymphangiosarcoma
31714,Malignant Cellular Infiltrate,"Lymphoma, Non-Hodgkin"
31715,Malignant Cellular Infiltrate,Neuroblastoma
31716,Malignant Cellular Infiltrate,Sezary Syndrome
31717,Malignant Cellular Infiltrate,Metastatic Carcinoma
31718,Benign Cellular Infiltrate,Pyogenic granuloma of skin and subcutaneous tissue
31719,Malignant Cellular Infiltrate,Malignant neoplasm of uvula
31720,Malignant Cellular Infiltrate,"Sarcoma, Myeloid"
31721,Malignant Cellular Infiltrate,Malignant neoplasm of lower third of esophagus
31722,Malignant Cellular Infiltrate,Malignant neoplasm of ampulla of Vater
31723,Malignant Cellular Infiltrate,Malignant retroperitoneal tumor
31724,Malignant Cellular Infiltrate,Malignant neoplasm of spleen
31725,Malignant Cellular Infiltrate,Malignant tumor of supraglottis
31726,Malignant Cellular Infiltrate,Malignant tumor of pleura
31727,Malignant Cellular Infiltrate,Malignant neoplasm of choroid
31728,Malignant Cellular Infiltrate,Malignant neoplasm of cerebellum
31729,Malignant Cellular Infiltrate,Posterior Pharyngeal Wall Squamous Cell Carcinoma
31730,Malignant Cellular Infiltrate,Testicular Teratoma with Somatic-Type Malignancy
31731,Malignant Cellular Infiltrate,large cell carcinoma of salivary gland
31732,Malignant Cellular Infiltrate,adenosquamous carcinoma of salivary gland
31733,Benign Cellular Infiltrate,Histiocytoma
31734,Malignant Cellular Infiltrate,carcinosarcoma of salivary gland
31735,Malignant Cellular Infiltrate,Intracortical osteosarcoma
31736,Malignant Cellular Infiltrate,Locally Metastatic Malignant Neoplasm
31737,Benign Cellular Infiltrate,benign tumor of hypopharynx
31738,Malignant Cellular Infiltrate,Grade 3 Malignant Neoplasm
31739,Malignant Cellular Infiltrate,Moderately Differentiated Malignant Neoplasm
31740,Malignant Cellular Infiltrate,Poorly Differentiated Malignant Neoplasm
31741,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia with Eosinophilia
31742,Malignant Cellular Infiltrate,Early Invasive Cervical Squamous Cell Carcinoma
31743,Malignant Cellular Infiltrate,Hereditary Female Breast Carcinoma
31744,Benign Cellular Infiltrate,Benign neoplasm of renal pelvis
31745,Benign Cellular Infiltrate,Metastatic Benign Neoplasm
31746,Malignant Cellular Infiltrate,Lymphomatous Adult T-Cell Leukemia/Lymphoma
31747,Malignant Cellular Infiltrate,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant"
31748,Malignant Cellular Infiltrate,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7
31749,Borderline Lesion,Lymphomatoid Papulosis
31750,Malignant Cellular Infiltrate,Malignant Mixed Tumor
31751,Malignant Cellular Infiltrate,Alveolar Soft Part Sarcoma
31752,Malignant Cellular Infiltrate,Mucoepidermoid Carcinoma
31753,Malignant Cellular Infiltrate,Verrucous carcinoma
31754,Benign Cellular Infiltrate,Angiofibroma
31755,Malignant Cellular Infiltrate,"Melanoma, Amelanotic"
31756,Benign Cellular Infiltrate,"Nevus, Intradermal"
31757,Malignant Cellular Infiltrate,Skin Basal Cell Carcinoma with Adnexal Differentiation
31758,Malignant Cellular Infiltrate,Metachronous Osteosarcoma
31759,Benign Cellular Infiltrate,Nodular fasciitis
31760,Malignant Cellular Infiltrate,Combined Hepatocellular Carcinoma and Cholangiocarcinoma
31761,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(17;17)(q21;q21)
31762,Benign Cellular Infiltrate,Congenital hemangioma
31763,Malignant Cellular Infiltrate,Grade III Meningioma
31764,Malignant Cellular Infiltrate,Papillary Meningioma
31765,Malignant Cellular Infiltrate,Ann Arbor Stage IIA Hodgkin Lymphoma
31766,Malignant Cellular Infiltrate,Pleomorphic Variant Mantle Cell Lymphoma
31767,Malignant Cellular Infiltrate,Classic Congenital Mesoblastic Nephroma
31768,Malignant Cellular Infiltrate,Cellular Congenital Mesoblastic Nephroma
31769,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant"
31770,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements"
31771,Malignant Cellular Infiltrate,Bladder Adenocarcinoma
31772,Malignant Cellular Infiltrate,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7
31773,Malignant Cellular Infiltrate,Transitional cell carcinoma of bladder
31774,Malignant Cellular Infiltrate,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma
31775,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Atrophic Variant"
31776,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern"
31777,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Papillary Pattern"
31778,Malignant Cellular Infiltrate,adenocarcinoma of epididymis
31779,Malignant Cellular Infiltrate,Primary Peritoneal Serous Adenocarcinoma
31780,Malignant Cellular Infiltrate,Adenocarcinofibroma
31781,Malignant Cellular Infiltrate,Gastric Adenocarcinoma
31782,Malignant Cellular Infiltrate,Malignant Ovarian Endometrioid Tumor
31783,Malignant Cellular Infiltrate,Ovarian Low Grade Endometrioid Stromal Sarcoma
31784,Malignant Cellular Infiltrate,Adult Medulloblastoma
31785,Malignant Cellular Infiltrate,CNS metastases
31786,Malignant Cellular Infiltrate,Paget's disease and intraductal carcinoma of breast
31787,Malignant Cellular Infiltrate,Cervical Verrucous Carcinoma
31788,Malignant Cellular Infiltrate,Cervical Papillary Squamous Cell Carcinoma
31789,Malignant Cellular Infiltrate,Cervical Serous Adenocarcinoma
31790,Malignant Cellular Infiltrate,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant"
31791,Malignant Cellular Infiltrate,Uterine Corpus Endometrial Stromal Sarcoma
31792,Malignant Cellular Infiltrate,Vaginal Endometrioid Adenocarcinoma
31793,Malignant Cellular Infiltrate,Vaginal Undifferentiated Sarcoma
31794,Malignant Cellular Infiltrate,Bartholin Gland Adenoid Cystic Carcinoma
31795,Malignant Cellular Infiltrate,Bartholin Gland Adenosquamous Carcinoma
31796,Malignant Cellular Infiltrate,liposarcoma of vulva
31797,Benign Cellular Infiltrate,"Vulvar Deep ""Aggressive"" Angiomyxoma"
31798,Malignant Cellular Infiltrate,Conventional (Clear Cell) Renal Cell Carcinoma
31799,Malignant Cellular Infiltrate,"Testicular Intratubular Germ Cell Neoplasia, Unclassified"
31800,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Acantholytic Variant"
31801,Malignant Cellular Infiltrate,Synchronous Bilateral Breast Carcinoma
31802,Malignant Cellular Infiltrate,Adenocarcinoma of Unknown Primary
31803,Malignant Cellular Infiltrate,Hereditary Fallopian Tube Carcinoma
31804,Malignant Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant"
31805,Malignant Cellular Infiltrate,"Testicular Seminoma, Tubular Variant"
31806,Malignant Cellular Infiltrate,Lymphoepithelial carcinoma
31807,Malignant Cellular Infiltrate,Pilomatrix carcinoma of skin
31808,Malignant Cellular Infiltrate,Adenocarcinoma in Situ
31809,Malignant Cellular Infiltrate,"Adenocarcinoma, intestinal type"
31810,Benign Cellular Infiltrate,Atypical neurofibroma
31811,Benign Cellular Infiltrate,Cellular Neurofibroma
31812,Malignant Cellular Infiltrate,Adenocarcinoma with spindle cell metaplasia
31813,Malignant Cellular Infiltrate,Poorly Differentiated Neuroblastoma
31814,Malignant Cellular Infiltrate,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor
31815,Malignant Cellular Infiltrate,Balloon cell malignant melanoma
31816,Malignant Cellular Infiltrate,Malignant melanoma in junctional nevus
31817,Malignant Cellular Infiltrate,Spindle Cell Melanoma
31818,Malignant Cellular Infiltrate,Uterine Carcinosarcoma
31819,Malignant Cellular Infiltrate,"Synovial sarcoma, spindle cell"
31820,Malignant Cellular Infiltrate,"Synovial sarcoma, epithelioid cell"
31821,Benign Cellular Infiltrate,Verrucous keratotic hemangioma
31822,Benign Cellular Infiltrate,Benign Pilar-Associated Mesenchyme Neoplasm
31823,Benign Cellular Infiltrate,Trichodiscoma
31824,Malignant Cellular Infiltrate,Mantle cell lymphoma
31825,Malignant Cellular Infiltrate,Adenocarcinoma of colon
31826,Malignant Cellular Infiltrate,Small Intestinal Adenosquamous Carcinoma
31827,Malignant Cellular Infiltrate,Small Intestinal Mucinous Adenocarcinoma
31828,Malignant Cellular Infiltrate,Mucinous adenocarcinoma of appendix
31829,Malignant Cellular Infiltrate,Colorectal Adenosquamous Carcinoma
31830,Malignant Cellular Infiltrate,Colorectal Undifferentiated Carcinoma
31831,Malignant Cellular Infiltrate,Lymphoma of retina
31832,Malignant Cellular Infiltrate,Malignant tumor of minor salivary gland
31833,Benign Cellular Infiltrate,Benign neoplasm of ethmoidal sinus
31834,Malignant Cellular Infiltrate,Gastric Cardia Carcinoma In Situ AJCC v6 and v7
31835,Malignant Cellular Infiltrate,Sarcoma of liver
31836,Benign Cellular Infiltrate,Ganglioneuroma of skin
31837,Malignant Cellular Infiltrate,Skin Angiosarcoma
31838,Malignant Cellular Infiltrate,"Breast Cancer, Familial"
31839,Malignant Cellular Infiltrate,Malignant Ovarian Germ Cell Neoplasm
31840,Malignant Cellular Infiltrate,Primary Cutaneous Intravascular Large B-Cell Lymphoma
31841,Malignant Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile"
31842,Malignant Cellular Infiltrate,Cutaneous Angioimmunoblastic T-Cell Lymphoma
31843,Malignant Cellular Infiltrate,Colon Intramucosal Adenocarcinoma
31844,Benign Cellular Infiltrate,Capillary hemangioma of orbit
31845,Benign Cellular Infiltrate,Cavernous hemangioma of orbit
31846,Benign Cellular Infiltrate,Lymphangioma circumscriptum
31847,Malignant Cellular Infiltrate,Lung Pleomorphic Carcinoma
31848,Borderline Lesion,Pulmonary Lymphomatoid Granulomatosis
31849,Malignant Cellular Infiltrate,Pleural Sarcomatoid Mesothelioma
31850,Malignant Cellular Infiltrate,Pleural Lymphoma
31851,Malignant Cellular Infiltrate,Malignant tumor of myocardium
31852,Malignant Cellular Infiltrate,Pleural Monophasic Synovial Sarcoma
31853,Malignant Cellular Infiltrate,Thymic Atypical Carcinoid Tumor
31854,Malignant Cellular Infiltrate,Thymic Typical Carcinoid Tumor
31855,Benign Cellular Infiltrate,Cardiac hemangioma
31856,Benign Cellular Infiltrate,Cardiac Capillary Hemangioma
31857,Malignant Cellular Infiltrate,Cardiac Biphasic Synovial Sarcoma
31858,Malignant Cellular Infiltrate,Malignant neoplasm of chest wall
31859,Malignant Cellular Infiltrate,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8"
31860,Benign Cellular Infiltrate,Benign neoplasm of nasal cavity
31861,Malignant Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm
31862,Benign Cellular Infiltrate,Lipoma of spinal cord
31863,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid cyst of skin
31864,Malignant Cellular Infiltrate,Gestational choriocarcinoma
31865,Malignant Cellular Infiltrate,Acute biphenotypic leukemia
31866,Malignant Cellular Infiltrate,Nasal Type Extranodal NK/T-Cell Lymphoma
31867,Benign Cellular Infiltrate,Encephalocraniocutaneous lipomatosis
31868,Benign Cellular Infiltrate,Proliferative fasciitis
31869,Malignant Cellular Infiltrate,Malignant neoplasm of pituitary gland
31870,Malignant Cellular Infiltrate,Breast Carcinoma with Chondroid Metaplasia
31871,Benign Cellular Infiltrate,Right atrial myxoma
31872,Malignant Cellular Infiltrate,Primary Lung Lymphoma
31873,Benign Cellular Infiltrate,calcifying aponeurotic fibroma
31874,Malignant Cellular Infiltrate,Neuroblastoma of brain
31875,Malignant Cellular Infiltrate,Adrenal Gland Angiosarcoma
31876,Malignant Cellular Infiltrate,Squamous cell carcinoma of mouth
31877,Malignant Cellular Infiltrate,sarcoma of lung
31878,Malignant Cellular Infiltrate,Melanoma in Congenital Melanocytic Nevus
31879,Malignant Cellular Infiltrate,Prostate carcinoma
31880,Malignant Cellular Infiltrate,Secondary malignant neoplasm of lymph node
31881,Malignant Cellular Infiltrate,Parathyroid Gland Adenocarcinoma
31882,Malignant Cellular Infiltrate,"Carcinoma, Ovarian Epithelial"
31883,Benign Cellular Infiltrate,Solid Angioleiomyoma
31884,Malignant Cellular Infiltrate,Malignant Female Reproductive System Neoplasm
31885,Malignant Cellular Infiltrate,Anaplastic Embryonal Rhabdomyosarcoma
31886,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma metastatic
31887,Encapsulated Mass,Thyroid Hurthle Cell Carcinoma
31888,Malignant Cellular Infiltrate,Primary Carcinoma Unspecified Site
31889,Malignant Cellular Infiltrate,Aleukemic leukemia
31890,Toxic effect,Environment-Related Malignant Neoplasm
31891,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage II
31892,Malignant Cellular Infiltrate,"Follicle center lymphoma, follicular grade I, II, III stage IV"
31893,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Hodgkin Lymphoma
31894,Malignant Cellular Infiltrate,Stage I Esophageal Squamous Cell Carcinoma AJCC v7
31895,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic
31896,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic
31897,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic
31898,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage II
31899,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent
31900,Malignant Cellular Infiltrate,Malignant Adult Brain Neoplasm
31901,Malignant Cellular Infiltrate,Apocrine Breast Carcinoma In Situ
31902,Malignant Cellular Infiltrate,Supratentorial Glioblastoma
31903,Malignant Cellular Infiltrate,Ovarian Cystadenocarcinoma
31904,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of ovary
31905,Malignant Cellular Infiltrate,mucinous adenocarcinoma of ovary
31906,Malignant Cellular Infiltrate,Gastric Diffuse Large B-Cell Lymphoma
31907,Benign Cellular Infiltrate,Benign Cardiac Schwannoma
31908,Malignant Cellular Infiltrate,Cardiac Leiomyosarcoma
31909,Malignant Cellular Infiltrate,Cardiac Malignant Peripheral Nerve Sheath Tumor
31910,Benign Cellular Infiltrate,Benign Connective and Soft Tissue Neoplasm
31911,Malignant Cellular Infiltrate,Secondary Heart Lymphoma
31912,Malignant Cellular Infiltrate,Malignant Inferior Vena Cava Neoplasm
31913,Malignant Cellular Infiltrate,Pulmonary Artery Choriocarcinoma
31914,Benign Cellular Infiltrate,Bone Epithelioid Hemangioma
31915,Malignant Cellular Infiltrate,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread"
31916,Benign Cellular Infiltrate,Retroperitoneal Ganglioneuroma
31917,Malignant Cellular Infiltrate,Keratinizing Head and Neck Squamous Cell Carcinoma
31918,Malignant Cellular Infiltrate,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous"
31919,Benign Cellular Infiltrate,Lipomatosis of Nerve
31920,Malignant Cellular Infiltrate,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified"
31921,Malignant Cellular Infiltrate,Nasopharyngeal Differentiated Carcinoma
31922,Malignant Cellular Infiltrate,Skull Base Chordoma
31923,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Signet Ring Variant"
31924,Malignant Cellular Infiltrate,Gastric Papillary Adenocarcinoma
31925,Benign Cellular Infiltrate,Benign Peripheral Nerve Granular Cell Tumor
31926,Malignant Cellular Infiltrate,Gastric Kaposi's Sarcoma
31927,Malignant Cellular Infiltrate,Non-Hodgkin's lymphoma of prostate
31928,Malignant Cellular Infiltrate,Stage II Skin Cancer
31929,Malignant Cellular Infiltrate,Stage III Skin Cancer
31930,Malignant Cellular Infiltrate,Recurrent Medulloblastoma
31931,Malignant Cellular Infiltrate,Malignant Cutaneous Granular Cell Tumor
31932,Malignant Cellular Infiltrate,Secondary malignant neoplasm of skin
31933,Malignant Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v7
31934,Benign Cellular Infiltrate,Fibroma of lung
31935,Benign Cellular Infiltrate,Leiomyoma of lung
31936,Malignant Cellular Infiltrate,adenoid cystic carcinoma of lung
31937,Malignant Cellular Infiltrate,Pleuropulmonary blastoma
31938,Malignant Cellular Infiltrate,carcinoma of pancreas with osteoclast-like giant cells
31939,Malignant Cellular Infiltrate,Serous cystadenocarcinoma of pancreas
31940,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v6 and v7
31941,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the liver
31942,Well Differentiated Neuroendocrine Lesion,Jejunal Somatostatin-Producing Neuroendocrine Tumor
31943,Malignant Cellular Infiltrate,Adult Central Nervous System Choriocarcinoma
31944,Malignant Cellular Infiltrate,Small intestine carcinoma stage II
31945,Malignant Cellular Infiltrate,Liver Fibrosarcoma
31946,Malignant Cellular Infiltrate,Gallbladder Angiosarcoma
31947,Malignant Cellular Infiltrate,Gallbladder Leiomyosarcoma
31948,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Carcinoid Tumor
31949,Malignant Cellular Infiltrate,Upper Gingival Verrucous Carcinoma
31950,Malignant Cellular Infiltrate,Stage IIIA Anal Canal Cancer AJCC v6 and v7
31951,Malignant Cellular Infiltrate,Parotid Gland Acinic Cell Carcinoma
31952,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of parotid gland
31953,Malignant Cellular Infiltrate,Submandibular Gland Adenocarcinoma
31954,Malignant Cellular Infiltrate,Major Salivary Gland Sarcoma
31955,Malignant Cellular Infiltrate,Posterior Tongue Mucoepidermoid Carcinoma
31956,Malignant Cellular Infiltrate,Stage IVA Nasopharyngeal Carcinoma AJCC v7
31957,Malignant Cellular Infiltrate,Stage II Nasal Cavity Cancer AJCC v6 and v7
31958,Malignant Cellular Infiltrate,Poorly Differentiated Thyroid Carcinoma
31959,Malignant Cellular Infiltrate,Thyroid Angiosarcoma
31960,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage III
31961,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
31962,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of accessory sinus
31963,Malignant Cellular Infiltrate,Recurrent Oral Cavity Carcinoma
31964,Malignant Cellular Infiltrate,carcinoma of middle ear
31965,Malignant Cellular Infiltrate,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
31966,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8"
31967,Malignant Cellular Infiltrate,carcinoma of lacrimal gland
31968,Malignant Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v7
31969,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7
31970,Malignant Cellular Infiltrate,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
31971,Malignant Cellular Infiltrate,Stage II Renal Pelvis Cancer AJCC v7
31972,Malignant Cellular Infiltrate,Stage II Ureter Cancer AJCC v7
31973,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v7
31974,Malignant Cellular Infiltrate,leiomyosarcoma of kidney
31975,Malignant Cellular Infiltrate,Ethmoid Sinus Adenocarcinoma
31976,Malignant Cellular Infiltrate,serous surface papillary carcinoma of ovary
31977,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v6 and v7
31978,Malignant Cellular Infiltrate,Stage IIC Fallopian Tube Cancer AJCC v6 and v7
31979,Malignant Cellular Infiltrate,Fallopian Tube Endometrioid Adenocarcinoma
31980,Malignant Cellular Infiltrate,Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7
31981,Malignant Cellular Infiltrate,Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7
31982,Malignant Cellular Infiltrate,Stage IIA Uterine Corpus Cancer AJCC v6
31983,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Cancer AJCC v7
31984,Malignant Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v6 and v7
31985,Malignant Cellular Infiltrate,Stage IB Vulvar Carcinoma AJCC v6
31986,Malignant Cellular Infiltrate,Metastatic Carcinoma to the Uterine Cervix
31987,Malignant Cellular Infiltrate,Cervical Adenoid Cystic Carcinoma
31988,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of kidney
31989,Malignant Cellular Infiltrate,Stage IB Testicular Cancer AJCC v6 and v7
31990,Malignant Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v6 and v7
31991,Low Grade Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1
31992,Low Grade Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1
31993,Malignant Cellular Infiltrate,Thymic Carcinoid Tumor
31994,Well Differentiated Neuroendocrine Lesion,Metastatic carcinoid tumor
31995,Malignant Cellular Infiltrate,teratocarcinoma of mediastinum
31996,Malignant Cellular Infiltrate,Thymic Lymphoma
31997,Malignant Cellular Infiltrate,Thymic Sarcomatoid Carcinoma
31998,Benign Cellular Infiltrate,Deep histiocytoma
31999,Benign Cellular Infiltrate,Benign Skeletal Muscle Neoplasm
32000,Malignant Cellular Infiltrate,Non-small cell carcinoma
32001,Benign Cellular Infiltrate,Tumorlet
32002,Malignant Cellular Infiltrate,"Papillary squamous cell carcinoma, non-invasive"
32003,Malignant Cellular Infiltrate,"Squamous cell carcinoma, large cell, nonkeratinizing"
32004,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Insulinoma
32005,Well Differentiated Neuroendocrine Lesion,"Glucagonoma, malignant"
32006,Tumor Vascular Invasion,"Gastrinoma, malignant"
32007,Malignant Cellular Infiltrate,minimally invasive follicular carcinoma of the thyroid gland
32008,Malignant Cellular Infiltrate,Malignant Childhood Germ Cell Tumor
32009,Malignant Cellular Infiltrate,Epithelioid Malignant Peripheral Nerve Sheath Tumor
32010,Benign Cellular Infiltrate,Benign Extraskeletal Cartilaginous and Osseous Neoplasm
32011,Malignant Cellular Infiltrate,Peripheral neuroblastoma
32012,Benign Cellular Infiltrate,Mediastinal Chondroma
32013,Benign Cellular Infiltrate,Mediastinal Leiomyoma
32014,Benign Cellular Infiltrate,Mediastinal Schwannoma
32015,Benign Cellular Infiltrate,Lipoma of pleura
32016,Malignant Cellular Infiltrate,Adenocarcinoma of ampulla of Vater
32017,Malignant Cellular Infiltrate,Stage II Ampulla of Vater Cancer AJCC v7
32018,Malignant Cellular Infiltrate,Malignant melanoma in precancerous melanosis
32019,Malignant Cellular Infiltrate,Fascial fibrosarcoma
32020,Benign Cellular Infiltrate,Ganglioneuromatosis
32021,Malignant Cellular Infiltrate,"Retinoblastoma, differentiated"
32022,Malignant Cellular Infiltrate,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
32023,Malignant Cellular Infiltrate,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7
32024,Malignant Cellular Infiltrate,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7
32025,Malignant Cellular Infiltrate,solid type ductal carcinoma in situ of breast
32026,Malignant Cellular Infiltrate,Pyriform Fossa Carcinoma
32027,Malignant Cellular Infiltrate,Stage IVB Osteosarcoma AJCC v7
32028,Intermediate Grade Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma
32029,Tumor Vascular Invasion,malignant gastrinoma of pancreas
32030,Intermediate Grade Neuroendocrine Lesion,Malignant Pancreatic Vipoma
32031,Tumor Vascular Invasion,Malignant Pancreatic Vipoma
32032,Malignant Cellular Infiltrate,Desmoplastic mesothelioma
32033,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
32034,Malignant Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7
32035,Malignant Cellular Infiltrate,"Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm"
32036,Malignant Cellular Infiltrate,small cell carcinoma of gallbladder
32037,Malignant Cellular Infiltrate,Parotid Gland Carcinoma
32038,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid Cyst of the Spinal Cord
32039,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type B Melanoma
32040,Malignant Cellular Infiltrate,Childhood Extragonadal Malignant Germ Cell Tumor
32041,Malignant Cellular Infiltrate,Childhood Atypical Teratoid/Rhabdoid Tumor
32042,Malignant Cellular Infiltrate,Choroid Necrotic Melanoma
32043,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
32044,Malignant Cellular Infiltrate,Early Favorable Hodgkin Lymphoma
32045,Malignant Cellular Infiltrate,Marginal zone lymphoma recurrent
32046,Malignant Cellular Infiltrate,Large cell neuroendocrine carcinoma
32047,Malignant Cellular Infiltrate,"Glandular intraepithelial neoplasia, grade III"
32048,Malignant Cellular Infiltrate,Mixed Ductal-Endocrine Carcinoma
32049,Malignant Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis
32050,Malignant Cellular Infiltrate,Burkitt-like lymphoma
32051,Benign Cellular Infiltrate,Central Nervous System Leiomyoma
32052,Benign Cellular Infiltrate,Central Nervous System Rhabdomyoma
32053,Malignant Cellular Infiltrate,Central Nervous System Germinoma
32054,Malignant Cellular Infiltrate,Central Nervous System Embryonal Carcinoma
32055,Malignant Cellular Infiltrate,Esophageal Basaloid Carcinoma
32056,Benign Cellular Infiltrate,Solitary Myofibromatosis
32057,Malignant Cellular Infiltrate,Recurrent Liver Carcinoma
32058,Malignant Cellular Infiltrate,Stage IV Liver Cancer
32059,Malignant Cellular Infiltrate,Hepatic cancer stage IVA
32060,Malignant Cellular Infiltrate,PRETEXT Stage 4 Hepatoblastoma
32061,Malignant Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma
32062,Malignant Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia
32063,Borderline Lesion,"Post-transplant lymphoproliferative disorder, polymorphic"
32064,Malignant Cellular Infiltrate,Blastic plasmacytoid dendritic cell neoplasm
32065,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Clinical Course
32066,Malignant Cellular Infiltrate,Plasmablastic lymphoma
32067,Malignant Cellular Infiltrate,Refractory Mature B-Cell Non-Hodgkin Lymphoma
32068,Malignant Cellular Infiltrate,Skin-associated lymphoid tissue lymphoma
32069,Malignant Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder
32070,Malignant Cellular Infiltrate,Methotrexate-Associated Follicular Lymphoma
32071,Malignant Cellular Infiltrate,Combined Lung Large Cell Neuroendocrine Carcinoma
32072,Malignant Cellular Infiltrate,Malignant Splenic Soft Tissue Neoplasm
32073,Malignant Cellular Infiltrate,follicular lymphoma of spleen
32074,Malignant Cellular Infiltrate,Seminoma
32075,Malignant Cellular Infiltrate,Retroperitoneal Carcinoma
32076,Malignant Cellular Infiltrate,Malignant neoplasm of anus
32077,Malignant Cellular Infiltrate,Burkitt Leukemia
32078,Malignant Cellular Infiltrate,Malignant Rectal Neoplasm
32079,Malignant Cellular Infiltrate,Malignant tumor of rectosigmoid junction
32080,Benign Cellular Infiltrate,Infiltrating angiolipoma
32081,Benign Cellular Infiltrate,Intramuscular lipoma
32082,Malignant Cellular Infiltrate,AIDS-Related Anal Non-Hodgkin Lymphoma
32083,Malignant Cellular Infiltrate,Adenocarcinoma of anal canal
32084,Malignant Cellular Infiltrate,Carcinoma of anal margin
32085,Malignant Cellular Infiltrate,Carcinoma of anal canal
32086,Malignant Cellular Infiltrate,Primary ameloblastic carcinoma
32087,Malignant Cellular Infiltrate,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)
32088,Malignant Cellular Infiltrate,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
32089,Malignant Cellular Infiltrate,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst
32090,Malignant Cellular Infiltrate,Malignant Esophageal Neoplasm by Anatomic Region
32091,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7
32092,Malignant Cellular Infiltrate,Secondary malignant neoplasm of small intestine
32093,Malignant Cellular Infiltrate,Thymic Carcinoma
32094,Malignant Cellular Infiltrate,olfactory neuroblastoma of nasal cavity
32095,Malignant Cellular Infiltrate,Adult Diffuse Large B-Cell Lymphoma
32096,Malignant Cellular Infiltrate,Childhood Diffuse Large B-Cell Lymphoma
32097,Malignant Cellular Infiltrate,Recurrent Female Reproductive System Carcinoma
32098,Malignant Cellular Infiltrate,Recurrent Head and Neck Carcinoma
32099,Malignant Cellular Infiltrate,Adamantinoma
32100,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma
32101,Malignant Cellular Infiltrate,Ovarian adenocarcinoma
32102,Malignant Cellular Infiltrate,Adult Hodgkin Lymphoma
32103,Malignant Cellular Infiltrate,Childhood Malignant Liver Neoplasm
32104,Malignant Cellular Infiltrate,Uveal melanoma
32105,Malignant Cellular Infiltrate,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary
32106,Malignant Cellular Infiltrate,carcinoma of gingiva
32107,Malignant Cellular Infiltrate,Light chain disease
32108,Malignant Cellular Infiltrate,sarcoma of penis
32109,Benign Cellular Infiltrate,Myxoma of the Endocardium
32110,Malignant Cellular Infiltrate,Breast cancer recurrent
32111,Malignant Cellular Infiltrate,Non-small cell lung cancer recurrent
32112,Malignant Cellular Infiltrate,Recurrent Childhood Acute Lymphoblastic Leukemia
32113,Malignant Cellular Infiltrate,Recurrent Adult Hodgkin Lymphoma
32114,Malignant Cellular Infiltrate,Mycosis fungoides stage IV
32115,Malignant Cellular Infiltrate,Adult Leiomyosarcoma
32116,Malignant Cellular Infiltrate,Stage II Adult Soft Tissue Sarcoma AJCC v7
32117,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer
32118,Malignant Cellular Infiltrate,Renal cell carcinoma recurrent
32119,Malignant Cellular Infiltrate,Ovarian epithelial cancer stage II
32120,Malignant Cellular Infiltrate,Neuroblastoma recurrent
32121,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor
32122,Malignant Cellular Infiltrate,Carcinoma in situ of vagina
32123,Malignant Cellular Infiltrate,Stage II Vaginal Cancer AJCC v6 and v7
32124,Low Grade Neuroendocrine Lesion,Regional Digestive System Neuroendocrine Tumor G1
32125,Malignant Cellular Infiltrate,Osteosarcoma recurrent
32126,Malignant Cellular Infiltrate,Recurrent Extrahepatic Bile Duct Carcinoma
32127,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v6 and v7
32128,Malignant Cellular Infiltrate,Recurrent Uveal Melanoma
32129,Malignant Cellular Infiltrate,Liver and Intrahepatic Biliary Tract Carcinoma
32130,Borderline Lesion,Angiocentric immunoproliferative lesion grade 2
32131,Malignant Cellular Infiltrate,Childhood Acute Monoblastic and Monocytic Leukemia
32132,Malignant Cellular Infiltrate,Childhood T Acute Lymphoblastic Leukemia
32133,Malignant Cellular Infiltrate,Vaginal adenocarcinoma
32134,Malignant Cellular Infiltrate,"Intraocular melanoma, spindle cell"
32135,Malignant Cellular Infiltrate,Dedifferentiated Solitary Fibrous Tumor
32136,Malignant Cellular Infiltrate,"Thymoma, type A, malignant"
32137,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor
32138,Malignant Cellular Infiltrate,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma
32139,Malignant Cellular Infiltrate,Adenocarcinoma of salivary gland
32140,Malignant Cellular Infiltrate,Endometrial Clear Cell Adenocarcinoma
32141,Bone Marrow Lymphoplasmacytic Infiltrate,Waldenstrom Macroglobulinemia
32142,Malignant Cellular Infiltrate,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
32143,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1
32144,Malignant Cellular Infiltrate,Recurrent Lip and Oral Cavity Carcinoma
32145,Malignant Cellular Infiltrate,Metastatic Adrenal Gland Pheochromocytoma
32146,Malignant Cellular Infiltrate,Stage I Oropharyngeal Carcinoma
32147,Malignant Cellular Infiltrate,Stage II Oropharyngeal Carcinoma
32148,Malignant Cellular Infiltrate,Stage III Childhood Hodgkin Lymphoma
32149,Malignant Cellular Infiltrate,Recurrent Childhood Hodgkin Lymphoma
32150,Malignant Cellular Infiltrate,Stage I Adult Non-Hodgkin Lymphoma
32151,Malignant Primitive Cellular Infiltrate,Dysgerminoma of ovary
32152,Benign Cellular Infiltrate,Mature Ovarian Teratoma
32153,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Follicular Lymphoma
32154,Malignant Cellular Infiltrate,Stage III Adult Immunoblastic Lymphoma
32155,Malignant Cellular Infiltrate,Recurrent Grade 2 Follicular Lymphoma
32156,Malignant Cellular Infiltrate,Recurrent Adult Lymphoblastic Lymphoma
32157,Malignant Cellular Infiltrate,Fibroblastic reticular cell tumor
32158,Malignant Cellular Infiltrate,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor
32159,Malignant Cellular Infiltrate,Stage II Lip Basal Cell Carcinoma
32160,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
32161,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage I
32162,Malignant Cellular Infiltrate,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7
32163,Malignant Cellular Infiltrate,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
32164,Malignant Cellular Infiltrate,Cloacogenic carcinoma
32165,Malignant Cellular Infiltrate,Adult Anaplastic Astrocytoma
32166,Malignant Cellular Infiltrate,Stage I Uterine Sarcoma AJCC v7
32167,Malignant Cellular Infiltrate,Adult Anaplastic Ependymoma
32168,Malignant Cellular Infiltrate,Localized Unresectable Neuroblastoma
32169,Malignant Cellular Infiltrate,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered"
32170,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Minimal Differentiation
32171,Malignant Cellular Infiltrate,Lymphoma stage III
32172,Malignant Cellular Infiltrate,Carcinoma of hard palate
32173,Malignant Cellular Infiltrate,Carcinoma of submandibular gland
32174,Malignant Cellular Infiltrate,Gastric Body Carcinoma
32175,Malignant Cellular Infiltrate,Malignant Sternal Neoplasm
32176,Malignant Cellular Infiltrate,Secondary malignant neoplasm of colon
32177,Malignant Cellular Infiltrate,Stage IV Rectal Carcinoma
32178,Benign Cellular Infiltrate,Diffuse neurofibroma
32179,Malignant Cellular Infiltrate,Mantle cell lymphoma stage I
32180,Malignant Cellular Infiltrate,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma
32181,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma
32182,Malignant Cellular Infiltrate,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma
32183,Malignant Cellular Infiltrate,Mantle cell lymphoma stage IV
32184,Malignant Cellular Infiltrate,Lynch Syndrome
32185,Malignant Cellular Infiltrate,Familial Retinoblastoma
32186,Malignant Cellular Infiltrate,Stage III Colorectal Cancer
32187,Malignant Cellular Infiltrate,Stage III Non-Hodgkin Lymphoma
32188,Malignant Cellular Infiltrate,Locally Advanced Malignant Neoplasm
32189,Malignant Cellular Infiltrate,Malignant Blood Vessel Neoplasm
32190,Malignant Cellular Infiltrate,Secondary malignant neoplasm of orbit
32191,Malignant Cellular Infiltrate,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma
32192,Malignant Cellular Infiltrate,Stage IV Soft Tissue Sarcoma AJCC v7
32193,Malignant Cellular Infiltrate,Leukemic Phase of Non-Hodgkin's Lymphoma
32194,Malignant Cellular Infiltrate,Stage IB Cutaneous Melanoma AJCC v7
32195,Malignant Cellular Infiltrate,Colorectal cancer recurrent
32196,Malignant Cellular Infiltrate,Stage 0 Esophageal Adenocarcinoma AJCC v7
32197,Malignant Cellular Infiltrate,Stage III Esophageal Adenocarcinoma AJCC v7
32198,Malignant Cellular Infiltrate,Esophageal squamous cell carcinoma recurrent
32199,Malignant Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v6
32200,Malignant Cellular Infiltrate,Bile duct cancer resectable
32201,Malignant Cellular Infiltrate,Angiocentric lymphoma refractory
32202,Malignant Cellular Infiltrate,Angiocentric lymphoma stage II
32203,Malignant Cellular Infiltrate,Ann Arbor Stage II Mature T- and NK-Cell Lymphoma
32204,Malignant Cellular Infiltrate,Ann Arbor Stage III Mature T- and NK-Cell Lymphoma
32205,Malignant Cellular Infiltrate,Peritoneal mesothelioma malignant recurrent
32206,Malignant Cellular Infiltrate,Metastatic angiosarcoma
32207,Malignant Cellular Infiltrate,Pineal germinoma
32208,Malignant Cellular Infiltrate,Stage IIIB Uterine Sarcoma AJCC v7
32209,Malignant Cellular Infiltrate,Stage IIIC Uterine Sarcoma AJCC v7
32210,Malignant Cellular Infiltrate,Retinoblastoma unilateral
32211,Malignant Cellular Infiltrate,Stage IIA Bone Cancer AJCC v7
32212,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7
32213,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage I
32214,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage IV
32215,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7
32216,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7
32217,Malignant Cellular Infiltrate,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7
32218,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage I
32219,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage III
32220,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7
32221,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7
32222,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7
32223,Malignant Cellular Infiltrate,Lung adenocarcinoma recurrent
32224,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage II"
32225,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage II
32226,Malignant Cellular Infiltrate,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7
32227,Malignant Cellular Infiltrate,Stage IIIB Small Intestinal Cancer AJCC v7
32228,Malignant Cellular Infiltrate,Stage IIIA Appendix Carcinoma AJCC v7
32229,Malignant Cellular Infiltrate,Stage IIIC Appendix Carcinoma AJCC v7
32230,Malignant Cellular Infiltrate,Stage IVA Appendix Carcinoma AJCC v7
32231,Malignant Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v7
32232,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v7
32233,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v7
32234,Malignant Cellular Infiltrate,Stage IIA Colorectal Cancer AJCC v7
32235,Malignant Cellular Infiltrate,Stage II Superficial Spreading Melanoma AJCC v6 and v7
32236,Malignant Cellular Infiltrate,Stage IV Superficial Spreading Melanoma AJCC v6 and v7
32237,Malignant Cellular Infiltrate,Epithelioid sarcoma non-metastatic
32238,Well Differentiated Neuroendocrine Lesion,Stage I Digestive System Neuroendocrine Tumor AJCC v7
32239,Malignant Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v7
32240,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v7
32241,Secondary Lesion,Metastatic leiomyosarcoma
32242,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage I
32243,Malignant Cellular Infiltrate,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7
32244,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I
32245,Malignant Cellular Infiltrate,Stage I Diffuse Large B-Cell Lymphoma
32246,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma recurrent
32247,Malignant Cellular Infiltrate,Extragonadal primary embryonal carcinoma
32248,Malignant Cellular Infiltrate,"Carcinoma bladder stage I, without cancer in situ"
32249,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage I
32250,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage III
32251,Malignant Cellular Infiltrate,Stage I Immature Testicular Teratoma AJCC v6 and v7
32252,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage III
32253,Malignant Cellular Infiltrate,Adenocarcinoma of the prostate metastatic
32254,Malignant Cellular Infiltrate,Recurrent Lung Carcinoma Cell Type Unspecified
32255,Malignant Cellular Infiltrate,Cervical carcinoma stage II AJCC v7
32256,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer
32257,Malignant Cellular Infiltrate,"Lymphoma, Mixed-Cell, Follicular"
32258,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage I
32259,Malignant Cellular Infiltrate,Oral Cavity Carcinoma
32260,Malignant Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v7
32261,Malignant Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v7
32262,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid Cyst
32263,Malignant Cellular Infiltrate,AIDS-Related Primary Effusion Lymphoma
32264,Malignant Cellular Infiltrate,Stage III Adult Hodgkin Lymphoma
32265,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v6 Stage
32266,Malignant Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma
32267,Malignant Cellular Infiltrate,Occult Lung Non-Small Cell Carcinoma
32268,Malignant Cellular Infiltrate,Small cell lung cancer extensive stage
32269,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v6 Stage
32270,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v6 Stage
32271,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v6 Stage
32272,Malignant Cellular Infiltrate,Recurrent Childhood Lymphoblastic Lymphoma
32273,Malignant Cellular Infiltrate,Stage IV Prostate Carcinoma
32274,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8"
32275,Malignant Cellular Infiltrate,Non-small cell lung cancer stage IIIB
32276,Malignant Cellular Infiltrate,Oropharyngeal Carcinoma
32277,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v7 Stage
32278,Malignant Cellular Infiltrate,Stage III Thyroid Gland Follicular Carcinoma AJCC v7
32279,Malignant Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v7
32280,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v7 Stage
32281,Malignant Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v7 Stage
32282,Malignant Cellular Infiltrate,Gallbladder Cancer by AJCC v7 Stage
32283,Malignant Cellular Infiltrate,Philadelphia chromosome positive chronic myelogenous leukemia
32284,Malignant Cellular Infiltrate,Blastema Predominant Kidney Wilms Tumor
32285,Malignant Cellular Infiltrate,Adult Acute Promyelocytic Leukemia with PML-RARA
32286,Malignant Cellular Infiltrate,Adult Acute Monoblastic Leukemia
32287,Malignant Cellular Infiltrate,Childhood Acute Erythroid Leukemia
32288,Malignant Cellular Infiltrate,Rectal Signet Ring Cell Adenocarcinoma
32289,Malignant Cellular Infiltrate,adenocarcinoma of gallbladder with squamous metaplasia
32290,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma
32291,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma
32292,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v6
32293,Malignant Cellular Infiltrate,Malignant Adrenal Gland Composite Pheochromocytoma
32294,Malignant Cellular Infiltrate,Intraocular Malignant Peripheral Nerve Sheath Tumor
32295,Malignant Cellular Infiltrate,Merkel cell carcinoma
32296,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome NOS
32297,Malignant Cellular Infiltrate,Anal carcinoma
32298,Malignant Cellular Infiltrate,Malignant tumor of gum
32299,Malignant Cellular Infiltrate,Carcinoma of the Floor of the Mouth
32300,Malignant Cellular Infiltrate,Malignant neoplasm of cheek mucosa
32301,Malignant Cellular Infiltrate,Malignant neoplasm of urinary bladder
32302,Local disease,Mast-Cell Sarcoma
32303,Malignant Cellular Infiltrate,Adult Brain Stem Gliosarcoma
32304,Malignant Cellular Infiltrate,Renal Cell Carcinoma
32305,Malignant Cellular Infiltrate,Sarcoma NCI Grade 2
32306,Malignant Cellular Infiltrate,Combined Lung Small Cell and Squamous Cell Carcinoma
32307,Malignant Cellular Infiltrate,Grade 1 Rectal Adenocarcinoma
32308,Malignant Cellular Infiltrate,Grade 3 Colon Adenocarcinoma
32309,Malignant Cellular Infiltrate,Small cell neuroendocrine carcinoma of bladder
32310,Malignant Cellular Infiltrate,Laryngeal Mucoepidermoid Carcinoma
32311,Malignant Cellular Infiltrate,Grade 1 Diffuse Follicular Lymphoma
32312,Malignant Cellular Infiltrate,Stage IV Adult Liver Cancer AJCC v7
32313,Malignant Cellular Infiltrate,Invasive Carcinoma
32314,Malignant Cellular Infiltrate,Pancreatic Well Differentiated Ductal Adenocarcinoma
32315,Malignant Cellular Infiltrate,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas
32316,Malignant Cellular Infiltrate,Pancreatic Hepatoid Adenocarcinoma
32317,Malignant Cellular Infiltrate,Pancreatic Medullary Carcinoma
32318,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Large Cell Neuroendocrine Carcinoma
32319,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor
32320,Malignant Cellular Infiltrate,Gastric Intramucosal Adenocarcinoma
32321,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Carcinoma
32322,Malignant Cellular Infiltrate,Small Intestinal Angiosarcoma
32323,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor
32324,Poorly Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Carcinoma
32325,Malignant Cellular Infiltrate,Colorectal Large Cell Neuroendocrine Carcinoma
32326,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor
32327,Intermediate Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor G2
32328,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor
32329,Malignant Cellular Infiltrate,Colorectal Serrated Adenocarcinoma
32330,Malignant Cellular Infiltrate,Colon Micropapillary Adenocarcinoma
32331,Malignant Cellular Infiltrate,Rectal Micropapillary Adenocarcinoma
32332,Malignant Cellular Infiltrate,Colorectal Lymphoma
32333,Malignant Cellular Infiltrate,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified"
32334,Malignant Cellular Infiltrate,Colorectal Burkitt Lymphoma
32335,Malignant Cellular Infiltrate,Colorectal Angiosarcoma
32336,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1
32337,Malignant Cellular Infiltrate,Primary hepatic neuroendocrine carcinoma
32338,Benign Cellular Infiltrate,Liver Lymphangioma
32339,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of liver
32340,Poorly Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Carcinoma
32341,Low Grade Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G1
32342,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma
32343,Poorly Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Carcinoma
32344,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of extrahepatic bile duct
32345,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma
32346,Malignant Cellular Infiltrate,High Grade Astrocytic Tumor
32347,Malignant Cellular Infiltrate,Adrenal Cortex Carcinoma by ENSAT Stage
32348,Malignant Cellular Infiltrate,ENSAT Stage I Adrenal Cortex Carcinoma
32349,Malignant Cellular Infiltrate,Uveal Melanoma by Gene Expression Profile
32350,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Soft Tissues
32351,Malignant Cellular Infiltrate,Childhood Central Nervous System Embryonal Neoplasm
32352,Malignant Cellular Infiltrate,Childhood Gliomatosis Cerebri
32353,Malignant Cellular Infiltrate,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma
32354,Malignant Cellular Infiltrate,Stage IIA Rectal Cancer AJCC v7
32355,Malignant Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v7
32356,Malignant Cellular Infiltrate,Stage IIIB Colon Cancer AJCC v7
32357,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v7
32358,Malignant Cellular Infiltrate,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
32359,Malignant Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
32360,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
32361,Malignant Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v7
32362,Malignant Cellular Infiltrate,Stage IIIA Esophageal Cancer AJCC v7
32363,Malignant Cellular Infiltrate,Hepatocellular Carcinoma by BCLC Stage
32364,Malignant Cellular Infiltrate,BCLC Stage A Hepatocellular Carcinoma
32365,Malignant Cellular Infiltrate,BCLC Stage 0 Adult Hepatocellular Carcinoma
32366,Malignant Cellular Infiltrate,adult nasal type extranodal NK/T-cell lymphoma
32367,Malignant Cellular Infiltrate,Familial Waldenstrom's Macroglobulinaemia
32368,Malignant Cellular Infiltrate,Familial Neuroblastoma
32369,Borderline Lesion,Recurrent Adult Grade III Lymphomatoid Granulomatosis
32370,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligoastrocytoma
32371,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligodendroglioma
32372,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone
32373,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
32374,Malignant Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis
32375,Malignant Cellular Infiltrate,Childhood Lung Non-Small Cell Carcinoma
32376,Malignant Cellular Infiltrate,Childhood Parathyroid Gland Carcinoma
32377,Malignant Cellular Infiltrate,Childhood Thyroid Gland Carcinoma
32378,Benign Cellular Infiltrate,Ectomesenchymal Chondromyxoid Tumor
32379,Malignant Cellular Infiltrate,"Malignant Mixed Tumor, Not Otherwise Specified"
32380,Malignant Cellular Infiltrate,Undifferentiated spindle cell sarcoma
32381,Malignant Cellular Infiltrate,Undifferentiated round cell sarcoma
32382,Malignant Cellular Infiltrate,Undifferentiated Epithelioid Sarcoma
32383,Benign Cellular Infiltrate,Bizarre parosteal osteochondromatous proliferation
32384,Benign Cellular Infiltrate,Giant Cell Lesion of Small Bones
32385,Benign Cellular Infiltrate,Benign Notochordal Cell Tumor
32386,Malignant Cellular Infiltrate,Ph-Like Acute Lymphoblastic Leukemia
32387,Malignant Cellular Infiltrate,ROSE Cluster 1
32388,Malignant Cellular Infiltrate,ROSE Cluster 6
32389,Malignant Cellular Infiltrate,ROSE Cluster 7
32390,Malignant Cellular Infiltrate,Core binding factor acute myeloid leukemia
32391,Malignant Cellular Infiltrate,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM"
32392,Borderline Lesion,Childhood Lymphomatoid Granulomatosis
32393,Borderline Lesion,Recurrent Childhood Lymphomatoid Granulomatosis
32394,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Testicular Immature Teratoma
32395,Malignant Cellular Infiltrate,Childhood Malignant Kidney Neoplasm
32396,Malignant Cellular Infiltrate,Infant Acute Undifferentiated Leukemia
32397,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma
32398,Malignant Cellular Infiltrate,Serous Tubal Intraepithelial Carcinoma
32399,Malignant Cellular Infiltrate,Malignant Uterine Ligament Neoplasm
32400,Malignant Cellular Infiltrate,Follicular Variant Thyroid Gland Papillary Carcinoma
32401,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with FLT3/ITD Mutation
32402,Malignant Cellular Infiltrate,Uterine Corpus High Grade Endometrial Stromal Sarcoma
32403,Benign Cellular Infiltrate,Benign Uterine Corpus PEComa
32404,Malignant Cellular Infiltrate,Neuroendocrine cervical carcinoma
32405,Malignant Cellular Infiltrate,Ovarian Cancer by FIGO Stage
32406,Malignant Cellular Infiltrate,FIGO Stage IC3 Ovarian Cancer
32407,Malignant Cellular Infiltrate,FIGO Stage IIIC Ovarian Cancer
32408,Malignant Cellular Infiltrate,"Peripheral T-Cell Lymphoma, Unclassifiable"
32409,Malignant Cellular Infiltrate,"Medulloblastoma, WNT-Activated"
32410,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated"
32411,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Mutant"
32412,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH"
32413,Malignant Cellular Infiltrate,Central Nervous System Embryonal Tumor with Rhabdoid Features
32414,Malignant Cellular Infiltrate,Central Nervous System Epithelioid Hemangioendothelioma
32415,Malignant Cellular Infiltrate,Central Nervous System Intravascular Large B-Cell Lymphoma
32416,Malignant Cellular Infiltrate,Advanced Malignant Solid Neoplasm
32417,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with PCM1-JAK2
32418,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-0
32419,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21
32420,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides AJCC v7
32421,Malignant Cellular Infiltrate,Recurrent Subsequent Malignant Neoplasm
32422,Malignant Cellular Infiltrate,Childhood Melanoma
32423,Primary Lesion,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor"
32424,Primary Lesion,Fourth Ventricle Ependymal Tumor
32425,Primary Lesion,Cerebellar and Fourth Ventricle Ependymal Tumor
32426,Primary Lesion,Infratentorial Ependymal Tumor
32427,Malignant Cellular Infiltrate,Recurrent Childhood T Acute Lymphoblastic Leukemia
32428,Malignant Cellular Infiltrate,Resectable Head and Neck Squamous Cell Carcinoma
32429,Malignant Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v8
32430,Malignant Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v8
32431,Malignant Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v8
32432,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v8
32433,Malignant Cellular Infiltrate,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
32434,Malignant Cellular Infiltrate,Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8
32435,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v8
32436,Malignant Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8
32437,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v8
32438,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8
32439,Malignant Cellular Infiltrate,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
32440,Malignant Cellular Infiltrate,Recurrent Atypical Teratoid/Rhabdoid Tumor
32441,Malignant Cellular Infiltrate,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
32442,Malignant Cellular Infiltrate,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
32443,Malignant Cellular Infiltrate,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
32444,Malignant Cellular Infiltrate,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
32445,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
32446,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
32447,Malignant Cellular Infiltrate,Clinical Stage 0 Gastric Cancer AJCC v8
32448,Malignant Cellular Infiltrate,Pathologic Stage IA Gastric Cancer AJCC v8
32449,Malignant Cellular Infiltrate,Pathologic Stage IIB Gastric Cancer AJCC v8
32450,Malignant Cellular Infiltrate,Pathologic Stage IIIC Gastric Cancer AJCC v8
32451,Malignant Cellular Infiltrate,Pathologic Stage IV Gastric Cancer AJCC v8
32452,Malignant Cellular Infiltrate,Metastatic Paraganglioma
32453,Malignant Cellular Infiltrate,Stage IIA Anal Cancer AJCC v8
32454,Malignant Cellular Infiltrate,Recurrent Lymphoma
32455,Malignant Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v8
32456,Malignant Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v8
32457,Malignant Cellular Infiltrate,Stage 0 Colon Cancer AJCC v8
32458,Malignant Cellular Infiltrate,Stage IIC Colon Cancer AJCC v8
32459,Malignant Cellular Infiltrate,Acute myeloid leukemia refractory
32460,Malignant Cellular Infiltrate,Intrahepatic Bile Duct Cancer by AJCC v8 Stage
32461,Malignant Cellular Infiltrate,Stage IA Intrahepatic Bile Duct Cancer AJCC v8
32462,Malignant Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v8
32463,Malignant Cellular Infiltrate,Stage III Hilar Cholangiocarcinoma AJCC v8
32464,Malignant Cellular Infiltrate,Stage IV Hilar Cholangiocarcinoma AJCC v8
32465,Malignant Cellular Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia
32466,Malignant Cellular Infiltrate,Refractory Ph-Like Acute Lymphoblastic Leukemia
32467,Malignant Cellular Infiltrate,Stage I Ampulla of Vater Cancer AJCC v8
32468,Malignant Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v8
32469,Malignant Cellular Infiltrate,Stage IIIA Ampulla of Vater Cancer AJCC v8
32470,Malignant Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v8
32471,Well Differentiated Neuroendocrine Lesion,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8
32472,Well Differentiated Neuroendocrine Lesion,Stage IV Jejunal Neuroendocrine Tumor AJCC v8
32473,Well Differentiated Neuroendocrine Lesion,Stage II Ileal Neuroendocrine Tumor AJCC v8
32474,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v8 Stage
32475,Well Differentiated Neuroendocrine Lesion,Stage I Appendix Neuroendocrine Tumor AJCC v8
32476,Well Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v8
32477,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v8
32478,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor by AJCC v8 Stage
32479,Well Differentiated Neuroendocrine Lesion,Stage I Colorectal Neuroendocrine Tumor AJCC v8
32480,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8
32481,Well Differentiated Neuroendocrine Lesion,Stage IV Colorectal Neuroendocrine Tumor AJCC v8
32482,Malignant Cellular Infiltrate,Rectal Carcinoma Metastatic in the Liver
32483,Malignant Cellular Infiltrate,Stage III Pleural Malignant Mesothelioma AJCC v8
32484,Malignant Cellular Infiltrate,Occult Lung Cancer AJCC v8
32485,Malignant Cellular Infiltrate,Stage IIIC Lung Cancer AJCC v8
32486,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v8
32487,Malignant Cellular Infiltrate,Stage IVB Lung Cancer AJCC v8
32488,Malignant Cellular Infiltrate,Stage IVB Bone Cancer AJCC v8
32489,Malignant Cellular Infiltrate,Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage
32490,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of lung
32491,Malignant Cellular Infiltrate,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
32492,Malignant Cellular Infiltrate,Pathologic Stage II Merkel Cell Carcinoma AJCC v8
32493,Malignant Cellular Infiltrate,Clinical Stage IA Cutaneous Melanoma AJCC v8
32494,Malignant Cellular Infiltrate,Clinical Stage IIA Cutaneous Melanoma AJCC v8
32495,Malignant Cellular Infiltrate,Pathologic Stage 0 Cutaneous Melanoma AJCC v8
32496,Malignant Cellular Infiltrate,Pathologic Stage II Cutaneous Melanoma AJCC v8
32497,Malignant Cellular Infiltrate,Occult Breast Carcinoma
32498,Malignant Cellular Infiltrate,Duodenal-type follicular lymphoma
32499,Malignant Cellular Infiltrate,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion
32500,Malignant Cellular Infiltrate,Leukemic Nonnodal Mantle Cell Lymphoma
32501,Malignant Cellular Infiltrate,Recurrent High Risk Myelodysplastic Syndrome
32502,Malignant Cellular Infiltrate,Refractory Soft Tissue Sarcoma
32503,Malignant Cellular Infiltrate,Recurrent Soft Tissue Sarcoma
32504,Malignant Cellular Infiltrate,Plasma Cell Myeloma by ISS Stage
32505,Malignant Cellular Infiltrate,Anatomic Stage I Breast Cancer AJCC v8
32506,Malignant Cellular Infiltrate,Anatomic Stage III Breast Cancer AJCC v8
32507,Malignant Cellular Infiltrate,Prognostic Stage II Breast Cancer AJCC v8
32508,Malignant Cellular Infiltrate,Prognostic Stage IIA Breast Cancer AJCC v8
32509,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v8
32510,Malignant Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v8
32511,Malignant Cellular Infiltrate,Stage III Vaginal Cancer AJCC v8
32512,Malignant Cellular Infiltrate,Stage IB Cervical Cancer AJCC v8
32513,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer AJCC v8
32514,Malignant Cellular Infiltrate,Stage II Cervical Cancer AJCC v8
32515,Malignant Cellular Infiltrate,Stage IIA1 Cervical Cancer AJCC v8
32516,Malignant Cellular Infiltrate,Stage IV Cervical Cancer AJCC v8
32517,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v8
32518,Malignant Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v8
32519,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Cancer AJCC v8
32520,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8
32521,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
32522,Malignant Cellular Infiltrate,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
32523,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
32524,Malignant Cellular Infiltrate,Stage II Uterine Corpus Adenosarcoma AJCC v8
32525,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8
32526,Malignant Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v8
32527,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v8 Stage
32528,Malignant Cellular Infiltrate,Stage II Primary Peritoneal Cancer AJCC v8
32529,Malignant Cellular Infiltrate,Stage 0is Penile Cancer AJCC v8
32530,Malignant Cellular Infiltrate,Stage I Penile Cancer AJCC v8
32531,Malignant Cellular Infiltrate,Stage IIB Penile Cancer AJCC v8
32532,Malignant Cellular Infiltrate,Stage IIIB Penile Cancer AJCC v8
32533,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v8 Stage
32534,Malignant Cellular Infiltrate,Stage IA Testicular Cancer AJCC v8
32535,Malignant Cellular Infiltrate,Stage II Testicular Cancer AJCC v8
32536,Malignant Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v8
32537,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v8 Stage
32538,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v8
32539,Malignant Cellular Infiltrate,Stage II Renal Pelvis Cancer AJCC v8
32540,Malignant Cellular Infiltrate,Stage II Ureter Cancer AJCC v8
32541,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v8
32542,Malignant Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v8
32543,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v8 Stage
32544,Malignant Cellular Infiltrate,Stage 0a Bladder Cancer AJCC v8
32545,Malignant Cellular Infiltrate,Stage 0is Bladder Cancer AJCC v8
32546,Malignant Cellular Infiltrate,Stage II Urethral Cancer AJCC v8
32547,Malignant Cellular Infiltrate,Stage IA Eyelid Carcinoma AJCC v8
32548,Malignant Cellular Infiltrate,Stage II Eyelid Carcinoma AJCC v8
32549,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v8
32550,Malignant Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8
32551,Malignant Cellular Infiltrate,Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8
32552,Malignant Cellular Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage
32553,Malignant Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage
32554,Encapsulated Mass,Stage II Thyroid Gland Follicular Carcinoma AJCC v8
32555,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8
32556,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8
32557,Malignant Cellular Infiltrate,Recurrent Extensive Stage Lung Small Cell Carcinoma
32558,Malignant Cellular Infiltrate,Stage IV Adrenal Cortex Carcinoma AJCC v8
32559,Malignant Cellular Infiltrate,Lugano Classification Stage II Adult Lymphoma AJCC v8
32560,Malignant Cellular Infiltrate,Lugano Classification Stage IV Adult Lymphoma AJCC v8
32561,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8
32562,Malignant Cellular Infiltrate,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8
32563,Malignant Cellular Infiltrate,Lugano Classification Stage IE Hodgkin Lymphoma AJCC v8
32564,Malignant Cellular Infiltrate,Lugano Classification Stage II Hodgkin Lymphoma AJCC v8
32565,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8
32566,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System
32567,Malignant Cellular Infiltrate,Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage
32568,Malignant Cellular Infiltrate,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage
32569,Malignant Cellular Infiltrate,B Lymphoblastic Lymphoma by Ann Arbor Stage
32570,Malignant Cellular Infiltrate,Burkitt Lymphoma by Ann Arbor Stage
32571,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma by Ann Arbor Stage
32572,Malignant Cellular Infiltrate,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage
32573,Malignant Cellular Infiltrate,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
32574,Malignant Cellular Infiltrate,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8
32575,Malignant Cellular Infiltrate,Plasma Cell Myeloma by RISS Stage
32576,Malignant Cellular Infiltrate,Recurrent Malignant Glioma
32577,Malignant Cellular Infiltrate,Recurrent Anaplastic Oligoastrocytoma
32578,Malignant Cellular Infiltrate,Skin squamous cell carcinoma recurrent
32579,Malignant Cellular Infiltrate,Marginal zone lymphoma refractory
32580,Malignant Cellular Infiltrate,Locally Advanced Angiosarcoma
32581,Malignant Cellular Infiltrate,Recurrent Central Nervous System Non-Hodgkin Lymphoma
32582,Malignant Cellular Infiltrate,Cardiac Myxofibrosarcoma
32583,Malignant Cellular Infiltrate,Refractory Colorectal Carcinoma
32584,Malignant Cellular Infiltrate,Refractory Thymic Carcinoma
32585,Malignant Cellular Infiltrate,Unresectable Cutaneous Melanoma
32586,Malignant Cellular Infiltrate,Refractory Human Papillomavirus-Related Malignant Neoplasm
32587,Malignant Cellular Infiltrate,Gastric Cardia Squamous Cell Carcinoma
32588,Malignant Cellular Infiltrate,Recurrent Endometrial Cancer
32589,Malignant Cellular Infiltrate,Recurrent T Acute Lymphoblastic Leukemia
32590,Malignant Cellular Infiltrate,Recurrent T-Cell Prolymphocytic Leukemia
32591,Malignant Cellular Infiltrate,Advanced Nasopharyngeal Squamous Cell Carcinoma
32592,Malignant Cellular Infiltrate,Fibrin-Associated Diffuse Large B-Cell Lymphoma
32593,Malignant Cellular Infiltrate,Extracavitary Primary Effusion Lymphoma
32594,Malignant Cellular Infiltrate,Refractory Malignant Neoplasm of Multiple Primary Sites
32595,Malignant Cellular Infiltrate,Refractory Malignant Soft Tissue Neoplasm
32596,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders
32597,Malignant Cellular Infiltrate,Recurrent Metastatic Digestive System Carcinoma
32598,Malignant Cellular Infiltrate,Refractory Head and Neck Carcinoma
32599,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline GATA2 Mutation
32600,Malignant Cellular Infiltrate,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements
32601,Malignant Cellular Infiltrate,Pelvic Rhabdomyosarcoma
32602,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes"
32603,Malignant Cellular Infiltrate,Distal Esophagus Adenocarcinoma
32604,Malignant Cellular Infiltrate,Locally Advanced Sarcoma
32605,Malignant Cellular Infiltrate,Metastatic Pancreatic Neuroendocrine Carcinoma
32606,Malignant Cellular Infiltrate,Resectable Soft Tissue Sarcoma
32607,Malignant Cellular Infiltrate,Refractory Hepatosplenic T-Cell Lymphoma
32608,Malignant Cellular Infiltrate,Advanced Lung Carcinoma
32609,Malignant Cellular Infiltrate,Metastatic Unresectable Carcinoma
32610,Malignant Cellular Infiltrate,Metastatic gastric adenocarcinoma
32611,Malignant Cellular Infiltrate,Refractory Colon Carcinoma
32612,Malignant Cellular Infiltrate,Locally Advanced Digestive System Carcinoma
32613,Malignant Cellular Infiltrate,Bile duct cancer recurrent
32614,Malignant Cellular Infiltrate,Recurrent Fallopian Tube Serous Adenocarcinoma
32615,Malignant Cellular Infiltrate,Recurrent Ovarian Serous Adenocarcinoma
32616,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma
32617,Malignant Cellular Infiltrate,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma
32618,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma
32619,Malignant Cellular Infiltrate,Recurrent Malignant Ovarian Brenner Tumor
32620,Malignant Cellular Infiltrate,Recurrent Malignant Brain Neoplasm
32621,Malignant Cellular Infiltrate,Metastatic Fibrolamellar Carcinoma
32622,Malignant Cellular Infiltrate,Hepatic cancer metastatic
32623,Absence of a Hormonal Syndrome,Non-Functioning Corticotroph Adenoma
32624,Absence of a Hormonal Syndrome,Sparsely Granulated Non-Functioning Corticotroph Adenoma
32625,Epithelial Component Present,MiT Family Translocation-Associated Renal Cell Carcinoma
32626,More Than Two Separate Tumor Masses Present in the Same Organ,Pituitary Gland Multiple Adenomas
32627,Carcinomatous Component Present,Resectable Renal Cell Carcinoma
32628,Malignant Cellular Infiltrate,Recurrent Metastatic Malignant Neoplasm
32629,Carcinomatous Component Present,Adenocarcinoma gastric recurrent
32630,Severe cytologic atypia,Digestive System Small Cell Neuroendocrine Carcinoma
32631,Cutaneous Involvement,Recurrent Cutaneous Melanoma of the Extremity
32632,Malignant Cellular Infiltrate,Advanced Sarcoma of the Extremity
32633,Regional Disease,Locally Advanced Unresectable Renal Cell Carcinoma
32634,Carcinomatous Component Present,Locally Advanced Unresectable Renal Cell Carcinoma
32635,Epithelial Component Present,Pancreatic adenocarcinoma recurrent
32636,Neuroendocrine Differentiation,Pituitary Gland Paraganglioma
32637,Solitary mass,Sellar Chordoma
32638,Malignant Cellular Infiltrate,Sellar Chondroid Chordoma
32639,Nuclear Expression of STAT6 Protein,Sellar Solitary Fibrous Tumor/Hemangiopericytoma
32640,Perivascular Arrangement of Tumor Cells,Sellar Solitary Fibrous Tumor/Hemangiopericytoma
32641,Benign Cellular Infiltrate,Benign Skull Base Neoplasm
32642,Malignant Cellular Infiltrate,Pituitary Gland Non-Hodgkin Lymphoma
32643,Malignant Germinomatous Cellular Infiltrate,Suprasellar Germinoma
32644,Malignant Cellular Infiltrate,Suprasellar Germinoma
32645,Pseudopapillary Pattern,Sellar Embryonal Carcinoma
32646,Malignant Cellular Infiltrate,Sellar Embryonal Carcinoma
32647,Geographic Necrosis,Sellar Embryonal Carcinoma
32648,Malignant Cellular Infiltrate,Recurrent Endometrial Undifferentiated Carcinoma
32649,Carcinomatous Component Present,"Neuroendocrine carcinoma, metastatic"
32650,Neuroendocrine Differentiation,Advanced Neuroendocrine Carcinoma
32651,Malignant Cellular Infiltrate,Chest Wall Sarcoma
32652,Malignant Cellular Infiltrate,Unresectable Lung Non-Small Cell Carcinoma
32653,Epithelial Component Present,Unresectable Lung Non-Small Cell Carcinoma
32654,Epithelial Component Present,Unresectable Digestive System Carcinoma
32655,Malignant Cellular Infiltrate,Smoldering Waldenstrom Macroglobulinemia
32656,Metastatic Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity
32657,Epithelial Component Present,Recurrent Digestive System Neuroendocrine Carcinoma
32658,Severe cytologic atypia,Recurrent Digestive System Neuroendocrine Carcinoma
32659,Well-Circumscribed Lesion,Cerebral Hemangioblastoma
32660,Precise Histogenesis Unknown,Medullary Hemangioblastoma
32661,Malignant Cellular Infiltrate,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome
32662,Well-Circumscribed Lesion,Broad Ligament Papillary Cystadenoma
32663,Well-Circumscribed Lesion,Epididymal Papillary Cystadenoma
32664,Follicular Structures Present,Thyroid Gland Spindle Cell Follicular Adenoma
32665,Encapsulated Mass,Thyroid Gland Black Follicular Adenoma
32666,Necrotic changes (finding),Refractory Malignant Peripheral Nerve Sheath Tumor
32667,Pseudoencapsulated Mass,Refractory Malignant Peripheral Nerve Sheath Tumor
32668,Ground Glass Nuclear Inclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma
32669,Follicular Cell Differentiation,Encapsulated Variant Thyroid Gland Papillary Carcinoma
32670,Nuclear Grooves,Encapsulated Variant Thyroid Gland Papillary Carcinoma
32671,Infiltrative Growth Pattern,Frontal Lobe Anaplastic Astrocytoma
32672,Ground Glass Nuclear Inclusion,Hobnail Variant Thyroid Gland Papillary Carcinoma
32673,Nuclear Grooves,Hobnail Variant Thyroid Gland Papillary Carcinoma
32674,Carcinomatous Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma
32675,Carcinomatous Component Present,Bladder cancer stage IV
32676,Metastatic Lesion,Metastatic Fallopian Tube Carcinoma
32677,Malignant Cellular Infiltrate,Stage IV Ovarian Carcinoma
32678,Metastatic Lesion,Stage IV Ovarian Carcinoma
32679,Epithelial Component Present,Stage IV Ovarian Carcinoma
32680,Malignant Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma
32681,Metastatic Lesion,Stage IV Esophageal Squamous Cell Carcinoma
32682,Malignant Cellular Infiltrate,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
32683,Secondary Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
32684,Lymphoplasmacytic Infiltrate,Metastatic Nasopharyngeal Undifferentiated Carcinoma
32685,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma
32686,Epithelial Component Present,Metastatic Pharyngeal Carcinoma
32687,Secondary Lesion,Stage IV Laryngeal Carcinoma
32688,Secondary Lesion,Metastatic Lip and Oral Cavity Carcinoma
32689,Carcinomatous Component Present,Metastatic Lip and Oral Cavity Carcinoma
32690,Epithelial Component Present,Metastatic Lip Carcinoma
32691,Metastatic Lesion,Metastatic Lip Squamous Cell Carcinoma
32692,Secondary Lesion,Metastatic Lip Squamous Cell Carcinoma
32693,Epithelial Component Present,Metastatic Lip Squamous Cell Carcinoma
32694,Metastatic Lesion,Lung squamous cell carcinoma stage IV
32695,Metastatic Lesion,Metastatic Lung Adenosquamous Carcinoma
32696,Epithelial Component Present,Metastatic Lung Adenosquamous Carcinoma
32697,Secondary Lesion,Metastatic Lung Small Cell Carcinoma
32698,Malignant Cellular Infiltrate,Metastatic Colorectal Carcinoma
32699,Metastatic Lesion,Metastatic Colon Carcinoma
32700,Malignant Cellular Infiltrate,Metastatic Neuroblastoma
32701,Secondary Lesion,Metastatic Neuroblastoma
32702,Cutaneous Involvement,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
32703,Refractory Disease,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
32704,Increased Cellularity Present,Frontal Lobe Anaplastic Oligodendroglioma
32705,Oligodendroglial Component Present,Frontal Lobe Anaplastic Oligodendroglioma
32706,Encapsulated Mass,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive"
32707,Malignant Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
32708,Epithelial Component Present,Localized Gastroesophageal Junction Adenocarcinoma
32709,Epithelial Component Present,Ectopic Thyroid Gland Thymoma
32710,Organoid Pattern,Tongue Alveolar Soft Part Sarcoma'
32711,Pseudoalveolar Pattern,Bladder Alveolar Soft Part Sarcoma
32712,Increased Cellularity Present,Cellular neurothekeoma
32713,Cutaneous Involvement,Scrotal Liposarcoma
32714,Cutaneous Involvement,Scrotal Sarcoma
32715,Malignant Cellular Infiltrate,Advanced Prostate Carcinoma
32716,Malignant Cellular Infiltrate,Locally Advanced Prostate Carcinoma
32717,Invasive Lesion,Advanced Prostate Adenocarcinoma
32718,Unresectable Mass,Locally Advanced Unresectable Prostate Carcinoma
32719,Carcinomatous Component Present,Locally Advanced Unresectable Prostate Carcinoma
32720,Metastatic Lesion,Advanced Cervical Carcinoma
32721,Metastatic Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma
32722,Epithelial Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma
32723,Secondary Lesion,Locally Advanced Unresectable Cervical Carcinoma
32724,Metastatic Lesion,Advanced Cervical Adenocarcinoma
32725,Benign Cellular Infiltrate,Thyroid Gland Schwannoma
32726,Malignant Cellular Infiltrate,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
32727,Indolent Clinical Course,Thyroid Gland Benign Vascular Neoplasm
32728,Benign Cellular Infiltrate,Thyroid Gland Hemangioma
32729,Nuclear Expression of STAT6 Protein,Thyroid Gland Solitary Fibrous Tumor
32730,S-100-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis
32731,Monoclonal Langerhans Cells Present,Thyroid Gland Langerhans Cell Histiocytosis
32732,Malignant Cellular Infiltrate,follicular dendritic cell sarcoma of thyroid gland
32733,Carcinomatous Component Present,Recurrent Primary Peritoneal Serous Adenocarcinoma
32734,Malignant Cellular Infiltrate,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
32735,Recurrent disease,Recurrent Low Grade Ovarian Serous Adenocarcinoma
32736,Low Grade Lesion,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma
32737,High Mitotic Activity,Extrapulmonary Small Cell Carcinoma
32738,Malignant Cellular Infiltrate,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma
32739,Vascular Channel Formation,Refractory Kaposi Sarcoma
32740,Malignant Cellular Infiltrate,Advanced Neuroendocrine Neoplasm
32741,Epithelial Component Present,Advanced Neuroendocrine Neoplasm
32742,Low Mitotic Activity,Advanced Pancreatic Neuroendocrine Tumor
32743,High Mitotic Activity,Metastatic Gastric Neuroendocrine Carcinoma
32744,Epithelial Component Present,Advanced Gastric Neuroendocrine Carcinoma
32745,Metastatic Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma
32746,Malignant Cellular Infiltrate,Advanced Small Intestinal Neuroendocrine Carcinoma
32747,Neuroendocrine Differentiation,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
32748,Epithelial Component Present,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
32749,Malignant Cellular Infiltrate,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
32750,Transformed Phase of Disease,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
32751,Malignant Cellular Infiltrate,Pelvic Cancer
32752,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Myelomonocytic Leukemia
32753,Recurrent disease,Recurrent Acute Myelomonocytic Leukemia
32754,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia
32755,Malignant Cellular Infiltrate,Recurrent Acute Monoblastic and Monocytic Leukemia
32756,Epithelial Component Present,Basal cell carcinoma
32757,Epithelial Component Present,Recurrent Biliary Tract Carcinoma
32758,Carcinomatous Component Present,Resectable Extrahepatic Bile Duct Adenocarcinoma
32759,Malignant Cellular Infiltrate,Adrenal Gland Sarcoma
32760,Carcinomatous Component Present,Hormone Receptor Positive Breast Carcinoma
32761,Malignant Cellular Infiltrate,Testicular cancer metastatic
32762,Benign Cellular Infiltrate,Hemangioma acquired
32763,Malignant Cellular Infiltrate,Nipple Duct Carcinoma
32764,Malignant Cellular Infiltrate,Tobacco-Related Carcinoma
32765,Malignant Cellular Infiltrate,Localized Primitive Neuroectodermal Tumor
32766,Malignant Cellular Infiltrate,Recurrent Primitive Neuroectodermal Tumor
32767,Malignant Cellular Infiltrate,Cholangiocarcinoma resectable
32768,Malignant Cellular Infiltrate,PNET of bone localized
32769,Malignant Cellular Infiltrate,Adult Pleomorphic Rhabdomyosarcoma
32770,Malignant Cellular Infiltrate,Childhood Desmoplastic Small Round Cell Tumor
32771,Malignant Cellular Infiltrate,Childhood Extraskeletal Osteosarcoma
32772,"Fully Differentiated ""Adult-Type"" Tissues Present",Adult Central Nervous System Immature Teratoma
32773,Malignant Cellular Infiltrate,Burkitt's lymphoma of small intestine
32774,Malignant Cellular Infiltrate,Ampulla of Vater Clear Cell Adenocarcinoma
32775,Malignant Cellular Infiltrate,Undifferentiated carcinoma of esophagus
32776,Well Differentiated Neuroendocrine Lesion,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
32777,Malignant Cellular Infiltrate,Colon Burkitt Lymphoma
32778,Intermediate Grade Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor
32779,Benign Cellular Infiltrate,Benign Bone Schwannoma
32780,Benign Cellular Infiltrate,Benign Osteoclastic Giant Cell-Rich Tumor of Bone
32781,Benign Cellular Infiltrate,Steroid Lipomatosis
32782,Malignant Cellular Infiltrate,Extraskeletal Myxoid Chondrosarcoma
32783,Malignant Cellular Infiltrate,Primary Cutaneous Mucinous Carcinoma
32784,Malignant Cellular Infiltrate,Basal cell carcinoma - follicular
32785,Malignant Cellular Infiltrate,Transplant-Related Hepatocellular Carcinoma
32786,Malignant Cellular Infiltrate,Human Papillomavirus-Related Verrucous Carcinoma
32787,Malignant Cellular Infiltrate,Human Papillomavirus-Related Squamous Cell Carcinoma
32788,Malignant Cellular Infiltrate,EBV-Related Carcinoma
32789,Malignant Cellular Infiltrate,EBV-Related Burkitt Lymphoma
32790,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
32791,Nuclear Clearing,Atypical follicular adenoma
32792,Malignant Cellular Infiltrate,Alkylating Agent-Related Acute Myeloid Leukemia
32793,Malignant Cellular Infiltrate,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia
32794,Malignant Cellular Infiltrate,Opisthorchis Viverrini-Related Cholangiocarcinoma
32795,Malignant Cellular Infiltrate,Immunodeficiency-Related Malignant Neoplasm
32796,Malignant Cellular Infiltrate,Lymphohistiocytoid Mesothelioma
32797,Malignant Cellular Infiltrate,Mucin-producing adenocarcinoma
32798,Malignant Cellular Infiltrate,Grade 1 Invasive Breast Carcinoma
32799,Malignant Cellular Infiltrate,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
32800,Malignant Cellular Infiltrate,Type 1 Papillary Renal Cell Carcinoma
32801,Malignant Cellular Infiltrate,"Papillary renal cell carcinoma, sporadic"
32802,Malignant Cellular Infiltrate,Localized tumors of the Ewing's family
32803,Malignant Cellular Infiltrate,Therapy-related acute myeloid leukemia and myelodysplastic syndrome
32804,Malignant Cellular Infiltrate,Alcohol-Related Esophageal Squamous Cell Carcinoma
32805,Malignant Cellular Infiltrate,Metaplastic carcinoma
32806,Malignant Cellular Infiltrate,Primary Myelofibrosis
32807,Malignant Cellular Infiltrate,Adenocarcinoma of prostate
32808,Malignant Cellular Infiltrate,Noninfiltrating Intraductal Carcinoma
32809,Malignant Cellular Infiltrate,Chondrosarcoma
32810,Benign Cellular Infiltrate,Ganglioneuroma
32811,Malignant Cellular Infiltrate,Hemangiosarcoma
32812,Malignant Cellular Infiltrate,Acute lymphocytic leukemia
32813,Malignant Cellular Infiltrate,Acute Megakaryocytic Leukemias
32814,Malignant Cellular Infiltrate,"Leukemia, Plasma Cell"
32815,Benign Cellular Infiltrate,"Lipomatosis, Multiple Symmetrical"
32816,Malignant Cellular Infiltrate,Lymphoma
32817,Benign Cellular Infiltrate,Benign Mastocytoma
32818,Malignant Cellular Infiltrate,Nephroblastoma
32819,Benign Cellular Infiltrate,Osteoblastoma
32820,Malignant Cellular Infiltrate,Pseudomyxoma Peritonei
32821,Malignant Cellular Infiltrate,Squamous cell carcinoma of the head and neck
32822,Malignant Cellular Infiltrate,Peripheral T-Cell Lymphoma
32823,Malignant Cellular Infiltrate,Malignant neoplasm of mandible
32824,Malignant Cellular Infiltrate,Nodular Sclerosis Classical Hodgkin Lymphoma
32825,Malignant Cellular Infiltrate,Malignant neoplasm of submandibular gland
32826,Malignant Cellular Infiltrate,Malignant tumor of palate
32827,Malignant Cellular Infiltrate,Malignant neoplasm of thoracic esophagus
32828,Malignant Cellular Infiltrate,Malignant neoplasm of maxillary sinus
32829,Malignant Cellular Infiltrate,malignant neoplasm of bone marrow
32830,Malignant Cellular Infiltrate,Malignant neoplasm of conjunctiva
32831,Malignant Cellular Infiltrate,Differentiated Granulocytic Sarcoma
32832,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage III
32833,Malignant Cellular Infiltrate,Grade 4 Clear Cell Renal Cell Carcinoma
32834,Malignant Cellular Infiltrate,Iatrogenic Kaposi Sarcoma
32835,Benign Cellular Infiltrate,Benign neoplasm of trachea
32836,Benign Cellular Infiltrate,Benign neoplasm of pleura
32837,Benign Cellular Infiltrate,Benign tumor of mediastinum
32838,Malignant Cellular Infiltrate,Grade 3a Malignant Neoplasm
32839,Malignant Cellular Infiltrate,Secondary Neoplasm
32840,Malignant Cellular Infiltrate,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma
32841,Malignant Cellular Infiltrate,"T-Cell Prolymphocytic Leukemia, Small Cell Variant"
32842,Benign Cellular Infiltrate,Benign neoplasm of thyroid gland
32843,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Liver
32844,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Brain
32845,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Lung
32846,Malignant Cellular Infiltrate,Carcinoma in situ of skin
32847,Malignant Cellular Infiltrate,Carcinoma in situ of prostate
32848,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v6
32849,Malignant Cellular Infiltrate,Sweat Gland Tubular Carcinoma
32850,Malignant Cellular Infiltrate,Undifferentiated carcinoma
32851,Malignant Cellular Infiltrate,Carcinomatosis
32852,Malignant Cellular Infiltrate,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative"
32853,Malignant Cellular Infiltrate,Diffuse Blastoid B-Cell Lymphoma
32854,Malignant Cellular Infiltrate,Solid pseudopapillary tumor of the pancreas
32855,Benign Cellular Infiltrate,"Lymphangioma, Cystic"
32856,Benign Cellular Infiltrate,Paraganglioma-Like Dermal Melanocytic Tumor
32857,Malignant Cellular Infiltrate,Hepatoblastoma
32858,Benign Cellular Infiltrate,Angiolipoma
32859,Benign Cellular Infiltrate,"Histiocytoma, Benign Fibrous"
32860,Malignant Cellular Infiltrate,Teratocarcinoma
32861,Malignant Cellular Infiltrate,gliosarcoma
32862,Malignant Cellular Infiltrate,Epithelioid hemangioendothelioma
32863,Benign Cellular Infiltrate,Lung Clear Cell Tumor
32864,Malignant Cellular Infiltrate,Digestive System Hodgkin Lymphoma
32865,Primary Lesion,Ependymoma of brain
32866,Malignant Cellular Infiltrate,Cystadenocarcinoma of pancreas
32867,Malignant Cellular Infiltrate,Anaplastic thyroid carcinoma
32868,Malignant Cellular Infiltrate,Medullary carcinoma of thyroid
32869,Malignant Cellular Infiltrate,Ann Arbor Stage IIB Hodgkin Lymphoma
32870,Malignant Cellular Infiltrate,Vagina Carcinoma
32871,Malignant Cellular Infiltrate,Small Intestinal Enteropathy-Associated T-Cell Lymphoma
32872,Malignant Cellular Infiltrate,Mycosis Fungoides Variant
32873,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype"
32874,Malignant Cellular Infiltrate,Type II Endometrial Adenocarcinoma
32875,Malignant Cellular Infiltrate,"Glioblastoma, IDH-Mutant"
32876,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation
32877,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
32878,Malignant Cellular Infiltrate,verrucous carcinoma of bladder
32879,Malignant Cellular Infiltrate,Bladder Urachal Urothelial Carcinoma
32880,Malignant Cellular Infiltrate,Bladder Papillary Clear Cell Adenocarcinoma
32881,Borderline Lesion,Prostate Stromal Proliferation of Uncertain Malignant Potential
32882,Malignant Cellular Infiltrate,Testicular Seminoma with Syncytiotrophoblastic Cells
32883,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern"
32884,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Enteric Pattern"
32885,Malignant Cellular Infiltrate,Stage IV Breast Cancer AJCC v6 and v7
32886,Borderline Lesion,Monoclonal Gammopathy of Undetermined Significance
32887,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Cancer AJCC v6
32888,Malignant Cellular Infiltrate,Clear cell adenocarcinoma of ovary
32889,Malignant Cellular Infiltrate,Uterine Ligament Endometrioid Adenocarcinoma
32890,Malignant Cellular Infiltrate,Type I Endometrial Adenocarcinoma
32891,Malignant Cellular Infiltrate,Grade 1 Endometrial Endometrioid Adenocarcinoma
32892,Malignant Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyosarcoma
32893,Malignant Cellular Infiltrate,Cervical Villoglandular Adenocarcinoma
32894,Malignant Cellular Infiltrate,Vaginal Warty Carcinoma
32895,Malignant Cellular Infiltrate,Adenocarcinoma Of Esophagus
32896,Malignant Cellular Infiltrate,Mucinous cystadenocarcinoma of ovary
32897,Malignant Cellular Infiltrate,Vaginal Undifferentiated Carcinoma
32898,Malignant Cellular Infiltrate,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma
32899,Malignant Cellular Infiltrate,basaloid squamous cell carcinoma of vulva
32900,Malignant Cellular Infiltrate,eccrine adenocarcinoma of vulva
32901,Malignant Cellular Infiltrate,Vulvar Sebaceous Carcinoma
32902,Malignant Cellular Infiltrate,Sebaceous Adenocarcinoma
32903,Malignant Cellular Infiltrate,Sarcoma of vulva
32904,Malignant Cellular Infiltrate,Vulvar Proximal-Type Epithelioid Sarcoma
32905,Malignant Cellular Infiltrate,Refractory anemia with ringed sideroblasts
32906,Malignant Cellular Infiltrate,Ductal Carcinoma In Situ with Microinvasion
32907,Malignant Cellular Infiltrate,Post-Radiotherapy Breast Angiosarcoma
32908,Malignant Cellular Infiltrate,Meningothelial sarcoma
32909,Malignant Cellular Infiltrate,Basaloid carcinoma
32910,Malignant Cellular Infiltrate,Adenocarcinoid tumor
32911,Malignant Cellular Infiltrate,Signet Ring Cell Intrahepatic Cholangiocarcinoma
32912,Malignant Cellular Infiltrate,Ceruminous adenocarcinoma
32913,Malignant Cellular Infiltrate,Adenocarcinoma with apocrine metaplasia
32914,Malignant Cellular Infiltrate,Epithelioid Cell Melanoma
32915,Benign Cellular Infiltrate,Cellular Blue Nevus
32916,Malignant Cellular Infiltrate,Lip and Oral Cavity Squamous Cell Carcinoma
32917,Malignant Cellular Infiltrate,Malignant Brenner Tumor
32918,Benign Cellular Infiltrate,Venous hemangioma
32919,Malignant Cellular Infiltrate,Anaplastic Oligodendroglioma
32920,Malignant Cellular Infiltrate,Malignant Outer Hair Sheath and Infundibulum Neoplasm
32921,Malignant Cellular Infiltrate,Carcinoma ex Eccrine Spiradenoma
32922,Malignant Cellular Infiltrate,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma
32923,Malignant Cellular Infiltrate,Hutchinson's Melanotic Freckle
32924,Malignant Cellular Infiltrate,Angioendotheliomatosis
32925,Malignant Cellular Infiltrate,Aleukemic Lymphoid Leukemia
32926,Malignant Cellular Infiltrate,Sporadic Gastric Adenocarcinoma
32927,Malignant Cellular Infiltrate,undifferentiated carcinoma of appendix
32928,Malignant Cellular Infiltrate,Colorectal Small Cell Neuroendocrine Carcinoma
32929,Malignant Cellular Infiltrate,Colorectal Squamous Cell Carcinoma
32930,Malignant Cellular Infiltrate,Colorectal Medullary Carcinoma
32931,Malignant Cellular Infiltrate,Rectal Adenosquamous Carcinoma
32932,Malignant Cellular Infiltrate,Clear Cell Intrahepatic Cholangiocarcinoma
32933,Malignant Cellular Infiltrate,Gastric Fundus Carcinoma In Situ AJCC v6 and v7
32934,Benign Cellular Infiltrate,Desmoplastic Nevus
32935,Benign Cellular Infiltrate,Benign neoplasm of breast
32936,Malignant Cellular Infiltrate,Stage 0 Vulvar Carcinoma
32937,Malignant Cellular Infiltrate,Cutaneous Mantle Cell Lymphoma
32938,Malignant Cellular Infiltrate,Thymic Mucosa-Associated Lymphoid Tissue Lymphoma
32939,Malignant Cellular Infiltrate,Malignant melanoma of conjunctiva
32940,Malignant Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Small Cell Variant"
32941,Malignant Cellular Infiltrate,Malignant melanoma of choroid
32942,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type I
32943,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type III
32944,Malignant Cellular Infiltrate,Angiosarcoma of spleen
32945,Malignant Cellular Infiltrate,Malignant Lung Hilum Neoplasm
32946,Malignant Cellular Infiltrate,Malignant neoplasm of epicardium
32947,Malignant Cellular Infiltrate,Cardiac Monophasic Synovial Sarcoma
32948,Malignant Cellular Infiltrate,Secondary malignant neoplasm of large intestine
32949,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone marrow
32950,Malignant Cellular Infiltrate,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8"
32951,Benign Cellular Infiltrate,Benign neoplasm of oropharynx
32952,Malignant Cellular Infiltrate,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation
32953,Malignant Cellular Infiltrate,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation
32954,Malignant Cellular Infiltrate,Gastric lymphoma
32955,Low Grade Neuroendocrine Lesion,Carcinoid tumor of intestine
32956,Malignant Cellular Infiltrate,T-Cell Large Granular Lymphocyte Leukemia
32957,"Fully Differentiated ""Adult-Type"" Tissues Present",Mediastinal Immature Teratoma
32958,Malignant Cellular Infiltrate,Bladder Sarcoma
32959,Benign Cellular Infiltrate,Skin Cavernous Hemangioma
32960,Benign Cellular Infiltrate,Spindle cell nevus of Reed
32961,Malignant Cellular Infiltrate,T-Cell Prolymphocytic Leukemia
32962,Malignant Cellular Infiltrate,Malignant neoplasm of olfactory nerve
32963,Malignant Cellular Infiltrate,"Paget's Disease, Mammary"
32964,Malignant Cellular Infiltrate,malignant neurologic neoplasms
32965,Benign Cellular Infiltrate,Left atrial myxoma
32966,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm
32967,Malignant Cellular Infiltrate,Disseminated squamous cell carcinoma
32968,Malignant Cellular Infiltrate,Ewing's sarcoma of bone
32969,Malignant Cellular Infiltrate,Desmoplastic Neurotropic Melanoma
32970,Malignant Cellular Infiltrate,Breast Carcinoma
32971,Benign Cellular Infiltrate,Benign neoplasm of neck
32972,Benign Cellular Infiltrate,Benign neoplasm of hilus of lung
32973,Malignant Cellular Infiltrate,Low grade myofibroblastic sarcoma
32974,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant"
32975,Malignant Cellular Infiltrate,Skin carcinoma
32976,Malignant Cellular Infiltrate,Ependymoblastoma
32977,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of ileum
32978,Malignant Cellular Infiltrate,Localized Lymphoma
32979,Malignant Cellular Infiltrate,Cancer of Neck
32980,Malignant Cellular Infiltrate,Secondary Malignant Neoplasm
32981,Malignant Cellular Infiltrate,Aleukemic Leukemia Cutis
32982,Malignant Cellular Infiltrate,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb
32983,Malignant Cellular Infiltrate,Angiocentric lymphoma recurrent
32984,Malignant Cellular Infiltrate,Malignant Testicular Non-Seminomatous Germ Cell Tumor
32985,Malignant Cellular Infiltrate,AIDS-Related Malignant Cervical Neoplasm
32986,Malignant Cellular Infiltrate,Epithelioid sarcoma recurrent
32987,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma
32988,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I supradiaphragmatic
32989,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic
32990,Malignant Cellular Infiltrate,Brain Stem Glioblastoma
32991,Malignant Cellular Infiltrate,Adenocarcinoma of large intestine
32992,Malignant Cellular Infiltrate,Adenoid cystic breast carcinoma
32993,Malignant Cellular Infiltrate,Childhood Glioblastoma
32994,Malignant Cellular Infiltrate,intraductal micropapillary carcinoma of breast
32995,Malignant Cellular Infiltrate,Apocrine breast carcinoma
32996,Malignant Cellular Infiltrate,neuroblastoma of spinal cord
32997,Well Differentiated Neuroendocrine Lesion,Metastatic Breast Carcinoid Tumor
32998,Malignant Cellular Infiltrate,Metastatic Signet Ring Cell Breast Carcinoma
32999,Benign Cellular Infiltrate,Breast Epithelioid Hemangioma
33000,Malignant Cellular Infiltrate,Ovarian Myxoid Liposarcoma
33001,Malignant Cellular Infiltrate,MALT lymphoma of stomach
33002,Malignant Cellular Infiltrate,Childhood Meningeal Melanoma
33003,Benign Cellular Infiltrate,Jugular Foramen Schwannoma
33004,Malignant Cellular Infiltrate,Advanced Favorable Non-Hodgkin Lymphoma
33005,Benign Cellular Infiltrate,Cavernous lymphangioma
33006,Malignant Cellular Infiltrate,mesenchymal chondrosarcoma of bone
33007,Benign Cellular Infiltrate,Cardiac neurofibroma
33008,Benign Cellular Infiltrate,Pleomorphic hyalinizing angiectatic tumor of soft tissue
33009,Malignant Cellular Infiltrate,Cardiac Kaposi's Sarcoma
33010,Malignant Cellular Infiltrate,Cardiac Myeloid Sarcoma
33011,Malignant Cellular Infiltrate,Radiation-Related Osteosarcoma
33012,Malignant Cellular Infiltrate,Inferior Vena Cava Leiomyosarcoma
33013,Malignant Cellular Infiltrate,Pulmonary Artery Leiomyosarcoma
33014,Malignant Cellular Infiltrate,Uterine Angiosarcoma
33015,Benign Cellular Infiltrate,Parotid Gland Lymphangioma
33016,Malignant Cellular Infiltrate,High grade surface osteosarcoma
33017,Benign Cellular Infiltrate,"Gastrointestinal stromal tumor, benign"
33018,Malignant Cellular Infiltrate,Gastrointestinal Stromal Sarcoma
33019,Malignant Cellular Infiltrate,Malignant Intracranial Germ Cell Tumor
33020,Malignant Cellular Infiltrate,Classic medulloblastoma
33021,Benign Cellular Infiltrate,Epidural Spinal Canal Angiolipoma
33022,Malignant Cellular Infiltrate,Primary Intraosseous Squamous Cell Carcinoma
33023,Malignant Cellular Infiltrate,Laryngeal Basaloid Carcinoma
33024,Malignant Cellular Infiltrate,Laryngeal Adenosquamous Carcinoma
33025,Malignant Cellular Infiltrate,undifferentiated carcinoma of larynx
33026,Malignant Cellular Infiltrate,Laryngeal Lymphoepithelial Carcinoma
33027,Malignant Cellular Infiltrate,Nevoid Melanoma
33028,Low Grade Neuroendocrine Lesion,Carcinoid tumor of the cecum
33029,Malignant Cellular Infiltrate,Central nervous system melanoma
33030,Malignant Cellular Infiltrate,Prostate Adenoid Cystic Carcinoma
33031,Malignant Cellular Infiltrate,Adenocarcinoma of cecum
33032,Malignant Cellular Infiltrate,cloacogenic carcinoma of rectum
33033,Malignant Cellular Infiltrate,Rectal Sarcomatoid Carcinoma
33034,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma of skin
33035,Malignant Cellular Infiltrate,Prostate Undifferentiated Carcinoma
33036,Malignant Cellular Infiltrate,Adenocarcinoma of anus
33037,Malignant Cellular Infiltrate,sarcoma of anus
33038,Malignant Cellular Infiltrate,Anal cancer metastatic
33039,Malignant Cellular Infiltrate,Carcinoma Metastatic to the Skin
33040,Malignant Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia Cutis
33041,Malignant Cellular Infiltrate,Occult Lung Carcinoma
33042,Malignant Cellular Infiltrate,Stage IB Lung Cancer AJCC v7
33043,Malignant Cellular Infiltrate,Stage IIA Lung Cancer AJCC v7
33044,Malignant Cellular Infiltrate,Stage IIB Lung Cancer AJCC v7
33045,Malignant Cellular Infiltrate,Stage IIB Esophageal Carcinoma
33046,Malignant Cellular Infiltrate,Stage IV Pancreatic Cancer AJCC v6 and v7
33047,Malignant Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v6 and v7
33048,Malignant Cellular Infiltrate,signet ring cell carcinoma of gallbladder
33049,Benign Cellular Infiltrate,Liver Lipoma
33050,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of liver
33051,Malignant Cellular Infiltrate,Liver Mucosa-Associated Lymphoid Tissue Lymphoma
33052,Malignant Cellular Infiltrate,undifferentiated carcinoma of extrahepatic bile duct
33053,Malignant Cellular Infiltrate,Adult Central Nervous System Embryonal Carcinoma
33054,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1
33055,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of extrahepatic bile duct
33056,Malignant Cellular Infiltrate,Stage IVC Lip Cancer AJCC v6 and v7
33057,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Cancer AJCC v6 and v7
33058,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Cancer AJCC v6 and v7
33059,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Carcinoma with Metastasis
33060,Malignant Cellular Infiltrate,Major Salivary Gland Adenocarcinoma
33061,Malignant Cellular Infiltrate,Major Salivary Gland Carcinoma
33062,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of submandibular gland
33063,Malignant Cellular Infiltrate,Submandibular Gland Squamous Cell Carcinoma
33064,Malignant Cellular Infiltrate,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma
33065,Malignant Cellular Infiltrate,Submandibular Gland Carcinoma ex Pleomorphic Adenoma
33066,Malignant Cellular Infiltrate,sarcoma of larynx
33067,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of trachea
33068,Malignant Cellular Infiltrate,Malignant Anterior Tongue Neoplasm
33069,Malignant Cellular Infiltrate,Colon Medullary Carcinoma
33070,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of accessory sinus
33071,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of nasal cavity
33072,Malignant Cellular Infiltrate,External Ear Basal Cell Carcinoma
33073,Malignant Cellular Infiltrate,Malignant Uveal Neoplasm
33074,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Melanoma
33075,Malignant Cellular Infiltrate,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
33076,Malignant Cellular Infiltrate,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7
33077,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v7
33078,Malignant Cellular Infiltrate,undifferentiated carcinoma of ureter
33079,Benign Cellular Infiltrate,Ureter Leiomyoma
33080,Malignant Cellular Infiltrate,Stage 0 Urethral Cancer AJCC v7
33081,Malignant Cellular Infiltrate,Stage II Urethral Cancer AJCC v7
33082,Malignant Cellular Infiltrate,Childhood Brain Germinoma
33083,Malignant Cellular Infiltrate,mucinous adenocarcinoma of salivary gland
33084,Malignant Cellular Infiltrate,Superficial basal cell carcinoma
33085,Malignant Cellular Infiltrate,Maxillary Sinus Adenoid Cystic Carcinoma
33086,Malignant Cellular Infiltrate,alveolar rhabdomyosarcoma of orbit
33087,Primary Lesion,Childhood Cerebral Ependymoma
33088,Malignant Cellular Infiltrate,Stage IIIA Fallopian Tube Cancer AJCC v7
33089,Malignant Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v7
33090,Malignant Cellular Infiltrate,Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7
33091,Malignant Cellular Infiltrate,Stage IC Uterine Corpus Cancer AJCC v6
33092,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Cancer AJCC v7
33093,Malignant Cellular Infiltrate,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm
33094,Malignant Cellular Infiltrate,Stage IB1 Cervical Cancer
33095,Malignant Cellular Infiltrate,Stage IVA Vulvar Cancer AJCC v6
33096,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma
33097,Malignant Cellular Infiltrate,undifferentiated carcinoma of cervix
33098,Malignant Cellular Infiltrate,Stage IIIC Testicular Cancer AJCC v6 and v7
33099,Malignant Cellular Infiltrate,Basal cell carcinoma of vulva
33100,Malignant Cellular Infiltrate,verrucous carcinoma of vulva
33101,Secondary Lesion,Metastatic carcinoid tumor
33102,Malignant Cellular Infiltrate,Malignant germ cell neoplasm of mediastinum
33103,Malignant Cellular Infiltrate,Thymic Adenosquamous Carcinoma
33104,Malignant Cellular Infiltrate,Thymic Adenocarcinoma
33105,Malignant Cellular Infiltrate,Thymic Small Cell Carcinoma
33106,Malignant Cellular Infiltrate,Stage IA Bone Sarcoma AJCC v7
33107,Malignant Cellular Infiltrate,Stage IB Bone Sarcoma AJCC v7
33108,Malignant Cellular Infiltrate,Stage III Bone Sarcoma AJCC v7
33109,Benign Cellular Infiltrate,Benign fibrohistiocytic neoplasm
33110,Benign Cellular Infiltrate,Lumbosacral Lipoma
33111,Malignant Cellular Infiltrate,Malignant Skeletal Muscle Neoplasm
33112,Malignant Cellular Infiltrate,"Squamous cell carcinoma, small cell, nonkeratinizing"
33113,Malignant Cellular Infiltrate,"Squamous cell carcinoma, clear cell type"
33114,Intermediate Grade Neuroendocrine Lesion,Malignant Pancreatic Insulinoma
33115,Tumor Vascular Invasion,Malignant Vipoma
33116,Malignant Cellular Infiltrate,"Adenocarcinoma, Tubular"
33117,Benign Cellular Infiltrate,Nodular tenosynovitis
33118,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Dysgerminoma
33119,Benign Cellular Infiltrate,Benign Osteogenic Neoplasm
33120,Malignant Cellular Infiltrate,Mediastinal Angiosarcoma
33121,Malignant Cellular Infiltrate,liposarcoma of mediastinum
33122,Malignant Cellular Infiltrate,Localized Bone Ewing Sarcoma
33123,Malignant Cellular Infiltrate,Malignant Mediastinal Soft Tissue Neoplasm
33124,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v7
33125,Malignant Cellular Infiltrate,Stage III Pleural Malignant Mesothelioma AJCC v7
33126,Malignant Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v7
33127,Malignant Cellular Infiltrate,Stage IV Ampulla of Vater Cancer AJCC v7
33128,Malignant Cellular Infiltrate,Stage IIIB Lung Large Cell Carcinoma AJCC v7
33129,Malignant Cellular Infiltrate,atypical medullary carcinoma of breast
33130,Malignant Cellular Infiltrate,Occult Lung Adenosquamous Carcinoma
33131,Malignant Cellular Infiltrate,Occult Lung Large Cell Carcinoma
33132,Malignant Cellular Infiltrate,Adenocarcinoma of lung stage IIIB
33133,Malignant Cellular Infiltrate,Adenocarcinoma of lung stage IIIA
33134,Malignant Cellular Infiltrate,Stage IVA Osteosarcoma AJCC v7
33135,Malignant Cellular Infiltrate,Stage IVB Bone Sarcoma AJCC v7
33136,Malignant Cellular Infiltrate,Stage I Osteosarcoma AJCC v7
33137,Malignant Cellular Infiltrate,Stage II Osteosarcoma AJCC v7
33138,Malignant Cellular Infiltrate,Chest Wall Lymphoma
33139,Benign Cellular Infiltrate,Chest Wall Fibromatosis
33140,Malignant Cellular Infiltrate,"Colorectal cancer, hereditary nonpolyposis, type 1"
33141,Benign Cellular Infiltrate,Mature Pericardial Teratoma
33142,Malignant Cellular Infiltrate,Pineal Region Yolk Sac Tumor
33143,Malignant Cellular Infiltrate,Malignant sex-cord stromal tumor
33144,Malignant Cellular Infiltrate,Pineal Region Choriocarcinoma
33145,Malignant Cellular Infiltrate,Recurrent Childhood Medulloblastoma
33146,Malignant Cellular Infiltrate,Malignant lymphoma of testis
33147,Malignant Cellular Infiltrate,Kadish Stage A Olfactory Neuroblastoma
33148,Malignant Cellular Infiltrate,Favorable Hodgkin Lymphoma
33149,Malignant Cellular Infiltrate,Advanced Favorable Hodgkin Lymphoma
33150,Malignant Cellular Infiltrate,Hodgkin Lymphoma by Clinical Course
33151,Malignant Cellular Infiltrate,Marginal zone lymphoma stage II
33152,Malignant Cellular Infiltrate,Marginal zone lymphoma stage III
33153,Malignant Cellular Infiltrate,Stage II Indolent Adult Non-Hodgkin Lymphoma
33154,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities
33155,Benign Cellular Infiltrate,Soft tissue perineurioma
33156,Malignant Cellular Infiltrate,Langerhans Cell Sarcoma
33157,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Variant MLL Translocations
33158,Benign Cellular Infiltrate,Polyp of middle ear
33159,Malignant Cellular Infiltrate,papillary carcinoma of penis
33160,Malignant Cellular Infiltrate,Sarcomatoid Carcinoma of the Penis
33161,Malignant Cellular Infiltrate,Ductal Breast Carcinoma with Squamous Metaplasia
33162,Benign Cellular Infiltrate,Central Nervous System Hemangioma
33163,Malignant Cellular Infiltrate,Plasma cell myeloma recurrent
33164,Malignant Cellular Infiltrate,Barrett's Adenocarcinoma
33165,Malignant Cellular Infiltrate,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma
33166,Malignant Cellular Infiltrate,Hepatoblastoma with Pure Fetal Epithelial Differentiation
33167,Malignant Cellular Infiltrate,Stage IVB Liver Cancer
33168,Malignant Cellular Infiltrate,Childhood Grade III Meningioma
33169,Malignant Cellular Infiltrate,Postsurgical Stage III Hepatoblastoma
33170,Malignant Cellular Infiltrate,Indolent multiple myeloma
33171,Malignant Cellular Infiltrate,Grade 2 Diffuse Follicular Lymphoma
33172,Malignant Cellular Infiltrate,Childhood T Lymphoblastic Lymphoma
33173,Malignant Cellular Infiltrate,Cutaneous Follicular Lymphoma
33174,Malignant Cellular Infiltrate,Grade 2 Cutaneous Follicular Lymphoma
33175,Malignant Cellular Infiltrate,Primary Cutaneous Hodgkin Lymphoma
33176,Malignant Cellular Infiltrate,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder
33177,Malignant Cellular Infiltrate,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder
33178,Malignant Cellular Infiltrate,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder
33179,Malignant Cellular Infiltrate,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
33180,Malignant Cellular Infiltrate,Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma
33181,Malignant Cellular Infiltrate,Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma
33182,Malignant Cellular Infiltrate,Minimally Invasive Mucinous Lung Adenocarcinoma
33183,Malignant Cellular Infiltrate,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
33184,Malignant Cellular Infiltrate,Splenic Lymphoblastic Lymphoma
33185,Malignant Cellular Infiltrate,Adult Acute Monoblastic and Monocytic Leukemia
33186,Malignant Cellular Infiltrate,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
33187,Malignant Cellular Infiltrate,Malignant neoplasm of lung
33188,Malignant Cellular Infiltrate,Hairy cell leukemia variant
33189,Malignant Cellular Infiltrate,AIDS-Related Cervical Kaposi Sarcoma
33190,Benign Cellular Infiltrate,Intramuscular lipoma
33191,Malignant Cellular Infiltrate,Exocervical Carcinoma
33192,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ovary
33193,Malignant Cellular Infiltrate,Malignant neoplasm of esophagus
33194,Malignant Cellular Infiltrate,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type
33195,Malignant Cellular Infiltrate,Refractory anaemia with excess blasts
33196,Malignant Cellular Infiltrate,Recurrent Urethral Cancer
33197,Malignant Cellular Infiltrate,Malignant neoplasm of thyroid
33198,Malignant Cellular Infiltrate,Ovarian Serous Adenocarcinoma
33199,Malignant Cellular Infiltrate,Adult Lymphoma
33200,Malignant Cellular Infiltrate,Cerebral Non-Hodgkin Lymphoma
33201,Malignant Cellular Infiltrate,Adenocarcinoma in situ in tubular adenoma
33202,Malignant Cellular Infiltrate,Adenocarcinoma in situ in a polyp
33203,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma
33204,Malignant Cellular Infiltrate,Hepatoma resectable
33205,Low Grade Neuroendocrine Lesion,Gastrointestinal Carcinoid Tumor
33206,Malignant Cellular Infiltrate,Childhood Hodgkin Lymphoma
33207,Malignant Cellular Infiltrate,squamous cell carcinoma of renal pelvis
33208,Malignant Cellular Infiltrate,Metastatic osteosarcoma
33209,Malignant Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v6 and v7
33210,Malignant Cellular Infiltrate,Stage II Rectal Cancer
33211,Malignant Cellular Infiltrate,Mycosis fungoides stage II
33212,Malignant Cellular Infiltrate,Localized Ewing Sarcoma
33213,Malignant Cellular Infiltrate,Metastatic Ewing's Sarcoma
33214,Malignant Cellular Infiltrate,Stage III Adult Soft Tissue Sarcoma AJCC v7
33215,Malignant Cellular Infiltrate,Ovarian cancer stage III
33216,Malignant Cellular Infiltrate,Stage V Kidney Wilms Tumor
33217,Malignant Cellular Infiltrate,Recurrent Retinoblastoma
33218,Malignant Cellular Infiltrate,Stage IVA Vaginal Cancer AJCC v6 and v7
33219,Low Grade Neuroendocrine Lesion,Localized Digestive System Neuroendocrine Tumor G1
33220,Low Grade Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Tumor G1
33221,Malignant Cellular Infiltrate,Stage I Penile Cancer AJCC v6
33222,Malignant Cellular Infiltrate,Stage II Penile Cancer AJCC v6
33223,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 1
33224,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 3
33225,Malignant Cellular Infiltrate,Recurrent Skin Carcinoma
33226,Malignant Cellular Infiltrate,Recurrent Salivary Gland Cancer
33227,Borderline Lesion,Lymphomatoid Granulomatosis
33228,Malignant Cellular Infiltrate,High Grade Ductal Breast Carcinoma In Situ
33229,Malignant Cellular Infiltrate,Childhood Burkitt Leukemia
33230,Malignant Cellular Infiltrate,Childhood Embryonal Rhabdomyosarcoma
33231,Malignant Cellular Infiltrate,Adult Acute Megakaryoblastic Leukemia
33232,Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma of colon
33233,Malignant Cellular Infiltrate,Small cell carcinoma of the cervix
33234,Malignant Cellular Infiltrate,Testicular yolk sac tumor
33235,Malignant Cellular Infiltrate,Testicular Mixed Yolk Sac Tumor and Teratoma
33236,Malignant Cellular Infiltrate,Acinic cell carcinoma of salivary gland
33237,Malignant Cellular Infiltrate,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma
33238,Malignant Cellular Infiltrate,Malignant mixed salivary gland tumor
33239,Malignant Cellular Infiltrate,Waldenstrom Macroglobulinemia
33240,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
33241,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
33242,Malignant Cellular Infiltrate,Follicular thyroid carcinoma
33243,Malignant Cellular Infiltrate,Treatment related leukaemia
33244,Malignant Cellular Infiltrate,Ann Arbor Stage I Grade 1 Follicular Lymphoma
33245,Malignant Cellular Infiltrate,Ann Arbor Stage I Grade 2 Follicular Lymphoma
33246,Malignant Cellular Infiltrate,Childhood Fibrosarcoma
33247,Malignant Cellular Infiltrate,Childhood Liposarcoma
33248,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Follicular Lymphoma
33249,Malignant Cellular Infiltrate,Stage II Adult Immunoblastic Lymphoma
33250,Malignant Cellular Infiltrate,Stage II Adult Lymphoblastic Lymphoma
33251,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage IV
33252,Malignant Cellular Infiltrate,Ann Arbor Stage IV Grade 1 Follicular Lymphoma
33253,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma recurrent
33254,Malignant Cellular Infiltrate,Tonsillar Undifferentiated Carcinoma
33255,Malignant Cellular Infiltrate,Postcricoid Squamous Cell Carcinoma
33256,Malignant Cellular Infiltrate,Recurrent Lip Basal Cell Carcinoma
33257,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia
33258,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
33259,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage III
33260,Malignant Cellular Infiltrate,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm
33261,Malignant Cellular Infiltrate,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7
33262,Malignant Cellular Infiltrate,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214
33263,Malignant Cellular Infiltrate,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
33264,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated CEBPA
33265,Malignant Cellular Infiltrate,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter
33266,Malignant Cellular Infiltrate,Refractory Cytopenia of Childhood
33267,Malignant Cellular Infiltrate,bilateral breast cancer
33268,Malignant Cellular Infiltrate,Papillary serous cystadenocarcinoma
33269,Malignant Cellular Infiltrate,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement
33270,Malignant Cellular Infiltrate,Palate carcinoma
33271,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma
33272,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma
33273,Malignant Cellular Infiltrate,Stage I Non-Hodgkin Lymphoma
33274,Malignant Cellular Infiltrate,Malignant melanoma of eye
33275,Malignant Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone
33276,Malignant Cellular Infiltrate,Stage IB Adult Soft Tissue Sarcoma AJCC v7
33277,Malignant Cellular Infiltrate,Localized Malignant Neoplasm
33278,Malignant Cellular Infiltrate,Stage IB Soft Tissue Sarcoma AJCC v7
33279,Malignant Cellular Infiltrate,Stage IB Breast Cancer AJCC v7
33280,Malignant Cellular Infiltrate,Stage III Merkel Cell Carcinoma AJCC v7
33281,Malignant Cellular Infiltrate,Stage IIA Cutaneous Melanoma AJCC v6 and v7
33282,Malignant Cellular Infiltrate,Metastases to abdominal cavity
33283,Malignant Cellular Infiltrate,Stage II Esophageal Adenocarcinoma AJCC v7
33284,Malignant Cellular Infiltrate,Recurrent Chronic Lymphoid Leukemia
33285,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type stage IV
33286,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage IV
33287,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma refractory
33288,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma recurrent
33289,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage I
33290,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage II
33291,Malignant Cellular Infiltrate,Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
33292,Malignant Cellular Infiltrate,Stage IIIB Vulvar Cancer AJCC v7
33293,Malignant Cellular Infiltrate,Stage IA Bone Cancer AJCC v7
33294,Malignant Cellular Infiltrate,Stage IVB Bone Cancer AJCC v7
33295,Malignant Cellular Infiltrate,Endometrial Squamous Cell Carcinoma
33296,Malignant Cellular Infiltrate,FIGO Stage III Carcinoma of the Fallopian Tube
33297,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7
33298,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage II
33299,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage III
33300,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Polyembryoma AJCC v6 and v7
33301,Malignant Cellular Infiltrate,Stage IV Ovarian Teratoma AJCC v6 and v7
33302,Malignant Cellular Infiltrate,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7
33303,Malignant Cellular Infiltrate,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7
33304,Malignant Cellular Infiltrate,Stage IV Lung Squamous Cell Carcinoma AJCC v7
33305,Malignant Cellular Infiltrate,Stage IIA Gastric Cancer AJCC v7
33306,Malignant Cellular Infiltrate,Stage IIIC Gastric Cancer AJCC v7
33307,Malignant Cellular Infiltrate,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7
33308,Malignant Cellular Infiltrate,Stage IIIC Esophageal Adenocarcinoma AJCC v7
33309,Malignant Cellular Infiltrate,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7
33310,Malignant Cellular Infiltrate,Stage I Appendix Carcinoma AJCC v7
33311,Malignant Cellular Infiltrate,Chondrosarcoma recurrent
33312,Malignant Cellular Infiltrate,Stage IIIB Appendix Carcinoma AJCC v7
33313,Malignant Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v7
33314,Well Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v7
33315,Malignant Cellular Infiltrate,Epithelioid sarcoma metastatic
33316,Well Differentiated Neuroendocrine Lesion,Stage IV Digestive System Neuroendocrine Tumor AJCC v7
33317,Hyaline Cartilage Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma
33318,Malignant Cellular Infiltrate,Stage I Intrahepatic Cholangiocarcinoma AJCC v7
33319,Malignant Cellular Infiltrate,Stage IVB Hilar Cholangiocarcinoma AJCC v7
33320,Malignant Cellular Infiltrate,Stage IA Distal Bile Duct Cancer AJCC v7
33321,Malignant Cellular Infiltrate,Stage IB Distal Bile Duct Cancer AJCC v7
33322,Secondary Lesion,Fibrosarcoma metastatic
33323,Malignant Cellular Infiltrate,Stage IA Eyelid Carcinoma AJCC v7
33324,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage II
33325,Malignant Cellular Infiltrate,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7
33326,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage IV
33327,Malignant Cellular Infiltrate,Recurrent Rhabdomyosarcoma
33328,Malignant Cellular Infiltrate,Synovial sarcoma metastatic
33329,Malignant Cellular Infiltrate,B-cell lymphoma stage IV
33330,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage I
33331,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma refractory
33332,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage IV
33333,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage 0
33334,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage II
33335,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma recurrent
33336,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma AJCC v7
33337,Malignant Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7
33338,Malignant Cellular Infiltrate,Testicular yolk sac tumor stage II
33339,Malignant Cellular Infiltrate,Acute Erythroblastic Leukemia
33340,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v7
33341,Malignant Cellular Infiltrate,Centroblastic lymphoma refractory
33342,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v7
33343,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage II
33344,Secondary Lesion,Metastatic Prostate Carcinoma
33345,Malignant Cellular Infiltrate,Stage 0 Uterine Corpus Cancer
33346,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage II
33347,Malignant Cellular Infiltrate,malignant neoplasm of large intestine stage IV
33348,Malignant Cellular Infiltrate,Acute myelomonocytic leukemia with abnormal eosinophils
33349,Malignant Cellular Infiltrate,Stage I Anal Canal Cancer AJCC v6 and v7
33350,Primary Lesion,Childhood Supratentorial Ependymoma
33351,Malignant Cellular Infiltrate,Lung Cancer by AJCC v6 Stage
33352,Malignant Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v6
33353,Malignant Cellular Infiltrate,Stage II Childhood Lymphoblastic Lymphoma
33354,Malignant Cellular Infiltrate,Stage IV Childhood Lymphoblastic Lymphoma
33355,Malignant Cellular Infiltrate,Malignant Testicular Germ Cell Tumor
33356,Malignant Cellular Infiltrate,Adult Glioblastoma
33357,Malignant Cellular Infiltrate,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7
33358,Malignant Cellular Infiltrate,Kaposi Sarcoma Related to Immunosuppressive Treatment
33359,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v7 Stage
33360,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v7 Stage
33361,Malignant Cellular Infiltrate,Breast Cancer by AJCC v7 Stage
33362,Malignant Cellular Infiltrate,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
33363,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer
33364,Malignant Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma
33365,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia without Maturation
33366,Malignant Cellular Infiltrate,Recurrent Carcinoma of Unknown Primary
33367,Malignant Cellular Infiltrate,Intraocular Lymphoma
33368,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma
33369,Malignant Cellular Infiltrate,Stage III Cervical Cancer AJCC v6 and v7
33370,Benign Cellular Infiltrate,Benign Adrenal Gland Composite Pheochromocytoma
33371,Benign Cellular Infiltrate,Pericardial Adenomatoid Tumor
33372,Malignant Cellular Infiltrate,Aggressive Non-Hodgkin Lymphoma
33373,Malignant Cellular Infiltrate,Invasive carcinoma of breast
33374,Malignant Cellular Infiltrate,Anaplastic Medulloblastoma
33375,Malignant Cellular Infiltrate,Aggressive Systemic Mastocytosis
33376,Malignant Cellular Infiltrate,Malignant Neoplasms
33377,Malignant Cellular Infiltrate,Adrenocortical carcinoma
33378,Malignant Cellular Infiltrate,Malignant neoplasm of duodenum
33379,Malignant Cellular Infiltrate,Malignant neoplasm of breast
33380,Malignant Cellular Infiltrate,Plasmacytoma
33381,Malignant Cellular Infiltrate,Malignant Mesothelioma of Peritoneum
33382,Malignant Cellular Infiltrate,Poorly Differentiated Fibrosarcoma
33383,Malignant Cellular Infiltrate,Epithelioid Sarcoma NCI Grade 2
33384,Malignant Cellular Infiltrate,Angiosarcoma NCI Grade 3
33385,Malignant Cellular Infiltrate,Conventional Fibrosarcoma
33386,Malignant Cellular Infiltrate,Stage I Adult Liver Cancer AJCC v7
33387,Malignant Cellular Infiltrate,Stage IIIB Adult Liver Cancer AJCC v7
33388,Malignant Cellular Infiltrate,Stage IIA1 Cervical Cancer AJCC v7
33389,Malignant Cellular Infiltrate,Stage IIA2 Cervical Cancer AJCC v7
33390,Malignant Cellular Infiltrate,Mixed Acinar-Ductal Carcinoma of the Pancreas
33391,Malignant Cellular Infiltrate,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma
33392,Low Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1
33393,Malignant Cellular Infiltrate,Esophageal Spindle Cell Carcinoma
33394,Malignant Cellular Infiltrate,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma
33395,Malignant Cellular Infiltrate,Gastric Hepatoid Adenocarcinoma
33396,Poorly Differentiated Neuroendocrine Lesion,Gastric Large Cell Neuroendocrine Carcinoma
33397,Low Grade Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1
33398,Malignant Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma
33399,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Carcinoma
33400,Malignant Cellular Infiltrate,Small Intestinal Mixed Adenoneuroendocrine Carcinoma
33401,Well Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor G2
33402,Malignant Cellular Infiltrate,Colorectal Mixed Adenoneuroendocrine Carcinoma
33403,Well Differentiated Neuroendocrine Lesion,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor
33404,Malignant Cellular Infiltrate,leiomyosarcoma of appendix
33405,Malignant Cellular Infiltrate,Colon Diffuse Large B-Cell Lymphoma
33406,Malignant Cellular Infiltrate,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma
33407,Malignant Cellular Infiltrate,undifferentiated carcinoma of anal canal
33408,Malignant Cellular Infiltrate,Metastatic Carcinoma in the Liver
33409,Malignant Cellular Infiltrate,Early Hepatocellular Carcinoma
33410,Malignant Cellular Infiltrate,Calcifying Nested Epithelial Stromal Tumor of the Liver
33411,Malignant Cellular Infiltrate,Extrarenal Rhabdoid Tumor of the Liver
33412,Malignant Cellular Infiltrate,Liver Yolk Sac Tumor
33413,Malignant Cellular Infiltrate,"Gallbladder Adenocarcinoma, Gastric Foveolar Type"
33414,Malignant Cellular Infiltrate,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type"
33415,Malignant Cellular Infiltrate,carcinosarcoma of extrahepatic bile duct
33416,Intermediate Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Tumor G2
33417,Malignant Cellular Infiltrate,Contralateral Breast Carcinoma
33418,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7
33419,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7
33420,Malignant Cellular Infiltrate,Uterine Ligament Adenosarcoma
33421,Malignant Cellular Infiltrate,Squamous cell carcinoma of pharynx
33422,Malignant Cellular Infiltrate,"Papillary Carcinoma of the Penis, Not Otherwise Specified"
33423,Malignant Cellular Infiltrate,ENSAT Stage II Adrenal Cortex Carcinoma
33424,Malignant Cellular Infiltrate,Glioblastoma by Gene Expression Profile
33425,Malignant Cellular Infiltrate,Proneural Glioblastoma
33426,Malignant Cellular Infiltrate,"Uterine Carcinosarcoma, Homologous Type"
33427,Malignant Cellular Infiltrate,Rare Childhood Malignant Neoplasm
33428,Malignant Cellular Infiltrate,Childhood Undifferentiated Pleomorphic Sarcoma
33429,Malignant Cellular Infiltrate,Childhood Brain Stem Gliosarcoma
33430,Malignant Cellular Infiltrate,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified"
33431,Malignant Cellular Infiltrate,Childhood Favorable Prognosis Hodgkin Lymphoma
33432,Malignant Cellular Infiltrate,Childhood Giant Cell Glioblastoma
33433,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7
33434,Malignant Cellular Infiltrate,Stage IIB Colon Cancer AJCC v7
33435,Malignant Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v7
33436,Malignant Cellular Infiltrate,Stage IA Esophageal Cancer AJCC v7
33437,Malignant Cellular Infiltrate,BCLC Stage C Hepatocellular Carcinoma
33438,Malignant Cellular Infiltrate,BCLC Stage A Adult Hepatocellular Carcinoma
33439,Malignant Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis
33440,Low Grade Neuroendocrine Lesion,Metastatic Digestive System Neuroendocrine Tumor G1
33441,Malignant Cellular Infiltrate,Recurrent Adult Grade III Lymphomatoid Granulomatosis
33442,Borderline Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis
33443,Malignant Cellular Infiltrate,Recurrent Childhood Pineoblastoma
33444,Malignant Cellular Infiltrate,Recurrent Extragonadal Seminoma
33445,Borderline Lesion,Recurrent Grade I Lymphomatoid Granulomatosis
33446,Malignant Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis
33447,Borderline Lesion,Recurrent Grade II Lymphomatoid Granulomatosis
33448,Malignant Cellular Infiltrate,Recurrent Pancreatic Neuroendocrine Carcinoma
33449,Malignant Cellular Infiltrate,Childhood Paranasal Sinus Carcinoma
33450,Malignant Cellular Infiltrate,Hereditary Nonpolyposis Colorectal Cancer
33451,Malignant Cellular Infiltrate,Malignant neoplasm of nipple of female breast
33452,Benign Cellular Infiltrate,"Mixed Tumor, Not Otherwise Specified"
33453,Malignant Cellular Infiltrate,ROSE Cluster 8
33454,Malignant Cellular Infiltrate,Fusion-Negative Alveolar Rhabdomyosarcoma
33455,Encapsulated Mass,Childhood Thyroid Gland Follicular Carcinoma
33456,Malignant Cellular Infiltrate,Tubulocystic renal cell carcinoma
33457,Malignant Cellular Infiltrate,Urothelial carcinoma bladder recurrent
33458,Malignant Cellular Infiltrate,Refractory Adult Acute Lymphoblastic Leukemia
33459,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Neuroendocrine Carcinoma
33460,Malignant Cellular Infiltrate,Primary Peritoneal Low Grade Serous Adenocarcinoma
33461,Malignant Cellular Infiltrate,Low Grade Broad Ligament Serous Adenocarcinoma
33462,Bone Marrow Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia recurrent
33463,Malignant Cellular Infiltrate,Rhabdomyosarcoma of cervix uteri
33464,Malignant Cellular Infiltrate,Cervical Angiosarcoma
33465,Malignant Cellular Infiltrate,Cervical Malignant Peripheral Nerve Sheath Tumor
33466,Malignant Cellular Infiltrate,Malignant Cervical Soft Tissue Neoplasm
33467,Malignant Cellular Infiltrate,Vaginal Papillary Carcinoma
33468,Malignant Cellular Infiltrate,FIGO Stage IIIB Ovarian Cancer
33469,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Sweat Gland Type
33470,Malignant Cellular Infiltrate,Lung Micropapillary Adenocarcinoma
33471,Malignant Cellular Infiltrate,Gingival Spindle Cell Carcinoma
33472,Malignant Cellular Infiltrate,"Anaplastic Astrocytoma, IDH-Wildtype"
33473,Benign Cellular Infiltrate,Central Nervous System Angiolipoma
33474,Malignant Cellular Infiltrate,Unresectable Digestive System Adenocarcinoma
33475,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA
33476,Malignant Cellular Infiltrate,histiocytic sarcoma of central nervous system
33477,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12)
33478,Malignant Cellular Infiltrate,basaloid squamous cell carcinoma of floor of mouth
33479,Malignant Cellular Infiltrate,Hormone refractory prostate cancer
33480,Primary Lesion,Parietal Lobe Ependymal Tumor
33481,Primary Lesion,Cerebellar Ependymal Tumor
33482,Primary Lesion,Frontal Lobe and Parietal Lobe Ependymal Tumor
33483,Primary Lesion,Posterior Cranial Fossa Ependymal Tumor
33484,Primary Lesion,"Temporal Lobe, Parietal Lobe, and Lateral Ventricle Ependymal Tumor"
33485,Malignant Cellular Infiltrate,Malignant Solid Neoplasm
33486,Malignant Cellular Infiltrate,Unresectable Leiomyosarcoma
33487,Malignant Cellular Infiltrate,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage
33488,Malignant Cellular Infiltrate,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8
33489,Malignant Cellular Infiltrate,Major Salivary Gland Cancer by AJCC v7 Stage
33490,Malignant Cellular Infiltrate,Major Salivary Gland Cancer by AJCC v8 Stage
33491,Malignant Cellular Infiltrate,Stage II Major Salivary Gland Cancer AJCC v8
33492,Malignant Cellular Infiltrate,Stage III Major Salivary Gland Cancer AJCC v8
33493,Malignant Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v8
33494,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v8 Stage
33495,Malignant Cellular Infiltrate,Stage IVA Nasopharyngeal Carcinoma AJCC v8
33496,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Soft Tissue
33497,Malignant Cellular Infiltrate,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
33498,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage
33499,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8
33500,Benign Cellular Infiltrate,Lung Adenofibroma
33501,Malignant Cellular Infiltrate,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
33502,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Adenocarcinoma AJCC v8
33503,Malignant Cellular Infiltrate,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8
33504,Malignant Cellular Infiltrate,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
33505,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
33506,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
33507,Malignant Cellular Infiltrate,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8
33508,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8
33509,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8
33510,Malignant Cellular Infiltrate,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8
33511,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage
33512,Malignant Cellular Infiltrate,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
33513,Malignant Cellular Infiltrate,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
33514,Malignant Cellular Infiltrate,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
33515,Malignant Cellular Infiltrate,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
33516,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
33517,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
33518,Malignant Cellular Infiltrate,Pathologic Stage IIA Gastric Cancer AJCC v8
33519,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8
33520,Malignant Cellular Infiltrate,Clinical Stage IIB Gastric Cancer AJCC v8
33521,Malignant Cellular Infiltrate,Stage IV Anal Cancer AJCC v8
33522,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v8 Stage
33523,Malignant Cellular Infiltrate,Stage IIA Appendix Carcinoma AJCC v8
33524,Malignant Cellular Infiltrate,Stage IIC Appendix Carcinoma AJCC v8
33525,Malignant Cellular Infiltrate,Stage IIB Colorectal Cancer AJCC v8
33526,Malignant Cellular Infiltrate,Stage IIB Colon Cancer AJCC v8
33527,Malignant Cellular Infiltrate,Stage IIIB Colon Cancer AJCC v8
33528,Malignant Cellular Infiltrate,Stage IVC Colon Cancer AJCC v8
33529,Malignant Cellular Infiltrate,Stage IIA Rectal Cancer AJCC v8
33530,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v8
33531,Malignant Cellular Infiltrate,Stage IA Hepatocellular Carcinoma AJCC v8
33532,Malignant Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v8
33533,Malignant Cellular Infiltrate,Stage IIIC Hilar Cholangiocarcinoma AJCC v8
33534,Malignant Cellular Infiltrate,Stage II Intrahepatic Cholangiocarcinoma AJCC v8
33535,Malignant Cellular Infiltrate,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
33536,Malignant Cellular Infiltrate,Stage II Distal Bile Duct Cancer AJCC v8
33537,Malignant Cellular Infiltrate,Stage IIIB Ampulla of Vater Cancer AJCC v8
33538,Malignant Cellular Infiltrate,Stage III Pancreatic Cancer AJCC v8
33539,Malignant Cellular Infiltrate,Non-squamous non-small cell lung cancer
33540,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor by AJCC v8 Stage
33541,Well Differentiated Neuroendocrine Lesion,Stage III Gastric Neuroendocrine Tumor AJCC v8
33542,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v8
33543,Well Differentiated Neuroendocrine Lesion,Stage II Pancreatic Neuroendocrine Tumor AJCC v8
33544,Malignant Cellular Infiltrate,Malignant Peritoneal Germ Cell Tumor
33545,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v8
33546,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v8
33547,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v8
33548,Malignant Cellular Infiltrate,Stage IIIA Lung Cancer AJCC v8
33549,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma by AJCC v7 Stage
33550,Malignant Cellular Infiltrate,Recurrent Anaplastic Astrocytoma
33551,Malignant Cellular Infiltrate,Stage IA Bone Cancer AJCC v8
33552,Malignant Cellular Infiltrate,Stage IV Bone Cancer AJCC v8
33553,Malignant Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v8 Stage
33554,Malignant Cellular Infiltrate,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
33555,Malignant Cellular Infiltrate,Invasive Mucinous Lung Adenocarcinoma
33556,Malignant Cellular Infiltrate,Lung Mucinous Adenocarcinoma In Situ
33557,Malignant Cellular Infiltrate,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
33558,Malignant Cellular Infiltrate,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8
33559,Malignant Cellular Infiltrate,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8"
33560,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Stage
33561,Malignant Cellular Infiltrate,Clinical Stage IV Merkel Cell Carcinoma AJCC v8
33562,Secondary Lesion,Intermediate Atypical Prostate Carcinoma
33563,Malignant Cellular Infiltrate,Clinical Stage 0 Cutaneous Melanoma AJCC v8
33564,Malignant Cellular Infiltrate,Recurrent Extranodal Diffuse Large B-cell Lymphoma
33565,Malignant Cellular Infiltrate,Recurrent Testicular Lymphoma
33566,Malignant Cellular Infiltrate,Recurrent Breast Lymphoma
33567,Malignant Cellular Infiltrate,Refractory Breast Lymphoma
33568,Malignant Cellular Infiltrate,Recurrent Intravascular Large B-Cell Lymphoma
33569,Malignant Cellular Infiltrate,Refractory Intravascular Large B-Cell Lymphoma
33570,Malignant Cellular Infiltrate,Primary cutaneous acral CD8 positive T-cell lymphoma
33571,Malignant Cellular Infiltrate,Advanced Head and Neck Squamous Cell Carcinoma
33572,Malignant Cellular Infiltrate,Anatomic Stage IA Breast Cancer AJCC v8
33573,Malignant Cellular Infiltrate,Anatomic Stage IIA Breast Cancer AJCC v8
33574,Malignant Cellular Infiltrate,Prognostic Stage IA Breast Cancer AJCC v8
33575,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v8 Stage
33576,Malignant Cellular Infiltrate,Stage IB Vulvar Cancer AJCC v8
33577,Malignant Cellular Infiltrate,Stage IVA Vaginal Cancer AJCC v8
33578,Malignant Cellular Infiltrate,Stage IB2 Cervical Cancer AJCC v8
33579,Malignant Cellular Infiltrate,Uterine Corpus Cancer by AJCC v8 Stage
33580,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Cancer AJCC v8
33581,Malignant Cellular Infiltrate,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage
33582,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
33583,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
33584,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
33585,Malignant Cellular Infiltrate,Stage I Ovarian Cancer AJCC v8
33586,Malignant Cellular Infiltrate,Stage IB Ovarian Cancer AJCC v8
33587,Malignant Cellular Infiltrate,Stage IC Ovarian Cancer AJCC v8
33588,Malignant Cellular Infiltrate,Stage III Ovarian Cancer AJCC v8
33589,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v8
33590,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v8 Stage
33591,Malignant Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v8
33592,Malignant Cellular Infiltrate,Stage IVB Fallopian Tube Cancer AJCC v8
33593,Malignant Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v8
33594,Malignant Cellular Infiltrate,Penile Cancer by AJCC v8 Stage
33595,Malignant Cellular Infiltrate,Stage 0a Penile Cancer AJCC v8
33596,Malignant Cellular Infiltrate,Stage IIA Penile Cancer AJCC v8
33597,Malignant Cellular Infiltrate,Stage II Prostate Cancer AJCC v8
33598,Malignant Cellular Infiltrate,Stage IIC Prostate Cancer AJCC v8
33599,Malignant Cellular Infiltrate,Stage IIIB Prostate Cancer AJCC v8
33600,Malignant Cellular Infiltrate,Stage IIIC Prostate Cancer AJCC v8
33601,Malignant Cellular Infiltrate,Stage IV Prostate Cancer AJCC v8
33602,Malignant Cellular Infiltrate,Stage IIB Testicular Cancer AJCC v8
33603,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
33604,Malignant Cellular Infiltrate,Stage IV Renal Pelvis and Ureter Cancer AJCC v8
33605,Malignant Cellular Infiltrate,Stage IIIA Bladder Cancer AJCC v8
33606,Malignant Cellular Infiltrate,Stage IIA Eyelid Carcinoma AJCC v8
33607,Malignant Cellular Infiltrate,Stage I Choroidal and Ciliary Body Melanoma AJCC v8
33608,Malignant Cellular Infiltrate,Stage II Choroidal and Ciliary Body Melanoma AJCC v8
33609,Malignant Cellular Infiltrate,Stage III Choroidal and Ciliary Body Melanoma AJCC v8
33610,Malignant Cellular Infiltrate,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8
33611,Malignant Cellular Infiltrate,Pathologic Stage III Retinoblastoma AJCC v8
33612,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8
33613,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8
33614,Malignant Cellular Infiltrate,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
33615,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8
33616,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8
33617,Malignant Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage
33618,Malignant Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v8
33619,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
33620,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
33621,Malignant Cellular Infiltrate,Adrenal Cortex Carcinoma by AJCC v7 Stage
33622,Malignant Cellular Infiltrate,Stage I Adrenal Cortex Carcinoma AJCC v8
33623,Malignant Cellular Infiltrate,Mycosis Fungoides by AJCC v7 Stage
33624,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Lymphoma AJCC v8
33625,Malignant Cellular Infiltrate,Lugano Classification Stage I Adult Lymphoma AJCC v8
33626,Malignant Cellular Infiltrate,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage
33627,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8
33628,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8
33629,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8
33630,Malignant Cellular Infiltrate,Childhood Lymphoma by AJCC v8 Stage
33631,Malignant Cellular Infiltrate,Lymphoma by AJCC v8 Stage
33632,Malignant Cellular Infiltrate,Stage B Chronic Lymphocytic Leukemia
33633,Malignant Cellular Infiltrate,Stage C Chronic Lymphocytic Leukemia
33634,Malignant Cellular Infiltrate,St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8
33635,Malignant Cellular Infiltrate,Follicular Lymphoma by Ann Arbor Stage
33636,Malignant Cellular Infiltrate,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage
33637,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage
33638,Malignant Cellular Infiltrate,Thoracic NUT Carcinoma
33639,Malignant Cellular Infiltrate,Refractory Pancreatic Carcinoma
33640,Malignant Cellular Infiltrate,Refractory Peripheral Primitive Neuroectodermal Tumor
33641,Malignant Cellular Infiltrate,Recurrent Anaplastic Oligodendroglioma
33642,Malignant Cellular Infiltrate,Refractory Primary Cutaneous Lymphoma
33643,Malignant Cellular Infiltrate,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma
33644,Malignant Cellular Infiltrate,Stage III Malignant Mediastinal Germ Cell Tumor
33645,Malignant Cellular Infiltrate,Metastatic Epithelioid Hemangioendothelioma
33646,Benign Cellular Infiltrate,hemangioma of mediastinum
33647,Malignant Cellular Infiltrate,Recurrent EBV-Related Lymphoma
33648,Malignant Cellular Infiltrate,Refractory Malignant Thymoma
33649,Malignant Cellular Infiltrate,Myxoid liposarcoma metastatic
33650,Malignant Cellular Infiltrate,Refractory Sarcoma
33651,Malignant Cellular Infiltrate,Refractory Laryngeal Squamous Cell Carcinoma
33652,Malignant Cellular Infiltrate,Recurrent Paranasal Sinus Squamous Cell Carcinoma
33653,Malignant Cellular Infiltrate,Refractory Leukemia
33654,Malignant Cellular Infiltrate,Refractory Chronic Leukemia
33655,Malignant Cellular Infiltrate,Refractory Ovarian Carcinoma
33656,Malignant Cellular Infiltrate,Recurrent Endometrial Endometrioid Adenocarcinoma
33657,Malignant Cellular Infiltrate,Metastatic Oral Cavity Squamous Cell Carcinoma
33658,Malignant Cellular Infiltrate,High-Risk Neuroblastoma
33659,Malignant Cellular Infiltrate,Refractory Urothelial Carcinoma
33660,Malignant Cellular Infiltrate,Recurrent Malignant Male Reproductive System Neoplasm
33661,Malignant Cellular Infiltrate,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
33662,Malignant Cellular Infiltrate,Unresectable Adrenal Cortex Carcinoma
33663,Malignant Cellular Infiltrate,Refractory Lung Small Cell Carcinoma
33664,Malignant Cellular Infiltrate,Refractory Liposarcoma
33665,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Viscera
33666,Malignant Cellular Infiltrate,Unresectable Dedifferentiated Liposarcoma
33667,Malignant Cellular Infiltrate,Resectable Sarcoma
33668,Malignant Cellular Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma
33669,Malignant Cellular Infiltrate,Locally Advanced Gastrointestinal Stromal Tumor
33670,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline DDX41 Mutation
33671,Malignant Cellular Infiltrate,Refractory Digestive System Carcinoma
33672,Malignant Cellular Infiltrate,Recurrent Burkitt Leukemia
33673,Malignant Cellular Infiltrate,Unresectable Rhabdomyosarcoma
33674,Malignant Cellular Infiltrate,Unresectable Synovial Sarcoma
33675,Malignant Cellular Infiltrate,Unresectable Pancreatic Neuroendocrine Carcinoma
33676,Malignant Cellular Infiltrate,Advanced Melanoma
33677,Malignant Cellular Infiltrate,Locally Advanced Skin Squamous Cell Carcinoma
33678,Malignant Cellular Infiltrate,Metastatic Lung Carcinoma
33679,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in Lymph Node
33680,Malignant Cellular Infiltrate,Metastatic Breast Carcinoma
33681,Malignant Cellular Infiltrate,Locally Advanced Unresectable Malignant Neoplasm
33682,Malignant Cellular Infiltrate,Locally Advanced Unresectable Sarcoma
33683,Malignant Cellular Infiltrate,Recurrent Acinic Cell Breast Carcinoma
33684,Malignant Cellular Infiltrate,Recurrent Clear Cell Renal Cell Carcinoma
33685,Malignant Cellular Infiltrate,Recurrent Minor Salivary Gland Adenocarcinoma
33686,Malignant Cellular Infiltrate,Recurrent Parotid Gland Undifferentiated Carcinoma
33687,Epithelial Component Present,Sparsely Granulated Non-Functioning Corticotroph Adenoma
33688,Malignant Cellular Infiltrate,Melanoma of Unknown Primary
33689,Malignant Cellular Infiltrate,MiT Family Translocation-Associated Renal Cell Carcinoma
33690,Epithelial Component Present,Monomorphous Plurihormonal Pituitary Gland Adenoma
33691,Malignant Cellular Infiltrate,Unresectable Renal Cell Carcinoma
33692,Epithelial Component Present,Unresectable Renal Cell Carcinoma
33693,Poorly Differentiated Neuroendocrine Lesion,Digestive System Large Cell Neuroendocrine Carcinoma
33694,Secondary Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm
33695,Malignant Cellular Infiltrate,Adenocarcinoma gastric recurrent
33696,Immunologic Deficiency Syndromes,Transplant-Related Squamous Cell Carcinoma
33697,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Squamous Cell Carcinoma
33698,Malignant Cellular Infiltrate,Advanced Cutaneous Melanoma of the Extremity
33699,Secondary Lesion,Advanced Cutaneous Melanoma of the Extremity
33700,Extensive Stage Lesion,Advanced Sarcoma of the Extremity
33701,Metastatic Lesion,Advanced Sarcoma of the Extremity
33702,Malignant Cellular Infiltrate,Pancreatic adenocarcinoma recurrent
33703,Regional Disease,Locally Advanced Unresectable Pancreatic Adenocarcinoma
33704,Neuronal Differentiation,Pituitary Gland Mixed Gangliocytoma-Adenoma
33705,Malignant Cellular Infiltrate,Sellar Neuroblastoma
33706,Increased Cellularity Present,Sellar Neuroblastoma
33707,Benign Cellular Infiltrate,Sellar Schwannoma
33708,Myxoid Stroma Formation,Sellar Chordoma
33709,Myxoid Stroma Formation,Sellar Chondroid Chordoma
33710,Cartilage-Like Elements Present,Sellar Chondroid Chordoma
33711,Mitotic Activity,Sellar Yolk Sac Tumor
33712,High Mitotic Activity,Sellar Embryonal Carcinoma
33713,Malignant Cellular Infiltrate,Sellar Teratoma with Malignant Transformation
33714,Malignant Cellular Infiltrate,Sellar Mixed Germ Cell Tumor
33715,Biphasic Pattern,Recurrent Uterine Corpus Carcinosarcoma
33716,Carcinomatous Component Present,Recurrent Uterine Corpus Carcinosarcoma
33717,Malignant Cellular Infiltrate,Recurrent Endometrial Mixed Cell Adenocarcinoma
33718,Malignant Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm
33719,Epithelial Component Present,"Neuroendocrine carcinoma, metastatic"
33720,Metastatic Lesion,Advanced Neuroendocrine Carcinoma
33721,Malignant Cellular Infiltrate,Locally Advanced Unresectable Gastric Adenocarcinoma
33722,Metastatic Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma
33723,Deep Lesion,Recurrent Desmoid-Type Fibromatosis
33724,Deep Lesion,Unresectable Desmoid-Type Fibromatosis
33725,Unresectable Mass,Unresectable Lung Carcinoma
33726,Carcinomatous Component Present,Unresectable Digestive System Carcinoma
33727,Metastatic Lesion,Metastatic Lung Adenocarcinoma
33728,Bone Marrow Involvement,Smoldering Waldenstrom Macroglobulinemia
33729,Poorly Differentiated Neuroendocrine Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma
33730,Epithelial Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma
33731,High Mitotic Activity,Locally Advanced Digestive System Neuroendocrine Carcinoma
33732,Neuroendocrine Differentiation,Locally Advanced Digestive System Neuroendocrine Carcinoma
33733,Recurrent disease,Recurrent Digestive System Neuroendocrine Carcinoma
33734,Slow Growing Mass,Spinal hemangioblastoma
33735,Well-Circumscribed Lesion,Medullary Hemangioblastoma
33736,Slow Growing Mass,Medullary Hemangioblastoma
33737,Epithelial Component Present,Broad Ligament Papillary Cystadenoma
33738,Benign Cellular Infiltrate,Thyroid Gland Black Follicular Adenoma
33739,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Black Follicular Adenoma
33740,Cafe-au-Lait Spots,Recurrent Neurofibromatosis Type 1
33741,Refractory Disease,Refractory Neurofibromatosis Type 1
33742,Cafe-au-Lait Spots,Refractory Neurofibromatosis Type 1
33743,Malignant Cellular Infiltrate,Encapsulated Variant Thyroid Gland Papillary Carcinoma
33744,Thyroglobulin Positive Neoplastic Cells Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma
33745,Biphasic Pattern,Third Ventricle Pilocytic Astrocytoma
33746,Low Cellularity Present,Third Ventricle Pilocytic Astrocytoma
33747,Malignant Cellular Infiltrate,Fourth Ventricle Medulloblastoma
33748,Follicular Cell Differentiation,Spindle Cell Variant Thyroid Gland Papillary Carcinoma
33749,Nuclear Pseudoinclusion,Hobnail Variant Thyroid Gland Papillary Carcinoma
33750,Carcinomatous Component Present,Metastatic Fallopian Tube Carcinoma
33751,Malignant Cellular Infiltrate,Metastatic Vulvar Carcinoma
33752,Adulthood Lesion,Stage IV adult soft tissue sarcoma
33753,Secondary Lesion,Metastatic Esophageal Carcinoma
33754,Malignant Cellular Infiltrate,Stage IV Esophageal Adenocarcinoma
33755,Epithelial Component Present,Stage IV Esophageal Adenocarcinoma
33756,Carcinomatous Component Present,Stage IV Esophageal Adenocarcinoma
33757,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma
33758,Secondary Lesion,Stage IV Nasopharyngeal Carcinoma
33759,Malignant Cellular Infiltrate,Metastatic Pharyngeal Carcinoma
33760,Malignant Cellular Infiltrate,Stage IV Laryngeal Carcinoma
33761,Epithelial Component Present,Metastatic Oral Cavity Carcinoma
33762,Malignant Cellular Infiltrate,Metastatic Lip Carcinoma
33763,Carcinomatous Component Present,Metastatic Lip Carcinoma
33764,Malignant Cellular Infiltrate,Metastatic Oral Cavity Adenoid Cystic Carcinoma
33765,Fibrotic Stroma Formation,Metastatic Oral Cavity Mucoepidermoid Carcinoma
33766,Metastatic Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma
33767,Malignant Cellular Infiltrate,Metastatic Lip Squamous Cell Carcinoma
33768,Secondary Lesion,Lung squamous cell carcinoma stage IV
33769,Carcinomatous Component Present,Metastatic Lung Adenosquamous Carcinoma
33770,Secondary Lesion,Metastatic Lung Non-Small Cell Carcinoma
33771,Necrotic changes (finding),Metastatic Lung Small Cell Carcinoma
33772,Peripheral Nuclear Palisading,Metastatic Lung Small Cell Carcinoma
33773,Nuclear Molding,Metastatic Lung Small Cell Carcinoma
33774,Epithelial Component Present,Metastatic Rectal Carcinoma
33775,Secondary Lesion,Metastatic Thyroid Gland Follicular Carcinoma
33776,CD56-Positive Neoplastic Cells Present,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
33777,Anaplasia,Frontal Lobe Anaplastic Oligodendroglioma
33778,Encapsulated Mass,"Thyroid Gland Follicular Carcinoma, Widely Invasive"
33779,Carcinomatous Component Present,Localized Gastric Carcinoma
33780,Refractory Disease,Refractory Aggressive Non-Hodgkin Lymphoma
33781,Epithelial Component Present,Thyroid Gland Mucinous Carcinoma
33782,Regional Disease,Locally Advanced Pancreatic Adenocarcinoma
33783,Tissue Differentiation Uncertain,Bladder Alveolar Soft Part Sarcoma
33784,Myxoid Stroma Formation,Cellular neurothekeoma
33785,Malignant Cellular Infiltrate,Parotid Gland Liposarcoma
33786,Malignant Cellular Infiltrate,Advanced Prostate Adenocarcinoma
33787,Regional Disease,Locally Advanced Prostate Adenocarcinoma
33788,Regional Disease,Locally Advanced Cervical Adenocarcinoma
33789,Malignant Cellular Infiltrate,Advanced Cervical Adenocarcinoma
33790,Pseudoencapsulated Mass,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor
33791,Benign Cellular Infiltrate,Thyroid Gland Lymphangioma
33792,Malignant Cellular Infiltrate,Thyroid Gland Leiomyosarcoma
33793,Thin-Walled Branching Vascular Pattern,Thyroid Gland Solitary Fibrous Tumor
33794,CD1a-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis
33795,"Fully Differentiated ""Adult-Type"" Tissues Present",Grade 1 Teratoma
33796,Carcinomatous Component Present,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma
33797,Vascular Channel Formation,"Kaposi's sarcoma, metastatic"
33798,Metastatic Lesion,Advanced Carcinoid Tumor
33799,Neuroendocrine Differentiation,Advanced Pancreatic Neuroendocrine Tumor
33800,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Neoplasm
33801,Poorly Differentiated Neuroendocrine Lesion,Metastatic Gastric Neuroendocrine Carcinoma
33802,Epithelial Component Present,Metastatic Gastric Neuroendocrine Carcinoma
33803,Necrotic changes (finding),Advanced Gastric Large Cell Neuroendocrine Carcinoma
33804,Metastatic Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma
33805,Carcinomatous Component Present,Advanced Gastric Large Cell Neuroendocrine Carcinoma
33806,Necrotic changes (finding),Advanced Gastric Small Cell Neuroendocrine Carcinoma
33807,Secondary Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma
33808,Neuroendocrine Differentiation,Advanced Gastric Small Cell Neuroendocrine Carcinoma
33809,Carcinomatous Component Present,Metastatic Small Intestinal Neuroendocrine Carcinoma
33810,Secondary Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma
33811,Epithelial Component Present,Advanced Small Intestinal Neuroendocrine Carcinoma
33812,Extensive Stage Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
33813,Neuroendocrine Differentiation,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma
33814,Extensive Stage Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma
33815,Recurrent disease,Recurrent Acute Myeloid Leukemia Not Otherwise Specified
33816,Recurrent disease,Recurrent Acute Erythroid Leukemia
33817,Malignant Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia
33818,Secondary Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma
33819,Epithelial Component Present,Advanced Digestive System Carcinoma
33820,Malignant Cellular Infiltrate,Metastatic basal cell carcinoma
33821,Metastatic Lesion,Locally Advanced Basal Cell Carcinoma
33822,Carcinomatous Component Present,Biochemically Recurrent Prostate Carcinoma
33823,Malignant Cellular Infiltrate,Biliary Tract Carcinoma
33824,Carcinomatous Component Present,Recurrent Biliary Tract Carcinoma
33825,Secondary Lesion,Metastatic Unresectable Basal Cell Carcinoma
33826,Malignant Cellular Infiltrate,Pancreatic adenocarcinoma resectable
33827,Malignant Cellular Infiltrate,Resectable Digestive System Carcinoma
33828,Resectable Mass,Resectable Digestive System Carcinoma
33829,Malignant Cellular Infiltrate,Bile duct adenocarcinoma resectable
33830,Epithelial Component Present,Hormone Receptor Positive Breast Carcinoma
33831,Malignant Cellular Infiltrate,Mucinous Adenocarcinoma
33832,Malignant Cellular Infiltrate,Undifferentiated (Embryonal) Sarcoma
33833,Malignant Cellular Infiltrate,Early gastric cancer
33834,Well Differentiated Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1
33835,Malignant Cellular Infiltrate,Papillary Eccrine Carcinoma
33836,Malignant Cellular Infiltrate,Cholangiocarcinoma non-resectable
33837,Malignant Cellular Infiltrate,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
33838,Malignant Cellular Infiltrate,Childhood Mesenchymal Chondrosarcoma
33839,Malignant Cellular Infiltrate,Pleural Carcinomatosis
33840,Malignant Cellular Infiltrate,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type"
33841,Malignant Cellular Infiltrate,Adult Central Nervous System Mixed Germ Cell Tumor
33842,Malignant Cellular Infiltrate,Childhood Central Nervous System Germinoma
33843,Malignant Cellular Infiltrate,mantle cell lymphoma of small intestine
33844,Well Differentiated Neuroendocrine Lesion,Small Intestinal VIP-Producing Neuroendocrine Tumor
33845,Well Differentiated Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor
33846,Malignant Cellular Infiltrate,Peripheral primitive neuroectodermal tumor of soft tissue
33847,Malignant Cellular Infiltrate,Inflammatory Leiomyosarcoma
33848,Glomeruloid Vessels Present,Glomeruloid hemangioma
33849,Malignant Cellular Infiltrate,Malignant vascular tumor of skin
33850,Malignant Cellular Infiltrate,EBV-Related Non-Hodgkin Lymphoma
33851,Borderline Lesion,Atypical follicular adenoma
33852,Malignant Cellular Infiltrate,"Leukemia, Myelocytic, Acute"
33853,Malignant Cellular Infiltrate,Helicobacter Pylori-Related Gastric Adenocarcinoma
33854,Benign Cellular Infiltrate,Giant Hemangioma
33855,Malignant Cellular Infiltrate,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable"
33856,Malignant Cellular Infiltrate,Myxoid/Round Cell Liposarcoma
33857,Secondary Lesion,Metastatic Penile Cancer
33858,Malignant Cellular Infiltrate,Metastatic Ureter Carcinoma
33859,Malignant Cellular Infiltrate,Grade 3 Invasive Breast Carcinoma
33860,Malignant Cellular Infiltrate,Villoglandular Endometrial Endometrioid Adenocarcinoma
33861,Malignant Cellular Infiltrate,Recurrent Peripheral Primitive Neuroectodermal Tumor
33862,Malignant Cellular Infiltrate,Thymic Papillary Adenocarcinoma
33863,Malignant Cellular Infiltrate,Bronchioloalveolar Adenocarcinoma
33864,Malignant Cellular Infiltrate,Choriocarcinoma
33865,Benign Cellular Infiltrate,Hemangioma
33866,Malignant Cellular Infiltrate,"Myeloid Leukemia, Chronic"
33867,Malignant Cellular Infiltrate,Mycosis Fungoides
33868,Malignant Cellular Infiltrate,Acute Myeloid Leukemia (AML-M2)
33869,Benign Cellular Infiltrate,Neurilemmoma
33870,Benign Cellular Infiltrate,Infantile digital fibromatosis
33871,Malignant Cellular Infiltrate,Immunoblastic Large-Cell Lymphoma
33872,Malignant Cellular Infiltrate,Chronic leukemia (category)
33873,Malignant Cellular Infiltrate,Cecum Carcinoma
33874,Malignant Cellular Infiltrate,Cutaneous Melanoma
33875,Malignant Cellular Infiltrate,Malignant tumor of base of tongue
33876,Malignant Cellular Infiltrate,Malignant neoplasm of soft palate
33877,Malignant Cellular Infiltrate,Malignant tumor of pyriform fossa
33878,Malignant Cellular Infiltrate,Malignant neoplasm of middle third of esophagus
33879,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma
33880,Malignant Cellular Infiltrate,Malignant neoplasm of sphenoidal sinus
33881,Malignant Cellular Infiltrate,Malignant Uterine Corpus Neoplasm
33882,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
33883,Malignant Cellular Infiltrate,Malignant tumor of orbit
33884,Malignant Cellular Infiltrate,Malignant tumor of lacrimal gland
33885,Malignant Cellular Infiltrate,Malignant neoplasm of cornea
33886,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm of Salivary Gland
33887,Malignant Cellular Infiltrate,Follicular mycosis fungoides
33888,Malignant Cellular Infiltrate,Lymphoma of eye
33889,Malignant Cellular Infiltrate,Posterior Pharyngeal Wall Carcinoma
33890,Malignant Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v7
33891,Malignant Cellular Infiltrate,Salivary Gland Myoepithelial Carcinoma
33892,Malignant Cellular Infiltrate,Malignant neoplasm of pineal gland
33893,Malignant Cellular Infiltrate,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites"
33894,Malignant Cellular Infiltrate,Immature Granulocytic Sarcoma
33895,Malignant Cellular Infiltrate,Columnar Cell Variant Thyroid Gland Papillary Carcinoma
33896,Malignant Cellular Infiltrate,Stage III Hodgkin Lymphoma
33897,Malignant Cellular Infiltrate,Grade 3 Clear Cell Renal Cell Carcinoma
33898,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with a Variant RARA Translocation
33899,Malignant Cellular Infiltrate,Invasive papillary breast carcinoma
33900,"Fully Differentiated ""Adult-Type"" Tissues Present",Testicular Dermoid Cyst
33901,Malignant Cellular Infiltrate,Early Invasive Cervical Adenocarcinoma
33902,Malignant Cellular Infiltrate,Carcinosarcoma of cervix uteri
33903,Malignant Cellular Infiltrate,Hereditary Male Breast Carcinoma
33904,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation
33905,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Lung
33906,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Brain
33907,Malignant Cellular Infiltrate,Colon Carcinoma Metastatic in the Liver
33908,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
33909,Malignant Cellular Infiltrate,Carcinoma in situ of trachea
33910,Malignant Cellular Infiltrate,"Carcinoma, Cribriform"
33911,Malignant Cellular Infiltrate,"Carcinoid, Goblet Cell"
33912,Malignant Cellular Infiltrate,"Leiomyosarcoma, Epithelioid"
33913,Malignant Cellular Infiltrate,"Leiomyosarcoma, Myxoid"
33914,Malignant Cellular Infiltrate,"Liposarcoma, Dedifferentiated"
33915,Malignant Cellular Infiltrate,Ki-1+ Anaplastic Large Cell Lymphoma
33916,Carcinomatous Component Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB
33917,Benign Cellular Infiltrate,Myofibromatosis
33918,Benign Cellular Infiltrate,Angiomyoma
33919,Benign Cellular Infiltrate,Leiomyomatosis
33920,Benign Cellular Infiltrate,Plexiform Neurofibroma
33921,Malignant Cellular Infiltrate,Skin Sarcomatoid Basal Cell Carcinoma
33922,Malignant Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma of Mucosa Site
33923,Malignant Cellular Infiltrate,Carcinoma of extrahepatic bile duct
33924,Malignant Cellular Infiltrate,Nasopharyngeal carcinoma
33925,Malignant Cellular Infiltrate,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta
33926,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype"
33927,Malignant Cellular Infiltrate,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
33928,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
33929,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
33930,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
33931,Malignant Cellular Infiltrate,Bladder Mixed Adenocarcinoma
33932,Malignant Cellular Infiltrate,Bladder Diffuse Clear Cell Adenocarcinoma
33933,Malignant Cellular Infiltrate,Adenocarcinoma of Skene Gland Origin
33934,Malignant Cellular Infiltrate,Penile Urethral Malignant Neoplasm
33935,Malignant Cellular Infiltrate,Prostatic Urethral Malignant Neoplasm
33936,Malignant Cellular Infiltrate,Primary Prostate Urothelial Carcinoma
33937,Malignant Cellular Infiltrate,Secondary Prostate Urothelial Carcinoma
33938,Malignant Cellular Infiltrate,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation
33939,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Hepatoid Pattern"
33940,Malignant Cellular Infiltrate,basal cell carcinoma of penis
33941,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern"
33942,Malignant Cellular Infiltrate,Esophageal carcinoma recurrent
33943,Malignant Cellular Infiltrate,Malignant Ovarian Serous Tumor
33944,Malignant Cellular Infiltrate,mucinous adenocarcinofibroma of ovary
33945,Malignant Cellular Infiltrate,Recurrent Cancer of Gallbladder
33946,Malignant Cellular Infiltrate,squamous cell carcinoma of ovary
33947,Malignant Cellular Infiltrate,Grade 2 Endometrial Endometrioid Adenocarcinoma
33948,Malignant Cellular Infiltrate,Grade 2 Endometrial Mucinous Adenocarcinoma
33949,Malignant Cellular Infiltrate,Serous Endometrial Intraepithelial Carcinoma
33950,Malignant Cellular Infiltrate,Cervical Basaloid Carcinoma
33951,Malignant Cellular Infiltrate,Uterine Corpus Low Grade Endometrial Stromal Sarcoma
33952,Malignant Cellular Infiltrate,Undifferentiated Endocervical Sarcoma
33953,Malignant Cellular Infiltrate,Squamous cell carcinoma of esophagus
33954,Malignant Cellular Infiltrate,Vaginal Non-Keratinizing Squamous Cell Carcinoma
33955,Malignant Cellular Infiltrate,Vaginal Adenosquamous Carcinoma
33956,Malignant Cellular Infiltrate,Vaginal Small Cell Carcinoma
33957,Malignant Cellular Infiltrate,Vaginal Carcinosarcoma
33958,Malignant Cellular Infiltrate,Bartholin Gland Small Cell Carcinoma
33959,Malignant Cellular Infiltrate,leiomyosarcoma of vulva
33960,Malignant Cellular Infiltrate,Breast Mucinous Cystadenocarcinoma
33961,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant"
33962,Malignant Cellular Infiltrate,Low Grade Adenosquamous Breast Carcinoma
33963,Malignant Cellular Infiltrate,Oncocytic Breast Carcinoma
33964,Malignant Cellular Infiltrate,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
33965,Malignant Cellular Infiltrate,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema
33966,Benign Cellular Infiltrate,Breast Angiomatosis
33967,Malignant Cellular Infiltrate,Squamous cell carcinoma of floor of mouth
33968,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx
33969,Malignant Cellular Infiltrate,Ovarian Wilms Tumor
33970,Malignant Cellular Infiltrate,Mesonephroma
33971,Malignant Cellular Infiltrate,polyembryoma of testis
33972,Malignant Cellular Infiltrate,"Adenocarcinoma, metastatic"
33973,Malignant Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
33974,Malignant Cellular Infiltrate,Solid carcinoma
33975,Malignant Cellular Infiltrate,Adenocarcinoma in villous adenoma
33976,Malignant Cellular Infiltrate,Adenocarcinoma in situ in tubulovillous adenoma
33977,Malignant Cellular Infiltrate,Adenocarcinoma in tubulovillous adenoma
33978,Malignant Cellular Infiltrate,Serous surface papillary carcinoma
33979,Malignant Cellular Infiltrate,Thyroid Gland Medullary Carcinoma with Amyloid Stroma
33980,Malignant Cellular Infiltrate,Adenocarcinoma with squamous metaplasia
33981,Malignant Cellular Infiltrate,"Ganglioneuroblastoma, Intermixed"
33982,Benign Cellular Infiltrate,Mature Ganglioneuroma
33983,Malignant Cellular Infiltrate,"Extra-adrenal paraganglioma, malignant"
33984,Benign Cellular Infiltrate,Junctional nevus
33985,Malignant Cellular Infiltrate,Melanoma Arising in Giant Congenital Nevus
33986,Malignant Cellular Infiltrate,"Spindle cell melanoma, type A"
33987,Benign Cellular Infiltrate,Fibrolipoma
33988,Benign Cellular Infiltrate,Bizarre leiomyoma
33989,Malignant Cellular Infiltrate,Low Grade Endometrial Stromal Sarcoma
33990,Malignant Cellular Infiltrate,"Mesothelioma, biphasic, malignant"
33991,"Undifferentiated ""Fetal-Type"" Tissues Present",Grade 3 Teratoma
33992,Malignant Cellular Infiltrate,Grade 3 Teratoma
33993,Malignant Cellular Infiltrate,Myxoid chondrosarcoma
33994,Benign Cellular Infiltrate,Pacinian tumor
33995,Malignant Cellular Infiltrate,Trichilemmocarcinoma
33996,Benign Cellular Infiltrate,Fibrofolliculoma
33997,Malignant Cellular Infiltrate,Meningeal sarcomatosis
33998,Malignant Cellular Infiltrate,Malignant lymphomatous polyposis
33999,Malignant Cellular Infiltrate,small cell carcinoma of appendix
34000,Malignant Cellular Infiltrate,clear cell adenocarcinoma of gallbladder
34001,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma
34002,Malignant Cellular Infiltrate,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7
34003,Malignant Cellular Infiltrate,Large cell carcinoma of lung
34004,Malignant Cellular Infiltrate,Giant cell carcinoma of lung
34005,Malignant Cellular Infiltrate,Epithelioid hemangioendothelioma of lung
34006,Malignant Cellular Infiltrate,Malignant mesothelioma
34007,Benign Cellular Infiltrate,Cockade nevus
34008,Malignant Cellular Infiltrate,Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
34009,Malignant Cellular Infiltrate,Choriocarcinoma of ovary
34010,Malignant Cellular Infiltrate,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
34011,Malignant Cellular Infiltrate,"Diffuse large B-cell lymphoma, unclassifiable, NOS"
34012,Malignant Cellular Infiltrate,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma
34013,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid cyst of orbit
34014,Malignant Cellular Infiltrate,Malignant tumor of iris
34015,Malignant Cellular Infiltrate,carcinosarcoma of lung
34016,Malignant Cellular Infiltrate,Primary Pulmonary Diffuse Large B-Cell Lymphoma
34017,Malignant Cellular Infiltrate,Malignant Lung and Pleural Neoplasm
34018,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type II
34019,Malignant Cellular Infiltrate,Pleural mesothelioma malignant localised
34020,Malignant Cellular Infiltrate,Intestinal Cancer
34021,Malignant Cellular Infiltrate,Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy
34022,Malignant Cellular Infiltrate,Cardiac Malignant Fibrous Histiocytoma
34023,Malignant Cellular Infiltrate,Kaposi's sarcoma of cornea
34024,Well Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor
34025,Well Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2
34026,Intermediate Grade Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2
34027,Malignant Cellular Infiltrate,Carcinoma in situ of cecum
34028,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v7
34029,Malignant Cellular Infiltrate,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma
34030,Malignant Cellular Infiltrate,Familial medullary thyroid carcinoma
34031,Benign Cellular Infiltrate,Benign neoplasm of male breast
34032,Malignant Cellular Infiltrate,Malignant Central Nervous System Neoplasm
34033,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of intestine
34034,Malignant Cellular Infiltrate,Malignant melanoma of rectum
34035,Malignant Cellular Infiltrate,Squamous cell carcinoma of palate
34036,Malignant Cellular Infiltrate,Anaplastic ganglioglioma
34037,Malignant Cellular Infiltrate,Breast Carcinoma with Osseous Metaplasia
34038,Malignant Cellular Infiltrate,Lymphoma of colon
34039,Malignant Cellular Infiltrate,Ewings sarcoma
34040,Malignant Cellular Infiltrate,Tongue Carcinoma
34041,Malignant Cellular Infiltrate,Adrenal neuroblastoma
34042,Benign Cellular Infiltrate,Benign pheochromocytoma of adrenal gland
34043,Malignant Cellular Infiltrate,Retroperitoneal sarcoma
34044,Malignant Cellular Infiltrate,Primary Bone Osteosarcoma
34045,Malignant Cellular Infiltrate,Invasive Prostate Carcinoma
34046,Malignant Cellular Infiltrate,M5b Acute differentiated monocytic leukemia
34047,Benign Cellular Infiltrate,Benign bone neoplasm
34048,Benign Cellular Infiltrate,Subcutaneous Nodular Fasciitis
34049,Benign Cellular Infiltrate,Myofibroblastoma
34050,Benign Cellular Infiltrate,Angiomyofibroblastoma
34051,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant"
34052,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Cellular Variant"
34053,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant"
34054,Malignant Cellular Infiltrate,Stomach Carcinoma
34055,Malignant Cellular Infiltrate,Carcinoma of glottis
34056,Malignant Cellular Infiltrate,Recurrent Hodgkin Lymphoma
34057,Malignant Cellular Infiltrate,Supraglottic Squamous Cell Carcinoma
34058,Malignant Cellular Infiltrate,Malignant neoplasm of thymus
34059,Malignant Cellular Infiltrate,Treatment related secondary malignancy
34060,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma recurrent
34061,Malignant Cellular Infiltrate,Recurrent Burkitt Lymphoma
34062,Malignant Cellular Infiltrate,Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma
34063,Malignant Cellular Infiltrate,Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma
34064,Malignant Cellular Infiltrate,Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma
34065,Malignant Cellular Infiltrate,Invasive Cribriform Breast Carcinoma
34066,Malignant Cellular Infiltrate,Infratentorial Glioblastoma
34067,Malignant Cellular Infiltrate,Cerebellar Glioblastoma
34068,Malignant Cellular Infiltrate,Brain sarcoma
34069,Malignant Cellular Infiltrate,Squamous cell breast carcinoma
34070,Malignant Cellular Infiltrate,Breast T-Cell Non-Hodgkin Lymphoma
34071,Benign Cellular Infiltrate,Benign phyllodes neoplasm of breast
34072,Benign Cellular Infiltrate,Breast Capillary Hemangioma
34073,Malignant Cellular Infiltrate,Breast adenocarcinoma
34074,Malignant Cellular Infiltrate,Gastric Burkitt Lymphoma
34075,Malignant Cellular Infiltrate,Cerebellar Papillary Meningioma
34076,Malignant Cellular Infiltrate,Metastatic Jugulotympanic Paraganglioma
34077,Malignant Cellular Infiltrate,Luminal B Breast Carcinoma
34078,Malignant Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor
34079,Malignant Cellular Infiltrate,Pulmonary Vein Leiomyosarcoma
34080,Malignant Cellular Infiltrate,Malignant Superior Vena Cava Neoplasm
34081,Malignant Cellular Infiltrate,Leiomyosarcoma of Vessels
34082,Malignant Cellular Infiltrate,Osteoblastic Osteosarcoma
34083,Malignant Cellular Infiltrate,keratinizing squamous cell carcinoma of nasal cavity
34084,Malignant Cellular Infiltrate,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant"
34085,Malignant Cellular Infiltrate,Central Nervous System Angiosarcoma
34086,Malignant Cellular Infiltrate,Central Nervous System Rhabdomyosarcoma
34087,Malignant Cellular Infiltrate,Stage IB Gastric Carcinoma
34088,Malignant Cellular Infiltrate,Undifferentiated carcinoma of stomach
34089,Malignant Cellular Infiltrate,Gastric Liposarcoma
34090,Malignant Cellular Infiltrate,Squamous cell carcinoma of colon
34091,Malignant Cellular Infiltrate,embryonal rhabdomyosarcoma of prostate
34092,Malignant Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate
34093,Malignant Cellular Infiltrate,Acinar Prostate Mucinous Adenocarcinoma
34094,Malignant Cellular Infiltrate,Squamous cell carcinoma of rectum
34095,Malignant Cellular Infiltrate,Nodulo-ulcerative basal cell carcinoma
34096,Malignant Cellular Infiltrate,Stage IV Uveal Melanoma AJCC v7
34097,Malignant Cellular Infiltrate,Prostate Acinar Adenocarcinoma
34098,Malignant Cellular Infiltrate,Childhood T Lymphoblastic Leukemia/Lymphoma
34099,Benign Cellular Infiltrate,Lung Myolipoma
34100,Benign Cellular Infiltrate,Endobronchial Leiomyoma
34101,Benign Cellular Infiltrate,Endobronchial Hamartoma
34102,Malignant Cellular Infiltrate,Esophageal Lymphoma
34103,Well Differentiated Neuroendocrine Lesion,Duodenal Gastrin-Producing Neuroendocrine Tumor
34104,Malignant Cellular Infiltrate,Stage II Gallbladder Cancer AJCC v6
34105,Malignant Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v6
34106,Malignant Cellular Infiltrate,Clear Cell Hepatocellular Carcinoma
34107,Malignant Cellular Infiltrate,leiomyosarcoma of liver
34108,Malignant Cellular Infiltrate,Bile duct clear cell adenocarcinoma
34109,Malignant Cellular Infiltrate,Bile duct signet-ring cell carcinoma
34110,Malignant Cellular Infiltrate,Pancreatic Non-Hodgkin Lymphoma
34111,Malignant Cellular Infiltrate,adenoid cystic carcinoma of pharynx
34112,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1
34113,Malignant Cellular Infiltrate,Bile duct mucinous adenocarcinoma
34114,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
34115,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7
34116,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Cancer AJCC v6 and v7
34117,Malignant Cellular Infiltrate,Salivary duct carcinoma
34118,Malignant Cellular Infiltrate,Major Salivary Gland Mucoepidermoid Carcinoma
34119,Malignant Cellular Infiltrate,Submandibular Gland Acinic Cell Carcinoma
34120,Malignant Cellular Infiltrate,Parotid Gland Adenocarcinoma
34121,Malignant Cellular Infiltrate,Malignant Mixed Tumor of the Minor Salivary Gland
34122,Malignant Cellular Infiltrate,Minor Salivary Gland Small Cell Carcinoma
34123,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland
34124,Benign Cellular Infiltrate,Parotid Gland Lipoma
34125,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Carcinoma AJCC v7
34126,Malignant Cellular Infiltrate,Stage III Paranasal Sinus Cancer AJCC v6 and v7
34127,Malignant Cellular Infiltrate,Stage IV Paranasal Sinus Cancer AJCC v7
34128,Malignant Cellular Infiltrate,Adenocarcinoma of Accessory Sinus
34129,Malignant Cellular Infiltrate,adenoid cystic carcinoma of accessory sinus
34130,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage II
34131,Malignant Cellular Infiltrate,Sphenoid Sinus Squamous Cell Carcinoma
34132,Malignant Cellular Infiltrate,Neck Carcinoma
34133,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lacrimal gland
34134,Malignant Cellular Infiltrate,squamous cell carcinoma of lacrimal gland
34135,Malignant Cellular Infiltrate,Intermediate Cell Type Iris Melanoma
34136,Malignant Cellular Infiltrate,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7
34137,Malignant Cellular Infiltrate,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
34138,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
34139,Malignant Cellular Infiltrate,squamous cell carcinoma of ureter
34140,Malignant Cellular Infiltrate,adenocarcinoma of ureter
34141,Malignant Cellular Infiltrate,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation
34142,Malignant Cellular Infiltrate,clear cell adenocarcinoma of urethra
34143,Malignant Cellular Infiltrate,small cell carcinoma of ureter
34144,Malignant Cellular Infiltrate,clear cell adenocarcinoma of bladder
34145,Malignant Cellular Infiltrate,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant"
34146,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage 0
34147,Malignant Cellular Infiltrate,Childhood Central Nervous System Yolk Sac Tumor
34148,Malignant Cellular Infiltrate,Salivary Gland Low Grade Cribriform Cystadenocarcinoma
34149,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of oropharynx
34150,Malignant Cellular Infiltrate,Minor Salivary Gland Acinic Cell Carcinoma
34151,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v6 and v7
34152,Malignant Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v6 and v7
34153,Malignant Cellular Infiltrate,Fallopian Tube Gestational Choriocarcinoma
34154,Malignant Cellular Infiltrate,Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7
34155,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Cancer AJCC v7
34156,Malignant Cellular Infiltrate,verrucous carcinoma of vagina
34157,Malignant Cellular Infiltrate,Cervical Endometrioid Adenocarcinoma
34158,Malignant Cellular Infiltrate,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells
34159,Malignant Cellular Infiltrate,rhabdomyosarcoma of testis
34160,Benign Cellular Infiltrate,Scrotal Hemangioma
34161,Malignant Cellular Infiltrate,Ovarian Liposarcoma
34162,Low Grade Neuroendocrine Lesion,Ascending Colon Neuroendocrine Tumor G1
34163,Malignant Cellular Infiltrate,yolk sac tumor of mediastinum
34164,Malignant Cellular Infiltrate,Osteosarcoma Arising in Paget Disease of Bone
34165,Malignant Cellular Infiltrate,"Chondrosarcoma, Clear Cell"
34166,Benign Cellular Infiltrate,Nuchal-type fibroma
34167,Malignant Cellular Infiltrate,Inflammatory liposarcoma
34168,Malignant Cellular Infiltrate,"Squamous cell carcinoma, microinvasive"
34169,Malignant Cellular Infiltrate,Squamous cell carcinoma with horn formation
34170,Malignant Cellular Infiltrate,"Transitional cell carcinoma, micropapillary"
34171,Tumor Vascular Invasion,"Glucagonoma, malignant"
34172,Malignant Cellular Infiltrate,Spindle cell rhabdomyosarcoma
34173,Encapsulated Mass,minimally invasive follicular carcinoma of the thyroid gland
34174,Malignant Cellular Infiltrate,Monophasic Synovial Sarcoma
34175,Malignant Cellular Infiltrate,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma
34176,Benign Cellular Infiltrate,Benign Childhood Germ Cell Tumor
34177,Benign Cellular Infiltrate,Epithelioid neurofibroma
34178,Malignant Cellular Infiltrate,Congenital Mesoblastic Nephroma
34179,Malignant Cellular Infiltrate,Malignant Soft Tissue Tumor of Uncertain Differentiation
34180,Malignant Cellular Infiltrate,Childhood Parosteal Osteosarcoma
34181,Malignant Cellular Infiltrate,Fibrosarcoma of bone
34182,Malignant Cellular Infiltrate,fibrosarcoma of soft tissue
34183,Malignant Cellular Infiltrate,sarcoma of mediastinum
34184,Malignant Cellular Infiltrate,Stage IA Osteosarcoma AJCC v7
34185,Malignant Cellular Infiltrate,Primary bone lymphoma
34186,Malignant Cellular Infiltrate,Stage 3 Neuroblastoma
34187,Benign Cellular Infiltrate,Infantile hemangioma
34188,Malignant Cellular Infiltrate,Stage I Pleural Malignant Mesothelioma AJCC v7
34189,Malignant Cellular Infiltrate,Stage IIA Lung Large Cell Carcinoma AJCC v7
34190,Malignant Cellular Infiltrate,Stage IA Lung Small Cell Carcinoma AJCC v7
34191,Benign Cellular Infiltrate,"Nevus, Spindle Cell"
34192,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma AJCC v7
34193,Malignant Cellular Infiltrate,Occult Lung Small Cell Carcinoma
34194,Capsular Invasion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion"
34195,Malignant Cellular Infiltrate,Occult Lung Squamous Cell Carcinoma
34196,Malignant Cellular Infiltrate,Stage IB Lung Adenocarcinoma AJCC v7
34197,Malignant Cellular Infiltrate,Hepatoid adenocarcinoma
34198,Malignant Cellular Infiltrate,"Adenocarcinoma, endocervical type"
34199,Malignant Cellular Infiltrate,"Mucinous adenocarcinoma, endocervical type"
34200,Malignant Cellular Infiltrate,Stage IIB Lung Adenocarcinoma AJCC v7
34201,Malignant Cellular Infiltrate,Stage IV Osteosarcoma AJCC v7
34202,Benign Cellular Infiltrate,Sternal Intraosseous Schwannoma
34203,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma
34204,Benign Cellular Infiltrate,Cardiac rhabdomyoma
34205,Benign Cellular Infiltrate,Epicardial Lipoma
34206,Intermediate Grade Neuroendocrine Lesion,malignant gastrinoma of pancreas
34207,Benign Cellular Infiltrate,Myxoid leiomyoma
34208,Poorly Differentiated Neuroendocrine Lesion,Gastric Small Cell Carcinoma
34209,Malignant Cellular Infiltrate,Small cell carcinoma of prostate
34210,Malignant Cellular Infiltrate,Malignant Pineal Region Germ Cell Tumor
34211,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pituitary gland
34212,Benign Cellular Infiltrate,Benign tumor of external ear
34213,Malignant Cellular Infiltrate,Grade 3 Cutaneous Follicular Lymphoma
34214,Malignant Cellular Infiltrate,Childhood Malignant Testicular Germ Cell Tumor
34215,Malignant Cellular Infiltrate,Well Differentiated Adrenal Cortex Carcinoma
34216,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type A Melanoma
34217,Malignant Cellular Infiltrate,Marginal zone lymphoma stage I
34218,Malignant Cellular Infiltrate,Marginal zone lymphoma stage IV
34219,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
34220,Malignant Cellular Infiltrate,"Thymoma, type B2, malignant"
34221,Malignant Cellular Infiltrate,Malignant Solitary Fibrous Tumor
34222,Malignant Cellular Infiltrate,Adult Classical Hodgkin Lymphoma
34223,Malignant Cellular Infiltrate,Primary Effusion Lymphoma
34224,Benign Cellular Infiltrate,Aggressive angiomyxoma
34225,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma
34226,Benign Cellular Infiltrate,Plexiform Schwannoma
34227,Benign Cellular Infiltrate,Central Nervous System Chondroma
34228,Benign Cellular Infiltrate,Central Nervous System Mature Teratoma
34229,Malignant Cellular Infiltrate,Central Nervous System Mixed Germ Cell Tumor
34230,Malignant Cellular Infiltrate,ISS Stage II Plasma Cell Myeloma
34231,Malignant Cellular Infiltrate,Prostate Cancer by Whitmore-Jewett Stage
34232,Malignant Cellular Infiltrate,Melanoma recurrent
34233,Malignant Cellular Infiltrate,Metastatic Non-Cutaneous Melanoma
34234,Malignant Cellular Infiltrate,Stage III Liver Cancer
34235,Malignant Cellular Infiltrate,Postsurgical Stage IV Hepatoblastoma
34236,Benign Cellular Infiltrate,Benign Fibroblastic Neoplasm
34237,Malignant Cellular Infiltrate,Acute monoblastic leukemia
34238,Benign Cellular Infiltrate,Spindle Cell/Pleomorphic Lipoma
34239,Malignant Cellular Infiltrate,Lymphoma by Site
34240,Malignant Cellular Infiltrate,Grade 3a Follicular Lymphoma
34241,Malignant Cellular Infiltrate,Common Variant Anaplastic Large Cell Lymphoma
34242,Malignant Cellular Infiltrate,AIDS-Related Diffuse Large B-cell Lymphoma
34243,Malignant Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
34244,Malignant Cellular Infiltrate,Methotrexate-Associated Diffuse Large B-Cell Lymphoma
34245,Malignant Cellular Infiltrate,Lung Basaloid Large Cell Carcinoma
34246,Benign Cellular Infiltrate,Ovarian Solid Teratoma
34247,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of spleen
34248,Malignant Cellular Infiltrate,Splenic Manifestation of Chronic Lymphocytic Leukemia
34249,Malignant Cellular Infiltrate,Splenic Small Lymphocytic Lymphoma
34250,Invasive Lesion,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension
34251,Malignant Cellular Infiltrate,Heavy Chain Deposition Disease
34252,Benign Cellular Infiltrate,Benign fibrohistiocytic neoplasm of skin
34253,Malignant Cellular Infiltrate,Urothelial cancer of renal pelvis
34254,Malignant Cellular Infiltrate,Accessory Urethral Gland Carcinoma
34255,Malignant Cellular Infiltrate,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype"
34256,Benign Cellular Infiltrate,Epithelioid hemangioma of skin
34257,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v6
34258,Malignant Cellular Infiltrate,Malignant neoplasm of oropharynx
34259,Malignant Cellular Infiltrate,Intraductal papillary adenocarcinoma with invasion
34260,Benign Cellular Infiltrate,Benign myoepithelioma
34261,Malignant Cellular Infiltrate,Malignant tumor of extrahepatic bile duct
34262,Malignant Cellular Infiltrate,Malignant Esophageal Neoplasm by Topographic Region
34263,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v7
34264,Malignant Cellular Infiltrate,Malignant neoplasm of kidney
34265,Malignant Cellular Infiltrate,Prostate cancer stage B
34266,Benign Cellular Infiltrate,Deep Penetrating Nevus
34267,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Myelodysplasia-Related Changes
34268,Malignant Cellular Infiltrate,Recurrent Male Reproductive System Carcinoma
34269,Malignant Cellular Infiltrate,Bilateral Malignant Neoplasm
34270,Malignant Cellular Infiltrate,Adenocarcinoma in tubular adenoma
34271,Malignant Cellular Infiltrate,Carcinoma in a polyp
34272,Malignant Cellular Infiltrate,Adenocarcinoma with osseous metaplasia
34273,Malignant Cellular Infiltrate,Resectable Malignant Liver Neoplasm
34274,Malignant Cellular Infiltrate,Adult Soft Tissue Sarcoma
34275,Malignant Cellular Infiltrate,Adenocarcinoma of appendix
34276,Malignant Cellular Infiltrate,fibrosarcoma of kidney
34277,Malignant Cellular Infiltrate,Paget Disease of the Scrotum
34278,Malignant Cellular Infiltrate,Osteosclerotic Plasma Cell Myeloma
34279,Malignant Cellular Infiltrate,Stage III Colon Cancer
34280,Malignant Cellular Infiltrate,Stage II Breast Cancer AJCC v6 and v7
34281,Malignant Cellular Infiltrate,Stage III Carcinoma of Stomach
34282,Malignant Cellular Infiltrate,Osteosarcoma localised
34283,Malignant Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v6 and v7
34284,Malignant Cellular Infiltrate,Anal cancer recurrent
34285,Malignant Cellular Infiltrate,Stage 0 Anal Canal Cancer AJCC v6 and v7
34286,Malignant Cellular Infiltrate,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
34287,Malignant Cellular Infiltrate,Ewing's sarcoma recurrent
34288,Malignant Cellular Infiltrate,Adult Liposarcoma
34289,Malignant Cellular Infiltrate,Localized Parathyroid Gland Carcinoma
34290,Secondary Lesion,Secondary malignant neoplasm of parathyroid gland
34291,Malignant Cellular Infiltrate,Recurrent Childhood Liver Cancer
34292,Malignant Cellular Infiltrate,Stage IV Kidney Wilms Tumor
34293,Malignant Cellular Infiltrate,Extraocular retinoblastoma
34294,Malignant Cellular Infiltrate,DS Stage I Plasma Cell Myeloma
34295,Malignant Cellular Infiltrate,DS Stage III Plasma Cell Myeloma
34296,Malignant Cellular Infiltrate,Small cell lung cancer limited stage
34297,Malignant Cellular Infiltrate,Stage III Vaginal Cancer AJCC v6 and v7
34298,Malignant Cellular Infiltrate,Penis carcinoma recurrent
34299,Malignant Cellular Infiltrate,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
34300,Malignant Cellular Infiltrate,Unresectable Extrahepatic Bile Duct Carcinoma
34301,Malignant Cellular Infiltrate,Small intestine carcinoma recurrent
34302,Malignant Cellular Infiltrate,Stage I Testicular Cancer AJCC v6 and v7
34303,Malignant Cellular Infiltrate,Adult Extraskeletal Osteosarcoma
34304,Borderline Lesion,Grade I Lymphomatoid Granulomatosis
34305,Malignant Cellular Infiltrate,Recurrent Lymphomatoid Granulomatosis
34306,Malignant Cellular Infiltrate,Childhood Hepatocellular Carcinoma
34307,Malignant Cellular Infiltrate,Adult Acute Myelomonocytic Leukemia
34308,Malignant Cellular Infiltrate,Anaplastic Carcinoma of the Rectum
34309,Malignant Cellular Infiltrate,Distal 1/3 of the Common Bile Duct Adenocarcinoma
34310,Well Differentiated Neuroendocrine Lesion,Pancreatic Somatostatinoma
34311,Malignant Cellular Infiltrate,Low Grade Salivary Gland Carcinoma
34312,Malignant Cellular Infiltrate,Undifferentiated carcinoma of nasopharynx
34313,Malignant Cellular Infiltrate,undifferentiated carcinoma of salivary gland
34314,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
34315,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH
34316,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v6
34317,Malignant Cellular Infiltrate,Stage III Hypopharyngeal Carcinoma AJCC v6
34318,Malignant Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v6 and v7
34319,Malignant Cellular Infiltrate,Oropharyngeal cancer recurrent
34320,Malignant Cellular Infiltrate,Stage II Childhood Hodgkin Lymphoma
34321,Malignant Cellular Infiltrate,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma
34322,Malignant Cellular Infiltrate,Transitional cell cancer of renal pelvis and ureter metastatic
34323,Malignant Cellular Infiltrate,Primary Childhood Soft Tissue Sarcoma
34324,Malignant Cellular Infiltrate,Ann Arbor Stage I Grade 3 Follicular Lymphoma
34325,Malignant Cellular Infiltrate,Stage I Ovarian Germ Cell Tumor AJCC v6 and v7
34326,Malignant Cellular Infiltrate,Stage III Ovarian Germ Cell Tumor AJCC v6 and v7
34327,Malignant Cellular Infiltrate,Stage II Adult Non-Hodgkin Lymphoma
34328,Malignant Cellular Infiltrate,Stage III Adult Non-Hodgkin Lymphoma
34329,Malignant Cellular Infiltrate,Stage IV Adult Burkitt Lymphoma
34330,Malignant Cellular Infiltrate,Retromolar Trigone Squamous Cell Carcinoma
34331,Malignant Cellular Infiltrate,Verrucous carcinoma of oral cavity
34332,Benign Cellular Infiltrate,Disseminated Juvenile Xanthogranuloma
34333,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity
34334,Benign Cellular Infiltrate,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor
34335,Malignant Cellular Infiltrate,Subglottic Verrucous Carcinoma
34336,Malignant Cellular Infiltrate,Squamous cell carcinoma of the paranasal sinus
34337,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage II
34338,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage II
34339,Malignant Cellular Infiltrate,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7
34340,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated NPM1
34341,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma stage IV
34342,Malignant Cellular Infiltrate,Laryngeal squamous cell carcinoma recurrent
34343,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage I
34344,Malignant Cellular Infiltrate,Refractory Thrombocytopenia
34345,Malignant Cellular Infiltrate,Burkitt lymphoma associated with AIDS
34346,Malignant Cellular Infiltrate,Primary Systemic Amyloidosis
34347,Malignant Cellular Infiltrate,Leptomeningeal sarcoma
34348,Malignant Cellular Infiltrate,Malignant Sebaceous Neoplasm
34349,Benign Cellular Infiltrate,Benign neoplasm of supraglottis
34350,Benign Cellular Infiltrate,Benign neoplasm of sternum
34351,Malignant Cellular Infiltrate,Hepatosplenic T-cell lymphoma
34352,Malignant Cellular Infiltrate,Tibial adamantinoma
34353,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma
34354,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma
34355,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma
34356,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma
34357,Malignant Cellular Infiltrate,Stage III Indolent Adult Non-Hodgkin Lymphoma
34358,Malignant Cellular Infiltrate,Bilateral Carcinoma
34359,Malignant Cellular Infiltrate,Secondary malignant neoplasm of sternum
34360,Benign Cellular Infiltrate,Benign neoplasm of chest wall
34361,Benign Cellular Infiltrate,Benign neoplasm of respiratory tract
34362,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pancreas
34363,Malignant Cellular Infiltrate,Stage IIB Adult Soft Tissue Sarcoma AJCC v7
34364,Malignant Cellular Infiltrate,Stage I Merkel Cell Carcinoma AJCC v7
34365,Malignant Cellular Infiltrate,Stage IIC Merkel Cell Carcinoma AJCC v7
34366,Malignant Cellular Infiltrate,Stage IIIB Merkel Cell Carcinoma AJCC v7
34367,Benign Cellular Infiltrate,Benign chondrogenic neoplasm
34368,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia refractory
34369,Malignant Cellular Infiltrate,Angiocentric lymphoma stage I
34370,Malignant Cellular Infiltrate,Angiocentric lymphoma stage III
34371,Malignant Cellular Infiltrate,Angiocentric lymphoma stage IV
34372,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage IV
34373,Malignant Cellular Infiltrate,Stage IA Uterine Sarcoma AJCC v7
34374,Malignant Cellular Infiltrate,Stage IVB Uterine Sarcoma AJCC v7
34375,Malignant Cellular Infiltrate,Rhabdoid Tumor of the Kidney
34376,Malignant Cellular Infiltrate,Stage IV Bone Cancer AJCC v7
34377,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
34378,Malignant Cellular Infiltrate,Stage II Ovarian Teratoma AJCC v6 and v7
34379,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IV
34380,Malignant Cellular Infiltrate,Stage IV Pharynx Carcinoma
34381,Malignant Cellular Infiltrate,Stage IIB Gastric Cancer AJCC v7
34382,Malignant Cellular Infiltrate,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7
34383,Malignant Cellular Infiltrate,Stage IIA Appendix Carcinoma AJCC v7
34384,Malignant Cellular Infiltrate,Stage IIB Appendix Carcinoma AJCC v7
34385,Malignant Cellular Infiltrate,Stage II Acral Lentiginous Melanoma AJCC v6 and v7
34386,Malignant Cellular Infiltrate,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7
34387,Malignant Cellular Infiltrate,Stage III Superficial Spreading Melanoma AJCC v7
34388,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma metastatic
34389,Well Differentiated Neuroendocrine Lesion,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7
34390,Secondary Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma
34391,Cartilaginous Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma
34392,Malignant Cellular Infiltrate,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
34393,Malignant Cellular Infiltrate,Stage IIIB Gallbladder Cancer AJCC v7
34394,Malignant Cellular Infiltrate,Recurrent Extraskeletal Myxoid Chondrosarcoma
34395,Malignant Cellular Infiltrate,Stage IV Distal Bile Duct Cancer AJCC v7
34396,Malignant Cellular Infiltrate,Stage IB Ampulla of Vater Cancer AJCC v7
34397,Malignant Cellular Infiltrate,Stage IIA Ampulla of Vater Cancer AJCC v7
34398,Malignant Cellular Infiltrate,Stage IIA Pancreatic Cancer AJCC v6 and v7
34399,Malignant Cellular Infiltrate,Fibrosarcoma metastatic
34400,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v7
34401,Malignant Cellular Infiltrate,Stage IIA Uveal Melanoma AJCC v7
34402,Malignant Cellular Infiltrate,Primary leiomyosarcoma
34403,Malignant Cellular Infiltrate,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7
34404,Malignant Cellular Infiltrate,Recurrent Malignant Peripheral Nerve Sheath Tumor
34405,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage IV
34406,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis recurrent
34407,Malignant Cellular Infiltrate,Burkitt's lymphoma refractory
34408,Malignant Cellular Infiltrate,Stage II Burkitt Lymphoma
34409,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma
34410,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma refractory
34411,Malignant Cellular Infiltrate,Stage IV Diffuse Large B-Cell Lymphoma
34412,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v7
34413,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v7
34414,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage I
34415,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage III
34416,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage II
34417,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v7
34418,Malignant Cellular Infiltrate,Stage IV Prostate Cancer AJCC v7
34419,Malignant Cellular Infiltrate,Centroblastic lymphoma recurrent
34420,Malignant Cellular Infiltrate,Centroblastic lymphoma stage II
34421,Malignant Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v6 and v7
34422,Malignant Cellular Infiltrate,Stage IV Fallopian Tube Cancer AJCC v6 and v7
34423,Malignant Cellular Infiltrate,Periosteal Osteosarcoma
34424,Malignant Cellular Infiltrate,"Endometrial stromal sarcoma, high grade"
34425,Malignant Cellular Infiltrate,Endometrial Stromal Sarcoma
34426,Malignant Cellular Infiltrate,Stage IV Esophageal Cancer AJCC v7
34427,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage IV
34428,Malignant Cellular Infiltrate,"Acute myeloid leukemia, inv(16)(p13q22)"
34429,Malignant Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v7
34430,Malignant Cellular Infiltrate,Well Differentiated Fibrosarcoma
34431,Malignant Cellular Infiltrate,FNCLCC Sarcoma Grade 2
34432,Malignant Cellular Infiltrate,FNCLCC Sarcoma Grade 3
34433,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v6 Stage
34434,Secondary Lesion,Metastatic Parathyroid Gland Carcinoma
34435,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v6 Stage
34436,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v6 Stage
34437,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v6 Stage
34438,Malignant Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v6 Stage
34439,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v6 Stage
34440,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage
34441,Malignant Cellular Infiltrate,Penis carcinoma
34442,Malignant Cellular Infiltrate,Stage 0 Uterine Corpus Cancer AJCC v6
34443,Malignant Cellular Infiltrate,Thymoma malignant noninvasive
34444,Encapsulated Mass,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7
34445,Malignant Cellular Infiltrate,Small Size Posterior Uveal Melanoma
34446,Malignant Cellular Infiltrate,Medium/Large Size Posterior Uveal Melanoma
34447,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8"
34448,Malignant Cellular Infiltrate,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary
34449,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v7 Stage
34450,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v7 Stage
34451,Malignant Cellular Infiltrate,Oropharyngeal Carcinoma by AJCC v7 Stage
34452,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage
34453,Malignant Cellular Infiltrate,Philadelphia chromosome negative chronic myelogenous leukemia
34454,Malignant Cellular Infiltrate,Tubular breast carcinoma
34455,Malignant Cellular Infiltrate,Invasive Lobular Breast Carcinoma with Predominant In Situ Component
34456,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia
34457,Malignant Cellular Infiltrate,Adult T Acute Lymphoblastic Leukemia
34458,Malignant Cellular Infiltrate,Lentigo maligna melanoma
34459,Malignant Cellular Infiltrate,Adult Acute Erythroid Leukemia
34460,Malignant Cellular Infiltrate,Gastric Intestinal-Type Adenocarcinoma
34461,Malignant Cellular Infiltrate,Carcinoma in situ of middle ear
34462,Malignant Cellular Infiltrate,Uterine Corpus Carcinosarcoma
34463,Malignant Cellular Infiltrate,Recurrent Childhood Burkitt Lymphoma
34464,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma
34465,Malignant Cellular Infiltrate,Ann Arbor Stage II Mantle Cell Lymphoma
34466,Malignant Cellular Infiltrate,Stage III Adrenal Cortex Carcinoma AJCC v7
34467,Malignant Cellular Infiltrate,Stage IV Adrenal Cortex Carcinoma AJCC v7
34468,Malignant Cellular Infiltrate,Stage III renal cell cancer
34469,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant recurrent
34470,Malignant Cellular Infiltrate,Multifocal Glioblastomas
34471,Malignant Cellular Infiltrate,Central Nervous System Ganglioneuroblastoma
34472,Malignant Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation
34473,Malignant Cellular Infiltrate,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
34474,Malignant Cellular Infiltrate,Angiosarcoma non-metastatic
34475,Malignant Cellular Infiltrate,Adenocarcinoma of the gastroesophageal junction
34476,Malignant Cellular Infiltrate,Acute leukemia
34477,Malignant Cellular Infiltrate,Sarcoma of soft tissue
34478,Malignant Cellular Infiltrate,Seminoma
34479,Malignant Cellular Infiltrate,Malignant neoplasm of mouth
34480,Malignant Cellular Infiltrate,Nasal cavity carcinoma
34481,Malignant Cellular Infiltrate,Malignant neoplasm of trachea
34482,Malignant Cellular Infiltrate,Pigmented Basal Cell Carcinoma
34483,Malignant Cellular Infiltrate,Adult Brain Medulloblastoma
34484,Malignant Cellular Infiltrate,Leiomyosarcoma NCI Grade 2
34485,Malignant Cellular Infiltrate,Sarcoma NCI Grade 3
34486,Malignant Cellular Infiltrate,AJCC Grade 2 Sarcoma
34487,Malignant Cellular Infiltrate,Conventional Angiosarcoma
34488,Malignant Cellular Infiltrate,Grade 3 Colorectal Adenocarcinoma
34489,Malignant Cellular Infiltrate,Grade 3 Rectal Adenocarcinoma
34490,Malignant Cellular Infiltrate,Intermediate Grade Ductal Breast Carcinoma In Situ
34491,Malignant Cellular Infiltrate,Meningeal Leukemia
34492,Malignant Cellular Infiltrate,"Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8"
34493,Malignant Cellular Infiltrate,Multifocal breast carcinoma
34494,Malignant Cellular Infiltrate,Multicentric Breast Carcinoma
34495,Malignant Cellular Infiltrate,Early-Stage Breast Carcinoma
34496,Malignant Cellular Infiltrate,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma
34497,Malignant Cellular Infiltrate,Pancreatic Moderately Differentiated Ductal Adenocarcinoma
34498,Malignant Cellular Infiltrate,Pancreatic Poorly Differentiated Ductal Adenocarcinoma
34499,Poorly Differentiated Neuroendocrine Lesion,Pancreatic Small Cell Neuroendocrine Carcinoma
34500,Well Differentiated Neuroendocrine Lesion,insulinoma
34501,Poorly Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Carcinoma
34502,Poorly Differentiated Neuroendocrine Lesion,Esophageal Large Cell Neuroendocrine Carcinoma
34503,Malignant Cellular Infiltrate,Esophageal Diffuse Large B-Cell Lymphoma
34504,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor
34505,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2
34506,Intermediate Grade Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2
34507,Benign Cellular Infiltrate,Benign Gastric Gastrointestinal Stromal Tumor
34508,Malignant Cellular Infiltrate,Secondary malignant neoplasm of stomach
34509,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1
34510,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Large Cell Neuroendocrine Carcinoma
34511,Malignant Cellular Infiltrate,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma
34512,Malignant Cellular Infiltrate,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
34513,Malignant Cellular Infiltrate,Small Intestinal T-Cell Non-Hodgkin Lymphoma
34514,Malignant Cellular Infiltrate,Intestinal Neuroendocrine Carcinoma
34515,Intermediate Grade Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor G2
34516,Poorly Differentiated Neuroendocrine Lesion,Colorectal Large Cell Neuroendocrine Carcinoma
34517,Malignant Cellular Infiltrate,High Grade Appendix Mucinous Adenocarcinoma
34518,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of appendix
34519,Malignant Cellular Infiltrate,Colorectal Kaposi Sarcoma
34520,Malignant Cellular Infiltrate,Peripheral Intrahepatic Cholangiocarcinoma
34521,Malignant Cellular Infiltrate,malignant epithelioid hemangioendothelioma of liver
34522,Malignant Cellular Infiltrate,hepatoid adenocarcinoma of gallbladder
34523,Well Differentiated Neuroendocrine Lesion,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma
34524,Malignant Cellular Infiltrate,Gallbladder Goblet Cell Carcinoid
34525,Well Differentiated Neuroendocrine Lesion,Gallbladder Tubular Carcinoid
34526,Epithelial Component Present,Clear cell papillary renal cell carcinoma
34527,Malignant Cellular Infiltrate,Refractory Diffuse Intrinsic Pontine Glioma
34528,Severe dysplasia,Stage 0is Bladder Cancer AJCC v8
34529,Recurrent disease,Recurrent Primary Vitreoretinal Lymphoma
34530,Malignant Cellular Infiltrate,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34531,Intraocular Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34532,Malignant Cellular Infiltrate,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
34533,Recurrent disease,Recurrent Paraganglioma
34534,Neuroendocrine Differentiation,Recurrent Paraganglioma
34535,Secondary Lesion,Locally Advanced Adrenal Gland Pheochromocytoma
34536,Neuroendocrine Differentiation,Recurrent Neuroendocrine Neoplasm
34537,Carcinomatous Component Present,Histiocytoid Breast Carcinoma
34538,Unresectable Mass,Unresectable Skin Squamous Cell Carcinoma
34539,Resectable Mass,Borderline Resectable Malignant Neoplasm
34540,Carcinomatous Component Present,Borderline Resectable Pancreatic Carcinoma
34541,Malignant Cellular Infiltrate,Borderline Resectable Carcinoma
34542,Epithelial Component Present,Borderline Resectable Pancreatic Adenocarcinoma
34543,Carcinomatous Component Present,Borderline Resectable Pancreatic Adenocarcinoma
34544,Epithelial Component Present,Colorectal Adenocarcinoma Metastatic in the Liver
34545,Malignant Cellular Infiltrate,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
34546,Immunologic Deficiency Syndromes,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder
34547,Epithelial Component Present,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
34548,Absence of Muscle Invasion,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34549,Epithelial Component Present,Anal Intraepithelial Neoplasia 3
34550,Necrotic changes (finding),Recurrent Giant Cell Glioblastoma
34551,Infiltrative Growth Pattern,Recurrent Giant Cell Glioblastoma
34552,Monomorphic Cellular Infiltrate,Recurrent Ependymoma
34553,Malignant Cellular Infiltrate,Metastatic Lung Neuroendocrine Neoplasm
34554,Refractory Disease,Refractory Barrett Esophagus
34555,Malignant Cellular Infiltrate,Cholangiocarcinoma metastatic
34556,Metastatic Lesion,Cholangiocarcinoma metastatic
34557,Transformed Phase of Disease,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma
34558,Malignant Cellular Infiltrate,Locally Advanced Urothelial Carcinoma
34559,Malignant Cellular Infiltrate,Metastatic Adenoid Cystic Carcinoma
34560,Perineural spread,Metastatic Adenoid Cystic Carcinoma
34561,Carcinomatous Component Present,Recurrent Adenoid Cystic Carcinoma
34562,Histiocytosis,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
34563,Refractory Disease,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
34564,Malignant Cellular Infiltrate,Recurrent Primary Effusion Lymphoma
34565,Recurrent disease,Recurrent Primary Effusion Lymphoma
34566,Diffuse Pattern,Refractory Primary Effusion Lymphoma
34567,Malignant Cellular Infiltrate,Refractory Primary Effusion Lymphoma
34568,Malignant Cellular Infiltrate,Recurrent Primary Lymphoma of Bone
34569,Immunologic Deficiency Syndromes,Recurrent HIV-Associated Lymphoproliferative Disorder
34570,Unclassifiable Lesion,"Recurrent NK-Cell Lymphoma, Unclassifiable"
34571,Subcutaneous Involvement,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
34572,Subcutaneous nodule,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
34573,Refractory Disease,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
34574,Malignant Cellular Infiltrate,Acquired cystic disease associated renal cell carcinoma
34575,Metastatic/Recurrent Disease,Kidney Synovial Sarcoma
34576,Benign Cellular Infiltrate,Childhood Cystic Nephroma
34577,Carcinomatous Component Present,Metastatic Bladder Squamous Cell Carcinoma
34578,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
34579,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
34580,Secondary Lesion,Metastatic Kidney Medullary Carcinoma
34581,Malignant Cellular Infiltrate,Neuroendocrine carcinoma of the bladder
34582,High Mitotic Activity,Metastatic Bladder Small Cell Carcinoma
34583,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
34584,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
34585,Secondary Lesion,Metastatic Malignant Genitourinary System Neoplasm
34586,Splenomegaly,Recurrent B-Cell Prolymphocytic Leukemia
34587,Secondary Lesion,Advanced Digestive System Neuroendocrine Neoplasm
34588,Metastatic Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
34589,Neuroendocrine Differentiation,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
34590,Refractory Disease,Refractory Transformed Chronic Lymphocytic Leukemia
34591,Epithelial Component Present,Refractory Endometrial Clear Cell Adenocarcinoma
34592,Secondary Lesion,Advanced Uterine Corpus Carcinosarcoma
34593,Sarcomatous Component Present,Advanced Uterine Corpus Carcinosarcoma
34594,Epithelial Component Present,Refractory Adrenal Gland Pheochromocytoma
34595,Recurrent disease,Endometrioid adenocarcinoma recurrent
34596,Tissue Differentiation Uncertain,Recurrent Desmoplastic Small Round Cell Tumor
34597,Malignant Cellular Infiltrate,Refractory Spindle Cell Sarcoma
34598,Malignant Cellular Infiltrate,Locally Advanced Salivary Gland Carcinoma
34599,High Mitotic Activity,Platinum-Sensitive Lung Small Cell Carcinoma
34600,High Grade Lesion,Platinum-Sensitive Lung Small Cell Carcinoma
34601,More than 10 Mitoses per 10HPF,Platinum-Sensitive Lung Small Cell Carcinoma
34602,Malignant Cellular Infiltrate,Unresectable Bladder Urothelial Carcinoma
34603,Borderline Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential
34604,Borderline Lesion,Cystadenocarcinoma of kidney
34605,Localized Lesion,Benign cystic nephroma
34606,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma
34607,Malignant Cellular Infiltrate,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34608,Refractory Disease,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34609,Diffuse Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
34610,Malignant Cellular Infiltrate,Histiocytoid Breast Carcinoma
34611,Schwannian Stroma Predominant Component of the Tumor Volume,Adrenal Gland Ganglioneuroma
34612,Unresectable Mass,Unresectable Skin Carcinoma
34613,Malignant Cellular Infiltrate,Metastatic Extracranial Malignant Solid Neoplasm
34614,Borderline Lesion,Monoclonal Gammopathy of Renal Significance
34615,Malignant Cellular Infiltrate,Borderline Resectable Malignant Neoplasm
34616,Metastatic Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma
34617,Regional Disease,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
34618,Slow Growing Mass,Peripheral Hemangioblastoma
34619,Precise Histogenesis Unknown,Peripheral Hemangioblastoma
34620,Capillary Sized Vascular Channel Formation,Peripheral Hemangioblastoma
34621,Secondary Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
34622,Immunosuppression-Related Post-Transplant Toxicity,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
34623,High Grade Lesion,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34624,Moderate dysplasia,Anal Intraepithelial Neoplasia 2
34625,Malignant Cellular Infiltrate,Anal Intraepithelial Neoplasia 3
34626,Malignant Cellular Infiltrate,Recurrent Giant Cell Glioblastoma
34627,Epithelial Component Present,Metastatic Lung Neuroendocrine Neoplasm
34628,Carcinomatous Component Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma
34629,Platinum Resistance,Platinum-Resistant Primary Peritoneal Carcinoma
34630,Carcinomatous Component Present,Cholangiocarcinoma metastatic
34631,Malignant Cellular Infiltrate,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
34632,Malignant Cellular Infiltrate,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma
34633,Epithelial Component Present,Metastatic Adenoid Cystic Carcinoma
34634,Diffuse Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
34635,Recurrent disease,Recurrent Primary Lymphoma of Bone
34636,Refractory Disease,Refractory Lymphoproliferative Disorder
34637,Recurrent disease,"Recurrent NK-Cell Lymphoma, Unclassifiable"
34638,Refractory Disease,"Refractory NK-Cell Lymphoma, Unclassifiable"
34639,Splenomegaly,Refractory T-Cell Prolymphocytic Leukemia
34640,Refractory Disease,Refractory Aggressive NK-Cell Leukemia
34641,Monomorphic Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
34642,Refractory Disease,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
34643,Recurrent disease,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
34644,Cutaneous Involvement,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
34645,Subcutaneous nodule,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
34646,CD8-Positive Neoplastic Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
34647,Rimming of Adipose Tissue Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
34648,Immunologic Deficiency Syndromes,HIV-Associated Lymphoproliferative Disorder
34649,Papillary Pattern,Laryngeal papillomatosis
34650,Recurrent disease,Laryngeal papillomatosis
34651,Benign Cellular Infiltrate,Metanephric Tumor
34652,Squamous metaplasia of bladder,Metastatic Bladder Squamous Cell Carcinoma
34653,Single Malignant Cells Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
34654,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
34655,Carcinomatous Component Present,large cell neuroendocrine carcinoma of bladder
34656,Carcinomatous Component Present,Metastatic Bladder Small Cell Carcinoma
34657,Metastatic Lesion,Metastatic Prostate Small Cell Carcinoma
34658,Secondary Lesion,Metastatic Prostate Small Cell Carcinoma
34659,Carcinomatous Component Present,Metastatic Prostate Small Cell Carcinoma
34660,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
34661,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
34662,Carcinomatous Component Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
34663,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
34664,S-100-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma
34665,HMB-45-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma
34666,Extensive Stage Lesion,Advanced Digestive System Neuroendocrine Neoplasm
34667,Carcinomatous Component Present,Refractory Cholangiocarcinoma
34668,Transformed Phase of Disease,Refractory Transformed Chronic Lymphocytic Leukemia
34669,Epithelial Component Present,Bladder Non-Invasive Urothelial Neoplasm
34670,Refractory Disease,Refractory Uterine Corpus Carcinosarcoma
34671,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Carcinoma
34672,Carcinomatous Component Present,Advanced Uterine Corpus Carcinosarcoma
34673,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma recurrent
34674,Malignant Cellular Infiltrate,Refractory Fibrosarcoma
34675,Epithelial Component Present,Locally Advanced Salivary Gland Carcinoma
34676,Platinum Resistance,Platinum-Resistant Lung Small Cell Carcinoma
34677,Malignant Cellular Infiltrate,Platinum-Resistant Lung Small Cell Carcinoma
34678,Epithelial Component Present,Platinum-Sensitive Lung Small Cell Carcinoma
34679,Nuclear Molding,Platinum-Sensitive Lung Small Cell Carcinoma
34680,Malignant Cellular Infiltrate,Unresectable Urethral Urothelial Carcinoma
34681,Epithelial Component Present,Unresectable Bladder Urothelial Carcinoma
34682,Epithelial Component Present,Unresectable Ureter Urothelial Carcinoma
34683,Unresectable Mass,Unresectable Renal Pelvis Urothelial Carcinoma
34684,Epithelial Component Present,Unresectable Renal Pelvis Urothelial Carcinoma
34685,Marked Thickening of the Bladder Urothelium Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential
34686,HIF1A Overexpression Positive,Hereditary clear cell renal cell carcinoma
34687,Papillary Pattern,Collecting Duct Carcinoma of the Kidney
34688,Malignant Cellular Infiltrate,Diffuse Intrinsic Pontine Glioma
34689,Diffuse Pattern,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34690,Recurrent disease,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
34691,Diffuse Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
34692,Unresectable Mass,Unresectable Paraganglioma
34693,Unresectable Mass,Unresectable Adrenal Gland Pheochromocytoma
34694,Epithelial Component Present,Unresectable Adrenal Gland Pheochromocytoma
34695,Malignant Cellular Infiltrate,Locally Advanced Adrenal Gland Pheochromocytoma
34696,Neuroendocrine Differentiation,Locally Advanced Adrenal Gland Pheochromocytoma
34697,Epithelial Component Present,Locally Advanced Adrenal Gland Pheochromocytoma
34698,Invasive Lesion,Histiocytoid Breast Carcinoma
34699,Neuroectodermal Differentiation,"Adrenal Gland Ganglioneuroblastoma, Nodular"
34700,Epithelial Component Present,Familial Adrenal Gland Pheochromocytoma
34701,Malignant Cellular Infiltrate,Unresectable Skin Squamous Cell Carcinoma
34702,Epithelial Component Present,Unresectable Skin Squamous Cell Carcinoma
34703,Malignant Cellular Infiltrate,Unresectable Skin Carcinoma
34704,Malignant Cellular Infiltrate,Unresectable Basal Cell Carcinoma
34705,Unresectable Mass,Unresectable Basal Cell Carcinoma
34706,Malignant Cellular Infiltrate,Unresectable Skin Basal Cell Carcinoma
34707,Unresectable Mass,Unresectable Skin Basal Cell Carcinoma
34708,Cutaneous Involvement,Unresectable Skin Basal Cell Carcinoma
34709,Carcinomatous Component Present,Unresectable Skin Basal Cell Carcinoma
34710,Extensive Stage Lesion,Advanced Extracranial Malignant Solid Neoplasm
34711,Secondary Lesion,Advanced Extracranial Malignant Solid Neoplasm
34712,Borderline Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma
34713,Malignant Cellular Infiltrate,Colorectal Adenocarcinoma Metastatic in the Liver
34714,Carcinomatous Component Present,Colorectal Adenocarcinoma Metastatic in the Liver
34715,Carcinomatous Component Present,Metastatic Lung Non-Small Cell Squamous Carcinoma
34716,Carcinomatous Component Present,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
34717,Multifocal Lesion,Multiple endocrine neoplasia type 4
34718,Epithelial Component Present,Multiple endocrine neoplasia type 4
34719,Well-Circumscribed Lesion,Peripheral Hemangioblastoma
34720,Metastatic Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
34721,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
34722,Recurrent disease,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
34723,Carcinomatous Component Present,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
34724,Malignant Cellular Infiltrate,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34725,In Situ Lesion,Anal Intraepithelial Neoplasia 3
34726,Absence of Invasion,Anal Intraepithelial Neoplasia 3
34727,Carcinomatous Component Present,Anal Intraepithelial Neoplasia 3
34728,Mitotic Activity,Recurrent Giant Cell Glioblastoma
34729,Microvascular Proliferation,Recurrent Giant Cell Glioblastoma
34730,Metastatic Lesion,Metastatic Lung Neuroendocrine Neoplasm
34731,Epithelial Component Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma
34732,Refractory Disease,Platinum-Resistant Primary Peritoneal Carcinoma
34733,Secondary Lesion,Cholangiocarcinoma metastatic
34734,Negative Bone Marrow and Peripheral Blood,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma
34735,Recurrent disease,Urothelial carcinoma recurrent
34736,Carcinomatous Component Present,Urothelial carcinoma recurrent
34737,Metastatic Lesion,Locally Advanced Urothelial Carcinoma
34738,Malignant Cellular Infiltrate,Recurrent Adenoid Cystic Carcinoma
34739,Diffuse Pattern,Recurrent Plasmablastic Lymphoma
34740,Recurrent disease,Recurrent Plasmablastic Lymphoma
34741,Diffuse Pattern,Refractory Plasmablastic Lymphoma
34742,CD56-Positive Neoplastic Cells Present,"Recurrent NK-Cell Lymphoma, Unclassifiable"
34743,Refractory Disease,Refractory T-Cell Prolymphocytic Leukemia
34744,Malignant Cellular Infiltrate,Recurrent Aggressive NK-Cell Leukemia
34745,CD56-Positive Neoplastic Cells Present,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
34746,Refractory Disease,Refractory B-Cell Prolymphocytic Leukemia
34747,Multifocal Lesion,Laryngeal papillomatosis
34748,Epithelial Component Present,Laryngeal papillomatosis
34749,Tissue Differentiation Uncertain,Kidney Synovial Sarcoma
34750,Epithelial Component Present,Metanephric stromal tumor
34751,Myxoid Stroma Formation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
34752,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
34753,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
34754,Poorly Differentiated Lesion,Metastatic Kidney Medullary Carcinoma
34755,Epithelial Component Present,Neuroendocrine carcinoma of the bladder
34756,High Mitotic Activity,large cell neuroendocrine carcinoma of bladder
34757,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of bladder
34758,Malignant Cellular Infiltrate,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
34759,Secondary Lesion,Metastatic Bladder Small Cell Carcinoma
34760,Epithelial Component Present,Metastatic Bladder Small Cell Carcinoma
34761,Necrotic changes (finding),Metastatic Prostate Small Cell Carcinoma
34762,Micropapillary Pattern,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
34763,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
34764,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
34765,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
34766,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
34767,Metastatic Lesion,Metastatic Malignant Genitourinary System Neoplasm
34768,Cutaneous Involvement,Subcutaneous Disorder
34769,Smooth Muscle Component Present,Kidney Epithelioid Type Angiomyolipoma
34770,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Recurrent B-Cell Prolymphocytic Leukemia
34771,Refractory Disease,Refractory Digestive System Neuroendocrine Neoplasm
34772,Malignant Cellular Infiltrate,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
34773,Malignant Cellular Infiltrate,Refractory Cholangiocarcinoma
34774,Transformed Phase of Disease,Recurrent Transformed B-cell Non-Hodgkin Lymphoma
34775,Epithelial Component Present,Refractory Uterine Corpus Carcinosarcoma
34776,Sarcomatous Component Present,Refractory Uterine Corpus Carcinosarcoma
34777,Epithelial Component Present,Advanced Uterine Corpus Carcinosarcoma
34778,Refractory Disease,Refractory Adrenal Gland Pheochromocytoma
34779,Metastatic/Recurrent Disease,Recurrent Desmoplastic Small Round Cell Tumor
34780,Recurrent disease,Recurrent Desmoplastic Small Round Cell Tumor
34781,Desmoplastic Stroma Formation,Refractory Desmoplastic Small Round Cell Tumor
34782,Malignant Cellular Infiltrate,Refractory Desmoplastic Small Round Cell Tumor
34783,Tissue Differentiation Uncertain,Refractory Desmoplastic Small Round Cell Tumor
34784,Malignant Cellular Infiltrate,Recurrent Fibrosarcoma
34785,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma recurrent
34786,Epithelial Component Present,Metastatic Salivary Gland Carcinoma
34787,Carcinomatous Component Present,Metastatic Salivary Gland Carcinoma
34788,Necrotic changes (finding),Platinum-Sensitive Lung Small Cell Carcinoma
34789,Peripheral Nuclear Palisading,Platinum-Sensitive Lung Small Cell Carcinoma
34790,Absence of Invasion,Bladder Urothelial Carcinoma in Situ
34791,Macronodular adrenal hyperplasia,Hereditary Leiomyomatosis and Renal Cell Cancer
34792,Cystic Change,Clear cell papillary renal cell carcinoma
34793,Primary Lesion,Primary Vitreoretinal Lymphoma
34794,Diffuse Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34795,Primary Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34796,Primary Lesion,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34797,Neuroendocrine Differentiation,Unresectable Paraganglioma
34798,Neuroendocrine Differentiation,Refractory Neuroendocrine Neoplasm
34799,Epithelial Component Present,Refractory Neuroendocrine Neoplasm
34800,Histiocytoid Differentiation,Histiocytoid Breast Carcinoma
34801,Neuroectodermal Differentiation,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
34802,Nodular lesions,"Adrenal Gland Ganglioneuroblastoma, Nodular"
34803,Hemorrhagic Neuroblastic Nodules Present,"Adrenal Gland Ganglioneuroblastoma, Nodular"
34804,Favorable Clinical Outcome,Adrenal Gland Ganglioneuroma
34805,Epithelial Component Present,Unresectable Skin Carcinoma
34806,Epithelial Component Present,Unresectable Basal Cell Carcinoma
34807,Metastatic Lesion,Advanced Extracranial Malignant Solid Neoplasm
34808,Resectable Mass,Borderline Resectable Pancreatic Carcinoma
34809,Epithelial Component Present,Borderline Resectable Pancreatic Carcinoma
34810,Borderline Resectable Mass,Borderline Resectable Carcinoma
34811,Epithelial Component Present,Metastatic Lung Non-Small Cell Squamous Carcinoma
34812,Metastatic Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
34813,Epithelial Component Present,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
34814,Metastatic Lesion,Colorectal Carcinoma Metastatic in the Liver
34815,Carcinomatous Component Present,Colorectal Carcinoma Metastatic in the Liver
34816,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
34817,Hyperplastic Tissue Present,Islet Glucagon Cell Hyperplasia
34818,Immunologic Deficiency Syndromes,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
34819,Refractory Disease,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
34820,Immunosuppression-Related Post-Transplant Toxicity,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
34821,Polymorphic Cellular Infiltrate,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder
34822,Recurrent disease,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34823,Epithelial Component Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34824,Epithelial Component Present,Anal Intraepithelial Neoplasia 2
34825,Nuclear Atypia,Recurrent Giant Cell Glioblastoma
34826,Anaplasia,Recurrent Giant Cell Glioblastoma
34827,Malignant Cellular Infiltrate,BAP1-Mutant Clear Cell Renal Cell Carcinoma
34828,Transformed Phase of Disease,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
34829,Unresectable Mass,Unresectable Lymphoma
34830,Unclassifiable Lesion,"Refractory NK-Cell Lymphoma, Unclassifiable"
34831,Malignant Cellular Infiltrate,Refractory T-Cell Prolymphocytic Leukemia
34832,Recurrent disease,Recurrent Aggressive NK-Cell Leukemia
34833,CD56-Positive Neoplastic Cells Present,Recurrent Aggressive NK-Cell Leukemia
34834,Malignant Cellular Infiltrate,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
34835,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Refractory B-Cell Prolymphocytic Leukemia
34836,Diffuse Lesion,Laryngeal papillomatosis
34837,Epithelial Component Present,Metanephric Tumor
34838,Metaplasia,Metastatic Bladder Squamous Cell Carcinoma
34839,Secondary Lesion,Metastatic Bladder Squamous Cell Carcinoma
34840,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
34841,Epithelial Component Present,Metastatic Kidney Medullary Carcinoma
34842,Carcinomatous Component Present,Metastatic Kidney Medullary Carcinoma
34843,Carcinomatous Component Present,Neuroendocrine carcinoma of the bladder
34844,Carcinomatous Component Present,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
34845,Poorly Differentiated Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
34846,Invasive Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
34847,Secondary Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
34848,Nested Pattern,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
34849,Metastatic Lesion,Advanced Digestive System Neuroendocrine Neoplasm
34850,Neuroendocrine Differentiation,Advanced Digestive System Neuroendocrine Neoplasm
34851,Epithelial Component Present,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
34852,Recurrent disease,Recurrent Transformed Chronic Lymphocytic Leukemia
34853,Transformed Phase of Disease,Recurrent Transformed Chronic Lymphocytic Leukemia
34854,Non-Invasive Lesion,Bladder Non-Invasive Urothelial Neoplasm
34855,Refractory Disease,Refractory Endometrial Clear Cell Adenocarcinoma
34856,Biphasic Pattern,Advanced Uterine Corpus Carcinosarcoma
34857,Extensive Stage Lesion,Advanced Uterine Corpus Carcinosarcoma
34858,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Advanced Uterine Corpus Carcinosarcoma
34859,Epithelial Component Present,'Refractory Paraganglioma'
34860,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma recurrent
34861,Metastatic/Recurrent Disease,Refractory Desmoplastic Small Round Cell Tumor
34862,Malignant Cellular Infiltrate,Metastatic Salivary Gland Carcinoma
34863,High Grade Lesion,Platinum-Resistant Lung Small Cell Carcinoma
34864,Malignant Cellular Infiltrate,Platinum-Sensitive Lung Small Cell Carcinoma
34865,Unresectable Mass,Unresectable Urethral Urothelial Carcinoma
34866,Biphasic Pattern,Malignant Kidney Mixed Epithelial and Stromal Tumor
34867,Malignant Cellular Infiltrate,Bladder Urothelial Carcinoma in Situ
34868,Severe dysplasia,Bladder Urothelial Carcinoma in Situ
34869,Desmoplastic Stroma Formation,Collecting Duct Carcinoma of the Kidney
34870,Multilocular Lesion,Cystic Partially Differentiated Nephroblastoma
34871,Multilocular Lesion,Benign cystic nephroma
34872,Infiltrative Growth Pattern,Renal medullary carcinoma
34873,Absence of Invasion,Stage 0is Bladder Cancer AJCC v8
34874,Malignant Cellular Infiltrate,Primary Vitreoretinal Lymphoma
34875,Intraocular Lesion,Primary Vitreoretinal Lymphoma
34876,Primary Lesion,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34877,Intraocular Lesion,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34878,Malignant Cellular Infiltrate,Recurrent Primary Vitreoretinal Lymphoma
34879,Intraocular Lesion,Recurrent Primary Vitreoretinal Lymphoma
34880,Malignant Cellular Infiltrate,Refractory Primary Vitreoretinal Lymphoma
34881,Intraocular Lesion,Refractory Primary Vitreoretinal Lymphoma
34882,Diffuse Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34883,Recurrent disease,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34884,Malignant Cellular Infiltrate,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
34885,Refractory Disease,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
34886,Epithelial Component Present,Recurrent Paraganglioma
34887,Neuroendocrine Differentiation,Unresectable Adrenal Gland Pheochromocytoma
34888,Refractory Disease,Refractory Neuroendocrine Neoplasm
34889,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Nodular"
34890,Secondary Lesion,Metastatic Extracranial Malignant Solid Neoplasm
34891,Malignant Cellular Infiltrate,Borderline Resectable Pancreatic Carcinoma
34892,Resectable Mass,Borderline Resectable Carcinoma
34893,Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma
34894,Secondary Lesion,Colorectal Adenocarcinoma Metastatic in the Liver
34895,Malignant Cellular Infiltrate,Metastatic Lung Non-Small Cell Squamous Carcinoma
34896,Secondary Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma
34897,Malignant Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Liver
34898,Hereditary Lesion,Glucagon Cell Hyperplasia and Neoplasia
34899,Malignant Cellular Infiltrate,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
34900,Borderline Lesion,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
34901,Recurrent disease,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
34902,Metastatic Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
34903,Secondary Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
34904,Malignant Cellular Infiltrate,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34905,Absence of Muscle Invasion,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34906,Epithelial Component Present,Anal Intraepithelial Neoplasia 1
34907,Mild dysplasia,Anal Intraepithelial Neoplasia 1
34908,Secondary Lesion,Metastatic Lung Neuroendocrine Neoplasm
34909,Carcinomatous Component Present,Platinum-Resistant Primary Peritoneal Carcinoma
34910,Epithelial Component Present,Cholangiocarcinoma metastatic
34911,Epithelial Component Present,Urothelial carcinoma recurrent
34912,Malignant Cellular Infiltrate,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
34913,Refractory Disease,Refractory Primary Effusion Lymphoma
34914,Malignant Cellular Infiltrate,"Recurrent NK-Cell Lymphoma, Unclassifiable"
34915,CD56-Positive Neoplastic Cells Present,Refractory Aggressive NK-Cell Leukemia
34916,Primary Lesion,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
34917,Malignant Cellular Infiltrate,Refractory B-Cell Prolymphocytic Leukemia
34918,Intra or Intercytoplasmic Lumina Present,Acquired cystic disease associated renal cell carcinoma
34919,Childhood Lesion,Childhood Cystic Nephroma
34920,Spindle Cell Component Present,Metanephric stromal tumor
34921,Epithelial Component Present,Metastatic Bladder Squamous Cell Carcinoma
34922,Infiltrative Growth Pattern,Metastatic Kidney Medullary Carcinoma
34923,Carcinomatous Component Present,Metastatic Sarcomatoid Renal Cell Carcinoma
34924,Metastatic Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
34925,Malignant Cellular Infiltrate,Metastatic Bladder Small Cell Carcinoma
34926,High Mitotic Activity,Metastatic Prostate Small Cell Carcinoma
34927,Malignant Cellular Infiltrate,Metastatic Prostate Small Cell Carcinoma
34928,More than 10 Mitoses per 10HPF,Metastatic Prostate Small Cell Carcinoma
34929,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
34930,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
34931,Epithelial Component Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
34932,Cutaneous Involvement,"Skin Diseases, Bacterial"
34933,Epithelial Component Present,Refractory Digestive System Neuroendocrine Neoplasm
34934,Malignant Cellular Infiltrate,Advanced Digestive System Neuroendocrine Neoplasm
34935,Epithelial Component Present,Advanced Digestive System Neuroendocrine Neoplasm
34936,Regional Disease,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
34937,Malignant Cellular Infiltrate,Refractory Transformed B-cell Non-Hodgkin Lymphoma
34938,Malignant Cellular Infiltrate,Refractory Endometrial Serous Adenocarcinoma
34939,Epithelial Component Present,Refractory Endometrial Mixed Cell Adenocarcinoma
34940,Malignant Cellular Infiltrate,Refractory Endometrial Clear Cell Adenocarcinoma
34941,Biphasic Pattern,Refractory Uterine Corpus Carcinosarcoma
34942,Neuroendocrine Differentiation,Refractory Adrenal Gland Pheochromocytoma
34943,Carcinomatous Component Present,Endometrioid adenocarcinoma recurrent
34944,Regional Disease,Locally Advanced Salivary Gland Carcinoma
34945,Neuroendocrine Differentiation,Platinum-Resistant Lung Small Cell Carcinoma
34946,Neuroendocrine Differentiation,Platinum-Sensitive Lung Small Cell Carcinoma
34947,Monoclonal Cellular Population Present,Clonal Hematopoiesis of Indeterminate Potential
34948,Biphasic Pattern,Benign mixed epithelial and stromal tumor of kidney
34949,Biphasic Pattern,Benign mixed epithelial and stromal tumor of kidney
34950,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Cystadenocarcinoma of kidney
34951,Tubular Pattern,Clear cell papillary renal cell carcinoma
34952,Non-Invasive Lesion,Stage 0a Bladder Cancer AJCC v8
34953,Refractory Disease,Refractory Primary Vitreoretinal Lymphoma
34954,Primary Lesion,Refractory Primary Vitreoretinal Lymphoma
34955,Malignant Cellular Infiltrate,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
34956,Primary Lesion,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
34957,Metastatic Lesion,Locally Advanced Adrenal Gland Pheochromocytoma
34958,Epithelial Component Present,Histiocytoid Breast Carcinoma
34959,Epithelial Component Present,Composite Paraganglioma
34960,Hereditary Lesion,Familial Adrenal Gland Pheochromocytoma
34961,Carcinomatous Component Present,Unresectable Skin Squamous Cell Carcinoma
34962,Cutaneous Involvement,Unresectable Skin Carcinoma
34963,Carcinomatous Component Present,Unresectable Basal Cell Carcinoma
34964,Monoclonal Gammapathies,Monoclonal Gammopathy of Renal Significance
34965,Carcinomatous Component Present,Borderline Resectable Carcinoma
34966,Epithelial Component Present,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
34967,Malignant Cellular Infiltrate,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
34968,Immunologic Deficiency Syndromes,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
34969,Malignant Cellular Infiltrate,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
34970,Carcinomatous Component Present,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34971,Carcinomatous Component Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
34972,Severe dysplasia,Anal Intraepithelial Neoplasia 3
34973,High Grade Lesion,Recurrent Giant Cell Glioblastoma
34974,Recurrent disease,Recurrent Giant Cell Glioblastoma
34975,Recurrent disease,Recurrent Ependymoma
34976,Refractory Disease,Platinum-Resistant Fallopian Tube Carcinoma
34977,Carcinomatous Component Present,Platinum-Resistant Fallopian Tube Carcinoma
34978,Malignant Cellular Infiltrate,Platinum-Resistant Primary Peritoneal Carcinoma
34979,Secondary Lesion,Locally Advanced Urothelial Carcinoma
34980,Regional Disease,Locally Advanced Urothelial Carcinoma
34981,Epithelial Component Present,Locally Advanced Urothelial Carcinoma
34982,Metastatic Lesion,Metastatic Adenoid Cystic Carcinoma
34983,Secondary Lesion,Metastatic Adenoid Cystic Carcinoma
34984,Carcinomatous Component Present,Metastatic Adenoid Cystic Carcinoma
34985,Recurrent disease,Recurrent Adenoid Cystic Carcinoma
34986,Malignant Cellular Infiltrate,Sarcoma of pelvis
34987,Diffuse Pattern,Recurrent Primary Effusion Lymphoma
34988,Primary Lesion,Refractory Primary Effusion Lymphoma
34989,Malignant Cellular Infiltrate,Refractory Primary Lymphoma of Bone
34990,Immunologic Deficiency Syndromes,Refractory HIV-Associated Lymphoproliferative Disorder
34991,Refractory Disease,Refractory HIV-Associated Lymphoproliferative Disorder
34992,CD8-Positive Neoplastic Cells Present,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
34993,Epithelial Component Present,Acquired cystic disease associated renal cell carcinoma
34994,Carcinomatous Component Present,Acquired cystic disease associated renal cell carcinoma
34995,High Grade Lesion,Kidney Synovial Sarcoma
34996,Neuroendocrine Differentiation,Kidney Neuroendocrine Neoplasm
34997,Cystic Change,Childhood Cystic Nephroma
34998,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
34999,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
35000,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
35001,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant"
35002,Malignant Cellular Infiltrate,Metastatic Kidney Medullary Carcinoma
35003,Metastatic Lesion,Metastatic Kidney Medullary Carcinoma
35004,Metastatic Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma
35005,Neuroendocrine Differentiation,Neuroendocrine carcinoma of the bladder
35006,Neuroendocrine Differentiation,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
35007,Necrotic changes (finding),Metastatic Bladder Small Cell Carcinoma
35008,Invasive Lesion,Metastatic Prostate Small Cell Carcinoma
35009,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35010,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35011,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
35012,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
35013,Malignant Cellular Infiltrate,Metastatic Malignant Genitourinary System Neoplasm
35014,Tissue Differentiation Uncertain,Kidney Epithelioid Type Angiomyolipoma
35015,Lipomatous Component Present,Kidney Epithelioid Type Angiomyolipoma
35016,Malignant Cellular Infiltrate,Recurrent B-Cell Prolymphocytic Leukemia
35017,Recurrent disease,Recurrent B-Cell Prolymphocytic Leukemia
35018,Unresectable Mass,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
35019,Epithelial Component Present,Refractory Cholangiocarcinoma
35020,Malignant Cellular Infiltrate,Recurrent Transformed Chronic Lymphocytic Leukemia
35021,Malignant Cellular Infiltrate,Refractory Transformed Chronic Lymphocytic Leukemia
35022,Refractory Disease,Refractory Endometrial Serous Adenocarcinoma
35023,Malignant Cellular Infiltrate,Refractory Endometrial Mixed Cell Adenocarcinoma
35024,Carcinomatous Component Present,Refractory Uterine Corpus Carcinosarcoma
35025,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma
35026,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma
35027,Architectural Distortion,Bladder Non-Invasive Papillary Urothelial Carcinoma
35028,Epithelial Component Present,Bladder Non-Invasive Papillary Urothelial Carcinoma
35029,Metastatic Lesion,Advanced Uterine Corpus Carcinosarcoma
35030,Carcinomatous Component Present,Endometrioid adenocarcinoma recurrent
35031,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma recurrent
35032,Refractory Disease,Refractory Desmoplastic Small Round Cell Tumor
35033,Refractory Disease,Refractory Fibrosarcoma
35034,Secondary Lesion,Locally Advanced Salivary Gland Carcinoma
35035,High Mitotic Activity,Platinum-Resistant Lung Small Cell Carcinoma
35036,Epithelial Component Present,Platinum-Resistant Lung Small Cell Carcinoma
35037,Carcinomatous Component Present,Platinum-Resistant Lung Small Cell Carcinoma
35038,Nuclear Molding,Platinum-Resistant Lung Small Cell Carcinoma
35039,More than 10 Mitoses per 10HPF,Platinum-Resistant Lung Small Cell Carcinoma
35040,Carcinomatous Component Present,Unresectable Urethral Urothelial Carcinoma
35041,Malignant Cellular Infiltrate,Unresectable Ureter Urothelial Carcinoma
35042,Carcinomatous Component Present,Unresectable Ureter Urothelial Carcinoma
35043,Malignant Cellular Infiltrate,Unresectable Renal Pelvis Urothelial Carcinoma
35044,Carcinomatous Component Present,Unresectable Renal Pelvis Urothelial Carcinoma
35045,Architectural Distortion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade"
35046,Architectural Distortion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade"
35047,Architectural Distortion,Stage 0a Bladder Cancer AJCC v8
35048,Non-Invasive Lesion,Stage 0is Bladder Cancer AJCC v8
35049,In Situ Lesion,Stage 0is Bladder Cancer AJCC v8
35050,Primary Lesion,Recurrent Primary Vitreoretinal Lymphoma
35051,Intraocular Lesion,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma
35052,Primary Lesion,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
35053,Epithelial Component Present,Unresectable Paraganglioma
35054,Regional Disease,Locally Advanced Adrenal Gland Pheochromocytoma
35055,Epithelial Component Present,Recurrent Neuroendocrine Neoplasm
35056,Malignant Cellular Infiltrate,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
35057,Malignant Cellular Infiltrate,"Adrenal Gland Ganglioneuroblastoma, Nodular"
35058,Neuroendocrine Differentiation,Composite Paraganglioma
35059,Neuroendocrine Differentiation,Familial Adrenal Gland Pheochromocytoma
35060,Carcinomatous Component Present,Unresectable Skin Carcinoma
35061,Epithelial Component Present,Unresectable Skin Basal Cell Carcinoma
35062,Malignant Cellular Infiltrate,Advanced Extracranial Malignant Solid Neoplasm
35063,Immunosuppression-Related Post-Transplant Toxicity,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
35064,Therapy-Related Toxicity,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder
35065,Immunologic Deficiency Syndromes,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
35066,Borderline Lesion,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder
35067,Refractory Disease,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder
35068,Immunosuppression-Related Post-Transplant Toxicity,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder
35069,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
35070,Epithelial Component Present,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
35071,High Grade Lesion,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma"
35072,Dysplasia,Anal Intraepithelial Neoplasia 1
35073,Dysplasia,Anal Intraepithelial Neoplasia 2
35074,Dysplasia,Anal Intraepithelial Neoplasia 3
35075,Diffuse Pattern,Recurrent Giant Cell Glioblastoma
35076,Primary Lesion,Recurrent Giant Cell Glioblastoma
35077,Slow Growing Mass,Recurrent Ependymoma
35078,Neuroendocrine Differentiation,Metastatic Lung Neuroendocrine Neoplasm
35079,Metaplasia,Refractory Barrett Esophagus
35080,Epithelial Component Present,Platinum-Resistant Fallopian Tube Carcinoma
35081,Epithelial Component Present,Platinum-Resistant Primary Peritoneal Carcinoma
35082,Malignant Cellular Infiltrate,Urothelial carcinoma recurrent
35083,Epithelial Component Present,Recurrent Adenoid Cystic Carcinoma
35084,Primary Lesion,Recurrent Primary Effusion Lymphoma
35085,Primary Lesion,Recurrent Primary Lymphoma of Bone
35086,Malignant Cellular Infiltrate,Recurrent Plasmablastic Lymphoma
35087,Malignant Cellular Infiltrate,Refractory Plasmablastic Lymphoma
35088,Refractory Disease,Refractory Plasmablastic Lymphoma
35089,Recurrent disease,Recurrent HIV-Associated Lymphoproliferative Disorder
35090,Malignant Cellular Infiltrate,"Refractory NK-Cell Lymphoma, Unclassifiable"
35091,CD56-Positive Neoplastic Cells Present,"Refractory NK-Cell Lymphoma, Unclassifiable"
35092,Malignant Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
35093,Cutaneous Involvement,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
35094,Cribriform Pattern,Acquired cystic disease associated renal cell carcinoma
35095,Malignant Cellular Infiltrate,Kidney Synovial Sarcoma
35096,Multilocular Lesion,Childhood Cystic Nephroma
35097,Malignant Cellular Infiltrate,Metastatic Bladder Squamous Cell Carcinoma
35098,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
35099,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant"
35100,Neuroendocrine Differentiation,Bladder Neuroendocrine Neoplasm
35101,Epithelial Component Present,Bladder Neuroendocrine Neoplasm
35102,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of bladder
35103,Necrotic changes (finding),Metastatic Bladder Large Cell Neuroendocrine Carcinoma
35104,Neuroendocrine Differentiation,Metastatic Bladder Small Cell Carcinoma
35105,Neuroendocrine Differentiation,Metastatic Prostate Small Cell Carcinoma
35106,Epithelial Differentiation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35107,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35108,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
35109,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
35110,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
35111,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
35112,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant"
35113,Malignant Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
35114,Perivascular Arrangement of Tumor Cells,Kidney Epithelioid Type Angiomyolipoma
35115,Thick-Walled Vessels Present,Kidney Epithelioid Type Angiomyolipoma
35116,Cystic Change,Kidney Mixed Epithelial and Stromal Tumor Family
35117,Secondary Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
35118,Refractory Disease,Refractory Cholangiocarcinoma
35119,Refractory Disease,Refractory WHO Grade II Glioma
35120,Malignant Cellular Infiltrate,Recurrent Transformed B-cell Non-Hodgkin Lymphoma
35121,Refractory Disease,Refractory Transformed B-cell Non-Hodgkin Lymphoma
35122,Transformed Phase of Disease,Refractory Transformed B-cell Non-Hodgkin Lymphoma
35123,Epithelial Component Present,Refractory Endometrial Serous Adenocarcinoma
35124,Refractory Disease,Refractory Endometrial Mixed Cell Adenocarcinoma
35125,Carcinomatous Component Present,Refractory Endometrial Mixed Cell Adenocarcinoma
35126,Malignant Cellular Infiltrate,Refractory Uterine Corpus Carcinosarcoma
35127,Non-Invasive Lesion,Bladder Non-Invasive Papillary Urothelial Carcinoma
35128,Malignant Cellular Infiltrate,Bladder Non-Invasive Papillary Urothelial Carcinoma
35129,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Advanced Uterine Corpus Carcinosarcoma
35130,Tissue of Mullerian Origin Present,Advanced Uterine Corpus Carcinosarcoma
35131,Neuroendocrine Differentiation,'Refractory Paraganglioma'
35132,Malignant Cellular Infiltrate,Recurrent Desmoplastic Small Round Cell Tumor
35133,Recurrent disease,Recurrent Fibrosarcoma
35134,Malignant Cellular Infiltrate,Recurrent Spindle Cell Sarcoma
35135,Recurrent disease,Recurrent Spindle Cell Sarcoma
35136,Secondary Lesion,Metastatic Salivary Gland Carcinoma
35137,Necrotic changes (finding),Platinum-Resistant Lung Small Cell Carcinoma
35138,Peripheral Nuclear Palisading,Platinum-Resistant Lung Small Cell Carcinoma
35139,Epithelial Component Present,Unresectable Urethral Urothelial Carcinoma
35140,Unresectable Mass,Unresectable Bladder Urothelial Carcinoma
35141,Unresectable Mass,Unresectable Ureter Urothelial Carcinoma
35142,In Situ Lesion,Bladder Urothelial Carcinoma in Situ
35143,Carcinomatous Component Present,Bladder Urothelial Carcinoma in Situ
35144,Architectural Distortion,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7
35145,Papillary Pattern,Clear cell papillary renal cell carcinoma
35146,Malignant Cellular Infiltrate,Recurrent Diffuse Intrinsic Pontine Glioma
35147,Papillary Pattern,Stage 0a Bladder Cancer AJCC v8
35148,Recurrent disease,Recurrent Neuroendocrine Neoplasm
35149,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Intermixed"
35150,Composite Lesion,"Adrenal Gland Ganglioneuroblastoma, Nodular"
35151,Benign Cellular Infiltrate,Adrenal Gland Ganglioneuroma
35152,Cutaneous Involvement,Unresectable Skin Squamous Cell Carcinoma
35153,Metastatic Lesion,Metastatic Extracranial Malignant Solid Neoplasm
35154,Borderline Resectable Mass,Borderline Resectable Malignant Neoplasm
35155,Borderline Resectable Mass,Borderline Resectable Pancreatic Carcinoma
35156,Epithelial Component Present,Borderline Resectable Carcinoma
35157,Malignant Cellular Infiltrate,Borderline Resectable Pancreatic Adenocarcinoma
35158,Metastatic Lesion,Colorectal Adenocarcinoma Metastatic in the Liver
35159,Secondary Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma
35160,Secondary Lesion,Colorectal Carcinoma Metastatic in the Liver
35161,Epithelial Component Present,Colorectal Carcinoma Metastatic in the Liver
35162,Therapy-Related Toxicity,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder
35163,Polymorphic Cellular Infiltrate,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
35164,Castration Resistance,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
35165,Delicate Vascular Network Formation,BAP1-Mutant Clear Cell Renal Cell Carcinoma
35166,Platinum Resistance,Platinum-Resistant Fallopian Tube Carcinoma
35167,Malignant Cellular Infiltrate,Platinum-Resistant Fallopian Tube Carcinoma
35168,Primary Lesion,Platinum-Resistant Primary Peritoneal Carcinoma
35169,Carcinomatous Component Present,Locally Advanced Urothelial Carcinoma
35170,Perineural spread,Recurrent Adenoid Cystic Carcinoma
35171,Malignant Cellular Infiltrate,Unresectable Lymphoma
35172,Refractory Disease,Refractory Primary Lymphoma of Bone
35173,Malignant Cellular Infiltrate,Refractory Aggressive NK-Cell Leukemia
35174,Malignant Cellular Infiltrate,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
35175,Rimming of Adipose Tissue Cells Present,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
35176,Subcutaneous Involvement,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
35177,Splenomegaly,Refractory B-Cell Prolymphocytic Leukemia
35178,Epithelial Component Present,Kidney Neuroendocrine Neoplasm
35179,Benign Cellular Infiltrate,Metanephric stromal tumor
35180,Metastatic Lesion,Metastatic Bladder Squamous Cell Carcinoma
35181,Anaplasia,Metastatic Sarcomatoid Renal Cell Carcinoma
35182,Malignant Cellular Infiltrate,Metastatic Sarcomatoid Renal Cell Carcinoma
35183,Poorly Differentiated Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma
35184,Secondary Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma
35185,Epithelial Component Present,Metastatic Sarcomatoid Renal Cell Carcinoma
35186,Necrotic changes (finding),large cell neuroendocrine carcinoma of bladder
35187,Epithelial Component Present,large cell neuroendocrine carcinoma of bladder
35188,High Mitotic Activity,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
35189,Secondary Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
35190,Epithelial Component Present,Metastatic Bladder Large Cell Neuroendocrine Carcinoma
35191,Metastatic Lesion,Metastatic Bladder Small Cell Carcinoma
35192,Epithelial Component Present,Metastatic Prostate Small Cell Carcinoma
35193,Biphasic Pattern,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35194,Anaplasia,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35195,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35196,Mesenchymal Differentiation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant"
35197,Papillary Pattern,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
35198,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant"
35199,High Grade Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
35200,Metastatic Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells
35201,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant"
35202,Neuroendocrine Differentiation,Refractory Digestive System Neuroendocrine Neoplasm
35203,Recurrent disease,Recurrent Transformed B-cell Non-Hodgkin Lymphoma
35204,Carcinomatous Component Present,Refractory Endometrial Serous Adenocarcinoma
35205,Carcinomatous Component Present,Refractory Endometrial Clear Cell Adenocarcinoma
35206,Mixed Cellular Population,Refractory Uterine Corpus Carcinosarcoma
35207,Tissue of Mullerian Origin Present,Refractory Uterine Corpus Carcinosarcoma
35208,Carcinomatous Component Present,Bladder Non-Invasive Papillary Urothelial Carcinoma
35209,Malignant Cellular Infiltrate,Advanced Uterine Corpus Carcinosarcoma
35210,Mixed Cellular Population,Advanced Uterine Corpus Carcinosarcoma
35211,Refractory Disease,'Refractory Paraganglioma'
35212,Epithelial Component Present,Endometrioid adenocarcinoma recurrent
35213,Desmoplastic Stroma Formation,Recurrent Desmoplastic Small Round Cell Tumor
35214,Refractory Disease,Refractory Spindle Cell Sarcoma
35215,Recurrent disease,Endometrioid adenocarcinoma recurrent
35216,Epithelial Component Present,Endometrioid adenocarcinoma recurrent
35217,Metastatic Lesion,Metastatic Salivary Gland Carcinoma
35218,Metastatic Lesion,Locally Advanced Salivary Gland Carcinoma
35219,Carcinomatous Component Present,Locally Advanced Salivary Gland Carcinoma
35220,Platinum Sensitivity,Platinum-Sensitive Lung Small Cell Carcinoma
35221,Carcinomatous Component Present,Platinum-Sensitive Lung Small Cell Carcinoma
35222,Carcinomatous Component Present,Unresectable Bladder Urothelial Carcinoma
35223,Papillary Pattern,Seminal Vesicle Adenocarcinoma
35224,Infiltrative Growth Pattern,Collecting Duct Carcinoma of the Kidney
35225,Multilocular Lesion,Childhood Multilocular Cystic Renal Neoplasm
